PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Eickholt, BJ; Ahmed, AI; Davies, M; Papakonstanti, EA; Pearce, W; Starkey, ML; Bilando, A; Need, AC; Smith, AJH; Hall, SM; Hamers, FP; Giese, KP; Bradbury, EJ; Vanhaesebroeck, B				Eickholt, Britta J.; Ahmed, Aminul I.; Davies, Meirion; Papakonstanti, Evangelia A.; Pearce, Wayne; Starkey, Michelle L.; Bilando, Antonio; Need, Anna C.; Smith, Andrew J. H.; Hall, Susan M.; Hamers, Frank P.; Giese, Karl P.; Bradbury, Elizabeth J.; Vanhaesebroeck, Bart			Control of Axonal Growth and Regeneration of Sensory Neurons by the p110 delta PI 3-Kinase	PLOS ONE			English	Article								The expression and function of the 8 distinct catalytic isoforms of PI 3-kinase (P13K) in the nervous system are unknown. Whereas most P13Ks have a broad tissue distribution, the tyrosine kinase-linked p110 delta isoform has previously been shown to be enriched in leukocytes. Here we report that p110 delta is also highly expressed in the nervous system. Inactivation of p110 delta in mice did not affect gross neuronal development but led to an increased vulnerability of dorsal root ganglia neurons to exhibit growth cone collapse and decreases in axonal extension. Loss of p110 delta activity also dampened axonal regeneration following peripheral nerve injury in adult mice and impaired functional recovery of locomotion. p110 delta inactivation resulted in reduced neuronal signaling through the Akt protein kinase, and increased activity of the small GTPase RhoA. Pharmacological inhibition of ROCK, a downstream effector of RhoA, restored axonal extension defects in neurons with inactive p110 delta, suggesting a key role of RhoA in p110 delta signaling in neurons. Our data identify p110 delta as an important signaling component for efficient axonal elongation in the developing and regenerating nervous system.	[Eickholt, Britta J.; Ahmed, Aminul I.] Kings Coll London, MRC, Ctr Dev Neurobiol, London WC2R 2LS, England; [Davies, Meirion; Starkey, Michelle L.; Hall, Susan M.; Bradbury, Elizabeth J.] Kings Coll London, Neurorestorat Grp, Wolfson Ctr Age Related Dis, London WC2R 2LS, England; [Papakonstanti, Evangelia A.; Pearce, Wayne; Bilando, Antonio; Vanhaesebroeck, Bart] Ludwig Inst Canc Res, London W1P 8BT, England; [Need, Anna C.; Giese, Karl P.] Kings Coll London, Ctr Cellular Basis Behav, Inst Psychiat, London WC2R 2LS, England; [Smith, Andrew J. H.] Univ Edinburgh, Gene Targeting Lab, Inst Stem Cell Res, Edinburgh, Midlothian, Scotland; [Hamers, Frank P.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Vanhaesebroeck, Bart] UCL, Dept Biochem & Mol Biol, London, England	University of London; King's College London; University of London; King's College London; Ludwig Institute for Cancer Research; University of London; King's College London; University of Edinburgh; Utrecht University; Utrecht University Medical Center; University of London; University College London	Eickholt, BJ (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, London WC2R 2LS, England.	Britta.J.Eickholt@kcl.ac.uk	Eickholt, Britta/C-5337-2009; Giese, Karl P/A-3112-2011	Giese, Karl P/0000-0003-4503-7344; Ahmed, Aminul/0000-0001-6670-0438; Need, Anna/0000-0003-3955-8207; Bradbury, Elizabeth/0000-0003-4252-0234; BILANCIO, Antonio/0000-0002-5118-3359; Eickholt, Britta/0000-0001-7873-8687; Papakonstanti, Evangelia/0000-0002-7119-6026; Pearce, Wayne/0000-0001-5407-4767	MRC [G9900989, G0400983, G120/818] Funding Source: UKRI; Medical Research Council [G0300058B] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/C505659/1, BB/C505659/2] Funding Source: Medline; Medical Research Council [G0400983, G9900989, G120/818] Funding Source: Medline; Wellcome Trust [GR067121] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007; Atwal JK, 2003, J NEUROSCI, V23, P7602; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; BI L, 2002, EARLY EMBRYONIC LETH, V13, P169; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Chadborn NH, 2006, J CELL SCI, V119, P951, DOI 10.1242/jcs.02801; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Chantry D, 1997, J BIOL CHEM, V272, P19236, DOI 10.1074/jbc.272.31.19236; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Gross RE, 2007, CELL TRANSPLANT, V16, P245, DOI 10.3727/000000007783464740; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; HU P, 1993, MOL CELL BIOL, V13, P7677, DOI 10.1128/MCB.13.12.7677; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Ito Y, 2006, EMBO REP, V7, P704, DOI 10.1038/sj.embor.7400737; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Mills J, 2003, J NEUROSCI, V23, P1638; Need AC, 2003, GENES BRAIN BEHAV, V2, P132, DOI 10.1034/j.1601-183X.2003.00020.x; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Okkenhaug K, 2002, SCIENCE, V297, P1031; Papakonstanti EA, 2007, EMBO J, V26, P3050, DOI 10.1038/sj.emboj.7601763; Rodgers EE, 2002, INT J DEV NEUROSCI, V20, P187, DOI 10.1016/S0736-5748(02)00047-3; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Sawyer C, 2003, CANCER RES, V63, P1667; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vanhaesebroeck B, 1999, NAT CELL BIOL, V1, P69, DOI 10.1038/9045; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Vogelaar CF, 2004, BRAIN RES, V1027, P67, DOI 10.1016/j.brainres.2004.08.036; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	40	86	89	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e869	10.1371/journal.pone.0000869	http://dx.doi.org/10.1371/journal.pone.0000869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17846664	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000207455600016
J	Rolland, M; Nickle, DC; Deng, W; Frahm, N; Brander, C; Learn, GH; Heckerman, D; Jojic, N; Jojic, V; Walker, BD; Mullins, JI				Rolland, Morgane; Nickle, David C.; Deng, Wenjie; Frahm, Nicole; Brander, Christian; Learn, Gerald H.; Heckerman, David; Jojic, Nebosja; Jojic, Vladimir; Walker, Bruce D.; Mullins, James I.			Recognition of HIV-1 Peptides by Host CTL Is Related to HIV-1 Similarity to Human Proteins	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-LYMPHOCYTE RESPONSES; CELL RESPONSES; IMMUNODOMINANT REGIONS; EPITOPE; INFECTION; AUTOANTIBODIES; PATHOGENESIS; ANTIBODIES; HOMOLOGY	Background. While human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocytes preferentially target specific regions of the viral proteome, HIV-1 features that contribute to immune recognition are not well understood. One hypothesis is that similarities between HIV and human proteins influence the host immune response, i.e., resemblance between viral and host peptides could preclude reactivity against certain HIV epitopes. Methodology/Principal Findings. We analyzed the extent of similarity between HIV-1 and the human proteome. Proteins from the HIV-1 B consensus sequence from 2001 were dissected into overlapping k-mers, which were then probed against a non-redundant database of the human proteome in order to identify segments of high similarity. We tested the relationship between HIV-1 similarity to host encoded peptides and immune recognition in HIV-infected individuals, and found that HIV immunogenicity could be partially modulated by the sequence similarity to the host proteome. ELISpot responses to peptides spanning the entire viral proteome evaluated in 314 individuals showed a trend indicating an inverse relationship between the similarity to the host proteome and the frequency of recognition. In addition, analysis of responses by a group of 30 HIV-infected individuals against 944 overlapping peptides representing a broad range of individual HIV-1B Nef variants, affirmed that the degree of similarity to the host was significantly lower for peptides with reactive epitopes than for those that were not recognized. Conclusions/Significance. Our results suggest that antigenic motifs that are scarcely represented in human proteins might represent more immunogenic CTL targets not selected against in the host. This observation could provide guidance in the design of more effective HIV immunogens, as sequences devoid of host-like features might afford superior immune reactivity.	[Rolland, Morgane; Nickle, David C.; Deng, Wenjie; Learn, Gerald H.; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Frahm, Nicole; Brander, Christian; Walker, Bruce D.] Massachusetts Gen Hosp, Partners AIDS Res Ctr, Harvard Med Sch, Charlestown, MA USA; [Heckerman, David; Jojic, Nebosja; Jojic, Vladimir] Microsoft Res, Machine Learning & Appl Stat Grp, Redmond, WA USA	University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Microsoft	Mullins, JI (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	jmullins@u.washington.edu	Nickle, David/ABF-2727-2020; Learn, Gerald H/B-6934-2011; Learn, Jerry/E-3356-2012	Learn, Gerald H/0000-0003-0434-7733; Brander, Christian/0000-0002-0548-5778	Boeing Corporation; NIH [AI57005]; University of Washington Center for AIDS Research [AI27757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005, P30AI027757] Funding Source: NIH RePORTER	Boeing Corporation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a gift from the Boeing Corporation, and by grants from the NIH to JIM (AI57005) and from the University of Washington Center for AIDS Research (AI27757). The funding agencies had no role in the study.	Albini A, 1998, P NATL ACAD SCI USA, V95, P13153, DOI 10.1073/pnas.95.22.13153; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BERZOFSKY JA, 1987, IMMUNOL REV, V98, P9, DOI 10.1111/j.1600-065X.1987.tb00518.x; Bihl F, 2006, J IMMUNOL, V176, P4094, DOI 10.4049/jimmunol.176.7.4094; Bonnet F, 2003, J RHEUMATOL, V30, P2005; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; Chretien P, 2003, CLIN EXP RHEUMATOL, V21, P210; CORDIALI P, 1992, AIDS RES HUM RETROV, V8, P1561, DOI 10.1089/aid.1992.8.1561; DEKEYSER F, 1992, CLIN IMMUNOL IMMUNOP, V62, P285, DOI 10.1016/0090-1229(92)90104-V; DENG W, VIROBLAST BLAS UNPUB; DOHLMAN JG, 1993, BIOCHEM BIOPH RES CO, V195, P686, DOI 10.1006/bbrc.1993.2100; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; GOLDING H, 1989, J CLIN INVEST, V83, P1430, DOI 10.1172/JCI114034; GOLDING H, 1988, J EXP MED, V167, P914, DOI 10.1084/jem.167.3.914; GonzalezConejero R, 1996, BRIT J HAEMATOL, V93, P464, DOI 10.1046/j.1365-2141.1996.00502.x; Goulder PJR, 2000, J VIROL, V74, P5679, DOI 10.1128/JVI.74.12.5679-5690.2000; Goulder PJR, 1997, J EXP MED, V185, P1423, DOI 10.1084/jem.185.8.1423; HABESHAW J, 1992, IMMUNOL TODAY, V13, P207, DOI 10.1016/0167-5699(92)90155-Z; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Jiang X, 2006, SCAND J IMMUNOL, V63, P338, DOI 10.1111/j.1365-3083.2006.01748.x; Jin YM, 2005, PROTEINS, V61, P167, DOI 10.1002/prot.20734; Jones NA, 2004, J EXP MED, V200, P1243, DOI 10.1084/jem.20040511; KLEIN MR, 1995, J EXP MED, V181, P1365, DOI 10.1084/jem.181.4.1365; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LANZAVECCHIA A, 1995, J EXP MED, V181, P1945, DOI 10.1084/jem.181.6.1945; Letvin NL, 1999, IMMUNOL REV, V170, P127, DOI 10.1111/j.1600-065X.1999.tb01334.x; Lichterfeld M, 2005, TRENDS IMMUNOL, V26, P166, DOI 10.1016/j.it.2005.01.003; LOPALCO L, 1993, EUR J IMMUNOL, V23, P2016, DOI 10.1002/eji.1830230844; Lucchiari-Hartz M, 2003, P NATL ACAD SCI USA, V100, P7755, DOI 10.1073/pnas.1232228100; Maksyutov AZ, 2004, J CLIN VIROL, V31, pS26, DOI 10.1016/j.jcv.2004.09.007; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; McClure MA, 2005, GENOMICS, V85, P512, DOI 10.1016/j.ygeno.2004.12.006; Metzner KJ, 2000, J EXP MED, V191, P1921, DOI 10.1084/jem.191.11.1921; Meyer-Olson D, 2006, BLOOD, V107, P2373, DOI 10.1182/blood-2005-04-1636; Moudgil KD, 2005, TRENDS IMMUNOL, V26, P355, DOI 10.1016/j.it.2005.05.007; Murphy PM, 2001, NAT IMMUNOL, V2, P116, DOI 10.1038/84214; Musey L, 1997, NEW ENGL J MED, V337, P1267, DOI 10.1056/NEJM199710303371803; Novitsky V, 2002, J VIROL, V76, P10155, DOI 10.1128/JVI.76.20.10155-10168.2002; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Plotz PH, 2003, NAT REV IMMUNOL, V3, P73, DOI 10.1038/nri976; Quan V, 1999, IMMUNOGENETICS, V49, P957, DOI 10.1007/s002510050579; Rakowicz-Szulczynska EM, 1998, CANCER LETT, V124, P213, DOI 10.1016/S0304-3835(97)00483-7; REIHER WE, 1986, P NATL ACAD SCI USA, V83, P9188, DOI 10.1073/pnas.83.23.9188; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shojania S, 2006, J BIOL CHEM, V281, P8347, DOI 10.1074/jbc.M510748200; TALAL N, 1990, ARTHRITIS RHEUM, V33, P774, DOI 10.1002/art.1780330603; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002; Zhu H, 2005, J IMMUNOL, V175, P2252, DOI 10.4049/jimmunol.175.4.2252; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	58	22	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e823	10.1371/journal.pone.0000823	http://dx.doi.org/10.1371/journal.pone.0000823			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786195	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455500007
J	Ku, YX; Ohara, S; Wang, LP; Lenz, FA; Hsiao, SS; Bodner, M; Hong, B; Zhou, YD				Ku, Yixuan; Ohara, Shinji; Wang, Liping; Lenz, Fred A.; Hsiao, Steven S.; Bodner, Mark; Hong, Bo; Zhou, Yong-Di			Prefrontal Cortex and Somatosensory Cortex in Tactile Crossmodal Association: An Independent Component Analysis of ERP Recordings	PLOS ONE			English	Article								Our previous studies on scalp-recorded event-related potentials (ERPs) showed that somatosensory N140 evoked by a tactile vibration in working memory tasks was enhanced when human subjects expected a coming visual stimulus that had been paired with the tactile stimulus. The results suggested that such enhancement represented the cortical activities involved in tactile-visual crossmodal association. In the present study, we further hypothesized that the enhancement represented the neural activities in somatosensory and frontal cortices in the crossmodal association. By applying independent component analysis (ICA) to the ERP data, we found independent components (ICs) located in the medial prefrontal cortex (around the anterior cingulate cortex, ACC) and the primary somatosensory cortex (SI). The activity represented by the IC in SI cortex showed enhancement in expectation of the visual stimulus. Such differential activity thus suggested the participation of SI cortex in the task-related crossmodal association. Further, the coherence analysis and the Granger causality spectral analysis of the ICs showed that SI cortex appeared to cooperate with ACC in attention and perception of the tactile stimulus in crossmodal association. The results of our study support with new evidence an important idea in cortical neurophysiology: higher cognitive operations develop from the modality-specific sensory cortices (in the present study, SI cortex) that are involved in sensation and perception of various stimuli.	[Ku, Yixuan; Ohara, Shinji; Wang, Liping; Lenz, Fred A.; Bodner, Mark; Zhou, Yong-Di] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD 21218 USA; [Hsiao, Steven S.; Zhou, Yong-Di] Johns Hopkins Univ, Krieger Mind Brain Inst, Baltimore, MD USA; [Hsiao, Steven S.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD USA; [Hong, Bo] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Wang, Liping] E China Normal Univ, Inst Cognit Neurosci, Shanghai 200062, Peoples R China; [Bodner, Mark] Mus Intelligence Neural Dev Inst, Costa Mesa, CA USA; [Ku, Yixuan; Hong, Bo] Tsinghua Univ, Beijing 100084, Peoples R China	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; East China Normal University; Tsinghua University	Zhou, YD (corresponding author), Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD 21218 USA.	yzhou12@jhmi.edu	Zhou, Yongdi/GOH-3291-2022; Ku, Yixuan/D-4063-2018	Ku, Yixuan/0000-0003-2804-5123	NINDS [NS-38493, NS-40059]; Johns Hopkins Institution Fund; MIND Institute; East China Normal University; National Science Foundation of China [30630022]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040059, R56NS038493, R01NS038493] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Johns Hopkins Institution Fund; MIND Institute; East China Normal University; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS Grants NS-38493 and NS-40059 to FA Lenz, and by a Johns Hopkins Institution Fund to Y-D Zhou. This work was also supported by a research fund from MIND Institute, and a research fund from East China Normal University to Y-D Zhou. Y Ku and B Hong were partially supported by the National Science Foundation of China 30630022.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALLISON T, 1992, ELECTROEN CLIN NEURO, V84, P301, DOI 10.1016/0168-5597(92)90082-M; Asada H, 1999, NEUROSCI LETT, V274, P29, DOI 10.1016/S0304-3940(99)00679-5; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bodner M, 1997, J NEUROPHYSIOL, V77, P2219, DOI 10.1152/jn.1997.77.4.2219; Botvinick M, 2004, PSYCHOL REV, V111, P395, DOI 10.1037/0033-295X.111.2.395; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Crottaz-Herbette S, 2006, J COGNITIVE NEUROSCI, V18, P766, DOI 10.1162/jocn.2006.18.5.766; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Debener S, 2005, COGNITIVE BRAIN RES, V22, P309, DOI 10.1016/j.cogbrainres.2004.09.006; Driver J, 2000, CURR BIOL, V10, pR731, DOI 10.1016/S0960-9822(00)00740-5; Druschky K, 2003, EXP BRAIN RES, V148, P186, DOI 10.1007/s00221-002-1293-4; Eimer M, 2001, NEUROSCI BIOBEHAV R, V25, P497, DOI 10.1016/S0149-7634(01)00029-X; Eimer M, 2002, J COGNITIVE NEUROSCI, V14, P254, DOI 10.1162/089892902317236885; Eimer M, 2003, CLIN NEUROPHYSIOL, V114, P1298, DOI 10.1016/S1388-2457(03)00107-X; Eimer M, 2003, EXP BRAIN RES, V151, P24, DOI 10.1007/s00221-003-1437-1; Falchier A, 2002, J NEUROSCI, V22, P5749; Forster B, 2005, PSYCHOPHYSIOLOGY, V42, P171, DOI 10.1111/j.1469-8986.2005.00268.x; Frot M, 1999, CEREB CORTEX, V9, P854, DOI 10.1093/cercor/9.8.854; Frot M, 2001, PAIN, V94, P65, DOI 10.1016/S0304-3959(01)00342-6; Fu KMG, 2003, J NEUROSCI, V23, P7510; Fuster JM, 2004, TRENDS COGN SCI, V8, P143, DOI 10.1016/j.tics.2004.02.004; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; GARCIALARREA L, 1995, PSYCHOPHYSIOLOGY, V32, P526, DOI 10.1111/j.1469-8986.1995.tb01229.x; GEWEKE J, 1982, J AM STAT ASSOC, V77, P323, DOI 10.2307/2287243; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; Gross J, 2004, P NATL ACAD SCI USA, V101, P13050, DOI 10.1073/pnas.0404944101; HAMALAINEN H, 1990, ELECTROEN CLIN NEURO, V75, P13, DOI 10.1016/0013-4694(90)90148-D; Hari R, 1999, PHILOS T R SOC B, V354, P1145, DOI 10.1098/rstb.1999.0470; HARI R, 1993, EUR J NEUROSCI, V5, P724, DOI 10.1111/j.1460-9568.1993.tb00536.x; Harris JA, 2002, J NEUROSCI, V22, P8720; HSIAO SS, 1993, J NEUROPHYSIOL, V70, P444, DOI 10.1152/jn.1993.70.1.444; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Kekoni J, 1997, BIOL PSYCHOL, V46, P125, DOI 10.1016/S0301-0511(97)05249-6; Kekoni J, 1996, EVOKED POTENTIAL, V100, P115, DOI 10.1016/0013-4694(95)00231-6; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kida T, 2004, CLIN NEUROPHYSIOL, V115, P871, DOI 10.1016/j.clinph.2003.11.037; Kida T, 2006, NEUROIMAGE, V32, P1355, DOI 10.1016/j.neuroimage.2006.05.015; Kosslyn SM, 2001, NEUROREPORT, V12, P2519, DOI 10.1097/00001756-200108080-00046; Le Pera D, 2005, NEUROSCI RES, V52, P379, DOI 10.1016/j.neures.2005.05.001; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; Lutkenhoner B, 2002, NEUROIMAGE, V15, P509, DOI 10.1006/nimg.2001.0991; Luu P, 2003, BRAIN, V126, P2119, DOI 10.1093/brain/awg257; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makeig S, 1999, J NEUROSCI, V19, P2665; Makeig S, 2004, PLOS BIOL, V2, P747, DOI 10.1371/journal.pbio.0020176; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Makeig S, 1996, PSYCHOPHYSIOLOGY, V33, pS58; Meftah EM, 2002, J NEUROPHYSIOL, V88, P3133, DOI 10.1152/jn.00121.2002; Michelson A., 1887, PHILOS MAG, V24, P463, DOI [10.1080/14786448708628131, DOI 10.1080/14786448708628131]; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Ohara S, 2006, NEUROSCIENCE, V139, P299, DOI 10.1016/j.neuroscience.2005.05.058; Ohara S, 2006, NEUROSCIENCE, V138, P1387, DOI 10.1016/j.neuroscience.2005.12.005; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Onton J, 2006, NEUROSCI BIOBEHAV R, V30, P808, DOI 10.1016/j.neubiorev.2006.06.007; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Restuccia D, 2001, BRAIN, V124, P757, DOI 10.1093/brain/124.4.757; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Schaefer M, 2006, NEUROIMAGE, V29, P587, DOI 10.1016/j.neuroimage.2005.07.016; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Talairach J., 1988, COPLANAR STEREOTAXIC, P122; Tarkka IM, 1996, NEUROSCIENCE, V75, P275, DOI 10.1016/0306-4522(96)00287-4; Taylor-Clarke M, 2004, NEUROSCI LETT, V354, P22, DOI 10.1016/j.neulet.2003.09.068; Taylor-Clarke M, 2002, CURR BIOL, V12, P233, DOI 10.1016/S0960-9822(01)00681-9; Tsujimoto T, 2006, J NEUROPHYSIOL, V95, P2987, DOI 10.1152/jn.00730.2005; Valeriani M, 2001, MUSCLE NERVE, V24, P1677, DOI 10.1002/mus.1203; Waberski TD, 2002, NEUROIMAGE, V17, P1347, DOI 10.1006/nimg.2002.1222; Zhou YD, 1997, EXP BRAIN RES, V116, P551, DOI 10.1007/PL00005783; Zhou YD, 2000, P NATL ACAD SCI USA, V97, P9777, DOI 10.1073/pnas.97.17.9777; Zhou YD, 2004, BEHAV BRAIN RES, V153, P573, DOI 10.1016/j.bbr.2003.12.024; Zhou YD, 1996, P NATL ACAD SCI USA, V93, P10533, DOI 10.1073/pnas.93.19.10533; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	78	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e771	10.1371/journal.pone.0000771	http://dx.doi.org/10.1371/journal.pone.0000771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712419	Green Published, gold			2022-12-27	WOS:000207455300019
J	Yeo, ZX; Wong, ST; Arjunan, SNV; Piras, V; Tomita, M; Selvarajoo, K; Giuliani, A; Tsuchiya, M				Yeo, Zhen Xuan; Wong, Sum Thai; Arjunan, Satya Nanda Vel; Piras, Vincent; Tomita, Masaru; Selvarajoo, Kumar; Giuliani, Alessandro; Tsuchiya, Masa			Sequential Logic Model Deciphers Dynamic Transcriptional Control of Gene Expressions	PLOS ONE			English	Article							CIS-REGULATORY LOGIC; NETWORK MOTIFS; ENDO16 GENE; ORGANIZATION; HYSTERESIS; NUMBERS	Background. Cellular signaling involves a sequence of events from ligand binding to membrane receptors through transcription factors activation and the induction of mRNA expression. The transcriptional-regulatory system plays a pivotal role in the control of gene expression. A novel computational approach to the study of gene regulation circuits is presented here. Methodology. Based on the concept of finite state machine, which provides a discrete view of gene regulation, a novel sequential logic model (SLM) is developed to decipher control mechanisms of dynamic transcriptional regulation of gene expressions. The SLM technique is also used to systematically analyze the dynamic function of transcriptional inputs, the dependency and cooperativity, such as synergy effect, among the binding sites with respect to when, how much and how fast the gene of interest is expressed. Principal Findings. SLM is verified by a set of well studied expression data on endo16 of Strongylocentrotus purpuratus ( sea urchin) during the embryonic midgut development. A dynamic regulatory mechanism for endo16 expression controlled by three binding sites, UI, R and Otx is identified and demonstrated to be consistent with experimental findings. Furthermore, we show that during transition from specification to differentiation in wild type endo16 expression profile, SLM reveals three binary activities are not sufficient to explain the transcriptional regulation of endo16 expression and additional activities of binding sites are required. Further analyses suggest detailed mechanism of R switch activity where indirect dependency occurs in between UI activity and R switch during specification to differentiation stage. Conclusions/Significance. The sequential logic formalism allows for a simplification of regulation network dynamics going from a continuous to a discrete representation of gene activation in time. In effect our SLM is non-parametric and model-independent, yet providing rich biological insight. The demonstration of the efficacy of this approach in endo16 is a promising step for further application of the proposed method.	[Arjunan, Satya Nanda Vel; Piras, Vincent; Tomita, Masaru; Selvarajoo, Kumar; Tsuchiya, Masa] Keio Univ, Inst Adv Biosci, Yamagata, Japan; [Yeo, Zhen Xuan] Genome Inst Singapore, Singapore, Singapore; [Wong, Sum Thai] Bioinformat Inst, Singapore, Singapore; [Giuliani, Alessandro] Inst Super Sanita, Dept Environm & Hlth, Rome, Italy	Keio University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Istituto Superiore di Sanita (ISS)	Tsuchiya, M (corresponding author), Keio Univ, Inst Adv Biosci, Yamagata, Japan.	tsuchiya@ttck.keio.ac.jp	Arjunan, Satya/AAL-2433-2020; Arjunan, Satya N. V./B-3441-2008; Giuliani, Alessandro/AAF-1740-2020; Giuliani, Alessandro/K-7589-2016; Piras, Vincent/K-3203-2012	Arjunan, Satya/0000-0002-2913-3347; Arjunan, Satya N. V./0000-0002-2913-3347; Giuliani, Alessandro/0000-0002-4640-804X; Giuliani, Alessandro/0000-0002-4640-804X; Piras, Vincent/0000-0002-3427-0995; Selvarajoo, Kumar/0000-0002-0314-9666	Agency for Science, Technology and Research of Singapore (A* STAR); Japan Science and Technology Agency/Core Research for Evolutional Science and Technology (JST CREST); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Yamagata Prefecture and Tsuruoka City, Japan	Agency for Science, Technology and Research of Singapore (A* STAR)(Agency for Science Technology & Research (A*STAR)); Japan Science and Technology Agency/Core Research for Evolutional Science and Technology (JST CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamagata Prefecture and Tsuruoka City, Japan	This work was supported by the Agency for Science, Technology and Research of Singapore (A* STAR), Japan Science and Technology Agency/ Core Research for Evolutional Science and Technology (JST CREST), Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), and Research fund by Yamagata Prefecture and Tsuruoka City, Japan.	Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Barrett CL, 2005, P NATL ACAD SCI USA, V102, P19103, DOI 10.1073/pnas.0505231102; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Blasi MF, 2005, PHYSICA A, V348, P349, DOI 10.1016/j.physa.2004.09.005; Bolouri H, 2003, P NATL ACAD SCI USA, V100, P9371, DOI 10.1073/pnas.1533293100; Bolouri H, 2002, DEV BIOL, V246, P2, DOI 10.1006/dbio.2002.0617; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; DICAMILLO B, 2005, BMC BIOINFORMATIC S4, V1, pS44; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Giuliani A, 1996, BIOL CYBERN, V74, P181, DOI 10.1007/BF00204206; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Istrail S, 2005, P NATL ACAD SCI USA, V102, P4954, DOI 10.1073/pnas.0409624102; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; MANO MM, 2001, DIGITAL DESIGN, P516; Martin S, 2007, BIOINFORMATICS, V23, P866, DOI 10.1093/bioinformatics/btm021; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Ruklisa Dace, 2005, Genome Inform, V16, P225; Setty Y, 2003, P NATL ACAD SCI USA, V100, P7702, DOI 10.1073/pnas.1230759100; Soinov LA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r6; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; Tamada Y, 2003, BIOINFORMATICS, V19, pII227, DOI 10.1093/bioinformatics/btg1082; Wolf DM, 1998, J THEOR BIOL, V195, P167, DOI 10.1006/jtbi.1998.0790; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896; Yuh CH, 1996, DEVELOPMENT, V122, P1069; Yuh CH, 2004, DEV BIOL, V269, P536, DOI 10.1016/j.ydbio.2004.02.025; Yuh CH, 2005, DEV BIOL, V281, P286, DOI 10.1016/j.ydbio.2005.02.034; Yuh CH, 2001, DEVELOPMENT, V128, P617; Yuh CH, 1996, DEVELOPMENT, V122, P4045	40	7	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e776	10.1371/journal.pone.0000776	http://dx.doi.org/10.1371/journal.pone.0000776			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712424	Green Published, gold			2022-12-27	WOS:000207455300024
J	Chang, EJ; Begum, R; Chait, BT; Gaasterland, T				Chang, Emmanuel J.; Begum, Rashida; Chait, Brian T.; Gaasterland, Terry			Prediction of Cyclin-Dependent Kinase Phosphorylation Substrates	PLOS ONE			English	Article							CDC28 PROTEIN-KINASE; HIDDEN MARKOV-MODELS; YEAST-CELL CYCLE; MASS-SPECTROMETRY; BUDDING YEAST; MULTISITE PHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; STRUCTURAL BASIS; DNA-REPLICATION	Protein phosphorylation, mediated by a family of enzymes called cyclin-dependent kinases (Cdks), plays a central role in the cell-division cycle of eukaryotes. Phosphorylation by Cdks directs the cell cycle by modifying the function of regulators of key processes such as DNA replication and mitotic progression. Here, we present a novel computational procedure to predict substrates of the cyclin-dependent kinase Cdc28 (Cdk1) in the Saccharomyces cerevisiae. Currently, most computational phosphorylation site prediction procedures focus solely on local sequence characteristics. In the present procedure, we model Cdk substrates based on both local and global characteristics of the substrates. Thus, we define the local sequence motifs that represent the Cdc28 phosphorylation sites and subsequently model clustering of these motifs within the protein sequences. This restraint reflects the observation that many known Cdk substrates contain multiple clustered phosphorylation sites. The present strategy defines a subset of the proteome that is highly enriched for Cdk substrates, as validated by comparing it to a set of bona fide, published, experimentally characterized Cdk substrates which was to our knowledge, comprehensive at the time of writing. To corroborate our model, we compared its predictions with three experimentally independent Cdk proteomic datasets and found significant overlap. Finally, we directly detected in vivo phosphorylation at Cdk motifs for selected putative substrates using mass spectrometry.	[Chang, Emmanuel J.; Begum, Rashida] CUNY York Coll, Dept Chem, Jamaica, NY 11451 USA; [Chang, Emmanuel J.; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA; [Gaasterland, Terry] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	City University of New York (CUNY) System; York College NY (CUNY); Rockefeller University; University of California System; University of California San Diego; Scripps Institution of Oceanography	Chang, EJ (corresponding author), CUNY York Coll, Dept Chem, Jamaica, NY 11451 USA.	echang@york.cuny.edu			Burroughs-Wellcome Interfaces in Science; State of New York; National Institutes of Health [RR00862]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER	Burroughs-Wellcome Interfaces in Science(Burroughs Wellcome Fund); State of New York; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	EJC was supported in part by a Burroughs-Wellcome Interfaces in Science fellowship, and a Graduate Research Technology Initiative grant from the State of New York. BTC acknowledges support from the National Institutes of Health (Grant RR00862).	Agarwal R, 2002, GENE DEV, V16, P1371, DOI 10.1101/gad.971402; Andrews B, 1998, TRENDS GENET, V14, P66, DOI 10.1016/S0168-9525(97)01322-X; Archambault V, 2004, MOL CELL, V14, P699, DOI 10.1016/j.molcel.2004.05.025; Aubol BE, 2002, BIOCHEMISTRY-US, V41, P10002, DOI 10.1021/bi020233y; Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2241, DOI 10.1093/nar/19.suppl.2241; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Brinkworth RI, 2003, P NATL ACAD SCI USA, V100, P74, DOI 10.1073/pnas.0134224100; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Chang EJ, 2004, ANAL CHEM, V76, P4472, DOI 10.1021/ac049637h; Chen SL, 2002, MOL CELL PROTEOMICS, V1, P186, DOI 10.1074/mcp.M100032-MCP200; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; CROSS FR, 1995, CURR OPIN CELL BIOL, V7, P790, DOI 10.1016/0955-0674(95)80062-X; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Doolin MT, 2001, MOL MICROBIOL, V40, P422, DOI 10.1046/j.1365-2958.2001.02388.x; ELASSER S, 1996, MOL BIOL CELL, V7, P1723; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; FLOTOW H, 1991, J BIOL CHEM, V266, P3724; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Gartner A, 1998, MOL CELL BIOL, V18, P3681, DOI 10.1128/MCB.18.7.3681; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Henchoz S, 1997, GENE DEV, V11, P3046, DOI 10.1101/gad.11.22.3046; Ho W, 1999, MOL CELL BIOL, V19, P5267; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hollunder J, 2005, PROTEOMICS, V5, P2082, DOI 10.1002/pmic.200401121; Holmes JK, 1996, J BIOL CHEM, V271, P25240, DOI 10.1074/jbc.271.41.25240; Holmes JK, 2001, EUR J BIOCHEM, V268, P4647, DOI 10.1046/j.1432-1327.2001.02392.x; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Huang HD, 2005, J COMPUT CHEM, V26, P1032, DOI 10.1002/jcc.20235; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; JEFFERY D, 2001, J MOL BIOL, V306; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Jones D T, 2001, Brief Bioinform, V2, P111, DOI 10.1093/bib/2.2.111; Kalkum M, 2003, P NATL ACAD SCI USA, V100, P2795, DOI 10.1073/pnas.0436605100; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; McBride HJ, 1999, J BIOL CHEM, V274, P21029, DOI 10.1074/jbc.274.30.21029; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Moses AM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r23; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nasmyth K, 1993, CURR OPIN CELL BIOL, V5, P166, DOI 10.1016/0955-0674(93)90099-C; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Nigg Erich A., 1993, Trends in Cell Biology, V3, P296, DOI 10.1016/0962-8924(93)90011-O; Nishizawa M, 1998, MOL BIOL CELL, V9, P2393, DOI 10.1091/mbc.9.9.2393; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Reynolds D, 2003, GENE DEV, V17, P1789, DOI 10.1101/gad.1074103; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Senawongse P, 2005, J CHEM INF MODEL, V45, P1147, DOI 10.1021/ci050047+; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Takeda DY, 2001, J BIOL CHEM, V276, P1993, DOI 10.1074/jbc.M005719200; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Velazquez-Dones A, 2005, J BIOL CHEM, V280, P41761, DOI 10.1074/jbc.M504156200; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Wu CH, 1997, COMPUT CHEM, V21, P237, DOI 10.1016/S0097-8485(96)00038-1; Wu CL, 1998, J BIOL CHEM, V273, P28107, DOI 10.1074/jbc.273.43.28107; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	67	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e656	10.1371/journal.pone.0000656	http://dx.doi.org/10.1371/journal.pone.0000656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668044	Green Published, gold			2022-12-27	WOS:000207452300002
J	Waltari, E; Hijmans, RJ; Peterson, AT; Nyari, AS; Perkins, SL; Guralnick, RP				Waltari, Eric; Hijmans, Robert J.; Peterson, A. Townsend; Nyari, Arpad S.; Perkins, Susan L.; Guralnick, Robert P.			Locating Pleistocene Refugia: Comparing Phylogeographic and Ecological Niche Model Predictions	PLOS ONE			English	Article							MITOCHONDRIAL-DNA PHYLOGEOGRAPHY; CLIMATE-CHANGE; SPECIES DISTRIBUTIONS; MOLECULAR PHYLOGEOGRAPHY; BIODIVERSITY INFORMATION; GENETIC CONSEQUENCES; EXTINCTION RISK; SPECIATION; CONSERVATISM; RANGE	Ecological niche models (ENMs) provide a means of characterizing the spatial distribution of suitable conditions for species, and have recently been applied to the challenge of locating potential distributional areas at the Last Glacial Maximum (LGM) when unfavorable climate conditions led to range contractions and fragmentation. Here, we compare and contrast ENM-based reconstructions of LGM refugial locations with those resulting from the more traditional molecular genetic and phylogeographic predictions. We examined 20 North American terrestrial vertebrate species from different regions and with different range sizes for which refugia have been identified based on phylogeographic analyses, using ENM tools to make parallel predictions. We then assessed the correspondence between the two approaches based on spatial overlap and areal extent of the predicted refugia. In 14 of the 20 species, the predictions from ENM and predictions based on phylogeographic studies were significantly spatially correlated, suggesting that the two approaches to development of refugial maps are converging on a similar result. Our results confirm that ENM scenario exploration can provide a useful complement to molecular studies, offering a less subjective, spatially explicit hypothesis of past geographic patterns of distribution.	[Waltari, Eric; Perkins, Susan L.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Hijmans, Robert J.] Int Rice Res Inst, Los Banos, Laguna, Philippines; [Peterson, A. Townsend; Nyari, Arpad S.] Univ Kansas, Museum Nat Hist, Lawrence, KS 66045 USA; [Peterson, A. Townsend; Nyari, Arpad S.] Univ Kansas, Biodivers Res Ctr, Lawrence, KS 66045 USA; [Guralnick, Robert P.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Guralnick, Robert P.] Univ Colorado, Univ Colorado Museum, Boulder, CO 80309 USA	American Museum of Natural History (AMNH); CGIAR; International Rice Research Institute (IRRI); University of Kansas; University of Kansas; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Waltari, E (corresponding author), Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA.	ewaltari@amnh.org	Guralnick, Rob/E-7767-2010; Hijmans, Robert/N-3299-2016; Peterson, A. Townsend/I-5697-2013; Perkins, Susan/D-3408-2018	Peterson, A. Townsend/0000-0003-0243-2379; Hijmans, Robert/0000-0001-5872-2872; Waltari, Eric/0000-0001-6930-9645; Perkins, Susan/0000-0002-5400-5662	U.S. Army Research Laboratory; U.S. Army Research Office [W911NF-05-1-0271.]	U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); U.S. Army Research Office	This research is based upon work supported by, or in part by, the U.S. Army Research Laboratory and the U.S. Army Research Office under grant number W911NF-05-1-0271.	Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Arbogast BS, 1999, J MAMMAL, V80, P142, DOI 10.2307/1383215; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Barrowclough GF, 2004, MOL ECOL, V13, P1911, DOI 10.1111/j.1365-294X.2004.02215.x; Brant SV, 2003, MOL ECOL, V12, P1435, DOI 10.1046/j.1365-294X.2003.01789.x; Brant SV, 2002, MOL PHYLOGENET EVOL, V22, P163, DOI 10.1006/mpev.2001.1057; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; Burns KJ, 2006, MOL PHYLOGENET EVOL, V38, P117, DOI 10.1016/j.ympev.2005.07.008; Canhos V.P., 2004, Biodiversity Informatics, V1, P1; Carstens BC, 2004, SYST BIOL, V53, P781, DOI 10.1080/10635150490522296; Carstens BC, 2007, EVOLUTION, V61, P1439, DOI 10.1111/j.1558-5646.2007.00117.x; Castoe TA, 2007, MOL PHYLOGENET EVOL, V42, P193, DOI 10.1016/j.ympev.2006.07.002; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Cook JA, 2004, MOL PHYLOGENET EVOL, V30, P767, DOI 10.1016/S1055-7903(03)00248-3; Crespi EJ, 2003, MOL ECOL, V12, P969, DOI 10.1046/j.1365-294X.2003.01797.x; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Edwards JL, 2000, SCIENCE, V289, P2312, DOI 10.1126/science.289.5488.2312; Edwards SV, 2000, EVOLUTION, V54, P1839; Fedorov VB, 2002, P ROY SOC B-BIOL SCI, V269, P2071, DOI 10.1098/rspb.2002.2126; Fink S, 2004, MOL ECOL, V13, P3501, DOI 10.1111/j.1365-294X.2004.02351.x; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Graham RW, 1996, SCIENCE, V272, P1601; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guralnick RP, 2006, PLOS BIOL, V4, P1908, DOI 10.1371/journal.pbio.0040381; Hasumi H., 2004, K 1 COUPLED MODEL MI, P34; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hoffman R.S., 1981, P25; Holt RD, 1996, EVOL ECOL, V10, P1, DOI 10.1007/BF01239342; Hopkins D. M., 1982, PALEOECOLOGY BERINGI; Howes BJ, 2006, MOL PHYLOGENET EVOL, V40, P183, DOI 10.1016/j.ympev.2006.03.008; Hugall A, 2002, P NATL ACAD SCI USA, V99, P6112, DOI 10.1073/pnas.092538699; Jackson ST, 2000, QUATERNARY SCI REV, V19, P489, DOI 10.1016/S0277-3791(99)00093-1; Jakob SS, 2007, MOL ECOL, V16, P1713, DOI 10.1111/j.1365-294X.2007.03228.x; Kidd DM, 2006, J BIOGEOGR, V33, P1851, DOI 10.1111/j.1365-2699.2006.01574.x; Knouft JH, 2006, ECOLOGY, V87, pS29, DOI 10.1890/0012-9658(2006)87[29:PAOTEO]2.0.CO;2; Marsh DM, 2004, ECOLOGY, V85, P3396, DOI 10.1890/03-0713; Martinez-Meyer E, 2006, J BIOGEOGR, V33, P1779, DOI [10.1111/j.1365-2699.2006.01612.x, 10.1111/j.1365-2699.2006.01482_33_10.x]; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; MARTINEZMEYER E, 2002, THESIS U KANSAS LAWR; Miller GH, 2002, QUATERNARY SCI REV, V21, P33, DOI 10.1016/S0277-3791(01)00085-3; Miller MP, 2006, MOL ECOL, V15, P145, DOI 10.1111/j.1365-294X.2005.02765.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2004, DIVERS DISTRIB, V10, P237, DOI 10.1111/j.1366-9516.2004.00097.x; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; PETERSON AT, 2005, CLIMATE CHANGE BIODI, P211; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; PIELOU EC, 1991, ICE AGE RETURN LIFE; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Ray N, 2001, INTERNET ARCHAEOLOGY, V11; Rodriguez-Robles JA, 1999, MOL ECOL, V8, P1923, DOI 10.1046/j.1365-294x.1999.00793.x; Ruegg KC, 2006, J BIOGEOGR, V33, P1172, DOI 10.1111/j.1365-2699.2006.01517.x; Runck AM, 2005, MOL ECOL, V14, P1445, DOI 10.1111/j.1365-294X.2005.02501.x; Soberon J, 1999, TRENDS ECOL EVOL, V14, P291, DOI 10.1016/S0169-5347(99)01617-1; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Sommer RS, 2006, MAMMAL REV, V36, P251, DOI 10.1111/j.1365-2907.2006.00093.x; Spellman GM, 2007, MOL ECOL, V16, P1055, DOI 10.1111/j.1365-294X.2007.03199.x; Steele CA, 2006, MOL ECOL, V15, P2477, DOI 10.1111/j.1365-294X.2006.02950.x; Stein Barbara R., 2004, Biodiversity Informatics, V1, P14; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Stone KD, 2002, MOL ECOL, V11, P2049, DOI 10.1046/j.1365-294X.2002.01596.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; WAKELEY J, 2006, COALESCENT THEORY, P220; Waltari E, 2005, MOL ECOL, V14, P3005, DOI 10.1111/j.1365-294X.2005.02625.x; Weisrock DW, 2000, MOL PHYLOGENET EVOL, V14, P152, DOI 10.1006/mpev.1999.0689; WELLS PV, 1983, ECOL MONOGR, V53, P341, DOI 10.2307/1942644; Wieczorek J, 2004, INT J GEOGR INF SCI, V18, P745, DOI 10.1080/13658810412331280211; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Yesson C, 2006, SYST BIOL, V55, P785, DOI 10.1080/1063515060081570; Zamudio KR, 2003, EVOLUTION, V57, P1631; Zink RM, 2000, CONSERV BIOL, V14, P1394, DOI 10.1046/j.1523-1739.2000.99082.x	85	418	430	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2007	2	7							e563	10.1371/journal.pone.0000563	http://dx.doi.org/10.1371/journal.pone.0000563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GH	17622339	Green Published, gold			2022-12-27	WOS:000207452000001
J	Badr, CE; Hewett, JW; Breakefield, XO; Tannous, BA				Badr, Christian E.; Hewett, Jeffrey W.; Breakefield, Xandra O.; Tannous, Bakhos A.			A Highly Sensitive Assay for Monitoring the Secretory Pathway and ER Stress	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSGENIC MOUSE MODEL; QUANTITATIVE MEASUREMENT; ALKALINE-PHOSPHATASE; GENE-EXPRESSION; QUALITY-CONTROL; PROTEIN; LUCIFERASE; GOLGI; CELLS	Background. The secretory pathway is a critical index of the capacity of cells to incorporate proteins into cellular membranes and secrete proteins into the extracellular space. Importantly it is disrupted in response to stress to the endoplasmic reticulum that can be induced by a variety of factors, including expression of mutant proteins and physiologic stress. Activation of the ER stress response is critical in the etiology of a number of diseases, such as diabetes and neurodegeneration, as well as cancer. We have developed a highly sensitive assay to monitor processing of proteins through the secretory pathway and endoplasmic reticulum ( ER) stress in real-time based on the naturally secreted Gaussia luciferase ( Gluc). Methodology/Principle Findings. An expression cassette for Gluc was delivered to cells, and its secretion was monitored by measuring luciferase activity in the conditioned medium. Gluc secretion was decreased down to 90% when these cells were treated with drugs that interfere with the secretory pathway at different steps. Fusing Gluc to a fluorescent protein allowed quantitation and visualization of the secretory pathway in real-time. Expression of this reporter protein did not itself elicit an ER stress response in cells; however, Gluc proved very sensitive at sensing this type of stress, which is associated with a temporary decrease in processing of proteins through the secretory pathway. The Gluc secretion assay was over 20,000-fold more sensitive as compared to the secreted alkaline phosphatase (SEAP), a well established assay for monitoring of protein processing and ER stress in mammalian cells. Conclusions/Significance. The Gluc assay provides a fast, quantitative and sensitive technique to monitor the secretory pathway and ER stress and its compatibility with high throughput screening will allow discovery of drugs for treatment of conditions in which the ER stress is generally induced.	[Badr, Christian E.; Hewett, Jeffrey W.; Breakefield, Xandra O.; Tannous, Bakhos A.] Massachusetts Gen Hosp, Dept Neurol, Mol Neurogenet Unit, Boston, MA 02114 USA; [Breakefield, Xandra O.; Tannous, Bakhos A.] Massachusetts Gen Hosp, Dept Radiol, Ctr Mol Imaging Res, Boston, MA 02114 USA; [Badr, Christian E.; Breakefield, Xandra O.; Tannous, Bakhos A.] Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Tannous, BA (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Mol Neurogenet Unit, Boston, MA 02114 USA.	btannous@hms.harvard.edu	badr, christian/AAX-1192-2020		NARSAD; Bachmann-Strauss Foundation; NINDS [5P01 NS037409, P30NS4577-05]; NIH [P50 CA86355-04, NS45776]; Brain Tumor Society; NATIONAL CANCER INSTITUTE [P50CA086355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045776, P01NS037409] Funding Source: NIH RePORTER	NARSAD(NARSAD); Bachmann-Strauss Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Tumor Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from NARSAD, Bachmann-Strauss Foundation, NINDS (5P01 NS037409 and P30NS4577-05), NIH (P50 CA86355-04 and NS45776) and Brain Tumor Society.	BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; BERTRAND F, 1994, AM J PHYSIOL, V266, pC611, DOI 10.1152/ajpcell.1994.266.3.C611; BREAKEFIELD XO, 1981, J NEUROSCI RES, V6, P349, DOI 10.1002/jnr.490060310; DESILVA AM, 1990, J CELL BIOL, V111, P857, DOI 10.1083/jcb.111.3.857; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; FORER A, 1972, SCIENCE, V175, P774, DOI 10.1126/science.175.4023.774; HEWETT JW, P NATL ACAD IN PRESS; Hiramatsu N, 2005, ANAL BIOCHEM, V339, P249, DOI 10.1016/j.ab.2005.01.023; Hiramatsu N, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl515; Hirota Morihiko, 2006, Journal of Toxicological Sciences, V31, P149, DOI 10.2131/jts.31.149; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Li F, 2005, BRAIN RES, V1048, P59, DOI 10.1016/j.brainres.2005.04.058; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Mao CH, 2004, NAT MED, V10, P1013, DOI 10.1038/nm1004-1013; Markova SV, 2004, J BIOL CHEM, V279, P3212, DOI 10.1074/jbc.M309639200; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; ROGALSKI AA, 1984, J CELL BIOL, V99, P1092, DOI 10.1083/jcb.99.3.1092; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Shang J, 2005, METHODS, V35, P390, DOI 10.1016/j.ymeth.2004.10.012; Stevens FJ, 1999, IMMUNOL TODAY, V20, P451, DOI 10.1016/S0167-5699(99)01502-9; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; TARTAKOFF A, 1978, J CELL BIOL, V79, P694, DOI 10.1083/jcb.79.3.694; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005	30	102	108	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e571	10.1371/journal.pone.0000571	http://dx.doi.org/10.1371/journal.pone.0000571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593970	Green Published, gold, Green Submitted			2022-12-27	WOS:000207451800015
J	Gosden, TP; Svensson, EI				Gosden, Thomas P.; Svensson, Erik I.			Female Sexual Polymorphism and Fecundity Consequences of Male Mating Harassment in the Wild	PLOS ONE			English	Article								Genetic and phenotypic variation in female response towards male mating attempts has been found in several laboratory studies, demonstrating sexually antagonistic co-evolution driven by mating costs on female fitness. Theoretical models suggest that the type and degree of genetic variation in female resistance could affect the evolutionary outcome of sexually antagonistic mating interactions, resulting in either rapid development of reproductive isolation and speciation or genetic clustering and female sexual polymorphisms. However, evidence for genetic variation of this kind in natural populations of non-model organisms is very limited. Likewise, we lack knowledge on female fecundity-consequences of matings and the degree of male mating harassment in natural settings. Here we present such data from natural populations of a colour polymorphic damselfly. Using a novel experimental technique of colour dusting males in the field, we show that heritable female colour morphs differ in their propensity to accept male mating attempts. These morphs also differ in their degree of resistance towards male mating attempts, the number of realized matings and in their fecundity-tolerance to matings and mating attempts. These results show that there may be genetic variation in both resistance and tolerance to male mating attempts ( fitness consequences of matings) in natural populations, similar to the situation in plant-pathogen resistance systems. Male mating harassment could promote the maintenance of a sexual mating polymorphism in females, one of few empirical examples of sympatric genetic clusters maintained by sexual conflict.	[Gosden, Thomas P.; Svensson, Erik I.] Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden	Lund University	Gosden, TP (corresponding author), Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden.	Thomas.Gosden@zooekol.lu.se	Gosden, Thomas/F-2154-2010; Svensson, Erik/E-8324-2010	Gosden, Thomas/0000-0002-5175-0405; Svensson, Erik/0000-0001-9006-016X	Swedish Research Council; The Swedish council for Environment, Agriculture and Spatial Planning (FORMAS); Oscar & Lilli Lamm Stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); The Swedish council for Environment, Agriculture and Spatial Planning (FORMAS)(Swedish Research Council Formas); Oscar & Lilli Lamm Stiftelse	This study was financially supported by grants from the Swedish Research Council (VR), The Swedish council for Environment, Agriculture and Spatial Planning (FORMAS) and Oscar & Lilli Lamm Stiftelse awarded to E. I. S.	Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; ARNQVIST G, 1992, ANIM BEHAV, V43, P559, DOI 10.1016/S0003-3472(05)81016-4; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Cooper G, 1996, P ROY SOC B-BIOL SCI, V263, P1343, DOI 10.1098/rspb.1996.0197; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Crudgington HS, 2005, AM NAT, V165, pS72, DOI 10.1086/429353; Crudgington HS, 2000, NATURE, V407, P855, DOI 10.1038/35038154; Eberhard WG, 2004, EVOLUTION, V58, P1947; Fincke OM, 2004, ANIM BEHAV, V67, P833, DOI 10.1016/j.anbehav.2003.04.017; Gavrilets S, 2000, NATURE, V407, P150, DOI 10.1038/35025140; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Gavrilets S, 2002, P NATL ACAD SCI USA, V99, P10533, DOI 10.1073/pnas.152011499; Hardling R, 2006, AM NAT, V167, P401, DOI 10.1086/498946; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Joron M, 2003, NATURE, V424, P191, DOI 10.1038/nature01713; Lew TA, 2006, EVOLUTION, V60, P97; Linder JE, 2005, J EVOLUTION BIOL, V18, P568, DOI 10.1111/j.1420-9101.2004.00872.x; Martin OY, 2003, NATURE, V423, P979, DOI 10.1038/nature01752; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; Reinhardt K, 2003, P ROY SOC B-BIOL SCI, V270, P2371, DOI 10.1098/rspb.2003.2515; Restif O, 2004, AM NAT, V164, pE90, DOI 10.1086/423713; Rice WR, 2006, PHILOS T R SOC B, V361, P287, DOI 10.1098/rstb.2005.1787; Rice WR, 1997, BEHAV ECOL SOCIOBIOL, V41, P1, DOI 10.1007/s002650050357; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; ROBERTSON HM, 1985, ANIM BEHAV, V33, P805, DOI 10.1016/S0003-3472(85)80013-0; Sakaluk SK, 2006, AM NAT, V167, P94, DOI 10.1086/498279; Sanchez-Guillen RA, 2005, BIOL J LINN SOC, V85, P471, DOI 10.1111/j.1095-8312.2005.00506.x; SCHLUTER D, 1988, EVOLUTION, V42, P849, DOI [10.2307/2408904, 10.1111/j.1558-5646.1988.tb02507.x]; *STATS, 2003, STATISTICA DAT AN SO; Stutt AD, 2001, P NATL ACAD SCI USA, V98, P5683, DOI 10.1073/pnas.101440698; Svensson EI, 2005, J EVOLUTION BIOL, V18, P1503, DOI 10.1111/j.1420-9101.2005.00946.x; Svensson EI, 2005, AM NAT, V165, P567, DOI 10.1086/429278; Wigby S, 2004, EVOLUTION, V58, P1028	35	70	71	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e580	10.1371/journal.pone.0000580	http://dx.doi.org/10.1371/journal.pone.0000580			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593979	gold, Green Published, Green Submitted			2022-12-27	WOS:000207451800024
J	Rosa, GT; Gillet, L; Smith, CM; de Lima, BD; Stevenson, PG				Rosa, Gustavo T.; Gillet, Laurent; Smith, Christopher M.; de Lima, Brigitte D.; Stevenson, Philip G.			IgG Fc Receptors Provide an Alternative Infection Route for Murine Gamma-Herpesvirus-68	PLOS ONE			English	Article								Background. Herpesviruses can be neutralized in vitro but remain infectious in immune hosts. One difference between these settings is the availability of immunoglobulin Fc receptors. The question therefore arises whether a herpesvirus exposed to apparently neutralizing antibody can still infect Fc receptor(+) cells. Principal Findings. Immune sera blocked murine gamma-herpesvirus-68 (MHV-68) infection of fibroblasts, but failed to block and even enhanced its infection of macrophages and dendritic cells. Viral glycoprotein-specific monoclonal antibodies also enhanced infection. MHV-68 appeared to be predominantly latent in macrophages regardless of whether Fc receptors were engaged, but the infection was not abortive and new virus production soon overwhelmed infected cultures. Lytically infected macrophages down-regulated MHC class I-restricted antigen presentation, endocytosis and their response to LPS. Conclusions. IgG Fc receptors limit the neutralization of gamma-herpesviruses such as MHV-68.	[Rosa, Gustavo T.; Gillet, Laurent; Smith, Christopher M.; de Lima, Brigitte D.; Stevenson, Philip G.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England	University of Cambridge	Stevenson, PG (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England.	pgs27@cam.ac.uk	Stevenson, Philip/F-6651-2011; Stevenson, Philip g/F-9688-2014	Stevenson, Philip g/0000-0002-3520-5060; Gillet, Laurent/0000-0002-1047-2525	Portuguese Foundation for Science and Technology; Wellcome Trust [GR076956MA]; Medical Research Council [G0400427, G9800903]; Cancer Research UK [C19612/A6189]; MRC [G9800943, G0400427] Funding Source: UKRI; Medical Research Council [G9800943] Funding Source: researchfish	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	GTR and BdL were supported by a Portuguese Foundation for Science and Technology studentships. This work was supported by a Wellcome Trust ( Senior Clinical Fellow GR076956MA to PGS) and grants from the Medical Research Council (G0400427, G9800903) and Cancer Research UK (C19612/A6189). LG is a Postdoctoral Researcher of the Fonds National Belge de la Recherche Scientifique (FNRS).	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Bennett NJ, 2005, PLOS BIOL, V3, P638, DOI 10.1371/journal.pbio.0030120; BLASKOVIC D, 1980, ACTA VIROL, V24, P468; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Cardin RD, 1996, J EXP MED, V184, P863, DOI 10.1084/jem.184.3.863; Christensen JP, 1999, P NATL ACAD SCI USA, V96, P5135, DOI 10.1073/pnas.96.9.5135; Coleman HM, 2005, J GEN VIROL, V86, P561, DOI 10.1099/vir.0.80565-0; Dal Conto AJ, 2000, J VIROL, V74, P11304, DOI 10.1128/JVI.74.23.11304-11310.2000; De Lima BD, 2004, J VIROL, V78, P5103, DOI 10.1128/JVI.78.10.5103-5112.2004; Dialyna IA, 2004, AIDS, V18, P1263, DOI 10.1097/00002030-200406180-00004; EHTISHAM S, 1993, J VIROL, V67, P5247, DOI 10.1128/JVI.67.9.5247-5252.1993; Flano E, 2000, J IMMUNOL, V165, P1074, DOI 10.4049/jimmunol.165.2.1074; Flano E, 2002, IMMUNOL RES, V25, P201, DOI 10.1385/IR:25:3:201; Galfre G, 1981, Methods Enzymol, V73, P3; Gangappa S, 2002, J VIROL, V76, P11460, DOI 10.1128/JVI.76.22.11460-11468.2002; Gill MB, 2006, J GEN VIROL, V87, P1465, DOI 10.1099/vir.0.81760-0; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000347; Gillet L, 2007, J VIROL, V81, P280, DOI 10.1128/JVI.01616-06; Gillet L, 2006, J GEN VIROL, V87, P3515, DOI 10.1099/vir.0.82313-0; Iankov ID, 2006, J VIROL, V80, P8530, DOI 10.1128/JVI.00593-06; Kim IJ, 2002, J IMMUNOL, V168, P3958, DOI 10.4049/jimmunol.168.8.3958; Knossow M, 2006, IMMUNOLOGY, V119, P1, DOI 10.1111/j.1365-2567.2006.02421.x; KOHL S, 1982, J IMMUNOL, V129, P370; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Lee Y, 2004, EUR J BIOCHEM, V271, P1094, DOI 10.1111/j.1432-1033.2004.04011.x; Liu LZ, 1999, J IMMUNOL, V163, P868; Lopes FB, 2004, J VIROL, V78, P13370, DOI 10.1128/JVI.78.23.13370-13375.2004; Lubinski JM, 2002, J VIROL, V76, P9232, DOI 10.1128/JVI.76.18.9232-9241.2002; Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482; MARTOS LM, 1970, J GEN VIROL, V7, P169, DOI 10.1099/0022-1317-7-2-169; May JS, 2005, TRAFFIC, V6, P780, DOI 10.1111/j.1600-0854.2005.00316.x; May JS, 2005, J VIROL, V79, P5059, DOI 10.1128/JVI.79.8.5059-5068.2005; May JS, 2005, J VIROL, V79, P3459, DOI 10.1128/JVI.79.6.3459-3467.2005; Mbopi-Keou FX, 2004, AIDS, V18, P338, DOI 10.1097/00002030-200401230-00030; MILLER G, 1972, J INFECT DIS, V125, P403, DOI 10.1093/infdis/125.4.403; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; PANTOPHLET R, ANN REV IMMUNOL, V24, P739; PEIRIS JSM, 1979, NATURE, V282, P509, DOI 10.1038/282509a0; Qiao SW, 2007, IMMUNOLOGY, V120, P145, DOI 10.1111/j.1365-2567.2006.02507.x; Sangster MY, 2000, J IMMUNOL, V164, P1820, DOI 10.4049/jimmunol.164.4.1820; SISSONS JGP, 1980, J INFECT DIS, V142, P442, DOI 10.1093/infdis/142.3.442; Speck SH, 1999, CURR OPIN MICROBIOL, V2, P403; Stevenson PG, 2004, CURR OPIN IMMUNOL, V16, P456, DOI 10.1016/j.coi.2004.05.002; Stevenson PG, 1999, J GEN VIROL, V80, P477, DOI 10.1099/0022-1317-80-2-477; Stevenson PG, 2002, MICROBES INFECT, V4, P1177, DOI 10.1016/S1286-4579(02)01643-X; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; Stevenson PG, 1999, P NATL ACAD SCI USA, V96, P9281, DOI 10.1073/pnas.96.16.9281; Stevenson PG, 1999, J VIROL, V73, P1075, DOI 10.1128/JVI.73.2.1075-1079.1999; Stevenson PG, 1998, J VIROL, V72, P943, DOI 10.1128/JVI.72.2.943-949.1998; Stevenson PG, 1999, EUR J IMMUNOL, V29, P1059, DOI 10.1002/(SICI)1521-4141(199904)29:04<1059::AID-IMMU1059>3.0.CO;2-L; Stewart JP, 1998, J EXP MED, V187, P1941, DOI 10.1084/jem.187.12.1941; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P2347, DOI 10.1099/0022-1317-73-9-2347; van Montfort T, 2007, J IMMUNOL, V178, P3177, DOI 10.4049/jimmunol.178.5.3177; Weck KE, 1999, J VIROL, V73, P3273, DOI 10.1128/JVI.73.4.3273-3283.1999; YAO QY, 1991, INT J CANCER, V48, P45; YAO QY, 1985, INT J CANCER, V35, P35, DOI 10.1002/ijc.2910350107; YOSHINO K, 1965, VIROLOGY, V26, P44, DOI 10.1016/0042-6822(65)90024-3; Zinkernagel RM, 2006, IMMUNOL REV, V211, P310, DOI 10.1111/j.0105-2896.2006.00402.x	58	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e560	10.1371/journal.pone.0000560	http://dx.doi.org/10.1371/journal.pone.0000560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593961	Green Submitted, Green Published, gold			2022-12-27	WOS:000207451800006
J	Zhang, SP; McCormack, FX; Levesque, RC; O'Toole, GA; Lau, GW				Zhang, Shiping; McCormack, Francis X.; Levesque, Roger C.; O'Toole, George A.; Lau, Gee W.			The Flagellum of Pseudomonas aeruginosa Is Required for Resistance to Clearance by Surfactant Protein A	PLOS ONE			English	Article								Surfactant protein A (SP-A) is an important lung innate immune protein that kills microbial pathogens by opsonization and membrane permeabilization. We investigated the basis of SP-A-mediated pulmonary clearance of Pseudomonas aeruginosa using genetically-engineered SP-A mice and a library of signature-tagged P. aeruginosa mutants. A mutant with an insertion into flgE, the gene that encodes flagellar hook protein, was preferentially cleared by the SP-A(+/+) mice, but survived in the SP-A(-/-) mice. Opsonization by SP-A did not play a role in flgE clearance. However, exposure to SP-A directly permeabilized and killed the flgE mutant, but not the wild-type parental strain. P. aeruginosa strains with mutation in other flagellar genes, as well as mucoid, nonmotile isolates from cystic fibrosis patients, were also permeabilized by SP-A. Provision of the wild-type fliC gene restored the resistance to SP-A-mediated membrane permeabilization in the fliC-deficient bacteria. In addition, non-mucoid, motile revertants of CF isolates reacquired resistance to SP-A-mediated membrane permeability. Resistance to SP-A was dependent on the presence of an intact flagellar structure, and independent of flagellar-dependent motility. We provide evidence that flagellar-deficient mutants harbor inadequate amounts of LPS required to resist membrane permeabilization by SP-A and cellular lysis by detergent targeting bacterial outer membranes. Thus, the flagellum of P. aeruginosa plays an indirect but important role resisting SP-A-mediated clearance and membrane permeabilization.	[Lau, Gee W.] Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA; [Zhang, Shiping; McCormack, Francis X.] Univ Cincinnati, Coll Med, Div Pulm & Crit Care Med, Cincinnati, OH USA; [Levesque, Roger C.] Univ Laval, Ctr Rech Fonct Struct & Ingn Prot, Ste Foy, PQ, Canada; [Levesque, Roger C.] Univ Laval, Fac Med, Ste Foy, PQ, Canada; [O'Toole, George A.] Dartmouth Med Sch, Dept Microbiol & Immunol, Hanover, NH USA	University of Illinois System; University of Illinois Urbana-Champaign; University System of Ohio; University of Cincinnati; Laval University; Laval University; Dartmouth College	Lau, GW (corresponding author), Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA.	geelau@uiuc.edu	McCormack, Francis X./ABE-8398-2020; Levesque, Roger C./ABD-8407-2021; Lau, Gee W/H-4073-2018	McCormack, Francis X./0000-0001-7168-9464; Levesque, Roger/0000-0001-8315-5937	NIH [AI057915, HL-68861]; American Lung Association [RG-131-N]; Department of Veterans Affairs (Merit Award); National Center for Research Resources [C06 RR 16515-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR001615] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI057915] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; Department of Veterans Affairs (Merit Award)(US Department of Veterans Affairs); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the NIH (AI057915) and American Lung Association (RG-131-N) to GWL; and the NIH (HL-68861) and the Department of Veterans Affairs (Merit Award) to FXM. This investigation was partially conducted at the University of Illinois at Urbana-Champaign in a facility constructed with the support from Research Facilities Improvement Program Grant Number C06 RR 16515-01 from the National Center for Research Resources, National Institutes of Health.	Arora SK, 2005, INFECT IMMUN, V73, P4395, DOI 10.1128/IAI.73.7.4395-4398.2005; Arora SK, 1998, INFECT IMMUN, V66, P1000, DOI 10.1128/IAI.66.3.1000-1007.1998; BAUGHMAN RP, 1993, AM REV RESPIR DIS, V147, P653, DOI 10.1164/ajrccm/147.3.653; BOYCE JR, 1982, INFECT IMMUN, V37, P840, DOI 10.1128/IAI.37.2.840-844.1982; Bren A, 2000, J BACTERIOL, V182, P6865, DOI 10.1128/JB.182.24.6865-6873.2000; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; Crowther JE, 2004, J IMMUNOL, V172, P6866, DOI 10.4049/jimmunol.172.11.6866; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Fleiszig SMJ, 2001, INFECT IMMUN, V69, P4931, DOI 10.1128/IAI.69.8.4931-4937.2001; GAYNOR CD, 1995, J IMMUNOL, V155, P5343; Griese M, 1997, EUR RESPIR J, V10, P1983, DOI 10.1183/09031936.97.10091983; Gunther A, 1996, AM J RESP CRIT CARE, V153, P176; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Hartshorn KL, 1998, AM J PHYSIOL-LUNG C, V274, pL958, DOI 10.1152/ajplung.1998.274.6.L958; HAWGOOD S, 1991, ANNU REV PHYSIOL, V53, P375, DOI 10.1146/annurev.ph.53.030191.002111; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; Kim W, 2003, J BACTERIOL, V185, P3111, DOI 10.1128/JB.185.10.3111-3117.2003; Kojima S, 2001, BIOCHEMISTRY-US, V40, P13041, DOI 10.1021/bi011263o; Kong FS, 2006, CELL MICROBIOL, V8, P1121, DOI 10.1111/j.1462-5822.2006.00696.x; Korfhagen TR, 1996, P NATL ACAD SCI USA, V93, P9594, DOI 10.1073/pnas.93.18.9594; KRATOCHVIL B, 1965, ANAL CHEM, V37, P111, DOI 10.1021/ac60220a028; Kuzmenko AI, 2006, BIOCHEMISTRY-US, V45, P2679, DOI 10.1021/bi0522652; Lau GW, 2005, TRENDS MICROBIOL, V13, P389, DOI 10.1016/j.tim.2005.05.011; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; LeVine AM, 1998, AM J RESP CELL MOL, V19, P700, DOI 10.1165/ajrcmb.19.4.3254; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; MAHENTHIRALINGAM E, 1995, INFECT IMMUN, V63, P4519, DOI 10.1128/IAI.63.11.4519-4523.1995; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Malloy JL, 2005, AM J PHYSIOL-LUNG C, V288, pL409, DOI 10.1152/ajplung.00322.2004; Mariencheck WI, 2003, AM J RESP CELL MOL, V28, P528, DOI 10.1165/rcmb.2002-0141OC; Mariencheck WI, 1999, AM J PHYSIOL-LUNG C, V277, pL777, DOI 10.1152/ajplung.1999.277.4.L777; McCormack FX, 2003, J BIOL CHEM, V278, P36250, DOI 10.1074/jbc.M303086200; NEWMAN SL, 1993, J CLIN INVEST, V92, P624, DOI 10.1172/JCI116630; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Potvin E, 2003, ENVIRON MICROBIOL, V5, P1294, DOI 10.1046/j.1462-2920.2003.00542.x; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rocchetta HL, 1999, MICROBIOL MOL BIOL R, V63, P523, DOI 10.1128/MMBR.63.3.523-553.1999; Rubio F, 2004, THORAX, V59, P318, DOI 10.1136/thx.2003.014902; Schaeffer LM, 2004, J IMMUNOL, V173, P1959, DOI 10.4049/jimmunol.173.3.1959; Singh PK, 2000, AM J PHYSIOL-LUNG C, V279, pL799, DOI 10.1152/ajplung.2000.279.5.L799; Soutourina OA, 2003, FEMS MICROBIOL REV, V27, P505, DOI 10.1016/S0168-6445(03)00064-0; Suwabe A, 1996, ARCH BIOCHEM BIOPHYS, V327, P285, DOI 10.1006/abbi.1996.0123; Tart AH, 2006, J BACTERIOL, V188, P6483, DOI 10.1128/JB.00636-06; Toutain CM, 2005, J BACTERIOL, V187, P771, DOI 10.1128/JB.187.2.771-777.2005; Wolfgang MC, 2004, P NATL ACAD SCI USA, V101, P6664, DOI 10.1073/pnas.0307553101; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Yan H, 2001, ANTIMICROB AGENTS CH, V45, P1558, DOI 10.1128/AAC.45.5.1558-1560.2001; Zeng H, 2003, J IMMUNOL, V171, P3668, DOI 10.4049/jimmunol.171.7.3668; Zhang SP, 2005, PLOS PATHOG, V1, P259, DOI 10.1371/journal.ppat.0010031	54	32	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e564	10.1371/journal.pone.0000564	http://dx.doi.org/10.1371/journal.pone.0000564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593964	Green Published, gold, Green Submitted			2022-12-27	WOS:000207451800009
J	Watanabe, H; Mizunami, M				Watanabe, Hidehiro; Mizunami, Makoto			Pavlov's Cockroach: Classical Conditioning of Salivation in an Insect	PLOS ONE			English	Article								Secretion of saliva to aid swallowing and digestion is an important physiological function found in many vertebrates and invertebrates. Pavlov reported classical conditioning of salivation in dogs a century ago. Conditioning of salivation, however, has been so far reported only in dogs and humans, and its underlying neural mechanisms remain elusive because of the complexity of the mammalian brain. We previously reported that, in cockroaches Periplaneta americana, salivary neurons that control salivation exhibited increased responses to an odor after conditioning trials in which the odor was paired with sucrose solution. However, no direct evidence of conditioning of salivation was obtained. In this study, we investigated the effects of conditioning trials on the level of salivation. Untrained cockroaches exhibited salivary responses to sucrose solution applied to the mouth but not to peppermint or vanilla odor applied to an antenna. After differential conditioning trials in which an odor was paired with sucrose solution and another odor was presented without pairing with sucrose solution, sucrose-associated odor induced an increase in the level of salivation, but the odor presented alone did not. The conditioning effect lasted for one day after conditioning trials. This study demonstrates, for the first time, classical conditioning of salivation in species other than dogs and humans, thereby providing the first evidence of sophisticated neural control of autonomic function in insects. The results provide a useful model system for studying cellular basis of conditioning of salivation in the simpler nervous system of insects.	[Watanabe, Hidehiro; Mizunami, Makoto] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan	Tohoku University	Mizunami, M (corresponding author), Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan.	makoto@biology.tohoku.ac.jp		Mizunami, Makoto/0000-0003-4168-2610	Ministry of Education, Science, Culture, Sports and Technology of Japan; Japan Society	Ministry of Education, Science, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by grants from the Ministry of Education, Science, Culture, Sports and Technology of Japan and Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists.	Ali DW, 1997, J EXP BIOL, V200, P1941; BALDERRAMA N, 1980, J INSECT PHYSIOL, V26, P499, DOI 10.1016/0022-1910(80)90123-7; Baranov V V, 1983, Neurosci Behav Physiol, V13, P245, DOI 10.1007/BF01150012; Burrows M., 1996, NEUROBIOLOGY INSECT; Daly KC, 2004, P NATL ACAD SCI USA, V101, P10476, DOI 10.1073/pnas.0401902101; DANILOVA LK, 1983, NEUROSCI BEHAV PHYSL, V12, P337; DAVIS NT, 1985, CELL TISSUE RES, V240, P593, DOI 10.1007/BF00216349; Ekstrom J, 1989, Proc Finn Dent Soc, V85, P323; FEATHER BW, 1967, J EXP PSYCHOL, V74, P389, DOI 10.1037/h0024709; GARRETT JR, 1987, J DENT RES, V66, P387, DOI 10.1177/00220345870660020201; Giurfa M, 2003, CURR OPIN NEUROBIOL, V13, P726, DOI 10.1016/j.conb.2003.10.015; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; HARRIS AH, 1974, ANNU REV PSYCHOL, V25, P107, DOI 10.1146/annurev.ps.25.020174.000543; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hermitte G, 2006, J COMP PHYSIOL A, V192, P69, DOI 10.1007/s00359-005-0052-y; HOLLAND R, 1970, ARCH ORAL BIOL, V15, P761, DOI 10.1016/0003-9969(70)90039-7; Just F, 1996, J EXP BIOL, V199, P407; Krontiris-Litowitz J, 1999, J COMP PHYSIOL A, V185, P181, DOI 10.1007/s003590050376; Kwon HW, 2004, J EXP BIOL, V207, P377, DOI 10.1242/jeb.00737; Li YS, 1999, J COMP NEUROL, V409, P647, DOI 10.1002/(SICI)1096-9861(19990712)409:4<647::AID-CNE9>3.0.CO;2-3; MATSUO R, 1999, FRONT ORAL BIOL, V11, P26; MAUELSHAGEN J, 1993, J NEUROPHYSIOL, V69, P609, DOI 10.1152/jn.1993.69.2.609; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Menzel Randolf, 2006, Behav Cogn Neurosci Rev, V5, P24, DOI 10.1177/1534582306289522; MILLER NE, 1969, SCIENCE, V163, P434, DOI 10.1126/science.163.3866.434; MIZUNAMI M, 1990, J GEN PHYSIOL, V95, P297, DOI 10.1085/jgp.95.2.297; MIZUNAMI M, 1988, J GEN PHYSIOL, V91, P703, DOI 10.1085/jgp.91.5.703; Mizunami M, 1996, J GEN PHYSIOL, V107, P121, DOI 10.1085/jgp.107.1.121; Nishino H, 2003, J COMP NEUROL, V455, P40, DOI 10.1002/cne.10450; Sakura M, 2002, J COMP PHYSIOL A, V188, P787, DOI 10.1007/s00359-002-0366-y; Sakura M, 2001, ZOOL SCI, V18, P21, DOI 10.2108/zsj.18.21; Sato C, 2006, NEUROREPORT, V17, P553, DOI 10.1097/01.wnr.0000209002.17610.79; Strausfeld NJ, 1999, J COMP NEUROL, V409, P603; THON B, 1980, J COMP PHYSIOL PSYCH, V94, P886, DOI 10.1037/h0077821; Walz B, 2006, ARCH INSECT BIOCHEM, V62, P141, DOI 10.1002/arch.20128; Watanabe H, 2003, ZOOL SCI, V20, P1447, DOI 10.2108/zsj.20.1447; Watanabe H, 2006, J EXP BIOL, V209, P766, DOI 10.1242/jeb.02049; WELLS DT, 1968, PSYCHOPHYSIOLOGY, V4, P278, DOI 10.1111/j.1469-8986.1968.tb02768.x; ZERNICKI B., 1961, ACTA BIOL EXPTL, V21, P163	39	29	29	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2007	2	6							e529	10.1371/journal.pone.0000529	http://dx.doi.org/10.1371/journal.pone.0000529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GD	17565382	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451600017
J	Winkeler, A; Sena-Esteves, M; Paulis, LEM; Li, HF; Waerzeggers, Y; Ruckriem, B; Himmelreich, U; Klein, M; Monfared, P; Rueger, MA; Heneka, M; Vollmar, S; Hoehn, M; Fraefel, C; Graf, R; Wienhard, K; Heiss, WD; Jacobs, AH				Winkeler, Alexandra; Sena-Esteves, Miguel; Paulis, Leonie E. M.; Li, Hongfeng; Waerzeggers, Yannic; Rueckriem, Benedikt; Himmelreich, Uwe; Klein, Markus; Monfared, Parisa; Rueger, Maria A.; Heneka, Michael; Vollmar, Stefan; Hoehn, Mathias; Fraefel, Cornel; Graf, Rudolf; Wienhard, Klaus; Heiss, Wolf D.; Jacobs, Andreas H.			Switching on the Lights for Gene Therapy	PLOS ONE			English	Article								Strategies for non-invasive and quantitative imaging of gene expression in vivo have been developed over the past decade. Non-invasive assessment of the dynamics of gene regulation is of interest for the detection of endogenous disease-specific biological alterations (e. g., signal transduction) and for monitoring the induction and regulation of therapeutic genes (e. g., gene therapy). To demonstrate that non-invasive imaging of regulated expression of any type of gene after in vivo transduction by versatile vectors is feasible, we generated regulatable herpes simplex virus type 1 (HSV-1) amplicon vectors carrying hormone (mifepristone) or antibiotic (tetracycline) regulated promoters driving the proportional co-expression of two marker genes. Regulated gene expression was monitored by fluorescence microscopy in culture and by positron emission tomography (PET) or bioluminescence (BLI) in vivo. The induction levels evaluated in glioma models varied depending on the dose of inductor. With fluorescence microscopy and BLI being the tools for assessing gene expression in culture and animal models, and with PET being the technology for possible application in humans, the generated vectors may serve to non-invasively monitor the dynamics of any gene of interest which is proportionally co-expressed with the respective imaging marker gene in research applications aiming towards translation into clinical application.	[Jacobs, Andreas H.] Max Planck Inst Neurol Res, Ctr Mol Med CMMC, Lab Gene Therapy & Mol Imaging, Cologne, Germany; Univ Cologne, Dept Neurol, Cologne, Germany; Univ Cologne, Dept Radiol, Cologne, Germany	Max Planck Society; University of Cologne; University of Cologne; University of Cologne	Jacobs, AH (corresponding author), Max Planck Inst Neurol Res, Ctr Mol Med CMMC, Lab Gene Therapy & Mol Imaging, Cologne, Germany.	Andreas.Jacobs@nf.mpg.de	Winkeler, Alexandra/B-7436-2014; Jacobs, Andreas H./AAA-6794-2020; Heneka, Michael/AAE-8011-2019; Heneka, Michael/E-8072-2015	Winkeler, Alexandra/0000-0003-3397-2570; Himmelreich, Uwe/0000-0002-2060-8895; Heneka, Michael/0000-0003-4996-1630; Fraefel, Cornel/0000-0001-7221-6706	Deutsche Forschungsgemeinschaft [DFG-Ja98/1-2]; Ministerium fur Schule; Wissenschaft und Forschung NRW [MSWF 516-40000299]; Center for Molecular Medicine Cologne [CMMC-TV46]; 6th FW EU [LSHC-CT-2004-503569]; DiMI [LSHB-CT-2005-512146]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministerium fur Schule; Wissenschaft und Forschung NRW; Center for Molecular Medicine Cologne; 6th FW EU; DiMI	This work is supported in part by the Deutsche Forschungsgemeinschaft (DFG-Ja98/1-2), Ministerium fur Schule, Wissenschaft und Forschung NRW (MSWF 516-40000299), Center for Molecular Medicine Cologne (CMMC-TV46), 6th FW EU grant EMIL (LSHC-CT-2004-503569) and DiMI (LSHB-CT-2005-512146).	BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; Black ME, 1996, P NATL ACAD SCI USA, V93, P3525, DOI 10.1073/pnas.93.8.3525; Blasberg RG, 2003, NUCL MED BIOL, V30, P879, DOI 10.1016/S0969-8051(03)00115-X; Burcin MM, 1999, P NATL ACAD SCI USA, V96, P355, DOI 10.1073/pnas.96.2.355; CHRISTOPHERSON KS, 1992, P NATL ACAD SCI USA, V89, P6314, DOI 10.1073/pnas.89.14.6314; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; Doubrovin M, 2001, P NATL ACAD SCI USA, V98, P9300, DOI 10.1073/pnas.161091198; Doubrovin M, 2004, BIOCONJUGATE CHEM, V15, P1376, DOI 10.1021/bc0498572; DUMORTIER J, 2005, GENE THER; Fotaki ME, 1997, GENE THER, V4, P901, DOI 10.1038/sj.gt.3300487; Fraefel C, 1996, J VIROL, V70, P7190, DOI 10.1128/JVI.70.10.7190-7197.1996; Freundlieb S, 1999, J GENE MED, V1, P4, DOI 10.1002/(SICI)1521-2254(199901/02)1:1<4::AID-JGM4>3.0.CO;2-Y; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gambhir SS, 1999, NUCL MED BIOL, V26, P481, DOI 10.1016/S0969-8051(99)00021-9; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Green Leeta A, 2002, Mol Imaging Biol, V4, P71, DOI 10.1016/S1095-0397(01)00071-1; Heiss WD, 2004, J NUCL MED, V45, P1811; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; HYNES NE, 1981, P NATL ACAD SCI-BIOL, V78, P2038, DOI 10.1073/pnas.78.4.2038; Iyer M, 2004, MOL THER, V10, P545, DOI 10.1016/j.ymthe.2004.06.118; Jacobs A H, 2002, Mol Imaging, V1, P309, DOI 10.1162/153535002321093936; Jacobs AH, 2003, HUM GENE THER, V14, P277, DOI 10.1089/10430340360535823; Jacobs Andreas, 1999, Neoplasia (New York), V1, P154, DOI 10.1038/sj.neo.7900007; Jacobs AH, 2007, CANCER RES, V67, P1706, DOI 10.1158/0008-5472.CAN-06-2418; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Lipshutz GS, 2001, MOL THER, V3, P284, DOI 10.1006/mthe.2001.0267; MAYO KE, 1982, CELL, V29, P99, DOI 10.1016/0092-8674(82)90094-0; Ponomarev V, 2001, NEOPLASIA, V3, P480, DOI 10.1038/sj.neo.7900204; SAITO Y, 1982, SCIENCE, V217, P1151, DOI 10.1126/science.7112121; Shah K, 2003, ONCOGENE, V22, P6865, DOI 10.1038/sj.onc.1206748; Shockett PE, 1996, P NATL ACAD SCI USA, V93, P5173, DOI 10.1073/pnas.93.11.5173; Sun X, 2001, GENE THER, V8, P1572, DOI 10.1038/sj.gt.3301554; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; TJUVAJEV JG, 1995, CANCER RES, V55, P6126; Tjuvajev Juri G., 1999, Neoplasia (New York), V1, P315, DOI 10.1038/sj.neo.7900053; Wang Y, 2002, MOL GENET GENOMICS, V268, P160, DOI 10.1007/s00438-002-0751-9; Wang YL, 1997, NAT BIOTECHNOL, V15, P239, DOI 10.1038/nbt0397-239; WANG YL, 1994, P NATL ACAD SCI USA, V91, P8180, DOI 10.1073/pnas.91.17.8180; Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949; Weissleder R, 2002, NAT REV CANCER, V2, P11, DOI 10.1038/nrc701; Wu JC, 2001, MOL THER, V4, P297, DOI 10.1006/mthe.2001.0460; WURM FM, 1986, P NATL ACAD SCI USA, V83, P5414, DOI 10.1073/pnas.83.15.5414; Yaghoubi SS, 2001, GENE THER, V8, P1072, DOI 10.1038/sj.gt.3301490; Yu YA, 2002, MOL GENET GENOMICS, V268, P169, DOI 10.1007/s00438-002-0750-x; Yu YJ, 2000, NAT MED, V6, P933, DOI 10.1038/78704	47	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2007	2	6							e528	10.1371/journal.pone.0000528	http://dx.doi.org/10.1371/journal.pone.0000528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GD	17565381	Green Published, gold, Green Submitted			2022-12-27	WOS:000207451600016
J	Gillet, L; May, JS; Stevenson, PG				Gillet, Laurent; May, Janet S.; Stevenson, Philip G.			Post-Exposure Vaccination Improves Gammaherpesvirus Neutralization	PLOS ONE			English	Article								Herpesvirus carriers transmit infection despite making virus-specific antibodies. Thus, their antibody responses are not necessarily optimal. An important question for infection control is whether vaccinating carriers might improve virus neutralization. The antibody response to murine gamma-herpesvirus-68 (MHV-68) blocks cell binding, but fails to block and even enhances an IgG Fc receptor-dependent infection of myeloid cells. Viral membrane fusion therefore remains intact. Although gH/gL-specific monoclonal antibodies can block infection at a post-binding step close to membrane fusion, gH/gL is a relatively minor antibody target in virus carriers. We show here that gH/gL-specific antibodies can block both Fc receptor-independent and Fc receptor-dependent infections, and that vaccinating virus carriers with a gH/gL fusion protein improves their capacity for virus neutralization both in vitro and in vivo. This approach has the potential to reduce herpesvirus transmission.	[Gillet, Laurent; May, Janet S.; Stevenson, Philip G.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Virol, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Stevenson, PG (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Virol, Cambridge CB2 2QQ, England.	pgs27@cam.ac.uk	Stevenson, Philip/F-6651-2011; Stevenson, Philip g/F-9688-2014	Stevenson, Philip g/0000-0002-3520-5060; Gillet, Laurent/0000-0002-1047-2525	Wellcome Trust [GR076956MA]; Medical Research Council [G0400427, G9800903]; Cancer Research UK [C19612/A6189]; Fonds National Belge de la Recherche Scientifique (FNRS); MRC [G0400427] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Fonds National Belge de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust ( Senior Clinical Fellow GR076956MA to PGS), the Medical Research Council (G0400427, G9800903) and Cancer Research UK (C19612/A6189). LG is a Postdoctoral Researcher of the Fonds National Belge de la Recherche Scientifique (FNRS).	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; BALACHANDRAN N, 1982, INFECT IMMUN, V37, P1132, DOI 10.1128/IAI.37.3.1132-1137.1982; Belz GT, 2000, P NATL ACAD SCI USA, V97, P2725, DOI 10.1073/pnas.040575197; Bitonti AJ, 2004, P NATL ACAD SCI USA, V101, P9763, DOI 10.1073/pnas.0403235101; Coleman HM, 2003, J VIROL, V77, P2410, DOI 10.1128/JVI.77.4.2410-2417.2003; DAVISON AJ, 1990, NUCLEIC ACIDS RES, V18, P4285, DOI 10.1093/nar/18.14.4285; De Lima BD, 2004, J VIROL, V78, P5103, DOI 10.1128/JVI.78.10.5103-5112.2004; DINGWELL KS, 1994, J VIROL, V68, P834, DOI 10.1128/JVI.68.2.834-845.1994; Gangappa S, 2002, J VIROL, V76, P11460, DOI 10.1128/JVI.76.22.11460-11468.2002; Gill MB, 2006, J GEN VIROL, V87, P1465, DOI 10.1099/vir.0.81760-0; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000705; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000347; Gillet L, 2007, J VIROL, V81, P280, DOI 10.1128/JVI.01616-06; Gillet L, 2006, J GEN VIROL, V87, P3515, DOI 10.1099/vir.0.82313-0; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; INADA T, 1985, J GEN VIROL, V66, P871, DOI 10.1099/0022-1317-66-4-871; Jiang R, 2006, J VIROL, V80, P7281, DOI 10.1128/JVI.00497-06; JOHNSON DC, 1987, J VIROL, V61, P2208, DOI 10.1128/JVI.61.7.2208-2216.1987; Kim IJ, 2002, J IMMUNOL, V168, P3958, DOI 10.4049/jimmunol.168.8.3958; KOHL S, 1986, J IMMUNOL, V137, P1688; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Lopes FB, 2004, J VIROL, V78, P13370, DOI 10.1128/JVI.78.23.13370-13375.2004; Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482; Marques S, 2003, J VIROL, V77, P7308, DOI 10.1128/JVI.77.13.7308-7318.2003; May JS, 2004, J GEN VIROL, V85, P137, DOI 10.1099/vir.0.19599-0; Mori Y, 2004, J VIROL, V78, P4609, DOI 10.1128/JVI.78.9.4609-4616.2004; Nagashunmugam T, 1998, J VIROL, V72, P5351, DOI 10.1128/JVI.72.7.5351-5359.1998; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; PEETERS B, 1993, J VIROL, V67, P170, DOI 10.1128/JVI.67.1.170-177.1993; RECTOR JT, 1982, INFECT IMMUN, V38, P168, DOI 10.1128/IAI.38.1.168-174.1982; Rosa GT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000560; ROTH MG, 1980, J VIROL, V35, P547, DOI 10.1128/JVI.35.2.547-550.1980; Sangster MY, 2000, J IMMUNOL, V164, P1820, DOI 10.4049/jimmunol.164.4.1820; Stevenson PG, 2004, CURR OPIN IMMUNOL, V16, P456, DOI 10.1016/j.coi.2004.05.002; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; Stevenson PG, 1999, P NATL ACAD SCI USA, V96, P9281, DOI 10.1073/pnas.96.16.9281; Stevenson PG, 1998, J VIROL, V72, P943, DOI 10.1128/JVI.72.2.943-949.1998; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; van Montfort T, 2007, J IMMUNOL, V178, P3177, DOI 10.4049/jimmunol.178.5.3177; Wang D, 2005, P NATL ACAD SCI USA, V102, P18153, DOI 10.1073/pnas.0509201102; Wang X, 1998, J VIROL, V72, P5552, DOI 10.1128/JVI.72.7.5552-5558.1998; Xu JK, 1996, J GEN VIROL, V77, P49, DOI 10.1099/0022-1317-77-1-49; Yewdell JW, 2002, NAT IMMUNOL, V3, P1019, DOI 10.1038/ni1102-1019	43	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e899	10.1371/journal.pone.0000899	http://dx.doi.org/10.1371/journal.pone.0000899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878934	Green Published, gold			2022-12-27	WOS:000207455700007
J	Siegmund, KD; Connor, CM; Campan, M; Long, TI; Weisenberger, DJ; Biniszkiewicz, D; Jaenisch, R; Laird, PW; Akbarian, S				Siegmund, Kimberly D.; Connor, Caroline M.; Campan, Mihaela; Long, Tiffany I.; Weisenberger, Daniel J.; Biniszkiewicz, Detlev; Jaenisch, Rudolf; Laird, Peter W.; Akbarian, Schahram			DNA Methylation in the Human Cerebral Cortex Is Dynamically Regulated throughout the Life Span and Involves Differentiated Neurons	PLOS ONE			English	Article							METHYLTRANSFERASES DNMT3A; SCHIZOPHRENIC-PATIENTS; GENE-EXPRESSION; PROMOTER; BRAIN; NEUROPATHOLOGY; REELIN; HYPERMETHYLATION; METHYLIGHT; PROTEIN	The role of DNA cytosine methylation, an epigenetic regulator of chromatin structure and function, during normal and pathological brain development and aging remains unclear. Here, we examined by MethyLight PCR the DNA methylation status at 50 loci, encompassing primarily 5' CpG islands of genes related to CNS growth and development, in temporal neocortex of 125 subjects ranging in age from 17 weeks of gestation to 104 years old. Two psychiatric disease cohorts-defined by chronic neurodegeneration (Alzheimer's) or lack thereof (schizophrenia)-were included. A robust and progressive rise in DNA methylation levels across the lifespan was observed for 8/50 loci (GABRA2, GAD1, HOXA1, NEUROD1, NEUROD2, PGR, STK11, SYK) typically in conjunction with declining levels of the corresponding mRNAs. Another 16 loci were defined by a sharp rise in DNA methylation levels within the first few months or years after birth. Disease-associated changes were limited to 2/50 loci in the Alzheimer's cohort, which appeared to reflect an acceleration of the age-related change in normal brain. Additionally, methylation studies on sorted nuclei provided evidence for bidirectional methylation events in cortical neurons during the transition from childhood to advanced age, as reflected by significant increases at 3, and a decrease at 1 of 10 loci. Furthermore, the DNMT3a de novo DNA methyl-transferase was expressed across all ages, including a subset of neurons residing in layers III and V of the mature cortex. Therefore, DNA methylation is dynamically regulated in the human cerebral cortex throughout the lifespan, involves differentiated neurons, and affects a substantial portion of genes predominantly by an age-related increase.	[Connor, Caroline M.; Akbarian, Schahram] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA; [Siegmund, Kimberly D.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Connor, Caroline M.] Univ Massachusetts, Sch Med, Grad Sch Biomed Sci, Program Neurobiol, Worcester, MA 01655 USA; [Campan, Mihaela; Long, Tiffany I.; Weisenberger, Daniel J.; Laird, Peter W.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Biniszkiewicz, Detlev; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Southern California; University of Massachusetts System; University of Massachusetts Worcester; University of Southern California; Massachusetts Institute of Technology (MIT); Whitehead Institute	Akbarian, S (corresponding author), Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA.	Schahram.akbarian@umassmed.edu	Weisenberger, Daniel/AAA-8314-2020; feng, jian/G-9313-2011; Laird, Peter W/G-8683-2012	Weisenberger, Daniel/0000-0001-8303-2603; Laird, Peter W/0000-0001-9117-3641	National Institute of Mental Health	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by grants from the National Institute of Mental Health.	Abdolmaleky HM, 2005, AM J MED GENET B, V134B, P60, DOI 10.1002/ajmg.b.30140; Ausio J, 2003, CLIN GENET, V64, P83, DOI 10.1034/j.1399-0004.2003.00124.x; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Braus DF, 2002, ARCH GEN PSYCHIAT, V59, P696, DOI 10.1001/archpsyc.59.8.696; Champagne FA, 2006, ENDOCRINOLOGY, V147, P2909, DOI 10.1210/en.2005-1119; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Debinski W, 2003, ANN NY ACAD SCI, V983, P232, DOI 10.1111/j.1749-6632.2003.tb05978.x; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Esteller M, 2005, ANNU REV PHARMACOL, V45, P629, DOI 10.1146/annurev.pharmtox.45.120403.095832; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Feng J, 2005, J NEUROSCI RES, V79, P734, DOI 10.1002/jnr.20404; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Heckers S, 1997, SCHIZOPHRENIA BULL, V23, P403, DOI 10.1093/schbul/23.3.403; Hoyaux D, 2000, BRAIN RES, V867, P280, DOI 10.1016/S0006-8993(00)02393-3; Huang HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000809; Isles AR, 2006, PHILOS T R SOC B, V361, P2229, DOI 10.1098/rstb.2006.1942; Ito H, 2007, J NEUROCHEM, V100, P545, DOI 10.1111/j.1471-4159.2006.04222.x; Jakovcevski I, 2005, GLIA, V49, P480, DOI 10.1002/glia.20134; JELLINGER K, 1978, ACTA NEUROCHIR, V42, P5, DOI 10.1007/BF01406628; Kornack DR, 1998, P NATL ACAD SCI USA, V95, P1242, DOI 10.1073/pnas.95.3.1242; Kundakovic M, 2007, MOL PHARMACOL, V71, P644, DOI 10.1124/mol.106.030635; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nagarajan RP, 2006, EPIGENETICS-US, V1, P172, DOI 10.4161/epi.1.4.3514; Nguyen' S, 2007, DEV DYNAM, V236, P1663, DOI 10.1002/dvdy.21176; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; OKUSKY J, 1982, J COMP NEUROL, V210, P307, DOI 10.1002/cne.902100309; Petronis A, 2001, TRENDS GENET, V17, P142, DOI 10.1016/S0168-9525(00)02213-7; Polesskaya OO, 2006, J NEUROSCI RES, V83, P362, DOI 10.1002/jnr.20732; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Preusser M, 2006, WIEN MED WOCHENSCHR, V156, P332, DOI 10.1007/s10354-006-0304-7; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Scarpa S, 2003, FEBS LETT, V541, P145, DOI 10.1016/S0014-5793(03)00277-1; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Song DL, 1996, DEVELOPMENT, V122, P627; Trinh BN, 2001, METHODS, V25, P456, DOI 10.1006/meth.2001.1268; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WEINBERGER DR, 1995, LANCET, V346, P552, DOI 10.1016/S0140-6736(95)91386-6; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Weisenberger DJ, 2002, GENE, V298, P91, DOI 10.1016/S0378-1119(02)00976-9; Widschwendter M, 2004, CANCER RES, V64, P3807, DOI 10.1158/0008-5472.CAN-03-3852; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Xie ZH, 2006, HUM MOL GENET, V15, P1375, DOI 10.1093/hmg/ddl059	55	328	339	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e895	10.1371/journal.pone.0000895	http://dx.doi.org/10.1371/journal.pone.0000895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878930	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455700003
J	Jo, S; Kim, T; Im, W				Jo, Sunhwan; Kim, Taehoon; Im, Wonpil			Automated Builder and Database of Protein/Membrane Complexes for Molecular Dynamics Simulations	PLOS ONE			English	Article							ENERGY TRANSDUCTION; POTASSIUM CHANNELS; ESCHERICHIA-COLI; WATER PERMEATION; OMPF PORIN; MEMBRANE; MECHANISM; ENERGETICS; GRAMICIDIN; TRANSPORT	Molecular dynamics simulations of membrane proteins have provided deeper insights into their functions and interactions with surrounding environments at the atomic level. However, compared to solvation of globular proteins, building a realistic protein/membrane complex is still challenging and requires considerable experience with simulation software. Membrane Builder in the CHARMM-GUI website (http://www.charmm-gui.org) helps users to build such a complex system using a web browser with a graphical user interface. Through a generalized and automated building process including system size determination as well as generation of lipid bilayer, pore water, bulk water, and ions, a realistic membrane system with virtually any kinds and shapes of membrane proteins can be generated in 5 minutes to 2 hours depending on the system size. Default values that were elaborated and tested extensively are given in each step to provide reasonable options and starting points for both non-expert and expert users. The efficacy of Membrane Builder is illustrated by its applications to 12 transmembrane and 3 interfacial membrane proteins, whose fully equilibrated systems with three different types of lipid molecules (DMPC, DPPC, and POPC) and two types of system shapes (rectangular and hexagonal) are freely available on the CHARMM-GUI website. One of the most significant advantages of using the web environment is that, if a problem is found, users can go back and re-generate the whole system again before quitting the browser. Therefore, Membrane Builder provides the intuitive and easy way to build and simulate the biologically important membrane system.	[Kim, Taehoon; Im, Wonpil] Univ Kansas, Ctr Bioinformat, Dept Mol Biosci, Lawrence, KS 66045 USA; [Jo, Sunhwan] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Im, W (corresponding author), Univ Kansas, Ctr Bioinformat, Dept Mol Biosci, Lawrence, KS 66045 USA.	wonpil@ku.edu		Jo, Sunhwan/0000-0002-4104-6473	The University of Kansas	The University of Kansas	Funding: This work was supported by institutional funding from The University of Kansas.	ALBERTS B, 2002, MOL BIOL CELL, pR34; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chakrabarti N, 2004, STRUCTURE, V12, P65, DOI 10.1016/j.str.2003.11.017; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; Dolan EA, 2002, BIOPHYS J, V82, P2317, DOI 10.1016/S0006-3495(02)75577-X; Dong JH, 2005, SCIENCE, V308, P1023, DOI 10.1126/science.1106592; Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185; Faraldo-Gomez JD, 2002, EUR BIOPHYS J BIOPHY, V31, P217, DOI 10.1007/s00249-002-0207-5; FELLER SE, 1995, J CHEM PHYS, V103, P10267, DOI 10.1063/1.469928; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Im W, 2002, J MOL BIOL, V319, P1177, DOI 10.1016/S0022-2836(02)00380-7; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Klauda JB, 2005, J PHYS CHEM B, V109, P5300, DOI 10.1021/jp0468096; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943; Petrache HI, 2000, J MOL BIOL, V302, P727, DOI 10.1006/jmbi.2000.4072; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Roux B, 2004, STRUCTURE, V12, P1343, DOI 10.1016/j.str.2004.06.013; Shen LY, 1997, BIOPHYS J, V73, P3, DOI 10.1016/S0006-3495(97)78042-1; Terstappen GC, 2001, TRENDS PHARMACOL SCI, V22, P23, DOI 10.1016/S0165-6147(00)01584-4; Tieleman DP, 1998, BIOPHYS J, V74, P2786, DOI 10.1016/S0006-3495(98)77986-X; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; White S.H., MEMBRANE PROTEINS KN; WOOLF TB, 1994, P NATL ACAD SCI USA, V91, P11631, DOI 10.1073/pnas.91.24.11631; Woolf TB, 1996, PROTEINS, V24, P92; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978	36	647	651	6	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e880	10.1371/journal.pone.0000880	http://dx.doi.org/10.1371/journal.pone.0000880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849009	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455600026
J	Lacey, S; Peters, A; Sathian, K				Lacey, Simon; Peters, Andrew; Sathian, K.			Cross-Modal Object Recognition Is Viewpoint-Independent	PLOS ONE			English	Article								Background. Previous research suggests that visual and haptic object recognition are viewpoint-dependent both within- and cross-modally. However, this conclusion may not be generally valid as it was reached using objects oriented along their extended y-axis, resulting in differential surface processing in vision and touch. In the present study, we removed this differential by presenting objects along the z-axis, thus making all object surfaces more equally available to vision and touch. Methodology/Principal Findings. Participants studied previously unfamiliar objects, in groups of four, using either vision or touch. Subsequently, they performed a four-alternative forced-choice object identification task with the studied objects presented in both unrotated and rotated (180 degrees about the x-, y-, and z-axes) orientations. Rotation impaired within-modal recognition accuracy in both vision and touch, but not cross- modal recognition accuracy. Within-modally, visual recognition accuracy was reduced by rotation about the x- and y- axes more than the z-axis, whilst haptic recognition was equally affected by rotation about all three axes. Cross-modal (but not within-modal) accuracy correlated with spatial (but not object) imagery scores. Conclusions/Significance. The viewpoint-independence of cross- modal object identification points to its mediation by a high-level abstract representation. The correlation between spatial imagery scores and cross- modal performance suggest that construction of this high-level representation is linked to the ability to perform spatial transformations. Within-modal viewpoint-dependence appears to have a different basis in vision than in touch, possibly due to surface occlusion being important in vision but not touch.	[Lacey, Simon; Peters, Andrew; Sathian, K.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Sathian, K.] Emory Univ, Dept Rehabil Med, Atlanta, GA 30322 USA; [Sathian, K.] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; [Sathian, K.] Atlanta Vet Affairs Med Ctr, Rehabil Res & Dev Ctr Excellence, Decatur, GA USA	Emory University; Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Sathian, K (corresponding author), Emory Univ, Dept Neurol, Atlanta, GA 30322 USA.	krish.sathian@emory.edu		Sathian, Krish/0000-0001-9495-2499; Peters, Andrew/0000-0001-9351-1456	National Eye Institute at NIH [R01 EY012440, K24 EY017332]; National Science Foundation [BCS 0519417]; Veterans Administration; NATIONAL EYE INSTITUTE [R01EY012440, K24EY017332] Funding Source: NIH RePORTER	National Eye Institute at NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Science Foundation(National Science Foundation (NSF)); Veterans Administration(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding: This work was supported by grants to KS from the National Eye Institute at NIH (R01 EY012440 and K24 EY017332) and the National Science Foundation (BCS 0519417). Support to KS by the Veterans Administration is also gratefully acknowledged.	Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Blajenkova O, 2006, APPL COGNITIVE PSYCH, V20, P239, DOI 10.1002/acp.1182; Bushnell EW, 1999, J EXP PSYCHOL HUMAN, V25, P1867, DOI 10.1037/0096-1523.25.6.1867; Casey SJ, 2005, EXP BRAIN RES, V166, P583, DOI 10.1007/s00221-005-2398-3; FREIDES D, 1974, PSYCHOL BULL, V81, P284, DOI 10.1037/h0036331; Gauthier I, 2002, NEURON, V34, P161, DOI 10.1016/S0896-6273(02)00622-0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Heller MA, 2002, PERCEPTION, V31, P747, DOI 10.1068/p3253; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; JOLICOEUR P, 1985, MEM COGNITION, V13, P289, DOI 10.3758/BF03202498; KLATZKY RL, 1987, J EXP PSYCHOL GEN, V116, P356; Kozhevnikov M, 2005, MEM COGNITION, V33, P710, DOI 10.3758/BF03195337; Lacey S, 2006, Q J EXP PSYCHOL, V59, P361, DOI 10.1080/17470210500173232; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Newell F, 2005, EXP BRAIN RES, V161, P233, DOI 10.1007/s00221-004-2067-y; Newell FN, 2001, PSYCHOL SCI, V12, P37, DOI 10.1111/1467-9280.00307; NEWELL KM, 1979, BRIT J PSYCHOL, V70, P87, DOI 10.1111/j.2044-8295.1979.tb02147.x; Norman JF, 2004, PERCEPT PSYCHOPHYS, V66, P342, DOI 10.3758/BF03194883; Pasqualotto A, 2005, EXP BRAIN RES, V166, P481, DOI 10.1007/s00221-005-2388-5; Peltier S, 2007, NEUROPSYCHOLOGIA, V45, P476, DOI 10.1016/j.neuropsychologia.2006.03.003; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; Reales JM, 1999, J EXP PSYCHOL LEARN, V25, P644, DOI 10.1037/0278-7393.25.3.644; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; TARR MJ, 1995, J EXP PSYCHOL HUMAN, V21, P1494, DOI 10.1037/0096-1523.21.6.1494; Zhang MM, 2004, COGN AFFECT BEHAV NE, V4, P251, DOI 10.3758/CABN.4.2.251	27	46	48	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e890	10.1371/journal.pone.0000890	http://dx.doi.org/10.1371/journal.pone.0000890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849019	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455600036
J	Moroni, F; Nobili, L; Curcio, G; De Carli, F; Fratello, F; Marzano, C; De Gennaro, L; Ferrillo, F; Cossu, M; Francione, S; Lo Russo, G; Bertini, M; Ferrara, M				Moroni, Fabio; Nobili, Lino; Curcio, Giuseppe; De Carli, Fabrizio; Fratello, Fabiana; Marzano, Cristina; De Gennaro, Luigi; Ferrillo, Franco; Cossu, Massimo; Francione, Stefano; Lo Russo, Giorgio; Bertini, Mario; Ferrara, Michele			Sleep in the Human Hippocampus: A Stereo-EEG Study	PLOS ONE			English	Article								Background. There is compelling evidence indicating that sleep plays a crucial role in the consolidation of new declarative, hippocampus-dependent memories. Given the increasing interest in the spatiotemporal relationships between cortical and hippocampal activity during sleep, this study aimed to shed more light on the basic features of human sleep in the hippocampus. Methodology/Principal Findings. We recorded intracerebral stereo-EEG directly from the hippocampus and neocortical sites in five epileptic patients undergoing presurgical evaluations. The time course of classical EEG frequency bands during the first three NREM-REM sleep cycles of the night was evaluated. We found that delta power shows, also in the hippocampus, the progressive decrease across sleep cycles, indicating that a form of homeostatic regulation of delta activity is present also in this subcortical structure. Hippocampal sleep was also characterized by: i) a lower relative power in the slow oscillation range during NREM sleep compared to the scalp EEG; ii) a flattening of the time course of the very low frequencies (up to 1 Hz) across sleep cycles, with relatively high levels of power even during REM sleep; iii) a decrease of power in the beta band during REM sleep, at odds with the typical increase of power in the cortical recordings. Conclusions/Significance. Our data imply that cortical slow oscillation is attenuated in the hippocampal structures during NREM sleep. The most peculiar feature of hippocampal sleep is the increased synchronization of the EEG rhythms during REM periods. This state of resonance may have a supportive role for the processing/consolidation of memory.	[Ferrara, Michele] Univ Aquila, Dept Internal Med & Publ Hlth, I-67100 Laquila, Italy; [Moroni, Fabio; Curcio, Giuseppe; Fratello, Fabiana; Marzano, Cristina; De Gennaro, Luigi; Bertini, Mario] Univ Roma La Sapienza, Dept Psychol, Rome, Italy; [Nobili, Lino; Cossu, Massimo; Francione, Stefano; Lo Russo, Giorgio] Osped Niguarda Ca Granda, Ctr Epilepsy Surg C Munari, Ctr Sleep Med, Milan, Italy; [De Carli, Fabrizio] CNR, Inst Bioimaging & Mol Physiol, Sect Genova, Genoa, Italy; [Ferrillo, Franco] Univ Genoa, Sleep Disorders Ctr, Genoa, Italy	University of L'Aquila; Sapienza University Rome; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Consiglio Nazionale delle Ricerche (CNR); University of Genoa	Ferrara, M (corresponding author), Univ Aquila, Dept Internal Med & Publ Hlth, I-67100 Laquila, Italy.	michele.ferrara@cc.univaq.it	Francione, Stefano/K-2615-2018; Russo, Giorgio Lo/AAC-5261-2022; Ferrara, Michele/AAB-7574-2022; Curcio, Giuseppe/M-1635-2014; Nobili, Lino/AAB-6398-2020; Francione, Stefano/AAC-7574-2022; De Carli, Fabrizio/F-8208-2013; Cossu, Massimo/HHM-9543-2022; De Gennaro, Luigi/L-8711-2015; Cossu, Massimo/K-2133-2018	Ferrara, Michele/0000-0003-2304-7576; Nobili, Lino/0000-0001-9317-5405; Francione, Stefano/0000-0002-0577-5193; De Carli, Fabrizio/0000-0002-1841-5146; De Gennaro, Luigi/0000-0003-3613-6631; Cossu, Massimo/0000-0002-1891-7648; Moroni, Fabio/0000-0003-0587-0614; Curcio, Giuseppe/0000-0003-2248-781X				Bodizs R, 2005, BRAIN RES BULL, V65, P169, DOI 10.1016/j.brainresbull.2005.01.002; Bodizs R, 2001, HIPPOCAMPUS, V11, P747, DOI 10.1002/hipo.1090; Borbely A A, 1982, Hum Neurobiol, V1, P195; Bragin A, 2002, ANN NEUROL, V52, P407, DOI 10.1002/ana.10291; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Cantero JL, 2004, NEUROIMAGE, V22, P1271, DOI 10.1016/j.neuroimage.2004.03.014; Cantero JL, 2003, J NEUROSCI, V23, P10897; CHROBAK JJ, 1994, J NEUROSCI, V14, P6160; Cossu M, 2005, J NEUROSURG, V103, P333, DOI 10.3171/ped.2005.103.4.0333; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; Dang-Vu TT, 2005, NEUROIMAGE, V28, P14, DOI 10.1016/j.neuroimage.2005.05.028; De Gennaro L, 2002, CLIN NEUROPHYSIOL, V113, P561, DOI 10.1016/S1388-2457(02)00045-7; DIJK DJ, 1990, SLEEP 90, P3; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; FREEMON FR, 1970, COMPR PSYCHIAT, V2, P544, DOI 10.1016/0010-440X(70)90017-9; Hahn TTG, 2007, P NATL ACAD SCI USA, V104, P5169, DOI 10.1073/pnas.0700222104; Hahn TTG, 2006, NAT NEUROSCI, V9, P1359, DOI 10.1038/nn1788; Hobson JA, 2002, NAT REV NEUROSCI, V3, P679, DOI 10.1038/nrn915; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000276; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; LANCEL M, 1992, SLEEP, V15, P102, DOI 10.1093/sleep/15.2.102; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Maquet P, 1997, MOL PSYCHIATR, V2, P195, DOI 10.1038/sj.mp.4000239; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nishida M, 2004, NEUROSCI RES, V50, P331, DOI 10.1016/j.neures.2004.08.004; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; RECHTSCHAFFEN A, 1986, NIH PUBLICATION, V204; ROBINSON TE, 1980, BRAIN RES REV, V2, P69, DOI 10.1016/0165-0173(80)90004-1; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Staba RJ, 2004, ANN NEUROL, V56, P108, DOI 10.1002/ana.20164; Staba RJ, 2002, J NEUROPHYSIOL, V88, P1743, DOI 10.1152/jn.2002.88.4.1743; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STEWART M, 1990, TRENDS NEUROSCI, V13, P163, DOI 10.1016/0166-2236(90)90040-H; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Uchida S, 2001, BRAIN RES, V891, P7, DOI 10.1016/S0006-8993(00)03154-1; Wehrle R, 2007, EUR J NEUROSCI, V25, P863, DOI 10.1111/j.1460-9568.2007.05314.x; Winson J, 1993, Curr Opin Neurobiol, V3, P243, DOI 10.1016/0959-4388(93)90217-M; WINSON J, 1974, ELECTROEN CLIN NEURO, V36, P291, DOI 10.1016/0013-4694(74)90171-0	46	43	43	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e867	10.1371/journal.pone.0000867	http://dx.doi.org/10.1371/journal.pone.0000867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848998	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455600014
J	Bergeron, A; Belcaid, M; Steward, GF; Poisson, G				Bergeron, Anne; Belcaid, Mahdi; Steward, Grieg F.; Poisson, Guylaine			Divide and Conquer: Enriching Environmental Sequencing Data	PLOS ONE			English	Article								Background. In environmental sequencing projects, a mix of DNA from a whole microbial community is fragmented and sequenced, with one of the possible goals being to reconstruct partial or complete genomes of members of the community. In communities with high diversity of species, a significant proportion of the sequences do not overlap any other fragment in the sample. This problem will arise not only in situations with a relatively even distribution of many species, but also when the community in a particular environment is routinely dominated by the same few species. In the former case, no genomes may be assembled at all, while in the latter case a few dominant species in an environment will always be sequenced at high coverage to the detriment of coverage of the greater number of sparse species. Methods and Results. Here we show that, with the same global sequencing effort, separating the species into two or more sub-communities prior to sequencing can yield a much higher proportion of sequences that can be assembled. We first use the Lander-Waterman model to show that, if the expected percentage of singleton sequences is higher than 25%, then, under the uniform distribution hypothesis, splitting the community is always a wise choice. We then construct simulated microbial communities to show that the results hold for highly non-uniform distributions. We also show that, for the distributions considered in the experiments, it is possible to estimate quite accurately the relative diversity of the two sub-communities. Conclusion. Given the fact that several methods exist to split microbial communities based on physical properties such as size, density, surface biochemistry, or optical properties, we strongly suggest that groups involved in environmental sequencing, and expecting high diversity, consider splitting their communities in order to maximize the information content of their sequencing effort.	[Bergeron, Anne] Univ Quebec, Montreal, PQ H3C 3P8, Canada; [Belcaid, Mahdi; Poisson, Guylaine] Univ Hawaii Manoa, Honolulu, HI 96822 USA; [Steward, Grieg F.] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA	University of Quebec; University of Quebec Montreal; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Bergeron, A (corresponding author), Univ Quebec, Montreal, PQ H3C 3P8, Canada.	bergeron.anne@uqam.ca	Steward, Grieg F./D-9768-2011; Bergeron, Anne/B-9861-2012	Steward, Grieg F./0000-0001-5988-0522; 	NSERC; National Science Foundation [OCE 04-42664, EF 04-24599]; National Center for Research Resources [P20 RR-16467]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016467] Funding Source: NIH RePORTER	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	AB was partly supported by NSERC. GFS was partly supported by a grant from the National Science Foundation (OCE 04-42664 and EF 04-24599). GP was partly supported by the NIH Grant number P20 RR-16467 from the National Center for Research Resources, and, as appropriate, its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Chen K, 2005, PLOS COMPUT BIOL, V1, P106, DOI 10.1371/journal.pcbi.0010024; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; LANDER E S, 1988, Genomics, V2, P231; OLLIVON M, 1986, ANAL BIOCHEM, V152, P262, DOI 10.1016/0003-2697(86)90408-2; RICE RH, 1972, VIROLOGY, V49, P602, DOI 10.1016/0042-6822(72)90512-0; RICKWOOD D, CENTRIFUGATION PRACT; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Scriver CR, 2001, ANNU REV GENOM HUM G, V2, P69, DOI 10.1146/annurev.genom.2.1.69; SMITH TJ, 1987, J VIROL METHODS, V16, P263, DOI 10.1016/0166-0934(87)90011-5; Steward GF, 2000, LIMNOL OCEANOGR, V45, P1697, DOI 10.4319/lo.2000.45.8.1697; Steward GF, 2007, ISME J, V1, P100, DOI 10.1038/ismej.2007.25; [No title captured]	18	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e830	10.1371/journal.pone.0000830	http://dx.doi.org/10.1371/journal.pone.0000830			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786202	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455500014
J	Diks, SH; Parikh, K; van der Sijde, M; Joore, J; Ritsema, T; Peppelenbosch, MP				Diks, Sander H.; Parikh, Kaushal; van der Sijde, Marijke; Joore, Jos; Ritsema, Tita; Peppelenbosch, Maikel P.			Evidence for a Minimal Eukaryotic Phosphoproteome?	PLOS ONE			English	Article								Background. Reversible phosphorylation catalysed by kinases is probably the most important regulatory mechanism in eukaryotes. Methodology/Principal Findings. We studied the in vitro phosphorylation of peptide arrays exhibiting the majority of PhosphoBase-deposited protein sequences, by factors in cell lysates from representatives of various branches of the eukaryotic species. We derived a set of substrates from the PhosphoBase whose phosphorylation by cellular extracts is common to the divergent members of different kingdoms and thus may be considered a minimal eukaryotic phosphoproteome. The protein kinases ( or kinome) responsible for phosphorylation of these substrates are involved in a variety of processes such as transcription, translation, and cytoskeletal reorganisation. Conclusions/Significance. These results indicate that the divergence in eukaryotic kinases is not reflected at the level of substrate phosphorylation, revealing the presence of a limited common substrate space for kinases in eukaryotes and suggests the presence of a set of kinase substrates and regulatory mechanisms in an ancestral eukaryote that has since remained constant in eukaryotic life.	[Diks, Sander H.; Parikh, Kaushal; van der Sijde, Marijke; Peppelenbosch, Maikel P.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Kinome Profiling Unit, Groningen, Netherlands; [Joore, Jos] Pepscan Presto, Lelystad, Flevoland, Netherlands; [Ritsema, Tita] Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands	University of Groningen; Utrecht University	Diks, SH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Kinome Profiling Unit, Groningen, Netherlands.	m.p.peppelenbosch@med.umcg.nl		Parikh, Kaushal/0000-0002-3247-3676; Peppelenbosch, Maikel/0000-0001-9112-6028; Joore, Jos/0000-0002-2744-4862	the regional programme of innovative actions in Groningen (IAG); Top Institute Pharma (TI Pharma); Netherlands Organisation for Scientific Research (NWO)	the regional programme of innovative actions in Groningen (IAG); Top Institute Pharma (TI Pharma); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported in part by grants from the regional programme of innovative actions in Groningen (IAG) and Top Institute Pharma (TI Pharma). SHD is supported by a Casimir fellowship funded by the Netherlands Organisation for Scientific Research (NWO).	Alexopoulos C. J., 1996; Besant PG, 2003, INT J BIOCHEM CELL B, V35, P297, DOI 10.1016/S1357-2725(02)00257-1; Bradham CA, 2006, DEV BIOL, V300, P180, DOI 10.1016/j.ydbio.2006.08.074; Brinkworth RI, 2003, P NATL ACAD SCI USA, V100, P74, DOI 10.1073/pnas.0134224100; Champion A., 2004, Functional & Integrative Genomics, V4, P163, DOI 10.1007/s10142-003-0096-4; Diks SH, 2004, J BIOL CHEM, V279, P49206, DOI 10.1074/jbc.M405028200; DOUVILLE E, 1994, CANCER METAST REV, V13, P1, DOI 10.1007/BF00690414; Forsberg J, 2001, PHOTOSYNTH RES, V68, P71, DOI 10.1023/A:1011891017067; Goldberg JM, 2006, PLOS GENET, V2, P291, DOI 10.1371/journal.pgen.0020038; Hanks SK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-111; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; HIRAYAMA T, 1992, PLANT MOL BIOL, V20, P653, DOI 10.1007/BF00046450; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Kreegipuu A, 1999, NUCLEIC ACIDS RES, V27, P237, DOI 10.1093/nar/27.1.237; Krupa A, 2002, GENOME BIOL, V3; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; LINDBERG RA, 1992, TRENDS BIOCHEM SCI, V17, P114, DOI 10.1016/0968-0004(92)90248-8; Lowenberg M, 2005, BLOOD, V106, P1703, DOI 10.1182/blood-2004-12-4790; Malathi K, 1999, GENETICS, V153, P1145; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; MATTHEWS HR, 1995, PHARMACOL THERAPEUT, V67, P323, DOI 10.1016/0163-7258(95)00020-8; MIRANDASAAVEDRA D, 2007, PROTEINS; Modesti A, 2001, ELECTROPHORESIS, V22, P576, DOI 10.1002/1522-2683(200102)22:3<576::AID-ELPS576>3.0.CO;2-P; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; Rudrabhatla P, 2004, BIOCHEMISTRY-US, V43, P12123, DOI 10.1021/bi0497042; Rudrabhatla P, 2006, PLANT MOL BIOL, V60, P293, DOI 10.1007/s11103-005-4109-7; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Segawa Y, 2006, P NATL ACAD SCI USA, V103, P12021, DOI 10.1073/pnas.0600021103; Steeg PS, 2003, CANCER LETT, V190, P1, DOI 10.1016/S0304-3835(02)00499-8; STERN DF, 1991, MOL CELL BIOL, V11, P987, DOI 10.1128/MCB.11.2.987; VARELA F G, 1974, Biosystems, V5, P187, DOI 10.1016/0303-2647(74)90031-8; Vieth M, 2005, DRUG DISCOV TODAY, V10, P839, DOI 10.1016/S1359-6446(05)03477-X; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Wolanin PM, 2002, GENOME BIOL, V3; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576	41	39	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e777	10.1371/journal.pone.0000777	http://dx.doi.org/10.1371/journal.pone.0000777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712425	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455300025
J	Green, RE; Taggart, MA; Senacha, KR; Raghavan, B; Pain, DJ; Jhala, Y; Cuthbert, R				Green, Rhys E.; Taggart, Mark A.; Senacha, Kalu Ram; Raghavan, Bindu; Pain, Deborah J.; Jhala, Yadvendradev; Cuthbert, Richard			Rate of Decline of the Oriental White-Backed Vulture Population in India Estimated from a Survey of Diclofenac Residues in Carcasses of Ungulates	PLOS ONE			English	Article								The non-steroidal anti-inflammatory drug diclofenac is a major cause of the rapid declines in the Indian subcontinent of three species of vultures endemic to South Asia. The drug causes kidney failure and death in vultures. Exposure probably arises through vultures feeding on carcasses of domesticated ungulates treated with the drug. However, before the study reported here, it had not been established from field surveys of ungulate carcasses that a sufficient proportion was contaminated to cause the observed declines. We surveyed diclofenac concentrations in samples of liver from carcasses of domesticated ungulates in India in 2004-2005. We estimated the concentration of diclofenac in tissues available to vultures, relative to that in liver, and the proportion of vultures killed after feeding on a carcass with a known level of contamination. We assessed the impact of this mortality on vulture population trend with a population model. We expected levels of diclofenac found in ungulate carcasses in 2004-2005 to cause oriental white-backed vulture population declines of 80-99% per year, depending upon the assumptions used in the model. This compares with an observed rate of decline, from road transect counts, of 48% per year in 2000-2003. The precision of the estimate based upon carcass surveys is low and the two types of estimate were not significantly different. Our analyses indicate that the level of diclofenac contamination found in carcasses of domesticated ungulates in 2004-2005 was sufficient to account for the observed rapid decline of the oriental white-backed vulture in India. The methods we describe could be used again to assess changes in the effect on vulture population trend of diclofenac and similar drugs. In this way, the effectiveness of the recent ban in India on the manufacture and importation of diclofenac for veterinary use could be monitored.	[Green, Rhys E.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England; [Green, Rhys E.; Pain, Deborah J.; Cuthbert, Richard] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Taggart, Mark A.] Univ Aberdeen, Dept Plant & Soil Sci, Sch Biol Sci, Aberdeen, Scotland; [Taggart, Mark A.] Univ Castilla La Mancha, Inst Invest Recursos Cineget, Ciudad Real, Spain; [Senacha, Kalu Ram; Raghavan, Bindu] Bombay Nat Hist Soc, Bombay, Maharashtra, India; [Jhala, Yadvendradev] Wildlife Inst India, Dehra Dun, Uttaranchal, India	University of Cambridge; Royal Society for Protection of Birds; University of Aberdeen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Wildlife Institute of India	Green, RE (corresponding author), Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England.	reg29@hermes.cam	Jhala, Yadvendradev/AAL-9711-2020	Taggart, Mark/0000-0002-0649-8490; Raghavan, Bindu/0000-0002-1819-5251	Darwin Initiative; Royal Society	Darwin Initiative; Royal Society(Royal Society of London)	The research is part of a programme on vulture conservation science co-funded by Darwin Initiative for the Survival of Species of the UK Government's Department for Environment, Food and Rural Affairs, the Royal Society for the Protection of Birds and the Zoological Society of London. The RSPB is a sponsor and also employs 3 of the authors of this paper as scientists who are members of its Conservation Science department. Other than that, sponsors have not been involved in any aspect of the preparation, review, approval or any other aspect of this paper.	Cuthbert R, 2007, BIOL LETTERS, V3, P90, DOI 10.1098/rsbl.2006.0554; Gilbert M, 2006, ORYX, V40, P388, DOI 10.1017/S0030605306001347; Green RE, 2004, J APPL ECOL, V41, P793, DOI 10.1111/j.0021-8901.2004.00954.x; Green RE, 2006, J APPL ECOL, V43, P949, DOI 10.1111/j.1365-2664.2006.01225.x; GRUBH RB, 1974, THESIS U BOMBAY MUMB; *IUCN, 2006, 2006 IUCN RED LIST T; Johnson JA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-65; Kalbfleisch J. G., 1979, PROBABILITY STAT INF; Oaks JL, 2004, NATURE, V427, P630, DOI 10.1038/nature02317; Prakash V, 2003, BIOL CONSERV, V109, P381, DOI 10.1016/S0006-3207(02)00164-7; ROTHERY P, 1988, BIRD STUDY, V35, P219, DOI 10.1080/00063658809476992; Shultz S, 2004, P ROY SOC B-BIOL SCI, V271, pS458, DOI 10.1098/rsbl.2004.0223; Swan G, 2006, PLOS BIOL, V4, P395, DOI 10.1371/journal.pbio.0040066; Swan GE, 2006, BIOL LETT-UK, V2, P279, DOI 10.1098/rsbl.2005.0425; Taggart MA, 2007, ENVIRON INT, V33, P759, DOI 10.1016/j.envint.2007.02.010; White C.M., 1994, NEW WORLD VULTURES G	16	54	64	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e686	10.1371/journal.pone.0000686	http://dx.doi.org/10.1371/journal.pone.0000686			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668064	Green Published, gold			2022-12-27	WOS:000207452300022
J	Appenzeller, O; Qualls, C; Barbic, F; Furlan, R; Porta, A				Appenzeller, Otto; Qualls, Clifford; Barbic, Franca; Furlan, Raffaello; Porta, Alberto			Stable Isotope Ratios in Hair and Teeth Reflect Biologic Rhythms	PLOS ONE			English	Article								Biologic rhythms give insight into normal physiology and disease. They can be used as biomarkers for neuronal degenerations. We present a diverse data set to show that hair and teeth contain an extended record of biologic rhythms, and that analysis of these tissues could yield signals of neurodegenerations. We examined hair from mummified humans from South America, extinct mammals and modern animals and people, both healthy and diseased, and teeth of hominins. We also monitored heart-rate variability, a measure of a biologic rhythm, in some living subjects and analyzed it using power spectra. The samples were examined to determine variations in stable isotope ratios along the length of the hair and across growth-lines of the enamel in teeth. We found recurring circa-annual periods of slow and fast rhythms in hydrogen isotope ratios in hair and carbon and oxygen isotope ratios in teeth. The power spectra contained slow and fast frequency power, matching, in terms of normalized frequency, the spectra of heart rate variability found in our living subjects. Analysis of the power spectra of hydrogen isotope ratios in hair from a patient with neurodegeneration revealed the same spectral features seen in the patient's heart-rate variability. Our study shows that spectral analysis of stable isotope ratios in readily available tissues such as hair could become a powerful diagnostic tool when effective treatments and neuroprotective drugs for neurodegenerative diseases become available. It also suggests that similar analyses of archaeological specimens could give insight into the physiology of ancient people and animals.	[Appenzeller, Otto] New Mexico Hlth Enhancement & Marathon Clin Res F, Albuquerque, NM USA; [Qualls, Clifford] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA; [Barbic, Franca; Furlan, Raffaello] Univ Milan, Osped L Sacco, Milan, Italy; [Porta, Alberto] Univ Milan, IRCCS, Ist Ortoped Galeazzi, Dipartimento Tecnol Salute, Milan, Italy	University of New Mexico; University of Milan; Luigi Sacco Hospital; IRCCS Istituto Ortopedico Galeazzi; University of Milan	Appenzeller, O (corresponding author), New Mexico Hlth Enhancement & Marathon Clin Res F, Albuquerque, NM USA.	oarun@unm.edu	Porta, Alberto/K-4390-2016; Furlan, Raffaello/AAH-3167-2021; Barbic, Franca/S-2183-2019; Barbic, Franca/GLV-2669-2022	Porta, Alberto/0000-0002-6720-9824; Furlan, Raffaello/0000-0001-5209-6786; Barbic, Franca/0000-0002-8283-1988; 	NMHEMC Research Foundation, Albuquerque NM USA	NMHEMC Research Foundation, Albuquerque NM USA	Funding: Funded by NMHEMC Research Foundation, Albuquerque NM USA.	Barbic F, 2007, HYPERTENSION, V49, P120, DOI 10.1161/01.HYP.0000250939.71343.7c; Botchkarev VA, 1997, J COMP NEUROL, V386, P379, DOI 10.1002/(SICI)1096-9861(19970929)386:3<379::AID-CNE4>3.0.CO;2-Z; BROMAGE TG, 1985, NATURE, V317, P525, DOI 10.1038/317525a0; Buijs RM, 2003, J ENDOCRINOL, V177, P17, DOI 10.1677/joe.0.1770017; CHESHIRE WP, 2000, AUTONOMIC NERVOUS 2, P105; Iranzo A, 2006, LANCET NEUROL, V5, P572, DOI 10.1016/S1474-4422(06)70476-8; Krause K, 2006, SEMIN CUTAN MED SURG, V25, P2, DOI 10.1016/j.sder.2006.01.002; Lincoln GA, 2006, SCIENCE, V314, P1941, DOI 10.1126/science.1132009; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Pregueiro AM, 2006, SCIENCE, V313, P644, DOI 10.1126/science.1121716; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Sharp ZD, 2003, J ARCHAEOL SCI, V30, P1709, DOI 10.1016/S0305-4403(03)00071-2; Sponheimer M, 2006, SCIENCE, V314, P980, DOI 10.1126/science.1133827; USGS MENLO PARK CALI; 2006, NATURE, V442, pR7	17	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e636	10.1371/journal.pone.0000636	http://dx.doi.org/10.1371/journal.pone.0000636			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653263	gold, Green Submitted, Green Published			2022-12-27	WOS:000207452200005
J	Sharpee, T; Bialek, W				Sharpee, Tatyana; Bialek, William			Neural Decision Boundaries for Maximal Information Transmission	PLOS ONE			English	Article							NATURAL IMAGES; STATISTICS; FEATURES; NEURONS; EFFICIENCY; RESPONSES; CONTRAST	We consider here how to separate multidimensional signals into two categories, such that the binary decision transmits the maximum possible information about those signals. Our motivation comes from the nervous system, where neurons process multidimensional signals into a binary sequence of responses (spikes). In a small noise limit, we derive a general equation for the decision boundary that locally relates its curvature to the probability distribution of inputs. We show that for Gaussian inputs the optimal boundaries are planar, but for non-Gaussian inputs the curvature is nonzero. As an example, we consider exponentially distributed inputs, which are known to approximate a variety of signals from natural environment.	[Sharpee, Tatyana] Crick Jacobs Ctr Theoret Biol, La Jolla, CA USA; [Sharpee, Tatyana] Salk Inst Biol Studies, Lab Computat Neurobiol, La Jolla, CA 92037 USA; [Bialek, William] Princeton Univ, Joseph Henry Labs Phys, Lewis Sigler Inst Integrat Genom, Princeton Ctr Theoret Phys, Princeton, NJ 08544 USA	Salk Institute; Princeton University	Sharpee, T (corresponding author), Crick Jacobs Ctr Theoret Biol, La Jolla, CA USA.	sharpee@salk.edu	Sharpee, Tatyana/E-8663-2010	Sharpee, Tatyana/0000-0002-7483-5081	NIMH; Swartz Foundation	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Swartz Foundation	Funding: This work was supported by the NIMH and the Swartz Foundation.	Arcas BAY, 2003, NEURAL COMPUT, V15, P1715, DOI 10.1162/08997660360675017; Atick JJ, 1990, NEURAL COMPUT, V2, P308, DOI 10.1162/neco.1990.2.3.308; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Balasubramanian V, 2001, NEURAL COMPUT, V13, P799, DOI 10.1162/089976601300014358; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BARLOW HB, 1959, P S MECH THOUGHT PRO; Bialek W, 2005, FEATURES DIMENSIONS; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; BUCHSBAUM G, 1983, PROC R SOC SER B-BIO, V220, P89, DOI 10.1098/rspb.1983.0090; COVER T. M., 2012, ELEMENTS INFORM THEO, DOI 10.1002/0471200611; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DeWeese M, 1996, NETWORK-COMP NEURAL, V7, P325, DOI 10.1088/0954-898X/7/2/013; Escabi MA, 2003, J NEUROSCI, V23, P11489; Fairhall AL, 2006, J NEUROPHYSIOL, V96, P2724, DOI 10.1152/jn.00995.2005; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Hsu A, 2004, J NEUROSCI, V24, P9201, DOI 10.1523/JNEUROSCI.2449-04.2004; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Linsker R., 1989, ADV NEURAL INFORMATI, P186; Machens CK, 2003, NAT NEUROSCI, V6, P341, DOI 10.1038/nn1036; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; MINSKY ML, 1969, PAPERT SA PERCEPTRON, P263; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; RIEKE F, 1997, SPIKES EXPLORING NEU, P416; RUDERMAN DL, 1994, NETWORK-COMP NEURAL, V5, P517, DOI 10.1088/0954-898X/5/4/006; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Sarpeshkar R, 1998, NEURAL COMPUT, V10, P1601, DOI 10.1162/089976698300017052; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Slee SJ, 2005, J NEUROSCI, V25, P9978, DOI 10.1523/JNEUROSCI.2666-05.2005; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; STRUIK DJ, 1988, LECT CLASSICAL DIFFE, P240	38	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e646	10.1371/journal.pone.0000646	http://dx.doi.org/10.1371/journal.pone.0000646			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653273	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452200015
J	Iseli, C; Ambrosini, G; Bucher, P; Jongeneel, CV				Iseli, Christian; Ambrosini, Giovanna; Bucher, Philipp; Jongeneel, C. Victor			Indexing Strategies for Rapid Searches of Short Words in Genome Sequences	PLOS ONE			English	Article								Searching for matches between large collections of short (14-30 nucleotides) words and sequence databases comprising full genomes or transcriptomes is a common task in biological sequence analysis. We investigated the performance of simple indexing strategies for handling such tasks and developed two programs, fetchGWI and tagger, that index either the database or the query set. Either strategy outperforms megablast for searches with more than 10,000 probes. FetchGWI is shown to be a versatile tool for rapidly searching multiple genomes, whose performance is limited in most cases by the speed of access to the filesystem. We have made publicly available a Web interface for searching the human, mouse, and several other genomes and transcriptomes with oligonucleotide queries.	[Iseli, Christian; Jongeneel, C. Victor] Univ Lausanne, Ludwig Inst Canc Res, Lausanne, Switzerland; [Iseli, Christian; Ambrosini, Giovanna; Bucher, Philipp; Jongeneel, C. Victor] Univ Lausanne, Swiss Inst Bioinformat, Lausanne, Switzerland; [Ambrosini, Giovanna; Bucher, Philipp] Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland	Ludwig Institute for Cancer Research; University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Swiss Institute Experimental Cancer Research	Iseli, C (corresponding author), Univ Lausanne, Ludwig Inst Canc Res, Batiment Genopode, Lausanne, Switzerland.	Christian.Iseli@licr.org	Iseli, Christian/AAM-3878-2020; Jongeneel, Cornelis V/B-2135-2012	Iseli, Christian/0000-0002-2296-2863; Ambrosini, Giovanna/0000-0003-1294-6541; Jongeneel, Cornelis Victor/0000-0002-3922-1906				Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Brenner S, 2000, P NATL ACAD SCI USA, V97, P1665, DOI 10.1073/pnas.97.4.1665; Iseli C, 2002, GENOME RES, V12, P1068, DOI 10.1101/gr.62002; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Knuth D, 1997, SORTING SEARCHING, P409; Kuhn RM, 2007, NUCLEIC ACIDS RES, V35, pD668, DOI 10.1093/nar/gkl928; Lal A, 1999, CURR OPIN MOL THER, V1, P720; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Praz V, 2004, NUCLEIC ACIDS RES, V32, pD542, DOI 10.1093/nar/gkh107; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Schmid CD, 2006, NUCLEIC ACIDS RES, V34, pD82, DOI 10.1093/nar/gkj146; Stalker J, 2004, GENOME RES, V14, P951, DOI 10.1101/gr.1863004; Wei CL, 2004, P NATL ACAD SCI USA, V101, P11701, DOI 10.1073/pnas.0403514101; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	16	56	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e579	10.1371/journal.pone.0000579	http://dx.doi.org/10.1371/journal.pone.0000579			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593978	gold, Green Published			2022-12-27	WOS:000207451800023
J	Timpka, T; Angbratt, M; Bolme, P; Hermansson, G; Hager, A; Valter, L				Timpka, Toomas; Angbratt, Marianne; Bolme, Per; Hermansson, Goran; Hager, Anders; Valter, Lars			A High-Precision Protocol for Identification of Preschool Children at Risk for Persisting Obesity	PLOS ONE			English	Article							CHILDHOOD OBESITY; OVERWEIGHT; WEIGHT; INTERVENTIONS; ADOLESCENTS; PREVALENCE; ADIPOSITY; ADULTS; MASS	Background. Recent studies suggest that adolescent adiposity is established already in preadolescence. Earlier studies have confirmed a strong tracking of obesity from adolescence to adulthood. Our aim was to examine the diagnostic accuracy of a population-derived protocol for identification of preschool children at risk for obesity in preadolescence. Methodology/Principal Findings. We analysed data obtained for child health surveillance up to age 5 from 5778 children born in a Swedish county in 1991. The basic data set included age, sex, and weight and height measurements from the regular checkups between ages 1.5 and 5. Data not routinely collected in the child health centre setting were disregarded. The children were at age 10 randomly assigned to protocol derivation and validation cohorts and assessed for obesity according to IOTF criteria. The accuracy of predicting obesity in the validation cohort was measured using decision precision, specificity, and sensitivity. The decision protocol selected 1.4% of preschool children as being at obesity risk. The precision of the protocol at age 10 was 82% for girls and 80% for boys, and the specificity was 100% for both boys and girls. The sensitivity was higher for girls (41%) than for boys (21%). The relative risk for obesity at age 10 estimated by the odds ratio for individuals selected by the protocol compared to non-selected peers was 212.6 (95% confidence interval 56.6 to 798.4) for girls and 120.3 (95% CI 24.5 to 589.9) for boys. Conclusion/Significance. A simple and inexpensive decision protocol based on BMI values proved to have high precision and specificity for identification of preschool children at risk for obesity persisting into adolescence, while the sensitivity was low especially for boys. Implementation and further evaluations of the protocol in child health centre settings are warranted.	[Timpka, Toomas; Angbratt, Marianne] Linkoping Univ, Dept Hlth & Soc, Sect Social Med & Publ Hlth, S-58183 Linkoping, Sweden; [Timpka, Toomas; Angbratt, Marianne; Valter, Lars] Ctr Publ Hlth, Ostergotland Cty Council, Linkoping, Sweden; [Bolme, Per; Hermansson, Goran; Hager, Anders] Linkoping Univ Hosp, Dept Paediat, S-58185 Linkoping, Sweden	Linkoping University; City Council Ostergotland; Linkoping University	Timpka, T (corresponding author), Linkoping Univ, Dept Hlth & Soc, Sect Social Med & Publ Hlth, S-58183 Linkoping, Sweden.	tti@ida.liu.se	Timpka, Toomas/E-8065-2018		Linkoping University Hospital, Sweden	Linkoping University Hospital, Sweden	Annual ALF financing (a special government subsidy) was obtained from Linkoping University Hospital, Sweden. The funding agency did not influence the research process in any aspect.	Andersen LF, 2005, SCAND J PUBLIC HEALT, V33, P99, DOI 10.1080/140349404100410019172; Barlow SE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.3.e29; Barlow SE, 2002, PEDIATRICS, V110, P222; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; CHADWICK D, 1993, BRIT MED J, V306, P1374; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dorosty AR, 2000, PEDIATRICS, V105, P1115, DOI 10.1542/peds.105.5.1115; Dubois L, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-9; Ekelund U, 2006, AM J CLIN NUTR, V83, P324; FEINSTEIN A, 1989, CLINIMETRICS; FLEGAL KM, 1993, CRIT REV FOOD SCI, V33, P307, DOI 10.1080/10408399309527625; Fox KR, 2004, J R SOC PROMO HEALTH, V124, P34, DOI 10.1177/146642400312400111; *IOM, 2005, PREV CHILDH OB HLTH; Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x; JOHANNSSON E, 2006, INT J OBES LOND 0221; Kim J, 2005, AM J PUBLIC HEALTH, V95, P1588, DOI 10.2105/AJPH.2004.054015; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Krassas Gerasimos E, 2004, Pediatr Endocrinol Rev, V1 Suppl 3, P455; Li CY, 2007, OBESITY, V15, P760, DOI 10.1038/oby.2007.585; Marild S, 2004, ACTA PAEDIATR, V93, P1588, DOI 10.1080/08035250410018265; McLean N, 2003, INT J OBESITY, V27, P987, DOI 10.1038/sj.ijo.0802383; McTigue KM, 2003, ANN INTERN MED, V139, P933, DOI 10.7326/0003-4819-139-11-200312020-00013; Nader PR, 2006, PEDIATRICS, V118, pE594, DOI 10.1542/peds.2005-2801; REILLY JJ, 2005, BRIT MED J, DOI DOI 10.1136/BMJ.38470.670903.EOAE; Smidt N, 2005, RADIOLOGY, V235, P347, DOI 10.1148/radiol.2352040507; STIELL IG, 1993, JAMA-J AM MED ASSOC, V269, P1127, DOI 10.1001/jama.269.9.1127; STIELL IG, 1994, JAMA-J AM MED ASSOC, V271, P827, DOI 10.1001/jama.271.11.827; Story MT, 2002, PEDIATRICS, V110, P210; Tappy L, 2006, INT J OBESITY, V30, pS36, DOI 10.1038/sj.ijo.0803517; TAYLOR PD, 2006, EXP PHYSL       1214; Toschke AM, 2005, OBES RES, V13, P1270, DOI 10.1038/oby.2005.151; Valerio G, 2006, NUTR METAB CARDIOVAS, V16, P272, DOI 10.1016/j.numecd.2005.10.008; Wardle J, 2005, P NUTR SOC, V64, P73, DOI 10.1079/PNS2004411; Wardle J, 2006, BRIT MED J, V332, P1130, DOI 10.1136/bmj.38807.594792.AE; Whitlock EP, 2005, PEDIATRICS, V116, pE125, DOI 10.1542/peds.2005-0242	35	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2007	2	6							e535	10.1371/journal.pone.0000535	http://dx.doi.org/10.1371/journal.pone.0000535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GE	17579709	Green Published, gold			2022-12-27	WOS:000207451700003
J	Arrigo, N; Arnold, C				Arrigo, Nils; Arnold, Claire			Naturalised Vitis Rootstocks in Europe and Consequences to Native Wild Grapevine	PLOS ONE			English	Article							GENETIC DIVERSITY; DNA; DIFFERENTIATION; IDENTIFICATION; POPULATIONS; COMMUNITIES; LOCI	The genus Vitis is represented by several coexisting species in Europe. Our study focuses on naturalised rootstocks that originate in viticulture. The consequences of their presence to the landscape and to native European species (Vitis vinifera ssp. silvestris) are evaluated. This study compares ecological traits (seven qualitative and quantitative descriptors) and the genetic diversity (10 SSR markers) of populations of naturalised rootstocks and native wild grapevines. 18 large naturalised rootstock populations were studied in the Rhone watershed. Wild European grapevines are present in four main habitats (screes, alluvial forests, hedges, and streamside hedges). In contrast, naturalised rootstock populations are mainly located in alluvial forests, but they clearly take advantage of alluvial system dynamics and connectivity at the landscape level. These latter populations appear to reproduce sexually, and show a higher genetic diversity than Vitis vinifera ssp. silvestris. The regrouping of naturalised rootstocks in interconnected populations tends to create active hybrid swarms of rootstocks. The rootstocks show characters of invasive plants. The spread of naturalised rootstocks in the environment, the acceleration of the decline of the European wild grapevine, and the propagation of genes of viticultural interest in natural populations are potential consequences that should be kept in mind when undertaking appropriate management measures.	[Arnold, Claire] Univ Neuchatel, Natl Ctr Competence Res Plant Survival, CH-2000 Neuchatel, Switzerland; [Arrigo, Nils] Univ Neuchatel, Lab Evolutionary Bot, CH-2000 Neuchatel, Switzerland	University of Neuchatel; University of Neuchatel	Arnold, C (corresponding author), Univ Neuchatel, Natl Ctr Competence Res Plant Survival, CH-2000 Neuchatel, Switzerland.	claire.arnold@unine.ch	Arnold, Claire/AAC-7330-2022	Arnold, Claire/0000-0002-1179-0728	Swiss Confederation [SER-COST C04.0262]; Laboratory of Evolutionary Botany (University of Neuchatel)	Swiss Confederation; Laboratory of Evolutionary Botany (University of Neuchatel)	Swiss Confederation SER-COST C04.0262, Laboratory of Evolutionary Botany (University of Neuchatel)	Abella SR, 2004, J TORREY BOT SOC, V131, P220, DOI 10.2307/4126952; Amoros C, 2002, FRESHWATER BIOL, V47, P761, DOI 10.1046/j.1365-2427.2002.00905.x; *APPL BIOS, 2001, ABI PRISM GENESCAN 3; *APPL BIOS, 2001, ABI PRISM GEN 3 7 NT; Aradhya MK, 2003, GENET RES, V81, P179, DOI 10.1017/S0016672303006177; Arnold C, 1998, VITIS, V37, P159; Arnold C., 2002, GEOBOTANICA HELVETIC, V76, P256; BELKHIR K, 1996, LAB GENOME P INTERAC; Bowers JE, 1999, AM J ENOL VITICULT, V50, P243; Bowers JE, 1996, GENOME, V39, P628, DOI 10.1139/g96-080; *CRAN, 2005, R PROJ STAT COMP 2 0; CRAWLEY MJ, 1986, PHILOS T ROY SOC B, V314, P711, DOI 10.1098/rstb.1986.0082; DELARZE R, 1998, GUIDE MILIEUX NATURE, P415; Desfayes M, 1989, B MURITHIENNE, V107, P161; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; *DIREN, 2007, REG DIREN DRIRE; *DIREN RHON ALP, 2001, GAL FOR CONFL AIN RH; *DRIRE PACA, 2007, DONN ENV; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Falush D, 2003, GENETICS, V164, P1567; FARQUET P, 1928, B MURITHIENNE, V16, P111; Forman R.T.T., 1986, LANDSCAPE ECOLOGY, P640; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Grassi F, 2003, THEOR APPL GENET, V107, P1315, DOI 10.1007/s00122-003-1321-1; LAGUNA E, 2004, TOLL NEGRE, V3, P11; Laguna E., 2003, FLORA MONTIBERICA, V23, P46; LEVADOUX L., 1956, Annales de l'Amelioration des Plantes, V6, P59; LEVADOUX L., 1962, ANN AMELIORATION PLANTES, V12, P19; Lin H, 1998, AM J ENOL VITICULT, V49, P403; LUMBRERAS EL, 2003, TOLL NEGRE, V2, P10; Meadows JS, 2006, NEW FOREST, V32, P335, DOI 10.1007/s11056-006-9007-6; MORANO LD, 1995, AM MIDL NAT, V134, P254, DOI 10.2307/2426296; *NATURA2000, 2007, RES EC EUR NAT 2000; Ocete R, 2002, VITIS, V41, P55; Olmo H., 1995, EVOLUTION CROP PLANT, V1, P485; *ONIVINS, 2007, LIST CLON AGR VAR PO; PlantyTabacchi AM, 1996, CONSERV BIOL, V10, P598, DOI 10.1046/j.1523-1739.1996.10020598.x; Pollefeys P, 2003, GENOME, V46, P1037, DOI 10.1139/G03-076; RIBEREAUGAYON J, 1971, SCI TECHNIQUES VIGNE, P725; Rives M., 1974, Vitis, V13, P186; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Schumann F., 1974, Vitis, V13, P198; SCHWARZENBACH H, 1968, Wein-Wissenschaft, V23, P145; Sefc K. M., 2000, Acta Horticulturae, P111; Sefc KM, 1999, GENOME, V42, P367, DOI 10.1139/gen-42-3-367; This P, 2004, THEOR APPL GENET, V109, P1448, DOI 10.1007/s00122-004-1760-3; This P, 2001, GENET SEL EVOL, V33, pS289, DOI 10.1186/BF03500885; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; THOMAS MR, 1993, THEOR APPL GENET, V86, P985, DOI 10.1007/BF00211051; VOUILLAMOZ J, 2006, SVMD SWISS VITIS MIC; Ward JV, 1999, REGUL RIVER, V15, P125, DOI 10.1002/(SICI)1099-1646(199901/06)15:1/3&lt;125::AID-RRR523&gt;3.0.CO;2-E	52	51	63	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2007	2	6							e521	10.1371/journal.pone.0000521	http://dx.doi.org/10.1371/journal.pone.0000521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GD	17565374	gold, Green Published, Green Submitted			2022-12-27	WOS:000207451600009
J	Barreau, F; Meinzer, U; Chareyre, F; Berrebi, D; Niwa-Kawakita, M; Dussaillant, M; Foligne, B; Ollendorff, V; Heyman, M; Bonacorsi, S; Lesuffleur, T; Sterkers, G; Giovannini, M; Hugot, JP				Barreau, Frederick; Meinzer, Ulrich; Chareyre, Fabrice; Berrebi, Dominique; Niwa-Kawakita, Michiko; Dussaillant, Monique; Foligne, Benoit; Ollendorff, Vincent; Heyman, Martine; Bonacorsi, Stephane; Lesuffleur, Thecla; Sterkers, Ghislaine; Giovannini, Marco; Hugot, Jean-Pierre			CARD15/NOD2 Is Required for Peyer's Patches Homeostasis in Mice	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; INCREASED INTESTINAL PERMEABILITY; NECROSIS-FACTOR-ALPHA; CROHNS-DISEASE; INTERFERON-GAMMA; NOD2 VARIANTS; BARRIER; CELLS; AGE; INFLAMMATION	Background. CARD15/NOD2 mutations are associated with susceptibility to Crohn's Disease (CD) and Graft Versus Host Disease (GVHD). CD and GVHD are suspected to be related with the dysfunction of Peyer's patches (PP) and isolated lymphoid follicles (LFs). Using a new mouse model invalidated for Card15/Nod2 (KO), we thus analysed the impact of the gene in these lymphoid formations together with the development of experimental colitis. Methodology/Principal Findings. At weeks 4, 12 and 52, the numbers of PPs and LFs were higher in KO mice while no difference was observed at birth. At weeks 4 and 12, the size and cellular composition of PPs were analysed by flow cytometry and immunohistochemistry. PPs of KO mice were larger with an increased proportion of M cells and CD4(+) T-cells. KO mice were also characterised by higher concentrations of TNF alpha, IFN gamma, IL12 and IL4 measured by ELISA. In contrast, little differences were found in the PP-free ileum and the spleen of KO mice. By Ussing chamber experiments, we found that this PP phenotype is associated with an increased of both paracellular permeability and yeast/bacterial translocation. Finally, KO mice were more susceptible to the colitis induced by TNBS. Conclusions. Card15/Nod2 deficiency induces an abnormal development and function of the PPs characterised by an exaggerated immune response and an increased permeability. These observations provide a comprehensive link between the molecular defect and the Human CARD15/NOD2 associated disorders: CD and GVHD.	[Barreau, Frederick; Meinzer, Ulrich; Dussaillant, Monique; Lesuffleur, Thecla; Hugot, Jean-Pierre] INSERM, U843, Paris, France; [Barreau, Frederick; Meinzer, Ulrich; Dussaillant, Monique; Lesuffleur, Thecla; Hugot, Jean-Pierre] Univ Paris Diderot, UMR S843, Paris, France; [Meinzer, Ulrich; Hugot, Jean-Pierre] Hop Robert Debre, AP HP, Serv Gastroenterol, F-75019 Paris, France; [Chareyre, Fabrice; Niwa-Kawakita, Michiko; Giovannini, Marco] Univ Paris Diderot, Inst Univ Hematol, Paris, France; [Chareyre, Fabrice; Niwa-Kawakita, Michiko; Giovannini, Marco] INSERM, U674, Paris, France; [Berrebi, Dominique] Univ Paris Diderot, EA3102, Paris, France; [Berrebi, Dominique] Inst Pasteur, Serv Anat Pathol, F-59019 Lille, France; [Foligne, Benoit] Inst Pasteur, Lab Bacteries Lact & Immunite Muqueuses, F-59019 Lille, France; [Ollendorff, Vincent] Univ Paul Cezanne, Fac St Jerome, INRA, UMR 1111, Marseille, France; [Ollendorff, Vincent] Univ Paul Cezanne, Fac St Jerome, IMRN, Marseille, France; [Heyman, Martine] INSERM, U793, Paris, France; [Heyman, Martine] Univ Paris 05, IFR94, Paris, France; [Bonacorsi, Stephane] Univ Paris Diderot, EA3105, Paris, France; [Bonacorsi, Stephane] Hop Robert Debre, AP HP, Microbiol Serv, F-75019 Paris, France; [Sterkers, Ghislaine] Hop Robert Debre, AP HP, Serv Immunol, F-75019 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Hugot, JP (corresponding author), INSERM, U843, Paris, France.	jean-pierre.hugot@rdb.aphp.fr	Foligne, Benoit/B-2754-2014; Meinzer, Ulrich/N-4282-2019; Hugot, Jean-Pierre/F-6594-2012; lesuffleur, thecla/AAC-2980-2020; berrebi, dominique/B-1419-2014; Bonacorsi, Stéphane/HGB-3185-2022	Foligne, Benoit/0000-0001-9263-9706; Kawakita, Michiko/0000-0002-9450-583X; Barreau, Frederick/0000-0002-7150-9619; Ollendorff, Vincent/0000-0001-9751-2202; Hugot, Jean-Pierre/0000-0002-8446-6056	Institut National de la Sante et de la Recherche Medicale; Broad Medical Research Program; la Mairie de Paris; la Fondation pour la Recherche Medicale; BREMICI; l'association Francois Aupetit and la region Ile de France	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Broad Medical Research Program; la Mairie de Paris; la Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); BREMICI; l'association Francois Aupetit and la region Ile de France(Region Ile-de-France)	This work was supported by the Institut National de la Sante et de la Recherche Medicale, the Broad Medical Research Program, la Mairie de Paris, la Fondation pour la Recherche Medicale, BREMICI, l'association Francois Aupetit and la region Ile de France.	Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; Berin MC, 1999, AM J PHYSIOL-CELL PH, V276, pC1046, DOI 10.1152/ajpcell.1999.276.5.C1046; Borghesi C, 1999, LAB INVEST, V79, P1393; Buhner S, 2006, GUT, V55, P342, DOI 10.1136/gut.2005.065557; Busca A, 2007, AM J HEMATOL, V82, P45, DOI 10.1002/ajh.20752; D'Inca R, 2006, ALIMENT PHARM THER, V23, P1455, DOI 10.1111/j.1365-2036.2006.02916.x; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Devlin SM, 2007, GASTROENTEROLOGY, V132, P576, DOI 10.1053/j.gastro.2006.11.013; Dohi T, 2001, J IMMUNOL, V167, P2781, DOI 10.4049/jimmunol.167.5.2781; Dohi T, 1999, J EXP MED, V189, P1169, DOI 10.1084/jem.189.8.1169; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; Elmaagacli AH, 2006, TRANSPLANTATION, V81, P247, DOI 10.1097/01.tp.0000188671.94646.16; Ferrier L, 2003, GASTROENTEROLOGY, V125, P795, DOI 10.1016/S0016-5085(03)01057-6; Fujimura Y, 1996, GUT, V38, P724, DOI 10.1136/gut.38.5.724; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Granell M, 2006, HAEMATOLOGICA, V91, P1372; Hess DJ, 2002, J SURG RES, V104, P88, DOI 10.1006/jsre.2002.6417; Hill GR, 2000, BLOOD, V95, P2754, DOI 10.1182/blood.V95.9.2754.009k25_2754_2759; Holler E, 2004, BLOOD, V104, P889, DOI 10.1182/blood-2003-10-3543; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Iiyama R, 2003, SCAND J IMMUNOL, V58, P620, DOI 10.1111/j.1365-3083.2003.01346.x; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; KATZ KD, 1989, GASTROENTEROLOGY, V97, P927, DOI 10.1016/0016-5085(89)91499-6; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; McKay DM, 1999, GUT, V44, P283, DOI 10.1136/gut.44.2.283; Meinzer U, 2005, INFLAMM BOWEL DIS, V11, P639, DOI 10.1097/01.MIB.0000165114.10687.bf; Murai M, 2003, NAT IMMUNOL, V4, P154, DOI 10.1038/ni879; Nascimbeni R, 2005, MODERN PATHOL, V18, P681, DOI 10.1038/modpathol.3800343; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pauleau AL, 2003, MOL CELL BIOL, V23, P7531, DOI 10.1128/MCB.23.21.7531-7539.2003; Perdue MH, 1999, AM J PHYSIOL-GASTR L, V277, pG1, DOI 10.1152/ajpgi.1999.277.1.G1; Polito JM, 1996, GASTROENTEROLOGY, V111, P580, DOI 10.1053/gast.1996.v111.pm8780560; TEAHON K, 1992, GUT, V33, P320, DOI 10.1136/gut.33.3.320; Van Kruiningen HJ, 2002, INFLAMM BOWEL DIS, V8, P180, DOI 10.1097/00054725-200205000-00004; VanKruiningen HJ, 1997, J CLIN GASTROENTEROL, V25, P470, DOI 10.1097/00004836-199709000-00017; WALLACE JL, 1990, AM J PHYSIOL, V258, pG527, DOI 10.1152/ajpgi.1990.258.4.G527; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Welniak LA, 2006, BLOOD, V107, P410, DOI 10.1182/blood-2004-11-4565; Youakim A, 1999, AM J PHYSIOL-GASTR L, V276, pG1279, DOI 10.1152/ajpgi.1999.276.5.G1279; Zeissig S, 2004, GUT, V53, P1295, DOI 10.1136/gut.2003.036632	43	114	118	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2007	2	6							e523	10.1371/journal.pone.0000523	http://dx.doi.org/10.1371/journal.pone.0000523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GD	17565376	Green Submitted, Green Published, gold			2022-12-27	WOS:000207451600011
J	Vojtech, E; Turnbull, LA; Hector, A				Vojtech, Eva; Turnbull, Lindsay A.; Hector, Andy			Differences in Light Interception in Grass Monocultures Predict Short-Term Competitive Outcomes under Productive Conditions	PLOS ONE			English	Article							ASYMMETRIC COMPETITION; NITROGEN DEPOSITION; SPECIES RICHNESS; FOUNDER CONTROL; PLANT; NUTRIENT; RATIO; COEXISTENCE; MECHANISMS; DIVERSITY	Due to its inherent asymmetry, competition for light is thought to cause loss of diversity from eutrophied systems. However, most of the work on this topic in grasslands has been phenomenological and has not measured light directly. We present the results of one of the few mechanistic experiments investigating the outcome of short-term competition using measurements of light interception from monocultures of five perennial grass species grown under fertilized and irrigated conditions. We found that the level of incident light intercepted by each species in monoculture, a direct measure of resource-reduction ability, was an excellent predictor of the relative competitive effect in pairwise mixtures. Competition for light was asymmetric in relation to differences in light intercepting ability. Our results are consistent with the idea that when light is a limiting resource, competition between species for this resource can be asymmetric, contributing to high dominance and low diversity.	[Vojtech, Eva; Turnbull, Lindsay A.; Hector, Andy] Univ Zurich, Inst Environm Sci, Zurich, Switzerland	University of Zurich	Vojtech, E (corresponding author), Univ Zurich, Inst Environm Sci, Zurich, Switzerland.	vojtech@uwinst.uzh.ch	Hector, Andrew/H-4199-2011; Turnbull, Lindsay A./A-2680-2012	Hector, Andrew/0000-0002-1309-7716; 	Swiss National Foundation [3100A0-107572]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	E.V is funded by the Swiss National Foundation grant 3100A0-107572 to A. H.	BEGON M, 1984, EVOL ECOL, P175; Berendse F, 1999, TRENDS ECOL EVOL, V14, P4, DOI 10.1016/S0169-5347(98)01451-7; Berendse F., 1990, Perspectives on plant competition., P93; Berntson GM, 2000, ECOLOGY, V81, P1072, DOI 10.1890/0012-9658(2000)081[1072:CTSDOR]2.0.CO;2; DYBZINSKI R, AM NATURALI IN PRESS; Fargione J, 2006, FUNCT ECOL, V20, P533, DOI 10.1111/j.1365-2435.2006.01116.x; Foster BL, 1998, ECOLOGY, V79, P2593, DOI 10.1890/0012-9658(1998)079[2593:SRIASG]2.0.CO;2; Freckleton RP, 2001, ECOL LETT, V4, P348, DOI 10.1046/j.1461-0248.2001.00231.x; Harpole WS, 2006, ECOL LETT, V9, P15, DOI 10.1111/j.1461-0248.2005.00836.x; Huisman J, 1999, ECOLOGY, V80, P211, DOI 10.1890/0012-9658(1999)080[0211:CFLBPS]2.0.CO;2; HUISMAN J, 1994, ECOLOGY, V75, P507, DOI 10.2307/1939554; HUSTON MA, 1994, AM NAT, V144, P954, DOI 10.1086/285720; Lauber K., 1996, FLORA HELVETICA; Leps J, 1999, J VEG SCI, V10, P219, DOI 10.2307/3237143; Miller TE, 2005, AM NAT, V165, P439, DOI 10.1086/428681; Nord-Larsen T, 2006, CAN J FOREST RES, V36, P418, DOI 10.1139/X05-255; Perry LG, 2003, J THEOR BIOL, V222, P425, DOI 10.1016/S0022-5193(03)00055-9; Rees M, 1997, J THEOR BIOL, V184, P353, DOI 10.1006/jtbi.1996.0297; REYNOLDS HL, 1993, AM NAT, V141, P51, DOI 10.1086/285460; Roem WJ, 2000, BIOL CONSERV, V92, P151, DOI 10.1016/S0006-3207(99)00049-X; Schwinning S, 1998, OECOLOGIA, V113, P447, DOI 10.1007/s004420050397; Schwinning S, 1996, ANN BOT-LONDON, V77, P47, DOI 10.1006/anbo.1996.0006; SCHWINNING S, 1995, OIKOS, V72, P422, DOI 10.2307/3546128; Silvertown J, 2006, J ECOL, V94, P801, DOI 10.1111/j.1365-2745.2006.01145.x; Stevens CJ, 2006, GLOBAL CHANGE BIOL, V12, P1823, DOI 10.1111/j.1365-2486.2006.01217.x; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Stevens MHH, 2002, ECOL LETT, V5, P420, DOI 10.1046/j.1461-0248.2002.00333.x; Tilman D., 1982, Monographs in Population Biology, pi; TILMAN D, 1991, ECOLOGY, V72, P1038, DOI 10.2307/1940604; TILMAN D, 1988; TILMAN D, 1991, AM NAT, V138, P1283, DOI 10.1086/285285; Turnbull LA, 2004, J ECOL, V92, P97, DOI 10.1111/j.1365-2745.2004.00856.x; Violle C, 2007, FUNCT ECOL, V21, P185, DOI 10.1111/j.1365-2435.2006.01241.x; WEDIN D, 1993, ECOL MONOGR, V63, P199, DOI 10.2307/2937180; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U	35	40	41	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2007	2	6							e499	10.1371/journal.pone.0000499	http://dx.doi.org/10.1371/journal.pone.0000499			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GD	17565366	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451600001
J	Vieux-Rochas, M; Coen, L; Sato, T; Kurihara, Y; Gitton, Y; Barbieri, O; Le Blay, K; Merlo, G; Ekker, M; Kurihara, H; Janvier, P; Levi, G				Vieux-Rochas, Maxence; Coen, Laurent; Sato, Takahiro; Kurihara, Yukiko; Gitton, Yorick; Barbieri, Ottavia; Le Blay, Karine; Merlo, Giorgio; Ekker, Marc; Kurihara, Hiroki; Janvier, Philippe; Levi, Giovanni			Molecular Dynamics of Retinoic Acid-Induced Craniofacial Malformations: Implications for the Origin of Gnathostome Jaws	PLOS ONE			English	Article								Background. Intake of retinoic acid (RA) or of its precursor, vitamin A, during early pregnancy is associated with increased incidence of craniofacial lesions. The origin of these teratogenic effects remains enigmatic as in cranial neural crest cells (CNCCs), which largely contribute to craniofacial structures, the RA-transduction pathway is not active. Recent results suggest that RA could act on the endoderm of the first pharyngeal arch (1stPA), through a RAR beta-dependent mechanism. Methodology/Principal Findings. Here we show that RA provokes dramatically different craniofacial malformations when administered at slightly different developmental times within a narrow temporal interval corresponding to the colonization of the 1(st) PA by CNCCs. We provide evidence showing that RA acts on the signalling epithelium of the 1(st) PA, gradually reducing the expression of endothelin-1 and Fgf8. These two molecular signals are instrumental in activating Dlx genes in incoming CNCCs, thereby triggering the morphogenetic programs, which specify different jaw elements. Conclusions/Significance. The anatomical series induced by RA-treatments at different developmental times parallels, at least in some instances, the supposed origin of modern jaws (e.g., the fate of the incus). Our results might provide a conceptual framework for the rise of jaw morphotypes characteristic of gnathostomes.	[Vieux-Rochas, Maxence; Coen, Laurent; Gitton, Yorick; Le Blay, Karine; Levi, Giovanni] Museum Natl Hist Nat, CNRS, UMR5166, Paris, France; [Sato, Takahiro; Kurihara, Yukiko; Kurihara, Hiroki] Univ Tokyo, Dept Physiol Chem & Metab, Grad Sch Med, Tokyo, Japan; [Barbieri, Ottavia] Univ Genoa, Transgen Unit, Dept Oncol Biol & Genet, IST,CBA, Genoa, Italy; [Merlo, Giorgio] Dulbecco Telethon Inst CNR ITB, Milan, Italy; [Ekker, Marc] Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON, Canada; [Janvier, Philippe] Museum Natl Hist Nat, CNRS, UMR 5143, Dept Hist Terre, Paris, France; [Janvier, Philippe] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); University of Tokyo; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Ottawa; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Natural History Museum London	Levi, G (corresponding author), Museum Natl Hist Nat, CNRS, UMR5166, Paris, France.	glevi@mnhn.fr	Barbieri, Ottavia/E-8768-2011; Levi, Giovanni/B-4416-2013; GITTON, Yorick/M-8524-2019	GITTON, Yorick/0000-0002-6808-6010; Kurihara, Hiroki/0000-0002-6476-5593; Levi, Giovanni/0000-0002-7041-6787	EU [PL503020, LSHM-CT-2005-018652]; French Government; Fondazione Telethon Funding Source: Custom	EU(European Commission); French Government; Fondazione Telethon(Fondazione Telethon)	This work was supported by grants from the EU community: Anabonos PL503020 and Crescendo LSHM-CT-2005-018652. M. V.-R. is recipient of a doctoral fellowship from the French Government.	Abu-Abed S, 2003, DEVELOPMENT, V130, P1449, DOI 10.1242/dev.00357; Acampora D, 1999, DEVELOPMENT, V126, P3795; Alles A J, 1992, Clin Dysmorphol, V1, P187; ALLES AJ, 1990, DEVELOPMENT, V108, P73; Arafa HMM, 2000, ARCH TOXICOL, V73, P547, DOI 10.1007/s002040050007; Beverdam A, 2002, GENESIS, V34, P221, DOI 10.1002/gene.10156; Brondani V, 2002, J MOL BIOL, V319, P715, DOI 10.1016/S0022-2836(02)00376-5; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Charite J, 2001, GENE DEV, V15, P3039, DOI 10.1101/gad.931701; Cheung Chui Shan, 2003, Neuroembryology, V2, P164, DOI 10.1159/000079403; Coberly S, 1996, PEDIATR PATHOL LAB M, V16, P823, DOI 10.1080/107710496175435; Collins MD, 1999, ANNU REV PHARMACOL, V39, P399, DOI 10.1146/annurev.pharmtox.39.1.399; Couly G, 2002, DEVELOPMENT, V129, P1061; Couly G, 1998, DEVELOPMENT, V125, P3445; Creuzet S, 2005, J ANAT, V207, P447, DOI 10.1111/j.1469-7580.2005.00485.x; Depew MJ, 2002, SCIENCE, V298, P381, DOI 10.1126/science.1075703; Depew MJ, 2005, J ANAT, V207, P501, DOI 10.1111/j.1469-7580.2005.00487.x; DOLLE P, 1990, DEVELOPMENT, V110, P1133; Dupe V, 1999, DEVELOPMENT, V126, P5051; Ellies DL, 1997, MECH DEVELOP, V61, P23, DOI 10.1016/S0925-4773(96)00616-8; Elmazar MMA, 2004, ARCH TOXICOL, V78, P660, DOI 10.1007/s00204-004-0586-8; Elmazar MMA, 2001, TOXICOL APPL PHARM, V170, P2, DOI 10.1006/taap.2000.9074; Elmazar MMA, 1996, TERATOLOGY, V53, P158, DOI 10.1002/(SICI)1096-9926(199603)53:3<158::AID-TERA3>3.0.CO;2-0; Escriva H, 2002, DEVELOPMENT, V129, P2905; Gavalas A, 2001, DEVELOPMENT, V128, P3017; GOULDING EH, 1986, J CRAN GENET DEV BIO, V6, P99; Graham A, 2001, BIOESSAYS, V23, P54, DOI 10.1002/1521-1878(200101)23:1<54::AID-BIES1007>3.0.CO;2-5; Haworth KE, 2004, DEVELOPMENT, V131, P4797, DOI 10.1242/dev.01337; Iulianella A, 1997, DEV DYNAM, V209, P92, DOI 10.1002/(SICI)1097-0177(199705)209:1<92::AID-AJA9>3.0.CO;2-S; Iulianella A, 2002, DEV BIOL, V247, P62, DOI 10.1006/dbio.2002.0685; Jiang XB, 2002, MECH DEVELOP, V117, P115, DOI 10.1016/S0925-4773(02)00206-X; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; KNUDSEN PA, 1967, ACTA ODONTOL SCAND, V25, P267, DOI 10.3109/00016356709104023; Kochhar DM, 1996, CHEM-BIOL INTERACT, V100, P1, DOI 10.1016/0009-2797(95)03681-4; Kontges G, 1996, DEVELOPMENT, V122, P3229; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; LEE YM, 1995, DEVELOPMENT, V121, P825; LOHNES D, 1994, DEVELOPMENT, V120, P2723; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; Mallo M, 1997, DEV BIOL, V184, P175, DOI 10.1006/dbio.1997.8519; Manley NR, 1998, DEV BIOL, V195, P1, DOI 10.1006/dbio.1997.8827; Mark M, 2003, PURE APPL CHEM, V75, P1709, DOI 10.1351/pac200375111709; Matt N, 2003, DEVELOPMENT, V130, P2083, DOI 10.1242/dev.00428; MORRISSKAY G, 1993, ANN ANAT, V175, P501, DOI 10.1016/S0940-9602(11)80209-8; Mulder GB, 1998, TERATOLOGY, V58, P263, DOI 10.1002/(SICI)1096-9926(199812)58:6<263::AID-TERA8>3.3.CO;2-1; Nugent P, 1999, INT J DEV BIOL, V43, P567; Ozeki H, 2004, MECH DEVELOP, V121, P387, DOI 10.1016/j.mod.2004.02.002; Park BK, 2004, DEV BIOL, V268, P532, DOI 10.1016/j.ydbio.2004.01.010; PRATT RM, 1987, J CRAN GENET DEV BIO, V7, P205; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; RUBERTE E, 1991, DEVELOPMENT, V111, P45; Ruest LB, 2004, DEVELOPMENT, V131, P4413, DOI 10.1242/dev.01291; Saadeddin A, 2004, AAPS PHARMSCI, V6, DOI 10.1208/ps060101; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Santagati F, 2003, NAT REV NEUROSCI, V4, P806, DOI 10.1038/nrn1221; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; SERBEDZIJA GN, 1992, DEVELOPMENT, V116, P297; Shigetani Y, 2000, DEV BIOL, V228, P73, DOI 10.1006/dbio.2000.9932; Shigetani Y, 2002, SCIENCE, V296, P1316, DOI 10.1126/science.1068310; SIMEONE A, 1995, MECH DEVELOP, V51, P83, DOI 10.1016/0925-4773(95)96241-M; SOPRANO DR, 1995, ANNU REV NUTR, V15, P111, DOI 10.1146/annurev.nu.15.070195.000551; Sucov HM, 1995, DEVELOPMENT, V121, P3997; SULIK KK, 1988, DEVELOPMENT, V103, P213; SULIK KK, 1995, TERATOLOGY, V51, P398, DOI 10.1002/tera.1420510605; Tahayato A, 2003, GENE EXPR PATTERNS, V3, P449, DOI 10.1016/S1567-133X(03)00066-8; Trainor PA, 2003, INT J DEV BIOL, V47, P541; Veitch E, 1999, CURR BIOL, V9, P1481, DOI 10.1016/S0960-9822(00)80118-9; WEBSTER WS, 1986, J CRAN GENET DEV BIO, V6, P211; Wei X, 1999, TERATOLOGY, V60, P83, DOI 10.1002/(SICI)1096-9926(199908)60:2<83::AID-TERA12>3.0.CO;2-O; Wendling O, 2000, DEVELOPMENT, V127, P1553; Yokota J, 2001, ATHEROSCLEROSIS, V159, P491, DOI 10.1016/S0021-9150(01)00530-5; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000	73	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e510	10.1371/journal.pone.0000510	http://dx.doi.org/10.1371/journal.pone.0000510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551590	Green Published, gold			2022-12-27	WOS:000207451500019
J	Voisine, C; Varma, H; Walker, N; Bates, EA; Stockwell, BR; Hart, AC				Voisine, Cindy; Varma, Hemant; Walker, Nicola; Bates, Emily A.; Stockwell, Brent R.; Hart, Anne C.			Identification of Potential Therapeutic Drugs for Huntington's Disease using Caenorhabditis elegans	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; HEAT-SHOCK FACTOR; MOUSE MODEL; PROTEIN AGGREGATION; POLYGLUTAMINE; TOXICITY; TRANSCRIPTION; SURVIVAL; DAF-16; SUPPRESSION	Background. The prolonged time course of Huntington's disease (HD) neurodegeneration increases both the time and cost of testing potential therapeutic compounds in mammalian models. An alternative is to initially assess the efficacy of compounds in invertebrate models, reducing time of testing from months to days. Methodology/Principal Findings. We screened candidate therapeutic compounds that were identified previously in cell culture/animal studies in a C. elegans HD model and found that two FDA approved drugs, lithium chloride and mithramycin, independently and in combination suppressed HD neurotoxicity. Aging is a critical contributor to late onset neurodegenerative diseases. Using a genetic strategy and a novel assay, we demonstrate that lithium chloride and mithramycin remain neuroprotective independent of activity of the forkhead transcription factor DAF-16, which mediates the effects of the insulin-like signaling pathway on aging. Conclusions/Significance. These results suggest that pathways involved in polyglutamine-induced degeneration are distinct from specific aging pathways. The assays presented here will be useful for rapid and inexpensive testing of other potential HD drugs and elucidating pathways of drug action. Additionally, the neuroprotection conferred by lithium chloride and mithramycin suggests that these drugs may be useful for polyglutamine disease therapy.	[Voisine, Cindy; Walker, Nicola; Bates, Emily A.; Hart, Anne C.] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA USA; [Varma, Hemant; Stockwell, Brent R.] Columbia Univ, Fairchild Ctr, Dept Biol Sci, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Fairchild Ctr, Dept Chem, New York, NY 10027 USA; [Voisine, Cindy; Walker, Nicola; Bates, Emily A.; Hart, Anne C.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Columbia University; Columbia University; Harvard University; Harvard Medical School	Hart, AC (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA USA.	hart@helix.mgh.harvard.edu	Voisine, Cindy/AAG-9045-2019; Stockwell, Brent R/AAE-7200-2019	Stockwell, Brent R/0000-0002-3532-3868; Voisine, Cindy/0000-0001-7165-9636	Hereditary Disease Foundation; Cure Huntington Disease Initiative; High Q Foundation; Ellison Medical Foundation; NIH [NS-040048, T32 AG20506]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020506] Funding Source: NIH RePORTER	Hereditary Disease Foundation; Cure Huntington Disease Initiative; High Q Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We gratefully acknowledge the support of the Hereditary Disease Foundation (C. V. and B. R. S.), Cure Huntington Disease Initiative (B. R. S.), the High Q Foundation (H. V. and B. R. S.), the Ellison Medical Foundation (A. C. H.) and the NIH (NS-040048 for A. C. H. and T32 AG20506 for C. V.). Brent R. Stockwell is supported in part by a Career Award at the Scientific Interface from the Burroughs Wellcome Fund.	Apostol BL, 2003, P NATL ACAD SCI USA, V100, P5950, DOI 10.1073/pnas.2628045100; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bates EA, 2006, J NEUROSCI, V26, P2830, DOI 10.1523/JNEUROSCI.3344-05.2006; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Berger Z, 2005, HUM MOL GENET, V14, P3003, DOI 10.1093/hmg/ddi331; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Chamberlain JS, 2000, CURR BIOL, V10, pR795, DOI 10.1016/S0960-9822(00)00768-5; Dedeoglu A, 2002, J NEUROSCI, V22, P8942; Diamond MI, 2000, P NATL ACAD SCI USA, V97, P657, DOI 10.1073/pnas.97.2.657; Faber PW, 1999, P NATL ACAD SCI USA, V96, P179, DOI 10.1073/pnas.96.1.179; Faber PW, 2002, P NATL ACAD SCI USA, V99, P17131, DOI 10.1073/pnas.262544899; Ferrante RJ, 2004, J NEUROSCI, V24, P10335, DOI 10.1523/JNEUROSCI.2599-04.2004; Fukuyama M, 2006, CURR BIOL, V16, P773, DOI 10.1016/j.cub.2006.02.073; Garigan D, 2002, GENETICS, V161, P1101; Geary TG, 2001, VET PARASITOL, V101, P371, DOI 10.1016/S0304-4017(01)00562-3; Gieseler K, 2000, CURR BIOL, V10, P1092, DOI 10.1016/S0960-9822(00)00691-6; GRANATO M, 1994, DEVELOPMENT, V120, P3005; GUSELLA JF, 1995, CURR OPIN NEUROBIOL, V5, P656, DOI 10.1016/0959-4388(95)80072-7; Hazeki N, 1999, BIOCHEM BIOPH RES CO, V256, P361, DOI 10.1006/bbrc.1999.0337; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hughes RE, 2001, P NATL ACAD SCI USA, V98, P13201, DOI 10.1073/pnas.191498198; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; JONES DE, 1995, ONCOGENE, V10, P2323; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; McCampbell A, 2001, P NATL ACAD SCI USA, V98, P15179, DOI 10.1073/pnas.261400698; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Piccioni F, 2004, HUM MOL GENET, V13, P437, DOI 10.1093/hmg/ddh045; Rand JB, 1995, METHOD CELL BIOL, V48, P187; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Tang BL, 2006, NEUROBIOL AGING, V27, P501, DOI 10.1016/j.neurobiolaging.2005.02.001; Van Raamsdonk JM, 2005, J NEUROCHEM, V95, P210, DOI 10.1111/j.1471-4159.2005.03357.x; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; Varma H, 2007, NAT CHEM BIOL, V3, P99, DOI 10.1038/nchembio852; Wang J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-1; Wang WF, 2005, NEUROBIOL DIS, V20, P500, DOI 10.1016/j.nbd.2005.03.026; Wood WB, 1988, NEMATODE CAENORHABDI	46	109	116	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e504	10.1371/journal.pone.0000504	http://dx.doi.org/10.1371/journal.pone.0000504			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551584	gold, Green Published			2022-12-27	WOS:000207451500013
J	Frazzetto, G; Di Lorenzo, G; Carola, V; Proietti, L; Sokolowska, E; Siracusano, A; Gross, C; Troisi, A				Frazzetto, Giovanni; Di Lorenzo, Giorgio; Carola, Valeria; Proietti, Luca; Sokolowska, Ewa; Siracusano, Alberto; Gross, Cornelius; Troisi, Alfonso			Early Trauma and Increased Risk for Physical Aggression during Adulthood: The Moderating Role of MAOA Genotype	PLOS ONE			English	Article								Previous research has reported that a functional polymorphism in the monoamine oxidase A (MAOA) gene promoter can moderate the association between early life adversity and increased risk for violence and antisocial behavior. In this study of a combined population of psychiatric outpatients and healthy volunteers (N = 235), we tested the hypothesis that MAOA genotype moderates the association between early traumatic life events (ETLE) experienced during the first 15 years of life and the display of physical aggression during adulthood, as assessed by the Aggression Questionnaire. An ANOVA model including gender, exposure to early trauma, and MAOA genotype as between-subjects factors showed significant MAOA x ETLE (F-1,F-227 = 8.20, P = 0.005) and gender x MAOA x ETLE (F-1,F-227 = 7.04, P = 0.009) interaction effects. Physical aggression scores were higher in men who had experienced early traumatic life events and who carried the low MAOA activity allele (MAOA-L). We repeated the analysis in the subgroup of healthy volunteers (N = 145) to exclude that the observed G x E interactions were due to the inclusion of psychiatric patients in our sample and were not generalizable to the population at large. The results for the subgroup of healthy volunteers were identical to those for the entire sample. The cumulative variance in the physical aggression score explained by the ANOVA effects involving the MAOA polymorphism was 6.6% in the entire sample and 12.1% in the sub-sample of healthy volunteers. Our results support the hypothesis that, when combined with exposure to early traumatic life events, low MAOA activity is a significant risk factor for aggressive behavior during adulthood and suggest that the use of dimensional measures focusing on behavioral aspects of aggression may increase the likelihood of detecting significant gene-by-environment interactions in studies of MAOA-related aggression.	[Frazzetto, Giovanni; Carola, Valeria; Sokolowska, Ewa; Gross, Cornelius] European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy; [Di Lorenzo, Giorgio; Proietti, Luca; Siracusano, Alberto; Troisi, Alfonso] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy	European Molecular Biology Laboratory (EMBL); University of Rome Tor Vergata	Gross, C (corresponding author), European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy.	gross@embl.it	carola, valeria/J-9724-2014; TROISI, ALFONSO/AAB-8010-2019; Di Lorenzo, Giorgio/B-1308-2013	TROISI, ALFONSO/0000-0002-3483-1318; Di Lorenzo, Giorgio/0000-0002-0576-4064; SIRACUSANO, ALBERTO/0000-0001-8406-093X	Fritz Thyssen Stiftung; Branco Weiss Fellowship	Fritz Thyssen Stiftung; Branco Weiss Fellowship	This work was supported by a grant from the Fritz Thyssen Stiftung (C. G.) and by 'Society in Science'-The Branco Weiss Fellowship (G. F.).	Bandelow B, 2002, COMPR PSYCHIAT, V43, P269, DOI 10.1053/comp.2002.33492; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Chen K, 2007, J BIOL CHEM, V282, P115, DOI 10.1074/jbc.M609830200; Deckert J, 1999, HUM MOL GENET, V8, P621, DOI 10.1093/hmg/8.4.621; Eisenberger NI, 2007, BIOL PSYCHIAT, V61, P1100, DOI 10.1016/j.biopsych.2006.08.007; Fan J, 2003, P NATL ACAD SCI USA, V100, P7406, DOI 10.1073/pnas.0732088100; Feinberg ME, 2007, ARCH GEN PSYCHIAT, V64, P457, DOI 10.1001/archpsyc.64.4.457; First M. B., 1997, STRUCTURED CLIN INTE; Foley DL, 2004, ARCH GEN PSYCHIAT, V61, P738, DOI 10.1001/archpsyc.61.7.738; Freeman B, 2003, BEHAV GENET, V33, P67, DOI 10.1023/A:1021055617738; Haberstick BC, 2005, AM J MED GENET B, V135B, P59, DOI 10.1002/ajmg.b.30176; Harris JA, 1997, BEHAV RES THER, V35, P1047, DOI 10.1016/S0005-7967(97)00064-8; Huizinga D, 2006, BIOL PSYCHIAT, V60, P677, DOI 10.1016/j.biopsych.2005.12.022; Johnson JG, 1999, ARCH GEN PSYCHIAT, V56, P600, DOI 10.1001/archpsyc.56.7.600; Kim-Cohen J, 2006, MOL PSYCHIATR, V11, P903, DOI 10.1038/sj.mp.4001851; Lesch KP, 2000, BEHAV SCI LAW, V18, P581, DOI 10.1002/1099-0798(200010)18:5<581::AID-BSL411>3.0.CO;2-L; LEVY ER, 1989, GENOMICS, V5, P368, DOI 10.1016/0888-7543(89)90072-4; LUNTZ BK, 1994, AM J PSYCHIAT, V151, P670; Meyer-Lindenberg A, 2006, P NATL ACAD SCI USA, V103, P6269, DOI 10.1073/pnas.0511311103; Moffitt TE, 2005, ARCH GEN PSYCHIAT, V62, P473, DOI 10.1001/archpsyc.62.5.473; Nilsson KW, 2006, BIOL PSYCHIAT, V59, P121, DOI 10.1016/j.biopsych.2005.06.024; Nordquist N, 2006, BIOCHEM BIOPH RES CO, V348, P763, DOI 10.1016/j.bbrc.2006.07.131; Pfohl B., 1995, STRUCTURED INTERVIEW; Raine A, 1997, AM J PSYCHIAT, V154, P1265; Raine A, 1996, ARCH GEN PSYCHIAT, V53, P544; REIF A, 2007, NEUROPSYCHO IN PRESS; Renn Paul, 2002, Attach Hum Dev, V4, P294, DOI 10.1080/14616730210167203; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Suris A, 2004, AGGRESS VIOLENT BEH, V9, P165, DOI 10.1016/S1359-1789(03)00012-0; Troisi A, 2004, J AFFECT DISORDERS, V79, P269, DOI 10.1016/S0165-0327(02)00406-8; Young SE, 2006, AM J PSYCHIAT, V163, P1019, DOI 10.1176/appi.ajp.163.6.1019	35	134	142	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2007	2	5							e486	10.1371/journal.pone.0000486	http://dx.doi.org/10.1371/journal.pone.0000486			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10FB	17534436	Green Published, Green Submitted, gold			2022-12-27	WOS:000207448800016
J	Dori, D; Choder, M				Dori, Dov; Choder, Mordechai			Conceptual Modeling in Systems Biology Fosters Empirical Findings: The mRNA Lifecycle	PLOS ONE			English	Article							P-BODIES; TRANSLATION TERMINATION; STRESS GRANULES; CELL SIMULATION; FACTOR ERF3; DECAY; PROTEINS; RELEASE; REPRESENTATION; RECRUITMENT	One of the main obstacles to understanding complex biological systems is the extent and rapid evolution of information, way beyond the capacity individuals to manage and comprehend. Current modeling approaches and tools lack adequate capacity to model concurrently structure and behavior of biological systems. Here we propose Object-Process Methodology (OPM), a holistic conceptual modeling paradigm, as a means to model both diagrammatically and textually biological systems formally and intuitively at any desired number of levels of detail. OPM combines objects, e.g., proteins, and processes, e.g., transcription, in a way that is simple and easily comprehensible to researchers and scholars. As a case in point, we modeled the yeast mRNA lifecycle. The mRNA lifecycle involves mRNA synthesis in the nucleus, mRNA transport to the cytoplasm, and its subsequent translation and degradation therein. Recent studies have identified specific cytoplasmic foci, termed processing bodies that contain large complexes of mRNAs and decay factors. Our OPM model of this cellular subsystem, presented here, led to the discovery of a new constituent of these complexes, the translation termination factor eRF3. Association of eRF3 with processing bodies is observed after a long-term starvation period. We suggest that OPM can eventually serve as a comprehensive evolvable model of the entire living cell system. The model would serve as a research and communication platform, highlighting unknown and uncertain aspects that can be addressed empirically and updated consequently while maintaining consistency.	[Dori, Dov] Technion Israel Inst Technol, Fac Ind Engn & Management, IL-32000 Haifa, Israel; [Choder, Mordechai] Technion Israel Inst Technol, Rappaport Fac Med, Dept Mol Biotechnol, IL-32000 Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Dori, D (corresponding author), Technion Israel Inst Technol, Fac Ind Engn & Management, IL-32000 Haifa, Israel.	dori@ie.technion.ac.il		Dori, Dov/0000-0002-2393-3124				Alkalaeva EZ, 2006, CELL, V125, P1125, DOI 10.1016/j.cell.2006.04.035; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; [Anonymous], 2011, ENCY KNOWLEDGE MANAG; Aragon AD, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r9; Bashkirov VI, 1997, J CELL BIOL, V136, P761, DOI 10.1083/jcb.136.4.761; *BIOUML, BIOUML FRAM SYST BIO; Blinov ML, 2006, NAT BIOTECHNOL, V24, P137, DOI 10.1038/nbt0206-137; BOOCH C, 1999, UML USER GUIDE; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Daneholt B, 1997, CELL, V88, P585, DOI 10.1016/S0092-8674(00)81900-5; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Dori D, 2003, LECT NOTES COMPUT SC, V2813, P570; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; Fillman C, 2005, CURR OPIN CELL BIOL, V17, P326, DOI 10.1016/j.ceb.2005.04.002; FUNAHAHSI A, 2007, CELLDESIGNER SYSTEMS; Harel D, 2005, NAT BIOTECHNOL, V23, P495, DOI 10.1038/nbt0405-495; HAREL D, 2003, LNCS, V2623, P2; Hedley WJ, 2001, PHILOS T ROY SOC A, V359, P1073, DOI 10.1098/rsta.2001.0817; Hosoda N, 2003, J BIOL CHEM, V278, P38287, DOI 10.1074/jbc.C300300200; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; KAM N, 2004, MODELLING MOL BIOL; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; KEET C, 2006, KNOWL WEB PHD S KWEP; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kofuji S, 2006, BIOCHEM BIOPH RES CO, V344, P547, DOI 10.1016/j.bbrc.2006.03.174; Kohn KW, 2001, CHAOS, V11, P84, DOI 10.1063/1.1338126; Kremerskothen J, 2006, J NEUROCHEM, V96, P1659, DOI 10.1111/j.1471-4159.2006.03679.x; KRITIKOU E, 2006, NATURE REV MOL CELL; LANGE C, 2003, CONS PROBL UML BAS S; LONGABAUGH WJR, 2007, BIOTAPESTRY; Lotan R, 2005, GENE DEV, V19, P3004, DOI 10.1101/gad.353205; Lovrics A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-494; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Maciag K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100045; Marx J, 2005, SCIENCE, V310, P764, DOI 10.1126/science.310.5749.764; Mayer R. E., 2001, MULTIMEDIA LEARNING; *OBJ MAN GROUP, INTR OMGS UN MOD LAN; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Peleg M, 2000, IEEE T SOFTWARE ENG, V26, P742, DOI 10.1109/32.879812; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Siau K., 2001, Journal of Database Management, V12, P26, DOI 10.4018/jdm.2001010103; Slepchenko BM, 2003, TRENDS CELL BIOL, V13, P570, DOI 10.1016/j.tcb.2003.09.002; *SYSML, 2007, SYSML OP SOURC SPEC; Takahashi K, 2003, BIOINFORMATICS, V19, P1727, DOI 10.1093/bioinformatics/btg221; TEIXEIRA D, 2005, RNA; Tyson JJ, 2002, BIOESSAYS, V24, P1095, DOI 10.1002/bies.10191; *UML 2, UN MOD LANG UML VERS; van der Kuyl AC, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-21; Watson JD, 2004, MOL BIOL GENE; WEBB K, 2004, P 3 INT JOINT C AUT; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Wilusz CJ, 2004, TRENDS GENET, V20, P491, DOI 10.1016/j.tig.2004.07.011	63	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e872	10.1371/journal.pone.0000872	http://dx.doi.org/10.1371/journal.pone.0000872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849002	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455600019
J	Lewis, MS; Pikaard, DJ; Nasrallah, M; Doelling, JH; Pikaard, CS				Lewis, Michelle S.; Pikaard, Diane J.; Nasrallah, Mikhail; Doelling, Jed H.; Pikaard, Craig S.			Locus-Specific Ribosomal RNA Gene Silencing in Nucleolar Dominance	PLOS ONE			English	Article								The silencing of one parental set of rRNA genes in a genetic hybrid is an epigenetic phenomenon known as nucleolar dominance. We showed previously that silencing is restricted to the nucleolus organizer regions (NORs), the loci where rRNA genes are tandemly arrayed, and does not spread to or from neighboring protein-coding genes. One hypothesis is that nucleolar dominance is the net result of hundreds of silencing events acting one rRNA gene at a time. A prediction of this hypothesis is that rRNA gene silencing should occur independent of chromosomal location. An alternative hypothesis is that the regulatory unit in nucleolar dominance is the NOR, rather than each individual rRNA gene, in which case NOR localization may be essential for rRNA gene silencing. To test these alternative hypotheses, we examined the fates of rRNA transgenes integrated at ectopic locations. The transgenes were accurately transcribed in all independent transgenic Arabidopsis thaliana lines tested, indicating that NOR localization is not required for rRNA gene expression. Upon crossing the transgenic A. thaliana lines as ovule parents with A. lyrata to form F1 hybrids, a new system for the study of nucleolar dominance, the endogenous rRNA genes located within the A. thaliana NORs are silenced. However, rRNA transgenes escaped silencing in multiple independent hybrids. Collectively, our data suggest that rRNA gene activation can occur in a gene-autonomous fashion, independent of chromosomal location, whereas rRNA gene silencing in nucleolar dominance is locus-dependent.	[Doelling, Jed H.] W Virginia Univ, Div Plant & Soil Sci, Morgantown, WV USA; [Lewis, Michelle S.; Pikaard, Diane J.; Pikaard, Craig S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Nasrallah, Mikhail] Cornell Univ, Dept Plant Biol, Ithaca, NY USA	West Virginia University; Washington University (WUSTL); Cornell University	Doelling, JH (corresponding author), W Virginia Univ, Div Plant & Soil Sci, Morgantown, WV USA.	Jed.Doelling@mail.wvu.edu; pikaard@biology.wustl.edu	Pikaard, Craig S/K-8772-2012	Pikaard, Craig S/0000-0001-8204-7459	National Institutes of Health [R01GM60380]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health grant R01GM60380 to CSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinions expressed in this paper are those of the authors and do not necessarily reflect the views of the NIH.	BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Chen ZJ, 1998, P NATL ACAD SCI USA, V95, P14891, DOI 10.1073/pnas.95.25.14891; Copenhaver GP, 1996, PLANT J, V9, P273, DOI 10.1046/j.1365-313X.1996.09020273.x; COPENHAVER GP, 1995, PLANT J, V7, P273, DOI 10.1046/j.1365-313X.1995.7020273.x; Copenhaver GP, 1996, PLANT J, V9, P259, DOI 10.1046/j.1365-313X.1996.09020259.x; DOELLING JH, 1995, PLANT J, V8, P683, DOI 10.1046/j.1365-313X.1995.08050683.x; DOELLING JH, 1993, P NATL ACAD SCI USA, V90, P7528, DOI 10.1073/pnas.90.16.7528; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; FLAVELL RB, 1986, OXF SURV PLANT MOL C, V3, P252; Frieman M, 1999, GENETICS, V152, P451; Gerbi S. A., 1985, MOL EVOLUTIONARY GEN, P419, DOI DOI 10.1007/978-1-4684-4988-4_7; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; HONJO T, 1973, J MOL BIOL, V80, P217, DOI 10.1016/0022-2836(73)90168-X; Huynh KD, 2005, NAT REV GENET, V6, P410, DOI 10.1038/nrg1604; KARPEN GH, 1988, GENE DEV, V2, P1745, DOI 10.1101/gad.2.12b.1745; Kononov ME, 1997, PLANT J, V11, P945, DOI 10.1046/j.1365-313X.1997.11050945.x; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Lewis MS, 2004, GENETICS, V167, P931, DOI 10.1534/genetics.103.026203; Lewis MS, 2001, P NATL ACAD SCI USA, V98, P14536, DOI 10.1073/pnas.251424098; McCLINTOCK BARBARA, 1934, ZEITSCHR ZELLJORSCH U MIKROSK ANAT, V21, P294, DOI 10.1007/BF00374060; MUSCARELLA DE, 1990, MOL CELL BIOL, V10, P3386, DOI 10.1128/MCB.10.7.3386; Nasrallah ME, 2000, PLANT PHYSIOL, V124, P1605, DOI 10.1104/pp.124.4.1605; Neves N, 2005, ANNU PLANT REV, V19, P201, DOI 10.1002/9780470988626.ch7; PHILLIPS RL, 1971, CHROMOSOMA, V36, P79, DOI 10.1007/BF00326423; Pikaard CS, 2000, PLANT MOL BIOL, V43, P163, DOI 10.1023/A:1006471009225; Pikaard CS, 2000, TRENDS GENET, V16, P495, DOI 10.1016/S0168-9525(00)02113-2; PREUSS S, 2007, BIOCH BIOPHYS ACTA; REEDER RH, 1985, J CELL BIOL, V101, P2013, DOI 10.1083/jcb.101.5.2013; REEDER RH, 1974, RIBOSOMES, P489; RITOSSA FM, 1965, P NATL ACAD SCI USA, V53, P737, DOI 10.1073/pnas.53.4.737; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; Viegas W., 2002, Current Genomics, V3, P563, DOI 10.2174/1389202023350237; VIERA A, 1990, GENOME, V33, P707; WALLACE H, 1966, BIOCHIM BIOPHYS ACTA, V114, P296, DOI 10.1016/0005-2787(66)90311-X; Wanzenbock EM, 1997, PLANT J, V11, P1007, DOI 10.1046/j.1365-313X.1997.11051007.x	36	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e815	10.1371/journal.pone.0000815	http://dx.doi.org/10.1371/journal.pone.0000815			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726545	Green Published, gold			2022-12-27	WOS:000207455400032
J	Lieberman, BS; Melott, AL				Lieberman, Bruce S.; Melott, Adrian L.			Considering the Case for Biodiversity Cycles: Re-Examining the Evidence for Periodicity in the Fossil Record	PLOS ONE			English	Article								We re-examine the evidence for a 62 million year (Myr) periodicity in biodiversity throughout the Phanerozoic history of animal life reported by [1], as well as related questions of periodicity in origination and extinction. We find that the signal is robust against variations in methods of analysis, and is based on fluctuations in the Paleozoic and a substantial part of the Mesozoic. Examination of origination and extinction is somewhat ambiguous, with results depending upon procedure. Origination and extinction intensity as defined by [1] may be affected by an artifact at 27 Myr in the duration of stratigraphic intervals. Nevertheless, when a procedure free of this artifact is implemented, the 27 Myr periodicity appears in origination, suggesting that the artifact may ultimately be based on a signal in the data. A 62 Myr feature appears in extinction, when this same procedure is used. We conclude that evidence for a periodicity at 62 Myr is robust, and evidence for periodicity at approximately 27 Myr is also present, albeit more ambiguous.	[Lieberman, Bruce S.] Univ Kansas, Dept Geol, Lawrence, KS 66045 USA; [Lieberman, Bruce S.] Univ Kansas, Nat Hist Museum, Lawrence, KS 66045 USA; [Melott, Adrian L.] Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA	University of Kansas; University of Kansas; University of Kansas	Lieberman, BS (corresponding author), Univ Kansas, Dept Geol, Lawrence, KS 66045 USA.	blieber@ku.edu			NASA Astrobiology: Exobiology and Evolutionary Biology [NNG04GM14G]	NASA Astrobiology: Exobiology and Evolutionary Biology(National Aeronautics & Space Administration (NASA))	This research was supported by NASA Astrobiology: Exobiology and Evolutionary Biology grant NNG04GM14G to ALM and BSL and a Madison and Lila Self Faculty Fellowship to BSL; funding organizations did not have any role and were not involved in the design and conduct of the study, the collection, analysis, and interpretation of the data, and the preparation, review, or approval of the manuscript.	Adrain JM, 2000, SCIENCE, V289, P110, DOI 10.1126/science.289.5476.110; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; Bambach RK, 2006, ANNU REV EARTH PL SC, V34, P127, DOI 10.1146/annurev.earth.33.092203.122654; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; BRIGHAM FO, 1988, FAST FOURIER TRANSFO, P448; CAMP CHARLES L., 1952, JOUR PALEONTOL, V26, P353; Cornette JL, 2007, COMPUT SCI ENG, V9, P61, DOI 10.1109/MCSE.2007.76; Cornette JL, 2004, P NATL ACAD SCI USA, V101, P187, DOI 10.1073/pnas.2637009100; Ding GH, 2006, PLOS COMPUT BIOL, V2, P918, DOI 10.1371/journal.pcbi.0020102; Droser ML, 2000, GEOLOGY, V28, P675, DOI 10.1130/0091-7613(2000)028<0675:DOTAES>2.3.CO;2; ELDREDGE N, 1998, PATTERN EVOLUTION, P219; Fischer A.G., 1977, SOC EC PALEONTOLOGIS, V25, P19; FISCHER AG, 1982, STUDIES GEOPHYS, P97; Foote M, 2005, PALEOBIOLOGY, V31, P6, DOI 10.1666/0094-8373(2005)031<0006:POAEIT>2.0.CO;2; Foote M, 2006, PALEOBIOLOGY, V32, P345, DOI 10.1666/05062.1; GILINSKY NL, 1991, PALEOBIOLOGY, V17, P145, DOI 10.1017/S0094837300010460; GRABAU AW, 1937, PALAEOZOIC FORMATI 2, V3, P850; HENBEST LLOYD G., 1952, JOUR PALEONTOL, V26, P299; Kirchner JW, 2000, P ROY SOC B-BIOL SCI, V267, P1301, DOI 10.1098/rspb.2000.1142; Kirchner JW, 2000, NATURE, V404, P177, DOI 10.1038/35004564; Kirchner JW, 2002, NATURE, V415, P65, DOI 10.1038/415065a; Laguna P, 1998, IEEE T BIO-MED ENG, V45, P698, DOI 10.1109/10.678605; Lu PJ, 2006, P NATL ACAD SCI USA, V103, P2736, DOI 10.1073/pnas.0511083103; Medvedev MV, 2007, ASTROPHYS J, V664, P879, DOI 10.1086/518757; Miller AI, 2003, SCIENCE, V302, P1030, DOI 10.1126/science.1089719; MULLER RA, 2002, ICE AGES ASTRONOMICA, P337; NEWELL ND, 1949, GEOL SOC AM BULL, V60, P1911; NEWELL NORMAN D., 1952, JOUR PALEONTOL, V26, P371; OGG JG, 2005, GEOLOGIC TIME SCALE, P610; Omerbashich M, 2006, COMPUT SCI ENG, V8, P26, DOI 10.1109/MCSE.2006.68; Peters SE, 2005, P NATL ACAD SCI USA, V102, P12326, DOI 10.1073/pnas.0502616102; Plotnick RE, 2001, PALEOBIOLOGY, V27, P126, DOI 10.1666/0094-8373(2001)027<0126:AMMMFO>2.0.CO;2; RAUP DM, 1986, SCIENCE, V231, P833, DOI 10.1126/science.11542060; RAUP DM, 1984, P NATL ACAD SCI-BIOL, V81, P801, DOI 10.1073/pnas.81.3.801; Rohde R.A., 2006, GEOL SOC AM M PROGR, P63; Rohde RA, 2005, NATURE, V434, P208, DOI 10.1038/nature03339; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; Sepkoski J. J., 2002, B AM PALEONTOL, V363, P560; Sepkoski J.J. Jr, 1986, P3; SIMPSON GEORGE GAYLORD, 1952, JOUR PALEONTOL, V26, P359; Smith AB, 2005, BIOL LETT-UK, V1, P443, DOI 10.1098/rsbl.2005.0345; van Dam JA, 2006, NATURE, V443, P687, DOI 10.1038/nature05163; VRBA ES, 1980, S AFR J SCI, V76, P61	43	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e759	10.1371/journal.pone.0000759	http://dx.doi.org/10.1371/journal.pone.0000759			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712407	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455300007
J	Nord, AS; Vranizan, K; Tingley, W; Zambon, AC; Hanspers, K; Fong, LG; Hu, Y; Bacchetti, P; Ferrin, TE; Babbitt, PC; Doniger, SW; Skarnes, WC; Young, SG; Conklin, BR				Nord, Alex S.; Vranizan, Karen; Tingley, Whittemore; Zambon, Alexander C.; Hanspers, Kristina; Fong, Loren G.; Hu, Yan; Bacchetti, Peter; Ferrin, Thomas E.; Babbitt, Patricia C.; Doniger, Scott W.; Skarnes, William C.; Young, Stephen G.; Conklin, Bruce R.			Modeling Insertional Mutagenesis Using Gene Length and Expression in Murine Embryonic Stem Cells	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; INTEGRATION; GENOME; TARGETS; SUPPRESSION; DROSOPHILA; RESOURCES; REGIONS; SITES; MICE	Background. High-throughput mutagenesis of the mammalian genome is a powerful means to facilitate analysis of gene function. Gene trapping in embryonic stem cells (ESCs) is the most widely used form of insertional mutagenesis in mammals. However, the rules governing its efficiency are not fully understood, and the effects of vector design on the likelihood of gene-trapping events have not been tested on a genome-wide scale. Methodology/Principal Findings. In this study, we used public gene-trap data to model gene-trap likelihood. Using the association of gene length and gene expression with gene-trap likelihood, we constructed spline-based regression models that characterize which genes are susceptible and which genes are resistant to gene-trapping techniques. We report results for three classes of gene-trap vectors, showing that both length and expression are significant determinants of trap likelihood for all vectors. Using our models, we also quantitatively identified hotspots of gene-trap activity, which represent loci where the high likelihood of vector insertion is controlled by factors other than length and expression. These formalized statistical models describe a high proportion of the variance in the likelihood of a gene being trapped by expression-dependent vectors and a lower, but still significant, proportion of the variance for vectors that are predicted to be independent of endogenous gene expression. Conclusions/Significance. The findings of significant expression and length effects reported here further the understanding of the determinants of vector insertion. Results from this analysis can be applied to help identify other important determinants of this important biological phenomenon and could assist planning of large-scale mutagenesis efforts.	[Nord, Alex S.; Fong, Loren G.; Hu, Yan; Young, Stephen G.] Univ Calif Los Angeles, Dept Med, MacDonald Med Res Labs, Los Angeles, CA 90024 USA; [Nord, Alex S.; Vranizan, Karen; Tingley, Whittemore; Zambon, Alexander C.; Hanspers, Kristina; Doniger, Scott W.; Conklin, Bruce R.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Nord, Alex S.; Ferrin, Thomas E.; Babbitt, Patricia C.] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA; [Nord, Alex S.; Ferrin, Thomas E.; Babbitt, Patricia C.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Tingley, Whittemore; Zambon, Alexander C.; Hanspers, Kristina; Conklin, Bruce R.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Vranizan, Karen] Univ Calif Berkeley, Funct Genom Lab, Berkeley, CA 94720 USA; [Bacchetti, Peter] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Doniger, Scott W.] Washington Univ, Sch Med, St Louis, MO USA; [Skarnes, William C.] Sanger Inst Hinxton, Wellcome Trust, Cambridge, England; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California Los Angeles; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Washington University (WUSTL); Wellcome Trust Sanger Institute; University of California System; University of California San Francisco	Nord, AS (corresponding author), Univ Calif Los Angeles, Dept Med, MacDonald Med Res Labs, Los Angeles, CA 90024 USA.	nordalex@u.washing-ton.edu; bconklin@gladstone.ucsf.edu	Conklin, Bruce/E-4738-2019	Nord, Alexander/0000-0003-4259-7514; Young, Stephen/0000-0001-7270-3176; Conklin, Bruce/0000-0003-1463-6061	NIH [HL66621, HG002766]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066621] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH Grants HL66621 and HG002766	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Baba Tomoya, 2006, Mol Syst Biol, V2; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; Boor C., 1978, PRACTICAL GUIDE SPLI; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Bushman FD, 2003, CELL, V115, P135, DOI 10.1016/S0092-8674(03)00760-8; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De-Zolt S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj026; Donoho G, 1998, MOL CELL BIOL, V18, P4070, DOI 10.1128/MCB.18.7.4070; Drysdale RA, 2005, NUCLEIC ACIDS RES, V33, pD390, DOI 10.1093/nar/gki046; Friedel RH, 2005, P NATL ACAD SCI USA, V102, P13188, DOI 10.1073/pnas.0505474102; Gorbunova V, 1997, NUCLEIC ACIDS RES, V25, P4650, DOI 10.1093/nar/25.22.4650; Hansen J, 2003, P NATL ACAD SCI USA, V100, P9918, DOI 10.1073/pnas.1633296100; Hicks GG, 1997, NAT GENET, V16, P338, DOI 10.1038/ng0897-338; HOLMESSON L, 2001, ADV GENET, V43, P33; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Liu HB, 2006, J VIROL, V80, P7765, DOI 10.1128/JVI.00542-06; Matthews KA, 2005, NAT REV GENET, V6, P179, DOI 10.1038/nrg1554; McCullagh P, 1989, GEN LINEAR MODELS; Miller DG, 2003, MOL CELL BIOL, V23, P3550, DOI 10.1128/MCB.23.10.3550-3557.2003; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; MULLER HP, 1994, EMBO J, V13, P4704, DOI 10.1002/j.1460-2075.1994.tb06794.x; Narezkina A, 2004, J VIROL, V78, P11656, DOI 10.1128/JVI.78.21.11656-11663.2004; Nord AS, 2006, NUCLEIC ACIDS RES, V34, pD642, DOI 10.1093/nar/gkj097; Osipovich AB, 2004, NUCLEIC ACIDS RES, V32, P2912, DOI 10.1093/nar/gkh604; SCHERDIN U, 1990, J VIROL, V64, P907, DOI 10.1128/JVI.64.2.907-912.1990; Schnutgen F, 2005, P NATL ACAD SCI USA, V102, P7221, DOI 10.1073/pnas.0502273102; Shigeoka T, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni022; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; SKARNES WC, 1992, GENE DEV, V6, P903, DOI 10.1101/gad.6.6.903; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Taganov KD, 2004, J VIROL, V78, P5848, DOI 10.1128/JVI.78.11.5848-5855.2004; To C, 2004, NUCLEIC ACIDS RES, V32, pD557, DOI 10.1093/nar/gkh106; VONMELCHNER H, 1989, J VIROL, V63, P3227, DOI 10.1128/JVI.63.8.3227-3233.1989; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100	41	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2007	2	7							e617	10.1371/journal.pone.0000617	http://dx.doi.org/10.1371/journal.pone.0000617			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GI	17637833	Green Published, gold, Green Submitted			2022-12-27	WOS:000207452100007
J	Mizrachy-Schwartz, S; Kravchenko-Balasha, N; Ben-Bassat, H; Klein, S; Levitzki, A				Mizrachy-Schwartz, Sarit; Kravchenko-Balasha, Nataly; Ben-Bassat, Hannah; Klein, Shoshana; Levitzki, Alexander			Optimization of Energy-Consuming Pathways towards Rapid Growth in HPV-Transformed Cells	PLOS ONE			English	Article								Cancer is a complex, multi-step process characterized by misregulated signal transduction and altered metabolism. Cancer cells divide faster than normal cells and their growth rates have been reported to correlate with increased metabolic flux during cell transformation. Here we report on progressive changes in essential elements of the biochemical network, in an in vitro model of transformation, consisting of primary human keratinocytes, human keratinocytes immortalized by human papillomavirus 16 (HPV16) and passaged repeatedly in vitro, and the extensively-passaged cells subsequently treated with the carcinogen benzo[a]pyrene. We monitored changes in cell growth, cell size and energy metabolism. The more transformed cells were smaller and divided faster, but the cellular energy flux was unchanged. During cell transformation the protein synthesis network contracted, as shown by the reduction in key cap-dependent translation factors. Moreover, there was a progressive shift towards internal ribosome entry site (IRES)-dependent translation. The switch from cap to IRES-dependent translation correlated with progressive activation of c-Src, an activator of AMP-activated protein kinase (AMPK), which controls energy-consuming processes, including protein translation. As cellular protein synthesis is a major energy-consuming process, we propose that the reduction in cell size and protein amount provide energy required for cell survival and proliferation. The cap to IRES-dependent switch seems to be part of a gradual optimization of energy-consuming mechanisms that redirects cellular processes to enhance cell growth, in the course of transformation.	[Mizrachy-Schwartz, Sarit; Kravchenko-Balasha, Nataly; Klein, Shoshana; Levitzki, Alexander] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, Unit Cellular Signaling, IL-91904 Jerusalem, Israel; [Ben-Bassat, Hannah] Hadassah Univ Hosp, Expt Surg Lab, IL-91120 Jerusalem, Israel; [Ben-Bassat, Hannah] Hadassah Univ Hosp, Israel Natl Skin Bank, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Levitzki, A (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, Unit Cellular Signaling, IL-91904 Jerusalem, Israel.	levitzki@vms.huji.ac.il	Kravchenko-Balasha, Nataly/D-7683-2016	Kravchenko-Balasha, Nataly/0000-0001-6943-7479				Akiri G, 1998, ONCOGENE, V17, P227, DOI 10.1038/sj.onc.1202019; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Carrera AC, 2004, J CELL SCI, V117, P4615, DOI 10.1242/jcs.01311; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Holcik M, 2005, RNA, V11, P1605, DOI 10.1261/rna.2158605; Holcik M, 2004, CURR CANCER DRUG TAR, V4, P299, DOI 10.2174/1568009043333005; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kato K, 2002, ONCOGENE, V21, P6082, DOI 10.1038/sj.onc.1205737; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Lang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017; MITRANIROSENBAUM S, 1992, INTERVIROLOGY, V33, P76, DOI 10.1159/000150234; MOUNTFORD PS, 1995, TRENDS GENET, V11, P179, DOI 10.1016/S0168-9525(00)89040-X; Otto GA, 2004, CELL, V119, P369, DOI 10.1016/j.cell.2004.09.038; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Santin AD, 2005, VIROLOGY, V331, P269, DOI 10.1016/j.virol.2004.09.045; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Svitkin YV, 2005, MOL CELL BIOL, V25, P10556, DOI 10.1128/MCB.25.23.10556-10565.2005; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; WARBURG O, 1956, SCIENCE, V124, P269; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	29	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2007	2	7							e628	10.1371/journal.pone.0000628	http://dx.doi.org/10.1371/journal.pone.0000628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GH	17622357	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452000019
J	Pfalz, M; Vogel, H; Mitchell-Olds, T; Kroymann, J				Pfalz, Marina; Vogel, Heiko; Mitchell-Olds, Thomas; Kroymann, Juergen			Mapping of QTL for Resistance against the Crucifer Specialist Herbivore Pieris brassicae in a New Arabidopsis Inbred Line Population, Da(1)-12xEi-2	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; INSECT RESISTANCE; SECONDARY METABOLISM; GENETIC-VARIATION; TRICHOME DENSITY; CHAIN ELONGATION; NATURAL ENEMIES; THALIANA; MYROSINASE; EXPRESSION	Background. In Arabidopsis thaliana and other crucifers, the glucosinolate-myrosinase system contributes to resistance against herbivory by generalist insects. As yet, it is unclear how crucifers defend themselves against crucifer-specialist insect herbivores. Methodology/Principal Findings. We analyzed natural variation for resistance against two crucifer specialist lepidopteran herbivores, Pieris brassicae and Plutella xylostella, among Arabidopsis thaliana accessions and in a new Arabidopsis recombinant inbred line (RIL) population generated from the parental accessions Da(1)-12 and Ei-2. This RIL population consists of 201 individual F-8 lines genotyped with 84 PCR-based markers. We identified six QTL for resistance against Pieris herbivory, but found only one weak QTL for Plutella resistance. To elucidate potential factors causing these resistance QTL, we investigated leaf hair ( trichome) density, glucosinolates and myrosinase activity, traits known to influence herbivory by generalist insects. We identified several previously unknown QTL for these traits, some of which display a complex pattern of epistatic interactions. Conclusions/Significance. Although some trichome, glucosinolate or myrosinase QTL colocalize with Pieris QTL, none of these traits explained the resistance QTL convincingly, indicating that resistance against specialist insect herbivores is influenced by other traits than resistance against generalists.	[Pfalz, Marina; Mitchell-Olds, Thomas; Kroymann, Juergen] Max Planck Inst Chem Ecol, Dept Genet & Evolut, Jena, Germany; [Vogel, Heiko] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany; [Mitchell-Olds, Thomas] Duke Univ, Dept Biol, Durham, NC USA	Max Planck Society; Max Planck Society; Duke University	Kroymann, J (corresponding author), Max Planck Inst Chem Ecol, Dept Genet & Evolut, Jena, Germany.	kroymann@ice.mpg.de	Kroymann, Juergen/B-4317-2013; Kroymann, Juergen/AAY-8562-2021; Mitchell-Olds, Thomas/K-8121-2012	Kroymann, Juergen/0000-0002-4573-6498; Mitchell-Olds, Thomas/0000-0003-3439-9921	Max Planck Society; Bundesministerium fur Bildung und Forschung [PTJ-BIO/0313063]; Deutsche Forschungsgemeinschaft [KR 2237/2-1, KR 2237/2-2]; European Commission [QLRT-2000-01097]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Max Planck Society, the Bundesministerium fur Bildung und Forschung (PTJ-BIO/0313063), the Deutsche Forschungsgemeinschaft (KR 2237/2-1 and KR 2237/2-2), and the European Commission ( Contract QLRT-2000-01097).	Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Barth C, 2006, PLANT J, V46, P549, DOI 10.1111/j.1365-313X.2006.02716.x; Benderoth M, 2006, P NATL ACAD SCI USA, V103, P9118, DOI 10.1073/pnas.0601738103; BONNEMAISON L, 1965, ANNU REV ENTOMOL, V10, P233, DOI 10.1146/annurev.en.10.010165.001313; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Buchner R., 1987, GLUCOSINOLATES RAPES, P50, DOI DOI 10.1007/978-94-009-3615-7; Campos de Quiros H., 2000, Theoretical and Applied Genetics, V101, P429, DOI 10.1007/s001220051500; CHADCHAWAN S, 1993, PLANT PHYSIOL, V103, P671, DOI 10.1104/pp.103.2.671; Field B, 2004, PLANT PHYSIOL, V135, P828, DOI 10.1104/pp.104.039347; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Handley R, 2005, ECOL ENTOMOL, V30, P284, DOI 10.1111/j.0307-6946.2005.00699.x; HILL DS, 1987, AGR INSECT PESTS TEM, P411; HUANG XP, 1994, J CHEM ECOL, V20, P1025, DOI 10.1007/BF02059739; Husebye H, 2002, PLANT PHYSIOL, V128, P1180, DOI 10.1104/pp.010925; Jander G, 2001, PLANT PHYSIOL, V126, P890, DOI 10.1104/pp.126.2.890; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kliebenstein D, 2002, GENETICS, V161, P325; Kliebenstein DJ, 2005, CURR OPIN PLANT BIOL, V8, P264, DOI 10.1016/j.pbi.2005.03.002; Kliebenstein DJ, 2001, GENETICS, V159, P359; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Koroleva OA, 2000, PLANT PHYSIOL, V124, P599, DOI 10.1104/pp.124.2.599; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Kroymann J, 2001, PLANT PHYSIOL, V127, P1077, DOI 10.1104/pp.010416; Lambrix V, 2001, PLANT CELL, V13, P2793, DOI 10.1105/tpc.13.12.2793; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; MAGRATH R, 1994, HEREDITY, V72, P290, DOI 10.1038/hdy.1994.39; Mauricio R, 2005, GENETICA, V123, P75, DOI 10.1007/s10709-002-2714-9; Mauricio R, 1998, AM NAT, V151, P20, DOI 10.1086/286099; Mauricio R, 1997, EVOLUTION, V51, P1435, DOI [10.2307/2411196, 10.1111/j.1558-5646.1997.tb01467.x]; Miles CI, 2005, J COMP PHYSIOL A, V191, P147, DOI 10.1007/s00359-004-0580-x; Mitchell-Olds T, 1998, GENETICS, V149, P739; MITHEN R, 1995, HEREDITY, V74, P210, DOI 10.1038/hdy.1995.29; Ratzka A, 2002, P NATL ACAD SCI USA, V99, P11223, DOI 10.1073/pnas.172112899; Raybould AF, 2001, HEREDITY, V87, P383, DOI 10.1046/j.1365-2540.2001.00954.x; Renwick JAA, 1999, ENTOMOL EXP APPL, V91, P51, DOI 10.1023/A:1003693005761; Renwick JAA, 2002, ENTOMOL EXP APPL, V104, P35, DOI 10.1023/A:1021231732022; SAMSON PR, 1983, PROT ECOL, V5, P199; Satagopan JM, 1996, GENETICS, V144, P805; SCHOONHO.LM, 1969, ENTOMOL EXP APPL, V12, P555, DOI 10.1007/BF00297086; SHELTON AM, 1991, J ENTOMOL SCI, V26, P17, DOI 10.18474/0749-8004-26.1.17; STADLER E, 1995, PHYSIOL ENTOMOL, V20, P175, DOI 10.1111/j.1365-3032.1995.tb00814.x; Symonds VV, 2005, GENETICS, V169, P1649, DOI 10.1534/genetics.104.031948; Thangstad OP, 2004, PLANT MOL BIOL, V54, P597, DOI 10.1023/B:PLAN.0000038272.99590.10; Tuinstra MR, 1997, THEOR APPL GENET, V95, P1005, DOI 10.1007/s001220050654; van Loon J.J.A., 1992, Chemoecology, V3, P39, DOI 10.1007/BF01261455; Van Ooijen JW, 1999, HEREDITY, V83, P613, DOI 10.1038/sj.hdy.6886230; Wang S., 2001, WINDOWS QTL CARTOGRA; Wittstock U, 2004, P NATL ACAD SCI USA, V101, P4859, DOI 10.1073/pnas.0308007101; Wittstock U, 2002, TRENDS PLANT SCI, V7, P263, DOI 10.1016/S1360-1385(02)02273-2; XUE JP, 1995, PLANT MOL BIOL, V27, P911, DOI 10.1007/BF00037019; Zhang JM, 2002, PHYSIOL PLANTARUM, V115, P25, DOI 10.1034/j.1399-3054.2002.1150103.x; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602	58	39	39	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e578	10.1371/journal.pone.0000578	http://dx.doi.org/10.1371/journal.pone.0000578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593977	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451800022
J	Vitousek, MN; Mitchell, MA; Woakes, AJ; Niemack, MD; Wikelski, M				Vitousek, Maren N.; Mitchell, Mark A.; Woakes, Anthony J.; Niemack, Michael D.; Wikelski, Martin			High Costs of Female Choice in a Lekking Lizard	PLOS ONE			English	Article							IGUANAS AMBLYRHYNCHUS-CRISTATUS; FALSE DISCOVERY RATE; POPULATION BIOLOGY; BODY-SIZE; MATING SYSTEM; MATE CHOICE; HEART-RATE; MARINE; EVOLUTION; PERFORMANCE	Although the cost of mate choice is an essential component of the evolution and maintenance of sexual selection, the energetic cost of female choice has not previously been assessed directly. Here we report that females can incur high energetic costs as a result of discriminating among potential mates. We used heart rate biologging to quantify energetic expenditure in lek-mating female Galapagos marine iguanas (Amblyrhynchus cristatus). Receptive females spent 78.9 +/- 23.2kJ of energy on mate choice over a 30-day period, which is equivalent to, similar to 3/4 one day's energy budget. Females that spent more time on the territories of high-quality, high-activity males displayed greater energetic expenditure on mate choice, lost more mass, and showed a trend towards producing smaller follicles. Choosy females also appear to face a reduced probability of survival if El Nino conditions occur in the year following breeding. These findings indicate that female choice can carry significant costs, and suggest that the benefits that lek-mating females gain through mating with a preferred male may be higher than previously predicted.	[Vitousek, Maren N.; Wikelski, Martin] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Mitchell, Mark A.] Louisiana State Univ, Dept Vet Clin Sci, Baton Rouge, LA 70803 USA; [Woakes, Anthony J.] Univ Birmingham, Ctr Ornithol, Sch Biosci, Edgbaston, England; [Niemack, Michael D.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Princeton University; Louisiana State University System; Louisiana State University; University of Birmingham; Princeton University	Vitousek, MN (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	mvitouse@princeton.edu		Vitousek, Maren N./0000-0003-2855-0832	SGER IOB [0118069]; NSF LTREB; Animal Behavior Society, Sigma Xi and Princeton University	SGER IOB; NSF LTREB(National Science Foundation (NSF)); Animal Behavior Society, Sigma Xi and Princeton University	This work was supported by grants SGER IOB 0118069 and NSF LTREB ( to MW) and grants from the Animal Behavior Society, Sigma Xi and Princeton University ( to MV). Our protocol adhered to the Animal Behavior Society Guidelines for the Use of Animals in Research, and was approved by the Princeton University IACUC Committee #1439.	ALATALO RV, 1998, P R SOC B, V353, P2297; Angilletta MJ, 2000, ECOLOGY, V81, P2957, DOI 10.1890/0012-9658(2000)081[2957:TEOTEO]2.0.CO;2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borgia G., 1979, SEXUAL SELECTION REP, P19; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Butler PJ, 2002, J EXP BIOL, V205, P1917; Byers JA, 2005, AM NAT, V166, P661, DOI 10.1086/497401; Gartrell BD, 2002, ZOO BIOL, V21, P253, DOI 10.1002/zoo.10017; GIBSON RM, 1992, BEHAV ECOL, V3, P300, DOI 10.1093/beheco/3.4.300; Gotthard K, 1999, BEHAV ECOL SOCIOBIOL, V45, P424, DOI 10.1007/s002650050580; Hancock TV, 2001, COMP BIOCHEM PHYS A, V130, P67, DOI 10.1016/S1095-6433(01)00365-8; Head ML, 2005, PLOS BIOL, V3, P289, DOI 10.1371/journal.pbio.0030033; in den Bosch HAJ, 1998, J HERPETOL, V32, P410, DOI 10.2307/1565456; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; Kirkpatrick M, 1996, EVOLUTION, V50, P2125, DOI [10.2307/2410684, 10.1111/j.1558-5646.1996.tb03603.x]; Kraak SBM, 1996, BEHAV ECOL, V7, P353, DOI 10.1093/beheco/7.3.353; LAURIE WA, 1990, J ANIM ECOL, V59, P515, DOI 10.2307/4878; LAURIE WA, 1990, J ANIM ECOL, V59, P529, DOI 10.2307/4879; LAURIE WA, 1990, J ANIM ECOL, V59, P545, DOI 10.2307/4880; LICHTENBELT WDV, 1993, ECOLOGY, V74, P1157, DOI 10.2307/1940486; Luttbeg B, 2001, ETHOLOGY, V107, P545, DOI 10.1046/j.1439-0310.2001.00694.x; MILES DB, 1995, OECOLOGIA, V103, P261, DOI 10.1007/BF00329089; MILINSKI M, 1992, P ROY SOC LOND B BIO, V268, P517; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; NORRIS K, 1993, NATURE, V362, P537, DOI 10.1038/362537a0; Partecke J, 2002, BEHAV ECOL SOCIOBIOL, V51, P579, DOI 10.1007/s00265-002-0469-z; PETRIE M, 1994, NATURE, V371, P598, DOI 10.1038/371598a0; POMIANKOWSKI A, 1995, P ROY SOC B-BIOL SCI, V260, P21, DOI 10.1098/rspb.1995.0054; RAUCH N, 1985, BEHAV ECOL SOCIOBIOL, V16, P125, DOI 10.1007/BF00295146; REYNOLDS JD, 1992, P ROY SOC B-BIOL SCI, V250, P57, DOI 10.1098/rspb.1992.0130; REYNOLDS JD, 1990, AM NAT, V136, P230, DOI 10.1086/285093; SHUSTER SM, 2003, MG BEH ECOL, pR7; Tallamy DW, 2003, P ROY SOC B-BIOL SCI, V270, P77, DOI 10.1098/rspb.2002.2198; TRILLMICH KGK, 1983, Z TIERPSYCHOL, V63, P141; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Wikelski M, 1997, ECOLOGY, V78, P2204, DOI 10.2307/2265956; Wikelski M, 2005, P ROY SOC B-BIOL SCI, V272, P1985, DOI 10.1098/rspb.2005.3205; Wikelski M, 2003, INTEGR COMP BIOL, V43, P376, DOI 10.1093/icb/43.3.376; Wikelski M, 1995, J BIOL RHYTHM, V10, P335, DOI 10.1177/074873049501000407; Wikelski M, 2001, ETHOLOGY, V107, P623, DOI 10.1046/j.1439-0310.2001.00701.x; Wikelski M, 1996, ANIM BEHAV, V52, P581, DOI 10.1006/anbe.1996.0199; Wong BBM, 2003, P ROY SOC B-BIOL SCI, V270, pS36, DOI 10.1098/rsbl.2003.0003	42	24	24	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e567	10.1371/journal.pone.0000567	http://dx.doi.org/10.1371/journal.pone.0000567			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593966	Green Published, gold, Green Submitted			2022-12-27	WOS:000207451800011
J	Zhu, PX; Aller, MI; Baron, U; Cambridge, S; Bausen, M; Herb, J; Sawinski, J; Cetin, A; Osten, P; Nelson, ML; Kugler, S; Seeburg, PH; Sprengel, R; Hasan, MT				Zhu, Peixin; Aller, M. Isabel; Baron, Udo; Cambridge, Sidney; Bausen, Melanie; Herb, Jan; Sawinski, Juergen; Cetin, Ali; Osten, Pavel; Nelson, Mark L.; Kuegler, Sebastian; Seeburg, Peter H.; Sprengel, Rolf; Hasan, Mazahir T.			Silencing and Un-silencing of Tetracycline-Controlled Genes in Neurons	PLOS ONE			English	Article								To identify the underlying reason for the controversial performance of tetracycline (Tet)-controlled regulated gene expression in mammalian neurons, we investigated each of the three components that comprise the Tet inducible systems, namely tetracyclines as inducers, tetracycline-transactivator (tTA) and reverse tTA (rtTA), and tTA-responsive promoters (P-tets). We have discovered that stably integrated P-tet becomes functionally silenced in the majority of neurons when it is inactive during development. Ptet silencing can be avoided when it is either not integrated in the genome or stably-integrated with basal activity. Moreover, long-term, high transactivator levels in neurons can often overcome integration-induced Ptet gene silencing, possibly by inducing promoter accessibility.	[Zhu, Peixin; Bausen, Melanie; Herb, Jan; Sawinski, Juergen; Cetin, Ali; Osten, Pavel; Seeburg, Peter H.; Sprengel, Rolf; Hasan, Mazahir T.] Max Planck Inst Med Res, Heidelberg, Germany; [Cambridge, Sidney; Hasan, Mazahir T.] Max Planck Inst Neurobiol, Munich, Germany; [Baron, Udo] Epiontis GmbH, Berlin, Germany; [Aller, M. Isabel] Univ Heidelberg, Dept Clin Neurobiol, Heidelberg, Germany; [Nelson, Mark L.] Paratek Pharmaceut Inc, Boston, MA USA; [Kuegler, Sebastian] Univ Gottingen, Dept Neurol, D-3400 Gottingen, Germany	Max Planck Society; Max Planck Society; Epiontis GmbH; Ruprecht Karls University Heidelberg; University of Gottingen	Hasan, MT (corresponding author), Max Planck Inst Med Res, Heidelberg, Germany.	mhasan@mpimf-heidelberg.mpg.de	Cambridge, Sidney/GYQ-5764-2022; Aller, Isabel/AAY-8409-2020; Hasan, Mazahir/L-3679-2017	Baron, Udo/0000-0001-7432-3601; Hasan, Mazahir/0000-0001-9985-7271; Aller, M.Isabel/0000-0002-6447-9896	Max Planck Society, Volkswagenstiftung; German-Israeli Project [I-663-64.11/2000]; Schloessmann Foundation	Max Planck Society, Volkswagenstiftung(Max Planck SocietyVolkswagen); German-Israeli Project; Schloessmann Foundation	This work was supported by funding from the Max Planck Society, Volkswagenstiftung (M. I. A.), German-Israeli Project (Grant No.: I-663-64.11/2000), and Schloessmann Foundation.	Ali SF, 1999, MOL BRAIN RES, V74, P237, DOI 10.1016/S0169-328X(99)00283-1; Aller MI, 2005, J NEUROSCI, V25, P11455, DOI 10.1523/JNEUROSCI.3153-05.2005; Baron U, 1997, NUCLEIC ACIDS RES, V25, P2723, DOI 10.1093/nar/25.14.2723; BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bejar R, 2002, J NEUROSCI, V22, P5719; Boger H, 1999, MECH DEVELOP, V83, P141, DOI 10.1016/S0925-4773(99)00042-8; Carpenter AE, 2005, MOL CELL BIOL, V25, P958, DOI 10.1128/MCB.25.3.958-968.2005; CHALFIE M, 1995, PHOTOCHEM PHOTOBIOL, V62, P651, DOI 10.1111/j.1751-1097.1995.tb08712.x; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Duan DS, 1998, J VIROL, V72, P8568, DOI 10.1128/JVI.72.11.8568-8577.1998; Eckenstein FP, 2006, EXP NEUROL, V198, P338, DOI 10.1016/j.expneurol.2005.12.020; Ferreira ME, 2005, J BIOL CHEM, V280, P21779, DOI 10.1074/jbc.M502627200; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Gossen M, 2002, ANNU REV GENET, V36, P153, DOI 10.1146/annurev.genet.36.041002.120114; Grimm D, 2003, MOL THER, V7, P839, DOI 10.1016/S1525-0016(03)00095-9; Harding TC, 1998, NAT BIOTECHNOL, V16, P553, DOI 10.1038/nbt0698-553; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Hasan MT, 2001, GENESIS, V29, P116, DOI 10.1002/gene.1014; Hennighausen L, 1995, J CELL BIOCHEM, V59, P463, DOI 10.1002/jcb.240590407; Jerecic J, 1999, ANN NY ACAD SCI, V868, P27, DOI 10.1111/j.1749-6632.1999.tb11271.x; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Krestel HE, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e39; Krestel HE, 2004, J NEUROSCI, V24, P10568, DOI 10.1523/JNEUROSCI.4579-03.2004; Kues WA, 2006, FASEB J, V20, P1200, DOI 10.1096/fj.05-5415fje; Lindeberg J, 2002, J NEUROSCI RES, V68, P248, DOI 10.1002/jnr.10213; Mansuy IM, 1998, NEURON, V21, P257, DOI 10.1016/S0896-6273(00)80533-4; Mayford M, 1999, TRENDS GENET, V15, P463, DOI 10.1016/S0168-9525(99)01846-6; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Michalon A, 2005, GENESIS, V43, P205, DOI 10.1002/gene.20175; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miyawaki A, 2003, CURR OPIN NEUROBIOL, V13, P591, DOI 10.1016/j.conb.2003.09.005; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Pankiewicz R, 2005, J GENE MED, V7, P117, DOI 10.1002/jgm.644; Schnepp BC, 2003, J VIROL, V77, P3495, DOI 10.1128/JVI.77.6.3495-3504.2003; Shevtsova Z, 2005, EXP PHYSIOL, V90, P53, DOI 10.1113/expphysiol.2004.028159; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Shimshek DR, 2005, PLOS BIOL, V3, P2017, DOI 10.1371/journal.pbio.0030354; Sprengel R, 2007, Handb Exp Pharmacol, P49; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tsien Roger Y, 2003, Harvey Lect, V99, P77; Uchida S, 2006, GENES BRAIN BEHAV, V5, P96, DOI 10.1111/j.1601-183X.2005.00139.x; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Yu TS, 2005, GENESIS, V41, P147, DOI 10.1002/gene.20110	49	63	64	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2007	2	6							e533	10.1371/journal.pone.0000533	http://dx.doi.org/10.1371/journal.pone.0000533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GE	17579707	Green Published, gold, Green Accepted			2022-12-27	WOS:000207451700001
J	Ali, GS; Palusa, SG; Golovkin, M; Prasad, J; Manley, JL; Reddy, ASN				Ali, Gul Shad; Palusa, Saiprasad G.; Golovkin, Maxim; Prasad, Jayendra; Manley, James L.; Reddy, Anireddy S. N.			Regulation of Plant Developmental Processes by a Novel Splicing Factor	PLOS ONE			English	Article							SERINE/ARGININE-RICH PROTEINS; MADS DOMAIN PROTEIN; PRE-MESSENGER-RNAS; FLOWERING-TIME; ARABIDOPSIS-THALIANA; BINDING-PROTEIN; GENE CONTROLS; SR PROTEINS; MERISTEM; ENCODES	Serine/arginine-rich (SR) proteins play important roles in constitutive and alternative splicing and other aspects of mRNA metabolism. We have previously isolated a unique plant SR protein (SR45) with atypical domain organization. However, the biological and molecular functions of this novel SR protein are not known. Here, we report biological and molecular functions of this protein. Using an in vitro splicing complementation assay, we showed that SR45 functions as an essential splicing factor. Furthermore, the alternative splicing pattern of transcripts of several other SR genes was altered in a mutant, sr45-1, suggesting that the observed phenotypic abnormalities in sr45-1 are likely due to altered levels of SR protein isoforms, which in turn modulate splicing of other pre-mRNAs. sr45-1 exhibited developmental abnormalities, including delayed flowering, narrow leaves and altered number of petals and stamens. The late flowering phenotype was observed under both long days and short days and was rescued by vernalization. FLC, a key flowering repressor, is up-regulated in sr45-1 demonstrating that SR45 influences the autonomous flowering pathway. Changes in the alternative splicing of SR genes and the phenotypic defects in the mutant were rescued by SR45 cDNA, further confirming that the observed defects in the mutant are due to the lack of SR45. These results indicate that SR45 is a novel plant-specific splicing factor that plays a crucial role in regulating developmental processes.	[Ali, Gul Shad; Palusa, Saiprasad G.; Golovkin, Maxim; Reddy, Anireddy S. N.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Ali, Gul Shad; Palusa, Saiprasad G.; Golovkin, Maxim; Reddy, Anireddy S. N.] Colorado State Univ, Program Mol Plant Biol, Ft Collins, CO 80523 USA; [Prasad, Jayendra; Manley, James L.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Colorado State University; Colorado State University; Columbia University	Reddy, ASN (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	reddy@colostate.edu		Manley, James/0000-0002-8341-1459; Reddy, Anireddy/0000-0002-4038-4091	Department of Energy [FG02-04ER15556]; NIH [GM048259]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048259, R37GM048259] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Department of Energy (DE-FG02-04ER15556) to ASNR and NIH grant GM048259 to JLM.	Ali GS, 2003, PLANT J, V36, P883, DOI 10.1046/j.1365-313X.2003.01932.x; Ali GS, 2006, J CELL SCI, V119, P3527, DOI 10.1242/jcs.03144; Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger D, 2000, GENE DEV, V14, P1119; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; BOSS PK, 2004, ENABLING PROMOTING R, V16, pS18; Byrne ME, 2005, CURR OPIN PLANT BIOL, V8, P59, DOI 10.1016/j.pbi.2004.11.009; Chalfun A, 2005, PLANT MOL BIOL, V57, P559, DOI 10.1007/s11103-005-0698-4; CLARK SE, 1993, DEVELOPMENT, V119, P397; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Fletcher JC, 2001, DEVELOPMENT, V128, P1323; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Golovkin M, 1996, PLANT CELL, V8, P1421, DOI 10.1105/tpc.8.8.1421; Golovkin M, 1998, PLANT CELL, V10, P1637, DOI 10.1105/tpc.10.10.1637; Golovkin M, 1999, J BIOL CHEM, V274, P36428, DOI 10.1074/jbc.274.51.36428; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Hanson J, 2001, PLANT MOL BIOL, V45, P247, DOI 10.1023/A:1006464907710; He YH, 2005, TRENDS PLANT SCI, V10, P30, DOI 10.1016/j.tplants.2004.11.003; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Horiguchi G, 2005, PLANT J, V43, P68, DOI 10.1111/j.1365-313X.2005.02429.x; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; Iida K, 2006, MOL BIOL EVOL, V23, P1085, DOI 10.1093/molbev/msj118; Isshiki M, 2006, PLANT CELL, V18, P146, DOI 10.1105/tpc.105.037069; Jack T, 2004, PLANT CELL, V16, pS1, DOI 10.1105/tpc.017038; Kalyna M, 2004, BIOCHEM SOC T, V32, P561, DOI 10.1042/BST0320561; Kalyna M, 2003, MOL BIOL CELL, V14, P3565, DOI 10.1091/mbc.E03-02-0109; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kayes JM, 1998, DEVELOPMENT, V125, P3843; Kim GT, 1998, PLANTA, V206, P175, DOI 10.1007/s004250050389; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lazar G, 2000, PLANT MOL BIOL, V42, P571, DOI 10.1023/A:1006394207479; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; LEE I, 1994, PLANT CELL, V6, P75, DOI 10.1105/tpc.6.1.75; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lim MH, 2004, PLANT CELL, V16, P731, DOI 10.1105/tpc.019331; Lopato S, 2002, J BIOL CHEM, V277, P39989, DOI 10.1074/jbc.M206455200; Lopato S, 1999, GENE DEV, V13, P987, DOI 10.1101/gad.13.8.987; Macknight R, 2002, PLANT CELL, V14, P877, DOI 10.1105/tpc.010456; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mockler TC, 2004, P NATL ACAD SCI USA, V101, P12759, DOI 10.1073/pnas.0404552101; Nelissen H, 2003, PLANT CELL, V15, P639, DOI 10.1105/tpc.007062; Noh YS, 2003, PLANT CELL, V15, P1671, DOI 10.1105/tpc.012161; Palusa SG, 2007, PLANT J, V49, P1091, DOI 10.1111/j.1365-313X.2006.03020.x; Prasad J, 1999, MOL CELL BIOL, V19, P6991; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; Reddy ASN, 2004, TRENDS PLANT SCI, V9, P541, DOI 10.1016/j.tplants.2004.09.007; Reddy ASN, 2001, CRIT REV PLANT SCI, V20, P523, DOI 10.1016/S0735-2689(01)80004-6; Reddy VS, 2004, PLANT CELL, V16, P185, DOI 10.1105/tpc.016600; ROMAC JMJ, 1995, GENE DEV, V9, P1400, DOI 10.1101/gad.9.11.1400; Running MP, 2004, P NATL ACAD SCI USA, V101, P7815, DOI 10.1073/pnas.0402385101; Sanford J R, 2003, Prog Mol Subcell Biol, V31, P33; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Shen HH, 2004, MOL CELL, V13, P367, DOI 10.1016/S1097-2765(04)00025-5; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Sung S, 2005, ANNU REV PLANT BIOL, V56, P491, DOI 10.1146/annurev.arplant.56.032604.144307; Tacke R, 1998, CELL, V93, P139, DOI 10.1016/S0092-8674(00)81153-8; Theodoris G, 2003, P NATL ACAD SCI USA, V100, P6837, DOI 10.1073/pnas.1132113100; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsukaya H, 2006, ANNU REV PLANT BIOL, V57, P477, DOI 10.1146/annurev.arplant.57.032905.105320; Wagner TA, 2001, PLANT CELL, V13, P303, DOI 10.1105/tpc.13.2.303; Wang BB, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r102; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Yang M, 1995, PLANT CELL, V7, P2227, DOI 10.1105/tpc.7.12.2227; Ziegelhoffer EC, 2000, P NATL ACAD SCI USA, V97, P7633, DOI 10.1073/pnas.130189397	70	98	104	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2007	2	5							e471	10.1371/journal.pone.0000471	http://dx.doi.org/10.1371/journal.pone.0000471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10FB	17534421	Green Published, Green Submitted, gold			2022-12-27	WOS:000207448800001
J	Thakur, NN; El-Gogo, S; Steer, B; Freimuller, K; Waha, A; Adler, H				Thakur, Nagendra N.; El-Gogo, Susanne; Steer, Beatrix; Freimueller, Klaus; Waha, Andreas; Adler, Heiko			A Gammaherpesviral Internal Repeat Contributes to Latency Amplification	PLOS ONE			English	Article								Background. Gammaherpesviruses cause important infections of humans, in particular in immunocompromised patients. The genomes of gammaherpesviruses contain variable numbers of internal repeats whose precise role for in vivo pathogenesis is not well understood. Methodology/Principal Findings. We used infection of laboratory mice with murine gammaherpesvirus 68 (MHV-68) to explore the biological role of the 40 bp internal repeat of MHV-68. We constructed several mutant viruses partially or completely lacking this repeat. Both in vitro and in vivo, the loss of the repeat did not substantially affect lytic replication of the mutant viruses. However, the extent of splenomegaly, which is associated with the establishment of latency, and the number of ex vivo reactivating and genome positive splenocytes were reduced. Since the 40 bp repeat is part of the hypothetical open reading frame (ORF) M6, it might function as part of M6 or as an independent structure. To differentiate between these two possibilities, we constructed an N-terminal M6STOP mutant, leaving the repeat structure intact but rendering ORF M6 unfunctional. Disruption of ORF M6 did neither affect lytic nor latent infection. In contrast to the situation in lytically infected NIH3T3 cells, the expression of the latency-associated genes K3 and ORF72 was reduced in the latently infected murine B cell line Ag8 in the absence of the 40 bp repeat. Conclusions/Significance. These data suggest that the 40 bp repeat contributes to latency amplification and might be involved in the regulation of viral gene expression.	[Thakur, Nagendra N.; Steer, Beatrix; Freimueller, Klaus; Adler, Heiko] GSF Natl Res Ctr Environm & Hlth, Inst Mol Immunol, Clin Cooperat Grp Hematopoiet Cell Transplantat, Munich, Germany; [Thakur, Nagendra N.; Steer, Beatrix] Univ Munich, Dept Med 3, Munich, Germany; [El-Gogo, Susanne] Tech Univ Munich, Inst Virol, Munich, Germany; [Waha, Andreas] Univ Bonn, Inst Neuropathol, D-5300 Bonn, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Technical University of Munich; University of Bonn	Adler, H (corresponding author), GSF Natl Res Ctr Environm & Hlth, Inst Mol Immunol, Clin Cooperat Grp Hematopoiet Cell Transplantat, Munich, Germany.	h.adler@gsf.de	Adler, Heiko/M-7355-2014	Adler, Heiko/0000-0002-6481-6709	Deutsche Forschungsgemeinschaft [Ad121/2-1, 2-2, 2-4]; BMBF [NGFN-2, FKZ 01GS0405]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Ad121/2-1, 2-2 and 2-4) and the BMBF (NGFN-2, FKZ 01GS0405).	AB RICKINSON, 2001, FIELDS VIROLOGY, P2575; Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Adler H, 2001, J VIROL, V75, P5692, DOI 10.1128/JVI.75.12.5692-5696.2001; Adler H, 2007, J VIROL, V81, P7300, DOI 10.1128/JVI.02406-06; ALLAN GJ, 1989, VIROLOGY, V173, P489, DOI 10.1016/0042-6822(89)90561-8; Almqvist J, 2005, J GEN VIROL, V86, P1261, DOI 10.1099/vir.0.80620-0; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; BLASKOVIC D, 1980, ACTA VIROL, V24, P468; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Cesarman E, 1999, SEMIN CANCER BIOL, V9, P165, DOI 10.1006/scbi.1998.0118; Chambeyron S, 2004, CURR OPIN CELL BIOL, V16, P256, DOI 10.1016/j.ceb.2004.03.004; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Coleman HM, 2005, J GEN VIROL, V86, P561, DOI 10.1099/vir.0.80565-0; Coleman HM, 2003, J VIROL, V77, P13093, DOI 10.1128/JVI.77.24.13093-13105.2003; Cook PR, 2003, J CELL SCI, V116, P4483, DOI 10.1242/jcs.00819; COX MA, 1990, J VIROL, V64, P313, DOI 10.1128/JVI.64.1.313-321.1990; Dantuma NP, 2000, P NATL ACAD SCI USA, V97, P8381, DOI 10.1073/pnas.140217397; Dean A, 2006, TRENDS GENET, V22, P38, DOI 10.1016/j.tig.2005.11.001; DELUCA NA, 1988, J VIROL, V62, P732, DOI 10.1128/JVI.62.3.732-743.1988; FALK K, 1995, J GEN VIROL, V76, P779, DOI 10.1099/0022-1317-76-4-779; Fowler P, 2003, J GEN VIROL, V84, P3405, DOI 10.1099/vir.0.19594-0; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hoge AT, 2000, J VIROL, V74, P7016, DOI 10.1128/JVI.74.15.7016-7023.2000; JEANG KT, 1983, J VIROL, V48, P135, DOI 10.1128/JVI.48.1.135-148.1983; JONES MD, 1983, NUCLEIC ACIDS RES, V11, P3919, DOI 10.1093/nar/11.12.3919; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; LAUX G, 1985, J VIROL, V56, P987, DOI 10.1128/JVI.56.3.987-995.1985; Lee BJ, 2003, J IMMUNOL, V170, P243, DOI 10.4049/jimmunol.170.1.243; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; LIEBERMAN PM, 1989, J VIROL, V63, P3040, DOI 10.1128/JVI.63.7.3040-3050.1989; Marques S, 2003, J VIROL, V77, P7308, DOI 10.1128/JVI.77.13.7308-7318.2003; McCormick C, 2006, J VIROL, V80, P6165, DOI 10.1128/JVI.02331-05; McCormick C, 2005, SCIENCE, V307, P739, DOI 10.1126/science.1105779; Messerle M, 1997, P NATL ACAD SCI USA, V94, P14759, DOI 10.1073/pnas.94.26.14759; Moorman NJ, 2003, J VIROL, V77, P10295, DOI 10.1128/JVI.77.19.10295-10303.2003; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Nash AA, 2001, PHILOS T R SOC B, V356, P569, DOI 10.1098/rstb.2000.0779; NUEBLING CM, 1989, J VIROL, V63, P4609, DOI 10.1128/JVI.63.11.4609-4615.1989; Oki M, 2002, CURR OPIN CELL BIOL, V14, P299, DOI 10.1016/S0955-0674(02)00327-7; Pearsall RS, 1999, GENOMICS, V55, P194, DOI 10.1006/geno.1998.5660; Rochford R, 2001, J VIROL, V75, P4955, DOI 10.1128/JVI.75.11.4955-4963.2001; Roizman B, 2001, FIELDS VIROL, P2381; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; SHAPIRO A, 1998, NAT MED, V4, P939; Simas JP, 1998, TRENDS MICROBIOL, V6, P276; Speck SH, 1999, CURR OPIN MICROBIOL, V2, P403; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Stevenson PG, 2004, CURR OPIN IMMUNOL, V16, P456, DOI 10.1016/j.coi.2004.05.002; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; Tao Q, 2003, CLIN IMMUNOL, V109, P53, DOI 10.1016/S1521-6616(03)00198-0; van Dyk LF, 2000, J VIROL, V74, P7451, DOI 10.1128/JVI.74.16.7451-7461.2000; Virgin HW, 1999, CURR OPIN IMMUNOL, V11, P371, DOI 10.1016/S0952-7915(99)80063-6; Virgin HW, 1999, J VIROL, V73, P2321, DOI 10.1128/JVI.73.3.2321-2332.1999; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Weinberg JB, 2004, VIRAL IMMUNOL, V17, P69, DOI 10.1089/088282404322875467; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	59	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e733	10.1371/journal.pone.0000733	http://dx.doi.org/10.1371/journal.pone.0000733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710133	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455200010
J	Abbas, UL; Anderson, RM; Mellors, JW				Abbas, Ume L.; Anderson, Roy M.; Mellors, John W.			Potential Impact of Antiretroviral Chemoprophylaxis on HIV-1 Transmission in Resource-Limited Settings	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; REVERSE-TRANSCRIPTASE; TENOFOVIR MONOTHERAPY; DEVELOPING-COUNTRIES; SENSITIVITY ANALYSIS; TYPE-1 POPULATIONS; INFECTED PATIENTS; NEWBORN MACAQUES; RESISTANT HIV-1	Background. The potential impact of pre-exposure chemoprophylaxis (PrEP) on heterosexual transmission of HIV-1 infection in resource-limited settings is uncertain. Methodology/Principle Findings. A deterministic mathematical model was used to simulate the effects of antiretroviral PrEP on an HIV-1 epidemic in sub-Saharan Africa under different scenarios (optimistic, neutral and pessimistic) both with and without sexual disinhibition. Sensitivity analyses were used to evaluate the effect of uncertainty in input parameters on model output and included calculation of partial rank correlations and standardized rank regressions. In the scenario without sexual disinhibition after PrEP initiation, key parameters influencing infections prevented were effectiveness of PrEP (partial rank correlation coefficient (PRCC) = 0.94), PrEP discontinuation rate (PRCC = -0.94), level of coverage (PRCC = 0.92), and time to achieve target coverage (PRCC = -0.82). In the scenario with sexual disinhibition, PrEP effectiveness and the extent of sexual disinhibition had the greatest impact on prevention. An optimistic scenario of PrEP with 90% effectiveness and 75% coverage of the general population predicted a 74% decline in cumulative HIV-1 infections after 10 years, and a 28.8% decline with PrEP targeted to the highest risk groups (16% of the population). Even with a 100% increase in at-risk behavior from sexual disinhibition, a beneficial effect (23.4%-62.7% decrease in infections) was seen with 90% effective PrEP across a broad range of coverage (25%-75%). Similar disinhibition led to a rise in infections with lower effectiveness of PrEP (<= 50%). Conclusions/Significance. Mathematical modeling supports the potential public health benefit of PrEP. Approximately 2.7 to 3.2 million new HIV-1 infections could be averted in southern sub-Saharan Africa over 10 years by targeting PrEP (having 90% effectiveness) to those at highest behavioral risk and by preventing sexual disinhibition. This benefit could be lost, however, by sexual disinhibition and by high PrEP discontinuation, especially with lower PrEP effectiveness (<= 50%).	[Abbas, Ume L.; Mellors, John W.] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA 15260 USA; [Anderson, Roy M.] Univ London, Fac Med, Imperial Coll, Dept Infect Dis Epidemiol, London, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Imperial College London; University of London	Abbas, UL (corresponding author), Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA 15260 USA.	abbasu@dom.pitt.edu	Abbas, Ume/AAW-4590-2021	Anderson, Roy/0000-0002-9528-3175	National Institute of Allergy and Infectious Diseases [R21AI064092, U01AI38858]; Bristol Myers Squibb Research Foundation; National Cancer Institute [20XS190A]; Microbicide Trials Network [U01AI068633]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI038858, U01AI068633, R21AI064092] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bristol Myers Squibb Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Microbicide Trials Network; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institute of Allergy and Infectious Diseases (R21AI064092). Ume L. Abbas acknowledges grant support from the National Institute of Allergy and Infectious Diseases ( R21AI064092). Roy M. Anderson acknowledges grant support from the Wellcome Trust. John W. Mellors acknowledges support from the Bristol Myers Squibb Research Foundation and grants from the National Institute of Allergy and Infectious Diseases (U01AI38858), the National Cancer Institute (SAIC contract 20XS190A) and the Microbicide Trials Network (U01AI068633).	Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V41, P632, DOI 10.1097/01.qai.0000194234.31078.bf; ANDERSON R M, 1991; ANDERSON RM, 1992, PHILOS T R SOC B, V336, P135, DOI 10.1098/rstb.1992.0052; ANDERSON RM, 1989, ANN NY ACAD SCI, V569, P240, DOI 10.1111/j.1749-6632.1989.tb27374.x; Aral SO, 2000, SEX TRANSM DIS, V27, P327, DOI 10.1097/00007435-200007000-00005; Asamoah-Odei E, 2004, LANCET, V364, P35, DOI 10.1016/S0140-6736(04)16587-2; ATCHISON R, 2005, ANTIVIR THER S, V10, P45; Blower S, 2004, CLIN INFECT DIS, V39, pS240, DOI 10.1086/422361; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Brenner BG, 2002, J VIROL, V76, P1753, DOI 10.1128/JVI.76.4.1753-1761.2002; Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b; Brown AJL, 2003, J INFECT DIS, V187, P683, DOI 10.1086/367989; *CDCP, CDC TRIALS PREEXP PR; Charpentier C, 2004, J VIROL, V78, P4234, DOI 10.1128/JVI.78.8.4234-4247.2004; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Cong ME, 2007, J VIROL, V81, P3037, DOI 10.1128/JVI.02712-06; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Deeks SG, 2005, J INFECT DIS, V192, P1537, DOI 10.1086/496892; Delaugerre C, 2001, AIDS, V15, P2189, DOI 10.1097/00002030-200111090-00016; *DEP EC SOC AFF PO, 2005, WORLD POP PROSP 2004; DESAI K, 2006, 16 INT AIDS C TOR CA; Deschamps MM, 1996, ANN INTERN MED, V125, P324, DOI 10.7326/0003-4819-125-4-199608150-00011; Doualla-Bell F, 2006, ANTIMICROB AGENTS CH, V50, P4182, DOI 10.1128/AAC.00714-06; Drummond MF., 2005, METHODS EC EVALUATIO, P55; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; FERRY B, 2001, AIDS S, V15, P41; Foss AM, 2003, AIDS, V17, P1227, DOI 10.1097/00002030-200305230-00015; Gandhi RT, 2003, CLIN INFECT DIS, V37, P1693, DOI 10.1086/379773; Garcia-Calleja JM, 2006, SEX TRANSM INFECT, V82, pIII64, DOI 10.1136/sti.2006.019901; Garcia-Lerma JG, 2006, ANTIVIR THER, V11, pS52; GARCIALERMA J, 2006, 13 C RETR OPP INF DE; GARNETT GP, 1993, PHILOS T R SOC B, V342, P137, DOI 10.1098/rstb.1993.0143; GARNETT GP, 1995, J ACQ IMMUN DEF SYND, V9, P500; GARNETT GP, 1994, IMA J MATH APPL MED, V11, P161; GENTLEMAN A, 2006, AIDS DRUG PROVOKES P; *GIL SCI, 2004, INV BROCH TEN DIS FU; *GIL SCI, 2005, INV BROCH EMTR TEN D; *GIL SCI INC, 2005, GIL RED PRIC VIR TRU; *GOV REP ZAMB MIN, 2005, ZAMB 2004 ANT CLIN S; GRANT R, 2006, 16 INT AIDS C TOR CA; Grant RM, 2005, SCIENCE, V309, P2170, DOI 10.1126/science.1116204; Grassly N. C., 2003, International Journal of Drug Policy, V14, P25, DOI 10.1016/S0955-3959(02)00224-4; Hance AJ, 2001, J VIROL, V75, P6410, DOI 10.1128/JVI.75.14.6410-6417.2001; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Iman RL, 2002, RELIAB ENG SYST SAFE, V78, P131, DOI 10.1016/S0951-8320(02)00133-3; IMAN RL, 1981, J QUAL TECHNOL, V13, P232, DOI 10.1080/00224065.1981.11978763; IMAN RL, 1981, J QUAL TECHNOL, V13, P174, DOI 10.1080/00224065.1981.11978748; Izopet J, 2002, J INFECT DIS, V185, P1506, DOI 10.1086/340215; Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112; Lifson JD, 2000, J VIROL, V74, P2584, DOI 10.1128/JVI.74.6.2584-2593.2000; Margot NA, 2006, ANTIMICROB AGENTS CH, V50, P4087, DOI 10.1128/AAC.00816-06; MAY RM, 1988, PHILOS T ROY SOC B, V321, P565, DOI 10.1098/rstb.1988.0108; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Miller MD, 2007, AIDS, V21, P265, DOI 10.1097/QAD.0b013e32801199ee; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Moatti JP, 2003, AIDS, V17, pS69, DOI 10.1097/00002030-200317003-00010; Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011; Morgan D, 2000, SEX TRANSM INFECT, V76, P193, DOI 10.1136/sti.76.3.193; Morison L, 2001, AIDS, V15, pS61, DOI 10.1097/00002030-200108004-00007; Palmer S, 2006, AIDS, V20, P701, DOI 10.1097/01.aids.0000216370.69066.7f; *PREP WATCH, AIDS VACC ADV COAL P; Rosenwirth B, 2000, J VIROL, V74, P1704, DOI 10.1128/JVI.74.4.1704-1711.2000; SALTELLI A, 2000, SENSITIVITY ANAL, P475; Shelton JD, 2006, LANCET, V367, P1120, DOI 10.1016/S0140-6736(06)68436-5; SHISANA O, 2005, S AFRICAN NATL HIV P; Stover J, 2006, SCIENCE, V311, P1474, DOI 10.1126/science.1121176; STOVER J, 2002, EPIDEMIOLOGICAL IMPA, P1; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; *SURV SURV LAB WOR, 2006, INT REC US BED CAPT; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; Turner D, 2004, JAIDS-J ACQ IMM DEF, V37, P1627, DOI 10.1097/00126334-200412150-00017; UNAIDS, 2006, REP GLOB AIDS EP; *UNAIDS WHO, 2006, EST STAT AIDS EP COU; *UNAIDS WHO, EP UPD DEC 2006; *UNAIDS WHO WORK G, 2003, EST SIZ POP RISK HIV; *US AG INT DEV MAC, DEM HLTH SURV; *US BUR CENS, US CENS BUR INT DAT; Van Rompay KKA, 2001, J INFECT DIS, V184, P429, DOI 10.1086/322781; Van Rompay KKA, 2000, J VIROL, V74, P1767, DOI 10.1128/JVI.74.4.1767-1774.2000; Van Rompay KKA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-25; Van Rompay KKA, 2006, J VIROL, V80, P6399, DOI 10.1128/JVI.02308-05; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weber J, 2005, J CLIN MICROBIOL, V43, P1395, DOI 10.1128/JCM.43.3.1395-1400.2005; Wegbreit J, 2006, AIDS, V20, P1217, DOI 10.1097/01.aids.0000232229.96134.56; WEINSTEIN MC, 1989, CONFRONTING AIDS SEX, P471; White KL, 2002, ANTIMICROB AGENTS CH, V46, P3437, DOI 10.1128/AAC.46.11.3437-3446.2002; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; Yerly S, 2004, ANTIVIR THER, V9, P375	89	130	135	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e875	10.1371/journal.pone.0000875	http://dx.doi.org/10.1371/journal.pone.0000875			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878928	Green Published, gold			2022-12-27	WOS:000207455700001
J	Busuttil, RA; Garcia, AM; Reddick, RL; Dolle, MET; Calder, RB; Nelson, JF; Vijg, J				Busuttil, Rita A.; Garcia, Ana Maria; Reddick, Robert L.; Dolle, Martijn E. T.; Calder, Robert B.; Nelson, James F.; Vijg, Jan			Intra-Organ Variation in Age-Related Mutation Accumulation in the Mouse	PLOS ONE			English	Article								Using a transgenic mouse model harboring chromosomally integrated lacZ mutational target genes, we previously demonstrated that mutations accumulate with age much more rapidly in the small intestine than in the brain. Here it is shown that in the small intestine point mutations preferentially accumulate in epithelial cells of the mucosa scraped off the underlying serosa. The mucosal cells are the differentiated villus cells that have undergone multiple cell divisions. A smaller age-related increase, also involving genome rearrangements, was observed in the serosa, which consists mainly of the remaining crypts and non-dividing smooth muscle cells. In the brain we observed an accumulation of only point mutations in no other areas than hypothalamus and hippocampus. To directly test for cell division as the determining factor in the generation of point mutations we compared mutation induction between mitotically active and quiescent embryonic fibroblasts from the same lacZ mice, treated with either UV (a point mutagen) or hydrogen peroxide (a clastogen). The results indicate that while point mutations are highly replication-dependent, genome rearrangements are as easily induced in nondividing cells as in mitotically active ones. This strongly suggests that the point mutations found to have accumulated in the mucosal part of the small intestine are the consequence of replication errors. The same is likely true for point mutations accumulating in hippocampus and hypothalamus of the brain since neurogenesis in these two areas continues throughout life. The observed intra-organ variation in mutation susceptibility as well as the variation in replication dependency of different types of mutations indicates the need to not only extend observations made on whole organs to their sub-structures but also take the type of mutations and mitotic activity of the cells into consideration. This should help elucidating the impact of genome instability and its consequences on aging and disease.	[Busuttil, Rita A.; Calder, Robert B.; Vijg, Jan] Buck Inst Age Res, Novato, CA USA; [Garcia, Ana Maria] Univ Texas San Antonio, San Antonio, TX USA; [Reddick, Robert L.; Nelson, James F.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Dolle, Martijn E. T.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Buck Institute for Research on Aging; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Health San Antonio; Netherlands National Institute for Public Health & the Environment	Vijg, J (corresponding author), Buck Inst Age Res, Novato, CA USA.	jvijg@buckinstitute.org			NIA NIH HHS [R01 AG020438, P01 AG017242, AG20438, AG17242] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG017242, R01AG020438] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Beck-Peccoz P, 2006, BEST PRACT RES CL EN, V20, P529, DOI 10.1016/j.beem.2006.11.001; Busuttil R, 2007, NEUROSCIENCE, V145, P1341, DOI 10.1016/j.neuroscience.2006.09.060; Busuttil RA, 2006, DNA REPAIR, V5, P52, DOI 10.1016/j.dnarep.2005.07.006; Busuttil RA, 2003, AGING CELL, V2, P287, DOI 10.1046/j.1474-9728.2003.00066.x; Chambers JM., 1992, STAT MODELS S; CRAVEN PA, 1986, J CLIN INVEST, V77, P850, DOI 10.1172/JCI112382; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Dolle MET, 1997, NAT GENET, V17, P431, DOI 10.1038/ng1297-431; Dolle MET, 1999, ENVIRON MOL MUTAGEN, V34, P112, DOI 10.1002/(SICI)1098-2280(1999)34:2/3&lt;112::AID-EM9&gt;3.0.CO;2-W; Dolle MET, 2000, P NATL ACAD SCI USA, V97, P8403, DOI 10.1073/pnas.97.15.8403; Dolle MET, 2002, GENOME RES, V12, P1732, DOI 10.1101/gr.125502; Drake JW, 1998, GENETICS, V148, P1667; FEIG DI, 1994, CANCER RES, V54, pS1890; Garcia Ana Maria, 2007, Methods Mol Biol, V371, P267; HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S; HINRICHS HR, 1964, ARCH PATHOL, V78, P245; Loeb LA, 1998, ADV CANCER RES, V72, P25, DOI 10.1016/S0065-230X(08)60699-5; MULLAART E, 1989, CARCINOGENESIS, V10, P393, DOI 10.1093/carcin/10.2.393; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; Ono T, 2004, CANCER RES, V64, P6919, DOI 10.1158/0008-5472.CAN-04-1476; *R DCT, 2006, R LANG ENV STAT COMP; Siqueira IR, 2005, INT J DEV NEUROSCI, V23, P663, DOI 10.1016/j.ijdevneu.2005.03.001; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Vijg J., 2007, AGING GENOME; Vogel F., 1997, HUMAN GENETICS PROBL; Yandell BS, 1997, PRACTICAL DATA ANAL	26	47	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e876	10.1371/journal.pone.0000876	http://dx.doi.org/10.1371/journal.pone.0000876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849005	Green Published, gold			2022-12-27	WOS:000207455600022
J	Lundstedt, AC; McCarthy, S; Gustafsson, MCU; Godaly, G; Jodal, U; Karpman, D; Leijonhufvud, I; Linden, C; Martinell, J; Ragnarsdottir, B; Samuelsson, M; Truedsson, L; Andersson, B; Svanborg, C				Lundstedt, Ann-Charlotte; McCarthy, Shane; Gustafsson, Mattias C. U.; Godaly, Gabriela; Jodal, Ulf; Karpman, Diana; Leijonhufvud, Irene; Linden, Carin; Martinell, Jeanette; Ragnarsdottir, Bryndis; Samuelsson, Martin; Truedsson, Lennart; Andersson, Bjorn; Svanborg, Catharina			A Genetic Basis of Susceptibility to Acute Pyelonephritis	PLOS ONE			English	Article								Background. For unknown reasons, urinary tract infections (UTIs) are clustered in certain individuals. Here we propose a novel, genetically determined cause of susceptibility to acute pyelonephritis, which is the most severe form of UTI. The IL-8 receptor, CXCR1, was identified as a candidate gene when mIL-8Rh mutant mice developed acute pyelonephritis (APN) with severe tissue damage. Methods and Findings. We have obtained CXCR1 sequences from two, highly selected APN prone patient groups, and detected three unique mutations and two known polymorphisms with a genotype frequency of 23% and 25% compared to 7% in controls (p<0.001 and p<0.0001, respectively). When reflux was excluded, 54% of the patients had CXCR1 sequence variants. The UTI prone children expressed less CXCR1 protein than the pediatric controls (p<0.0001) and two sequence variants were shown to impair transcription. Conclusions. The results identify a genetic innate immune deficiency, with a strong link to APN and renal scarring.	[Lundstedt, Ann-Charlotte; Gustafsson, Mattias C. U.; Godaly, Gabriela; Leijonhufvud, Irene; Ragnarsdottir, Bryndis; Samuelsson, Martin; Truedsson, Lennart; Svanborg, Catharina] Lund Univ, Dept Microbiol Immunol & Glycobiol, Inst Lab Med, Lund, Sweden; [McCarthy, Shane; Andersson, Bjorn] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Jodal, Ulf; Martinell, Jeanette] Gothenburg Univ, Dept Pediat, Queen Silvia Childrens Hosp, S-41124 Gothenburg, Sweden; [Karpman, Diana] Lund Univ, Dept Pediat, Lund, Sweden; [Linden, Carin] Gothenburg Univ, Dept Infect Dis, Gothenburg, Sweden	Lund University; Karolinska Institutet; Queen Silvia Children's Hospital; University of Gothenburg; Lund University; University of Gothenburg	Svanborg, C (corresponding author), Lund Univ, Dept Microbiol Immunol & Glycobiol, Inst Lab Med, Lund, Sweden.	Catharina.Svanborg@med.lu.se	Andersson, Bjorn/G-9832-2013; Godaly, Gabriela/AAD-7545-2019; Gustafsson, Mattias C. U./A-7451-2010; Godaly, Gabriela/C-8786-2014	Andersson, Bjorn/0000-0002-4624-0259; Godaly, Gabriela/0000-0002-3467-1350; Gustafsson, Mattias C. U./0000-0003-3260-0724; Godaly, Gabriela/0000-0002-3467-1350; Karpman, Diana/0000-0001-7220-7658; Aradottir, Sigridur Sunna/0000-0002-6898-3256	Swedish Medical Research Council [-07934, 14577, 14578]; The Royal Physiographic Society; The Medical Faculty, Lund University; Foundation for Strategic Research; Beijer Foundation; Bristol-Myers Squibb; Swedish Medical Research Council	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); The Royal Physiographic Society; The Medical Faculty, Lund University; Foundation for Strategic Research; Beijer Foundation; Bristol-Myers Squibb(Bristol-Myers Squibb); Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	This study was supported by grants from the Swedish Medical Research Council (grants no. -07934, 14577, 14578); The Royal Physiographic Society and The Medical Faculty, Lund University. The sequencing efforts were supported by the Genome Project of the Foundation for Strategic Research and the Beijer Foundation. Catharina Svanborg was a recipient of the Bristol-Myers Squibb, unrestricted grant and Gabriela Godaly is the recipient of Junior Research Scientist Grant from the Swedish Medical Research Council.	AGACE WW, 1995, INFECT IMMUN, V63, P4054, DOI 10.1128/IAI.63.10.4054-4062.1995; AHUJA SK, 1992, NAT GENET, V2, P31, DOI 10.1038/ng0992-31; AHUJA SK, 1994, J BIOL CHEM, V269, P26381; ANDERSEN HJ, 1966, J PEDIATR-US, V68, P542, DOI 10.1016/S0022-3476(66)80391-8; Anderson KL, 1998, BLOOD, V92, P1576, DOI 10.1182/blood.V92.5.1576.417k29_1576_1585; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Artifoni L, 2007, J UROLOGY, V177, P1102, DOI 10.1016/j.juro.2006.10.037; BAILEY RR, 1978, BRIT MED J, V1, P48, DOI 10.1136/bmj.1.6104.48-e; Chotivanich K, 2002, BLOOD, V100, P1172, DOI 10.1182/blood.V100.4.1172.h81602001172_1172_1176; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; DECKER CJ, 1995, CURR OPIN CELL BIOL, V7, P386, DOI 10.1016/0955-0674(95)80094-8; EDEN CS, 1984, INFECTION, V12, P118, DOI 10.1007/BF01641692; Frendeus B, 2000, J EXP MED, V192, P881, DOI 10.1084/jem.192.6.881; Frendeus B, 2001, J INFECT DIS, V183, pS56, DOI 10.1086/318848; Gbadegesin RA, 2006, INT J IMMUNOGENET, V33, P49, DOI 10.1111/j.1744-313X.2006.00565.x; Gehring NH, 2001, NAT GENET, V28, P389, DOI 10.1038/ng578; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HAGBERG L, 1984, INFECT IMMUN, V46, P839, DOI 10.1128/IAI.46.3.839-844.1984; HAGBERG L, 1985, J IMMUNOL, V134, P4118; Hang L, 2000, J INFECT DIS, V182, P1738, DOI 10.1086/317599; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Hodson C J, 1975, Br J Radiol, VSuppl 13, P1; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Jakobsson B, 1999, PEDIATRICS, V104, P222, DOI 10.1542/peds.104.2.222; Kunin CM, 1997, URINARY TRACT INFECT; Lennartsson A, 2003, BIOCHEM BIOPH RES CO, V311, P853, DOI 10.1016/j.bbrc.2003.10.067; LLOYD A, 1993, CYTOGENET CELL GENET, V63, P238, DOI 10.1159/000133541; LOMBERG H, 1983, NEW ENGL J MED, V308, P1189, DOI 10.1056/NEJM198305193082003; Lundstedt AC, 2007, J INFECT DIS, V195, P1227, DOI 10.1086/512620; Mao SF, 1999, MOL CELL BIOL, V19, P3635; MARTINELL J, 1995, PEDIATR NEPHROL, V9, P131, DOI 10.1007/BF00860724; MEYERS S, 1995, MOL CELL BIOL, V15, P1974; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; POBER JS, 1990, TRANSPLANTATION, V50, P537, DOI 10.1097/00007890-199010000-00001; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; RANSLEY PG, 1978, BRIT J RADIOL      S, V14, P1; Sherry ST, 1999, GENOME RES, V9, P677; Smithson A, 2005, CLIN DIAGN LAB IMMUN, V12, P1358, DOI 10.1128/CDLI.12.12.1358-1363.2005; SORENSEN UB, 1988, INFECT IMMUN; SPRENGER H, 1994, J IMMUNOL, V153, P2524; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STAMM WE, 1991, REV INFECT DIS, V13, P77; Sun W, 2006, WORLD J GASTROENTERO, V12, P5005, DOI 10.3748/wjg.v12.i31.5005; Svanborg C, 2001, ANN MED, V33, P563, DOI 10.3109/07853890109002101; Svensson M, 2005, KIDNEY INT, V67, P103, DOI 10.1111/j.1523-1755.2005.00060.x; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Wilkinson NC, 1999, J BIOL CHEM, V274, P438, DOI 10.1074/jbc.274.1.438; Wolf M, 1998, EUR J IMMUNOL, V28, P164, DOI 10.1002/(SICI)1521-4141(199801)28:01<164::AID-IMMU164>3.0.CO;2-S; Yamada R, 2004, J MOL MED-JMM, V82, P558, DOI 10.1007/s00109-004-0547-y	52	64	65	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e825	10.1371/journal.pone.0000825	http://dx.doi.org/10.1371/journal.pone.0000825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786197	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455500009
J	McGurk, L; Morrison, H; Keegan, LP; Sharpe, J; O'Connell, MA				McGurk, Leeanne; Morrison, Harris; Keegan, Liam P.; Sharpe, James; O'Connell, Mary A.			Three-Dimensional Imaging of Drosophila melanogaster	PLOS ONE			English	Article								Background. The major hindrance to imaging the intact adult Drosophila is that the dark exoskeleton makes it impossible to image through the cuticle. We have overcome this obstacle and describe a method whereby the internal organs of adult Drosophila can be imaged in 3D by bleaching and clearing the adult and then imaging using a technique called optical projection tomography (OPT). The data is displayed as 2D optical sections and also in 3D to provide detail on the shape and structure of the adult anatomy. Methodology. We have used OPT to visualize in 2D and 3D the detailed internal anatomy of the intact adult Drosophila. In addition this clearing method used for OPT was tested for imaging with confocal microscopy. Using OPT we have visualized the size and shape of neurodegenerative vacuoles from within the head capsule of flies that suffer from age-related neurodegeneration due to a lack of ADAR mediated RNA-editing. In addition we have visualized tau-lacZ expression in 2D and 3D. This shows that the wholemount adult can be stained without any manipulation and that this stain penetrates well as we have mapped the localization pattern with respect to the internal anatomy. Conclusion. We show for the first time that the intact adult Drosophila can be imaged in 3D using OPT, also we show that this method of clearing is also suitable for confocal microscopy to image the brain from within the intact head. The major advantage of this is that organs can be represented in 3D in their natural surroundings. Furthermore optical sections are generated in each of the three planes and are not prone to the technical limitations that are associated with manual sectioning. OPT can be used to dissect mutant phenotypes and to globally map gene expression in both 2D and 3D.	[McGurk, Leeanne; Morrison, Harris; Keegan, Liam P.; O'Connell, Mary A.] MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Sharpe, James] Ctr Regulacio Genom, Syst Biol Program, Barcelona, Spain	University of Edinburgh; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	O'Connell, MA (corresponding author), MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland.	Mary.O'Connell@hgu.mrc.ac.uk	Keegan, Liam P./AAL-3753-2021; Sharpe, James/AAB-7948-2019; O'Connell, Mary Anne/U-7693-2019; Keegan, Liam P/F-1106-2017; Sharpe, James/L-1150-2014; McGurk, Leeanne/L-6734-2019; OConnell, Mary Anne/G-4740-2015	Keegan, Liam P./0000-0001-7915-5790; O'Connell, Mary Anne/0000-0003-3844-6174; Keegan, Liam P/0000-0001-7915-5790; Sharpe, James/0000-0002-1434-9743; McGurk, Leeanne/0000-0002-6493-6751; OConnell, Mary Anne/0000-0003-3844-6174	Medical Research Council [U.1275.01.005.00001.01]; Medical Research Council [MC_U127574434, MC_U127584490] Funding Source: researchfish; MRC [MC_U127584490, MC_U127574434] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	LM was funded by a MRC Capacity Building Area Research Studentship and this work was funded by the Medical Research Council U.1275.01.005.00001.01.	Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; ASHBURNER M, 1990, DROSOPHILA LAB HDB; Baldock RA, 2003, NEUROINFORMATICS, V1, P309, DOI 10.1385/NI:1:4:309; BALLINGER DG, 1989, P NATL ACAD SCI USA, V86, P9402, DOI 10.1073/pnas.86.23.9402; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; Christiansen JH, 2006, NUCLEIC ACIDS RES, V34, pD637, DOI 10.1093/nar/gkj006; Crowther DC, 2004, CURR OPIN PHARMACOL, V4, P513, DOI 10.1016/j.coph.2004.07.001; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Ferber D, 2001, SCIENCE, V292, P1983; *FLYBRAIN, ONL ATL DAT DROS NER; Gates J, 2000, GENETICS, V156, P1765; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Jenett A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-544; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kerwin J, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-27; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Lee K, 2006, PLANT CELL, V18, P2145, DOI 10.1105/tpc.106.043042; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; LUDWIG MZ, 1993, P NATL ACAD SCI USA, V90, P6233, DOI 10.1073/pnas.90.13.6233; Ma E, 2001, J CLIN INVEST, V107, P685, DOI 10.1172/JCI11625; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Piccin A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e55; Rein K, 2002, CURR BIOL, V12, P227, DOI 10.1016/S0960-9822(02)00656-5; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Rong YS, 2001, GENETICS, V157, P1307; Salvaterra Paul M., 2001, Gene Expression Patterns, V1, P73, DOI 10.1016/S1567-133X(01)00011-4; Sarma S, 2005, BRAIN RES BULL, V66, P449, DOI 10.1016/j.brainresbull.2005.05.022; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Spradling AC, 1999, GENETICS, V153, P135; Stapleton M, 2006, RNA, V12, P1922, DOI 10.1261/rna.254306; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382	36	52	52	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e834	10.1371/journal.pone.0000834	http://dx.doi.org/10.1371/journal.pone.0000834			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786206	Green Published, gold			2022-12-27	WOS:000207455500018
J	Thiel, M; Caldwell, CC; Kreth, S; Kuboki, S; Chen, P; Smith, P; Ohta, A; Lentsch, AB; Lukashev, D; Sitkovsky, MV				Thiel, Manfred; Caldwell, Charles C.; Kreth, Simone; Kuboki, Satoshi; Chen, P.; Smith, Patrick; Ohta, Akio; Lentsch, Alex B.; Lukashev, Dmitry; Sitkovsky, Michail V.			Targeted Deletion of HIF-1 alpha Gene in T Cells Prevents their Inhibition in Hypoxic Inflamed Tissues and Improves Septic Mice Survival	PLOS ONE			English	Article							NF-KAPPA-B; LYMPHOCYTE DEVELOPMENT; ADENOSINE RECEPTORS; ACTIVATION; EXPRESSION; REPRESSION; REVEALS; P50	Background. Sepsis patients may die either from an overwhelming systemic immune response and/or from an immunoparalysis-associated lack of anti-bacterial immune defence. We hypothesized that bacterial superantigen-activated T cells may be prevented from contribution into anti-bacterial response due to the inhibition of their effector functions by the hypoxia inducible transcription factor (HIF-1 alpha) in inflamed and hypoxic areas. Methodology/ Principal Findings. Using the Cre-lox-P-system we generated mice with a T-cell targeted deletion of the HIF-1 alpha gene and analysed them in an in vivo model of bacterial sepsis. We show that deletion of the HIF-1 alpha gene leads to higher levels of pro-inflammatory cytokines, stronger anti-bacterial effects and much better survival of mice. These effects can be at least partially explained by significantly increased NF-kappa B activation in TCR activated HIF-1 alpha deficient T cells. Conclusions/Significance. T cells can be recruited to powerfully contribute to anti-bacterial response if they are relieved from inhibition by HIF-1 alpha in inflamed and hypoxic areas. Our experiments uncovered the before unappreciated reserve of anti-bacterial capacity of T cells and suggest novel therapeutic anti-pathogen strategies based on targeted deletion or inhibition of HIF-1 alpha in T cells.	[Thiel, Manfred; Caldwell, Charles C.; Chen, P.; Smith, Patrick; Ohta, Akio; Lukashev, Dmitry; Sitkovsky, Michail V.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Thiel, Manfred; Kreth, Simone] Univ Munich, Klinikum Grosshadern, Dept Anaesthesiol, D-8000 Munich, Germany; [Caldwell, Charles C.; Kuboki, Satoshi; Lentsch, Alex B.] Univ Cincinnati, Coll Med, Dept Surg, Trauma Sepsis & Inflammat Res Grp, Cincinnati, OH 45267 USA; [Caldwell, Charles C.] Shriners Hosp Children, Dept Res, Cincinnati, OH USA; [Ohta, Akio; Lukashev, Dmitry; Sitkovsky, Michail V.] Northeastern Univ, New England Inflammat & Tissue Protect Inst, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Munich; University System of Ohio; University of Cincinnati; Northeastern University	Sitkovsky, MV (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	m.sitkovsky@neu.edu	Lukashev, Dmitriy/F-8133-2010	Caldwell, Charles/0000-0003-1692-4550; Kreth, Simone/0000-0002-0073-2098	New England Inflammation and Tissue Protection Institute at Northeastern University, Boston [1R21 AT002788-01]; National Institutes of Health; Shriner's Hospital for Children [8560]; German National Research Foundation [TH733/2-1]; National Institute of Allergy and Infectious Diseases Intramural program; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT002788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072760] Funding Source: NIH RePORTER	New England Inflammation and Tissue Protection Institute at Northeastern University, Boston; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriner's Hospital for Children; German National Research Foundation(German Research Foundation (DFG)); National Institute of Allergy and Infectious Diseases Intramural program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by New England Inflammation and Tissue Protection Institute at Northeastern University, Boston, 1R21 AT002788-01(MS), National Institutes of Health grants, and Shriner's Hospital for Children Project 8560 (CCC) as well as by the German National Research Foundation Grant TH733/2-1 and National Institute of Allergy and Infectious Diseases Intramural program.	Andreakos E, 2006, P NATL ACAD SCI USA, V103, P14459, DOI 10.1073/pnas.0603493103; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Caldwell CC, 2001, J IMMUNOL, V167, P6140, DOI 10.4049/jimmunol.167.11.6140; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chen KF, 2005, NUCLEIC ACIDS RES, V33, P5190, DOI 10.1093/nar/gki839; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Ebong S, 1999, INFECT IMMUN, V67, P6603; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Kojima H, 2002, P NATL ACAD SCI USA, V99, P2170, DOI 10.1073/pnas.052706699; Kuboki S, 2007, AM J PHYSIOL-GASTR L, V292, pG201, DOI 10.1152/ajpgi.00186.2006; Laughlin KM, 1996, J PHARMACOL EXP THER, V277, P1049; Lukac R, 2006, J VIS COMMUN IMAGE R, V17, P1, DOI 10.1016/j.jvcir.2005.08.007; Lukashev DE, 2003, BIOCHEM PHARMACOL, V65, P2081, DOI 10.1016/S0006-2952(03)00158-8; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; TEN RM, 1992, EMBO J, V11, P195, DOI 10.1002/j.1460-2075.1992.tb05042.x; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Zheng Y, 2003, J EXP MED, V197, P861, DOI 10.1084/jem.20021610	26	131	136	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e853	10.1371/journal.pone.0000853	http://dx.doi.org/10.1371/journal.pone.0000853			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786224	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455500036
J	Fraser, C				Fraser, Christophe			Estimating Individual and Household Reproduction Numbers in an Emerging Epidemic	PLOS ONE			English	Article								Reproduction numbers, defined as averages of the number of people infected by a typical case, play a central role in tracking infectious disease outbreaks. The aim of this paper is to develop methods for estimating reproduction numbers which are simple enough that they could be applied with limited data or in real time during an outbreak. I present a new estimator for the individual reproduction number, which describes the state of the epidemic at a point in time rather than tracking individuals over time, and discuss some potential benefits. Then, to capture more of the detail that micro-simulations have shown is important in outbreak dynamics, I analyse a model of transmission within and between households, and develop a method to estimate the household reproduction number, defined as the number of households infected by each infected household. This method is validated by numerical simulations of the spread of influenza and measles using historical data, and estimates are obtained for would-be emerging epidemics of these viruses. I argue that the household reproduction number is useful in assessing the impact of measures that target the household for isolation, quarantine, vaccination or prophylactic treatment, and measures such as social distancing and school or workplace closures which limit between-household transmission, all of which play a key role in current thinking on future infectious disease mitigation.	Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC, Ctr Outbreak Anal & Modelling, London, England	Imperial College London	Fraser, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC, Ctr Outbreak Anal & Modelling, London, England.	c.fraser@imperial.ac.uk	Fraser, Christophe/A-8109-2008	Fraser, Christophe/0000-0003-2399-9657	Royal Society University Research Fellowship	Royal Society University Research Fellowship(Royal Society of London)	The work was funded by a Royal Society University Research Fellowship. The sponsors played no role in the study.	Amundsen EJ, 2004, EPIDEMIOL INFECT, V132, P1139, DOI 10.1017/S0950268804002997; BAILEY NTJ, 1957, MATHE THEORY EPIDEMI; Ball F, 2002, MATH BIOSCI, V180, P73, DOI 10.1016/S0025-5564(02)00125-6; Ball F, 2006, STAT METHODS MED RES, V15, P481, DOI 10.1177/0962280206071643; Ball F, 1997, ANN APPL PROBAB, V7, P46; BECKER NG, 1995, MATH BIOSCI, V127, P207, DOI 10.1016/0025-5564(94)00055-5; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Cauchemez S, 2006, AM J EPIDEMIOL, V164, P591, DOI 10.1093/aje/kwj274; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Hall R, 1996, EPIDEMIOL INFECT, V117, P443, DOI 10.1017/S0950268800059100; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Klinkenberg D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000012; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; LONGINI IM, 1982, BIOMETRICS, V38, P115, DOI 10.2307/2530294; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; LUDWIG D, 1975, Mathematical Biosciences, V23, P33, DOI 10.1016/0025-5564(75)90119-4; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; O'Neill PD, 2000, J ROY STAT SOC C-APP, V49, P517, DOI 10.1111/1467-9876.00210; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Riley S, 2006, P NATL ACAD SCI USA, V103, P12637, DOI 10.1073/pnas.0510873103; Simpson JA, 2002, PARASITOLOGY, V124, P247, DOI 10.1017/S0031182001001202; SIMPSON REH, 1952, LANCET, V263, P549; SVENSSON A, 2006, MATH BIOSCI IN PRESS, DOI DOI 10.1016/J.MBS.2006.1.0.010; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; White PJ, 2006, AIDS, V20, P1898, DOI 10.1097/01.aids.0000244213.23574.fa; Wu JT, 2006, PLOS MED, V3, P1532, DOI 10.1371/journal.pmed.0030361	38	192	193	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e758	10.1371/journal.pone.0000758	http://dx.doi.org/10.1371/journal.pone.0000758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712406	Green Submitted, gold, Green Published			2022-12-27	WOS:000207455300006
J	Heldermon, CD; Hennig, AK; Ohlemiller, KK; Ogilvie, JM; Herzog, ED; Breidenbach, A; Vogler, C; Wozniak, DF; Sands, MS				Heldermon, Coy D.; Hennig, Anne K.; Ohlemiller, Kevin K.; Ogilvie, Judith M.; Herzog, Erik D.; Breidenbach, Annalisa; Vogler, Carole; Wozniak, David F.; Sands, Mark S.			Development of Sensory, Motor and Behavioral Deficits in the Murine Model of Sanfilippo Syndrome Type B	PLOS ONE			English	Article								Background. Mucopolysaccharidosis (MPS) IIIB (Sanfilippo Syndrome type B) is caused by a deficiency in the lysosomal enzyme N-acetyl-glucosaminidase (Naglu). Children with MPS IIIB develop disturbances of sleep, activity levels, coordination, vision, hearing, and mental functioning culminating in early death. The murine model of MPS IIIB demonstrates lysosomal distention in multiple tissues, a shortened life span, and behavioral changes. Principal Findings. To more thoroughly assess MPS IIIB in mice, alterations in circadian rhythm, activity level, motor function, vision, and hearing were tested. The suprachiasmatic nucleus (SCN) developed pathologic changes and locomotor analysis showed that MPS IIIB mice start their daily activity later and have a lower proportion of activity during the night than wild-type controls. Rotarod assessment of motor function revealed a progressive inability to coordinate movement in a rocking paradigm. Purkinje cell counts were significantly reduced in the MPS IIIB animals compared to age matched controls. By electroretinography (ERG), MPS IIIB mice had a progressive decrease in the amplitude of the dark-adapted b-wave response. Corresponding pathology revealed shortening of the outer segments, thinning of the outer nuclear layer, and inclusions in the retinal pigmented epithelium. Auditory-evoked brainstem responses (ABR) demonstrated progressive hearing deficits consistent with the observed loss of hair cells in the inner ear and histologic abnormalities in the middle ear. Conclusions/Significance. The mouse model of MPS IIIB has several quantifiable phenotypic alterations and is similar to the human disease. These physiologic and histologic changes provide insights into the progression of this disease and will serve as important parameters when evaluating various therapies.	[Heldermon, Coy D.; Hennig, Anne K.; Ohlemiller, Kevin K.; Sands, Mark S.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Ogilvie, Judith M.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Herzog, Erik D.; Breidenbach, Annalisa] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Vogler, Carole] St Louis Univ, Sch Med, St Louis, MO USA; [Wozniak, David F.] Washington Univ, Dept Psychiat, St Louis, MO USA	Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL)	Sands, MS (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.	msands@im.wustl.edu		Sands, Mark/0000-0002-5559-0832; Ogilvie, Judith/0000-0001-9499-9975; Heldermon, Coy/0000-0002-2148-2868; Herzog, Erik/0000-0001-7209-5174	National MPS Society; NIH [HL007088, DK57586, DC04946, MH63104, P30 DC004665, P30 NS057105]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004665, R03DC004946] Funding Source: NIH RePORTER	National MPS Society; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a grant from the National MPS Society (JMO) and NIH grants: HL007088 (CDH), DK57586 (MSS), DC04946 (AKH), MH63104 (EDH), P30 DC004665 (D. D. Simmons), P30 NS057105 (DFW). The funders had no role in any aspect of design, data collection, or manuscript preparation.	ANDRIA G, 1979, CLIN GENET, V15, P500; Barone R, 1999, NEUROPEDIATRICS, V30, P270, DOI 10.1055/s-2007-973503; BAX MCO, 1995, ARCH DIS CHILD, V73, P77, DOI 10.1136/adc.73.1.77; BREDENKAMP JK, 1992, ANN OTO RHINOL LARYN, V101, P472, DOI 10.1177/000348949210100605; CLEARY MA, 1993, ARCH DIS CHILD, V69, P403, DOI 10.1136/adc.69.3.403; Colville GA, 1996, DEV MED CHILD NEUROL, V38, P538; Cressant A, 2004, J NEUROSCI, V24, P10229, DOI 10.1523/JNEUROSCI.3558-04.2004; Daly TM, 1999, P NATL ACAD SCI USA, V96, P2296, DOI 10.1073/pnas.96.5.2296; DELMONTE MA, 1983, ARCH OPHTHALMOL-CHIC, V101, P1255; Ellinwood NM, 2003, J INHERIT METAB DIS, V26, P489, DOI 10.1023/A:1025177411938; FERRER I, 1988, NEUROPATH APPL NEURO, V14, P315, DOI 10.1111/j.1365-2990.1988.tb00891.x; Fraser J, 2005, ARCH DIS CHILD, V90, P1239, DOI 10.1136/adc.2004.065482; Fraser J, 2002, CLIN GENET, V62, P418, DOI 10.1034/j.1399-0004.2002.620512.x; Gorlin R., 1995, OXFORD MONOGRAPHS ME, V28, P318; HADFIELD MG, 1980, ARCH NEUROL-CHICAGO, V37, P645, DOI 10.1001/archneur.1980.00500590069012; Hennig AK, 2004, MOL THER, V10, P106, DOI 10.1016/j.ymthe.2004.03.018; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; INOUYE M, 1980, J COMP NEUROL, V190, P357, DOI 10.1002/cne.901900209; Johnson KR, 2006, BRAIN RES, V1091, P79, DOI 10.1016/j.brainres.2006.02.021; KREISEL B, 1978, BRAIN RES BULL, V3, P707, DOI 10.1016/0361-9230(78)90022-9; Kriegsfeld LJ, 2004, J NEUROSCI, V24, P2449, DOI 10.1523/JNEUROSCI.5323-03.2004; LAVERY MA, 1983, ARCH OPHTHALMOL-CHIC, V101, P1263; Leung L S, 1971, Birth Defects Orig Artic Ser, V7, P32; Li HH, 1999, P NATL ACAD SCI USA, V96, P14505, DOI 10.1073/pnas.96.25.14505; Li HH, 2002, J NEUROSCI RES, V69, P30, DOI 10.1002/jnr.10278; Mariotti R, 2003, CLIN ELECTROENCEPHAL, V34, P18, DOI 10.1177/155005940303400108; MARSH J, 1985, CLIN GENET, V27, P258; Monroy MA, 2002, BONE, V30, P352, DOI 10.1016/S8756-3282(01)00679-2; NIDIFFER FD, 1983, J MENT DEFIC RES, V27, P185; Ohlemiller KK, 2000, EXP EYE RES, V71, P469, DOI 10.1006/exer.2000.0897; Ohlemiller KK, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P581; Ohlemiller KK, 2002, HEARING RES, V169, P69, DOI 10.1016/S0378-5955(02)00341-6; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Papsin BC, 1998, OTOLARYNG HEAD NECK, V118, P30, DOI 10.1016/S0194-5998(98)70371-7; VANDEKAMP JJP, 1981, CLIN GENET, V20, P152; VANSCHROJENSTEINDEVALK HMJ, 1987, AM J MED GENET, V28, P125; Warren EJ, 2006, EUR J NEUROSCI, V23, P2477, DOI 10.1111/j.1460-9568.2006.04777.x; Yogalingam G, 2000, BBA-MOL BASIS DIS, V1502, P415, DOI 10.1016/S0925-4439(00)00066-1; Zafeiriou DI, 2001, BRAIN DEV-JPN, V23, P385, DOI 10.1016/S0387-7604(01)00242-X	39	67	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e772	10.1371/journal.pone.0000772	http://dx.doi.org/10.1371/journal.pone.0000772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712420	Green Published, gold			2022-12-27	WOS:000207455300020
J	Coudeyre, E; Tubach, F; Rannou, F; Baron, G; Coriat, F; Brin, S; Revel, M; Poiraudeau, S				Coudeyre, Emmanuel; Tubach, Florence; Rannou, Francois; Baron, Gabriel; Coriat, Fernand; Brin, Sylvie; Revel, Michel; Poiraudeau, Serge			Effect of a Simple Information Booklet on Pain Persistence after an Acute Episode of Low Back Pain: A Non-Randomized Trial in a Primary Care Setting	PLOS ONE			English	Article							POPULATION-BASED INTERVENTION; RANDOMIZED CONTROLLED-TRIAL; FEAR-AVOIDANCE BELIEFS; EDUCATIONAL BOOKLET; EXERCISE THERAPY; DISABILITY; HEALTH; VALIDATION; GUIDELINES; VERSION	Objective. Mass-media campaigns have been known to modify the outcome of low back pain (LBP). We assessed the impact on outcome of standardized written information on LBP given to patients with acute LBP. Methods. Design: A 3-month pragmatic, multicenter controlled trial with geographic stratification. Setting: Primary care practice in France. Participants: 2752 patients with acute LBP. Intervention: An advice book on LBP (the "back book''). Main outcome measures: The main outcome measure was persistence of LBP three months after baseline evaluation. Results. 2337 (85%) patients were assessed at follow-up and 12.4% of participants reported persistent LBP. The absolute risk reduction of reporting persistent back pain in the intervention group was 3.6% lower than in the control group (10.5% vs. 14.1%; 95% confidence interval [-6.3%; -1.0%]; p value adjusted for cluster effect = 0.01). Patients in the intervention group were more satisfied than those in the control group with the information they received about physical activities, when to consult their physician, and how to prevent a new episode of LBP. However, the number of patients who had taken sick leave was similar, as was the mean sick-leave duration, in both arms, and, among patients with persistent pain at follow-up, the intervention and control groups did not differ in disability or fear-avoidance beliefs. Conclusions. The level of improvement of an information booklet is modest, but the cost and complexity of the intervention is minimal. Therefore, the implications and generalizability of this intervention are substantial. Trial Registration. ClinicalTrials.gov NCT00343057	[Coudeyre, Emmanuel; Revel, Michel; Poiraudeau, Serge] Univ Paris 05, Serv Med Phys & Readaptat, Hop Cochin, AP HP,Inst Federatif Rech Handicap IFR 25,INSERM, Paris, France; [Coudeyre, Emmanuel] Ctr Med Phys & Readaptat Notre Dame, Chamalieres, France; [Tubach, Florence; Baron, Gabriel] Hop Bichat Claude Bernard, INSERM, U738, Dept Epidemiol Biostat & Rech Clin, F-75877 Paris, France; [Coriat, Fernand; Brin, Sylvie] Grp Sanofi Aventis, Lab Aventis, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Sanofi-Aventis; Sanofi France	Poiraudeau, S (corresponding author), Univ Paris 05, Serv Med Phys & Readaptat, Hop Cochin, AP HP,Inst Federatif Rech Handicap IFR 25,INSERM, Paris, France.	serge.poiraudeau@cch.aphp.fr		Poiraudeau, Serge/0000-0002-1988-9124	Sanofi-Aventis	Sanofi-Aventis(Sanofi-Aventis)	This study was funded by Sanofi-Aventis. The funding sponsor took part in the design and conduct of the study and collection, management, and analysis of the data. It was not involved in the writing and final approval of the manuscript. Independent data analysis was conducted by one of the authors (FT) who did not receive compensation or funding for conducting the analyses.	Abenhaim L, 2000, SPINE, V25, p1S, DOI 10.1097/00007632-200002151-00001; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; [Anonymous], 2000, J RADIOL, V81, P1665; BREART G, 1991, REV EPIDEMIOL SANTE, V39, pS5; Breen AC, 2006, EUR SPINE J, V15, P641, DOI 10.1007/s00586-005-0883-9; Buchbinder R, 2004, BRIT MED J, V328, P321, DOI 10.1136/bmj.328.7435.321; Buchbinder R, 2001, BRIT MED J, V322, P1516, DOI 10.1136/bmj.322.7301.1516; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; Chaory K, 2004, SPINE, V29, P908, DOI 10.1097/00007632-200404150-00018; Cherkin DC, 1998, NEW ENGL J MED, V339, P1021, DOI 10.1056/NEJM199810083391502; Cherkin DC, 1996, SPINE, V21, P345, DOI 10.1097/00007632-199602010-00019; Coudeyre E, 2003, Ann Readapt Med Phys, V46, P553, DOI 10.1016/j.annrmp.2003.02.001; de Jong JR, 2005, CLIN J PAIN, V21, P9, DOI 10.1097/00002508-200501000-00002; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Druss BG, 2000, AM J PSYCHIAT, V157, P1274, DOI 10.1176/appi.ajp.157.8.1274; FEUERSTEIN M, 1995, PHYS THER, V75, P267, DOI 10.1093/ptj/75.4.267; Godwin Marshall, 2003, BMC Med Res Methodol, V3, P28, DOI 10.1186/1471-2288-3-28; Hagen KB, 2002, SPINE, V27, P1736, DOI 10.1097/00007632-200208150-00010; HAGEN KB, 2005, COCHRANE DATABASE SY; Harris AD, 2004, CLIN INFECT DIS, V38, P1586, DOI 10.1086/420936; Hayden JA, 2005, ANN INTERN MED, V142, P765, DOI 10.7326/0003-4819-142-9-200505030-00013; Hayden JA, 2005, ANN INTERN MED, V142, P776, DOI 10.7326/0003-4819-142-9-200505030-00014; Hayden JA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000335.pub2; Hazard RG, 2000, SPINE, V25, P1419, DOI 10.1097/00007632-200006010-00015; Heymans MW, 2005, SPINE, V30, P2153, DOI 10.1097/01.brs.0000182227.33627.15; Koes BW, 2006, BMJ-BRIT MED J, V332, P1430, DOI 10.1136/bmj.332.7555.1430; KOPEC JA, 1995, SPINE, V20, P341, DOI 10.1097/00007632-199502000-00016; Linton SJ, 2002, J OCCUP REHABIL, V12, P223, DOI 10.1023/A:1020218422974; Malmivaara A, 2006, SPINE, V31, P1405, DOI 10.1097/01.brs.0000219868.30427.66; ORR CJB, 1989, BRIT J HOSP MED, V42, P439; Ostelo RWJG, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002014.pub2; Pfingsten M, 2000, EUR J PAIN-LONDON, V4, P259, DOI 10.1053/eujp.2000.0178; Prescott RJ, 1999, HEALTH TECHNOL ASSES, V3, P1, DOI DOI 10.3310/hta3200; Raspe H, 2004, SPINE, V29, P1017, DOI 10.1097/00007632-200405010-00013; Roberts L, 2002, SPINE, V27, P1821, DOI 10.1097/00007632-200209010-00002; ROLAND M, 1989, J ROY COLL GEN PRACT, V39, P244; *ROYAL COLL GEN PR, 1996, CLIN GUID MAN AC LOW; Udermann Brian E, 2004, Spine J, V4, P425, DOI 10.1016/j.spinee.2004.01.016; Valat JP, 2000, JOINT BONE SPINE, V67, P456; van Tulder M, 2006, EUR SPINE J, V15, pS169, DOI 10.1007/s00586-006-1071-2; van Tulder MW, 2006, EUR SPINE J, V15, pS64, DOI 10.1007/s00586-005-1048-6; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; WADDELL G, 1998, BACK PAIN REVOLUTION, P266; Wessels T, 2006, EUR SPINE J, V15, P1633, DOI 10.1007/s00586-006-0073-4	44	44	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e706	10.1371/journal.pone.0000706	http://dx.doi.org/10.1371/journal.pone.0000706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684553	Green Published, gold			2022-12-27	WOS:000207452400010
J	Gillet, L; May, JS; Colaco, S; Stevenson, PG				Gillet, Laurent; May, Janet S.; Colaco, Susanna; Stevenson, Philip G.			The Murine Gammaherpesvirus-68 gp150 Acts as an Immunogenic Decoy to Limit Virion Neutralization	PLOS ONE			English	Article								Herpesviruses maintain long-term infectivity without marked antigenic variation. They must therefore evade neutralization by other means. Immune sera block murine gammaherpesvirus-68 (MHV-68) infection of fibroblasts, but fail to block and even enhance its infection of IgG Fc receptor-bearing cells, suggesting that the antibody response to infection is actually poor at ablating virion infectivity completely. Here we analyzed this effect further by quantitating the glycoprotein-specific antibody response of MHV-68 carrier mice. Gp150 was much the commonest glycoprotein target and played a predominant role in driving Fc receptor-dependent infection: when gp150-specific antibodies were boosted, Fc receptor-dependent infection increased; and when gp150-specific antibodies were removed, Fc receptor-dependent infection was largely lost. Neither gp150-specific monoclonal antibodies nor gp150-specific polyclonal sera gave significant virion neutralization. Gp150 therefore acts as an immunogenic decoy, distorting the MHV-68-specific antibody response to promote Fc receptor-dependent infection and so compromise virion neutralization. This immune evasion mechanism may be common to many non-essential herpesvirus glycoproteins.	[Gillet, Laurent; May, Janet S.; Colaco, Susanna; Stevenson, Philip G.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England	University of Cambridge	Stevenson, PG (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England.	pgs27@cam.ac.uk	Stevenson, Philip g/F-9688-2014; Stevenson, Philip/F-6651-2011	Stevenson, Philip g/0000-0002-3520-5060; Gillet, Laurent/0000-0002-1047-2525	Fonds National Belge de la Recherche Scientifique (FNRS); Wellcome Trust [GR076956MA]; Medical Research Council [G0400427, G9800903]; CRUK [C19612/A6189]; Medical Research Council [G9800943] Funding Source: researchfish; MRC [G9800943, G0400427] Funding Source: UKRI	Fonds National Belge de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Laurent Gillet is a Postdoctoral Researcher of the Fonds National Belge de la Recherche Scientifique (FNRS). Philip Stevenson is a Wellcome Trust Senior Clinical Fellow (GR076956MA). This work was also supported by Medical Research Council grants G0400427 and G9800903 and a CRUK project grant (C19612/A6189).	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Atalay R, 2002, J VIROL, V76, P8596, DOI 10.1128/JVI.76.17.8596-8608.2002; Belz GT, 2000, P NATL ACAD SCI USA, V97, P2725, DOI 10.1073/pnas.040575197; Birkmann A, 2001, J VIROL, V75, P11583, DOI 10.1128/JVI.75.23.11583-11593.2001; BLASKOVIC D, 1980, ACTA VIROL, V24, P468; Boname JM, 2005, J VIROL, V79, P3163, DOI 10.1128/JVI.79.5.3163-3168.2005; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Cardin RD, 1996, J EXP MED, V184, P863, DOI 10.1084/jem.184.3.863; Chandran B, 1998, VIROLOGY, V243, P208, DOI 10.1006/viro.1998.9055; Coleman HM, 2003, J VIROL, V77, P2410, DOI 10.1128/JVI.77.4.2410-2417.2003; Dal Conto AJ, 2000, J VIROL, V74, P11304, DOI 10.1128/JVI.74.23.11304-11310.2000; DAVISON AJ, 1990, NUCLEIC ACIDS RES, V18, P4285, DOI 10.1093/nar/18.14.4285; De Lima BD, 2004, J VIROL, V78, P5103, DOI 10.1128/JVI.78.10.5103-5112.2004; DINGWELL KS, 1994, J VIROL, V68, P834, DOI 10.1128/JVI.68.2.834-845.1994; Fowler P, 2003, J GEN VIROL, V84, P3405, DOI 10.1099/vir.0.19594-0; Galfre G, 1981, Methods Enzymol, V73, P3; Gill MB, 2006, J GEN VIROL, V87, P1465, DOI 10.1099/vir.0.81760-0; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000347; Gillet L, 2007, J VIROL, V81, P280, DOI 10.1128/JVI.01616-06; Gillet L, 2006, J GEN VIROL, V87, P3515, DOI 10.1099/vir.0.82313-0; Janz A, 2000, J VIROL, V74, P10142, DOI 10.1128/JVI.74.21.10142-10152.2000; JOHNSON DC, 1988, J VIROL, V62, P1347, DOI 10.1128/JVI.62.4.1347-1354.1988; KOHL S, 1982, J IMMUNOL, V129, P370; Lee BJ, 2003, J IMMUNOL, V170, P243, DOI 10.4049/jimmunol.170.1.243; Lopes FB, 2004, J VIROL, V78, P13370, DOI 10.1128/JVI.78.23.13370-13375.2004; May JS, 2005, TRAFFIC, V6, P780, DOI 10.1111/j.1600-0854.2005.00316.x; May JS, 2005, J VIROL, V79, P5059, DOI 10.1128/JVI.79.8.5059-5068.2005; May JS, 2005, J GEN VIROL, V86, P919, DOI 10.1099/vir.0.80661-0; May JS, 2005, J VIROL, V79, P3459, DOI 10.1128/JVI.79.6.3459-3467.2005; May JS, 2004, J GEN VIROL, V85, P137, DOI 10.1099/vir.0.19599-0; Means RE, 2004, VIROLOGY, V326, P67, DOI 10.1016/j.virol.2004.05.015; MILLER N, 1988, J VIROL, V62, P2366, DOI 10.1128/JVI.62.7.2366-2372.1988; Mozdzanowska K, 2003, J VIROL, V77, P8322, DOI 10.1128/JVI.77.15.8322-8328.2003; PEETERS B, 1993, J VIROL, V67, P170, DOI 10.1128/JVI.67.1.170-177.1993; ROSA GT, 2007, PLOSONE IN PRESS; ROTH MG, 1980, J VIROL, V35, P547, DOI 10.1128/JVI.35.2.547-550.1980; SCHERLE PA, 1986, J EXP MED, V164, P1114, DOI 10.1084/jem.164.4.1114; Shannon-Lowe CD, 2006, P NATL ACAD SCI USA, V103, P7065, DOI 10.1073/pnas.0510512103; Simas JP, 1998, TRENDS MICROBIOL, V6, P276; SISSONS JGP, 1980, J INFECT DIS, V142, P442, DOI 10.1093/infdis/142.3.442; Sitki-Green D, 2003, J VIROL, V77, P1840, DOI 10.1128/JVI.77.3.1840-1847.2003; Stevenson PG, 2005, VIRAL IMMUNOL, V18, P445, DOI 10.1089/vim.2005.18.445; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; Stevenson PG, 1999, P NATL ACAD SCI USA, V96, P9281, DOI 10.1073/pnas.96.16.9281; Stevenson PG, 1999, J VIROL, V73, P1075, DOI 10.1128/JVI.73.2.1075-1079.1999; Stevenson PG, 1998, J VIROL, V72, P943, DOI 10.1128/JVI.72.2.943-949.1998; Stewart JP, 2004, J VIROL, V78, P10449, DOI 10.1128/JVI.78.19.10449-10459.2004; TANNER J, 1987, CELL, V50, P203, DOI 10.1016/0092-8674(87)90216-9; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; THORLEYLAWSON DA, 1982, J VIROL, V43, P730, DOI 10.1128/JVI.43.2.730-736.1982; Turk SM, 2006, J VIROL, V80, P9628, DOI 10.1128/JVI.00622-06; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Wang FZ, 2001, J VIROL, V75, P7517, DOI 10.1128/JVI.75.16.7517-7527.2001; WILDY P, 1985, BRIT MED BULL, V41, P86, DOI 10.1093/oxfordjournals.bmb.a072032; Xu JK, 1996, J GEN VIROL, V77, P49, DOI 10.1099/0022-1317-77-1-49; YAO QY, 1991, INT J CANCER, V48, P45; YAO QY, 1985, INT J CANCER, V35, P35, DOI 10.1002/ijc.2910350107; Zinkernagel RM, 2006, IMMUNOL REV, V211, P310, DOI 10.1111/j.0105-2896.2006.00402.x	58	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e705	10.1371/journal.pone.0000705	http://dx.doi.org/10.1371/journal.pone.0000705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684552	gold, Green Published, Green Submitted			2022-12-27	WOS:000207452400009
J	Emerson, D; Rentz, JA; Lilburn, TG; Davis, RE; Aldrich, H; Chan, C; Moyer, CL				Emerson, David; Rentz, Jeremy A.; Lilburn, Timothy G.; Davis, Richard E.; Aldrich, Henry; Chan, Clara; Moyer, Craig L.			A Novel Lineage of Proteobacteria Involved in Formation of Marine Fe-Oxidizing Microbial Mat Communities	PLOS ONE			English	Article							HYDROTHERMAL VENT SYSTEM; LOIHI SEAMOUNT; SP-NOV.; MINERAL DEPOSITION; IRON; DIVERSITY; BACTERIA; DEEP; OCEAN; OXIDE	Background. For decades it has been recognized that neutrophilic Fe-oxidizing bacteria (FeOB) are associated with hydrothermal venting of Fe(II)-rich fluids associated with seamounts in the world's oceans. The evidence was based almost entirely on the mineralogical remains of the microbes, which themselves had neither been brought into culture or been assigned to a specific phylogenetic clade. We have used both cultivation and cultivation-independent techniques to study Fe-rich microbial mats associated with hydrothermal venting at Loihi Seamount, a submarine volcano. Methodology/Principle Findings. Using gradient enrichment techniques, two iron-oxidizing bacteria, strains PV-1 and JV-1, were isolated. Chemolithotrophic growth was observed under microaerobic conditions; Fe(II) and Fe-0 were the only energy sources that supported growth. Both strains produced filamentous stalk-like structures composed of multiple nanometer sized fibrils of Fe-oxyhydroxide. These were consistent with mineralogical structures found in the iron mats. Phylogenetic analysis of the small subunit (SSU) rRNA gene demonstrated that strains PV-1 and JV-1 were identical and formed a monophyletic group deeply rooted within the Proteobacteria. The most similar sequence (85.3% similarity) from a cultivated isolate came from Methylophaga marina. Phylogenetic analysis of the RecA and GyrB protein sequences confirmed that these strains are distantly related to other members of the Proteobacteria. A cultivation-independent analysis of the SSU rRNA gene by terminal-restriction fragment (T-RF) profiling showed that this phylotype was most common in a variety of microbial mats collected at different times and locations at Loihi. Conclusions. On the basis of phylogenetic and physiological data, it is proposed that isolate PV-1(T) (= ATCC BAA-1019: JCM 14766) represents the type strain of a novel species in a new genus, Mariprofundus ferrooxydans gen. nov., sp. nov. Furthermore, the strain is the first cultured representative of a new candidatus class of the Proteobacteria that is widely distributed in deep-sea environments, Candidatus zeta (zeta)-Proteobacteria cl. nov.	[Emerson, David; Rentz, Jeremy A.; Lilburn, Timothy G.] Amer Type Culture Collect, Manassas, VA USA; [Aldrich, Henry] Univ Florida, Dept Microbiol, Gainesville, FL USA; [Chan, Clara] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Davis, Richard E.; Moyer, Craig L.] Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA	State University System of Florida; University of Florida; Woods Hole Oceanographic Institution; Western Washington University	Emerson, D (corresponding author), Amer Type Culture Collect, Manassas, VA USA.	demerson@gmu.edu	Chan, Clara S/B-6420-2011; Davis, Richard/AAC-8464-2019	Chan, Clara S/0000-0003-1810-4994; Davis, Richard/0000-0003-1601-6384	National Science Foundation [0348330]; NASA Astobiology Institute; Direct For Biological Sciences [0810973] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NASA Astobiology Institute; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided to DE and CLM by the National Science Foundation (0348330) and to DE through the NASA Astobiology Institute.	ALT JC, 1988, MAR GEOL, V81, P227, DOI 10.1016/0025-3227(88)90029-1; Amend JP, 2005, PALAEOGEOGR PALAEOCL, V219, P131, DOI 10.1016/j.palaeo.2004.10.018; Bach W, 2003, GEOCHIM COSMOCHIM AC, V67, P3871, DOI 10.1016/S0016-7037(03)00304-1; Bogan BW, 2003, INT J SYST EVOL MICR, V53, P1389, DOI 10.1099/ijs.0.02568-0; Chan CS, 2004, SCIENCE, V303, P1656, DOI 10.1126/science.1092098; CHAO LSL, 2007, MAR ECOL, V28, P1; DAVIS RE, 2005, EOS T AGU, V86; Delaney JR, 1998, SCIENCE, V281, P222, DOI 10.1126/science.281.5374.222; Dhillon A, 2003, APPL ENVIRON MICROB, V69, P2765, DOI 10.1128/AEM.69.5.2765-2772.2003; Dinh HT, 2004, NATURE, V427, P829, DOI 10.1038/nature02321; Eder W, 2001, APPL ENVIRON MICROB, V67, P3077, DOI 10.1128/AEM.67.7.3077-3085.2001; Edwards KJ, 2004, GEOMICROBIOL J, V21, P393, DOI 10.1080/01490450490485863; Edwards KJ, 2003, APPL ENVIRON MICROB, V69, P2906, DOI 10.1128/AEM.69.5.2906-2913.2003; Emerson D, 2005, METHOD ENZYMOL, V397, P112, DOI 10.1016/S0076-6879(05)97006-7; EMERSON D, 1993, J BACTERIOL, V175, P7808, DOI 10.1128/JB.175.24.7808-7818.1993; Emerson D, 1997, APPL ENVIRON MICROB, V63, P4784, DOI 10.1128/AEM.63.12.4784-4792.1997; Emerson D, 2002, APPL ENVIRON MICROB, V68, P3085, DOI 10.1128/AEM.68.6.3085-3093.2002; Emerson D, 2000, ENVIRONMENTAL MICROBE-METAL INTERACTIONS, P31; EMERSON D, 2007, INT J SYST IN PRESS; Engebretson JJ, 2003, APPL ENVIRON MICROB, V69, P4823, DOI 10.1128/AEM.69.8.4823-4829.2003; Fortin D, 2005, EARTH-SCI REV, V72, P1, DOI 10.1016/j.earscirev.2005.03.002; Garrity GM, 2001, BERGEYS MANUAL SYSTE, V1, P155; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HALLBECK EL, 2005, BERGEYS MANUAL SYSTE, P880; HALLBECK L, 1993, J GEN MICROBIOL, V139, P1531, DOI 10.1099/00221287-139-7-1531; HANE BG, 1993, ELECTROPHORESIS, V14, P967, DOI 10.1002/elps.11501401154; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; HOLM NG, 1987, CHEM GEOL, V63, P45, DOI 10.1016/0009-2541(87)90073-8; JANNASCH HW, 1985, SCIENCE, V229, P717, DOI 10.1126/science.229.4715.717; Juniper S. K., 1995, MICR EXTREM UNUSUAL, P219; JUNIPER SK, 1988, CAN MINERAL, V26, P859; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kennedy CB, 2003, GEOMICROBIOL J, V20, P199, DOI 10.1080/01490450303873; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Ludwig W, 2005, BERGEYS MANUAL SYSTE, V2, P49, DOI DOI 10.1007/978-0-387-21609-6_8; McCollom TM, 2000, DEEP-SEA RES PT I, V47, P85, DOI 10.1016/S0967-0637(99)00048-5; Mergaert J, 2003, INT J SYST EVOL MICR, V53, P1961, DOI 10.1099/ijs.0.02684-0; MOYER CL, 1994, APPL ENVIRON MICROB, V60, P871, DOI 10.1128/AEM.60.3.871-879.1994; MOYER CL, 1995, APPL ENVIRON MICROB, V61, P1555, DOI 10.1128/AEM.61.4.1555-1562.1995; OLSEN GJ, 1994, COMPUT APPL BIOSCI, V10, P41; Pikuta EV, 2003, EXTREMOPHILES, V7, P327, DOI 10.1007/s00792-003-0326-7; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sievert SM, 2007, ENVIRON MICROBIOL, V9, P271, DOI 10.1111/j.1462-2920.2006.01156.x; Sobolev D, 2004, GEOMICROBIOL J, V21, P1, DOI 10.1080/01490450490253310; Staudigel H, 2006, P NATL ACAD SCI USA, V103, P6448, DOI 10.1073/pnas.0600830103; Stead DE, 1998, PLANT CELL TISS ORG, V52, P17, DOI 10.1023/A:1005991706343; Taylor CD, 1999, APPL ENVIRON MICROB, V65, P2253; Thorseth IH, 2001, EARTH PLANET SC LETT, V194, P31, DOI 10.1016/S0012-821X(01)00537-4; Wallace IM, 2005, BIOINFORMATICS, V21, P1408, DOI 10.1093/bioinformatics/bti159; WEISS JV, 2007, GEOMICROBIO IN PRESS; YANG P, 1993, SYST APPL MICROBIOL, V16, P47, DOI 10.1016/S0723-2020(11)80250-X	53	279	292	7	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e667	10.1371/journal.pone.0000667	http://dx.doi.org/10.1371/journal.pone.0000667			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668050	Green Published, gold			2022-12-27	WOS:000207452300008
J	Yao, YG; Bandelt, HJ; Young, NS				Yao, Yong-Gang; Bandelt, Hans-Juergen; Young, Neal S.			External Contamination in Single Cell mtDNA Analysis	PLOS ONE			English	Article							MITOCHONDRIAL-DNA MUTATIONS; CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; SEQUENCE; INHERITANCE; ACCUMULATION; PENETRANCE; PHYLOGENY; DELETIONS; ABUNDANT	Background. Mitochondrial DNA (mtDNA) variation in single hematopoietic cells, muscle fibers, oocytes, and from tiny amount of tumor tissues and degraded clinical specimens has been reported in many medical publications. External DNA contamination, notoriously difficult to avoid, threatens the integrity of such studies. Methodology/Principal Findings. Employing a phylogenetic approach, we analyzed the geographic origins of mtDNA sequence anomalies observed during multiple studies of mtDNA sequence variation in a total of 7094 single hematopoietic cells. 40 events with irregular mtDNA patterns were detected: eight instances (from seven different haplotypes) could be traced to laboratory personnel; six cases were caused by sample cross-contamination. The sources of the remaining events could not be identified, and the anomalous sequence variation referred to matrilines from East Asia, Africa, or West Eurasia, respectively. These mtDNA sequence anomalies could be best explained by contamination. Conclusions. Using the known world mtDNA phylogeny, we could distinguish the geographic origin of the anomalous mtDNA types, providing some useful information regarding the source of contamination. Our data suggest that routine mtDNA sequence analysis of laboratory personnel is insufficient to identify and eliminate all contaminants. A rate of 0.6% of external contamination in this study, while low, is not negligible: Unrecognized contaminants will be mistaken as evidence of remarkable somatic mutations associated with the development of cancer and other diseases. The effective contamination rate can increase by a factor of more than an order of magnitude in some studies that did not institute high standards. Our results are of particular relevance to mtDNA research in medicine, and such an approach should be adopted to maintain and improve quality control in single-cell analyses.	[Yao, Yong-Gang; Young, Neal S.] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; [Bandelt, Hans-Juergen] Univ Hamburg, Dept Math, Hamburg, Germany	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Hamburg	Yao, YG (corresponding author), NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA.	yaoy3@nhlbi.nih.gov	Yao, Yong-Gang/AAH-2303-2021	Yao, Yong-Gang/0000-0002-2955-0693	NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL002315, ZIAHL002315] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program of the NIH.	Alonso A, 2005, J CLIN PATHOL, V58, P83, DOI 10.1136/jcp.2004.017673; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bandelt HJ, 2007, EUR J HUM GENET, V15, P400, DOI 10.1038/sj.ejhg.5201781; Bandelt HJ, 2007, BIOCHEM BIOPH RES CO, V352, P283, DOI 10.1016/j.bbrc.2006.10.131; Bandelt HJ, 2006, NUCL ACID M, V18, P117; Bandelt HJ, 2005, J MED GENET, V42, P957, DOI 10.1136/jmg.2005.033589; Bandelt HJ, 2005, BIOCHEM BIOPH RES CO, V333, P122, DOI 10.1016/j.bbrc.2005.04.055; Behar DM, 2006, AM J HUM GENET, V78, P487, DOI 10.1086/500307; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212; Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Chan CCW, 2005, MOL HUM REPROD, V11, P843, DOI 10.1093/molehr/gah243; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; Chomyn A, 2003, BIOCHEM BIOPH RES CO, V304, P519, DOI 10.1016/S0006-291X(03)00625-9; Cormio A, 2005, NEUROBIOL AGING, V26, P655, DOI 10.1016/j.neurobiolaging.2004.06.014; Czarnecka AM, 2006, J APPL GENET, V47, P67, DOI 10.1007/BF03194602; Del Bo R, 2003, NEUROBIOL AGING, V24, P829, DOI 10.1016/S0197-4580(02)00233-6; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Durham SE, 2006, NEUROMUSCULAR DISORD, V16, P381, DOI 10.1016/j.nmd.2006.03.012; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Jakupciak JP, 2005, J MOL DIAGN, V7, P258, DOI 10.1016/S1525-1578(10)60553-3; Johns DR, 2003, ANN NEUROL, V54, P422, DOI 10.1002/ana.10771; Kirches E, 2001, INT J CANCER, V93, P534, DOI 10.1002/ijc.1375; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; LEONARD JL, 2007, J ARCHAEOL IN PRESS, DOI DOI 10.1016/J.JAS.2006.1010.1023; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; MORAES CT, 1992, AM J HUM GENET, V50, P934; Nagley P, 1998, TRENDS GENET, V14, P513, DOI 10.1016/S0168-9525(98)01580-7; Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199; Ogasawara Y, 2005, BLOOD, V106, P3271, DOI 10.1182/blood-2005-01-0150; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pak JW, 2003, AGING CELL, V2, P1, DOI 10.1046/j.1474-9728.2003.00034.x; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Sampietro ML, 2006, MOL BIOL EVOL, V23, P1801, DOI 10.1093/molbev/msl047; Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350; Shin MG, 2004, BLOOD, V103, P553, DOI 10.1182/blood-2003-05-1724; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Vega A, 2004, ONCOGENE, V23, P1314, DOI 10.1038/sj.onc.1207214; Verma Mukesh, 2007, Cancer Res, V67, P437, DOI 10.1158/0008-5472.CAN-06-4119; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang CY, 2007, INT J CANCER, V121, P1253, DOI 10.1002/ijc.22822; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Yao YG, 2006, HUM GENET, V119, P505, DOI 10.1007/s00439-006-0154-9; Yao YG, 2007, BLOOD, V109, P756, DOI 10.1182/blood-2006-01-011007; Yao YG, 2007, HUM MOL GENET, V16, P286, DOI 10.1093/hmg/ddl457; Zanssen S, 2005, PLOS MED, V2, P1082, DOI 10.1371/journal.pmed.0020401	64	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e681	10.1371/journal.pone.0000681	http://dx.doi.org/10.1371/journal.pone.0000681			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668059	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452300017
J	Buceta, J; Herranz, H; Canela-Xandri, O; Reigada, R; Sagues, F; Milan, M				Buceta, Javier; Herranz, Hector; Canela-Xandri, Oriol; Reigada, Ramon; Sagues, Francesc; Milan, Marco			Robustness and Stability of the Gene Regulatory Network Involved in DV Boundary Formation in the Drosophila Wing	PLOS ONE			English	Article							DORSAL-VENTRAL BOUNDARY; INDUCIBLE ANTAGONIST; PATTERN-FORMATION; NOTCH ACTIVATION; FRINGE; EXPRESSION; SERRATE; PROTEIN; SIGNAL; CELLS	Gene regulatory networks have been conserved during evolution. The Drosophila wing and the vertebrate hindbrain share the gene network involved in the establishment of the boundary between dorsal and ventral compartments in the wing and adjacent rhombomeres in the hindbrain. A positive feedback-loop between boundary and non-boundary cells and mediated by the activities of Notch and Wingless/Wnt-1 leads to the establishment of a Notch dependent organizer at the boundary. By means of a Systems Biology approach that combines mathematical modeling and both in silico and in vivo experiments in the Drosophila wing primordium, we modeled and tested this regulatory network and present evidence that a novel property, namely refractoriness to the Wingless signaling molecule, is required in boundary cells for the formation of a stable dorsal-ventral boundary. This new property has been validated in vivo, promotes mutually exclusive domains of Notch and Wingless activities and confers stability to the dorsal-ventral boundary. A robustness analysis of the regulatory network complements our results and ensures its biological plausibility.	[Buceta, Javier; Canela-Xandri, Oriol] CeRQT, Barcelona, Spain; [Herranz, Hector; Milan, Marco] ICREA, Barcelona, Spain; [Herranz, Hector; Milan, Marco] IRB, Barcelona, Spain; [Reigada, Ramon; Sagues, Francesc] Univ Barcelona, Dept Quim Fis, E-08028 Barcelona, Spain	ICREA; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona	Buceta, J (corresponding author), CeRQT, Parc Cient Barcelona, Barcelona, Spain.	jbuceta@pcb.ub.es; mmilan@pcb.ub.es	Sagues, Francesc/K-6414-2015; Milan, Marco/H-1450-2015; Buceta, Javier/ABB-1696-2021; Reigada, Ramon/A-2450-2012; Buceta, Javier/E-3705-2010	Sagues, Francesc/0000-0002-2956-5676; Milan, Marco/0000-0002-7111-6444; Buceta, Javier/0000-0003-1791-0011; Buceta, Javier/0000-0003-1791-0011; Reigada, Ramon/0000-0003-2177-7014	Ramon y Cajal; Juan de la Cierva; MEC [FIS2005-457, FIS2006-01197, BQU2003-05042-C02-01, BFU2004-00167/BMC]; DURSI [2005-SGR/00653, 2005-SGR/00118]; EU [LSHM-CP-2003-503330]; IRB Barcelona; ICREA Funding Source: Custom	Ramon y Cajal(Spanish Government); Juan de la Cierva(Instituto de Salud Carlos III); MEC(European Commission); DURSI; EU(European Commission); IRB Barcelona; ICREA(ICREA)	J.B. and H.H. acknowledge the Ramon y Cajal and the Juan de la Cierva programs, which provide their researcher contracts, respectively. Partial support was provided by MEC under grants FIS2005-457 and FIS2006-01197 (O.C-X. and J.B.), BQU2003-05042-C02-01 (R. R. and F. S), and BFU2004-00167/BMC (H. H and M. M.), and by DURSI through projects 2005-SGR/00653 (O.C-X., J.B., R. R., and F. S.) and 2005-SGR/00118 (H. H. and M. M.). M. M.'s laboratory also acknowledges support from an EU research contract LSHM-CP-2003-503330 (APOPIS) and IRB Barcelona intramural funds.	Amoyel M, 2005, DEVELOPMENT, V132, P775, DOI 10.1242/dev.01616; Axelrod JD, 1996, SCIENCE, V271, P1826, DOI 10.1126/science.271.5257.1826; Buceta J, 2005, BIOPHYS J, V89, P2199, DOI 10.1529/biophysj.105.063743; Cheng YC, 2004, DEV CELL, V6, P539, DOI 10.1016/S1534-5807(04)00097-8; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; deCelis JF, 1996, DEVELOPMENT, V122, P359; deCelis JF, 1997, DEVELOPMENT, V124, P3241; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; DiazBenjumea FJ, 1995, DEVELOPMENT, V121, P4215; Doherty D, 1996, GENE DEV, V10, P421, DOI 10.1101/gad.10.4.421; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Gerlitz O, 2002, GENE DEV, V16, P1055, DOI 10.1101/gad.991802; Giraldez AJ, 2003, DEVELOPMENT, V130, P6533, DOI 10.1242/dev.00904; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; Gonzalez A, 2006, GENETICS, V174, P1625, DOI 10.1534/genetics.106.061218; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Herranz H, 2006, EMBO REP, V7, P297, DOI 10.1038/sj.embor.7400617; Ibanes M, 2006, MOL SYST BIOL, V2, DOI 10.1038/mbs4100098; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; KOCH AJ, 1994, REV MOD PHYS, V66, P1481, DOI 10.1103/RevModPhys.66.1481; Kruse K, 2004, DEVELOPMENT, V131, P4843, DOI 10.1242/dev.01335; Kyoda K, 1999, Pac Symp Biocomput, P77; LUMSDEN A, 1991, PHILOS T R SOC B, V331, P281, DOI 10.1098/rstb.1991.0017; Micchelli CA, 1999, NATURE, V401, P473, DOI 10.1038/46779; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Milan M, 1998, GENE DEV, V12, P2912, DOI 10.1101/gad.12.18.2912; Milan M, 2000, DEVELOPMENT, V127, P3069; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Rauskolb C, 1999, NATURE, V401, P476, DOI 10.1038/46786; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; Rulifson EJ, 1996, NATURE, V384, P72, DOI 10.1038/384072a0; RULIFSON EJ, 1995, DEVELOPMENT, V121, P2813; Sakamoto K, 2002, DEV BIOL, V241, P313, DOI 10.1006/dbio.2001.0517; SCHLOOSER G, 2004, MODULARITY DEV EVOLU; Shoresh M, 1998, GENETICS, V150, P283; Tolwinski NS, 2004, TRENDS GENET, V20, P177, DOI 10.1016/j.tig.2004.02.003; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Zeng CY, 1998, P NATL ACAD SCI USA, V95, P10637, DOI 10.1073/pnas.95.18.10637; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615; Zeng YA, 2004, DEVELOPMENT, V131, P2911, DOI 10.1242/dev.01177	45	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2007	2	7							e602	10.1371/journal.pone.0000602	http://dx.doi.org/10.1371/journal.pone.0000602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GH	17622347	gold, Green Submitted, Green Published			2022-12-27	WOS:000207452000009
J	Geiger, T; Levitzki, A				Geiger, Tamar; Levitzki, Alexander			Loss of Robustness and Addiction to IGF1 during Early Keratinocyte Transformation by Human Papilloma Virus 16	PLOS ONE			English	Article								Infection of keratinocytes with high risk human Papilloma virus causes immortalization, and when followed by further mutations, leads to cervical cancer and other anogenital tumors. Here we monitor the progressive loss of robustness in an in vitro model of the early stages of transformation that comprises normal keratinocytes and progressive passages of HPV16 immortalized cells. As transformation progresses, the cells acquire higher proliferation rates and gain the ability to grow in soft agar. Concurrently, the cells lose robustness, becoming more sensitive to serum starvation and DNA damage by Cisplatin. Loss of robustness in the course of transformation correlates with significant reductions in the activities of the anti-apoptotic proteins PKB/Akt, Erk, Jnk and p38 both under normal growth conditions and upon stress. In parallel, loss of robustness is manifested by the shrinkage of the number of growth factors that can rescue starving cells from apoptosis, with the emergence of dependence solely on IGF1. Treatment with IGF1 activates PKB/Akt and Jnk and through them inhibits p53, rescuing the cells from starvation. We conclude that transformation in this model induces higher susceptibility of cells to stress due to reduced anti-apoptotic signaling and hyper-activation of p53 upon stress.	[Geiger, Tamar; Levitzki, Alexander] Hebrew Univ Jerusalem, Dept Biol Chem, Alexander Silverman Inst Life Sci, Unit Cellular Signaling, Jerusalem, Israel	Hebrew University of Jerusalem	Levitzki, A (corresponding author), Hebrew Univ Jerusalem, Dept Biol Chem, Alexander Silverman Inst Life Sci, Unit Cellular Signaling, Jerusalem, Israel.	levitzki@vms.huji.ac.il	Geiger, Tamar/C-2349-2014	Geiger, Tamar/0000-0002-9526-197X	Hebrew University; Algen Biopharmaceuticals Ltd	Hebrew University; Algen Biopharmaceuticals Ltd	Funds from the Hebrew University and Algen Biopharmaceuticals Ltd.	Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; BenBassat H, 1997, CANCER RES, V57, P3741; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; Berkovich E, 2003, ONCOGENE, V22, P161, DOI 10.1038/sj.onc.1206144; Billecke CA, 2002, ONCOGENE, V21, P4481, DOI 10.1038/sj.onc.1205546; Boyer SN, 1996, CANCER RES, V56, P4620; BRAUN L, 1990, CANCER RES, V50, P7324; BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0; CHAN WK, 1990, NUCLEIC ACIDS RES, V18, P763, DOI 10.1093/nar/18.4.763; CHONG T, 1990, NUCLEIC ACIDS RES, V18, P465, DOI 10.1093/nar/18.3.465; De Potter IY, 2001, EXP CELL RES, V271, P315, DOI 10.1006/excr.2001.5390; DURST M, 1991, J VIROL, V65, P796; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Edmondson SR, 2003, ENDOCR REV, V24, P737, DOI 10.1210/er.2002-0021; Fang XJ, 2000, BIOCHEM J, V352, P135, DOI 10.1042/0264-6021:3520135; Galvan V, 2003, J BIOL CHEM, V278, P13325, DOI 10.1074/jbc.M211398200; GIRINSKY T, 1995, CANCER RES, V55, P3726; HEMBREE JR, 1994, CANCER RES, V54, P3160; Hershko T, 2005, CELL DEATH DIFFER, V12, P377, DOI 10.1038/sj.cdd.4401575; Krause D, 2001, J BIOL CHEM, V276, P19244, DOI 10.1074/jbc.M008186200; Lembo D, 2006, VIRUS RES, V122, P189, DOI 10.1016/j.virusres.2006.06.011; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Liu YM, 2000, J CELL BIOCHEM, V78, P334, DOI 10.1002/(SICI)1097-4644(20000801)78:2<334::AID-JCB15>3.3.CO;2-6; MITRANIROSENBAUM S, 1992, INTERVIROLOGY, V33, P76, DOI 10.1159/000150234; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Nishino T, 2002, J BIOL CHEM, V277, P33943, DOI 10.1074/jbc.M201338200; Niu GL, 2005, MOL CELL BIOL, V25, P7432, DOI 10.1128/MCB.25.17.7432-7440.2005; Pestell KE, 2000, MOL PHARMACOL, V57, P503, DOI 10.1124/mol.57.3.503; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Reinmuth N, 2002, CLIN CANCER RES, V8, P3259; Rey O, 1999, ONCOGENE, V18, P6997, DOI 10.1038/sj.onc.1203180; Rodeck U, 1997, J CELL SCI, V110, P113; Salcedo M, 2002, INT J EXP PATHOL, V83, P275, DOI 10.1046/j.1365-2613.2002.00198.x; Sanclemente G, 2002, J EUR ACAD DERMATOL, V16, P231, DOI 10.1046/j.1473-2165.2002.00419.x; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schuler M, 2003, CELL DEATH DIFFER, V10, P451, DOI 10.1038/sj.cdd.4401180; Shen MR, 2006, CARCINOGENESIS, V27, P962, DOI 10.1093/carcin/bgi336; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Thompson N, 2005, CURR OPIN PHARMACOL, V5, P350, DOI 10.1016/j.coph.2005.04.007; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang YZ, 1998, PROSTATE, V35, P165; Wei LH, 2001, ONCOGENE, V20, P5799, DOI 10.1038/sj.onc.1204733; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; Wu YP, 2004, GROWTH HORM IGF RES, V14, P52, DOI 10.1016/j.ghir.2003.08.003; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	50	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2007	2	7							e605	10.1371/journal.pone.0000605	http://dx.doi.org/10.1371/journal.pone.0000605			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GH	17622350	Green Published, gold, Green Submitted			2022-12-27	WOS:000207452000012
J	Le Roux, JJ; Wieczorek, AM; Wright, MG; Tran, CT				Le Roux, Johannes J.; Wieczorek, Ania M.; Wright, Mark G.; Tran, Carol T.			Super-Genotype: Global Monoclonality Defies the Odds of Nature	PLOS ONE			English	Article								The ability to respond to natural selection under novel conditions is critical for the establishment and persistence of introduced alien species and their ability to become invasive. Here we correlated neutral and quantitative genetic diversity of the weed Pennisetum setaceum Forsk. Chiov. (Poaceae) with differing global (North American and African) patterns of invasiveness and compared this diversity to native range populations. Numerous molecular markers indicate complete monoclonality within and among all of these areas (F-ST=0.0) and is supported by extreme low quantitative trait variance (Q(ST)=0.00065-0.00952). The results support the general-purpose-genotype hypothesis that can tolerate all environmental variation. However, a single global genotype and widespread invasiveness under numerous environmental conditions suggests a super-genotype. The super-genotype described here likely evolved high levels of plasticity in response to fluctuating environmental conditions during the Early to Mid Holocene. During the Late Holocene, when environmental conditions were predominantly constant but extremely inclement, strong selection resulted in only a few surviving genotypes.	[Le Roux, Johannes J.; Wieczorek, Ania M.; Tran, Carol T.] Univ Hawaii Manoa, Dept Trop Plant & Soil Sci, Honolulu, HI 96822 USA; [Wright, Mark G.] Univ Hawaii Manoa, Dept Plant & Environm Sci, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Le Roux, JJ (corresponding author), Univ Hawaii Manoa, Dept Trop Plant & Soil Sci, Honolulu, HI 96822 USA.	roux@hawaii.edu	Wright, Mark G/A-7349-2009	Le Roux, Johannes/0000-0001-7911-9810; Wright, Mark/0000-0002-1643-7560	USDATSTAR	USDATSTAR(United States Department of Agriculture (USDA))	The research conducted in this study was financially supported by a USDATSTAR grant to Dr. Ania Wieczorek.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Asker S. E., 1992, APOMIXIS PLANTS; ASSIENAN B, 1995, THEOR APPL GENET, V91, P672, DOI 10.1007/BF00223296; Baker H. G., 1965, The genetics of colonizing species., P147; BAKER HG, 1967, EVOLUTION, V21, P853, DOI 10.1111/j.1558-5646.1967.tb03440.x; Barcaccia G, 2006, HEREDITY, V96, P322, DOI 10.1038/sj.hdy.6800808; BORNKAMM R, 1989, J ARID ENVIRON, V17, P271, DOI 10.1016/S0140-1963(18)30915-7; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; Carino DA, 1999, MOL ECOL, V8, P2127, DOI 10.1046/j.1365-294x.1999.00786.x; CHABOUDEZ P, 1994, AUST J BOT, V42, P283, DOI 10.1071/BT9940283; Cox GW, 2004, ALIEN SPECIES EVOLUT; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; ELLSTRAND NC, 1987, AM J BOT, V74, P123, DOI 10.2307/2444338; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; Gasse F, 2000, QUATERNARY SCI REV, V19, P189, DOI 10.1016/S0277-3791(99)00061-X; Hamilton MB, 1999, BIOTECHNIQUES, V27, P500, DOI 10.2144/99273st03; Joubert D. F., 2002, Dinteria, P37; KALENDAR R, 2004, FASTPCR PCR PRIMER D; LAVERGNE S, P NATL ACAD SCI US, V104, P3883; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Martel E, 2004, PLANT SYST EVOL, V249, P139, DOI 10.1007/s00606-004-0191-6; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Milton SJ, 1998, S AFR J SCI, V94, P57; Neumann K., 1989, AFR ARCHAEOL REV, V7, P97, DOI DOI 10.1007/BF01116839; Nicoll K, 2004, QUATERNARY SCI REV, V23, P561, DOI 10.1016/j.quascirev.2003.10.004; Novak SJ, 2000, CAN J BOT, V78, P1469, DOI 10.1139/cjb-78-11-1469; Palenchar PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r91; Parker IM, 2003, CONSERV BIOL, V17, P59, DOI 10.1046/j.1523-1739.2003.02019.x; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Pigliucci M, 2006, J EXP BIOL, V209, P2362, DOI 10.1242/jeb.02070; Poulin J, 2005, DIVERS DISTRIB, V11, P241, DOI 10.1111/j.1366-9516.2005.00136.x; Prentice IC, 2000, J BIOGEOGR, V27, P507, DOI 10.1046/j.1365-2699.2000.00425.x; Price JP, 2002, P ROY SOC B-BIOL SCI, V269, P2429, DOI 10.1098/rspb.2002.2175; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Rambuda TD, 2004, DIVERS DISTRIB, V10, P409, DOI 10.1111/j.1366-9516.2004.00100.x; Reed DH, 2003, EVOLUTION, V57, P1822; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Saltonstall K, 2003, MOL ECOL, V12, P1689, DOI 10.1046/j.1365-294X.2003.01849.x; *SAS I, 2001, P REG SAS I; *SAS I, 2001, P NEST SAS I; Schmelzer GH, 1997, EUPHYTICA, V96, P23, DOI 10.1023/A:1002974304592; Schwilk DW, 1997, PLANT ECOL, V132, P77, DOI 10.1023/A:1009755320731; Stenoien HK, 2005, MOL ECOL, V14, P137, DOI 10.1111/j.1365-294X.2004.02359.x; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; WILLIAMS DG, 1993, FUNCT ECOL, V7, P623, DOI 10.2307/2390140; WILLIAMS DG, 1995, ECOLOGY, V76, P1569, DOI 10.2307/1938158	47	49	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2007	2	7							e590	10.1371/journal.pone.0000590	http://dx.doi.org/10.1371/journal.pone.0000590			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GG	17611622	gold, Green Published			2022-12-27	WOS:000207451900007
J	Denoeud, L; Turbelin, C; Ansart, S; Valleron, AJ; Flahault, A; Carrat, F				Denoeud, Lise; Turbelin, Clement; Ansart, Severine; Valleron, Alain-Jacques; Flahault, Antoine; Carrat, Fabrice			Predicting Pneumonia and Influenza Mortality from Morbidity Data	PLOS ONE			English	Article								Background. Few European countries conduct reactive surveillance of influenza mortality, whereas most monitor morbidity. Methodology/Principal Findings. We developed a simple model based on Poisson seasonal regression to predict excess cases of pneumonia and influenza mortality during influenza epidemics, based on influenza morbidity data and the dominant types/subtypes of circulating viruses. Epidemics were classified in three levels of mortality burden ("high", "moderate" and "low"). The model was fitted on 14 influenza seasons and was validated on six subsequent influenza seasons. Five out of the six seasons in the validation set were correctly classified. The average absolute difference between observed and predicted mortality was 2.8 per 100,000 (18% of the average excess mortality) and Spearman's rank correlation coefficient was 0.89 (P=0.05). Conclusions/Significance. The method described here can be used to estimate the influenza mortality burden in countries where specific pneumonia and influenza mortality surveillance data are not available.	[Denoeud, Lise; Turbelin, Clement; Ansart, Severine; Valleron, Alain-Jacques; Flahault, Antoine; Carrat, Fabrice] Univ Paris 06, UMR S 707, Paris, France; [Denoeud, Lise; Turbelin, Clement; Ansart, Severine; Valleron, Alain-Jacques; Flahault, Antoine; Carrat, Fabrice] INSERM, U707, Paris, France; [Valleron, Alain-Jacques; Flahault, Antoine; Carrat, Fabrice] Hop St Antoine, AP HP, F-75571 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Carrat, F (corresponding author), Univ Paris 06, UMR S 707, Paris, France.	carrat@u707.jussieu.fr	Carrat, Fabrice/AAU-8480-2020; Ansart, Severine/AAQ-1210-2021	Carrat, Fabrice/0000-0002-8672-7918; DENOEUD-NDAM, Lise/0000-0002-9482-1461	Universite Pierre et Marie Curie, Paris 6; INSERM	Universite Pierre et Marie Curie, Paris 6; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This study received financial support from 'Universite Pierre et Marie Curie, Paris 6' and 'INSERM'.	CARRAT F, 1995, J EPIDEMIOL COMMUN H, V49, P419, DOI 10.1136/jech.49.4.419; Carrat F, 1998, J EPIDEMIOL COMMUN H, V52, p32S; COSTAGLIOLA D, 1991, AM J PUBLIC HEALTH, V81, P97, DOI 10.2105/AJPH.81.1.97; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Fleming DM, 2003, VACCINE, V21, P1749, DOI 10.1016/S0264-410X(03)00066-5; FLEMING DM, 1993, LANCET, V342, P1507, DOI 10.1016/S0140-6736(05)80082-0; LEFEVRE H, 2005, SURVEILLANCE NATL MA; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; SPRENGER MJW, 1993, INT J EPIDEMIOL, V22, P334, DOI 10.1093/ije/22.2.334; SPRENGER MJW, 1991, INT J EPIDEMIOL, V20, P1118, DOI 10.1093/ije/20.4.1118; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Xia YC, 2005, J R STAT SOC C-APPL, V54, P659, DOI 10.1111/j.1467-9876.2005.05383.x	16	21	21	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2007	2	5							e464	10.1371/journal.pone.0000464	http://dx.doi.org/10.1371/journal.pone.0000464			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DZ	17520023	Green Published, Green Submitted, gold			2022-12-27	WOS:000207446000012
J	Fontaine, KM; Cooley, JR; Simon, C				Fontaine, Kathryn M.; Cooley, John R.; Simon, Chris			Evidence for Paternal Leakage in Hybrid Periodical Cicadas (Hemiptera: Magicicada spp.)	PLOS ONE			English	Article								Mitochondrial inheritance is generally assumed to be maternal. However, there is increasing evidence of exceptions to this rule, especially in hybrid crosses. In these cases, mitochondria are also inherited paternally, so "paternal leakage'' of mitochondria occurs. It is important to understand these exceptions better, since they potentially complicate or invalidate studies that make use of mitochondrial markers. We surveyed F-1 offspring of experimental hybrid crosses of the 17-year periodical cicadas Magicicada septendecim, M. septendecula, and M. cassini for the presence of paternal mitochondrial markers at various times during development (1-day eggs; 3-,6-, 9-week eggs; 16-month old 1(st) and 2(nd) instar nymphs). We found evidence of paternal leakage in both reciprocal hybrid crosses in all of these samples. The relative difficulty of detecting paternal mtDNA in the youngest eggs and ease of detecting leakage in older eggs and in nymphs suggests that paternal mitochondria proliferate as the eggs develop. Our data support recent theoretical predictions that paternal leakage may be more common than previously estimated.	[Fontaine, Kathryn M.; Cooley, John R.; Simon, Chris] Univ Connecticut, Dept Ecol & Evolut Biol, Storrs, CT 06269 USA	University of Connecticut	Cooley, JR (corresponding author), Univ Connecticut, Dept Ecol & Evolut Biol, Storrs, CT 06269 USA.	john.cooley@uconn.edu			National Science Foundation [DEB 99-74369, DEB 04-22386, DEB 05-29679, DEB 06-19012]; University of Connecticut Research Foundation	National Science Foundation(National Science Foundation (NSF)); University of Connecticut Research Foundation	Funding: This material is based upon work partially supported by the National Science Foundation under Grant No. DEB 99-74369, DEB 04-22386, DEB 05-29679, and DEB 06-19012 (REU), and from a University of Connecticut Research Foundation grant to CS. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the NSF or other granting agencies.	Alexander R. D., 1962, Miscellaneous Publications Museum of Zoology University of Michigan, Vno. 121, P1; Andolfatto P, 2003, EVOLUTION, V57, P305, DOI 10.1111/j.0014-3820.2003.tb00265.x; Arunkumar KP, 2006, MOL PHYLOGENET EVOL, V40, P419, DOI 10.1016/j.ympev.2006.02.023; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barr CM, 2005, NEW PHYTOL, V168, P39, DOI 10.1111/j.1469-8137.2005.01492.x; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Budowle B, 2003, ANNU REV GENOM HUM G, V4, P119, DOI 10.1146/annurev.genom.4.070802.110352; Chesser RK, 1998, GENETICS, V150, P1309; Cooley JR, 2003, BIOSCIENCE, V53, P151, DOI 10.1641/0006-3568(2003)053[0151:TSASIP]2.0.CO;2; Cooley JR, 2001, MOL ECOL, V10, P661, DOI 10.1046/j.1365-294x.2001.01210.x; Cooley JR, 2001, BEHAVIOUR, V138, P827, DOI 10.1163/156853901753172674; COOLEY JR, 1999, SEXUAL BEHAV N AM CI, P326; COX RT, 1991, AM MIDL NAT, V125, P63, DOI 10.2307/2426370; Cox RT, 2003, EVOLUTION, V57, P428; Cox RT, 1998, AM NAT, V152, P162, DOI 10.1086/286158; DUNNING DC, 1979, ANIM BEHAV, V27, P1073, DOI 10.1016/0003-3472(79)90056-3; DYBAS HS, 1974, ECOL MONOGR, V44, P279, DOI 10.2307/2937032; DYBAS HS, 1962, ECOLOGY, V43, P444, DOI 10.2307/1933373; Gantenbein B, 2005, P ROY SOC B-BIOL SCI, V272, P697, DOI 10.1098/rspb.2004.3017; Gillham N.W., 1994, ORGANELLE GENES GENO; GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hoarau G, 2002, MOL BIOL EVOL, V19, P2261, DOI 10.1093/oxfordjournals.molbev.a004049; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; KARBAN R, 1981, OECOLOGIA, V51, P260, DOI 10.1007/BF00540611; KONDO R, 1992, GENET RES, V59, P81, DOI 10.1017/S0016672300030287; KONDO R, 1990, GENETICS, V126, P657; Kvist L, 2003, MOL BIOL EVOL, V20, P243, DOI 10.1093/molbev/msg025; LANSMAN RA, 1983, P NATL ACAD SCI-BIOL, V80, P1969, DOI 10.1073/pnas.80.7.1969; LLOYD M, 1966, EVOLUTION, V20, P466, DOI 10.1111/j.1558-5646.1966.tb03381.x; LLOYD M, 1966, EVOLUTION, V20, P133, DOI 10.1111/j.1558-5646.1966.tb03350.x; MAGOULAS A, 1993, MOL BIOL EVOL, V10, P319; MAIER CT, 1982, ANN ENTOMOL SOC AM, V75, P14, DOI 10.1093/aesa/75.1.14; MARLATT C, 1923, USDA BUREAU ENTOMOLO, V71; Marshall DC, 2000, EVOLUTION, V54, P1313, DOI 10.1111/j.0014-3820.2000.tb00564.x; MEUSEL MS, 1993, CURR GENET, V24, P539, DOI 10.1007/BF00351719; Osborn H., 1902, OHIO NAT, V3, P323; Piganeau G, 2004, MOL BIOL EVOL, V21, P2319, DOI 10.1093/molbev/msh244; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; ROKAS A, 2003, TRENDS ECOLOGY EVOLU, V18; Sackton TB, 2003, EVOLUTION, V57, P2315; SATTA Y, 1988, GENET RES, V52, P1, DOI 10.1017/S0016672300027245; SATTA Y, 1990, GENETICS, V126, P657; Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350; Sherengul W, 2006, GENES GENET SYST, V81, P399, DOI 10.1266/ggs.81.399; Shitara H, 1998, GENETICS, V148, P851; Simon C, 2000, EVOLUTION, V54, P1326; Simon C., 1988, Bulletin of the Entomological Society of America, V34, P163; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; St John JC, 2002, THERIOGENOLOGY, V57, P109, DOI 10.1016/S0093-691X(01)00661-6; Steinborn R, 1998, FEBS LETT, V426, P352, DOI 10.1016/S0014-5793(98)00350-0; Sutovsky P, 2000, BIOL REPROD, V63, P582, DOI 10.1095/biolreprod63.2.582; Sutovsky P, 2003, BIOL REPROD, V68, P1793, DOI 10.1095/biolreprod.102.012799; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Ujvari B, 2007, BIOL LETTERS, V3, P189, DOI 10.1098/rsbl.2006.0587; WHITE JA, 1973, ECOLOGY, V54, P573, DOI 10.2307/1935342; WILLIAMS KS, 1995, ANNU REV ENTOMOL, V40, P269, DOI 10.1146/annurev.en.40.010195.001413; Xu JP, 2005, GENOME, V48, P951, DOI [10.1139/g05-082, 10.1139/G05-082]; YOUNG D, 1983, J COMP PHYSIOL, V152, P197, DOI 10.1007/BF00611184; Zhao X, 2004, HEREDITY, V93, P399, DOI 10.1038/sj.hdy.6800516	60	49	50	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e892	10.1371/journal.pone.0000892	http://dx.doi.org/10.1371/journal.pone.0000892			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849021	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455600038
J	Glas, J; Seiderer, J; Wetzke, M; Konrad, A; Torok, HP; Schmechel, S; Tonenchi, L; Grassl, C; Dambacher, J; Pfennig, S; Maier, K; Griga, T; Klein, W; Epplen, JT; Schiemann, U; Folwaczny, C; Lohse, P; Goke, B; Ochsenkuhn, T; Muller-Myhsok, B; Folwaczny, M; Mussack, T; Brand, S				Glas, Juergen; Seiderer, Julia; Wetzke, Martin; Konrad, Astrid; Toeroek, Helga-Paula; Schmechel, Silke; Tonenchi, Laurian; Grassl, Christine; Dambacher, Julia; Pfennig, Simone; Maier, Kerstin; Griga, Thomas; Klein, Wolfram; Epplen, Joerg T.; Schiemann, Uwe; Folwaczny, Christian; Lohse, Peter; Goeke, Burkhard; Ochsenkuehn, Thomas; Mueller-Myhsok, Bertram; Folwaczny, Matthias; Mussack, Thomas; Brand, Stephan			rs1004819 Is the Main Disease-Associated IL23R Variant in German Crohn's Disease Patients: Combined Analysis of IL23R, CARD15, and OCTN1/2 Variants	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CATION TRANSPORTER GENES; T-CELL; EXPERIMENTAL COLITIS; DENDRITIC CELLS; PROMOTER POLYMORPHISM; FRAMESHIFT MUTATION; MONOCLONAL-ANTIBODY	Background. The IL23R gene has been identified as a susceptibility gene for inflammatory bowel disease (IBD) in the North American population. The aim of our study was to test this association in a large German IBD cohort and to elucidate potential interactions with other IBD genes as well as phenotypic consequences of IL23R variants. Methods. Genomic DNA from 2670 Caucasian individuals including 833 patients with Crohn's disease (CD), 456 patients with ulcerative colitis (UC), and 1381 healthy unrelated controls was analyzed for 10 IL23R SNPs. Genotyping included the NOD2 variants p.Arg702Trp, p.Gly908Arg, and p.Leu1007fsX1008 and polymorphisms in SLC22A4/OCTN1 (1672 C -> T) and SLC22A5/OCTN2 (-207 G -> C). Results. All IL23R gene variants analyzed displayed highly significant associations with CD. The strongest association was found for the SNP rs1004819 [P = 1.92x10(-11); OR 1.56; 95 % CI (1.37-1.78)]. 93.2% of the rs1004819 TT homozygous carriers as compared to 78% of CC wildtype carriers had ileal involvement [P = 0.004; OR 4.24; CI (1.46-12.34)]. The coding SNP rs11209026 (p.Arg381Gln) was protective for CD [P = 8.04x10(-8); OR 0.43; CI (0.31-0.59)]. Similar, but weaker associations were found in UC. There was no evidence for epistasis between the IL23R gene and the CD susceptibility genes CARD15 and SLC22A4/5. Conclusion. IL23R is an IBD susceptibility gene, but has no epistatic interaction with CARD15 and SLC22A4/5. rs1004819 is the major IL23R variant associated with CD in the German population, while the p. Arg381Gln IL23R variant is a protective marker for CD and UC.	[Glas, Juergen; Seiderer, Julia; Wetzke, Martin; Konrad, Astrid; Toeroek, Helga-Paula; Schmechel, Silke; Dambacher, Julia; Pfennig, Simone; Goeke, Burkhard; Ochsenkuehn, Thomas; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Glas, Juergen; Wetzke, Martin; Tonenchi, Laurian; Grassl, Christine; Maier, Kerstin; Folwaczny, Matthias] Univ Munich, Clin Prevent Dent & Parodontol, Munich, Germany; [Folwaczny, Christian; Mussack, Thomas] Univ Munich, Dept Surg, Munich, Germany; [Griga, Thomas] Knappschaftskrankenhaus Dortmund, Dept Internal Med, Dortmund, Germany; [Klein, Wolfram; Epplen, Joerg T.] Ruhr Univ Bochum, Dept Human Genet, Bochum, Germany; [Schiemann, Uwe] Inselspital Bern, Dept Gen Internal Med, CH-3010 Bern, Switzerland; [Lohse, Peter] Univ Munich, Inst Clin Chem Grosshadern, Munich, Germany; [Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80804 Munich, Germany	University of Munich; University of Munich; University of Munich; Ruhr University Bochum; University of Bern; University Hospital of Bern; University of Munich; Max Planck Society	Brand, S (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	stephan.brand@med.uni-muenchen.de	Müller-Myhsok, Bertram/A-3289-2013; Wetzke, Martin/HDM-2614-2022	Epplen, Joerg T./0000-0002-6087-3327	University of Munich; Deutsche Forschungsgemeinschaft (DFG) [KO 2228/4-1, BR 1912/5-1]; Broad Medical Foundation [IBD-0126R2]; Else-Kroner-Fresenius-Stiftung [P50/05/EKMS05/62]; DCCV e. V	University of Munich; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Broad Medical Foundation; Else-Kroner-Fresenius-Stiftung; DCCV e. V	J. Seiderer and J. Dambacher were supported by grants from the University of Munich (FoFoLe Nr. 422; Habilitationsstipendium to J. S. and Promotionsstipendium to J. D.). A. Konrad was supported by grants of the Deutsche Forschungsgemeinschaft (DFG; KO 2228/4-1). J. Glas and H.-P. Torok were supported by a grant from the Broad Medical Foundation (IBD-0126R2). S. Brand was supported by grants from the DFG (BR 1912/5-1) and the Else-Kroner-Fresenius-Stiftung (P50/05/EKMS05/62) and by the Ludwig-Demling Grant 2007 from DCCV e. V. This work contains parts of the unpublished degree theses of M. Wetzke and J. Dambacher. We thank B. Salil for excellent technical support. Design and conduct of the study, collection, analysis, interpretation of the data, preparation, review and approval of the manuscript were completely independent of the sponsors of this study.	Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Becker C, 2006, J IMMUNOL, V177, P2760, DOI 10.4049/jimmunol.177.5.2760; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brand S, 2006, AM J GASTROENTEROL, V101, P99, DOI 10.1111/j.1572-0241.2005.00361.x; Brand S, 2005, INFLAMM BOWEL DIS, V11, P645, DOI 10.1097/01.MIB.0000168372.94907.d2; Brandt F, 2007, INT J MOD PHYS A, V22, P1, DOI 10.1142/S0217751X0703501X; Cardon LR, 2006, SCIENCE, V314, P1403, DOI 10.1126/science.1136668; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Dambacher J, 2007, INFLAMM BOWEL DIS, V13, P71, DOI 10.1002/ibd.20008; Dubinsky MC, 2007, INFLAMM BOWEL DIS, V13, P511, DOI 10.1002/ibd.20126; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Fuss IJ, 2006, INFLAMM BOWEL DIS, V12, P9, DOI 10.1097/01.MIB.0000194183.92671.b6; Glas J, 2006, INFLAMM BOWEL DIS, V12, P606, DOI 10.1097/01.ibd.0000225346.23765.6b; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hao JS, 2006, CANCER IMMUNOL IMMUN, V55, P1426, DOI 10.1007/s00262-006-0171-5; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Mizoguchi A, 2007, J CLIN INVEST, V117, P605, DOI 10.1172/JCI30150; Neurath MF, 2007, NAT MED, V13, P26, DOI 10.1038/nm0107-26; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Noble CL, 2005, GASTROENTEROLOGY, V129, P1854, DOI 10.1053/j.gastro.2005.09.025; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Samoilova EB, 1998, J IMMUNOL, V161, P6480; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schnitzler F, 2006, IMMUNOGENETICS, V58, P99, DOI 10.1007/s00251-005-0073-2; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Simpson SJ, 1998, J EXP MED, V187, P1225, DOI 10.1084/jem.187.8.1225; Thakker P, 2007, J IMMUNOL, V178, P2589, DOI 10.4049/jimmunol.178.4.2589; Torok HP, 2005, GUT, V54, P1421, DOI 10.1136/gut.2005.066340; Tremelling M, 2007, GASTROENTEROLOGY, V132, P1657, DOI 10.1053/j.gastro.2007.02.051; Vaknin-Dembinsky A, 2006, J IMMUNOL, V176, P7768, DOI 10.4049/jimmunol.176.12.7768; Limbergen J, 2007, GUT, V56, P1173, DOI 10.1136/gut.2007.122069; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Waibler Z, 2007, MOL IMMUNOL, V44, P1483, DOI 10.1016/j.molimm.2006.09.001; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zhang ZL, 2007, INT IMMUNOPHARMACOL, V7, P409, DOI 10.1016/j.intimp.2006.09.024; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; ZHOU L, 2007, NAT IMMUNOL     0620	53	115	118	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e819	10.1371/journal.pone.0000819	http://dx.doi.org/10.1371/journal.pone.0000819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786191	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455500003
J	Moffett, A; Shackelford, N; Sarkar, S				Moffett, Alexander; Shackelford, Nancy; Sarkar, Sahotra			Malaria in Africa: Vector Species' Niche Models and Relative Risk Maps	PLOS ONE			English	Article							ANOPHELES-GAMBIAE COMPLEX; CHROMOSOMAL INVERSION POLYMORPHISM; PERMETHRIN-IMPREGNATED BEDNETS; CHAIN-REACTION METHOD; HUMAN-BLOOD INDEX; PLASMODIUM-FALCIPARUM; POPULATION-STRUCTURE; FUNESTUS DIPTERA; GILES COMPLEX; KISUMU AREA	A central theoretical goal of epidemiology is the construction of spatial models of disease prevalence and risk, including maps for the potential spread of infectious disease. We provide three continent-wide maps representing the relative risk of malaria in Africa based on ecological niche models of vector species and risk analysis at a spatial resolution of 1 arc-minute (9 185 275 cells of approximately 4 sq km). Using a maximum entropy method we construct niche models for 10 malaria vector species based on species occurrence records since 1980, 19 climatic variables, altitude, and land cover data (in 14 classes). For seven vectors (Anopheles coustani, A. funestus, A. melas, A. merus, A. moucheti, A. nili, and A. paludis) these are the first published niche models. We predict that Central Africa has poor habitat for both A. arabiensis and A. gambiae, and that A. quadriannulatus and A. arabiensis have restricted habitats in Southern Africa as claimed by field experts in criticism of previous models. The results of the niche models are incorporated into three relative risk models which assume different ecological interactions between vector species. The "additive'' model assumes no interaction; the "minimax'' model assumes maximum relative risk due to any vector in a cell; and the "competitive exclusion'' model assumes the relative risk that arises from the most suitable vector for a cell. All models include variable anthrophilicity of vectors and spatial variation in human population density. Relative risk maps are produced from these models. All models predict that human population density is the critical factor determining malaria risk. Our method of constructing relative risk maps is equally general. We discuss the limits of the relative risk maps reported here, and the additional data that are required for their improvement. The protocol developed here can be used for any other vector-borne disease.	[Moffett, Alexander; Shackelford, Nancy; Sarkar, Sahotra] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Sarkar, S (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	sarkar@mail.utexas.edu						Adugna N, 1996, ETHIOPIAN MED J, V34, P1; Afrane YA, 2005, J MED ENTOMOL, V42, P974, DOI 10.1603/0022-2585(2005)042[0974:EOMCCB]2.0.CO;2; Akogbeto M., 1988, Parassitologia (Rome), V30, P7; Ameneshewa B, 1996, ANN TROP MED PARASIT, V90, P515, DOI 10.1080/00034983.1996.11813077; Antonio-Nkondjio C, 2005, T ROY SOC TROP MED H, V99, P347, DOI 10.1016/j.trstmh.2004.07.003; Antonio-Nkondjio C, 2002, J MED ENTOMOL, V39, P350, DOI 10.1603/0022-2585-39.2.350; Antonio-Nkondjio C, 2006, J MED ENTOMOL, V43, P1215, DOI 10.1603/0022-2585(2006)43[1215:COTMVS]2.0.CO;2; APPAWU MA, 1994, ACTA TROP, V56, P15, DOI 10.1016/0001-706X(94)90036-1; Aranda C, 2005, J MED ENTOMOL, V42, P180, DOI 10.1603/0022-2585(2005)042[0180:ECOMTI]2.0.CO;2; Awolola TS, 2005, ACTA TROP, V95, P204, DOI 10.1016/j.actatropica.2005.06.002; Awolola TS, 2002, ANN TROP MED PARASIT, V96, P75, DOI 10.1179/000349802125000538; Awono-Ambene HP, 2004, J MED ENTOMOL, V41, P561, DOI 10.1603/0022-2585-41.4.561; Ayala D, 2006, ACTA TROP, V97, P292, DOI 10.1016/j.actatropica.2005.12.002; BEIER JC, 1988, J MED ENTOMOL, V25, P9, DOI 10.1093/jmedent/25.1.9; BLACK WC, 2005, BIOL DIS VECTORS; BOCKARIE MJ, 1994, ANN TROP MED PARASIT, V88, P251, DOI 10.1080/00034983.1994.11812865; Bogh C, 1998, MED VET ENTOMOL, V12, P52, DOI 10.1046/j.1365-2915.1998.00091.x; Bogh C, 2001, J MED ENTOMOL, V38, P822, DOI 10.1603/0022-2585-38.6.822; Bonnet S, 2003, T ROY SOC TROP MED H, V97, P53, DOI 10.1016/S0035-9203(03)90022-8; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bryan J.H., 1987, Parassitologia (Rome), V29, P221; BRYAN JH, 1982, GENETICA, V59, P167, DOI 10.1007/BF00056539; CAMBOURNAC F J C, 1982, Parassitologia (Rome), V24, P265; Cano J, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-21; Carnahan J, 2002, J HERED, V93, P249, DOI 10.1093/jhered/93.4.249; CHANDLER JA, 1975, T ROY SOC TROP MED H, V69, P415, DOI 10.1016/0035-9203(75)90200-X; Charalambous M, 1999, B ENTOMOL RES, V89, P111, DOI 10.1017/S0007485399000188; Charlwood JD, 1996, J MED ENTOMOL, V33, P202, DOI 10.1093/jmedent/33.2.202; Charlwood JD, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-9; Charlwood JD, 2001, ACTA TROP, V80, P1, DOI 10.1016/S0001-706X(01)00152-8; Chen H, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-17; Clarke D, 1996, T ROY SOC TROP MED H, V90, P302, DOI 10.1016/S0035-9203(96)90262-X; COENE J, 1993, MED VET ENTOMOL, V7, P127, DOI 10.1111/j.1365-2915.1993.tb00665.x; COETZEE M, 1989, Mosquito Systematics, V21, P100; Coetzee M, 2004, AM J TROP MED HYG, V70, P103, DOI 10.4269/ajtmh.2004.70.103; COETZEE M, 1993, S AFR J SCI, V89, P227; Coetzee Maureen, 1994, Mosquito Systematics, V26, P125; Cohuet A, 2004, J MED ENTOMOL, V41, P901, DOI 10.1603/0022-2585-41.5.901; Cohuet A, 2004, INSECT MOL BIOL, V13, P251, DOI 10.1111/j.0962-1075.2004.00482.x; Cohuet A, 2003, AM J TROP MED HYG, V69, P200, DOI 10.4269/ajtmh.2003.69.200; COLLINS FH, 1995, ANNU REV ENTOMOL, V40, P195, DOI 10.1146/annurev.en.40.010195.001211; COLUZZI M, 1985, B ZOOL, V52, P45, DOI 10.1080/11250008509440343; CONSTANTINI C, 1998, AM J TROP MED HYG, V58, P56; COOSEMANS M, 1989, Parassitologia (Rome), V31, P113; Costantini C, 1996, MED VET ENTOMOL, V10, P203, DOI 10.1111/j.1365-2915.1996.tb00733.x; *CTR INT EARTH SCI, 2004, GRIDD POP WORLD GPW; Cuamba N, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-2; De Castro MC, 2004, AM J TROP MED HYG, V71, P103, DOI 10.4269/ajtmh.2004.71.103; Dekker T, 1998, MED VET ENTOMOL, V12, P136, DOI 10.1046/j.1365-2915.1998.00073.x; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; Dia I, 2005, J MED ENTOMOL, V42, P104, DOI 10.1603/0022-2585(2005)042[0104:COHCAO]2.0.CO;2; Diallo M, 2003, EMERG INFECT DIS, V9, P362, DOI 10.3201/eid0903.020219; Diggle P, 2002, J R STAT SOC C-APPL, V51, P493, DOI 10.1111/1467-9876.00283; DossouYovo J, 1995, TROP MED PARASITOL, V46, P263; Drakeley C, 2003, TROP MED INT HEALTH, V8, P767, DOI 10.1046/j.1365-3156.2003.01100.x; Duchemin JB, 2001, MED VET ENTOMOL, V15, P50, DOI 10.1046/j.1365-2915.2001.00276.x; Elissa N, 1999, J AM MOSQUITO CONTR, V15, P15; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; ELSAID S, 1986, J AM MOSQUITO CONTR, V2, P158; *ESRI, 2004, ARCGIS 9 1; FAYE O, 1994, B SOC PATHOL EXOT, V87, P157; Faye O, 1997, J MED ENTOMOL, V34, P285, DOI 10.1093/jmedent/34.3.285; Fettene M, 2002, MED VET ENTOMOL, V16, P214, DOI 10.1046/j.1365-2915.2002.00354.x; Fettene M, 2004, AFR ENTOMOL, V12, P83; Fillinger U, 2004, TROP MED INT HEALTH, V9, P1274, DOI 10.1111/j.1365-3156.2004.01335.x; Fontenille D, 1997, T ROY SOC TROP MED H, V91, P647, DOI 10.1016/S0035-9203(97)90506-X; FONTENILLE D, 1992, J MED ENTOMOL, V29, P197, DOI 10.1093/jmedent/29.2.197; FONTENILLE D, 1993, ANN PARASIT HUM COMP, V68, P239; Fuller T, 2007, BIOL CONSERV, V134, P593, DOI 10.1016/j.biocon.2006.08.028; Fuller T, 2006, BIOL CONSERV, V133, P131, DOI 10.1016/j.biocon.2006.04.040; GAD A M, 1987, Journal of the Egyptian Society of Parasitology, V17, P207; GARRETTJONES C, 1980, B ENTOMOL RES, V70, P165, DOI 10.1017/S0007485300007422; GARRETTJONES C, 1963, WHOMAL391; Gemperli A, 2006, TROP MED INT HEALTH, V11, P1032, DOI 10.1111/j.1365-3156.2006.01640.x; Gillies M, 1987, ANOPHELINAE AFRICA S; GILLIES MT, 1965, B ENTOMOL RES, V56, P237, DOI 10.1017/S0007485300056339; Gimnig JE, 2001, J MED ENTOMOL, V38, P282, DOI 10.1603/0022-2585-38.2.282; GITHEKO AK, 1994, ACTA TROP, V58, P307, DOI 10.1016/0001-706X(94)90024-8; GITHEKO AK, 1993, MED VET ENTOMOL, V7, P373, DOI 10.1111/j.1365-2915.1993.tb00708.x; Githeko AK, 1996, EXP PARASITOL, V82, P306, DOI 10.1006/expr.1996.0038; GREEN C A, 1982, Journal of Heredity, V73, P3; Guerra CA, 2006, ANN TROP MED PARASIT, V100, P189, DOI 10.1179/136485906X91512; Habtewold T, 2004, MED VET ENTOMOL, V18, P408, DOI 10.1111/j.0269-283X.2004.00525.x; Habtewold T, 2001, T ROY SOC TROP MED H, V95, P584, DOI 10.1016/S0035-9203(01)90086-0; Hadis M, 1997, T ROY SOC TROP MED H, V91, P376, DOI 10.1016/S0035-9203(97)90245-5; Haji H, 1996, T ROY SOC TROP MED H, V90, P494, DOI 10.1016/S0035-9203(96)90292-8; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; Haworth J., 1988, P1379; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Haydon DT, 2006, NATURE, V443, P692, DOI 10.1038/nature05177; HIGHTON RB, 1979, B ENTOMOL RES, V69, P43, DOI 10.1017/S0007485300017879; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hogg JC, 1996, MED VET ENTOMOL, V10, P385, DOI 10.1111/j.1365-2915.1996.tb00761.x; Hunt RH, 1998, T ROY SOC TROP MED H, V92, P231, DOI 10.1016/S0035-9203(98)90761-1; Ijumba JN, 2002, MED VET ENTOMOL, V16, P28, DOI 10.1046/j.0269-283x.2002.00337.x; IJUMBA JN, 1990, MED VET ENTOMOL, V4, P425, DOI 10.1111/j.1365-2915.1990.tb00461.x; Illoldi-Rangel P, 2004, J MAMMAL, V85, P658, DOI 10.1644/BER-024; JAENSON TGT, 1994, T ROY SOC TROP MED H, V88, P620, DOI 10.1016/0035-9203(94)90197-X; JOSHI GP, 1975, ANN TROP MED PARASIT, V69, P91, DOI 10.1080/00034983.1975.11686988; Kamau L, 2003, J MED ENTOMOL, V40, P664, DOI 10.1603/0022-2585-40.5.664; Kamau L, 2002, J MED ENTOMOL, V39, P78, DOI 10.1603/0022-2585-39.1.78; Kengne P, 2003, MED VET ENTOMOL, V17, P67, DOI 10.1046/j.1365-2915.2003.00411.x; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Kleinschmidt I, 2000, INT J EPIDEMIOL, V29, P355, DOI 10.1093/ije/29.2.355; Kleinschmidt I, 2001, TROP MED INT HEALTH, V6, P779, DOI 10.1046/j.1365-3156.2001.00790.x; Klinkenberg E, 2003, ACTA TROP, V85, P71, DOI 10.1016/S0001-706X(02)00254-1; Kuhn KG, 2002, J MED ENTOMOL, V39, P621, DOI 10.1603/0022-2585-39.4.621; laGrange JJP, 1995, AFR ENTOMOL, V3, P217; LAMBERT DM, 1983, EVOLUTION, V37, P484, DOI [10.2307/2408262, 10.1111/j.1558-5646.1983.tb05565.x]; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; Lemasson JJ, 1997, J MED ENTOMOL, V34, P396, DOI 10.1093/jmedent/34.4.396; Levine RS, 2004, J MED ENTOMOL, V41, P607, DOI 10.1603/0022-2585-41.4.607; Levine RS, 2004, AM J TROP MED HYG, V70, P105, DOI 10.4269/ajtmh.2004.70.105; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; LOGAN TM, 1991, J AM MOSQUITO CONTR, V7, P395; MacNab YC, 2001, BIOMETRICS, V57, P949, DOI 10.1111/j.0006-341X.2001.00949.x; MATOLA YG, 1987, J TROP MED HYG, V90, P127; Mboera LEG, 1999, ENTOMOL EXP APPL, V92, P83, DOI 10.1023/A:1003780811793; Mbogo CNM, 1996, MED VET ENTOMOL, V10, P251, DOI 10.1111/j.1365-2915.1996.tb00739.x; MBOGO CNM, 1993, J AM MOSQUITO CONTR, V9, P225; MEKURIA Y, 1982, Parassitologia (Rome), V24, P237; Mendis C, 2000, MED VET ENTOMOL, V14, P171, DOI 10.1046/j.1365-2915.2000.00228.x; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; MNZAVA AEP, 1986, ACTA TROP, V43, P277; MNZAVA AEP, 1995, MED VET ENTOMOL, V9, P316, DOI 10.1111/j.1365-2915.1995.tb00140.x; MNZAVA AEP, 1994, J AM MOSQUITO CONTR, V10, P507; MNZAVA AEP, 1989, ACTA TROP, V46, P323, DOI 10.1016/0001-706X(89)90045-4; MOSHA FW, 1983, T ROY SOC TROP MED H, V77, P344, DOI 10.1016/0035-9203(83)90161-X; MOSHA FW, 1982, WHOVBC82867; MPOFU SM, 1985, T ROY SOC TROP MED H, V79, P169, DOI 10.1016/0035-9203(85)90327-X; Mukabayire O, 1999, MOL ECOL, V8, P289, DOI 10.1046/j.1365-294X.1999.00567.x; Munga S, 2005, J MED ENTOMOL, V42, P993, DOI 10.1603/0022-2585(2005)042[0993:OSPAEH]2.0.CO;2; Muturi EJ, 2006, J VECTOR ECOL, V31, P129, DOI 10.3376/1081-1710(2006)31[129:MSDAAI]2.0.CO;2; Mwangangi JM, 2003, J AM MOSQUITO CONTR, V19, P371; NIGATU W, 1995, J AM MOSQUITO CONTR, V11, P238; Onyabe DY, 2001, MEM I OSWALDO CRUZ, V96, P1081, DOI 10.1590/S0074-02762001000800009; Ortega-Huerta MA, 2004, DIVERS DISTRIB, V10, P39, DOI 10.1111/j.1472-4642.2004.00051.x; PASKEWITZ SM, 1993, J MED ENTOMOL, V30, P953, DOI 10.1093/jmedent/30.5.953; PAWAR SS, 2007, BIOL CONSER IN PRESS; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; PETRARCA V, 1987, MED VET ENTOMOL, V1, P303, DOI 10.1111/j.1365-2915.1987.tb00359.x; PETRARCA V, 1991, J MED ENTOMOL, V28, P307, DOI 10.1093/jmedent/28.3.307; Petrarca V, 2000, MED VET ENTOMOL, V14, P149, DOI 10.1046/j.1365-2915.2000.00231.x; Petrarca V, 1998, J MED ENTOMOL, V35, P16, DOI 10.1093/jmedent/35.1.16; Petrarca V., 1984, Parassitologia (Rome), V26, P247; PETRARCA V, 1990, Parassitologia (Rome), V32, P371; PETRARCA V, 1983, Parassitologia (Rome), V25, P29; PETROVICHEV N, 1986, SOV EDUC, V28, P41, DOI 10.2753/RES1060-9393280341; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pinto J, 2006, MED VET ENTOMOL, V20, P27, DOI 10.1111/j.1365-2915.2006.00611.x; Quakyi IA, 2000, AM J TROP MED HYG, V63, P222; ROBERT V, 1991, B WORLD HEALTH ORGAN, V69, P735; ROBERT V, 1993, TROP MED PARASITOL, V44, P14; Robert V, 1998, J MED ENTOMOL, V35, P948, DOI 10.1093/jmedent/35.6.948; ROBERT V, 1989, ANN PARASIT HUM COMP, V64, P290, DOI 10.1051/parasite/1989644290; ROBERT V, 1990, T ROY SOC TROP MED H, V84, P346, DOI 10.1016/0035-9203(90)90309-3; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Schneider P, 2000, MED VET ENTOMOL, V14, P165, DOI 10.1046/j.1365-2915.2000.00204.x; SERVICE MW, 1978, ANN TROP MED PARASIT, V72, P377, DOI 10.1080/00034983.1978.11719332; SHARP BL, 1991, B ENTOMOL RES, V81, P107, DOI 10.1017/S000748530005330X; SHARP BL, 1983, J ENTOMOL SOC S AFR, V46, P367; SHARP BL, 1984, J ENTOMOL SOC S AFR, V47, P251; SHARP BL, 1993, J AM MOSQUITO CONTR, V9, P414; Simard F, 2000, INSECT MOL BIOL, V9, P467, DOI 10.1046/j.1365-2583.2000.00210.x; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Smits A, 1996, J MED ENTOMOL, V33, P545, DOI 10.1093/jmedent/33.4.545; Smits A, 1995, B ENTOMOL RES, V85, P541, DOI 10.1017/S0007485300033046; Snow RW, 1996, PARASITOL TODAY, V12, P455, DOI 10.1016/S0169-4758(96)30032-X; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Sousa CA, 2001, J MED ENTOMOL, V38, P122, DOI 10.1603/0022-2585-38.1.122; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Sylla EHK, 2000, T ROY SOC TROP MED H, V94, P652, DOI 10.1016/S0035-9203(00)90219-0; Taye A, 2006, ACTA TROP, V97, P50, DOI 10.1016/j.actatropica.2005.08.002; TAYLOR CE, 1993, MED VET ENTOMOL, V7, P351, DOI 10.1111/j.1365-2915.1993.tb00704.x; THOMSON MC, 1995, MED VET ENTOMOL, V9, P413, DOI 10.1111/j.1365-2915.1995.tb00015.x; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Toure YT, 1996, MED VET ENTOMOL, V10, P197, DOI 10.1111/j.1365-2915.1996.tb00731.x; TOURE YT, 1983, PARASSITOLOGIA, V25, P367; Traore-Lamizana M, 2001, J MED ENTOMOL, V38, P480, DOI 10.1603/0022-2585-38.4.480; Tripet F, 2005, GENETICS, V169, P313, DOI 10.1534/genetics.104.026534; Tripet F, 2003, AM J TROP MED HYG, V68, P1; Tsy JMLP, 2003, MALARIA J, V2; *UN, 2002, WORLD URB PROSP 2001; United Nations, 2004, WORLD URB PROSP 2003; VanRensburg AJ, 1996, J AM MOSQUITO CONTR, V12, P271; VULULE JM, 1994, MED VET ENTOMOL, V8, P71, DOI 10.1111/j.1365-2915.1994.tb00389.x; Walker TW, 1996, J AM MOSQUITO CONTR, V12, P172; Waller LA, 1997, J AM STAT ASSOC, V92, P607, DOI 10.2307/2965708; White G B, 1971, East Afr Med J, V48, P120; WHITE GB, 1973, B ENTOMOL RES, V62, P613, DOI 10.1017/S0007485300005502; WHITE GB, 1972, B ENTOMOL RES, V62, P295, DOI 10.1017/S0007485300047738; White GB., 1989, MALARIA GEOGRAPHICAL, P7; *WHO, 2003, INT TRAV HLTH SIT 1; Wondji C, 2005, J MED ENTOMOL, V42, P998, DOI 10.1603/0022-2585(2005)042[0998:SAPOTA]2.0.CO;2; WOYESSA A, 2004, ETHIOP J HEALTH DEV, V18, P2; Yawson AE, 2004, MED VET ENTOMOL, V18, P372, DOI 10.1111/j.0269-283X.2004.00519.x; Zhou GF, 2004, J MED ENTOMOL, V41, P1001, DOI 10.1603/0022-2585-41.6.1001	199	110	121	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e824	10.1371/journal.pone.0000824	http://dx.doi.org/10.1371/journal.pone.0000824			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786196	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455500008
J	Tamm, E; Kivisild, T; Reidla, M; Metspalu, M; Smith, DG; Mulligan, CJ; Bravi, CM; Rickards, O; Martinez-Labarga, C; Khusnutdinova, EK; Fedorova, SA; Golubenko, MV; Stepanov, VA; Gubina, MA; Zhadanov, SI; Ossipova, LP; Damba, L; Voevoda, MI; Dipierri, JE; Villems, R; Malhi, RS				Tamm, Erika; Kivisild, Toomas; Reidla, Maere; Metspalu, Mait; Smith, David Glenn; Mulligan, Connie J.; Bravi, Claudio M.; Rickards, Olga; Martinez-Labarga, Cristina; Khusnutdinova, Elsa K.; Fedorova, Sardana A.; Golubenko, Maria V.; Stepanov, Vadim A.; Gubina, Marina A.; Zhadanov, Sergey I.; Ossipova, Ludmila P.; Damba, Larisa; Voevoda, Mikhail I.; Dipierri, Jose E.; Villems, Richard; Malhi, Ripan S.			Beringian Standstill and Spread of Native American Founders	PLOS ONE			English	Article							MITOCHONDRIAL GENOME VARIATION; MTDNA VARIATION; DNA DIVERSITY; NEW-WORLD; POPULATION; HAPLOTYPES; PREHISTORY; MIGRATION; SEQUENCES; LINEAGES	Native Americans derive from a small number of Asian founders who likely arrived to the Americas via Beringia. However, additional details about the intial colonization of the Americas remain unclear. To investigate the pioneering phase in the Americas we analyzed a total of 623 complete mtDNAs from the Americas and Asia, including 20 new complete mtDNAs from the Americas and seven from Asia. This sequence data was used to direct high-resolution genotyping from 20 American and 26 Asian populations. Here we describe more genetic diversity within the founder population than was previously reported. The newly resolved phylogenetic structure suggests that ancestors of Native Americans paused when they reached Beringia, during which time New World founder lineages differentiated from their Asian sister-clades. This pause in movement was followed by a swift migration southward that distributed the founder types all the way to South America. The data also suggest more recent bi-directional gene flow between Siberia and the North American Arctic.	[Malhi, Ripan S.] Univ Illinois, Inst Genom Biol, Dept Anthropol, Champaign, IL USA; [Kivisild, Toomas] Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge, England; [Smith, David Glenn] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Mulligan, Connie J.] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Bravi, Claudio M.] Inst Multidisciplinario Biol Celular, La Plata, Buenos Aires, Argentina; [Rickards, Olga; Martinez-Labarga, Cristina] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Khusnutdinova, Elsa K.] Russian Acad Sci, Ufa Res Ctr, Inst Biochem & Genet, Ufa 450001, Russia; [Fedorova, Sardana A.] Russian Acad Med Sci, Yakut Res Ctr, Dept Mol Genet, Yakutia, Russia; [Golubenko, Maria V.; Stepanov, Vadim A.] Russian Acad Med Sci, Tomsk Res Ctr, Inst Med Genet, Tomsk, Russia; [Gubina, Marina A.; Zhadanov, Sergey I.; Ossipova, Ludmila P.; Damba, Larisa; Voevoda, Mikhail I.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [Zhadanov, Sergey I.] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; [Dipierri, Jose E.] Univ Nacl Jujuy, Inst Biol Altura, San Salvador De Jujuy, Argentina; [Tamm, Erika; Kivisild, Toomas; Reidla, Maere; Metspalu, Mait; Fedorova, Sardana A.; Golubenko, Maria V.; Zhadanov, Sergey I.; Damba, Larisa; Villems, Richard] Univ Tartu, Dept Evolutionary Biol, Estonian Bioctr, EE-50090 Tartu, Estonia	University of Illinois System; University of Illinois Urbana-Champaign; University of Cambridge; University of California System; University of California Davis; State University System of Florida; University of Florida; University of Rome Tor Vergata; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Russian Academy of Medical Sciences; Russian Academy of Medical Sciences; Russian Academy of Sciences; Tomsk National Research Medical Center; Research Institute of Medical Genetics - Tomsk; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; University of Pennsylvania; Estonian Biocentre; University of Tartu	Malhi, RS (corresponding author), Univ Illinois, Inst Genom Biol, Dept Anthropol, Champaign, IL USA.	malhi@uiuc.edu	Kivisild, Toomas/P-5889-2017; Metspalu, Mait/G-8671-2015; Tamm, Erika/G-2818-2017; Golubenko, Maria V/A-8107-2014; MARTINEZ-LABARGA, CRISTINA M/K-6011-2014; Voevoda, Mikhail/N-6713-2015; Gubina, Marina/AAD-9163-2019; Stepanov, Vadim A./N-7657-2014; Khusnutdinova, Elza Kamilevna/A-4810-2013; Stepanov, Vadim/G-4320-2013; Osipova, Ludmila P/O-6480-2014; Fedorova, Sardana/K-5445-2017; Rickards, Olga/L-7878-2015	Kivisild, Toomas/0000-0002-6297-7808; Metspalu, Mait/0000-0003-3099-9161; Tamm, Erika/0000-0003-0694-3598; Golubenko, Maria V/0000-0002-7692-9954; MARTINEZ-LABARGA, CRISTINA M/0000-0003-0439-0379; Voevoda, Mikhail/0000-0001-9425-413X; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Stepanov, Vadim/0000-0002-5166-331X; Osipova, Ludmila P/0000-0001-7602-1156; Rickards, Olga/0000-0003-2880-7466; Dipierri, Jose Edgardo/0000-0002-1679-0727; Fedorova, Sardana/0000-0002-6952-3868; Malhi, Ripan/0000-0002-1484-0292	NSF BCS [0422144]; University of Tartu [PBGMR06901]	NSF BCS(National Science Foundation (NSF)); University of Tartu	Funding for this work is from NSF BCS#0422144 to RSM and from the University of Tartu #PBGMR06901 to TK.	BAILLIET G, 1994, AM J HUM GENET, V55, P27; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Bermisheva MA, 2005, RUSS J GENET+, V41, P66, DOI 10.1007/s11177-005-0069-x; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; CRAWFORD MH, 1998, ORIGINS NATIVE AM EV; Derbeneva OA, 2002, AM J HUM GENET, V71, P415, DOI 10.1086/341720; Dillehay TD, 1999, EVOL ANTHROPOL, V7, P206, DOI 10.1002/(SICI)1520-6505(1999)7:6<206::AID-EVAN5>3.0.CO;2-G; Eshleman JA, 2003, EVOL ANTHROPOL, V12, P7, DOI 10.1002/evan.10048; Fedorova SA, 2003, MOL BIOL+, V37, P544, DOI 10.1023/A:1025135326954; Forster P, 1996, AM J HUM GENET, V59, P935; Goltsova T V, 2005, Genetika, V41, P954; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; Helgason A, 2006, AM J PHYS ANTHROPOL, V130, P123, DOI 10.1002/ajpa.20313; Herrnstadt C, 2003, AM J HUM GENET, V72, P1585, DOI 10.1086/375406; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; HORAI S, 1993, MOL BIOL EVOL, V47, P10; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kaestle FA, 2001, AM J PHYS ANTHROPOL, V115, P1, DOI 10.1002/ajpa.1051; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; KOLMAN CJ, 1995, GENETICS, V140, P275; Kolman CJ, 1997, GENETICS, V147, P1289; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Lorenz JG, 1996, AM J PHYS ANTHROPOL, V101, P307, DOI 10.1002/(SICI)1096-8644(199611)101:3<307::AID-AJPA1>3.0.CO;2-W; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Malhi RS, 2003, AM J PHYS ANTHROPOL, V120, P108, DOI 10.1002/ajpa.10138; Malhi RS, 2002, AM J HUM GENET, V70, P905, DOI 10.1086/339690; Malyarchuk BA, 2004, ANN HUM GENET, V68, P324, DOI 10.1046/j.1529-8817.2004.00099.x; MELTON PE, 2007, AM J PHYS ANTHR 0305; Merriwether DA, 1996, MOL PHYLOGENET EVOL, V5, P241, DOI 10.1006/mpev.1996.0017; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; NON AL, 2006, MOL PHYLOGENET EVOL; Pakendorf B, 2006, HUM GENET, V120, P334, DOI 10.1007/s00439-006-0213-2; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Rickards O, 1999, AM J HUM GENET, V65, P519, DOI 10.1086/302513; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Santos SEB, 1996, ANN HUM GENET, V60, P305, DOI 10.1111/j.1469-1809.1996.tb01194.x; SCHROEDER KB, 2007, BIOL LETT; Schurr TG, 2004, AM J HUM BIOL, V16, P420, DOI 10.1002/ajhb.20041; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; Siguroardottir S, 2000, AM J HUM GENET, V66, P1599, DOI 10.1086/302902; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; SZATHMARY EJE, 1993, AM J HUM GENET, V53, P793; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; TORRONI A, 1993, AM J HUM GENET, V53, P563; WAKELEY J, 1993, J MOL EVOL, V37, P613; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663	50	380	398	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e829	10.1371/journal.pone.0000829	http://dx.doi.org/10.1371/journal.pone.0000829			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786201	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455500013
J	Comeau, AM; Tetart, F; Trojet, SN; Prere, MF; Krisch, HM				Comeau, Andre M.; Tetart, Francoise; Trojet, Sabrina N.; Prere, Marie-Francoise; Krisch, H. M.			Phage-Antibiotic Synergy (PAS): beta-Lactam and Quinolone Antibiotics Stimulate Virulent Phage Growth	PLOS ONE			English	Article								Although the multiplication of bacteriophages (phages) has a substantial impact on the biosphere, comparatively little is known about how the external environment affects phage production. Here we report that sub-lethal concentrations of certain antibiotics can substantially stimulate the host bacterial cell's production of some virulent phage. For example, a low dosage of cefotaxime, a cephalosporin, increased an uropathogenic Escherichia coli strain's production of the phage phi MFP by more than 7-fold. We name this phenomenon Phage-Antibiotic Synergy (PAS). A related effect was observed in diverse host-phage systems, including the T4-like phages, with beta-lactam and quinolone antibiotics, as well as mitomycin C. A common characteristic of these antibiotics is that they inhibit bacterial cell division and trigger the SOS system. We therefore examined the PAS effect within the context of the bacterial SOS and filamentation responses. We found that the PAS effect appears SOS-independent and is primarily a consequence of cellular filamentation; it is mimicked by cells that constitutively filament. The fact that completely unrelated phages manifest this phenomenon suggests that it confers an important and general advantage to the phages.	[Comeau, Andre M.; Tetart, Francoise; Trojet, Sabrina N.; Prere, Marie-Francoise; Krisch, H. M.] Univ Toulouse 3, CNRS, Lab Microbiol & Genet Mol, F-31062 Toulouse, France; [Prere, Marie-Francoise] Ctr Hosp Univ Toulouse, Inst Fed Biol, Bacteriol Lab, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse	Krisch, HM (corresponding author), Univ Toulouse 3, CNRS, Lab Microbiol & Genet Mol, F-31062 Toulouse, France.	krisch@ibcg.biotoul.fr	Comeau, André/E-7461-2012		CNRS; Ministere de la Recherche (ACI-Microbiology Biodefense Initiative)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de la Recherche (ACI-Microbiology Biodefense Initiative)(Ministry of Research, France)	This work was supported by the CNRS and by a grant from the Ministere de la Recherche (ACI-Microbiology Biodefense Initiative).	Ackermann HW, 2003, RES MICROBIOL, V154, P245, DOI 10.1016/S0923-2508(03)00067-6; Andersson MI, 2003, J ANTIMICROB CHEMOTH, V51, P1, DOI 10.1093/jac/dkg212; BURTON P, 1983, MOL GEN GENET, V190, P309, DOI 10.1007/BF00330656; Dressman HK, 1999, J BACTERIOL, V181, P4391, DOI 10.1128/JB.181.14.4391-4396.1999; Goerke C, 2006, ANTIMICROB AGENTS CH, V50, P171, DOI 10.1128/AAC.50.1.171-177.2006; Gottfredsson M, 1998, ANTIMICROB AGENTS CH, V42, P1005, DOI 10.1128/AAC.42.5.1005; JOSHI A, 1982, J VIROL, V41, P1038, DOI 10.1128/JVI.41.3.1038-1043.1982; KARAM J, 1994, MOL BIOL BACTERIOPHA, P633; Liu GW, 2001, MOL MICROBIOL, V40, P909, DOI 10.1046/j.1365-2958.2001.02434.x; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; Monod C, 1997, J MOL BIOL, V267, P237, DOI 10.1006/jmbi.1996.0867; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Paddison P, 1998, GENETICS, V148, P1539; PIDDOCK LJV, 1990, ANTIMICROB AGENTS CH, V34, P2331, DOI 10.1128/AAC.34.12.2331; SEKIGUCHI M, 1967, P NATL ACAD SCI USA, V58, P2315, DOI 10.1073/pnas.58.6.2315; SUZUKI H, 1967, J BACTERIOL, V93, P675, DOI 10.1128/JB.93.2.675-682.1967; YAMAGAMI H, 1969, J VIROL, V3, P343, DOI 10.1128/JVI.3.3.343-349.1969	17	218	221	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e799	10.1371/journal.pone.0000799	http://dx.doi.org/10.1371/journal.pone.0000799			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726529	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455400016
J	Wood, RJ; Maynard-Smith, MD; Robinson, VL; Oyston, PCF; Titball, RW; Roach, PL				Wood, Robert J.; Maynard-Smith, Michael D.; Robinson, Victoria L.; Oyston, Petra C. F.; Titball, Rick W.; Roach, Peter L.			Kinetic Analysis of Yersinia pestis DNA Adenine Methyltransferase Activity Using a Hemimethylated Molecular Break Light Oligonucleotide	PLOS ONE			English	Article							DAM METHYLASE; RECOGNITION SEQUENCE; CLEAVAGE; PSEUDOTUBERCULOSIS; REPLICATION; MECHANISM; PLASMID; MUTANT; ASSAY	Background. DNA adenine methylation plays an important role in several critical bacterial processes including mismatch repair, the timing of DNA replication and the transcriptional control of gene expression. The dependence of bacterial virulence on DNA adenine methyltransferase (Dam) has led to the proposal that selective Dam inhibitors might function as broad spectrum antibiotics. Methodology/Principal Findings. Herein we report the expression and purification of Yersinia pestis Dam and the development of a continuous fluorescence based assay for DNA adenine methyltransferase activity that is suitable for determining the kinetic parameters of the enzyme and for high throughput screening against potential Dam inhibitors. The assay utilised a hemimethylated break light oligonucleotide substrate containing a GATC methylation site. When this substrate was fully methylated by Dam, it became a substrate for the restriction enzyme DpnI, resulting in separation of fluorophore (fluorescein) and quencher (dabcyl) and therefore an increase in fluorescence. The assays were monitored in real time using a fluorescence microplate reader in 96 well format and were used for the kinetic characterisation of Yersinia pestis Dam, its substrates and the known Dam inhibitor, S-adenosylhomocysteine. The assay has been validated for high throughput screening, giving a Z-factor of 0.71 +/- 0.07 indicating that it is a sensitive assay for the identification of inhibitors. Conclusions/Significance. The assay is therefore suitable for high throughput screening for inhibitors of DNA adenine methyltransferases and the kinetic characterisation of the inhibition.	[Wood, Robert J.; Maynard-Smith, Michael D.; Roach, Peter L.] Univ Southampton, Sch Chem, Southampton, Hants, England; [Robinson, Victoria L.; Oyston, Petra C. F.; Titball, Rick W.] Def Sci & Technol Lab, Salisbury, Wilts, England	University of Southampton; Defence Science & Technology Laboratory	Wood, RJ (corresponding author), Univ Southampton, Sch Chem, Southampton, Hants, England.	rjw4@soton.ac.uk; plr2@soton.ac.uk	Roach, Peter/AAW-7071-2021; Roach, Peter/C-6248-2013	Roach, Peter/0000-0001-9880-2877	Defence Science and Technology Laboratory; Engineering and Physical Sciences Research Council; Royal Society via a University Research Fellowship	Defence Science and Technology Laboratory; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society via a University Research Fellowship	RJW was supported by the Defence Science and Technology Laboratory, MDMS was supported by the Engineering and Physical Sciences Research Council and PLR was supported by the Royal Society via a University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRAJ JA, 1983, J BACTERIOL, V153, P562, DOI 10.1128/JB.153.1.562-565.1983; Berdis AJ, 1998, P NATL ACAD SCI USA, V95, P2874, DOI 10.1073/pnas.95.6.2874; Bheemanaik S, 2006, BIOCHEM J, V399, P177, DOI 10.1042/BJ20060854; Bheemanaik S, 2006, BIOL CHEM, V387, P515, DOI 10.1515/BC.2006.067; Biggins JB, 2000, P NATL ACAD SCI USA, V97, P13537, DOI 10.1073/pnas.240460997; Dryden D. S, 1999, BACTERIAL DNA METHYL, P283; GEIER GE, 1979, J BIOL CHEM, V254, P1408; GEIER GE, 1979, CLIN RES, V27, pA604; HANISH J, 1991, NUCLEIC ACIDS RES, V19, P829, DOI 10.1093/nar/19.4.829; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; HERMAN GE, 1982, J BIOL CHEM, V257, P2605; Hernday AD, 2003, MOL CELL, V12, P947, DOI 10.1016/S1097-2765(03)00383-6; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Julio SM, 2001, INFECT IMMUN, V69, P7610, DOI 10.1128/IAI.69.12.7610-7615.2001; KOSSYKH VG, 1995, J BIOL CHEM, V270, P14389, DOI 10.1074/jbc.270.24.14389; Kossykh VG, 1997, J BACTERIOL, V179, P3239, DOI 10.1128/jb.179.10.3239-3243.1997; Li J, 2000, NUCLEIC ACIDS RES, V28, P481, DOI 10.1093/nar/28.2.481; Li J, 2007, ANAL CHEM, V79, P1050, DOI 10.1021/ac061694i; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; Low DA, 2001, INFECT IMMUN, V69, P7197, DOI 10.1128/IAI.69.12.7197-7204.2001; Mashhoon N, 2004, J BIOL CHEM, V279, P52075, DOI 10.1074/jbc.M408182200; Mashhoon N, 2006, J BIOMOL SCREEN, V11, P497, DOI 10.1177/1087057106287933; MODRICH P, 1989, J BIOL CHEM, V264, P6597; Ranasinghe RT, 2005, CHEM COMMUN, P5487, DOI 10.1039/b509522k; REICH NO, 1990, J BIOL CHEM, V265, P8966; Rizzo J, 2002, MOL CELL PROBE, V16, P277, DOI 10.1006/mcpr.2002.0423; Robinson VL, 2005, FEMS MICROBIOL LETT, V252, P251, DOI 10.1016/j.femsle.2005.09.001; Sambrook J., 2001, MOL CLONING LAB MANU; SANCHEZ JA, 1992, J CELL SCI, V103, P907; Taylor VL, 2005, MICROBIOL-SGM, V151, P1919, DOI 10.1099/mic.0.27959-0; WOBBE CR, 1985, P NATL ACAD SCI USA, V82, P5710, DOI 10.1073/pnas.82.17.5710; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zinoviev VV, 2003, J BIOL CHEM, V278, P7829, DOI 10.1074/jbc.M210769200	33	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e801	10.1371/journal.pone.0000801	http://dx.doi.org/10.1371/journal.pone.0000801			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726531	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455400018
J	Craddock, RM; Lockstone, HE; Rider, DA; Wayland, MT; Harris, LJW; McKenna, PJ; Bahn, S				Craddock, Rachel M.; Lockstone, Helen E.; Rider, David A.; Wayland, Matthew T.; Harris, Laura J. W.; McKenna, Peter J.; Bahn, Sabine			Altered T-Cell Function in Schizophrenia: A Cellular Model to Investigate Molecular Disease Mechanisms	PLOS ONE			English	Article								Despite decades of research into the aetiology and pathophysiology of schizophrenia, our understanding of this devastating disorder remains incomplete, with adverse consequences for both diagnosis and treatment. Here we investigate whether differences between patients and controls can be observed in peripheral patient tissue, with a view of establishing a means for dynamic investigations into cell function. In vitro stimulation of peripheral blood CD3+ pan T cells with anti-CD3 (clone OKT3) was used to investigate disease-associated cell responses. T cells from both medicated (n = 39), unmedicated (n = 6) and minimally medicated (n = 5) schizophrenia patients were found to have significantly lower proliferative responses to stimulation, compared to well-matched controls (n = 32). Expression of CD3 and TCR (T cell receptor) ab chains was equivalent between patients and controls, ensuring equal stimulation with anti-CD3, and there was no significant difference in the proportions of CD4+ and CD8+ T cells between samples (n = 12). Lower T cell proliferation in schizophrenia patients was not found to result from deficient early tyrosine phosphorylation signalling or lower IL-2 (interleukin-2) production, as these parameters were similar between patients and controls, as was the expression of CD25, the IL-2 receptor a chain. Analysis of CD45 isoforms, however, revealed that patients had a significantly greater percentage of CD8+ and CD4+ CD45RA+ cells before stimulation and significantly higher fluorescence intensity of CD45RA on CD4+ and CD8+ cells before and after stimulation. There was significantly higher expression of CD45 RB on both CD4+ and CD8+ unstimulated cells, with a trend towards lower numbers of CD45RO+ T cells in patient blood. Gene expression analysis in freshly isolated T cells from six minimally treated or first onset patients and six controls was carried out using human whole-genome CodeLink microarrays to identify functional pathways that may affect the ability of patient cells to respond to stimulation. Functional profiling showed prominent transcript changes in categories pertaining to cell cycle machinery, intracellular signalling, oxidative stress and metabolism. Intriguingly, chromosomal location analysis of genes significantly altered between schizophrenia and controls revealed clusters at 1p36, 1q42 and 6p22, which have previously been identified as strong susceptibility loci for schizophrenia.	[Craddock, Rachel M.; Lockstone, Helen E.; Wayland, Matthew T.; Harris, Laura J. W.; Bahn, Sabine] Univ Cambridge, Inst Biotechnol, Cambridge, England; [Rider, David A.] Inst Mol & Cell Biol, Proteos, Singapore; [McKenna, Peter J.] Fulbourn Hosp, Cambridge, England	University of Cambridge; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Bahn, S (corresponding author), Univ Cambridge, Inst Biotechnol, Cambridge, England.	sb209@cam.ac.uk	Wayland, Matthew/V-6751-2019	Wayland, Matthew/0000-0002-8095-858X; McKenna, Peter/0000-0001-5474-1144; Rider, David/0000-0003-1972-2524	The Stanley Medical Research Institute (SMRI); National Alliance for Research into Schizophrenia and Depression (NARSAD)	The Stanley Medical Research Institute (SMRI); National Alliance for Research into Schizophrenia and Depression (NARSAD)(NARSAD)	This research was supported by The Stanley Medical Research Institute (SMRI) and the National Alliance for Research into Schizophrenia and Depression (NARSAD). SB is a NARSAD Essel Investigator. GE Healthcare UK, provided CodeLink (TM) Human Whole Genome Bioarrays.	AKBAR AN, 1988, J IMMUNOL, V140, P2171; ALLEN ME, 1995, EUR J IMMUNOL, V25, P1547, DOI 10.1002/eji.1830250612; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cazzullo CL, 1998, SCHIZOPHR RES, V31, P49, DOI 10.1016/S0920-9964(97)00153-9; CHANG HL, 1991, J IMMUNOL, V147, P1687; CHENGAPPA KNR, 1992, SCHIZOPHR RES, V8, P75, DOI 10.1016/0920-9964(92)90063-B; CHENGAPPA KNR, 1992, SCHIZOPHR RES, V7, P49; CHENGAPPA KNR, 1991, BIOL PSYCHIAT, V30, P731, DOI 10.1016/0006-3223(91)90019-I; Cope AP, 2002, ARTHRITIS RES THER, V4, pS197, DOI 10.1186/ar557; DELISI LE, 1982, BIOL PSYCHIAT, V17, P1003; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; Faint JM, 2001, J IMMUNOL, V167, P212, DOI 10.4049/jimmunol.167.1.212; Frommberger UH, 1997, EUR ARCH PSY CLIN N, V247, P228, DOI 10.1007/BF02900219; GANGULI R, 1987, ANN NY ACAD SCI, V496, P676, DOI 10.1111/j.1749-6632.1987.tb35829.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; HENNEBERG AE, 1994, SCHIZOPHR RES, V14, P15, DOI 10.1016/0920-9964(94)90004-3; Lewis DA, 2002, NEUROPSYCHOPHARMACOL, V26, P143, DOI 10.1016/S0893-133X(01)00393-1; Ma CS, 2004, IMMUNOL CELL BIOL, V82, P67, DOI 10.1046/j.0818-9641.2003.01206.x; MULLER N, 1991, PSYCHIAT RES, V37, P147, DOI 10.1016/0165-1781(91)90072-W; Muller N, 1999, EUR ARCH PSY CLIN N, V249, P62; Muller N, 2000, World J Biol Psychiatry, V1, P173, DOI 10.3109/15622970009150588; POULTON TA, 1988, IMMUNOLOGY, V64, P419; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Prabakaran S, 2007, J PROTEOME RES, V6, P141, DOI 10.1021/pr060308a; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; RIEDEL M, 2006, J PSYCHIAT RES; RUSSO R, 1994, LANCET, V343, P356, DOI 10.1016/S0140-6736(94)91193-2; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SALMON M, 1994, EUR J IMMUNOL, V24, P892, DOI 10.1002/eji.1830240417; SHINITZKY M, 1991, ANN NY ACAD SCI, V621, P205; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Torrey EF, 2001, BRAIN BEHAV IMMUN, V15, P401, DOI 10.1006/brbi.2001.0649; Wills MR, 2002, J IMMUNOL, V168, P5455, DOI 10.4049/jimmunol.168.11.5455; Zhang XY, 2002, J PSYCHIATR RES, V36, P331	37	68	73	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e692	10.1371/journal.pone.0000692	http://dx.doi.org/10.1371/journal.pone.0000692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668069	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452300027
J	Ronald, J; Akey, JM				Ronald, James; Akey, Joshua M.			The Evolution of Gene Expression QTL in Saccharomyces cerevisiae	PLOS ONE			English	Article							NATURAL-SELECTION; LINKAGE ANALYSIS; RAPID EVOLUTION; POPULATION; REVEALS; RATES; IDENTIFICATION; MECHANISMS; GENEALOGY; ALIGNMENT	Understanding the evolutionary forces that influence patterns of gene expression variation will provide insights into the mechanisms of evolutionary change and the molecular basis of phenotypic diversity. To date, studies of gene expression evolution have primarily been made by analyzing how gene expression levels vary within and between species. However, the fundamental unit of heritable variation in transcript abundance is the underlying regulatory allele, and as a result it is necessary to understand gene expression evolution at the level of DNA sequence variation. Here we describe the evolutionary forces shaping patterns of genetic variation for 1206 cis-regulatory QTL identified in a cross between two divergent strains of Saccharomyces cerevisiae. We demonstrate that purifying selection against mildly deleterious alleles is the dominant force governing cis-regulatory evolution in S. cerevisiae and estimate the strength of selection. We also find that essential genes and genes with larger codon bias are subject to slightly stronger cis-regulatory constraint and that positive selection has played a role in the evolution of major trans-acting QTL.	[Ronald, James; Akey, Joshua M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Akey, JM (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	akeyj@u.washington.edu		Akey, Joshua/0000-0002-4411-1330	JMA	JMA	JMA is an Alfred P. Sloan research fellow. The sponsors played no role in any aspect of the project other than funding.	Bing N, 2005, GENETICS, V170, P533, DOI 10.1534/genetics.105.041103; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Doniger SW, 2005, GENOME RES, V15, P701, DOI 10.1101/gr.3578205; Fay JC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r26; Fay JC, 2001, GENETICS, V158, P1227; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Gu ZL, 2005, P NATL ACAD SCI USA, V102, P1092, DOI 10.1073/pnas.0409159102; Hahn MW, 2007, GENETICA, V129, P7, DOI 10.1007/s10709-006-0029-y; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; HEATON B, 1992, NUCLEIC ACIDS RES, V20, P5365, DOI 10.1093/nar/20.20.5365; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Hughes AL, 2005, GENETICS, V169, P533, DOI 10.1534/genetics.104.036939; Hughes AL, 2003, P NATL ACAD SCI USA, V100, P15754, DOI 10.1073/pnas.2536718100; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Khaitovich P, 2004, PLOS BIOL, V2, P682, DOI 10.1371/journal.pbio.0020132; Krone SM, 1997, THEOR POPUL BIOL, V51, P210, DOI 10.1006/tpbi.1997.1299; Lan H, 2006, PLOS GENET, V2, P51, DOI 10.1371/journal.pgen.0020006; Landry CR, 2005, GENETICS, V171, P1813, DOI 10.1534/genetics.105.047449; Lee SI, 2006, P NATL ACAD SCI USA, V103, P14062, DOI 10.1073/pnas.0601852103; Lemos B, 2005, EVOLUTION, V59, P126; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; MORTIMER RK, 1986, GENETICS, V113, P35; MUHLRAD D, 1992, GENE DEV, V6, P2100, DOI 10.1101/gad.6.11.2100; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Neuhauser C, 1997, GENETICS, V145, P519; Ohta T, 2002, P NATL ACAD SCI USA, V99, P16134, DOI 10.1073/pnas.252626899; Petretto E, 2006, PLOS GENET, V2, P1625, DOI 10.1371/journal.pgen.0020172; Rifkin SA, 2005, NATURE, V438, P220, DOI 10.1038/nature04114; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Ronald J, 2006, GENETICS, V174, P541, DOI 10.1534/genetics.106.060863; Ruderfer DM, 2006, NAT GENET, V38, P1077, DOI 10.1038/ng1859; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Townsend JP, 2003, MOL BIOL EVOL, V20, P955, DOI 10.1093/molbev/msg106; Whitehead A, 2006, P NATL ACAD SCI USA, V103, P5425, DOI 10.1073/pnas.0507648103; Whitehead A, 2006, MOL ECOL, V15, P1197, DOI 10.1111/j.1365-294X.2006.02868.x; Wong WSW, 2004, GENETICS, V167, P949, DOI 10.1534/genetics.102.010959; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	49	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e678	10.1371/journal.pone.0000678	http://dx.doi.org/10.1371/journal.pone.0000678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668057	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452300015
J	Suzuki, M; McHugh, J; Tork, C; Shelley, B; Klein, SM; Aebischer, P; Svendsen, CN				Suzuki, Masatoshi; McHugh, Jacalyn; Tork, Craig; Shelley, Brandon; Klein, Sandra M.; Aebischer, Patrick; Svendsen, Clive N.			GDNF Secreting Human Neural Progenitor Cells Protect Dying Motor Neurons, but Not Their Projection to Muscle, in a Rat Model of Familial ALS	PLOS ONE			English	Article								Background. Amyotrophic lateral sclerosis (ALS) is a fatal, progressive neurodegenerative disease characterized by rapid loss of muscle control and eventual paralysis due to the death of large motor neurons in the brain and spinal cord. Growth factors such as glial cell line derived neurotrophic factor (GDNF) are known to protect motor neurons from damage in a range of models. However, penetrance through the blood brain barrier and delivery to the spinal cord remains a serious challenge. Although there may be a primary dysfunction in the motor neuron itself, there is also increasing evidence that excitotoxicity due to glial dysfunction plays a crucial role in disease progression. Clearly it would be of great interest if wild type glial cells could ameliorate motor neuron loss in these models, perhaps in combination with the release of growth factors such as GDNF. Methodology/Principal Findings. Human neural progenitor cells can be expanded in culture for long periods and survive transplantation into the adult rodent central nervous system, in some cases making large numbers of GFAP positive astrocytes. They can also be genetically modified to release GDNF (hNPC(GDNF)) and thus act as long-term 'mini pumps' in specific regions of the rodent and primate brain. In the current study we genetically modified human neural stem cells to release GDNF and transplanted them into the spinal cord of rats over-expressing mutant SOD1 (SOD1(G93A)). Following unilateral transplantation into the spinal cord of SOD1(G93A) rats there was robust cellular migration into degenerating areas, efficient delivery of GDNF and remarkable preservation of motor neurons at early and end stages of the disease within chimeric regions. The progenitors retained immature markers, and those not secreting GDNF had no effect on motor neuron survival. Interestingly, this robust motor neuron survival was not accompanied by continued innervation of muscle end plates and thus resulted in no improvement in ipsilateral limb use. Conclusions/Significance. The potential to maintain dying motor neurons by delivering GDNF using neural progenitor cells represents a novel and powerful treatment strategy for ALS. While this approach represents a unique way to prevent motor neuron loss, our data also suggest that additional strategies may also be required for maintenance of neuromuscular connections and full functional recovery. However, simply maintaining motor neurons in patients would be the first step of a therapeutic advance for this devastating and incurable disease, while future strategies focus on the maintenance of the neuromuscular junction.	[Suzuki, Masatoshi; McHugh, Jacalyn; Tork, Craig; Shelley, Brandon; Klein, Sandra M.; Svendsen, Clive N.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Svendsen, Clive N.] Univ Wisconsin, Dept Anat, Madison, WI 53706 USA; [Svendsen, Clive N.] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Aebischer, Patrick] Ecole Polytech Fed Lausanne, Brain & Mind Inst, Lausanne, Switzerland	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Svendsen, CN (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	svendsen@waisman.wisc.edu	Aebischer, Patrick/E-1387-2013		ALS association; University of Wisconsin Foundation	ALS association; University of Wisconsin Foundation	This work was supported by the grant from the ALS association and the University of Wisconsin Foundation.	Acsadi G, 2002, HUM GENE THER, V13, P1047, DOI 10.1089/104303402753812458; Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700; Arvidsson A, 2003, NEUROBIOL DIS, V14, P542, DOI 10.1016/j.nbd.2003.08.002; Barbeito LH, 2004, BRAIN RES REV, V47, P263, DOI 10.1016/j.brainresrev.2004.05.003; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Behrstock S, 2006, GENE THER, V13, P379, DOI 10.1038/sj.gt.3302679; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Capowski EE, 2007, J NEUROSCI METH, V163, P338, DOI 10.1016/j.jneumeth.2007.02.022; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Deglon N, 2000, HUM GENE THER, V11, P179, DOI 10.1089/10430340050016256; Deitch JS, 2002, J NEUROL SCI, V193, P117, DOI 10.1016/S0022-510X(01)00656-6; Deshpande DM, 2006, ANN NEUROL, V60, P32, DOI 10.1002/ana.20901; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Ganel R, 2006, NEUROBIOL DIS, V21, P556, DOI 10.1016/j.nbd.2005.08.014; Garbuzova-Davis S, 2002, EXP NEUROL, V174, P169, DOI 10.1006/exnr.2002.7860; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; Guillot S, 2004, NEUROBIOL DIS, V16, P139, DOI 10.1016/j.nbd.2004.01.017; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hemendinger R, 2005, EXP NEUROL, V196, P235, DOI 10.1016/j.expneurol.2005.07.025; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Herbik MA, 2006, FOLIA NEUROPATHOL, V44, P149; Hitoshi S, 2002, DEVELOPMENT, V129, P233; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Klein SM, 2005, HUM GENE THER, V16, P509, DOI 10.1089/hum.2005.16.509; Leitner ML, 1999, J NEUROSCI, V19, P9322; Li W, 2007, EXP NEUROL, V203, P457, DOI 10.1016/j.expneurol.2006.08.028; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Mohajeri MH, 1999, HUM GENE THER, V10, P1853, DOI 10.1089/10430349950017536; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; NIKKHAH G, 1994, NEUROSCIENCE, V63, P57, DOI 10.1016/0306-4522(94)90007-8; Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427; Ostenfeld T, 2002, DEV BRAIN RES, V134, P43, DOI 10.1016/S0165-3806(01)00291-7; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Perrelet D, 2002, NAT CELL BIOL, V4, P175, DOI 10.1038/ncb751; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Rakowicz WP, 2002, J NEUROSCI, V22, P3953, DOI 10.1523/JNEUROSCI.22-10-03953.2002; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Sagot Y, 1996, J NEUROSCI, V16, P2335; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Suzuki M, 2007, AMYOTROPH LATERAL SC, V8, P20, DOI 10.1080/17482960600982447; Svendsen CN, 2004, NAT MED, V10, P224, DOI 10.1038/nm0304-224; Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634; Svendsen CN, 1996, EXP NEUROL, V137, P376, DOI 10.1006/exnr.1996.0039; van Damme P, 2005, NEURODEGENER DIS, V2, P147, DOI 10.1159/000089620; von Bartheld CS, 2001, MOL NEUROBIOL, V24, P1, DOI 10.1385/MN:24:1-3:001; Watanabe K, 2004, DEV NEUROSCI-BASEL, V26, P275, DOI 10.1159/000082144; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Wright LS, 2003, J NEUROCHEM, V86, P179, DOI 10.1046/j.1471-4159.2003.01826.x; Xu LY, 2006, TRANSPLANTATION, V82, P865, DOI 10.1097/01.tp.0000235532.00920.7a	60	224	232	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e689	10.1371/journal.pone.0000689	http://dx.doi.org/10.1371/journal.pone.0000689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668067	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452300025
J	Molnar-Szakacs, I; Wu, AD; Robles, FJ; Iacoboni, M				Molnar-Szakacs, Istvan; Wu, Allan D.; Robles, Francisco J.; Iacoboni, Marco			Do You See What I Mean? Corticospinal Excitability During Observation of Culture-Specific Gestures	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTEX EXCITABILITY; LEFT-HEMISPHERE; SOCIAL CATEGORIZATION; PREMOTOR CORTEX; MIRROR NEURONS; SELF; RECOGNITION; MODULATION; FACILITATION	People all over the world use their hands to communicate expressively. Autonomous gestures, also known as emblems, are highly social in nature, and convey conventionalized meaning without accompanying speech. To study the neural bases of cross-cultural social communication, we used single pulse transcranial magnetic stimulation (TMS) to measure corticospinal excitability (CSE) during observation of culture-specific emblems. Foreign Nicaraguan and familiar American emblems as well as meaningless control gestures were performed by both a Euro-American and a Nicaraguan actor. Euro-American participants demonstrated higher CSE during observation of the American compared to the Nicaraguan actor. This motor resonance phenomenon may reflect ethnic and cultural ingroup familiarity effects. However, participants also demonstrated a nearly significant (p = 0.053) actor by emblem interaction whereby both Nicaraguan and American emblems performed by the American actor elicited similar CSE, whereas Nicaraguan emblems performed by the Nicaraguan actor yielded higher CSE than American emblems. The latter result cannot be interpreted simply as an effect of ethnic ingroup familiarity. Thus, a likely explanation of these findings is that motor resonance is modulated by interacting biological and cultural factors.	[Molnar-Szakacs, Istvan] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Biol Creat, Los Angeles, CA 90095 USA; [Molnar-Szakacs, Istvan; Wu, Allan D.; Robles, Francisco J.; Iacoboni, Marco] Univ Calif Los Angeles, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA USA; [Molnar-Szakacs, Istvan; Iacoboni, Marco] Univ Calif Los Angeles, FPR UCLA Ctr Culture Brain & Dev, Los Angeles, CA USA; [Molnar-Szakacs, Istvan; Iacoboni, Marco] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Wu, Allan D.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Iacoboni, Marco] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Molnar-Szakacs, I (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Biol Creat, Los Angeles, CA 90095 USA.	imolnar@ucla.edu			FPR-UCLA Center for Culture, Brain and Development, Brain Mapping Medical Research Organization; Brain Mapping Support Foundation; Pierson-Lovelace Foundation; Ahmanson Foundation; Tamkin Foundation; Jennifer Jones-Simon Foundation; Capital Group Companies Charitable Foundation; Robson Family; William M. and Linda R. Dietel Philanthropic Fund at the Northern Piedmont Community Foundation; Northstar Fund; National Center for Research Resources [RR12169, RR13642, RR08655, NINDS K23-NS045764]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013642, C06RR012169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS045764] Funding Source: NIH RePORTER	FPR-UCLA Center for Culture, Brain and Development, Brain Mapping Medical Research Organization; Brain Mapping Support Foundation; Pierson-Lovelace Foundation; Ahmanson Foundation; Tamkin Foundation; Jennifer Jones-Simon Foundation; Capital Group Companies Charitable Foundation; Robson Family; William M. and Linda R. Dietel Philanthropic Fund at the Northern Piedmont Community Foundation; Northstar Fund; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by the FPR-UCLA Center for Culture, Brain and Development, Brain Mapping Medical Research Organization, Brain Mapping Support Foundation, Pierson-Lovelace Foundation, The Ahmanson Foundation, Tamkin Foundation, Jennifer Jones-Simon Foundation, Capital Group Companies Charitable Foundation, Robson Family, William M. and Linda R. Dietel Philanthropic Fund at the Northern Piedmont Community Foundation, Northstar Fund and the National Center for Research Resources grants RR12169, RR13642 and RR08655 and NINDS K23-NS045764 (ADW).	Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Aziz-Zadeh L, 2004, EUR J NEUROSCI, V19, P2609, DOI 10.1111/j.0953-816X.2004.03348.x; Aziz-Zadeh L, 2002, EXP BRAIN RES, V144, P127, DOI 10.1007/s00221-002-1037-5; Baldissera F, 2001, EUR J NEUROSCI, V13, P190, DOI 10.1046/j.0953-816x.2000.01368.x; Bigler RS, 2006, ADV CHILD DEV BEHAV, V34, P39, DOI 10.1016/S0065-2407(06)80004-2; Birdwhistell R., 1970, KINESICS CONTEXT; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Buccino G, 2004, BRAIN LANG, V89, P370, DOI 10.1016/S0093-934X(03)00356-0; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Clark S, 2004, NEUROPSYCHOLOGIA, V42, P105, DOI 10.1016/S0028-3932(03)00144-1; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; EKMAN P, 1972, J COMMUN, V22, P353, DOI 10.1111/j.1460-2466.1972.tb00163.x; EKMAN P., 1969, SEMIOTICA, V1, P49, DOI DOI 10.1515/SEMI.1969.1.1.49; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fecteau S, 2005, NEUROREPORT, V16, P1591, DOI 10.1097/01.wnr.0000179079.54906.1b; Ferrari PF, 2003, EUR J NEUROSCI, V17, P1703, DOI 10.1046/j.1460-9568.2003.02601.x; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Gaertner SL., 1999, CULTURAL DIVIDES UND, P173; Gallagher HL, 2004, NEUROPSYCHOLOGIA, V42, P1725, DOI 10.1016/j.neuropsychologia.2004.05.006; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GALLESE V, 2002, ATTENTION PERFORM, P247; Goldin-Meadow S, 2005, TRENDS COGN SCI, V9, P234, DOI 10.1016/j.tics.2005.03.006; Goldin-Meadow S., 2003, HEARING GESTURE OUR; Heiser M, 2003, EUR J NEUROSCI, V17, P1123, DOI 10.1046/j.1460-9568.2003.02530.x; Hewstone M, 2002, ANNU REV PSYCHOL, V53, P575, DOI 10.1146/annurev.psych.53.100901.135109; HORNSTEIN H, 1976, CRUELTY KINDNESS NEW; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Iverson JM, 2005, PSYCHOL SCI, V16, P367, DOI 10.1111/j.0956-7976.2005.01542.x; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Johnson-Frey SH, 2005, CEREB CORTEX, V15, P681, DOI 10.1093/cercor/bhh169; KENDON A, 1981, SEMIOTICA, V37, P129; Kendon A., 1972, STUDIES DYADIC COMMU, P177, DOI DOI 10.1016/B978-0-08-015867-9.50013-7; Kendon A., 1983, NONVERBAL INTERACTIO, V11, P13, DOI [10.1016/j.specom.2013.09.008, DOI 10.1016/J.SPECOM.2013.09.008]; Koski L, 2005, CLIN NEUROPHYSIOL, V116, P2099, DOI 10.1016/j.clinph.2005.06.006; MAASS A, 1989, J PERS SOC PSYCHOL, V57, P981, DOI 10.1037/0022-3514.57.6.981; McNeill D., 1992, HAND MIND WHAT HANDS; Molnar-Szakacs I, 2005, CEREB CORTEX, V15, P986, DOI 10.1093/cercor/bhh199; Molnar-Szakacs I, 2005, EUR J NEUROSCI, V21, P2000, DOI 10.1111/j.1460-9568.2005.04019.x; Molnar-Szakacs I, 2006, SOC COGN AFFECT NEUR, V1, P235, DOI 10.1093/scan/nsl029; Molnar-Szakacs I, 2006, NEUROIMAGE, V33, P923, DOI 10.1016/j.neuroimage.2006.07.035; Morris D., 1979, GESTURES THEIR ORIGI; Nakamura A, 2004, NEUROIMAGE, V23, P25, DOI 10.1016/j.neuroimage.2004.04.034; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PARK B, 1982, J PERS SOC PSYCHOL, V42, P1051, DOI 10.1037/0022-3514.42.6.1051; Patuzzo S, 2003, NEUROPSYCHOLOGIA, V41, P1272, DOI 10.1016/S0028-3932(02)00293-2; PAYRATO L, 1993, J PRAGMATICS, V20, P193, DOI 10.1016/0378-2166(93)90046-R; Perani D, 2001, NEUROIMAGE, V14, P749, DOI 10.1006/nimg.2001.0872; RABBIE JM, 1982, COOPERATION HELPING, P128; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Robbins JM, 2005, PERS SOC PSYCHOL REV, V9, P32, DOI 10.1207/s15327957pspr0901_3; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Stevens JA, 2000, NEUROREPORT, V11, P109, DOI 10.1097/00001756-200001170-00022; Tai YF, 2004, CURR BIOL, V14, P117, DOI 10.1016/j.cub.2004.01.005; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; Theoret H, 2004, COGNITIVE BRAIN RES, V20, P54, DOI 10.1016/j.cogbrainres.2004.01.003; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Uddin LQ, 2006, SOC COGN AFFECT NEUR, V1, P65, DOI 10.1093/scan/nsl003; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; ZAIDEL E, 1978, CEREBRAL CORRELATES, P263	66	80	80	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2007	2	7							e626	10.1371/journal.pone.0000626	http://dx.doi.org/10.1371/journal.pone.0000626			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GI	17637842	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452100016
J	Abel, U; Deichmann, A; Bartholomae, C; Schwarzwaelder, K; Glimm, H; Howe, S; Thrasher, A; Garrigue, A; Hacein-Bey-Abina, S; Cavazzana-Calvo, M; Fischer, A; Jaeger, D; von Kalle, C; Schmidt, M				Abel, Ulrich; Deichmann, Annette; Bartholomae, Cynthia; Schwarzwaelder, Kerstin; Glimm, Hanno; Howe, Steven; Thrasher, Adrian; Garrigue, Alexandrine; Hacein-Bey-Abina, Salima; Cavazzana-Calvo, Marina; Fischer, Alain; Jaeger, Dirk; von Kalle, Christof; Schmidt, Manfred			Real-Time Definition of Non-Randomness in the Distribution of Genomic Events	PLOS ONE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; RETROVIRAL VECTOR INTEGRATION; GENE-THERAPY; SEQUENCE; ASSOCIATION; REPEATS; TARGETS; CANCER	Features such as mutations or structural characteristics can be non-randomly or non-uniformly distributed within a genome. So far, computer simulations were required for statistical inferences on the distribution of sequence motifs. Here, we show that these analyses are possible using an analytical, mathematical approach. For the assessment of non-randomness, our calculations only require information including genome size, number of ( sampled) sequence motifs and distance parameters. We have developed computer programs evaluating our analytical formulas for the real-time determination of expected values and p-values. This approach permits a flexible cluster definition that can be applied to most effectively identify non-random or non-uniform sequence motif distribution. As an example, we show the effectivity and reliability of our mathematical approach in clinical retroviral vector integration site distribution.	[Abel, Ulrich; Deichmann, Annette; Bartholomae, Cynthia; Schwarzwaelder, Kerstin; Glimm, Hanno; Jaeger, Dirk; von Kalle, Christof; Schmidt, Manfred] Natl Ctr Tumor Dis, Dept Translat Oncol, Heidelberg, Germany; [Abel, Ulrich; Howe, Steven] Tumor Ctr Heidelberg Mannheim, Dept Med Biostat, Heidelberg, Germany; [Thrasher, Adrian] UCL, Mol Immunol Unit, Inst Child Hlth, London, England; [Thrasher, Adrian] Great Ormond St Hosp NHS Trust, Dept Clin Immunol, London, England; [Garrigue, Alexandrine; Hacein-Bey-Abina, Salima; Cavazzana-Calvo, Marina; Fischer, Alain] Univ Paris 05, INSERM Unit 768, Hop Necker, Paris, France; [Garrigue, Alexandrine; Hacein-Bey-Abina, Salima; Cavazzana-Calvo, Marina; Fischer, Alain] Univ Paris 05, Fac Med, Paris, France; [Hacein-Bey-Abina, Salima; Cavazzana-Calvo, Marina] Hop Necker Enfants Malad, Dept Biotherapies, Paris, France; [Fischer, Alain] Hop Necker Enfants Malad, Unite Immunol & Hematol Pediat, Paris, France; [von Kalle, Christof] Cincinnati Childrens Res Fdn, Div Expt Hematol, Cincinnati, OH USA	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	von Kalle, C (corresponding author), Natl Ctr Tumor Dis, Dept Translat Oncol, Heidelberg, Germany.	christof.kalle@nct-heidelberg.de; manfred.schmidt@nct-heidelberg.de	Howe, Steven J/C-4801-2008	Howe, Steven J/0000-0003-2940-2874; Garrigue, Alexandrine/0000-0002-2660-3681	Deutsche Forschungsgemeinschaft [SPP1230]; German Ministry of Education and Research; EU; Great Ormond Street Hospital Childrens Charity [V1223] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); EU(European Commission); Great Ormond Street Hospital Childrens Charity	This work was supported by the Deutsche Forschungsgemeinschaft ( Grant SPP1230), the German Ministry of Education and Research ( Grant TREATID) and the EU ( VIth Framework Program, CONSERT and CLINIGENE).	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Bushman FD, 2003, CELL, V115, P135, DOI 10.1016/S0092-8674(03)00760-8; Calmels B, 2005, BLOOD, V106, P2530, DOI 10.1182/blood-2005-03-1115; Camargo AA, 2001, P NATL ACAD SCI USA, V98, P12103, DOI 10.1073/pnas.201182798; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Du Y, 2005, BLOOD, V106, P3932, DOI 10.1182/blood-2005-03-1113; DUDEWICZ EJ, 1988, MODERN MATH STAT; Garrigan D, 2006, NAT REV GENET, V7, P669, DOI 10.1038/nrg1941; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; HARTUNG J, 1987, STATISTIK; Hematti P, 2004, PLOS BIOL, V2, P2183, DOI 10.1371/journal.pbio.0020423; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laufs S, 2003, BLOOD, V101, P2191, DOI 10.1182/blood-2002-02-0627; Li ZX, 2002, SCIENCE, V296, P497, DOI 10.1126/science.1068893; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Modlich U, 2005, BLOOD, V105, P4235, DOI 10.1182/blood-2004-11-4535; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Riva A, 2004, COMPUT BIOL CHEM, V28, P109, DOI 10.1016/j.compbiolchem.2003.12.004; Subramanian S, 2003, BIOINFORMATICS, V19, P681, DOI 10.1093/bioinformatics/btg067; Subramanian S, 2003, BIOINFORMATICS, V19, P549, DOI 10.1093/bioinformatics/btg029; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Wang JX, 2006, GENE, V365, P11, DOI 10.1016/j.gene.2005.09.031; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wu XL, 2006, VIROLOGY, V344, P292, DOI 10.1016/j.virol.2005.08.047; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413	37	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e570	10.1371/journal.pone.0000570	http://dx.doi.org/10.1371/journal.pone.0000570			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593969	Green Submitted, Green Published, gold			2022-12-27	WOS:000207451800014
J	Fowler, MA; Sidiropoulou, K; Ozkan, ED; Phillips, CW; Cooper, DC				Fowler, Melissa A.; Sidiropoulou, Kyriaki; Ozkan, Emin D.; Phillips, Christopher W.; Cooper, Donald C.			Corticolimbic Expression of TRPC4 and TRPC5 Channels in the Rodent Brain	PLOS ONE			English	Article							LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE-RECEPTOR-5; SYNAPTIC PLASTICITY; SURFACE EXPRESSION; PREFRONTAL CORTEX; SUBSTANTIA-NIGRA; CALCIUM CURRENTS; RECEPTOR; ACTIVATION; MODULATION	The canonical transient receptor potential ( TRPC) channels are a family of non-selective cation channels that are activated by increases in intracellular Ca2+ and G(q)/phospholipase C-coupled receptors. We used quantitative real-time PCR, in situ hybridization, immunoblots and patch-clamp recording from several brain regions to examine the expression of the predominant TRPC channels in the rodent brain. Quantitative real-time PCR of the seven TRPC channels in the rodent brain revealed that TRPC4 and TRPC5 channels were the predominant TRPC subtypes in the adult rat brain. In situ hybridization histochemistry and immunoblotting further resolved a dense corticolimbic expression of the TRPC4 and TRPC5 channels. Total protein expression of HIP TRPC4 and 5 proteins increased throughout development and peaked late in adulthood (6-9 weeks). In adults, TRPC4 expression was high throughout the frontal cortex, lateral septum (LS), pyramidal cell layer of the hippocampus ( HIP), dentate gyrus (DG), and ventral subiculum (vSUB). TRPC5 was highly expressed in the frontal cortex, pyramidal cell layer of the HIP, DG, and hypothalamus. Detailed examination of frontal cortical layer mRNA expression indicated TRPC4 mRNA is distributed throughout layers 2-6 of the prefrontal cortex (PFC), motor cortex (MCx), and somatosensory cortex (SCx). TRPC5 mRNA expression was concentrated specifically in the deep layers 5/6 and superficial layers 2/3 of the PFC and anterior cingulate. Patch-clamp recording indicated a strong metabotropic glutamate-activated cation current-mediated depolarization that was dependent on intracellular Ca2+ and inhibited by protein kinase C in brain regions associated with dense TRPC4 or 5 expression and absent in regions lacking TRPC4 and 5 expression. Overall, the dense corticolimbic expression pattern suggests that these Gq/PLC coupled nonselective cation channels may be involved in learning, memory, and goal-directed behaviors.	[Fowler, Melissa A.; Ozkan, Emin D.; Phillips, Christopher W.; Cooper, Donald C.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Sidiropoulou, Kyriaki] FORTH, Computat Biol Lab, IMBB, Vassilika Vouton, Heraklio, Greece	University of Texas System; University of Texas Southwestern Medical Center Dallas; Foundation for Research & Technology - Hellas (FORTH)	Cooper, DC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	Don.Cooper@utsouthwestern.edu	Ozkan, Emin Deniz/A-5752-2009; Sidiropoulou, Kyriaki/AAA-2126-2021	Ozkan, Emin Deniz/0000-0002-1073-6703; Sidiropoulou, Kyriaki/0000-0001-7400-4678	NIDA K [K-01 DA017750-01]; NARSAD Young Investigator; NIDA institutional training [T32-DA7290]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA017750, T32DA007290] Funding Source: NIH RePORTER	NIDA K(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NARSAD Young Investigator(NARSAD); NIDA institutional training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a NIDA K award (K-01 DA017750-01) to DCC, a NARSAD Young Investigator award to DCC, and a NIDA institutional training grant (T32-DA7290) to MAF.	Ajay SM, 2006, PHYSIOLOGY, V21, P289, DOI 10.1152/physiol.00009.2006; BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; Carr DB, 2002, J NEUROSCI, V22, P6846; Chung YH, 2006, BRAIN RES, V1085, P132, DOI 10.1016/j.brainres.2006.02.087; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Cooper DC, 2005, PLOS BIOL, V3, P1123, DOI 10.1371/journal.pbio.0030175; Cooper DC, 2002, NEUROCHEM INT, V41, P333, DOI 10.1016/S0197-0186(02)00068-2; De March Z, 2006, NEUROSCI LETT, V402, P35, DOI 10.1016/j.neulet.2006.03.061; Glazebrook PA, 2005, PFLUG ARCH EUR J PHY, V451, P125, DOI 10.1007/s00424-005-1468-5; Gold SJ, 2004, METHOD ENZYMOL, V389, P205; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Gruenbaum LM, 1999, LEARN MEMORY, V6, P292; Gubellini P, 2004, NEUROPHARMACOLOGY, V46, P761, DOI 10.1016/j.neuropharm.2003.11.021; HARDIE RC, 2006, J PHYSL; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kampfer H, 1999, J INVEST DERMATOL, V113, P369, DOI 10.1046/j.1523-1747.1999.00704.x; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kanki H, 2001, MOL PHARMACOL, V60, P989, DOI 10.1124/mol.60.5.989; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Martorana A, 2006, EUR J NEUROSCI, V24, P732, DOI 10.1111/j.1460-9568.2006.04932.x; Miura M, 2002, J NEUROSCI, V22, P8379; Nasif FJ, 2005, J PHARMACOL EXP THER, V312, P1305, DOI 10.1124/jpet.104.075184; Nasif FJ, 2005, J NEUROSCI, V25, P3674, DOI 10.1523/JNEUROSCI.0010-05.2005; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; Ordaz B, 2005, J BIOL CHEM, V280, P30788, DOI 10.1074/jbc.M504745200; Otsuka Y, 1998, TOHOKU J EXP MED, V185, P139, DOI 10.1620/tjem.185.139; Putney James W Jr, 2004, Novartis Found Symp, V258, P123; Putney JW, 2005, PFLUG ARCH EUR J PHY, V451, P29, DOI 10.1007/s00424-005-1416-4; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; SCHIEGG A, 1995, J NEUROPHYSIOL, V74, P1046, DOI 10.1152/jn.1995.74.3.1046; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; Simonyi A, 2005, DRUG NEWS PERSPECT, V18, P353, DOI 10.1358/dnp.2005.18.6.927927; Sosa R, 2002, J NEUROCHEM, V81, P973, DOI 10.1046/j.1471-4159.2002.00883.x; STEFANI A, 1994, J NEUROSCI, V14, P6734; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; VENKATACHALAM K, 2004, NOV FDN S, P172; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; von Bohlen und Halbach O, 2005, CELL TISSUE RES, V322, P201, DOI 10.1007/s00441-005-0004-4; Xie Q, 2005, EXP EYE RES, V81, P5, DOI 10.1016/j.exer.2005.01.003; Zhang F, 1997, SCIENCE, V275, P1318, DOI 10.1126/science.275.5304.1318; Zhu HF, 2005, CRYST GROWTH DES, V5, P289, DOI 10.1021/cg0498857; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	54	118	118	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e573	10.1371/journal.pone.0000573	http://dx.doi.org/10.1371/journal.pone.0000573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593972	Green Submitted, gold, Green Published			2022-12-27	WOS:000207451800017
J	Ganesh, SK; Sharma, Y; Dayhoff, J; Fales, HM; Van Eyk, J; Kickler, TS; Billings, EM; Nabel, EG				Ganesh, Santhi K.; Sharma, Yugal; Dayhoff, Judith; Fales, Henry M.; Van Eyk, Jennifer; Kickler, Thomas S.; Billings, Eric M.; Nabel, Elizabeth G.			Detection of Venous Thromboembolism by Proteomic Serum Biomarkers	PLOS ONE			English	Article							ACUTE PULMONARY-EMBOLISM; DEEP-VEIN THROMBOSIS; D-DIMER; CANCER; DIAGNOSIS; PATTERNS; MARKERS	Background. Available blood assays for venous thromboembolism (VTE) suffer from diminished specificity. Compared with single marker tests, such as D-dimer, a multi-marker strategy may improve diagnostic ability. We used direct mass spectrometry (MS) analysis of serum from patients with VTE to determine whether protein expression profiles would predict diagnosis. Methods and Results. We developed a direct MS and computational approach to the proteomic analysis of serum. Using this new method, we analyzed serum from inpatients undergoing radiographic evaluation for VTE. In a balanced cohort of 76 patients, a neural network-based prediction model was built using a training subset of the cohort to first identify proteomic patterns of VTE. The proteomic patterns were then validated in a separate group of patients within the cohort. The model yielded a sensitivity of 68% and specificity of 89%, which exceeded the specificity of D-dimer assay tested by latex agglutination, ELISA, and immunoturbimetric methods (sensitivity/specificity of 63.2%/60.5%, 97.4%/21.1%, 97.4%/15.8%, respectively). We validated differences in protein expression between patients with and without VTE using more traditional gel-based analysis of the same serum samples. Conclusion. Protein expression analysis of serum using direct MS demonstrates potential diagnostic utility for VTE. This pilot study is the first such direct MS study to be applied to a cardiovascular disease. Differences in protein expression were identified and subsequently validated in a separate group of patients. The findings in this initial cohort can be evaluated in other independent cohorts, including patients with inflammatory conditions and chronic (but not acute) VTE, for the diagnosis of VTE.	[Ganesh, Santhi K.; Sharma, Yugal; Dayhoff, Judith; Fales, Henry M.; Billings, Eric M.; Nabel, Elizabeth G.] NHLBI, Bethesda, MD 20892 USA; [Ganesh, Santhi K.; Nabel, Elizabeth G.] NHGRI, Bethesda, MD 20892 USA; [Van Eyk, Jennifer; Kickler, Thomas S.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University	Nabel, EG (corresponding author), NHLBI, Bldg 10, Bethesda, MD 20892 USA.	nabele@nhlbi.nih.gov			National Heart, Lung and Blood Institute; Division of Intramural Research; National Heart, Lung and Blood Institute Proteomic Initiative [NO-HV-28120]; Donald P. Amos Family Foundation; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100021, Z01HL001003] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200334] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute Proteomic Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Donald P. Amos Family Foundation; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Heart, Lung and Blood Institute, Division of Intramural Research, and in part by the National Heart, Lung and Blood Institute Proteomic Initiative (contract NO-HV-28120) (JVE) and the Donald P. Amos Family Foundation (JVE). We have no disclosures.	Andrews RT, 2004, CIRCULATION, V109, pI22, DOI 10.1161/01.CIR.0000122872.86196.09; Baggerly KA, 2004, BIOINFORMATICS, V20, P777, DOI 10.1093/bioinformatics/btg484; Bates SM, 2004, NEW ENGL J MED, V351, P268, DOI 10.1056/NEJMcp031676; Berkowitz DE, 2003, CIRCULATION, V108, P2000, DOI 10.1161/01.CIR.0000092948.04444.C7; Bockenstedt P, 2003, NEW ENGL J MED, V349, P1203, DOI 10.1056/NEJMp030084; Brotman DJ, 2003, AM J MED, V114, P276, DOI 10.1016/S0002-9343(02)01520-6; Check E, 2004, NATURE, V429, P496, DOI 10.1038/429496a; Coombes KR, 2005, NAT BIOTECHNOL, V23, P291, DOI 10.1038/nbt0305-291; Fedullo PF, 2003, NEW ENGL J MED, V349, P1247, DOI 10.1056/NEJMcp035442; Fu Q, 2005, PROTEOMICS, V5, P2656, DOI 10.1002/pmic.200402048; Goldhaber SZ, 2003, CIRCULATION, V108, P2726, DOI 10.1161/01.CIR.0000097829.89204.0C; Goldhaber SZ, 2004, LANCET, V363, P1295, DOI 10.1016/S0140-6736(04)16004-2; Goldhaber SZ, 2003, CIRCULATION, V108, P2834, DOI 10.1161/01.CIR.0000098427.74047.42; Hirsh J, 1996, CIRCULATION, V93, P2212, DOI 10.1161/01.CIR.93.12.2212; Kelly J, 2002, ARCH INTERN MED, V162, P747, DOI 10.1001/archinte.162.7.747; Liotta LA, 2003, NATURE, V425, P905, DOI 10.1038/425905a; Manolio T, 2003, NEW ENGL J MED, V349, P1587, DOI 10.1056/NEJMp038136; Morrow DA, 2003, CIRCULATION, V108, P250, DOI 10.1161/01.CIR.0000078080.37974.D2; NEDELKOV D, 2006, MOL CELL PROTEOMICS; Nelsestuen GL, 2005, PROTEOMICS, V5, P4012, DOI 10.1002/pmic.200401234; Papadopoulos MC, 2004, LANCET, V363, P1358, DOI 10.1016/S0140-6736(04)16046-7; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Petricoin EF, 2002, NAT REV DRUG DISCOV, V1, P683, DOI 10.1038/nrd891; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Ransohoff DF, 2003, SCIENCE, V299, P1679, DOI 10.1126/science.1083158; Reyzer ML, 2003, J MASS SPECTROM, V38, P1081, DOI 10.1002/jms.525; Sakkinen PA, 1999, AM J EPIDEMIOL, V149, P261; Stears RL, 2003, NAT MED, V9, P140, DOI 10.1038/nm0103-140; WELLS PS, 1995, CIRCULATION, V91, P2184, DOI 10.1161/01.CIR.91.8.2184; Wells PS, 1997, LANCET, V350, P1795, DOI 10.1016/S0140-6736(97)08140-3; Wells PS, 1998, LANCET, V351, P1405, DOI 10.1016/S0140-6736(05)79444-7; Zhu W, 2003, P NATL ACAD SCI USA, V100, P14666, DOI 10.1073/pnas.2532248100; 1990, JAMA, V263, P2753	34	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2007	2	6							e544	10.1371/journal.pone.0000544	http://dx.doi.org/10.1371/journal.pone.0000544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GE	17579716	Green Published, gold, Green Submitted			2022-12-27	WOS:000207451700010
J	Gilbert, MTP; Haselkorn, T; Bunce, M; Sanchez, JJ; Lucas, SB; Jewell, LD; Van Marck, E; Worobey, M				Gilbert, M. Thomas P.; Haselkorn, Tamara; Bunce, Michael; Sanchez, Juan J.; Lucas, Sebastian B.; Jewell, Laurence D.; Van Marck, Eric; Worobey, Michael			The Isolation of Nucleic Acids from Fixed, Paraffin-Embedded Tissues-Which Methods Are Useful When?	PLOS ONE			English	Article								Museums and pathology collections around the world represent an archive of genetic material to study populations and diseases. For preservation purposes, a large portion of these collections has been fixed in formalin-containing solutions, a treatment that results in cross-linking of biomolecules. Cross-linking not only complicates isolation of nucleic acid but also introduces polymerase "blocks" during PCR. A wide variety of methods exists for the recovery of DNA and RNA from archival tissues, and although a number of previous studies have qualitatively compared the relative merits of the different techniques, very few have undertaken wide scale quantitative comparisons. To help address this issue, we have undertaken a study that investigates the quality of nucleic acids recovered from a test panel of fixed specimens that have been manipulated following a number of the published protocols. These include methods of pre-treating the samples prior to extraction, extraction and nucleic acid purification methods themselves, and a post-extraction enzymatic repair technique. We find that although many of the published methods have distinct positive effects on some characteristics of the nucleic acids, the benefits often come at a cost. In addition, a number of the previously published techniques appear to have no effect at all. Our findings recommend that the extraction methodology adopted should be chosen carefully. Here we provide a quick reference table that can be used to determine appropriate protocols for particular aims.	[Gilbert, M. Thomas P.; Haselkorn, Tamara; Worobey, Michael] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Bunce, Michael] Murdoch Univ, Ancient DNA Lab, Sch Biol Sci & Biotechnol, Perth, WA, Australia; [Sanchez, Juan J.] Natl Inst Toxicol & Forens Sci, Tenerife, Spain; [Lucas, Sebastian B.] St Thomas Hosp, Dept Pathol, London, England; [Jewell, Laurence D.] Univ Alberta Hosp, Dept Lab Med & Pathol, Edmonton, AB T6G 2R7, Canada; [Van Marck, Eric] Univ Antwerp, Dept Pathol, Univ Hosp, B-2020 Antwerp, Belgium	University of Arizona; Murdoch University; Guy's & St Thomas' NHS Foundation Trust; University of Alberta; University of Antwerp	Gilbert, MTP (corresponding author), Univ Copenhagen, Ancient DNA & Evolut, Niels Bohr Inst, Copenhagen, Denmark.	mtpgilbert@gmail.com	Gilbert, Marcus TP/A-8936-2013	Gilbert, Marcus TP/0000-0002-5805-7195; Bunce, Michael/0000-0002-0302-4206	NIAID/NIH [5-R21-AI065371]; Packard Foundation; FORMAPLEX [FP6-MEIF-CT-2005-025002]; University of Arizona NSF Integrative Graduate Training [DGE-0114420]; Ellen and Aage Andersen's Foundation; European Commission [G6RD-CT-2002-00844]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065371] Funding Source: NIH RePORTER	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Packard Foundation(The David & Lucile Packard Foundation); FORMAPLEX; University of Arizona NSF Integrative Graduate Training; Ellen and Aage Andersen's Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIAID/NIH grant 5-R21-AI065371 and the Packard Foundation (MW), a Marie Curie Actions FP6-MEIF-CT-2005-025002 "FORMAPLEX" grant (MTPG), a University of Arizona NSF Integrative Graduate Training (IGERT) grant Genomics Initiative DGE-0114420 (TSH) and the Ellen and Aage Andersen's Foundation and the European Commission (G6RD-CT-2002-00844) (JJS).	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BANERJEE SK, 1995, BIOTECHNIQUES, V18, P768; Benavides J, 2006, J VIROL METHODS, V137, P317, DOI 10.1016/j.jviromet.2006.07.009; BONI J, 1993, J VIROL METHODS, V42, P309, DOI 10.1016/0166-0934(93)90042-P; Bonin S, 2005, J CLIN PATHOL, V58, P313, DOI 10.1136/jcp.2004.016477; Bonin S, 2003, J CLIN PATHOL-MOL PA, V56, P184, DOI 10.1136/mp.56.3.184; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; BRUTLAG D, 1969, BIOCHEMISTRY-US, V8, P3214, DOI 10.1021/bi00836a013; Coura R, 2005, J CLIN PATHOL, V58, P894, DOI 10.1136/jcp.2004.021352; DELAMBALLERIE X, 1994, J CLIN PATHOL, V47, P466, DOI 10.1136/jcp.47.5.466; Fang SG, 2002, BIOTECHNIQUES, V33, P604, DOI 10.2144/02333rr03_11827a; Feldman M Y, 1973, Prog Nucleic Acid Res Mol Biol, V13, P1, DOI 10.1016/S0079-6603(08)60099-9; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; GILBERT MTP, ELECTROPHOR IN PRESS; GOELZ SE, 1985, BIOCHEM BIOPH RES CO, V130, P118, DOI 10.1016/0006-291X(85)90390-0; GREER CE, 1991, AM J CLIN PATHOL, V95, P117, DOI 10.1093/ajcp/95.2.117; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; ILYIN YV, 1969, J MOL BIOL, V41, P299, DOI 10.1016/0022-2836(69)90395-7; ISOLA J, 1994, AM J PATHOL, V145, P1301; JACKSON V, 1978, CELL, V15, P945, DOI 10.1016/0092-8674(78)90278-7; JACKSON V, 1981, P NATL ACAD SCI-BIOL, V78, P6081, DOI 10.1073/pnas.78.10.6081; Krafft AE, 1995, J WILDLIFE DIS, V32, P410; Legrand B, 2002, FORENSIC SCI INT, V125, P205, DOI 10.1016/S0379-0738(01)00641-7; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Longy M, 1997, DIAGN MOL PATHOL, V6, P167, DOI 10.1097/00019606-199706000-00007; Miething F, 2006, J HISTOCHEM CYTOCHEM, V39, P351; MOLLER K, 1977, EUR J BIOCHEM, V76, P175, DOI 10.1111/j.1432-1033.1977.tb11583.x; Pattyn F, 2006, NUCLEIC ACIDS RES, V34, pD684, DOI 10.1093/nar/gkj155; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Romero RL, 1997, J FORENSIC SCI, V42, P708; ROSENTHAL R, 1978, PSYCHOL BULL, V85, P185, DOI 10.1037/0033-2909.85.1.185; Sambrook J., 2002, MOL CLONING LAB MANU; Sanchez JJ, 2006, ELECTROPHORESIS, V27, P1713, DOI 10.1002/elps.200500671; Shedlock AM, 1997, BIOTECHNIQUES, V22, P394, DOI 10.2144/97223bm03; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; Shi SR, 2004, HISTOCHEM CELL BIOL, V122, P211, DOI 10.1007/s00418-004-0693-x; Shi SR, 2002, J HISTOCHEM CYTOCHEM, V50, P1005, DOI 10.1177/002215540205000802; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; STANTA G, 1991, BIOTECHNIQUES, V11, P304; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; SULLIVAN KM, 1993, BIOTECHNIQUES, V15, P636; VARSHAVSKY AJ, 1979, CELL, V16, P453, DOI 10.1016/0092-8674(79)90021-7; VARSHAVSKY AJ, 1974, BIOCHIM BIOPHYS ACTA, V340, P207, DOI 10.1016/0005-2787(74)90114-2; Vince A, 1998, BRIT J HAEMATOL, V101, P349, DOI 10.1046/j.1365-2141.1998.00702.x; Wickham CL, 2000, J CLIN PATHOL-MOL PA, V53, P19, DOI 10.1136/mp.53.1.19; Wu L, 2002, APPL IMMUNOHISTO M M, V10, P269, DOI 10.1097/00022744-200209000-00015	47	282	332	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2007	2	6							e537	10.1371/journal.pone.0000537	http://dx.doi.org/10.1371/journal.pone.0000537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GE	17579711	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451700005
J	Olah, Z; Josvay, K; Pecze, L; Letoha, T; Babai, N; Budai, D; Otvos, F; Szalma, S; Vizler, C				Olah, Zoltan; Josvay, Katalin; Pecze, Laszlo; Letoha, Tamas; Babai, Norbert; Budai, Denes; Otvos, Ferenc; Szalma, Sandor; Vizler, Csaba			Anti-calmodulins and Tricyclic Adjuvants in Pain Therapy Block the TRPV1 Channel	PLOS ONE			English	Article								Ca2+-loaded calmodulin normally inhibits multiple Ca2+-channels upon dangerous elevation of intracellular Ca2+ and protects cells from Ca2+-cytotoxicity, so blocking of calmodulin should theoretically lead to uncontrolled elevation of intracellular Ca2+. Paradoxically, classical anti-psychotic, anti-calmodulin drugs were noted here to inhibit Ca2+-uptake via the vanilloid inducible Ca2+-channel/inflamatory pain receptor 1 (TRPV1), which suggests that calmodulin inhibitors may block pore formation and Ca2+ entry. Functional assays on TRPV1 expressing cells support direct, dose-dependent inhibition of vanilloid-induced Ca-45(2+)-uptake at mu M concentrations: calmidazolium (broad range)>= trifluoperazine (narrow range)>chlorpromazine/amitriptyline>"' fluphenazine>>W-7 and W-13 (only partially). Most likely a short acidic domain at the pore loop of the channel orifice functions as binding site either for Ca2+ or anti-calmodulin drugs. Camstatin, a selective peptide blocker of calmodulin, inhibits vanilloid-induced Ca2+-uptake in intact TRPV1(+) cells, and suggests an extracellular site of inhibition. TRPV1+, inflammatory pain-conferring nociceptive neurons from sensory ganglia, were blocked by various anti-psychotic and anti-calmodulin drugs. Among them, calmidazolium, the most effective calmodulin agonist, blocked Ca2+-entry by a non-competitive kinetics, affecting the TRPV1 at a different site than the vanilloid binding pocket. Data suggest that various calmodulin antagonists dock to an extracellular site, not found in other Ca2+-channels. Calmodulin antagonist-evoked inhibition of TRPV1 and NMDA receptors/Ca2+-channels was validated by microiontophoresis of calmidazolium to laminectomised rat monitored with extracellular single unit recordings in vivo. These unexpected findings may explain empirically noted efficacy of clinical pain adjuvant therapy that justify efforts to develop hits into painkillers, selective to sensory Ca2+-channels but not affecting motoneurons.	[Olah, Zoltan; Josvay, Katalin; Pecze, Laszlo; Otvos, Ferenc; Vizler, Csaba] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Olah, Zoltan; Letoha, Tamas] Acheuron Hungary Ltd, Szeged, Hungary; [Olah, Zoltan; Szalma, Sandor] Acheuron Pharmaceut Inc, San Diego, CA USA; [Letoha, Tamas] Univ Szeged, Dept Med Chem, Fac Gen Med, Szeged, Hungary; [Babai, Norbert] Univ Pecs, Dept Expt Zool & Neurobiol, Pecs, Hungary; [Budai, Denes] Univ Szeged, Dept Biol, Gyula Juhsz Fac Educ, Szeged, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University; University of Pecs; Szeged University	Olah, Z (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary.	zolah@brc.hu	Letoha, Tamas/ABG-6348-2020; Babai, Norbert/T-2952-2019	Szalma, Sandor/0000-0001-7591-3902	Jedlik Program [NKFP-1-00019/2005]; GVOP; National Office for Research and Technology [OM-00051/2005, OMFB-01575/2006]; Hungarian Ministry of Health [552/2006];  [MC-IRG030854-PAINKILLER];  [GVOP-3.3.1-05/1.-2005-05-0057/3.0]	Jedlik Program; GVOP; National Office for Research and Technology(National Office for Research and TechnologyTurkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Hungarian Ministry of Health; ; 	ZO was supported by MC-IRG030854-PAINKILLER; Anyos Jedlik Program NKFP-1-00019/2005; GVOP-3.3.1-05/1.-2005-05-0057/3.0. DB was also supported by GVOP, CV was also supported by grants the National Office for Research and Technology (OM-00051/2005 and OMFB-01575/2006) and the Hungarian Ministry of Health (552/2006).	ACS G, 1995, J PHARMACOL EXP THER, V274, P1090; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; Brown DC, 2005, ANESTHESIOLOGY, V103, P1052, DOI 10.1097/00000542-200511000-00020; Bruening-Wright A, 2002, J NEUROSCI, V22, P6499; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Del Carlo B, 2002, BBA-BIOMEMBRANES, V1558, P133, DOI 10.1016/S0005-2736(01)00419-9; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Douglass PM, 2002, BIOCONJUGATE CHEM, V13, P1186, DOI 10.1021/bc010080b; Fang L, 2002, J NEUROSCI, V22, P4196, DOI 10.1523/JNEUROSCI.22-10-04196.2002; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Garcia-Martinez C, 2000, J BIOL CHEM, V275, P32552, DOI 10.1074/jbc.M002391200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Harper JL, 2000, BIOCHEM PHARMACOL, V60, P317, DOI 10.1016/S0006-2952(00)00349-X; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johanson RA, 2000, J NEUROSCI, V20, P2860; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; Jung J, 1999, J NEUROSCI, V19, P529; JUNG J, 2003, J BIOL CHEM; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; KARAI L, 1994, J BIOL CHEM; Karai LJ, 2004, J BIOL CHEM, V279, P16377, DOI 10.1074/jbc.M310891200; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; KHOROMI S, 2006, PAIN; Kieburtz K, 1998, NEUROLOGY, V51, P1682, DOI 10.1212/WNL.51.6.1682; Kitaguchi T, 2005, BIOCHEMISTRY-US, V44, P15544, DOI 10.1021/bi051494l; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Likic VA, 2005, PROTEIN SCI, V14, P2955, DOI 10.1110/ps.051681605; Liu M, 2003, J BIOL CHEM, V278, P5462, DOI 10.1074/jbc.M209111200; Marshall ICB, 2003, BRIT J PHARMACOL, V138, P172, DOI 10.1038/sj.bjp.0705003; MAX MB, 1994, ANN NEUROL, V35, pS50, DOI 10.1002/ana.410350715; Menendez L, 1996, BRAIN RES, V731, P114, DOI 10.1016/S0006-8993(96)00480-5; Mohapatra DP, 2003, MOL CELL NEUROSCI, V23, P314, DOI 10.1016/S1044-7431(03)00054-X; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Olah Z, 2002, J BIOL CHEM, V277, P35752, DOI 10.1074/jbc.M201551200; Olah Z, 2001, J BIOL CHEM, V276, P31163, DOI 10.1074/jbc.M101607200; Olah Z, 2001, J BIOL CHEM, V276, P11021, DOI 10.1074/jbc.M008392200; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Rigden DJ, 2003, FEMS MICROBIOL LETT, V221, P103, DOI 10.1016/S0378-1097(03)00160-5; Robinson LR, 2004, ARCH PHYS MED REHAB, V85, P1, DOI 10.1016/S0003-9993(03)00476-3; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Slemmon JR, 1996, J BIOL CHEM, V271, P15911, DOI 10.1074/jbc.271.27.15911; Soldatov MM, 2003, TRENDS PHARMACOL SCI, V24, P167, DOI 10.1016/S0165-6147(03)00065-8; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tender GC, 2005, J NEUROSURG, V102, P522, DOI 10.3171/jns.2005.102.3.0522; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Williams M, 1999, J MED CHEM, V42, P1481, DOI 10.1021/jm9805034; Zhang T, 2001, INFORM RETRIEVAL, V4, P5, DOI 10.1023/A:1011441423217; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	57	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2007	2	6							e545	10.1371/journal.pone.0000545	http://dx.doi.org/10.1371/journal.pone.0000545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GE	17579717	gold, Green Submitted, Green Published			2022-12-27	WOS:000207451700011
J	Bergsten, J; Miller, KB				Bergsten, Johannes; Miller, Kelly B.			Phylogeny of Diving Beetles Reveals a Coevolutionary Arms Race between the Sexes	PLOS ONE			English	Article								Background. Darwin illustrated his sexual selection theory with male and female morphology of diving beetles, but maintained a cooperative view of their interaction. Present theory suggests that instead sexual conflict should be a widespread evolutionary force driving both intersexual coevolutionary arms races and speciation. Methodology/Principal Findings. We combined Bayesian phylogenetics, complete taxon sampling and a multi-gene approach to test the arms race scenario on a robust diving beetle phylogeny. As predicted, suction cups in males and modified dorsal surfaces in females showed a pronounced coevolutionary pattern. The female dorsal modifications impair the attachment ability of male suction cups, but each antagonistic novelty in females corresponds to counter-differentiation of suction cups in males. Conclusions. A recently diverged sibling species pair in Japan is possibly one consequence of this arms race and we suggest that future studies on hypoxia might reveal the key to the extraordinary selection for female counter-adaptations in diving beetles.	[Bergsten, Johannes] Nat Hist Museum, Dept Entomol, London SW7 5BD, England; [Bergsten, Johannes] Imperial Coll London, Div Biol, Ascot, Berks, England; [Miller, Kelly B.] Univ New Mexico, Museum SW Biol, Dept Entomol, Albuquerque, NM 87131 USA	Natural History Museum London; Imperial College London; University of New Mexico	Bergsten, J (corresponding author), Nat Hist Museum, Dept Entomol, Cromwell Rd, London SW7 5BD, England.	j.bergsten@nhm.ac.uk	Miller, Kelly/I-6651-2012		US National Science Foundation	US National Science Foundation(National Science Foundation (NSF))	support came from US National Science Foundation, Stiftelsen J.C. Kempes Minnes Stipendiefond and Helge Axson Johnsons Stiftelse.	AIKEN RB, 1992, ETHOL ECOL EVOL, V4, P245, DOI 10.1080/08927014.1992.9523136; AIKEN RB, 1992, CAN J ZOOL, V70, P1321, DOI 10.1139/z92-185; Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; Arnqvist G, 2002, EVOLUTION, V56, P936; Arnqvist G., 2005, SEXUAL CONFLICT, P360; Barraclough TG, 2001, TRENDS ECOL EVOL, V16, P391, DOI 10.1016/S0169-5347(01)02161-9; Bergsten J, 2006, SYST ENTOMOL, V31, P145, DOI 10.1111/j.1365-3113.2005.00309.x; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bergsten J, 2001, BIOL J LINN SOC, V73, P221, DOI 10.1006/bijl.2001.0540; BROOKS R, 2005, TREE, V20, P294; Brower AVZ, 1997, P ROY SOC B-BIOL SCI, V264, P969, DOI 10.1098/rspb.1997.0134; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Cordero C, 2003, J EVOLUTION BIOL, V16, P1, DOI 10.1046/j.1420-9101.2003.00506.x; Darwin C., 1871, P423; DOBSON M, 1994, MAMMAL REV, V24, P91, DOI 10.1111/j.1365-2907.1994.tb00137.x; Eberhard WG, 2004, EVOLUTION, V58, P1947; Edvardsson M, 2006, BEHAV GENET, V36, P775, DOI 10.1007/s10519-005-9043-6; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; GOLOBOFF P, 2003, TNT SOFTWARE VER 1 0; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Hosken D, 2005, AM NAT, V165, pS1, DOI 10.1086/429355; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2000, SCIENCE, V288, P2349, DOI 10.1126/science.288.5475.2349; Koene JM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-25; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Martin OY, 2003, NATURE, V423, P979, DOI 10.1038/nature01752; Miller KB, 2003, BIOL J LINN SOC, V79, P359, DOI 10.1046/j.1095-8312.2003.00195.x; NAUMANN H, 1955, GELBRANDKAFER, P80; Pischedda A, 2006, PLOS BIOL, V4, P2099, DOI 10.1371/journal.pbio.0040356; Pizzari T, 2003, EVOLUTION, V57, P1223, DOI 10.1111/j.0014-3820.2003.tb00331.x; Rice WR, 1998, ENDLESS FORMS, P261; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Ronquist F, 2004, TRENDS ECOL EVOL, V19, P475, DOI 10.1016/j.tree.2004.07.002; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Tregenza T, 2006, PHILOS T R SOC B, V361, P229, DOI 10.1098/rstb.2005.1796; WESENBERGLUND C, 1912, BIOL STUDIEN DYTISCI, P129; Wichard W., 2002, Biological atlas of aquatic insects	42	54	56	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2007	2	6							e522	10.1371/journal.pone.0000522	http://dx.doi.org/10.1371/journal.pone.0000522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GD	17565375	gold, Green Published			2022-12-27	WOS:000207451600010
J	Wang, Q; Pang, YP				Wang, Qi; Pang, Yuan-Ping			Accurate Reproduction of 161 Small-Molecule Complex Crystal Structures using the EUDOC Program: Expanding the Use of EUDOC to Supramolecular Chemistry	PLOS ONE			English	Article							CHEMICAL DATABASE; DRUG-LEAD; INHIBITORS; IDENTIFICATION; QUINOXALINE; DISCOVERY; GENOME	EUDOC is a docking program that has successfully predicted small-molecule-bound protein complexes and identified drug leads from chemical databases. To expand the application of the EUDOC program to supramolecular chemistry, we tested its ability to reproduce crystal structures of small-molecule complexes. Of 161 selected crystal structures of small-molecule guest-host complexes, EUDOC reproduced all these crystal structures with guest structure mass-weighted root mean square deviations (mwRMSDs) of < 1.0 angstrom relative to the corresponding crystal structures. In addition, the average interaction energy of these 161 guest-host complexes (-50.1 kcal/mol) was found to be nearly half of that of 153 previously tested small-molecule-bound protein complexes (-108.5 kcal/mol), according to the interaction energies calculated by EUDOC. 31 of the 161 complexes could not be reproduced with mwRMSDs of < 1.0 angstrom if neighboring hosts in the crystal structure of a guest-host complex were not included as part of the multimeric host system, whereas two of the 161 complexes could not be reproduced with mwRMSDs of < 1.0 angstrom if water molecules were excluded from the host system. These results demonstrate the significant influence of crystal packing on small molecule complexation and suggest that EUDOC is able to predict small-molecule complexes and that it is useful for the design of new materials, molecular sensors, and multimeric inhibitors of protein-protein interactions.	[Wang, Qi; Pang, Yuan-Ping] Mayo Clin, Comp Aided Mol Design Lab, Rochester, MN 55905 USA	Mayo Clinic	Pang, YP (corresponding author), Mayo Clin, Comp Aided Mol Design Lab, Rochester, MN 55905 USA.	pang@mayo.edu		Pang, Yuan-Ping/0000-0003-0838-2560	U. S. Army Medical Research Acquisition Activity [W81XWH-04-2-0001]; National Institutes of Health [5R01AI054574-03]; Mayo Graduate School; Mayo Foundation for Medical Education and Research	U. S. Army Medical Research Acquisition Activity; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Graduate School; Mayo Foundation for Medical Education and Research	This work was supported by the U. S. Army Medical Research Acquisition Activity (W81XWH-04-2-0001), the National Institutes of Health (5R01AI054574-03), Mayo Graduate School, and the Mayo Foundation for Medical Education and Research.	Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DESJARLAIS RL, 1990, P NATL ACAD SCI USA, V87, P6644, DOI 10.1073/pnas.87.17.6644; Dooley AJ, 2006, BIOORG MED CHEM LETT, V16, P830, DOI 10.1016/j.bmcl.2005.11.018; DUFFY EM, 1994, J AM CHEM SOC, V116, P6337, DOI 10.1021/ja00093a038; Eyal E, 2005, J MOL BIOL, V351, P431, DOI 10.1016/j.jmb.2005.05.066; Frisch M.J., 2016, GAUSSIAN16 REV B01; LEHN JM, 1993, SCIENCE, V260, P1762, DOI 10.1126/science.8511582; Miller MA, 2002, NAT REV DRUG DISCOV, V1, P220, DOI 10.1038/nrd745; Pang YP, 2007, CLIN PHARMACOL THER, V81, P30, DOI 10.1038/sj.clpt.6100030; Pang YP, 2001, J COMPUT CHEM, V22, P1750, DOI 10.1002/jcc.1129; Pang YP, 2001, FEBS LETT, V502, P93, DOI 10.1016/S0014-5793(01)02672-2; PANG YP, 2007, IBM J RES D IN PRESS; Park JG, 2006, BIOORGAN MED CHEM, V14, P395, DOI 10.1016/j.bmc.2005.08.018; PASCAL RA, 1993, J AM CHEM SOC, V115, P8507, DOI 10.1021/ja00071a094; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Perola E, 2000, J MED CHEM, V43, P401, DOI 10.1021/jm990408a; Raves ML, 1997, NAT STRUCT BIOL, V4, P57, DOI 10.1038/nsb0197-57; REBEK J, 1986, J AM CHEM SOC, V108, P5637, DOI 10.1021/ja00278a052; Sun H, 2002, MOL PHARMACOL, V62, P220, DOI 10.1124/mol.62.2.220	21	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2007	2	6							e531	10.1371/journal.pone.0000531	http://dx.doi.org/10.1371/journal.pone.0000531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GD	17565384	Green Submitted, Green Published, gold			2022-12-27	WOS:000207451600019
J	Selman, M; Carrillo, G; Estrada, A; Mejia, M; Becerril, C; Cisneros, J; Gaxiola, M; Perez-Padilla, R; Navarro, C; Richards, T; Dauber, J; King, TE; Pardo, A; Kaminski, N				Selman, Moises; Carrillo, Guillermo; Estrada, Andrea; Mejia, Mayra; Becerril, Carina; Cisneros, Jose; Gaxiola, Miguel; Perez-Padilla, Rogelio; Navarro, Carmen; Richards, Thomas; Dauber, James; King, Talmadge E., Jr.; Pardo, Annie; Kaminski, Naftali			Accelerated Variant of Idiopathic Pulmonary Fibrosis: Clinical Behavior and Gene Expression Pattern	PLOS ONE			English	Article							LUNG-FUNCTION; PATHOGENESIS; SURVIVAL; MATRIX-METALLOPROTEINASE-9; THERAPY; MARKER	Background. Idiopathic pulmonary fibrosis (IPF) is characterized by the insidious onset of dyspnea or cough. However, a subset of patients has a short duration of symptoms with rapid progression to end-stage disease. In this study, we evaluated clinical and molecular features of "rapid'' and "slow'' progressors with IPF. Methods and Findings. 26 patients with,6 months of symptoms before first presentation [rapid progressors] and 88 patients with >24 months of symptoms [slow progressors] were studied. Survival was analyzed by the Kaplan-Meyer method and proportional hazard's model. Lung microarrays and tissue proteins were measured in a subset of patients. No differences were found in age, physiologic impairment and bronchoalveolar lavage (BAL) cellular profile. There were more males (OR = 6.5; CI: 1.4-29.5; p = 0.006) and smokers (OR = 3.04; CI: 1.1-8.3; p = 0.04) in the rapid progressors group. Survival from the beginning of symptoms was significantly reduced in rapid progressors (HR = 9.0; CI: 4.48-18.3; p<0.0001) and there was a tendency for decreased survival from the time of diagnosis (HR = 1.5; CI: 0.81-2.87; p = 0.18). We identified 437 differentially expressed genes. Lungs of rapid progressors overexpressed genes involved in morphogenesis, oxidative stress, migration/proliferation, and genes from fibroblasts/smooth muscle cells. Upregulation of two of these genes, adenosine-2B receptor and prominin-1/CD133, was validated by immunohistochemistry and were expressed by alveolar epithelial cells. BAL from rapid progressors showed a >2-fold increase of active matrix metalloproteinase-9, and induced a higher fibroblast migration compared with slow progressors and controls [238 +/- 98% versus 123 +/- 29% (p < 0.05) and 30 +/- 17% (p < 0.01)]. Conclusions/Significance. A subgroup of IPF patients, predominantly smoking males, display an accelerated clinical course and have a gene expression pattern that is different from those with slower progression and longer survival. These findings highlight the variability in the progression of IPF, and may explain, in part, the difficulty in obtaining significant and reproducible results in studies of therapeutic interventions in patients with IPF.	[Selman, Moises; Carrillo, Guillermo; Estrada, Andrea; Mejia, Mayra; Becerril, Carina; Cisneros, Jose; Gaxiola, Miguel; Perez-Padilla, Rogelio; Navarro, Carmen] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Richards, Thomas; Dauber, James; Kaminski, Naftali] Univ Pittsburgh, Dorothy P & Richard P Simmons Ctr Interstitial Lu, Pittsburgh, PA USA; [King, Talmadge E., Jr.] San Francisco Gen Hosp, Div Pulm & Crit Care Med, Dept Med, San Francisco, CA 94110 USA; [Pardo, Annie] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City 04510, DF, Mexico	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; San Francisco General Hospital Medical Center; Universidad Nacional Autonoma de Mexico	Selman, M (corresponding author), Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico.	mselmanl@yahoo.com.mx		Cisneros, Jose/0000-0002-4592-4464; Kaminski, Naftali/0000-0001-5917-4601	Universidad Nacional Autonoma de Mexico [SDI.PTID.05.6]; NIH [HL073745, HL079394]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL079394, R01HL073745] Funding Source: NIH RePORTER	Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was partially supported by Universidad Nacional Autonoma de Mexico Grant SDI.PTID.05.6. Naftali Kaminski's work was supported by NIH grant HL073745, HL079394 and by a generous donation from the Simmons family. Funding sources were not involved in study design, performance, analysis or manuscript preparation.	*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; Ambrosini V, 2003, EUR RESPIR J, V22, P821, DOI 10.1183/09031936.03.00022703; Atkinson JJ, 2003, AM J RESP CELL MOL, V28, P12, DOI 10.1165/rcmb.2002-0166TR; Ben-Dor A, 2000, J COMPUT BIOL, V7, P559, DOI 10.1089/106652700750050943; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolton WK, 2001, NEPHRON, V88, P6, DOI 10.1159/000045952; Carr BA, 2003, J BIOL CHEM, V278, P15473, DOI 10.1074/jbc.M300319200; Chunn JL, 2006, AM J PHYSIOL-LUNG C, V290, pL579, DOI 10.1152/ajplung.00258.2005; Cisneros-Lira J, 2003, AM J PHYSIOL-LUNG C, V285, pL949, DOI 10.1152/ajplung.00074.2003; Collard HR, 2004, CHEST, V125, P2169, DOI 10.1378/chest.125.6.2169; Demling N, 2006, CELL TISSUE RES, V323, P475, DOI 10.1007/s00441-005-0069-0; Egan JJ, 2005, THORAX, V60, P270, DOI 10.1136/thx.2004.035436; Fukuda Y, 1998, LAB INVEST, V78, P687; Gahl WA, 2002, MOL GENET METAB, V76, P234, DOI 10.1016/S1096-7192(02)00044-6; Gay SE, 1998, AM J RESP CRIT CARE, V157, P1063, DOI 10.1164/ajrccm.157.4.9703022; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Hanford LE, 2003, AM J RESP CELL MOL, V29, pS77; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; He JQ, 2002, AM J RESP CRIT CARE, V166, P323, DOI 10.1164/rccm.2111059; Heguy A, 2006, J MOL MED, V84, P318, DOI 10.1007/s00109-005-0008-2; Hogan CM, 2001, ANN INTERN MED, V134, P761, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00013; HYDE DM, 1992, AM REV RESPIR DIS, V146, P1042, DOI 10.1164/ajrccm/146.4.1042; Kaminski N, 2002, AM J RESP CELL MOL, V27, P125, DOI 10.1165/ajrcmb.27.2.f247; Kania G, 2005, STEM CELLS, V23, P791, DOI 10.1634/stemcells.2004-0232; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977, DOI 10.2214/ajr.169.4.9308447; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; Marshall A, 2005, LIVER TRANSPLANT, V11, P427, DOI 10.1002/lt.20347; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; MCCORMAC FX, 1995, AM J RESP CRIT CARE, V152, P751, DOI 10.1164/ajrccm.152.2.7633738; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Pardo A, 2003, AM J RESP CRIT CARE, V167, P925, DOI 10.1164/rccm.200209-1007OC; PEREZPADILLA R, 1993, AM REV RESPIR DIS, V148, P49, DOI 10.1164/ajrccm/148.1.49; Radom-Aizik S, 2005, MED SCI SPORT EXER, V37, P1680, DOI 10.1249/01.mss.0000181838.96815.4d; Raghu G, 2004, NEW ENGL J MED, V350, P125, DOI 10.1056/NEJMoa030511; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Selman M, 2000, AM J PHYSIOL-LUNG C, V279, pL562, DOI 10.1152/ajplung.2000.279.3.L562; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; Selman M, 1998, CHEST, V114, P507, DOI 10.1378/chest.114.2.507; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Shmelkov SV, 2005, INT J BIOCHEM CELL B, V37, P715, DOI 10.1016/j.biocel.2004.08.010; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Woodruff PG, 2005, AM J RESP CRIT CARE, V172, P1383, DOI 10.1164/rccm.200505-686OC; Yu Q, 2000, GENE DEV, V14, P163; Zhong HY, 2005, AM J RESP CELL MOL, V32, P2, DOI 10.1165/rcmb.2004-0103OC	45	196	203	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2007	2	5							e482	10.1371/journal.pone.0000482	http://dx.doi.org/10.1371/journal.pone.0000482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10FB	17534432	Green Accepted, gold, Green Published			2022-12-27	WOS:000207448800012
J	del Rio, G; Kane, DJ; Ball, KD; Bredesen, DE				del Rio, Gabriel; Kane, Darci J.; Ball, Keith D.; Bredesen, Dale E.			A Novel Motif Identified in Dependence Receptors	PLOS ONE			English	Article								Programmed cell death signaling is a critical feature of development, cellular turnover, oncogenesis, and neurodegeneration, among other processes. Such signaling may be transduced via specific receptors, either following ligand binding-to death receptors-or following the withdrawal of trophic ligands-from dependence receptors. Although dependence receptors display functional similarities, no common structural domains have been identified. Therefore, we employed the Multiple Expectation Maximization for Motif Elicitation and the Motif Alignment and Search Tool software programs to identify a novel transmembrane motif, dubbed dependence-associated receptor transmembrane (DART) motif, that is common to all described dependence receptors. Of 3,465 human transmembrane proteins, 25 (0.7%) display the DART motif. The predicted secondary structure features an alpha helical structure, with an unusually high percentage of valine residues. At least four of the proteins undergo regulated intramembrane proteolysis. To date, we have not identified a function for this putative domain. We speculate that the DART motif may be involved in protein processing, interaction with other proteins or lipids, or homomultimerization.	[del Rio, Gabriel; Kane, Darci J.; Ball, Keith D.; Bredesen, Dale E.] Buck Inst Age Res, Novato, CA USA; [Bredesen, Dale E.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	Buck Institute for Research on Aging; University of California System; University of California San Francisco	Bredesen, DE (corresponding author), Buck Inst Age Res, Novato, CA USA.	dbredesen@buckinstitute.org			American Bioscience, Inc.; NIH [NS45093, AG12282, NS33376]; CoNaCyT [SEP-2004-C01-47399/A-1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033376, R01NS045093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012282] Funding Source: NIH RePORTER	American Bioscience, Inc.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CoNaCyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant to the Buck Institute from American Bioscience, Inc., by NIH grants NS45093, AG12282 and NS33376 to DEB and by CoNaCyT grant SEP-2004-C01-47399/A-1 to GDR.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Beher D, 1996, J BIOL CHEM, V271, P1613, DOI 10.1074/jbc.271.3.1613; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bredesen DE, 2005, CELL DEATH DIFFER, V12, P1031, DOI 10.1038/sj.cdd.4401680; Bredesen DE, 2004, PHYSIOL REV, V84, P411, DOI 10.1152/physrev.00027.2003; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Caceres J, 1997, J CELL BIOCHEM, V65, P145, DOI 10.1002/(SICI)1097-4644(199705)65:2<145::AID-JCB2>3.0.CO;2-U; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Galvan V, 2002, J NEUROCHEM, V82, P283, DOI 10.1046/j.1471-4159.2002.00970.x; Gurezka R, 1999, J BIOL CHEM, V274, P9265, DOI 10.1074/jbc.274.14.9265; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Mehlen P, 2004, APOPTOSIS, V9, P37, DOI 10.1023/B:APPT.0000012120.66221.b2; MEHLEN P, 2003, SCI STKE, pPE55; Williamson TG, 1996, J BIOL CHEM, V271, P31215, DOI 10.1074/jbc.271.49.31215	16	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2007	2	5							e463	10.1371/journal.pone.0000463	http://dx.doi.org/10.1371/journal.pone.0000463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DZ	17520022	Green Published, gold, Green Submitted			2022-12-27	WOS:000207446000011
J	Hurowitz, EH; Drori, I; Stodden, VC; Donoho, DL; Brown, PO				Hurowitz, Evan H.; Drori, Iddo; Stodden, Victoria C.; Donoho, David L.; Brown, Patrick O.			Virtual Northern Analysis of the Human Genome	PLOS ONE			English	Article							RNA; DATABASE	Background. We applied the Virtual Northern technique to human brain mRNA to systematically measure human mRNA transcript lengths on a genome-wide scale. Methodology/Principal Findings. We used separation by gel electrophoresis followed by hybridization to cDNA microarrays to measure 8,774 mRNA transcript lengths representing at least 6,238 genes at high (>90%) confidence. By comparing these transcript lengths to the Refseq and H-Invitational full-length cDNA databases, we found that nearly half of our measurements appeared to represent novel transcript variants. Comparison of length measurements determined by hybridization to different cDNAs derived from the same gene identified clones that potentially correspond to alternative transcript variants. We observed a close linear relationship between ORF and mRNA lengths in human mRNAs, identical in form to the relationship we had previously identified in yeast. Some functional classes of protein are encoded by mRNAs whose untranslated regions (UTRs) tend to be longer or shorter than average; these functional classes were similar in both human and yeast. Conclusions/Significance. Human transcript diversity is extensive and largely unannotated. Our length dataset can be used as a new criterion for judging the completeness of cDNAs and annotating mRNA sequences. Similar relationships between the lengths of the UTRs in human and yeast mRNAs and the functions of the proteins they encode suggest that UTR sequences serve an important regulatory role among eukaryotes.	[Hurowitz, Evan H.; Brown, Patrick O.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Drori, Iddo; Stodden, Victoria C.; Donoho, David L.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Brown, Patrick O.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Brown, PO (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	pbrown@cmgm.stanford.edu			NIH [CA77097]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA077097] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant CA77097 and by the Howard Hughes Medical Institute. P.O.B. is an investigator of the Howard Hughes Medical Institute. Neither the NIH nor HHMI participated in the design and conduct of the study or the manuscript.	Chen SSB, 1998, SIAM J SCI COMPUT, V20, P33, DOI 10.1137/S1064827596304010; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Donoho D.L, 2004, COMM PURE APPL MATH; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P6, DOI 10.1109/TIT.2005.860430; Donoho DL, 2005, P NATL ACAD SCI USA, V102, P9446, DOI 10.1073/pnas.0502269102; Hurowitz EH, 2004, GENOME BIOL, V5; Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; SAUNDERS MA, 2005, PDCO PRIMAL DUAL INT; Stamm S, 2000, DNA CELL BIOL, V19, P739, DOI 10.1089/104454900750058107; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Suzuki Y, 1997, GENE, V200, P149, DOI 10.1016/S0378-1119(97)00411-3; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Wheeler DL, 2004, NUCLEIC ACIDS RES, V32, pD35, DOI 10.1093/nar/gkh073; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3754, DOI 10.1093/nar/gkf492	23	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2007	2	5							e460	10.1371/journal.pone.0000460	http://dx.doi.org/10.1371/journal.pone.0000460			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DZ	17520019	gold, Green Published			2022-12-27	WOS:000207446000008
J	Van Ert, MN; Easterday, WR; Huynh, LY; Okinaka, RT; Hugh-Jones, ME; Ravel, J; Zanecki, SR; Pearson, T; Simonson, TS; U'Ren, JM; Kachur, SM; Leadem-Dougherty, RR; Rhoton, SD; Zinser, G; Farlow, J; Coker, PR; Smith, KL; Wang, BX; Kenefic, LJ; Fraser-Liggett, CM; Wagner, DM; Keim, P				Van Ert, Matthew N.; Easterday, W. Ryan; Huynh, Lynn Y.; Okinaka, Richard T.; Hugh-Jones, Martin E.; Ravel, Jacques; Zanecki, Shaylan R.; Pearson, Talima; Simonson, Tatum S.; U'Ren, Jana M.; Kachur, Sergey M.; Leadem-Dougherty, Rebecca R.; Rhoton, Shane D.; Zinser, Guenevier; Farlow, Jason; Coker, Pamala R.; Smith, Kimothy L.; Wang, Bingxiang; Kenefic, Leo J.; Fraser-Liggett, Claire M.; Wagner, David M.; Keim, Paul			Global Genetic Population Structure of Bacillus anthracis	PLOS ONE			English	Article								Anthrax, caused by the bacterium Bacillus anthracis, is a disease of historical and current importance that is found throughout the world. The basis of its historical transmission is anecdotal and its true global population structure has remained largely cryptic. Seven diverse B. anthracis strains were whole-genome sequenced to identify rare single nucleotide polymorphisms (SNPs), followed by phylogenetic reconstruction of these characters onto an evolutionary model. This analysis identified SNPs that define the major clonal lineages within the species. These SNPs, in concert with 15 variable number tandem repeat (VNTR) markers, were used to subtype a collection of 1,033 B. anthracis isolates from 42 countries to create an extensive genotype data set. These analyses subdivided the isolates into three previously recognized major lineages (A, B, and C), with further subdivision into 12 clonal sub-lineages or sub-groups and, finally, 221 unique MLVA15 genotypes. This rare genomic variation was used to document the evolutionary progression of B. anthracis and to establish global patterns of diversity. Isolates in the A lineage are widely dispersed globally, whereas the B and C lineages occur on more restricted spatial scales. Molecular clock models based upon genome-wide synonymous substitutions indicate there was a massive radiation of the A lineage that occurred in the mid-Holocene (3,064-6,127 ybp). On more recent temporal scales, the global population structure of B. anthracis reflects colonial-era importation of specific genotypes from the Old World into the New World, as well as the repeated industrial importation of diverse genotypes into developed countries via spore-contaminated animal products. These findings indicate humans have played an important role in the evolution of anthrax by increasing the proliferation and dispersal of this now global disease. Finally, the value of global genotypic analysis for investigating bioterrorist-mediated outbreaks of anthrax is demonstrated.	[Van Ert, Matthew N.; Easterday, W. Ryan; Huynh, Lynn Y.; Okinaka, Richard T.; Zanecki, Shaylan R.; Pearson, Talima; Simonson, Tatum S.; U'Ren, Jana M.; Kachur, Sergey M.; Leadem-Dougherty, Rebecca R.; Rhoton, Shane D.; Zinser, Guenevier; Farlow, Jason; Smith, Kimothy L.; Kenefic, Leo J.; Wagner, David M.; Keim, Paul] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Okinaka, Richard T.; Keim, Paul] Los Alamos Natl Lab, Los Alamos, NM USA; [Hugh-Jones, Martin E.; Coker, Pamala R.] Louisiana State Univ, Dept Environm Studies, Baton Rouge, LA 70803 USA; [Ravel, Jacques; Fraser-Liggett, Claire M.] Inst Genom Res, Rockville, MD USA; [Wang, Bingxiang] Lanzhou Inst Biol Prod, Lanzhou, Peoples R China; [Keim, Paul] Translat Genom Res Inst, Pathogen Genom Div, Phoenix, AZ USA	Northern Arizona University; United States Department of Energy (DOE); Los Alamos National Laboratory; Louisiana State University System; Louisiana State University; J. Craig Venter Institute; Translational Genomics Research Institute	Keim, P (corresponding author), No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA.	Paul.Keim@nau.edu	Smith, Kimothy/AAI-9775-2020; Easterday, W. Ryan/M-6732-2015; Pearson, Talima/O-7840-2019; Keim, Paul S/A-2269-2010; Ravel, Jacques/D-2530-2009; Wagner, David M/A-5125-2010; U'Ren, Jana M/Y-2113-2019	Easterday, W. Ryan/0000-0001-5865-7062; Pearson, Talima/0000-0003-3696-041X; U'Ren, Jana M/0000-0001-7608-5029; Ravel, Jacques/0000-0002-0851-2233; Wagner, David/0000-0003-2684-6007; Fraser, Claire/0000-0003-1462-2428	National Institutes of Health, General Medical Sciences; U.S. Departments of Energy and Homeland Security	National Institutes of Health, General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Departments of Energy and Homeland Security	Funding for this work was provided by the National Institutes of Health, General Medical Sciences and the U.S. Departments of Energy and Homeland Security.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], 1997, GUNS GERMS STEEL; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Cheung DTL, 2005, J CLIN MICROBIOL, V43, P1992, DOI 10.1128/JCM.43.4.1992-1994.2005; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; DOIG AT, 1951, LANCET, V260, P1011; Dragon DC, 1999, J APPL MICROBIOL, V87, P208, DOI 10.1046/j.1365-2672.1999.00872.x; Drake JW, 1999, ANN NY ACAD SCI, V870, P100, DOI 10.1111/j.1749-6632.1999.tb08870.x; Drake JW, 1998, GENETICS, V148, P1667; Easterday WR, 2005, J CLIN MICROBIOL, V43, P1995, DOI 10.1128/JCM.43.4.1995-1997.2005; Fasanella A, 2005, J CLIN MICROBIOL, V43, P3398, DOI 10.1128/JCM.43.7.3398-3401.2005; Fouet AS, 2002, J CLIN MICROBIOL, V40, P4732, DOI 10.1128/JCM.40.12.4732-4734.2002; GEERING W, 1997, ANTHRAX AUSTR; Gierczynski R, 2004, FEMS MICROBIOL LETT, V239, P235, DOI 10.1016/j.femsle.2004.08.038; GREEN DM, 1958, LANCET, V2, P153; HANSON RP, 1959, J AM VET MDE ASS, V135; Hoffmaster AR, 2002, EMERG INFECT DIS, V8, P1111, DOI 10.3201/eid0810.020394; JAMIESON WM, 1955, LANCET, V1, P560; JONES WI, 1967, J BACTERIOL, V94, P600, DOI 10.1128/JB.94.3.600-608.1967; Kassen R, 2004, NATURE, V431, P984, DOI 10.1038/nature02923; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Keim P, 2001, J CLIN MICROBIOL, V39, P4566, DOI 10.1128/JCM.39.12.4566-4567.2001; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; KEIM PS, 2007, INTRO EVOLU IN PRESS; KLEMM DORIS M., 1959, JOUR AMER VET MED ASSOC, V135, P458; KOLONIN G V, 1971, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, V48, P118; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Legge TM, 1905, LANCET, V1, P841; Lowell JL, 2005, J CLIN MICROBIOL, V43, P650, DOI 10.1128/JCM.43.2.650-656.2005; Maho A, 2006, J CLIN MICROBIOL, V44, P3422, DOI 10.1128/JCM.01269-06; Mignot T, 2001, MOL MICROBIOL, V42, P1189, DOI 10.1046/j.1365-2958.2001.02692.x; Morin PA, 1999, BIOTECHNIQUES, V27, P538, DOI 10.2144/99273rr02; Okinaka R, 2006, PLOS PATHOG, V2, P1025, DOI 10.1371/journal.ppat.0020122; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Read TD, 2002, SCIENCE, V296, P2028, DOI 10.1126/science.1071837; Slamti L, 2004, J BACTERIOL, V186, P3531, DOI 10.1128/JB.186.11.3531-3538.2004; Smith KL, 2000, J CLIN MICROBIOL, V38, P3780, DOI 10.1128/JCM.38.10.3780-3784.2000; Stephens AJ, 2006, J MED MICROBIOL, V55, P43, DOI 10.1099/jmm.0.46157-0; Van Ert MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06; VANNESS GB, 1971, SCIENCE, V172, P1303, DOI 10.1126/science.172.3990.1303; Vogler AJ, 2002, ANTIMICROB AGENTS CH, V46, P511, DOI 10.1128/AAC.46.2.511-513.2002; Worobey M, 2005, HEREDITY, V94, P459, DOI 10.1038/sj.hdy.6800636; ZINSER G, 2002, EVOLUTIONARY RELATIO	43	271	283	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2007	2	5							e461	10.1371/journal.pone.0000461	http://dx.doi.org/10.1371/journal.pone.0000461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DZ	17520020	Green Published, gold, Green Submitted			2022-12-27	WOS:000207446000009
J	Gardner, A; West, SA; Griffin, AS				Gardner, Andy; West, Stuart A.; Griffin, Ashleigh S.			Is Bacterial Persistence a Social Trait?	PLOS ONE			English	Article							NONINHERITED RESISTANCE; SEED DORMANCY; EVOLUTION; COOPERATION; BISTABILITY; COMPETITION; SURVIVAL; CONFLICT; ALTRUISM; BEHAVIOR	The ability of bacteria to evolve resistance to antibiotics has been much reported in recent years. It is less well-known that within populations of bacteria there are cells which are resistant due to a non-inherited phenotypic switch to a slow-growing state. Although such 'persister' cells are receiving increasing attention, the evolutionary forces involved have been relatively ignored. Persistence has a direct benefit to cells because it allows survival during catastrophes-a form of bet-hedging. However, persistence can also provide an indirect benefit to other individuals, because the reduced growth rate can reduce competition for limiting resources. This raises the possibility that persistence is a social trait, which can be influenced by kin selection. We develop a theoretical model to investigate the social consequences of persistence. We predict that selection for persistence is increased when: (a) cells are related (e. g. a single, clonal lineage); and (b) resources are scarce. Our model allows us to predict how the level of persistence should vary with time, across populations, in response to intervention strategies and the level of competition. More generally, our results clarify the links between persistence and other bet-hedging or social behaviours.	[Gardner, Andy] Univ Oxford, St Johns Coll, Oxford, England; [Gardner, Andy; West, Stuart A.; Griffin, Ashleigh S.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland	University of Oxford; University of Edinburgh	Gardner, A (corresponding author), Univ Oxford, St Johns Coll, Oxford, England.	andy.gardner@ed.ac.uk	West, Stuart A/M-3608-2014; Griffin, Ashleigh/C-6244-2014; Gardner, Andy/K-5353-2013	West, Stuart A/0000-0003-2152-3153; Griffin, Ashleigh/0000-0001-7674-9825; Gardner, Andy/0000-0002-1304-3734	Royal Society	Royal Society(Royal Society of London)	All three authors are supported by Royal Society fellowships.	Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bigger JW, 1944, LANCET, V2, P497; COZENS RM, 1986, ANTIMICROB AGENTS CH, V29, P797, DOI 10.1128/AAC.29.5.797; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; EAGLE H, 1949, J EXP MED, V90, P595, DOI 10.1084/jem.90.6.595; ELLNER S, 1986, J THEOR BIOL, V123, P173, DOI 10.1016/S0022-5193(86)80151-5; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Frank, 1998, FDN SOCIAL EVOLUTION; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Gardner A, 2006, J EVOLUTION BIOL, V19, P1707, DOI 10.1111/j.1420-9101.2006.01104.x; GODFRAY HCJ, 1987, ECOL ENTOMOL, V12, P251, DOI 10.1111/j.1365-2311.1987.tb01003.x; Graumann PL, 2006, MOL MICROBIOL, V61, P560, DOI 10.1111/j.1365-2958.2006.05264.x; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1970, NATURE, V228, P1218, DOI 10.1038/2281218a0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Keren I, 2004, FEMS MICROBIOL LETT, V234, P187, DOI 10.1016/j.femsle.2004.03.006; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Lee SW, 1944, J BACTERIOL, V48, P393, DOI 10.1128/JB.48.4.393-399.1944; Levin BR, 2004, SCIENCE, V305, P1578, DOI 10.1126/science.1103077; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Massey RC, 2001, CURR BIOL, V11, P1810, DOI 10.1016/S0960-9822(01)00507-3; Palkova Z, 2004, EMBO REP, V5, P470, DOI 10.1038/sj.embor.7400145; Peters JM, 1999, P ROY SOC B-BIOL SCI, V266, P379, DOI 10.1098/rspb.1999.0648; PHILIPPI T, 1989, TRENDS ECOL EVOL, V4, P41, DOI 10.1016/0169-5347(89)90138-9; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; Rees M, 1996, PHILOS T R SOC B, V351, P1299, DOI 10.1098/rstb.1996.0113; Rees M, 2006, AM NAT, V168, pE53, DOI 10.1086/505762; Ringel MS, 1998, J THEOR BIOL, V194, P195, DOI 10.1006/jtbi.1998.0754; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Shapiro JA, 1997, BACTERIA MULTICELLUL; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Strassmann JE, 2000, NATURE, V404, P555, DOI 10.1038/35007175; Sufya N, 2003, J APPL MICROBIOL, V95, P1261, DOI 10.1046/j.1365-2672.2003.02079.x; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Wingreen NS, 2006, PLOS BIOL, V4, P1486, DOI 10.1371/journal.pbio.0040299; Wiuff C, 2005, ANTIMICROB AGENTS CH, V49, P1483, DOI 10.1128/AAC.49.4.1483-1494.2005	45	65	65	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e752	10.1371/journal.pone.0000752	http://dx.doi.org/10.1371/journal.pone.0000752			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710151	Green Submitted, gold, Green Published			2022-12-27	WOS:000207455200028
J	Pattaradilokrat, S; Cheesman, SJ; Carter, R				Pattaradilokrat, Sittiporn; Cheesman, Sandra J.; Carter, Richard			Linkage Group Selection: Towards Identifying Genes Controlling Strain Specific Protective Immunity in Malaria	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; PLASMODIUM-CHABAUDI-CHABAUDI; HETEROLOGOUS STRAINS; ENZYME VARIATION; FALCIPARUM; INFECTIONS; PARASITES; SEQUENCE; ANTIGEN; ANTIBODIES	Protective immunity against blood infections of malaria is partly specific to the genotype, or strain, of the parasites. The target antigens of Strain Specific Protective Immunity are expected, therefore, to be antigenically and genetically distinct in different lines of parasite. Here we describe the use of a genetic approach, Linkage Group Selection, to locate the target(s) of Strain Specific Protective Immunity in the rodent malaria parasite Plasmodium chabaudi chabaudi. In a previous such analysis using the progeny of a genetic cross between P. c. chabaudi lines AS-pyr1 and CB, a location on P. c. chabaudi chromosome 8 containing the gene for merozoite surface protein-1, a known candidate antigen for Strain Specific Protective Immunity, was strongly selected. P. c. chabaudi apical membrane antigen-1, another candidate for Strain Specific Protective Immunity, could not have been evaluated in this cross as AS-pyr1 and CB are identical within the cell surface domain of this protein. Here we use Linkage Group Selection analysis of Strain Specific Protective Immunity in a cross between P. c. chabaudi lines CB-pyr10 and AJ, in which merozoite surface protein-1 and apical membrane antigen-1 are both genetically distinct. In this analysis strain specific immune selection acted strongly on the region of P. c. chabaudi chromosome 8 encoding merozoite surface protein-1 and, less strongly, on the P. c. chabaudi chromosome 9 region encoding apical membrane antigen-1. The evidence from these two independent studies indicates that Strain Specific Protective Immunity in P. c. chabaudi in mice is mainly determined by a narrow region of the P. c. chabaudi genome containing the gene for the P. c. chabaudi merozoite surface protein-1 protein. Other regions, including that containing the gene for P. c. chabaudi apical membrane antigen-1, may be more weakly associated with Strain Specific Protective Immunity in these parasites.	[Pattaradilokrat, Sittiporn; Cheesman, Sandra J.; Carter, Richard] Univ Edinburgh, Ashworth Labs, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland	University of Edinburgh	Carter, R (corresponding author), Univ Edinburgh, Ashworth Labs, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland.	r.carter@ed.ac.uk		Pattaradilokrat, Sittiporn/0000-0002-1516-1961	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Babiker HA, 1999, T ROY SOC TROP MED H, V93, pS11, DOI 10.1016/S0035-9203(99)90321-8; Beale G.H., 1978, P213; BOYLE DB, 1982, INFECT IMMUN, V38, P94, DOI 10.1128/IAI.38.1.94-102.1982; BROWN KN, 1985, ANN INST PASTEUR IMM, VC136, P11, DOI 10.1016/S0769-2625(85)80036-2; CARDIGAN FC, 1969, MIL MED, V134, P1135; CARTER R, 1978, PARASITOLOGY, V76, P241, DOI 10.1017/S0031182000048137; CARTER R, 1975, ANN TROP MED PARASIT, V69, P187, DOI 10.1080/00034983.1975.11687000; CARTER R, 1973, T ROY SOC TROP MED H, V67, P830, DOI 10.1016/0035-9203(73)90011-4; Carter R, 2007, INT J PARASITOL, V37, P285, DOI 10.1016/j.ijpara.2006.11.013; Cavanagh DR, 2004, INFECT IMMUN, V72, P6492, DOI 10.1128/IAI.72.11.6492-6502.2004; Cheesman S, 2006, INFECT IMMUN, V74, P2996, DOI 10.1128/IAI.74.5.2996-3001.2006; Cheesman SJ, 2003, MOL BIOCHEM PARASIT, V131, P83, DOI 10.1016/S0166-6851(03)00195-6; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; CONWAY DJ, 1991, PARASITOLOGY, V103, P1, DOI 10.1017/S0031182000059217; CONWAY DJ, 1991, PARASITOLOGY, V103, P7, DOI 10.1017/S0031182000059229; Crewther PE, 1996, INFECT IMMUN, V64, P3310, DOI 10.1128/IAI.64.8.3310-3317.1996; Culleton R, 2005, GENOME RES, V15, P92, DOI 10.1101/gr.2866205; DAY K P, 1991, Immunology Today, V12, pA68; de Roode JC, 2004, P ROY SOC B-BIOL SCI, V271, P1073, DOI 10.1098/rspb.2004.2695; Ferguson HM, 2002, P ROY SOC B-BIOL SCI, V269, P1217, DOI 10.1098/rspb.2002.2023; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Grech K, 2002, MOL BIOCHEM PARASIT, V123, P95, DOI 10.1016/S0166-6851(02)00142-1; Hunt P, 2004, MOL BIOCHEM PARASIT, V136, P157, DOI 10.1016/j.molbiopara.2004.03.008; JARRA W, 1985, PARASITE IMMUNOL, V7, P595, DOI 10.1111/j.1365-3024.1985.tb00103.x; JEFFERY GM, 1966, B WORLD HEALTH ORGAN, V35, P873; Jones TR, 2000, AM J TROP MED HYG, V62, P675, DOI 10.4269/ajtmh.2000.62.675; Kooij TWA, 2005, PLOS PATHOG, V1, P349, DOI 10.1371/journal.ppat.0010044; Magesa SM, 2002, ACTA TROP, V84, P83, DOI 10.1016/S0001-706X(02)00179-1; Marshall VM, 1996, MOL BIOCHEM PARASIT, V77, P109, DOI 10.1016/0166-6851(96)02583-2; Martinelli A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-11; Martinelli A, 2005, P NATL ACAD SCI USA, V102, P814, DOI 10.1073/pnas.0405097102; Martinelli A, 2004, MOL BIOCHEM PARASIT, V136, P117, DOI 10.1016/j.molbiopara.2004.02.011; MCGREGOR IA, 1956, BRIT MED J, V2, P686, DOI 10.1136/bmj.2.4994.686; MCGREGOR IA, 1974, B WORLD HEALTH ORGAN, V50, P259; MCKEAN PG, 1993, MOL BIOCHEM PARASIT, V62, P199, DOI 10.1016/0166-6851(93)90109-B; MCKEAN PG, 1993, MOL BIOCHEM PARASIT, V62, P211, DOI 10.1016/0166-6851(93)90110-J; MENDIS KN, 1991, IMMUNOPARASITOL TOD, pA34, DOI 10.1016/S0167-5699(05)80010-6; MILLER LH, 1993, MOL BIOCHEM PARASIT, V59, P1, DOI 10.1016/0166-6851(93)90002-F; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Polley SD, 2003, GENETICS, V165, P555; Polley SD, 2003, INFECT IMMUN, V71, P1833, DOI 10.1128/IAI.71.4.1833-1842.2003; Polley SD, 2001, GENETICS, V158, P1505; POWELL RD, 1972, P HELM SOC WASH, V39, P51; TANABE K, 1987, J MOL BIOL, V195, P273, DOI 10.1016/0022-2836(87)90649-8; THOMAS AW, 1990, MOL BIOCHEM PARASIT, V42, P285, DOI 10.1016/0166-6851(90)90172-I; WALLIKER D, 1975, PARASITOLOGY, V70, P19, DOI 10.1017/S0031182000048824	46	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e857	10.1371/journal.pone.0000857	http://dx.doi.org/10.1371/journal.pone.0000857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848988	Green Submitted, gold, Green Published			2022-12-27	WOS:000207455600004
J	Seamari, Y; Narvaez, JA; Vico, FJ; Lobo, D; Sanchez-Vives, MV				Seamari, Yamina; Narvaez, Jose A.; Vico, Francisco J.; Lobo, Daniel; Sanchez-Vives, Maria V.			Robust Off- and Online Separation of Intracellularly Recorded Up and Down Cortical States	PLOS ONE			English	Article							MEMBRANE-POTENTIAL FLUCTUATIONS; STRIATAL NEURONS; NEOCORTICAL NEURONS; NETWORK ACTIVITY; FIRING PATTERNS; IN-VIVO; SLOW; OSCILLATION; SYNCHRONIZATION; MECHANISMS	Background. The neuronal cortical network generates slow (<1 Hz) spontaneous rhythmic activity that emerges from the recurrent connectivity. This activity occurs during slow wave sleep or anesthesia and also in cortical slices, consisting of alternating up (active, depolarized) and down (silent, hyperpolarized) states. The search for the underlying mechanisms and the possibility of analyzing network dynamics in vitro has been subject of numerous studies. This exposes the need for a detailed quantitative analysis of the membrane fluctuating behavior and computerized tools to automatically characterize the occurrence of up and down states. Methodology/Principal Findings. Intracellular recordings from different areas of the cerebral cortex were obtained from both in vitro and in vivo preparations during slow oscillations. A method that separates up and down states recorded intracellularly is defined and analyzed here. The method exploits the crossover of moving averages, such that transitions between up and down membrane regimes can be anticipated based on recent and past voltage dynamics. We demonstrate experimentally the utility and performance of this method both offline and online, the online use allowing to trigger stimulation or other events in the desired period of the rhythm. This technique is compared with a histogram-based approach that separates the states by establishing one or two discriminating membrane potential levels. The robustness of the method presented here is tested on data that departs from highly regular alternating up and down states. Conclusions/Significance. We define a simple method to detect cortical states that can be applied in real time for offline processing of large amounts of recorded data on conventional computers. Also, the online detection of up and down states will facilitate the study of cortical dynamics. An open-source MATLAB (R) toolbox, and Spike 2 (R)-compatible version are made freely available.	[Vico, Francisco J.; Lobo, Daniel] Univ Malaga, Dept Lenguajes & Ciencias Computac, Escuela Tecn Super Ingn Informat, E-29071 Malaga, Spain; [Seamari, Yamina; Narvaez, Jose A.] Univ Malaga, Dept Fisiol Gen, Fac Med, E-29071 Malaga, Spain; [Sanchez-Vives, Maria V.] Univ Miguel Hernandez, Consejo Super Invest Cient, Alicante, San Juan Alican, Spain	Universidad de Malaga; Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche	Vico, FJ (corresponding author), Univ Malaga, Dept Lenguajes & Ciencias Computac, Escuela Tecn Super Ingn Informat, E-29071 Malaga, Spain.	fjv@geb.uma.es	Sanchez-Vives, Maria/J-8526-2014	Sanchez-Vives, Maria/0000-0002-8437-9083; Seamari, Yamina/0000-0002-6411-6120; Narvaez, Jose A./0000-0002-3575-6903; Lobo, Daniel/0000-0003-4666-6118	Programa de Perfeccionamiento de Doctores of the Junta de Andalucia; Ministerio de Educacion y Ciencia (Spain)	Programa de Perfeccionamiento de Doctores of the Junta de Andalucia; Ministerio de Educacion y Ciencia (Spain)(Spanish Government)	Funding: This work has been funded in part by Programa de Perfeccionamiento de Doctores of the Junta de Andalucia and grants for short stays of Universidad de Malaga to YS. MVSV was funded by Ministerio de Educacion y Ciencia (Spain). The sponsors played no role in the study.	Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; AGHAJANIAN GK, 1989, SYNAPSE, V3, P331, DOI 10.1002/syn.890030406; Amzica F, 1997, NEUROLOGY, V49, P952, DOI 10.1212/WNL.49.4.952; AMZICA F, 1995, J NEUROPHYSIOL, V73, P20, DOI 10.1152/jn.1995.73.1.20; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Azouz R, 1999, J NEUROSCI, V19, P2209; Benucci A, 2004, NEURAL COMPUT, V16, P2351, DOI 10.1162/0899766041941871; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Crochet S, 2005, EUR J NEUROSCI, V21, P1030, DOI 10.1111/j.1460-9568.2005.03932.x; Crochet S, 2004, CEREB CORTEX, V14, P1110, DOI 10.1093/cercor/bhh071; ELLINGER AG, 1971, ART INVESTMENT; FUENTEALBA P, 2005, THAL REL SY IN PRESS; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Holcman D, 2006, PLOS COMPUT BIOL, V2, P174, DOI 10.1371/journal.pcbi.0020023; Kasanetz F, 2002, J PHYSIOL-LONDON, V543, P577, DOI 10.1113/jphysiol.2002.0024786; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Lewis BL, 2000, CEREB CORTEX, V10, P1168, DOI 10.1093/cercor/10.12.1168; Mahon S, 2003, J PHYSIOL-PARIS, V97, P557, DOI 10.1016/j.jphysparis.2004.01.013; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; McCormick DA, 2003, CEREB CORTEX, V13, P1219, DOI 10.1093/cercor/bhg104; METHERATE R, 1993, J NEUROSCI, V13, P5312, DOI 10.1523/JNEUROSCI.13-12-05312.1993; Mukovski M, 2007, CEREB CORTEX, V17, P400, DOI 10.1093/cercor/bhj157; Peters Y, 2004, SYNAPSE, V52, P143, DOI 10.1002/syn.20015; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Reig R, 2006, CEREB CORTEX, V16, P688, DOI 10.1093/cercor/bhj014; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Simon NR, 2000, BRAIN RES, V860, P64, DOI 10.1016/S0006-8993(00)01974-0; Steriade M, 1996, J NEUROSCI, V16, P392, DOI 10.1523/jneurosci.16-01-00392.1996; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Timofeev I, 1996, J PHYSIOL-LONDON, V494, P265, DOI 10.1113/jphysiol.1996.sp021489; Tseng KY, 2001, J NEUROSCI, V21, P6430, DOI 10.1523/JNEUROSCI.21-16-06430.2001; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Wilson CJ, 1996, J NEUROSCI, V16, P2397	38	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e888	10.1371/journal.pone.0000888	http://dx.doi.org/10.1371/journal.pone.0000888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849017	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455600034
J	Wong, H; Victor, JM; Mozziconacci, J				Wong, Hua; Victor, Jean-Marc; Mozziconacci, Julien			An All-Atom Model of the Chromatin Fiber Containing Linker Histones Reveals a Versatile Structure Tuned by the Nucleosomal Repeat Length	PLOS ONE			English	Article								In the nucleus of eukaryotic cells, histone proteins organize the linear genome into a functional and hierarchical architecture. In this paper, we use the crystal structures of the nucleosome core particle, B-DNA and the globular domain of H5 linker histone to build the first all-atom model of compact chromatin fibers. In this 3D jigsaw puzzle, DNA bending is achieved by solving an inverse kinematics problem. Our model is based on recent electron microscopy measurements of reconstituted fiber dimensions. Strikingly, we find that the chromatin fiber containing linker histones is a polymorphic structure. We show that different fiber conformations are obtained by tuning the linker histone orientation at the nucleosomes entry/exit according to the nucleosomal repeat length. We propose that the observed in vivo quantization of nucleosomal repeat length could reflect nature's ability to use the DNA molecule's helical geometry in order to give chromatin versatile topological and mechanical properties.	[Wong, Hua; Victor, Jean-Marc; Mozziconacci, Julien] Univ Paris 06, Lab Phys Theor Mat Condensee, Paris, France; [Mozziconacci, Julien] European Mol Biol Lab, Heidelberg, Germany	UDICE-French Research Universities; Sorbonne Universite; European Molecular Biology Laboratory (EMBL)	Mozziconacci, J (corresponding author), Univ Paris 06, Lab Phys Theor Mat Condensee, Paris, France.	pipo@lptmc.jussieu.fr	Victor, Jean-Marc/AAB-1362-2020; Mozziconacci, Julien/M-4731-2019					ALLAN J, 1980, NATURE, V288, P675, DOI 10.1038/288675a0; Arya G, 2006, P NATL ACAD SCI USA, V103, P16236, DOI 10.1073/pnas.0604817103; Barbi M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.031910; BARTOLOME S, 1994, J CELL SCI, V107, P2983; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; BEDNAR J, 1995, J CELL BIOL, V131, P1365, DOI 10.1083/jcb.131.6.1365; Ben-Haim E, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051921; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Boomsma W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-159; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Buss S. R., 2005, Journal of Graphics Tools, V10, P37; Daban JR, 1998, BIOCHEMISTRY-US, V37, P4299, DOI 10.1021/bi973117h; Daban JR, 2000, BIOCHEMISTRY-US, V39, P3861, DOI 10.1021/bi992628w; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; DUBOCHET J, 1978, SCIENCE, V202, P280, DOI 10.1126/science.694532; Duggan MM, 2000, J MOL BIOL, V304, P21, DOI 10.1006/jmbi.2000.4205; Fan L, 2006, P NATL ACAD SCI USA, V103, P8384, DOI 10.1073/pnas.0508951103; Hamiche A, 1996, J MOL BIOL, V257, P30, DOI 10.1006/jmbi.1996.0144; Hud NV, 2001, P NATL ACAD SCI USA, V98, P14925, DOI 10.1073/pnas.261560398; LAVERY R, 1995, COMPUT PHYS COMMUN, V91, P135, DOI 10.1016/0010-4655(95)00046-I; Lee KC, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.128101; LEFORESTIER A, 1993, BIOPHYS J, V65, P56, DOI 10.1016/S0006-3495(93)81063-4; MAKAROV V, 1985, FEBS LETT, V181, P357, DOI 10.1016/0014-5793(85)80292-1; Mangenot S, 2003, J MOL BIOL, V333, P907, DOI 10.1016/j.jmb.2003.09.015; MIRZABEKOV AD, 1990, J MOL BIOL, V211, P479, DOI 10.1016/0022-2836(90)90366-T; Mozziconacci J, 2003, J STRUCT BIOL, V143, P72, DOI 10.1016/S1047-8477(03)00102-3; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Sivolob A, 2003, J MOL BIOL, V331, P1025, DOI 10.1016/S0022-2836(03)00831-3; TATCHELL K, 1978, P NATL ACAD SCI USA, V75, P3583, DOI 10.1073/pnas.75.8.3583; Travers A, 1999, TRENDS BIOCHEM SCI, V24, P4, DOI 10.1016/S0968-0004(98)01339-5; VANHOLDE K, 1995, J BIOL CHEM, V270, P8373, DOI 10.1074/jbc.270.15.8373; VANHOLDE KE, SPRINGER SERIES MOL; WIDOM J, 1985, CELL, V43, P207, DOI 10.1016/0092-8674(85)90025-X; WIDOM J, 1992, P NATL ACAD SCI USA, V89, P1095, DOI 10.1073/pnas.89.3.1095; WILLIAMS SP, 1986, BIOPHYS J, V49, P233, DOI 10.1016/S0006-3495(86)83637-2; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6; WORCEL A, 1981, P NATL ACAD SCI-BIOL, V78, P1461, DOI 10.1073/pnas.78.3.1461; YAO J, 1993, P NATL ACAD SCI USA, V90, P9364, DOI 10.1073/pnas.90.20.9364	41	110	110	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e877	10.1371/journal.pone.0000877	http://dx.doi.org/10.1371/journal.pone.0000877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849006	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455600023
J	Auerbach, RK; Tuanyok, A; Probert, WS; Kenefic, L; Vogler, AJ; Bruce, DC; Munk, C; Brettin, TS; Eppinger, M; Ravel, J; Wagner, DM; Keim, P				Auerbach, Raymond K.; Tuanyok, Apichai; Probert, William S.; Kenefic, Leo; Vogler, Amy J.; Bruce, David C.; Munk, Christine; Brettin, Thomas S.; Eppinger, Mark; Ravel, Jacques; Wagner, David M.; Keim, Paul			Yersinia pestis Evolution on a Small Timescale: Comparison of Whole Genome Sequences from North America	PLOS ONE			English	Article								Background. Yersinia pestis, the etiologic agent of plague, was responsible for several devastating epidemics throughout history and is currently of global importance to current public heath and biodefense efforts. Y. pestis is widespread in the Western United States. Because Y. pestis was first introduced to this region just over 100 years ago, there has been little time for genetic diversity to accumulate. Recent studies based upon single nucleotide polymorphisms have begun to quantify the genetic diversity of Y. pestis in North America. Methodology/Principal Findings. To examine the evolution of Y. pestis in North America, a gapped genome sequence of CA88-4125 was generated. Sequence comparison with another North American Y. pestis strain, CO92, identified seven regions of difference (six inversions, one rearrangement), differing IS element copy numbers, and several SNPs. Conclusions/Significance. The relatively large number of inverted/rearranged segments suggests that North American Y. pestis strains may be undergoing inversion fixation at high rates over a short time span, contributing to higher-than-expected diversity in this region. These findings will hopefully encourage the scientific community to sequence additional Y. pestis strains from North America and abroad, leading to a greater understanding of the evolutionary history of this pathogen.	[Auerbach, Raymond K.; Tuanyok, Apichai; Kenefic, Leo; Vogler, Amy J.; Wagner, David M.; Keim, Paul] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Bruce, David C.; Munk, Christine; Brettin, Thomas S.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA; [Probert, William S.] Calif Dept Publ Hlth, Microbial Dis Lab, Richmond, CA USA; [Keim, Paul] Translat Genom Res Inst, Pathogen Genom Div, Phoenix, AZ USA; [Eppinger, Mark; Ravel, Jacques] Inst Genom Res, J Craig Venter Inst, Rockville, MD USA	Northern Arizona University; United States Department of Energy (DOE); Los Alamos National Laboratory; California Department of Public Health; Translational Genomics Research Institute; J. Craig Venter Institute	Keim, P (corresponding author), No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA.	Paul.Keim@nau.edu	Ravel, Jacques/D-2530-2009; Keim, Paul S/A-2269-2010; Wagner, David M/A-5125-2010	Wagner, David/0000-0003-2684-6007; Ravel, Jacques/0000-0002-0851-2233	Intelligence Technology Innovation Center [CA88-4125]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [NO1-AI-30071]	Intelligence Technology Innovation Center; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for Y. pestis CA88-4125 sequencing was provided by the Intelligence Technology Innovation Center. JR and ME were supported with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under NIAID contract NO1-AI-30071.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; ACHTMAN M, 2004, YERSINIA MOL CELLULA, P432; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Belda E, 2005, MOL BIOL EVOL, V22, P1456, DOI 10.1093/molbev/msi134; Chain PSG, 2006, J BACTERIOL, V188, P4453, DOI 10.1128/JB.00124-06; Cully JF, 2001, J MAMMAL, V82, P894, DOI 10.1644/1545-1542(2001)082&lt;0894:ICOSPI&gt;2.0.CO;2; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; DEVIGNAT R, 1951, Bull World Health Organ, V4, P247; Girard JM, 2004, P NATL ACAD SCI USA, V101, P8408, DOI 10.1073/pnas.0401561101; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Jackson PJ, 1997, APPL ENVIRON MICROB, V63, P1400, DOI 10.1128/AEM.63.4.1400-1405.1997; Keim P, 1997, J BACTERIOL, V179, P818, DOI 10.1128/jb.179.3.818-824.1997; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LINK V B, 1955, Public Health Monogr, V26, P1; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; Touchman JW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000220; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309	22	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e770	10.1371/journal.pone.0000770	http://dx.doi.org/10.1371/journal.pone.0000770			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712418	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455300018
J	Ponseti, J; Siebner, HR; Kloppel, S; Wolff, S; Granert, O; Jansen, O; Mehdorn, HM; Bosinski, HA				Ponseti, Jorge; Siebner, Hartwig R.; Kloeppel, Stefan; Wolff, Stephan; Granert, Oliver; Jansen, Olav; Mehdorn, Hubertus M.; Bosinski, Hartmut A.			Homosexual Women Have Less Grey Matter in Perirhinal Cortex than Heterosexual Women	PLOS ONE			English	Article								Is sexual orientation associated with structural differences in the brain? To address this question, 80 homosexual and heterosexual men and women ( 16 homosexual men and 15 homosexual women) underwent structural MRI. We used voxel-based morphometry to test for differences in grey matter concentration associated with gender and sexual orientation. Compared with heterosexual women, homosexual women displayed less grey matter bilaterally in the temporo-basal cortex, ventral cerebellum, and left ventral premotor cortex. The relative decrease in grey matter was most prominent in the left perirhinal cortex. The left perirhinal area also showed less grey matter in heterosexual men than in heterosexual women. Thus, in homosexual women, the perirhinal cortex grey matter displayed a more male-like structural pattern. This is in accordance with previous research that revealed signs of sex-atypical prenatal androgenization in homosexual women, but not in homosexual men. The relevance of the perirhinal area for high order multimodal ( olfactory and visual) object, social, and sexual processing is discussed.	[Ponseti, Jorge; Bosinski, Hartmut A.] Univ Kiel, Sect Sexual Med, Kiel, Germany; [Siebner, Hartwig R.; Granert, Oliver] Univ Kiel, Dept Neurol, D-2300 Kiel, Germany; [Siebner, Hartwig R.; Granert, Oliver] NeuroImage Nord, Hamburg, Germany; [Kloeppel, Stefan] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Kloeppel, Stefan] Univ Freiburg, Dept Neurol, D-7800 Freiburg, Germany; [Wolff, Stephan; Jansen, Olav] Univ Kiel, Dept Neurosurg, Neuroradiol Sect, Kiel, Germany	University of Kiel; University of Kiel; University of London; University College London; University of Freiburg; University of Kiel	Ponseti, J (corresponding author), Univ Kiel, Sect Sexual Med, Kiel, Germany.	ponseti@sexmed.uni-kiel.de	Jansen, Olav/D-2547-2010; Siebner, Hartwig R/G-4052-2016; Mehdorn, Maximilian/D-2495-2010	Granert, Oliver/0000-0002-0656-1023; Kloppel, Stefan/0000-0001-6452-9964	Federal Ministry of Education and Research [01 GO 0511]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Structural MRI was performed in the MRI unit sponsored by the Federal Ministry of Education and Research. HS (grant 01 GO 0511) is supported by a structural grant sponsored by the Federal Ministry of Education and Research to NeuroImageNord.	Allen JS, 2003, NEUROIMAGE, V18, P880, DOI 10.1016/S1053-8119(03)00034-X; ALLEN LS, 1992, P NATL ACAD SCI USA, V89, P7199, DOI 10.1073/pnas.89.15.7199; [Anonymous], 2011, J SEX MED, DOI DOI 10.1111/j.1743-6109.2011.02449.x; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Berglund H, 2006, P NATL ACAD SCI USA, V103, P8269, DOI 10.1073/pnas.0600331103; Byne W, 2001, HORM BEHAV, V40, P86, DOI 10.1006/hbeh.2001.1680; DOTY RL, 1985, NEUROPSYCHOLOGIA, V23, P667, DOI 10.1016/0028-3932(85)90067-3; ENGEN T, 1987, AM SCI, V75, P497; FRANKE G, 1996, SYMPTOM CHECKLISTE D; Garcia-Falgueras A, 2006, BRAIN RES, V1116, P103, DOI 10.1016/j.brainres.2006.07.115; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; GRAMMER K, 1993, ETHOL SOCIOBIOL, V14, P201, DOI 10.1016/0162-3095(93)90006-4; HUMMEL T, 1991, EXPERIENTIA, V47, P712, DOI 10.1007/BF01958823; Im K, 2006, NEUROIMAGE, V31, P31, DOI 10.1016/j.neuroimage.2005.11.042; Kirk KM, 2000, BEHAV GENET, V30, P345, DOI 10.1023/A:1026557719181; Lasco MS, 2002, BRAIN RES, V936, P95, DOI 10.1016/S0006-8993(02)02590-8; Lee ACH, 2006, NEUROIMAGE, V33, P362, DOI 10.1016/j.neuroimage.2006.06.021; LEVAY S, 1991, SCIENCE, V253, P1034, DOI 10.1126/science.1887219; Luders E, 2006, HUM BRAIN MAPP, V27, P314, DOI 10.1002/hbm.20187; Luders E, 2005, NEUROIMAGE, V26, P493, DOI 10.1016/j.neuroimage.2005.02.010; Mayeaux DJ, 2004, PHYSIOL BEHAV, V82, P653, DOI 10.1016/j.physbeh.2004.06.002; Mustanski BS, 2002, ANN REV SEX RES, V13, P89; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Passe TJ, 1997, PROG NEURO-PSYCHOPH, V21, P1231, DOI 10.1016/S0278-5846(97)00160-7; Pause BM, 1996, BIOL PSYCHOL, V44, P31, DOI 10.1016/S0301-0511(96)05207-6; PETERS M, 1991, CAN J PSYCHOL, V45, P507, DOI 10.1037/h0084307; Petrulis A, 2003, NEUROSCIENCE, V122, P599, DOI 10.1016/j.neuroscience.2003.08.009; Ponseti J, 2006, NEUROIMAGE, V33, P825, DOI 10.1016/j.neuroimage.2006.08.002; Rahman Q, 2005, NEUROSCI BIOBEHAV R, V29, P1057, DOI 10.1016/j.neubiorev.2005.03.002; Raz N, 2004, NEUROBIOL AGING, V25, P377, DOI 10.1016/S0197-4580(03)00118-0; Royet JP, 2003, NEUROIMAGE, V20, P713, DOI 10.1016/S1053-8119(03)00388-4; Savic I, 2005, P NATL ACAD SCI USA, V102, P7356, DOI 10.1073/pnas.0407998102; SCHIFFER B, 2006, J PSYCHIAT RES; Sowell E, 2006, CEREB CORTEX; SWAAB DF, 1990, BRAIN RES, V537, P141, DOI 10.1016/0006-8993(90)90350-K; van Anders SM, 2005, HORM BEHAV, V47, P92, DOI 10.1016/j.yhbeh.2004.09.003; VERCHISNKI B, 2000, NEUROIMAGE, V11, P228	40	35	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e762	10.1371/journal.pone.0000762	http://dx.doi.org/10.1371/journal.pone.0000762			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712410	gold, Green Submitted, Green Published			2022-12-27	WOS:000207455300010
J	Krarup, A; Wallis, R; Presanis, JS; Gal, P; Sim, RB				Krarup, Anders; Wallis, Russell; Presanis, Julia S.; Gal, Peter; Sim, Robert B.			Simultaneous Activation of Complement and Coagulation by MBL-Associated Serine Protease 2	PLOS ONE			English	Article								The complement system is an important immune mechanism mediating both recognition and elimination of foreign bodies. The lectin pathway is one pathway of three by which the complement system is activated. The characteristic protease of this pathway is Mannan-binding lectin (MBL)-associated serine protease 2 (MASP2), which cleaves complement proteins C2 and C4. We present a novel and alternative role of MASP2 in the innate immune system. We have shown that MASP2 is capable of promoting fibrinogen turnover by cleavage of prothrombin, generating thrombin. By using a truncated active form of MASP2 as well as full-length MASP2 in complex with MBL, we have shown that the thrombin generated is active and can cleave both factor XIII and fibrinogen, forming cross-linked fibrin. To explore the biological significance of these findings we showed that fibrin was covalently bound on a bacterial surface to which MBL/MASP2 complexes were bound. These findings suggest that, as has been proposed for invertebrates, limited clotting may contribute to the innate immune response.	[Krarup, Anders; Wallis, Russell; Presanis, Julia S.; Sim, Robert B.] Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England; [Wallis, Russell] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Gal, Peter] Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, Budapest, Hungary	University of Oxford; University of Leicester; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences	Krarup, A (corresponding author), Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England.	anders.krarup@bioch.ox.ac.uk	Sim, Bob/A-1354-2008; Gal, Peter/B-5886-2011	Sim, Bob/0000-0002-2855-7455; Wallis, Russell/0000-0002-8705-5295	Medical Research Council UK; Hungarian National Science Foundation [OTKA T046444]; British-Hungarian Bilateral ST Project [GB4/03]; MRC [G0501425] Funding Source: UKRI; Medical Research Council [G0501425] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Hungarian National Science Foundation; British-Hungarian Bilateral ST Project; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council UK, the Hungarian National Science Foundation Grant OTKA T046444, and the British-Hungarian Bilateral S&T Project GB4/03. AK is the recipient of an MRC doctoral training award. JSP held an MRC doctoral training award. The funding sources were not involved in the design, analysis, or interpretation of the results obtained in this study.	Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; BAJZAR L, 1990, J BIOL CHEM, V265, P16948; Bereczky Z, 2003, PATHOPHYSIOL HAEMO T, V33, P430, DOI 10.1159/000083841; Chen CB, 2004, J BIOL CHEM, V279, P26058, DOI 10.1074/jbc.M401318200; Chen CB, 2001, J BIOL CHEM, V276, P25894, DOI 10.1074/jbc.M103539200; DOWNING MR, 1975, J BIOL CHEM, V250, P8897; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Hajela K, 2002, IMMUNOBIOLOGY, V205, P467, DOI 10.1078/0171-2985-00147; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; KAUFMAN RJ, 1991, NUCLEIC ACIDS RES, V19, P4485, DOI 10.1093/nar/19.16.4485; KAY AB, 1974, BRIT J HAEMATOL, V27, P669, DOI 10.1111/j.1365-2141.1974.tb06633.x; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Krem MM, 2000, TRENDS CARDIOVAS MED, V10, P171, DOI 10.1016/S1050-1738(00)00068-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Masuda Y, 2001, PEPTIDES, V22, P1511, DOI 10.1016/S0196-9781(01)00473-9; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Matsushita M, 2002, J IMMUNOL, V168, P3502, DOI 10.4049/jimmunol.168.7.3502; Mullarky IK, 2005, INFECT IMMUN, V73, P3888, DOI 10.1128/IAI.73.7.3888-3895.2005; Muta T, 1996, CURR OPIN IMMUNOL, V8, P41, DOI 10.1016/S0952-7915(96)80103-8; Pike RN, 2005, FEBS J, V272, P4842, DOI 10.1111/j.1742-4658.2005.04880.x; PILATTE Y, 1989, J IMMUNOL METHODS, V120, P37, DOI 10.1016/0022-1759(89)90286-X; Presanis JS, 2004, MOL IMMUNOL, V40, P921, DOI 10.1016/j.molimm.2003.10.013; REID KBM, 1981, ANNU REV BIOCHEM, V50, P433, DOI 10.1146/annurev.bi.50.070181.002245; Rossi V, 2001, J BIOL CHEM, V276, P40880, DOI 10.1074/jbc.M105934200; SENIOR RM, 1986, J CLIN INVEST, V77, P1014, DOI 10.1172/JCI112353; SIM RB, 1981, METHOD ENZYMOL, V80, P26; SIM RB, 1981, METHOD ENZYMOL, V80, P43; SKOGEN WF, 1988, BLOOD, V71, P1475; TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Travis J, 1983, Behring Inst Mitt, P56	35	185	207	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2007	2	7							e623	10.1371/journal.pone.0000623	http://dx.doi.org/10.1371/journal.pone.0000623			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GI	17637839	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452100013
J	Mzilahowa, T; McCall, PJ; Hastings, IM				Mzilahowa, Themba; McCall, Philip J.; Hastings, Ian M.			"Sexual" Population Structure and Genetics of the Malaria Agent P. falciparum	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; LINKAGE DISEQUILIBRIUM; INOCULATION RATES; DRUG-RESISTANCE; PARASITES; TRANSMISSION; MARKERS; INFECTIONS; INTENSITY; EVOLUTION	The population genetics and structure of P. falciparum determine the rate at which malaria evolves in response to interventions such as drugs and vaccines. This has been the source of considerable recent controversy, but here we demonstrate the organism to be essentially sexual, in an area of moderately high transmission in the Lower Shire Valley, Malawi. Seven thousand mosquitoes were collected and dissected, and genetic data were obtained on 190 oocysts from 56 infected midguts. The oocysts were genotyped at three microsatellite loci and the MSP1 locus. Selfing rate was estimated as 50% and there was significant genotypic linkage disequilibrium (LD) in the pooled oocysts. A more appropriate analysis searching for genotypic LD in outcrossed oocysts and/or haplotypic LD in the selfed oocysts found no evidence for LD, indicating that the population was effectively sexual. Inbreeding estimates at MSP1 were higher than at the microsatellites, possibly indicative of immune action against MSP1, but the effect was confounded by the probable presence of null mutations. Mating appeared to occur at random in mosquitoes and evidence regarding whether malaria clones in the same host were related ( presumably through simultaneous inoculation in the same mosquito bite) was ambiguous. This is the most detailed genetic analysis yet of P. falciparum sexual stages, and shows P. falciparum to be a sexual organism whose genomes are in linkage equilibrium, which acts to slow the emergence of drug resistance and vaccine insensitivity, extending the likely useful therapeutic lifespan of drugs and vaccines.	[Mzilahowa, Themba; McCall, Philip J.; Hastings, Ian M.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Mzilahowa, Themba] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi	Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi	Hastings, IM (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	hastings@liverpool.ac.uk		McCall, Philip J/0000-0002-0007-3985; Hastings, Ian/0000-0002-1332-742X	UNICEF/UNDP/World Bank/WHO; Gates Malaria Partnership (GMP)	UNICEF/UNDP/World Bank/WHO(World Health Organization); Gates Malaria Partnership (GMP)	Financial support from the UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR) and the Gates Malaria Partnership (GMP) is gratefully acknowledged.	Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 2000, GENET RES, V75, P285, DOI 10.1017/S0016672300004481; [Anonymous], 1987, PUBLICATIONS S AFRIC; [Anonymous], 1993, MOSQUITO ECOLOGY FIE; Anthony TG, 2000, PARASITOLOGY, V121, P121, DOI 10.1017/S003118209900623X; Ayala FJ, 1998, P NATL ACAD SCI USA, V95, P3346, DOI 10.1073/pnas.95.7.3346; BENNETT J. H., 1956, HEREDITY, V10, P51, DOI 10.1038/hdy.1956.3; BURKOT TR, 1988, AM J TROP MED HYG, V39, P135, DOI 10.4269/ajtmh.1988.39.135; Carter R, 2000, NAT MED, V6, P241, DOI 10.1038/73062; CONWAY DJ, 1991, PARASITOLOGY, V103, P1, DOI 10.1017/S0031182000059217; Conway DJ, 1999, P NATL ACAD SCI USA, V96, P4506, DOI 10.1073/pnas.96.8.4506; CURTIS CF, 1986, T ROY SOC TROP MED H, V80, P889, DOI 10.1016/0035-9203(86)90248-8; Durand P, 2003, AM J TROP MED HYG, V68, P345, DOI 10.4269/ajtmh.2003.68.345; DYE C, 1991, PARASITOL TODAY, V7, P236, DOI 10.1016/0169-4758(91)90236-H; Dye C, 1997, P ROY SOC B-BIOL SCI, V264, P61, DOI 10.1098/rspb.1997.0009; DYE C, 1990, NATURE, V348, P120, DOI 10.1038/348120b0; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J., 2002, FSTAT PROGRAM ESTIMA; GREEN RF, 1995, J THEOR BIOL, V174, P87, DOI 10.1006/jtbi.1995.0081; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hastings IM, 2006, PARASITOLOGY, V132, P615, DOI 10.1017/S0031182005009790; Hastings IM, 1996, PARASITOLOGY, V112, P155, DOI 10.1017/S0031182000084717; Hastings IM, 1997, PARASITOL TODAY, V13, P375, DOI 10.1016/S0169-4758(97)01110-1; Hastings IM, 1997, PARASITOLOGY, V115, P133, DOI 10.1017/S0031182097001261; Hastings IM, 2003, TRENDS PARASITOL, V19, P70, DOI 10.1016/S1471-4922(02)00017-X; Hastings IM, 2005, ACTA TROP, V94, P218, DOI 10.1016/j.actatropica.2005.04.003; HASTINGS IM, 2003, J PARASITOL, V89, pS62; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; HILL WG, 1995, GENET RES, V65, P53, DOI 10.1017/S0016672300033000; Hill William G., 1995, Proceedings of the Royal Society of London Series B Biological Sciences, V262, P249, DOI 10.1098/rspb.1995.0203; HUDSON RR, 1994, J EVOLUTION BIOL, V7, P535, DOI 10.1046/j.1420-9101.1994.7050535.x; MAYNARDSMITH J, 1993, P NATIONAL ACADEMY S, V90, P4384; Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335; MZILAHOWA T, 2005, THESIS LIVERPOOL SCH; PAUL REL, 1995, SCIENCE, V269, P1709, DOI 10.1126/science.7569897; Paul REL, 1999, T ROY SOC TROP MED H, V93, P587, DOI 10.1016/S0035-9203(99)90057-3; PONNUDURAI T, 1991, T ROY SOC TROP MED H, V85, P175, DOI 10.1016/0035-9203(91)90012-N; PROVINE EWB, 1986, SELECTED PAPERS S WR; RANFORDCARTWRIGHT LC, 1991, MOL BIOCHEM PARASIT, V49, P239, DOI 10.1016/0166-6851(91)90067-G; Razakandrainibe FG, 2005, P NATL ACAD SCI USA, V102, P17388, DOI 10.1073/pnas.0508871102; READ AF, 1992, PARASITOL TODAY, V8, P239, DOI 10.1016/0169-4758(92)90125-L; ROSENBERG R, 1990, T ROY SOC TROP MED H, V84, P209, DOI 10.1016/0035-9203(90)90258-G; Schneider S., 2000, ARLEQUIN VER 2 000 S; SMITH T, 1993, ACTA TROP, V54, P55, DOI 10.1016/0001-706X(93)90068-M; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Su XZ, 1996, GENOMICS, V33, P430, DOI 10.1006/geno.1996.0218; Talisuna AO, 2002, T ROY SOC TROP MED H, V96, P310, DOI 10.1016/S0035-9203(02)90108-2; Tibayrenc M., 1995, Advances in Parasitology, V36, P47, DOI 10.1016/S0065-308X(08)60490-X; TIBAYRENC M, 1990, P NATL ACAD SCI USA, V87, P2414, DOI 10.1073/pnas.87.7.2414; WALLIKER D, 1991, PARASITOL TODAY, V7, P232, DOI 10.1016/0169-4758(91)90235-G; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; WALLIKER D, 1990, NATURE, V348, P120, DOI 10.1038/348120a0; WHO, 1975, MAN PRACT ENT 2	55	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2007	2	7							e613	10.1371/journal.pone.0000613	http://dx.doi.org/10.1371/journal.pone.0000613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GI	17637829	Green Published, gold, Green Submitted			2022-12-27	WOS:000207452100003
J	Eddleston, M; Udayakumara, N; Adhikari, S; de Silva, D; Sheriff, MHR; Waidyaratne, DL				Eddleston, Michael; Udayakumara, Nilantha; Adhikari, Sriyantha; de Silva, Dhamika; Sheriff, M. H. Rezvi; Waidyaratne, Dhananjaya L.			The Importance of Poisoning vs. Road Traffic Injuries as a Cause of Death in Rural Sri Lanka	PLOS ONE			English	Article								Background. Road traffic crashes are considered by the WHO to be the most important global cause of death from injury. However, this may not be true for large areas of rural Asia where road vehicles are uncommon. The issue is important, since emphasising the importance of road traffic crashes risks switching resources to urban areas, away from already underfunded rural regions. In this study, we compared the importance of road traffic crashes with other forms of injury in a poor rural region of South Asia. Methodology/Principal Findings. We collected data on all deaths from injury in the North Central Province of Sri Lanka (NCP; population 1,105,198 at 2001 census) over 18 months using coronial, hospital, and police data. We calculated the incidence of death from all forms of intentional and unintentional injury in the province. The annual incidence of death from injury in the province was high: 84.2 per 100,000 population. Half of the deaths were from self-harm (41.3/100,000). Poisoning (35.7/100,000)-in particular, pesticide self-poisoning (23.7/100,000)-was the most common cause of death, being 3.9-fold more common than road traffic crashes (9.1/100,000). Conclusions/Significance. In poor rural regions of South Asia, fatal self-harm and pesticide self-poisoning in particular are significantly more important than road traffic injuries as a cause of death. It is possible that the data used by the WHO to calculate global injury estimates are biased towards urban areas with better data collection but little pesticide poisoning. More studies are required to inform a debate about the importance of different forms of injury and how avoidable deaths from any cause can be prevented. In the meantime, marked improvements in the effectiveness of therapy for pesticide poisoning, safer storage, reduced pesticide use, or reductions in pesticide toxicity are required urgently to reduce the number of deaths from self-poisoning in rural Asia.	[Eddleston, Michael] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Eddleston, Michael; Sheriff, M. H. Rezvi] Univ Colombo, Dept Clin Med, Ox Col Collaborat, Colombo, Sri Lanka; [de Silva, Dhamika] Off Prov Director Hlth Serv, Anuradhapura, North Central P, Sri Lanka; [Waidyaratne, Dhananjaya L.] Anuradhapura Gen Hosp, Anuradhapura, North Central P, Sri Lanka	University of Oxford; University of Colombo	Eddleston, M (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England.	eddlestonm@yahoo.com			Wellcome's Tropical Interest Group [GR063560MA]; Wellcome Trust/National Health; Medical Research Council International Collaborative Research [071669MA]	Wellcome's Tropical Interest Group; Wellcome Trust/National Health(Wellcome Trust); Medical Research Council International Collaborative Research	ME is a Wellcome Trust Career Development Fellow; this work was funded by grant GR063560MA from the Wellcome's Tropical Interest Group to ME. The South Asian Clinical Toxicology Research Collaboration (SACTRC) is funded by the Wellcome Trust/National Health and Medical Research Council International Collaborative Research Grant 071669MA.	Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; Bertolote JM, 2006, BRIT J PSYCHIAT, V189, P201, DOI 10.1192/bjp.bp.105.020834; Bose A, 2006, TROP MED INT HEALTH, V11, P1553, DOI 10.1111/j.1365-3156.2006.01707.x; *DEP CENS STAT GOS, 2007, MIDY POP VIT STAT DI; Eddleston M, 2006, CLIN TOXICOL, V44, P283, DOI 10.1080/15563650600584444; Eddleston M, 2005, BRIT J PSYCHIAT, V187, P583, DOI 10.1192/bjp.187.6.583; Eddleston M, 2005, LANCET, V366, P1452, DOI 10.1016/S0140-6736(05)67598-8; Eddleston M, 2004, BMJ-BRIT MED J, V328, P42, DOI 10.1136/bmj.328.7430.42; Eddleston M, 2007, INT J EPIDEMIOL, V36, P208, DOI 10.1093/ije/dyl240; FERNANDO R, 1998, MANAGEMENT POISONING, P192; Gajalakshmi V, 2007, INT J EPIDEMIOL, V36, P203, DOI 10.1093/ije/dyl308; Gawarammana IB, 2004, MED J AUSTRALIA, V180, P20, DOI 10.5694/j.1326-5377.2004.tb05768.x; Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150; International Fund for Agricultural Development, 2002, ASS RUR POV AS PAC; Joseph A, 2003, BRIT MED J, V326, P1121, DOI 10.1136/bmj.326.7399.1121; Krug EG, 2004, LANCET, V364, P1563, DOI 10.1016/S0140-6736(04)17328-5; Kularatne SAM, 2002, POSTGRAD MED J, V78, P276, DOI 10.1136/pmj.78.919.276; [李献云 Li Xianyun], 2002, [中国心理卫生杂志, Chinese Mental Health Journal], V16, P681; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; Pearson V, 2002, SUICIDE LIFE-THREAT, V32, P359, DOI 10.1521/suli.32.4.359.22345; Peden M., 2004, WORLD REPORT ROAD TR; Phillips MR, 2002, LANCET, V360, P1728, DOI 10.1016/S0140-6736(02)11681-3; Sharma SK, 2004, AM J TROP MED HYG, V71, P234, DOI 10.4269/ajtmh.2004.71.234; THEAKSTON RDG, 1990, T ROY SOC TROP MED H, V84, P301, DOI 10.1016/0035-9203(90)90297-R; WHO, 2001, WORLD HLTH REPORT 20; *WHO REG OFF W PAC, 2005, FACT SHEET HLTH POV; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization, 2004, WORLD HLTH REP 2004; Yang GH, 2005, BIOMED ENVIRON SCI, V18, P379	29	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2007	2	7							e599	10.1371/journal.pone.0000599	http://dx.doi.org/10.1371/journal.pone.0000599			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GH	17622344	gold, Green Published			2022-12-27	WOS:000207452000006
J	Pandit, A; Arjyal, A; Day, JN; Paudyal, B; Dangol, S; Zimmerman, MD; Yadav, B; Stepniewska, K; Campbell, JI; Dolecek, C; Farrar, JJ; Basnyat, B				Pandit, Anil; Arjyal, Amit; Day, Jeremy N.; Paudyal, Buddhi; Dangol, Sabina; Zimmerman, Mark D.; Yadav, Bharat; Stepniewska, Kasia; Campbell, James I.; Dolecek, Christiane; Farrar, Jeremy J.; Basnyat, Buddha			An Open Randomized Comparison of Gatifloxacin versus Cefixime for the Treatment of Uncomplicated Enteric Fever	PLOS ONE			English	Article							RESISTANT SALMONELLA-TYPHI; MULTIDRUG-RESISTANT; SEROVAR TYPHI; PARATYPHI-A; THERAPY; CHLOROMYCETIN; KATHMANDU	Objective. To assess the efficacy of gatifloxacin versus cefixime in the treatment of uncomplicated culture positive enteric fever. Design. A randomized, open-label, active control trial with two parallel arms. Setting. Emergency Room and Outpatient Clinics in Patan Hospital, Lagankhel, Lalitpur, Nepal. Participants. Patients with clinically diagnosed uncomplicated enteric fever meeting the inclusion criteria. Interventions. Patients were allocated to receive one of two drugs, Gatifloxacin or Cefixime. The dosages used were Gatifloxacin 10 mg/kg, given once daily for 7 days, or Cefixime 20 mg/kg/day given in two divided doses for 7 days. Outcome Measures. The primary outcome measure was fever clearance time. The secondary outcome measure was overall treatment failure ( acute treatment failure and relapse). Results. Randomization was carried out in 390 patients before enrollment was suspended on the advice of the independent data safety monitoring board due to significant differences in both primary and secondary outcome measures in the two arms and the attainment of a priori defined endpoints. Median (95% confidence interval) fever clearance times were 92 hours (84-114 hours) for gatifloxacin recipients and 138 hours (105-164 hours) for cefixime-treated patients ( Hazard Ratio[ 95% CI] = 2.171 [1.545-3.051], p<0.0001). 19 out of 70 (27%) patients who completed the 7 day trial had acute clinical failure in the cefixime group as compared to 1 out of 88 patients (1%) in gatifloxacin group( Odds Ratio [ 95% CI] = 0.031 [0.004 - 0.237], p<0.001). Overall treatment failure patients ( relapsed patients plus acute treatment failure patients plus death) numbered 29. They were determined to be ( 95% confidence interval) 37.6 % (27.14%-50.2%) in the cefixime group and 3.5% (2.2%-11.5%) in the gatifloxacin group (HR[95% CI] = 0.084 [0.025-0.280], p<0.0001). There was one death in the cefixime group. Conclusions. Based on this study, gatifloxacin is a better treatment for uncomplicated enteric fever as compared to cefixime. Trial Registration. Current Controlled Trials ISRCTN75784880	[Pandit, Anil; Arjyal, Amit; Paudyal, Buddhi; Dangol, Sabina; Zimmerman, Mark D.; Yadav, Bharat; Basnyat, Buddha] Patan Hosp, Lagankhel, Lalitpur, Nepal; [Day, Jeremy N.; Stepniewska, Kasia; Campbell, James I.; Dolecek, Christiane; Farrar, Jeremy J.] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Day, Jeremy N.; Campbell, James I.; Dolecek, Christiane; Farrar, Jeremy J.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Day, Jeremy N.] N Manchester Grp Hosp, Reg Infect Dis Unit, Manchester, Lancs, England; [Basnyat, Buddha] Nepal Int Clin, Kathmandu, Nepal	University of Oxford; University of Oxford	Basnyat, B (corresponding author), Patan Hosp, Lagankhel, Lalitpur, Nepal.	rishibas@wlink.com.np	Farrar, Jeremy J./HGA-7610-2022	Stepniewska, Kasia/0000-0002-1713-6209; Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust of Great Britain	Wellcome Trust of Great Britain(Wellcome Trust)	This work was funded by the Wellcome Trust of Great Britain. The study sponsor had no role in study design; collection, analysis, and interpretation of data; writing of the paper; and decision to submit it for publication. The funding source had no involvement in the authors' work.	Ansari I, 2005, TROP DOCT, V35, P57; Basnyat B, 2005, CLIN INFECT DIS, V41, P1467, DOI 10.1086/497136; Basnyat B, 2004, WILD ENVIRON MED, V15, P216, DOI 10.1580/1080-6032(2004)15[216:PROTBE]2.0.CO;2; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; BHUTTA ZA, 1994, PEDIATR INFECT DIS J, V13, P990, DOI 10.1097/00006454-199411000-00010; CAMMIE FL, 2005, HARRISONS PRINCIPLES, P897; Cao X T, 1999, Pediatr Infect Dis J, V18, P245; Capparelli EV, 2005, ANTIMICROB AGENTS CH, V49, P1106, DOI 10.1128/AAC.49.3.1106-1112.2005; Chinh NT, 2000, ANTIMICROB AGENTS CH, V44, P1855, DOI 10.1128/AAC.44.7.1855-1859.2000; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Donaldson AR, 2004, ANN PHARMACOTHER, V38, P602, DOI 10.1345/aph.1D360; GIRGIS NI, 1995, PEDIATR INFECT DIS J, V14, P603, DOI 10.1097/00006454-199507000-00010; GIRGIS NI, 1993, DRUG EXP CLIN RES, V19, P47; Greenberg AL, 2005, CLIN INFECT DIS, V40, P1210, DOI 10.1086/428847; Khovidhunkit W, 2004, ANN INTERN MED, V141, P969, DOI 10.7326/0003-4819-141-12-200412210-00022; Liu P, 2005, J CLIN PHARMACOL, V45, P564, DOI 10.1177/0091270004273679; Lu T, 1999, ANTIMICROB AGENTS CH, V43, P2969, DOI 10.1128/AAC.43.12.2969; Maskey AP, 2006, CLIN INFECT DIS, V42, P1247, DOI 10.1086/503033; Matsumoto Y, 2001, ANTIMICROB AGENTS CH, V45, P2450, DOI 10.1128/AAC.45.9.2450-2454.2001; Memon IA, 1997, SOUTHERN MED J, V90, P1204, DOI 10.1097/00007611-199712000-00008; Murdoch DR, 2004, AM J TROP MED HYG, V70, P670, DOI 10.4269/ajtmh.2004.70.670; Pandit A, 2005, LANCET, V366, P1603, DOI 10.1016/S0140-6736(05)67653-2; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Parry CM, 2003, NEW ENGL J MED, V348, P1184; Pichichero ME, 2005, CLIN INFECT DIS, V41, P470, DOI 10.1086/431584; Rabbani M W, 1998, J Pak Med Assoc, V48, P163; RICHENS J, 2003, OXFORD TXB MED, P503; Shirakawa T, 2006, DIAGN MICR INFEC DIS, V54, P299, DOI 10.1016/j.diagmicrobio.2005.10.016; THAVER D, 2005, COCHRANE DB SYST REV, V18; Threlfall EJ, 1999, LANCET, V353, P1590, DOI 10.1016/S0140-6736(99)01001-6; WOODWARD TE, 1948, ANN INTERN MED, V29, P131, DOI 10.7326/0003-4819-29-1-131; World Health Organization, 2003, TREATM TYPH FEV BACK	33	58	58	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e542	10.1371/journal.pone.0000542	http://dx.doi.org/10.1371/journal.pone.0000542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593957	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451800002
J	Calzolari, D; Paternostro, G; Harrington, PL; Piermarocchi, C; Duxbury, PM				Calzolari, Diego; Paternostro, Giovanni; Harrington, Patrick L., Jr.; Piermarocchi, Carlo; Duxbury, Phillip M.			Selective Control of the Apoptosis Signaling Network in Heterogeneous Cell Populations	PLOS ONE			English	Article								Background. Selective control in a population is the ability to control a member of the population while leaving the other members relatively unaffected. The concept of selective control is developed using cell death or apoptosis in heterogeneous cell populations as an example. Control of apoptosis is essential in a variety of therapeutic environments, including cancer where cancer cell death is a desired outcome and Alzheimer's disease where neuron survival is the desired outcome. However, in both cases these responses must occur with minimal response in other cells exposed to treatment; that is, the response must be selective. Methodology and Principal Findings. Apoptosis signaling in heterogeneous cells is described by an ensemble of gene networks with identical topology but different link strengths. Selective control depends on the statistics of signaling in the ensemble of networks, and we analyze the effects of superposition, non-linearity and feedback on these statistics. Parallel pathways promote normal statistics while series pathways promote skew distributions, which in the most extreme cases become log-normal. We also show that feedback and non-linearity can produce bimodal signaling statistics, as can discreteness and non-linearity. Two methods for optimizing selective control are presented. The first is an exhaustive search method and the second is a linear programming based approach. Though control of a single gene in the signaling network yields little selectivity, control of a few genes typically yields higher levels of selectivity. The statistics of gene combinations susceptible to selective control in heterogeneous apoptosis networks is studied and is used to identify general control strategies. Conclusions and Significance. We have explored two methods for the study of selectivity in cell populations. The first is an exhaustive search method limited to three node perturbations. The second is an effective linear model, based on interpolation of single node sensitivity, in which the selective combinations can be found by linear programming optimization. We found that selectivity is promoted by acting on the least sensitive nodes in the case of weak populations, while selective control of robust populations is optimized through perturbations of more sensitive nodes. High throughput experiments with heterogeneous cell lines could be designed in an analogous manner, with the further possibility of incorporating the selectivity optimization process into a closed-loop control system.	[Harrington, Patrick L., Jr.; Piermarocchi, Carlo; Duxbury, Phillip M.] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; [Calzolari, Diego; Paternostro, Giovanni] Burnham Inst Med Res, La Jolla, CA USA	Michigan State University; Sanford Burnham Prebys Medical Discovery Institute	Duxbury, PM (corresponding author), Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA.	duxbury@pa.msu.edu	Piermarocchi, Carlo/A-2427-2008; Piermarocchi, Carlo/AAH-2162-2019	Piermarocchi, Carlo/0000-0003-2762-8562; Piermarocchi, Carlo/0000-0003-2762-8562; duxbury, Phillip/0000-0003-4549-4764	Burnham Institute; Michigan State University	Burnham Institute; Michigan State University	The work was supported by the Burnham Institute and by Michigan State University. The funders had no role in the work described in the manuscript or in its preparation.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; Ankarcrona M, 2005, INT J GERIATR PSYCH, V20, P101, DOI 10.1002/gps.1260; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Barrett CL, 2006, PLOS COMPUT BIOL, V2, P429, DOI 10.1371/journal.pcbi.0020052; Buchler NE, 2005, P NATL ACAD SCI USA, V102, P9559, DOI 10.1073/pnas.0409553102; Colizza V, 2005, PHYSICA A, V352, P1, DOI 10.1016/j.physa.2004.12.030; Cormen Thomas H., 2009, INTRO ALGORITHMS; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; Dealy S, 2005, COMPLEXITY, V11, P52, DOI 10.1002/cplx.20100; Drossel B, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016110; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Eissing T, 2005, IEE P SYST BIOL, V152, P221, DOI 10.1049/ip-syb:20050046; Feng XJ, 2004, BIOPHYS J, V87, P2195, DOI 10.1529/biophysj.104.044131; Feng XJ, 2004, BIOPHYS J, V86, P1270, DOI 10.1016/S0006-3495(04)74201-0; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kauffman S.A., 1993, ORIGINS ORDER; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Klein S, 2006, CURR SIGNAL TRANSD T, V1, P1, DOI 10.2174/157436206775269244; Klemm K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.055101; Ku J, 2004, J COMPUT BIOL, V11, P642, DOI 10.1089/cmb.2004.11.642; Lee JM, 2006, BRIEF BIOINFORM, V7, P140, DOI 10.1093/bib/bbl007; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Lu KP, 2004, TRENDS BIOCHEM SCI, V29, P200, DOI 10.1016/j.tibs.2004.02.002; Perkins TJ, 2006, PLOS COMPUT BIOL, V2, P417, DOI 10.1371/journal.pcbi.0020051; Petak I, 2006, CURR SIGNAL TRANSD T, V1, P113, DOI 10.2174/157436206775269217; Pompl PN, 2003, ARCH NEUROL-CHICAGO, V60, P369, DOI 10.1001/archneur.60.3.369; Reed JC, 2005, BLOOD, V106, P408, DOI 10.1182/blood-2004-07-2761; Shmulevich I, 2005, P NATL ACAD SCI USA, V102, P13439, DOI 10.1073/pnas.0506771102; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Zhou HJ, 2005, P NATL ACAD SCI USA, V102, P10052, DOI 10.1073/pnas.0409296102	33	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2007	2	6							e547	10.1371/journal.pone.0000547	http://dx.doi.org/10.1371/journal.pone.0000547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GE	17579719	gold, Green Published, Green Submitted			2022-12-27	WOS:000207451700013
J	Melov, S; Adlard, PA; Morten, K; Johnson, F; Golden, TR; Hinerfeld, D; Schilling, B; Mavros, C; Masters, CL; Volitakis, I; Li, QX; Laughton, K; Hubbard, A; Cherny, RA; Gibson, B; Bush, AI				Melov, Simon; Adlard, Paul A.; Morten, Karl; Johnson, Felicity; Golden, Tamara R.; Hinerfeld, Doug; Schilling, Birgit; Mavros, Christine; Masters, Colin L.; Volitakis, Irene; Li, Qiao-Xin; Laughton, Katrina; Hubbard, Alan; Cherny, Robert A.; Gibson, Brad; Bush, Ashley I.			Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau	PLOS ONE			English	Article								Age-related neurodegenerative disease has been mechanistically linked with mitochondrial dysfunction via damage from reactive oxygen species produced within the cell. We determined whether increased mitochondrial oxidative stress could modulate or regulate two of the key neurochemical hallmarks of Alzheimer's disease (AD): tau phosphorylation, and beta-amyloid deposition. Mice lacking superoxide dismutase 2 (SOD2) die within the first week of life, and develop a complex heterogeneous phenotype arising from mitochondrial dysfunction and oxidative stress. Treatment of these mice with catalytic antioxidants increases their lifespan and rescues the peripheral phenotypes, while uncovering central nervous system pathology. We examined sod2 null mice differentially treated with high and low doses of a catalytic antioxidant and observed striking elevations in the levels of tau phosphorylation (at Ser-396 and other phospho-epitopes of tau) in the low-dose antioxidant treated mice at AD-associated residues. This hyperphosphorylation of tau was prevented with an increased dose of the antioxidant, previously reported to be sufficient to prevent neuropathology. We then genetically combined a well-characterized mouse model of AD (Tg2576) with heterozygous sod2 knockout mice to study the interactions between mitochondrial oxidative stress and cerebral A beta load. We found that mitochondrial SOD2 deficiency exacerbates amyloid burden and significantly reduces metal levels in the brain, while increasing levels of Ser-396 phosphorylated tau. These findings mechanistically link mitochondrial oxidative stress with the pathological features of AD.	[Melov, Simon; Morten, Karl; Johnson, Felicity; Golden, Tamara R.; Hinerfeld, Doug; Schilling, Birgit; Gibson, Brad] Buck Inst Age Res, Novato, CA USA; [Adlard, Paul A.; Mavros, Christine; Masters, Colin L.; Volitakis, Irene; Li, Qiao-Xin; Laughton, Katrina; Cherny, Robert A.; Bush, Ashley I.] Univ Melbourne, Mental Hlth Res Inst Victoria, Parkville, Vic 3052, Australia; [Adlard, Paul A.; Mavros, Christine; Masters, Colin L.; Volitakis, Irene; Li, Qiao-Xin; Laughton, Katrina; Cherny, Robert A.; Bush, Ashley I.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Hubbard, Alan] Univ Calif Berkeley, Sch Publ Hlth, EHS Biostat, Berkeley, CA 94720 USA; [Bush, Ashley I.] Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA	Buck Institute for Research on Aging; University of Melbourne; University of Melbourne; University of California System; University of California Berkeley; Harvard University; Massachusetts General Hospital	Melov, S (corresponding author), Buck Inst Age Res, Novato, CA USA.	smelov@buckinsti-tute.org; bush@helix.mgh.harvard.edu	Bush, Ashley/Y-2457-2019; Melov, Simon/AAC-9469-2020; MORTEN, Karl/GXM-6291-2022; Bush, Ashley I/A-1186-2007	Bush, Ashley/0000-0001-8259-9069; Bush, Ashley I/0000-0001-8259-9069; Melov, Simon/0000-0001-8554-2834; Sommerville, Christine/0000-0002-9226-1691; Morten, Karl/0000-0001-6926-6550; Volitakis, Irene/0000-0003-0766-817X	National Institutes of Health [AG18679, PO1 AG25901, AG12686]; American Health Assistance Foundation; Institute for the Study of Aging; Ellison Medical Foundation; Australian Research Council; National Health and Medical Research Council; NATIONAL INSTITUTE ON AGING [P01AG025901, R01AG012686, R29AG012686, R01AG018679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation; Institute for the Study of Aging; Ellison Medical Foundation(Lawrence Ellison Foundation); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants AG18679 and PO1 AG25901 (S. M), AG12686 (A. I. B.), and a grant from the American Health Assistance Foundation (A. I. B.). It was also supported by an award from the Institute for the Study of Aging and an Ellison Medical Foundation award (S. M); the Australian Research Council Federation Fellowship (A. I. B.); the National Health and Medical Research Council Howard Florey Centenary Research Fellowship (P. A). We would like to thank Nicole Nagulko and Lawreen Asuncion for excellent animal work, and Sue Doctrow for helpful comments.	Ali SS, 2004, FREE RADICAL BIO MED, V37, P1191, DOI 10.1016/j.freeradbiomed.2004.07.002; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Bancroft G.D., 1996, THEORY PRACTICE PATH, V4th ed.; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bayer TA, 2003, P NATL ACAD SCI USA, V100, P14187, DOI 10.1073/pnas.2332818100; Bellingham SA, 2004, J NEUROCHEM, V91, P423, DOI 10.1111/j.1471-4159.2004.02731.x; Blass JP, 2001, J NEUROSCI RES, V66, P851, DOI 10.1002/jnr.10087; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Crouch PJ, 2006, DRUG NEWS PERSPECT, V19, P469, DOI 10.1358/dnp.2006.19.8.1021492; Dewachter I, 2000, EXP GERONTOL, V35, P831, DOI 10.1016/S0531-5565(00)00149-2; Dias-Santagata D, 2007, J CLIN INVEST, V117, P236, DOI 10.1172/JCI28769; Esposito L, 2006, J NEUROSCI, V26, P5167, DOI 10.1523/JNEUROSCI.0482-06.2006; Friedman JS, 2004, BLOOD, V104, P2565, DOI 10.1182/blood-2003-11-3858; Friedman JS, 2001, J EXP MED, V193, P925, DOI 10.1084/jem.193.8.925; Galas MC, 2006, J BIOL CHEM, V281, P19296, DOI 10.1074/jbc.M601849200; Golden TR, 2005, FREE RADICAL BIO MED, V39, P152, DOI 10.1016/j.freeradbiomed.2005.03.002; Hinerfeld D, 2004, J NEUROCHEM, V88, P657, DOI 10.1046/j.1471-4159.2003.02195.x; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang TT, 2001, FREE RADICAL BIO MED, V31, P1101, DOI 10.1016/S0891-5849(01)00694-3; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; KOBAYASHI K, 1992, BIOTECH HISTOCHEM, V67, P256, DOI 10.3109/10520299209110033; Li B, 2007, ACTA NEUROPATHOL, V113, P501, DOI 10.1007/s00401-007-0207-8; Li F, 2004, J NEUROCHEM, V89, P1308, DOI 10.1111/j.1471-4159.2004.02455.x; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Marcus DL, 2006, MED SCI MONITOR, V12, pBR8; Maynard CJ, 2006, J INORG BIOCHEM, V100, P952, DOI 10.1016/j.jinorgbio.2006.02.010; Maynard CJ, 2002, J BIOL CHEM, V277, P44670, DOI 10.1074/jbc.M204379200; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Melov S, 2001, J NEUROSCI, V21, P8348, DOI 10.1523/JNEUROSCI.21-21-08348.2001; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Phinney AL, 2003, P NATL ACAD SCI USA, V100, P14193, DOI 10.1073/pnas.2332851100; Qi XP, 2003, INVEST OPHTH VIS SCI, V44, P1088, DOI 10.1167/iovs.02-0864; Richardson James A, 2002, ILAR J, V43, P89; Samper E, 2003, AGING CELL, V2, P277, DOI 10.1046/j.1474-9728.2003.00062.x; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schonheit B, 2004, NEUROBIOL AGING, V25, P697, DOI 10.1016/j.neurobioalging.2003.09.009; Smith MA, 1999, DRUG DEVELOP RES, V46, P26, DOI 10.1002/(SICI)1098-2299(199901)46:1<26::AID-DDR5>3.0.CO;2-8; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; Strassburger M, 2005, FREE RADICAL BIO MED, V38, P1458, DOI 10.1016/j.freeradbiomed.2005.02.009; Takuma K, 2005, FASEB J, V19, P597, DOI 10.1096/fj.04-2582fje; van Leuven F, 2000, PROG NEUROBIOL, V61, P305, DOI 10.1016/S0301-0082(99)00055-6; Van Remmen H, 2001, AM J PHYSIOL-HEART C, V281, pH1422, DOI 10.1152/ajpheart.2001.281.3.H1422; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; Van Remmen H, 1999, ARCH BIOCHEM BIOPHYS, V363, P91, DOI 10.1006/abbi.1998.1060; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wirths O, 2001, NEUROSCI LETT, V306, P116, DOI 10.1016/S0304-3940(01)01876-6	55	252	255	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2007	2	6							e536	10.1371/journal.pone.0000536	http://dx.doi.org/10.1371/journal.pone.0000536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GE	17579710	Green Published, gold			2022-12-27	WOS:000207451700004
J	Sundquist, A; Ronaghi, M; Tang, HX; Pevzner, P; Batzoglou, S				Sundquist, Andreas; Ronaghi, Mostafa; Tang, Haixu; Pevzner, Pavel; Batzoglou, Serafim			Whole-Genome Sequencing and Assembly with High-Throughput, Short-Read Technologies	PLOS ONE			English	Article								While recently developed short-read sequencing technologies may dramatically reduce the sequencing cost and eventually achieve the $1000 goal for re-sequencing, their limitations prevent the de novo sequencing of eukaryotic genomes with the standard shotgun sequencing protocol. We present SHRAP (SHort Read Assembly Protocol), a sequencing protocol and assembly methodology that utilizes high-throughput short-read technologies. We describe a variation on hierarchical sequencing with two crucial differences: (1) we select a clone library from the genome randomly rather than as a tiling path and (2) we sample clones from the genome at high coverage and reads from the clones at low coverage. We assume that 200 bp read lengths with a 1% error rate and inexpensive random fragment cloning on whole mammalian genomes is feasible. Our assembly methodology is based on first ordering the clones and subsequently performing read assembly in three stages: (1) local assemblies of regions significantly smaller than a clone size, (2) clone-sized assemblies of the results of stage 1, and (3) chromosome-sized assemblies. By aggressively localizing the assembly problem during the first stage, our method succeeds in assembling short, unpaired reads sampled from repetitive genomes. We tested our assembler using simulated reads from D. melanogaster and human chromosomes 1, 11, and 21, and produced assemblies with large sets of contiguous sequence and a misassembly rate comparable to other draft assemblies. Tested on D. melanogaster and the entire human genome, our clone-ordering method produces accurate maps, thereby localizing fragment assembly and enabling the parallelization of the subsequent steps of our pipeline. Thus, we have demonstrated that truly inexpensive de novo sequencing of mammalian genomes will soon be possible with high-throughput, short-read technologies using our methodology.	[Sundquist, Andreas; Batzoglou, Serafim] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Ronaghi, Mostafa] Stanford Genome Technol Ctr, Stanford, CA USA; [Tang, Haixu] Indiana Univ, Sch Informat, Bloomington, IN USA; [Pevzner, Pavel] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	Stanford University; Stanford University; Indiana University System; Indiana University Bloomington; University of California System; University of California San Diego	Sundquist, A (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.	asundqui@cs.stanford.edu			NIH [R01HG003571-02]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003571] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This project was supported in part by NIH grant R01HG003571-02. AS was partly supported by an SAP Labs Stanford Graduate Fellowship.	Batzoglou S, 1999, GENOME RES, V9, P1163, DOI 10.1101/gr.9.12.1163; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chaisson M, 2004, BIOINFORMATICS, V20, P2067, DOI 10.1093/bioinformatics/bth205; CHEE MS, 1990, CURR TOP MICROBIOL, V154, P125; EDWARDS A, 1990, GENOMICS, V6, P593, DOI 10.1016/0888-7543(90)90493-E; ELTOUKHY H, 2006, 2006 IEEE INT C AC S, P1032; FIERS W, 1978, NATURE, V273, P113, DOI 10.1038/273113a0; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Havlak P, 2004, GENOME RES, V14, P721, DOI 10.1101/gr.2264004; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mewes HW, 1997, NATURE, V387, P7, DOI 10.1038/387s007; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; Pevzner P.A., 2001, P 5 ANN INT C COMP M, P256; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pop M, 2004, GENOME RES, V14, P149; Ramanathan A, 2004, ANAL BIOCHEM, V330, P227, DOI 10.1016/j.ab.2004.03.029; ROACH JC, 1995, GENOMICS, V26, P345, DOI 10.1016/0888-7543(95)80219-C; Roach JC, 2000, GENOME RES, V10, P1020, DOI 10.1101/gr.10.7.1020; Rogers YH, 2005, NATURE, V437, P326, DOI 10.1038/437326a; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Ronaghi M, 1999, ANAL BIOCHEM, V267, P65, DOI 10.1006/abio.1998.2978; SANGER F, 1982, J MOL BIOL, V162, P729, DOI 10.1016/0022-2836(82)90546-0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Siegel AF, 2000, GENOMICS, V68, P237, DOI 10.1006/geno.2000.6303; Venter JC, 1996, NATURE, V381, P364, DOI 10.1038/381364a0; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weber JL, 1997, GENOME RES, V7, P401, DOI 10.1101/gr.7.5.401; Zhou SG, 2003, GENOME RES, V13, P2142, DOI 10.1101/gr.1128803	35	86	98	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2007	2	5							e484	10.1371/journal.pone.0000484	http://dx.doi.org/10.1371/journal.pone.0000484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10FB	17534434	gold, Green Published			2022-12-27	WOS:000207448800014
J	Brommer, JE; Kirkpatrick, M; Qvarnstrom, A; Gustafsson, L				Brommer, Jon E.; Kirkpatrick, Mark; Qvarnstrom, Anna; Gustafsson, Lars			The Intersexual Genetic Correlation for Lifetime Fitness in the Wild and Its Implications for Sexual Selection	PLOS ONE			English	Article								Background. The genetic benefits of mate choice are limited by the degree to which male and female fitness are genetically correlated. If the intersexual correlation for fitness is small or negative, choosing a highly fit mate does not necessarily result in high fitness offspring. Methodology/Principal Finding. Using an animal-model approach on data from a pedigreed population of over 7,000 collared flycatchers (Ficedula albicollis), we estimate the intersexual genetic correlation in Lifetime Reproductive Success (LRS) in a natural population to be negative in sign (-0.85 +/- 0.6). Simulations show this estimate to be robust in sign to the effects of extra-pair parentage. The genetic benefits in this population are further limited by a low level of genetic variation for fitness in males. Conclusions/Significance. The potential for indirect sexual selection is nullified by sexual antagonistic fitness effects in this natural population. Our findings and the scarce evidence from other studies suggest that the intersexual genetic correlation for lifetime fitness may be very low in nature. We argue that this form of conflict can, in general, both constrain and maintain sexual selection, depending on the sex-specific additive genetic variances in lifetime fitness.	[Brommer, Jon E.] Univ Helsinki, Dept Biol & Environm Sci, Helsinki, Finland; [Kirkpatrick, Mark] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Qvarnstrom, Anna; Gustafsson, Lars] Uppsala Univ, Dept Ecol & Evolut, Uppsala, Sweden	University of Helsinki; University of Texas System; University of Texas Austin; Uppsala University	Brommer, JE (corresponding author), Univ Helsinki, Dept Biol & Environm Sci, Helsinki, Finland.	jon.brommer@helsinki.fi	Brommer, Jon E/C-3613-2008; Gustafsson, Lars/O-8056-2019; Gustafsson, Lars/A-7634-2012	Brommer, Jon E/0000-0002-2435-2612; Gustafsson, Lars/0000-0001-6566-2863; Gustafsson, Lars/0000-0001-6566-2863; Qvarnstrom, Anna/0000-0002-1178-4053	Academy of Finland (JEB); Swedish Research Council (LG, AQ); NSF [DEB-09973221, EF-0328594]	Academy of Finland (JEB)(Academy of Finland); Swedish Research Council (LG, AQ)(Swedish Research Council); NSF(National Science Foundation (NSF))	This work was financed by the Academy of Finland (JEB), The Swedish Research Council (LG, AQ), and NSF grants DEB-09973221 and EF-0328594 (MK).	Arnqvist Goran, 2005, pUnpaginated; Charmantier A, 2005, MOL ECOL, V14, P2839, DOI 10.1111/j.1365-294X.2005.02619.x; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Csillery K, 2006, GENETICS, V173, P2091, DOI 10.1534/genetics.106.057331; Eshel I, 2000, EVOL ECOL RES, V2, P509; Fisher, 1958, GENETICAL THEORY NAT; Foerster K, 2007, NATURE, V447, P1107, DOI 10.1038/nature05912; Gibson JR, 2002, P ROY SOC B-BIOL SCI, V269, P499, DOI 10.1098/rspb.2001.1863; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; Kirkpatrick M, 2004, EVOLUTION, V58, P683; Kirkpatrick M, 1997, P NATL ACAD SCI USA, V94, P1282, DOI 10.1073/pnas.94.4.1282; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Lynch M., 1998, GENETICS ANAL QUANTI; McCleery RH, 2004, AM NAT, V164, pE62, DOI 10.1086/422660; Merila J, 2000, AM NAT, V155, P301, DOI 10.1086/303330; Pischedda A, 2006, PLOS BIOL, V4, P2099, DOI 10.1371/journal.pbio.0040356; Qvarnstrom A, 2006, NATURE, V441, P84, DOI 10.1038/nature04564; Rice WR, 2000, P NATL ACAD SCI USA, V97, P12953, DOI 10.1073/pnas.97.24.12953; ROBERTSON A, 1966, ANIM PROD, V8, P95, DOI 10.1017/S0003356100037752; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Sheldon BC, 2003, EVOLUTION, V57, P406; Sheldon BC, 1999, ANIM BEHAV, V57, P285, DOI 10.1006/anbe.1998.0968; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	25	97	97	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e744	10.1371/journal.pone.0000744	http://dx.doi.org/10.1371/journal.pone.0000744			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710144	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455200021
J	Weinberger, M; Feng, L; Paul, A; Smith, DL; Hontz, RD; Smith, JS; Vujcic, M; Singh, KK; Huberman, JA; Burhans, WC				Weinberger, Martin; Feng, Li; Paul, Anita; Smith, Daniel L., Jr.; Hontz, Robert D.; Smith, Jeffrey S.; Vujcic, Marija; Singh, Keshav K.; Huberman, Joel A.; Burhans, William C.			DNA Replication Stress Is a Determinant of Chronological Lifespan in Budding Yeast	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CDK INHIBITOR SIC1; CELL-CYCLE ARREST; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; STATIONARY-PHASE; GENOMIC INSTABILITY; MITOCHONDRIAL BIOGENESIS; CHROMOSOME INSTABILITY; CHECKPOINT CONTROLS	The chronological lifespan of eukaryotic organisms is extended by the mutational inactivation of conserved growth-signaling pathways that regulate progression into and through the cell cycle. Here we show that in the budding yeast S. cerevisiae, these and other lifespan-extending conditions, including caloric restriction and osmotic stress, increase the efficiency with which nutrient-depleted cells establish or maintain a cell cycle arrest in G1. Proteins required for efficient G1 arrest and longevity when nutrients are limiting include the DNA replication stress response proteins Mec1 and Rad53. Ectopic expression of CLN3 encoding a G1 cyclin downregulated during nutrient depletion increases the frequency with which nutrient depleted cells arrest growth in S phase instead of G1. Ectopic expression of CLN3 also shortens chronological lifespan in concert with age-dependent increases in genome instability and apoptosis. These findings indicate that replication stress is an important determinant of chronological lifespan in budding yeast. Protection from replication stress by growth-inhibitory effects of caloric restriction, osmotic and other stresses may contribute to hormesis effects on lifespan. Replication stress also likely impacts the longevity of higher eukaryotes, including humans.	[Weinberger, Martin; Feng, Li; Burhans, William C.] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA; [Paul, Anita; Huberman, Joel A.] Roswell Pk Canc Inst, Dept Canc Biol, Buffalo, NY 14263 USA; [Smith, Daniel L., Jr.; Hontz, Robert D.; Smith, Jeffrey S.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Vujcic, Marija; Singh, Keshav K.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; University of Virginia; Roswell Park Cancer Institute	Burhans, WC (corresponding author), Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA.	wburhans@buffalo.edu		Smith Jr, Daniel/0000-0002-1602-2023	NCI Cancer Center [P30 CA016056, CA121904, CA113655, GM075240, CA095908, GM070566]; NATIONAL CANCER INSTITUTE [R01CA121904, R01CA095908, R01CA113655, P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075240, R01GM070566] Funding Source: NIH RePORTER	NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by a NCI Cancer Center Support Grant (P30 CA016056) to Roswell Park Cancer Institute, CA121904 and CA113655 to K. K. S., GM075240 to J. S. S., and CA095908 and GM070566 to J. A. H.	Abulaiti A, 2006, CANCER RES, V66, P10505, DOI 10.1158/0008-5472.CAN-06-2351; Admire A, 2006, GENE DEV, V20, P159, DOI 10.1101/gad.1392506; Alexander MR, 2001, MOL BIOL CELL, V12, P53, DOI 10.1091/mbc.12.1.53; Allen C, 2006, J CELL BIOL, V174, P89, DOI 10.1083/jcb.200604072; Amberg DC., 2005, METHODS YEAST GENETI; Andalis AA, 2004, GENETICS, V167, P1109, DOI 10.1534/genetics.104.029256; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barbe E., 1996, MEDITERR POLIT, V1, P25; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Belli G, 2001, MOL MICROBIOL, V39, P1022, DOI 10.1046/j.1365-2958.2001.02297.x; Bitterman KJ, 2003, MICROBIOL MOL BIOL R, V67, P376, DOI 10.1128/MMBR.67.3.376-399.2003; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Cameroni E, 2004, CELL CYCLE, V3, P462; Carter CD, 2005, MOL CELL BIOL, V25, P10273, DOI 10.1128/MCB.25.23.10273-10285.2005; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cobb JA, 2005, GENE DEV, V19, P3055, DOI 10.1101/gad.361805; CROSS FR, 1988, MOL CELL BIOL, V8, P4675, DOI 10.1128/MCB.8.11.4675; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Dohrmann PR, 2006, GENETICS, V174, P87, DOI 10.1534/genetics.106.060236; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fabrizio P, 2004, FEBS LETT, V557, P136, DOI 10.1016/S0014-5793(03)01462-5; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fikaris AJ, 2006, J BIOL CHEM, V281, P34759, DOI 10.1074/jbc.M606737200; Flattery-O'Brien JA, 1998, J BIOL CHEM, V273, P8564, DOI 10.1074/jbc.273.15.8564; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Granot D, 2003, FEMS YEAST RES, V4, P7, DOI 10.1016/S1567-1356(03)00154-5; Gredilla R, 2005, ENDOCRINOLOGY, V146, P3713, DOI 10.1210/en.2005-0378; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Guthrie C, 1991, METHODS ENZYMOLOGY, V194; Hall DD, 1998, EMBO J, V17, P4370, DOI 10.1093/emboj/17.15.4370; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Hoopes LLM, 2002, MOL CELL BIOL, V22, P4136, DOI 10.1128/MCB.22.12.4136-4146.2002; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; JOHNSTON GC, 1980, MOL GEN GENET, V178, P357, DOI 10.1007/BF00270484; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2002, MOL CELL BIOL, V22, P8056, DOI 10.1128/MCB.22.22.8056-8066.2002; KATAOKA T, 1984, CELL, V37, P437, DOI 10.1016/0092-8674(84)90374-X; Khakhar RR, 2003, TRENDS CELL BIOL, V13, P493, DOI 10.1016/S0962-8924(03)00171-5; Khurana V, 2006, CURR BIOL, V16, P230, DOI 10.1016/j.cub.2005.12.042; Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1046/j.1365-2958.2001.02317.x; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; LILLIE SH, 1980, J BACTERIOL, V143, P1384, DOI 10.1128/JB.143.3.1384-1394.1980; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Longo VD, 2005, NAT REV GENET, V6, DOI 10.1038/nrg1706; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Mai B, 1997, MOL CELL BIOL, V17, P6491, DOI 10.1128/MCB.17.11.6491; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Miwa S, 2004, ANN NY ACAD SCI, V1019, P388, DOI 10.1196/annals.1297.069; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; OGURA M, 1989, P NATL ACAD SCI USA, V86, P5918, DOI 10.1073/pnas.86.15.5918; Parviz F, 1998, J BACTERIOL, V180, P4508, DOI 10.1128/JB.180.17.4508-4515.1998; Pedruzzi I, 2003, MOL CELL, V12, P1607, DOI 10.1016/S1097-2765(03)00485-4; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Reinders A, 1998, GENE DEV, V12, P2943, DOI 10.1101/gad.12.18.2943; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Sidorova JM, 1997, GENE DEV, V11, P3032, DOI 10.1101/gad.11.22.3032; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; SMITH DL, 2007, AGEING CELL IN PRESS; Swinnen E, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-3; T Burhans D, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-58; Tanaka S, 2002, GENE DEV, V16, P2639, DOI 10.1101/gad.1011002; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; Wang Y, 2004, PLOS BIOL, V2, P610, DOI 10.1371/journal.pbio.0020128; Wanke V, 2005, EMBO J, V24, P4271, DOI 10.1038/sj.emboj.7600889; Weinberger M, 2005, J CELL SCI, V118, P3543, DOI 10.1242/jcs.02477; WernerWashburne M, 1996, MOL MICROBIOL, V19, P1159, DOI 10.1111/j.1365-2958.1996.tb02461.x; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2000, MOL CELL BIOL, V20, P9076, DOI 10.1128/MCB.20.23.9076-9083.2000; Zinzalla V, 2007, MOL MICROBIOL, V63, P1482, DOI 10.1111/j.1365-2958.2007.05599.x	88	84	86	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e748	10.1371/journal.pone.0000748	http://dx.doi.org/10.1371/journal.pone.0000748			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710147	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455200024
J	Aldridge, JE; Horibe, T; Hoogenraad, NJ				Aldridge, Jonathan E.; Horibe, Tomohisa; Hoogenraad, Nicholas J.			Discovery of Genes Activated by the Mitochondrial Unfolded Protein Response (mtUPR) and Cognate Promoter Elements	PLOS ONE			English	Article								In an accompanying paper, we show that the mitochondrial Unfolded Protein Response or mtUPR is initiated by the activation of transcription of chop through an AP-1 element in the chop promoter. Further, we show that the c/ebp beta gene is similarly activated and CHOP and C/EBP beta subsequently hetero-dimerise to activate transcription of mtUPR responsive genes. Here, we report the discovery of six additional mtUPR responsive genes. We found that these genes encoding mitochondrial proteases YME1L1 and MPP beta, import component Tim17A and enzymes NDUFB2, endonuclease G and thioredoxin 2, all contain a CHOP element in their promoters. In contrast, genes encoding mitochondrial proteins Afg3L2, Paraplegin, Lon and SAM 50, which do not have a CHOP element, were not up-regulated. Conversely, genes with CHOP elements encoding cytosolic proteins were not induced by the accumulation of unfolded proteins in mitochondria. These results indicate that mtUPR responsive genes appear to share a requirement for a CHOP element, but that this is not sufficient for the regulation of the mtUPR. A more detailed analysis of promoters of mtUPR responsive genes revealed at least two additional highly conserved, putative regulatory sites either side of the CHOP element, one a motif of 12 bp which lies 14 bp upstream of the CHOP site and another 9 bp element, 2 bp downstream of the CHOP site. Both of these additional elements are conserved in the promoters of 9 of the ten mtUPR responsive genes we have identified so far, the exception being the Cpn60/10 bidirectional promoter. Mutation of each of these elements substantially reduced the mtUPR responsiveness of the promoters suggesting that these elements coordinately regulate mtUPR.	[Aldridge, Jonathan E.; Horibe, Tomohisa; Hoogenraad, Nicholas J.] La Trobe Univ, Dept Biochem, Melbourne, Vic, Australia	La Trobe University	Hoogenraad, NJ (corresponding author), La Trobe Univ, Dept Biochem, Melbourne, Vic, Australia.	n.hoogenraad@latrobe.edu.au	Hoogenraad, Nicholas J/C-7505-2011					Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; HORIBE T, 2007, PLOSONE IN PRESS; Kelly SE, 1996, J BIOL CHEM, V271, P6881, DOI 10.1074/jbc.271.12.6881; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Langer T, 1996, EXPERIENTIA, V52, P1069, DOI 10.1007/BF01952104; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Martinus RD, 1996, EUR J BIOCHEM, V240, P98, DOI 10.1111/j.1432-1033.1996.0098h.x; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Ohsato T, 2002, EUR J BIOCHEM, V269, P5765, DOI 10.1046/j.1432-1033.2002.03238.x; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schroder M, 2006, MOL BIOTECHNOL, V34, P279, DOI 10.1385/MB:34:2:279; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	26	209	212	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e874	10.1371/journal.pone.0000874	http://dx.doi.org/10.1371/journal.pone.0000874			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849004	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455600021
J	MacDonald, SM; Song, G; Poon, CS				MacDonald, Shawna M.; Song, Gang; Poon, Chi-Sang			Nonassociative Learning Promotes Respiratory Entrainment to Mechanical Ventilation	PLOS ONE			English	Article								(B)ackground. Patient-ventilator synchrony is a major concern in critical care and is influenced by phasic lung-volume feedback control of the respiratory rhythm. Routine clinical application of positive end-expiratory pressure (PEEP) introduces a tonic input which, if unopposed, might disrupt respiratory-ventilator entrainment through sustained activation of the vagally-mediated Hering-Breuer reflex. We suggest that this potential adverse effect may be averted by two differentiator forms of nonassociative learning (habituation and desensitization) of the Hering-Breuer reflex via pontomedullary pathways. Methodology/Principal Findings. We tested these hypotheses in 17 urethane-anesthetized adult Sprague-Dawley rats under controlled mechanical ventilation. Without PEEP, phrenic discharge was entrained 1:1 to the ventilator rhythm. Application of PEEP momentarily dampened the entrainment to higher ratios but this effect was gradually adapted by nonassociative learning. Bilateral electrolytic lesions of the pneumotaxic center weakened the adaptation to PEEP, whereas sustained stimulation of the pneumotaxic center weakened the entrainment independent of PEEP. In all cases, entrainment was abolished after vagotomy. Conclusions/Significance. Our results demonstrate an important functional role for pneumotaxic desensitization and extra-pontine habituation of the Hering-Breuer reflex elicited by lung inflation: acting as buffers or high-pass filters against tonic vagal volume input, these differentiator forms of nonassociative learning help to restore respiratory-ventilator entrainment in the face of PEEP. Such central sites-specific habituation and desensitization of the Hering-Breuer reflex provide a useful experimental model of nonassociative learning in mammals that is of particular significance in understanding respiratory rhythmogenesis and coupled-oscillator entrainment mechanisms, and in the clinical management of mechanical ventilation in respiratory failure.	[MacDonald, Shawna M.; Song, Gang; Poon, Chi-Sang] MIT, Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Poon, CS (corresponding author), MIT, Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cpoon@mit.edu			NHLBI NIH HHS [R01 HL079503, HL072849, HL079503, R01 HL072849, R01 HL067966, HL067966] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079503, R01HL072849, R01HL067966] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allo JC, 2006, CRIT CARE MED, V34, P2997, DOI 10.1097/01.CCM.0000242520.50665.9F; BACONNIER PF, 1993, J THEOR BIOL, V164, P149, DOI 10.1006/jtbi.1993.1145; Baumer JH, 2000, ARCH DIS CHILD-FETAL, V82, pF5, DOI 10.1136/fn.82.1.F5; Beresford MW, 2000, ARCH DIS CHILD-FETAL, V82, pF14, DOI 10.1136/fn.82.1.F14; Breuer J., 1970, BREATHING, P365; Brochard L, 2002, INTENS CARE MED, V28, P1376, DOI 10.1007/s00134-002-1438-8; Chao DC, 1997, CHEST, V112, P1592, DOI 10.1378/chest.112.6.1592; Dick CR, 1996, CLIN CHEST MED, V17, P423, DOI 10.1016/S0272-5231(05)70325-7; GAUTIER H, 1981, J APPL PHYSIOL, V51, P1162, DOI 10.1152/jappl.1981.51.5.1162; GRAVES C, 1986, AM J PHYSIOL, V250, pR902, DOI 10.1152/ajpregu.1986.250.5.R902; GRIPPI MA, 1985, J APPL PHYSIOL, V58, P1360, DOI 10.1152/jappl.1985.58.4.1360; GUZ A, 1971, J PHYSIOL-LONDON, V213, P329, DOI 10.1113/jphysiol.1971.sp009385; GUZ A, 1964, CLIN SCI, V27, P293; Haberthur C, 2005, CRIT CARE, V9, pR407, DOI 10.1186/cc3735; HAMILTON RD, 1988, RESP PHYSIOL, V73, P145, DOI 10.1016/0034-5687(88)90062-X; HAMILTON RD, 1990, RESP PHYSIOL, V81, P87, DOI 10.1016/0034-5687(90)90072-7; Hering E., 1970, BREATHING, P359; Imanaka H, 2000, CRIT CARE MED, V28, P402, DOI 10.1097/00003246-200002000-00019; Kondili E, 2003, BRIT J ANAESTH, V91, P106, DOI 10.1093/bja/aeg129; Lumsden T, 1923, J PHYSIOL-LONDON, V57, P153; MADOR MJ, 1990, CHEST, V97, P877, DOI 10.1378/chest.97.4.877; Matsugu M, 1998, J COMPUT NEUROSCI, V5, P35, DOI 10.1023/A:1008826326829; McGuire M, 2007, RESP PHYSIOL NEUROBI, V158, P107, DOI 10.1016/j.resp.2007.01.017; MUZZIN S, 1992, AM J PHYSIOL, V263, pR292, DOI 10.1152/ajpregu.1992.263.2.R292; MUZZIN S, 1989, RESP PHYSIOL, V75, P157, DOI 10.1016/0034-5687(89)90060-1; Oddo M, 2006, INTENS CARE MED, V32, P501, DOI 10.1007/s00134-005-0045-x; PEPE PE, 1982, AM REV RESPIR DIS, V126, P166; PETRILLO GA, 1983, CAN J PHYSIOL PHARM, V61, P599, DOI 10.1139/y83-092; PETRILLO GA, 1984, AM J PHYSIOL, V246, pR311, DOI 10.1152/ajpregu.1984.246.3.R311; Poon Chi-Sang, 2006, Behav Brain Funct, V2, P29, DOI 10.1186/1744-9081-2-29; Poon CS, 2000, RESP PHYSIOL, V122, P83, DOI 10.1016/S0034-5687(00)00152-3; Poon CS, 2004, ADV EXP MED BIOL, V551, P95; Poon CS, 2000, NEUROSCI LETT, V284, P5, DOI 10.1016/S0304-3940(00)00993-9; Poon CS, 1997, RESP PHYSIOL, V108, P117, DOI 10.1016/S0034-5687(97)00014-5; Saito Y, 1999, DEV MED CHILD NEUROL, V41, P560, DOI 10.1017/S0012162299001188; Sharshar T, 2003, AM J RESP CRIT CARE, V168, P760, DOI 10.1164/rccm.200203-241OC; Simon PM, 1999, AM J RESP CRIT CARE, V160, P950, DOI 10.1164/ajrccm.160.3.9712057; Simon PM, 2000, J APPL PHYSIOL, V89, P760, DOI 10.1152/jappl.2000.89.2.760; Sinderby C, 1999, NAT MED, V5, P1433, DOI 10.1038/71012; Siniaia MS, 2000, J PHYSIOL-LONDON, V523, P479, DOI 10.1111/j.1469-7793.2000.t01-1-00479.x; Song G, 2006, J NEUROSCI, V26, P300, DOI 10.1523/JNEUROSCI.3029-05.2006; Song G, 2004, RESP PHYSIOL NEUROBI, V143, P281, DOI 10.1016/j.resp.2004.05.009; STANLEY NN, 1975, J APPL PHYSIOL, V38, P474, DOI 10.1152/jappl.1975.38.3.474; Thille AW, 2006, INTENS CARE MED, V32, P1515, DOI 10.1007/s00134-006-0301-8; Tobin M. J., 2006, PRINCIPLES PRACTICE, P1121; Tobin MJ, 2001, NEW ENGL J MED, V344, P1986, DOI 10.1056/NEJM200106283442606; Tobin MJ, 2001, AM J RESP CRIT CARE, V163, P1059, DOI 10.1164/ajrccm.163.5.2005125; Tryfon S, 2001, RESPIRATION, V68, P140, DOI 10.1159/000050483; VIBERT JF, 1981, BIOL CYBERN, V41, P119, DOI 10.1007/BF00335366; WIDDICOMBE J, 1961, CLIN SCI, V21, P163; YOUNES M, 1985, J APPL PHYSIOL, V59, P1072, DOI 10.1152/jappl.1985.59.4.1072; YOUNES M, 1987, J APPL PHYSIOL, V62, P1502, DOI 10.1152/jappl.1987.62.4.1502; Young DL, 2003, J APPL PHYSIOL, V94, P1213, DOI 10.1152/japplphysiol.00639.2002	53	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e865	10.1371/journal.pone.0000865	http://dx.doi.org/10.1371/journal.pone.0000865			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848996	Green Published, gold			2022-12-27	WOS:000207455600012
J	Moura, G; Pinheiro, M; Arrais, J; Gomes, AC; Carreto, L; Freitas, A; Oliveira, JL; Santos, MAS				Moura, Gabriela; Pinheiro, Miguel; Arrais, Joel; Gomes, Ana Cristina; Carreto, Laura; Freitas, Adelaide; Oliveira, Jose L.; Santos, Manuel A. S.			Large Scale Comparative Codon-Pair Context Analysis Unveils General Rules that Fine-Tune Evolution of mRNA Primary Structure	PLOS ONE			English	Article								Background. Codon usage and codon-pair context are important gene primary structure features that influence mRNA decoding fidelity. In order to identify general rules that shape codon-pair context and minimize mRNA decoding error, we have carried out a large scale comparative codon-pair context analysis of 119 fully sequenced genomes. Methodologies/Principal Findings. We have developed mathematical and software tools for large scale comparative codon-pair context analysis. These methodologies unveiled general and species specific codon-pair context rules that govern evolution of mRNAs in the 3 domains of life. We show that evolution of bacterial and archeal mRNA primary structure is mainly dependent on constraints imposed by the translational machinery, while in eukaryotes DNA methylation and tri-nucleotide repeats impose strong biases on codon-pair context. Conclusions. The data highlight fundamental differences between prokaryotic and eukaryotic mRNA decoding rules, which are partially independent of codon usage.	[Moura, Gabriela; Gomes, Ana Cristina; Carreto, Laura; Santos, Manuel A. S.] Univ Aveiro, Dept Biol, Ctr Environm & Marine Studies, P-3800 Aveiro, Portugal; [Pinheiro, Miguel; Arrais, Joel; Oliveira, Jose L.] Univ Aveiro, Inst Elect & Telemat Engn, P-3800 Aveiro, Portugal; [Freitas, Adelaide] Univ Aveiro, Dept Math, P-3800 Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro	Santos, MAS (corresponding author), Univ Aveiro, Dept Biol, Ctr Environm & Marine Studies, P-3800 Aveiro, Portugal.	msantos@bio.ua.pt	Pinheiro, Miguel/K-6572-2017; Freitas, Adelaide/H-8880-2012; Oliveira, José Luis/A-2223-2012; Moura, Gabriela/GPF-9079-2022; Santos, Manuel/E-6704-2010; Moura, Gabriela R/E-6717-2010	Pinheiro, Miguel/0000-0002-6601-7513; Freitas, Adelaide/0000-0002-4685-1615; Oliveira, José Luis/0000-0002-6672-6176; Moura, Gabriela/0000-0003-2243-6123; Santos, Manuel/0000-0002-0437-1146; Moura, Gabriela R/0000-0003-2243-6123; Arrais, Joel/0000-0003-4937-2334	FEDER/FCT [POCTI/BME/39030, SAU-MMO/55476, BIA-PRO/55472, BIA-MIC/55466, PTDC/MAT/72974/2006]; Human Frontier Science Programme [RGP45/2005]; Fundação para a Ciência e a Tecnologia [POCI/BIA-PRO/55472/2004, POCI/BIA-MIC/55466/2004, POCTI/BME/39030/2001, POCI/SAU-MMO/55476/2004, PTDC/MAT/72974/2006] Funding Source: FCT	FEDER/FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Human Frontier Science Programme(Human Frontier Science Program); Fundação para a Ciência e a Tecnologia	This study was supported by FEDER/FCT projects POCTI/BME/39030; SAU-MMO/55476; BIA-PRO/55472; BIA-MIC/55466; PTDC/MAT/72974/2006 and Human Frontier Science Programme project RGP45/2005.	AKASHI H, 1994, GENETICS, V136, P927; ATKINS JF, 1991, ANNU REV GENET, V25, P201; Berg OG, 1997, NUCLEIC ACIDS RES, V25, P1397, DOI 10.1093/nar/25.7.1397; BEUTLER E, 1989, P NATL ACAD SCI USA, V86, P192, DOI 10.1073/pnas.86.1.192; Borstnik B, 2002, GENOME RES, V12, P909, DOI 10.1101/gr.138802; Boycheva S, 2003, BIOINFORMATICS, V19, P987, DOI 10.1093/bioinformatics/btg082; Buchan JR, 2006, NUCLEIC ACIDS RES, V34, P1015, DOI 10.1093/nar/gkj488; BUCKINGHAM RH, 1990, EXPERIENTIA, V46, P1126, DOI 10.1007/BF01936922; BUCKINGHAM RH, 1986, ACCURACY MOL PROCESS, P83; Caburet S, 2004, GENETICS, V167, P1813, DOI 10.1534/genetics.104.029082; Campbell A, 1999, P NATL ACAD SCI USA, V96, P9184, DOI 10.1073/pnas.96.16.9184; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100; Cliften PF, 2006, GENETICS, V172, P863, DOI 10.1534/genetics.105.048900; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; CURRAN JF, 1989, J MOL BIOL, V209, P65, DOI 10.1016/0022-2836(89)90170-8; CURRAN JF, 1995, NUCLEIC ACIDS RES, V23, P4104, DOI 10.1093/nar/23.20.4104; DIX DB, 1989, P NATL ACAD SCI USA, V86, P6888, DOI 10.1073/pnas.86.18.6888; Duan JB, 2003, J MOL EVOL, V57, P694, DOI 10.1007/s00239-003-2519-1; Fedorov A, 2002, NUCLEIC ACIDS RES, V30, P1192, DOI 10.1093/nar/30.5.1192; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699; HABERMAN SJ, 1973, BIOMETRICS, V29, P205, DOI 10.2307/2529686; Hooper SD, 2000, NUCLEIC ACIDS RES, V28, P3517, DOI 10.1093/nar/28.18.3517; Hooper SD, 2002, J MOL EVOL, V54, P365, DOI 10.1007/s00239-001-0051-8; IRWIN B, 1995, J BIOL CHEM, V270, P22801, DOI 10.1074/jbc.270.39.22801; Kennedy SP, 2001, GENOME RES, V11, P1641, DOI 10.1101/gr.190201; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Lao PJ, 2000, GENOME RES, V10, P228, DOI 10.1101/gr.10.2.228; Lin YW, 2005, GENOMICS, V86, P431, DOI 10.1016/j.ygeno.2005.07.003; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; McVean GAT, 2000, J MOL EVOL, V50, P264, DOI 10.1007/s002399910031; Moura G, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r28; MURGOLA EJ, 1984, J MOL BIOL, V175, P19, DOI 10.1016/0022-2836(84)90442-X; Nakashima H, 1998, DNA Res, V5, P251, DOI 10.1093/dnares/5.5.251; Nakashima H, 1997, DNA Res, V4, P185, DOI 10.1093/dnares/4.3.185; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Percudani R, 1997, J MOL BIOL, V268, P322, DOI 10.1006/jmbi.1997.0942; Percudani R, 1999, MOL BIOL EVOL, V16, P1752, DOI 10.1093/oxfordjournals.molbev.a026087; Pinheiro M, 2006, METHOD INFORM MED, V45, P163, DOI 10.1055/s-0038-1634061; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rocha EPC, 1999, MOL MICROBIOL, V32, P11, DOI 10.1046/j.1365-2958.1999.01334.x; Rocha EPC, 2002, NUCLEIC ACIDS RES, V30, P1886, DOI 10.1093/nar/30.9.1886; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Shah AA, 2002, BIOINFORMATICS, V18, P1046, DOI 10.1093/bioinformatics/18.8.1046; SIMENOFF JS, 2003, ANAL CATEGORICAL DAT; Stahl G, 2002, TRENDS BIOCHEM SCI, V27, P178, DOI 10.1016/S0968-0004(02)02064-9; Tate WP, 1996, PROG NUCLEIC ACID RE, V52, P293, DOI 10.1016/S0079-6603(08)60970-8; Tekaia F, 2002, GENE, V297, P51, DOI 10.1016/S0378-1119(02)00871-5; Tork S, 2004, NUCLEIC ACIDS RES, V32, P415, DOI 10.1093/nar/gkh201; van de Lagemaat LN, 2005, GENOME RES, V15, P1243, DOI 10.1101/gr.3910705	53	71	85	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e847	10.1371/journal.pone.0000847	http://dx.doi.org/10.1371/journal.pone.0000847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786218	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455500030
J	Asai, A; Sahani, N; Kaneki, M; Ouchi, Y; Martyn, JAJ; Yasuhara, SE				Asai, Akihiro; Sahani, Nita; Kaneki, Masao; Ouchi, Yasuyoshi; Martyn, J. A. Jeevendra; Yasuhara, Shingo Egusa			Primary Role of Functional Ischemia, Quantitative Evidence for the Two-Hit Mechanism, and Phosphodiesterase-5 Inhibitor Therapy in Mouse Muscular Dystrophy	PLOS ONE			English	Article								Background. Duchenne Muscular Dystrophy (DMD) is characterized by increased muscle damage and an abnormal blood flow after muscle contraction: the state of functional ischemia. Until now, however, the cause-effect relationship between the pathogenesis of DMD and functional ischemia was unclear. We examined (i) whether functional ischemia is necessary to cause contraction-induced myofiber damage and (ii) whether functional ischemia alone is sufficient to induce the damage. Methodology/Principal Findings. In vivo microscopy was used to document assays developed to measure intramuscular red blood cell flux, to quantify the amount of vasodilatory molecules produced from myofibers, and to determine the extent of myofiber damage. Reversal of functional ischemia via pharmacological manipulation prevented contraction-induced myofiber damage in mdx mice, the murine equivalent of DMD. This result indicates that functional ischemia is required for, and thus an essential cause of, muscle damage in mdx mice. Next, to determine whether functional ischemia alone is enough to explain the disease, the extent of ischemia and the amount of myofiber damage were compared both in control and mdx mice. In control mice, functional ischemia alone was found insufficient to cause a similar degree of myofiber damage observed in mdx mice. Additional mechanisms are likely contributing to cause more severe myofiber damage in mdx mice, suggestive of the existence of a "two-hit'' mechanism in the pathogenesis of this disease. Conclusions/Significance. Evidence was provided supporting the essential role of functional ischemia in contraction-induced myofiber damage in mdx mice. Furthermore, the first quantitative evidence for the "two-hit'' mechanism in this disease was documented. Significantly, the vasoactive drug tadalafil, a phosphodiesterase 5 inhibitor, administered to mdx mice ameliorated muscle damage.	[Asai, Akihiro; Sahani, Nita; Kaneki, Masao; Martyn, J. A. Jeevendra; Yasuhara, Shingo Egusa] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Shriners Hosp Children,Dept Anesthesiol & Crit Ca, Boston, MA 02115 USA; [Asai, Akihiro; Ouchi, Yasuyoshi] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo, Japan	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Tokyo	Yasuhara, SE (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Shriners Hosp Children,Dept Anesthesiol & Crit Ca, Boston, MA 02115 USA.	shingo_yasuhara@yahoo.com	Asai, Akihiro/AAH-3162-2021	Asai, Akihiro/0000-0003-3029-5754	Shriners Philanthropy Grant [8830]; NIH [GM31569, GM55082]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055082, R23GM031569, R01GM031569] Funding Source: NIH RePORTER	Shriners Philanthropy Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This works was made possible through a Shriners Philanthropy Grant (# 8830 to SEY). Additional financial support was provided by NIH (# GM31569, GM55082 to JAJ).	AUWERX JH, 1989, BLOOD, V74, P1807; Berg BR, 1996, AM J PHYSIOL-HEART C, V271, pH2263, DOI 10.1152/ajpheart.1996.271.6.H2263; Bia BL, 1999, J MOL CELL CARDIOL, V31, P1857, DOI 10.1006/jmcc.1999.1018; Bloom TJ, 2002, CAN J PHYSIOL PHARM, V80, P1132, DOI 10.1139/Y02-149; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; BURBACH JA, 1987, AM J ANAT, V179, P291, DOI 10.1002/aja.1001790311; Carter AB, 2004, AM J RESP CELL MOL, V31, P43, DOI 10.1165/rcmb.2003-0377OC; Chao DS, 1998, J NEUROCHEM, V71, P784; Chiba S, 2001, J AUTON PHARMACOL, V21, P7, DOI 10.1046/j.1365-2680.2001.00199.x; CORCONDILAS A, 1964, J APPL PHYSIOL, V19, P142, DOI 10.1152/jappl.1964.19.1.142; Crosbie RH, 1998, HUM MOL GENET, V7, P823, DOI 10.1093/hmg/7.5.823; Doughty JM, 1999, AM J PHYSIOL-HEART C, V276, pH1107, DOI 10.1152/ajpheart.1999.276.3.H1107; EDWARDS RJ, 1984, PRENATAL DIAG, V4, P267, DOI 10.1002/pd.1970040406; *EL LIL CO DRUG IN, EL LIL RAT STUD SHOW; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; EMERY AEH, 1977, NATURE, V266, P472, DOI 10.1038/266472a0; ENGEL WK, 1971, REV NEUROL, V124, P291; Ferreira LF, 2006, J PHYSIOL-LONDON, V573, P787, DOI 10.1113/jphysiol.2006.104802; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GRIFFITH TM, 1985, EUR J PHARMACOL, V112, P195, DOI 10.1016/0014-2999(85)90496-0; HOFFMAN EP, 1989, NEURON, V2, P1019, DOI 10.1016/0896-6273(89)90226-2; HUNTER EG, 1983, CAN J PHYSIOL PHARM, V61, P182, DOI 10.1139/y83-028; IGNARRO LJ, 1987, CIRC RES, V61, P866, DOI 10.1161/01.RES.61.6.866; Ito K, 2006, HUM MOL GENET, V15, P2266, DOI 10.1093/hmg/ddl151; JERUSALEM F, 1974, BRAIN, V97, P115, DOI 10.1093/brain/97.1.115; Kim MB, 2003, MICROCIRCULATION, V10, P167, DOI 10.1038/sj.mn.7800182; KOBAYASHI Y, 1983, TOHOKU J EXP MED, V140, P381, DOI 10.1620/tjem.140.381; KOMORI K, 1990, BLOOD VESSELS, V27, P238; Lau KS, 1998, FEBS LETT, V431, P71, DOI 10.1016/S0014-5793(98)00728-5; Lau KS, 2000, PHYSIOL GENOMICS, V2, P21, DOI 10.1152/physiolgenomics.2000.2.1.21; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; Lopes-Ferreira M, 2001, INT J EXP PATHOL, V82, P55, DOI 10.1046/j.1365-2613.2001.00181.x; Louboutin JP, 2001, MOL MED, V7, P355, DOI 10.1007/BF03402218; MACLEOD KM, 1987, MOL PHARMACOL, V32, P59; MARTENSSON J, 1989, P NATL ACAD SCI USA, V86, P471, DOI 10.1073/pnas.86.2.471; MATSUDA R, 1995, J BIOCHEM-TOKYO, V118, P959, DOI 10.1093/jb/118.5.959; Mavrogeni S, 2005, CHEST, V127, P143, DOI 10.1378/chest.127.1.143; MENDELL JR, 1971, SCIENCE, V172, P1143, DOI 10.1126/science.172.3988.1143; MIIKE T, 1987, J NEUROL SCI, V82, P67, DOI 10.1016/0022-510X(87)90007-4; MIYATAKE M, 1989, J NEUROL SCI, V93, P11, DOI 10.1016/0022-510X(89)90157-3; MOHR T, 1987, PHYS THER, V67, P526, DOI 10.1093/ptj/67.4.526; Morikawa K, 2003, J CLIN INVEST, V112, P1871, DOI 10.1172/JCI200319351; MUSCH BC, 1975, J NEUROL SCI, V26, P221, DOI 10.1016/0022-510X(75)90034-9; Petrof BJ, 1998, MOL CELL BIOCHEM, V179, P111, DOI 10.1023/A:1006812004945; Rando TA, 2001, MICROSC RES TECHNIQ, V55, P223, DOI 10.1002/jemt.1172; RICH MM, 1989, J NEUROSCI, V9, P1781, DOI 10.1523/jneurosci.09-05-01781.1989; Sander M, 2000, P NATL ACAD SCI USA, V97, P13818, DOI 10.1073/pnas.250379497; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Strahler A.N., 1957, EOS T AM GEOPHYS UN, V38, P913, DOI [DOI 10.1029/TR038I006P00913, 10.1029/TR038i006p00913]; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Tidball JG, 2004, MOL GENET METAB, V82, P312, DOI 10.1016/j.ymgme.2004.06.006; TIDBALL JG, 1995, J CELL SCI, V108, P2197; Toda N, 2005, PHARMACOL THERAPEUT, V106, P233, DOI 10.1016/j.pharmthera.2004.11.011; TOMODA T, 1991, ACTA HAEMATOL-BASEL, V86, P183; TSAI AG, 1989, MICROVASC RES, V37, P308, DOI 10.1016/0026-2862(89)90049-6; TSAI AG, 1991, INT J MICROCIRC, V10, P317; Uruno A, 2005, CIRCULATION, V112, P727, DOI 10.1161/CIRCULATIONAHA.104.500959; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; WELLER B, 1990, J NEUROL SCI, V100, P9, DOI 10.1016/0022-510X(90)90005-8; White R, 1997, EUR J PHARMACOL, V339, P157, DOI 10.1016/S0014-2999(97)01397-6; Winston BW, 1999, CLIN INVEST MED, V22, P236	61	98	101	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e806	10.1371/journal.pone.0000806	http://dx.doi.org/10.1371/journal.pone.0000806			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726536	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455400023
J	Franke, A; Hampe, J; Rosenstiel, P; Becker, C; Wagner, F; Hasler, R; Little, RD; Huse, K; Ruether, A; Balschun, T; Wittig, M; ElSharawy, A; Mayr, G; Albrecht, M; Prescott, NJ; Onnie, CM; Fournier, H; Keith, T; Radelof, U; Platzer, M; Mathew, CG; Stoll, M; Krawczak, M; Nurnberg, P; Schreiber, S				Franke, Andre; Hampe, Jochen; Rosenstiel, Philip; Becker, Christian; Wagner, Florian; Haesler, Robert; Little, Randall D.; Huse, Klaus; Ruether, Andreas; Balschun, Tobias; Wittig, Michael; ElSharawy, Abdou; Mayr, Gabriele; Albrecht, Mario; Prescott, Natalie J.; Onnie, Clive M.; Fournier, Helene; Keith, Tim; Radelof, Uwe; Platzer, Matthias; Mathew, Christopher G.; Stoll, Monika; Krawczak, Michael; Nuernberg, Peter; Schreiber, Stefan			Systematic Association Mapping Identifies NELL1 as a Novel IBD Disease Gene	PLOS ONE			English	Article								Crohn disease (CD), a sub-entity of inflammatory bowel disease (IBD), is a complex polygenic disorder. Although recent studies have successfully identified CD-associated genetic variants, these susceptibility loci explain only a fraction of the heritability of the disease. Here, we report on a multi-stage genome-wide scan of 393 German CD cases and 399 controls. Among the 116,161 single-nucleotide polymorphisms tested, an association with the known CD susceptibility gene NOD2, the 5q31 haplotype, and the recently reported CD locus at 5p13.1 was confirmed. In addition, SNP rs1793004 in the gene encoding nel-like 1 precursor (NELL1, chromosome 11p15.1) showed a consistent disease-association in independent German population- and family-based samples (942 cases, 1082 controls, 375 trios). Subsequent fine mapping and replication in an independent sample of 454 French/Canadian CD trios supported the authenticity of the NELL1 association. Further confirmation in a large German ulcerative colitis (UC) sample indicated that NELL1 is a ubiquitous IBD susceptibility locus (combined p < 10(-6); OR = 1.66, 95% CI: 1.30-2.11). The novel 5p13.1 locus was also replicated in the French/Canadian sample and in an independent UK CD patient panel (453 cases, 521 controls, combined p < 10(-6) for SNP rs1992660). Several associations were replicated in at least one independent sample, point to an involvement of ITGB6 (upstream), GRM8 (downstream), OR5V1 (downstream), PPP3R2 (downstream), NM_ 152575(upstream) and HNF4G (intron).	[Franke, Andre; Rosenstiel, Philip; Haesler, Robert; ElSharawy, Abdou; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Hampe, Jochen; Schreiber, Stefan] Univ Hosp Schleswig Holstein, Dept Med 1, Kiel, Germany; [Becker, Christian; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Becker, Christian; Wagner, Florian; Radelof, Uwe] RZPD German Resource Ctr Genome Res, Berlin, Germany; [Little, Randall D.; Keith, Tim] Genizon BioSciences5, Quebec City, PQ, Canada; [Huse, Klaus] Leibniz Inst Age Res, Genome Anal Grp, Jena, Germany; [Ruether, Andreas; Wittig, Michael; Krawczak, Michael; Schreiber, Stefan] Univ Kiel, PopGen Biobank, Kiel, Germany; [Mayr, Gabriele; Albrecht, Mario] Max Planck Inst Informat, Saarbrucken, Germany; [Prescott, Natalie J.; Onnie, Clive M.; Mathew, Christopher G.] Kings Coll London, Sch Med, Dept Med & Mol Genet, London WC2R 2LS, England; [Stoll, Monika] Univ Munster, Leibniz Inst Arteriosclerosis Res, Munster, Germany; [Krawczak, Michael] Univ Kiel, Inst Med Stat & Informat, Kiel, Germany; [Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany	University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Cologne; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Kiel; Max Planck Society; University of London; King's College London; University of Munster; University of Kiel; University of Cologne	Schreiber, S (corresponding author), Univ Kiel, Inst Clin Mol Biol, Kiel, Germany.	s.schreiber@mucosa.de	Prescott, Natalie J/F-6490-2011; Elsharawy, Abdou/C-9848-2010; Häsler, Robert/A-4908-2009; Krawczak, Michael/A-8964-2010; Hampe, Jochen/A-2555-2010; Franke, Andre/B-2151-2010; Mathew, Christopher G/G-3434-2015; Little, Randall/O-7172-2014; Balschun, Tobias/B-2356-2010; Albrecht, Mario/B-6694-2008; Rosenstiel, Philip/A-5137-2009	Prescott, Natalie J/0000-0002-5901-7371; Häsler, Robert/0000-0003-4174-8229; Krawczak, Michael/0000-0003-2603-1502; Hampe, Jochen/0000-0002-2421-6127; Franke, Andre/0000-0003-1530-5811; Mathew, Christopher G/0000-0003-4178-1838; Albrecht, Mario/0000-0002-3103-9624; Rosenstiel, Philip/0000-0002-9692-8828; Huse, Klaus/0000-0003-3854-1884; Elsharawy, Abdou/0000-0002-5089-9435	Medical Research Council [G0000934] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0000934] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ABITBOL V, 1995, GASTROENTEROLOGY, V108, P417, DOI 10.1016/0016-5085(95)90068-3; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Biank V, 2007, AM J GASTROENTEROL, V102, P391, DOI 10.1111/j.1572-0241.2006.01011.x; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; COMPSTON JE, 1987, GUT, V28, P410, DOI 10.1136/gut.28.4.410; Croucher PJP, 2003, EUR J HUM GENET, V11, P6, DOI 10.1038/sj.ejhg.5200897; CUMMINGS JRF, 2007, INFLAMM BOWEL DIS; Daly MJ, 2005, EUR J HUM GENET, V13, P835, DOI 10.1038/sj.ejhg.5201403; de Ridder L, 2007, INFLAMM BOWEL DIS, V13, P1083, DOI 10.1002/ibd.20171; Desai J, 2006, HUM MOL GENET, V15, P1329, DOI 10.1093/hmg/ddl053; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fingerlin TE, 2004, AM J HUM GENET, V74, P432, DOI 10.1086/381652; Fisher SA, 2006, HUM MUTAT, V27, P778, DOI 10.1002/humu.20358; Franke A, 2006, HUM MUTAT, V27, P583, DOI 10.1002/humu.20306; Friedrichs F, 2006, HUM GENET, V119, P305, DOI 10.1007/s00439-006-0133-1; Friedrichs F, 2006, WORLD J GASTROENTERO, V12, P3651, DOI 10.3748/wjg.v12.i23.3651; Hampe J, 2001, BIOINFORMATICS, V17, P654, DOI 10.1093/bioinformatics/17.7.654; Hampe J, 2002, LANCET, V359, P1661, DOI 10.1016/S0140-6736(02)08590-2; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P79, DOI 10.1006/bbrc.1999.1638; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P752, DOI 10.1006/bbrc.1999.1753; KUSTER W, 1989, AM J MED GENET, V32, P105, DOI 10.1002/ajmg.1320320122; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Lin ZW, 2007, GASTROENTEROLOGY, V132, pA451; Lin ZW, 2007, GASTROENTEROLOGY, V132, pA450; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Luce MJ, 1999, GENE, V231, P121, DOI 10.1016/S0378-1119(99)00093-1; MATSUHASHI S, 1995, DEV DYNAM, V203, P212, DOI 10.1002/aja.1002030209; Matsuhashi S, 1996, DEV DYNAM, V207, P233; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; McGovern DPB, 2005, HUM MOL GENET, V14, P1245, DOI 10.1093/hmg/ddi135; McIntyre LM, 2000, GENET EPIDEMIOL, V19, P18, DOI 10.1002/1098-2272(200007)19:1<18::AID-GEPI2>3.0.CO;2-Y; Monteleone G, 2005, GASTROENTEROLOGY, V129, P1420, DOI 10.1053/j.gastro.2005.09.005; Newman WG, 2006, HUM MUTAT, V27, P353, DOI 10.1002/humu.20301; Nicolae DL, 2006, PLOS GENET, V2, P665, DOI 10.1371/journal.pgen.0020067; Noble CL, 2005, GUT, V54, P1416, DOI 10.1136/gut.2005.066621; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Onnie CM, 2006, INFLAMM BOWEL DIS, V12, P263, DOI 10.1097/01.MIB.0000209791.98866.ba; ORHOLM M, 1991, NEW ENGL J MED, V324, P84, DOI 10.1056/NEJM199101103240203; PARKES M, 2007, NAT GENET; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; ROUX C, 1995, OSTEOPOROSIS INT, V5, P156, DOI 10.1007/BF02106094; Russell RK, 2007, J PEDIATR-US, V150, P268, DOI 10.1016/j.jpeds.2006.12.010; Schreiber S, 2005, NAT REV GENET, V6, P376, DOI 10.1038/nrg1607; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Steffens M, 2006, HUM HERED, V62, P20, DOI 10.1159/000095850; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Tan K, 2006, STRUCTURE, V14, P33, DOI 10.1016/j.str.2005.09.017; TEUBER M, 2005, JALA-J ASSOC LAB AUT, V10, P43; Thompson NP, 1996, BRIT MED J, V312, P95; Torok HP, 2005, GUT, V54, P1421, DOI 10.1136/gut.2005.066340; TRUELOVE SC, 1976, GUT, V17, P192, DOI 10.1136/gut.17.3.192; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Vermeire S, 2005, GASTROENTEROLOGY, V129, P1845, DOI 10.1053/j.gastro.2005.10.006; VOORBERG J, 1991, J CELL BIOL, V113, P195, DOI 10.1083/jcb.113.1.195; Waetzig GH, 2002, J IMMUNOL, V168, P5342, DOI 10.4049/jimmunol.168.10.5342; Waetzig GH, 2004, FASEB J, V18, P91, DOI 10.1096/fj.04-2073fje; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005; Weersma RK, 2007, GASTROENTEROLOGY, V132, pA445; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yamazaki K, 2004, J HUM GENET, V49, P664, DOI 10.1007/s10038-004-0204-x; Zhang XL, 2002, J CLIN INVEST, V110, P861, DOI 10.1172/JCI200215375; NATURE, V447, P661	79	107	114	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e691	10.1371/journal.pone.0000691	http://dx.doi.org/10.1371/journal.pone.0000691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684544	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000207452400001
J	Kaelin, CB; Cooper, GM; Sidow, A; Barsh, GS				Kaelin, Christopher B.; Cooper, Gregory M.; Sidow, Arend; Barsh, Gregory S.			Mammalian Comparative Sequence Analysis of the Agrp Locus	PLOS ONE			English	Article								Agouti-related protein encodes a neuropeptide that stimulates food intake. Agrp expression in the brain is restricted to neurons in the arcuate nucleus of the hypothalamus and is elevated by states of negative energy balance. The molecular mechanisms underlying Agrp regulation, however, remain poorly defined. Using a combination of transgenic and comparative sequence analysis, we have previously identified a 760 bp conserved region upstream of Agrp which contains STAT binding elements that participate in Agrp transcriptional regulation. In this study, we attempt to improve the specificity for detecting conserved elements in this region by comparing genomic sequences from 10 mammalian species. Our analysis reveals a symmetrical organization of conserved sequences upstream of Agrp, which cluster into two inverted repeat elements. Conserved sequences within these elements suggest a role for homeodomain proteins in the regulation of Agrp and provide additional targets for functional evaluation.	[Kaelin, Christopher B.; Sidow, Arend; Barsh, Gregory S.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Cooper, Gregory M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Sidow, Arend] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Barsh, Gregory S.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	Stanford University; University of Washington; University of Washington Seattle; Stanford University; Stanford University	Barsh, GS (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	gbarsh@stanford.edu	Cooper, Gregory/D-6914-2011	Cooper, Gregory/0000-0001-5509-9923	National Institutes of Health [DK-48506]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This investigation was supported by grants from the National Institutes of Health to GSB (DK-48506).	Boswell T, 2002, MOL BRAIN RES, V100, P31, DOI 10.1016/S0169-328X(02)00145-6; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Cerda-Reverter JM, 2003, ENDOCRINOLOGY, V144, P4552, DOI 10.1210/en.2003-0453; Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596; CLARK ME, 1995, MOL CELL BIOL, V15, P6169; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-192; Cooper GM, 2003, GENOME RES, V13, P813, DOI 10.1101/gr.1064503; de Souza FSJ, 2005, MOL CELL BIOL, V25, P3076, DOI 10.1128/MCB.25.8.3076-3086.2005; Doghman M, 2007, MOL CELL ENDOCRINOL, V265, P108, DOI 10.1016/j.mce.2006.12.025; Drazen DL, 2003, DIABETES, V52, P2928, DOI 10.2337/diabetes.52.12.2928; Foucher I, 2003, DEVELOPMENT, V130, P1867, DOI 10.1242/dev.00414; Foucher I, 2002, DEVELOPMENT, V129, P4065; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Gao J, 2002, BRAIN RES, V936, P87, DOI 10.1016/S0006-8993(02)02493-9; Henry BA, 2001, BRAIN RES, V918, P40, DOI 10.1016/S0006-8993(01)02918-3; HISANO S, 1988, NEUROSCI LETT, V95, P13, DOI 10.1016/0304-3940(88)90624-6; Kaelin CB, 2004, ENDOCRINOLOGY, V145, P5798, DOI 10.1210/en.2004-0956; Kaelin CB, 2006, MOL ENDOCRINOL, V20, P2591, DOI 10.1210/me.2006-0107; Kamegai J, 2000, ENDOCRINOLOGY, V141, P4797, DOI 10.1210/en.141.12.4797; Kelley CG, 2002, MOL ENDOCRINOL, V16, P2413, DOI 10.1210/me.2002-0189; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Makimura Hideo, 2003, BMC Physiol, V3, P5, DOI 10.1186/1472-6793-3-5; Mayer CM, 2003, BIOCHEM BIOPH RES CO, V307, P847, DOI 10.1016/S0006-291X(03)01289-0; Moriguchi T, 2002, J BIOL CHEM, V277, P16985, DOI 10.1074/jbc.M107962200; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Phillips-Singh D, 2003, CELL TISSUE RES, V313, P217, DOI 10.1007/s00441-003-0755-8; RAVEHAREL N, 2005, J BIOL CHEM; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; STANLEY BG, 1986, PEPTIDES, V7, P1189; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95	33	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e702	10.1371/journal.pone.0000702	http://dx.doi.org/10.1371/journal.pone.0000702			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684549	gold, Green Published			2022-12-27	WOS:000207452400006
J	Strating, JRPM; Bouw, G; Hafmans, TGM; Martens, GJM				Strating, Jeroen R. P. M.; Bouw, Gerrit; Hafmans, Theo G. M.; Martens, Gerard J. M.			Disparate Effects of p24 alpha and p24 delta on Secretory Protein Transport and Processing	PLOS ONE			English	Article								Background. The p24 family is thought to be somehow involved in endoplasmic reticulum (ER)-to-Golgi protein transport. A subset of the p24 proteins (p24 alpha(3), -beta(1), -gamma(3) and -delta(2)) is upregulated when Xenopus laevis intermediate pituitary melanotrope cells are physiologically activated to produce vast amounts of their major secretory cargo, the prohormone proopiomelanocortin (POMC). Methodology/Principal Findings. Here we find that transgene expression of p24 alpha(3) or p24 delta(2) specifically in the Xenopus melanotrope cells in both cases causes an effective displacement of the endogenous p24 proteins, resulting in severely distorted p24 systems and disparate melanotrope cell phenotypes. Transgene expression of p24 alpha(3) greatly reduces POMC transport and leads to accumulation of the prohormone in large, ER-localized electron-dense structures, whereas p24 delta(2)-transgenesis does not influence the overall ultrastructure of the cells nor POMC transport and cleavage, but affects the Golgi-based processes of POMC glycomaturation and sulfation. Conclusions/Significance. Transgenic expression of two distinct p24 family members has disparate effects on secretory pathway functioning, illustrating the specificity and non-redundancy of our transgenic approach. We conclude that members of the p24 family furnish subcompartments of the secretory pathway with specific sets of machinery cargo to provide the proper microenvironments for efficient and correct secretory protein transport and processing.	[Strating, Jeroen R. P. M.; Bouw, Gerrit; Hafmans, Theo G. M.; Martens, Gerard J. M.] Radboud Univ Nijmegen, Dept Mol Anim Physiol, Nijmegen Ctr Mol Life Sci, Inst Neurosci,Fac Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Martens, GJM (corresponding author), Radboud Univ Nijmegen, Dept Mol Anim Physiol, Nijmegen Ctr Mol Life Sci, Inst Neurosci,Fac Sci, NL-6525 ED Nijmegen, Netherlands.	g.martens@ncmls.ru.nl	Strating, Jeroen/F-4399-2019; Martens, Gerard JM/D-1925-2010	Strating, Jeroen/0000-0003-2509-5213; 	Netherlands Organisation for Scientific Research-Earth and Life Sciences [811.38.002]	Netherlands Organisation for Scientific Research-Earth and Life Sciences(Netherlands Organization for Scientific Research (NWO))	This work was supported by grant 811.38.002 from The Netherlands Organisation for Scientific Research-Earth and Life Sciences (NWO-ALW).	Belden WJ, 2001, MOL BIOL CELL, V12, P957, DOI 10.1091/mbc.12.4.957; Belden WJ, 1996, J BIOL CHEM, V271, P26939, DOI 10.1074/jbc.271.43.26939; Bouw G, 2004, MOL BIOL CELL, V15, P1244, DOI 10.1091/mbc.E03-08-0600; BRAKS JAM, 1994, CELL, V78, P263, DOI 10.1016/0092-8674(94)90296-8; Carney GE, 2004, BIOL CELL, V96, P271, DOI 10.1016/j.biolcel.2004.01.004; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; CHU DTW, 1989, DEV BIOL, V136, P104, DOI 10.1016/0012-1606(89)90134-6; Collin RWJ, 2005, J NEUROCHEM, V94, P1015, DOI 10.1111/j.1471-4159.2005.03243.x; Denzel A, 2000, CURR BIOL, V10, P55, DOI 10.1016/S0960-9822(99)00266-3; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; ElrodErickson MJ, 1996, MOL BIOL CELL, V7, P1043, DOI 10.1091/mbc.7.7.1043; Emery G, 1999, PROTOPLASMA, V207, P24, DOI 10.1007/BF01294710; Emery G, 2003, J CELL SCI, V116, P4821, DOI 10.1242/jcs.00802; Gommel D, 1999, FEBS LETT, V447, P179, DOI 10.1016/S0014-5793(99)00246-X; Gupta V, 2006, J CELL SCI, V119, P1703, DOI 10.1242/jcs.02885; HOLTHUIS JCM, 1995, J CELL SCI, V108, P3295; Jansen EJR, 2002, FEBS LETT, V516, P201, DOI 10.1016/S0014-5793(02)02523-1; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Kuiper RP, 2001, BIOCHEM J, V360, P421, DOI 10.1042/0264-6021:3600421; Kuiper RP, 2000, BIOCHEM CELL BIOL, V78, P289, DOI 10.1139/bcb-78-3-289; Kuiper RP, 2000, MOL BIOL CELL, V11, P131, DOI 10.1091/mbc.11.1.131; Lavoie C, 1999, J CELL BIOL, V146, P285, DOI 10.1083/jcb.146.2.285; Majoul I, 1998, J CELL BIOL, V143, P601, DOI 10.1083/jcb.143.3.601; Majoul I, 2001, DEV CELL, V1, P139, DOI 10.1016/S1534-5807(01)00004-1; MARTENS GJM, 1982, EUR J BIOCHEM, V126, P17, DOI 10.1111/j.1432-1033.1982.tb06739.x; MARTENS GJM, 1986, NUCLEIC ACIDS RES, V14, P3791, DOI 10.1093/nar/14.9.3791; Marzioch M, 1999, MOL BIOL CELL, V10, P1923, DOI 10.1091/mbc.10.6.1923; Mironov AA, 2003, DEV CELL, V5, P583, DOI 10.1016/S1534-5807(03)00294-6; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Rojo M, 2000, J CELL SCI, V113, P1043; Rojo M, 1997, J CELL BIOL, V139, P1119, DOI 10.1083/jcb.139.5.1119; Rotter J, 2002, J CELL SCI, V115, P1049; SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x; Simpson JC, 2006, MOL BIOL CELL, V17, P723, DOI 10.1091/mbc.E05-06-0580; Sparrow D B, 2000, Nucleic Acids Res, V28, pE12, DOI 10.1093/nar/28.4.e12; Springer S, 2000, P NATL ACAD SCI USA, V97, P4034, DOI 10.1073/pnas.070044097; STAMNES MA, 1995, P NATL ACAD SCI USA, V92, P8011, DOI 10.1073/pnas.92.17.8011; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; van Kuppeveld FJM, 1997, MOL CELL ENDOCRINOL, V136, P29, DOI 10.1016/S0303-7207(97)00211-6; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Wen CH, 1999, J CELL BIOL, V145, P1165, DOI 10.1083/jcb.145.6.1165	44	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e704	10.1371/journal.pone.0000704	http://dx.doi.org/10.1371/journal.pone.0000704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684551	gold, Green Published			2022-12-27	WOS:000207452400008
J	Efferth, T; Giaisi, M; Merling, A; Krammer, PH; Li-Weber, M				Efferth, Thomas; Giaisi, Marco; Merling, Annette; Krammer, Peter H.; Li-Weber, Min			Artesunate Induces ROS-Mediated Apoptosis in Doxorubicin-Resistant T Leukemia Cells	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; CANCER; DEATH; ANTIMALARIALS; ARTEMISININ; INHIBITION; QINGHAOSU; TOXICITY; MEDICINE; NECROSIS	Background. A major obstacle for successful cancer treatment often is the development of drug resistance in cancer cells during chemotherapy. Therefore, there is an urgent need for novel drugs with improved efficacy against tumor cells and with less toxicity on normal cells. Artesunate (ART), a powerful anti-malarial herbal compound, has been shown to inhibit growth of various tumor cell lines in vitro and of xenografted Kaposi's sarcoma in mice in vivo. However, the molecular mechanisms by which ART exerts its cytotoxicity have not been elucidated. The ART-class of anti-malarial compounds is attractive due to their activity against multidrug-resistant Plasmodium falciparum and Plasmodium vivax strains. Another salient feature of these compounds is the lack of severe side effects in malaria patients. Methodology and Principal Findings. In this study, we used T-cell leukemias as a model system to study the molecular mechanisms of ART-induced apoptosis. The most typical anticancer drugs are DNA intercalators such as Doxorubicin. To investigate drug sensitivity and resistance, we chose a Doxorubicin-resistant leukemia cell line and investigated the killing effect of ART on these cells. We show that ART induces apoptosis in leukemic T cells mainly through the mitochondrial pathway via generation of reactive oxygen species (ROS), a mechanism different from Doxorubicin. This is confirmed by the fact that the antioxidant N-Acetyle-Cysteine (NAC) could completely block ROS generation and, consequently, inhibited ART-induced apoptosis. Therefore, ART can overcome the Doxorubicin-resistance and induce the Doxorubicin-resistant leukemia cells to undergo apoptosis. We also show that ART can synergize with Doxorubicin to enhance apoptotic cell death in leukemic T cells. This synergistic effect can be largely explained by the fact that ART and Doxorubicin use different killing mechanisms. Conclusions. Our studies raise the possibility to develop ART in combination with other established anticancer drugs which induce apoptosis through the pathways or mechanisms different from ART.	[Giaisi, Marco; Merling, Annette; Krammer, Peter H.; Li-Weber, Min] German Canc Res Ctr, Tumor Immunol Program, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Li-Weber, M (corresponding author), German Canc Res Ctr, Tumor Immunol Program, D-6900 Heidelberg, Germany.	m.li-weber@dkfz-heidelberg.de		Efferth, Thomas/0000-0002-3096-3292	Deutsche Forschungsgemeinschaft; Tumor Center Heidelberg/Mannheim	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tumor Center Heidelberg/Mannheim	This work was supported by the Deutsche Forschungsgemeinschaft and the Tumor Center Heidelberg/Mannheim.	ABELSON PH, 1990, SCIENCE, V247, P513, DOI 10.1126/science.2300807; Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Boik J., 2001, J NAT PROD; Brana MF, 2001, CURR PHARM DESIGN, V7, P1745, DOI 10.2174/1381612013397113; BREWER TG, 1994, AM J TROP MED HYG, V51, P251, DOI 10.4269/ajtmh.1994.51.251; BUSTOS MDG, 1994, B WORLD HEALTH ORGAN, V72, P729; Debatin KM, 2004, ONCOGENE, V23, P2950, DOI 10.1038/sj.onc.1207558; Dell'Eva R, 2004, BIOCHEM PHARMACOL, V68, P2359, DOI 10.1016/j.bcp.2004.08.021; Efferth T, 2006, CURR DRUG TARGETS, V7, P407, DOI 10.2174/138945006776359412; Efferth T, 2005, IN VIVO, V19, P225; Efferth T, 2003, INT J ONCOL, V23, P1231; Efferth T, 2003, MOL PHARMACOL, V64, P382, DOI 10.1124/mol.64.2.382; Efferth T, 2002, BLOOD CELL MOL DIS, V28, P160, DOI 10.1006/bcmd.2002.0492; Efferth T, 1996, ARZNEIMITTEL-FORSCH, V46, P196; Efferth T, 2001, INT J ONCOL, V18, P767; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Gordi T, 2004, TOXICOL LETT, V147, P99, DOI 10.1016/j.toxlet.2003.12.009; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; HICKMAN JA, 1992, CANCER METAST REV, V11, P121, DOI 10.1007/BF00048059; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; Kiechle FL, 2002, CLIN CHIM ACTA, V326, P27, DOI 10.1016/S0009-8981(02)00297-8; KIMMIG A, 1990, CANCER RES, V50, P6793; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; KRUNGKRAI SR, 1987, T ROY SOC TROP MED H, V81, P710, DOI 10.1016/0035-9203(87)90003-4; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; MYERS CE, 1977, SCIENCE, V197, P165, DOI 10.1126/science.877547; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; NOSTEN F, 1995, DRUG SAFETY, V12, P264, DOI 10.2165/00002018-199512040-00006; Orrenius S, 2004, TOXICOL LETT, V149, P19, DOI 10.1016/j.toxlet.2003.12.017; Price R, 1998, AM J TROP MED HYG, V59, P883, DOI 10.4269/ajtmh.1998.59.883; RHOADS CP, 1947, T ASSOC AM PHYSICIAN, V60, P110; Ribeiro I R, 1998, Med Trop (Mars), V58, P50; Scaffidi C, 1997, J BIOL CHEM, V272, P26953, DOI 10.1074/jbc.272.43.26953; Schulze-Bergkamen H, 2004, SEMIN ONCOL, V31, P90, DOI 10.1053/j.seminoncol.2003.11.006; Sugimoto K, 2002, BRIT J HAEMATOL, V118, P229, DOI 10.1046/j.1365-2141.2002.03577.x; UBEZIO P, 1994, FREE RADICAL BIO MED, V16, P509, DOI 10.1016/0891-5849(94)90129-5; Yokochi T, 2004, MOL PHARMACOL, V66, P1415, DOI 10.1124/mol.104.002634	38	187	206	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e693	10.1371/journal.pone.0000693	http://dx.doi.org/10.1371/journal.pone.0000693			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668070	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452300028
J	Mailloux, RJ; Beriault, R; Lemire, J; Singh, R; Chenier, DR; Hamel, RD; Appanna, VD				Mailloux, Ryan J.; Beriault, Robin; Lemire, Joseph; Singh, Ranji; Chenier, Daniel R.; Hamel, Robert D.; Appanna, Vasu D.			The Tricarboxylic Acid Cycle, an Ancient Metabolic Network with a Novel Twist	PLOS ONE			English	Article								The tricarboxylic acid (TCA) cycle is an essential metabolic network in all oxidative organisms and provides precursors for anabolic processes and reducing factors (NADH and FADH(2)) that drive the generation of energy. Here, we show that this metabolic network is also an integral part of the oxidative defence machinery in living organisms and alpha-ketoglutarate ( KG) is a key participant in the detoxification of reactive oxygen species (ROS). Its utilization as an anti-oxidant can effectively diminish ROS and curtail the formation of NADH, a situation that further impedes the release of ROS via oxidative phosphorylation. Thus, the increased production of KG mediated by NADP-dependent isocitrate dehydrogenase (NADP-ICDH) and its decreased utilization via the TCA cycle confer a unique strategy to modulate the cellular redox environment. Activities of alpha-ketoglutarate dehydrogenase (KGDH), NAD-dependent isocitrate dehydrogenase (NAD-ICDH), and succinate dehydrogenase (SDH) were sharply diminished in the cellular systems exposed to conditions conducive to oxidative stress. These findings uncover an intricate link between TCA cycle and ROS homeostasis and may help explain the ineffective TCA cycle that characterizes various pathological conditions and ageing.	[Mailloux, Ryan J.; Beriault, Robin; Lemire, Joseph; Singh, Ranji; Chenier, Daniel R.; Hamel, Robert D.; Appanna, Vasu D.] Laurentian Univ, Dept Chem & Biochem, Sudbury, ON P3E 2C6, Canada	Laurentian University	Appanna, VD (corresponding author), Laurentian Univ, Dept Chem & Biochem, Sudbury, ON P3E 2C6, Canada.	VAppanna@lauren-tian.ca		Mailloux, Ryan/0000-0003-3986-9830; Appanna, Vasu/0000-0002-0138-5665	Ontario Center of Excellence and Industry Canada	Ontario Center of Excellence and Industry Canada	This work was supported by funding from Ontario Center of Excellence and Industry Canada.	ANDERSON S, 1992, FEBS LETT, V308, P94, DOI 10.1016/0014-5793(92)81059-U; Aydin S, 2005, FOOD CHEM TOXICOL, V43, P1093, DOI 10.1016/j.fct.2005.02.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Bubber P, 2004, NEUROCHEM INT, V45, P1021, DOI 10.1016/j.neuint.2004.05.007; Bunik VI, 2003, EUR J BIOCHEM, V270, P1036, DOI 10.1046/j.1432-1033.2003.03470.x; Bunik VI, 2003, EUR J BIOCHEM, V270, P1035, DOI 10.1046/j.1432-1033.2003.03467.x; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Das J, 2006, BIOESSAYS, V28, P890, DOI 10.1002/bies.20463; Devin A, 2007, AM J PHYSIOL-CELL PH, V292, pC52, DOI 10.1152/ajpcell.00208.2006; Exley C, 2004, FREE RADICAL BIO MED, V36, P380, DOI 10.1016/j.freeradbiomed.2003.11.017; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Frank J, 2000, FREE RADICAL BIO MED, V29, P1096, DOI 10.1016/S0891-5849(00)00395-6; Genova ML, 2004, ANN NY ACAD SCI, V1011, P86, DOI 10.1196/annals.1293.010; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Johnson P, 2002, COMP BIOCHEM PHYS C, V133, P493, DOI 10.1016/S1532-0456(02)00120-5; Kwik-Uribe CL, 2003, BRAIN RES, V973, P1, DOI 10.1016/S0006-8993(03)02457-0; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Mailloux RJ, 2007, TOXICOL IN VITRO, V21, P16, DOI 10.1016/j.tiv.2006.07.013; Mailloux RJ, 2006, J BIOCHEM MOL TOXIC, V20, P198, DOI 10.1002/jbt.20137; Mailloux RJ, 2006, ANAL BIOCHEM, V359, P210, DOI 10.1016/j.ab.2006.09.019; Middaugh J, 2005, J BIOL CHEM, V280, P3159, DOI 10.1074/jbc.M411979200; Noctor G, 2006, PLANT CELL ENVIRON, V29, P409, DOI 10.1111/j.1365-3040.2005.01476.x; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Romanov V, 1999, ANAL BIOCHEM, V268, P49, DOI 10.1006/abio.1998.3033; Sadka A, 2000, PLANT SCI, V158, P173, DOI 10.1016/S0168-9452(00)00328-9; Sargazi M, 2006, J TRACE ELEM MED BIO, V19, P267, DOI 10.1016/j.jtemb.2005.11.002; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Sgherri C, 2002, PLANT PHYSIOL BIOCH, V40, P591, DOI 10.1016/S0981-9428(02)01421-3; Singh R, 2005, J BIOCHEM BIOPH METH, V64, P189, DOI 10.1016/j.jbbm.2005.07.005; Singh R, 2005, EXTREMOPHILES, V9, P367, DOI 10.1007/s00792-005-0450-7; Tappia PS, 2006, FREE RADICAL BIO MED, V41, P349, DOI 10.1016/j.freeradbiomed.2006.03.025; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Urso ML, 2003, TOXICOLOGY, V189, P41, DOI 10.1016/S0300-483X(03)00151-3; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901; Yumoto I, 2000, J BACTERIOL, V182, P1903, DOI 10.1128/JB.182.7.1903-1909.2000; Zhu XW, 2004, BRAIN RES, V1000, P32, DOI 10.1016/j.brainres.2004.01.012	41	230	236	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e690	10.1371/journal.pone.0000690	http://dx.doi.org/10.1371/journal.pone.0000690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668068	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452300026
J	Singh, K; Mogare, D; Giridharagopalan, RO; Gogiraju, R; Pande, G; Chattopadhyay, S				Singh, Kamini; Mogare, Devraj; Giridharagopalan, Ramprasad Obula; Gogiraju, Rajinikanth; Pande, Gopal; Chattopadhyay, Samit			p53 Target Gene SMAR1 Is Dysregulated in Breast Cancer: Its Role in Cancer Cell Migration and Invasion	PLOS ONE			English	Article								Tumor suppressor SMAR1 interacts and stabilizes p53 through phosphorylation at its serine-15 residue. We show that SMAR1 transcription is regulated by p53 through its response element present in the SMAR1 promoter. Upon Doxorubicin induced DNA damage, acetylated p53 is recruited on SMAR1 promoter that allows activation of its transcription. Once SMAR1 is induced, cell cycle arrest is observed that is correlated to increased phospho-ser-15-p53 and decreased p53 acetylation. Further we demonstrate that SMAR1 expression is drastically reduced during advancement of human breast cancer. This was correlated with defective p53 expression in breast cancer where acetylated p53 is sequestered into the heterochromatin region and become inaccessible to activate SMAR1 promoter. In a recent report we have shown that SMAR1 represses Cyclin D1 transcription through recruitment of HDAC1 dependent repressor complex at the MAR site of Cyclin D1 promoter. Here we show that downmodulation of SMAR1 in high grade breast carcinoma is correlated with upregulated Cyclin D1 expression. We also established that SMAR1 inhibits tumor cell migration and metastases through inhibition of TGF beta signaling and its downstream target genes including cutl1 and various focal adhesion molecules. Thus, we report that SMAR1 plays a central role in coordinating p53 and TGF beta pathways in human breast cancer.	[Singh, Kamini; Mogare, Devraj; Chattopadhyay, Samit] Pune Univ, Natl Ctr Cell Sci, Pune, Maharashtra, India; [Giridharagopalan, Ramprasad Obula; Gogiraju, Rajinikanth; Pande, Gopal] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Savitribai Phule Pune University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Chattopadhyay, S (corresponding author), Pune Univ, Natl Ctr Cell Sci, Pune, Maharashtra, India.	samit@nccs.res.in		Pande, Gopal/0000-0002-0730-1389; Gogiraju, Rajinikanth/0000-0003-1284-9338	National Centre for Cell Science (NCCS); Department of Biotechnology (DBT); Department of Science and Technology (DST); Indian Council of Medical Research (ICMR), Government of India	National Centre for Cell Science (NCCS); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Science and Technology (DST)(Department of Science & Technology (India)); Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR))	This work is supporter by National Centre for Cell Science (NCCS), Department of Biotechnology (DBT), Department of Science and Technology (DST) and Indian Council of Medical Research (ICMR), Government of India.	ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Azuma H, 2005, JNCI-J NATL CANCER I, V97, P1734, DOI 10.1093/jnci/dji399; Bazzoni G, 2003, CURR OPIN CELL BIOL, V15, P525, DOI 10.1016/S0955-0674(03)00104-2; Beier F, 2001, MOL BIOL CELL, V12, P3852, DOI 10.1091/mbc.12.12.3852; Birot AM, 2000, GENE, V253, P189, DOI 10.1016/S0378-1119(00)00244-4; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Chacko BM, 2001, NAT STRUCT BIOL, V8, P248, DOI 10.1038/84995; Chattopadhyay S, 2000, GENOMICS, V68, P93, DOI 10.1006/geno.2000.6279; Chen HB, 2005, J BIOL CHEM, V280, P21329, DOI 10.1074/jbc.M500362200; Cleton-Jansen AM, 2001, CANCER RES, V61, P1171; de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587; Ezzell RM, 1997, EXP CELL RES, V231, P14, DOI 10.1006/excr.1996.3451; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Galande S, 2002, CURR CANCER DRUG TAR, V2, P157, DOI 10.2174/1568009023333917; Gohler T, 2005, NUCLEIC ACIDS RES, V33, P1087, DOI 10.1093/nar/gki252; Goldmann WH, 2002, BIOCHEM BIOPH RES CO, V290, P749, DOI 10.1006/bbrc.2001.6243; Harkonen P, 2005, PROSTATE, V62, P267, DOI 10.1002/pros.20147; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; HENDERSON IC, 1991, BREAST DIS, P504; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; Holnthoner W, 2002, J BIOL CHEM, V277, P45847, DOI 10.1074/jbc.M209354200; Jalota A, 2005, J BIOL CHEM, V280, P16019, DOI 10.1074/jbc.M413200200; Johnson-Leger CA, 2002, BLOOD, V100, P2479, DOI 10.1182/blood-2001-11-0098; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kaul R, 2003, INT J CANCER, V103, P606, DOI 10.1002/ijc.10881; Kaul-Ghanekar R, 2005, J BIOL CHEM, V280, P9450, DOI 10.1074/jbc.M412206200; Kaul-Ghanekar R, 2004, NUCLEIC ACIDS RES, V32, P4862, DOI 10.1093/nar/gkh807; Kochetkova M, 2002, CANCER RES, V62, P4599; Labat-Robert J, 2002, SEMIN CANCER BIOL, V12, P187, DOI 10.1016/S1044-579X(02)00022-6; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; Lee RJ, 1999, J BIOL CHEM, V274, P7341, DOI 10.1074/jbc.274.11.7341; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Michl P, 2005, CANCER CELL, V7, P521, DOI 10.1016/j.ccr.2005.05.018; Muraoka-Cook RS, 2005, CLIN CANCER RES, V11, p937S; Nepveu A, 2001, GENE, V270, P1, DOI 10.1016/S0378-1119(01)00485-1; Prives C, 2001, CELL, V107, P815, DOI 10.1016/S0092-8674(01)00619-5; Rampalli S, 2005, MOL CELL BIOL, V25, P8415, DOI 10.1128/MCB.25.19.8415-8429.2005; Roy S, 2005, CELL DEATH DIFFER, V12, P482, DOI 10.1038/sj.cdd.4401581; Sottile J, 1998, J CELL SCI, V111, P2933; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Suzui M, 2002, CANCER RES, V62, P3997; Vaghefi H, 2004, ONCOGENE, V23, P8078, DOI 10.1038/sj.onc.1207953; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Yakmovych I, 2001, FASEB J, V15, P553; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Zhu Q, 2004, MOL CELL BIOL, V24, P4810, DOI 10.1128/MCB.24.11.4810-4823.2004; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	50	51	52	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e660	10.1371/journal.pone.0000660	http://dx.doi.org/10.1371/journal.pone.0000660			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668048	gold, Green Published			2022-12-27	WOS:000207452300006
J	Mochel, F; Charles, P; Seguin, F; Barritault, J; Coussieu, C; Perin, L; Le Bouc, Y; Gervais, C; Carcelain, G; Vassault, A; Feingold, J; Rabier, D; Durr, A				Mochel, Fanny; Charles, Perrine; Seguin, Francois; Barritault, Julie; Coussieu, Christiane; Perin, Laurence; Le Bouc, Yves; Gervais, Christiane; Carcelain, Guislaine; Vassault, Anne; Feingold, Josue; Rabier, Daniel; Durr, Alexandra			Early Energy Deficit in Huntington Disease: Identification of a Plasma Biomarker Traceable during Disease Progression	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; GLUCOSE-METABOLISM; SKELETAL-MUSCLE; TRANSGENIC MICE; AMINO-ACIDS; BODY-WEIGHT; DEFECTS; CELLS; PHOSPHORYLATION; ABNORMALITIES	Huntington disease (HD) is a fatal neurodegenerative disorder, with no effective treatment. The pathogenic mechanisms underlying HD have not been elucidated, but weight loss, associated with chorea and cognitive decline, is a characteristic feature of the disease that is accessible to investigation. We, therefore, performed a multiparametric study exploring body weight and the mechanisms of its loss in 32 presymptomatic carriers and HD patients in the early stages of the disease, compared to 21 controls. We combined this study with a multivariate statistical analysis of plasma components quantified by proton nuclear magnetic resonance (H-1 NMR) spectroscopy. We report evidence of an early hypermetabolic state in HD. Weight loss was observed in the HD group even in presymptomatic carriers, although their caloric intake was higher than that of controls. Inflammatory processes and primary hormonal dysfunction were excluded. H-1 NMR spectroscopy on plasma did, however, distinguish HD patients at different stages of the disease and presymptomatic carriers from controls. This distinction was attributable to low levels of the branched chain amino acids (BCAA), valine, leucine and isoleucine. BCAA levels were correlated with weight loss and, importantly, with disease progression and abnormal triplet repeat expansion size in the HD1 gene. Levels of IGF1, which is regulated by BCAA, were also significantly lower in the HD group. Therefore, early weight loss in HD is associated with a systemic metabolic defect, and BCAA levels may be used as a biomarker, indicative of disease onset and early progression. The decreased plasma levels of BCAA may correspond to a critical need for Krebs cycle energy substrates in the brain that increased metabolism in the periphery is trying to provide.	[Mochel, Fanny; Durr, Alexandra] Hop La Pitie Salpetriere, INSERM, UMR 679, Paris, France; [Charles, Perrine; Feingold, Josue; Durr, Alexandra] Hop La Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, Paris, France; [Seguin, Francois; Barritault, Julie] Hop La Miletrie, Poitiers, France; [Seguin, Francois; Barritault, Julie] Fac Med & Pharm, INSERM, Poitiers, France; [Coussieu, Christiane] Hop La Pitie Salpetriere, AP HP, Lab Endocrinol, Paris, France; [Perin, Laurence; Le Bouc, Yves] Hop Enfants Armand Trousseau, AP HP, Paris, France; [Gervais, Christiane] Hop La Pitie Salpetriere, AP HP, Serv Dietet, Paris, France; [Carcelain, Guislaine] Hop La Pitie Salpetriere, AP HP, Immunol Lab, Paris, France; [Vassault, Anne; Rabier, Daniel] Hop Necker Enfants Malad, AP HP, Lab Biochim Metab, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Poitiers; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Durr, A (corresponding author), Hop La Pitie Salpetriere, INSERM, UMR 679, Paris, France.	durr@ccr.jussieu.fr			Fondation pour la Recherche Medicale (France); Pitie-Salpetriere Hospital Paris (France) [17-06]	Fondation pour la Recherche Medicale (France)(Fondation pour la Recherche Medicale); Pitie-Salpetriere Hospital Paris (France)	Funding: Dr Mochel was supported by the Fondation pour la Recherche Medicale (France).; The authors gratefully acknowledge Alexis Brice, Merle Ruberg and Charles Roe for their helpful suggestions. They also acknowledge Anne Faudet for her expert technical assistance and Anne Desfarge for her help with the dietary assessment of both the controls and HD patients. This study was approved by the Committee de Protection des Personnes (CPP) from the Pitie-Salpetriere Hospital Paris (France) on October 18, 2006 (project n# 17-06).	Antonini A, 1996, BRAIN, V119, P2085, DOI 10.1093/brain/119.6.2085; Behrens PF, 2002, BRAIN, V125, P1908, DOI 10.1093/brain/awf180; Bixel MG, 2001, J HISTOCHEM CYTOCHEM, V49, P407, DOI 10.1177/002215540104900314; Browne SE, 2004, NEUROCHEM RES, V29, P531, DOI 10.1023/B:NERE.0000014824.04728.dd; Colin E, 2005, EUR J NEUROSCI, V21, P1478, DOI 10.1111/j.1460-9568.2005.03985.x; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; De Bandt JP, 2006, J NUTR, V136, p308S, DOI 10.1093/jn/136.1.308S; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; Engelke UFH, 2005, NMR BIOMED, V18, P331, DOI 10.1002/nbm.966; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; GRAFTON ST, 1992, ARCH NEUROL-CHICAGO, V49, P1161, DOI 10.1001/archneur.1992.00530350075022; Greenamyre JT, 2007, NEW ENGL J MED, V356, P518, DOI 10.1056/NEJMcibr067022; HARP JB, 1991, DIABETES, V40, P95, DOI 10.2337/diabetes.40.1.95; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Hutson SM, 2001, J NUTR, V131, p846S, DOI 10.1093/jn/131.3.846S; Joshi MA, 2006, BIOCHEM J, V400, P153, DOI 10.1042/BJ20060869; Klivenyi P, 2004, J NEUROCHEM, V88, P1352, DOI 10.1046/j.1471-4159.2003.02263.x; KREMER HPH, 1989, J NEUROL SCI, V90, P335, DOI 10.1016/0022-510X(89)90120-2; KUWERT T, 1993, J NEUROL, V241, P31, DOI 10.1007/BF00870669; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lodi R, 2000, ANN NEUROL, V48, P72; Marder K, 2000, NEUROLOGY, V54, P452, DOI 10.1212/WNL.54.2.452; Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003; Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200; Mochel F, 2005, J CLIN ENDOCR METAB, V90, P3780, DOI 10.1210/jc.2005-0009; Pavese N, 2006, NEUROLOGY, V66, P1638, DOI 10.1212/01.wnl.0000222734.56412.17; PERRY TL, 1969, LANCET, V1, P806; PHILLIPSON OT, 1977, CLIN SCI MOL MED, V52, P311, DOI 10.1042/cs0520311; Popovic V, 2004, EUR J ENDOCRINOL, V151, P451, DOI 10.1530/eje.0.1510451; Rangone H, 2005, J BIOL CHEM, V280, P22021, DOI 10.1074/jbc.M407528200; Robbins AO, 2006, EUR J NEUROL, V13, pE7, DOI 10.1111/j.1468-1331.2006.01319.x; Roe CR, 1999, MOL GENET METAB, V68, P243, DOI 10.1006/mgme.1999.2911; SANBERG PR, 1981, MED J AUSTRALIA, V1, P407, DOI 10.5694/j.1326-5377.1981.tb135681.x; Siesling S, 1998, MOVEMENT DISORD, V13, P915, DOI 10.1002/mds.870130609; Strand AD, 2005, HUM MOL GENET, V14, P1863, DOI 10.1093/hmg/ddi192; STRAUS DS, 1988, BIOCHIM BIOPHYS ACTA, V972, P33; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Szpetnar Maria, 2004, Ann Univ Mariae Curie Sklodowska Med, V59, P91; Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E; Teahan O, 2006, ANAL CHEM, V78, P4307, DOI 10.1021/ac051972y; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; Trejo A, 2004, NUTRITION, V20, P192, DOI 10.1016/j.nut.2003.10.007; Underwood BR, 2006, BRAIN, V129, P877, DOI 10.1093/brain/awl027; Walsh MC, 2006, AM J CLIN NUTR, V84, P531, DOI 10.1093/ajcn/84.3.531; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004	47	169	172	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e647	10.1371/journal.pone.0000647	http://dx.doi.org/10.1371/journal.pone.0000647			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653274	gold, Green Submitted, Green Published			2022-12-27	WOS:000207452200016
J	van der Velde, N; Stricker, BHC; Roelandt, JRTC; Ten Cate, FJ; van der Cammen, JM				van der Velde, Nathalie; Stricker, Bruno H. Ch.; Roelandt, Jos R. T. C.; Ten Cate, Folkert J.; van der Cammen, J. M.			Can Echocardiographic Findings Predict Falls in Older Persons?	PLOS ONE			English	Article							FUNCTIONAL REACH; SYNCOPE; PRESSURE; RISK	Background. The European and American guidelines state the need for echocardiography in patients with syncope. 50% of older adults with syncope present with a fall. Nonetheless, up to now no data have been published addressing echocardiographic abnormalities in older fallers. Method and Findings. In order to determine the association between echocardiographic abnormalities and falls in older adults, we performed a prospective cohort study, in which 215 new consecutive referrals (age 77.4, SD 6.0) of a geriatric outpatient clinic of a Dutch university hospital were included. During the previous year, 139 had experienced a fall. At baseline, all patients underwent routine two-dimensional and Doppler echocardiography. Falls were recorded during a three-month follow-up. Multivariate adjustment for confounders was performed with a Cox proportional hazards model. 55 patients (26%) fell at least once during follow-up. The adjusted hazard ratio of a fall during follow-up was 1.35 (95% CI, 1.08-1.71) for pulmonary hypertension, 1.66 (95% CI, 1.01 to 2.89) for mitral regurgitation, 2.41 (95% CI, 1.32 to 4.37) for tricuspid regurgitation and 1.76 (95% CI, 1.03 to 3.01) for pulmonary regurgitation. For aortic regurgitation the risk of a fall was also increased, but non-significantly (hazard ratio, 1.57 [95% CI, 0.85 to 2.92]). Trend analysis of the severity of the different regurgitations showed a significant relationship for mitral, tricuspid and pulmonary valve regurgitation and pulmonary hypertension. Conclusions. Echo(Doppler) cardiography can be useful in order to identify risk indicators for falling. Presence of pulmonary hypertension or regurgitation of mitral, tricuspid or pulmonary valves was associated with a higher fall risk. Our study indicates that the diagnostic work-up for falls in older adults might be improved by adding an echo(Doppler) cardiogram in selected groups.	[van der Velde, Nathalie; van der Cammen, J. M.] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [van der Velde, Nathalie; van der Cammen, J. M.] Erasmus Univ, Med Ctr, Sect Geriatr, Rotterdam, Netherlands; [van der Velde, Nathalie; Stricker, Bruno H. Ch.] Erasmus Univ, Med Ctr, Dept Epidemiol & Biostat, Rotterdam, Netherlands; [Roelandt, Jos R. T. C.; Ten Cate, Folkert J.] Erasmus Univ, Med Ctr, Dept Cardiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van der Cammen, JM (corresponding author), Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands.	t.vandercammen@erasmusmc.nl		ten Cate, Folkert/0000-0003-2335-5595; van der Velde, Nathalie/0000-0002-6477-6209	Erasmus MC; Merck Sharp Dome; Will-Pharma	Erasmus MC; Merck Sharp Dome; Will-Pharma	Funding: This study was funded by the Erasmus MC, and by grants from Merck Sharp & Dome, and Will-Pharma. The study's sponsors had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	ARANOW WS, 2003, BROCKLEHURSTS TXB GE, P407; Bohannon RW, 1998, CLIN REHABIL, V12, P434, DOI 10.1191/026921598673062266; Brignole M, 2004, EUR HEART J, V25, P2054, DOI 10.1016/j.ehj.2004.09.004; CAMPBELL AJ, 1981, AGE AGEING, V10, P47, DOI 10.1093/ageing/10.1.47; Carey BJ, 2001, AGE AGEING, V30, P19, DOI 10.1093/ageing/30.suppl_4.19; CUMMINGS SR, 1988, J AM GERIATR SOC, V36, P613, DOI 10.1111/j.1532-5415.1988.tb06155.x; DALLAGLIO V, 1989, EUR HEART J, V10, P334, DOI 10.1093/oxfordjournals.eurheartj.a059490; Dey AB, 1997, PACE, V20, P818, DOI 10.1111/j.1540-8159.1997.tb03911.x; Dokainish H, 2003, J AM SOC ECHOCARDIOG, V16, P664, DOI 10.1016/S0894-7317(03)00227-X; DUNCAN PW, 1992, J GERONTOL, V47, pM93, DOI 10.1093/geronj/47.3.M93; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRIED PL, 2001, J GERONTOL, V3, pM146; Galie N, 2004, CURR OPIN CARDIOL, V19, P575, DOI 10.1097/01.hco.0000142066.14966.85; Hatle L, 1985, DOPPLER ULTRASOUND C, V2nd; HELMCKE F, 1987, CIRCULATION, V75, P175, DOI 10.1161/01.CIR.75.1.175; Kannus P, 2005, AM J PUBLIC HEALTH, V95, P422, DOI 10.2105/AJPH.2004.047779; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Kho JK, 1999, ECHO MANUAL, P37; KHO JK, 1999, ECHO MANUAL, P45; Lanzarini L, 2002, AM HEART J, V144, P1087, DOI 10.1067/mhj.2002.126350; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Linzer M, 1997, ANN INTERN MED, V126, P989, DOI 10.7326/0003-4819-126-12-199706150-00012; McQuillan BM, 2001, CIRCULATION, V104, P2797, DOI 10.1161/hc4801.100076; MOHTY D, 2007, DATE; Newman AB, 2001, J GERONTOL A-BIOL, V56, pM158, DOI 10.1093/gerona/56.3.M158; Panther R, 1998, J AM SOC ECHOCARDIOG, V11, P294, DOI 10.1016/S0894-7317(98)70092-6; QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744; Ray P, 2006, CRIT CARE, V10, DOI 10.1186/cc4926; Rivera J M, 1994, J Am Soc Echocardiogr, V7, P480; Sarasin FP, 2002, HEART, V88, P363, DOI 10.1136/heart.88.4.363; Shaw FE, 1997, POSTGRAD MED J, V73, P635, DOI 10.1136/pgmj.73.864.635; Tromp AM, 2001, J CLIN EPIDEMIOL, V54, P837, DOI 10.1016/S0895-4356(01)00349-3; Van der Velde N, 2007, BRIT J CLIN PHARMACO, V63, P232, DOI 10.1111/j.1365-2125.2006.02736.x; Wohrle J, 2003, Z GERONTOL GERIATR, V36, P2, DOI 10.1007/s00391-003-0140-y	35	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e654	10.1371/journal.pone.0000654	http://dx.doi.org/10.1371/journal.pone.0000654			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653281	Green Published, gold			2022-12-27	WOS:000207452200023
J	Barquero-Calvo, E; Chaves-Olarte, E; Weiss, DS; Guzman-Verri, C; Chacon-Diaz, C; Rucavado, A; Moriyon, I; Moreno, E				Barquero-Calvo, Elias; Chaves-Olarte, Esteban; Weiss, David S.; Guzman-Verri, Caterina; Chacon-Diaz, Carlos; Rucavado, Alexandra; Moriyon, Ignacio; Moreno, Edgardo			Brucella abortus Uses a Stealthy Strategy to Avoid Activation of the Innate Immune System during the Onset of Infection	PLOS ONE			English	Article								Background. To unravel the strategy by which Brucella abortus establishes chronic infections, we explored its early interaction with innate immunity. Methodology/Principal Findings. Brucella did not induce proinflammatory responses as demonstrated by the absence of leukocyte recruitment, humoral or cellular blood changes in mice. Brucella hampered neutrophil (PMN) function and PMN depletion did not influence the course of infection. Brucella barely induced proinflammatory cytokines and consumed complement, and was strongly resistant to bactericidal peptides, PMN extracts and serum. Brucella LPS (BrLPS), NH-polysaccharides, cyclic glucans, outer membrane fragments or disrupted bacterial cells displayed low biological activity in mice and cells. The lack of proinflammatory responses was not due to conspicuous inhibitory mechanisms mediated by the invading Brucella or its products. When activated 24 h post-infection macrophages did not kill Brucella, indicating that the replication niche was not fusiogenic with lysosomes. Brucella intracellular replication did not interrupt the cell cycle or caused cytotoxicity in WT, TLR4 and TLR2 knockout cells. TNF-alpha-induction was TLR4- and TLR2-dependent for live but not for killed B. abortus. However, intracellular replication in TLR4, TLR2 and TLR4/2 knockout cells was not altered and the infection course and anti-Brucella immunity development upon BrLPS injection was unaffected in TLR4 mutant mice. Conclusion/Significance. We propose that Brucella has developed a stealth strategy through PAMPs reduction, modification and hiding, ensuring by this manner low stimulatory activity and toxicity for cells. This strategy allows Brucella to reach its replication niche before activation of antimicrobial mechanisms by adaptive immunity. This model is consistent with clinical profiles observed in humans and natural hosts at the onset of infection and could be valid for those intracellular pathogens phylogenetically related to Brucella that also cause long lasting infections.	[Barquero-Calvo, Elias; Chaves-Olarte, Esteban; Guzman-Verri, Caterina; Chacon-Diaz, Carlos; Moreno, Edgardo] Univ Nacl, Escuela Med Vet, Programa Invest Enfermedades Trop, Heredia, Costa Rica; [Chaves-Olarte, Esteban; Chacon-Diaz, Carlos] Univ Costa Rica, Fac Microbiol, Ctr Invest Enfermedades Trop, San Jose, Costa Rica; [Weiss, David S.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Weiss, David S.] NYU, Sch Med, Skirball Inst, New York, NY USA; [Rucavado, Alexandra] Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica; [Moriyon, Ignacio] Univ Navarra, Dept Microbiol, Navarra, Spain	Universidad Nacional Costa Rica; Universidad Costa Rica; New York University; New York University; Universidad Costa Rica; University of Navarra	Moreno, E (corresponding author), Univ Nacl, Escuela Med Vet, Programa Invest Enfermedades Trop, Heredia, Costa Rica.	emoreno@medvet.una.ac.cr	Rucavado, Alexandra/AGY-1867-2022; Guzman-Verri, Caterina/AAP-3074-2020; Moriyon, Ignacio/N-4764-2016	Guzman-Verri, Caterina/0000-0003-1036-920X; Moriyon, Ignacio/0000-0002-4288-0195; BARQUERO-CALVO, ELIAS/0000-0003-4428-3340	Universidad Nacional [FIDA-2006]; FS-CONARE UNA/UCR, Costa Rica [NeTropica 8-N-2005]; IFS [B/3456-1, B/3456-2]; Ministerio de Ciencia y Tecnologia of Spain [AGL2004-01162/GAN]	Universidad Nacional; FS-CONARE UNA/UCR, Costa Rica; IFS(International Foundation for Science); Ministerio de Ciencia y Tecnologia of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by grants from FIDA-2006, from the Universidad Nacional, FS-CONARE UNA/UCR, Costa Rica, NeTropica 8-N-2005, grant B/3456-1 and B/3456-2, from IFS and AGL2004-01162/GAN from Ministerio de Ciencia y Tecnologia of Spain.	ACKERMANN MR, 1988, VET PATHOL, V25, P28, DOI 10.1177/030098588802500104; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Aragon V, 1996, J BACTERIOL, V178, P1070, DOI 10.1128/jb.178.4.1070-1079.1996; Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202; Ariza J, 1999, REV MED MICROBIOL, V10, P125; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Baldwin C. L., 2004, Brucella: molecular and cellular biology, P341; Billard E, 2005, INFECT IMMUN, V73, P8418, DOI 10.1128/IAI.73.12.8418-8424.2005; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; BOHME DH, 1959, J EXP MED, V110, P9, DOI 10.1084/jem.110.1.9; Buwitt-Beckmann U, 2005, FEBS J, V272, P6354, DOI 10.1111/j.1742-4658.2005.05029.x; Campos MA, 2004, INFECT IMMUN, V72, P176, DOI 10.1128/IAI.72.1.176-186.2004; CANNAT A, 1981, ANN INST PASTEUR IMM, VD132, P15; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Chaves-Olarte E, 2002, CELL MICROBIOL, V4, P663, DOI 10.1046/j.1462-5822.2002.00221.x; Cheminay U, 2004, INFECT IMMUN, V72, P468, DOI 10.1128/IAI.72.1.468-477.2004; Chen DX, 2004, BLOOD, V104, P1344, DOI 10.1182/blood-2003-12-4365; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; COATES TD, 1992, MANUAL CLIN LAB IMMU, P409; Copin R, 2007, J IMMUNOL, V178, P5182, DOI 10.4049/jimmunol.178.8.5182; DETEJADA GM, 1995, INFECT IMMUN, V63, P3054; Duenas AI, 2004, INT IMMUNOL, V16, P1467, DOI 10.1093/intimm/dxh148; ELBERG SS, 1957, J EXP MED, V106, P545, DOI 10.1084/jem.106.4.545; ENRIGHT FM, 1990, VET IMMUNOL IMMUNOP, V26, P171, DOI 10.1016/0165-2427(90)90065-Z; FERNANDES DM, 1995, INFECT IMMUN, V63, P1130, DOI 10.1128/IAI.63.3.1130-1133.1995; Freer E, 1996, J BACTERIOL, V178, P5867, DOI 10.1128/jb.178.20.5867-5876.1996; Fretin D, 2005, CELL MICROBIOL, V7, P687, DOI 10.1111/j.1462-5822.2005.00502.x; FUKUHARA M, 1969, BIOCHEM PHARMACOL, V18, P475; GAMAZO C, 1989, INFECT IMMUN, V57, P1419, DOI 10.1128/IAI.57.5.1419-1426.1989; Garcia-Ramallo E, 2002, J IMMUNOL, V169, P6467, DOI 10.4049/jimmunol.169.11.6467; Giambartolomei GH, 2004, J IMMUNOL, V173, P4635, DOI 10.4049/jimmunol.173.7.4635; GOMEZMIGUEL MJ, 1986, INFECT IMMUN, V53, P678; Gross A, 2000, INFECT IMMUN, V68, P342, DOI 10.1128/IAI.68.1.342-351.2000; Guzman-Verri C, 2002, P NATL ACAD SCI USA, V99, P12375, DOI 10.1073/pnas.192439399; Guzman-Verri C, 2001, J BIOL CHEM, V276, P44435, DOI 10.1074/jbc.M105606200; Huang LY, 2003, J IMMUNOL, V171, P1441, DOI 10.4049/jimmunol.171.3.1441; HUDSON L, 1976, P298; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; JIANG XS, 1993, INFECT IMMUN, V61, P124, DOI 10.1128/IAI.61.1.124-134.1993; Kawai Y, 2000, FEMS IMMUNOL MED MIC, V28, P197, DOI 10.1016/S0928-8244(00)00156-5; KILLION JW, 1986, INFECT IMMUN, V54, P1; Kim S, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-22; KOSSACK RE, 1981, INFECT IMMUN, V31, P674, DOI 10.1128/IAI.31.2.674-678.1981; Kwak SH, 2006, THROMB HAEMOSTASIS, V95, P829, DOI 10.1160/TH05-12-0782; Lamontagne J, 2007, J PROTEOME RES, V6, P1519, DOI 10.1021/pr060636a; Lapaque N, 2006, CELL MICROBIOL, V8, P401, DOI 10.1111/j.1462-5822.2005.00629.x; Lapaque N, 2005, CURR OPIN MICROBIOL, V8, P60, DOI 10.1016/j.mib.2004.12.003; Lembo A, 2003, INFECT IMMUN, V71, P6058, DOI 10.1128/IAI.71.10.6058-6062.2003; Manterola L, 2005, J BACTERIOL, V187, P5631, DOI 10.1128/JB.187.16.5631-5639.2005; Marchesini MI, 2004, MICROB PATHOGENESIS, V37, P95, DOI 10.1016/j.micpath.2004.06.001; Mastroeni P, 2004, MICROBES INFECT, V6, P398, DOI 10.1016/j.micinf.2003.12.009; MORENO E, 1984, INFECT IMMUN, V46, P74, DOI 10.1128/IAI.46.1.74-80.1984; Moreno E., 2004, Brucella: molecular and cellular biology, P287; MORENO E, 1981, INFECT IMMUN, V31, P362, DOI 10.1128/IAI.31.1.362-370.1981; Moreno E, 2002, P NATL ACAD SCI USA, V99, P1, DOI 10.1073/pnas.022622699; MORENO E, 2001, PROKARYOTES 1, V5, P315; MORIYON I, 2004, INTRACELLULAR PATHOG, P204; Murphy EA, 2001, FEMS IMMUNOL MED MIC, V32, P85, DOI 10.1111/j.1574-695X.2001.tb00536.x; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; PHILLIPS M, 1989, AM J VET RES, V50, P318; Pizarro-Cerda J, 1999, J IMMUNOL, V162, P3519; PUGH GW, 1989, AM J VET RES, V50, P323; Rafiei A, 2006, J INFECTION, V53, P315, DOI 10.1016/j.jinf.2005.11.024; Rajashekara G, 2005, CELL MICROBIOL, V7, P1459, DOI 10.1111/j.1462-5822.2005.00570.x; RASOOL O, 1992, INFECT IMMUN, V60, P1699, DOI 10.1128/IAI.60.4.1699-1702.1992; RILEY LK, 1984, INFECT IMMUN, V46, P224, DOI 10.1128/IAI.46.1.224-230.1984; Rittig MG, 2003, J LEUKOCYTE BIOL, V74, P1045, DOI 10.1189/jlb.0103015; Sander A, 1997, J CLIN MICROBIOL, V35, P584, DOI 10.1128/JCM.35.3.584-587.1997; Santamaria C, 2005, ANTIMICROB AGENTS CH, V49, P1340, DOI [10.1128/AAC.49.4.1340-1345.2005, 10.1128/AAc.49.4.1340-1345.2005]; Sha J, 2004, INFECT IMMUN, V72, P3987, DOI 10.1128/IAI.72.7.3987-4003.2004; SPINK WW, 1956, NATURE BRUCELLOSIS, P464; Sun YH, 2002, INFECT IMMUN, V70, P4826, DOI 10.1128/IAI.70.9.4826-4832.2002; THIELE OW, 1969, EUR J BIOCHEM, V7, P393, DOI 10.1111/j.1432-1033.1969.tb19621.x; Weiss DS, 2005, INFECT IMMUN, V73, P5137, DOI 10.1128/IAI.73.8.5137-5143.2005; Weiss DS, 2004, J IMMUNOL, V172, P4463, DOI 10.4049/jimmunol.172.7.4463; WEISS DS, 2002, MOL CELLULAR MICROBI, P439; YOUNG EJ, 1985, J INFECT DIS, V151, P682, DOI 10.1093/infdis/151.4.682; Zahringer U, 2004, J BIOL CHEM, V279, P21046, DOI 10.1074/jbc.M313370200; Zhan YF, 1996, INFECT IMMUN, V64, P2782, DOI 10.1128/IAI.64.7.2782-2786.1996	79	224	242	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2007	2	7							e631	10.1371/journal.pone.0000631	http://dx.doi.org/10.1371/journal.pone.0000631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GI	17637846	Green Submitted, gold, Green Published			2022-12-27	WOS:000207452100020
J	Boggio, EM; Putignano, E; Sassoe-Pognetto, M; Pizzorusso, T; Giustetto, M				Boggio, Elena M.; Putignano, Elena; Sassoe-Pognetto, Marco; Pizzorusso, Tommaso; Giustetto, Maurizio			Visual Stimulation Activates ERK in Synaptic and Somatic Compartments of Rat Cortical Neurons with Parallel Kinetics	PLOS ONE			English	Article								Background. Extracellular signal-regulated kinase (ERK) signalling pathway plays a crucial role in regulating diverse neuronal processes, such as cell proliferation and differentiation, and long-term synaptic plasticity. However, a detailed understanding of the action of ERK in neurons is made difficult by the lack of knowledge about its subcellular localization in response to physiological stimuli. To address this issue, we have studied the effect of visual stimulation in vivo of dark-reared rats on the spatial-temporal dynamics of ERK activation in pyramidal neurons of the visual cortex. Methodology/Principal Findings. Using immunogold electron microscopy, we show that phosphorylated ERK (pERK) is present in dendritic spines, both at synaptic and non-synaptic plasma membrane domains. Moreover, pERK is also detected in presynaptic axonal boutons forming connections with dendritic spines. Visual stimulation after dark rearing during the critical period causes a rapid increase in the number of pERK-labelled synapses in cortical layers I-II/III. This visually-induced activation of ERK at synaptic sites occurs in pre- and post-synaptic compartments and its temporal profile is identical to that of ERK activation in neuronal cell bodies. Conclusions/Significance. Visual stimulation in vivo increases pERK expression at pre- and post-synaptic sites of axo-spinous junctions, suggesting that ERK plays an important role in the local modulation of synaptic function. The data presented here support a model in which pERK can have early and late actions both centrally in the cell nucleus and peripherally at synaptic contacts.	[Boggio, Elena M.; Sassoe-Pognetto, Marco; Giustetto, Maurizio] Univ Turin, Dipartimento Anat Farmacol & Med Legale, Turin, Italy; [Boggio, Elena M.; Sassoe-Pognetto, Marco; Giustetto, Maurizio] Univ Turin, Ist Nazl Neurosci, Turin, Italy; [Putignano, Elena; Pizzorusso, Tommaso] Scuola Normale Super Pisa, Pisa, Italy; [Putignano, Elena; Pizzorusso, Tommaso] CNR, Inst Neurosci, I-56100 Pisa, Italy; [Pizzorusso, Tommaso] Univ Florence, Dipartimento Psicol, Florence, Italy	University of Turin; University of Turin; Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Florence	Giustetto, M (corresponding author), Univ Turin, Dipartimento Anat Farmacol & Med Legale, Turin, Italy.	maurizio.giustetto@unito.it	giustetto, maurizio/D-6606-2011; Sassoe-Pognetto, Marco/AAE-3536-2022; Pizzorusso, Tommaso/D-1399-2013	giustetto, maurizio/0000-0003-1323-4060; Sassoe-Pognetto, Marco/0000-0001-8906-0613; Putignano, Elena/0000-0002-4313-408X; Pizzorusso, Tommaso/0000-0001-5614-0668	MIUR [PRIN 2005053844, PRIN 2005059123]; FIRB [RBNE019J7C]; Regione Piemonte [142]	MIUR(Ministry of Education, Universities and Research (MIUR)); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Regione Piemonte(Regione Piemonte)	This work was supported by MIUR (PRIN #2005053844 to MG; PRIN #2005059123 to MSP; FIRB project #RBNE019J7C), Regione Piemonte (Grant #142 to MG).	Adams JP, 2000, J NEUROCHEM, V75, P2277, DOI 10.1046/j.1471-4159.2000.0752277.x; Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Banko JL, 2004, J NEUROCHEM, V91, P462, DOI 10.1111/j.1471-4159.2004.02734.x; Berardi N, 2004, NEURON, V44, P905, DOI 10.1016/S0896-6273(04)00796-2; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Burkhalter A, 2006, J NEUROSCI, V26, P12274, DOI 10.1523/JNEUROSCI.2599-06.2006; Cancedda L, 2003, J NEUROSCI, V23, P7012, DOI 10.1523/JNEUROSCI.23-18-07012.2003; Coogan AN, 1999, J NEUROPHYSIOL, V81, P103, DOI 10.1152/jn.1999.81.1.103; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Futter M, 2005, P NATL ACAD SCI USA, V102, P3489, DOI 10.1073/pnas.0409802102; Galvan A, 2006, NEUROSCIENCE, V143, P351, DOI 10.1016/j.neuroscience.2006.09.019; Giovannini MG, 2001, J NEUROSCI, V21, P7053, DOI 10.1523/JNEUROSCI.21-18-07053.2001; Goldin M, 2003, EUR J NEUROSCI, V17, P2529, DOI 10.1046/j.1460-9568.2003.02694.x; Gong RM, 2006, NEUROREPORT, V17, P1575, DOI 10.1097/01.wnr.0000234742.42818.ff; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Holzer M, 2001, NEUROSCIENCE, V105, P1031, DOI 10.1016/S0306-4522(01)00245-7; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Lisman J., 2006, SCI STKE, V2006, pr; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Otis KO, 2006, CURR OPIN NEUROBIOL, V16, P329, DOI 10.1016/j.conb.2006.05.001; Putignano E, 2007, NEURON, V53, P747, DOI 10.1016/j.neuron.2007.02.007; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Ratto GM, 2006, ADV EXP MED BIOL, V557, P122; Rosenblum K, 2000, J NEUROSCI, V20, P977, DOI 10.1523/JNEUROSCI.20-03-00977.2000; SASSOEPOGNETTO M, 1994, J NEUROSCI, V14, P5131; Schafe GE, 2000, J NEUROSCI, V20, P8177; Schroder FH, 2006, EAU EBU UPDATE SERIE, V4, P2; Selcher JC, 2003, LEARN MEMORY, V10, P26, DOI 10.1101/lm.51103; Sgambato V, 1998, J NEUROSCI, V18, P8814; Sindreu CB, 2007, NEURON, V53, P79, DOI 10.1016/j.neuron.2006.11.024; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; Wallace W, 2004, J NEUROSCI, V24, P6928, DOI 10.1523/JNEUROSCI.1110-04.2004; Wang LJ, 2002, CIRC RES, V91, P821, DOI 10.1161/01.RES.0000041029.97988.E9; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Yung Y, 1997, FEBS LETT, V408, P292, DOI 10.1016/S0014-5793(97)00442-0; Zhong SP, 2000, J BIOL CHEM, V275, P20980, DOI 10.1074/jbc.M909934199; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	59	35	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2007	2	7							e604	10.1371/journal.pone.0000604	http://dx.doi.org/10.1371/journal.pone.0000604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GH	17622349	gold, Green Published, Green Submitted			2022-12-27	WOS:000207452000011
J	Anginot, A; Dacquin, R; Mazzorana, M; Jurdic, P				Anginot, Adrienne; Dacquin, Romain; Mazzorana, Marlene; Jurdic, Pierre			Lymphocytes and the Dap12 Adaptor Are Key Regulators of Osteoclast Activation Associated with Gonadal Failure	PLOS ONE			English	Article								Bone resorption by osteoclasts is necessary to maintain bone homeostasis. Osteoclast differentiation from hematopoietic progenitors and their activation depend on M-CSF and RANKL, but also requires co-stimulatory signals acting through receptors associated with DAP12 and FcR gamma adaptors. Dap12 mutant mice (K Delta 75) are osteopetrotic due to inactive osteoclasts but, surprisingly, these mice are more sensitive than WT mice to bone loss following an ovariectomy. Because estrogen withdrawal is known to disturb bone mass, at least in part, through lymphocyte interaction, we looked at the role of mature lymphocytes on osteoclastogenesis and bone mass in the absence of functional DAP12. Lymphocytes were found to stimulate an early osteoclast differentiation response from Dap12-deficient progenitors in vitro. In vivo, Rag1-/- mice lacking mature lymphocytes did not exhibit any bone phenotype, but lost their bone mass after ovariectomy like K Delta 75 mice. K Delta 75; Rag1-/ double mutant female mice exhibited a more severe osteopetrosis than Dap12-deficient animals but lost their bone mass after ovariectomy, like single mutants. These results suggest that both DAP12 and mature lymphocytes act synergistically to maintain bone mass under physiological conditions, while playing similar but not synergistic co-stimulatory roles in protecting bone loss after gonadal failure. Thus, our data support a role for lymphocytes during osteoclast differentiation and suggest that they may function as accessory cells when regular osteoclast function is compromised.	[Anginot, Adrienne; Dacquin, Romain; Mazzorana, Marlene; Jurdic, Pierre] Univ Lyon 1, Ecole Normale Super, Inst Federatif Biosci Gerland Lyon Sud, CNRS,INRA,Inst Genom Fonct Lyon, F-69365 Lyon, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Jurdic, P (corresponding author), Univ Lyon 1, Ecole Normale Super, Inst Federatif Biosci Gerland Lyon Sud, CNRS,INRA,Inst Genom Fonct Lyon, F-69365 Lyon, France.	pierre.jurdic@enslyon.fr	Anginot, Adrienne/N-9299-2017	MAZZORANA, Marlene/0000-0002-3956-4319	Agence Nationale pour la Recherche, ANR; Fondation pour la Recherche Medicale (FRM); INSERM; French Ministry of Research; Association pour la Recherche contre le Cancer (ARC)	Agence Nationale pour la Recherche, ANR(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR))	This work was supported by grants from the Agence Nationale pour la Recherche, ANR maladies rares; Fondation pour la Recherche Medicale (FRM), and ProA program from INSERM. A. Anginot was a recipient of a PhD grant from the French Ministry of Research and from the Association pour la Recherche contre le Cancer (ARC); R. Dacquin has been a recipient of an ARC fellowship and is currently recipient of INSERM fellowship.	Baron R, 2004, NAT MED, V10, P458, DOI 10.1038/nm0504-458; Carlsten H, 2005, IMMUNOL REV, V208, P194, DOI 10.1111/j.0105-2896.2005.00326.x; Cella M, 2003, J EXP MED, V198, P645, DOI 10.1084/jem.20022220; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Cenci S, 2003, P NATL ACAD SCI USA, V100, P10405, DOI 10.1073/pnas.1533207100; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; Gao YH, 2007, J CLIN INVEST, V117, P122, DOI 10.1172/JCI30074; Humphrey MB, 2004, J BONE MINER RES, V19, P224, DOI 10.1359/JBMR.0301234; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Lee SK, 2006, J BONE MINER RES, V21, P1704, DOI 10.1359/JBMR.060726; LI Y, 2007, BLOOD; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; MASUZAWA T, 1994, J CLIN INVEST, V94, P1090, DOI 10.1172/JCI117424; Miyaura C, 1997, P NATL ACAD SCI USA, V94, P9360, DOI 10.1073/pnas.94.17.9360; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nataf S, 2005, AM J PATHOL, V166, P275, DOI 10.1016/S0002-9440(10)62251-1; Onoe Y, 2000, J BONE MINER RES, V15, P541, DOI 10.1359/jbmr.2000.15.3.541; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Perry MJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE1159, DOI 10.1152/ajpendo.2000.279.5.E1159; Roggia C, 2001, P NATL ACAD SCI USA, V98, P13960, DOI 10.1073/pnas.251534698; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Shibutani T, 2000, J BIOMED MATER RES, V50, P153, DOI 10.1002/(SICI)1097-4636(200005)50:2<153::AID-JBM9>3.0.CO;2-R; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Thurmond TS, 2000, ENDOCRINOLOGY, V141, P2309, DOI 10.1210/en.141.7.2309; Tomasello E, 2000, IMMUNITY, V13, P355, DOI 10.1016/S1074-7613(00)00035-2; Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014; TURNER RT, 1994, ENDOCR REV, V15, P275, DOI 10.1210/er.15.3.275; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550	35	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2007	2	7							e585	10.1371/journal.pone.0000585	http://dx.doi.org/10.1371/journal.pone.0000585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GG	17611620	gold, Green Submitted, Green Published			2022-12-27	WOS:000207451900005
J	Wu, YL; Torchia, J; Yao, W; Lane, NE; Lanier, LL; Nakamura, MC; Humphrey, MB				Wu, Yalei; Torchia, James; Yao, Wei; Lane, Nancy E.; Lanier, Lewis L.; Nakamura, Mary C.; Humphrey, Mary Beth			Bone Microenvironment Specific Roles of ITAM Adapter Signaling during Bone Remodeling Induced by Acute Estrogen-Deficiency	PLOS ONE			English	Article								Immunoreceptor tyrosine-based activation motif (ITAM) signaling mediated by DAP12 or Fc epsilon receptor I gamma chain (FcR gamma) have been shown to be critical for osteoclast differentiation and maturation under normal physiological conditions. Their function in pathological conditions is unknown. We studied the role of ITAM signaling during rapid bone remodeling induced by acute estrogen-deficiency in wild-type (WT), DAP12-deficient (DAP12-/-), FcR gamma-deficient (FcR gamma-/-) and double-deficient (DAP12-/- FcR gamma-/-) mice. Six weeks after ovariectomy (OVX), DAP12-/-FcR gamma-/- mice showed resistance to lumbar vertebral body (LVB) trabecular bone loss, while WT, DAP12-/- and FcR gamma-/- mice had significant LVB bone loss. In contrast, all ITAM adapter-deficient mice responded to OVX with bone loss in both femur and tibia of approximately 40%, relative to basal bone volumes. Only WT mice developed significant cortical bone loss after OVX. In vitro studies showed microenvironmental changes induced by OVX are indispensable for enhanced osteoclast formation and function. Cytokine changes, including TGF beta and TNF alpha, were able to induce osteoclastogenesis independent of RANKL in BMMs from WT but not DAP12-/- and DAP12-/-FcR gamma-/- mice. FSH stimulated RANKL-induced osteoclast differentiation from BMMs in WT, but not DAP12-/- and DAP12-/-FcR gamma-/- mice. Our study demonstrates that although ITAM adapter signaling is critical for normal bone remodeling, estrogen-deficiency induces an ITAM adapter-independent bypass mechanism allowing for enhanced osteoclastogenesis and activation in specific bony microenvironments.	[Humphrey, Mary Beth] VA Med Ctr, Dept Med & Microbiol & Immunol, Oklahoma City, OK USA; [Humphrey, Mary Beth] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Wu, Yalei; Torchia, James; Nakamura, Mary C.] Univ Calif San Francisco, Dept Med, VA Med Ctr, San Francisco, CA USA; [Wu, Yalei; Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Yao, Wei; Lane, Nancy E.] Univ Calif Davis, Dept Med, Sacramento, CA 95817 USA; [Lanier, Lewis L.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; University of California System; University of California San Francisco	Humphrey, MB (corresponding author), VA Med Ctr, Dept Med & Microbiol & Immunol, Oklahoma City, OK USA.	marybeth-humphrey@ouhsc.edu	Nakamura, Mary/ABI-2887-2020; Lanier, Lewis L/E-2139-2014; Yao, Wei/O-8187-2019; yao, wei/GVS-3913-2022	Nakamura, Mary/0000-0001-8127-9426; Lanier, Lewis L/0000-0003-1308-3952; Yao, Wei/0000-0002-1198-1161; yao, wei/0000-0002-1198-1161; Torchia, James/0000-0001-5291-8698	Veterans Affairs; National Institutes of Health [RO1 AR050038, R01 AR043052, K24- AR048841, R01 AI068129]; Abbott Scholars in Rheumatology; Rosalind Russell Center for Arthritis Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR048841, R01AR043052, R01AR050038] Funding Source: NIH RePORTER	Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott Scholars in Rheumatology; Rosalind Russell Center for Arthritis Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Veterans Affairs (MBH and MCN), National Institutes of Health Grants RO1 AR050038 (MCN), R01 AR043052 (NEL), K24- AR048841 (NEL), and R01 AI068129 (LLL), Abbott Scholars in Rheumatology (MBH), and the Rosalind Russell Center for Arthritis Research (MCN). LLL is an American Cancer Society Research Professor. MCN is an American Cancer Society Research Scholar.	Daci E, 2000, J BONE MINER RES, V15, P1510, DOI 10.1359/jbmr.2000.15.8.1510; Daws MR, 2003, J IMMUNOL, V171, P594, DOI 10.4049/jimmunol.171.2.594; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hankenson KD, 2005, MATRIX BIOL, V24, P362, DOI 10.1016/j.matbio.2005.05.008; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Humphrey MB, 2006, J BONE MINER RES, V21, P237, DOI 10.1359/JBMR.051016; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Lindberg MK, 2006, BONE, V38, P85, DOI 10.1016/j.bone.2005.07.027; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Oshima S, 2006, FEBS LETT, V580, P1251, DOI 10.1016/j.febslet.2006.01.038; PACIFICI R, 1991, P NATL ACAD SCI USA, V88, P5134, DOI 10.1073/pnas.88.12.5134; Philbrick WM, 1998, P NATL ACAD SCI USA, V95, P11846, DOI 10.1073/pnas.95.20.11846; Riggs BL, 2000, J CLIN INVEST, V106, P1203, DOI 10.1172/JCI11468; Sun L, 2006, CELL, V125, P247, DOI 10.1016/j.cell.2006.01.051; Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Van Wesenbeeck L, 2002, P NATL ACAD SCI USA, V99, P14303, DOI 10.1073/pnas.202332999; Wise GE, 1998, EUR J ORAL SCI, V106, P397, DOI 10.1111/j.1600-0722.1998.tb02205.x; Zhao HB, 2005, J BONE MINER RES, V20, P2116, DOI 10.1359/JBMR.050724	25	51	51	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2007	2	7							e586	10.1371/journal.pone.0000586	http://dx.doi.org/10.1371/journal.pone.0000586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GG	17611621	Green Submitted, gold, Green Published			2022-12-27	WOS:000207451900006
J	Marino, S; Nusse, R				Marino, Susan; Nusse, Roel			Mutants in the Mouse NuRD/Mi2 Component P66 alpha Are Embryonic Lethal	PLOS ONE			English	Article							DNA METHYLATION; HISTONE; COMPLEX; BINDING; IDENTIFICATION; PROTEIN; ROLES; MBD2; LOCALIZATION; DEACETYLASES	Background. The NuRD/Mi2 chromatin complex is involved in histone modifications and contains a large number of subunits, including the p66 protein. There are two mouse and human p66 paralogs, p66 alpha and p66 beta. The functions of these genes are not clear, in part because there are no mutants available, except in invertebrate model systems. Methodology. We made loss of function mutants in the mouse p66 alpha gene (mp66 alpha, official name Gatad2a, MGI:2384585). We found that mp66 alpha is essential for development, as mutant embryos die around day 10 of embryogenesis. The gene is not required for normal blastocyst development or for implantation. The phenotype of mutant embryos and the pattern of gene expression in mutants are consistent with a role of mp66 alpha in gene silencing. Conclusion. mp66 alpha is an essential gene, required for early mouse development. The lethal phenotype supports a role in execution of methylated DNA silencing.	[Marino, Susan; Nusse, Roel] Stanford Univ, Beckman Ctr, Sch Med, Howard Hughes Med Inst,Dept Dev Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Nusse, R (corresponding author), Stanford Univ, Beckman Ctr, Sch Med, Howard Hughes Med Inst,Dept Dev Biol, Stanford, CA 94305 USA.	rnusse@stanford.edu			Howard Hughes Medical Institute; US ARMY Medical Research and Material Command [DAMD17-99-1-9386]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US ARMY Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	The work was supported by the Howard Hughes Medical Institute and a grant from the US ARMY Medical Research and Material Command (DAMD17-99-1-9386).	Brackertz M, 2006, NUCLEIC ACIDS RES, V34, P397, DOI 10.1093/nar/gkj437; Brackertz M, 2002, J BIOL CHEM, V277, P40958, DOI 10.1074/jbc.M207467200; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Crook JM, 2006, NAT CELL BIOL, V8, P212, DOI 10.1038/ncb0306-212; Drewell RA, 2002, NUCLEIC ACIDS RES, V30, P1139, DOI 10.1093/nar/30.5.1139; Feng Q, 2002, MOL CELL BIOL, V22, P536, DOI 10.1128/MCB.22.2.536-546.2002; Feng Q, 2001, GENE DEV, V15, P827; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Hogan B, 1994, MANIPULATING MOUSE E; Joyner AL, 2000, GENE TARGETING PRACT; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kantor B, 2003, GENE EXPR PATTERNS, V3, P697, DOI 10.1016/j.modgep.2003.07.003; Kon C, 2005, GENETICS, V169, P2087, DOI 10.1534/genetics.104.034595; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lei H, 1996, DEVELOPMENT, V122, P3195; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wang HB, 2001, NUCLEIC ACIDS RES, V29, P2517, DOI 10.1093/nar/29.12.2517; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	34	21	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2007	2	6							e519	10.1371/journal.pone.0000519	http://dx.doi.org/10.1371/journal.pone.0000519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GD	17565372	gold, Green Published, Green Submitted			2022-12-27	WOS:000207451600007
J	Andrews, R; Ahringer, J				Andrews, Robert; Ahringer, Julie			Asymmetry of Early Endosome Distribution in C. elegans Embryos	PLOS ONE			English	Article							ANTERIOR-POSTERIOR POLARITY; CAENORHABDITIS-ELEGANS; ANTEROPOSTERIOR AXIS; CYTOPLASMIC DYNEIN; CELL POLARITY; PROTEIN; POLARIZATION; PAR-3; GENE; TRANSPORT	Background. Endocytosis is involved in the regulation of many cellular events, including signalling, cell migration, and cell polarity. To begin to investigate roles for endocytosis in early C. elegans development, we examined the distribution and dynamics of early endosomes (EEs) in embryos. Methodology/Principal Findings. EEs are primarily found at the cell periphery with an initially uniform distribution after fertilization. Strikingly, we find that during the first cell cycle, EEA-1 positive EEs become enriched at the anterior cortex. In contrast, the Golgi compartment shows no asymmetry in distribution. Asymmetric enrichment of EEs depends on acto-myosin contractility and embryonic PAR polarity. In addition to their localization at the cortex, EEs are also found around the centrosome. These EEs move rapidly (1.3um/s) from the cortex directly to the centrosome, a speed comparable to that of the minus end directed motor dynein. Conclusions/Significance. We speculate that the asymmetry of early endosomes might play a role in cell asymmetries or fate decisions.	[Ahringer, Julie] Univ Cambridge, Gurdon Inst, Cambridge, England; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	University of Cambridge; University of Cambridge	Ahringer, J (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge, England.	jaa@mole.bio.cam.ac.uk		Ahringer, Julie/0000-0002-7074-4051	Wellcome Trust	Wellcome Trust(Wellcome Trust)	The work was funded by the Wellcome Trust. They had no role in the study.	Ahringer J., 2006, WORMBOOK, P1, DOI [DOI 10.1895/WORMBOOK.1.47.1, 10.1895/wormbook.1.47.1]; BRENNER S, 1974, GENETICS, V77, P71; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Cowan CR, 2004, NATURE, V431, P92, DOI 10.1038/nature02825; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Emery G, 2006, CURR OPIN CELL BIOL, V18, P407, DOI 10.1016/j.ceb.2006.06.009; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gillingham AK, 2002, MOL BIOL CELL, V13, P3761, DOI 10.1091/mbc.E02-06-0349; Goldstein B, 1996, DEVELOPMENT, V122, P1467; Hung TJ, 1999, DEVELOPMENT, V126, P127; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nishiura M, 2004, J BIOL CHEM, V279, P22799, DOI 10.1074/jbc.M313362200; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; Patton A, 2005, CURR BIOL, V15, P1045, DOI 10.1016/j.cub.2005.04.057; Poteryaev D, 2005, MOL BIOL CELL, V16, P2139, DOI 10.1091/mbc.E04-08-0726; Praitis V, 2001, GENETICS, V157, P1217; Roggo L, 2002, EMBO J, V21, P1673, DOI 10.1093/emboj/21.7.1673; Rolls MM, 2002, MOL BIOL CELL, V13, P1778, DOI 10.1091/mbc.01-10-0514; Sadler PL, 2000, DEVELOPMENT, V127, P355; Sato K, 2006, MOL BIOL CELL, V17, P3085, DOI 10.1091/mbc.E06-03-0211; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Shaye DD, 2002, NATURE, V420, P686, DOI 10.1038/nature01234; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; STROME S, 1986, J CELL BIOL, V103, P2241, DOI 10.1083/jcb.103.6.2241; Tabuse Y, 1998, DEVELOPMENT, V125, P3607	31	42	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e493	10.1371/journal.pone.0000493	http://dx.doi.org/10.1371/journal.pone.0000493			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551574	Green Published, gold, Green Submitted			2022-12-27	WOS:000207451500003
J	Lamontagne, B; Abou Elela, S				Lamontagne, Bruno; Abou Elela, Sherif			Short RNA Guides Cleavage by Eukaryotic RNase III	PLOS ONE			English	Article							SILENCING IN-VITRO; SACCHAROMYCES-CEREVISIAE; MODEL SYSTEM; YEAST; MECHANISM; U2; DETERMINANTS; RECOGNITION; SUBSTRATE; U5	In eukaryotes, short RNAs guide a variety of enzymatic activities that range from RNA editing to translation repression. It is hypothesized that pre-existing proteins evolved to bind and use guide RNA during evolution. However, the capacity of modern proteins to adopt new RNA guides has never been demonstrated. Here we show that Rnt1p, the yeast orthologue of the bacterial dsRNA-specific RNase III, can bind short RNA transcripts and use them as guides for sequence-specific cleavage. Target cleavage occurred at a constant distance from the Rnt1p binding site, leaving the guide RNA intact for subsequent cleavage. Our results indicate that RNase III may trigger sequence-specific RNA degradation independent of the RNA1 machinery, and they open the road for a new generation of precise RNA silencing tools that do not trigger a dsRNA-mediated immune response.	[Lamontagne, Bruno; Abou Elela, Sherif] Univ Sherbrooke, Fac Med Sci Sante, Dept Microbiol & Infectiol, Lab Genom Fonct,Grp ARN, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Abou Elela, S (corresponding author), Univ Sherbrooke, Fac Med Sci Sante, Dept Microbiol & Infectiol, Lab Genom Fonct,Grp ARN, Sherbrooke, PQ J1K 2R1, Canada.	Sherif.Abou.Elela@USherbrooke.ca		Abou Elela, Sherif/0000-0002-0630-3294	Canadian Institutes for Health Research (CIHR); Genome Canada/Genome Quebec Competition III	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada/Genome Quebec Competition III(Genome Canada)	This work was supported by funds from the Canadian Institutes for Health Research (CIHR) and Genome Canada/Genome Quebec Competition III. S. A. is a Chercheur-Boursier Senior of the Fonds de la Recherche en Sante du Quebec.	AbouElela S, 1996, CELL, V85, P115, DOI 10.1016/S0092-8674(00)81087-9; ARES M, 1986, CELL, V47, P49, DOI 10.1016/0092-8674(86)90365-X; ARES M, 1990, GENE DEV, V4, P2132, DOI 10.1101/gad.4.12a.2132; BARTLETT R, 1990, BIOESSAYS, V12, P457, DOI 10.1002/bies.950121002; BECKER DM, 1991, METHOD ENZYMOL, V194, P182; Catala M, 2004, MOL BIOL CELL, V15, P3015, DOI 10.1091/mbc.E04-03-0183; CECH TR, 1989, BIOCHEM INT, V18, P7; Chanfreau C, 2000, P NATL ACAD SCI USA, V97, P3142, DOI 10.1073/pnas.070043997; Chanfreau G, 1997, GENE DEV, V11, P2741, DOI 10.1101/gad.11.20.2741; DAVIES J, 1992, CIBA F SYMP, V171, P24; Elela SA, 1998, EMBO J, V17, P3738, DOI 10.1093/emboj/17.13.3738; Gan JH, 2006, CELL, V124, P355, DOI 10.1016/j.cell.2005.11.034; Ge DL, 2005, CURR BIOL, V15, P140, DOI 10.1016/j.cub.2004.12.001; Ghazal G, 2005, MOL CELL BIOL, V25, P2981, DOI 10.1128/MCB.25.8.2981-2994.2005; Ghazal G, 2006, J MOL BIOL, V363, P332, DOI 10.1016/j.jmb.2006.08.028; Guthrie C, 1991, GUIDE YEAST GENETICS; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Jeffares DC, 1998, J MOL EVOL, V46, P18, DOI 10.1007/PL00006280; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Lafontaine DLJ, 1998, TRENDS BIOCHEM SCI, V23, P383, DOI 10.1016/S0968-0004(98)01260-2; Lamontagne B, 2004, J MOL BIOL, V338, P401, DOI 10.1016/j.jmb.2004.02.059; Lamontagne B, 2004, J BIOL CHEM, V279, P2231, DOI 10.1074/jbc.M309324200; Lamontagne B, 2003, J MOL BIOL, V327, P985, DOI 10.1016/S0022-2836(03)00231-6; Lamontagne B, 2001, Curr Issues Mol Biol, V3, P71; Lamontagne B, 2001, METHOD ENZYMOL, V342, P159, DOI 10.1016/S0076-6879(01)42543-2; Larose S, 2007, J BIOL CHEM, V282, P4373, DOI 10.1074/jbc.M607145200; Lebars I, 2001, EMBO J, V20, P7250, DOI 10.1093/emboj/20.24.7250; Lee A, 2005, MOL CELL, V19, P39, DOI 10.1016/j.molcel.2005.05.021; Lin Shi-Lung, 2006, V342, P295, DOI 10.1385/1-59745-123-1:295; Madeo F, 2002, CURR GENET, V41, P208, DOI 10.1007/s00294-002-0310-2; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Poole AM, 1998, J MOL EVOL, V46, P1, DOI 10.1007/PL00006275; RIEDEL N, 1986, P NATL ACAD SCI USA, V83, P8097, DOI 10.1073/pnas.83.21.8097; Rose MD., 1990, METHODS YEAST GENETI; Takei Y, 2002, J BIOL CHEM, V277, P23800, DOI 10.1074/jbc.M112100200; Tijsterman M, 2004, CELL, V117, P1, DOI 10.1016/S0092-8674(04)00293-4; Vickers TA, 2003, J BIOL CHEM, V278, P7108, DOI 10.1074/jbc.M210326200; Wilson HR, 2002, EMBO J, V21, P4154, DOI 10.1093/emboj/cdf395; Wintersberger U, 2001, METHOD ENZYMOL, V341, P414, DOI 10.1016/S0076-6879(01)41167-0; Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739	42	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2007	2	5							e472	10.1371/journal.pone.0000472	http://dx.doi.org/10.1371/journal.pone.0000472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10FB	17534422	Green Submitted, gold, Green Published			2022-12-27	WOS:000207448800002
J	Massone, C; Hofmann-Wellenhof, R; Ahlgrimm-Siess, V; Gabler, G; Ebner, C; Soyer, HP				Massone, Cesare; Hofmann-Wellenhof, Rainer; Ahlgrimm-Siess, Verena; Gabler, Gerald; Ebner, Christoph; Soyer, H. Peter			Melanoma Screening with Cellular Phones	PLOS ONE			English	Article								Background. Mobile teledermatology has recently been shown to be suitable for teledermatology despite limitations in image definition in preliminary studies. The unique aspect of mobile teledermatology is that this system represents a filtering or triage system, allowing a sensitive approach for the management of patients with emergent skin diseases. Methodology/Principal Findings. In this study we investigated the feasibility of teleconsultation using a new generation of cellular phones in pigmented skin lesions. 18 patients were selected consecutively in the Pigmented Skin Lesions Clinic of the Department of Dermatology, Medical University of Graz, Graz (Austria). Clinical and dermoscopic images were acquired using a Sony Ericsson with a built-in two-megapixel camera. Two teleconsultants reviewed the images on a specific web application (http://www.dermahandy.net/default.asp) where images had been uploaded in JPEG format. Compared to the face-to-face diagnoses, the two teleconsultants obtained a score of correct telediagnoses of 89% and of 91.5% reporting the clinical and dermoscopic images, respectively. Conclusions/Significance. The present work is the first study performing mobile teledermoscopy using cellular phones. Mobile teledermatology has the potential to become an easy applicable tool for everyone and a new approach for enhanced self-monitoring for skin cancer screening in the spirit of the eHealth program of the European Commission Information for Society and Media.	[Massone, Cesare; Hofmann-Wellenhof, Rainer; Ahlgrimm-Siess, Verena; Ebner, Christoph; Soyer, H. Peter] Med Univ Graz, Dept Dermatol, Graz, Austria; [Gabler, Gerald] Graz Univ Clin & Gen Hosp, Dept IT & Telecommun, Graz, Austria	Medical University of Graz	Soyer, HP (corresponding author), Med Univ Graz, Dept Dermatol, Graz, Austria.	peter.soyer@meduni-graz.at	Soyer, H. Peter/E-6000-2010; Soyer, H. Peter/W-3791-2017	Soyer, H. Peter/0000-0002-4770-561X; Soyer, H. Peter/0000-0002-4770-561X; massone, cesare/0000-0002-0996-643X				Argenziano G, 2001, LANCET ONCOL, V2, P443, DOI 10.1016/S1470-2045(00)00422-8; Balch CM, 2004, CA-CANCER J CLIN, V54, P131, DOI 10.3322/canjclin.54.3.131; Braun RP, 2005, ARCH DERMATOL, V141, P254, DOI 10.1001/archderm.141.2.254; Braun RP, 2000, J AM ACAD DERMATOL, V42, P770, DOI 10.1067/mjd.2000.103977; Burg G, 2005, DERMATOLOGY, V210, P169, DOI 10.1159/000082573; Carli P, 2004, J AM ACAD DERMATOL, V50, P683, DOI 10.1016/j.jaad.2003.09.009; Diepgen TL, 2002, BRIT J DERMATOL, V146, P1, DOI 10.1046/j.1365-2133.146.s61.2.x; Eedy DJ, 2001, BRIT J DERMATOL, V144, P696, DOI 10.1046/j.1365-2133.2001.04124.x; *EUR COMM INF SOC, 2006, ICT HLTH I2010 TRANS, P9; GRIN CM, 1990, ARCH DERMATOL, V126, P763, DOI 10.1001/archderm.126.6.763; Grob JJ, 1998, ARCH DERMATOL, V134, P103, DOI 10.1001/archderm.134.1.103-a; Kittler H, 2002, LANCET ONCOL, V3, P159, DOI 10.1016/S1470-2045(02)00679-4; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Massone C, 2006, BRIT J DERMATOL, V154, P801, DOI 10.1111/j.1365-2133.2006.07175.x; Massone C, 2005, ARCH DERMATOL, V141, P1319, DOI 10.1001/archderm.141.10.1319; Massone C, 2005, CURR OPIN ONCOL, V17, P147, DOI 10.1097/01.cco.0000152627.36243.26; Meystre S, 2005, TELEMED J E-HEALTH, V11, P63, DOI 10.1089/tmj.2005.11.63; Moreno-Ramirez D, 2005, J TELEMED TELECARE, V11, P298, DOI 10.1258/1357633054893364; Piccolo D, 1999, ARCH DERMATOL, V135, P1467, DOI 10.1001/archderm.135.12.1467; Piccolo D, 2000, J TELEMED TELECARE, V6, P132, DOI 10.1258/1357633001935202; Provost N, 1998, DERMATOLOGY, V196, P299, DOI 10.1159/000017925; Schaffer JV, 2004, J AM ACAD DERMATOL, V51, pS65, DOI 10.1016/j.jaad.2004.01.030; Shapiro M, 2004, ARCH DERMATOL, V140, P525, DOI 10.1001/archderm.140.5.525; Soyer HP, 2005, PLOS MED, V2, P293, DOI 10.1371/journal.pmed.0020087; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; Wolf IH, 1998, MELANOMA RES, V8, P425, DOI 10.1097/00008390-199810000-00007	26	96	97	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2007	2	5							e483	10.1371/journal.pone.0000483	http://dx.doi.org/10.1371/journal.pone.0000483			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10FB	17534433	gold, Green Published, Green Submitted			2022-12-27	WOS:000207448800013
J	Webb, TJ; Freckleton, RP				Webb, Thomas J.; Freckleton, Robert P.			Only Half Right: Species with Female-Biased Sexual Size Dimorphism Consistently Break Rensch's Rule	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; BODY-SIZE; WATER STRIDER; ALLOMETRY; EVOLUTION; PATTERNS; SELECTION; ECOLOGY; MASS	Background. Most animal species display Sexual Size Dimorphism (SSD): males and females consistently attain different sizes, most frequently with females being larger than males. However the selective mechanisms driving patterns of SSD remain controversial. 'Rensch's rule' proposes a general scaling phenomenon for all taxa, whereby SSD increases with average body size when males are larger than females, and decreases with body size when females are larger than males. Rensch's rule appears to be general in the former case, but there is little evidence for the rule when females are larger then males. Methodology/Principal Findings. Using comprehensive data for 1291 species of birds across 30 families, we find strong support for Rensch's rule in families where males are typically larger than females, but no overall support for the rule in families with female-biased SSD. Reviewing previous studies of a broad range of taxa (arthropods, reptiles, fish and birds) showing predominantly female-biased SSD, we conclude that Rensch's conjecture is the exception rather than the rule in such species. Conclusions/Significance. The absence of consistent scaling of SSD in taxa with female-biased SSD, the most prevalent direction of dimorphism, calls into question previous general evolutionary explanations for Rensch's rule. We propose that, unlike several other ecological scaling relationships, Rensch's rule does not exist as an independent scaling phenomenon.	[Webb, Thomas J.; Freckleton, Robert P.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Webb, TJ (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	t.j.webb@sheffield.ac.uk	Freckleton, Rob P/B-6455-2013; Webb, Tom/D-5224-2011	Webb, Tom/0000-0003-3183-8116; Freckleton, Robert/0000-0002-8338-864X	NERC [NE/C004167/1]	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by NERC grant NE/C004167/1 to RPF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1997, AM NAT, V149, P540, DOI 10.1086/286004; Andersen NM, 1997, BIOL J LINN SOC, V61, P345, DOI 10.1111/j.1095-8312.1997.tb01796.x; [Anonymous], 1994, SEXUAL SELECTION; Baker RH, 2001, EVOLUTION, V55, P1373; BENNETT PM, 2002, EVOLUTIONARY ECOLOGY; Blanckenhorn WU, 2007, AM NAT, V169, P245, DOI 10.1086/510597; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Catry P, 1999, AUK, V116, P158, DOI 10.2307/4089462; CLUTTONBROCK TH, 1977, NATURE, V269, P797, DOI 10.1038/269797a0; Colwell RK, 2000, AM NAT, V156, P495, DOI 10.1086/303406; COOK JR, 1994, J AM STAT ASSOC, V89, P1314, DOI 10.2307/2290994; FAIRBAIRN DJ, 1994, AM NAT, V144, P101, DOI 10.1086/285663; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Fairbairn DJ, 2005, AM NAT, V166, pS69, DOI 10.1086/444600; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Hormiga G, 2000, SYST BIOL, V49, P435, DOI 10.1080/10635159950127330; Huey RB, 2006, ZOOLOGY, V109, P318, DOI 10.1016/j.zool.2006.04.003; Jannot JE, 2003, CAN J ZOOL, V81, P1956, DOI 10.1139/Z03-194; Johansson F, 2005, BIOL J LINN SOC, V86, P507, DOI 10.1111/j.1095-8312.2005.00549.x; Kodric-Brown A, 2006, P NATL ACAD SCI USA, V103, P8733, DOI 10.1073/pnas.0602994103; Kratochvil L, 2002, BIOL J LINN SOC, V76, P303, DOI 10.1046/j.1095-8312.2002.00064.x; MUELLER HC, 1986, WILSON BULL, V98, P387; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Phillimore AB, 2006, AM NAT, V168, P220, DOI 10.1086/505763; PITNICK S, 1995, P NATL ACAD SCI USA, V92, P10614, DOI 10.1073/pnas.92.23.10614; Pyron M, 1996, BIOL J LINN SOC, V57, P327; REISS MJ, 1986, J THEOR BIOL, V121, P163, DOI 10.1016/S0022-5193(86)80090-X; Rensch B., 1959, EVOLUTION SPECIES LE; Roff Derek A., 1992; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; SIVINSKI JM, 1992, J INSECT BEHAV, V5, P491, DOI 10.1007/BF01058194; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Smith RJ, 2002, INT J PRIMATOL, V23, P1095, DOI 10.1023/A:1019654100876; Smith RJ, 1999, J HUM EVOL, V36, P423, DOI 10.1006/jhev.1998.0281; Szekely T, 2004, P NATL ACAD SCI USA, V101, P12224, DOI 10.1073/pnas.0404503101; Tubaro PL, 2003, BIOL J LINN SOC, V80, P519, DOI 10.1046/j.1095-8312.2003.00252.x; WEBSTER MS, 1992, EVOLUTION, V46, P1621, DOI 10.1111/j.1558-5646.1992.tb01158.x; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; [No title captured]; [No title captured]; [No title captured]; [No title captured]	44	89	95	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e897	10.1371/journal.pone.0000897	http://dx.doi.org/10.1371/journal.pone.0000897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878932	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000207455700005
J	Matouk, IJ; DeGroot, N; Mezan, S; Ayesh, S; Abu-Iail, R; Hochberg, A; Galun, E				Matouk, Imad J.; DeGroot, Nathan; Mezan, Shaul; Ayesh, Suhail; Abu-Iail, Rasha; Hochberg, Abraham; Galun, Eithan			The H19 Non-Coding RNA Is Essential for Human Tumor Growth	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; IMPRINTED H19; HEPATOCELLULAR-CARCINOMA; BIALLELIC EXPRESSION; CELL-PROLIFERATION; CANCER; KINASE; MARKER; IDENTIFICATION	Background. Mutations and epigenetic aberrant signaling of growth factors pathways contribute to carcinogenesis. Recent studies reveal that non-coding RNAs are controllers of gene expression. H19 is an imprinted gene that demonstrates maternal monoallelic expression without a protein product; although its expression is shut off in most tissues postnatally, it is reactivated during adult tissue regeneration and tumorigenesis. Moreover, H19 is highly expressed in liver metastasis derived from a range of carcinomas. The objective of this study is to explore the role of H19 in carcinogenesis, and to determine its identification as an anti-tumor target. Methodology/Principle Findings. By controlling oxygen pressure during tumor cell growth and H19 expression levels, we investigated the role of H19 expression in vitro and in vivo in hepatocellular (HCC) and bladder carcinoma. Hypoxia upregulates the level of H19 RNA. Ablations of tumorigenicity of HCC and bladder carcinomas in vivo are seen by H19 knockdown which also significantly abrogates anchorage-independent growth after hypoxia recovery, while ectopic H19 expression enhances tumorigenic potential of carcinoma cells in vivo. Knocking-down H19 message in hypoxic stress severely diminishes p57(kip2) induction. We identified a number of potential downstream targets of H19 RNA, including angiogenin and FGF18. Conclusions. H19 RNA harbors pro-tumorigenic properties, thus the H19 gene behaves as an oncogene and may serve as a potential new target for anti-tumor therapy.	[Galun, Eithan] Hadassah Hebrew Univ Hosp, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Matouk, Imad J.; DeGroot, Nathan; Mezan, Shaul; Ayesh, Suhail; Abu-Iail, Rasha; Hochberg, Abraham] Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem	Galun, E (corresponding author), Hadassah Hebrew Univ Hosp, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	eithang@hadassah.org.il	Galun, Eithan/AAD-9117-2022	Galun, Eithan/0000-0002-6243-6702	Israeli Science Foundation; Israeli Ministry of Science, through a grant from the National Gene Therapy Knowledge Center; Blum; Harold Grinspoon; Horowitz; Wolfson Foundation;  [LSHB-CT-2004-512034];  [LSHB-CT-2005-018961]	Israeli Science Foundation(Israel Science Foundation); Israeli Ministry of Science, through a grant from the National Gene Therapy Knowledge Center; Blum; Harold Grinspoon; Horowitz; Wolfson Foundation; ; 	This work is supported by the Israeli Science Foundation, the Israeli Ministry of Science, through a grant from the National Gene Therapy Knowledge Center and through grants LSHB-CT-2004-512034 (MOLEDA) and LSHB-CT-2005-018961 (INTHER). Additional support was provided through grants from the Blum, the Harold Grinspoon, the Horowitz and the Wolfson Foundations.	Adriaenssens E, 2002, EXP CELL RES, V275, P215, DOI 10.1006/excr.2002.5500; Aoki Y, 1998, VIROLOGY, V250, P140, DOI 10.1006/viro.1998.9361; Ariel I, 2000, J CLIN PATHOL-MOL PA, V53, P320, DOI 10.1136/mp.53.6.320; Ariel I, 1998, J CLIN PATHOL-MOL PA, V51, P21, DOI 10.1136/mp.51.1.21; Ariel L, 2004, MOL CARCINOGEN, V41, P69, DOI 10.1002/mc.20046; Ayesh S, 2002, MOL CARCINOGEN, V35, P63, DOI 10.1002/mc.10075; Barsyte-Lovejoy D, 2006, CANCER RES, V66, P5330, DOI 10.1158/0008-5472.CAN-06-0037; Benezra R, 2001, ONCOGENE, V20, P8334, DOI 10.1038/sj.onc.1205160; Berteaux N, 2005, J BIOL CHEM, V280, P29625, DOI 10.1074/jbc.M504033200; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Busca R, 2005, J CELL BIOL, V170, P49, DOI 10.1083/jcb.200501067; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cao X, 2006, ONCOGENE, V25, P3719, DOI 10.1038/sj.onc.1209408; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Coulouarn C, 2006, HEPATOLOGY, V44, P1003, DOI 10.1002/hep.21293; Datta K, 2004, CANCER RES, V64, P456, DOI 10.1158/0008-5472.CAN-03-2706; Dugimont T, 1998, ONCOGENE, V16, P2395, DOI 10.1038/sj.onc.1201742; Dugimont T, 1995, BIOL CELL, V85, P117, DOI 10.1016/0248-4900(96)85272-5; Elkin M, 1998, CARCINOGENESIS, V19, P2095, DOI 10.1093/carcin/19.12.2095; ELKIN M, 1995, FEBS LETT, V374, P57, DOI 10.1016/0014-5793(95)01074-O; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fellig Y, 2004, BIOCHEM BIOPH RES CO, V321, P269, DOI 10.1016/j.bbrc.2004.06.148; Gabory A, 2006, CYTOGENET GENOME RES, V113, P188, DOI 10.1159/000090831; Graveel CR, 2001, ONCOGENE, V20, P2704, DOI 10.1038/sj.onc.1204391; Guehenneux F, 1997, LEUKEMIA, V11, P370, DOI 10.1038/sj.leu.2400599; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Iizuka N, 2002, CANCER RES, V62, P3939; Ito Y, 2003, CANCER RES, V63, P6651; Ito Y, 2001, ONCOLOGY-BASEL, V61, P221, DOI 10.1159/000055378; Jiang Z, 2004, AM J CLIN PATHOL, V122, P275, DOI 10.1309/EJUYUQPEX1MG68MK; Kaplan JL, 2003, J RECONSTR MICROSURG, V19, P63, DOI 10.1055/s-2003-37807; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Kashatus D, 2006, GENE DEV, V20, P225, DOI 10.1101/gad.1352206; Katzenellenbogen M, 2006, CANCER RES, V66, P4001, DOI 10.1158/0008-5472.CAN-05-2937; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Kim KS, 1997, CANCER LETT, V119, P143, DOI 10.1016/S0304-3835(97)00264-4; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; LIU Z, 2006, DEV BIOL; Lottin S, 2002, ONCOGENE, V21, P1625, DOI 10.1038/sj.onc.1205233; Lottin S, 2002, CARCINOGENESIS, V23, P1885, DOI 10.1093/carcin/23.11.1885; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Manoharan H, 2003, MOL CARCINOGEN, V38, P40, DOI 10.1002/mc.10144; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Matouk I, 2005, CANC THER, V3, P249; Matsuoka S, 1996, P NATL ACAD SCI USA, V93, P3026, DOI 10.1073/pnas.93.7.3026; Meyer AM, 2004, CARCINOGENESIS, V25, P1517, DOI 10.1093/carcin/bgh150; MOLL R, 1995, AM J PATHOL, V147, P1383; Moreno MJ, 2006, GLIA, V53, P845, DOI 10.1002/glia.20345; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; Nozaki S, 2001, ONCOGENE, V20, P2178, DOI 10.1038/sj.onc.1204292; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ogushi T, 2005, CANCER RES, V65, P3700, DOI 10.1158/0008-5472.CAN-04-3497; OLSON KA, 1995, P NATL ACAD SCI USA, V92, P442, DOI 10.1073/pnas.92.2.442; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; Pelosi G, 2003, BRIT J CANCER, V88, P537, DOI 10.1038/sj.bjc.6600731; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Poon TCW, 2006, GASTROENTEROLOGY, V131, P1262, DOI 10.1053/j.gastro.2006.08.014; PUISIEUX A, 1991, CANCER RES, V51, P6185; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Rubin MA, 2004, CANCER RES, V64, P3814, DOI 10.1158/0008-5472.CAN-03-3881; Scott RE, 2005, DIFFERENTIATION, V73, P294; Seibold S, 2003, FASEB J, V17, P1180, DOI 10.1096/fj.02-0934fje; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Smith P, 2006, CELL CYCLE, V5, P1262, DOI 10.4161/cc.5.12.2813; Tang J, 2006, J BIOL CHEM, V281, P6664, DOI 10.1074/jbc.M506991200; Thorgeirsson SS, 2006, HEPATOLOGY, V43, pS145, DOI 10.1002/hep.21063; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Triest BV, 2000, CLIN CANCER RES, V6, P1063; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; Wald O, 2006, J IMMUNOL, V177, P6983, DOI 10.4049/jimmunol.177.10.6983; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Wu MX, 1998, SCIENCE, V281, P998, DOI 10.1126/science.281.5379.998; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhao YQ, 2001, AM J PHYSIOL-HEART C, V280, pH1821, DOI 10.1152/ajpheart.2001.280.4.H1821	79	530	565	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e845	10.1371/journal.pone.0000845	http://dx.doi.org/10.1371/journal.pone.0000845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786216	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455500028
J	Dawson-Scully, K; Armstrong, GAB; Kent, C; Robertson, RM; Sokolowski, MB				Dawson-Scully, Ken; Armstrong, Gary A. B.; Kent, Clement; Robertson, R. Meldrum; Sokolowski, Marla B.			Natural Variation in the Thermotolerance of Neural Function and Behavior due to a cGMP-Dependent Protein Kinase	PLOS ONE			English	Article							HEAT-SHOCK; SMOOTH-MUSCLE; TEMPERATURE; CANTHARIDIN; ADAPTATION; CURRENTS; LOCUST; GENE	Although it is acknowledged that genetic variation contributes to individual differences in thermotolerance, the specific genes and pathways involved and how they are modulated by the environment remain poorly understood. We link natural variation in the thermotolerance of neural function and behavior in Drosophila melanogaster to the foraging gene (for, which encodes a cGMP-dependent protein kinase (PKG)) as well as to its downstream target, protein phosphatase 2A (PP2A). Genetic and pharmacological manipulations revealed that reduced PKG (or PP2A) activity caused increased thermotolerance of synaptic transmission at the larval neuromuscular junction. Like synaptic transmission, feeding movements were preserved at higher temperatures in larvae with lower PKG levels. In a comparative assay, pharmacological manipulations altering thermotolerance in a central circuit of Locusta migratoria demonstrated conservation of this neuroprotective pathway. In this circuit, either the inhibition of PKG or PP2A induced robust thermotolerance of neural function. We suggest that PKG and therefore the polymorphism associated with the allelic variation in for may provide populations with natural variation in heat stress tolerance. for's function in behavior is conserved across most organisms, including ants, bees, nematodes, and mammals. PKG's role in thermotolerance may also apply to these and other species. Natural variation in thermotolerance arising from genes involved in the PKG pathway could impact the evolution of thermotolerance in natural populations.	[Dawson-Scully, Ken; Kent, Clement; Sokolowski, Marla B.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Armstrong, Gary A. B.; Robertson, R. Meldrum] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	University of Toronto; University Toronto Mississauga; Queens University - Canada	Sokolowski, MB (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	msokolow@utm.utoronto.ca	Robertson, Robert M/B-2482-2009; Kent, Clement F./B-9982-2008	Robertson, Robert M/0000-0002-2666-7861; Kent, Clement F./0000-0003-4994-0098; Sokolowski, Marla/0000-0002-7462-8007; Armstrong, Gary/0000-0003-4613-8817	Heart and Stroke Foundation of Canada; Canadian Institutes of Health Research; National Science and Engineering Council	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by funding from The Heart and Stroke Foundation of Canada for KD-S, The Canadian Institutes of Health Research for KD-S, MBS and CK, and by the National Science and Engineering Council for RMR and GABA.	Armstrong GAB, 2006, J NEUROSCI, V26, P12118, DOI 10.1523/JNEUROSCI.3347-06.2006; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Bressin S, 2000, J EXP BIOL, V203, P2511; CAIRNS J, 1994, J BIOL CHEM, V269, P9176; Dawson-Scully K, 1998, NEUROREPORT, V9, P2589, DOI 10.1097/00001756-199808030-00030; DEBELLE JS, 1987, HEREDITY, V59, P73, DOI 10.1038/hdy.1987.98; DEBELLE JS, 1989, GENETICS, V123, P157; Feder ME, 1997, J THERM BIOL, V22, P1, DOI 10.1016/S0306-4565(96)00028-9; Glazer JL, 2005, AM FAM PHYSICIAN, V71, P2133; GRAZIANO MJ, 1988, MOL PHARMACOL, V33, P706; GRIDER JR, 1993, AM J PHYSIOL, V264, pG334, DOI 10.1152/ajpgi.1993.264.2.G334; Guschina IA, 2006, FEBS LETT, V580, P5477, DOI 10.1016/j.febslet.2006.06.066; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Karunanithi S, 1999, J NEUROSCI, V19, P4360; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; LI YM, 1993, BIOCHEM PHARMACOL, V46, P1435, DOI 10.1016/0006-2952(93)90109-A; LI YM, 1992, P NATL ACAD SCI USA, V89, P11867, DOI 10.1073/pnas.89.24.11867; Macleod GT, 2002, J NEUROPHYSIOL, V88, P2659, DOI 10.1152/jn.00515.2002; Newman AEM, 2003, J INSECT PHYSIOL, V49, P1039, DOI 10.1016/j.jinsphys.2003.08.001; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; PEREIRA HS, 1993, P NATL ACAD SCI USA, V90, P5044, DOI 10.1073/pnas.90.11.5044; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Ramirez JM, 1999, J NEUROPHYSIOL, V81, P795, DOI 10.1152/jn.1999.81.2.795; Rinehart JP, 2006, P NATL ACAD SCI USA, V103, P14223, DOI 10.1073/pnas.0606840103; ROTHERMEL JD, 1988, BIOCHEM J, V251, P757, DOI 10.1042/bj2510757; SOKOLOWSKI MB, 1982, ANIM BEHAV, V30, P1252, DOI 10.1016/S0003-3472(82)80218-2; SOKOLOWSKI MB, 1989, J INSECT BEHAV, V2, P829, DOI 10.1007/BF01049403; Spiewok S, 2006, PHYSIOL BIOCHEM ZOOL, V79, P188, DOI 10.1086/498181; Tryba AK, 2004, J NEUROPHYSIOL, V92, P2844, DOI 10.1152/jn.00752.2003; Wang HD, 2004, P NATL ACAD SCI USA, V101, P12610, DOI 10.1073/pnas.0404648101; White RE, 2002, CARDIOVASC RES, V53, P650, DOI 10.1016/S0008-6363(01)00428-X; WHYARD S, 1986, J COMP PHYSIOL B, V156, P813, DOI 10.1007/BF00694255; Zhou XB, 1996, J BIOL CHEM, V271, P19760, DOI 10.1074/jbc.271.33.19760	33	49	50	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e773	10.1371/journal.pone.0000773	http://dx.doi.org/10.1371/journal.pone.0000773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712421	Green Published, gold			2022-12-27	WOS:000207455300021
J	Jun, JK; Jin, DZZ				Jun, Joseph K.; Jin, Dezhe Z.			Development of Neural Circuitry for Precise Temporal Sequences through Spontaneous Activity, Axon Remodeling, and Synaptic Plasticity	PLOS ONE			English	Article							NEURONAL REPLACEMENT; SILENT SYNAPSES; SYNFIRE CHAINS; IN-VIVO; PROPAGATION; GENERATION; SYNCHRONY; DYNAMICS; PATTERNS; SPIKING	Temporally precise sequences of neuronal spikes that span hundreds of milliseconds are observed in many brain areas, including songbird premotor nucleus, cat visual cortex, and primary motor cortex. Synfire chains-networks in which groups of neurons are connected via excitatory synapses into a unidirectional chain-are thought to underlie the generation of such sequences. It is unknown, however, how synfire chains can form in local neural circuits, especially for long chains. Here, we show through computer simulation that long synfire chains can develop through spike-time dependent synaptic plasticity and axon remodeling-the pruning of prolific weak connections that follows the emergence of a finite number of strong connections. The formation process begins with a random network. A subset of neurons, called training neurons, intermittently receive superthreshold external input. Gradually, a synfire chain emerges through a recruiting process, in which neurons within the network connect to the tail of the chain started by the training neurons. The model is robust to varying parameters, as well as natural events like neuronal turnover and massive lesions. Our model suggests that long synfire chain can form during the development through self-organization, and axon remodeling, ubiquitous in developing neural circuits, is essential in the process.	[Jun, Joseph K.; Jin, Dezhe Z.] Penn State Univ, Dept Phys, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Jin, DZZ (corresponding author), Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA.	djin@phys.psu.edu	Jin, Dezhe/AAE-6788-2020		Huck Institute of Life Sciences; Pennsylvania State University; A.P. Sloan Research Fellowship; ONR [N000140410208]	Huck Institute of Life Sciences; Pennsylvania State University; A.P. Sloan Research Fellowship(Alfred P. Sloan Foundation); ONR(Office of Naval Research)	Research supported by the Huck Institute of Life Sciences, The Pennsylvania State University; A.P. Sloan Research Fellowship; and ONR grant N000140410208.	Abeles M., 1982, LOCAL CORTICAL CIRCU; Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Airey DC, 2000, NEUROREPORT, V11, P1749, DOI 10.1097/00001756-200006050-00030; ALVAREZBUYLLA A, 1990, SCIENCE, V249, P1444, DOI 10.1126/science.1698312; AMARI SI, 1972, IEEE T COMPUT, VC 21, P1197, DOI 10.1109/T-C.1972.223477; Atasoy D, 2006, NEURON, V50, P345, DOI 10.1016/j.neuron.2006.04.018; Atwood HL, 1999, LEARN MEMORY, V6, P542, DOI 10.1101/lm.6.6.542; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Buonomano DV, 2005, J NEUROPHYSIOL, V94, P2275, DOI 10.1152/jn.01250.2004; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; FLADBY T, 1987, ACTA PHYSIOL SCAND, V129, P239, DOI 10.1111/j.1748-1716.1987.tb08064.x; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hertz J, 1996, NETWORK-COMP NEURAL, V7, P357, DOI 10.1088/0954-898X/7/2/017; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Immelmann K., 1969, P61; Innocenti GM, 2005, NAT REV NEUROSCI, V6, P955, DOI 10.1038/nrn1790; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jin DZ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208102; JIN DZ, 2007, J COMP NEUR IN PRESS; Kasthuri N, 2003, NATURE, V424, P426, DOI 10.1038/nature01836; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kitano K, 2002, NEUROREPORT, V13, P795, DOI 10.1097/00001756-200205070-00012; KLEINFELD D, 1988, BIOPHYS J, V54, P1039, DOI 10.1016/S0006-3495(88)83041-8; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Levy N, 2001, NEURAL NETWORKS, V14, P815, DOI 10.1016/S0893-6080(01)00044-2; LIU DWC, 1990, J NEUROSCI, V10, P3947, DOI 10.1523/JNEUROSCI.10-12-03947.1990; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; NOTTEBOHM F, 1985, ANN NY ACAD SCI, V457, P143, DOI 10.1111/j.1749-6632.1985.tb20803.x; Nottebohm F, 2002, J NEUROSCI, V22, P624, DOI 10.1523/JNEUROSCI.22-03-00624.2002; Nowotny T, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011908; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; Reyes AD, 2003, NAT NEUROSCI, V6, P593, DOI 10.1038/nn1056; Ruthazer ES, 2006, J NEUROSCI, V26, P3594, DOI 10.1523/JNEUROSCI.0069-06.2006; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; Shen WH, 2006, NEURON, V50, P401, DOI 10.1016/j.neuron.2006.03.017; SOMPOLINSKY H, 1986, PHYS REV LETT, V57, P2861, DOI 10.1103/PhysRevLett.57.2861; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; THOMPSON JA, 2006, J NEUROBIOL, V66, P1; THOMPSON W, 1977, NEUROSCIENCE, V2, P523, DOI 10.1016/0306-4522(77)90049-5; van Rossum MCW, 2000, J NEUROSCI, V20, P8812	46	61	63	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e723	10.1371/journal.pone.0000723	http://dx.doi.org/10.1371/journal.pone.0000723			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684568	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452400025
J	Brynedal, B; Duvefelt, K; Jonasdottir, G; Roos, IM; Akesson, E; Palmgren, J; Hillert, J				Brynedal, Boel; Duvefelt, Kristina; Jonasdottir, Gudrun; Roos, Izaura M.; Akesson, Eva; Palmgren, Juni; Hillert, Jan			HLA-A Confers an HLA-DRB1 Independent Influence on the Risk of Multiple Sclerosis	PLOS ONE			English	Article								A recent high-density linkage screen confirmed that the HLA complex contains the strongest genetic factor for the risk of multiple sclerosis (MS). In parallel, a linkage disequilibrium analysis using 650 single nucleotide polymorphisms (SNP) markers of the HLA complex mapped the entire genetic effect to the HLA-DR-DQ subregion, reflected by the well-established risk haplotype HLA-DRB1*15, DQB1*06. Contrary to this, in a cohort of 1,084 MS patients and 1,347 controls, we show that the HLA-A gene confers an HLA-DRB1 independent influence on the risk of MS (P = 8.4 x 10(-10)). This supports the opposing view, that genes in the HLA class I region indeed exert an additional influence on the risk of MS, and confirms that the class I allele HLA-A*02 is negatively associated with the risk of MS (OR = 0.63, P = 7610 212) not explained by linkage disequilibrium with class II. The combination of HLA-A and HLA-DRB1 alleles, as represented by HLA-A*02 and HLA-DRB1*15, was found to influence the risk of MS 23-fold. These findings imply complex autoimmune mechanisms involving both the regulatory and the effector arms of the immune system in the triggering of MS.	[Brynedal, Boel; Duvefelt, Kristina; Roos, Izaura M.; Akesson, Eva; Hillert, Jan] Karolinska Inst, Dept Clin Neurosci, Div Neurol, Stockholm, Sweden; [Duvefelt, Kristina; Palmgren, Juni] Karolinska Univ Hosp, Clin Res Ctr, Mutat Anal Facil, Stockholm, Sweden; [Jonasdottir, Gudrun] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Brynedal, B (corresponding author), Karolinska Inst, Dept Clin Neurosci, Div Neurol, Stockholm, Sweden.	boel.brynedal@ki.se	Lima Bomfim, Izaura/J-3462-2012	Palmgren, Juni/0000-0002-9031-8615; Lima Bomfim, Izaura/0000-0003-0890-3872	Swedish Research Council [11220]; Swedish society of Neurologically Disabled, Bibbi & Nils Jensens Foundation; Swedish Foundation for Strategic Research and Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish society of Neurologically Disabled, Bibbi & Nils Jensens Foundation; Swedish Foundation for Strategic Research and Karolinska Institutet	This study was supported by grants from the Swedish Research Council (project number 11220), the Swedish society of Neurologically Disabled, Bibbi & Nils Jensens Foundation, the Swedish Foundation for Strategic Research and Karolinska Institutet.	Barcellos LF, 2003, AM J HUM GENET, V72, P710, DOI 10.1086/367781; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Fogdell-Hahn A, 2000, TISSUE ANTIGENS, V55, P140, DOI 10.1034/j.1399-0039.2000.550205.x; Friese MA, 2005, BRAIN, V128, P1747, DOI 10.1093/brain/awh578; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Harbo HF, 2004, TISSUE ANTIGENS, V63, P237, DOI 10.1111/j.0001-2815.2004.00173.x; HILLERT J, 1994, ANN NEUROL, V36, pS15, DOI 10.1002/ana.410360706; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; JERSILD C, 1973, LANCET, V2, P1221; JERSILD C, 1972, ACTA NEUROL SCAND, V48, P377; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Modin H, 2004, AM J HUM GENET, V74, P1321, DOI 10.1086/420977; NAITO S, 1972, TISSUE ANTIGENS, V2, P1; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Sawcer S, 2005, AM J HUM GENET, V77, P454; YEO TW, 2007, ANN NEUROL; J NEUROIMMUNOL, V143, P39	20	127	130	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e664	10.1371/journal.pone.0000664	http://dx.doi.org/10.1371/journal.pone.0000664			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653284	gold, Green Published, Green Submitted			2022-12-27	WOS:000207452200026
J	Heimesaat, MM; Fischer, A; Siegmund, B; Kupz, A; Niebergall, J; Fuchs, D; Jahn, HK; Freudenberg, M; Loddenkemper, C; Batra, A; Lehr, HA; Liesenfeld, O; Blaut, M; Gobel, UB; Schumann, RR; Bereswill, S				Heimesaat, Markus M.; Fischer, Andre; Siegmund, Britta; Kupz, Andreas; Niebergall, Julia; Fuchs, David; Jahn, Hannah-Katharina; Freudenberg, Marina; Loddenkemper, Christoph; Batra, Arvind; Lehr, Hans-Anton; Liesenfeld, Oliver; Blaut, Michael; Goebel, Ulf B.; Schumann, Ralf R.; Bereswill, Stefan			Shift Towards Pro-inflammatory Intestinal Bacteria Aggravates Acute Murine Colitis via Toll-like Receptors 2 and 4	PLOS ONE			English	Article							ESCHERICHIA-COLI; MUCOSAL FLORA; MODELS; CELLS; TLR4; LIPOPOLYSACCHARIDE; EXPRESSION; GENE	Background. Gut bacteria trigger colitis in animal models and are suspected to aggravate inflammatory bowel diseases. We have recently reported that Escherichia coli accumulates in murine ileitis and exacerbates small intestinal inflammation via Toll-like receptor (TLR) signaling. Methodology and Principal Findings. Because knowledge on shifts in the intestinal microflora during colitis is limited, we performed a global survey of the colon flora of C57BL/10 wild-type (wt), TLR2(-/-), TLR4(-/-), and TLR2/4(-/-) mice treated for seven days with 3.5% dextrane-sulfate-sodium (DSS). As compared to wt animals, TLR2(-/-), TLR4(-/-), and TLR2/4(-/-) mice displayed reduced macroscopic signs of acute colitis and the amelioration of inflammation was associated with reduced IFN-gamma levels in mesenteric lymph nodes, lower amounts of neutrophils, and less FOXP3-positive T-cells in the colon in situ. During acute colitis E. coli increased in wt and TLR-deficient mice (P<0.05), but the final numbers reached were significantly lower in TLR2(-/-), TLR4(-/-) and TLR2/4(-/-) animals, as compared to wt controls (P<0.01). Concentrations of Bacteroides/Prevotella spp., and enterococci did not increase during colitis, but their numbers were significantly reduced in the colon of DSS-treated TLR2/4(-/-) animals (P<0.01). Numbers of lactobacilli and clostridia remained unaffected by colitis, irrespective of the TLR-genotype of mice. Culture-independent molecular analyses confirmed the microflora shifts towards enterobacteria during colitis and showed that the gut flora composition was similar in both, healthy wt and TLR-deficient animals. Conclusions and Significance. DSS-induced colitis is characterized by a shift in the intestinal microflora towards pro-inflammatory Gram-negative bacteria. Bacterial products exacerbate acute inflammation via TLR2- and TLR4-signaling and direct the recruitment of neutrophils and regulatory T-cells to intestinal sites. E. coli may serve as a biomarker for colitis severity and DSS-induced barrier damage seems to be a valuable model to further identify bacterial factors involved in maintaining intestinal homeostasis and to test therapeutic interventions based upon anti-TLR strategies.	[Heimesaat, Markus M.; Fischer, Andre; Kupz, Andreas; Niebergall, Julia; Fuchs, David; Jahn, Hannah-Katharina; Liesenfeld, Oliver; Goebel, Ulf B.; Schumann, Ralf R.; Bereswill, Stefan] Charite Univ Med Berlin, Inst Mikrobiol & Hyg, Berlin, Germany; [Siegmund, Britta; Batra, Arvind] Charite Univ Med Berlin, Med Klin 1, Berlin, Germany; [Freudenberg, Marina] Max Planck Inst Immunobiol, D-7800 Freiburg, Germany; [Loddenkemper, Christoph] Charite Univ Med Berlin, Inst Pathol, Berlin, Germany; [Lehr, Hans-Anton] Ctr Univ Hosp Vaudois, Inst Univ Pathol, Lausanne, Switzerland; [Blaut, Michael] Deutsch Inst Ernahrungsforsch, Abt Gastrointestinale Mikrobiol, Potsdam, Nuthetal, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Bereswill, S (corresponding author), Charite Univ Med Berlin, Inst Mikrobiol & Hyg, Charite Campus Mitte, Berlin, Germany.	stefan.bereswill@charite.de	Siegmund, Britta/E-6929-2018; Kupz, Andreas/J-3844-2014; Eckhardt, Erik/G-1567-2010	Siegmund, Britta/0000-0002-0055-958X; Kupz, Andreas/0000-0002-9259-7873; Freudenberg, Marina Alexandra/0000-0001-5894-1805; Heimesaat, Markus/0000-0001-6399-651X	Sonnenfeld Foundation Berlin, Germany	Sonnenfeld Foundation Berlin, Germany	Funding: This work was supported by grants from the Deutsche Forschungsgemeinschaft to U.B. G., O.L., R.R.S., C.L. (KFO104/project 6; SFB633/ projects A7, B6, Z1), to B. S. (Emmy-Noether-Programm of the DFG, 749/3-4, 749/5-1) and to M. F. (DFG-SPP1110/ project Fr448/4-3). A.F. is supported by a grant from the Sonnenfeld Foundation Berlin, Germany.	Aebischer T, 2006, FEMS IMMUNOL MED MIC, V46, P221, DOI 10.1111/rp10.1016-j.femsim.2004.05.008; Araki A, 2005, J GASTROENTEROL, V40, P16, DOI 10.1007/s00535-004-1492-9; Basset Christelle, 2002, Science Progress, V85, P33, DOI 10.3184/003685002783238861; Beelen DW, 1999, BLOOD, V93, P3267, DOI 10.1182/blood.V93.10.3267.410k22_3267_3275; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Fort MM, 2005, J IMMUNOL, V174, P6416, DOI 10.4049/jimmunol.174.10.6416; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Hans W, 2000, EUR J GASTROEN HEPAT, V12, P267, DOI 10.1097/00042737-200012030-00002; Hart AL, 2005, GASTROENTEROLOGY, V129, P50, DOI 10.1053/j.gastro.2005.05.013; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Husebye E, 2005, CHEMOTHERAPY, V51, P1, DOI 10.1159/000081988; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Lange S, 1996, APMIS, V104, P823, DOI 10.1111/j.1699-0463.1996.tb04948.x; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; Pizarro TT, 2003, TRENDS MOL MED, V9, P218, DOI 10.1016/S1471-4914(03)00052-2; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Rath HC, 2001, INFECT IMMUN, V69, P2277, DOI 10.1128/IAI.69.4.2277-2285.2001; Ruiz PA, 2005, J IMMUNOL, V174, P2990, DOI 10.4049/jimmunol.174.5.2990; Schuppler M, 2004, INFECT IMMUN, V72, P1983, DOI 10.1128/IAI.72.4.1983-1990.2004; Siegmund B, 2001, J PHARMACOL EXP THER, V296, P99; Stevceva L, 1999, J GASTROEN HEPATOL, V14, P54, DOI 10.1046/j.1440-1746.1999.01806.x; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Tlaskalova-Hogenova H, 2005, ANN NY ACAD SCI, V1051, P787, DOI 10.1196/annals.1361.122; Vowinkel T, 2007, GASTROENTEROLOGY, V132, P955, DOI 10.1053/j.gastro.2006.12.027; Waidmann M, 2003, GASTROENTEROLOGY, V125, P162, DOI 10.1016/S0016-5085(03)00672-3	34	160	167	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e662	10.1371/journal.pone.0000662	http://dx.doi.org/10.1371/journal.pone.0000662			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653282	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000207452200024
J	Liu, PY; Vikis, H; Lu, Y; Wang, DL; You, M				Liu, Pengyuan; Vikis, Haris; Lu, Yan; Wang, Daolong; You, Ming			Large-Scale In Silico Mapping of Complex Quantitative Traits in Inbred Mice	PLOS ONE			English	Article								Understanding the genetic basis of common disease and disease-related quantitative traits will aid in the development of diagnostics and therapeutics. The processs of gene discovery can be sped up by rapid and effective integration of well-defined mouse genome and phenome data resources. We describe here an in silico gene-discovery strategy through genome-wide association (GWA) scans in inbred mice with a wide range of genetic variation. We identified 937 quantitative trait loci (QTLs) from a survey of 173 mouse phenotypes, which include models of human disease (atherosclerosis, cardiovascular disease, cancer and obesity) as well as behavioral, hematological, immunological, metabolic, and neurological traits. 67% of QTLs were refined into genomic regions <0.5 Mb with similar to 40-fold increase in mapping precision as compared with classical linkage analysis. This makes for more efficient identification of the genes that underlie disease. We have identified two QTL genes, Adam12 and Cdh2, as causal genetic variants for atherogenic diet-induced obesity. Our findings demonstrate that GWA analysis in mice has the potential to resolve multiple tightly linked QTLs and achieve single-gene resolution. These high-resolution QTL data can serve as a primary resource for positional cloning and gene identification in the research community.	[You, Ming] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	You, M (corresponding author), Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA.	youm@wudosis.wustl.edu			US National Institutes of Health [CA099187, CA099147, ES012063, ES013340]; NATIONAL CANCER INSTITUTE [R01CA099147, R01CA099187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013340, R01ES012063] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding: Our research was supported by grants from the US National Institutes of Health (CA099187, CA099147, ES012063 and ES013340).	Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Altman D.G., 1991, PRACTICAL STATISTIC; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bale TL, 2003, ENDOCRINOLOGY, V144, P2580, DOI 10.1210/en.2002-0091; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brewer H., 2005, ATHEROTHROMBOSIS COR, P55; Brockmann GA, 1998, GENETICS, V150, P369; Brockmann GA, 2000, GENOME RES, V10, P1941, DOI 10.1101/gr.GR1499R; Buhman KK, 2000, NAT MED, V6, P1341, DOI 10.1038/82153; Bymaster FP, 2003, NEUROCHEM RES, V28, P437, DOI 10.1023/A:1022844517200; Castro CHM, 2004, J CELL SCI, V117, P2853, DOI 10.1242/jcs.01133; Chartrel N, 2007, SCIENCE, V315, DOI 10.1126/science.1135047; Cheverud JM, 2001, MAMM GENOME, V12, P3, DOI 10.1007/s003350010218; Christians JK, 2004, MAMM GENOME, V15, P482, DOI 10.1007/s00335-004-3046-0; Christians JK, 2003, MAMM GENOME, V14, P175, DOI 10.1007/s00335-002-3041-2; Christians JK, 2006, GENETICS, V173, P1547, DOI 10.1534/genetics.106.057513; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; de Mora JF, 2003, EMBO J, V22, P3039, DOI 10.1093/emboj/cdg280; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Flaherty L, 2005, GENOME RES, V15, P1741, DOI 10.1101/gr.3841405; Goudriaan JR, 2003, J LIPID RES, V44, P2270, DOI 10.1194/jlr.M300143-JLR200; Grupe A, 2001, SCIENCE, V292, P1915, DOI 10.1126/science.1058889; HEDRICK PW, 1987, GENETICS, V117, P331; Hollander M., 1973, NONPARAMETRIC STAT, P68; Holst B, 2007, ENDOCRINOLOGY, V148, P13, DOI 10.1210/en.2006-0933; HUANG LS, 1995, J CLIN INVEST, V96, P2152, DOI 10.1172/JCI118269; Ishida T, 2003, J CLIN INVEST, V111, P347, DOI [10.1172/JCI200316306, 10.1172/JCI16306]; Lauwers E, 2006, BIOCHEM BIOPH RES CO, V351, P21, DOI 10.1016/j.bbrc.2006.09.141; Liao GC, 2004, SCIENCE, V306, P690, DOI 10.1126/science.1100636; Liu PY, 2006, NAT GENET, V38, P888, DOI 10.1038/ng1849; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Masaki M, 2005, ENDOCRINOLOGY, V146, P1752, DOI 10.1210/en.2004-1082; Miyasaka K, 2002, J GASTROENTEROL, V37, P102, DOI 10.1007/BF03326426; Moechars D, 2006, GASTROENTEROLOGY, V131, P1131, DOI 10.1053/j.gastro.2006.07.009; Morris KH, 1999, MAMM GENOME, V10, P225, DOI 10.1007/s003359900977; Naaz A, 2004, FASEB J, V18, P1925, DOI 10.1096/fj.04-2631fje; Nadeau JH, 2000, NAT GENET, V25, P381, DOI 10.1038/78051; Patel HR, 2006, DIABETES, V55, P3091, DOI 10.2337/db05-0624; Payseur BA, 2007, GENETICS, V175, P1999, DOI 10.1534/genetics.106.067868; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Pletcher MT, 2004, PLOS BIOL, V2, P2159, DOI 10.1371/journal.pbio.0020393; Pritchard JK, 2000, GENETICS, V155, P945; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Rollins J, 2006, TRENDS CARDIOVAS MED, V16, P220, DOI 10.1016/j.tcm.2006.04.003; Tremblay F, 2007, ENDOCRINOLOGY, V148, P501, DOI 10.1210/en.2006-1275; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Vaughn TT, 1999, GENET RES, V74, P313, DOI 10.1017/S0016672399004103; Wade CM, 2005, NAT GENET, V37, P1175, DOI 10.1038/ng1666; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weng W, 1996, P NATL ACAD SCI USA, V93, P14788, DOI 10.1073/pnas.93.25.14788; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010; Yamada M, 2001, NATURE, V410, P207, DOI 10.1038/35065604; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; Zhang ZQ, 2003, P NATL ACAD SCI USA, V100, P12642, DOI 10.1073/pnas.2133947100; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; [No title captured]	61	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e651	10.1371/journal.pone.0000651	http://dx.doi.org/10.1371/journal.pone.0000651			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653278	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452200020
J	Pettay, JE; Helle, S; Jokela, J; Lummaa, V				Pettay, Jenni E.; Helle, Samuli; Jokela, Jukka; Lummaa, Virpi			Natural Selection on Female Life-History Traits in Relation to Socio-Economic Class in Pre-Industrial Human Populations	PLOS ONE			English	Article							PHENOTYPIC SELECTION; EVOLUTION; LONGEVITY; FITNESS; RATES; REPRODUCTION; MORTALITY; BENEFITS; QUALITY	Life-history theory predicts that resource scarcity constrains individual optimal reproductive strategies and shapes the evolution of life-history traits. In species where the inherited structure of social class may lead to consistent resource differences among family lines, between-class variation in resource availability should select for divergence in optimal reproductive strategies. Evaluating this prediction requires information on the phenotypic selection and quantitative genetics of life-history trait variation in relation to individual lifetime access to resources. Here, we show using path analysis how resource availability, measured as the wealth class of the family, affected the opportunity and intensity of phenotypic selection on the key life-history traits of women living in pre-industrial Finland during the 1800s and 1900s. We found the highest opportunity for total selection and the strongest selection on earlier age at first reproduction in women of the poorest wealth class, whereas selection favoured older age at reproductive cessation in mothers of the wealthier classes. We also found clear differences in female life-history traits across wealth classes: the poorest women had the lowest age-specific survival throughout their lives, they started reproduction later, delivered fewer offspring during their lifetime, ceased reproduction younger, had poorer offspring survival to adulthood and, hence, had lower fitness compared to the wealthier women. Our results show that the amount of wealth affected the selection pressure on female life-history in a pre-industrial human population.	[Pettay, Jenni E.; Helle, Samuli] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland; [Jokela, Jukka] Swiss Fed Inst Aquat Sci & Technol, Eawag, Dubendorf, Switzerland; [Jokela, Jukka] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Integrat Biol IBZ, Zurich, Switzerland; [Lummaa, Virpi] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Turku; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Sheffield	Pettay, JE (corresponding author), Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland.	jenni.pettay@utu.fi	Lummaa, Virpi/AHB-0181-2022	Jokela, Jukka/0000-0002-1731-727X	The Academy of Finland; The Finnish Cultural Foundation; The Royal Society	The Academy of Finland(Academy of Finland); The Finnish Cultural Foundation(Finnish Cultural Foundation); The Royal Society(Royal Society of London)	This work was supported by The Academy of Finland (V.L., S.H., J.J. and J.E.P.), The Finnish Cultural Foundation (J.E.P) and The Royal Society (V.L.).	Allison P. D., 1995, SURVIVAL ANAL USING; Ardia DR, 2005, J ANIM ECOL, V74, P517, DOI 10.1111/j.1365-2656.2005.00950.x; ARNOLD SJ, 1984, EVOLUTION, V38, P709, DOI [10.2307/2408383, 10.1111/j.1558-5646.1984.tb00344.x]; Brommer JE, 2004, AM NAT, V163, P505, DOI 10.1086/382547; Charmantier A, 2005, P ROY SOC B-BIOL SCI, V272, P1415, DOI 10.1098/rspb.2005.3117; Cichon M, 2001, J EVOLUTION BIOL, V14, P180, DOI 10.1046/j.1420-9101.2001.00243.x; Collett D, 2003, MODELING SURVIVAL DA; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Dribe M, 2004, POP STUD-J DEMOG, V58, P297, DOI 10.1080/0032472042000272357; Endler J.A., 1986, Monographs in Population Biology, pviii; Grace JB, 2003, STRUCTURAL EQUATION MODELING, P281, DOI 10.1017/CBO9780511542138.012; Hatcher L., 1994, STEP BY STEP APPROAC; HEERVA I, 1983, KUSTAVIN HIST; Helle S, 2005, P ROY SOC B-BIOL SCI, V272, P29, DOI 10.1098/rspb.2004.2944; HILTUNEN M, 1996, SIIKAJOKILAAKSON HIS, V1; HRDY SB, 1992, ETHOL SOCIOBIOL, V13, P409, DOI 10.1016/0162-3095(92)90011-R; Jasienska G, 2001, FOUND HUM B, P59; Kaar P, 1996, P ROY SOC B-BIOL SCI, V263, P1475, DOI 10.1098/rspb.1996.0215; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kirk KM, 2001, EVOLUTION, V55, P423; Lahdenpera M, 2004, NATURE, V428, P178, DOI 10.1038/nature02367; LAHELMA E, 1990, SOC SCI MED, V31, P257, DOI 10.1016/0277-9536(90)90272-T; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Little RC, 1996, SAS SYSTEM MIXED MOD; Lummaa V, 1998, NATURE, V394, P533, DOI 10.1038/28977; Lummaa V, 2001, J ANIM ECOL, V70, P739, DOI 10.1046/j.0021-8790.2001.00537.x; Lycett JE, 2000, P ROY SOC B-BIOL SCI, V267, P31, DOI 10.1098/rspb.2000.0962; Mace R, 1996, ETHOL SOCIOBIOL, V17, P263, DOI 10.1016/0162-3095(96)00044-1; Mace R, 1996, BEHAV ECOL SOCIOBIOL, V38, P75, DOI 10.1007/s002650050219; MARTIKAINEN P, 1995, POP STUD-J DEMOG, V49, P71, DOI 10.1080/0032472031000148256; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; Mitchell Randall J., 1993, P211; Moring B, 1996, CONTINUITY CHANGE, V11, P91, DOI 10.1017/S0268416000003106; Mulder MB, 1998, TRENDS ECOL EVOL, V13, P266, DOI 10.1016/S0169-5347(98)01357-3; Petraitis PS, 1996, FUNCT ECOL, V10, P421, DOI 10.2307/2389934; Pettay JE, 2005, P NATL ACAD SCI USA, V102, P2838, DOI 10.1073/pnas.0406709102; REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x; Reznick DN, 2005, CAN J FISH AQUAT SCI, V62, P791, DOI 10.1139/F05-079; Roff Derek, 2002, pi; SAARI L, 2000, RYMATTYLAN HIST, V2; Scheiner SM, 2000, J EVOLUTION BIOL, V13, P423, DOI 10.1046/j.1420-9101.2000.00191.x; Scott S., 2002, DUNCAN; Soininen AM, 1974, OLD TRADITIONAL AGR; THAPA S, 1988, NATURE, V335, P679, DOI 10.1038/335679a0; Tomer A, 2003, STRUCTURAL EQUATION MODELING, P125, DOI 10.1017/CBO9780511542138.006; TURPEINEN O, 1978, POP STUD-J DEMOG, V32, P523, DOI 10.2307/2173725; Turpeinen O., 1986, NALKA VAI TAUTI TAPP; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Walker R, 2006, AM J HUM BIOL, V18, P295, DOI 10.1002/ajhb.20510; Westendorp RGJ, 1998, NATURE, V396, P743, DOI 10.1038/25519; Wilson AJ, 2006, PLOS BIOL, V4, P1270, DOI 10.1371/journal.pbio.0040216; WIRILANDER K, 1974, HERRASVAKEA SUOMEN S; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	53	74	75	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2007	2	7							e606	10.1371/journal.pone.0000606	http://dx.doi.org/10.1371/journal.pone.0000606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GH	17622351	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000207452000013
J	Hagmann, P; Kurant, M; Gigandet, X; Thiran, P; Wedeen, VJ; Meuli, R; Thiran, JP				Hagmann, Patric; Kurant, Maciej; Gigandet, Xavier; Thiran, Patrick; Wedeen, Van J.; Meuli, Reto; Thiran, Jean-Philippe			Mapping Human Whole-Brain Structural Networks with Diffusion MRI	PLOS ONE			English	Article							SMALL-WORLD; CONNECTIONAL ORGANIZATION; WIRING OPTIMIZATION; SCHIZOPHRENIA; ARCHITECTURE; NEUROSCIENCE; MECHANICS; CIRCUITRY; MATTER; AREAS	Understanding the large-scale structural network formed by neurons is a major challenge in system neuroscience. A detailed connectivity map covering the entire brain would therefore be of great value. Based on diffusion MRI, we propose an efficient methodology to generate large, comprehensive and individual white matter connectional datasets of the living or dead, human or animal brain. This non-invasive tool enables us to study the basic and potentially complex network properties of the entire brain. For two human subjects we find that their individual brain networks have an exponential node degree distribution and that their global organization is in the form of a small world.	[Hagmann, Patric; Meuli, Reto] CHU Vaudois, Dept Radiol, CH-1011 Lausanne, Switzerland; [Hagmann, Patric; Meuli, Reto] Univ Lausanne, Lausanne, Switzerland; [Hagmann, Patric; Gigandet, Xavier; Thiran, Jean-Philippe] Ecole Polytech Fed Lausanne, Signal Proc Inst, CH-1015 Lausanne, Switzerland; [Kurant, Maciej; Thiran, Patrick] Ecole Polytech Fed Lausanne, Lab Comp Commun & Applicat, CH-1015 Lausanne, Switzerland; [Wedeen, Van J.] Harvard Univ, Sch Med, MGH Martinos Ctr Biomed Imaging, Charlestown, MA USA	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Harvard University	Hagmann, P (corresponding author), CHU Vaudois, Dept Radiol, CH-1011 Lausanne, Switzerland.	patric.hagmann@epfl.ch		Thiran, Jean-Philippe/0000-0003-2938-9657	Swiss National Science Foundation (SNSF); Center for Biomedical Imaging (CIBM) of the Geneva-Lausanne Universities; EPFL; foundations Leenaards and Louis-Jeantet	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Center for Biomedical Imaging (CIBM) of the Geneva-Lausanne Universities; EPFL; foundations Leenaards and Louis-Jeantet	This work was supported by the Swiss National Science Foundation (SNSF), Professor Pierre Schnyder and Mr Yves Paternot as well as the Center for Biomedical Imaging (CIBM) of the Geneva-Lausanne Universities and the EPFL, the foundations Leenaards and Louis-Jeantet. The sponsors had no role in the design or analysis of the study.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bartzokis G, 2002, NEUROPSYCHOPHARMACOL, V27, P672, DOI 10.1016/S0893-133X(02)00364-0; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Bota M, 2003, NAT NEUROSCI, V6, P795, DOI 10.1038/nn1096; Burns GAPC, 2000, PHILOS T R SOC B, V355, P55, DOI 10.1098/rstb.2000.0549; Callaghan P.T., 1991, PRINCIPLES NUCL MAGN, P492; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; CHERNIAK C, 1994, J NEUROSCI, V14, P2418; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; CRICK F, 1993, NATURE, V361, P109, DOI 10.1038/361109a0; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Hagmann P., 2005, DIFFUSION MRI BRAIN; HAGMANN P, 2004, DIFFUSION SPECTRUM I, P623; Hilgetag CC, 2005, ANAT EMBRYOL, V210, P411, DOI 10.1007/s00429-005-0041-5; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Hilgetag CC, 2004, NEUROINFORMATICS, V2, P353, DOI 10.1385/NI:2:3:353; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Kaiser M, 2004, NEUROCOMPUTING, V58, P297, DOI 10.1016/j.neucom.2004.01.059; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; KALNA G, 2006, CLUSTERING COEFCIENT; KENNEDY H, 1986, J COMP NEUROL, V247, P398, DOI 10.1002/cne.902470309; Kim BJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.168701; Klyachko VA, 2003, P NATL ACAD SCI USA, V100, P7937, DOI 10.1073/pnas.0932745100; Koch C, 1999, SCIENCE, V284, P96, DOI 10.1126/science.284.5411.96; Kubicki M, 2003, BIOL PSYCHIAT, V54, P1171, DOI 10.1016/S0006-3223(03)00419-0; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Le Bihan D, 1991, Magn Reson Q, V7, P1; Le Bihan D., 1995, DIFFUSION PERFUSION, V1st; Lin CP, 2003, NEUROIMAGE, V19, P482, DOI 10.1016/S1053-8119(03)00154-X; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; ROCKEL AJ, 1980, BRAIN, V103, P221, DOI 10.1093/brain/103.2.221; Rose SE, 2006, NEUROIMAGE, V32, P16, DOI 10.1016/j.neuroimage.2006.03.003; Saramaki J, 2006, GEN CLUSTERING COEFF; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; SCANNELL JW, 1995, J NEUROSCI, V15, P1463; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Sincich LC, 2005, ANNU REV NEUROSCI, V28, P303, DOI 10.1146/annurev.neuro.28.061604.135731; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197	56	546	565	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2007	2	7							e597	10.1371/journal.pone.0000597	http://dx.doi.org/10.1371/journal.pone.0000597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GG	17611629	Green Published, gold, Green Submitted			2022-12-27	WOS:000207451900014
J	Ryu, B; Kim, DS; DeLuca, AM; Alani, RM				Ryu, Byungwoo; Kim, Dave S.; DeLuca, Amena M.; Alani, Rhoda M.			Comprehensive Expression Profiling of Tumor Cell Lines Identifies Molecular Signatures of Melanoma Progression	PLOS ONE			English	Article								Background. Gene expression profiling has revolutionized our ability to molecularly classify primary human tumors and significantly enhanced the development of novel tumor markers and therapies; however, progress in the diagnosis and treatment of melanoma over the past 3 decades has been limited, and there is currently no approved therapy that significantly extends lifespan in patients with advanced disease. Profiling studies of melanoma to date have been inconsistent due to the heterogeneous nature of this malignancy and the limited availability of informative tissue specimens from early stages of disease. Methodology/Principle Findings. In order to gain an improved understanding of the molecular basis of melanoma progression, we have compared gene expression profiles from a series of melanoma cell lines representing discrete stages of malignant progression that recapitulate critical characteristics of the primary lesions from which they were derived. Here we describe the unsupervised hierarchical clustering of profiling data from melanoma cell lines and melanocytes. This clustering identifies two distinctive molecular subclasses of melanoma segregating aggressive metastatic tumor cell lines from less-aggressive primary tumor cell lines. Further analysis of expression signatures associated with melanoma progression using functional annotations categorized these transcripts into three classes of genes: 1) Upregulation of activators of cell cycle progression, DNA replication and repair (CDCA2, NCAPH, NCAPG, NCAPG2, PBK, NUSAP1, BIRC5, ESCO2, HELLS, MELK, GINS1, GINS4, RAD54L, TYMS, and DHFR), 2) Loss of genes associated with cellular adhesion and melanocyte differentiation (CDH3, CDH1, c-KIT, PAX3, CITED1/MSG-1, TYR, MELANA, MC1R, and OCA2), 3) Upregulation of genes associated with resistance to apoptosis (BIRC5/survivin). While these broad classes of transcripts have previously been implicated in the progression of melanoma and other malignancies, the specific genes identified within each class of transcripts are novel. In addition, the transcription factor NF-KB was specifically identified as being a potential "master regulator'' of melanoma invasion since NF-KB binding sites were identified as consistent consensus sequences within promoters of progression-associated genes. Conclusions/Significance. We conclude that tumor cell lines are a valuable resource for the early identification of gene signatures associated with malignant progression in tumors with significant heterogeneity like melanoma. We further conclude that the development of novel data reduction algorithms for analysis of microarray studies is critical to allow for optimized mining of important, clinically-relevant datasets. It is expected that subsequent validation studies in primary human tissues using such an approach will lead to more rapid translation of such studies to the identification of novel tumor biomarkers and therapeutic targets.	[Ryu, Byungwoo; Kim, Dave S.; DeLuca, Amena M.; Alani, Rhoda M.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Ryu, B (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21205 USA.	bryu1@jhmi.edu; ralani@jhmi.edu	Pillay, Nischalan/F-9536-2012	Alani, Rhoda/0000-0003-2741-2665; Ryu, Byungwoo/0000-0001-6334-6787	National Institutes of Health [CA107017, CA113779]; American Skin Association; Flight Attendant Medical Research Institute; Murren Family Foundation; Henry and Elaine Kaufman Foundation; NATIONAL CANCER INSTITUTE [K01CA113779, R01CA107017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Skin Association; Flight Attendant Medical Research Institute; Murren Family Foundation; Henry and Elaine Kaufman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health Grants CA107017 (RA) and CA113779 (BR), American Skin Association (R. A., A. D.), Flight Attendant Medical Research Institute (R. A.), The Murren Family Foundation (R. A.), and The Henry and Elaine Kaufman Foundation (R. A.).	Atkins Michael B., 1997, Current Opinion in Oncology, V9, P205; Banerjee D, 2002, BBA-MOL BASIS DIS, V1587, P164, DOI 10.1016/S0925-4439(02)00079-0; Beullens M, 2005, J BIOL CHEM, V280, P40003, DOI 10.1074/jbc.M507274200; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bonitsis N., 2006, Experimental Oncology, V28, P187; Cilensek ZM, 2002, CANCER BIOL THER, V1, P380; CLARK WH, 1984, HUM PATHOL, V15, P1147, DOI 10.1016/S0046-8177(84)80310-X; Coopman PJ, 2006, CANCER LETT, V241, P159, DOI 10.1016/j.canlet.2005.11.004; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Grossman D, 2001, CANCER METAST REV, V20, P3, DOI 10.1023/A:1013123532723; Gyorffy B, 2007, J INVEST DERMATOL, V127, P394, DOI 10.1038/sj.jid.5700543; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Herlyn D, 1991, Cancer Treat Res, V54, P105; HERLYN M, 1985, CANCER RES, V45, P5670; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hornyak TJ, 2001, MECH DEVELOP, V101, P47, DOI 10.1016/S0925-4773(00)00569-4; HOUGHTON AN, 1988, J EXP MED, V167, P197, DOI 10.1084/jem.167.1.197; Hsu MY, 1998, AM J PATHOL, V153, P1435, DOI 10.1016/S0002-9440(10)65730-6; HSU MYE, 1999, WISTAR WM MELANOMA C, P259; Jaeger J, 2007, CLIN CANCER RES, V13, P806, DOI 10.1158/1078-0432.CCR-06-1820; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kimura K, 2001, J BIOL CHEM, V276, P5417, DOI 10.1074/jbc.C000873200; Kong LY, 2006, BIOCHEM BIOPH RES CO, V339, P1204, DOI 10.1016/j.bbrc.2005.11.136; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; MANCIANTI ML, 1989, TUMOR PROGR MELANOMA, P369; Meier F, 2000, AM J PATHOL, V156, P193, DOI 10.1016/S0002-9440(10)64719-0; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; Nishimura EK, 1999, DEV BIOL, V215, P155, DOI 10.1006/dbio.1999.9478; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Pla P, 2001, J CELL PHYSIOL, V189, P121, DOI 10.1002/jcp.10008; Quackenbush J, 2006, NEW ENGL J MED, V354, P2463, DOI 10.1056/NEJMra042342; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Roesch A, 2006, MODERN PATHOL, V19, P1378, DOI 10.1038/modpathol.3800663; Rofstad EK, 2000, CANCER RES, V60, P4932; Rumpler G, 2003, EXP DERMATOL, V12, P761, DOI 10.1111/j.0906-6705.2003.00082.x; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Simons-Evelyn M, 2001, BLOOD CELL MOL DIS, V27, P825, DOI 10.1006/bcmd.2001.0452; Smith AP, 2004, CANCER BIOL THER, V3, P104, DOI 10.4161/cbt.3.1.661; SPRITZ RA, 1994, HUM MOL GENET, V3, P1469, DOI 10.1093/hmg/3.suppl_1.1469; Sun LQ, 2004, GENE DEV, V18, P1035, DOI 10.1101/gad.1176104; Suzuki I, 1996, ENDOCRINOLOGY, V137, P1627, DOI 10.1210/en.137.5.1627; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ueda Y, 2006, PIGM CELL RES, V19, P112, DOI 10.1111/j.1600-0749.2006.00304.x; Ueno M, 2005, MOL CELL BIOL, V25, P10528, DOI 10.1128/MCB.25.23.10528-10532.2005; Vachtenheim J, 1999, CELL MOL BIOL, V45, P1075; Valyi-Nagy I, 1991, Basic Life Sci, V57, P315; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Weeraratna AT, 2004, ONCOGENE, V23, P2264, DOI 10.1038/sj.onc.1207337; Wesley UV, 2005, CANCER RES, V65, P1325, DOI 10.1158/0008-5472.CAN-04-1852; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Zindy F, 1997, CELL GROWTH DIFFER, V8, P1139	58	210	232	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2007	2	7							e594	10.1371/journal.pone.0000594	http://dx.doi.org/10.1371/journal.pone.0000594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GG	17611626	Green Published, gold			2022-12-27	WOS:000207451900011
J	Murthy, T; Rolfs, A; Hu, YH; Shi, ZW; Raphael, J; Moreira, D; Kelley, F; McCarron, S; Jepson, D; Taycher, E; Zuo, DM; Mohr, SE; Fernandez, M; Brizuela, L; LaBaer, J				Murthy, Tal; Rolfs, Andreas; Hu, Yanhui; Shi, Zhenwei; Raphael, Jacob; Moreira, Donna; Kelley, Fontina; McCarron, Seamus; Jepson, Daniel; Taycher, Elena; Zuo, Dongmei; Mohr, Stephanie E.; Fernandez, Mauricio; Brizuela, Leonardo; LaBaer, Joshua			A Full-Genomic Sequence-Verified Protein-Coding Gene Collection for Francisella tularensis	PLOS ONE			English	Article								The rapid development of new technologies for the high throughput ( HT) study of proteins has increased the demand for comprehensive plasmid clone resources that support protein expression. These clones must be full-length, sequence-verified and in a flexible format. The generation of these resources requires automated pipelines supported by software management systems. Although the availability of clone resources is growing, current collections are either not complete or not fully sequence-verified. We report an automated pipeline, supported by several software applications that enabled the construction of the first comprehensive sequence-verified plasmid clone resource for more than 96% of protein coding sequences of the genome of F. tularensis, a highly virulent human pathogen and the causative agent of tularemia. This clone resource was applied to a HT protein purification pipeline successfully producing recombinant proteins for 72% of the genes. These methods and resources represent significant technological steps towards exploiting the genomic information of F. tularensis in discovery applications.	[Murthy, Tal; Rolfs, Andreas; Hu, Yanhui; Shi, Zhenwei; Raphael, Jacob; Moreira, Donna; Kelley, Fontina; McCarron, Seamus; Jepson, Daniel; Taycher, Elena; Zuo, Dongmei; Mohr, Stephanie E.; Fernandez, Mauricio; Brizuela, Leonardo; LaBaer, Joshua] Harvard Univ, Sch Med, Harvard Inst Prote, Dept Biol Chem & Mol Pharmacol, Cambridge, MA 02138 USA; [Mohr, Stephanie E.; LaBaer, Joshua] Harvard Univ, Sch Med, DF HCC DNA Resource Core, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	LaBaer, J (corresponding author), Harvard Univ, Sch Med, Harvard Inst Prote, Dept Biol Chem & Mol Pharmacol, Cambridge, MA 02138 USA.	josh@hms.harvard.edu		Hu, Yanhui/0000-0003-1494-1402; Mohr, Stephanie/0000-0001-9639-7708	NIAID/NIH [AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the NIAID/NIH grant for the New England Regional Center for Excellence #AI057159.	Braun P, 2003, TRENDS BIOTECHNOL, V21, P383, DOI 10.1016/S0167-7799(03)00189-6; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; Chambers SP, 2004, PROTEIN EXPRES PURIF, V36, P40, DOI 10.1016/j.pep.2004.03.003; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Dieckman L, 2002, PROTEIN EXPRES PURIF, V25, P1, DOI 10.1006/prep.2001.1602; Ecker A, 2006, MOL BIOCHEM PARASIT, V145, P265, DOI 10.1016/j.molbiopara.2005.10.006; FORTIER AH, 1995, INFECT IMMUN, V63, P1478, DOI 10.1128/IAI.63.4.1478-1483.1995; Heyman JA, 1999, GENOME RES, V9, P383; Hu YH, 2007, GENOME RES, V17, P536, DOI 10.1101/gr.6037607; LaBaer J, 2004, GENOME RES, V14, P2190, DOI 10.1101/gr.2482804; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Murthy TVS, 2004, PROTEIN EXPRES PURIF, V36, P217, DOI 10.1016/j.pep.2004.04.002; Park J, 2005, P NATL ACAD SCI USA, V102, P8114, DOI 10.1073/pnas.0503141102; Parrish JR, 2004, J PROTEOME RES, V3, P582, DOI 10.1021/pr0341134; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Serruto D, 2006, FEBS LETT, V580, P2985, DOI 10.1016/j.febslet.2006.04.084; Sjostedt A, 2006, MICROBES INFECT, V8, P561, DOI 10.1016/j.micinf.2005.08.001; Temple G, 2006, HUM MOL GENET, V15, pR31, DOI 10.1093/hmg/ddl048; Witt AE, 2006, J PROTEOME RES, V5, P599, DOI 10.1021/pr050395r	22	21	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e577	10.1371/journal.pone.0000577	http://dx.doi.org/10.1371/journal.pone.0000577			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593976	gold, Green Published			2022-12-27	WOS:000207451800021
J	Raine, NE; Chittka, L				Raine, Nigel E.; Chittka, Lars			The Adaptive Significance of Sensory Bias in a Foraging Context: Floral Colour Preferences in the Bumblebee Bombus terrestris	PLOS ONE			English	Article								Innate sensory biases could play an important role in helping naive animals to find food. As inexperienced bees are known to have strong innate colour biases we investigated whether bumblebee (Bombus terrestris) colonies with stronger biases for the most rewarding flower colour (violet) foraged more successfully in their local flora. To test the adaptive significance of variation in innate colour bias, we compared the performance of colour-naive bees, from nine bumblebee colonies raised from local wild-caught queens, in a laboratory colour bias paradigm using violet (bee UV-blue) and blue (bee blue) artificial flowers. The foraging performance of the same colonies was assessed under field conditions. Colonies with a stronger innate bias for violet over blue flowers in the laboratory harvested more nectar per unit time under field conditions. In fact, the colony with the strongest bias for violet (over blue) brought in 41% more nectar than the colony with the least strong bias. As violet flowers in the local area produce more nectar than blue flowers (the next most rewarding flower colour), these data are consistent with the hypothesis that local variation in flower traits could drive selection for innate colour biases.	[Raine, Nigel E.; Chittka, Lars] Univ London, Sch Biol & Chem Sci, London, England	University of London	Raine, NE (corresponding author), Univ London, Sch Biol & Chem Sci, London, England.	n.e.raine@qmul.ac.uk	Chittka, Lars/C-3110-2012; Raine, Nigel/AAK-6425-2020	Chittka, Lars/0000-0001-8153-1732; Raine, Nigel/0000-0001-6343-2829	Natural Environment Research Council [NER/A/S/2003/00469]; German Research Foundation (Deutsche Forschungsgemeinschaft) [Ch 147/3-1]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	Financial support for this work was provided by grants from the Natural Environment Research Council (NER/A/S/2003/00469) and the German Research Foundation (Deutsche Forschungsgemeinschaft: Ch 147/3-1). The study funders played no role in designing the study, data collection/analysis or preparation of the manuscript.	ALLEN T, 1978, Journal of the Kansas Entomological Society, V51, P329; BANSCHBACH VS, 1994, J COMP PHYSIOL A, V175, P107, DOI 10.1007/BF00217441; BASOLO AL, 1995, TRENDS ECOL EVOL, V10, P489, DOI 10.1016/S0169-5347(00)89196-X; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Bruce MJ, 2001, J EVOLUTION BIOL, V14, P786, DOI 10.1046/j.1420-9101.2001.00326.x; Cakmak Ibrahim, 1995, BeeScience, V3, P165; Chittka L, 2004, POPUL ECOL, V46, P243, DOI 10.1007/s10144-004-0180-1; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; Chittka L, 1996, J THEOR BIOL, V181, P179, DOI 10.1006/jtbi.1996.0124; Chittka L, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P106, DOI 10.1017/CBO9780511542268.007; Chittka L., 2005, PRACTICAL POLLINATIO, P157; Chittka L., 2001, ECOLOGY SENSING, P19; Chittka L, 2006, CURR OPIN PLANT BIOL, V9, P428, DOI 10.1016/j.pbi.2006.05.002; Chittka Lars, 2004, P165; Collins SA, 1999, P ROY SOC B-BIOL SCI, V266, P2309, DOI 10.1098/rspb.1999.0924; Dawkins MS, 1996, AM NAT, V148, P937, DOI 10.1086/285964; Dyer AG, 2006, ENTOMOL GEN, V28, P257; Dyer AG, 2006, NATURE, V442, P525, DOI 10.1038/442525a; Dyer AG, 2004, J COMP PHYSIOL A, V190, P105, DOI 10.1007/s00359-003-0475-2; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; FISHER RA, 1954, STAT METHODS RES WOR, P356; Gegear RJ, 2004, CAN J ZOOL, V82, P587, DOI 10.1139/Z04-029; GIURFA M, 1995, J COMP PHYSIOL A, V177, P247; Gumbert A, 2000, BEHAV ECOL SOCIOBIOL, V48, P36, DOI 10.1007/s002650000213; HEINRICH B, 1977, BEHAV ECOL SOCIOBIOL, V2, P247, DOI 10.1007/BF00299738; Heinrich B., 1979, BUMBLEBEE EC; Ings TC, 2006, J APPL ECOL, V43, P940, DOI 10.1111/j.1365-2664.2006.01199.x; Ings TC, 2005, OECOLOGIA, V144, P508, DOI 10.1007/s00442-005-0081-9; LAVERTY TM, 1994, ANIM BEHAV, V47, P531, DOI 10.1006/anbe.1994.1077; LUNAU K, 1995, J COMP PHYSIOL A, V177, P1; Lunau K, 1996, J COMP PHYSIOL A, V178, P477, DOI 10.1007/BF00190178; Menzel R, 1985, EXPT BEHAV ECOLOGY, P55; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Pelletier L, 2003, OIKOS, V103, P688, DOI 10.1034/j.1600-0706.2003.12592.x; Raine NE, 2005, ENTOMOL GEN, V28, P81; RAINE NE, 2007, ENTOMOL GEN IN PRESS; Raine NE, 2007, NATURWISSENSCHAFTEN, V94, P459, DOI 10.1007/s00114-006-0184-0; Raine NE, 2006, ADV STUD BEHAV, V36, P305, DOI 10.1016/S0065-3454(06)36007-X; Raine NE, 2007, ENTOMOL GEN, V29, P179; Raine NE, 2006, ENTOMOL GEN, V28, P241; RAUH W, 1987, FLORA DEUTSCHLAND SE, P606; Schmid-Hempel P, 1998, ANIM BEHAV, V55, P819, DOI 10.1006/anbe.1997.0661; Schmid-Hempel P., 1990, NATURWISSENSCHAFTEN, V27, P50; Schmid-Hempel R, 1998, FUNCT ECOL, V12, P22, DOI 10.1046/j.1365-2435.1998.00153.x; SCHMIDHEMPEL R, 1991, ANIM BEHAV, V41, P910, DOI 10.1016/S0003-3472(05)80362-8; Smith C, 2004, P ROY SOC B-BIOL SCI, V271, P949, DOI 10.1098/rspb.2004.2690; Spaethe J, 2003, J EXP BIOL, V206, P3447, DOI 10.1242/jeb.00570; Spaethe J, 2002, INSECT SOC, V49, P142, DOI 10.1007/s00040-002-8293-z; Willmer PG, 2004, ADV STUD BEHAV, V34, P347, DOI 10.1016/S0065-3454(04)34009-X	49	168	172	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2007	2	6							e556	10.1371/journal.pone.0000556	http://dx.doi.org/10.1371/journal.pone.0000556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GE	17579727	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451700021
J	Munoz-Alarcon, A; Pavlovic, M; Wismar, J; Schmitt, B; Eriksson, M; Kylsten, P; Dushay, MS				Munoz-Alarcon, Andres; Pavlovic, Maja; Wismar, Jasmine; Schmitt, Bertram; Eriksson, Maria; Kylsten, Per; Dushay, Mitchell S.			Characterization of lamin Mutation Phenotypes in Drosophila and Comparison to Human Laminopathies	PLOS ONE			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; HUTCHINSON-GILFORD-PROGERIA; NUCLEAR LAMINS; A/C GENE; PARTIAL LIPODYSTROPHY; MOLECULAR ANALYSIS; MELANOGASTER; EXPRESSION; PROTEIN; MUSCLE	Lamins are intermediate filament proteins that make up the nuclear lamina, a matrix underlying the nuclear membrane in all metazoan cells that is important for nuclear form and function. Vertebrate A-type lamins are expressed in differentiating cells, while B-type lamins are expressed ubiquitously. Drosophila has two lamin genes that are expressed in A-and B-type patterns, and it is assumed that similarly expressed lamins perform similar functions. However, Drosophila and vertebrate lamins are not orthologous, and their expression patterns evolved independently. It is therefore of interest to examine the effects of mutations in lamin genes. Mutations in the mammalian lamin A/C gene cause a range of diseases, collectively called laminopathies, that include muscular dystrophies and premature aging disorders. We compared the sequences of lamin genes from different species, and we have characterized larval and adult phenotypes in Drosophila bearing mutations in the lam gene that is expressed in the B-type pattern. Larvae move less and show subtle muscle defects, and surviving lam adults are flightless and walk like aged wild-type flies, suggesting that lam phenotypes might result from neuromuscular defects, premature aging, or both. The resemblance of Drosophila lam phenotypes to human laminopathies suggests that some lamin functions may be performed by differently expressed genes in flies and mammals. Such still-unknown functions thus would not be dependent on lamin gene expression pattern, suggesting the presence of other lamin functions that are expression dependent. Our results illustrate a complex interplay between lamin gene expression and function through evolution.	[Dushay, Mitchell S.] Uppsala Univ, EBC, Dept Comparat Physiol, Uppsala, Sweden; [Munoz-Alarcon, Andres; Pavlovic, Maja; Kylsten, Per; Dushay, Mitchell S.] Sodertorns Hogskola, Dept Life Sci, Huddinge, Sweden; [Munoz-Alarcon, Andres; Pavlovic, Maja; Eriksson, Maria] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Wismar, Jasmine; Schmitt, Bertram] Max Planck Inst Hirnforsch, Neurochem Abt, D-60528 Frankfurt, Germany	Uppsala University; Sodertorn University; Karolinska Institutet; Max Planck Society	Dushay, MS (corresponding author), Uppsala Univ, EBC, Dept Comparat Physiol, Uppsala, Sweden.	mitch.dushay@ebc.uu.se			Graduate Research School in Genomics and Bioinformatics; Swedish Animal Welfare Agency; Sodetorns hogskola and Uppsala University	Graduate Research School in Genomics and Bioinformatics; Swedish Animal Welfare Agency; Sodetorns hogskola and Uppsala University	`A. M. A. and M. P. were supported by grants from the Graduate Research School in Genomics and Bioinformatics (awarded to PK and MD, respectively), and MSD was supported by grants from the Swedish Animal Welfare Agency, and by Sodetorns hogskola and Uppsala University	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Bechert K, 2003, EXP CELL RES, V286, P75, DOI 10.1016/S0014-4827(03)00104-6; Beremendi A, 2005, NEUROSCIENCE, V134, P397, DOI 10.1016/j.neuroscience.2005.04.046; Bonne G, 2000, ANN NEUROL, V48, P170, DOI 10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brodsky GL, 2000, CIRCULATION, V101, P473, DOI 10.1161/01.CIR.101.5.473; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; BURKE B, 2006, HUM GENET, V7, P369; Canki-Klain N, 2000, CROAT MED J, V41, P389; Casares P, 1997, GENET SEL EVOL, V29, P589, DOI 10.1051/gse:19970504; Crossley A.C., 1978, P499; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Erber A, 1999, J MOL EVOL, V49, P260, DOI 10.1007/PL00006548; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Favreau C, 2003, EXP CELL RES, V282, P14, DOI 10.1006/excr.2002.5669; Goddeeris MM, 2003, AGING CELL, V2, P257, DOI 10.1046/j.1474-9728.2003.00060.x; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Grotewiel MS, 2005, AGEING RES REV, V4, P372, DOI 10.1016/j.arr.2005.04.001; Gruenbaum Y, 2003, INT REV CYTOL, V226, P1, DOI 10.1016/S0074-7696(03)01001-5; Haithcock E, 2005, P NATL ACAD SCI USA, V102, P16690, DOI 10.1073/pnas.0506755102; HAMILTON BA, 1991, P NATL ACAD SCI USA, V88, P2731, DOI 10.1073/pnas.88.7.2731; Hegele RA, 2007, EXP CELL RES, V313, P2134, DOI 10.1016/j.yexcr.2007.03.023; Hidalgo A, 2000, DEVELOPMENT, V127, P393; Iyengar B, 1999, GENETICS, V153, P1809; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; Leal SM, 2002, J NEUROBIOL, V50, P245, DOI 10.1002/neu.10030; LenzBohme B, 1997, J CELL BIOL, V137, P1001, DOI 10.1083/jcb.137.5.1001; Maraldi NM, 2005, J CELL PHYSIOL, V203, P319, DOI 10.1002/jcp.20217; Melcer S, 2007, EXP CELL RES, V313, P2157, DOI 10.1016/j.yexcr.2007.03.004; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; OSMAN M, 1990, GENOMICS, V8, P217, DOI 10.1016/0888-7543(90)90274-X; Osouda S, 2005, DEV BIOL, V284, P219, DOI 10.1016/j.ydbio.2005.05.022; Padiath QS, 2006, NAT GENET, V38, P1114, DOI 10.1038/ng1872; Prufert K, 2004, J CELL SCI, V117, P6105, DOI 10.1242/jcs.01532; Riemer D, 2000, GENE, V255, P317, DOI 10.1016/S0378-1119(00)00323-1; RIEMER D, 1995, J CELL SCI, V108, P3189; RIEMER D, 1994, EUR J CELL BIOL, V63, P299; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schulze SR, 2005, GENETICS, V171, P185, DOI 10.1534/genetics.105.043208; Shcherbata HR, 2007, EMBO J, V26, P481, DOI 10.1038/sj.emboj.7601503; Shumaker DK, 2003, CURR OPIN CELL BIOL, V15, P358, DOI 10.1016/S0955-0674(03)00050-4; Stuurman N, 1999, EXP CELL RES, V248, P350, DOI 10.1006/excr.1999.4396; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; TULLY T, 1990, COLD SPRING HARB SYM, V55, P203; Varga R, 2006, P NATL ACAD SCI USA, V103, P3250, DOI 10.1073/pnas.0600012103; Vytopil M, 2002, NEUROMUSCULAR DISORD, V12, P958, DOI 10.1016/S0960-8966(02)00178-5; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Yang P, 2000, GENETICS, V155, P1161	49	24	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2007	2	6							e532	10.1371/journal.pone.0000532	http://dx.doi.org/10.1371/journal.pone.0000532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GD	17565385	gold, Green Published, Green Submitted			2022-12-27	WOS:000207451600020
J	Broor, S; Parveen, S; Bharaj, P; Prasad, VS; Srinivasulu, KN; Sumanth, KM; Kapoor, SK; Fowler, K; Sullender, WM				Broor, Shobha; Parveen, Shama; Bharaj, Preeti; Prasad, Velisetty S.; Srinivasulu, Kavalu N.; Sumanth, Krishna M.; Kapoor, Suresh Kumar; Fowler, Karen; Sullender, Wayne M.			A Prospective Three-Year Cohort Study of the Epidemiology and Virology of Acute Respiratory Infections of Children in Rural India	PLOS ONE			English	Article							SYNCYTIAL VIRUS-INFECTION; RAPID DETECTION; ETIOLOGY	Background. Acute respiratory infection (ARI) is a major killer of children in developing countries. Although the frequency of ARI is similar in both developed and developing countries, mortality due to ARI is 10-50 times higher in developing countries. Viruses are common causes of ARI among such children, yet the disease burden of these infections in rural communities is unknown. Methodology/Principal Findings. A prospective longitudinal study was carried out in children enrolled from two rural Indian villages at birth and followed weekly for the development of ARI, classified as upper respiratory infection, acute lower respiratory infection (ALRI), or severe ALRI. Respiratory syncytial virus (RSV), influenza, parainfluenza viruses and adenoviruses in nasopharyngeal aspirates were detected by direct fluorescent antibody testing (DFA) and, in addition, centrifugation enhanced culture for RSV was done. 281 infants enrolled in 39 months and followed until 42 months. During 440 child years of follow-up there were 1307 ARIs, including 236 ALRIs and 19 severe ALRIs. Virus specific incidence rates per 1000 child years for RSV were total ARI 234, ALRI 39, and severe ALRI 9; for influenza A total ARI 141, ALRI 39; for INF B total ARI 37; for PIV1 total ARI 23, for PIV2 total ARI 28, ALRI 5; for parainfluenza virus 3 total ARI 229, ALRI 48, and severe ALRI 5 and for adenovirus total ARI 18, ALRI 5. Repeat infections with RSV were seen in 18 children. Conclusions/Significance. RSV, influenza A and parainfluenza virus 3 were important causes of ARI among children in rural communities in India. These data will be useful for vaccine design, development and implementation purposes.	[Broor, Shobha; Parveen, Shama; Bharaj, Preeti; Prasad, Velisetty S.; Srinivasulu, Kavalu N.; Sumanth, Krishna M.] All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India; [Kapoor, Suresh Kumar] All India Inst Med Sci, Comprehens Rural Hlth Serv Project, Ctr Community Med, New Delhi 110029, India; [Fowler, Karen; Sullender, Wayne M.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA; [Fowler, Karen] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Fowler, Karen] Univ Alabama Birmingham, Dept Maternal & Child Hlth, Birmingham, AL USA; [Sullender, Wayne M.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Broor, S (corresponding author), All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India.	shobha.broor@gmail.com	Broor, Shobha/AAX-4163-2021; Bharaj, Preeti/AAX-7394-2020	Broor, Shobha/0000-0001-9679-4180; Bharaj, Preeti/0000-0002-9411-9373	Indo-U.S. Vaccine Action Program; Department of Biotechnology (India); National Institute for Allergy and Infectious Disease (USA) [R03 AI50693]; Council of Scientific and Industrial Research (India); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI050693] Funding Source: NIH RePORTER	Indo-U.S. Vaccine Action Program; Department of Biotechnology (India)(Department of Biotechnology (DBT) India); National Institute for Allergy and Infectious Disease (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the study was received from Indo-U.S. Vaccine Action Program, Department of Biotechnology (India) and National Institute for Allergy and Infectious Disease, R03 AI50693 (USA). Support for Shama Parveen was received from the Council of Scientific and Industrial Research (India).	BOSHCIPINTO C, 2002, 1 M 6 7 FEBR 2002 MA; *CHERG, 2001, 5074 CHERG UN POP DI; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; HENDERSON FW, 1979, NEW ENGL J MED, V300, P530, DOI 10.1056/NEJM197903083001004; HILLIS WD, 1971, INDIAN J MED RES, V59, P1354; JAIN A, 1991, J MED MICROBIOL, V35, P219, DOI 10.1099/00222615-35-4-219; Jennings LC, 2004, PEDIATR INFECT DIS J, V23, P1003, DOI 10.1097/01.inf.0000143648.04673.6c; JOHN TJ, 1991, REV INFECT DIS, V13, pS463; Kapoor SK, 2001, J EPIDEMIOL COMMUN H, V55, P366, DOI 10.1136/jech.55.5.366; KLOENE W, 1970, AM J EPIDEMIOL, V92, P307, DOI 10.1093/oxfordjournals.aje.a121212; Landry ML, 2000, J CLIN MICROBIOL, V38, P708, DOI 10.1128/JCM.38.2.708-711.2000; Maitreyi RS, 2000, J CLIN VIROL, V16, P41, DOI 10.1016/S1386-6532(99)00075-X; Nokes DJ, 2004, J INFECT DIS, V190, P1828, DOI 10.1086/425040; Parveen S, 2006, J MED VIROL, V78, P659, DOI 10.1002/jmv.20590; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Rajala MS, 2003, J CLIN MICROBIOL, V41, P2311, DOI 10.1128/JCM.41.6.2311-2316.2003; REDDAIAH V P, 1988, Indian Journal of Pediatrics, V55, P424, DOI 10.1007/BF02810367; Robertson SE, 2004, B WORLD HEALTH ORGAN, V82, P914; Scott PD, 2006, J INFECT DIS, V193, P59, DOI 10.1086/498246; SELWYN BJ, 1990, REV INFECT DIS, V12, pS870; Shann F, 1999, LANCET, V354, pS7, DOI 10.1016/S0140-6736(99)90250-7; *WHO, 2000, INT MAN CHILDH ILL H; WHO, 1994, MOTH BAB PACK IMPL S; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; WOLONTIS S, 1969, Scandinavian Journal of Infectious Diseases, V1, P119, DOI 10.3109/inf.1969.1.issue-2.08	25	105	106	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e491	10.1371/journal.pone.0000491	http://dx.doi.org/10.1371/journal.pone.0000491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551572	Green Published, gold, Green Submitted			2022-12-27	WOS:000207451500001
J	van der Sande, MAB; Kaye, S; Miles, DJC; Waight, P; Jeffries, DJ; Ojuola, OO; Palmero, M; Pinder, M; Ismaili, J; Flanagan, KL; Aveika, AA; Zaman, A; Rowland-Jones, S; McConkey, SJ; Whittle, HC; Marchant, A				van der Sande, Marianne A. B.; Kaye, Steve; Miles, David J. C.; Waight, Pauline; Jeffries, David J.; Ojuola, Olubukola O.; Palmero, Melba; Pinder, Margaret; Ismaili, Jamila; Flanagan, Katie L.; Aveika, Akum A.; Zaman, Akram; Rowland-Jones, Sarah; McConkey, Samuel J.; Whittle, Hilton C.; Marchant, Arnaud			Risk Factors for and Clinical Outcome of Congenital Cytomegalovirus Infection in a Peri-Urban West-African Birth Cohort	PLOS ONE			English	Article								Background. Congenital cytomegalovirus (CMV) infection is the most prevalent congenital infection worldwide. Epidemiology and clinical outcomes are known to vary with socio-economic background, but few data are available from developing countries, where the overall burden of infectious diseases is frequently high. Methodology/Principal Findings. As part of an ongoing birth cohort study in The Gambia among term infants, urine samples were collected at birth and tested by PCR for the presence of CMV DNA. Risk factors for transmission and clinical outcome were assessed, including placental malaria infection. Babies were followed up at home monthly for morbidity and anthropometry, and at one year of age a clinical evaluation was performed. The prevalence of congenital CMV infection was 5.4% (40/741). A higher prevalence of hepatomegaly was the only significant clinical difference at birth. Congenitally infected children were more often first born babies (adjusted odds ratio (OR) 5.3, 95% confidence interval (CI) 2.0-13.7), more frequently born in crowded compounds (adjusted OR 2.9, 95% CI 1.0-8.3) and active placental malaria was more prevalent (adjusted OR 2.9, 95% CI 1.0-8.4). These associations were corrected for maternal age, bed net use and season of birth. During the first year of follow up, mothers of congenitally infected children reported more health complaints for their child. Conclusions/Significance. In this study, the prevalence of congenital CMV among healthy neonates was much higher than previously reported in industrialised countries, and was associated with active placental malaria infection. There were no obvious clinical implications during the first year of life. The effect of early life CMV on the developing infant in the Gambia could be mitigated by environmental factors, such as the high burden of other infections.	[van der Sande, Marianne A. B.; Kaye, Steve; Miles, David J. C.; Waight, Pauline; Jeffries, David J.; Ojuola, Olubukola O.; Palmero, Melba; Pinder, Margaret; Ismaili, Jamila; Flanagan, Katie L.; Aveika, Akum A.; Zaman, Akram; Rowland-Jones, Sarah; McConkey, Samuel J.; Whittle, Hilton C.; Marchant, Arnaud] MRC Labs, Fajara, Gambia	MRC Laboratory Molecular Biology	van der Sande, MAB (corresponding author), MRC Labs, Fajara, Gambia.	Marianne.van.der.Sande@rivm.nl	McConkey, Samuel/E-7307-2012	Flanagan, Katie/0000-0002-1575-1953; van der Sande, Marianne AB/0000-0002-4778-6739; McConkey, Samuel/0000-0001-9085-7793	Glaxo Smith Kline Biologicals (Belgium); Medical Research Council (UK); Medical Research Council [MC_U190088483, MC_U190081978, MC_U190085854] Funding Source: researchfish; MRC [MC_U190085854, MC_U190081978, MC_U190088483] Funding Source: UKRI	Glaxo Smith Kline Biologicals (Belgium)(GlaxoSmithKline); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by Glaxo Smith Kline Biologicals (Belgium), and the Medical Research Council (UK). The funders of the study were not involved in design, conduct, collection-analysis-interpretetation of data, nor in the preparation-review-approval of the manuscript.	Barbi M, 2003, PEDIATR INFECT DIS J, V22, P39, DOI 10.1097/00006454-200301000-00012; BELLO C, 1991, J CLIN PATHOL, V44, P366, DOI 10.1136/jcp.44.5.366; Boppana SB, 2005, J PEDIATR-US, V146, P817, DOI 10.1016/j.jpeds.2005.01.059; Boppana SB, 1999, PEDIATRICS, V104, P55, DOI 10.1542/peds.104.1.55; BOPPANA SB, 1992, PEDIATR INFECT DIS J, V11, P93, DOI 10.1097/00006454-199202000-00007; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; BURNY W, 2004, EXPERT REV ANTI-INFE, V2, P6; Chow SSW, 2006, J MED VIROL, V78, P747, DOI 10.1002/jmv.20618; Doyle M, 1996, PEDIATR INFECT DIS J, V15, P1102, DOI 10.1097/00006454-199612000-00010; Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5; Fowler KB, 2003, JAMA-J AM MED ASSOC, V289, P1008, DOI 10.1001/jama.289.8.1008; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; Gaytant MA, 2005, J MED VIROL, V76, P71, DOI 10.1002/jmv.20325; Gaytant MA, 2003, EUR J PEDIATR, V162, P248, DOI 10.1007/s00431-002-1115-3; Ismail MR, 2000, HUM PATHOL, V31, P85, DOI 10.1016/S0046-8177(00)80203-8; Ismaili J, 2003, CLIN EXP IMMUNOL, V133, P414, DOI 10.1046/j.1365-2249.2003.02243.x; Iwasaki S, 2007, AUDIOL NEURO-OTOL, V12, P31, DOI 10.1159/000096156; Looney RJ, 1999, CLIN IMMUNOL, V90, P213, DOI 10.1006/clim.1998.4638; Marchant A, 2003, J CLIN INVEST, V111, P1747, DOI 10.1172/JCI17470; Marin Gabriel M A, 2005, An Pediatr (Barc), V62, P38; Moore SE, 2006, P NUTR SOC, V65, P311, DOI 10.1079/PNS2006503; Moutaftsi M, 2002, BLOOD, V99, P2913, DOI 10.1182/blood.V99.8.2913; Mussi-Pinhata MM, 1998, J PEDIATR-US, V132, P285, DOI 10.1016/S0022-3476(98)70446-9; NICKELL SP, 1987, PARASITE IMMUNOL, V9, P161, DOI 10.1111/j.1365-3024.1987.tb00497.x; Numazaki K, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-22; Okoko BJ, 2003, ACTA TROP, V87, P193, DOI 10.1016/S0001-706X(03)00097-4; Olsson J, 2000, MECH AGEING DEV, V121, P187; Pass Robert F, 2005, Herpes, V12, P50; Pawelec G, 2005, IMMUNOL REV, V205, P257, DOI 10.1111/j.0105-2896.2005.00271.x; Picone O, 2005, PRENATAL DIAG, V25, P34, DOI 10.1002/pd.944; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Ross SA, 2006, J PEDIATR-US, V148, P332, DOI 10.1016/j.jpeds.2005.09.003; Schleiss MR, 2005, EXPERT REV VACCINES, V4, P381, DOI 10.1586/14760584.4.3.381; Schleiss Mark R, 2004, Expert Rev Anti Infect Ther, V2, P389, DOI 10.1586/14787210.2.3.389; Schlesinger Y, 2005, ISR MED ASSOC J, V7, P237; van der Loeff MFS, 2003, AIDS, V17, P1841, DOI [10.1097/00002030-200308150-00014, 10.1097/01.aids.0000076303.76477.49]; Vochem M, 1998, PEDIATR INFECT DIS J, V17, P53, DOI 10.1097/00006454-199801000-00012; WHITTLE HC, 1984, NATURE, V312, P449, DOI 10.1038/312449a0; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; Wreghitt TG, 2003, CLIN INFECT DIS, V37, P1603, DOI 10.1086/379711; Yamamoto AY, 2001, PEDIATR INFECT DIS J, V20, P188, DOI 10.1097/00006454-200102000-00014	41	61	63	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e492	10.1371/journal.pone.0000492	http://dx.doi.org/10.1371/journal.pone.0000492			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551573	Green Submitted, Green Published, gold			2022-12-27	WOS:000207451500002
J	Blais, J; Rico, C; van Oosterhout, C; Cable, J; Turner, GF; Bernatchez, L				Blais, Jonatan; Rico, Ciro; van Oosterhout, Cock; Cable, Joanne; Turner, George F.; Bernatchez, Louis			MHC Adaptive Divergence between Closely Related and Sympatric African Cichlids	PLOS ONE			English	Article							MAJOR-HISTOCOMPATIBILITY-COMPLEX; MATE CHOICE; CLASS-I; SEXUAL SELECTION; LAKE MALAWI; ANTIGEN PRESENTATION; BALANCING SELECTION; CLASS-IIB; EVOLUTION; SPECIATION	Background. The haplochromine cichlid species assemblages of Lake Malawi and Victoria represent some of the most important study systems in evolutionary biology. Identifying adaptive divergence between closely-related species can provide important insights into the processes that may have contributed to these spectacular radiations. Here, we studied a pair of sympatric Lake Malawi species, Pseudotropheus fainzilberi and P. emmiltos, whose reproductive isolation depends on olfactory communication. We tested the hypothesis that these species have undergone divergent selection at MHC class II genes, which are known to contribute to olfactory-based mate choice in other taxa. Methodology/Principal Findings. Divergent selection on functional alleles was inferred from the higher genetic divergence at putative antigen binding sites (ABS) amino acid sequences than at putatively neutrally evolving sites at intron 1, exon 2 synonymous sequences and exon 2 amino acid residues outside the putative ABS. In addition, sympatric populations of these fish species differed significantly in communities of eukaryotic parasites. Conclusions/Significance. We propose that local host-parasite coevolutionary dynamics may have driven adaptive divergence in MHC alleles, influencing odor-mediated mate choice and leading to reproductive isolation. These results provide the first evidence for a novel mechanism of adaptive speciation and the first evidence of adaptive divergence at the MHC in closely related African cichlid fishes.	[Blais, Jonatan; Bernatchez, Louis] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Blais, Jonatan; Rico, Ciro] CSIC, Estac Biol Donana, E-41080 Seville, Spain; [Blais, Jonatan; van Oosterhout, Cock; Turner, George F.] Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Cable, Joanne] Cardiff Univ, Sch Biol Sci, Cardiff, S Glam, Wales	Laval University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Hull; Cardiff University	Bernatchez, L (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada.	Louis.Bernatchez@bio.ulaval.ca	Cable, Joanne/A-4360-2010; Rico, Ciro/P-9750-2019; Rico, Ciro/K-5725-2015	Cable, Joanne/0000-0002-8510-7055; Rico, Ciro/0000-0002-0822-336X; Rico, Ciro/0000-0002-0822-336X; Bernatchez, Louis/0000-0002-8085-9709; Turner, George/0000-0003-0099-7261; van Oosterhout, Cock/0000-0002-5653-738X	Natural Science and Engineering Research Council of Canada; Fond Quebecois pour la Nature et les Technologies of Quebec; Natural and Environment Research Council [NER/J/S/2002/00706]; British Ecological Society; Consejo Superior de Investigacion Scientifica of Spain; Biotechnology and Biological Sciences Research Council of the UK	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fond Quebecois pour la Nature et les Technologies of Quebec; Natural and Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); British Ecological Society; Consejo Superior de Investigacion Scientifica of Spain; Biotechnology and Biological Sciences Research Council of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	JB was supported by a post-graduate scholarship from the Natural Science and Engineering Research Council of Canada and Fond Quebecois pour la Nature et les Technologies of Quebec. JC was funded by an Advanced Research Fellowship from the Natural and Environment Research Council (NER/J/S/2002/00706) of the UK. Field work by CvO., JB, and JC was funded by the British Ecological Society. CR was supported by the Consejo Superior de Investigacion Scientifica of Spain. GFT was funded by the Biotechnology and Biological Sciences Research Council of the UK and field work by the Natural and Environment Research Council of the UK. LB was funded by the Natural Science and Engineering Research Council of Canada (Discovery Grant Program).	Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; Albertson RC, 1999, P NATL ACAD SCI USA, V96, P5107, DOI 10.1073/pnas.96.9.5107; Allender CJ, 2003, P NATL ACAD SCI USA, V100, P14074, DOI 10.1073/pnas.2332665100; Anzai T, 2003, P NATL ACAD SCI USA, V100, P7708, DOI 10.1073/pnas.1230533100; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Blais J, 2004, EVOLUTION, V58, P2498; Borghans JAM, 2003, EUR J IMMUNOL, V33, P3353, DOI 10.1002/eji.200324365; Buckling A, 2002, NATURE, V420, P496, DOI 10.1038/nature01164; Carroll LS, 2002, P NATL ACAD SCI USA, V99, P2187, DOI 10.1073/pnas.042244899; Cohen S, 2002, MOL BIOL EVOL, V19, P1870, DOI 10.1093/oxfordjournals.molbev.a004011; Deutsch JC, 1997, BIOL J LINN SOC, V62, P1; DOMINEY WJ, 1984, EVOLUTION FISH SPECI, P231; Emes RD, 2004, GENOME RES, V14, P591, DOI 10.1101/gr.1940604; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Fenton A, 2002, J ANIM ECOL, V71, P893, DOI 10.1046/j.1365-2656.2002.00656.x; FRANK SA, 1994, PHILOS T R SOC B, V346, P283, DOI 10.1098/rstb.1994.0145; Garamszegi LZ, 2003, EVOLUTION, V57, P905, DOI 10.1554/0014-3820(2003)057[0905:TEOIDA]2.0.CO;2; Genner MJ, 2005, FISH FISH, V6, P1, DOI 10.1111/j.1467-2679.2005.00173.x; Getty T, 2002, AM NAT, V159, P363, DOI 10.1086/338992; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, GENETICS, V132, P583; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Hughes AL, 2000, IMMUNOGENETICS, V51, P473, DOI 10.1007/s002510050646; Jacob S, 2002, NAT GENET, V30, P175, DOI 10.1038/ng830; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; KONINGS A, 2001, MALAWI CICHLIDS THEI, P352; Kornfield I, 2000, ANNU REV ECOL SYST, V31, P163, DOI 10.1146/annurev.ecolsys.31.1.163; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Krasnov BR, 2004, J BIOGEOGR, V31, P1857, DOI 10.1111/j.1365-2699.2004.01132.x; Kruiswijk CP, 2005, IMMUNOGENETICS, V56, P894, DOI 10.1007/s00251-005-0767-5; Landry C, 2001, P ROY SOC B-BIOL SCI, V268, P1279, DOI 10.1098/rspb.2001.1659; Lederberg J, 1999, GENETICS, V153, P1; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Maan ME, 2006, BEHAV ECOL, V17, P691, DOI 10.1093/beheco/ark020; Malaga-Trillo E, 1998, GENETICS, V149, P1527; Milinski M, 2005, P NATL ACAD SCI USA, V102, P4414, DOI 10.1073/pnas.0408264102; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nielsen R, 2001, GENETICS, V158, P885; NOWAK MA, 1992, P NATL ACAD SCI USA, V89, P10896, DOI 10.1073/pnas.89.22.10896; Nunn CL, 2004, AM NAT, V164, pS90, DOI 10.1086/424608; ONO H, 1993, MOL BIOL EVOL, V10, P1060; ONO H, 1992, P NATL ACAD SCI USA, V89, P11886, DOI 10.1073/pnas.89.24.11886; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Plenderleith M, 2005, BIOL LETT-UK, V1, P411, DOI 10.1098/rsbl.2005.0355; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Reusch TBH, 2001, NATURE, V414, P300, DOI 10.1038/35104547; Reusch TBH, 2005, J MOL EVOL, V61, P531, DOI 10.1007/s00239-004-0340-0; RIBBINK AJ, 1983, S AFR J ZOOL, V18, P149; Rico C, 2002, MOL ECOL, V11, P1585, DOI 10.1046/j.1365-294X.2002.01537.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schierup MH, 2000, GENET RES, V76, P63, DOI 10.1017/S0016672300004547; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 1999, ECOL LETT, V2, P262; Skarstein F, 2005, J FISH BIOL, V67, P969, DOI 10.1111/j.0022-1112.2005.00796.x; Sommer S, 2005, BEHAV ECOL SOCIOBIOL, V58, P181, DOI 10.1007/s00265-005-0909-7; Sorhannus U, 2006, J MOL EVOL, V63, P231, DOI 10.1007/s00239-006-0016-z; Summers K, 2003, BIOL REV, V78, P639, DOI 10.1017/S146479310300616X; Switzer WM, 2005, NATURE, V434, P376, DOI 10.1038/nature03341; Taylor MI, 1998, ANIM BEHAV, V56, P379, DOI 10.1006/anbe.1998.0795; Terai Y, 2006, PLOS BIOL, V4, P2244, DOI 10.1371/journal.pbio.0040433; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; Turner GT, 1999, EVOLUTION OF BIOLOGICAL DIVERSITY, P113; van den Berg HA, 2003, J THEOR BIOL, V224, P249, DOI 10.1016/S0022-5193(03)00162-0; van Oosterhout C, 2006, EVOLUTION, V60, P2562, DOI 10.1111/j.0014-3820.2006.tb01890.x; vonSchantz T, 1996, P ROY SOC B-BIOL SCI, V263, P265, DOI 10.1098/rspb.1996.0041; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Westneat DF, 1998, P ROY SOC B-BIOL SCI, V265, P1065, DOI 10.1098/rspb.1998.0400; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Yampolsky LY, 2005, GENETICS, V170, P1459, DOI 10.1534/genetics.104.039107; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981	84	86	87	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e734	10.1371/journal.pone.0000734	http://dx.doi.org/10.1371/journal.pone.0000734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710134	gold, Green Published			2022-12-27	WOS:000207455200011
J	Knapen, T; van Ee, R; Blake, R				Knapen, Tomas; van Ee, Raymond; Blake, Randolph			Stimulus Motion Propels Traveling Waves in Binocular Rivalry	PLOS ONE			English	Article							VISUAL-CORTEX; INTEGRATION; DIRECTION; DYNAMICS; FEEDBACK; DEPTH	State transitions in the nervous system often take shape as traveling waves, whereby one neural state is replaced by another across space in a wave-like manner. In visual perception, transitions between the two mutually exclusive percepts that alternate when the two eyes view conflicting stimuli (binocular rivalry) may also take shape as traveling waves. The properties of these waves point to a neural substrate of binocular rivalry alternations that have the hallmark signs of lower cortical areas. In a series of experiments, we show a potent interaction between traveling waves in binocular rivalry and stimulus motion. The course of the traveling wave is biased in the motion direction of the suppressed stimulus that gains dominance by means of the wave-like transition. Thus, stimulus motion may propel the traveling wave across the stimulus to the extent that the stimulus motion dictates the traveling wave's direction completely. Using a computational model, we show that a speed-dependent asymmetry in lateral inhibitory connections between retinotopically organized and motion-sensitive neurons can explain our results. We argue that such a change in suppressive connections may play a vital role in the resolution of dynamic occlusion situations.	[Knapen, Tomas; van Ee, Raymond] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands; [Blake, Randolph] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA	Utrecht University; Vanderbilt University	Knapen, T (corresponding author), Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands.	t.h.j.knapen@phys.uu.nl; r.vanee@phys.uu.nl		van Ee, Raymond/0000-0002-1134-8665	NIH [EY016752, EY13358]; National Academy of Science (KNAW); Netherlands Organization for Scientific Research (NWO); Utrecht University; NATIONAL EYE INSTITUTE [R01EY016752, R01EY013358, P30EY008126] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Academy of Science (KNAW); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Utrecht University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Part of this work has been conducted during a research visit of TK at Vanderbilt University made possible by grants NIH EY016752 and NIH EY13358 to RB and grants from the National Academy of Science (KNAW) to RvE. RvE was supported by a grant from The Netherlands Organization for Scientific Research (NWO) as well as by a High Potential grant from Utrecht University.	Alais D, 2006, NEURON, V52, P911, DOI 10.1016/j.neuron.2006.10.027; Andrews TJ, 2002, VISION RES, V42, P301, DOI 10.1016/S0042-6989(01)00286-3; Andrews TJ, 1999, NAT NEUROSCI, V2, P405, DOI 10.1038/8068; BLAKE R, 1985, BIOL CYBERN, V52, P391, DOI 10.1007/BF00449596; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; BRADLEY DC, 1995, NATURE, V373, P609, DOI 10.1038/373609a0; Brooks KR, 2006, VISION RES, V46, P605, DOI 10.1016/j.visres.2005.06.015; DeAngelis GC, 2003, J NEUROPHYSIOL, V89, P1094, DOI 10.1152/jn.00717.2002; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; Grunewald A, 2004, J NEUROSCI, V24, P9185, DOI 10.1523/JNEUROSCI.1884-04.2004; Lee SH, 2005, NAT NEUROSCI, V8, P22, DOI 10.1038/nn1365; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; Muckli L, 2005, PLOS BIOL, V3, P1501, DOI 10.1371/journal.pbio.0030265; Nguyen VA, 2003, VISION RES, V43, P2003, DOI 10.1016/S0042-6989(03)00314-6; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Rinzel J, 1998, SCIENCE, V279, P1351, DOI 10.1126/science.279.5355.1351; SHIMOJO S, 1988, NATURE, V333, P265, DOI 10.1038/333265a0; Sillito AM, 2006, TRENDS NEUROSCI, V29, P307, DOI 10.1016/j.tins.2006.05.001; SILLITO AM, 1977, J PHYSIOL-LONDON, V273, P791, DOI 10.1113/jphysiol.1977.sp012124; SILLITO AM, 1994, NATURE, V369, P479, DOI 10.1038/369479a0; van Ee R, 2001, NATURE, V410, P690, DOI 10.1038/35070569; WADE NJ, 1984, PERCEPT PSYCHOPHYS, V35, P111, DOI 10.3758/BF03203891; Wilson HR, 2001, NATURE, V412, P907, DOI 10.1038/35091066; Xie XH, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051904	24	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e739	10.1371/journal.pone.0000739	http://dx.doi.org/10.1371/journal.pone.0000739			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710139	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455200016
J	Shimeld, SM; van den Heuvel, M; Dawber, R; Briscoe, J				Shimeld, Sebastian M.; van den Heuvel, Marcel; Dawber, Rebecca; Briscoe, James			An Amphioxus Gli Gene Reveals Conservation of Midline Patterning and the Evolution of Hedgehog Signalling Diversity in Chordates	PLOS ONE			English	Article								Background. Hedgehog signalling, interpreted in receiving cells by Gli transcription factors, plays a central role in the development of vertebrate and Drosophila embryos. Many aspects of the signalling pathway are conserved between these lineages, however vertebrates have diverged in at least one key aspect: they have evolved multiple Gli genes encoding functionally-distinct proteins, increasing the complexity of the hedgehog-dependent transcriptional response. Amphioxus is one of the closest living relatives of the vertebrates, having split from the vertebrate lineage prior to the widespread gene duplication prominent in early vertebrate evolution. Principal Findings. We show that amphioxus has a single Gli gene, which is deployed in tissues adjacent to sources of hedgehog signalling derived from the midline and anterior endoderm. This shows the duplication and divergence of the Gli gene family, and hence the origin of vertebrate Gli functional diversity, was specific to the vertebrate lineage. However we also show that the single amphioxus Gli gene produces two distinct transcripts encoding different proteins. We utilise three tests of Gli function to examine the transcription regulatory capacities of these different proteins, demonstrating one has activating activity similar to Gli2, while the other acts as a weak repressor, similar to Gli3. Conclusions. These data show that vertebrates and amphioxus have evolved functionally-similar repertoires of Gli proteins using parallel molecular routes; vertebrates via gene duplication and divergence, and amphioxus via alternate splicing of a single gene. Our results demonstrate that similar functional complexity of intercellular signalling can be achieved via different evolutionary pathways.	[Shimeld, Sebastian M.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [van den Heuvel, Marcel; Dawber, Rebecca] Univ Oxford, MRC, Funct Genet Unit, Dept Human Anat & Genet, Oxford OX1 3PS, England; [Briscoe, James] Natl Inst Med Res, London NW7 1AA, England	University of Oxford; University of Oxford; MRC National Institute for Medical Research	Shimeld, SM (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	sebastian.shimeld@zoo.ox.ac.uk		Shimeld, Sebastian/0000-0003-0195-7536; Briscoe, James/0000-0002-1020-5240	MRC; BBSRC; Royal Society; Medical Research Council [MC_U117560541, MC_U137761451] Funding Source: researchfish; MRC [MC_U137761451, MC_U117560541] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank The MRC, BBSRC and Royal Society for support and Michael Schubert for critical comments on the manuscript.	Altaba ARI, 1999, NAT CELL BIOL, V1, pE147, DOI 10.1038/14099; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Aza-Blanc P, 2000, DEVELOPMENT, V127, P4293; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; Boorman CJ, 2002, EVOL DEV, V4, P354, DOI 10.1046/j.1525-142X.2002.02021.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Candiani S, 1998, J COMP NEUROL, V392, P343; Cheng L, 2004, DEV BIOL, V274, P348, DOI 10.1016/j.ydbio.2004.07.020; Currie PD, 1996, NATURE, V382, P452, DOI 10.1038/382452a0; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ferrier DEK, 2001, DEV BIOL, V237, P270, DOI 10.1006/dbio.2001.0375; Ferrier DEK, 2001, DEV GENES EVOL, V211, P103, DOI 10.1007/s004270000124; Gorbman A, 1999, GEN COMP ENDOCR, V113, P251, DOI 10.1006/gcen.1998.7193; Gostling NJ, 2003, EVOL DEV, V5, P136, DOI 10.1046/j.1525-142X.2003.03020.x; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hardcastle Z, 1998, DEVELOPMENT, V125, P2803; Herzog W, 2003, DEV BIOL, V254, P36, DOI 10.1016/S0012-1606(02)00124-0; HOLLAND LZ, 1995, DEV BIOL, V171, P665, DOI 10.1006/dbio.1995.1313; Holland LZ, 1999, EVOL DEV, V1, P153, DOI 10.1046/j.1525-142x.1999.99019.x; HOLLAND PWH, 1991, FEBS LETT, V291, P211, DOI 10.1016/0014-5793(91)81286-H; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; Imai KS, 2004, DEVELOPMENT, V131, P4047, DOI 10.1242/dev.01270; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jackman WR, 2000, DEV BIOL, V220, P16, DOI 10.1006/dbio.2000.9630; Kozmik Z, 2001, GENESIS, V29, P172, DOI 10.1002/gene.1021; Langeland JA, 1998, DEV GENES EVOL, V208, P569, DOI 10.1007/s004270050216; Lee J, 1997, DEVELOPMENT, V124, P2537; Lewis KE, 1999, DEV BIOL, V216, P469, DOI 10.1006/dbio.1999.9519; Lewis KE, 2001, DEVELOPMENT, V128, P3485; Lowe CJ, 2006, PLOS BIOL, V4, P1603, DOI 10.1371/journal.pbio.0040291; Marcelle C, 1997, DEVELOPMENT, V124, P3955; Materna SC, 2006, DEV BIOL, V300, P108, DOI 10.1016/j.ydbio.2006.08.032; Mazet F, 2006, CURR BIOL, V16, pR314, DOI 10.1016/j.cub.2006.03.088; Methot N, 2001, DEVELOPMENT, V128, P733; Miwata K, 2006, DEV BIOL, V292, P546, DOI 10.1016/j.ydbio.2006.01.024; Moore-Scott BA, 2005, DEV BIOL, V278, P323, DOI 10.1016/j.ydbio.2004.10.027; Mullor JL, 2000, DEV BIOL, V228, P211, DOI 10.1006/dbio.2000.9862; NAKAGAWA S, 1995, DEVELOPMENT, V121, P1321; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Norris W, 2000, J CELL SCI, V113, P2695; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Panopoulou G, 2003, GENOME RES, V13, P1056, DOI 10.1101/gr.874803; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; RUPPERT JM, 1988, MOL CELL BIOL, V8, P3104, DOI 10.1128/MCB.8.8.3104; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Sbrogna JL, 2003, DEV BIOL, V254, P19, DOI 10.1016/S0012-1606(02)00027-1; Sharman AC, 1999, DEV GENES EVOL, V209, P260, DOI 10.1007/s004270050251; Shimeld SM, 1999, DEV GENES EVOL, V209, P40, DOI 10.1007/s004270050225; Speek M, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-13; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Takatori N, 2002, MECH DEVELOP, V116, P235, DOI 10.1016/S0925-4773(02)00150-8; Tanimura A, 1998, J VIROL, V72, P3958, DOI 10.1128/JVI.72.5.3958-3964.1998; Tay SY, 2005, DEVELOPMENT, V132, P625, DOI 10.1242/dev.01606; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Venkatesh TV, 1999, DEV GENES EVOL, V209, P254; von Mering C, 1999, CURR BIOL, V9, P1319, DOI 10.1016/S0960-9822(00)80054-8; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Walton KD, 2006, DEV BIOL, V300, P153, DOI 10.1016/j.ydbio.2006.08.064; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang Y, 2002, MECH DEVELOP, V117, P315, DOI 10.1016/S0925-4773(02)00197-1; Yamada L, 2003, DEV GENES EVOL, V213, P245, DOI 10.1007/s00427-003-0316-x; Yasui K, 2000, DEVELOPMENT, V127, P187; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916	75	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e864	10.1371/journal.pone.0000864	http://dx.doi.org/10.1371/journal.pone.0000864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848995	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455600011
J	de Boer, OJ; van der Meer, JJ; Teeling, P; van der Loos, CM; van der Wal, AC				de Boer, Onno J.; van der Meer, Jelger J.; Teeling, Peter; van der Loos, Chris M.; van der Wal, Allard C.			Low Numbers of FOXP3 Positive Regulatory T Cells Are Present in all Developmental Stages of Human Atherosclerotic Lesions	PLOS ONE			English	Article								Background. T cell mediated inflammation contributes to atherogenesis and the onset of acute cardiovascular disease. Effector T cell functions are under a tight control of a specialized T cell subset, regulatory T cells (Treg). At present, nothing is known about the in situ presence of Treg in human atherosclerotic tissue. In the present study we investigated the frequency of naturally occurring Treg cells in all developmental stages of human atherosclerotic lesions including complicated thrombosed plaques. Methodology. Normal arteries, early lesions (American Heart Association classification types I, II, and III), fibrosclerotic plaques (types Vb and Vc) and 'high risk' plaques (types IV, Va and VI) were obtained at surgery and autopsy. Serial sections were immunostained for markers specific for regulatory T cells (FOXP3 and GITR) and the frequency of these cells was expressed as a percentage of the total numbers of CD3(+) T cells. Results were compared with Treg counts in biopsies of normal and inflammatory skin lesions (psoriasis, spongiotic dermatitis and lichen planus). Principle findings. In normal vessel fragments T cells were virtually absent. Treg were present in the intima during all stages of plaque development (0.5-5%). Also in the adventitia of atherosclerotic vessels Treg were encountered, in similar low amounts. High risk lesions contained significantly increased numbers of Treg compared to early lesions (mean: 3.9 and 1.2%, respectively). The frequency of FOXP3(+) cells in high risk lesions was also higher compared to stable lesions (1.7%), but this difference was not significant. The mean numbers of intimal FOXP3 positive cells in atherosclerotic lesions (2.4%) was much lower than those in normal (24.3%) or inflammatory skin lesions (28%). Conclusion. Low frequencies of Treg in all developmental stages of human plaque formation could explain the smoldering chronic inflammatory process that takes place throughout the longstanding course of atherosclerosis.	[de Boer, Onno J.; van der Meer, Jelger J.; Teeling, Peter; van der Loos, Chris M.; van der Wal, Allard C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	de Boer, OJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	o.j.deboer@amc.uva.nl		van der Wal, Allard/0000-0001-5590-3758; de Boer, Onno/0000-0001-8844-1326	Academic Medical Center, University of Amsterdam	Academic Medical Center, University of Amsterdam	Academic Medical Center, University of Amsterdam (no external funding)	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Bacchetta R, 2005, AUTOIMMUN REV, V4, P491, DOI 10.1016/j.autrev.2005.04.005; Crispin JC, 2003, J AUTOIMMUN, V21, P273, DOI 10.1016/S0896-8411(03)00121-5; de Boer OJ, 2007, J HISTOCHEM CYTOCHEM, V55, P891, DOI 10.1369/jhc.6A7119.2007; De Palma R, 2006, CIRCULATION, V113, P640, DOI 10.1161/CIRCULATIONAHA.105.537712; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Engelse MA, 1999, CIRC RES, V85, P931; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hosono M, 2003, ATHEROSCLEROSIS, V168, P73, DOI 10.1016/S0021-9150(03)00024-8; JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; KOVANEN PT, 1995, CIRCULATION, V92, P1084, DOI 10.1161/01.CIR.92.5.1084; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Maggi E, 2005, AUTOIMMUN REV, V4, P579, DOI 10.1016/j.autrev.2005.04.010; Mallat Z, 2003, CIRCULATION, V108, P1232, DOI 10.1161/01.CIR.0000089083.61317.A1; Mor A, 2007, ARTERIOSCL THROM VAS, V27, P893, DOI 10.1161/01.ATV.0000259365.31469.89; Mor A, 2006, EUR HEART J, V27, P2530, DOI 10.1093/eurheartj/ehl222; Palinski W, 2000, J INTERN MED, V247, P371, DOI 10.1046/j.1365-2796.2000.00656.x; Roncador G, 2005, EUR J IMMUNOL, V35, P1681, DOI 10.1002/eji.200526189; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sardella G, 2007, THROMB RES, V120, P631, DOI 10.1016/j.thromres.2006.12.005; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Sommeijer DW, 2004, J HISTOCHEM CYTOCHEM, V52, P1141, DOI 10.1369/jhc.3A6207.2004; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; van der Wal AC, 1998, HEART, V80, P14, DOI 10.1136/hrt.80.1.14; VANDERWAL AC, 1989, LAB INVEST, V61, P166; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Zhou XH, 2000, CIRCULATION, V102, P2919	32	186	190	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e779	10.1371/journal.pone.0000779	http://dx.doi.org/10.1371/journal.pone.0000779			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712427	Green Submitted, gold, Green Published			2022-12-27	WOS:000207455300027
J	Popescu, F; Fazli, S; Badower, Y; Blankertz, B; Muller, KR				Popescu, Florin; Fazli, Siamac; Badower, Yakob; Blankertz, Benjamin; Mueller, Klaus-R.			Single Trial Classification of Motor Imagination Using 6 Dry EEG Electrodes	PLOS ONE			English	Article								Background. Brain computer interfaces (BCI) based on electro-encephalography (EEG) have been shown to detect mental states accurately and non-invasively, but the equipment required so far is cumbersome and the resulting signal is difficult to analyze. BCI requires accurate classification of small amplitude brain signal components in single trials from recordings which can be compromised by currents induced by muscle activity. Methodology/Principal Findings. A novel EEG cap based on dry electrodes was developed which does not need time-consuming gel application and uses far fewer electrodes than on a standard EEG cap set-up. After optimizing the placement of the 6 dry electrodes through off-line analysis of standard cap experiments, dry cap performance was tested in the context of a well established BCI cursor control paradigm in 5 healthy subjects using analysis methods which do not necessitate user training. The resulting information transfer rate was on average about 30% slower than the standard cap. The potential contribution of involuntary muscle activity artifact to the BCI control signal was found to be inconsequential, while the detected signal was consistent with brain activity originating near the motor cortex. Conclusions/Significance. Our study shows that a surprisingly simple and convenient method of brain activity imaging is possible, and that simple and robust analysis techniques exist which discriminate among mental states in single trials. Within 15 minutes the dry BCI device is set-up, calibrated and ready to use. Peak performance matched reported EEG BCI state of the art in one subject. The results promise a practical non-invasive BCI solution for severely paralyzed patients, without the bottleneck of setup effort and limited recording duration that hampers current EEG recording technique. The presented recording method itself, BCI not considered, could significantly widen the use of EEG for emerging applications requiring longterm brain activity and mental state monitoring.	[Popescu, Florin; Fazli, Siamac; Badower, Yakob; Blankertz, Benjamin; Mueller, Klaus-R.] Fraunhofer Inst FIRST, Intelligent Data Anal Lab, Berlin, Germany; [Blankertz, Benjamin; Mueller, Klaus-R.] Tech Univ Berlin, Machine Learning Lab, Berlin, Germany	Fraunhofer Gesellschaft; Technical University of Berlin	Popescu, F (corresponding author), Fraunhofer Inst FIRST, Intelligent Data Anal Lab, Berlin, Germany.	florin.popescu@first.fhg.de	Mueller, Klaus-Robert/Y-3547-2019; Muller, Klaus R/C-3196-2013; Fazli, Siamac/GYQ-9627-2022; Fazli, Siamac/D-7720-2013	Mueller, Klaus-Robert/0000-0002-3861-7685; Fazli, Siamac/0000-0003-3397-0647; Blankertz, Benjamin/0000-0002-2437-4846	European Union's Marie Curie Excellence Team [MEXT-CT-2004-014194]	European Union's Marie Curie Excellence Team	Funding: This work was supported by the European Union's Marie Curie Excellence Team project MEXT-CT-2004-014194, entitled "BRAIN2ROBOT"	Birbaumer N, 2003, IEEE T NEUR SYS REH, V11, P120, DOI 10.1109/TNSRE.2003.814439; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; BLANKERTZ B, 2007, NEUROIMAGE IN PRESS; Blankertz B, 2006, J UNIVERS COMPUT SCI, V12, P581; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P153, DOI 10.1109/TNSRE.2006.875642; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P147, DOI 10.1109/TNSRE.2006.875557; Bonnet MH, 2001, PHYSIOL BEHAV, V74, P291, DOI 10.1016/S0031-9384(01)00581-9; Dornhege G., 2007, BRAIN COMPUTER INTER; Falco C, 2005, CLIN NEUROPHYSIOL, V116, P1771, DOI 10.1016/j.clinph.2005.04.012; FARQUHAR J, 2006, REGULARISED CSP SENS, P14; Koles ZJ, 1998, ELECTROEN CLIN NEURO, V107, P343, DOI 10.1016/S0013-4694(98)00084-4; KRAULEDAT M, 2007, ADV NEURAL INF PROC; Lemm S, 2005, IEEE T BIO-MED ENG, V52, P1541, DOI 10.1109/TBME.2005.851521; Niedermeyer E., 1999, ELECTROENCEPHALOGRAP; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; WENTRUP MG, 2005, NEUR ENG 2005 C P 2, P128; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	17	133	142	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e637	10.1371/journal.pone.0000637	http://dx.doi.org/10.1371/journal.pone.0000637			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653264	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452200006
J	Sugaya, K; Matsubara, S; Kagamihara, Y; Kawata, A; Hayashi, H				Sugaya, Keizo; Matsubara, Shiro; Kagamihara, Yasuhiro; Kawata, Akihiro; Hayashi, Hideaki			Polyglutamine Expansion Mutation Yields a Pathological Epitope Linked to Nucleation of Protein Aggregate: Determinant of Huntington's Disease Onset	PLOS ONE			English	Article								Polyglutamine (polyQ) expansion mutation causes conformational, neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. These diseases are characterized by the aggregation of misfolded proteins, such as amyloid fibrils, which are toxic to cells. Amyloid fibrils are formed by a nucleated growth polymerization reaction. Unexpectedly, the critical nucleus of polyQ aggregation was found to be a monomer, suggesting that the rate-limiting nucleation process of polyQ aggregation involves the folding of mutated protein monomers. The monoclonal antibody 1C2 selectively recognizes expanded pathogenic and aggregate-prone glutamine repeats in polyQ diseases, including Huntington's disease (HD), as well as binding to polyleucine. We have therefore assayed the in vitro and in vivo aggregation kinetics of these monomeric proteins. We found that the repeat-length-dependent differences in aggregation lag times of variable lengths of polyQ and polyleucine tracts were consistently related to the integration of the length-dependent intensity of anti-1C2 signal on soluble monomers of these proteins. Surprisingly, the correlation between the aggregation lag times of polyQ tracts and the intensity of anti-1C2 signal on soluble monomers of huntingtin precisely reflected the repeat-length dependent age-of-onset of HD patients. These data suggest that the alterations in protein surface structure due to polyQ expansion mutation in soluble monomers of the mutated proteins act as an amyloid-precursor epitope. This, in turn, leads to nucleation, a key process in protein aggregation, thereby determining HD onset. These findings provide new insight into the gain-of-function mechanisms of polyQ diseases, in which polyQ expansion leads to nucleation rather than having toxic effects on the cells.	[Sugaya, Keizo; Matsubara, Shiro; Kagamihara, Yasuhiro; Kawata, Akihiro; Hayashi, Hideaki] Tokyo Metropolitan Neurol Hosp, Dept Neurol, Tokyo, Japan	Tokyo Metropolitan Institute for Neuroscience	Sugaya, K (corresponding author), Tokyo Metropolitan Neurol Hosp, Dept Neurol, Tokyo, Japan.	keizo_sugaya@member.metro.tokyo.jp		Sugaya, Kiminobu/0000-0002-2788-5457	Tokyo Metropolitan Government	Tokyo Metropolitan Government(Tokyo Metropolitan Government)	Funding: This study was funded by the Tokyo Metropolitan Government.	Bates G, 1996, BIOESSAYS, V18, P175, DOI 10.1002/bies.950180303; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Di Prospero NA, 2005, NAT REV GENET, V6, P756, DOI 10.1038/nrg1690; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Dorsman JC, 2002, HUM MOL GENET, V11, P1487, DOI 10.1093/hmg/11.13.1487; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Heiser V, 2000, P NATL ACAD SCI USA, V97, P6739, DOI 10.1073/pnas.110138997; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lunkes A, 1999, PHILOS T R SOC B, V354, P1013, DOI 10.1098/rstb.1999.0453; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Nagai Y, 2003, HUM MOL GENET, V12, P1253, DOI 10.1093/hmg/ddg144; Page KJ, 1998, EUR J NEUROSCI, V10, P1835, DOI 10.1046/j.1460-9568.1998.00185.x; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Rong J, 2006, J NEUROSCI, V26, P6019, DOI 10.1523/JNEUROSCI.1251-06.2006; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Thompson AJ, 2002, CURR MED CHEM, V9, P1751; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	32	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e635	10.1371/journal.pone.0000635	http://dx.doi.org/10.1371/journal.pone.0000635			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653262	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452200004
J	Adhikary, D; Behrends, U; Boerschmann, H; Pfunder, A; Burdach, S; Moosmann, A; Witter, K; Bornkamm, GW; Mautner, J				Adhikary, Dinesh; Behrends, Uta; Boerschmann, Heike; Pfuender, Andrea; Burdach, Stefan; Moosmann, Andreas; Witter, Klaus; Bornkamm, Georg W.; Mautner, Josef			Immunodominance of Lytic Cycle Antigens in Epstein-Barr Virus-Specific CD4+T Cell Preparations for Therapy	PLOS ONE			English	Article								Background. Epstein-Barr virus (EBV) is associated with a number of human malignancies. EBV-positive post-transplant lymphoproliferative disease in solid organ and hematopoietic stem cell transplant recipients has been successfully treated by the adoptive transfer of polyclonal EBV-specific T cell lines containing CD4+ and CD8+ T cell components. Although patients receiving T cell preparations with a higher CD4+ T cell proportion show better clinical responses, the specificity of the infused CD4+ component has remained completely unknown. Methodology/Principal Findings. We generated LCL-stimulated T cell lines from 21 donors according to clinical protocols, and analyzed the antigen specificity of the CD4+ component in EBV-specific T cell preparations using a genetically engineered EBV mutant that is unable to enter the lytic cycle, and recombinantly expressed and purified EBV proteins. Surprisingly, CD4+ T cell lines from acutely and persistently EBV-infected donors consistently responded against EBV lytic cycle antigens and autoantigens, but barely against latent cycle antigens of EBV hitherto considered principal immunotherapeutic targets. Lytic cycle antigens were predominantly derived from structural proteins of the virus presented on MHC II via receptor-mediated uptake of released viral particles, but also included abundant infected cell proteins whose presentation involved intercellular protein transfer. Importantly, presentation of virion antigens was severely impaired by acyclovir treatment of stimulator cells, as currently performed in most clinical protocols. Conclusions/Significance. These results indicate that structural antigens of EBV are the immunodominant targets of CD4+ T cells in LCL-stimulated T cell preparations. These findings add to our understanding of the immune response against this human tumor-virus and have important implications for the improvement of immunotherapeutic strategies against EBV.	[Adhikary, Dinesh; Behrends, Uta; Bornkamm, Georg W.; Mautner, Josef] GSF Natl Res Ctr Environm & Hlth, Inst Clin & Mol Biol, Clin Cooperat Grp, Munich, Germany; [Adhikary, Dinesh; Behrends, Uta; Boerschmann, Heike; Pfuender, Andrea; Burdach, Stefan; Mautner, Josef] Univ Technol, Childrens Hosp, Munich, Germany; [Moosmann, Andreas] Univ Munich, GSF Natl Res Ctr Environm & Hlth, Dept Gene Vectors, Clin Cooperat Grp Mol Oncol, Munich, Germany; [Moosmann, Andreas] Univ Munich, Dept Otorhinolaryngol, Munich, Germany; [Witter, Klaus] Univ Munich, Immunogenet Lab, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Munich	Mautner, J (corresponding author), GSF Natl Res Ctr Environm & Hlth, Inst Clin & Mol Biol, Clin Cooperat Grp, Munich, Germany.	mautner@gsf.de		Moosmann, Andreas/0000-0001-8044-5146	Deutsche Forschungsgemeinschaft [SFB455]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (SFB455).	Adhikary D, 2006, J EXP MED, V203, P995, DOI 10.1084/jem.20051287; Bollard CM, 2004, J EXP MED, V200, P1623, DOI 10.1084/jem.20040890; Davis JE, 2004, TISSUE ANTIGENS, V63, P285, DOI 10.1111/j.0001-2815.2004.00227.x; Dolcetti R, 2003, J CELL PHYSIOL, V196, P207, DOI 10.1002/jcp.10263; Feederle R, 2006, J VIROL, V80, P9435, DOI 10.1128/JVI.00473-06; Feng WH, 2002, CANCER RES, V62, P1920; Foster AE, 2006, EXPERT OPIN BIOL TH, V6, P215, DOI 10.1517/14712598.6.3.215; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Gottschalk S, 2005, ANNU REV MED, V56, P29, DOI 10.1146/annurev.med.56.082103.104727; Gottschalk S, 2005, LEUKEMIA LYMPHOMA, V46, P1, DOI 10.1080/10428190400002202; Gudgeon NH, 2005, J VIROL, V79, P5477, DOI 10.1128/JVI.79.9.5477-5488.2005; GUSSONI E, 1997, EVALUATING HUMAN T C; Haahr S, 2006, REV MED VIROL, V16, P297, DOI 10.1002/rmv.503; Haque T, 2002, LANCET, V360, P436, DOI 10.1016/S0140-6736(02)09672-1; HAQUE T, 2007, BLOOD IN PRESS; Heller KN, 2006, J EXP MED, V203, P805, DOI 10.1084/jem.20060215; Ho WY, 2003, CANCER CELL, V3, P431, DOI 10.1016/S1535-6108(03)00113-2; Israel BF, 2003, ONCOGENE, V22, P5122, DOI 10.1038/sj.onc.1206548; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; Khanna R, 1997, J IMMUNOL, V158, P3619; Khanna R, 1995, VIROLOGY, V214, P633, DOI 10.1006/viro.1995.0076; KHANNA R, 1992, J EXP MED, V176, P169, DOI 10.1084/jem.176.1.169; Khanna R, 2000, ANNU REV MICROBIOL, V54, P19, DOI 10.1146/annurev.micro.54.1.19; KIEFF E, 2006, FIELDS VIROLOGY, P2603; Kimura H, 1999, J CLIN MICROBIOL, V37, P132, DOI 10.1128/JCM.37.1.132-136.1999; Kuppers R, 2003, NAT REV IMMUNOL, V3, P801, DOI 10.1038/nri1201; Landais E, 2005, J IMMUNOL, V175, P7939, DOI 10.4049/jimmunol.175.12.7939; Landais E, 2005, INT J DEV BIOL, V49, P285, DOI 10.1387/ijdb.041947el; Leen A, 2001, J VIROL, V75, P8649, DOI 10.1128/JVI.75.18.8649-8659.2001; Mautner J, 2004, EUR J IMMUNOL, V34, P2500, DOI 10.1002/eji.200324794; Moosmann A, 2002, BLOOD, V100, P1755, DOI 10.1182/blood.V100.5.1755.h81702001755_1755_1764; Moss P, 2005, NAT REV IMMUNOL, V5, P9, DOI 10.1038/nri1526; Munz C, 2000, J EXP MED, V191, P1649, DOI 10.1084/jem.191.10.1649; MURRAY RJ, 1992, J EXP MED, V176, P157, DOI 10.1084/jem.176.1.157; Nimmerjahn F, 2003, EUR J IMMUNOL, V33, P3331, DOI 10.1002/eji.200324342; Nimmerjahn F, 2003, EUR J IMMUNOL, V33, P1250, DOI 10.1002/eji.200323730; Papesch M, 2001, CLIN OTOLARYNGOL, V26, P3, DOI 10.1046/j.1365-2273.2001.00431.x; Poole BD, 2006, AUTOIMMUNITY, V39, P63, DOI 10.1080/08916930500484849; Pudney VA, 2005, J EXP MED, V201, P349, DOI 10.1084/jem.20041542; Rickinson A.B., 2006, FIELDS VIROLOGY, P2655; Rooney C M, 1998, J Natl Cancer Inst Monogr, P89; Rooney CM, 1998, BLOOD, V92, P1549, DOI 10.1182/blood.V92.5.1549.417k32_1549_1555; ROONEY CM, 1995, LANCET, V345, P9, DOI 10.1016/S0140-6736(95)91150-2; Savoldo B, 2006, BLOOD, V108, P2942, DOI 10.1182/blood-2006-05-021782; Sawada S, 2005, AUTOIMMUN REV, V4, P106, DOI 10.1016/j.autrev.2004.08.034; Steven NM, 1997, J EXP MED, V185, P1605, DOI 10.1084/jem.185.9.1605; Tan LC, 1999, J IMMUNOL, V162, P1827; Taylor GS, 2006, J IMMUNOL, V177, P3746, DOI 10.4049/jimmunol.177.6.3746; Tey SK, 2006, IMMUNOL CELL BIOL, V84, P281, DOI 10.1111/j.1440-1711.2006.01441.x; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Wilkie GM, 2004, J IMMUNOTHER, V27, P309, DOI 10.1097/00002371-200407000-00007; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	52	61	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2007	2	7							e583	10.1371/journal.pone.0000583	http://dx.doi.org/10.1371/journal.pone.0000583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GG	17611619	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451900003
J	McNaghten, AD; Wolfe, MI; Onorato, I; Nakashima, AK; Valdiserri, RO; Mokotoff, E; Romaguera, RA; Kroliczak, A; Janssen, RS; Sullivan, PS				McNaghten, A. D.; Wolfe, Mitchell I.; Onorato, Ida; Nakashima, Allyn K.; Valdiserri, Ronald O.; Mokotoff, Eve; Romaguera, Raul A.; Kroliczak, Alice; Janssen, Robert S.; Sullivan, Patrick S.			Improving the Representativeness of Behavioral and Clinical Surveillance for Persons with HIV in the United States: The Rationale for Developing a Population-Based Approach	PLOS ONE			English	Article							PNEUMOCYSTIS-CARINII-PNEUMONIA; NATIONAL PROBABILITY SAMPLES; LOW-PREVALENCE DISEASES; CRACK COCAINE USE; ANTIRETROVIRAL THERAPY; RISK BEHAVIORS; AIDS; CHEMOPROPHYLAXIS; SURVIVAL; MEN	The need for a new surveillance approach to understand the clinical outcomes and behaviors of people in care for HIV evolved from the new challenges for monitoring clinical outcomes in the HAART era, the impact of the epidemic on an increasing number of areas in the US, and the need for representative data to describe the epidemic and related resource utilization and needs. The Institute of Medicine recommended that the Centers for Disease Control and Prevention and the Heath Resources and Services Administration coordinate efforts to survey a random sample of HIV-infected persons in care, in order to more accurately measure the need for prevention and care services. The Medical Monitoring Project (MMP) was created to meet these needs. This manuscript describes the evolution and design of MMP, a new nationally representative clinical outcomes and behavioral surveillance system, and describes how MMP data will be used locally and nationally to identify care and treatment utilization needs, and to plan for prevention interventions and services.	[McNaghten, A. D.; Wolfe, Mitchell I.; Onorato, Ida; Nakashima, Allyn K.; Valdiserri, Ronald O.; Romaguera, Raul A.; Janssen, Robert S.; Sullivan, Patrick S.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Mokotoff, Eve] Michigan Dept Community Hlth, Detroit, MI USA; [Kroliczak, Alice] US Hlth Resources & Serv Adm, Rockville, MD 20857 USA	Centers for Disease Control & Prevention - USA; United States Health Resources & Service Administration (HRSA)	McNaghten, AD (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	aom5@cdc.gov		Sullivan, Patrick Sean/0000-0002-7728-0587				Buehler JW, 1996, PUBLIC HEALTH REP, V111, P133; Campsmith Michael L, 2003, Health Qual Life Outcomes, V1, P12, DOI 10.1186/1477-7525-1-12; Campsmith ML, 2000, J ACQ IMMUN DEF SYND, V25, P192, DOI 10.1097/00126334-200010010-00015; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; *CDCP, 2003, GUID HIV PREV COMM P; *CDCP, 2001, HIV PREV STRAT PLAN; *CDCP, 2006, HIV AIDS SURV REP 20, V17, P1; *CDCP, 2004, HIV AIDS SURV REP 20, V15, P1; *CDCP, 2003, HIPAA PRIV RUL PUBL; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P329; Centers for Disease Control and Prevention, 2003, MMWR MORB MORTAL WKL, V52, P581; Centers for Disease Control and Prevention, 1985, MMWR-MORBID MORTAL W, V34, P373; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; CHAISSON RE, 1993, AIDS, V7, P857, DOI 10.1097/00002030-199306000-00015; DIAZ T, 1993, AIDS, V7, P1227, DOI 10.1097/00002030-199309000-00012; DIAZ T, 1993, JAMA-J AM MED ASSOC, V269, P2845, DOI 10.1001/jama.1993.03500220031012; Dworkin MS, 2001, J INFECT DIS, V183, P1409, DOI 10.1086/319866; Dworkin MS, 2000, J INFECT DIS, V182, P611, DOI 10.1086/315734; Dybul Mark, 2002, MMWR Recomm Rep, V51, P1; FARIZO KM, 1992, JAMA-J AM MED ASSOC, V267, P1798, DOI 10.1001/jama.267.13.1798; Fleming PL, 2000, AM J PUBLIC HEALTH, V90, P1037, DOI 10.2105/AJPH.90.7.1037; Frankel MR, 1999, HEALTH SERV RES, V34, P969; Gange SJ, 2007, INT J EPIDEMIOL; Glynn MK, 2007, PUBLIC HEALTH REP, V122, P63, DOI 10.1177/00333549071220S110; GOSTIN LO, LEG SURV STAT CONF L; Hall HI, 2005, J RURAL HEALTH, V21, P245, DOI 10.1111/j.1748-0361.2005.tb00090.x; HANSON DL, 1995, ARCH INTERN MED, V155, P1537, DOI 10.1001/archinte.155.14.1537; *HLTH ED RES TRUST, HIV LAWS IND STAT; *HLTH RES SERV ADM, GOV PERF RES ACT FIN; *HLTH RES SERV ADM, TITL 1 GRANTS EL MET; Holmberg SD, 1998, JAMA-J AM MED ASSOC, V279, P384, DOI 10.1001/jama.279.5.384; *I MED, 2004, MEAS WHAT MATT ALL P, P1; Jones JL, 2000, INT J TUBERC LUNG D, V4, P1026; Jones JL, 2000, J ACQ IMMUN DEF SYND, V24, P270; *KAIS FAM FDN, TOT RYAN WHIT CARE A; Kaplan Jonathan E, 2002, MMWR Recomm Rep, V51, P1; Karon JM, 1997, J ACQ IMMUN DEF SYND, V16, P116, DOI 10.1097/00042560-199710010-00007; Kellerman SE, 2002, JAIDS-J ACQ IMM DEF, V31, P202, DOI 10.1097/00126334-200210010-00011; Kitahata MM, 2003, J GEN INTERN MED, V18, P95, DOI 10.1046/j.1525-1497.2003.11049.x; Lansky A, 2000, SEX TRANSM DIS, V27, P483, DOI 10.1097/00007435-200009000-00012; Matthews GW, 2000, PRINCIPLES PRACTICE, P215; McNaghten AD, 2003, JAIDS-J ACQ IMM DEF, V32, P499, DOI 10.1097/00126334-200304150-00006; McNaghten AD, 1999, AIDS, V13, P1687, DOI 10.1097/00002030-199909100-00012; Montgomery JP, 2003, AIDS CARE, V15, P829, DOI 10.1080/09540120310001618676; Moorman AC, 1998, J ACQ IMMUN DEF SYND, V19, P182, DOI 10.1097/00042560-199810010-00013; Moorman AC, 1999, ANN EPIDEMIOL, V9, P349, DOI 10.1016/S1047-2797(99)00005-8; Nakashima AK, 2003, JAIDS-J ACQ IMM DEF, V32, pS68, DOI 10.1097/00126334-200302011-00011; NEAL JJ, 2002, 9 C RETR OPP INF; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Rosenberg PS, 1998, JAMA-J AM MED ASSOC, V279, P1894, DOI 10.1001/jama.279.23.1894; Shapiro MF, 1999, HEALTH SERV RES, V34, P951; Sullivan PS, 2005, PUBLIC HEALTH REP, V120, P230, DOI 10.1177/003335490512000304; Sullivan PS, 1998, J ACQ IMMUN DEF SYND, V19, P266, DOI 10.1097/00042560-199811010-00009; United States Department of Health and Human Services, 2000, HLTH PEOPL 2010, V1; Weidle PJ, 1999, AIDS, V13, pS61	55	57	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2007	2	6							e550	10.1371/journal.pone.0000550	http://dx.doi.org/10.1371/journal.pone.0000550			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GE	17579722	Green Published, gold			2022-12-27	WOS:000207451700016
J	Yap, JS; Wang, CG; Wu, RL				Yap, John Stephen; Wang, Chenguang; Wu, Rongling			A Computational Approach for Functional Mapping of Quantitative Trait Loci That Regulate Thermal Performance Curves	PLOS ONE			English	Article								Whether and how thermal reaction norm is under genetic control is fundamental to understand the mechanistic basis of adaptation to novel thermal environments. However, the genetic study of thermal reaction norm is difficult because it is often expressed as a continuous function or curve. Here we derive a statistical model for dissecting thermal performance curves into individual quantitative trait loci (QTL) with the aid of a genetic linkage map. The model is constructed within the maximum likelihood context and implemented with the EM algorithm. It integrates the biological principle of responses to temperature into a framework for genetic mapping through rigorous mathematical functions established to describe the pattern and shape of thermal reaction norms. The biological advantages of the model lie in the decomposition of the genetic causes for thermal reaction norm into its biologically interpretable modes, such as hotter-colder, faster-slower and generalist-specialist, as well as the formulation of a series of hypotheses at the interface between genetic actions/interactions and temperature-dependent sensitivity. The model is also meritorious in statistics because the precision of parameter estimation and power of QTLdetection can be increased by modeling the mean-covariance structure with a small set of parameters. The results from simulation studies suggest that the model displays favorable statistical properties and can be robust in practical genetic applications. The model provides a conceptual platform for testing many ecologically relevant hypotheses regarding organismic adaptation within the Eco-Devo paradigm.	[Yap, John Stephen; Wang, Chenguang; Wu, Rongling] Univ Florida, Dept Stat, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Wu, RL (corresponding author), Univ Florida, Dept Stat, Gainesville, FL 32611 USA.	rwu@mail.ifas.ufl.edu			NSF [0540745]; NIH [R01 NS041670]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041670] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The preparation of this manuscript is supported by NSF grant (0540745) and NIH grant (R01 NS041670) to R. W.	Angilletta MJ, 2003, TRENDS ECOL EVOL, V18, P234, DOI 10.1016/S0169-5347(03)00087-9; Arthur W, 2002, NATURE, V415, P757, DOI 10.1038/415757a; Brett JR, 1979, FISH PHYSIOL, V8, P599, DOI DOI 10.1016/S1546-5098(08)60033-3; CARROLL RJ, 1984, J AM STAT ASSOC, V79, P321, DOI 10.2307/2288271; Cronk QCB, 2005, NEW PHYTOL, V166, P39, DOI 10.1111/j.1469-8137.2005.01369.x; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Dusheck J, 2002, NATURE, V418, P578, DOI 10.1038/418578a; Elliott J.M., 1994, QUANTITATIVE ECOLOGY; GILCHRIST GW, 1995, AM NAT, V146, P252, DOI 10.1086/285797; GOMULKIEWICZ R, 1992, EVOLUTION, V46, P390, DOI [10.2307/2409860, 10.1111/j.1558-5646.1992.tb02047.x]; HUEY RB, 1979, AM ZOOL, V19, P357; HUEY RB, 1993, AM NAT, V142, pS21, DOI 10.1086/285521; HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5; Izem R, 2005, AM NAT, V166, P277, DOI 10.1086/431314; JANSEN RC, 1994, GENETICS, V136, P1447; JIANG CJ, 1995, GENETICS, V140, P1111; Kingsolver JG, 2004, EVOLUTION, V58, P1521, DOI 10.1111/j.0014-3820.2004.tb01732.x; Kingsolver JG, 2001, GENETICA, V112, P87, DOI 10.1023/A:1013323318612; KOROL AB, 1995, GENETICS, V140, P1137; LANDER ES, 1989, GENETICS, V121, P185; Lynch M., 1998, GENETICS ANAL QUANTI; Ma CX, 2002, GENETICS, V161, P1751; Ojanguren AF, 2001, J THERM BIOL, V26, P165, DOI 10.1016/S0306-4565(00)00038-3; PELLETIER D, 1995, J EXP BIOL, V198, P1493; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Somero G. N., 1996, ANIMALS TEMPERATURE, P53; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; Wu RL, 2006, NAT REV GENET, V7, P229, DOI 10.1038/nrg1804; Wu RL, 2004, BIOMETRICS, V60, P729, DOI 10.1111/j.0006-341X.2004.00223.x; XU SH, 1995, GENETICS, V141, P1189; YANG RQ, 2006, GENETICS; ZENG ZB, 1994, GENETICS, V136, P1457; Zhao W, 2005, BIOINFORMATICS, V21, P2469, DOI 10.1093/bioinformatics/bti382; Zimmerman DL, 2001, TEST-SPAIN, V10, P1, DOI 10.1007/BF02595823	39	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2007	2	6							e554	10.1371/journal.pone.0000554	http://dx.doi.org/10.1371/journal.pone.0000554			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GE	17579725	Green Published, gold, Green Submitted			2022-12-27	WOS:000207451700019
J	Shin, SL; Hoebeek, FE; Schonewille, M; De Zeeuw, CI; Aertsen, A; De Schutter, E				Shin, Soon-Lim; Hoebeek, Freek E.; Schonewille, Martijn; De Zeeuw, Chris I.; Aertsen, Ad; De Schutter, Erik			Regular Patterns in Cerebellar Purkinje Cell Simple Spike Trains	PLOS ONE			English	Article							LONG-TERM DEPRESSION; IN-VITRO; NEURONS; RAT; RESPONSES; SYNAPSES; COMPLEX; LTD; SYNCHRONIZATION; TRANSMISSION	Background. Cerebellar Purkinje cells (PC) in vivo are commonly reported to generate irregular spike trains, documented by high coefficients of variation of interspike-intervals (ISI). In strong contrast, they fire very regularly in the in vitro slice preparation. We studied the nature of this difference in firing properties by focusing on short-term variability and its dependence on behavioral state. Methodology/Principal Findings. Using an analysis based on CV2 values, we could isolate precise regular spiking patterns, lasting up to hundreds of milliseconds, in PC simple spike trains recorded in both anesthetized and awake rodents. Regular spike patterns, defined by low variability of successive ISIs, comprised over half of the spikes, showed a wide range of mean ISIs, and were affected by behavioral state and tactile stimulation. Interestingly, regular patterns often coincided in nearby Purkinje cells without precise synchronization of individual spikes. Regular patterns exclusively appeared during the up state of the PC membrane potential, while single ISIs occurred both during up and down states. Possible functional consequences of regular spike patterns were investigated by modeling the synaptic conductance in neurons of the deep cerebellar nuclei (DCN). Simulations showed that these regular patterns caused epochs of relatively constant synaptic conductance in DCN neurons. Conclusions/Significance. Our findings indicate that the apparent irregularity in cerebellar PC simple spike trains in vivo is most likely caused by mixing of different regular spike patterns, separated by single long intervals, over time. We propose that PCs may signal information, at least in part, in regular spike patterns to downstream DCN neurons.	[Shin, Soon-Lim; De Schutter, Erik] Univ Antwerp, B-2020 Antwerp, Belgium; [Hoebeek, Freek E.; Schonewille, Martijn; De Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Aertsen, Ad] Univ Freiburg, Fac Biol, Freiburg, Germany; [Aertsen, Ad] Univ Freiburg, Bernstein Ctr Computat Neurosci, Freiburg, Germany; [De Schutter, Erik] Okinawa Inst Sci & Technol, Computat Neurosci Unit, Okinawa, Japan	University of Antwerp; Erasmus University Rotterdam; Erasmus MC; University of Freiburg; University of Freiburg; Okinawa Institute of Science & Technology Graduate University	De Schutter, E (corresponding author), Univ Antwerp, B-2020 Antwerp, Belgium.	erik@tnb.ua.ac.be	De Schutter, Erik/G-8460-2011; Schonewille, Martijn/E-6170-2013	De Schutter, Erik/0000-0001-8618-5138; 	European Commission; IUAP; GSKE; FWO; NOW; NeuroBsik; Prinses Beatrix Fonds; BMBF	European Commission(European CommissionEuropean Commission Joint Research Centre); IUAP; GSKE; FWO(FWO); NOW; NeuroBsik; Prinses Beatrix Fonds; BMBF(Federal Ministry of Education & Research (BMBF))	This study was funded by the European Commission, in Belgium by IUAP, GSKE, FWO, in the Netherlands by NOW, NeuroBsik, Prinses Beatrix Fonds, and in Germany by the BMBF. These organisations had not influence on the study design, collection, analysis, interpretation of data; or writing of the paper; and on the decision to submit it for publication to PloS One.	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; Chan-Palay V, 1977, CEREBELLAR DENTATE N; Coltz JD, 1999, J NEUROSCI, V19, P1782; DEZEEUW CI, 1994, J COMP NEUROL, V349, P428, DOI 10.1002/cne.903490308; EGGERMONT JJ, 1995, NEUROREPORT, V6, P2125, DOI 10.1097/00001756-199511000-00007; Gauck V, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-15-j0004.2001; Goossens HHLM, 2004, EUR J NEUROSCI, V19, P687, DOI 10.1111/j.0953-816X.2003.03173.x; Goossens J, 2001, J NEUROSCI, V21, P5813, DOI 10.1523/JNEUROSCI.21-15-05813.2001; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Heil P, 2004, CURR OPIN NEUROBIOL, V14, P461, DOI 10.1016/j.conb.2004.07.002; Hoebeek FE, 2005, NEURON, V45, P953, DOI 10.1016/j.neuron.2005.02.012; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; JAEGER D, 1994, EXP BRAIN RES, V100, P200; Jorntell H, 2003, J NEUROSCI, V23, P9620; Kistler WM, 2002, NEURAL COMPUT, V14, P2597, DOI 10.1162/089976602760407991; Kitazawa S, 1998, NATURE, V392, P494, DOI 10.1038/33141; Koch Christof, 1999, P1; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Konishi M, 2003, ANNU REV NEUROSCI, V26, P31, DOI 10.1146/annurev.neuro.26.041002.131123; LeDoux MS, 1998, NEUROSCIENCE, V86, P533, DOI 10.1016/S0306-4522(98)00007-4; Loewenstein Y, 2005, NAT NEUROSCI, V8, P202, DOI 10.1038/nn1393; Maex R, 2000, J PHYSIOL-LONDON, V523, P175, DOI 10.1111/j.1469-7793.2000.t01-1-00175.x; Ohyama T, 2003, TRENDS NEUROSCI, V26, P222, DOI 10.1016/S0166-2236(03)00054-7; Pedroarena CM, 2003, J NEUROPHYSIOL, V89, P704, DOI 10.1152/jn.00558.2002; Raman IM, 1999, J NEUROSCI, V19, P1663; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Rieke F., 1997, SPIKES EXPLORING NEU; Schonewille M, 2006, NAT NEUROSCI, V9, P459, DOI 10.1038/nn0406-459; SHIDARA M, 1993, NATURE, V365, P50, DOI 10.1038/365050a0; Shin SL, 2007, EUR J NEUROSCI, V25, P785, DOI 10.1111/j.1460-9568.2007.05308.x; Shin SL, 2006, J NEUROPHYSIOL, V96, P3485, DOI 10.1152/jn.00570.2006; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Steuber V, 2007, NEURON, V54, P121, DOI 10.1016/j.neuron.2007.03.015; Telgkamp P, 2002, J NEUROSCI, V22, P8447; Telgkamp P, 2004, NEURON, V41, P113, DOI 10.1016/S0896-6273(03)00802-X; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Vos BP, 1999, EUR J NEUROSCI, V11, P2621, DOI 10.1046/j.1460-9568.1999.00678.x; Vos BP, 1999, J NEUROSCI, V19; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648	44	84	84	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2007	2	5							e485	10.1371/journal.pone.0000485	http://dx.doi.org/10.1371/journal.pone.0000485			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10FB	17534435	Green Published, gold			2022-12-27	WOS:000207448800015
J	Aris-Brosou, S				Aris-Brosou, Stephane			Dating Phylogenies with Hybrid Local Molecular Clocks	PLOS ONE			English	Article								Background. Because rates of evolution and species divergence times cannot be estimated directly from molecular data, all current dating methods require that specific assumptions be made before inferring any divergence time. These assumptions typically bear either on rates of molecular evolution (molecular clock hypothesis, local clocks models) or on both rates and times (penalized likelihood, Bayesian methods). However, most of these assumptions can affect estimated dates, oftentimes because they underestimate large amounts of rate change. Principal Findings. A significant modification to a recently proposed ad hoc rate-smoothing algorithm is described, in which local molecular clocks are automatically placed on a phylogeny. This modification makes use of hybrid approaches that borrow from recent theoretical developments in microarray data analysis. An ad hoc integration of phylogenetic uncertainty under these local clock models is also described. The performance and accuracy of the new methods are evaluated by reanalyzing three published data sets. Conclusions. It is shown that the new maximum likelihood hybrid methods can perform better than penalized likelihood and almost as well as uncorrelated Bayesian models. However, the new methods still tend to underestimate the actual amount of rate change. This work demonstrates the difficulty of estimating divergence times using local molecular clocks.	[Aris-Brosou, Stephane] Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada; [Aris-Brosou, Stephane] Univ Ottawa, Dept Math & Stat, Ottawa, ON K1N 6N5, Canada	University of Ottawa; University of Ottawa	Aris-Brosou, S (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada.	sarisbro@uottawa.ca		Aris-Brosou, Stephane/0000-0003-4987-0296				Amrine-Madsen H, 2003, MOL PHYLOGENET EVOL, V28, P186, DOI 10.1016/S1055-7903(03)00122-2; Aris-Brosou S, 2003, MOL BIOL EVOL, V20, P1947, DOI 10.1093/molbev/msg226; Aris-Brosou S, 2006, GENOME, V49, P767, DOI 10.1139/G06-038; Aris-Brosou S, 2006, GENE, V378, P58, DOI 10.1016/j.gene.2006.04.024; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edwards AWF, 1992, LIKELIHOOD; Felsenstein J, 2004, INFERRING PHYLOGENIE; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Ho SYW, 2005, MOL BIOL EVOL, V22, P1355, DOI 10.1093/molbev/msi125; Huelsenbeck JP, 2000, GENETICS, V154, P1879; KAUFMAN L, 1990, FINDING GROUPS DATA, pR14; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pollard KS, 2002, MATH BIOSCI, V176, P99, DOI 10.1016/S0025-5564(01)00116-X; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Rambaut A, 1998, MOL BIOL EVOL, V15, P442, DOI 10.1093/oxfordjournals.molbev.a025940; Rannala B, 2002, SYST BIOL, V51, P754, DOI 10.1080/10635150290102429; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Seiffert ER, 2003, NATURE, V422, P421, DOI 10.1038/nature01489; Smith AB, 2006, MOL BIOL EVOL, V23, P1832, DOI 10.1093/molbev/msl039; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; Welch JJ, 2005, SYST BIOL, V54, P672, DOI 10.1080/10635150590947212; Won H, 2006, SYST BIOL, V55, P610, DOI 10.1080/10635150600812619; Yang Z., 2006, COMPUTATIONAL MOL EV, p[xvi, 357], DOI DOI 10.1093/NAR/GKP952; Yang ZH, 2003, SYST BIOL, V52, P705, DOI 10.1080/10635150390235557; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang Ziheng, 2004, Acta Zoologica Sinica, V50, P645; Yoder AD, 2000, MOL BIOL EVOL, V17, P1081, DOI 10.1093/oxfordjournals.molbev.a026389; ZUCKERKANDL EMILE, 1965, P97; [No title captured]	42	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e879	10.1371/journal.pone.0000879	http://dx.doi.org/10.1371/journal.pone.0000879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849008	gold, Green Submitted, Green Published			2022-12-27	WOS:000207455600025
J	Brownstein, JS; Sordo, M; Kohane, IS; Mandl, KD				Brownstein, John S.; Sordo, Margarita; Kohane, Isaac S.; Mandl, Kenneth D.			The Tell-Tale Heart: Population-Based Surveillance Reveals an Association of Rofecoxib and Celecoxib with Myocardial Infarction	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; UPPER GASTROINTESTINAL TOXICITY; CONFLICT-OF-INTEREST; CARDIOVASCULAR EVENTS; COX-2 INHIBITORS; CYCLO-OXYGENASE-2 INHIBITORS; CYCLOOXYGENASE-2 INHIBITORS; PUBLIC-HEALTH; RISK; SAFETY	Background. COX-2 selective inhibitors are associated with myocardial infarction (MI). We sought to determine whether population health monitoring would have revealed the effect of COX-2 inhibitors on population-level patterns of MI. Methodology/Principal Findings. We conducted a retrospective study of inpatients at two Boston hospitals, from January 1997 to March 2006. There was a population-level rise in the rate of MI that reached 52.0 MI-related hospitalizations per 100,000 (a two standard deviation exceedence) in January of 2000, eight months after the introduction of rofecoxib and one year after celecoxib. The exceedence vanished within one month of the withdrawal of rofecoxib. Trends in inpatient stay due to MI were tightly coupled to the rise and fall of prescriptions of COX-2 inhibitors, with an 18.5% increase in inpatient stays for MI when both rofecoxib and celecoxib were on the market (P<0.001). For every million prescriptions of rofecoxib and celecoxib, there was a 0.5% increase in MI (95% CI 0.1 to 0.9) explaining 50.3% of the deviance in yearly variation of MI-related hospitalizations. There was a negative association between mean age at MI and volume of prescriptions for celecoxib and rofecoxib (Spearman correlation, -0.67, P<0.05). Conclusions/Significance. The strong relationship between prescribing and outcome time series supports a population-level impact of COX-2 inhibitors on MI incidence. Further, mean age at MI appears to have been lowered by use of these medications. Use of a population monitoring approach as an adjunct to pharmacovigilence methods might have helped confirm the suspected association, providing earlier support for the market withdrawal of rofecoxib.	[Brownstein, John S.; Sordo, Margarita; Kohane, Isaac S.; Mandl, Kenneth D.] Harvard Mit Div Hlth Sci & Technol, Informat Program, Childrens Hosp, Boston, MA USA; [Brownstein, John S.; Mandl, Kenneth D.] Childrens Hosp Boston, Div Emergency Med, Boston, MA USA; [Brownstein, John S.; Kohane, Isaac S.; Mandl, Kenneth D.] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Sordo, Margarita] Brigham & Womens Hosp, Decis Syst Grp, Boston, MA 02115 USA; [Kohane, Isaac S.; Mandl, Kenneth D.] Harvard Med Sch, Ctr Biomed Informat, Boston, MA USA; [Kohane, Isaac S.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Brownstein, JS (corresponding author), Harvard Mit Div Hlth Sci & Technol, Informat Program, Childrens Hosp, Boston, MA USA.	john_brownstein@harvard.edu	Kohane, Isaac Kohane/K-3716-2012; Brownstein, John S/A-1438-2011	Kohane, Isaac Kohane/0000-0003-2192-5160; 	National Library of Medicine, National Institutes of Health [R01 LM007677-01, 5U54LM008748-02.20]; Canadian Institutes of Health Research [200510MFE-154492]; Massachusetts Institute of Technology Center for Biomedical Innovation; NATIONAL LIBRARY OF MEDICINE [U54LM008748, R01LM007677] Funding Source: NIH RePORTER	National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Massachusetts Institute of Technology Center for Biomedical Innovation; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported grant numbers R01 LM007677-01 and 5U54LM008748-02.20 from the National Library of Medicine, National Institutes of Health, grant number 200510MFE-154492 from the Canadian Institutes of Health Research and a grant from the Massachusetts Institute of Technology Center for Biomedical Innovation. The funders had no role in the design or conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	American Heart Association, 2005, HEART DIS STROKE STA; Avorn J, 2006, CIRCULATION, V113, P2173, DOI 10.1161/CIRCULATIONAHA.106.625749; Baune B, 2006, PLOS MED, V3, P734, DOI 10.1371/journal.pmed.0030220; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; BORER JS, 2007, EUR HEART J; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Caldwell B, 2006, J ROY SOC MED, V99, P132, DOI 10.1258/jrsm.99.3.132; Campion EW, 2000, NEW ENGL J MED, V343, P1485, DOI 10.1056/NEJM200011163432009; Crawford LM, 2005, FOOD DRUG LAW J, V60, P99; Curfman GD, 2005, NEW ENGL J MED, V353, P2813, DOI 10.1056/NEJMe058314; Davis RL, 2005, EPIDEMIOLOGY, V16, P336, DOI 10.1097/01.ede.0000155506.05636.a4; Drazen JM, 2005, NEW ENGL J MED, V352, P1131, DOI 10.1056/NEJMe058038; *FOOD DRUG ADM, 2003, MEDWATCH REP CONS; Gerber Y, 2006, CIRCULATION, V113, P2285, DOI 10.1161/CIRCULATIONAHA.105.590463; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; Hauben M, 2003, DRUG SAFETY, V26, P159, DOI 10.2165/00002018-200326030-00003; Heeley E, 2001, LANCET, V358, P1872, DOI 10.1016/S0140-6736(01)06898-2; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1366, DOI 10.1136/bmj.330.7504.1366; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hutwagner LC, 1997, EMERG INFECT DIS, V3, P395, DOI 10.3201/eid0303.970322; *IMS HLTH, 2006, COMM REQ THER CLASS; *IOM, 2006, FUT DRUG SAF PROM PR; Jick H, 1998, NEW ENGL J MED, V339, P719, DOI 10.1056/NEJM199809103391102; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Levesque LE, 2005, ANN INTERN MED, V142, P481, DOI 10.7326/0003-4819-142-7-200504050-00113; Mandl KD, 2004, J AM MED INFORM ASSN, V11, P141, DOI 10.1197/jamia.M1356; Mann RD, 2004, PHARMACOEPIDEM DR S, V13, P501, DOI 10.1002/pds.994; McCullagh P, 1989, GEN LINEAR MODELS; Milane MS, 2006, PLOS MED, V3, P816, DOI 10.1371/journal.pmed.0030190; Moore N, 2003, PHARMACOEPIDEM DR S, V12, P271, DOI 10.1002/pds.848; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330; Psaty BM, 2005, NEW ENGL J MED, V352, P1133, DOI 10.1056/NEJMe058042; Psaty BM, 2004, JAMA-J AM MED ASSOC, V292, P2622, DOI 10.1001/jama.292.21.2622; Psaty BM, 2007, NEW ENGL J MED, V356, P2522, DOI 10.1056/NEJMe078099; Rawson NSB, 1995, STAT MED, V14, P2627, DOI 10.1002/sim.4780142404; Ray WA, 2006, NEW ENGL J MED, V354, P194, DOI 10.1056/NEJMsb053432; Reis BY, 2003, P NATL ACAD SCI USA, V100, P1961, DOI 10.1073/pnas.0335026100; ROSENBERG L, 1990, NEW ENGL J MED, V322, P213, DOI 10.1056/NEJM199001253220401; Solomon DH, 2004, CIRCULATION, V109, P2068, DOI 10.1161/01.CIR.0000127578.21885.3E; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Strom BL, 2004, JAMA-J AM MED ASSOC, V292, P2643, DOI 10.1001/jama.292.21.2643; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; Tsui FC, 2003, J AM MED INFORM ASSN, V10, P399, DOI 10.1197/jamia.M1345; Waxman HA, 2005, NEW ENGL J MED, V352, P2576, DOI 10.1056/NEJMp058136; WILLIAMS SM, 1992, BRIT MED J, V304, P1359, DOI 10.1136/bmj.304.6838.1359; WILLICH SN, 1993, NEW ENGL J MED, V329, P1684, DOI 10.1056/NEJM199312023292302; Wysowski DK, 2001, AM J GASTROENTEROL, V96, P1698, DOI 10.1016/S0002-9270(01)02490-X; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947; Zhou WG, 2004, PHARMACOEPIDEM DR S, V13, P505, DOI 10.1002/pds.998; 1998, MMWR MORB MORTAL WKL, V50, P90	53	40	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e840	10.1371/journal.pone.0000840	http://dx.doi.org/10.1371/journal.pone.0000840			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786211	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455500023
J	Lee, SJ				Lee, Se-Jin			Quadrupling Muscle Mass in Mice by Targeting TGF-beta Signaling Pathways	PLOS ONE			English	Article							MYOSTATIN PROPEPTIDE; GENE; MUTATIONS; GROWTH	Myostatin is a transforming growth factor-beta family member that normally acts to limit skeletal muscle growth. Mice genetically engineered to lack myostatin activity have about twice the amount of muscle mass throughout the body, and similar effects are seen in cattle, sheep, dogs, and a human with naturally occurring loss-of-function mutations in the myostatin gene. Hence, there is considerable interest in developing agents capable of inhibiting myostatin activity for both agricultural and human therapeutic applications. We previously showed that the myostatin binding protein, follistatin, can induce dramatic increases in muscle mass when overexpressed as a transgene in mice. In order to determine whether this effect of follistatin results solely from inhibition of myostatin activity, I analyzed the effect of this transgene in myostatin-null mice. Mstn(-/-) mice carrying a follistatin transgene had about four times the muscle mass of wild type mice, demonstrating the existence of other regulators of muscle mass with similar activity to myostatin. The greatest effect on muscle mass was observed in offspring of mothers homozygous for the Mstn mutation, raising the possibility that either myostatin itself or a downstream regulator may normally be transferred from the maternal to fetal circulations. These findings demonstrate that the capacity for increasing muscle growth by manipulating TGF-beta signaling pathways is much more extensive than previously appreciated and suggest that muscle mass may be controlled at least in part by a systemic mode of action of myostatin.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University	Lee, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	sjlee@jhmi.edu			National Institutes of Health [R01HD35887, U54AR052646]; Muscular Dystrophy Association [MDA3765]; Merck Research Laboratories; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Merck Research Laboratories(Merck & Company); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institutes of Health ( R01HD35887 and U54AR052646), a grant from the Muscular Dystrophy Association ( MDA3765), and a gift from Merck Research Laboratories.	Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bogdanovich S, 2005, FASEB J, V19, P543, DOI 10.1096/fj.04-2796com; BULLOUGH WS, 1962, BIOL REV, V37, P307, DOI 10.1111/j.1469-185X.1962.tb01615.x; BULLOUGH WS, 1965, CANCER RES, V25, P1683; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Grobet L, 2003, GENESIS, V35, P227, DOI 10.1002/gene.10188; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Grobet L, 1998, MAMM GENOME, V9, P210, DOI 10.1007/s003359900727; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Hill JJ, 2003, MOL ENDOCRINOL, V17, P1144, DOI 10.1210/me.2002-0366; Ji SQ, 1998, AM J PHYSIOL-REG I, V275, pR1265, DOI 10.1152/ajpregu.1998.275.4.R1265; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Thies RS, 2001, GROWTH FACTORS, V18, P251; Wagner KR, 2002, ANN NEUROL, V52, P832, DOI 10.1002/ana.10385; Welle S, 2007, AM J PHYSIOL-ENDOC M, V292, pE985, DOI 10.1152/ajpendo.00531.2006; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	26	233	249	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e789	10.1371/journal.pone.0000789	http://dx.doi.org/10.1371/journal.pone.0000789			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726519	Green Published, gold			2022-12-27	WOS:000207455400006
J	Slotman, MA; Parmakelis, A; Marshall, JC; Awono-Ambene, PH; Antonio-Nkondjo, C; Simard, F; Caccone, A; Powell, JR				Slotman, Michel A.; Parmakelis, Aristeidis; Marshall, Jonathon C.; Awono-Ambene, Parfait H.; Antonio-Nkondjo, Christophe; Simard, Frederic; Caccone, Adalgisa; Powell, Jeffrey R.			Patterns of Selection in Anti-Malarial Immune Genes in Malaria Vectors: Evidence for Adaptive Evolution in LRIM1 in Anopheles arabiensis	PLOS ONE			English	Article							GAMBIAE COMPLEX; PLASMODIUM; RESPONSES; IDENTIFICATION; INTROGRESSION; INFERENCE; SEQUENCE; PCR	Background. Co-evolution between Plasmodium species and its vectors may result in adaptive changes in genes that are crucial components of the vector's defense against the pathogen. By analyzing which genes show evidence of positive selection in malaria vectors, but not in closely related non-vectors, we can identify genes that are crucial for the mosquito's resistance against Plasmodium. Methodology/Principle Findings. We investigated genetic variation of three anti-malarial genes; CEC1, GNBP-B1 and LRIM1, in both vector and non-vector species of the Anopheles gambiae complex. Whereas little protein differentiation was observed between species in CEC1 and GNBP-B1, McDonald-Kreitman and maximum likelihood tests of positive selection show that LRIM1 underwent adaptive evolution in a primary malaria vector; An. arabiensis. In particular, two adjacent codons show clear signs of adaptation by having accumulated three out of four replacement substitutions. Furthermore, our data indicate that this LRIM1 allele has introgressed from An. arabiensis into the other main malaria vector An. gambiae. Conclusions/Significance. Although no evidence exists to link the adaptation of LRIM1 to P. falciparum infection, an adaptive response of a known anti-malarial gene in a primary malaria vector is intriguing, and may suggest that this gene could play a role in Plasmodium resistance in An. arabiensis. If so, our data also predicts that LRIM1 alleles in An. gambiae vary in their level of resistance against P. falciparum.	[Slotman, Michel A.; Parmakelis, Aristeidis; Marshall, Jonathon C.; Caccone, Adalgisa; Powell, Jeffrey R.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Awono-Ambene, Parfait H.; Antonio-Nkondjo, Christophe; Simard, Frederic] Org Coordinat Lutte Endemies Afrique Cent, Yaounde, Cameroon; [Simard, Frederic] Inst Rech Dev, Yaounde, Cameroon	Yale University; Institut de Recherche pour le Developpement (IRD)	Slotman, MA (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	michel.slotman@yale.edu	Frederic, SIMARD/AFV-5001-2022; Parmakelis, Aristeidis/AAD-1162-2020; Marshall, Jonathon C./AGG-8101-2022; SIMARD, Frederic/J-9489-2016; Caccone, Adalgisa/AAE-4238-2021	Frederic, SIMARD/0000-0002-2871-5329; Parmakelis, Aristeidis/0000-0003-3092-4194; SIMARD, Frederic/0000-0002-2871-5329; Caccone, Adalgisa/0000-0002-8949-9260; Antonio Nkondjio, Christophe/0000-0003-0073-1578	National Institutes of Health [RO1 A1 046018]; Marie Curie Outgoing International Fellowship [MOIF-CT-2006-021357]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie Outgoing International Fellowship(European Commission)	This research was supported by National Institutes of Health grant RO1 A1 046018 to JRP. Additionally, AP was supported by a Marie Curie Outgoing International Fellowship ( Contract No. MOIF-CT-2006-021357).	Besansky NJ, 2006, ANN TROP MED PARASIT, V100, P277, DOI 10.1179/136485906X105624; BESANSKY NJ, 1994, P NATL ACAD SCI USA, V91, P6885, DOI 10.1073/pnas.91.15.6885; Besansky NJ, 2003, P NATL ACAD SCI USA, V100, P10818, DOI 10.1073/pnas.1434337100; Breman JG, 2001, AM J TROP MED HYG, V64, pIV, DOI 10.4269/ajtmh.2001.64.iv; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; COLLINS FH, 1984, AM J TROP MED HYG, V33, P538, DOI 10.4269/ajtmh.1984.33.538; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Donnelly MJ, 2001, MOL BIOL EVOL, V18, P1353, DOI 10.1093/oxfordjournals.molbev.a003919; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Ferguson HM, 2002, TRENDS PARASITOL, V18, P256, DOI 10.1016/S1471-4922(02)02281-X; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Kim W, 2004, J MED ENTOMOL, V41, P447, DOI 10.1603/0022-2585-41.3.447; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lambrechts L, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-3; Little TJ, 2005, INSECT MOL BIOL, V14, P599, DOI 10.1111/j.1365-2583.2005.00588.x; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Onyabe DY, 2001, MOL ECOL, V10, P2577, DOI 10.1046/j.0962-1083.2001.01387.x; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozen S, 2000, Methods Mol Biol, V132, P365; Schlenke TA, 2003, GENETICS, V164, P1471; Simard F, 2007, INFECT GENET EVOL, V7, P285, DOI 10.1016/j.meegid.2006.11.004; Slotman MA, 2005, AM J TROP MED HYG, V73, P326, DOI 10.4269/ajtmh.2005.73.326; Tahar R, 2002, EMBO J, V21, P6673, DOI 10.1093/emboj/cdf664; Vizioli J, 2000, INSECT MOL BIOL, V9, P75, DOI 10.1046/j.1365-2583.2000.00164.x; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Warr E, 2006, INSECT BIOCHEM MOLEC, V36, P769, DOI 10.1016/j.ibmb.2006.07.006; White BJ, 2007, AM J TROP MED HYG, V76, P334; Yang, 2006, COMPUTATIONAL MOL EV, P357; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	38	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e793	10.1371/journal.pone.0000793	http://dx.doi.org/10.1371/journal.pone.0000793			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726523	Green Published, gold			2022-12-27	WOS:000207455400010
J	Mattei, E; Corbi, N; Di Certo, MG; Strimpakos, G; Severini, C; Onori, A; Desantis, A; Libri, V; Buontempo, S; Floridi, A; Fanciulli, M; Baban, D; Davies, KE; Passananti, C				Mattei, Elisabetta; Corbi, Nicoletta; Di Certo, Maria Grazia; Strimpakos, Georgios; Severini, Cinzia; Onori, Annalisa; Desantis, Agata; Libri, Valentina; Buontempo, Serena; Floridi, Aristide; Fanciulli, Maurizio; Baban, Dilair; Davies, Kay E.; Passananti, Claudio			Utrophin Up-Regulation by an Artificial Transcription Factor in Transgenic Mice	PLOS ONE			English	Article								Duchenne Muscular Dystrophy (DMD) is a severe muscle degenerative disease, due to absence of dystrophin. There is currently no effective treatment for DMD. Our aim is to up-regulate the expression level of the dystrophin related gene utrophin in DMD, complementing in this way the lack of dystrophin functions. To this end we designed and engineered several synthetic zinc finger based transcription factors. In particular, we have previously shown that the artificial three zinc finger protein named Jazz, fused with the appropriate effector domain, is able to drive the transcription of a test gene from the utrophin promoter "A''. Here we report on the characterization of Vp16-Jazz-transgenic mice that specifically over-express the utrophin gene at the muscular level. A Chromatin Immunoprecipitation assay (ChIP) demonstrated the effective access/binding of the Jazz protein to active chromatin in mouse muscle and Vp16-Jazz was shown to be able to up-regulate endogenous utrophin gene expression by immunohistochemistry, western blot analyses and real-time PCR. To our knowledge, this is the first example of a transgenic mouse expressing an artificial gene coding for a zinc finger based transcription factor. The achievement of Vp16-Jazz transgenic mice validates the strategy of transcriptional targeting of endogenous genes and could represent an exclusive animal model for use in drug discovery and therapeutics.	[Mattei, Elisabetta; Fanciulli, Maurizio; Passananti, Claudio] Roman Oncogenom Ctr, Italian Assoc Canc Res, Rome, Italy; [Mattei, Elisabetta; Di Certo, Maria Grazia; Strimpakos, Georgios; Severini, Cinzia] European Brain Res Inst, Consiglio Nazl Ric, Ist Neurobiol & Med Mol, Rome, Italy; [Corbi, Nicoletta; Onori, Annalisa; Desantis, Agata; Libri, Valentina; Buontempo, Serena; Passananti, Claudio] Regina Elena Inst Canc Res, Consiglio Nazl Ric, Ist Biol & Patol Mol, Rome, Italy; [Di Certo, Maria Grazia; Desantis, Agata; Floridi, Aristide] Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; [Floridi, Aristide; Fanciulli, Maurizio] Regina Elena Inst Canc Res, Lab B, Rome, Italy; [Baban, Dilair; Davies, Kay E.] Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genet Unit, Oxford, England	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of L'Aquila; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of Oxford	Passananti, C (corresponding author), Roman Oncogenom Ctr, Italian Assoc Canc Res, Rome, Italy.	passananti@ifo.it	Severini, Cinzia/AAX-3569-2020; Passananti, Claudio/K-9593-2016; Maria Grazia, Di Certo/AAW-8769-2020; Corbi, Nicoletta/K-2313-2014; Corbi, Nicoletta/AAW-8835-2020; fanciulli, maurizio/ABH-6745-2020	Severini, Cinzia/0000-0002-6932-704X; STRIMPAKOS, GEORGIOS/0000-0002-6021-9704; PASSANANTI, CLAUDIO/0000-0002-9288-5736; Libri, Valentina/0000-0002-2080-1089; CORBI, NICOLETTA/0000-0002-4505-1632	Telethon A160, Regional Grant-Lazio; FIRB; Regione Lazio; Medical Research Council UK; Medical Research Council [MC_U137761449] Funding Source: researchfish; MRC [MC_U137761449] Funding Source: UKRI	Telethon A160, Regional Grant-Lazio(Fondazione Telethon); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Regione Lazio(Regione Lazio); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Telethon A160, Regional Grant-Lazio ( AIRC), FIRB project "Epigenetica e Cromatina'' and M. I. U. R. ex 60%. Dr. Maria Grazia Di Certo is a recipient of a fellowship supported by Regione Lazio fundings for "Sviluppo della Ricerca sul Cervello''. Dr. Dilair Baban and Prof. Kay E. Davies are supported by the Medical Research Council UK.	Beltran A, 2006, ASSAY DRUG DEV TECHN, V4, P317, DOI 10.1089/adt.2006.4.317; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Blancafort P, 2005, P NATL ACAD SCI USA, V102, P11716, DOI 10.1073/pnas.0501162102; Blancafort P, 2004, MOL PHARMACOL, V66, P1361, DOI 10.1124/mol.104.002758; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Campbell KP, 1996, NATURE, V384, P308, DOI 10.1038/384308a0; CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11168, DOI 10.1073/pnas.91.23.11168; Choo Y, 1997, CURR OPIN STRUC BIOL, V7, P117, DOI 10.1016/S0959-440X(97)80015-2; CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11163, DOI 10.1073/pnas.91.23.11163; Corbi N, 2000, GENE THER, V7, P1076, DOI 10.1038/sj.gt.3301204; Corbi N, 1997, FEBS LETT, V417, P71, DOI 10.1016/S0014-5793(97)01257-X; Corbi N, 2004, BIOCHEM CELL BIOL, V82, P428, DOI 10.1139/O04-047; Cossu G, 2004, TRENDS MOL MED, V10, P516, DOI 10.1016/j.molmed.2004.08.007; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; Dennis CL, 1996, NUCLEIC ACIDS RES, V24, P1646, DOI 10.1093/nar/24.9.1646; Dreier B, 2005, J BIOL CHEM, V280, P35588, DOI 10.1074/jbc.M506654200; Dreier B, 2001, J BIOL CHEM, V276, P29466, DOI 10.1074/jbc.M102604200; Dreier B, 2000, J MOL BIOL, V303, P489, DOI 10.1006/jmbi.2000.4133; Gramolini AO, 1999, J NEUROPATH EXP NEUR, V58, P235, DOI 10.1097/00005072-199903000-00003; Gramolini AO, 2001, AM J PHYSIOL-CELL PH, V281, pC1300, DOI 10.1152/ajpcell.2001.281.4.C1300; Jamieson AC, 2003, NAT REV DRUG DISCOV, V2, P361, DOI 10.1038/nrd1087; Janssen PML, 2005, AM J PHYSIOL-HEART C, V289, pH2373, DOI 10.1152/ajpheart.00448.2005; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; Lee DK, 2003, CURR TOP MED CHEM, V3, P645, DOI 10.2174/1568026033452384; Libri V, 2004, FEBS LETT, V560, P75, DOI 10.1016/S0014-5793(04)00075-4; Matecki S, 2004, AM J PHYSIOL-LUNG C, V287, pL569, DOI 10.1152/ajplung.00117.2004; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; Miura P, 2006, TRENDS MOL MED, V12, P122, DOI 10.1016/j.molmed.2006.01.002; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nagy A., 2003, MANIPULATING MOUSE E; Nowak KJ, 2004, EMBO REP, V5, P872, DOI 10.1038/sj.embor.7400221; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Odom GL, 2007, BBA-MOL BASIS DIS, V1772, P243, DOI 10.1016/j.bbadis.2006.09.007; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; Onori A, 2007, BIOCHEM CELL BIOL, V85, P358, DOI 10.1139/O07-015; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Pandolfi PP, 2001, ONCOGENE, V20, P3116, DOI 10.1038/sj.onc.1204299; Papworth M, 2006, GENE, V366, P27, DOI 10.1016/j.gene.2005.09.011; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Rafael JA, 1998, NAT GENET, V19, P79, DOI 10.1038/ng0598-79; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Segal DJ, 1999, P NATL ACAD SCI USA, V96, P2758, DOI 10.1073/pnas.96.6.2758; Squire S, 2002, HUM MOL GENET, V11, P3333, DOI 10.1093/hmg/11.26.3333; Stocksley MA, 2005, NEUROMUSCULAR DISORD, V15, P437, DOI 10.1016/j.nmd.2005.03.008; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Voisin V, 2004, INT REV CYTOL, V240, P1, DOI 10.1016/S0074-7696(04)40001-1; Wakefield PM, 2000, GENE THER, V7, P201, DOI 10.1038/sj.gt.3301066; Weir AP, 2004, NEUROMUSCULAR DISORD, V14, P19, DOI 10.1016/j.nmd.2003.09.004	50	37	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e774	10.1371/journal.pone.0000774	http://dx.doi.org/10.1371/journal.pone.0000774			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712422	Green Published, gold			2022-12-27	WOS:000207455300022
J	Tao, H; Berno, AJ; Cox, DR; Frazer, KA				Tao, Heng; Berno, Anthony J.; Cox, David R.; Frazer, Kelly A.			In Vitro Human Keratinocyte Migration Rates Are Associated with SNPs in the KRT1 Interval	PLOS ONE			English	Article								Efforts to develop effective therapeutic treatments for promoting fast wound healing after injury to the epidermis are hindered by a lack of understanding of the factors involved. Re-epithelialization is an essential step of wound healing involving the migration of epidermal keratinocytes over the wound site. Here, we examine genetic variants in the keratin-1 (KRT1) locus for association with migration rates of human epidermal keratinocytes (HEK) isolated from different individuals. Although the role of intermediate filament genes, including KRT1, in wound activated keratinocytes is well established, this is the first study to examine if genetic variants in humans contribute to differences in the migration rates of these cells. Using an in vitro scratch wound assay we observe quantifiable variation in HEK migration rates in two independent sets of samples; 24 samples in the first set and 17 samples in the second set. We analyze genetic variants in the KRT1 interval and identify SNPs significantly associated with HEK migration rates in both samples sets. Additionally, we show in the first set of samples that the average migration rate of HEK cells homozygous for one common haplotype pattern in the KRT1 interval is significantly faster than that of HEK cells homozygous for a second common haplotype pattern. Our study demonstrates that genetic variants in the KRT1 interval contribute to quantifiable differences in the migration rates of keratinocytes isolated from different individuals. Furthermore we show that in vitro cell assays can successfully be used to deconstruct complex traits into simple biological model systems for genetic association studies.	[Tao, Heng; Berno, Anthony J.; Cox, David R.; Frazer, Kelly A.] Perlegen Sci, Mountain View, CA USA		Frazer, KA (corresponding author), Perlegen Sci, Mountain View, CA USA.	kfrazer@scripps.edu		Frazer, Kelly/0000-0002-6060-8902	NHGRI [5 R44 HG002638-03]	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by an NHGRI grant (5 R44 HG002638-03) to K. A. Frazer.	BISHOP JO, 1974, NATURE, V250, P199, DOI 10.1038/250199a0; BRANDHORST BP, 1974, J MOL BIOL, V85, P451, DOI 10.1016/0022-2836(74)90444-6; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Coulombe PA, 1997, BIOCHEM BIOPH RES CO, V236, P231, DOI 10.1006/bbrc.1997.6945; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; FUCHS E, 1994, CURR OPIN GENET DEV, V4, P725, DOI 10.1016/0959-437X(94)90140-X; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; HOLLAND CA, 1980, J MOL BIOL, V138, P755, DOI 10.1016/0022-2836(80)90064-9; Jackson DA, 2000, FASEB J, V14, P242, DOI 10.1096/fasebj.14.2.242; JOHNSON LD, 1985, P NATL ACAD SCI USA, V82, P1896, DOI 10.1073/pnas.82.7.1896; Lee YS, 1998, J INVEST DERMATOL, V111, P762, DOI 10.1046/j.1523-1747.1998.00365.x; Li XM, 2001, HEREDITY, V86, P668, DOI 10.1046/j.1365-2540.2001.00879.x; Mahr S, 2006, AM J HUM GENET, V78, P793, DOI 10.1086/503849; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Masinde GL, 2001, GENOME RES, V11, P2027, DOI 10.1101/gr.203701; MASINDE GL, 2005, FUNCT INTEGR GENOMIC, P1; McBrearty BA, 1998, P NATL ACAD SCI USA, V95, P11792, DOI 10.1073/pnas.95.20.11792; Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381; Pant PVK, 2006, GENOME RES, V16, P331, DOI 10.1101/gr.4559106; Porter RM, 2003, TRENDS GENET, V19, P278, DOI 10.1016/S0168-9525(03)00071-4; POUMAY Y, 1995, J INVEST DERMATOL, V104, P271, DOI 10.1111/1523-1747.ep12612810; Rogers MA, 2005, J INVEST DERMATOL, V124, P536, DOI 10.1111/j.0022-202X.2004.23530.x; Sambrook J., 2002, MOL CLONING LAB MANU; Spurzem JR, 2002, AM J PHYSIOL-LUNG C, V282, pL1108, DOI 10.1152/ajplung.00148.2001; STEINERT PM, 1985, J BIOL CHEM, V260, P7142; STELLMACH V, 1991, P NATL ACAD SCI USA, V88, P4582, DOI 10.1073/pnas.88.11.4582; Tao H, 2006, PLOS GENET, V2, P848, DOI 10.1371/journal.pgen.0020093; Vaitomaa J, 2003, APPL ENVIRON MICROB, V69, P7289, DOI 10.1128/AEM.69.12.7289-7297.2003; Wong P, 2003, J CELL BIOL, V163, P327, DOI 10.1083/jcb.200305032; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207; Zegers MMP, 2003, EMBO J, V22, P4155, DOI 10.1093/emboj/cdg398	31	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e697	10.1371/journal.pone.0000697	http://dx.doi.org/10.1371/journal.pone.0000697			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668073	Green Published, gold			2022-12-27	WOS:000207452300031
J	Voelkl, B; Huber, L				Voelkl, Bernhard; Huber, Ludwig			Imitation as Faithful Copying of a Novel Technique in Marmoset Monkeys	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; MOVEMENT IMITATION	Imitative learning has received great attention due to its supposed role in the development of culture and the cognitive demands it poses on the individual. Evidence for imitation in non-human primate species, therefore, could shed light on the early origins of proto-cultural traits in the primate order. Imitation has been defined as the learning of an act by seeing it done or, more specifically, as the copying of a novel or otherwise improbable act. But despite a century of research and the detection of mirror neurons the empirical basis for this most advanced form of observational learning is weak. Few, if any, studies have shown that the observer has learned the response topography, i.e., the specific action by which the response is made. In an experimental set-up we confronted marmoset monkeys (Callithrix jacchus) with a conspecific model that was previously trained to open a plastic box in a peculiar way. Employing detailed motion analyses we show that the observers precisely copied the movement patterns of the novel action demonstrated by the model. A discriminant analysis classified 13 out of 14 observer movements (92.86%) as model movements and only one as non-observer movement. This evidence of imitation in non-human primates questions the dominant opinion that imitation is a human-specific ability. Furthermore, the high matching degree suggests that marmosets possess the neuronal mechanism to code the actions of others and to map them onto their own motor repertoire, rather than priming existing motor-templates.	[Voelkl, Bernhard; Huber, Ludwig] Univ Vienna, Dept Neurobiol & Cognit Res, Vienna, Austria	University of Vienna	Huber, L (corresponding author), Univ Vienna, Dept Neurobiol & Cognit Res, Vienna, Austria.	ludwig.huber@univie.ac.at	Voelkl, Bernhard/D-1390-2009	Voelkl, Bernhard/0000-0001-5454-2508; Huber, Ludwig/0000-0002-0217-136X	Austrian Science Fund [P 12011-BIO]; European Community [NEST 012929]	Austrian Science Fund(Austrian Science Fund (FWF)); European Community(European Commission)	This work has received funding from the Austrian Science Fund (P 12011-BIO) and the European Community (NEST 012929).	[Anonymous], 1956, LEARNING INSTINCT AN; BRASS M, 2005, TRENDS COGNITIVE NEU; Byrne RW, 1998, BEHAV BRAIN SCI, V21, P667, DOI 10.1017/S0140525X98001745; Byrne RW, 2003, PHILOS T R SOC B, V358, P529, DOI 10.1098/rstb.2002.1219; Call J, 2005, ANIM COGN, V8, P151, DOI 10.1007/s10071-004-0237-8; CUSTANCE DM, 1995, BEHAVIOUR, V132, P837, DOI 10.1163/156853995X00036; Ferrari PF, 2005, J COGNITIVE NEUROSCI, V17, P212, DOI 10.1162/0898929053124910; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Fragaszy D, 2004, LEARN BEHAV, V32, P24; Galef BG, 2004, LEARN BEHAV, V32, P53; Heyes C, 2001, TRENDS COGN SCI, V5, P253, DOI 10.1016/S1364-6613(00)01661-2; Heyes CM, 2000, ADV STUD BEHAV, V29, P215, DOI 10.1016/S0065-3454(08)60106-0; Huber L, 1998, BEHAV BRAIN SCI, V21, P694, DOI 10.1017/S0140525X9833174X; HURLEY S, 2006, PERSPECTIVES IMITATI; Iacoboni M, 2005, CURR OPIN NEUROBIOL, V15, P632, DOI 10.1016/j.conb.2005.10.010; Meltzoff AN, 1997, EARLY DEV PARENTING, V6, P179, DOI 10.1002/(SICI)1099-0917(199709/12)6:3/4<179::AID-EDP157>3.0.CO;2-R; MELTZOFF AN, IMITATIVE MIND DEV E; MOORE BR, 1992, BEHAVIOUR, V122, P231, DOI 10.1163/156853992X00525; Myowa-Yamakoshi M, 2000, J COMP PSYCHOL, V114, P381, DOI 10.1037/0735-7036.114.4.381; Paukner A, 2005, BIOL LETTERS, V1, P219, DOI 10.1098/rsbl.2004.0291; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G., 2005, PERSPECTIVES IMITATI, V1, P55, DOI DOI 10.1146/ANNUREV.NEURO.27.070203.144230; Rumiati RI, 2002, EXP BRAIN RES, V142, P425, DOI 10.1007/s00221-001-0956-x; Subiaul F, 2004, SCIENCE, V305, P407, DOI 10.1126/science.1099136; THORNDIKE EL, 1898, PSYCHOL REV MONOGR S, V2, P79; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; Voelkl B, 2000, ANIM BEHAV, V60, P195, DOI 10.1006/anbe.2000.1457; Whiten A, 2005, NATURE, V437, P52, DOI 10.1038/nature04023; Whiten A., 1992, ADV STUDY BEHAV; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238; Zentall TR, 2004, LEARN BEHAV, V32, P15, DOI 10.3758/BF03196003	32	79	81	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2007	2	7							e611	10.1371/journal.pone.0000611	http://dx.doi.org/10.1371/journal.pone.0000611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GH	17622356	gold, Green Published			2022-12-27	WOS:000207452000018
J	Favato, G; Mariani, P; Mills, RW; Capone, A; Pelagatti, M; Pieri, V; Marcobelli, A; Trotta, MG; Zucchi, A; Catapano, AL				Favato, Giampiero; Mariani, Paolo; Mills, Roger W.; Capone, Alessandro; Pelagatti, Matteo; Pieri, Vasco; Marcobelli, Alberico; Trotta, Maria G.; Zucchi, Alberto; Catapano, Alberico L.			ASSET (Age/Sex Standardised Estimates of Treatment): A Research Model to Improve the Governance of Prescribing Funds in Italy	PLOS ONE			English	Article								Background. The primary objective of this study was to make the first step in the modelling of pharmaceutical demand in Italy, by deriving a weighted capitation model to account for demographic differences among general practices. The experimental model was called ASSET (Age/Sex Standardised Estimates of Treatment). Methods and Major Findings. Individual prescription costs and demographic data referred to 3,175,691 Italian subjects and were collected directly from three Regional Health Authorities over the 12-month period between October 2004 and September 2005. The mean annual prescription cost per individual was similar for males (196.13 euro) and females (195.12 euro). After 65 years of age, the mean prescribing costs for males were significantly higher than females. On average, costs for a 75-year-old subject would be 12 times the costs for a 25-34 year-old subject if male, 8 times if female. Subjects over 65 years of age (22% of total population) accounted for 56% of total prescribing costs. The weightings explained approximately 90% of the evolution of total prescribing costs, in spite of the pricing and reimbursement turbulences affecting Italy in the 2000-2005 period. The ASSET weightings were able to explain only about 25% of the variation in prescribing costs among individuals. Conclusions. If mainly idiosyncratic prescribing by general practitioners causes the unexplained variations, the introduction of capitation-based budgets would gradually move practices with high prescribing costs towards the national average. It is also possible, though, that the unexplained individual variation in prescribing costs is the result of differences in the clinical characteristics or socio-economic conditions of practice populations. If this is the case, capitation-based budgets may lead to unfair distribution of resources. The ASSET age/sex weightings should be used as a guide, not as the ultimate determinant, for an equitable allocation of prescribing resources to regional authorities and general practices.	[Favato, Giampiero; Mills, Roger W.] Henley Management Coll, Sch Projects Proc & Syst, Henley On Thames, England; [Mariani, Paolo; Pelagatti, Matteo] Bicocca Univ, Dept Stat Sci, Milan, Italy; [Favato, Giampiero; Capone, Alessandro; Pieri, Vasco; Catapano, Alberico L.] SEFAP, Milan, Italy; [Marcobelli, Alberico] Reg Hlth Author ASSR Marche, Ancona, Italy; [Trotta, Maria G.] Reg Hlth Author ASSR Basilicata, Potenza, Italy; [Zucchi, Alberto] Local Hlth Author ASL Milano 3, Monza, Italy; [Catapano, Alberico L.] Univ Milan, Dept Pharmacol Sci, Milan, Italy	University of Reading; University of Milano-Bicocca; University of Milan	Favato, G (corresponding author), Henley Management Coll, Sch Projects Proc & Syst, Henley On Thames, England.	gfavato@chicagogsb.edu	Pelagatti, Matteo Maria/B-1451-2010; Mariani, Paolo/F-4090-2015; Catapano, alberico/AAC-2827-2019	Pelagatti, Matteo Maria/0000-0002-1860-7535; Mariani, Paolo/0000-0003-4293-1009; Catapano, alberico/0000-0002-7593-2094; Favato, Giampiero/0000-0003-3499-2979				*AG IT FARM AIFA, 2005, OSMED REP 2000 2005; Baker Y, 1998, BRIT MED J, V317, P210, DOI 10.1136/bmj.317.7152.210b; Carr-Hill R, 1999, BRIT MED J, V318, P1145, DOI 10.1136/bmj.318.7191.1145; COULTER A, 1994, BRIT MED J, V308, P207, DOI 10.1136/bmj.308.6922.207c; Diehr P, 1999, ANNU REV PUBL HEALTH, V20, P125, DOI 10.1146/annurev.publhealth.20.1.125; GIARDA DP, 2005, C OLTR DECL FOND ROD; GREEN W, 1993, EC ANAL, P500; *ISTAT, DEM STAT AN IT POP 2; *ISTAT, DEM PROJ IT POP AG S; LLOYD DCEF, 1995, BRIT MED J, V311, P991; Majeed A, 1998, BRIT MED J, V316, P748, DOI 10.1136/bmj.316.7133.748; Majeed A, 1999, BRIT MED J, V318, P772, DOI 10.1136/bmj.318.7186.772; Newhouse J P, 1989, Health Care Financ Rev, V10, P41; *NHS, ASTRO PUS CHAPT STAR; Rice N, 2000, BRIT MED J, V320, P284, DOI 10.1136/bmj.320.7230.284; ROBERTS SJ, 1993, BRIT MED J, V307, P485, DOI 10.1136/bmj.307.6902.485; SHELDON TA, 1994, BRIT MED J, V309, P1059, DOI 10.1136/bmj.309.6961.1059; SMITH P, 1994, BRIT MED J, V309, P1050, DOI 10.1136/bmj.309.6961.1050; Smith PC, 1999, BRIT MED J, V318, P776, DOI 10.1136/bmj.318.7186.776; Whynes DK, 1996, BRIT MED J, V312, P488, DOI 10.1136/bmj.312.7029.488	20	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2007	2	7							e592	10.1371/journal.pone.0000592	http://dx.doi.org/10.1371/journal.pone.0000592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GG	17611624	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000207451900009
J	Ciucci, F; Putignano, E; Baroncelli, L; Landi, S; Berardi, N; Maffei, L				Ciucci, Francesca; Putignano, Elena; Baroncelli, Laura; Landi, Silvia; Berardi, Nicoletta; Maffei, Lamberto			Insulin-Like Growth Factor 1 (IGF-1) Mediates the Effects of Enriched Environment (EE) on Visual Cortical Development	PLOS ONE			English	Article								Enriched environment (EE) has been recently shown to affect visual cortex development and plasticity, and to prevent dark rearing effects. The factors mediating EE effects on visual cortical development and plasticity are still unclear. We have investigated whether IGF-1 is involved in mediating EE effects on the developing visual cortex. We show that EE increases the number of IGF-1 positive neurons in the visual cortex at P18. Increasing IGF-1 in the visual cortex of non-EE rats by means of osmotic minipumps implanted at P18 mimics EE effects, accelerating visual acuity development, assessed with Visual Evoked Potentials (VEPs). Blocking IGF-1 action in the visual cortex of EE rats by means of the IGF-1 receptor antagonist JB1 from P18 completely blocks EE action on visual acuity development. These results show that IGF-1 is a key factor mediating EE effects on visual cortical development. We then show that IGF-1 affects GAD65 immunoreactivity in perisomatic innervation and the condensation of Chondroitin Sulphate Proteoglycans (CSPGs) in perineuronal nets (PNNs) in the visual cortex. This suggests that IGF-1 action in mediating EE effects could be exerted through the modulation of intracortical inhibitory circuitry and PNN development.	[Ciucci, Francesca; Putignano, Elena; Baroncelli, Laura; Landi, Silvia; Maffei, Lamberto] Scuola Normale Super Pisa, Pisa, Italy; [Berardi, Nicoletta] Univ Florence, Dept Psychol, Florence, Italy; [Berardi, Nicoletta; Maffei, Lamberto] CNR, Inst Neurosci, I-56100 Pisa, Italy	Scuola Normale Superiore di Pisa; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Ciucci, F (corresponding author), Scuola Normale Super Pisa, Pisa, Italy.	francesca.ciucci@in.cnr.it	Landi, Silvia/P-9418-2018; Baroncelli, Laura/K-5823-2016	Landi, Silvia/0000-0001-7999-3452; Baroncelli, Laura/0000-0001-6739-2860; Putignano, Elena/0000-0002-4313-408X	MIUR PRIN	MIUR PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This project was supported by MIUR PRIN to LM.	Aberg ND, 2006, THESCIENTIFICWORLDJO, V6, P53, DOI 10.1100/tsw.2006.22; BARTLETT WP, 1991, DEV BIOL, V147, P239, DOI 10.1016/S0012-1606(05)80021-1; Bartoletti A, 2004, NAT NEUROSCI, V7, P215, DOI 10.1038/nn1201; BENEVENTO LA, 1995, BRAIN RES, V689, P172, DOI 10.1016/0006-8993(95)00553-3; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; BONDY C, 1992, NEUROSCIENCE, V46, P909, DOI 10.1016/0306-4522(92)90193-6; BONDY CA, 1993, ANN NY ACAD SCI, V692, P33; BONDY CA, 1991, J NEUROSCI, V11, P3442; Camarero G, 2003, DEV BIOL, V262, P242, DOI 10.1016/S0012-1606(03)00387-7; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001; Carro E, 2000, J NEUROSCI, V20, P2926; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; D'Ercole AJ, 2002, NEUROPEPTIDES, V36, P209, DOI 10.1054/npep.2002.0893; DErcole AJ, 1996, MOL NEUROBIOL, V13, P227, DOI 10.1007/BF02740625; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; Ding Q, 2006, NEUROSCIENCE, V140, P823, DOI 10.1016/j.neuroscience.2006.02.084; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fernandez AM, 1997, NEUROSCIENCE, V76, P117; Gianfranceschi L, 2003, P NATL ACAD SCI USA, V100, P12486, DOI 10.1073/pnas.1934836100; GREENOUGH WT, 1973, EXP NEUROL, V41, P371, DOI 10.1016/0014-4886(73)90278-1; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Keyvani K, 2004, J NEUROPATH EXP NEUR, V63, P598, DOI 10.1093/jnen/63.6.598; KOLB B, 1993, BEHAV NEUROSCI, V107, P799, DOI 10.1037/0735-7044.107.5.799; Koopmans GC, 2006, EUR J NEUROSCI, V23, P1035, DOI 10.1111/j.1460-9568.2006.04627.x; Lander C, 1997, J NEUROSCI, V17, P1928; Landi S, 2007, FASEB J, V21, P130, DOI 10.1096/fj.06-6083com; Lodovichi C, 2000, J NEUROSCI, V20, P2155; Markowska AL, 1998, NEUROSCIENCE, V87, P559, DOI 10.1016/S0306-4522(98)00143-2; MILLER MW, 1986, DEV BRAIN RES, V25, P271, DOI 10.1016/0165-3806(86)90217-8; Morales B, 2002, J NEUROSCI, V22, P8084; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; PAXINOS G, 1986, RAT STEREOTAXIC BRAI; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; PIETRZKOWSKI Z, 1992, CANCER RES, V52, P6447; PIETRZKOWSKI Z, 1993, CANCER RES, V53, P1102; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pizzorusso T, 1999, EUR J NEUROSCI, V11, P204, DOI 10.1046/j.1460-9568.1999.00417.x; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; ROSENZWE.MR, 1966, AM PSYCHOL, V21, P321, DOI 10.1037/h0023555; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; ROTWEIN P, 1988, P NATL ACAD SCI USA, V85, P265, DOI 10.1073/pnas.85.1.265; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Silver MA, 2000, J COMP NEUROL, V422, P652, DOI 10.1002/1096-9861(20000710)422:4<652::AID-CNE11>3.0.CO;2-1; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Tropea D, 2003, J NEUROSCI, V23, P7034, DOI 10.1523/JNEUROSCI.23-18-07034.2003; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; WOLFF JR, 1984, ADV EXP MED BIOL, V181, P215	60	84	88	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2007	2	5							e475	10.1371/journal.pone.0000475	http://dx.doi.org/10.1371/journal.pone.0000475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10FB	17534425	Green Published, Green Submitted, gold			2022-12-27	WOS:000207448800005
J	Nabatov, AA; Pollakis, G; Linnemann, T; Paxton, WA; de Baar, MP				Nabatov, Alexey A.; Pollakis, Georgios; Linnemann, Thomas; Paxton, William A.; de Baar, Michel P.			Statins Disrupt CCR5 and RANTES Expression Levels in CD4(+) T Lymphocytes In Vitro and Preferentially Decrease Infection of R5 Versus X4 HIV-1	PLOS ONE			English	Article								Background. Statins have previously been shown to reduce the in vitro infection of human immunodeficiency virus type 1 (HIV-1) through modulation of Rho GTPase activity and lipid raft formation at the cell surface, as well as by disrupting LFA-1 incorporation into viral particles. Principle Findings. Here we demonstrate that treatment of an enriched CD4(+) lymphocyte population with lovastatin (Lov), mevastatin (Mev) and simvastatin (activated and non-activated, Sim(A) and Sim(N), respectively) can reduce the cell surface expression of the CC-chemokine receptor CCR5 (P<0.01 for Sim(A) and Lov). The lowered CCR5 expression was associated with down-regulation of CCR5 mRNA expression. The CC-chemokine RANTES protein and mRNA expression levels were slightly increased in CD4(+) enriched lymphocytes treated with statins. Both R5 and X4 HIV-1 were reduced for their infection of statin-treated cells; however, in cultures where statins were removed and where a decrease in CCR5 expression was observed, there was a preferential inhibition of infection with an R5 versus X4 virus. Conclusions. The results indicate that the modulation of CC-chemokine receptor (CCR5) and CC-chemokine (RANTES) expression levels should be considered as contributing to the anti-viral effects of statins, preferentially inhibiting R5 viruses. This observation, in combination with the immunomodulatory activity exerted by statins, suggests they may possess more potent anti-HIV-1 activity when applied during the early stages of infection or in lowering viral transmission. Alternatively, statin treatment could be considered as a way to modulate immune induction such as during vaccination protocols.	[Nabatov, Alexey A.; Pollakis, Georgios; Linnemann, Thomas; Paxton, William A.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol,Lab Expt Virol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [de Baar, Michel P.] Primagen, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Paxton, WA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol,Lab Expt Virol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands.	w.a.paxton@amc.uva.nl	Nabatov, Alexey/R-5291-2016; Georgios, Pollakis/Y-2341-2019; paxton, william/R-9747-2019	Nabatov, Alexey/0000-0001-7932-1445; Paxton, William/0000-0001-5200-0801; Pollakis, Georgios/0000-0002-9659-5461; Paxton, William/0000-0002-2654-5186	European Union [QLK2-CT-1999-01321, QLK2-CT-2001-01316]	European Union(European Commission)	This work was supported by grants from the European Union (QLK2-CT-1999-01321 and QLK2-CT-2001-01316 "Eurovac-I and -II").	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Blanpain C, 2001, J BIOL CHEM, V276, P23795, DOI 10.1074/jbc.M100583200; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; del Real G, 2004, J EXP MED, V200, P541, DOI 10.1084/jem.20040061; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Frauenschuh A, 2004, VACCINE, V23, P546, DOI 10.1016/j.vaccine.2004.06.024; Giguere JF, 2004, J VIROL, V78, P12062, DOI 10.1128/JVI.78.21.12062-12065.2004; HUANG RD, 1996, FINANCIAL MARKETS I, V5, P1; Kim JJ, 1998, J CLIN INVEST, V102, P1112, DOI 10.1172/JCI3986; Kraft K, 2001, J BIOL CHEM, V276, P34408, DOI 10.1074/jbc.M102782200; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Manes S, 1999, EMBO J, V18, P6211, DOI 10.1093/emboj/18.22.6211; Moncunill G, 2005, AIDS, V19, P1697, DOI 10.1097/01.aids.0000183517.60384.db; Nabatov AA, 2004, J VIROL, V78, P524, DOI 10.1128/JVI.78.1.524-530.2004; Negredo E, 2006, AIDS, V20, P619, DOI 10.1097/01.aids.0000210617.90954.0e; Neuhaus O, 2002, NEUROLOGY, V59, P990, DOI 10.1212/WNL.59.7.990; Nguyen DH, 2002, BLOOD, V99, P4298, DOI 10.1182/blood-2001-11-0087; Nguyen DH, 2002, J IMMUNOL, V168, P4121, DOI 10.4049/jimmunol.168.8.4121; Paxton WA, 1998, VIROLOGY, V244, P66, DOI 10.1006/viro.1998.9082; Paxton WA, 2001, J INFECT DIS, V183, P1678, DOI 10.1086/320701; Percherancier Y, 2001, J BIOL CHEM, V276, P31936, DOI 10.1074/jbc.M104013200; Yoon HA, 2007, IMMUNOLOGY, V120, P182, DOI 10.1111/j.1365-2567.2006.02490.x; Yoshida M, 2001, ARTERIOSCL THROM VAS, V21, P1165, DOI 10.1161/hq0701.092143; Zhang YJ, 1999, J VIROL, V73, P3443, DOI 10.1128/JVI.73.4.3443-3448.1999	28	36	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2007	2	5							e470	10.1371/journal.pone.0000470	http://dx.doi.org/10.1371/journal.pone.0000470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DZ	17520029	Green Published, Green Submitted, gold			2022-12-27	WOS:000207446000018
J	Hansen, ABE; Lohse, N; Gerstoft, J; Kronborg, G; Laursen, A; Pedersen, C; Sorensen, HT; Obel, N				Hansen, Ann-Brit Eg; Lohse, Nicolai; Gerstoft, Jan; Kronborg, Gitte; Laursen, Alex; Pedersen, Court; Sorensen, Henrik Toft; Obel, Niels			Cause-Specific Excess Mortality in Siblings of Patients Co-Infected with HIV and Hepatitis C Virus	PLOS ONE			English	Article								Background. Co-infection with hepatitis C in HIV-infected individuals is associated with 3- to 4-fold higher mortality among these patients' siblings, compared with siblings of mono-infected HIV-patients or population controls. This indicates that risk factors shared by family members partially account for the excess mortality of HIV/HCV-co-infected patients. We aimed to explore the causes of death contributing to the excess sibling mortality. Methodology and Principal Findings. We retrieved causes of death from the Danish National Registry of Deaths and estimated cause-specific excess mortality rates (EMR) for siblings of HIV/HCV-co-infected individuals (n = 436) and siblings of HIV mono-infected individuals (n = 1837) compared with siblings of population controls (n = 281,221). Siblings of HIV/HCV-co-infected individuals had an all-cause EMR of 3.03 (95% CI, 1.56-4.50) per 1,000 person-years, compared with siblings of matched population controls. Substance abuse-related deaths contributed most to the elevated mortality among siblings [EMR = 2.25 (1.09-3.40)] followed by unnatural deaths [EMR = 0.67 (20.05-1.39)]. No siblings of HIV/HCV co-infected patients had a liver-related diagnosis as underlying cause of death. Siblings of HIV-mono-infected individuals had an all-cause EMR of 0.60 (0.16-1.05) compared with siblings of controls. This modest excess mortality was due to deaths from an unknown cause [EMR = 0.28 (0.07-0.48)], deaths from substance abuse [EMR = 0.19 (-0.04-0.43)], and unnatural deaths [EMR = 0.18 (-0.06-0.42)]. Conclusions. HCV co-infection among HIV-infected patients was a strong marker for family-related mortality due to substance abuse and other unnatural causes. To reduce morbidity and mortality in HIV/HCV-co-infected patients, the advances in antiviral treatment of HCV should be accompanied by continued focus on interventions targeted at substance abuse-related risk factors.	[Hansen, Ann-Brit Eg; Pedersen, Court] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark; [Hansen, Ann-Brit Eg] Univ So Denmark, Odense, Denmark; [Hansen, Ann-Brit Eg] Rigshosp, Danish HIV Cohort Study, DK-2100 Copenhagen, Denmark; [Lohse, Nicolai; Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Gerstoft, Jan; Obel, Niels] Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Kronborg, Gitte] Hvidovre Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Laursen, Alex] Aarhus Univ Hosp Skejby, Dept Infect Dis, Aarhus, Denmark; [Sorensen, Henrik Toft] Boston Univ, Dept Epidemiol, Boston, MA 02215 USA	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Rigshospitalet; University of Copenhagen; Aarhus University; Rigshospitalet; University of Copenhagen; University of Copenhagen; Aarhus University; Boston University	Hansen, ABE (corresponding author), Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark.	ann-brit.eg.hansen@rh.regionh.dk	Kronborg, Gitte/E-4757-2010; Hansen, Ann-Brit/ABA-1921-2020; Lohse, Nicolai/ABE-5884-2020; Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Lohse, Nicolai/0000-0001-8403-8759; Hansen, Ann-Brit Eg/0000-0003-4228-3822; Laursen, Alex Lund/0000-0002-1206-156X	Danish AIDS Foundation, Odense University Hospital, Preben; Anna Simonsen's Foundation; Foundation of the Danish Association of Pharmacists; Clinical Institute at the University of Southern Denmark	Danish AIDS Foundation, Odense University Hospital, Preben; Anna Simonsen's Foundation; Foundation of the Danish Association of Pharmacists; Clinical Institute at the University of Southern Denmark	The Danish HIV Cohort Study receives funding from the Danish AIDS Foundation, Odense University Hospital, Preben and Anna Simonsen's Foundation, the Foundation of the Danish Association of Pharmacists, and the Clinical Institute at the University of Southern Denmark. No funding sources were involved in study design, data collection, analysis, report writing or approval of the manuscript.	Amin J, 2006, LANCET, V368, P938, DOI 10.1016/S0140-6736(06)69374-4; [Anonymous], CIVIL REGISTRATION S; Antonucci G, 2005, CLIN INFECT DIS, V40, pE101, DOI 10.1086/430445; Backus LI, 2005, AIDS, V19, pS13, DOI 10.1097/01.aids.0000192065.09281.01; CADORET RJ, 1995, ARCH GEN PSYCHIAT, V52, P42; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; GWAMZI N, 2007, 14 C RETR OPP INF LO; Hansen ABE, 2007, J INFECT DIS, V195, P230, DOI 10.1086/510246; Juel K, 2001, UGESKRIFT LAEGER, V163, P4190; Juel K, 1999, DAN MED BULL, V46, P354; Kendler KS, 2003, AM J PSYCHIAT, V160, P687, DOI 10.1176/appi.ajp.160.4.687; Lohse N, 2005, SCAND J INFECT DIS, V37, P338, DOI 10.1080/00365540510031692; MABECH CE, 1980, UGESKRIFT LAEGER, V142, P256; Miller MF, 2005, CLIN INFECT DIS, V41, P713, DOI 10.1086/432618; Qurishi N, 2003, LANCET, V362, P1708, DOI 10.1016/S0140-6736(03)14844-1; Rothman K, 1986, MODERN EPIDEMIOLOGY; SCHULZSCHAEFFER W, 1993, FORENSIC SCI INT, V62, P157, DOI 10.1016/0379-0738(93)90062-F; Sulkowski MS, 2005, AIDS, V19, pS8, DOI 10.1097/01.aids.0000192064.09281.48; Sullivan PS, 2006, AIDS, V20, P1171, DOI 10.1097/01.aids.0000226958.87471.48; Wahren CA, 1997, SUBST USE MISUSE, V32, P2163, DOI 10.3109/10826089709035627; Weis N, 2006, CLIN INFECT DIS, V42, P1481, DOI 10.1086/503569; SURVIVAL ANAL EPIDEM	22	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e738	10.1371/journal.pone.0000738	http://dx.doi.org/10.1371/journal.pone.0000738			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710138	Green Published, gold			2022-12-27	WOS:000207455200015
J	Goytia, M; Chamond, N; Cosson, A; Coatnoan, N; Hermant, D; Berneman, A; Minoprio, P				Goytia, Maira; Chamond, Nathalie; Cosson, Alain; Coatnoan, Nicolas; Hermant, Daniel; Berneman, Armand; Minoprio, Paola			Molecular and Structural Discrimination of Proline Racemase and Hydroxyproline-2-Epimerase from Nosocomial and Bacterial Pathogens	PLOS ONE			English	Article								The first eukaryotic proline racemase (PRAC), isolated from the human Trypanosoma cruzi pathogen, is a validated therapeutic target against Chagas' disease. This essential enzyme is implicated in parasite life cycle and infectivity and its ability to trigger host B-cell nonspecific hypergammaglobulinemia contributes to parasite evasion and persistence. Using previously identified PRAC signatures and data mining we present the identification and characterization of a novel PRAC and five hydroxyproline epimerases (HyPRE) from pathogenic bacteria. Single-mutation of key HyPRE catalytic cysteine abrogates enzymatic activity supporting the presence of two reaction centers per homodimer. Furthermore, evidences are provided that Brucella abortus PrpA [for 'proline racemase' virulence factor A] and homologous proteins from two Brucella spp are bona fide HyPREs and not 'one way' directional PRACs as described elsewhere. Although the mechanisms of aminoacid racemization and epimerization are conserved between PRAC and HyPRE, our studies demonstrate that substrate accessibility and specificity partly rely on contraints imposed by aromatic or aliphatic residues distinctively belonging to the catalytic pockets. Analysis of PRAC and HyPRE sequences along with reaction center structural data disclose additional valuable elements for in silico discrimination of the enzymes. Furthermore, similarly to PRAC, the lymphocyte mitogenicity displayed by HyPREs is discussed in the context of bacterial metabolism and pathogenesis. Considering tissue specificity and tropism of infectious pathogens, it would not be surprising if upon infection PRAC and HyPRE play important roles in the regulation of the intracellular and extracellular amino acid pool profiting the microrganism with precursors and enzymatic pathways of the host.	[Goytia, Maira; Chamond, Nathalie; Cosson, Alain; Coatnoan, Nicolas; Hermant, Daniel; Berneman, Armand; Minoprio, Paola] Inst Pasteur, Dept Immunol, Lab Immunobiol Infect Trypanosoma, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Minoprio, P (corresponding author), Inst Pasteur, Dept Immunol, Lab Immunobiol Infect Trypanosoma, F-75724 Paris, France.	pmm@pasteur.fr	Chamond, Nathalie/C-5907-2018	Chamond, Nathalie/0000-0002-0518-2929; Minoprio, Paola/0000-0002-1659-833X; COATNOAN, Nicolas/0000-0003-4129-0019	Institut Pasteur and Fonds Dedies (Sanofi/Aventis/Ministere de la Recherche) [17]; Fondation pour la Recherche Medicale (FRM)	Institut Pasteur and Fonds Dedies (Sanofi/Aventis/Ministere de la Recherche)(Sanofi-AventisMinistry of Research, France); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	Funding: This work was supported by grants of Institut Pasteur and Fonds Dedies n degrees 17 (Sanofi/Aventis/Ministere de la Recherche). MG is a fellow from Fondation pour la Recherche Medicale (FRM).	Adams E, 1970, Int Rev Connect Tissue Res, V5, P1; ADAMS E, 1959, J BIOL CHEM, V234, P2073; ADAMS E, 1964, J BIOL CHEM, V239, P1525; BEJARANO PA, 1989, INFECT IMMUN, V57, P3783, DOI 10.1128/IAI.57.12.3783-3787.1989; BELASCO JG, 1986, BIOCHEMISTRY-US, V25, P2552, DOI 10.1021/bi00357a040; Bouza E, 2005, CLIN MICROBIOL INFEC, V11, P57, DOI 10.1111/j.1469-0691.2005.01165.x; Buschiazzo A, 2006, P NATL ACAD SCI USA, V103, P1705, DOI 10.1073/pnas.0509010103; CARDINALE GJ, 1968, BIOCHEMISTRY-US, V7, P3970, DOI 10.1021/bi00851a026; Chamond N, 2005, MOL MICROBIOL, V58, P46, DOI 10.1111/j.1365-2958.2005.04808.x; Chamond N., 2002, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V2, P247, DOI 10.2174/1568008023340604; Chamond N, 2003, J BIOL CHEM, V278, P15484, DOI 10.1074/jbc.M210830200; de Bentzmann S, 2000, LAB INVEST, V80, P209, DOI 10.1038/labinvest.3780024; FISHER LM, 1986, BIOCHEMISTRY-US, V25, P2529, DOI 10.1021/bi00357a037; Godfroid J, 2005, VET RES, V36, P313, DOI 10.1051/vetres:2005003; GRYDER RM, 1969, J BACTERIOL, V97, P292, DOI 10.1128/JB.97.1.292-306.1969; Gryder RM, 1970, J BACTERIOL, V101, P948, DOI 10.1128/JB.101.3.948-958.1970; Harrington DJ, 1996, INFECT IMMUN, V64, P1885, DOI 10.1128/IAI.64.6.1885-1891.1996; Kipnis E, 2006, MED MALADIES INFECT, V36, P78, DOI 10.1016/j.medmal.2005.10.007; MACFARLANE L, 1991, J INFECTION, V23, P346, DOI 10.1016/0163-4453(91)93620-R; Spera JM, 2006, P NATL ACAD SCI USA, V103, P16514, DOI 10.1073/pnas.0603362103; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; RADHAKRISHNAN AN, 1957, J BIOL CHEM, V226, P559; RAMASWAMY SG, 1984, J BIOL CHEM, V259, P249; Reina-San-Martin B, 2000, NAT MED, V6, P890, DOI 10.1038/78651; Reina-San-Martin B, 2000, PARASITOL TODAY, V16, P62, DOI 10.1016/S0169-4758(99)01591-4; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; STADTMAN TC, 1957, J BIOL CHEM, V228, P983; Stoddart B, 2002, CURR OPIN INFECT DIS, V15, P513, DOI 10.1097/00001432-200210000-00010; VALLE D, 1973, BIOCHEM BIOPH RES CO, V54, P1418, DOI 10.1016/0006-291X(73)91144-3; VALLE D, 1975, NATURE, V253, P214, DOI 10.1038/253214a0; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Yoshimura T, 2003, J BIOSCI BIOENG, V96, P103, DOI 10.1016/S1389-1723(03)90111-3	34	38	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e885	10.1371/journal.pone.0000885	http://dx.doi.org/10.1371/journal.pone.0000885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849014	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455600031
J	Purves, DW; Lichstein, JW; Pacala, SW				Purves, Drew W.; Lichstein, Jeremy W.; Pacala, Stephen W.			Crown Plasticity and Competition for Canopy Space: A New Spatially Implicit Model Parameterized for 250 North American Tree Species	PLOS ONE			English	Article							JAPONICA DON,D. PLANTATIONS; PREDICTION MODELS; FOREST INVENTORY; TROPICAL FOREST; GROWTH; DYNAMICS; SURVIVORSHIP; DISPLACEMENT; ARCHITECTURE; DIAMETER	Background. Canopy structure, which can be defined as the sum of the sizes, shapes and relative placements of the tree crowns in a forest stand, is central to all aspects of forest ecology. But there is no accepted method for deriving canopy structure from the sizes, species and biomechanical properties of the individual trees in a stand. Any such method must capture the fact that trees are highly plastic in their growth, forming tessellating crown shapes that fill all or most of the canopy space. Methodology/Principal Findings. We introduce a new, simple and rapidly-implemented model-the Ideal Tree Distribution, ITD-with tree form (height allometry and crown shape), growth plasticity, and space-filling, at its core. The ITD predicts the canopy status (in or out of canopy), crown depth, and total and exposed crown area of the trees in a stand, given their species, sizes and potential crown shapes. We use maximum likelihood methods, in conjunction with data from over 100,000 trees taken from forests across the coterminous US, to estimate ITD model parameters for 250 North American tree species. With only two free parameters per species-one aggregate parameter to describe crown shape, and one parameter to set the so-called depth bias-the model captures between-species patterns in average canopy status, crown radius, and crown depth, and within-species means of these metrics vs stem diameter. The model also predicts much of the variation in these metrics for a tree of a given species and size, resulting solely from deterministic responses to variation in stand structure. Conclusions/Significance. This new model, with parameters for US tree species, opens up new possibilities for understanding and modeling forest dynamics at local and regional scales, and may provide a new way to interpret remote sensing data of forest canopies, including LIDAR and aerial photography.	[Purves, Drew W.; Lichstein, Jeremy W.; Pacala, Stephen W.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Purves, Drew W.] Microsoft Res, External Res Off, Cambridge, England	Princeton University; Microsoft	Purves, DW (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	dpurves@microsoft.com	Lichstein, Jeremy/GMW-6555-2022					Barnes B. V., 1998, FOREST ECOLOGY, V4th; Bechtold WA, 2004, WEST J APPL FOR, V19, P245, DOI 10.1093/wjaf/19.4.245; Bechtold WA, 2003, SOUTH J APPL FOR, V27, P269, DOI 10.1093/sjaf/27.4.269; Beringer J, 2005, AGR FOREST METEOROL, V131, P143, DOI 10.1016/j.agrformet.2005.05.006; Brisson J, 1997, ECOLOGY, V78, P2378; Brown S, 2005, ECOL APPL, V15, P1083, DOI 10.1890/04-0829; Canham CD, 2006, ECOL APPL, V16, P540, DOI 10.1890/1051-0761(2006)016[0540:NAOCTC]2.0.CO;2; Canham CD, 2004, CAN J FOREST RES, V34, P778, DOI [10.1139/x03-232, 10.1139/X03-232]; CASPERSEN JP, 2004, FOREST ECOL MANAG, V200, P540; Coates KD, 2003, FOREST ECOL MANAG, V186, P297, DOI 10.1016/S0378-1127(03)00301-3; DELEUZE C, 1993, CANADIAN J FOREST RE, V26, P1957; Di Lucca CM, 1999, STAND DENSITY MANAGEMENT: USING THE PLANNING TOOLS, PROCEEDING, P7; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Fujita T, 2003, J ECOL, V91, P686, DOI 10.1046/j.1365-2745.2003.00796.x; Herwitz SR, 2000, ECOLOGY, V81, P585, DOI 10.1890/0012-9658(2000)081[0585:LTSACA]2.0.CO;2; HILBORN R, 1997, ECOLOGICAL DETECTIVE, pR17; HORN H S, 1971, P144; Jensen JLR, 2006, CAN J FOREST RES, V36, P1129, DOI 10.1139/X06-007; KOBE RK, 1995, ECOL APPL, V5, P517, DOI 10.2307/1942040; MacFarlane DW, 2003, FOREST ECOL MANAG, V173, P145, DOI 10.1016/S0378-1127(02)00011-7; McRoberts RE, 2005, J FOREST, V103, P304; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; MITCHELL KJ, 1969, YALE U SCH FORESTRY, V75; Moorcroft PR, 2003, P ROY SOC B-BIOL SCI, V270, P1215, DOI 10.1098/rspb.2002.2251; Muth CC, 2003, CAN J FOREST RES, V33, P1323, DOI 10.1139/X03-045; Muth CC, 2002, CAN J FOREST RES, V32, P247, DOI [10.1139/x01-196, 10.1139/X01-196]; Naesset E, 2002, REMOTE SENS ENVIRON, V79, P105, DOI 10.1016/S0034-4257(01)00243-7; Nelson R, 1997, REMOTE SENS ENVIRON, V60, P327, DOI 10.1016/S0034-4257(96)00214-3; Olesen T, 2001, ECOLOGY, V82, P2719, DOI 10.1890/0012-9658(2001)082[2719:AOACTR]2.0.CO;2; Oliver Chadwick D., 1996; Pacala SW, 1996, ECOL MONOGR, V66, P1, DOI 10.2307/2963479; Piboule A, 2005, ANN FOREST SCI, V62, P645, DOI 10.1051/forest:2005071; PINKER RT, 1988, BOUND-LAY METEOROL, V43, P43, DOI 10.1007/BF00153968; Poorter L, 2006, ECOLOGY, V87, P1289, DOI 10.1890/0012-9658(2006)87[1289:AOMTST]2.0.CO;2; Purves DW, 2004, GLOBAL CHANGE BIOL, V10, P1737, DOI 10.1111/j.1365-2486.2004.00844.x; Roberts SD, 2005, FOREST ECOL MANAG, V213, P54, DOI 10.1016/j.foreco.2005.03.025; Roelandt C, 2001, ECOL MODEL, V143, P191, DOI 10.1016/S0304-3800(01)00331-3; Shugart H. H., 1984, A theory of forest dynamics. The ecological implications of forest succession models.; Smith WB, 2002, ENVIRON POLLUT, V116, pS233, DOI 10.1016/S0269-7491(01)00255-X; SORRENSENCOTHERN KA, 1993, ECOL MONOGR, V63, P277, DOI 10.2307/2937102; Stoll P, 2005, J ECOL, V93, P395, DOI 10.1111/j.0022-0477.2005.00989.x; Takahashi T, 2005, J FOREST RES-JPN, V10, P305, DOI 10.1007/s10310-005-0150-2; Takahashi T, 2005, J FOREST RES-JPN, V10, P135, DOI 10.1007/s10310-004-0125-8; UMEKI K, 1995, ECOL MODEL, V82, P11, DOI 10.1016/0304-3800(94)00081-R; Uriarte M, 2004, J ECOL, V92, P348, DOI 10.1111/j.0022-0477.2004.00867.x; WELLER DE, 1987, ECOL MONOGR, V57, P23, DOI 10.2307/1942637; Wyckoff PH, 2005, CAN J FOREST RES, V35, P13, DOI 10.1139/x04-142; YOUNG TP, 1991, ECOLOGY, V72, P1464, DOI 10.2307/1941119; [No title captured]	49	118	124	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e870	10.1371/journal.pone.0000870	http://dx.doi.org/10.1371/journal.pone.0000870			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849000	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455600017
J	Staiger, H; Machicao, F; Stefan, N; Tschritter, O; Thamer, C; Kantartzis, K; Schafer, SA; Kirchhoff, K; Fritsche, A; Haring, HU				Staiger, Harald; Machicao, Fausto; Stefan, Norbert; Tschritter, Otto; Thamer, Claus; Kantartzis, Konstantinos; Schaefer, Silke A.; Kirchhoff, Kerstin; Fritsche, Andreas; Haering, Hans-Ulrich			Polymorphisms within Novel Risk Loci for Type 2 Diabetes Determine beta-Cell Function	PLOS ONE			English	Article								Background. Type 2 diabetes arises when insulin resistance-induced compensatory insulin secretion exhausts. Insulin resistance and/or beta-cell dysfunction result from the interaction of environmental factors (high-caloric diet and reduced physical activity) with a predisposing polygenic background. Very recently, genetic variations within four novel genetic loci (SLC30A8, HHEX, EXT2, and LOC387761) were reported to be more frequent in subjects with type 2 diabetes than in healthy controls. However, associations of these variations with insulin resistance and/or beta-cell dysfunction were not assessed. Methodology/Principal Findings. By genotyping of 921 metabolically characterized German subjects for the reported candidate single nucleotide polymorphisms (SNPs), we show that the major alleles of the SLC30A8 SNP rs13266634 and the HHEX SNP rs7923837 associate with reduced insulin secretion stimulated by orally or intravenously administered glucose, but not with insulin resistance. In contrast, the other reported type 2 diabetes candidate SNPs within the EXT2 and LOC387761 loci did not associate with insulin resistance or beta-cell dysfunction, respectively. Conclusions/Significance. The HHEX and SLC30A8 genes encode for proteins that were shown to be required for organogenesis of the ventral pancreas and for insulin maturation/storage, respectively. Therefore, the major alleles of type 2 diabetes candidate SNPs within these genetic loci represent crucial alleles for beta-cell dysfunction and, thus, might confer increased susceptibility of beta-cells towards adverse environmental factors.	[Staiger, Harald; Machicao, Fausto; Stefan, Norbert; Tschritter, Otto; Thamer, Claus; Kantartzis, Konstantinos; Schaefer, Silke A.; Kirchhoff, Kerstin; Fritsche, Andreas; Haering, Hans-Ulrich] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, D-7400 Tubingen, Germany	Eberhard Karls University of Tubingen	Haring, HU (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, D-7400 Tubingen, Germany.	hans-ulrich.haering@med.uni-tuebingen.de	Kantartzis, Konstantinos/AAC-3999-2019; Staiger, Harald/N-5871-2014	Staiger, Harald/0000-0002-9507-5333; Stefan, Norbert/0000-0002-2186-9595; Kantartzis, Konstantinos/0000-0002-0584-1138	German Research Foundation [KFO 114/2]	German Research Foundation(German Research Foundation (DFG))	The study was supported by a grant from the German Research Foundation (KFO 114/2).	Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Freeman H, 2006, HUM MOL GENET, V15, pR202, DOI 10.1093/hmg/ddl191; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; Hara K, 2000, BIOCHEM BIOPH RES CO, V271, P212, DOI 10.1006/bbrc.2000.2605; Koch M, 1999, DIABETOLOGIA, V42, P758, DOI 10.1007/s001250051225; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Nielsen EMD, 2003, DIABETES, V52, P573, DOI 10.2337/diabetes.52.2.573; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Tripathy D, 2003, DIABETES CARE, V26, P1395, DOI 10.2337/diacare.26.5.1395; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang CL, 2006, DIABETES, V55, P2645, DOI 10.2337/db06-0643	24	138	141	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e832	10.1371/journal.pone.0000832	http://dx.doi.org/10.1371/journal.pone.0000832			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786204	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455500016
J	Wang, Q; Lee, C				Wang, Qi; Lee, Christopher			Distinguishing Functional Amino Acid Covariation from Background Linkage Disequilibrium in HIV Protease and Reverse Transcriptase	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CORRELATED MUTATIONS; POSITIVE EPISTASIS; V3 LOOP; RECOMBINATION; SEQUENCES; CONTACTS; COVARIABILITY; CONSERVATION; PREDICTION	Correlated amino acid mutation analysis has been widely used to infer functional interactions between different sites in a protein. However, this analysis can be confounded by important phylogenetic effects broadly classifiable as background linkage disequilibrium (BLD). We have systematically separated the covariation induced by selective interactions between amino acids from background LD, using synonymous (S) vs. amino acid (A) mutations. Covariation between two amino acid mutations, (A, A), can be affected by selective interactions between amino acids, whereas covariation within (A, S) pairs or (S, S) pairs cannot. Our analysis of the pol gene - including the protease and the reverse transcriptase genes - in HIV reveals that (A, A) covariation levels are enormously higher than for either (A, S) or (S, S), and thus cannot be attributed to phylogenetic effects. The magnitude of these effects suggests that a large portion of (A, A) covariation in the HIV pol gene results from selective interactions. Inspection of the most prominent (A, A) interactions in the HIV pol gene showed that they are known sites of independently identified drug resistance mutations, and physically cluster around the drug binding site. Moreover, the specific set of (A, A) interaction pairs was reproducible in different drug treatment studies, and vanished in untreated HIV samples. The (S, S) covariation curves measured a low but detectable level of background LD in HIV.	[Wang, Qi; Lee, Christopher] Univ Calif Los Angeles, Inst Mol Biol, Inst Genom & Proteom, Ctr Computat Biol, Los Angeles, CA 90024 USA; [Lee, Christopher] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lee, C (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Inst Genom & Proteom, Ctr Computat Biol, Los Angeles, CA 90024 USA.	leec@chem.ucla.edu		Wang, Qi/0000-0002-6420-1720	NIH [U54 RR021813]; DOE [DE-FC02-02ER63421]; Dreyfus Foundation; UCLA; UCLA AIDS Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR021813] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); Dreyfus Foundation; UCLA(University of California System); UCLA AIDS Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work is supported by grants from the NIH (U54 RR021813) and DOE (DE-FC02-02ER63421), a Dreyfus Foundation Teacher-Scholar Award to CJL, as well as UCLA dissertation year fellowship and UCLA AIDS Institute fellowship to QW.	AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ane C, 2005, MOL BIOL EVOL, V22, P914, DOI 10.1093/molbev/msi076; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Bickel PJ, 1996, AIDS RES HUM RETROV, V12, P1401, DOI 10.1089/aid.1996.12.1401; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; BROWN AHD, 1975, THEOR POPUL BIOL, V8, P184, DOI 10.1016/0040-5809(75)90031-3; Chen LM, 2004, J VIROL, V78, P3722, DOI 10.1128/JVI.78.7.3722-3732.2004; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; DOOLITTLE RF, 1994, TRENDS BIOCHEM SCI, V19, P15, DOI 10.1016/0968-0004(94)90167-8; Fariselli P, 2001, PROTEINS, P157, DOI 10.1002/prot.1173; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Gilbert PB, 2005, AIDS RES HUM RETROV, V21, P1016, DOI 10.1089/aid.2005.21.1016; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Gonzales MJ, 2003, AIDS, V17, P791, DOI 10.1097/00002030-200304110-00003; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hofacker IL, 1999, COMPUT CHEM, V23, P401, DOI 10.1016/S0097-8485(99)00013-3; Hoffman NG, 2003, VIROLOGY, V314, P536, DOI 10.1016/S0042-6822(03)00484-7; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; Johnson Victoria A, 2006, Top HIV Med, V14, P125; Korber B, 1998, SCIENCE, V280, P1868, DOI 10.1126/science.280.5371.1868; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Larson SM, 2000, J MOL BIOL, V303, P433, DOI 10.1006/jmbi.2000.4146; Leitner T, 1996, P NATL ACAD SCI USA, V93, P10864, DOI 10.1073/pnas.93.20.10864; Lemey P, 2005, J VIROL, V79, P11981, DOI 10.1128/JVI.79.18.11981-11989.2005; LEWONTIN RC, 1988, GENETICS, V120, P849; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Noivirt O, 2005, PROTEIN ENG DES SEL, V18, P247, DOI 10.1093/protein/gzi029; OHTA T, 1970, GENET RES, V16, P165, DOI 10.1017/S0016672300002391; Olmea O, 1997, FOLD DES, V2, pS25, DOI 10.1016/S1359-0278(97)00060-6; Olmea O, 1999, J MOL BIOL, V293, P1221, DOI 10.1006/jmbi.1999.3208; Pan C, 2007, NUCLEIC ACIDS RES, V35, pD371, DOI 10.1093/nar/gkl855; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Rhodes T, 2003, J VIROL, V77, P11193, DOI 10.1128/JVI.77.20.11193-11200.2003; Service SK, 2001, HUM MOL GENET, V10, P545, DOI 10.1093/hmg/10.5.545; Shafer RW, 2002, CLIN MICROBIOL REV, V15, P247, DOI 10.1128/CMR.15.2.247-277.2002; Shapiro B, 2006, MOL BIOL EVOL, V23, P1724, DOI 10.1093/molbev/msl037; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Svicher V, 2005, ANTIMICROB AGENTS CH, V49, P2015, DOI 10.1128/AAC.49.5.2015-2025.2005; Thomas DJ, 1996, PROTEIN ENG, V9, P941, DOI 10.1093/protein/9.11.941; Thomson MM, 2005, AIDS REV, V7, P210; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wollenberg KR, 2000, P NATL ACAD SCI USA, V97, P3288, DOI 10.1073/pnas.070154797; Wu TD, 2003, J VIROL, V77, P4836, DOI 10.1128/JVI.77.8.4836-4847.2003; Zhuang JL, 2002, J VIROL, V76, P11273, DOI 10.1128/JVI.76.22.11273-11282.2002	58	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e814	10.1371/journal.pone.0000814	http://dx.doi.org/10.1371/journal.pone.0000814			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726544	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455400031
J	Kleps, RA; Myers, TC; Lipcius, RN; Henderson, TO				Kleps, Robert A.; Myers, Terrell C.; Lipcius, Romuald N.; Henderson, Thomas O.			A Sex-Specific Metabolite Identified in a Marine Invertebrate Utilizing Phosphorus-31 Nuclear Magnetic Resonance	PLOS ONE			English	Article								Hormone level differences are generally accepted as the primary cause for sexual dimorphism in animal and human development. Levels of low molecular weight metabolites also differ between men and women in circulating amino acids, lipids and carbohydrates and within brain tissue. While investigating the metabolism of blue crab tissues using Phosphorus-31 Nuclear Magnetic Resonance, we discovered that only the male blue crab (Callinectes sapidus) contained a phosphorus compound with a chemical shift well separated from the expected phosphate compounds. Spectra obtained from male gills were readily differentiated from female gill spectra. Analysis from six years of data from male and female crabs documented that the sex-specificity of this metabolite was normal for this species. Microscopic analysis of male and female gills found no differences in their gill anatomy or the presence of parasites or bacteria that might produce this phosphorus compound. Analysis of a rare gynandromorph blue crab (laterally, half male and half female) proved that this sex-specificity was an intrinsic biochemical process and was not caused by any variations in the diet or habitat of male versus female crabs. The existence of a sex-specific metabolite is a previously unrecognized, but potentially significant biochemical phenomenon. An entire enzyme system has been synthesized and activated only in one sex. Unless blue crabs are a unique species, sex-specific metabolites are likely to be present in other animals. Would the presence or absence of a sex-specific metabolite affect an animal's development, anatomy and biochemistry?	[Kleps, Robert A.] Univ Illinois, Res Resources Ctr, Chicago, IL 60680 USA; [Myers, Terrell C.; Henderson, Thomas O.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA; [Lipcius, Romuald N.] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; William & Mary; Virginia Institute of Marine Science	Kleps, RA (corresponding author), Univ Illinois, Res Resources Ctr, Chicago, IL 60680 USA.	kleps@uic.edu						BUCKLEY PF, 1994, BIOL PSYCHIAT, V36, P792, DOI 10.1016/0006-3223(94)90591-6; BURT CT, 1992, COMP BIOCHEM PHYS A, V103, P715, DOI 10.1016/0300-9629(92)90171-L; CLARIDGE TDW, 2004, TETRAHEDRON ORGANIC, V19, P15; Crews D, 2005, HORM BEHAV, V48, P384, DOI 10.1016/j.yhbeh.2005.04.003; Curry BB, 2001, INT J TOXICOL, V20, P153, DOI 10.1080/109158101317097737; FOGARTY MJ, 2006, BLUE CRAB C IN PRESS; Glickman SE, 2005, HORM BEHAV, V48, P403, DOI 10.1016/j.yhbeh.2005.07.013; GLONEK T, 1970, SCIENCE, V169, P192, DOI 10.1126/science.169.3941.192; HENDERSO.TO, 1972, ARCH BIOCHEM BIOPHYS, V149, P484, DOI 10.1016/0003-9861(72)90348-7; HINES AH, 2007, BLUE CRAB C IN PRESS; HORIGUCHI M, 1959, NATURE, V184, P901, DOI 10.1038/184901b0; Johnston CM, 1995, PHILOS T R SOC B, V350, P297, DOI 10.1098/rstb.1995.0165; Kariotoglou DM, 2003, COMP BIOCHEM PHYS B, V136, P27, DOI 10.1016/S1096-4959(03)00168-4; Kawachi T, 2002, J NEUROL SCI, V199, P79, DOI 10.1016/S0022-510X(02)00112-0; KITTREDGE JS, 1969, SCIENCE, V164, P37, DOI 10.1126/science.164.3875.37; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Koning A. J. de, 1970, Biochimica et Biophysica Acta, V202, P187; KONING AJ, 2003, S AFR J SCI, V99, P521; Lamont LS, 2003, J APPL PHYSIOL, V95, P1259, DOI 10.1152/japplphysiol.01028.2002; Laz EV, 2004, MOL CELL PROTEOMICS, V3, P1170, DOI 10.1074/mcp.M400102-MCP200; Lipcius RN, 2002, MAR ECOL PROG SER, V226, P45, DOI 10.3354/meps226045; LIPCIUS RN, 2000, SPINY LOBSTERS FISHE, P1, DOI DOI 10.1002/9780470698808.CH; Lipcius Romuald N., 2007, BLUE CRAB CALLINECTE, P535; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Miller T.J., 2005, TECHNICAL REPORT SER; Mittendorfer B, 2005, J NUTR, V135, P681, DOI 10.1093/jn/135.4.681; Mukhamedova KS, 2000, CHEM NAT COMPD+, V36, P329, DOI 10.1023/A:1002804409503; OHLSSON A, 1971, CANNABINOID CONSTITU, P29; Oliveira RF, 2005, HORM BEHAV, V48, P430, DOI 10.1016/j.yhbeh.2005.06.002; Quin LD, 2001, COMP BIOCHEM PHYS B, V128, P173, DOI 10.1016/S1096-4959(00)00310-9; Ren J, 2004, ENDOCRINE, V25, P73, DOI 10.1385/ENDO:25:2:073; Riehemann S, 1999, NMR BIOMED, V12, P483, DOI 10.1002/(SICI)1099-1492(199912)12:8<483::AID-NBM589>3.0.CO;2-D; Silliman BR, 2002, P NATL ACAD SCI USA, V99, P10500, DOI 10.1073/pnas.162366599; Stanley EG, 2005, ANAL BIOCHEM, V343, P195, DOI 10.1016/j.ab.2005.01.024; Tarnopolsky MA, 2001, CURR OPIN CLIN NUTR, V4, P521, DOI 10.1097/00075197-200111000-00010; Tipton KD, 2001, CURR OPIN CLIN NUTR, V4, P493, DOI 10.1097/00075197-200111000-00005; Towle DW, 2001, J EXP BIOL, V204, P4005; Tweedie EP, 2004, J EXP BIOL, V207, P2589, DOI 10.1242/jeb.01070; van den Broek HHLP, 2005, MULT SCLER J, V11, P349, DOI 10.1191/1352458505ms1174rr; Van ENGEL W. A., 1958, COMMERCIAL FISH REV, V20, P6; Volkow ND, 1997, AM J PSYCHIAT, V154, P119; WASEF SZY, 2004, GENDER MED, V1, P12, DOI DOI 10.1016/S1550-8579(04)80006-8; WHITNEY JO, 1974, COMP BIOCHEM PHYSIOL, V49, P433, DOI 10.1016/0300-9629(74)90559-3; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923	44	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e780	10.1371/journal.pone.0000780	http://dx.doi.org/10.1371/journal.pone.0000780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712428	Green Published, gold			2022-12-27	WOS:000207455300028
J	Eshaghi, M; Karuturi, RKM; Li, JT; Chu, ZQ; Liu, ET; Liu, JH				Eshaghi, Majid; Karuturi, R. Krishna M.; Li, Juntao; Chu, Zhaoqing; Liu, Edison T.; Liu, Jianhua			Global Profiling of DNA Replication Timing and Efficiency Reveals that Efficient Replication/Firing Occurs Late during S-Phase in S. pombe	PLOS ONE			English	Article								Background. During S. pombe S-phase, initiation of DNA replication occurs at multiple sites (origins) that are enriched with AT-rich sequences, at various times. Current studies of genome-wide DNA replication profiles have focused on the DNA replication timing and origin location. However, the replication and/or firing efficiency of the individual origins on the genomic scale remain unclear. Methodology/Principal Findings. Using the genome-wide ORF-specific DNA microarray analysis, we show that in S. pombe, individual origins fire with varying efficiencies and at different times during S-phase. The increase in DNA copy number plotted as a function of time is approximated to the near-sigmoidal model, when considering the replication start and end timings at individual loci in cells released from HU-arrest. Replication efficiencies differ from origin to origin, depending on the origin's firing efficiency. We have found that DNA replication is inefficient early in S-phase, due to inefficient firing at origins. Efficient replication occurs later, attributed to efficient but late-firing origins. Furthermore, profiles of replication timing in cds1 Delta cells are abnormal, due to the failure in resuming replication at the collapsed forks. The majority of the inefficient origins, but not the efficient ones, are found to fire in cds1 Delta cells after HU removal, owing to the firing at the remaining unused (inefficient) origins during HU treatment. Conclusions/Significance. Taken together, our results indicate that efficient DNA replication/firing occurs late in S-phase progression in cells after HU removal, due to efficient late-firing origins. Additionally, checkpoint kinase Cds1p is required for maintaining the efficient replication/firing late in S-phase. We further propose that efficient late-firing origins are essential for ensuring completion of DNA duplication by the end of S-phase.	[Eshaghi, Majid; Karuturi, R. Krishna M.; Li, Juntao; Chu, Zhaoqing; Liu, Edison T.; Liu, Jianhua] Genome Inst Singapore, Singapore, Singapore; [Liu, Jianhua] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore	Liu, JH (corresponding author), Genome Inst Singapore, Singapore, Singapore.	liujh@gis.a-star.edu.sg	Liu, Edison/C-4141-2008	Liu, Jianhua/0000-0003-1165-9348; ?, ??/0000-0002-3982-9858	Agency for Science, Technology and Research (A-STAR), Singapore	Agency for Science, Technology and Research (A-STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology and Research (A-STAR), Singapore.	ALKHODAIRY F, 1994, MOL BIOL CELL, V5, P147, DOI 10.1091/mbc.5.2.147; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Dai JL, 2005, P NATL ACAD SCI USA, V102, P337, DOI 10.1073/pnas.0408811102; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; ENOCH T, 1992, GENE DEV, V6, P2035, DOI 10.1101/gad.6.11.2035; Feng WY, 2006, NAT CELL BIOL, V8, P148, DOI 10.1038/ncb1358; Gilbert DM, 2001, J CELL BIOL, V152, pF11, DOI 10.1083/jcb.152.2.F11; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; Heichinger C, 2006, EMBO J, V25, P5171, DOI 10.1038/sj.emboj.7601390; Jeon Y, 2005, P NATL ACAD SCI USA, V102, P6419, DOI 10.1073/pnas.0405088102; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; Legouras I, 2006, YEAST, V23, P951, DOI 10.1002/yea.1416; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; MacAlpine D, 2005, CHROMOSOME RES, V13, P309, DOI 10.1007/s10577-005-1508-1; MacNeill SA, 1997, METHOD ENZYMOL, V283, P440; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; Patel PK, 2006, MOL BIOL CELL, V17, P308, DOI 10.1091/mbc.E05-07-0657; Peng X, 2005, MOL BIOL CELL, V16, P1026, DOI 10.1091/mbc.E04-04-0299; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Rhind N, 2006, NAT CELL BIOL, V8, P1313, DOI 10.1038/ncb1206-1313; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Schubeler D, 2002, NAT GENET, V32, P438, DOI 10.1038/ng1005; SEATON BL, 1992, GENE, V119, P83, DOI 10.1016/0378-1119(92)90069-2; Segurado M, 2003, EMBO REP, V4, P1048, DOI 10.1038/sj.embor.7400008; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yabuki N, 2002, GENES CELLS, V7, P781, DOI 10.1046/j.1365-2443.2002.00559.x; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	32	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e722	10.1371/journal.pone.0000722	http://dx.doi.org/10.1371/journal.pone.0000722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684567	Green Published, gold, Green Submitted			2022-12-27	WOS:000207452400024
J	Hossler, P; Mulukutla, BC; Hu, WS				Hossler, Patrick; Mulukutla, Bhanu Chandra; Hu, Wei-Shou			Systems Analysis of N-Glycan Processing in Mammalian Cells	PLOS ONE			English	Article								N-glycosylation plays a key role in the quality of many therapeutic glycoprotein biologics. The biosynthesis reactions of these oligosaccharides are a type of network in which a relatively small number of enzymes give rise to a large number of N-glycans as the reaction intermediates and terminal products. Multiple glycans appear on the glycoprotein molecules and give rise to a heterogeneous product. Controlling the glycan distribution is critical to the quality control of the product. Understanding N-glycan biosynthesis and the etiology of microheterogeneity would provide physiological insights, and facilitate cellular engineering to enhance glycoprotein quality. We developed a mathematical model of glycan biosynthesis in the Golgi and analyzed the various reaction variables on the resulting glycan distribution. The Golgi model was modeled as four compartments in series. The mechanism of protein transport across the Golgi is still controversial. From the viewpoint of their holding time distribution characteristics, the two main hypothesized mechanisms, vesicular transport and Golgi maturation models, resemble four continuous mixing-tanks (4CSTR) and four plug-flow reactors (4PFR) in series, respectively. The two hypotheses were modeled accordingly and compared. The intrinsic reaction kinetics were first evaluated using a batch (or single PFR) reactor. A sufficient holding time is needed to produce terminally-processed glycans. Altering enzyme concentrations has a complex effect on the final glycan distribution, as the changes often affect many reaction steps in the network. Comparison of the glycan profiles predicted by the 4CSTR and 4PFR models points to the 4PFR system as more likely to be the true mechanism. To assess whether glycan heterogeneity can be eliminated in the biosynthesis of biotherapeutics the 4PFR model was further used to assess whether a homogeneous glycan profile can be created through metabolic engineering. We demonstrate by the spatial localization of enzymes to specific compartments all terminally processed N-glycans can be synthesized as homogeneous products with a sufficient holding time in the Golgi compartments. The model developed may serve as a guide to future engineering of glycoproteins.	[Hossler, Patrick; Mulukutla, Bhanu Chandra; Hu, Wei-Shou] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hu, WS (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	acre@cems.umn.edu			NIH [GM08347]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	P.H. was supported by an NIH Biotechnology Training Grant (GM08347).	Abeijon C, 1997, TRENDS BIOCHEM SCI, V22, P203, DOI 10.1016/S0968-0004(97)01053-0; BENDIAK B, 1987, J BIOL CHEM, V262, P5784; BENDIAK B, 1993, EUR J BIOCHEM, V216, P405, DOI 10.1111/j.1432-1033.1993.tb18158.x; BENDIAK B, 1987, J BIOL CHEM, V262, P5775; CARRAWAY KL, 1989, BIOESSAYS, V10, P117, DOI 10.1002/bies.950100406; CHANDRASEKARAN EV, 1984, CANCER RES, V44, P4059; Chen WE, 2005, WIREL NETW MOB COMP, V1, P3; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; de Graffenried CL, 2004, CURR OPIN CELL BIOL, V16, P356, DOI 10.1016/j.ceb.2004.06.007; Elsner M, 2003, MOL MEMBR BIOL, V20, P221, DOI 10.1080/0968768031000114024; Ferrara C, 2006, BIOTECHNOL BIOENG, V93, P851, DOI 10.1002/bit.20777; Grabenhorst E, 1999, J BIOL CHEM, V274, P36107, DOI 10.1074/jbc.274.51.36107; Hamilton SR, 2003, SCIENCE, V301, P1244, DOI 10.1126/science.1088166; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Hooker AD, 1999, BIOTECHNOL BIOENG, V63, P559, DOI 10.1002/(SICI)1097-0290(19990605)63:5<559::AID-BIT6>3.0.CO;2-L; Hossler P, 2006, BIOTECHNOL BIOENG, V95, P946, DOI 10.1002/bit.21062; Ikeda Y, 2001, TRENDS GLYCOSCI GLYC, V13, P167, DOI 10.4052/tigg.13.167; Jost F, 2005, GLYCOBIOLOGY, V15, P165, DOI 10.1093/glycob/cwh157; Kindt T.J., 1984, ANTIBODY ENIGMA; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Krambeck FJ, 2005, BIOTECHNOL BIOENG, V92, P711, DOI 10.1002/bit.20645; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Malhotra V, 2006, NATURE, V441, P939, DOI 10.1038/441939a; Marsh BJ, 2002, NAT REV MOL CELL BIO, V3, P789, DOI 10.1038/nrm933; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; MILLA ME, 1989, P NATL ACAD SCI USA, V86, P1786, DOI 10.1073/pnas.86.6.1786; Mironov A, 1998, FASEB J, V12, P249; MOREMEN KW, 1991, J BIOL CHEM, V266, P16876; NISHIKAWA A, 1992, J BIOL CHEM, V267, P18199; NISHIKAWA Y, 1988, J BIOL CHEM, V263, P8270; NISHIU J, 1995, BIOSCI BIOTECH BIOCH, V59, P1750, DOI 10.1271/bbb.59.1750; Oguri S, 1997, J BIOL CHEM, V272, P22721, DOI 10.1074/jbc.272.36.22721; PAQUET MR, 1984, J BIOL CHEM, V259, P4716; PAULSON JC, 1977, J BIOL CHEM, V252, P2356; RABOUILLE C, 1995, J CELL SCI, V108, P1617; RAO AK, 1976, BIOCHEMISTRY-US, V15, P5001, DOI 10.1021/bi00668a009; Seth G, 2006, ADV BIOCHEM ENG BIOT, V101, P119, DOI 10.1007/10_017; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; SHOREIBAH MG, 1992, J BIOL CHEM, V267, P2920; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; SPELLMAN MW, 1989, J BIOL CHEM, V264, P14100; Stephens DJ, 2001, J CELL SCI, V114, P1053; TABAS I, 1979, J BIOL CHEM, V254, P1655; TULSIANI DRP, 1989, METHOD ENZYMOL, V179, P446; Umana P, 1997, BIOTECHNOL BIOENG, V55, P890, DOI 10.1002/(SICI)1097-0290(19970920)55:6<890::AID-BIT7>3.0.CO;2-B; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13845; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13835; Wildt S, 2005, NAT REV MICROBIOL, V3, P119, DOI 10.1038/nrmicro1087; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; YEO KT, 1985, J BIOL CHEM, V260, P7896	54	82	87	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e713	10.1371/journal.pone.0000713	http://dx.doi.org/10.1371/journal.pone.0000713			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684559	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452400016
J	Hanson, EK; Ballantyne, J				Hanson, Erin K.; Ballantyne, Jack			An Ultra-High Discrimination Y Chromosome Short Tandem Repeat Multiplex DNA Typing System	PLOS ONE			English	Article							STR LOCI; ALLELE FREQUENCIES; FORENSIC CASEWORK; HUMAN-EVOLUTION; VALIDATION; AMPLIFICATION; HAPLOTYPES; MARKERS; DYS634	In forensic casework, Y chromosome short tandem repeat markers (Y-STRs) are often used to identify a male donor DNA profile in the presence of excess quantities of female DNA, such as is found in many sexual assault investigations. Commercially available Y-STR multiplexes incorporating 12-17 loci are currently used in forensic casework (Promega's PowerPlex (R) Y and Applied Biosystems' AmpF/STR (R) Yfiler (R)). Despite the robustness of these commercial multiplex Y-STR systems and the ability to discriminate two male individuals in most cases, the coincidence match probabilities between unrelated males are modest compared with the standard set of autosomal STR markers. Hence there is still a need to develop new multiplex systems to supplement these for those cases where additional discriminatory power is desired or where there is a coincidental Y-STR match between potential male participants. Over 400 Y-STR loci have been identified on the Y chromosome. While these have the potential to increase the discrimination potential afforded by the commercially available kits, many have not been well characterized. In the present work, 91 loci were tested for their relative ability to increase the discrimination potential of the commonly used 'core' Y-STR loci. The result of this extensive evaluation was the development of an ultra high discrimination (UHD) multiplex DNA typing system that allows for the robust co-amplification of 14 non-core Y-STR loci. Population studies with a mixed African American and American Caucasian sample set (n = 572) indicated that the overall discriminatory potential of the UHD multiplex was superior to all commercial kits tested. The combined use of the UHD multiplex and the Applied Biosystems' AmpF/STR (R) Yfiler (R) kit resulted in 100% discrimination of all individuals within the sample set, which presages its potential to maximally augment currently available forensic casework markers. It could also find applications in human evolutionary genetics and genetic genealogy.	[Hanson, Erin K.; Ballantyne, Jack] Univ Cent Florida, Grad Program Biomol Sci, Orlando, FL 32816 USA; [Ballantyne, Jack] Univ Cent Florida, Dept Chem, Orlando, FL 32816 USA; [Hanson, Erin K.; Ballantyne, Jack] Natl Ctr Forens Sci, Orlando, FL USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Ballantyne, J (corresponding author), Univ Cent Florida, Grad Program Biomol Sci, Orlando, FL 32816 USA.	jballant@mail.ucf.edu		Ballantyne, Jack/0000-0002-9681-2120	Office of Justice Programs [1998-IJ-CX-K003]; National Institute of Justice, Department of Justice	Office of Justice Programs; National Institute of Justice, Department of Justice	This work was supported under Award number 1998-IJ-CX-K003 from the Office of Justice Programs, National Institute of Justice, Department of Justice. Points of view in this document are those of the authors and do not necessarily represent the official position of the U. S. Department of Justice. While this project was supported under the above mentioned award, the awarded funding is no longer available.	Alves C, 2006, PROG FORENSIC GENET, V1288, P201; Ayub Q, 2000, Nucleic Acids Res, V28, pe8, DOI 10.1093/nar/28.2.e8; Betz A, 2001, FORENSIC SCI INT, V118, P126, DOI 10.1016/S0379-0738(00)00482-5; BROOKFIELD JFY, 1995, CURR BIOL, V5, P1114, DOI 10.1016/S0960-9822(95)00224-7; Butler JM, 2006, FORENSIC SCI INT, V156, P250, DOI 10.1016/j.forsciint.2005.02.011; Butler JM, 2002, FORENSIC SCI INT, V129, P10, DOI 10.1016/S0379-0738(02)00195-0; Cerri N, 2003, CROAT MED J, V44, P289; COMEY CT, 1994, J FORENSIC SCI, V39, P1254; Corach D, 2001, FORENSIC SCI INT, V118, P131, DOI 10.1016/S0379-0738(00)00483-7; Dai HL, 2003, J FORENSIC SCI, V48, P1430; Daniels DL, 2004, J FORENSIC SCI, V49, P668; DE KP, 1997, INT J LEGAL MED, V110, P134; Dekairelle AF, 2001, FORENSIC SCI INT, V118, P122, DOI 10.1016/S0379-0738(00)00481-3; Delfin FC, 2005, INT J LEGAL MED, V119, P158, DOI 10.1007/s00414-004-0503-y; GAO Y, 2006, PROGR FORENSIC GENET, V11, P186; Gao YZ, 2005, J FORENSIC SCI, V50, P708; GILL P, 1985, NATURE, V318, P577, DOI 10.1038/318577a0; Hall A, 2003, ANAL BIOANAL CHEM, V376, P1234, DOI 10.1007/s00216-003-2039-2; Hanson EK, 2004, J FORENSIC SCI, V49, P40; HANSON EK, 2005, LEG MED TOKYO; HANSON EK, 2007, LEG MED TOKYO; Hanson EK, 2006, J FORENSIC SCI, V51, P1298, DOI 10.1111/j.1556-4029.2006.00263.x; Hanson EK, 2007, J FORENSIC SCI, V52, P498, DOI 10.1111/j.1556-4029.2007.00395.x; Honda K, 1999, J FORENSIC SCI, V44, P868; Iida R, 2003, J FORENSIC SCI, V48, P1088; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Jobling MA, 1997, INT J LEGAL MED, V110, P118, DOI 10.1007/s004140050050; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; Kayser M, 2004, AM J HUM GENET, V74, P1183, DOI 10.1086/421531; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; Kline MC, 2003, ANAL CHEM, V75, P2463, DOI 10.1021/ac026410i; Krenke BE, 2005, FORENSIC SCI INT, V148, P1, DOI 10.1016/j.forsciint.2004.07.008; Lahn BT, 2001, NAT REV GENET, V2, P207, DOI 10.1038/35056058; Martin P, 2000, INT CONGR SER, P526; Mitchell RJ, 1996, CURR OPIN GENET DEV, V6, P737, DOI 10.1016/S0959-437X(96)80029-3; Mulero JJ, 2006, J FORENSIC SCI, V51, P64, DOI 10.1111/j.1556-4029.2005.00016.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Pizzamiglio M, 2000, INT CONGR SER, P529; Prinz M, 2001, CROAT MED J, V42, P288; Prinz M, 1997, FORENSIC SCI INT, V85, P209, DOI 10.1016/S0379-0738(96)02096-8; Redd AJ, 2002, FORENSIC SCI INT, V130, P97, DOI 10.1016/S0379-0738(02)00347-X; Schoske R, 2004, FORENSIC SCI INT, V139, P107, DOI 10.1016/j.forsciint.2003.10.007; Shewale JG, 2004, J FORENSIC SCI, V49, P1278; *SWGDAM, 2004, FORENSIC SCI COMMUN, V6, P1; *SWGDAM Y STR SUBC, 2007, FORENSIC SCI COMMUNI, V6; Tang JP, 2003, INT J LEGAL MED, V117, P263, DOI 10.1007/s00414-003-0371-x; Tang JP, 2003, J FORENSIC SCI, V48, P1186; Tsuji A, 2001, AM J FOREN MED PATH, V22, P288, DOI 10.1097/00000433-200109000-00018; VONWURMSCHWARK N, 2003, PROGR FORENSIC GENET, V9, P487; Wang XD, 2004, J FORENSIC SCI, V49, P632; White PS, 1999, GENOMICS, V57, P433, DOI 10.1006/geno.1999.5782; Yoshida Yasushi, 2004, J Med Invest, V51, P238, DOI 10.2152/jmi.51.238; Yun LB, 2004, J FORENSIC SCI, V49, P1373; Zhang Geng-Qian, 2004, Yichuan, V26, P295; Zhang ZX, 2005, J FORENSIC SCI, V50, P1492	55	32	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e688	10.1371/journal.pone.0000688	http://dx.doi.org/10.1371/journal.pone.0000688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668066	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452300024
J	Pelli, DG; Tillman, KA				Pelli, Denis G.; Tillman, Katharine A.			Parts, Wholes, and Context in Reading: A Triple Dissociation	PLOS ONE			English	Article							FEATURE-INTEGRATION; CASE ALTERNATION; RECOGNITION; MODEL; PSYCHOPHYSICS; IDENTIFICATION; OBJECTS; SHAPES; WORDS; FACES	Research in object recognition has tried to distinguish holistic recognition from recognition by parts. One can also guess an object from its context. Words are objects, and how we recognize them is the core question of reading research. Do fast readers rely most on letter-by-letter decoding (i.e., recognition by parts), whole word shape, or sentence context? We manipulated the text to selectively knock out each source of information while sparing the others. Surprisingly, the effects of the knockouts on reading rate reveal a triple dissociation. Each reading process always contributes the same number of words per minute, regardless of whether the other processes are operating.	[Pelli, Denis G.; Tillman, Katharine A.] NYU, New York, NY 10012 USA	New York University	Pelli, DG (corresponding author), NYU, New York, NY 10012 USA.	denis.pelli@nyu.edu		Tillman, Katharine/0000-0001-9440-7239	NIH [R01-EY004432]; NATIONAL EYE INSTITUTE [R01EY004432] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by NIH grant R01-EY004432	ALLEN PA, 1994, 35 ANN M PSYCH SOC S; BECKMANN PJ, 1991, SID 91, P106; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; BOUMA H, 1973, VISION RES, V13, P767, DOI 10.1016/0042-6989(73)90041-2; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CAVE CB, 1993, PERCEPTION, V22, P229, DOI 10.1068/p220229; Chall J.S., 1983, LEARNING READ GREAT, DOI DOI 10.1038/nn.4186; Chung STL, 1998, VISION RES, V38, P2949, DOI 10.1016/S0042-6989(98)00072-8; COLTHEART M, 1974, B PSYCHONOMIC SOC, V3, P102; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; DIKKER S, SENSITIVITY SY UNPUB; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; ESTEVEZ O, 1982, VISION RES, V22, P681, DOI 10.1016/0042-6989(82)90104-3; FREEMAN J, 2007, J VISION IN PRESS, V7; Gough P. B., 1972, LANGUAGE EAR EYE REL; GOUGH PB, 1981, PERCEPTION PRINT REA; GROFF P, 1975, VISIBLE LANG, V9, P67; Huey E.B., 1908, PSYCHOL PEDAGOGY REA; Lau E, 2006, BRAIN LANG, V98, P74, DOI 10.1016/j.bandl.2006.02.003; Legge GB, 2007, PSYCHOPHYSICS READIN; Legge GE, 2002, VISION RES, V42, P2219, DOI 10.1016/S0042-6989(02)00131-1; LEVI DM, 2007, J VISION IN PRESS, V7; Martelli M, 2005, J VISION, V5, P58, DOI 10.1167/5.1.6; MASSON MEJ, 1983, MEM COGNITION, V11, P262, DOI 10.3758/BF03196973; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; MCCLELLAND JL, 1976, J EXP PSYCHOL HUMAN, V2, P80, DOI 10.1037/0096-1523.2.1.80; Neisser U., 1967, COGNITIVE PSYCHOL; PAAP KR, 1984, J EXP PSYCHOL HUMAN, V10, P413, DOI 10.1037/0096-1523.10.3.413; Pelli DG, 2006, VISION RES, V46, P4646, DOI 10.1016/j.visres.2006.04.023; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Pelli DG, 2003, NATURE, V423, P752, DOI 10.1038/nature01516; PELLI DG, 2007, J VISION IN PRESS, V7; Potter M.C., 1984, NEW METHODS READING, P91; PRINZMETAL W, 1995, CURR DIR PSYCHOL SCI, V4, P90, DOI 10.1111/1467-8721.ep10772335; RAYNER K, 1975, J EDUC PSYCHOL, V67, P301, DOI 10.1037/h0077015; Rayner K, 2002, SCI AM, V286, P84, DOI 10.1038/scientificamerican0302-84; Reichle ED, 2006, COGN SYST RES, V7, P4, DOI 10.1016/j.cogsys.2005.07.002; ROBSON JG, 1981, VISION RES, V21, P409, DOI 10.1016/0042-6989(81)90169-3; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; SMITH F, 1969, PSYCHON SCI, V14, P261; SMITH F, 1969, AM J PSYCHOL, V82, P248, DOI 10.2307/1421250; Stanovich K. E., 1995, J RES READ, V18, P87; Sternberg S, 2003, CORTEX, V39, P180, DOI 10.1016/S0010-9452(08)70097-2; Tanaka J. W., 1997, PSYCHOL LEARN MOTIV, V36, P83, DOI DOI 10.1016/S0079-7421(08)60282-0; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Tjan BS, 1998, VISION RES, V38, P2335, DOI 10.1016/S0042-6989(97)00255-1; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; TVERSKY B, 1984, J EXP PSYCHOL GEN, V113, P169, DOI 10.1037/0096-3445.113.2.169; UNDERWOOD NR, 1985, READ RES QUART, V20, P153, DOI 10.2307/747752; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747; Yu DY, 2007, J VISION, V7, DOI 10.1167/7.2.2; ZWEIG E, LANGUAGE COGNI UNPUB; [No title captured]	57	57	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e680	10.1371/journal.pone.0000680	http://dx.doi.org/10.1371/journal.pone.0000680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668058	Green Published, gold			2022-12-27	WOS:000207452300016
J	Stoddart, CA; Bales, CA; Bare, JC; Chkhenkeli, G; Galkina, SA; Kinkade, AN; Moreno, ME; Rivera, JM; Ronquillo, RE; Sloan, B; Black, PL				Stoddart, Cheryl A.; Bales, Cheryl A.; Bare, Jennifer C.; Chkhenkeli, George; Galkina, Sofiya A.; Kinkade, April N.; Moreno, Mary E.; Rivera, Jose M.; Ronquillo, Rollie E.; Sloan, Barbara; Black, Paul L.			Validation of the SCID-hu Thy/Liv Mouse Model with Four Classes of Licensed Antiretrovirals	PLOS ONE			English	Article								Background. The SCID-hu Thy/Liv mouse model of HIV-1 infection is a useful platform for the preclinical evaluation of antiviral efficacy in vivo. We performed this study to validate the model with representatives of all four classes of licensed antiretrovirals. Methodology/Principal Findings. Endpoint analyses for quantification of Thy/Liv implant viral load included ELISA for cell-associated p24, branched DNA assay for HIV-1 RNA, and detection of infected thymocytes by intracellular staining for Gag-p24. Antiviral protection from HIV-1-mediated thymocyte depletion was assessed by multicolor flow cytometric analysis of thymocyte subpopulations based on surface expression of CD3, CD4, and CD8. These mice can be productively infected with molecular clones of HIV-1 (e. g., the X4 clone NL4-3) as well as with primary R5 and R5X4 isolates. To determine whether results in this model are concordant with those found in humans, we performed direct comparisons of two drugs in the same class, each of which has known potency and dosing levels in humans. Here we show that second-generation antiretrovirals were, as expected, more potent than their first-generation predecessors: emtricitabine was more potent than lamivudine, efavirenz was more potent than nevirapine, and atazanavir was more potent than indinavir. After interspecies pharmacodynamic scaling, the dose ranges found to inhibit viral replication in the SCID-hu Thy/Liv mouse were similar to those used in humans. Moreover, HIV-1 replication in these mice was genetically stable; treatment of the mice with lamivudine did not result in the M184V substitution in reverse transcriptase, and the multidrug-resistant NY index case HIV-1 retained its drug-resistance substitutions. Conclusion. Given the fidelity of such comparisons, we conclude that this highly reproducible mouse model is likely to predict clinical antiviral efficacy in humans.	[Stoddart, Cheryl A.] Univ Calif San Francisco, Dept Med, Div Expt Med, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA; [Black, Paul L.] NIAID, Div Aids, Targeted Intervent Branch, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Stoddart, CA (corresponding author), Univ Calif San Francisco, Dept Med, Div Expt Med, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA.	cheryl.stoddart@ucsf.edu			NIAID, NIH [N01-AI-05418]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005418] Funding Source: NIH RePORTER	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole or in part with Federal funds from NIAID, NIH, under contract no. N01-AI-05418.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Aldrovandi GM, 1996, J VIROL, V70, P1505, DOI 10.1128/JVI.70.3.1505-1511.1996; ALDROVANDI GM, 1993, NATURE, V363, P732, DOI 10.1038/363732a0; Aldrovandi GM, 1998, J VIROL, V72, P7032, DOI 10.1128/JVI.72.9.7032-7039.1998; Amado RG, 1999, J VIROL, V73, P6361, DOI 10.1128/JVI.73.8.6361-6369.1999; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; BAST RC, 2000, CANC MED E 5 ONLINE; Berges BK, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-76; Berkowitz RD, 2000, AIDS RES HUM RETROV, V16, P1039, DOI 10.1089/08892220050075291; Berkowitz RD, 1999, J VIROL, V73, P7817, DOI 10.1128/JVI.73.9.7817-7822.1999; Berkowitz RD, 1998, J IMMUNOL, V161, P3702; Berkowitz RD, 1998, J VIROL, V72, P10108, DOI 10.1128/JVI.72.12.10108-10117.1998; BONYHADI ML, 1993, NATURE, V363, P728, DOI 10.1038/363728a0; Datema R, 1996, ANTIMICROB AGENTS CH, V40, P750, DOI 10.1128/AAC.40.3.750; De Clercq E, 2004, J CLIN VIROL, V30, P115, DOI 10.1016/j.jcv.2004.02.009; Fenger J, 1999, ENVIRONM POLLUT SER, V1, P3; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Gorantla S, 2007, J VIROL, V81, P2700, DOI 10.1128/JVI.02010-06; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; JAMIESON BD, 1995, J VIROL, V69, P6259, DOI 10.1128/JVI.69.10.6259-6264.1995; Jamieson BD, 1997, J VIROL, V71, P8245, DOI 10.1128/JVI.71.11.8245-8253.1997; KANESHIMA H, 1991, P NATL ACAD SCI USA, V88, P4523, DOI 10.1073/pnas.88.10.4523; KANESHIMA H, 1994, J VIROL, V68, P8188, DOI 10.1128/JVI.68.12.8188-8192.1994; Keir ME, 2002, J IMMUNOL, V168, P325, DOI 10.4049/jimmunol.168.1.325; Kitchen SG, 1998, AIDS RES HUM RETROV, V14, pS235; Kitchen SG, 1997, J VIROL, V71, P6928, DOI 10.1128/JVI.71.9.6928-6934.1997; Koka PS, 1998, J VIROL, V72, P5121, DOI 10.1128/JVI.72.6.5121-5127.1998; Kovalev G, 1999, J IMMUNOL, V162, P7555; KROWKA JF, 1991, J IMMUNOL, V146, P3751; Manz MG, 2007, IMMUNITY, V26, P537, DOI 10.1016/j.immuni.2007.05.001; Markowitz M, 2005, LANCET, V365, P1031, DOI 10.1016/S0140-6736(05)74227-6; MCCUNE J, 1991, ANNU REV IMMUNOL, V9, P399, DOI 10.1146/annurev.iy.09.040191.002151; MCCUNE JM, 1990, SCIENCE, V247, P564, DOI 10.1126/science.2300816; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; McCune JM, 1997, SCIENCE, V278, P2141, DOI 10.1126/science.278.5346.2141; McCutchen D, 1996, EDUC PSYCHOL REV, V8, P187, DOI 10.1007/BF01464072; Miller ED, 2001, J VIROL, V75, P8498, DOI 10.1128/JVI.75.18.8498-8506.2001; MORDENTI J, 1986, J PHARM SCI, V75, P1028, DOI 10.1002/jps.2600751104; NAMIKAWA R, 1988, SCIENCE, V242, P1684, DOI 10.1126/science.3201256; NAMIKAWA R, 1990, J EXP MED, V172, P1055, DOI 10.1084/jem.172.4.1055; Rabin L, 1996, ANTIMICROB AGENTS CH, V40, P755, DOI 10.1128/AAC.40.3.755; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Robinson BS, 2000, ANTIMICROB AGENTS CH, V44, P2093, DOI 10.1128/AAC.44.8.2093-2099.2000; STANLEY SK, 1993, J EXP MED, V178, P1151, DOI 10.1084/jem.178.4.1151; Stoddart CA, 2000, ANTIMICROB AGENTS CH, V44, P783, DOI 10.1128/AAC.44.3.783-786.2000; Stoddart CA, 1998, ANTIMICROB AGENTS CH, V42, P2113, DOI 10.1128/AAC.42.8.2113; Stoddart CA, 2003, J VIROL, V77, P2124, DOI 10.1128/JVI.77.3.2124-2133.2003; Strizki JM, 2001, P NATL ACAD SCI USA, V98, P12718, DOI 10.1073/pnas.221375398; SU L, 1995, IMMUNITY, V2, P25, DOI 10.1016/1074-7613(95)90076-4; Su LS, 1997, VIROLOGY, V227, P45, DOI 10.1006/viro.1996.8338; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Valentin A, 1997, J VIROL, V71, P9817, DOI 10.1128/JVI.71.12.9817-9822.1997; WithersWard ES, 1997, NAT MED, V3, P1102, DOI 10.1038/nm1097-1102; YOUNG SD, 1995, ANTIMICROB AGENTS CH, V39, P2602, DOI 10.1128/AAC.39.12.2602; Zhang LG, 2007, BLOOD, V109, P2978, DOI 10.1182/blood-2006-07-033159	56	43	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e655	10.1371/journal.pone.0000655	http://dx.doi.org/10.1371/journal.pone.0000655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668043	gold, Green Published, Green Submitted			2022-12-27	WOS:000207452300001
J	Supp, GG; Schlogl, A; Trujillo-Barreto, N; Muller, MM; Gruber, T				Supp, Gernot G.; Schloegl, Alois; Trujillo-Barreto, Nelson; Mueller, Matthias M.; Gruber, Thomas			Directed Cortical Information Flow during Human Object Recognition: Analyzing Induced EEG Gamma-Band Responses in Brain's Source Space	PLOS ONE			English	Article							REPETITION PRIMING TASK; HIGH-RESOLUTION EEG; FUNCTIONAL CONNECTIVITY; OSCILLATORY SYNCHRONY; NEURONAL MECHANISMS; EVOKED-POTENTIALS; CAUSAL RELATIONS; PARIETAL CORTEX; PHASE SYNCHRONY; NEURAL ACTIVITY	The increase of induced gamma-band responses (iGBRs; oscillations >30 Hz) elicited by familiar (meaningful) objects is well established in electroencephalogram (EEG) research. This frequency-specific change at distinct locations is thought to indicate the dynamic formation of local neuronal assemblies during the activation of cortical object representations. As analytically power increase is just a property of a single location, phase-synchrony was introduced to investigate the formation of large-scale networks between spatially distant brain sites. However, classical phase-synchrony reveals symmetric, pair-wise correlations and is not suited to uncover the directionality of interactions. Here, we investigated the neural mechanism of visual object processing by means of directional coupling analysis going beyond recording sites, but rather assessing the directionality of oscillatory interactions between brain areas directly. This study is the first to identify the directionality of oscillatory brain interactions in source space during human object recognition and suggests that familiar, but not unfamiliar, objects engage widespread reciprocal information flow. Directionality of cortical information-flow was calculated based upon an established Granger-Causality coupling-measure (partial-directed coherence; PDC) using autoregressive modeling. To enable comparison with previous coupling studies lacking directional information, phase-locking analysis was applied, using wavelet-based signal decompositions. Both, autoregressive modeling and wavelet analysis, revealed an augmentation of iGBRs during the presentation of familiar objects relative to unfamiliar controls, which was localized to inferior-temporal, superior-parietal and frontal brain areas by means of distributed source reconstruction. The multivariate analysis of PDC evaluated each possible direction of brain interaction and revealed widespread reciprocal information-transfer during familiar object processing. In contrast, unfamiliar objects entailed a sparse number of only unidirectional connections converging to parietal areas. Considering the directionality of brain interactions, the current results might indicate that successful activation of object representations is realized through reciprocal (feed-forward and feed-backward) information-transfer of oscillatory connections between distant, functionally specific brain areas.	[Mueller, Matthias M.; Gruber, Thomas] Univ Leipzig, Inst Psychol 1, Leipzig, Germany; [Supp, Gernot G.] Univ Hamburg, Dept Neurophysiol & Pathophysiol, Ctr Med Expt, Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Supp, Gernot G.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Schloegl, Alois] Graz Univ Technol, Inst Human Comp Interfaces, A-8010 Graz, Austria; [Schloegl, Alois] Inst Comp Architecture & Software Technol, Fraunhofer Inst FIRST, Intelligent Data Anal Grp, Berlin, Germany; [Trujillo-Barreto, Nelson] Cuban Neurosci Ctr, Havana, Cuba	Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Max Planck Society; Graz University of Technology; Fraunhofer Gesellschaft	Gruber, T (corresponding author), Univ Leipzig, Inst Psychol 1, Leipzig, Germany.	gruber@rz.uni-leipzig.de	Trujillo-Barreto, Nelson J/G-3764-2013	Trujillo-Barreto, Nelson J/0000-0001-6581-7503; Schlogl, Alois/0000-0002-5621-8100	Max Planck Society; Deutsche-Forschungsgemeinschaft (DFG)	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche-Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was in part supported by a Post-Doctoral Fellowship of the Max Planck Society to G. S. and by a grant of the Deutsche-Forschungsgemeinschaft (DFG).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Astolfi L, 2005, CLIN NEUROPHYSIOL, V116, P920, DOI 10.1016/j.clinph.2004.10.012; Astolfi L, 2007, HUM BRAIN MAPP, V28, P143, DOI 10.1002/hbm.20263; Astolfi L, 2006, IEEE T BIO-MED ENG, V53, P1802, DOI 10.1109/TBME.2006.873692; Babiloni F, 2005, NEUROIMAGE, V24, P118, DOI 10.1016/j.neuroimage.2004.09.036; Baccala L A, 2001, Prog Brain Res, V130, P33; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Baccala LA, 2006, BIOL CYBERN, V95, P135, DOI 10.1007/s00422-006-0075-7; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Bertrand O, 2000, INT J PSYCHOPHYSIOL, V38, P211, DOI 10.1016/S0167-8760(00)00166-5; BERTRAND O, 1994, NATO ADV SCI INST SE, V271, P231; Blinowska KJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.050902; Bosch-Bayard J, 2001, CLIN ELECTROENCEPHAL, V32, P47, DOI 10.1177/155005940103200203; Bressler SL, 2001, TRENDS COGN SCI, V5, P26, DOI 10.1016/S1364-6613(00)01564-3; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Brovelli A, 2005, NEUROIMAGE, V28, P154, DOI 10.1016/j.neuroimage.2005.05.045; Busch NA, 2006, NEUROIMAGE, V33, P1169, DOI 10.1016/j.neuroimage.2006.07.034; COOPER R, 1965, ELECTROEN CLIN NEURO, V18, P217, DOI 10.1016/0013-4694(65)90088-X; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; David O, 2004, NEUROIMAGE, V21, P659, DOI 10.1016/j.neuroimage.2003.10.006; Ding MZ, 2000, BIOL CYBERN, V83, P35, DOI 10.1007/s004229900137; Eckhorn R, 1990, NEURAL COMPUT, V2, P293, DOI 10.1162/neco.1990.2.3.293; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.1093/biomet/68.3.589; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; EVANS AC, 1993, STAT NEUROANATOMICAL; Fenske MJ, 2006, PROG BRAIN RES, V155, P3, DOI 10.1016/S0079-6123(06)55001-0; Fiebach CJ, 2005, J NEUROSCI, V25, P3414, DOI 10.1523/JNEUROSCI.4107-04.2005; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fuster JM, 1997, TRENDS NEUROSCI, V20, P451, DOI 10.1016/S0166-2236(97)01128-4; Fuster JM, 2006, INT J PSYCHOPHYSIOL, V60, P125, DOI 10.1016/j.ijpsycho.2005.12.015; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Gross J, 2004, P NATL ACAD SCI USA, V101, P13050, DOI 10.1073/pnas.0404944101; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Gruber T, 1999, CLIN NEUROPHYSIOL, V110, P2074, DOI 10.1016/S1388-2457(99)00176-5; Gruber T, 2006, NEUROIMAGE, V29, P888, DOI 10.1016/j.neuroimage.2005.09.004; Gruber T, 2005, CEREB CORTEX, V15, P109, DOI 10.1093/cercor/bhh113; Gruber T, 2004, EUR J NEUROSCI, V19, P1073, DOI 10.1111/j.0953-816X.2004.03176.x; Gruber T, 2002, J COGNITIVE NEUROSCI, V14, P732, DOI 10.1162/08989290260138636; Gruber T, 2002, COGNITIVE BRAIN RES, V13, P377, DOI 10.1016/S0926-6410(01)00130-6; Gruber T, 2006, EUR J NEUROSCI, V24, P2654, DOI 10.1111/j.1460-9568.2006.05130.x; Gruber T, 2006, BRAIN RES, V1097, P194, DOI 10.1016/j.brainres.2006.04.069; JENSEN O, TRENDS NEUR IN PRESS; Jerbi K, 2007, P NATL ACAD SCI USA, V104, P7676, DOI 10.1073/pnas.0609632104; Junghofer M, 2000, PSYCHOPHYSIOLOGY, V37, P523, DOI 10.1111/1469-8986.3740523; Kaiser J, 2003, NEUROSCIENTIST, V9, P475, DOI 10.1177/1073858403259137; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kaminski M, 1997, ELECTROEN CLIN NEURO, V102, P216, DOI 10.1016/S0013-4694(96)95721-5; Keil A, 2001, NEUROSCI BIOBEHAV R, V25, P527, DOI 10.1016/S0149-7634(01)00031-8; Konig P, 2006, BIOL CYBERN, V94, P325, DOI [10.1007/s00422-006-0050-3, 10.1007/S00422-006-0050-3]; Kus R, 2004, IEEE T BIO-MED ENG, V51, P1501, DOI 10.1109/TBME.2004.827929; Lachaux JP, 2006, NEUROIMAGE, V30, P1302, DOI 10.1016/j.neuroimage.2005.11.023; Lachaux JP, 2003, J PHYSIOLOGY-PARIS, V97, P613, DOI 10.1016/j.jphysparis.2004.01.018; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Mainy N, 2007, HUM BRAIN MAPP, V28, P183, DOI 10.1002/hbm.20264; Martinovic J, 2007, J COGNITIVE NEUROSCI, V19, P921, DOI 10.1162/jocn.2007.19.6.921; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Muller MM, 2004, J COGNITIVE NEUROSCI, V16, P503, DOI 10.1162/089892904322926827; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; PEISSIG JJ, 2006, ANN REV PSYCHOL; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Pfurtscheller G, 1999, J CLIN NEUROPHYSIOL, V16, P512, DOI 10.1097/00004691-199911000-00003; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Salazar RF, 2004, EUR J NEUROSCI, V20, P1391, DOI 10.1111/j.1460-9568.2004.03579.x; Sameshima K, 1999, J NEUROSCI METH, V94, P93, DOI 10.1016/S0165-0270(99)00128-4; Schlogl A, 2006, PROG BRAIN RES, V159, P135, DOI 10.1016/S0079-6123(06)59009-0; Schlogl A, 2006, SIGNAL PROCESS, V86, P2426, DOI 10.1016/j.sigpro.2005.11.007; SCHLOGL A, 2007, BIOSIG PROJECT; Schneider T, 2001, ACM T MATH SOFTWARE, V27, P58, DOI 10.1145/382043.382316; Schnitzler M, 2005, INT REV NEUROBIOL, V68, P173, DOI 10.1016/S0074-7742(05)68007-5; Shafritz KM, 2002, P NATL ACAD SCI USA, V99, P10917, DOI 10.1073/pnas.152694799; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Snijders Tom A. B., 1999, CONNECTIONS, V22, P161; Sporns O, 2002, BEHAV BRAIN RES, V135, P69, DOI 10.1016/S0166-4328(02)00157-2; Supp GG, 2005, EUR J NEUROSCI, V21, P1139, DOI 10.1111/j.1460-9568.2005.03906.x; Supp GG, 2004, NEUROREPORT, V15, P1209, DOI 10.1097/00001756-200405190-00026; Tallon-Baudry C, 2003, J PHYSIOL-PARIS, V97, P355, DOI 10.1016/j.jphysparis.2003.09.009; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TANAKA K, 1993, SCIENCE, V262, P685, DOI 10.1126/science.8235589; Treisman A, 1998, PHILOS T ROY SOC B, V353, P1295, DOI 10.1098/rstb.1998.0284; Trujillo-Barreto NJ, 2004, NEUROIMAGE, V21, P1300, DOI 10.1016/j.neuroimage.2003.11.008; Uhlhaas PJ, 2006, J NEUROSCI, V26, P8168, DOI 10.1523/JNEUROSCI.2002-06.2006; ULLMAN S, 1995, CEREB CORTEX, V5, P1, DOI 10.1093/cercor/5.1.1; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; UNGERLEIDER LG, 1995, SCIENCE, V270, P769, DOI 10.1126/science.270.5237.769; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P74, DOI 10.1002/(SICI)1097-0193(1996)4:1<74::AID-HBM5>3.0.CO;2-M; Wright JJ, 1996, BEHAV BRAIN SCI, V19, P285, DOI 10.1017/S0140525X00042679; ZETTERBERG L H, 1969, Mathematical Biosciences, V5, P227, DOI 10.1016/0025-5564(69)90044-3; ZIONGOLUMBIC E, 2006, CEREB CORTEX	96	106	110	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e684	10.1371/journal.pone.0000684	http://dx.doi.org/10.1371/journal.pone.0000684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668062	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452300020
J	Lucas, M; Ulsenheimer, A; Pfafferot, K; Heeg, MHJ; Gaudieri, S; Gruner, N; Rauch, A; Gerlach, JT; Jung, MC; Zachoval, R; Pape, GR; Schraut, W; Santantonio, T; Nitschko, H; Obermeier, M; Phillips, R; Scriba, TJ; Semmo, N; Day, C; Weber, JN; Fidler, S; Thimme, R; Haberstroh, A; Baumert, TF; Klenerman, P; Diepolder, HM				Lucas, Michaela; Ulsenheimer, Axel; Pfafferot, Katja; Heeg, Malte H. J.; Gaudieri, Silvana; Gruener, Norbert; Rauch, Andri; Gerlach, J. Tilman; Jung, Maria-Christina; Zachoval, Reinhart; Pape, Gerd R.; Schraut, Winfried; Santantonio, Teresa; Nitschko, Hans; Obermeier, Martin; Phillips, Rodney; Scriba, Thomas J.; Semmo, Nasser; Day, Cheryl; Weber, Jonathan N.; Fidler, Sarah; Thimme, Robert; Haberstroh, Anita; Baumert, Thomas F.; Klenerman, Paul; Diepolder, Helmut M.			Tracking Virus-Specific CD4+T Cells during and after Acute Hepatitis C Virus Infection	PLOS ONE			English	Article								Background. CD4+ T cell help is critical in maintaining antiviral immune responses and such help has been shown to be sustained in acute resolving hepatitis C. In contrast, in evolving chronic hepatitis C CD4+ T cell helper responses appear to be absent or short-lived, using functional assays. Methodology/Principal Findings. Here we used a novel HLA-DR1 tetramer containing a highly targeted CD4+ T cell epitope from the hepatitis C virus non-structural protein 4 to track number and phenotype of hepatitis C virus specific CD4+ T cells in a cohort of seven HLA-DR1 positive patients with acute hepatitis C in comparison to patients with chronic or resolved hepatitis C. We observed peptide-specific T cells in all seven patients with acute hepatitis C regardless of outcome at frequencies up to 0.65% of CD4+ T cells. Among patients who transiently controlled virus replication we observed loss of function, and/or physical deletion of tetramer+ CD4+ T cells before viral recrudescence. In some patients with chronic hepatitis C very low numbers of tetramer+ cells were detectable in peripheral blood, compared to robust responses detected in spontaneous resolvers. Importantly we did not observe escape mutations in this key CD4+ T cell epitope in patients with evolving chronic hepatitis C. Conclusions/Significance. During acute hepatitis C a CD4+ T cell response against this epitope is readily induced in most, if not all, HLA-DR1+ patients. This antiviral T cell population becomes functionally impaired or is deleted early in the course of disease in those where viremia persists.	[Ulsenheimer, Axel; Heeg, Malte H. J.; Gruener, Norbert; Gerlach, J. Tilman; Jung, Maria-Christina; Zachoval, Reinhart; Pape, Gerd R.; Schraut, Winfried; Diepolder, Helmut M.] Univ Munich, Dept Med 2, Munich, Germany; [Ulsenheimer, Axel; Heeg, Malte H. J.; Gruener, Norbert; Gerlach, J. Tilman; Jung, Maria-Christina; Zachoval, Reinhart; Pape, Gerd R.; Schraut, Winfried; Diepolder, Helmut M.] Univ Munich, Inst Immunol, D-8000 Munich, Germany; [Lucas, Michaela; Phillips, Rodney; Scriba, Thomas J.; Semmo, Nasser; Day, Cheryl; Klenerman, Paul] Univ Oxford, Nuffield Dept Clin Med, Peter Medawar Bldg Pathogen Res, Oxford, England; [Lucas, Michaela; Pfafferot, Katja; Gaudieri, Silvana; Rauch, Andri] Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA, Australia; [Lucas, Michaela; Pfafferot, Katja; Gaudieri, Silvana; Rauch, Andri] Murdoch Univ, Perth, WA, Australia; [Gaudieri, Silvana] Univ Western Australia, Ctr Forens Sci, Sch Anat & Human Biol, Nedlands, WA 6009, Australia; [Rauch, Andri] Univ Hosp, Div Infect Dis, Bern, Switzerland; [Santantonio, Teresa] Univ Bari, Clin Malattie Infett, Bari, Italy; [Nitschko, Hans; Obermeier, Martin] Univ Munich, Max Von Pettenkofer Inst, Dept Virol, Munich, Germany; [Weber, Jonathan N.; Fidler, Sarah] Univ London Imperial Coll Sci Technol & Med, Dept Med, St Marys Hosp, London, England; [Thimme, Robert; Haberstroh, Anita] Univ Freiburg, Freiburg, Germany; [Baumert, Thomas F.] Univ Strasbourg 1, INSERM, U748, Strasbourg, France	University of Munich; University of Munich; University of Oxford; Royal Perth Hospital; University of Western Australia; Murdoch University; University of Western Australia; University of Bern; University Hospital of Bern; Universita degli Studi di Bari Aldo Moro; University of Munich; Imperial College London; University of Freiburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Diepolder, HM (corresponding author), Univ Munich, Dept Med 2, Munich, Germany.	hdiepold@med.uni-muenchen.de	Day, Cheryl L/J-9844-2012; Day, Cheryl/GQQ-9720-2022; Scriba, Thomas/AAH-9413-2020; Baumert, Thomas/ABF-4718-2020; Rauch, Andri/E-9948-2017; Scriba, Thomas/H-3633-2013; Scriba, Thomas/GPX-2573-2022	Day, Cheryl L/0000-0002-6497-4846; Baumert, Thomas/0000-0002-8864-2168; Rauch, Andri/0000-0001-5297-6062; Scriba, Thomas/0000-0002-0641-1359; Lucas, Michaela/0000-0001-8881-9990; , Silvana/0000-0001-6873-0198; klenerman, paul/0000-0003-4307-9161	Wellcome Trust; James Martin School of the 21st Century, Oxford; Kompetenznetz Hepatitis HepNet [10.2.1]; Priority 1 "Life Sciences, Genomics and Biotechnology for Health" programme in the 6th Framework Programme of the EU [LSHM-CT-2004-503359]	Wellcome Trust(Wellcome TrustEuropean Commission); James Martin School of the 21st Century, Oxford; Kompetenznetz Hepatitis HepNet; Priority 1 "Life Sciences, Genomics and Biotechnology for Health" programme in the 6th Framework Programme of the EU	Funding: This work was supported by funding from the Wellcome Trust, the James Martin School of the 21st Century, Oxford and the Kompetenznetz Hepatitis HepNet (Teilprojekt 10.2.1). This work is part of the activities of the VIRGIL European Network of Excellence on Antiviral Drug Resistance supported by a grant (LSHM-CT-2004-503359) from the Priority 1 "Life Sciences, Genomics and Biotechnology for Health" programme in the 6th Framework Programme of the EU.	Butt Adeel A, 2005, Expert Rev Anti Infect Ther, V3, P241, DOI 10.1586/14787210.3.2.241; Cox AL, 2005, J EXP MED, V201, P1741, DOI 10.1084/jem.20050121; Day CL, 2003, J CLIN INVEST, V112, P831, DOI 10.1172/JCI200318509; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; Gerlach JT, 2005, J VIROL, V79, P12425, DOI 10.1128/JVI.79.19.12425-12433.2005; Gerlach JT, 1999, GASTROENTEROLOGY, V117, P933, DOI 10.1016/S0016-5085(99)70353-7; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Kasprowicz V, 2006, J VIROL, V80, P11209, DOI 10.1128/JVI.01173-06; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Lechner F, 2000, EUR J IMMUNOL, V30, P2479, DOI 10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Lucas M, 2004, J VIROL, V78, P7284, DOI 10.1128/JVI.78.13.7284-7287.2004; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; Neumann-Haefelin C, 2006, HEPATOLOGY, V43, P563, DOI 10.1002/hep.21049; Scriba TJ, 2005, J IMMUNOL, V175, P6334, DOI 10.4049/jimmunol.175.10.6334; Scriba TJ, 2005, J CLIN INVEST, V115, P443, DOI 10.1172/JCI200523084; Seth N, 2005, J IMMUNOL, V175, P6948, DOI 10.4049/jimmunol.175.10.6948; Spangenberg HC, 2005, HEPATOLOGY, V42, P828, DOI 10.1002/hep.20856; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Timm J, 2004, J EXP MED, V200, P1593, DOI 10.1084/jem.20041006; Ulsenheimer A, 2006, J VIRAL HEPATITIS, V13, P708, DOI 10.1111/j.1365-2893.2006.00747.x; Ulsenheimer A, 2003, HEPATOLOGY, V37, P1189, DOI 10.1053/jhep.2003.50194; Witt CS, 2002, TISSUE ANTIGENS, V60, P474, DOI 10.1034/j.1399-0039.2002.600602.x; zur Wiesch JS, 2005, J IMMUNOL, V175, P3603, DOI 10.4049/jimmunol.175.6.3603	24	61	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e649	10.1371/journal.pone.0000649	http://dx.doi.org/10.1371/journal.pone.0000649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653276	Green Published, gold, Green Submitted			2022-12-27	WOS:000207452200018
J	Ocorr, KA; Crawley, T; Gibson, G; Bodmer, R				Ocorr, Karen A.; Crawley, Timothy; Gibson, Greg; Bodmer, Rolf			Genetic Variation for Cardiac Dysfunction in Drosophila	PLOS ONE			English	Article								Background. Common diseases may be attributed to combinations of variant alleles, but there are few model systems where the interactions among such variants can be studied in controlled genetic crosses. While association studies are designed to detect common polymorphisms of moderate effect, new approaches are required to characterize the impact on disease of interactions among rare alleles. Methodology/Principal Findings. We show that wild populations of Drosophila melanogaster harbor rare polymorphisms of major effect (RAME) that predispose flies to a specific disease phenotype, age-dependent cardiac dysfunction. A screen of fifty inbred wild-type lines revealed a continuous spectrum of pacing-induced heart failure that generally increases in frequency with age. High-speed video analysis of the inbred lines with high rates of inducible heart failure indicates specific defects in cardiac function, including arrhythmias and contractile disorders ('cardiomyopathies'). A combination of bulked segregant analysis and single feature polymorphism (SFP) detection localizes one of the cardiac susceptibility loci to the 97C interval on the fly genome. Conclusions/Significance. Wild-type Drosophila, like humans, are predisposed to cardiac dysfunction. Identification of factors associated with these naturally occurring cardiac traits promises to provide important insights into the epidemiology of cardiac disease.	[Gibson, Greg] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Ocorr, Karen A.; Crawley, Timothy; Bodmer, Rolf] Burnham Inst Med Res, Ctr Neurosci & Aging, La Jolla, CA USA	University of North Carolina; North Carolina State University; Sanford Burnham Prebys Medical Discovery Institute	Gibson, G (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	ggibson@unity.ncsu.edu; rolf@burnham.org		Ocorr, Karen/0000-0003-2593-0119	National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute at the National Institutes of Health	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung, and Blood Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Institute of General Medical Sciences and the National Heart, Lung, and Blood Institute at the National Institutes of Health.	Akasaka T, 2006, P NATL ACAD SCI USA, V103, P11999, DOI 10.1073/pnas.0603098103; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Bier E, 2004, GENE, V342, P1, DOI 10.1016/j.gene.2004.07.018; Borevitz JO, 2002, GENETICS, V160, P683; Borevitz Justin, 2006, V323, P137; Dowse H, 1995, J NEUROGENET, V10, P153, DOI 10.3109/01677069509083461; Gibson G, 2002, GENET RES, V80, P1, DOI 10.1017/S0016672302005839; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Nikoh N, 2004, GENETICS, V168, P1963, DOI 10.1534/genetics.104.028712; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Palsson A, 2004, GENETICS, V167, P1199, DOI 10.1534/genetics.104.026252; RISCH N, 1996, SCIENCE, V273, P1517; Robbins J, 1999, GENET RES, V74, P121, DOI 10.1017/S0016672399003924; Taylor Matthew R, 2006, Novartis Found Symp, V274, P73; Wessel RJ, 2004, BIOTECHNIQUES, V37, P58, DOI 10.2144/04371ST01; Wessells RJ, 2004, NAT GENET, V36, P1275, DOI 10.1038/ng1476; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103	18	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2007	2	7							e601	10.1371/journal.pone.0000601	http://dx.doi.org/10.1371/journal.pone.0000601			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GH	17622346	Green Published, gold, Green Submitted			2022-12-27	WOS:000207452000008
J	Hemond, CC; Kanwisher, NG; Op de Beeck, HP				Hemond, Christopher C.; Kanwisher, Nancy G.; Op de Beeck, Hans P.			A Preference for Contralateral Stimuli in Human Object- and Face-Selective Cortex	PLOS ONE			English	Article								Visual input from the left and right visual fields is processed predominantly in the contralateral hemisphere. Here we investigated whether this preference for contralateral over ipsilateral stimuli is also found in high-level visual areas that are important for the recognition of objects and faces. Human subjects were scanned with functional magnetic resonance imaging ( fMRI) while they viewed and attended faces, objects, scenes, and scrambled images in the left or right visual field. With our stimulation protocol, primary visual cortex responded only to contralateral stimuli. The contralateral preference was smaller in object- and face-selective regions, and it was smallest in the fusiform gyrus. Nevertheless, each region showed a significant preference for contralateral stimuli. These results indicate that sensitivity to stimulus position is present even in high-level ventral visual cortex.	[Hemond, Christopher C.; Kanwisher, Nancy G.; Op de Beeck, Hans P.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Hemond, Christopher C.; Kanwisher, Nancy G.; Op de Beeck, Hans P.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Kanwisher, Nancy G.] Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Op de Beeck, Hans P.] Univ Leuven KU Leuven, Expt Psychol Lab, Louvain, Belgium	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); KU Leuven	Op de Beeck, HP (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hans.opdebeeck@psy.kuleuven.be	Hemond, Christopher/AAJ-7568-2020	Hemond, Christopher/0000-0002-2408-4638; Op de Beeck, Hans/0000-0002-2250-212X	McGovern Institute for Brain Research [EY13455, R21-NS0490SZ]; National Center for Research Resources [P41-RR14075, R01 RR16594-01A1, BIRN002]; Mental Illness and Neuroscience Discovery (MIND) Institute; (FEDRA) of Belgium [IUAP P6/29]; Human Frontier Science Program; Fund for Scientific Research - Flanders; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR016594, P41RR014075] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013455] Funding Source: NIH RePORTER	McGovern Institute for Brain Research; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Mental Illness and Neuroscience Discovery (MIND) Institute; (FEDRA) of Belgium; Human Frontier Science Program(Human Frontier Science Program); Fund for Scientific Research - Flanders(FWO); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants EY13455 and R21-NS0490SZ (N.G.K.), the McGovern Institute for Brain Research, the National Center for Research Resources (P41-RR14075, R01 RR16594-01A1 and the NCRR BIRN Morphometric Project BIRN002), the Mental Illness and Neuroscience Discovery ( MIND) Institute, and a federal research action (FEDRA) of Belgium ( grant IUAP P6/29). Hans P. Op de Beeck was supported by the Human Frontier Science Program and the Fund for Scientific Research - Flanders.	Brewer AA, 2005, NAT NEUROSCI, V8, P1102, DOI 10.1038/nn1507; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DiCarlo JJ, 2003, J NEUROPHYSIOL, V89, P3264, DOI 10.1152/jn.00358.2002; Eger E, 2004, NEUROIMAGE, V22, P232, DOI 10.1016/j.neuroimage.2003.12.028; Eger E, 2005, NEUROIMAGE, V26, P1128, DOI 10.1016/j.neuroimage.2005.03.010; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Hellige J. B., 1993, HEMISPHERIC ASYMMETR; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; MARSOLEK CJ, 1995, J EXP PSYCHOL HUMAN, V21, P375, DOI 10.1037/0096-1523.21.2.375; Newell FN, 2005, VISION RES, V45, P2065, DOI 10.1016/j.visres.2005.02.021; Niemeier M, 2005, CEREB CORTEX, V15, P325, DOI 10.1093/cercor/bhh134; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; Op de Beeck HP, 2006, J NEUROSCI, V26, P13025, DOI 10.1523/JNEUROSCI.2481-06.2006; Pourtois G, 2005, J COGNITIVE NEUROSCI, V17, P1043, DOI 10.1162/0898929054475181; ROLLS ET, 2004, VISUAL NEUROSCIENCES, P1165; Rousselet GA, 2004, TRENDS COGN SCI, V8, P363, DOI 10.1016/j.tics.2004.06.003; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839	22	120	120	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e574	10.1371/journal.pone.0000574	http://dx.doi.org/10.1371/journal.pone.0000574			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593973	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451800018
J	Hastings, ML; Allemand, E; Duelli, DM; Myers, MP; Krainer, AR				Hastings, Michelle L.; Allemand, Eric; Duelli, Dominik M.; Myers, Michael P.; Krainer, Adrian R.			Control of Pre-mRNA Splicing by the General Splicing Factors PUF60 and U2AF(65)	PLOS ONE			English	Article								Pre-mRNA splicing is a crucial step in gene expression, and accurate recognition of splice sites is an essential part of this process. Splice sites with weak matches to the consensus sequences are common, though it is not clear how such sites are efficiently utilized. Using an in vitro splicing-complementation approach, we identified PUF60 as a factor that promotes splicing of an intron with a weak 39 splice-site. PUF60 has homology to U2AF(65), a general splicing factor that facilitates 39 splice-site recognition at the early stages of spliceosome assembly. We demonstrate that PUF60 can functionally substitute for U2AF(65) in vitro, but splicing is strongly stimulated by the presence of both proteins. Reduction of either PUF60 or U2AF(65) in cells alters the splicing pattern of endogenous transcripts, consistent with the idea that regulation of PUF60 and U2AF(65) levels can dictate alternative splicing patterns. Our results indicate that recognition of 39 splice sites involves different U2AF-like molecules, and that modulation of these general splicing factors can have profound effects on splicing.	[Hastings, Michelle L.; Allemand, Eric; Duelli, Dominik M.; Myers, Michael P.; Krainer, Adrian R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Krainer, AR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	krainer@cshl.edu	Hastings, MICHELLE L./AAK-6627-2021; allemand, eric/ABE-4272-2021	allemand, eric/0000-0002-9617-5336; Krainer, Adrian/0000-0001-9024-9501; Hastings, Michelle L./0000-0002-4253-9261	American Cancer Society; NCI [CA45508]; NIH [GM42699]; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042699, R37GM042699] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M. L. H. was supported by a postdoctoral fellowship from the American Cancer Society. M. P. M was supported by NCI grant CA45508. This work was supported by NIH grant GM42699 to A. R. K.	Andreadis A, 2005, BBA-MOL BASIS DIS, V1739, P91, DOI 10.1016/j.bbadis.2004.08.010; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Berglund JA, 1997, CELL, V89, P781, DOI 10.1016/S0092-8674(00)80261-5; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; Bertram L, 2005, NEW ENGL J MED, V352, P884, DOI 10.1056/NEJMoa042765; Bouffard P, 2000, RNA, V6, P66, DOI 10.1017/S1355838200990277; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Cazalla D, 2005, MOL CELL BIOL, V25, P2969, DOI 10.1128/MCB.25.8.2969-2980.2005; Chen XG, 2004, J MOL MED, V82, P232, DOI 10.1007/s00109-004-0529-0; DEMCZUK S, 1993, P NATL ACAD SCI USA, V90, P2574, DOI 10.1073/pnas.90.7.2574; Dowhan DH, 2005, MOL CELL, V17, P429, DOI 10.1016/j.molcel.2004.12.025; Duelli DM, 2005, J CELL BIOL, V171, P493, DOI 10.1083/jcb.200507069; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Graveley BR, 2001, RNA, V7, P806, DOI 10.1017/S1355838201010317; Guth S, 2001, MOL CELL BIOL, V21, P7673, DOI 10.1128/MCB.21.22.7673-7681.2001; HANNON GJ, 1990, CELL, V61, P1247, DOI 10.1016/0092-8674(90)90689-C; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Hastings ML, 2001, RNA, V7, P471, DOI 10.1017/S1355838201002552; Hertel KJ, 1997, CURR OPIN CELL BIOL, V9, P350, DOI 10.1016/S0955-0674(97)80007-5; HOLTZMAN DM, 1991, TRENDS BIOCHEM SCI, V16, P140, DOI 10.1016/0968-0004(91)90056-2; IMAI H, 1993, J CLIN INVEST, V92, P2419, DOI 10.1172/JCI116848; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Konarska MM, 2005, GENE DEV, V19, P2255, DOI 10.1101/gad.1363105; KRAINER AR, 1990, GENE DEV, V4, P1158, DOI 10.1101/gad.4.7.1158; KRAINER AR, 1984, CELL, V36, P993, DOI 10.1016/0092-8674(84)90049-7; Kralovicova J, 2005, NUCLEIC ACIDS RES, V33, P4882, DOI 10.1093/nar/gki811; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Lim SR, 2001, J BIOL CHEM, V276, P45476, DOI 10.1074/jbc.M107632200; LIN CH, 1995, RNA, V1, P234; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; Lutzelberger M, 2005, J BIOL CHEM, V280, P25478, DOI 10.1074/jbc.M413737200; MacMillan AM, 1997, P NATL ACAD SCI USA, V94, P133, DOI 10.1073/pnas.94.1.133; MacMorris M, 2003, RNA, V9, P847, DOI 10.1261/rna.5480803; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Mayeda A, 1999, METH MOL B, V118, P309; McCurrach ME, 2001, METHOD CELL BIOL, V66, P197; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; Murray MV, 1999, GENE DEV, V13, P87, DOI 10.1101/gad.13.1.87; Page-McCaw PS, 1999, RNA, V5, P1548, DOI 10.1017/S1355838299991938; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Poleev A, 2000, EUR J BIOCHEM, V267, P4002, DOI 10.1046/j.1432-1327.2000.01431.x; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; Roca X, 2003, NUCLEIC ACIDS RES, V31, P6321, DOI 10.1093/nar/gkg830; Rudner DZ, 1998, MOL CELL BIOL, V18, P4004, DOI 10.1128/MCB.18.7.4004; RUSKIN B, 1988, CELL, V52, P207, DOI 10.1016/0092-8674(88)90509-0; SAKAMOTO H, 1987, J BIOCHEM-TOKYO, V102, P1289, DOI 10.1093/oxfordjournals.jbchem.a122167; STAKNIS D, 1994, MOL CELL BIOL, V14, P2994, DOI 10.1128/MCB.14.5.2994; Tajiri T, 2003, CLIN CANCER RES, V9, P3345; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; TRESS ML, 2007, P NATL ACAD SCI US; Van Buskirk C, 2002, DEV CELL, V2, P343, DOI 10.1016/S1534-5807(02)00128-4; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; Xu YZ, 2004, EMBO J, V23, P376, DOI 10.1038/sj.emboj.7600050; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; ZAMORE PD, 1991, EMBO J, V10, P207, DOI 10.1002/j.1460-2075.1991.tb07937.x; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; ZAMORE PD, 1989, P NATL ACAD SCI USA, V86, P9243, DOI 10.1073/pnas.86.23.9243; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031; Zhu J, 2000, GENE DEV, V14, P3166, DOI 10.1101/gad.189500; Zorio DAR, 1999, NATURE, V402, P835, DOI 10.1038/45597	66	89	101	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2007	2	6							e538	10.1371/journal.pone.0000538	http://dx.doi.org/10.1371/journal.pone.0000538			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GE	17579712	Green Published, Green Accepted, gold			2022-12-27	WOS:000207451700006
J	Becherer, U; Pasche, M; Nofal, S; Hof, D; Matti, U; Rettig, J				Becherer, Ute; Pasche, Mathias; Nofal, Shahira; Hof, Detlef; Matti, Ulf; Rettig, Jens			Quantifying Exocytosis by Combination of Membrane Capacitance Measurements and Total Internal Reflection Fluorescence Microscopy in Chromaffin Cells	PLOS ONE			English	Article								Total internal reflection fluorescence microscopy (TIRF-Microscopy) allows the observation of individual secretory vesicles in real-time during exocytosis. In contrast to electrophysiological methods, such as membrane capacitance recording or carbon fiber amperometry, TIRF-Microscopy also enables the observation of vesicles as they reside close to the plasma membrane prior to fusion. However, TIRF-Microscopy is limited to the visualization of vesicles that are located near the membrane attached to the glass coverslip on which the cell grows. This has raised concerns as to whether exocytosis measured with TIRF-Microscopy is comparable to global secretion of the cell measured with membrane capacitance recording. Here we address this concern by combining TIRF-Microscopy and membrane capacitance recording to quantify exocytosis from adrenal chromaffin cells. We found that secretion measured with TIRF-Microscopy is representative of the overall secretion of the cells, thereby validating for the first time the TIRF method as a measure of secretion. Furthermore, the combination of these two techniques provides a new tool for investigating the molecular mechanism of synaptic transmission with combined electrophysiological and imaging techniques.	[Becherer, Ute; Pasche, Mathias; Nofal, Shahira; Hof, Detlef; Matti, Ulf; Rettig, Jens] Univ Saarland, Inst Physiol, Homburg, Saar, Germany	Saarland University	Becherer, U (corresponding author), Univ Saarland, Inst Physiol, Homburg, Saar, Germany.	ute.becherer@uks.eu; jrettig@uks.eu	Becherer, Ute/AGW-2576-2022; Rettig, Jens/K-5103-2013; Becherer, Ute/F-6711-2010	Rettig, Jens/0000-0001-6160-3954; Becherer, Ute/0000-0001-6005-7517; Matti, Ulf/0000-0001-5548-1081; Nofal, Shahira/0000-0003-0405-9002	Deutsche Forschungsgemeinschaft [SFB 530]; HOMFOR	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); HOMFOR	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 530 to U. B. and J. R.) and HOMFOR.	Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; Angleson JK, 1997, TRENDS NEUROSCI, V20, P281, DOI 10.1016/S0166-2236(97)01083-7; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Ashery U, 1999, EUR J CELL BIOL, V78, P525, DOI 10.1016/S0171-9335(99)80017-X; Beaumont V, 2003, BIOCHEM SOC T, V31, P819, DOI 10.1042/BST0310819; Becherer U, 2003, NAT NEUROSCI, V6, P846, DOI 10.1038/nn1087; Dernick G, 2005, NAT METHODS, V2, P699, DOI 10.1038/nmeth0905-699; Eitzen G, 2003, BBA-MOL CELL RES, V1641, P175, DOI 10.1016/S0167-4889(03)00087-9; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Han WP, 1999, P NATL ACAD SCI USA, V96, P14577, DOI 10.1073/pnas.96.25.14577; Johns LM, 2001, J CELL BIOL, V153, P177, DOI 10.1083/jcb.153.1.177; Lang T, 1997, NEURON, V18, P857, DOI 10.1016/S0896-6273(00)80325-6; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nofal S, 2007, J NEUROSCI, V27, P1386, DOI 10.1523/JNEUROSCI.4714-06.2007; Oheim M, 1998, EUR BIOPHYS J BIOPHY, V27, P83, DOI 10.1007/s002490050114; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; Perrais D, 2004, J PHYSIOL-LONDON, V560, P413, DOI 10.1113/jphysiol.2004.064410; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Toonen RF, 2006, EMBO J, V25, P3725, DOI 10.1038/sj.emboj.7601256; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7	27	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e505	10.1371/journal.pone.0000505	http://dx.doi.org/10.1371/journal.pone.0000505			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551585	gold, Green Published			2022-12-27	WOS:000207451500014
J	Graziano, A; d'Aquino, R; Cusella-De Angelis, MG; Laino, G; Piattelli, A; Pacifici, M; De Rosa, A; Papaccio, G				Graziano, Antonio; d'Aquino, Riccardo; Cusella-De Angelis, Maria Gabriella; Laino, Gregorio; Piattelli, Adriano; Pacifici, Maurizio; De Rosa, Alfredo; Papaccio, Gianpaolo			Concave Pit-Containing Scaffold Surfaces Improve Stem Cell-Derived Osteoblast Performance and Lead to Significant Bone Tissue Formation	PLOS ONE			English	Article							VASCULAR-PERMEABILITY FACTOR; OSTEOGENIC DIFFERENTIATION; TYROSINE KINASE; GROWTH-FACTORS; RECEPTOR; TRANSDUCTION; DEGRADATION; SECRETE; BMP-2	Background. Scaffold surface features are thought to be important regulators of stem cell performance and endurance in tissue engineering applications, but details about these fundamental aspects of stem cell biology remain largely unclear. Methodology and Findings. In the present study, smooth clinical-grade lactide-coglyolic acid 85: 15 (PLGA) scaffolds were carved as membranes and treated with NMP (N-metil-pyrrolidone) to create controlled subtractive pits or microcavities. Scanning electron and confocal microscopy revealed that the NMP-treated membranes contained: (i) large microcavities of 80120 mu m in diameter and 40-100 mu m in depth, which we termed primary; and (ii) smaller microcavities of 10-20 mu m in diameter and 3-10 mu m in depth located within the primary cavities, which we termed secondary. We asked whether a microcavity-rich scaffold had distinct bone-forming capabilities compared to a smooth one. To do so, mesenchymal stem cells derived from human dental pulp were seeded onto the two types of scaffold and monitored over time for cytoarchitectural characteristics, differentiation status and production of important factors, including bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF). We found that the microcavity-rich scaffold enhanced cell adhesion: the cells created intimate contact with secondary microcavities and were polarized. These cytological responses were not seen with the smooth-surface scaffold. Moreover, cells on the microcavity-rich scaffold released larger amounts of BMP-2 and VEGF into the culture medium and expressed higher alkaline phosphatase activity. When this type of scaffold was transplanted into rats, superior bone formation was elicited compared to cells seeded on the smooth scaffold. Conclusion. In conclusion, surface microcavities appear to support a more vigorous osteogenic response of stem cells and should be used in the design of therapeutic substrates to improve bone repair and bioengineering applications in the future.	[Graziano, Antonio; d'Aquino, Riccardo; Papaccio, Gianpaolo] Secondo Ateneo Napoli, Dipartimento Med Sperimentale, Sez Istol & Embriol, Naples, Italy; [d'Aquino, Riccardo; Laino, Gregorio; De Rosa, Alfredo] Secondo Ateneo Napoli, Dipartimento Discipline Odontostomatol Ortodontic, Naples, Italy; [Cusella-De Angelis, Maria Gabriella] Univ Pavia, Dipartimento Med Sperimentale, Sez Anat Umana, I-27100 Pavia, Italy; [Piattelli, Adriano] Univ G DAnnunzio, Dipartimento Sci Odontostomatol, Chieti, Italy; [Pacifici, Maurizio] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA	University of Pavia; G d'Annunzio University of Chieti-Pescara; Jefferson University	Graziano, A (corresponding author), Secondo Ateneo Napoli, Dipartimento Med Sperimentale, Sez Istol & Embriol, Naples, Italy.	gianpaolo.papaccio@unina2.it	; Papaccio, Gianpaolo/B-7150-2014	Cusella De Angelis, Maria Gabriella/0000-0003-2642-3346; Papaccio, Gianpaolo/0000-0002-4014-5306	2nd University of Naples; MIUR	2nd University of Naples; MIUR(Ministry of Education, Universities and Research (MIUR))	This study was supported by the 2nd University of Naples (2004-5 to G.P.) and MIUR (Project of relevant interest 2005 to G. P.) grants.	BELLOWS CG, 1991, BONE MINER, V14, P27, DOI 10.1016/0169-6009(91)90100-E; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; CONNOLLY DT, 1991, J CELL BIOCHEM, V47, P219, DOI 10.1002/jcb.240470306; COOMBES AGA, 1992, BIOMATERIALS, V13, P297, DOI 10.1016/0142-9612(92)90053-Q; d'Aquino R, 2007, CELL DEATH DIFFER, V14, P1162, DOI 10.1038/sj.cdd.4402121; De Luca F, 2001, ENDOCRINOLOGY, V142, P430, DOI 10.1210/en.142.1.430; Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Erickson DM, 1997, J ORTHOP RES, V15, P371, DOI 10.1002/jor.1100150309; FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gomes ME, 2006, TISSUE ENG, V12, P801, DOI 10.1089/ten.2006.12.801; Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Kirschner P., 2000, RES DIALOGUE LEARNIN, V2, P1; Knaus P, 2001, BIOL CHEM, V382, P1189, DOI 10.1515/BC.2001.149; Laino G, 2006, J CELL PHYSIOL, V206, P693, DOI 10.1002/jcp.20526; Laino G, 2005, J BONE MINER RES, V20, P1394, DOI 10.1359/JBMR.050325; LIU F, 1995, MOL CELL BIOL, V15, P3479; Marletta G, 2007, BIOMATERIALS, V28, P1132, DOI 10.1016/j.biomaterials.2006.10.027; MIDY V, 1994, BIOCHEM BIOPH RES CO, V199, P380, DOI 10.1006/bbrc.1994.1240; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Miyazono K, 1999, BONE, V25, P91, DOI 10.1016/S8756-3282(99)00113-1; Neufeld Gera, 1994, Progress in Growth Factor Research, V5, P89, DOI 10.1016/0955-2235(94)90019-1; Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034; Papaccio G, 2006, J CELL PHYSIOL, V208, P319, DOI 10.1002/jcp.20667; Park BS, 2005, J BIOMED MATER RES A, V74A, P640, DOI 10.1002/jbm.a.30326; Peng HR, 2005, J BONE MINER RES, V20, P2017, DOI 10.1359/JBMR.050708; PLOUET J, 1989, EMBO J, V8, P3801, DOI 10.1002/j.1460-2075.1989.tb08557.x; Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074; SAITOH H, 1994, J ORAL REHABIL, V21, P431, DOI 10.1111/j.1365-2842.1994.tb01157.x; SCHOTT RJ, 1993, CARDIOVASC RES, V27, P1155, DOI 10.1093/cvr/27.7.1155; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Shen Francis H, 2006, Spine J, V6, P615, DOI 10.1016/j.spinee.2006.03.006; Stahelin AC, 1997, ARTHROSCOPY, V13, P238, DOI 10.1016/S0749-8063(97)90162-6; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Velema J, 2006, ADV BIOCHEM ENG BIOT, V102, P187, DOI 10.1007/10_013; Wang DS, 1997, ENDOCRINOLOGY, V138, P2953, DOI 10.1210/en.138.7.2953; WINET H, 1993, J BIOMED MATER RES, V27, P667, DOI 10.1002/jbm.820270514; WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212; Yamashita H, 1996, BONE, V19, P569, DOI 10.1016/S8756-3282(96)00259-1	42	55	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e496	10.1371/journal.pone.0000496	http://dx.doi.org/10.1371/journal.pone.0000496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551577	gold, Green Submitted, Green Published			2022-12-27	WOS:000207451500006
J	Zhou, D; Xue, J; Chen, JM; Morcillo, P; Lambert, JD; White, KP; Haddad, GG				Zhou, Dan; Xue, Jin; Chen, Jianming; Morcillo, Patrick; Lambert, J. David; White, Kevin P.; Haddad, Gabriel G.			Experimental Selection for Drosophila Survival in Extremely Low O-2 Environment	PLOS ONE			English	Article								Background. Cellular hypoxia, if severe enough, results usually in injury or cell death. Our research in this area has focused on the molecular mechanisms underlying hypoxic tissue injury to explore strategies to prevent injury or enhance tolerance. The current experiments were designed to determine the genetic basis for adaptation to long term low O-2 environments. Methodology/Principal Findings. With long term experimental selection over many generations, we obtained a Drosophila melanogaster strain that can live perpetually in extremely low, normally lethal, O-2 condition (as low as 4% O-2). This strain shows a dramatic phenotypic divergence from controls, including a decreased recovery time from anoxic stupor, a higher rate of O-2 consumption in hypoxic conditions, and a decreased body size and mass due to decreased cell number and size. Expression arrays showed that about 4% of the Drosophila genome altered in expression and about half of the alteration was down-regulation. The contribution of some altered transcripts to hypoxia tolerance was examined by testing the survival of available corresponding P-element insertions (and their excisions) under extremely low O-2 conditions. We found that down-regulation of several candidate genes including Best1, broad, CG7102, dunce, lin19-like and sec6 conferred severe hypoxia tolerance in Drosophila. Conclusions/Significance. We have identified a number of genes that play an important role in the survival of a selected Drosophila strain in extremely low O-2 conditions, selected by decreasing O-2 availability over many generations. Because of conservation of pathways, we believe that such genes are critical in hypoxia adaptation in physiological or pathological conditions not only in Drosophila but also in mammals.	[White, Kevin P.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [White, Kevin P.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [White, Kevin P.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Zhou, Dan; Xue, Jin; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, Sect Resp Med, La Jolla, CA 92093 USA; [Zhou, Dan; Xue, Jin; Haddad, Gabriel G.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Chen, Jianming] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; [Morcillo, Patrick] Yeshiva Univ, Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY USA; [Lambert, J. David] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Zhou, Dan; Xue, Jin; Haddad, Gabriel G.] Rady Childrens Hosp San Diego, San Diego, CA USA	University of Chicago; University of Chicago; University of Chicago; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Yeshiva University; Albert Einstein College of Medicine; University of Rochester; Rady Childrens Hospital San Diego	White, KP (corresponding author), Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA.	kpwhite@uchicago.edu; ghaddad@ucsd.edu	Zhou, Dan/T-7203-2017	Lambert, J. David/0000-0002-7005-0244; Zhou, Dan/0000-0001-6401-9040; Morcillo, Patrick/0000-0001-9543-2487	National Institutes of Health [RO1NS037756, PO1HD032573]; Helen Hay Whitney Foundation; W.M. Keck Foundation; Beckman Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; W.M. Keck Foundation(W.M. Keck Foundation); Beckman Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health grants to GGH (RO1NS037756 and PO1HD032573), a postdoctoral fellowship from the Helen Hay Whitney Foundation to JDL and by grants from the W.M. Keck Foundation, the Beckman Foundation and the NIH to KPW.	ALBERGHINA M, 1982, J NEUROSCI RES, V7, P147, DOI 10.1002/jnr.490070206; Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; Bayer CA, 1997, DEV BIOL, V187, P267, DOI 10.1006/dbio.1997.8620; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bruder ED, 2004, ENDOCRINOLOGY, V145, P5364, DOI 10.1210/en.2004-0582; Carini R, 2004, GASTROENTEROLOGY, V127, P914, DOI 10.1053/j.gastro.2004.06.018; Chen QF, 2002, J BIOL CHEM, V277, P3274, DOI 10.1074/jbc.M109479200; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; DAVIS RL, 1981, J CELL BIOL, V90, P101, DOI 10.1083/jcb.90.1.101; Dong Z, 2001, J BIOL CHEM, V276, P18702, DOI 10.1074/jbc.M011774200; Douglas RM, 2003, J APPL PHYSIOL, V94, P2068, DOI 10.1152/japplphysiol.01029.2002; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erler JT, 2004, MOL CELL BIOL, V24, P2875, DOI 10.1128/MCB.24.7.2875-2889.2004; Filippov V, 2000, J EXP BIOL, V203, P2747; Greenway SC, 2000, J EXP ZOOL, V287, P477, DOI 10.1002/1097-010X(20001201)287:7<477::AID-JEZ3>3.0.CO;2-4; GREKSA LP, 1988, AM J PHYS ANTHROPOL, V75, P77, DOI 10.1002/ajpa.1330750109; GREKSA LP, 1985, ANN HUM BIOL, V12, P225, DOI 10.1080/03014468500007721; GROOTHUIS JR, 1987, AM J DIS CHILD, V141, P992, DOI 10.1001/archpedi.1987.04460090069028; HADDAD GG, 1993, PROG NEUROBIOL, V40, P277, DOI 10.1016/0301-0082(93)90014-J; Haddad GG, 1997, P NATL ACAD SCI USA, V94, P10809, DOI 10.1073/pnas.94.20.10809; HADDAD GG, 1997, J INSECT PHYSL, V43, P203; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; Henry JR, 2004, J EXP BIOL, V207, P3559, DOI 10.1242/jeb.01189; Jacobs EGJ, 2000, J PEDIATR ENDOCR MET, V13, P387; Jones NM, 2004, J NEUROCHEM, V89, P157, DOI 10.1111/j.1471-4159.2004.02324.x; KISS I, 1988, GENETICS, V118, P247; Li TR, 2003, DEV CELL, V5, P59, DOI 10.1016/S1534-5807(03)00192-8; Lloyd TE, 2000, NEURON, V26, P45, DOI 10.1016/S0896-6273(00)81136-8; Ma E, 2001, J CLIN INVEST, V107, P685, DOI 10.1172/JCI11625; Ma EB, 1999, MOL BRAIN RES, V63, P217, DOI 10.1016/S0169-328X(98)00265-4; MONGE C, 1991, PHYSIOL REV, V71, P1135, DOI 10.1152/physrev.1991.71.4.1135; Neckar J, 2005, AM J PHYSIOL-HEART C, V288, pH1566, DOI 10.1152/ajpheart.00586.2004; Pachori AS, 2004, P NATL ACAD SCI USA, V101, P12282, DOI 10.1073/pnas.0404616101; Raval AP, 2003, J NEUROSCI, V23, P384, DOI 10.1523/JNEUROSCI.23-02-00384.2003; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vartiainen N, 2002, J NEUROCHEM, V82, P329, DOI 10.1046/j.1471-4159.2002.00959.x; White KP, 2001, NAT REV GENET, V2, P528, DOI 10.1038/35080565; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Xi L, 2006, MOL CELL BIOCHEM, V291, P205, DOI 10.1007/s11010-006-9194-7	42	68	70	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2007	2	5							e490	10.1371/journal.pone.0000490	http://dx.doi.org/10.1371/journal.pone.0000490			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10FB	17534440	gold, Green Published, Green Submitted			2022-12-27	WOS:000207448800020
J	Yeh, LLL; Liu, JY; Lin, KS; Liu, YS; Chiou, JM; Liang, KY; Tsai, TF; Wang, LH; Chen, CT; Huang, CY				Yeh, Lan Lan Liang; Liu, Jah-Yao; Lin, Kao-Si; Liu, Yu-Shen; Chiou, Jeng-Min; Liang, Kung-Yee; Tsai, Te-Feng; Wang, Li-Hsiang; Chen, Chiung-Tong; Huang, Ching-Yi			A Randomised Placebo-Controlled Trial of a Traditional Chinese Herbal Formula in the Treatment of Primary Dysmenorrhoea	PLOS ONE			English	Article							WOMEN; MEDICINE; PREVALENCE; SEVERITY; EFFICACY; PAIN	Background. Most traditional Chinese herbal formulas consist of at least four herbs. Four-Agents-Decoction (Si Wu Tang) is a documented eight hundred year old formula containing four herbs and has been widely used to relieve menstrual discomfort in Taiwan. However, no specific effect had been systematically evaluated. We applied Western methodology to assess its effectiveness and safety for primary dysmenorrhoea and to evaluate the compliance and feasibility for a future trial. Methodology/Principal Findings. A randomised, double-blind, placebo-controlled, pilot clinical trial was conducted in an ad hoc clinic setting at a teaching hospital in Taipei, Taiwan. Seventy-eight primary dysmenorrheic young women were enrolled after 326 women with self-reported menstrual discomfort in the Taipei metropolitan area of Taiwan were screened by a questionnaire and subsequently diagnosed by two gynaecologists concurrently with pelvic ultrasonography. A dosage of 15 odorless capsules daily for five days starting from the onset of bleeding or pain was administered. Participants were followed with two to four cycles for an initial washout interval, one to two baseline cycles, three to four treatment cycles, and three follow-up cycles. Study outcome was pain intensity measured by using unmarked horizontal visual analog pain scale in an online daily diary submitted directly by the participants for 5 days starting from the onset of bleeding or pain of each menstrual cycle. Overall-pain was the average pain intensity among days in pain and peak-pain was the maximal single-day pain intensity. At the end of treatment, both the overall-pain and peak-pain decreased in the Four-Agents-Decoction (Si Wu Tang) group and increased in the placebo group; however, the differences between the two groups were not statistically significant. The trends persisted to follow-up phase. Statistically significant differences in both peak-pain and overall-pain appeared in the first follow-up cycle, at which the reduced peak-pain in the Four-Agents-Decoction (Si Wu Tang) group did not differ significantly by treatment length. However, the reduced peak-pain did differ profoundly among women treated for four menstrual cycles (2.69 (2.06) cm, mean (standard deviation), for the 20 women with Four-Agents-Decoction and 4.68 (3.16) for the 22 women with placebo, p = .020.) There was no difference in adverse symptoms between the Four-Agents-Decoction (Si Wu Tang) and placebo groups. Conclusion/significance. Four-Agents-Decoction (Si Wu Tang) therapy in this pilot post-market clinical trial, while meeting the standards of conventional medicine, showed no statistically significant difference in reducing menstrual pain intensity of primary dysmenorrhoea at the end of treatment. Its use, with our dosage regimen and treatment length, was not associated with adverse reactions. The finding of statistically significant pain-reducing effect in the first follow-up cycle was unexpected and warrants further study. A larger similar trial among primary dysmenorrheic young women with longer treatment phase and multiple batched study products can determine the definitive efficacy of this historically documented formula. Trial Registration. Controlled-Trials.com ISRCTN23374750	[Yeh, Lan Lan Liang; Huang, Ching-Yi] Natl Hlth Res Inst, Div Clin Res, Zhunan, Taiwan; [Liu, Jah-Yao] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Obstet & Gynaecol, Taipei, Taiwan; [Lin, Kao-Si; Wang, Li-Hsiang] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Chinese Med, Taipei, Taiwan; [Liu, Yu-Shen] Taipei Municipal Hosp, Zhongxiao Branch, Sect Obstet & Gynaecol, Taipei, Taiwan; [Chiou, Jeng-Min] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Liang, Kung-Yee] Natl Hlth Res Inst, Div Biostat & Bioinformat, Zhunan, Taiwan; [Tsai, Te-Feng] Taipei Municipal Hosp, Zhongxiao Branch, Sect Chinese Med, Taipei, Taiwan; [Chen, Chiung-Tong] Natl Hlth Res Inst, Div Biotechnol & Pharmaceut Res, Zhunan, Taiwan	National Health Research Institutes - Taiwan; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Taipei Municipal WanFang Hospital; Academia Sinica - Taiwan; National Health Research Institutes - Taiwan; Taipei Municipal WanFang Hospital; National Health Research Institutes - Taiwan	Yeh, LLL (corresponding author), Natl Hlth Res Inst, Div Clin Res, Zhunan, Taiwan.	lanlanliang2@yahoo.com	Chen, Chiung-Tong/D-2075-2010; Chiou, Jeng-Min/AAQ-3736-2021	Chiou, Jeng-Min/0000-0003-4554-9454	Department of Health, Taiwan; Office of National Science and Technology Program for Biotechnology and Pharmaceuticals, Taiwan; Tri-Service General Hospital of National Defense Medical Centre [TSGH-C94-62]	Department of Health, Taiwan; Office of National Science and Technology Program for Biotechnology and Pharmaceuticals, Taiwan; Tri-Service General Hospital of National Defense Medical Centre	This study was an intramural research with additional funding support from other government agencies between 2003 and 2004: Department of Health, Taiwan and The Office of National Science and Technology Program for Biotechnology and Pharmaceuticals, Taiwan. These two funding agencies executed periodical monitoring and auditing. Post hoc study funding was partially supported by a grant (TSGH-C94-62) from the Tri-Service General Hospital of National Defense Medical Centre. Nobody from the government funding agencies or the three companies participated in study design or in the collection, analysis, and interpretation of data, and had no involvement in the authors' work. The investigators solely determined to write this report and made the decision to submit it for publication as part of research activity.	Altunyurt S, 2005, J REPROD MED, V50, P251; ANDERSCH B, 1982, AM J OBSTET GYNECOL, V144, P655, DOI 10.1016/0002-9378(82)90433-1; Bensoussan A, 1998, JAMA-J AM MED ASSOC, V280, P1585, DOI 10.1001/jama.280.18.1585; CHAO PDL, 2005, YB CHINESE MED PHARM, V21, P413; Coco AS, 1999, AM FAM PHYSICIAN, V60, P489; De Smet PAGM, 2002, NEW ENGL J MED, V347, P2046, DOI 10.1056/NEJMra020398; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Dmitrovic R, 2000, ACTA OBSTET GYN SCAN, V79, P1112, DOI 10.1034/j.1600-0412.2000.0790121112.x; Dmitrovic R, 2003, EUR J OBSTET GYN R B, V107, P191, DOI 10.1016/S0301-2115(02)00372-X; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Harlow SD, 1996, BRIT J OBSTET GYNAEC, V103, P1134, DOI 10.1111/j.1471-0528.1996.tb09597.x; Hillen TIJ, 1999, J ADOLESCENT HEALTH, V25, P40, DOI 10.1016/S1054-139X(98)00147-5; HROBJARTSSON A, 2002, HAST CENT S, P107; Hsieh KH, 1996, PEDIAT ALLERG IMM-UK, V7, P130, DOI 10.1111/j.1399-3038.1996.tb00120.x; Huskisson E., 1983, PAIN MEASUREMENT ASS, P33; Jensen MP, 2003, J PAIN, V4, P407, DOI 10.1016/S1526-5900(03)00716-8; Kennedy S, 2006, FERTIL STERIL, V86, P762, DOI 10.1016/j.fertnstert.2006.02.092; KLEIN JR, 1981, PEDIATRICS, V68, P661; Kotani N, 1997, AM J CHINESE MED, V25, P205, DOI 10.1142/S0192415X9700024X; Marjoribanks J., 2003, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD001751, DOI 10.1002/14651858.CD001751]; Milsom I, 2002, CLIN THER, V24, P1384, DOI 10.1016/S0149-2918(02)80043-1; Mol BWJ, 1998, FERTIL STERIL, V70, P1101, DOI 10.1016/S0015-0282(98)00355-0; Ng T P, 1992, Ann Acad Med Singap, V21, P323; Pedron-Nuevo N, 1998, Ginecol Obstet Mex, V66, P492; Proctor ML, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002120; ROBINSON JC, 1992, AM J OBSTET GYNECOL, V166, P578; Todd KH, 1996, ANN EMERG MED, V27, P485, DOI 10.1016/S0196-0644(96)70238-X; Wang L, 2004, OCCUP ENVIRON MED, V61, P1021, DOI 10.1136/oem.2003.012302; Ziaei S, 2001, BRIT J OBSTET GYNAEC, V108, P1181, DOI 10.1111/j.1471-0528.2003.00279.x; Zondervan KT, 1998, BRIT J OBSTET GYNAEC, V105, P93, DOI 10.1111/j.1471-0528.1998.tb09357.x	30	49	49	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e719	10.1371/journal.pone.0000719	http://dx.doi.org/10.1371/journal.pone.0000719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710126	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455200003
J	Jonsson, SR; LaRue, RS; Stenglein, MD; Fahrenkrug, SC; Andresdottir, V; Harris, RS				Jonsson, Stefan R.; LaRue, Rebecca S.; Stenglein, Mark D.; Fahrenkrug, Scott C.; Andresdottir, Valgerdur; Harris, Reuben S.			The Restriction of Zoonotic PERV Transmission by Human APOBEC3G	PLOS ONE			English	Article								The human APOBEC3G protein is an innate anti-viral factor that can dominantly inhibit the replication of some endogenous and exogenous retroviruses. The prospects of purposefully harnessing such an anti-viral defense are under investigation. Here, long-term co-culture experiments were used to show that porcine endogenous retrovirus (PERV) transmission from pig to human cells is reduced to nearly undetectable levels by expressing human APOBEC3G in virus-producing pig kidney cells. Inhibition occurred by a deamination-independent mechanism, likely after particle production but before the virus could immortalize by integration into human genomic DNA. PERV inhibition did not require the DNA cytosine deaminase activity of APOBEC3G and, correspondingly, APOBEC3G-attributable hypermutations were not detected. In contrast, over-expression of the sole endogenous APOBEC3 protein of pigs failed to interfere significantly with PERV transmission. Together, these data constitute the first proof-of-principle demonstration that APOBEC3 proteins can be used to fortify the innate anti-viral defenses of cells to prevent the zoonotic transmission of an endogenous retrovirus. These studies suggest that human APOBEC3G-transgenic pigs will provide safer, PERV-less xenotransplantation resources and that analogous cross-species APOBEC3-dependent restriction strategies may be useful for thwarting other endogenous as well as exogenous retrovirus infections.	[Jonsson, Stefan R.; LaRue, Rebecca S.; Stenglein, Mark D.; Harris, Reuben S.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Jonsson, Stefan R.; LaRue, Rebecca S.; Stenglein, Mark D.; Harris, Reuben S.] Univ Minnesota, Inst Mol Virol, Minneapolis, MN USA; [Jonsson, Stefan R.; LaRue, Rebecca S.; Stenglein, Mark D.; Fahrenkrug, Scott C.; Harris, Reuben S.] Univ Minnesota, Arnold & Mabel Beckman Ctr Transposon Res, Minneapolis, MN USA; [Jonsson, Stefan R.; Andresdottir, Valgerdur] Univ Iceland, Inst Expt Pathol, Reykjavik, Iceland; [Fahrenkrug, Scott C.] Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Iceland; University of Minnesota System; University of Minnesota Twin Cities	Harris, RS (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	rsh@umn.edu	Stenglein, Mark/E-3541-2017	Stenglein, Mark/0000-0002-0993-813X; Fahrenkrug, Scott/0000-0002-7176-6551	NIH; Spring Point Project; Icelandic Research Fund; Val Bjornson Icelandic Exchange Scholarship; 3M Science and Technology Graduate Fellowship; Searle Scholarship; University of Minnesota	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spring Point Project; Icelandic Research Fund; Val Bjornson Icelandic Exchange Scholarship; 3M Science and Technology Graduate Fellowship(3M); Searle Scholarship; University of Minnesota(University of Minnesota System)	Funding: These studies were funded in part by grants from the NIH to RSH and from Spring Point Project to SCF. SRJ was supported in part by the Icelandic Research Fund for Graduate Students and a 2004-2005 Val Bjornson Icelandic Exchange Scholarship. MDS was supported in part by a 3M Science and Technology Graduate Fellowship. RSH was supported in part by a Searle Scholarship and a University of Minnesota McKnight Land Grant Professorship. Sponsors did not contribute to the study design, to the collection, analysis and interpretation of data, to writing the paper or to the decision to submit it for publication.	AbuBakar S, 2004, EMERG INFECT DIS, V10, P2228, DOI 10.3201/eid1012.040452; Abudu A, 2006, CURR BIOL, V16, P1565, DOI 10.1016/j.cub.2006.06.055; Agarwal S, 2006, MOL THER, V14, P555, DOI 10.1016/j.ymthe.2006.03.025; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Chiu YL, 2006, TRENDS IMMUNOL, V27, P291, DOI 10.1016/j.it.2006.04.003; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Cooper DKC, 2002, ANNU REV MED, V53, P133, DOI 10.1146/annurev.med.53.082901.103900; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; Derse D, 2007, P NATL ACAD SCI USA, V104, P2915, DOI 10.1073/pnas.0609444104; Dieckhoff B, 2007, ARCH VIROL, V152, P629, DOI 10.1007/s00705-006-0868-y; Dorak M.T., 2006, REAL TIME PCR, P89; Dutko JA, 2005, CURR BIOL, V15, P661, DOI 10.1016/j.cub.2005.02.051; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Hering BJ, 2006, NAT MED, V12, P301, DOI 10.1038/nm1369; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Huthoff H, 2005, VIROLOGY, V334, P147, DOI 10.1016/j.virol.2005.01.038; Jonsson SR, 2006, NUCLEIC ACIDS RES, V34, P5683, DOI 10.1093/nar/gkl721; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kuwaki K, 2005, NAT MED, V11, P29, DOI 10.1038/nm1171; LeTissier P, 1997, NATURE, V389, P681, DOI 10.1038/39489; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Lipatov AS, 2004, J VIROL, V78, P8951, DOI 10.1128/JVI.78.17.8951-8959.2004; Lochelt M, 2005, P NATL ACAD SCI USA, V102, P7982, DOI 10.1073/pnas.0501445102; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Paradis K, 1999, SCIENCE, V285, P1236, DOI 10.1126/science.285.5431.1236; Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282; Russell RA, 2005, J VIROL, V79, P8724, DOI 10.1128/JVI.79.14.8724-8731.2005; Sasada A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-32; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schumacher AJ, 2005, P NATL ACAD SCI USA, V102, P9854, DOI 10.1073/pnas.0501694102; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Specke V, 2001, VIROLOGY, V285, P177, DOI 10.1006/viro.2001.0934; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Takeuchi Y, 2005, REV SCI TECH OIE, V24, P323, DOI 10.20506/rst.24.1.1575; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Weiss RA, 1999, SCIENCE, V285, P1221, DOI 10.1126/science.285.5431.1221; Wichroski MJ, 2006, PLOS PATHOG, V2, pe41, DOI DOI 10.1371/journal.ppat.0020041; Yamada K, 2005, NAT MED, V11, P32, DOI 10.1038/nm1172; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	57	49	50	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e893	10.1371/journal.pone.0000893	http://dx.doi.org/10.1371/journal.pone.0000893			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849022	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455600039
J	Verkhedkar, KD; Raman, K; Chandra, NR; Vishveshwara, S				Verkhedkar, Ketki D.; Raman, Karthik; Chandra, Nagasuma R.; Vishveshwara, Saraswathi			Metabolome Based Reaction Graphs of M-tuberculosis and M-leprae: A Comparative Network Analysis	PLOS ONE			English	Article							PROTEIN STRUCTURES; MYCOLIC ACIDS; SMALL WORLD; IDENTIFICATION; MODULARITY; RECONSTRUCTION; ORGANIZATION; CENTRALITY; BIOLOGY	Background. Several types of networks, such as transcriptional, metabolic or protein-protein interaction networks of various organisms have been constructed, that have provided a variety of insights into metabolism and regulation. Here, we seek to exploit the reaction-based networks of three organisms for comparative genomics. We use concepts from spectral graph theory to systematically determine how differences in basic metabolism of organisms are reflected at the systems level and in the overall topological structures of their metabolic networks. Methodology/Principal Findings. Metabolome-based reaction networks of Mycobacterium tuberculosis, Mycobacterium leprae and Escherichia coli have been constructed based on the KEGG LIGAND database, followed by graph spectral analysis of the network to identify hubs as well as the sub-clustering of reactions. The shortest and alternate paths in the reaction networks have also been examined. Sub-cluster profiling demonstrates that reactions of the mycolic acid pathway in mycobacteria form a tightly connected sub-cluster. Identification of hubs reveals reactions involving glutamate to be central to mycobacterial metabolism, and pyruvate to be at the centre of the E. coli metabolome. The analysis of shortest paths between reactions has revealed several paths that are shorter than well established pathways. Conclusions. We conclude that severe downsizing of the leprae genome has not significantly altered the global structure of its reaction network but has reduced the total number of alternate paths between its reactions while keeping the shortest paths between them intact. The hubs in the mycobacterial networks that are absent in the human metabolome can be explored as potential drug targets. This work demonstrates the usefulness of constructing metabolome based networks of organisms and the feasibility of their analyses through graph spectral methods. The insights obtained from such studies provide a broad overview of the similarities and differences between organisms, taking comparative genomics studies to a higher dimension.	[Verkhedkar, Ketki D.; Vishveshwara, Saraswathi] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Raman, Karthik; Chandra, Nagasuma R.] Indian Inst Sci, Bioinformat Ctr, Supercomp Educ & Res Ctr, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Vishveshwara, S (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	sv@mbu.iisc.ernet.in	Raman, Karthik/Q-5278-2019; Raman, Karthik/A-6459-2011	Raman, Karthik/0000-0002-9311-7093; Chandra, Nagasuma/0000-0002-9939-8439	computational genomics initiative at IISc; Department of Biotechnology, India; Indian Government agency	computational genomics initiative at IISc; Department of Biotechnology, India(Department of Biotechnology (DBT) India); Indian Government agency	Funding: Support was obtained from the computational genomics initiative at IISc, funded by Department of Biotechnology, India. This support was an academic research grant from an Indian Government agency, and no financial claims are associated with it.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barabasi A. L., 2002, FORMULA UNIVERSAL LA; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Becker SA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-8; Bilke S, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.036106; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Bu DB, 2003, NUCLEIC ACIDS RES, V31, P2443, DOI 10.1093/nar/gkg340; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Eisenberg E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.138701; Felix L, 2007, BIOMOL ENG, V24, P327, DOI 10.1016/j.bioeng.2007.02.008; Fell DA, 2000, NAT BIOTECHNOL, V18, P1121, DOI 10.1038/81025; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Gansner ER, 2000, SOFTWARE PRACT EXPER, V30, P1203, DOI 10.1002/1097-024X(200009)30:11<1203::AID-SPE338>3.0.CO;2-N; Goto S, 2002, NUCLEIC ACIDS RES, V30, P402, DOI 10.1093/nar/30.1.402; GROSS J, 1999, DISCRETE MATH ITS AP; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; HALL KM, 1970, MANAGE SCI, V17, P219, DOI 10.1287/mnsc.17.3.219; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Holme P, 2003, BIOINFORMATICS, V19, P532, DOI 10.1093/bioinformatics/btg033; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kanna N, 1999, J MOL BIOL, V292, P441, DOI 10.1006/jmbi.1999.3058; Kettner Carsten, 2007, In Silico Biology, V7, pS57; KIM TY, 2007, BIOTECHNOLO IN PRESS, DOI DOI 10.1002/BIT.21433; Krishnadev O, 2005, PROTEINS, V61, P152, DOI 10.1002/prot.20532; Kunin V, 2004, MOL BIOL EVOL, V21, P1171, DOI 10.1093/molbev/msh085; Liang Z, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-457; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Ma HW, 2003, BIOINFORMATICS, V19, P270, DOI 10.1093/bioinformatics/19.2.270; Ma HW, 2003, BIOINFORMATICS, V19, P1423, DOI 10.1093/bioinformatics/btg177; Papin JA, 2004, TRENDS BIOCHEM SCI, V29, P641, DOI 10.1016/j.tibs.2004.10.001; Park DU, 2005, BIOINFORMATICS, V21, P3234, DOI 10.1093/bioinformatics/bti512; Park J, 2001, Genome Inform, V12, P135; Patra SM, 2000, BIOPHYS CHEM, V84, P13, DOI 10.1016/S0301-4622(99)00134-9; Rahman SA, 2006, BIOINFORMATICS, V22, P1767, DOI 10.1093/bioinformatics/btl181; Raman K, 2005, PLOS COMPUT BIOL, V1, P349, DOI 10.1371/journal.pcbi.0010046; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sen TZ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-355; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sistla RK, 2005, PROTEINS, V59, P616, DOI 10.1002/prot.20444; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; van Helden J, 2002, E SCHERING RES FDN W, V38, P245; Vishveshwara S., 2002, J THEOR COMPUT CHEM, V1, P187, DOI DOI 10.1142/S0219633602000117; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Wolf YI, 2002, BIOESSAYS, V24, P105, DOI 10.1002/bies.10059; Wuchty S, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-8; Zhao J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-386	50	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e881	10.1371/journal.pone.0000881	http://dx.doi.org/10.1371/journal.pone.0000881			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849010	Green Submitted, gold, Green Published			2022-12-27	WOS:000207455600027
J	Kachhap, SK; Faith, D; Qian, DZ; Shabbeer, S; Galloway, NL; Pili, R; Denmeade, SR; DeMarzo, AM; Carducci, MA				Kachhap, Sushant K.; Faith, Dennis; Qian, David Z.; Shabbeer, Shabana; Galloway, Nathan L.; Pili, Roberto; Denmeade, Samuel R.; DeMarzo, Angelo M.; Carducci, Michael A.			The N-Myc Down Regulated Gene1 (NDRG1) Is a Rab4a Effector Involved in Vesicular Recycling of E-Cadherin	PLOS ONE			English	Article								Cell to cell adhesion is mediated by adhesion molecules present on the cell surface. Downregulation of molecules that form the adhesion complex is a characteristic of metastatic cancer cells. Downregulation of the N-myc down regulated gene1 (NDRG1) increases prostate and breast metastasis. The exact function of NDRG1 is not known. Here by using live cell confocal microscopy and in vitro reconstitution, we report that NDRG1 is involved in recycling the adhesion molecule E-cadherin thereby stabilizing it. Evidence is provided that NDRG1 recruits on recycling endosomes in the Trans Golgi network by binding to phosphotidylinositol 4-phosphate and interacts with membrane bound Rab4aGTPase. NDRG1 specifically interacts with constitutively active Rab4aQ67L mutant protein and not with GDP-bound Rab4aS22N mutant proving NDRG1 as a novel Rab4a effector. Transferrin recycling experiments reveals NDRG1 colocalizes with transferrin during the recycling phase. NDRG1 alters the kinetics of transferrin recycling in cells. NDRG1 knockdown cells show a delay in recycling transferrin, conversely NDRG1 overexpressing cells reveal an increase in rate of transferrin recycling. This novel finding of NDRG1 as a recycling protein involved with recycling of E-cadherin will aid in understanding NDRG1 role as a metastasis suppressor protein.	[Kachhap, Sushant K.; Faith, Dennis; Qian, David Z.; Shabbeer, Shabana; Galloway, Nathan L.; Pili, Roberto; Denmeade, Samuel R.; DeMarzo, Angelo M.; Carducci, Michael A.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Prostate Canc Program, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine	Kachhap, SK (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Prostate Canc Program, Baltimore, MD 21218 USA.	kachhsu@jhmi.edu	Galloway, Nathan/K-4843-2012; Qian, David Z/AAL-3441-2021; Carducci, Michael/R-8164-2019		Prostate Cancer Foundation; NCI SPORE [P50CA58236]; AEGON International Fellowship; NATIONAL CANCER INSTITUTE [P50CA058236] Funding Source: NIH RePORTER	Prostate Cancer Foundation; NCI SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AEGON International Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work is supported by the David Koch Fund which was provided by the Prostate Cancer Foundation, the Prostate Cancer Foundation and the NCI SPORE Grant P50CA58236. SKK is supported by the AEGON International Fellowship.	Agnantis NJ, 2004, IN VIVO, V18, P481; Angst E, 2006, BRIT J CANCER, V95, P307, DOI 10.1038/sj.bjc.6603256; Anitei M, 2006, CURR BIOL, V16, pR418, DOI 10.1016/j.cub.2006.05.010; Bandyopadhyay S, 2004, ONCOGENE, V23, P5675, DOI 10.1038/sj.onc.1207734; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Cangul H, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-27; CHOI SY, 2006, CELL DEATH DIFFER; Choudhury RR, 2005, BIOCHEM SOC SYMP, V72, P31, DOI 10.1042/bss0720031; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Chua MS, 2007, MODERN PATHOL, V20, P76, DOI 10.1038/modpathol.3800711; Elferink LA, 2005, METHOD ENZYMOL, V403, P732, DOI 10.1016/S0076-6879(05)03064-8; Faith D, 2005, PROSTATE, V65, P73, DOI 10.1002/pros.20258; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Guang RJ, 2000, CANCER RES, V60, P749; Hunter M, 2005, BIOCHEM BIOPH RES CO, V332, P982, DOI 10.1016/j.bbrc.2005.05.050; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; KOHN EC, 1991, PHARMACOL THERAPEUT, V52, P235, DOI 10.1016/0163-7258(91)90011-A; Kyuno J, 2003, BIOCHEM BIOPH RES CO, V309, P52, DOI 10.1016/S0006-291X(03)01522-5; Lachat P, 2002, HISTOCHEM CELL BIOL, V118, P399, DOI 10.1007/s00418-002-0460-9; Lazarescu E, 2006, GENE, V374, P77, DOI 10.1016/j.gene.2006.01.025; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; LIOTTA LA, 1988, BREAST CANCER RES TR, V11, P113, DOI 10.1007/BF01805835; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; McCaffrey MW, 2001, FEBS LETT, V495, P21, DOI 10.1016/S0014-5793(01)02359-6; Nishie A, 2001, CLIN CANCER RES, V7, P2145; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Perret E, 2005, CURR OPIN CELL BIOL, V17, P423, DOI 10.1016/j.ceb.2005.06.008; Piquemal D, 1999, BBA-MOL CELL RES, V1450, P364, DOI 10.1016/S0167-4889(99)00056-7; Polishchuk RS, 2006, TRAFFIC, V7, P1092, DOI 10.1111/j.1600-0854.2006.00453.x; Radhakrishna H, 1999, J CELL SCI, V112, P855; Rapaport D, 2006, TRAFFIC, V7, P52, DOI 10.1111/j.1600-0854.2005.00359.x; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; RINKERSCHAEFFER CW, 1993, CANCER METAST REV, V12, P3, DOI 10.1007/BF00689785; Sakai T, 1998, BIOCHEM BIOPH RES CO, V242, P151, DOI 10.1006/bbrc.1997.7577; Salnikow K, 1999, TOXICOL APPL PHARM, V160, P127, DOI 10.1006/taap.1999.8759; Shaw E, 2002, PROTEINS, V47, P163, DOI 10.1002/prot.10083; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; Taketomi Y, 2003, BIOCHEM BIOPH RES CO, V306, P339, DOI 10.1016/S0006-291X(03)00942-2; Taketomi Y, 2007, J IMMUNOL, V178, P7042, DOI 10.4049/jimmunol.178.11.7042; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Utleg AG, 2003, PROSTATE, V56, P150, DOI 10.1002/pros.10255; Wang XD, 2002, J IMMUNOL, V168, P4612, DOI 10.4049/jimmunol.168.9.4612; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	47	90	95	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e844	10.1371/journal.pone.0000844	http://dx.doi.org/10.1371/journal.pone.0000844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786215	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455500027
J	Wei, JN; Wang, LZ; Zhu, JW; Zhang, SF; Nandi, OI; Kang, L				Wei, Jianing; Wang, Lizhong; Zhu, Junwei; Zhang, Sufang; Nandi, Owi I.; Kang, Le			Plants Attract Parasitic Wasps to Defend Themselves against Insect Pests by Releasing Hexenol	PLOS ONE			English	Article							LIRIOMYZA-SATIVAE DIPTERA; INDUCED VOLATILES; NATURAL ENEMIES; ZEA-MAYS; ODORS; LEAFMINER; RESPONSES; LOCATION; INDUCE; RBCL	Background. Plant volatiles play an important role in defending plants against insect attacks by attracting their natural enemies. For example, green leaf volatiles (GLVs) and terpenoids emitted from herbivore-damaged plants were found to be important in the host location of parasitic wasps. However, evidence of the functional roles and mechanisms of these semiochemicals from a system of multiple plants in prey location by the parasitoid is limited. Little is known about the potential evolutionary trends between herbivore-induced host plant volatiles and the host location of their parasitoids. Methodology/Principal Findings. The present study includes hierarchical cluster analyses of plant volatile profiles from seven families of host and non-host plants of pea leafminer, Liriomyza huidobrensis, and behavioral responses of a naive parasitic wasp, Opius dissitus, to some principal volatile compounds. Here we show that plants can effectively pull wasps, O. dissitus, towards them by releasing a universally induced compound, (Z)-3-hexenol, and potentially keep these plants safe from parasitic assaults by leafminer pests, L. huidobrensis. Specifically, we found that volatile profiles from healthy plants revealed a partly phylogenetic signal, while the inducible compounds of the infested-plants did not result from the fact that the induced plant volatiles dominate most of the volatile blends of the host and non-host plants of the leafminer pests. We further show that the parasitoids are capable of distinguishing the damaged host plant from the non-host plant of the leafminers. Conclusions/Significance. Our results suggest that, as the most passive scenario of plant involvement, leafminers and mechanical damages evoke similar semio-chemicals. Using ubiquitous compounds, such as hexenol, for host location by general parasitoids could be an adaptation of the most conservative evolution of tritrophic interaction. Although for this, other compounds may be used to improve the precision of the host location by the parasitoids.	[Wei, Jianing; Wang, Lizhong; Zhang, Sufang; Kang, Le] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Zhu, Junwei] Iowa State Univ, Dept Entomol, Iowa City, IA USA; [Nandi, Owi I.] Inst Systemat Bot, Zurich, Switzerland	Chinese Academy of Sciences; Institute of Zoology, CAS; Iowa State University	Kang, L (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	lkang@ioz.ac.cn	Kang, Le/ABD-1116-2022; Wei, Jianing/L-7575-2019	Kang, Le/0000-0003-4262-2329; Wei, Jianing/0000-0002-8517-2164; Zhu, Junwei/0000-0001-9846-9656	National Basic Research Program of China [2006CB102006]; Chinese Academy of Sciences; National Nature Science Foundation of China [30670356, 30621003]	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by the National Basic Research Program of China (973 Program) (No. 2006CB102006), the Chinese Academy of Sciences (Project No: KSCX2-YW-N-006), and the National Nature Science Foundation of China (30670356 and 30621003).	*AM CHEM SOC, 2007, CHEM ABSTR DAT; Arimura G, 2005, BBA-MOL CELL BIOL L, V1734, P91, DOI 10.1016/j.bbalip.2005.03.001; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; CHASE MW, 1993, ANN MO BOT GARD, V80, P528, DOI 10.2307/2399846; D'Alessandro M, 2005, CHEM SENSES, V30, P739, DOI 10.1093/chemse/bji066; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DICKE M, 1990, J CHEM ECOL, V16, P3091, DOI 10.1007/BF00979614; Dicke M, 1999, ENTOMOL EXP APPL, V91, P131, DOI 10.1023/A:1003608019062; Dicke M, 1999, J CHEM ECOL, V25, P1907, DOI 10.1023/A:1020942102181; Dicke Marcel, 1999, P62; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Gouinguene S, 2005, J CHEM ECOL, V31, P1023, DOI 10.1007/s10886-005-4245-1; HATANAKA A, 1993, PHYTOCHEMISTRY, V34, P1201, DOI 10.1016/0031-9422(91)80003-J; HEGNAUER R, 1966, CHEMOTAXONOMIE PFLAN, V1; Hoballah ME, 2005, J CHEM ECOL, V31, P2003, DOI 10.1007/s10886-005-6074-7; Hoballah MEF, 2002, J CHEM ECOL, V28, P951, DOI 10.1023/A:1015253600083; HOPKE J, 1994, FEBS LETT, V352, P146, DOI 10.1016/0014-5793(94)00948-1; KANG L, 1996, ECOLOGY SUSTAINABLE; Kappers IF, 2005, SCIENCE, V309, P2070, DOI 10.1126/science.1116232; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; LEWIS WJ, 1990, J CHEM ECOL, V16, P3067, DOI 10.1007/BF00979613; Liscombe DK, 2005, PHYTOCHEMISTRY, V66, P1374, DOI 10.1016/j.phytochem.2005.04.029; Mumm R, 2005, CHEM SENSES, V30, P337, DOI 10.1093/chemse/bji028; Nandi OI, 1998, ANN MO BOT GARD, V85, P137, DOI 10.2307/2992003; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; PARRELLA MP, 1987, ANNU REV ENTOMOL, V32, P201, DOI 10.1146/annurev.en.32.010187.001221; Schnee C, 2006, P NATL ACAD SCI USA, V103, P1129, DOI 10.1073/pnas.0508027103; Shiojiri K, 2006, PLOS BIOL, V4, P1044, DOI 10.1371/journal.pbio.0040164; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI 10.1006/bojl.2000.0380; Spencer K. A., 1990, SERIES ENTOMOLOGICA, V45, DOI 10.2307/4110790; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN, P62; Turlings TCJ, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P21, DOI 10.1017/CBO9780511542664.003; TURLINGS TCJ, 1995, P NATL ACAD SCI USA, V92, P4169, DOI 10.1073/pnas.92.10.4169; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Van Den Boom CEM, 2004, J CHEM ECOL, V30, P69, DOI 10.1023/B:JOEC.0000013183.72915.99; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Wei JN, 2006, CHEM SENSES, V31, P467, DOI 10.1093/chemse/bjj051; Wei JN, 2006, PLANTA, V224, P279, DOI 10.1007/s00425-005-0212-x; Zhao YX, 2002, EUR J ENTOMOL, V99, P445, DOI 10.14411/eje.2002.056; Zhao YX, 2002, PHYSIOL ENTOMOL, V27, P103, DOI 10.1046/j.1365-3032.2002.00275.x; Zhu JW, 2005, J CHEM ECOL, V31, P1733, DOI 10.1007/s10886-005-5923-8	42	67	77	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e852	10.1371/journal.pone.0000852	http://dx.doi.org/10.1371/journal.pone.0000852			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786223	gold, Green Submitted, Green Published			2022-12-27	WOS:000207455500035
J	Miguel, RN; Wong, J; Westoll, JF; Brooks, HJ; O'Neill, LAJ; Gay, NJ; Bryant, CE; Monie, TP				Miguel, Ricardo Nunez; Wong, Joyce; Westoll, Julian F.; Brooks, Heather J.; O'Neill, Luke A. J.; Gay, Nicholas J.; Bryant, Clare E.; Monie, Tom P.			A Dimer of the Toll-Like Receptor 4 Cytoplasmic Domain Provides a Specific Scaffold for the Recruitment of Signalling Adaptor Proteins	PLOS ONE			English	Article								The Toll-like receptor 4 (TLR4) is a class I transmembrane receptor expressed on the surface of immune system cells. TLR4 is activated by exposure to lipopolysaccharides derived from the outer membrane of Gram negative bacteria and forms part of the innate immune response in mammals. Like other class 1 receptors, TLR4 is activated by ligand induced dimerization, and recent studies suggest that this causes concerted conformational changes in the receptor leading to self association of the cytoplasmic Toll/Interleukin 1 receptor (TIR) signalling domain. This homodimerization event is proposed to provide a new scaffold that is able to bind downstream signalling adaptor proteins. TLR4 uses two different sets of adaptors; TRAM and TRIF, and Mal and MyD88. These adaptor pairs couple two distinct signalling pathways leading to the activation of interferon response factor 3 (IRF-3) and nuclear factor kappa B (NF kappa B) respectively. In this paper we have generated a structural model of the TLR4 TIR dimer and used molecular docking to probe for potential sites of interaction between the receptor homodimer and the adaptor molecules. Remarkably, both the Mal and TRAM adaptors are strongly predicted to bind at two symmetry-related sites at the homodimer interface. This model of TLR4 activation is supported by extensive functional studies involving site directed mutagenesis, inhibition by cell permeable peptides and stable protein phosphorylation of receptor and adaptor TIR domains. Our results also suggest a molecular mechanism for two recent findings, the caspase 1 dependence of Mal signalling and the protective effects conferred by the Mal polymorphism Ser180Leu.	[Miguel, Ricardo Nunez; Wong, Joyce; Westoll, Julian F.; Gay, Nicholas J.; Monie, Tom P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Brooks, Heather J.; Bryant, Clare E.] Univ Cambridge, Dept Vet Med, Cambridge, England; [O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland	University of Cambridge; University of Cambridge; Trinity College Dublin	Gay, NJ (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	njg11@cam.ac.uk; ceb27@cam.ac.uk; tpm22@cam.ac.uk	Miguel, Ricardo Nunez/F-4412-2010; Monie, Tom/H-4662-2019	Monie, Tom/0000-0003-4097-1680; O'Neill, Luke/0000-0002-4333-2748	UK Medical Research Council and Biotechnology; Biological Sciences Research Council; MRC [G0400007] Funding Source: UKRI; Medical Research Council [G0400007] Funding Source: researchfish	UK Medical Research Council and Biotechnology(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants to NJG from the UK Medical Research Council and Biotechnology and Biological Sciences Research Council.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Casal E, 2006, BIOCHEMISTRY-US, V45, P12917, DOI 10.1021/bi060717k; Cheng TMK, 2007, PROTEINS, V68, P503, DOI 10.1002/prot.21419; de Bakker PIW, 2001, BIOINFORMATICS, V17, P748, DOI 10.1093/bioinformatics/17.8.748; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Hunter P, 2006, EMBO REP, V7, P667, DOI 10.1038/sj.embor.7400742; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lin RT, 1999, MOL CELL BIOL, V19, P959; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Miguel RN, 2004, BIOINFORMATICS, V20, P2380, DOI 10.1093/bioinformatics/bth255; Miyake K, 2004, TRENDS MICROBIOL, V12, P186, DOI 10.1016/j.tim.2004.02.009; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; RAETZ CRH, 1991, FASEB J, V5, P2652, DOI 10.1096/fasebj.5.12.1916089; RICHMOND TJ, 1984, J MOL BIOL, V178, P63, DOI 10.1016/0022-2836(84)90231-6; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Ronni T, 2003, MOL CELL BIOL, V23, P2543, DOI 10.1128/MCB.23.7.2543-2555.2003; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Toshchakov VY, 2007, J IMMUNOL, V178, P2655, DOI 10.4049/jimmunol.178.5.2655; Toshchakov VU, 2005, J IMMUNOL, V175, P494, DOI 10.4049/jimmunol.175.1.494; Vakser IA, 1997, PROTEINS, P226; Weber ANR, 2005, J BIOL CHEM, V280, P22793, DOI 10.1074/jbc.M502074200; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600	45	154	156	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e788	10.1371/journal.pone.0000788	http://dx.doi.org/10.1371/journal.pone.0000788			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726518	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455400005
J	Alberts, R; Terpstra, P; Li, Y; Breitling, R; Nap, JP; Jansen, RC				Alberts, Rudi; Terpstra, Peter; Li, Yang; Breitling, Rainer; Nap, Jan-Peter; Jansen, Ritsert C.			Sequence Polymorphisms Cause Many False cis eQTLs	PLOS ONE			English	Article							GENE-EXPRESSION; MODEL; GENOMICS	Many investigations have reported the successful mapping of quantitative trait loci (QTLs) for gene expression phenotypes (eQTLs). Local eQTLs, where expression phenotypes map to the genes themselves, are of especially great interest, because they are direct candidates for previously mapped physiological QTLs. Here we show that many mapped local eQTLs in genetical genomics experiments do not reflect actual expression differences caused by sequence polymorphisms in cis-acting factors changing mRNA levels. Instead they indicate hybridization differences caused by sequence polymorphisms in the mRNA region that is targeted by the microarray probes. Many such polymorphisms can be detected by a sensitive and novel statistical approach that takes the individual probe signals into account. Applying this approach to recent mouse and human eQTL data, we demonstrate that indeed many local eQTLs are falsely reported as "cis-acting'' or "cis'' and can be successfully detected and eliminated with this approach.	[Alberts, Rudi; Li, Yang; Breitling, Rainer; Nap, Jan-Peter; Jansen, Ritsert C.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen Bioinformat Ctr, Haren, Netherlands; [Terpstra, Peter; Jansen, Ritsert C.] Univ Groningen, Univ Med Ctr Groningen, Groningen Bioinformat Ctr, Groningen, Netherlands; [Nap, Jan-Peter] Univ Appl Sci, Hanze Univ Groningen, Inst Life Sci & Technol, Bioinformat Expertise Ctr, Groningen, Netherlands	University of Groningen; University of Groningen	Jansen, RC (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen Bioinformat Ctr, Haren, Netherlands.	r.c.jansen@rug.nl	Jansen, Ritsert C/C-1160-2013; Li, Yang/HGT-8446-2022	Jansen, Ritsert C/0000-0003-2977-9110; Li, Yang/0000-0003-4022-7341; Breitling, Rainer/0000-0001-7173-0922	Netherlands Organisation for Scientific Research	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	RA, RB, YL, and JPN received funding for this work from The Netherlands Organisation for Scientific Research.	Alberts R, 2005, GENETICS, V171, P1437, DOI 10.1534/genetics.105.045930; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Gilad Y, 2005, GENOME RES, V15, P674, DOI 10.1101/gr.3335705; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Hsieh WP, 2003, GENETICS, V165, P747; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jansen RC, 2004, TRENDS GENET, V20, P223, DOI 10.1016/j.tig.2004.03.002; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Peirce JL, 2006, MAMM GENOME, V17, P643, DOI 10.1007/s00335-005-0187-8; Petretto E, 2006, PLOS GENET, V2, P1625, DOI 10.1371/journal.pgen.0020172; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964	17	107	108	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2007	2	7							e622	10.1371/journal.pone.0000622	http://dx.doi.org/10.1371/journal.pone.0000622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GI	17637838	Green Published, gold, Green Submitted			2022-12-27	WOS:000207452100012
J	Miles, J; Mitchell, JA; Chakalova, L; Goyenechea, B; Osborne, CS; O'Neill, L; Tanimoto, K; Engel, JD; Fraser, P				Miles, Joanne; Mitchell, Jennifer A.; Chakalova, Lyubomira; Goyenechea, Beatriz; Osborne, Cameron S.; O'Neill, Laura; Tanimoto, Keiji; Engel, James Douglas; Fraser, Peter			Intergenic Transcription, Cell-Cycle and the Developmentally Regulated Epigenetic Profile of the Human Beta-Globin Locus	PLOS ONE			English	Article								Several lines of evidence have established strong links between transcriptional activity and specific post-translation modifications of histones. Here we show using RNA FISH that in erythroid cells, intergenic transcription in the human beta-globin locus occurs over a region of greater than 250 kb including several genes in the nearby olfactory receptor gene cluster. This entire region is transcribed during S phase of the cell cycle. However, within this region there are similar to 20 kb sub-domains of high intergenic transcription that occurs outside of S phase. These sub-domains are developmentally regulated and enriched with high levels of active modifications primarily to histone H3. The sub-domains correspond to the beta-globin locus control region, which is active at all developmental stages in erythroid cells, and the region flanking the developmentally regulated, active globin genes. These results correlate high levels of non-S phase intergenic transcription with domain-wide active histone modifications to histone H3.	[Miles, Joanne; Mitchell, Jennifer A.; Chakalova, Lyubomira; Goyenechea, Beatriz; Osborne, Cameron S.; Fraser, Peter] Babraham Inst, Lab Chromatin & Gene Express, Cambridge, England; [O'Neill, Laura] Univ Birmingham, Inst Biomed Res, Sch Med, Birmingham, W Midlands, England; [Tanimoto, Keiji; Engel, James Douglas] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Birmingham; University of Michigan System; University of Michigan	Fraser, P (corresponding author), Babraham Inst, Lab Chromatin & Gene Express, Babraham Res Campus, Cambridge, England.	peter.fraser@bbsrc.ac.uk	Chakalova, Lyubomira/C-6810-2012; Tanimoto, Keiji/B-2600-2014; Osborne, Cameron/N-1398-2017	Osborne, Cameron/0000-0003-4126-2499; Tanimoto, Keiji/0000-0003-1971-6546; Fraser, Peter/0000-0002-0041-1227; Mitchell, Jennifer/0000-0002-7147-4604	Medical Research Council; Biotechnology and Biological Sciences Research Council UK; MRC [G117/530] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/00001151] Funding Source: researchfish; Medical Research Council [G117/530] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council and the Biotechnology and Biological Sciences Research Council UK.	Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Bulger M, 2003, MOL CELL BIOL, V23, P5234, DOI 10.1128/MCB.23.15.5234-5244.2003; Calzolari R, 1999, EMBO J, V18, P949, DOI 10.1093/emboj/18.4.949; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chakalova L, 2005, BLOOD, V105, P2154, DOI 10.1182/blood-2003-11-4069; Chakalova L, 2004, METHOD ENZYMOL, V375, P479; CHAKALOVA L, 2005, NATURE REV IN PRESS; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; DICKERMAN HW, 1976, ARCH BIOCHEM BIOPHYS, V177, P1, DOI 10.1016/0003-9861(76)90408-2; Drewell RA, 2002, P NATL ACAD SCI USA, V99, P16853, DOI 10.1073/pnas.222671199; FIBACH E, 1989, BLOOD, V73, P100; FIBACH E, 1990, AM J HEMATOL, V35, P151, DOI 10.1002/ajh.2830350303; Forsberg EC, 2000, P NATL ACAD SCI USA, V97, P14494, DOI 10.1073/pnas.97.26.14494; FRASER P, 1993, GENE DEV, V7, P106, DOI 10.1101/gad.7.1.106; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Haussecker D, 2005, MOL CELL BIOL, V25, P9724, DOI 10.1128/MCB.25.21.9724-9733.2005; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Ho YG, 2006, MOL CELL, V23, P365, DOI 10.1016/j.molcel.2006.05.041; HUMBERT C, 1992, J CELL SCI, V103, P97; Jones EA, 2005, J IMMUNOL, V175, P7437, DOI 10.4049/jimmunol.175.11.7437; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kim A, 2004, P NATL ACAD SCI USA, V101, P7028, DOI 10.1073/pnas.0307985101; Leach KM, 2001, MOL CELL BIOL, V21, P2629, DOI 10.1128/MCB.21.8.2629-2640.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long QM, 1998, GENOMICS, V54, P542, DOI 10.1006/geno.1998.5608; Masternak K, 2003, NAT IMMUNOL, V4, P132, DOI 10.1038/ni883; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Peterson KR, 1996, P NATL ACAD SCI USA, V93, P6605, DOI 10.1073/pnas.93.13.6605; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Rogan DF, 2004, P NATL ACAD SCI USA, V101, P2446, DOI 10.1073/pnas.0308327100; Routledge SJE, 2002, J MOL BIOL, V323, P601, DOI 10.1016/S0022-2836(02)01011-2; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schubeler D, 2000, GENE DEV, V14, P940; Schubeler D, 2001, P NATL ACAD SCI USA, V98, P11432, DOI 10.1073/pnas.201394698; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Tanimoto K, 1999, NATURE, V398, P344, DOI 10.1038/18698; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; TUAN D, 1992, P NATL ACAD SCI USA, V89, P11219, DOI 10.1073/pnas.89.23.11219; WANSINK DG, 1994, J CELL SCI, V107, P1449; Xiang P, 2006, BIOCHEM BIOPH RES CO, V344, P623, DOI 10.1016/j.bbrc.2006.03.189	49	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2007	2	7							e630	10.1371/journal.pone.0000630	http://dx.doi.org/10.1371/journal.pone.0000630			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GI	17637845	Green Published, gold			2022-12-27	WOS:000207452100019
J	Sakarya, O; Armstrong, KA; Adamska, M; Adamski, M; Wang, IF; Tidor, B; Degnan, BM; Oakley, TH; Kosik, KS				Sakarya, Onur; Armstrong, Kathryn A.; Adamska, Maja; Adamski, Marcin; Wang, I-Fan; Tidor, Bruce; Degnan, Bernard M.; Oakley, Todd H.; Kosik, Kenneth S.			A Post-Synaptic Scaffold at the Origin of the Animal Kingdom	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PROTEOMIC ANALYSIS; GENE STRUCTURES; NERVOUS-SYSTEM; PROTEIN; BINDING; GENOME; CONDUCTION; ALGORITHM; INFERENCE	Background. The evolution of complex sub-cellular structures such as the synapse requires the assembly of multiple proteins, each conferring added functionality to the integrated structure. Tracking the early evolution of synapses has not been possible without genomic information from the earliest branching animals. As the closest extant relatives to the Eumetazoa, Porifera (sponges) represent a pivotal group for understanding the evolution of nervous systems, because sponges lack neurons with clearly recognizable synapses, in contrast to eumetazoan animals. Methodology/Principal Findings. We show that the genome of the demosponge Amphimedon queenslandica possesses a nearly complete set of post-synaptic protein homologs whose conserved interaction motifs suggest assembly into a complex structure. In the critical synaptic scaffold gene, dlg, residues that make hydrogen bonds and van der Waals interactions with the PDZ ligand are 100% conserved between sponge and human, as is the motif organization of the scaffolds. Expression in Amphimedon of multiple post-synaptic gene homologs in larval flask cells further supports the existence of an assembled structure. Among the few post-synaptic genes absent from Amphimedon, but present in Eumetazoa, are receptor genes including the entire ionotropic glutamate receptor family. Conclusions/Significance. Highly conserved protein interaction motifs and co-expression in sponges of multiple proteins whose homologs interact in eumetazoan synapses indicate that a complex protein scaffold was present at the origin of animals, perhaps predating nervous systems. A relatively small number of crucial innovations to this pre-existing structure may represent the founding changes that led to a post-synaptic element.	[Sakarya, Onur; Wang, I-Fan; Kosik, Kenneth S.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Sakarya, Onur; Kosik, Kenneth S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Sakarya, Onur] Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA; [Armstrong, Kathryn A.; Tidor, Bruce] MIT, Biol Engn Div, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Adamska, Maja; Adamski, Marcin; Degnan, Bernard M.] Univ Queensland, Sch Integrat Biol, Brisbane, Qld, Australia; [Oakley, Todd H.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Massachusetts Institute of Technology (MIT); University of Queensland; University of California System; University of California Santa Barbara	Kosik, KS (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA.	kosik@lifesci.ucsb.edu	Adamska, Maja/M-4128-2014; Oakley, Todd/A-5419-2008; Adamska, Maja/L-3306-2015	Oakley, Todd/0000-0002-4478-915X; Degnan, Bernard/0000-0001-7573-8518; /0000-0002-3320-3969; Wang, I-Fan/0000-0002-6856-0691; Adamska, Maja/0000-0002-4223-8450	Australian Research Council; US Department of Energy Joint Genome Institute	Australian Research Council(Australian Research Council); US Department of Energy Joint Genome Institute(United States Department of Energy (DOE))	This work was supported by Australian Research Council grants to B. M. D.; We gratefully acknowledge the significant contribution and support of The US Department of Energy Joint Genome Institute in the production of Amphimedon (Reniera) and Nematostella genomic and EST sequences used in this study through the Community Sequencing Program. The following individuals contributed helpful comments: Boris Shraiman, Yoram Barak, Ilya Feit, James Weaver, Michi Izumi, Dan Morse, Ambuj Singh, Omer Egecioglu, Eduardo Orias, Sally Leys, Sira Sriswasdi, and Gus Gurely. We thank Daniel Rokhsar and Martindale for making Amphimedom (Reniera) and Nematostella genomic and EST sequences available.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BORCHIELLINI C, 2001, J EVOLUTION BIOL, P171; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUNGER AT, 1988, PROTEINS, V4, P148, DOI 10.1002/prot.340040208; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CavalierSmith T, 1996, CAN J ZOOL, V74, P2031, DOI 10.1139/z96-231; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; Erpenbeck D, 2007, MOL BIOL EVOL, V24, P19, DOI 10.1093/molbev/msl154; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Grant SGN, 2006, BIOCHEM SOC T, V34, P59, DOI 10.1042/BST0340059; Grembecka J, 2006, BIOCHEMISTRY-US, V45, P3674, DOI 10.1021/bi052225y; Grimmelikhuijzen C.J.P., 1995, Experientia Supplementum (Basel), V72, P7; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hooper J, 2002, SYSTEMA PORIFERA GUI, V2; Hooper J. N. A., 2002, SYSTEMA PORIFERA GUI, V1-2; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Larroux C, 2006, EVOL DEV, V8, P150, DOI 10.1111/j.1525-142X.2006.00086.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWN ID, 1981, SCIENCE, V211, P1169, DOI 10.1126/science.7466387; Leys SP, 1999, J EXP BIOL, V202, P1139; Leys SP, 2001, BIOL BULL-US, V201, P323, DOI 10.2307/1543611; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Rokas A, 2003, EVOL DEV, V5, P346, DOI 10.1046/j.1525-142X.2003.03042.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Sonnhammer ELL, 2002, TRENDS GENET, V18, P619, DOI 10.1016/S0168-9525(02)02793-2; Sullivan JC, 2006, NUCLEIC ACIDS RES, V34, pD495, DOI 10.1093/nar/gkj020; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TURNBULL AP, 2001, CRYSTAL STR IN PRESS; VONOSSOWSKI I, 2002, CRYSTAL STR IN PRESS; Wang XJ, 2007, MOL BIOL EVOL, V24, P363, DOI 10.1093/molbev/msl167; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	52	185	188	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e506	10.1371/journal.pone.0000506	http://dx.doi.org/10.1371/journal.pone.0000506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551586	Green Submitted, gold, Green Published			2022-12-27	WOS:000207451500015
J	Sadis, C; Teske, G; Stokman, G; Kubjak, C; Claessen, N; Moore, F; Loi, P; Diallo, B; Barvais, L; Goldman, M; Florquin, S; Le Moine, A				Sadis, Claude; Teske, Gwen; Stokman, Geurt; Kubjak, Carole; Claessen, Nike; Moore, Fabrice; Loi, Patrizia; Diallo, Bilo; Barvais, Luc; Goldman, Michel; Florquin, Sandrine; Le Moine, Alain			Nicotine Protects Kidney from Renal Ischemia/Reperfusion Injury through the Cholinergic Anti-Inflammatory Pathway	PLOS ONE			English	Article								Kidney ischemia/reperfusion injury (I/R) is characterized by renal dysfunction and tubular damages resulting from an early activation of innate immunity. Recently, nicotine administration has been shown to be a powerful inhibitor of a variety of innate immune responses, including LPS-induced toxaemia. This cholinergic anti-inflammatory pathway acts via the alpha 7 nicotinic acetylcholine receptor (alpha 7nAChR). Herein, we tested the potential protective effect of nicotine administration in a mouse model of renal I/R injury induced by bilateral clamping of kidney arteries. Renal function, tubular damages and inflammatory response were compared between control animals and mice receiving nicotine at the time of ischemia. Nicotine pretreatment protected mice from renal dysfunction in a dose-dependent manner and through the alpha 7nAChR, as attested by the absence of protection in alpha 7nAChR-deficient mice. Additionally, nicotine significantly reduced tubular damages, prevented neutrophil infiltration and decreased productions of the CXC-chemokine KC, TNF-alpha and the proinflammatory high-mobility group box 1 protein. Reduced tubular damage in nicotine pre-treated mice was associated with a decrease in tubular cell apoptosis and proliferative response as attested by the reduction of caspase-3 and Ki67 positive cells, respectively. All together, these data highlight that nicotine exerts a protective anti-inflammatory effect during kidney I/R through the cholinergic alpha 7nAChR pathway. In addition, this could provide an opportunity to overcome the effect of surgical cholinergic denervation during kidney transplantation.	[Sadis, Claude; Kubjak, Carole; Moore, Fabrice; Loi, Patrizia; Goldman, Michel; Le Moine, Alain] Univ Libre Bruxelles, Inst Med Immunol, Gosselies, Belgium; [Teske, Gwen; Stokman, Geurt; Claessen, Nike; Florquin, Sandrine] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Sadis, Claude; Barvais, Luc] Univ Libre Bruxelles, Dept Anesthesiol, Erasme Hosp, Brussels, Belgium; [Diallo, Bilo] Biovallee, Gosselies, Belgium	Universite Libre de Bruxelles; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Le Moine, A (corresponding author), Univ Libre Bruxelles, Inst Med Immunol, Gosselies, Belgium.	alemoine@ulb.ac.be	Florquin, Sandrine/B-8242-2012		Walloon Region; FNRS-Belgium; GlaxoSmithKline Biologicals (Rixensart, Belgium)	Walloon Region; FNRS-Belgium(Fonds de la Recherche Scientifique - FNRS); GlaxoSmithKline Biologicals (Rixensart, Belgium)(GlaxoSmithKline)	C.S. is a research fellow at the Fondation Erasme. A.L. is a Research Associate of the FNRS-Belgium. This work was funded by research grants of the Walloon Region and the FNRS-Belgium. The Institute for Medical Immunology is supported by GlaxoSmithKline Biologicals (Rixensart, Belgium) and the government of the Walloon Region.	Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Boros P, 2006, AM J TRANSPLANT, V6, P652, DOI 10.1111/j.1600-6143.2005.01228.x; Crockett ET, 2006, BMC CLIN PATHOL, V6, DOI 10.1186/1472-6890-6-3; Daemen MARC, 2001, TRANSPLANTATION, V71, P1007; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Gill N, 2005, CHEST, V128, P2847, DOI 10.1378/chest.128.4.2847; Izuishi K, 2006, J IMMUNOL, V176, P7154, DOI 10.4049/jimmunol.176.12.7154; Joosten SA, 2005, KIDNEY INT, V68, P1, DOI 10.1111/j.1523-1755.2005.00376.x; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Lieberthal W, 2000, AM J PHYSIOL-RENAL, V278, pF1, DOI 10.1152/ajprenal.2000.278.1.F1; Lien YHH, 2003, LIFE SCI, V74, P543, DOI 10.1016/j.lfs.2003.08.001; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mai HQ, 2003, J BIOL CHEM, V278, P1886, DOI 10.1074/jbc.M209044200; Metz CN, 2005, NAT IMMUNOL, V6, P756, DOI 10.1038/ni0805-756; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Rouschop KMA, 2005, J AM SOC NEPHROL, V16, P2034, DOI 10.1681/ASN.2005010054; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; Sener G, 2005, PHARMACOLOGY, V74, P37, DOI 10.1159/000083245; Serobyan N, 2005, BRIT J HAEMATOL, V129, P257, DOI 10.1111/j.1365-2141.2005.05446.x; Thomas GAO, 2005, NAT CLIN PRACT GASTR, V2, P536, DOI 10.1038/ncpgasthep0316; Toborek M, 2007, J CELL BIOCHEM, V100, P279, DOI 10.1002/jcb.21013; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; van Westerloo DJ, 2005, J INFECT DIS, V191, P2138, DOI 10.1086/430323; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; YANG D, 2006, J LEUKOC BIOL; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82	31	106	117	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2007	2	5							e469	10.1371/journal.pone.0000469	http://dx.doi.org/10.1371/journal.pone.0000469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DZ	17520028	Green Published, gold, Green Submitted			2022-12-27	WOS:000207446000017
J	Hou, W; Yap, JSF; Wu, S; Liu, T; Cheverud, JM; Wu, RL				Hou, Wei; Yap, John Stephen F.; Wu, Song; Liu, Tian; Cheverud, James M.; Wu, Rongling			Haplotyping a Quantitative Trait with a High-Density Map in Experimental Crosses	PLOS ONE			English	Article								Background. The ultimate goal of genetic mapping of quantitative trait loci (QTL) is the positional cloning of genes involved in any agriculturally or medically important phenotype. However, only a small portion (<= 1%) of the QTL detected have been characterized at the molecular level, despite the report of hundreds of thousands of QTL for different traits and populations. Methods/Results. We develop a statistical model for detecting and characterizing the nucleotide structure and organization of haplotypes that underlie QTL responsible for a quantitative trait in an F-2 pedigree. The discovery of such haplotypes by the new model will facilitate the molecular cloning of a QTL. Our model is founded on population genetic properties of genes that are segregating in a pedigree, constructed with the mixture-based maximum likelihood context and implemented with the EM algorithm. The closed forms have been derived to estimate the linkage and linkage disequilibria among different molecular markers, such as single nucleotide polymorphisms, and quantitative genetic effects of haplotypes constructed by non-alleles of these markers. Results from the analysis of a real example in mouse have validated the usefulness and utilization of the model proposed. Conclusion. The model is flexible to be extended to model a complex network of genetic regulation that includes the interactions between different haplotypes and between haplotypes and environments.	[Yap, John Stephen F.; Wu, Song; Liu, Tian; Wu, Rongling] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [Hou, Wei] Univ Florida, Dept Epidemiol & Hlth Policy Res, Gainesville, FL 32611 USA; [Cheverud, James M.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Washington University (WUSTL)	Wu, RL (corresponding author), Univ Florida, Dept Stat, Gainesville, FL 32611 USA.	rwu@mail.ifas.ufl.edu	hou, wei/GWM-4800-2022		NSF [0540745]	NSF(National Science Foundation (NSF))	The preparation of this manuscript is supported by NSF grant (0540745) to RW.	Bader JS, 2001, PHARMACOGENOMICS, V2, P11, DOI 10.1517/14622416.2.1.11; Burnham K. P., 1998, MODEL SELECTION INFE; CHURCHILL GA, 1994, GENETICS, V138, P963; Eyheramendy S, 2007, GENOME RES, V17, P88, DOI 10.1101/gr.5675406; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; JANSEN RC, 1994, GENETICS, V136, P1447; Judson R, 2000, Pharmacogenomics, V1, P15, DOI 10.1517/14622416.1.1.15; Kao CH, 1999, GENETICS, V152, P1203; LANDER ES, 1989, GENETICS, V121, P185; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Lin M, 2006, CURR GENOMICS, V7, P59, DOI 10.2174/138920206776389775; Lou XY, 2003, GENETICS, V163, P1533; LOUIS TA, 1982, J ROY STAT SOC B MET, V44, P226; Lynch M., 1998, GENETICS ANAL QUANTI; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Sebastiani P, 2003, P NATL ACAD SCI USA, V100, P9900, DOI 10.1073/pnas.1633613100; Tian L, 2004, GENETICS, V168, P503, DOI 10.1534/genetics.104.029603; Vaughn TT, 1999, GENET RES, V74, P313, DOI 10.1017/S0016672399004103; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang K, 2002, P NATL ACAD SCI USA, V99, P7335, DOI 10.1073/pnas.102186799	23	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e732	10.1371/journal.pone.0000732	http://dx.doi.org/10.1371/journal.pone.0000732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710132	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455200009
J	Kretschmer, B; Luthje, K; Guse, AH; Ehrlich, S; Koch-Nolte, F; Haag, F; Fleischer, B; Breloer, M				Kretschmer, Birte; Luethje, Katja; Guse, Andreas H.; Ehrlich, Svenja; Koch-Nolte, Friedrich; Haag, Friedrich; Fleischer, Bernhard; Breloer, Minka			CD83 Modulates B Cell Function In Vitro: Increased IL-10 and Reduced Ig Secretion by CD83Tg B Cells	PLOS ONE			English	Article								The murine transmembrane glycoprotein CD83 is an important regulator for both thymic T cell maturation and peripheral T cell responses. Recently, we reported that CD83 also has a function on B cells: Ubiquitous transgenic (Tg) expression of CD83 interfered with the immunoglobulin (Ig) response to infectious agents and to T cell dependent as well as T cell independent model antigen immunization. Here we compare the function of CD83Tg B cells that overexpress CD83 and CD83 mutant (CD83mu) B cells that display a drastically reduced CD83 expression. Correlating with CD83 expression, the basic as well as the lipopolysaccharide (LPS) induced expression of the activation markers CD86 and MHC-II are significantly increased in CD83Tg B cells and reciprocally decreased in CD83mu B cells. Wild-type B cells rapidly upregulate CD83 within three hours post BCR or TLR engagement by de novo protein synthesis. The forced premature overexpression of CD83 on the CD83Tg B cells results in reduced calcium signaling, reduced Ig secretion and a reciprocally increased IL-10 production upon in vitro activation. This altered phenotype is mediated by CD83 expressed on the B cells themselves, since it is observed in the absence of accessory cells. In line with this finding, purified CD83mu B cells displayed a reduced IL-10 production and slightly increased Ig secretion upon LPS stimulation in vitro. Taken together, our data strongly suggest that CD83 is expressed by B cells upon activation and contributes to the regulation of B cell function.	[Kretschmer, Birte; Luethje, Katja; Ehrlich, Svenja; Fleischer, Bernhard; Breloer, Minka] Bernhard Nocht Inst Trop Med, Dept Immunol, Hamburg, Germany; [Guse, Andreas H.] Univ Med Ctr Hamburg Eppendorf, Inst Biochem & Mol Biol 1, Hamburg, Germany; [Koch-Nolte, Friedrich; Haag, Friedrich; Fleischer, Bernhard] Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany	Bernhard Nocht Institut fur Tropenmedizin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Breloer, M (corresponding author), Bernhard Nocht Inst Trop Med, Dept Immunol, Hamburg, Germany.	Breloer@bni-hamburg.de	Breloer, Minka/F-3999-2018	Breloer, Minka/0000-0001-6199-4908; Koch-Nolte, Friedrich/0000-0003-1730-6674	Deutsche Forschungsgemeinschaft [FL129/5-1, 5-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the "Deutsche Forschungsgemeinschaft" (FL129/5-1, 5-2).	Aerts-Toegaert C, 2007, EUR J IMMUNOL, V37, P686, DOI 10.1002/eji.200636535; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; Berchtold S, 2002, IMMUNOBIOLOGY, V205, P231, DOI 10.1078/0171-2985-00128; Berchtold S, 1999, FEBS LETT, V461, P211, DOI 10.1016/S0014-5793(99)01465-9; Breloer M, 2007, EUR J IMMUNOL, V37, P634, DOI 10.1002/eji.200636852; BURDIN N, 1995, J IMMUNOL, V154, P2533; Cao WP, 2005, BIOCHEM J, V385, P85, DOI 10.1042/BJ20040741; Cramer SO, 2000, INT IMMUNOL, V12, P1347, DOI 10.1093/intimm/12.9.1347; Dudziak D, 2005, J IMMUNOL, V174, P6672, DOI 10.4049/jimmunol.174.11.6672; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Fujimoto Y, 2002, CELL, V108, P755, DOI 10.1016/S0092-8674(02)00673-6; Fujimoto Yoko, 2006, Journal of Medical and Dental Sciences, V53, P85; Garcia-Martinez LF, 2004, J IMMUNOL, V173, P2995, DOI 10.4049/jimmunol.173.5.2995; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GUSE AH, 1993, BIOCHEM J, V291, P447, DOI 10.1042/bj2910447; Hirano N, 2006, BLOOD, V107, P1528, DOI 10.1182/blood-2005-05-2073; Klein E, 2005, INT IMMUNOL, V17, P477, DOI 10.1093/intimm/dxh228; KOZLOW EJ, 1993, BLOOD, V81, P454, DOI 10.1182/blood.V81.2.454.454; Lechmann M, 2002, TRENDS IMMUNOL, V23, P273, DOI 10.1016/S1471-4906(02)02214-7; Lechmann M, 2001, J EXP MED, V194, P1813, DOI 10.1084/jem.194.12.1813; Luthje K, 2006, EUR J IMMUNOL, V36, P2035, DOI 10.1002/eji.200636068; Lund Frances E., 2005, V8, P25; McKinsey TA, 2000, MOL IMMUNOL, V37, P783, DOI 10.1016/S0161-5890(00)00099-7; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nitschke L, 2005, CURR OPIN IMMUNOL, V17, P290, DOI 10.1016/j.coi.2005.03.005; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prechtel AT, 2007, J IMMUNOL, V178, P5454, DOI 10.4049/jimmunol.178.9.5454; Senechal B, 2004, BLOOD, V103, P4207, DOI 10.1182/blood-2003-12-4350; Serra P, 2006, TRENDS IMMUNOL, V27, P7, DOI 10.1016/j.it.2005.11.003; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Twist CJ, 1998, IMMUNOGENETICS, V48, P383, DOI 10.1007/s002510050449; Wolenski M, 2003, SCAND J IMMUNOL, V58, P306, DOI 10.1046/j.1365-3083.2003.01303.x; ZHOU LJ, 1992, J IMMUNOL, V149, P735; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588; ZHOU LJ, 1995, J IMMUNOL, V154, P3821; Zinser E, 2004, J EXP MED, V200, P345, DOI 10.1084/jem.20030973	40	36	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e755	10.1371/journal.pone.0000755	http://dx.doi.org/10.1371/journal.pone.0000755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710154	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455200031
J	de Jonge, HJM; Fehrmann, RSN; de Bont, ESJM; Hofstra, RMW; Gerbens, F; Kamps, WA; de Vries, EGE; van der Zee, AGJ; Meerman, GJT; ter Elst, A				de Jonge, Hendrik J. M.; Fehrmann, Rudolf S. N.; de Bont, Eveline S. J. M.; Hofstra, Robert M. W.; Gerbens, Frans; Kamps, Willem A.; de Vries, Elisabeth G. E.; van der Zee, Ate G. J.; Meerman, Gerard J. te; ter Elst, Arja			Evidence Based Selection of Housekeeping Genes	PLOS ONE			English	Article							EXPRESSION; RNA; PCR; QUANTIFICATION; MESSENGER	For accurate and reliable gene expression analysis, normalization of gene expression data against housekeeping genes (reference or internal control genes) is required. It is known that commonly used housekeeping genes (e. g. ACTB, GAPDH, HPRT1, and B2M) vary considerably under different experimental conditions and therefore their use for normalization is limited. We performed a meta-analysis of 13,629 human gene array samples in order to identify the most stable expressed genes. Here we show novel candidate housekeeping genes (e. g. RPS13, RPL27, RPS20 and OAZ1) with enhanced stability among a multitude of different cell types and varying experimental conditions. None of the commonly used housekeeping genes were present in the top 50 of the most stable expressed genes. In addition, using 2,543 diverse mouse gene array samples we were able to confirm the enhanced stability of the candidate novel housekeeping genes in another mammalian species. Therefore, the identified novel candidate housekeeping genes seem to be the most appropriate choice for normalizing gene expression data.	[de Jonge, Hendrik J. M.; de Bont, Eveline S. J. M.; Kamps, Willem A.; ter Elst, Arja] Univ Groningen, Dept Pediat, Univ Med Ctr Groningen, Div Pediat Oncol Hematol,Beatrix Childrens Hosp, NL-9700 AB Groningen, Netherlands; [Fehrmann, Rudolf S. N.; Hofstra, Robert M. W.; Gerbens, Frans; Meerman, Gerard J. te] Univ Groningen, Dept Genet, Univ Med Ctr Groningen, NL-9700 AB Groningen, Netherlands; [Fehrmann, Rudolf S. N.; van der Zee, Ate G. J.] Univ Groningen, Dept Gynecol, Univ Med Ctr Groningen, NL-9700 AB Groningen, Netherlands; [Fehrmann, Rudolf S. N.; de Vries, Elisabeth G. E.] Univ Groningen, Dept Med Oncol, Univ Med Ctr Groningen, NL-9700 AB Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	ter Elst, A (corresponding author), Univ Groningen, Dept Pediat, Univ Med Ctr Groningen, Div Pediat Oncol Hematol,Beatrix Childrens Hosp, NL-9700 AB Groningen, Netherlands.	a.ter.elst@med.umcg.nl	Fehrmann, Rudolf/E-2551-2011	Fehrmann, Rudolf/0000-0002-7516-315X; de Vries, Elisabeth/0000-0002-8949-7425; Hofstra, Robert/0000-0001-7498-3829	Dutch Cancer Society [3661]; Foundation for Pediatric Oncology	Dutch Cancer Society(KWF Kankerbestrijding); Foundation for Pediatric Oncology	This work was supported by a grant from the Dutch Cancer Society (grantnr 3661) to E.S.J.M. de B, a grant of the Foundation for Pediatric Oncology to H.J.M. de J and A ter E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fink L, 1998, NAT MED, V4, P1329, DOI 10.1038/3327; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; JOHNSON ML, 1995, BIOTECHNIQUES, V19, P712; Lee SJ, 2002, CRIT REV EUKAR GENE, V12, P297, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i4.40; Novak JP, 2002, GENOMICS, V79, P104, DOI 10.1006/geno.2001.6675; Solanas M, 2001, ANAL BIOCHEM, V288, P99, DOI 10.1006/abio.2000.4889; SPANAKIS E, 1993, NUCLEIC ACIDS RES, V21, P3809, DOI 10.1093/nar/21.16.3809; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	16	535	563	4	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e898	10.1371/journal.pone.0000898	http://dx.doi.org/10.1371/journal.pone.0000898			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878933	Green Published, gold			2022-12-27	WOS:000207455700006
J	Norian, LA; Allen, PM				Norian, Lyse A.; Allen, Paul M.			Rapid Maturation of Effector T Cells in Tumors, but Not Lymphoid Organs, during Tumor Regression	PLOS ONE			English	Article							CHEMICALLY-INDUCED SARCOMAS; IN-VIVO; ANTITUMOR IMMUNITY; LINEAGE RELATIONSHIP; ESTABLISHED TUMORS; CUTTING EDGE; MEMORY CTL; IFN-GAMMA; ANTIGEN; LYMPHOCYTES	Increasing the efficacy of adoptively transferred, tumor antigen specific T cells is a major goal of immunotherapy. Clearly, a more thorough understanding of the effector phase of T cell responses, within the tumor site itself, would be beneficial. To examine this issue, we adoptively transferred tumor antigen-specific effector T cells into tumor-bearing mice, then performed kinetic evaluations of their phenotype, function, and survival in tumors, draining lymph nodes (dLNs), and spleens during regression of murine fibrosarcomas. Effector function in tumors was quantitated through the use of a novel intratumoral cytolytic assay. This approach revealed dynamic changes in the phenotype, cytolytic capacity, and viability of tumor infiltrating effector T cells during the course of tumor regression. Over a period of days, T cells within tumors rapidly transitioned from a CD25(hi)/CD27(hi) to a CD25(low)/CD27(low) phenotype and displayed an increase in cytolytic capacity, indicative of effector maturation. Simultaneously, however, the viability of maturing T cells within tumors diminished. In contrast, transferred T cells trafficking through lymphoid organs were much more static, as they maintained a stable phenotype, robust cytolytic activity, and high viability. Therefore, there exists a marked phenotypic and functional divergence between tumor-infiltrating effector T cells and their counterparts in lymphoid organs. Our results indicate that the population of tumor-infiltrating T cells is unique in experiencing rapid effector maturation post-transfer, and suggest that strategies aimed at prolonging the survival of CD25(low)/CD27(low) full effectors, which displayed the highest levels of intratumoral cytolytic activity, should enhance the efficacy of T cell based tumor immunotherapies.	[Norian, Lyse A.; Allen, Paul M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Norian, LA (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	lnorian@wustl.edu		Norian, Lyse/0000-0003-1016-313X	NIH [P50CA94056]; Cancer Research Institute Samuel and Ruth Engelberg Fellowship; NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute Samuel and Ruth Engelberg Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH grant P50CA94056 (PMA) Cancer Research Institute Samuel and Ruth Engelberg Fellowship (LAN)	Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Blattman JN, 2004, SCIENCE, V305, P200, DOI 10.1126/science.1100369; Bronte V, 2005, J EXP MED, V201, P1257, DOI 10.1084/jem.20042028; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DELEO AB, 1977, J EXP MED, V146, P720, DOI 10.1084/jem.146.3.720; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Gajewski TF, 2006, IMMUNOL REV, V213, P131, DOI 10.1111/j.1600-065X.2006.00442.x; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Hanson HL, 2000, IMMUNITY, V13, P265, DOI 10.1016/S1074-7613(00)00026-1; Harlin H, 2006, CANCER IMMUNOL IMMUN, V55, P1185, DOI 10.1007/s00262-005-0118-2; Hendricks J, 2003, J EXP MED, V198, P1369, DOI 10.1084/jem.20030916; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Hollenbaugh JA, 2004, J IMMUNOL, V173, P1738, DOI 10.4049/jimmunol.173.3.1738; Ikeda H, 1997, P NATL ACAD SCI USA, V94, P6375, DOI 10.1073/pnas.94.12.6375; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Jarnicki AG, 2006, J IMMUNOL, V177, P896, DOI 10.4049/jimmunol.177.2.896; Kang SS, 2005, J IMMUNOL, V174, P5382, DOI 10.4049/jimmunol.174.9.5382; Koneru M, 2005, J IMMUNOL, V174, P1830, DOI 10.4049/jimmunol.174.4.1830; Koneru M, 2006, J IMMUNOL, V176, P6103, DOI 10.4049/jimmunol.176.10.6103; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Lyman MA, 2004, J IMMUNOL, V172, P6558, DOI 10.4049/jimmunol.172.11.6558; Matsui K, 2003, INT IMMUNOL, V15, P797, DOI 10.1093/intimm/dxg078; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Mortarini R, 2003, CANCER RES, V63, P2535; Norian LA, 2004, J IMMUNOL, V173, P835, DOI 10.4049/jimmunol.173.2.835; O'Mara LA, 2005, J IMMUNOL, V174, P4662, DOI 10.4049/jimmunol.174.8.4662; Oehen S, 1998, J IMMUNOL, V161, P5338; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Palmer DC, 2004, J IMMUNOL, V173, P7209, DOI 10.4049/jimmunol.173.12.7209; Pardoll DM, 2002, NAT REV IMMUNOL, V2, P227, DOI 10.1038/nri774; Powell DJ, 2005, BLOOD, V105, P241, DOI 10.1182/blood-2004-06-2482; Powell DJ, 2004, J IMMUNOTHER, V27, P36, DOI 10.1097/00002371-200401000-00004; Radoja S, 2001, J IMMUNOL, V166, P6074, DOI 10.4049/jimmunol.166.10.6074; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Rosenberg SA, 2005, J IMMUNOL, V175, P6169, DOI 10.4049/jimmunol.175.9.6169; SRIVASTAVA PK, 1986, P NATL ACAD SCI USA, V83, P3407, DOI 10.1073/pnas.83.10.3407; Stumbles PA, 2004, J IMMUNOL, V173, P5923, DOI 10.4049/jimmunol.173.10.5923; Tomiyama H, 2004, EUR J IMMUNOL, V34, P999, DOI 10.1002/eji.200324478; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Yang YP, 2004, NAT IMMUNOL, V5, P508, DOI 10.1038/ni1059; Ye SW, 2006, J CLIN IMMUNOL, V26, P447, DOI 10.1007/s10875-006-9040-4; Yu P, 2005, J EXP MED, V201, P779, DOI 10.1084/jem.20041684; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	48	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e821	10.1371/journal.pone.0000821	http://dx.doi.org/10.1371/journal.pone.0000821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786193	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455500005
J	Pedersen, BR; Kamwendo, D; Blood, M; Mwapasa, V; Molyneux, M; North, K; Rogerson, SJ; Zimmerman, P; Meshnick, SR				Pedersen, Bonnie R.; Kamwendo, Deborah; Blood, Melinda; Mwapasa, Victor; Molyneux, Malcolm; North, Kari; Rogerson, Stephen J.; Zimmerman, Peter; Meshnick, Steven R.			CCR5 Haplotypes and Mother-to-Child HIV Transmission in Malawi	PLOS ONE			English	Article								Background. CCR5 and CCR2 gene polymorphisms (SNPs) have been associated with protection against HIV transmission in adults and with delayed progression to AIDS. The CCR5 Delta 32 deletion and SNP -2459G are associated with reduced expression of the CCR5 protein. Methodology/Principal Findings. We investigated the association between infant CCR2/CCR5 diplotype and HIV mother to child transmission (MTCT) in Malawi. Blood samples from infants (n = 552) of HIV positive women who received nevirapine were genotyped using a post-PCR multiplex ligase detection reaction and haplotypes were identified based on 8 CCR2/CCR5 SNPs and the open reading frame 32 base pair deletion. Following verification of Hardy-Weinberg equilibrium, log linear regression was performed to examine the association between mutations and MTCT. Overall, protection against MTCT was weakly associated with two CCR5 SNPs, -2459G (Risk ratio [RR], 0.78; confidence interval [CI], 0.54-1.12), and the linked CCR5 -2135T (RR, 0.78; CI, 0.54-1.13). No child carried the CCR5 D32 SNP. Maternal Viral Load (MVL) was found to be an effect measure modifier. Among mothers with low MVL, statistically significant protection against MTCT was observed for -2459G (RR, 0.50; CI, 0.27-0.91), and -2135T (RR, 0.51; CI, 0.28-0.92). Statistically significant protection was not found at high MVL. Conclusions/Significance. Results from this study suggest that CCR5 SNPs -2459G and -2135T associated with reduced receptor expression protect against MTCT of HIV at low MVLs, whereas high MVLs may over-ride differences in coreceptor availability.	[Pedersen, Bonnie R.; Kamwendo, Deborah; North, Kari; Meshnick, Steven R.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Blood, Melinda; Zimmerman, Peter] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Mwapasa, Victor; Molyneux, Malcolm] Univ Malawi, Coll Med, Blantyre, Malawi; [Rogerson, Stephen J.] Univ Melbourne, Melbourne, Vic, Australia	University of North Carolina; University of North Carolina Chapel Hill; Case Western Reserve University; University of Malawi; University of Melbourne	Zimmerman, P (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.	paz@case.edu; meshnick@unc.edu		Joubert, Bonnie/0000-0001-7952-1180; Rogerson, Stephen/0000-0003-4287-1982; Mwapasa, Victor/0000-0002-2748-8902	NIH [AI 49084, 5P01AI051649-05]; NIH-FIC [5 D43 TW00908]; Center for AIDS Research at the University of North Carolina; FOGARTY INTERNATIONAL CENTER [D43TW000908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI051649, R01AI049084] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Center for AIDS Research at the University of North Carolina; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant # AI 49084 (SM), 5P01AI051649-05 (PZ), the NIH-FIC grant # 5 D43 TW00908 and the Center for AIDS Research at the University of North Carolina. SJR is a Wellcome Trust Senior Overseas Fellow in Biomedical Sciences. Pregnant women in this study were given nevirapine provided by Global Strategies for HIV Prevention. None of the sponsors had any input in the manuscript.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Anzala AO, 1998, LANCET, V351, P1632, DOI 10.1016/S0140-6736(05)77688-1; Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Bertolli J, 1996, J INFECT DIS, V174, P722, DOI 10.1093/infdis/174.4.722; BRUSE S, 2006, MULTIPLEX LIGASE DET; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Clegg AO, 2000, AIDS, V14, P103, DOI 10.1097/00002030-200001280-00004; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Easterbrook PJ, 1999, J INFECT DIS, V180, P1096, DOI 10.1086/314997; Eugen-Olsen J, 1998, J ACQ IMMUN DEF SYND, V18, P110, DOI 10.1097/00042560-199806010-00002; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Heitjan DF, 1997, AM J PUBLIC HEALTH, V87, P548, DOI 10.2105/AJPH.87.4.548; Hladik F, 2005, J VIROL, V79, P11677, DOI 10.1128/JVI.79.18.11677-11684.2005; HUANG RD, 1996, FINANCIAL MARKETS I, V5, P1; John GC, 2001, J INFECT DIS, V184, P89, DOI 10.1086/321006; Kawamura T, 2003, P NATL ACAD SCI USA, V100, P8401, DOI 10.1073/pnas.1432450100; Knudsen TB, 2001, J MED VIROL, V65, P441, DOI 10.1002/jmv.2054.abs; Kostrikis LG, 1998, NAT MED, V4, P350, DOI 10.1038/nm0398-350; Kostrikis LG, 1999, J VIROL, V73, P10264, DOI 10.1128/JVI.73.12.10264-10271.1999; Kwiek JJ, 2006, PLOS MED, V3, P70, DOI 10.1371/journal.pmed.0030010; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Little R. J. A., 1987, STAT ANAL MISSING DA; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Mangano A, 2001, J INFECT DIS, V183, P1574, DOI 10.1086/320705; McDermott DH, 1998, LANCET, V352, P866, DOI 10.1016/S0140-6736(98)04158-0; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Mwapasa V, 2004, AIDS, V18, P1051, DOI 10.1097/00002030-200404300-00014; Mwapasa V, 2006, AIDS, V20, P1869, DOI 10.1097/01.aids.0000244206.41500.27; Ometto L, 2000, AIDS, V14, P1721, DOI 10.1097/00002030-200008180-00006; Princen K, 2005, CYTOKINE GROWTH F R, V16, P659, DOI 10.1016/j.cytogfr.2005.05.009; Rouzioux C, 1995, AM J EPIDEMIOL, V142, P1330, DOI 10.1093/oxfordjournals.aje.a117601; Rubin DB, 2004, MULTIPLE IMPUTATION; Salkowitz JR, 2003, CLIN IMMUNOL, V108, P234, DOI 10.1016/S1521-6616(03)00147-5; Salkowitz JR, 2001, CLIN IMMUNOL, V98, P200, DOI 10.1006/clim.2000.4969; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Schinkel J, 1999, J INFECT DIS, V179, P825, DOI 10.1086/314658; Tang JM, 2002, J VIROL, V76, P662, DOI 10.1128/JVI.76.2.662-672.2002; Thomas SM, 2006, AIDS, V20, P1879, DOI 10.1097/01.aids.0000244207.49123.ff; *UNAIDS, 2004, AIDS EP UPD; Zimmerman PA, 1997, MOL MED, V3, P23, DOI 10.1007/BF03401665	44	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e838	10.1371/journal.pone.0000838	http://dx.doi.org/10.1371/journal.pone.0000838			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786209	Green Published, gold			2022-12-27	WOS:000207455500021
J	Yokota, Y; Ghashghaei, HT; Han, C; Watson, H; Campbell, KJ; Anton, ES				Yokota, Yukako; Ghashghaei, H. T.; Han, Christine; Watson, Hannah; Campbell, Kenneth J.; Anton, E. S.			Radial Glial Dependent and Independent Dynamics of Interneuronal Migration in the Developing Cerebral Cortex	PLOS ONE			English	Article							LATERAL GANGLIONIC EMINENCE; GABAERGIC INTERNEURONS; CORTICAL INTERNEURONS; NEURONAL MIGRATION; TANGENTIAL MIGRATION; INHIBITORY NEURONS; BASEMENT-MEMBRANE; CELL-MIGRATION; NUCLEOKINESIS; ADULT	Interneurons originating from the ganglionic eminence migrate tangentially into the developing cerebral wall as they navigate to their distinct positions in the cerebral cortex. Compromised connectivity and differentiation of interneurons are thought to be an underlying cause in the emergence of neurodevelopmental disorders such as schizophrenia. Previously, it was suggested that tangential migration of interneurons occurs in a radial glia independent manner. Here, using simultaneous imaging of genetically defined populations of interneurons and radial glia, we demonstrate that dynamic interactions with radial glia can potentially influence the trajectory of interneuronal migration and thus the positioning of interneurons in cerebral cortex. Furthermore, there is extensive local interneuronal migration in tangential direction opposite to that of pallial orientation (i.e., in a medial to lateral direction from cortex to ganglionic eminence) all across the cerebral wall. This counter migration of interneurons may be essential to locally position interneurons once they invade the developing cerebral wall from the ganglionic eminence. Together, these observations suggest that interactions with radial glial scaffold and localized migration within the expanding cerebral wall may play essential roles in the guidance and placement of interneurons in the developing cerebral cortex.	[Yokota, Yukako; Ghashghaei, H. T.; Han, Christine; Watson, Hannah; Anton, E. S.] Univ N Carolina, Sch Med, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA; [Yokota, Yukako; Ghashghaei, H. T.; Han, Christine; Watson, Hannah; Anton, E. S.] Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Chapel Hill, NC USA; [Campbell, Kenneth J.] Cincinnati Childrens Hosp, Dev Biol Program, Cincinnati, OH USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Cincinnati Children's Hospital Medical Center	Anton, ES (corresponding author), Univ N Carolina, Sch Med, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA.	anton@med.unc.edu	Campbell, Kenneth/ABC-3570-2021		NIH [MH060929]; Staglin Award (NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060929] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Staglin Award (NARSAD)(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by NIH grant MH060929 and Staglin Award (NARSAD) to EA.	Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2001, DEVELOPMENT, V128, P353; Ang ESBC, 2003, J NEUROSCI, V23, P5805; Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Campbell K, 2003, CURR OPIN NEUROBIOL, V13, P50, DOI 10.1016/S0959-4388(03)00009-6; Cobos I, 2001, DEV BIOL, V239, P30, DOI 10.1006/dbio.2001.0422; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; Denaxa M, 2001, DEVELOPMENT, V128, P4635; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Gongidi V, 2004, NEURON, V41, P57, DOI 10.1016/S0896-6273(03)00818-3; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Halfter W, 2002, J NEUROSCI, V22, P6029; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; Hevner RF, 2004, NEUROSCIENCE, V124, P605, DOI 10.1016/j.neuroscience.2003.11.033; Higginbotham H, 2006, MOL CELL NEUROSCI, V32, P118, DOI 10.1016/j.mcn.2006.03.003; Kappeler C, 2006, HUM MOL GENET, V15, P1387, DOI 10.1093/hmg/ddl062; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2006, NAT MED, V12, P1016, DOI 10.1038/nm1478; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin O, 2003, DEVELOPMENT, V130, P1889, DOI 10.1242/dev.00417; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Metin C, 1996, J NEUROSCI, V16, P3219; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Moya F, 2004, CEREB CORTEX, V14, P610, DOI 10.1093/cercor/bhh022; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Nadarajah B, 2002, NAT NEUROSCI, V5, P218, DOI 10.1038/nn813; Nadarajah B, 2003, CEREB CORTEX, V13, P607, DOI 10.1093/cercor/13.6.607; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; ORourke NA, 1997, DEVELOPMENT, V124, P997; OROURKE NA, 1995, DEVELOPMENT, V121, P2165; Parnavelas JG, 2001, NEURON, V31, P881, DOI 10.1016/S0896-6273(01)00437-8; Polleux F, 2002, DEVELOPMENT, V129, P3147; Poluch S, 2007, GLIA, V55, P822, DOI 10.1002/glia.20488; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Schmid RS, 2006, GLIA, V53, P345, DOI 10.1002/glia.20274; Schmid RS, 2004, DEVELOPMENT, V131, P6023, DOI 10.1242/dev.01532; Stenman J, 2003, J NEUROSCI, V23, P167; Tanaka DH, 2006, DEVELOPMENT, V133, P2167, DOI 10.1242/dev.02382; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Yabut O, 2007, BRAIN RES, V1140, P75, DOI 10.1016/j.brainres.2005.09.070; Yun K, 2002, DEVELOPMENT, V129, P5029; Yun KS, 2003, J COMP NEUROL, V461, P151, DOI 10.1002/cne.10685	50	81	81	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e794	10.1371/journal.pone.0000794	http://dx.doi.org/10.1371/journal.pone.0000794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726524	gold, Green Published			2022-12-27	WOS:000207455400011
J	Frye, M; Fisher, AG; Watt, FM				Frye, Michaela; Fisher, Amanda G.; Watt, Fiona M.			Epidermal Stem Cells Are Defined by Global Histone Modifications that Are Altered by Myc-Induced Differentiation	PLOS ONE			English	Article								Activation of Myc induces epidermal stem cells to exit their niche and differentiate into sebocytes and interfollicular epidermis, a process that is associated with widespread changes in gene transcription. We have identified chromatin modifications that are characteristic of epidermal stem cells and investigated the effects of Myc activation. Quiescent stem cells in the interfollicular epidermis and the hair follicle bulge had high levels of tri-methylated histone H3 at lysine 9 and H4 at lysine 20. Chromatin in both stem cell populations was hypoacteylated at histone H4 and lacked mono-methylation of histone H4 at lysine 20. Myc-induced exit from the stem cell niche correlated with increased acetylation at histone H4 and transiently increased mono-methylation at lysine 20. The latter was replaced by epigenetic modifications that are largely associated with chromatin silencing: di-methylation at histone H3 lysine 9 and histone H4 lysine 20. These modifications correlated with changes in the specific histone methyltransferases Set8 and Ash-1. The Myc-induced switch from mono-to di-methylated H4K20 required HDAC activity and was blocked by the HDAC inhibitor trichostatin A (TSA). TSA treatment induced a similar epidermal phenotype to activation of Myc, and activation of Myc in the presence of TSA resulted in massive stimulation of terminal differentiation. We conclude that Myc-induced chromatin modifications play a major role in Myc-induced exit from the stem cell compartment.	[Frye, Michaela; Watt, Fiona M.] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge, England; [Fisher, Amanda G.] Imperial Coll Sch Med, Lymphocyte Dev Grp, London, England; [Watt, Fiona M.] Univ Cambridge, Canc Res UK Cambridge Res Inst, Cambridge, England	University of Cambridge; Imperial College London; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Watt, FM (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge, England.	fiona.watt@cancer.org.uk	Watt, Fiona/AHB-0226-2022	Watt, Fiona/0000-0001-9151-5154; Frye, Michaela/0000-0002-5636-6840	Cancer Research UK; EuroStemCell; Medical Research Council; Wellcome Trust; MRC [MC_U120027516] Funding Source: UKRI; Medical Research Council [G0300723B, MC_U120027516] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); EuroStemCell(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by funds from Cancer Research UK (FMW and MF), EuroStemCell (FMW), the Medical Research Council (AF) and the Wellcome Trust (FMW).	Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Baxter J, 2004, EMBO J, V23, P4462, DOI 10.1038/sj.emboj.7600414; Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; BICKENBACH JR, 1981, J DENT RES, V60, P1611, DOI 10.1177/002203458106000311011; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Cowling VH, 2006, SEMIN CANCER BIOL, V16, P242, DOI 10.1016/j.semcancer.2006.08.001; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; DITTEL BN, 1993, BLOOD, V81, P2272; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Frye M, 2003, DEVELOPMENT, V130, P2793, DOI 10.1242/dev.00462; Frye M, 2006, CURR BIOL, V16, P971, DOI 10.1016/j.cub.2006.04.027; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gebhardt A, 2006, J CELL BIOL, V172, P139, DOI 10.1083/jcb.200506057; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; KONDO T, 2006, CURR OPIN GENET DEV; Konstantinopoulos PA, 2006, DRUG DISCOV TODAY, V11, P91, DOI 10.1016/S1359-6446(05)03713-X; Kubicek S, 2006, E SCHERING RES FDN W, V57, P1; Legg J, 2003, DEVELOPMENT, V130, P6049, DOI 10.1242/dev.00837; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; Markova NG, 2007, J INVEST DERMATOL, V127, P1126, DOI 10.1038/sj.jid.5700684; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; ONEILL LP, 1995, EMBO J, V14, P3946, DOI 10.1002/j.1460-2075.1995.tb00066.x; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Sims JK, 2006, J BIOL CHEM, V281, P12760, DOI 10.1074/jbc.M513462200; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Talasz H, 2005, J BIOL CHEM, V280, P38814, DOI 10.1074/jbc.M505563200; Terranova R, 2005, EXP CELL RES, V310, P344, DOI 10.1016/j.yexcr.2005.07.031; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; Xi RW, 2005, SCIENCE, V310, P1487, DOI 10.1126/science.1120140; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	44	83	84	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e763	10.1371/journal.pone.0000763	http://dx.doi.org/10.1371/journal.pone.0000763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712411	Green Published, gold			2022-12-27	WOS:000207455300011
J	Mukherjee, S; Abd-El-Latif, M; Bronstein, M; Ben-nun-Shaul, O; Kler, S; Oppenheim, A				Mukherjee, Santanu; Abd-El-Latif, Mahmoud; Bronstein, Michal; Ben-nun-Shaul, Orly; Kler, Stanislav; Oppenheim, Ariella			High Cooperativity of the SV40 Major Capsid Protein VP1 in Virus Assembly	PLOS ONE			English	Article								SV40 is a small, non enveloped DNA virus with an icosahedral capsid of 45 nm. The outer shell is composed of pentamers of the major capsid protein, VP1, linked via their flexible carboxy-terminal arms. Its morphogenesis occurs by assembly of capsomers around the viral minichromosome. However the steps leading to the formation of mature virus are poorly understood. Intermediates of the assembly reaction could not be isolated from cells infected with wt SV40. Here we have used recombinant VP1 produced in insect cells for in vitro assembly studies around supercoiled heterologous plasmid DNA carrying a reporter gene. This strategy yields infective nanoparticles, affording a simple quantitative transduction assay. We show that VP1 assembles under physiological conditions into uniform nanoparticles of the same shape, size and CsCl density as the wild type virus. The stoichiometry is one DNA molecule per capsid. VP1 deleted in the C-arm, which is unable to assemble but can bind DNA, was inactive indicating genuine assembly rather than non-specific DNA-binding. The reaction requires host enzymatic activities, consistent with the participation of chaperones, as recently shown. Our results demonstrate dramatic cooperativity of VP1, with a Hill coefficient of similar to 6. These findings suggest that assembly may be a concerted reaction. We propose that concerted assembly is facilitated by simultaneous binding of multiple capsomers to a single DNA molecule, as we have recently reported, thus increasing their local concentration. Emerging principles of SV40 assembly may help understanding assembly of other complex systems. In addition, the SV40-based nanoparticles described here are potential gene therapy vectors that combine efficient gene delivery with safety and flexibility.	[Mukherjee, Santanu; Abd-El-Latif, Mahmoud; Bronstein, Michal; Ben-nun-Shaul, Orly; Kler, Stanislav; Oppenheim, Ariella] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Hematol, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem	Mukherjee, S (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA.	ariella@cc.huji.ac.il	Mukherjee, Santanu/AAF-1684-2020	Mukherjee, Santanu/0000-0001-8344-7200	ISRAEL SCIENCE FOUNDATION [240/04]; NIH [R21 EB002982]; Herman Poley endowment fund through The Friends of the Hebrew University; Israeli Ministry of Absorption; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB002982] Funding Source: NIH RePORTER	ISRAEL SCIENCE FOUNDATION(Israel Science Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Herman Poley endowment fund through The Friends of the Hebrew University; Israeli Ministry of Absorption; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The research was supported by the ISRAEL SCIENCE FOUNDATION ( grant No. 240/04) and by NIH grant # R21 EB002982. SM was a recipient of a PhD Fellowship from the Herman Poley endowment fund through The Friends of the Hebrew University. SK is a recipient of a PhD Fellowship of Israeli Ministry of Absorption.	AMBROSE C, 1986, P NATL ACAD SCI USA, V83, P3287, DOI 10.1073/pnas.83.10.3287; Arad U, 2005, HUM GENE THER, V16, P361, DOI 10.1089/hum.2005.16.361; BAKER TS, 1988, P NATL ACAD SCI USA, V85, P422, DOI 10.1073/pnas.85.2.422; BAUMGARTNER I, 1979, VIROLOGY, V96, P54, DOI 10.1016/0042-6822(79)90172-7; Bina M, 1983, Cold Spring Harb Symp Quant Biol, V47 Pt 1, P565; BLACK PH, 1964, VIROLOGY, V24, P381, DOI 10.1016/0042-6822(64)90175-8; BLASQUEZ V, 1986, J MOL BIOL, V191, P97, DOI 10.1016/0022-2836(86)90425-0; BLASQUEZ V, 1983, J BIOL CHEM, V258, P8477; Chen XJS, 1998, EMBO J, V17, P3233, DOI 10.1093/emboj/17.12.3233; Chromy LR, 2003, P NATL ACAD SCI USA, V100, P10477, DOI 10.1073/pnas.1832245100; CLEVER J, 1993, J BIOL CHEM, V268, P20877; COCAPRADOS M, 1979, J VIROL, V31, P199, DOI 10.1128/JVI.31.1.199-208.1979; COLOMAR MC, 1993, J VIROL, V67, P2779, DOI 10.1128/JVI.67.5.2779-2786.1993; DalyotHerman N, 1996, J MOL BIOL, V259, P69, DOI 10.1006/jmbi.1996.0302; Daniels R, 2006, MOL CELL, V24, P955, DOI 10.1016/j.molcel.2006.11.001; Daniels R, 2006, J VIROL, V80, P6575, DOI 10.1128/JVI.00347-06; Endres D, 2002, BIOPHYS J, V83, P1217, DOI 10.1016/S0006-3495(02)75245-4; FANNING E, 1980, VIROLOGY, V102, P1, DOI 10.1016/0042-6822(80)90064-1; FERNANDEZMUNOZ R, 1979, J VIROL, V29, P612, DOI 10.1128/JVI.29.2.612-623.1979; FORSTOVA J, 1993, J VIROL, V67, P1405; FREIFELDER D, 1982, PHYS BIOCH, P663; GARBER EA, 1980, VIROLOGY, V107, P389, DOI 10.1016/0042-6822(80)90306-2; GARBER EA, 1978, VIROLOGY, V90, P305, DOI 10.1016/0042-6822(78)90315-X; GIDONI D, 1985, SCIENCE, V230, P511, DOI 10.1126/science.2996137; Gillock ET, 1997, J VIROL, V71, P2857, DOI 10.1128/JVI.71.4.2857-2865.1997; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Goldmann C, 1999, J VIROL, V73, P4465, DOI 10.1128/JVI.73.5.4465-4469.1999; Gordon-Shaag A, 1998, J MOL BIOL, V275, P187, DOI 10.1006/jmbi.1997.1461; Gordon-Shaag A, 2002, J VIROL, V76, P5915, DOI 10.1128/JVI.76.12.5915-5924.2002; Hill A.V., 1910, J PHYSIOL-LONDON, V40, piv; Ishizu KI, 2001, J VIROL, V75, P61, DOI 10.1128/JVI.75.1.61-72.2001; Kimchi-Sarfaty C, 2006, CANCER GENE THER, V13, P648, DOI 10.1038/sj.cgt.7700943; Kimchi-Sarfaty C, 2004, CURR PHARM BIOTECHNO, V5, P451, DOI 10.2174/1389201043376670; Kimchi-Sarfaty C, 2003, HUM GENE THER, V14, P167, DOI 10.1089/104303403321070865; Kondo R, 1998, GENE THER, V5, P575, DOI 10.1038/sj.gt.3300623; Kosukegawa A, 1996, BBA-GEN SUBJECTS, V1290, P37; Li PP, 2003, J VIROL, V77, P7527, DOI 10.1128/JVI.77.13.7527-7538.2003; Li PP, 2002, P NATL ACAD SCI USA, V99, P1353, DOI 10.1073/pnas.032668699; Li PP, 2001, J VIROL, V75, P7321, DOI 10.1128/JVI.75.16.7321-7329.2001; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Mannova P, 2002, J GEN VIROL, V83, P2309, DOI 10.1099/0022-1317-83-9-2309; MARTIN RG, 1977, VIROLOGY, V83, P433, DOI 10.1016/0042-6822(77)90190-8; Mukherjee S, 2006, J AM CHEM SOC, V128, P2538, DOI 10.1021/ja056656f; Nakanishi A, 2007, J VIROL, V81, P3778, DOI 10.1128/JVI.02664-06; NG SC, 1984, J VIROL, V50, P471, DOI 10.1128/JVI.50.2.471-477.1984; OPPENHEIM A, 1992, J VIROL, V66, P5320, DOI 10.1128/JVI.66.9.5320-5328.1992; OPPENHEIM A, 1994, J MOL BIOL, V238, P501, DOI 10.1006/jmbi.1994.1310; Ou WC, 1999, J GEN VIROL, V80, P39, DOI 10.1099/0022-1317-80-1-39; Pawlita M, 1996, J VIROL, V70, P7517, DOI 10.1128/JVI.70.11.7517-7526.1996; ROITMAN V, 2005, THESIS HEBREW U JERU; Roitman-Shemer V, 2007, BIOCHEM BIOPH RES CO, V353, P424, DOI 10.1016/j.bbrc.2006.12.038; SALUNKE DM, 1986, CELL, V46, P895, DOI 10.1016/0092-8674(86)90071-1; Sandalon Z, 1997, VIROLOGY, V237, P414, DOI 10.1006/viro.1997.8796; Sandalon Z, 1997, HUM GENE THER, V8, P843, DOI 10.1089/hum.1997.8.7-843; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SPENCE SL, 1994, J VIROL, V68, P4227, DOI 10.1128/JVI.68.7.4227-4240.1994; SPENCE SL, 1994, VIROLOGY, V204, P200, DOI 10.1006/viro.1994.1524; Srinivasan A, 1997, MOL CELL BIOL, V17, P4761, DOI 10.1128/MCB.17.8.4761; Stehle T, 1996, STRUCTURE, V4, P165, DOI 10.1016/S0969-2126(96)00020-2; Stokrova J, 1999, FEBS LETT, V445, P119, DOI 10.1016/S0014-5793(99)00003-4; Touze A, 2001, J GEN VIROL, V82, P3005, DOI 10.1099/0022-1317-82-12-3005; Zlotnick A, 1999, BIOCHEMISTRY-US, V38, P14644, DOI 10.1021/bi991611a; ZLOTNICK A, 1994, J MOL BIOL, V241, P59, DOI 10.1006/jmbi.1994.1473	63	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e765	10.1371/journal.pone.0000765	http://dx.doi.org/10.1371/journal.pone.0000765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712413	Green Published, gold			2022-12-27	WOS:000207455300013
J	Nielsen, HB; Mundy, J; Willenbrock, H				Nielsen, Henrik Bjorn; Mundy, John; Willenbrock, Hanni			Functional Associations by Response Overlap (FARO), a Functional Genomics Approach Matching Gene Expression Phenotypes	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; MICROARRAY; REGULATOR; STRESS; MUTANT; MAP; CONNECTIVITY; SUMMARIES; PATHWAYS	The systematic comparison of transcriptional responses of organisms is a powerful tool in functional genomics. For example, mutants may be characterized by comparing their transcript profiles to those obtained in other experiments querying the effects on gene expression of many experimental factors including treatments, mutations and pathogen infections. Similarly, drugs may be discovered by the relationship between the transcript profiles effectuated or impacted by a candidate drug and by the target disease. The integration of such data enables systems biology to predict the interplay between experimental factors affecting a biological system. Unfortunately, direct comparisons of gene expression profiles obtained in independent, publicly available microarray experiments are typically compromised by substantial, experiment-specific biases. Here we suggest a novel yet conceptually simple approach for deriving 'Functional Association(s) by Response Overlap' (FARO) between microarray gene expression studies. The transcriptional response is defined by the set of differentially expressed genes independent from the magnitude or direction of the change. This approach overcomes the limited comparability between studies that is typical for methods that rely on correlation in gene expression. We apply FARO to a compendium of 242 diverse Arabidopsis microarray experimental factors, including phyto-hormones, stresses and pathogens, growth conditions/stages, tissue types and mutants. We also use FARO to confirm and further delineate the functions of Arabidopsis MAP kinase 4 in disease and stress responses. Furthermore, we find that a large, well-defined set of genes responds in opposing directions to different stress conditions and predict the effects of different stress combinations. This demonstrates the usefulness of our approach for exploiting public microarray data to derive biologically meaningful associations between experimental factors. Finally, our results indicate that FARO is more powerful in associating mutants in common pathways than existing methods such as co-expression analysis.	[Nielsen, Henrik Bjorn; Willenbrock, Hanni] Tech Univ Denmark, Bioctr, Ctr Biol Sequence Anal, Kongens Lyngby, Denmark; [Mundy, John] Univ Copenhagen, Bioctr, Inst Mol Biol, Copenhagen, Denmark	Technical University of Denmark; University of Copenhagen	Nielsen, HB (corresponding author), Tech Univ Denmark, Bioctr, Ctr Biol Sequence Anal, Kongens Lyngby, Denmark.	hbjorn@cbs.dtu.dk	mundy, john/A-2361-2013; Nielsen, Henrik Bjorn/B-8961-2019	mundy, john/0000-0001-7490-4588; Nielsen, Henrik Bjorn/0000-0003-2281-5713	Danish Center for Scientific Computing [LSHB-CT-2005-511977]; Danish Technical and Agricultural and Veterinary Research Councils	Danish Center for Scientific Computing; Danish Technical and Agricultural and Veterinary Research Councils	This study was supported financially by The Danish Center for Scientific Computing; EU, ADIT (IP), FP6, contract no.: LSHB-CT-2005-511977; and The Danish Technical and Agricultural and Veterinary Research Councils, in part via the STF program.	Andreasson E, 2005, EMBO J, V24, P2579, DOI 10.1038/sj.emboj.7600737; *ATGENEXPRESS, 2006, ATGENEXPRESS MULT CO; Blangiardo M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r54; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; BRODERSEN P, 2006, PLANT J; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Conover WJ, 1971, PRACTICAL NONPARAMET, P97; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; de Lichtenberg U, 2005, BIOINFORMATICS, V21, P1164, DOI 10.1093/bioinformatics/bti093; Droillard MJ, 2004, FEBS LETT, V574, P42, DOI 10.1016/j.febslet.2004.08.001; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; HOLLANDER M, 1973, NONPARAMETRIC STAT M, P15; Horak J, 2003, PLANT BIOLOGY, V5, P245, DOI 10.1055/s-2003-40789; Huang DS, 2006, BIOINFORMATICS, V22, P1259, DOI 10.1093/bioinformatics/btl065; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kiba T, 2005, PLANT CELL PHYSIOL, V46, P339, DOI 10.1093/pcp/pci033; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lottaz C, 2006, BIOINFORMATICS, V22, P2315, DOI 10.1093/bioinformatics/btl385; Marshall E, 2004, SCIENCE, V306, P630, DOI 10.1126/science.306.5696.630; Martinez C, 2004, PLANT J, V37, P209, DOI 10.1046/j.1365-313X.2003.01954.x; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Miklos GLG, 2004, NAT BIOTECHNOL, V22, P615, DOI 10.1038/nbt965; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mizuno T, 2004, CURR OPIN PLANT BIOL, V7, P499, DOI 10.1016/j.pbi.2004.07.015; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tajima Y, 2004, PLANT CELL PHYSIOL, V45, P28, DOI 10.1093/pcp/pcg154; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Van Driessche N, 2005, NAT GENET, V37, P471, DOI 10.1038/ng1545; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	44	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e676	10.1371/journal.pone.0000676	http://dx.doi.org/10.1371/journal.pone.0000676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668056	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452300014
J	Santos, JG; Vomel, M; Struck, R; Homberg, U; Nassel, DR; Wegener, C				Santos, Jonathan G.; Voemel, Matthias; Struck, Rafael; Homberg, Uwe; Nassel, Dick R.; Wegener, Christian			Neuroarchitecture of Peptidergic Systems in the Larval Ventral Ganglion of Drosophila melanogaster	PLOS ONE			English	Article							PIGMENT-DISPERSING FACTOR; CENTRAL-NERVOUS-SYSTEM; CRUSTACEAN CARDIOACTIVE PEPTIDE; FMRFAMIDE NEUROPEPTIDE GENE; IMMUNOREACTIVE VPLI NEURONS; TACHYKININ-RELATED PEPTIDES; VASOPRESSIN-LIKE; CLOCK NEURONS; FRUIT-FLY; IMMUNOCYTOCHEMICAL LOCALIZATION	Recent studies on Drosophila melanogaster and other insects have revealed important insights into the functions and evolution of neuropeptide signaling. In contrast, in- and output connections of insect peptidergic circuits are largely unexplored. Existing morphological descriptions typically do not determine the exact spatial location of peptidergic axonal pathways and arborizations within the neuropil, and do not identify peptidergic in- and output compartments. Such information is however fundamental to screen for possible peptidergic network connections, a prerequisite to understand how the CNS controls the activity of peptidergic neurons at the synaptic level. We provide a precise 3D morphological description of peptidergic neurons in the thoracic and abdominal neuromeres of the Drosophila larva based on fasciclin-2 (Fas2) immunopositive tracts as landmarks. Comparing the Fas2 "coordinates'' of projections of sensory or other neurons with those of peptidergic neurons, it is possible to identify candidate in-and output connections of specific peptidergic systems. These connections can subsequently be more rigorously tested. By immunolabeling and GAL4-directed expression of marker proteins, we analyzed the projections and compartmentalization of neurons expressing 12 different peptide genes, encoding approximately 75% of the neuropeptides chemically identified within the Drosophila CNS. Results are assembled into standardized plates which provide a guide to identify candidate afferent or target neurons with overlapping projections. In general, we found that putative dendritic compartments of peptidergic neurons are concentrated around the median Fas2 tracts and the terminal plexus. Putative peptide release sites in the ventral nerve cord were also more laterally situated. Our results suggest that i) peptidergic neurons in the Drosophila ventral nerve cord have separated in- and output compartments in specific areas, and ii) volume transmission is a prevailing way of peptidergic communication within the CNS. The data can further be useful to identify colocalized transmitters and receptors, and develop peptidergic neurons as new landmarks.	[Santos, Jonathan G.; Voemel, Matthias; Struck, Rafael; Wegener, Christian] Univ Marburg, Dept Biol, Emmy Noether Neuropeptide Grp, Marburg, Germany; [Nassel, Dick R.] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	Philipps University Marburg; Stockholm University	Wegener, C (corresponding author), Univ Marburg, Dept Biol, Emmy Noether Neuropeptide Grp, Marburg, Germany.	wegener@staff.uni-marburg.de	Homberg, Uwe/AFH-8214-2022	Homberg, Uwe/0000-0002-8229-7236; Wegener, Christian/0000-0003-4481-3567	Deutsche Forschungsgemeinschaft (DFG) [We 2652/2-1,2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG We 2652/2-1,2) to CW.	AGNATI LF, 1995, NEUROSCIENCE, V69, P711, DOI 10.1016/0306-4522(95)00308-6; AGRICOLA H, 1985, CELL TISSUE RES, V239, P203, DOI 10.1007/BF00214920; AGRICOLA H. J., 1995, NERVOUS SYSTEMS INVE, P303; Allan DW, 2003, CELL, V113, P73, DOI 10.1016/S0092-8674(03)00204-6; ANDERSON MS, 1988, J NEUROSCI, V8, P242; Baggerman G, 2005, J MASS SPECTROM, V40, P250, DOI 10.1002/jms.744; Baraban SC, 2004, TRENDS NEUROSCI, V27, P135, DOI 10.1016/j.tins.2004.01.008; Bate Michael, 1993, P1013; Baumgardt M, 2007, PLOS BIOL, V5, P295, DOI 10.1371/journal.pbio.0050037; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broeck JV, 2001, PEPTIDES, V22, P241, DOI 10.1016/S0196-9781(00)00376-4; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; CANTERA R, 1992, CELL TISSUE RES, V269, P459, DOI 10.1007/BF00353901; CHIN AC, 1990, DNA CELL BIOL, V9, P263, DOI 10.1089/dna.1990.9.263; Choi MY, 2001, CELL TISSUE RES, V306, P459, DOI 10.1007/s00441-001-0467-x; Choi YJ, 2005, J COMP NEUROL, V482, P372, DOI 10.1002/cne.20419; Claeys I, 2002, PEPTIDES, V23, P807, DOI 10.1016/S0196-9781(01)00666-0; DIRCKSEN H, 1988, CELL TISSUE RES, V254, P347; DIRCKSEN H, 1987, CELL TISSUE RES, V250, P377; Dulcis D, 2005, J NEUROBIOL, V64, P259, DOI 10.1002/neu.20136; East PD, 1997, TISSUE CELL, V29, P347, DOI 10.1016/S0040-8166(97)80010-9; ECKERT M, 1981, CELL TISSUE RES, V217, P633; Eckert M, 2002, J COMP NEUROL, V452, P264, DOI 10.1002/cne.10382; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Ewer J, 2005, HORM BEHAV, V48, P418, DOI 10.1016/j.yhbeh.2005.05.018; Ewer J, 1996, J COMP NEUROL, V370, P330; Gade G, 1997, PHYSIOL REV, V77, P963, DOI 10.1152/physrev.1997.77.4.963; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; Hamasaka Y, 2006, J COMP NEUROL, V494, P314, DOI 10.1002/cne.20807; Hamasaka Y, 2005, J NEUROBIOL, V65, P225, DOI 10.1002/neu.20184; Hamasaka Y, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.43; Hartenstein V, 2006, J ENDOCRINOL, V190, P555, DOI 10.1677/joe.1.06964; HelfrichForster C, 1997, J COMP NEUROL, V380, P335, DOI 10.1002/(SICI)1096-9861(19970414)380:3<335::AID-CNE4>3.0.CO;2-3; Hewes RS, 2003, DEVELOPMENT, V130, P1771, DOI 10.1242/dev.00404; Hewes RS, 1998, J NEUROSCI, V18, P7138; HORODYSKI FM, 1993, EUR J BIOCHEM, V215, P221, DOI 10.1111/j.1432-1033.1993.tb18026.x; Husain QM, 2004, J NEUROBIOL, V59, P181, DOI 10.1002/neu.10309; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Ito K, 2003, MICROSC RES TECHNIQ, V62, P170, DOI 10.1002/jemt.10369; Johnson E, 2000, J INSECT PHYSIOL, V46, P1229, DOI 10.1016/S0022-1910(00)00043-3; Johnson E. C., 2006, Invertebrate neuropeptides and hormones: basic knowledge and recent advances, P179; Johnson EC, 2005, J EXP BIOL, V208, P1239, DOI 10.1242/jeb.01529; Katz PS, 1996, TRENDS NEUROSCI, V19, P54, DOI 10.1016/0166-2236(96)89621-4; Kean L, 2002, AM J PHYSIOL-REG I, V282, pR1297, DOI 10.1152/ajpregu.00584.2001; Kim YJ, 2004, P NATL ACAD SCI USA, V101, P6704, DOI 10.1073/pnas.0305291101; Kim YJ, 2006, CURR BIOL, V16, P1395, DOI 10.1016/j.cub.2006.06.027; KUPFERMANN I, 1991, PHYSIOL REV, V71, P683, DOI 10.1152/physrev.1991.71.3.683; KUTSCH W, 1994, ADV INSECT PHYSIOL, V24, P1, DOI 10.1016/S0065-2806(08)60082-X; Landgraf M, 2003, DEV BIOL, V260, P207, DOI 10.1016/S0012-1606(03)00215-X; Lee D, 2003, J NEUROSCI, V23, P4625; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lenz C, 2000, BIOCHEM BIOPH RES CO, V273, P1126, DOI 10.1006/bbrc.2000.3062; Lohr R, 2002, J NEUROSCI, V22, P10357; Luan HJ, 2006, J NEUROSCI, V26, P573, DOI 10.1523/JNEUROSCI.3916-05.2006; LUNDQUIST T, 1990, J COMP NEUROL, V294, P161, DOI 10.1002/cne.902940202; MADDRELL SH, 1964, J EXP BIOL, V41, P459; MARDER E, 1987, J COMP NEUROL, V259, P150, DOI 10.1002/cne.902590111; McIver S.B., 1985, P71; McNabb SL, 1997, NEURON, V19, P813, DOI 10.1016/S0896-6273(00)80963-0; Melcher C, 2006, PLOS BIOL, V4, P316, DOI 10.1371/journal.pbio.0040068; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Meng XJ, 2002, MECH DEVELOP, V117, P5, DOI 10.1016/S0925-4773(02)00175-2; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Mulloney B, 2003, MICROSC RES TECHNIQ, V60, P253, DOI 10.1002/jemt.10265; MURPHEY RK, 1985, J COMP PHYSIOL A, V156, P381, DOI 10.1007/BF00610730; Nassel DR, 2006, CELL TISSUE RES, V326, P1, DOI 10.1007/s00441-006-0210-8; NASSEL DR, 1992, J COMP NEUROL, V322, P45, DOI 10.1002/cne.903220105; NASSEL DR, 1989, J COMP NEUROL, V283, P450, DOI 10.1002/cne.902830312; Nassel DR, 2002, PROG NEUROBIOL, V68, P1, DOI 10.1016/S0301-0082(02)00057-6; Nassel DR, 1996, PROG NEUROBIOL, V48, P325, DOI 10.1016/0301-0082(95)00048-8; NEUPERT S, 2006, P INV NEUR C GUAN ME; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; Nusbaum MP, 2001, TRENDS NEUROSCI, V24, P146, DOI 10.1016/S0166-2236(00)01723-9; O'Brien MA, 1998, J EXP BIOL, V201, P193; Park JH, 1998, J BIOL RHYTHM, V13, P219, DOI 10.1177/074873098129000066; Park JH, 2003, DEVELOPMENT, V130, P2645, DOI 10.1242/dev.00503; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Persson MGS, 2001, J NEUROBIOL, V48, P19, DOI 10.1002/neu.1040; PFLUGER HJ, 1988, PHILOS T R SOC B, V321, P1, DOI 10.1098/rstb.1988.0090; Predel R, 2004, J COMP NEUROL, V474, P379, DOI 10.1002/cne.20145; Predel R, 2001, J COMP NEUROL, V436, P363; Predel R, 2001, PEPTIDES, V22, P199, DOI 10.1016/S0196-9781(00)00383-1; Predel R, 2007, J COMP NEUROL, V500, P498, DOI 10.1002/cne.21183; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Sanchez-Soriano N, 2005, DEV BIOL, V288, P126, DOI 10.1016/j.ydbio.2005.09.026; Santos JG, 2006, CELL TISSUE RES, V326, P187, DOI 10.1007/s00441-006-0211-7; SCHNEIDER LE, 1993, J COMP NEUROL, V337, P446, DOI 10.1002/cne.903370308; SCHNEIDER LE, 1988, P NATL ACAD SCI USA, V85, P1993, DOI 10.1073/pnas.85.6.1993; SCHNEIDER LE, 1991, J COMP NEUROL, V304, P608, DOI 10.1002/cne.903040408; Schrader S, 2000, J COMP NEUROL, V425, P34; Siviter RJ, 2000, J BIOL CHEM, V275, P23273, DOI 10.1074/jbc.M002875200; Strand P., 1999, P 4 INT C ENV RAD AR; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Suster ML, 2003, J NEUROBIOL, V55, P233, DOI 10.1002/neu.10202; TAGHERT PH, 1990, J NEUROSCI, V10, P1929; Taghert PH, 2003, ADV GENET, V49, P1, DOI 10.1016/S0065-2660(03)01001-0; Taylor CAM, 2004, J NEUROBIOL, V58, P379, DOI 10.1002/neu.10301; Terhzaz S, 1999, J EXP BIOL, V202, P3667; Terhzaz S, 2007, BIOCHEM BIOPH RES CO, V352, P305, DOI 10.1016/j.bbrc.2006.11.030; THOMPSON KSJ, 1991, J COMP PHYSIOL A, V168, P605, DOI 10.1007/BF00215083; THOMPSON KSJ, 1991, J COMP PHYSIOL A, V168, P619, DOI 10.1007/BF00215084; VEENSTRA JA, 1994, BIOCHEM BIOPH RES CO, V204, P292, DOI 10.1006/bbrc.1994.2458; VEENSTRA JA, 1991, PEPTIDES, V12, P1285, DOI 10.1016/0196-9781(91)90208-7; Verleyen P, 2004, BIOCHEM BIOPH RES CO, V320, P334, DOI 10.1016/j.bbrc.2004.05.173; Verleyen P, 2004, J NEUROCHEM, V88, P311, DOI 10.1046/j.1471-4159.2003.02161.x; Vitzthum H, 1996, J COMP NEUROL, V369, P419, DOI 10.1002/(SICI)1096-9861(19960603)369:3&lt;419::AID-CNE7&gt;3.0.CO;2-8; Vomel M, 2007, DEV NEUROBIOL, V67, P792, DOI 10.1002/dneu.20392; Wegener C, 2006, J NEUROCHEM, V96, P1362, DOI 10.1111/j.1471-4159.2005.03634.x; Wegener C, 2004, J NEUROPHYSIOL, V91, P912, DOI 10.1152/jn.00678.2003; WHITE K, 1986, J COMP NEUROL, V247, P430, DOI 10.1002/cne.902470403; Williamson M, 2001, BIOCHEM BIOPH RES CO, V281, P544, DOI 10.1006/bbrc.2001.4402; Winther AME, 2006, MOL CELL NEUROSCI, V31, P399, DOI 10.1016/j.mcn.2005.10.010; Winther AME, 2003, J COMP NEUROL, V464, P180, DOI 10.1002/cne.10790; Winther AME, 2001, J EXP BIOL, V204, P1269; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Yoon JG, 1995, J COMP NEUROL, V363, P475, DOI 10.1002/cne.903630310; Zawarzin A, 1924, Z WISS ZOOL ABT A, V122, P323; Zitnan D, 2004, COMPREHENSIVE MOL IN, P1; Zlatic M, 2003, NEURON, V37, P41, DOI 10.1016/S0896-6273(02)01131-5	121	51	51	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e695	10.1371/journal.pone.0000695	http://dx.doi.org/10.1371/journal.pone.0000695			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668072	gold, Green Published			2022-12-27	WOS:000207452300030
J	Suga, K; Welch, DM; Tanaka, Y; Sakakura, Y; Hagiwara, A				Suga, Koushirou; Welch, David Mark; Tanaka, Yukari; Sakakura, Yoshitaka; Hagiwara, Atsushi			Analysis of Expressed Sequence Tags of the Cyclically Parthenogenetic Rotifer Brachionus plicatilis	PLOS ONE			English	Article							POPULATION-GROWTH; GENE-EXPRESSION; SEXUAL REPRODUCTION; SPECIES COMPLEX; GENERATION; EVOLUTION; PATTERNS; DIFFERENTIATION; SPECIATION; PHYLOGENY	Background. Rotifers are among the most common non-arthropod animals and are the most experimentally tractable members of the basal assemblage of metazoan phyla known as Gnathifera. The monogonont rotifer Brachionus plicatilis is a developing model system for ecotoxicology, aquatic ecology, cryptic speciation, and the evolution of sex, and is an important food source for finfish aquaculture. However, basic knowledge of the genome and transcriptome of any rotifer species has been lacking. Methodology/Principal Findings. We generated and partially sequenced a cDNA library from B. plicatilis and constructed a database of over 2300 expressed sequence tags corresponding to more than 450 transcripts. About 20% of the transcripts had no significant similarity to database sequences by BLAST; most of these contained open reading frames of significant length but few had recognized Pfam motifs. Sixteen transcripts accounted for 25% of the ESTs; four of these had no significant similarity to BLAST or Pfam databases. Putative up-and downstream untranslated regions are relatively short and AT rich. In contrast to bdelloid rotifers, there was no evidence of a conserved trans-spliced leader sequence among the transcripts and most genes were single-copy. Conclusions/Significance. Despite the small size of this EST project it revealed several important features of the rotifer transcriptome and of individual monogonont genes. Because there is little genomic data for Gnathifera, the transcripts we found with no known function may represent genes that are species-, class-, phylum-or even superphylum-specific; the fact that some are among the most highly expressed indicates their importance. The absence of trans-spliced leader exons in this monogonont species contrasts with their abundance in bdelloid rotifers and indicates that the presence of this phenomenon can vary at the subphylum level. Our EST database provides a relatively large quantity of transcript-level data for B. plicatilis, and more generally of rotifers and other gnathiferan phyla, and can be browsed and searched at gmod.mbl.edu.	[Welch, David Mark] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA; [Suga, Koushirou; Tanaka, Yukari] Nagasaki Ind Promot Fdn, Omura, Japan; [Sakakura, Yoshitaka] Nagasaki Univ, Fac Fisheries, Nagasaki 852, Japan; [Hagiwara, Atsushi] Nagasaki Univ, Grad Sch Sci & Technol, Nagasaki 852, Japan	Marine Biological Laboratory - Woods Hole; Nagasaki University; Nagasaki University	Welch, DM (corresponding author), Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA.	dmarkwelch@mbl.edu	Hagiwara, Atsushi/O-3606-2018; Sakakura, Yoshitaka/AAL-9491-2020	Hagiwara, Atsushi/0000-0001-7514-8737; Sakakura, Yoshitaka/0000-0003-0205-8364; Mark Welch, David/0000-0001-9774-4580	Nagasaki Prefecture Collaboration of Regional Entities for the Advancement of Technological Excellence, Japan Science and Technology Agency; US NSF [EF-0412674, MCB-0544199]	Nagasaki Prefecture Collaboration of Regional Entities for the Advancement of Technological Excellence, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); US NSF(National Science Foundation (NSF))	This research was supported by the Nagasaki Prefecture Collaboration of Regional Entities for the Advancement of Technological Excellence, Japan Science and Technology Agency to KS, YT, YS and AH, and US NSF grants EF-0412674 and MCB-0544199 to DMW.	Allen E J, 1910, J MAR BIOL ASS, V8, P421, DOI [DOI 10.1017/50025315400073690, DOI 10.1017/S0025315400073690]; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ASAMIZU E, 1999, DNA RES, V6; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; CAIN GD, 1970, ARCH BIOCHEM BIOPHYS, V141, P264, DOI 10.1016/0003-9861(70)90131-1; Campillo S, 2005, HYDROBIOLOGIA, V546, P181, DOI 10.1007/s10750-005-4120-7; Caprioli M, 2004, COMP BIOCHEM PHYS A, V139, P527, DOI 10.1016/j.cbpb.2004.10.019; CHAO A, 1984, SCAND J STAT, V11, P265; Chen L, 2005, PLANT SCI, V168, P359, DOI 10.1016/j.plantsci.2004.08.009; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; CLEMENT P, 1993, HYDROBIOLOGIA, V255, P527, DOI 10.1007/BF00025882; Derry AM, 2003, LIMNOL OCEANOGR, V48, P675, DOI 10.4319/lo.2003.48.2.0675; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gallardo WG, 1997, HYDROBIOLOGIA, V358, P113, DOI 10.1023/A:1003124205002; Gallardo WG, 1999, J EXP MAR BIOL ECOL, V240, P179, DOI 10.1016/S0022-0981(99)00055-6; Giribet G, 2000, SYST BIOL, V49, P539, DOI 10.1080/10635159950127385; Gomez A, 2005, HYDROBIOLOGIA, V546, P83, DOI 10.1007/s10750-005-4104-7; Gomez A, 2002, EVOLUTION, V56, P1431; Gomez A, 2002, J EVOLUTION BIOL, V15, P158, DOI 10.1046/j.1420-9101.2002.00368.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HAGIWARA A, 1993, NIPPON SUISAN GAKK, V59, P93, DOI 10.2331/suisan.59.93; Hagiwara A, 2001, AQUACULTURE, V200, P111, DOI 10.1016/S0044-8486(01)00696-2; HAGIWARA A, 1994, ISR J AQUACULT-BAMID, V46, P13; Harcus YM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r39; Hastings KEM, 2005, TRENDS GENET, V21, P240, DOI 10.1016/j.tig.2005.02.005; HIRAYAMA K, 1983, B JPN SOC SCI FISH, V49, P505; Hutchinson G. E., 1957, TREATISE LIMNOLOGY, VI; Kaneko G, 2005, HYDROBIOLOGIA, V546, P117, DOI 10.1007/s10750-005-4107-4; Kaneko G, 2002, FISHERIES SCI, V68, P1317, DOI 10.1046/j.1444-2906.2002.00570.x; Lapinski J, 2003, FEBS LETT, V553, P387, DOI 10.1016/S0014-5793(03)01062-7; Lee YM, 2005, MAR POLLUT BULL, V51, P757, DOI 10.1016/j.marpolbul.2005.02.014; Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525; Marcial HS, 2005, HYDROBIOLOGIA, V546, P569, DOI 10.1007/s10750-005-4302-3; Markus R, 2005, IMMUNOL LETT, V101, P108, DOI 10.1016/j.imlet.2005.03.021; Miyakawa M., 1988, Suisan Zoshoku, V35, P237; Nakamura Kazuyo, 1994, Mycoscience, V35, P383, DOI 10.1007/BF02268509; Ortells R, 2003, FRESHWATER BIOL, V48, P2194, DOI 10.1046/j.1365-2427.2003.01159.x; Ortells R, 2000, ARCH HYDROBIOL, V149, P529; Papakostas S, 2005, MAR BIOL, V147, P1129, DOI 10.1007/s00227-005-0012-7; Pouchkina-Stantcheva NN, 2005, MOL BIOL EVOL, V22, P1482, DOI 10.1093/molbev/msi139; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sawbridge T, 2003, PLANT SCI, V165, P1077, DOI 10.1016/S0168-9452(03)00303-0; SCOTT JM, 1983, HYDROBIOLOGIA, V104, P155, DOI 10.1007/BF00045963; Serrano MG, 2002, EQUINE VET J, V34, P135; Snell TW, 2006, MAR BIOL, V149, P763, DOI 10.1007/s00227-006-0251-2; Snell TW, 2003, ECOTOXICOLOGY, V12, P475, DOI 10.1023/B:ECTX.0000003033.09923.a8; Snell TW, 1995, HYDROBIOLOGIA, V313, P231, DOI 10.1007/BF00025956; Snell TW, 1999, CUR TOP ECOTOX ENVIR, P169; Stelzer CP, 2003, LIMNOL OCEANOGR, V48, P939, DOI 10.4319/lo.2003.48.2.0939; Suatoni E, 2006, MOL PHYLOGENET EVOL, V41, P86, DOI 10.1016/j.ympev.2006.04.025; Wallace R.L., 2001, ECOLOGY CLASSIFICATI, P187; Watanabe H, 2005, GENOME, V48, P606, DOI 10.1139/G05-038; Welch DBM, 2000, INVERTEBR BIOL, V119, P17; Welch DBM, 2001, HYDROBIOLOGIA, V446, P315, DOI 10.1023/A:1017502923286; Welch DBM, 2001, HYDROBIOLOGIA, V446, P333, DOI 10.1023/A:1017511108265; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; Yang YZ, 2003, FEBS LETT, V538, P183, DOI 10.1016/S0014-5793(03)00164-9; Yoshinaga T, 2003, J EXP MAR BIOL ECOL, V287, P261, DOI 10.1016/S0022-0981(02)00574-9	60	50	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e671	10.1371/journal.pone.0000671	http://dx.doi.org/10.1371/journal.pone.0000671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668053	Green Published, gold			2022-12-27	WOS:000207452300011
J	Zacksenhouse, M; Lebedev, MA; Carmena, JM; O'Doherty, JE; Henriquez, C; Nicolelis, MAL				Zacksenhouse, Miriam; Lebedev, Mikhail A.; Carmena, Jose M.; O'Doherty, Joseph E.; Henriquez, Craig; Nicolelis, Miguel A. L.			Cortical Modulations Increase in Early Sessions with Brain-Machine Interface	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; DORSAL; MODELS; REPRESENTATION; PREDICTION; MOVEMENTS; NEURONS; NOISE	Background. During planning and execution of reaching movements, the activity of cortical motor neurons is modulated by a diversity of motor, sensory, and cognitive signals. Brain-machine interfaces (BMIs) extract part of these modulations to directly control artificial actuators. However, cortical modulations that emerge in the novel context of operating the BMI are poorly understood. Methodology/Principal Findings. Here we analyzed the changes in neuronal modulations that occurred in different cortical motor areas as monkeys learned to use a BMI to control reaching movements. Using spike-train analysis methods we demonstrate that the modulations of the firing-rates of cortical neurons increased abruptly after the monkeys started operating the BMI. Regression analysis revealed that these enhanced modulations were not correlated with the kinematics of the movement. The initial enhancement in firing rate modulations declined gradually with subsequent training in parallel with the improvement in behavioral performance. Conclusions/Significance. We conclude that the enhanced modulations are related to computational tasks that are significant especially in novel motor contexts. Although the function and neuronal mechanism of the enhanced cortical modulations are open for further inquiries, we discuss their potential role in processing execution errors and representing corrective or explorative activity. These representations are expected to contribute to the formation of internal models of the external actuator and their decoding may facilitate BMI improvement.	[Zacksenhouse, Miriam] Technion Israel Inst Technol, Fac Mech Engn, IL-32000 Haifa, Israel; [Lebedev, Mikhail A.; Carmena, Jose M.; Nicolelis, Miguel A. L.] Duke Univ, Dept Neurobiol, Durham, NC USA; [Lebedev, Mikhail A.; Carmena, Jose M.; Henriquez, Craig; Nicolelis, Miguel A. L.] Duke Univ, Ctr Neuroengn, Durham, NC USA; [O'Doherty, Joseph E.; Henriquez, Craig; Nicolelis, Miguel A. L.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Nicolelis, Miguel A. L.] Duke Univ, Dept Psychol & Brain Sci, Durham, NC USA	Technion Israel Institute of Technology; Duke University; Duke University; Duke University; Duke University	Zacksenhouse, M (corresponding author), Technion Israel Inst Technol, Fac Mech Engn, IL-32000 Haifa, Israel.	mermz@tx.technion.ac.il	O'Doherty, Joseph E/D-5116-2009; Lebedev, Mikhail A/H-5066-2016	O'Doherty, Joseph E/0000-0001-8175-5699; Lebedev, Mikhail A/0000-0003-0355-8723; Zacksenhouse, Miriam/0000-0003-3022-5449	DARPA; James S. McDonnel Foundation; NIH; NSF; Christopher Reeve Paralysis Foundation	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); James S. McDonnel Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Christopher Reeve Paralysis Foundation	This work was supported by grants from DARPA, the James S. McDonnel Foundation, NIH and NSF to MALN, the Christopher Reeve Paralysis Foundation to JMC, and the Fund for promotion of Research at the Technion to MZ.	ASHE J, 1994, CEREB CORTEX, V4, P590, DOI 10.1093/cercor/4.6.590; Bizzi E, 1998, TRENDS COGN SCI, V2, P97, DOI 10.1016/S1364-6613(98)01146-2; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Clower DM, 1996, NATURE, V383, P618, DOI 10.1038/383618a0; Dayan P, 2001, COMPUTATIONAL NEUROS; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; FANO U, 1947, PHYS REV, V72, P26, DOI 10.1103/PhysRev.72.26; Flanagan JR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-20-j0005.1999; Georgopoulos AP, 2000, CURR OPIN NEUROBIOL, V10, P238, DOI 10.1016/S0959-4388(00)00072-6; GEORGOPOULOS AP, 1992, SCIENCE, V256, P1692, DOI 10.1126/science.256.5064.1692; GEORGOPOULOS AP, 1989, SCIENCE, V243, P234, DOI 10.1126/science.2911737; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Golub GH., 2013, MATRIX COMPUTATIONS; Gomez JE, 2000, EUR J NEUROSCI, V12, P3748, DOI 10.1046/j.1460-9568.2000.00232.x; Hansen P.C., 1998, RANK DEFICIENT DISCR; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hoshi E, 2004, PROG BRAIN RES, V143, P507, DOI 10.1016/S0079-6123(03)43047-1; Johnson DH, 1996, J COMPUT NEUROSCI, V3, P275, DOI 10.1007/BF00161089; Johnson MTV, 2001, CURR OPIN NEUROBIOL, V11, P684, DOI 10.1016/S0959-4388(01)00269-0; JORDAN MI, 1992, COGNITIVE SCI, V16, P307, DOI 10.1207/s15516709cog1603_1; Kawagoe A, 1999, IEEE T APPL SUPERCON, V9, P727, DOI 10.1109/77.783398; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; Kirby M, 2001, GEOMETRIC DATA ANAL; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Laubach M, 2000, NATURE, V405, P567, DOI 10.1038/35014604; Lebedev MA, 2005, J NEUROSCI, V25, P4681, DOI 10.1523/JNEUROSCI.4088-04.2005; Lee JH, 2006, J NEUROSCI, V26, P3330, DOI 10.1523/JNEUROSCI.3898-05.2006; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Nicolelis MAL, 2001, NATURE, V409, P403, DOI 10.1038/35053191; Nicolelis MAL, 2003, NAT REV NEUROSCI, V4, P417, DOI 10.1038/nrn1105; Padoa-Schioppa C, 2004, J NEUROPHYSIOL, V91, P449, DOI 10.1152/jn.00876.2002; Passaglia CL, 2004, J NEUROPHYSIOL, V92, P1023, DOI 10.1152/jn.01089.2003; Paz R, 2003, NAT NEUROSCI, V6, P882, DOI 10.1038/nn1097; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Scott SH, 2003, CURR OPIN NEUROBIOL, V13, P671, DOI 10.1016/j.conb.2003.10.012; SNYDER DL, 1975, POINT PROCESSES; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2	45	44	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2007	2	7							e619	10.1371/journal.pone.0000619	http://dx.doi.org/10.1371/journal.pone.0000619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GI	17637835	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452100009
J	Cai, XJ				Cai, Xinjiang			Molecular Evolution and Functional Divergence of the Ca(2+) Sensor Protein in Store-operated Ca(2+) Entry: Stromal Interaction Molecule	PLOS ONE			English	Article								Receptor-mediated Ca(2+) signaling in many non-excitable cells initially induces Ca(2+) release from intracellular Ca(2+) stores, followed by Ca(2+) influx across the plasma membrane. Recent findings have suggested that stromal interaction molecules (STIMs) function as the Ca(2+) sensor to detect changes of Ca(2+) content in the intracellular Ca(2+) stores. Human STIMs and invertebrate STIM share several functionally important protein domains, but diverge significantly in the C-terminus. To better understand the evolutionary significance of STIM activity, phylogenetic analysis of the STIM protein family was conducted after extensive database searching. Results from phylogeny and sequence analysis revealed early adaptation of the C-terminal divergent domains in Urochordata, before the expansion of STIMs in Vertebrata. STIMs were subsequently subjected to one round of gene duplication as early as in the Euteleostomi lineage in vertebrates, with a second round of fish-specific gene duplication. After duplication, STIM-1 and STIM-2 molecules appeared to have undergone purifying selection indicating strong evolutionary constraints within each group. Furthermore, sequence analysis of the EF-hand Ca(2+) binding domain and the SAM domain, together with functional divergence studies, identified critical regions/residues likely underlying functional changes, and provided evidence for the hypothesis that STIM-1 and STIM-2 might have developed distinct functional properties after duplication.	[Cai, Xinjiang] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University	Cai, XJ (corresponding author), Duke Univ, Med Ctr, Dept Med Cardiol, Durham, NC 27710 USA.	xinjiang.cai@duke.edu	Cai, Xinjiang/F-4843-2010	Cai, Xinjiang/0000-0001-8933-7133				Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bruno WJ, 2000, MOL BIOL EVOL, V17, P189, DOI 10.1093/oxfordjournals.molbev.a026231; CAI X, 2007, 2007 7 EUR S PROT SO, P133; Cai XJ, 2007, J MOL BIOL, V368, P1284, DOI 10.1016/j.jmb.2007.03.022; Cai XJ, 2006, MOL BIOL EVOL, V23, P550, DOI 10.1093/molbev/msj056; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Grimshaw SJ, 2004, J BIOL CHEM, V279, P2192, DOI 10.1074/jbc.M305605200; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Hille B., 2001, ION CHANNELS EXCITAB, P814; HOLLAND PWH, 1994, DEVELOPMENT, P125; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; KIM CA, 1993, NATURE, V362, P270; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Leveugle M, 2004, J MOL EVOL, V58, P168, DOI 10.1007/s00239-003-2538-y; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; LORINNEBEL C, 2007, J PHYSL; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; Nicholas K.B., 1997, EMBNETNEWS, V4, P1; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schultz J, 1997, PROTEIN SCI, V6, P249; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SHAW GS, 1992, BIOCHEMISTRY-US, V31, P9572, DOI 10.1021/bi00155a009; Smyth JT, 2006, BBA-MOL CELL RES, V1763, P1147, DOI 10.1016/j.bbamcr.2006.08.050; Soboloff J, 2006, BBA-MOL CELL RES, V1763, P1161, DOI 10.1016/j.bbamcr.2006.09.023; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; STRANGE K, 2007, CELL CALCIU IN PRESS, DOI DOI 10.1016/J.CECA.2007.1002.1007; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Taylor CW, 2006, TRENDS BIOCHEM SCI, V31, P597, DOI 10.1016/j.tibs.2006.09.007; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yan XH, 2006, J GEN PHYSIOL, V128, P443, DOI 10.1085/jgp.200609611; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	51	38	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2007	2	7							e609	10.1371/journal.pone.0000609	http://dx.doi.org/10.1371/journal.pone.0000609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GH	17622354	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452000016
J	Vedder, AC; Linthorst, GE; Houge, G; Groener, JEM; Ormel, EE; Bouma, BJ; Aerts, JMFG; Hirth, A; Hollak, CEM				Vedder, Anouk C.; Linthorst, Gabor E.; Houge, Gunnar; Groener, Johannna E. M.; Ormel, Els E.; Bouma, Berto J.; Aerts, Johannes M. F. G.; Hirth, Asle; Hollak, Carla E. M.			Treatment of Fabry Disease: Outcome of a Comparative Trial with Agalsidase Alfa or Beta at a Dose of 0.2 mg/kg	PLOS ONE			English	Article							ENZYME-REPLACEMENT THERAPY; RENAL-FUNCTION; GALACTOSIDASE; SAFETY; PRECISION; INFUSION; EFFICACY	Background. Two different enzyme preparations, agalsidase alfa (Replagal (TM), Shire) and beta (Fabrazyme (TM), Genzyme), are registered for treatment of Fabry disease. We compared the efficacy of and tolerability towards the two agalsidase preparations administered at identical protein dose in a randomized controlled open label trial. Methodology/Principal Findings. Thirty-four Fabry disease patients were treated with either agalsidase alfa or agalsidase beta at equal dose of 0.2 mg/kg biweekly. Primary endpoint was reduction in left ventricular mass after 12 and 24 months of treatment. Other endpoints included occurrence of treatment failure (defined as progression of cardiac, renal or cerebral disease), glomerular filtration rate, pain, anti-agalsidase antibodies, and globotriaosylceramide levels in plasma and urine. After 12 and 24 months of treatment no reduction in left ventricular mass was seen, which was not different between the two treatment groups. Also, no differences in glomerular filtration rate, pain and decline in globotriaosylceramide levels were found. Antibodies developed only in males (4/8 in the agalsidase alfa group and 6/8 in the agalsidase beta group). Treatment failure within 24 months of therapy was seen in 8/34 patients: 6 male patients (3 in each treatment group) and 2 female patients (both agalsidase alfa). The occurrence of treatment failures did not differ between the two treatment groups; chi(2) = 0.38 p = 0.54. Conclusion. Our study revealed no difference in reduction of left ventricular mass or other disease parameters after 12 and 24 months of treatment with either agalsidase alfa or beta at a dose of 0.2 mg/kg biweekly. Treatment failure occurred frequently in both groups and seems related to age and severe pre-treatment disease. Trial Registration. International Standard Randomized Clinical Trial ISRCTN45178534	[Vedder, Anouk C.; Linthorst, Gabor E.; Ormel, Els E.; Hollak, Carla E. M.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands; [Vedder, Anouk C.; Linthorst, Gabor E.; Groener, Johannna E. M.; Aerts, Johannes M. F. G.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Houge, Gunnar] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Bouma, Berto J.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Hirth, Asle] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Bergen; Haukeland University Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Bergen; Haukeland University Hospital	Hollak, CEM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med Endocrinol & Metab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.e.hollak@amc.uva.nl	Aerts, Johannes/A-1028-2009	Aerts, Johannes/0000-0001-8168-2565; Bouma, Berto/0000-0002-1433-9692	Dutch Health Care Insurance Board	Dutch Health Care Insurance Board	The sponsor (Dutch Health Care Insurance Board) had no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript.	[Anonymous], 2014, METABOLIC MOL BASES; Apperloo AJ, 1996, J AM SOC NEPHROL, V7, P567; Banikazemi M, 2007, ANN INTERN MED, V146, P77, DOI 10.7326/0003-4819-146-2-200701160-00148; Beck M, 2004, EUR J CLIN INVEST, V34, P838, DOI 10.1111/j.1365-2362.2004.01424.x; Bengtsson BA, 2003, LANCET, V361, P352, DOI 10.1016/S0140-6736(03)12357-4; Blom D, 2003, AM J HUM GENET, V72, P23, DOI 10.1086/345309; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; Breunig F, 2006, KIDNEY INT, V69, P1216, DOI 10.1038/sj.ki.5000208; CABLE WJL, 1982, NEUROLOGY, V32, P1139; Desnick RJ, 2004, EXPERT OPIN BIOL TH, V4, P1167, DOI 10.1517/14712598.4.7.1167; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; *FDA, 2002, FDA BRIEF REP REPL; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gaspari F, 1998, J AM SOC NEPHROL, V9, P310; Hoffmann B, 2005, J MED GENET, V42, P247, DOI 10.1136/jmg.2004.025791; Hopkin RJ, 2003, GENET MED, V5, P144, DOI 10.1097/01.GIM.0000069509.57929.CD; KINT J A, 1970, Science (Washington D C), V167, P1268, DOI 10.1126/science.167.3922.1268; Lee SY, 2003, J MICROBIOL BIOTECHN, V13, P313; LEVY D, 1987, AM J CARDIOL, V59, P956, DOI 10.1016/0002-9149(87)91133-7; Linthorst GE, 2004, KIDNEY INT, V66, P1589, DOI 10.1111/j.1523-1755.2004.00924.x; MacDermot KD, 2001, J MED GENET, V38, P769, DOI 10.1136/jmg.38.11.769; Mignani R, 2004, J NEPHROL, V17, P354; Palmieri V, 1999, J AM COLL CARDIOL, V34, P1625, DOI 10.1016/S0735-1097(99)00396-4; Pastores GM, 2001, LANCET, V358, P601, DOI 10.1016/S0140-6736(01)05816-0; RedonnetVernhet I, 1996, J MED GENET, V33, P682, DOI 10.1136/jmg.33.8.682; Ries M, 2005, PEDIATRICS, V115, pE344, DOI 10.1542/peds.2004-1678; Sakuraba H, 2006, J HUM GENET, V51, P180, DOI 10.1007/s10038-005-0342-9; Schiffmann R, 2003, MUSCLE NERVE, V28, P703, DOI 10.1002/mus.10497; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schiffmann R, 2006, NEPHROL DIAL TRANSPL, V21, P345, DOI 10.1093/ndt/gfi152; Schwarting A, 2006, CLIN NEPHROL, V66, P77; Spinelli L, 2004, CLIN GENET, V66, P158, DOI 10.1111/j.1399-0004.2004.00284.x; Taketomi T, 1996, J BIOCHEM-TOKYO, V120, P573; Weidemann F, 2003, CIRCULATION, V108, P1299, DOI 10.1161/01.CIR.0000091253.71282.04; Whitfield PD, 2005, J INHERIT METAB DIS, V28, P21, DOI 10.1007/s10545-005-4415-x; Whybra C, 2004, CLIN GENET, V65, P299, DOI 10.1111/j.1399-0004.2004.00219.x; Wilcox WR, 2004, AM J HUM GENET, V75, P65, DOI 10.1086/422366	37	155	163	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2007	2	7							e598	10.1371/journal.pone.0000598	http://dx.doi.org/10.1371/journal.pone.0000598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GH	17622343	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452000005
J	Amela, I; Cedano, J; Querol, E				Amela, Isaac; Cedano, Juan; Querol, Enrique			Pathogen Proteins Eliciting Antibodies Do Not Share Epitopes with Host Proteins: A Bioinformatics Approach	PLOS ONE			English	Article								The best way to prevent diseases caused by pathogens is by the use of vaccines. The advent of genomics enables genome-wide searches of new vaccine candidates, called reverse vaccinology. The most common strategy to apply reverse vaccinology is by designing subunit recombinant vaccines, which usually generate an humoral immune response due to B-cell epitopes in proteins. A major problem for this strategy is the identification of protective immunogenic proteins from the surfome of the pathogen. Epitope mimicry may lead to auto-immune phenomena related to several human diseases. A sequence-based computational analysis has been carried out applying the BLASTP algorithm. Therefore, two huge databases have been created, one with the most complete and current linear B-cell epitopes, and the other one with the surface-protein sequences of the main human respiratory bacterial pathogens. We found that none of the 7353 linear B-cell epitopes analysed shares any sequence identity region with human proteins capable of generating antibodies, and that only 1% of the 2175 exposed proteins analysed contain a stretch of shared sequence with the human proteome. These findings suggest the existence of a mechanism to avoid autoimmunity. We also propose a strategy for corroborating or warning about the viability of a protein linear B-cell epitope as a putative vaccine candidate in a reverse vaccinology study; so, epitopes without any sequence identity with human proteins should be very good vaccine candidates, and the other way around.	[Querol, Enrique] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Querol, E (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.	enric.querol@uab.es	Cedano, Juan/HIR-3692-2022	Cedano, Juan/0000-0003-1380-8036	European Union [LSHB-CT-2006-037325]; MEC (Ministerio de Educacion y Ciencia, Spain) [BFU2004-06377-CO2-01]; Centre de Referencia de R+D de Biotecnologia de la Generalitat de Catalunya; UAB (Universitat Autonoma de Barcelona)	European Union(European Commission); MEC (Ministerio de Educacion y Ciencia, Spain)(Spanish Government); Centre de Referencia de R+D de Biotecnologia de la Generalitat de Catalunya(Generalitat de Catalunya); UAB (Universitat Autonoma de Barcelona)	This research was supported by Grants LSHB-CT-2006-037325 funded under the Sixth Research Framework Programme of the European Union; BFU2004-06377-CO2-01 from the MEC (Ministerio de Educacion y Ciencia, Spain); and by the Centre de Referencia de R+D de Biotecnologia de la Generalitat de Catalunya. I. Amela is a predoctoral fellowship recipient from the UAB (Universitat Autonoma de Barcelona).	Abdissa A, 2006, CLIN INFECT DIS, V42, P1362, DOI 10.1086/503422; Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001; ALAALDEEN DAA, 1994, INFECT IMMUN, V62, P2984, DOI 10.1128/IAI.62.7.2984-2990.1994; AlaAldeen DAA, 1996, VACCINE, V14, P49, DOI 10.1016/0264-410X(95)00136-O; Aloy P, 1997, COMPUT APPL BIOSCI, V13, P231; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ASKELOF P, 1990, P NATL ACAD SCI USA, V87, P1347, DOI 10.1073/pnas.87.4.1347; Banks DJ, 2004, J INFECT DIS, V190, P727, DOI 10.1086/422697; Bannantine JP, 2000, CELL MICROBIOL, V2, P35; Beghetto E, 2006, FEMS MICROBIOL LETT, V262, P14, DOI 10.1111/j.1574-6968.2006.00360.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benner GE, 1999, INFECT IMMUN, V67, P1922; Benoist C, 2001, NAT IMMUNOL, V2, P797, DOI 10.1038/ni0901-797; Birkeland HCG, 2004, CURR TOP MICROBIOL, V282, P89; Borchardt JK, 2004, DRUG NEWS PERSPECT, V17, P219, DOI 10.1358/dnp.2004.17.3.829020; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chang B, 2005, INFECT IMMUN, V73, P4272, DOI 10.1128/IAI.73.7.4272-4280.2005; Chatenoud L, 2000, Rev Prat, V50, P1497; Chiavolini D, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-14; Corech R, 2005, J CLIN MICROBIOL, V43, P3956, DOI 10.1128/JCM.43.8.3956-3962.2005; DIAS WO, 1994, BRAZ J MED BIOL RES, V27, P2607; DUCHENE M, 1989, J BACTERIOL, V171, P4130; El-Adhami W, 1999, INFECT IMMUN, V67, P1935; Erkkila L, 2004, ATHEROSCLEROSIS, V177, P321, DOI 10.1016/j.atherosclerosis.2004.08.021; Finco O, 2005, VACCINE, V23, P1178, DOI 10.1016/j.vaccine.2004.07.045; Fitzpatrick DA, 2005, J MOL EVOL, V61, P90, DOI 10.1007/s00239-004-0290-6; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gattiker A, 2003, COMPUT BIOL CHEM, V27, P49, DOI 10.1016/S1476-9271(02)00094-4; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932; Guzman CA, 1999, J INFECT DIS, V179, P901, DOI 10.1086/314655; Hausman SZ, 2000, INFECT IMMUN, V68, P3763, DOI 10.1128/IAI.68.6.3763-3767.2000; JANSON H, 1993, INFECT IMMUN, V61, P4546, DOI 10.1128/IAI.61.11.4546-4552.1993; Keil DJ, 1999, VACCINE, V18, P860, DOI 10.1016/S0264-410X(99)00322-9; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Li B, 2005, INFECT IMMUN, V73, P3734, DOI 10.1128/IAI.73.6.3734-3739.2005; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Liu DF, 2004, INFECT IMMUN, V72, P6961, DOI 10.1128/IAI.72.12.6961-6968.2004; LUGTENBERG B, 1986, INFECT IMMUN, V52, P175, DOI 10.1128/IAI.52.1.175-182.1986; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Mascarell L, 2005, J VIROL, V79, P9872, DOI 10.1128/JVI.79.15.9872-9884.2005; Mattoo S, 2000, INFECT IMMUN, V68, P2024, DOI 10.1128/IAI.68.4.2024-2033.2000; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McArthur JD, 2006, MOL MICROBIOL, V59, P1, DOI 10.1111/j.1365-2958.2005.04967.x; McMillan DJ, 2004, FEMS IMMUNOL MED MIC, V40, P249, DOI 10.1016/S0928-8244(04)00003-3; Miyamoto Y, 2007, EXP CELL RES, V313, P791, DOI 10.1016/j.yexcr.2006.11.017; Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002; Moss J, 2001, INFECT IMMUN, V69, P1185, DOI 10.1128/IAI.69.2.1185-1188.2001; Moyle PM, 2006, J ORG CHEM, V71, P6846, DOI 10.1021/jo060960p; Murphy TF, 2006, INFECT IMMUN, V74, P5169, DOI 10.1128/IAI.00692-06; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; NOVOTNY P, 1991, J INFECT DIS, V164, P114, DOI 10.1093/infdis/164.1.114; NOVOTNY P, 1991, DEV BIOLOGICALS, V73, P243; Okamoto S, 2005, VACCINE, V23, P4852, DOI 10.1016/j.vaccine.2005.02.035; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Philipovskiy AV, 2005, INFECT IMMUN, V73, P1532, DOI 10.1128/IAI.73.3.1532-1542.2005; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; POOLMAN JT, 1995, INFECT AGENT DIS, V4, P13; Price BM, 2001, INFECT IMMUN, V69, P3510, DOI 10.1128/IAI.69.5.3510-3515.2001; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; Rappuoli R, 2003, SCIENCE, V302, P602, DOI 10.1126/science.1092329; Ring G O, 1927, Trans Am Ophthalmol Soc, V25, P93; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Saha S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-79; Saha S., 2004, BCEPRED PREDICTION C; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Sambri V, 2004, VACCINE, V22, P1131, DOI 10.1016/j.vaccine.2003.09.035; Seepersaud R, 2005, INFECT IMMUN, V73, P1671, DOI 10.1128/IAI.73.3.1671-1683.2005; Thomas LD, 2003, FEMS IMMUNOL MED MIC, V37, P155, DOI 10.1016/S0928-8244(03)00073-7; Toseland Christopher P, 2005, Immunome Res, V1, P4, DOI 10.1186/1745-7580-1-4; Turner PC, 2001, MICROBIOL-SGM, V147, P1277, DOI 10.1099/00221287-147-5-1277; Umelo-Njaka E, 2001, VACCINE, V19, P1406, DOI 10.1016/S0264-410X(00)00362-5; van den Elsen J, 1999, J BIOL CHEM, V274, P1495, DOI 10.1074/jbc.274.3.1495; Vermont C, 2002, FEMS IMMUNOL MED MIC, V34, P89, DOI 10.1111/j.1574-695X.2002.tb00608.x; Viau M, 2005, MOL IMMUNOL, V42, P849, DOI 10.1016/j.molimm.2004.07.047; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Vohra H, 2005, RES MICROBIOL, V156, P575, DOI 10.1016/j.resmic.2004.12.009; Vytvytska O, 2002, PROTEOMICS, V2, P580, DOI 10.1002/1615-9861(200205)2:5<580::AID-PROT580>3.0.CO;2-G; WEERATNA R, 1994, INFECT IMMUN, V62, P3454, DOI 10.1128/IAI.62.8.3454-3462.1994; Weichhart T, 2003, INFECT IMMUN, V71, P4633, DOI 10.1128/IAI.71.8.4633-4641.2003; Welsch JA, 2004, J IMMUNOL, V172, P5606, DOI 10.4049/jimmunol.172.9.5606; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; Worgall S, 2005, J CLIN INVEST, V115, P1281, DOI 10.1172/JCI200523135; Zagursky RJ, 2000, INFECT IMMUN, V68, P2525, DOI 10.1128/IAI.68.5.2525-2534.2000	84	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e512	10.1371/journal.pone.0000512	http://dx.doi.org/10.1371/journal.pone.0000512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551592	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451500021
J	Bejon, P; Ogada, E; Mwangi, T; Milligan, P; Lang, T; Fegan, G; Gilbert, SC; Peshu, N; Marsh, K; Hill, AVS				Bejon, Philip; Ogada, Edna; Mwangi, Tabitha; Milligan, Paul; Lang, Trudie; Fegan, Greg; Gilbert, Sarah C.; Peshu, Norbert; Marsh, Kevin; Hill, Adrian V. S.			Extended Follow-Up Following a Phase 2b Randomized Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in Kenya	PLOS ONE			English	Article								Background. "FFM ME-TRAP" is sequential immunisation with two attenuated poxvirus vectors (FP9 and modified vaccinia virus Ankara) delivering the pre-erythrocytic malaria antigen ME-TRAP. Over nine months follow-up in our original study, there was no evidence that FFM ME-TRAP provided protection against malaria. The incidence of malaria was slightly higher in children who received FFM ME-TRAP, but this was not statistically significant (hazard ratio 1.5, 95% CI 1.0-2.3). Although the study was unblinded, another nine months follow-up was planned to monitor the incidence of malaria and other serious adverse events. Methods and Findings. 405 children aged 1-6 yrs were initially randomized to vaccination with either FFM ME-TRAP or control (rabies vaccine). 380 children were still available for follow-up after the first nine months. Children were seen weekly and whenever they were unwell for nine months monitoring. The axillary temperature was measured, and blood films taken when febrile. The primary analysis was time to parasitaemia >2,500/mu l. During the second nine months monitoring, 49 events met the primary endpoint (febrile malaria with parasites >2,500/mu l) in the Intention To Treat (ITT) group. 23 events occurred among the 189 children in the FFM ME-TRAP group, and 26 among the 194 children in the control group. In the full 18 months of monitoring, there were 63 events in the FFM ME-TRAP group and 60 in the control group (HR = 1.2, CI 0.84-1.73, p = 0.35). There was no evidence that the HR changed over the 18 months (test for interaction between time and vaccination p = 0.11). Conclusions. Vaccination with FFM ME-TRAP was not protective against malaria in this study. Malaria incidence during 18 months of surveillance was similar in both vaccine groups. Trial Registration. Controlled-Trials.com ISRCTN88335123	[Bejon, Philip; Ogada, Edna; Mwangi, Tabitha; Fegan, Greg; Peshu, Norbert; Marsh, Kevin] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; [Mwangi, Tabitha; Lang, Trudie; Hill, Adrian V. S.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Mwangi, Tabitha; Fegan, Greg] London Sch Hyg & Trop Med, London WC1, England; [Gilbert, Sarah C.; Hill, Adrian V. S.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Marsh, Kevin] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England	Kenya Medical Research Institute; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Bejon, P (corresponding author), Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya.	pbejon@well.ox.ac.uk	Milligan, Paul/D-8985-2017; Fegan, Greg/O-8079-2018	Milligan, Paul/0000-0003-3430-3395; Gilbert, Sarah/0000-0002-6823-9750; Fegan, Greg/0000-0002-2663-2765; Ogada, Edna/0000-0003-0181-2505	Wellcome Trust [073597]; Gates Malaria Partnership at the London School of Hygiene and Tropical Medicine	Wellcome Trust(Wellcome TrustEuropean Commission); Gates Malaria Partnership at the London School of Hygiene and Tropical Medicine	PB holds a Wellcome Trust training fellowship (073597), KM is supported by the Wellcome Trust and AVSH is a Wellcome Trust Principal Research Fellow. The study was funded by the Wellcome Trust and the Gates Malaria Partnership at the London School of Hygiene and Tropical Medicine. The funders had no role in trial design, conduct, analysis, presentation or decision to publish.	BEJON P, 2006, VACCINE; Bejon P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010029; Flanagan KL, 2006, AM J TROP MED HYG, V74, P367, DOI 10.4269/ajtmh.2006.74.367; Gilbert SC, 1997, NAT BIOTECHNOL, V15, P1280, DOI 10.1038/nbt1197-1280; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Webster DP, 2005, P NATL ACAD SCI USA, V102, P4836, DOI 10.1073/pnas.0406381102	7	51	54	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e707	10.1371/journal.pone.0000707	http://dx.doi.org/10.1371/journal.pone.0000707			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710125	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000207455200002
J	Mor, Z; Kent, CK; Kohn, RP; Klausner, JD				Mor, Zohar; Kent, Charlotte K.; Kohn, Robert P.; Klausner, Jeffrey D.			Declining Rates in Male Circumcision amidst Increasing Evidence of its Public Health Benefit	PLOS ONE			English	Article								Background. Recent experimental evidence has demonstrated the benefits of male circumcision for the prevention of human immunodeficiency virus (HIV) infection. Studies have also shown that male circumcision is cost-effective and reduces the risk for certain ulcerative sexually transmitted diseases (STDs). The epidemiology of male circumcision in the United States is poorly studied and most prior reports were limited by self-reported measures. The study objective was to describe male circumcision trends among men attending the San Francisco municipal STD clinic, and to correlate the findings with HIV, syphilis and sexual orientation. Methods and Findings. A cross sectional study was performed by reviewing all electronic records of males attending the San Francisco municipal STD clinic between 1996 and 2005. The prevalence of circumcision over time and by subpopulation such as race/ethnicity and sexual orientation were measured. The findings were further correlated with the presence of syphilis and HIV infection. Circumcision status was determined by physical examination and disease status by clinical evaluation with laboratory confirmation. Among 58,598 male patients, 32,613 (55.7%, 95% Confidence Interval (CI) 55.2-56.1) were circumcised. Male circumcision varied significantly by decade of birth (increasing between 1920 and 1950 and declining overall since the 1960's), race/ethnicity (Black: 62.2%, 95% CI 61.2-63.2, White: 60.0%, 95% CI 59.46-60.5, Asian Pacific Islander: 48.2%, 46.9-49.5 95% CI, and Hispanic: 42.2%, 95% CI 41.3-43.1), and sexual orientation (gay/bisexual: 73.0%, 95% CI 72.6-73.4; heterosexual: 66.0%, 65.5-66.5). Male circumcision may have been modestly protective against syphilis in HIV-uninfected heterosexual men (PR 0.92, 95% C.I. 0.83-1.02, P = 0.06). Conclusions. Male circumcision was common among men seeking STD services in San Francisco but has declined substantially in recent decades. Male circumcision rates differed by race/ethnicity and sexual orientation. Given recent studies suggesting the public health benefits of male circumcision, a reconsideration of national male circumcision policy is needed to respond to current trends.	[Mor, Zohar] Emory Univ, Hubert H Humphrey Fellowship Program, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Kent, Charlotte K.; Kohn, Robert P.; Klausner, Jeffrey D.] San Francisco Dept Publ Hlth, Sexually Transmitted Dis Prevent & Control Sect, San Francisco, CA USA	Emory University; Rollins School Public Health; San Francisco Department of Public Health	Mor, Z (corresponding author), Emory Univ, Hubert H Humphrey Fellowship Program, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	zmor@sph.emory.edu; Jeff.Klausner@sfdph.org						Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey R C, 2001, Lancet Infect Dis, V1, P223, DOI 10.1016/S1473-3099(01)00117-7; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Buchbinder SP, 2005, JAIDS-J ACQ IMM DEF, V39, P82, DOI 10.1097/01.qai.0000134740.41585.f4; Fergusson DM, 2006, PEDIATRICS, V118, P1971, DOI 10.1542/peds.2006-1175; FINK AJ, 1986, NEW ENGL J MED, V315, P1167; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Grulich AE, 2001, AIDS, V15, P1188, DOI 10.1097/00002030-200106150-00020; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Kim JD, 1999, IEEE COMMUN LETT, V3, P1, DOI 10.1109/4234.740111; KRIESS JK, 1993, J INFECT DIS, V168, P1404, DOI 10.1093/infdis/168.6.1404; Langeni T, 2005, J BIOSOC SCI, V37, P75, DOI 10.1017/S0021932003006400; Laumann EO, 1997, JAMA-J AM MED ASSOC, V277, P1052, DOI 10.1001/jama.277.13.1052; Milos MF, 2004, LANCET, V363, P1998, DOI 10.1016/S0140-6736(04)16418-0; Moses S, 1998, SEX TRANSM INFECT, V74, P368, DOI 10.1136/sti.74.5.368; Schoen EJ, 2006, J UROLOGY, V175, P1111, DOI 10.1016/S0022-5347(05)00399-X; Schoen EJ, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.3.e36; Stang HJ, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.6.e5; Szabo R, 2000, BRIT MED J, V320, P1592, DOI 10.1136/bmj.320.7249.1592; Urassa M, 1997, AIDS, V11, P73, DOI 10.1097/00002030-199701000-00011; *US BUR CENS, 2000 CENS; Van Howe RS, 2005, J R SOC PROMO HEALTH, V125, P259, DOI 10.1177/146642400512500607; VanHowe RS, 1997, BRIT J UROL, V80, P776, DOI 10.1046/j.1464-410X.1997.00467.x; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Wawer MJ, 2005, AIDS, V19, P2181, DOI 10.1097/01.aids.0000194132.51006.4f; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442	26	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e861	10.1371/journal.pone.0000861	http://dx.doi.org/10.1371/journal.pone.0000861			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848992	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455600008
J	Pankow, S; Bamberger, C				Pankow, Sandra; Bamberger, Casimir			The p53 Tumor Suppressor-Like Protein nvp63 Mediates Selective Germ Cell Death in the Sea Anemone Nematostella vectensis	PLOS ONE			English	Article							DNA-DAMAGE; CLIMATE-CHANGE; ELEGANS P53; P63; APOPTOSIS; HOMOLOG; HYDRA; DROSOPHILA-P53; IDENTIFICATION; MUTATIONS	Here we report the identification and molecular function of the p53 tumor suppressor-like protein nvp63 in a non-bilaterian animal, the starlet sea anemone Nematostella vectensis. So far, p53-like proteins had been found in bilaterians only. The evolutionary origin of p53-like proteins is highly disputed and primordial p53-like proteins are variably thought to protect somatic cells from genotoxic stress. Here we show that ultraviolet (UV) irradiation at low levels selectively induces programmed cell death in early gametes but not somatic cells of adult N. vectensis polyps. We demonstrate with RNA interference that nvp63 mediates this cell death in vivo. Nvp63 is the most archaic member of three p53-like proteins found in N. vectensis and in congruence with all known p53-like proteins, nvp63 binds to the vertebrate p53 DNA recognition sequence and activates target gene transcription in vitro. A transactivation inhibitory domain at its C-terminus with high homology to the vertebrate p63 may regulate nvp63 on a molecular level. The genotoxic stress induced and nvp63 mediated apoptosis in N. vectensis gametes reveals an evolutionary ancient germ cell protective pathway which relies on p63-like proteins and is conserved from cnidarians to vertebrates.	[Pankow, Sandra] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Bamberger, C (corresponding author), Sundgauallee 64, Freiburg, Germany.	casimir.bamberger@bluewin.ch	Bamberger, Casimir/E-7356-2011; Bamberger, Tom Casimir/D-1292-2014	Bamberger, Tom Casimir/0000-0002-3830-4486; Pankow, Sandra/0000-0003-3213-9886				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bamberger C, 2001, FEBS LETT, V501, P121, DOI 10.1016/S0014-5793(01)02643-6; Baum JS, 2005, SEMIN CELL DEV BIOL, V16, P245, DOI 10.1016/j.semcdb.2004.12.008; Bottger A, 2007, SEMIN CANCER BIOL, V17, P134, DOI 10.1016/j.semcancer.2006.11.008; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Brusca RC, 2002, INVERTEBRATES; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chang CC, 2002, DEV BIOL, V252, P100, DOI 10.1006/dbio.2002.0840; Cikala M, 1999, CURR BIOL, V9, P959, DOI 10.1016/S0960-9822(99)80423-0; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Dunn SR, 2006, J MOL EVOL, V63, P95, DOI 10.1007/s00239-005-0236-7; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Extavour CG, 2005, EVOL DEV, V7, P201, DOI 10.1111/j.1525-142X.2005.05023.x; Finnerty JR, 1999, EVOL DEV, V1, P16, DOI 10.1046/j.1525-142x.1999.99010.x; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hainaut P, 1998, NUCLEIC ACIDS RES, V26, P205, DOI 10.1093/nar/26.1.205; HAND C, 1992, BIOL BULL, V182, P169, DOI 10.2307/1542110; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Jacobs WB, 2005, NEURON, V48, P743, DOI 10.1016/j.neuron.2005.10.027; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Kuznetsov SG, 2003, ZOOLOGY, V106, P109, DOI 10.1078/0944-2006-00105; Kuznetsov SG, 2002, J EXP BIOL, V205, P3809; LARKMAN A, 1980, ULTRASTRUCTURAL ASPE, P61; Lesser MP, 2007, P NATL ACAD SCI USA, V104, P5259, DOI 10.1073/pnas.0700910104; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Malloy KD, 1997, P NATL ACAD SCI USA, V94, P1258, DOI 10.1073/pnas.94.4.1258; METZ B, 2001, SPECIAL REPORT SAFEG; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nordstrom W, 2000, CELL DEATH DIFFER, V7, P1035, DOI 10.1038/sj.cdd.4400766; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rentzsch F, 2005, DEV BIOL, V278, P1, DOI 10.1016/j.ydbio.2004.10.007; Saccone C, 2003, J MOL EVOL, V57, pS277, DOI 10.1007/s00239-003-0037-9; Schroder HC, 2005, PROG MOLEC, V39, P111; Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009; Serber Z, 2002, MOL CELL BIOL, V22, P8601, DOI 10.1128/MCB.22.24.8601-8611.2002; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Solomon S., 2007, PHYS SCI BASIS WORKI; Soussi T, 2005, BIOCHEM BIOPH RES CO, V331, P834, DOI 10.1016/j.bbrc.2005.03.190; STEPHENSON TA, 1935, BRIT SEA ANEMONES, P415; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Sullivan JC, 2006, NUCLEIC ACIDS RES, V34, pD495, DOI 10.1093/nar/gkj020; Technau U, 2003, DEV BIOL, V260, P191, DOI 10.1016/S0012-1606(03)00241-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Wilhelm SW, 2002, PHOTOCHEM PHOTOBIOL, V76, P268, DOI 10.1562/0031-8655(2002)076<0268:EOBDUL>2.0.CO;2; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	51	52	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e782	10.1371/journal.pone.0000782	http://dx.doi.org/10.1371/journal.pone.0000782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848985	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455600001
J	Wang, WH; Liu, XY; Gelinas, D; Ciruna, B; Sun, Y				Wang, Wenhui; Liu, Xinyu; Gelinas, Danielle; Ciruna, Brian; Sun, Yu			A Fully Automated Robotic System for Microinjection of Zebrafish Embryos	PLOS ONE			English	Article								As an important embodiment of biomanipulation, injection of foreign materials (e.g., DNA, RNAi, sperm, protein, and drug compounds) into individual cells has significant implications in genetics, transgenics, assisted reproduction, and drug discovery. This paper presents a microrobotic system for fully automated zebrafish embryo injection, which overcomes the problems inherent in manual operation, such as human fatigue and large variations in success rates due to poor reproducibility. Based on computer vision and motion control, the microrobotic system performs injection at a speed of 15 zebrafish embryos (chorion unremoved) per minute, with a survival rate of 98% (n = 350 embryos), a success rate of 99% (n = 350 embryos), and a phenotypic rate of 98.5% (n = 210 embryos). The sample immobilization technique and microrobotic control method are applicable to other biological injection applications such as the injection of mouse oocytes/embryos and Drosophila embryos to enable high-throughput biological and pharmaceutical research.	[Wang, Wenhui; Liu, Xinyu; Sun, Yu] Univ Toronto, Adv Micro & Nanosyst Lab, Toronto, ON, Canada; [Gelinas, Danielle; Ciruna, Brian] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Ciruna, B (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	ciruna@sickkids.ca; sun@mie.utoronto.ca	Liu, Xinyu/B-5529-2009; Wang, Wenhui/H-7514-2018	Liu, Xinyu/0000-0001-5705-9765; Wang, Wenhui/0000-0002-5884-6098; Sun, Yu/0000-0001-7895-0741				Chun K, 1999, PROC IEEE MICR ELECT, P406, DOI 10.1109/MEMSYS.1999.746863; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; HASHMI S, 1995, BIOTECHNIQUES, V19, P766; Kim DH, 2006, IEEE T NANOBIOSCI, V5, P89, DOI 10.1109/TNB.2006.875054; KOBAYASHI K, 1992, MOL REPROD DEV, V33, P81, DOI 10.1002/mrd.1080330112; Kumar R, 2003, IROS 2003: PROCEEDINGS OF THE 2003 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P3186; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; Lin MTS, 2000, INT J DERMATOL, V39, P161, DOI 10.1046/j.1365-4362.2000.00925.x; Matsuoka H, 2005, J BIOTECHNOL, V116, P185, DOI 10.1016/j.jbiotec.2004.10.010; Mattos L., 2007, P IEEE INT C ROB AUT; Muraoka O, 2006, NAT CELL BIOL, V8, P329, DOI 10.1038/ncb1379; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; PILLARISETTI A, 2006, P S HAPT INT VIRT EN; Rols MP, 2006, BBA-BIOMEMBRANES, V1758, P423, DOI 10.1016/j.bbamem.2006.01.005; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Sun Y, 2002, INT J ROBOT RES, V21, P861, DOI 10.1177/0278364902021010833; Sundaram J., 2004, BIOPHYS J, V87, P1013; Tsang M, 2002, NAT CELL BIOL, V4, P165, DOI 10.1038/ncb749; Walther W, 2000, DRUGS, V60, P249, DOI 10.2165/00003495-200060020-00002; Wang WH, 2007, INT J ROBOT RES, V26, P821, DOI 10.1177/0278364907080254; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; Zappe S, 2006, LAB CHIP, V6, P1012, DOI 10.1039/b600238b	23	178	186	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e862	10.1371/journal.pone.0000862	http://dx.doi.org/10.1371/journal.pone.0000862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848993	Green Published, gold			2022-12-27	WOS:000207455600009
J	Liu, TL; Papagiannakopoulos, T; Puskar, K; Qi, SP; Santiago, F; Clay, W; Lao, KQ; Lee, YH; Nelson, SF; Kornblum, HI; Doyle, F; Petzold, L; Shraiman, B; Kosik, KS				Liu, Tsunglin; Papagiannakopoulos, Thales; Puskar, Kathy; Qi, Shuping; Santiago, Fernando; Clay, William; Lao, Kaiqin; Lee, Yohan; Nelson, Stanley F.; Kornblum, Harley I.; Doyle, Frank; Petzold, Linda; Shraiman, Boris; Kosik, Kenneth S.			Detection of a MicroRNA Signal in an In Vivo Expression Set of mRNAs	PLOS ONE			English	Article								Background. microRNAs (miRNAs) are approximately 21 nucleotide non-coding transcripts capable of regulating gene expression. The most widely studied mechanism of regulation involves binding of a miRNA to the target mRNA. As a result, translation of the target mRNA is inhibited and the mRNA may be destabilized. The inhibitory effects of miRNAs have been linked to diverse cellular processes including malignant proliferation, apoptosis, development, differentiation, and metabolic processes. We asked whether endogenous fluctuations in a set of mRNA and miRNA profiles contain correlated changes that are statistically distinguishable from the many other fluctuations in the data set. Methodology/Principal Findings. RNA was extracted from 12 human primary brain tumor biopsies. These samples were used to determine genome-wide mRNA expression levels by microarray analysis and a miRNA profile by real-time reverse transcription PCR. Correlation coefficients were determined for all possible mRNA-miRNA pairs and the distribution of these correlations compared to the random distribution. An excess of high positive and negative correlation pairs were observed at the tails of these distributions. Most of these highest correlation pairs do not contain sufficiently complementary sequences to predict a target relationship; nor do they lie in physical proximity to each other. However, by examining pairs in which the significance of the correlation coefficients is modestly relaxed, negative correlations do tend to predict targets and positive correlations tend to predict physically proximate pairs. A subset of high correlation pairs were experimentally validated by over-expressing or suppressing a miRNA and measuring the correlated mRNAs. Conclusions/Significance. Sufficient information exists within a set of tumor samples to detect endogenous correlations between miRNA and mRNA levels. Based on the validations the causal arrow for these correlations is likely to be directed from the miRNAs to the mRNAs. From these data sets, we inferred and validated a tumor suppression pathway linked to miR-181c.	[Liu, Tsunglin; Papagiannakopoulos, Thales; Santiago, Fernando; Kosik, Kenneth S.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Liu, Tsunglin; Papagiannakopoulos, Thales; Santiago, Fernando; Kosik, Kenneth S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Shraiman, Boris] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Puskar, Kathy; Petzold, Linda] Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA; [Doyle, Frank] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Lee, Yohan; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Qi, Shuping; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Dept Psychiat Mol, Los Angeles, CA 90095 USA; [Qi, Shuping; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Dept Med Pharmacol, Los Angeles, CA 90095 USA; [Qi, Shuping; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Clay, William] Jackson State Univ, Dept Math, Jackson, MS USA; [Lao, Kaiqin] Appl Biosyst Inc, Foster City, CA 94404 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Jackson State University; Thermo Fisher Scientific; Applied Biosystems	Kosik, KS (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA.	kosik@lifesci.ucsb.edu	Nelson, Stanley F/D-4771-2009; Santiago, Fernando Enrique/GLS-9127-2022	Nelson, Stanley F/0000-0002-2082-3114; Santiago, Fernando/0000-0001-9514-3722	W.M. Keck Foundation; NIH Neuroscience Microarray Consortium [U24NSNS052108, NS052563]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS052563, R01NS052563] Funding Source: NIH RePORTER	W.M. Keck Foundation(W.M. Keck Foundation); NIH Neuroscience Microarray Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the W.M. Keck Foundation, the NIH Neuroscience Microarray Consortium U24NSNS052108, and NS052563.	Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Lao Kaiqin, 2007, Biotechnology Journal, V2, P33, DOI 10.1002/biot.200600119; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Linares LK, 2007, NAT CELL BIOL, V9, P331, DOI 10.1038/ncb1545; Liu L, 1999, MOL CELL BIOL, V19, P1202; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Massirer KB, 2006, BIOESSAYS, V28, P449, DOI 10.1002/bies.20406; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Nguyen DX, 2004, EMBO J, V23, P1609, DOI 10.1038/sj.emboj.7600176; NILSEN TW, 2007, MECH MICRORNA MEDIAT; Nutt CL, 2003, CANCER RES, V63, P1602; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Watts GS, 2004, NEOPLASIA, V6, P187, DOI 10.1593/neo.03292; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043	26	53	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e804	10.1371/journal.pone.0000804	http://dx.doi.org/10.1371/journal.pone.0000804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726534	gold, Green Published			2022-12-27	WOS:000207455400021
J	Nassanian, H; Sanchez, AM; Lo, A; Bradley, KA; Lee, B				Nassanian, Hoorig; Sanchez, Ana M.; Lo, Alice; Bradley, Kenneth A.; Lee, Benhur			Efficient Construction of an Inverted Minimal H1 Promoter Driven siRNA Expression Cassette: Facilitation of Promoter and siRNA Sequence Exchange	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; GENETIC INTERFERENCE; MAMMALIAN-CELLS; MESSENGER-RNA; DC-SIGN; TRANSCRIPTION; LIBRARIES; SCREENS; SYSTEM	Background. RNA interference (RNAi), mediated by small interfering RNA (siRNA), is an effective method used to silence gene expression at the post-transcriptional level. Upon introduction into target cells, siRNAs incorporate into the RNA-induced silencing complex (RISC). The antisense strand of the siRNA duplex then "guides'' the RISC to the homologous mRNA, leading to target degradation and gene silencing. In recent years, various vector-based siRNA expression systems have been developed which utilize opposing polymerase III promoters to independently drive expression of the sense and antisense strands of the siRNA duplex from the same template. Principal Findings. We show here the use of a ligase chain reaction (LCR) to develop a new vector system called pinv-H1 in which a DNA sequence encoding a specific siRNA is placed between two inverted minimal human H1 promoters (similar to 100 bp each). Expression of functional siRNAs from this construct has led to efficient silencing of both reporter and endogenous genes. Furthermore, the inverted H1 promoter-siRNA expression cassette was used to generate a retrovirus vector capable of transducing and silencing expression of the targeted protein by>80% in target cells. Conclusions. The unique design of this construct allows for the efficient exchange of siRNA sequences by the directional cloning of short oligonucleotides via asymmetric restriction sites. This provides a convenient way to test the functionality of different siRNA sequences. Delivery of the siRNA cassette by retroviral transduction suggests that a single copy of the siRNA expression cassette efficiently knocks down gene expression at the protein level. We note that this vector system can potentially be used to generate a random siRNA library. The flexibility of the ligase chain reaction suggests that additional control elements can easily be introduced into this siRNA expression cassette.	[Nassanian, Hoorig; Sanchez, Ana M.; Lo, Alice; Bradley, Kenneth A.; Lee, Benhur] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Lee, Benhur] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Lee, Benhur] Univ Calif Los Angeles, David Geffen Sch Med, AIDS Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lee, B (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	bleebhl@microbio.ucla.edu	Lee, Benhur/A-8554-2016	Lee, Benhur/0000-0003-0760-1709	Burroughs Wellcome Fund Career Development Award; UCLA AIDS Institute; NIH National Research Service Award [1 F31 AI 61847]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052021, F31AI061847] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Career Development Award(Burroughs Wellcome Fund); UCLA AIDS Institute; NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	BL is a Charles E. Culpepper Medical Scholar and is a recipient of the Burroughs Wellcome Fund Career Development Award. Support from the UCLA AIDS Institute is acknowledged. AMS is a recipient of an NIH National Research Service Award (grant 1 F31 AI 61847).	Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chalmers FM, 2001, BIOTECHNIQUES, V30, P249, DOI 10.2144/01302bm02; CURTIS BM, 1992, P NATL ACAD SCI USA, V89, P8356, DOI 10.1073/pnas.89.17.8356; Devroe Eric, 2002, BMC Biotechnol, V2, P15, DOI 10.1186/1472-6750-2-15; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Gupta S, 2004, P NATL ACAD SCI USA, V101, P1927, DOI 10.1073/pnas.0306111101; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; JORGENSEN R, 1990, TRENDS BIOTECHNOL, V8, P340, DOI 10.1016/0167-7799(90)90220-R; Kaykas A, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-16; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Luo B, 2004, P NATL ACAD SCI USA, V101, P5494, DOI 10.1073/pnas.0400551101; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Myslinski E, 2001, NUCLEIC ACIDS RES, V29, P2502, DOI 10.1093/nar/29.12.2502; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x; Schuck S, 2004, P NATL ACAD SCI USA, V101, P4912, DOI 10.1073/pnas.0401285101; Sen G, 2004, NAT GENET, V36, P183, DOI 10.1038/ng1288; Shen HL, 2007, LEUKEMIA RES, V31, P515, DOI 10.1016/j.leukres.2006.09.011; Shirane D, 2004, NAT GENET, V36, P190, DOI 10.1038/ng1290; Tran N, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-21; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zecherle GN, 1996, MOL CELL BIOL, V16, P5801; Zheng LX, 2004, P NATL ACAD SCI USA, V101, P135, DOI 10.1073/pnas.2136685100	31	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e767	10.1371/journal.pone.0000767	http://dx.doi.org/10.1371/journal.pone.0000767			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712415	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455300015
J	Vucinic, D; Sejnowski, TJ				Vucinic, Dejan; Sejnowski, Terrence J.			A Compact Multiphoton 3D Imaging System for Recording Fast Neuronal Activity	PLOS ONE			English	Article							2-PHOTON EXCITATION; SCANNING MICROSCOPY; SATURABLE ABSORBER; LASER; FLUORESCENCE; FEMTOSECOND; GENERATION; DENDRITES; COMPENSATION; DISPERSION	We constructed a simple and compact imaging system designed specifically for the recording of fast neuronal activity in a 3D volume. The system uses an Yb:KYW femtosecond laser we designed for use with acousto-optic deflection. An integrated two-axis acousto-optic deflector, driven by digitally synthesized signals, can target locations in three dimensions. Data acquisition and the control of scanning are performed by a LeCroy digital oscilloscope. The total cost of construction was one order of magnitude lower than that of a typical Ti:sapphire system. The entire imaging apparatus, including the laser, fits comfortably onto a small rig for electrophysiology. Despite the low cost and simplicity, the convergence of several new technologies allowed us to achieve the following capabilities: i) full-frame acquisition at video rates suitable for patch clamping; ii) random access in under ten microseconds with dwelling ability in the nominal focal plane; iii) three-dimensional random access with the ability to perform fast volume sweeps at kilohertz rates; and iv) fluorescence lifetime imaging. We demonstrate the ability to record action potentials with high temporal resolution using intracellularly loaded potentiometric dye di-2-ANEPEQ. Our design proffers easy integration with electrophysiology and promises a more widespread adoption of functional two-photon imaging as a tool for the study of neuronal activity. The software and firmware we developed is available for download at http://neurospy.org/ under an open source license.	[Vucinic, Dejan; Sejnowski, Terrence J.] Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, La Jolla, CA 92037 USA; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego	Vucinic, D (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, La Jolla, CA 92037 USA.	dejan@salk.edu	Sejnowski, Terrence/AAV-5558-2021		Howard Hughes Medical Institute; National Institutes of Health	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the Howard Hughes Medical Institute and by the National Institutes of Health.	ANTIC S, 1995, J NEUROSCI, V15, P1392; Antic SD, 2003, J PHYSIOL-LONDON, V550, P35, DOI 10.1113/jphysiol.2002.033746; Becker W, 2004, MICROSC RES TECHNIQ, V63, P58, DOI 10.1002/jemt.10421; Bewersdorf J, 1998, J MICROSC-OXFORD, V191, P28; Brunner F, 2000, OPT LETT, V25, P1119, DOI 10.1364/OL.25.001119; DAVILA HV, 1973, NATURE-NEW BIOL, V241, P159, DOI 10.1038/newbio241159a0; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dimitrov D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000440; Djurisic M, 2004, J NEUROSCI, V24, P6703, DOI 10.1523/JNEUROSCI.0307-04.2004; Dombeck DA, 2005, J NEUROPHYSIOL, V94, P3628, DOI 10.1152/jn.00416.2005; EVELETH JH, 1974, Patent No. 3851951; FLUHLER E, 1985, BIOCHEMISTRY-US, V24, P5749, DOI 10.1021/bi00342a010; Gobel W, 2004, OPT LETT, V29, P1285, DOI 10.1364/OL.29.001285; Griesinger CB, 2005, NATURE, V435, P212, DOI 10.1038/nature03567; Hellstrom JE, 2006, APPL PHYS B-LASERS O, V83, P235, DOI 10.1007/s00340-006-2171-8; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hubener G, 2003, J PHYS CHEM B, V107, P7896, DOI 10.1021/jp0345809; Iyer V, 2006, J NEUROPHYSIOL, V95, P535, DOI 10.1152/jn.00865.2005; Iyer V, 2003, J BIOMED OPT, V8, P460, DOI 10.1117/1.1580827; Jaque D, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2345828; Jung JC, 2003, OPT LETT, V28, P902, DOI 10.1364/OL.28.000902; Kano H., 1996, Bioimaging, V4, P187, DOI 10.1002/1361-6374(199609)4:3<187::AID-BIO9>3.3.CO;2-V; KELLER U, 1992, OPT LETT, V17, P505, DOI 10.1364/OL.17.000505; Keller U, 1996, IEEE J SEL TOP QUANT, V2, P435, DOI 10.1109/2944.571743; Klopp P, 2002, OPT EXPRESS, V10, P108, DOI 10.1364/OE.10.000108; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Koester HJ, 1999, BIOPHYS J, V77, P2226, DOI 10.1016/S0006-3495(99)77063-3; Kuhn B, 2004, BIOPHYS J, V87, P631, DOI 10.1529/biophysj.104.040477; Lagatsky AA, 2003, ELECTRON LETT, V39, P1108, DOI 10.1049/el:20030735; Lechleiter JD, 2002, BIOPHYS J, V83, P2292, DOI 10.1016/S0006-3495(02)73989-1; Levene MJ, 2004, J NEUROPHYSIOL, V91, P1908, DOI 10.1152/jn.01007.2003; Liu H, 2001, OPT LETT, V26, P1723, DOI 10.1364/OL.26.001723; Martinez-Corral M, 2003, PROC SPIE, V5182, P112; Ngoi BKA, 2001, OPT EXPRESS, V9, P200, DOI 10.1364/OE.9.000200; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Patterson GH, 2000, BIOPHYS J, V78, P2159, DOI 10.1016/S0006-3495(00)76762-2; Paunescu G, 2004, APPL PHYS B-LASERS O, V79, P555, DOI 10.1007/s00340-004-1561-z; Reddy GD, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2141504; Roorda RD, 2004, J NEUROPHYSIOL, V92, P609, DOI 10.1152/jn.00087.2004; Salome R, 2006, J NEUROSCI METH, V154, P161, DOI 10.1016/j.jneumeth.2005.12.010; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Svoboda K, 1996, OPT LETT, V21, P1411, DOI 10.1364/OL.21.001411; Theer P, 2003, OPT LETT, V28, P1022, DOI 10.1364/OL.28.001022; Tsai PS, 2003, NEURON, V39, P27, DOI 10.1016/S0896-6273(03)00370-2; Vucinic D, 2006, OPT LETT, V31, P2447, DOI 10.1364/OL.31.002447; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Zaouter Y, 2006, OPT LETT, V31, P119, DOI 10.1364/OL.31.000119	50	50	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e699	10.1371/journal.pone.0000699	http://dx.doi.org/10.1371/journal.pone.0000699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684546	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452400003
J	Miyake, K; Tanaka, T; McNeil, PL				Miyake, Katsuya; Tanaka, Toru; McNeil, Paul L.			Lectin-Based Food Poisoning: A New Mechanism of Protein Toxicity	PLOS ONE			English	Article								Background. Ingestion of the lectins present in certain improperly cooked vegetables can result in acute GI tract distress, but the mechanism of toxicity is unknown. In vivo, gut epithelial cells are constantly exposed to mechanical and other stresses and consequently individual cells frequently experience plasma membrane disruptions. Repair of these cell surface disruptions allows the wounded cell to survive: failure results in necrotic cell death. Plasma membrane repair is mediated, in part, by an exocytotic event that adds a patch of internal membrane to the defect site. Lectins are known to inhibit exocytosis. We therefore tested the novel hypothesis that lectin toxicity is due to an inhibitory effect on plasma membrane repair. Methods and Findings. Repair of plasma membrane disruptions and exocytosis of mucus was assessed after treatment of cultured cell models and excised segments of the GI tract with lectins. Plasma membrane disruptions were produced by focal irradiation of individual cells, using a microscope-based laser, or by mechanical abrasion of multiple cells, using a syringe needle. Repair was then assessed by monitoring the cytosolic penetration of dyes incapable of crossing the intact plasma membrane. We found that cell surface-bound lectins potently inhibited plasma membrane repair, and the exocytosis of mucus that normally accompanies the repair response. Conclusions. Lectins potently inhibit plasma membrane repair, and hence are toxic to wounded cells. This represents a novel form of protein-based toxicity, one that, we propose, is the basis of plant lectin food poisoning.	[Miyake, Katsuya; McNeil, Paul L.] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Tanaka, Toru] Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama 35002, Japan; [McNeil, Paul L.] Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA	University System of Georgia; Augusta University; Josai University; University System of Georgia; Augusta University	McNeil, PL (corresponding author), Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA.	pmcneil@mcg.edu			NASA; Marine Biological Laboratory	NASA(National Aeronautics & Space Administration (NASA)); Marine Biological Laboratory	L. M. was supported by a grant from NASA; K. M. by summer fellowships (Marine Biological Laboratory).	Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Boehm S, 1998, J NEUROCHEM, V71, P2421; EDELSON PJ, 1974, J EXP MED, V140, P1364, DOI 10.1084/jem.140.5.1364; Evans RC, 2002, GASTROENTEROLOGY, V122, P1784, DOI 10.1053/gast.2002.33659; HART CA, 1988, SCAND J GASTROENTERO, V23, P1153, DOI 10.3109/00365528809090184; Kilpatrick DC, 1999, MOL BIOTECHNOL, V11, P55, DOI 10.1007/BF02789176; LORENZSONN V, 1982, GASTROENTEROLOGY, V82, P838; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; MCNEIL PL, 1989, GASTROENTEROLOGY, V96, P1238, DOI 10.1016/S0016-5085(89)80010-1; McNeil PL, 2003, P NATL ACAD SCI USA, V100, P4592, DOI 10.1073/pnas.0736739100; Miyake K, 2006, PLOS BIOL, V4, P1525, DOI 10.1371/journal.pbio.0040276; NACHBAR MS, 1980, AM J CLIN NUTR, V33, P2338, DOI 10.1093/ajcn/33.11.2338; Sauvion N, 2004, J INSECT PHYSIOL, V50, P1137, DOI 10.1016/j.jinsphys.2004.10.006; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Steinhardt RA, 2005, ANN NY ACAD SCI, V1066, P152, DOI 10.1196/annals.1363.017; SWANSON JA, 1987, SCIENCE, V238, P548, DOI 10.1126/science.2443981; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Vasconcelos IM, 2004, TOXICON, V44, P385, DOI 10.1016/j.toxicon.2004.05.005; WEISER MM, 1976, LANCET, V1, P567	19	58	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e687	10.1371/journal.pone.0000687	http://dx.doi.org/10.1371/journal.pone.0000687			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668065	gold, Green Published			2022-12-27	WOS:000207452300023
J	Karrasch, T; Kim, JS; Jang, BI; Jobin, C				Karrasch, Thomas; Kim, Joo-Sung; Jang, Byung Ik; Jobin, Christian			The Flavonoid Luteolin Worsens Chemical-Induced Colitis in NF-kappa B-EGFP Transgenic Mice through Blockade of NF-kappa B-Dependent Protective Molecules	PLOS ONE			English	Article								Background. The flavonoid luteolin has anti-inflammatory properties both in vivo and in vitro. However, the impact of luteolin on experimental models of colitis is unknown. Methodology/Principal Findings. To address the therapeutic impact of luteolin, NF-kappa B-EGFP transgenic mice were fed a chow diet containing 2% luteolin-or isoflavone-free control chow (AIN-76), and acute colitis was induced using 3% dextran sodium sulfate (DSS). Additionally, development of spontaneous colitis was evaluated in IL-10(-/-); NF-kappa B-EGFP transgenic mice fed 2% luteolin chow diet or control chow diet. Interestingly, NF-kappa B-EGFP transgenic mice exposed to luteolin showed worse DSS-induced colitis (weight loss, histological scores) compared to control-fed mice, whereas spontaneous colitis in IL-10(-/-); NF-kappa B-EGFP mice was significantly attenuated. Macroscopic imaging of live resected colon showed enhanced EGFP expression (NF-kappa B activity) in luteolin-fed mice as compared to control-fed animals after DSS exposure, while cecal EGFP expression was attenuated in luteolin-fed IL-10(-/-) mice. Interestingly, confocal microscopy showed that EGFP positive cells were mostly located in the lamina propria and not in the epithelium. Caspase 3 activation was significantly enhanced whereas COX-2 gene expression was reduced in luteolin-fed, DSS-exposed NF-kappa B-EGFP transgenic mice as assessed by Western blot and immunohistochemical analysis. In vitro, luteolin sensitized colonic epithelial HT29 cells to TNF alpha-induced apoptosis, caspase 3 activation, DNA fragmentation and reduced TNF alpha-induced C-IAP1, C-IAP2 and COX-2 gene expression. Conclusions/Significance. We conclude that while luteolin shows beneficial effects on spontaneous colitis, it aggravates DSS-induced experimental colitis by blocking NF-kappa B-dependent protective molecules in enterocytes.	[Jobin, Christian] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA; Univ N Carolina, Ctr GI Biol & Dis, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Jobin, C (corresponding author), Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA.	Job@med.unc.edu	Kim, Jung M/D-3112-2015; Kim, Joo Sung/D-5765-2012	Kim, Jung M/0000-0002-6506-7519; 	NIH [ROI DK 47700, P30 DK034987]; American Institute of Cancer Research; Crohn's and Colitis Foundation of America; NCI [P50 CA106991]; NATIONAL CANCER INSTITUTE [P50CA106991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, R01DK047700] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute of Cancer Research; Crohn's and Colitis Foundation of America; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH ROI DK 47700 and American Institute of Cancer Research grants to C. Jobin; by the Crohn's and Colitis Foundation of America fellowship to T. Karrasch; by NIH P30 DK034987 to CGIBD and in part by NCI UNC GI SPORE grant P50 CA106991 to C. Jobin.	Aggarwal BB, 2004, ANN NY ACAD SCI, V1030, P434, DOI 10.1196/annals.1329.054; Araki A, 2005, J GASTROENTEROL, V40, P16, DOI 10.1007/s00535-004-1492-9; Bent S, 2004, AM J MED, V116, P478, DOI 10.1016/j.amjmed.2003.10.036; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; Chen CC, 2004, MOL PHARMACOL, V66, P683; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; CIACCI C, 1993, GASTROENTEROLOGY, V105, P93, DOI 10.1016/0016-5085(93)90014-4; Cominelli F, 2004, NEW ENGL J MED, V351, P2045, DOI 10.1056/NEJMp048253; COOPER HS, 1993, LAB INVEST, V69, P238; Cui XF, 2000, BBA-GEN SUBJECTS, V1524, P178, DOI 10.1016/S0304-4165(00)00155-0; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Egan LJ, 2004, P NATL ACAD SCI USA, V101, P2452, DOI 10.1073/pnas.0306734101; Egan LJ, 2003, AM J PHYSIOL-CELL PH, V285, pC1028, DOI 10.1152/ajpcell.00167.2003; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Gupta RK, 2004, NAT BIOTECHNOL, V22, P653, DOI 10.1038/nbt0604-653; Haller D, 2004, J PEDIATR GASTR NUTR, V38, P123, DOI 10.1097/00005176-200402000-00004; Haller D, 2002, J BIOL CHEM, V277, P38168, DOI 10.1074/jbc.M205737200; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; Hendricks JJA, 2004, J EXP MED, V200, P1667, DOI 10.1084/jem.20040819; Hibi T, 2003, J GASTROENTEROL, V38, P36; Hougee S, 2005, BIOCHEM PHARMACOL, V69, P241, DOI 10.1016/j.bcp.2004.10.002; Jian YT, 2005, WORLD J GASTROENTERO, V11, P1747, DOI 10.3748/wjg.v11.i12.1747; Jijon HB, 2005, EUR J IMMUNOL, V35, P718, DOI 10.1002/eji.200425688; Jobin C, 1997, J IMMUNOL, V158, P226; Jobin C, 2000, INFLAMM BOWEL DIS, V6, P206, DOI 10.1097/00054725-200008000-00007; Karrasch T, 2006, J CELL PHYSIOL, V207, P809, DOI 10.1002/jcp.20626; Karrasch T, 2007, J IMMUNOL, V178, P6522, DOI 10.4049/jimmunol.178.10.6522; Kawamori T, 1998, CANCER RES, V58, P409; Kim JS, 2005, IMMUNOLOGY, V115, P375, DOI 10.1111/j.1365-2567.2005.02156.x; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Loftus EV, 2002, GASTROENTEROL CLIN N, V31, P1, DOI 10.1016/S0889-8553(01)00002-4; Lorenz RG, 2005, SPRINGER SEMIN IMMUN, V27, P233, DOI 10.1007/s00281-005-0208-4; Maeda S, 2002, GUT, V50, P771, DOI 10.1136/gut.50.6.771; Magness ST, 2004, J IMMUNOL, V173, P1561, DOI 10.4049/jimmunol.173.3.1561; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Morteau O, 2000, J CLIN INVEST, V105, P469, DOI 10.1172/JCI6899; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957; Ruiz PA, 2006, J NUTR, V136, P664, DOI 10.1093/jn/136.3.664; Sampson W, 2005, NEW ENGL J MED, V353, P337, DOI 10.1056/NEJMp058130; Sartor RB, 1997, AM J GASTROENTEROL, V92, pS5; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Sugimoto K, 2002, GASTROENTEROLOGY, V123, P1912, DOI 10.1053/gast.2002.37050; Tormakangas L, 2005, BIOCHEM PHARMACOL, V70, P1222, DOI 10.1016/j.bcp.2005.07.012; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; Wendum D, 2004, VIRCHOWS ARCH, V445, P327, DOI 10.1007/s00428-004-1105-2; Williams KL, 2001, GASTROENTEROLOGY, V120, P925, DOI 10.1053/gast.2001.22470; Xagorari A, 2001, J PHARMACOL EXP THER, V296, P181; Yan SR, 2005, ONCOGENE, V24, P6482, DOI 10.1038/sj.onc.1208810	52	45	46	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2007	2	7							e596	10.1371/journal.pone.0000596	http://dx.doi.org/10.1371/journal.pone.0000596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GG	17611628	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451900013
J	Luabeya, KKA; Mpontshane, N; Mackay, M; Ward, H; Elson, I; Chhagan, M; Tomkins, A; Van den Broeck, J; Bennish, ML				Luabeya, Kany-Kany Angelique; Mpontshane, Nontobeko; Mackay, Malanie; Ward, Honorine; Elson, Inga; Chhagan, Meera; Tomkins, Andrew; Van den Broeck, Jan; Bennish, Michael L.			Zinc or Multiple Micronutrient Supplementation to Reduce Diarrhea and Respiratory Disease in South African Children: A Randomized Controlled Trial	PLOS ONE			English	Article								Background. Prophylactic zinc supplementation has been shown to reduce diarrhea and respiratory illness in children in many developing countries, but its efficacy in children in Africa is uncertain. Objective. To determine if zinc, or zinc plus multiple micronutrients, reduces diarrhea and respiratory disease prevalence. Design. Randomized, double-blind, controlled trial. Setting. Rural community in South Africa. Participants. Three cohorts: 32 HIV-infected children; 154 HIV-uninfected children born to HIV-infected mothers; and 187 HIV-uninfected children born to HIV-uninfected mothers. Interventions. Children received either 1250 IU of vitamin A; vitamin A and 10 mg of zinc; or vitamin A, zinc, vitamins B1, B2, B6, B12, C, D, E, and K and copper, iodine, iron, and niacin starting at 6 months and continuing to 24 months of age. Homes were visited weekly. Outcome Measures. Primary outcome was percentage of days of diarrhea per child by study arm within each of the three cohorts. Secondary outcomes were prevalence of upper respiratory symptoms and percentage of children who ever had pneumonia by maternal report, or confirmed by the field worker. Results. Among HIV-uninfected children born to HIV-infected mothers, median percentage of days with diarrhea was 2.3% for 49 children allocated to vitamin A; 2.5% in 47 children allocated to receive vitamin A and zinc; and 2.2% for 46 children allocated to multiple micronutrients ( P = 0.852). Among HIV-uninfected children born to HIV-uninfected mothers, median percentage of days of diarrhea was 2.4% in 56 children in the vitamin A group; 1.8% in 57 children in the vitamin A and zinc group; and 2.7% in 52 children in the multiple micronutrient group ( P = 0.857). Only 32 HIV-infected children were enrolled, and there were no differences between treatment arms in the prevalence of diarrhea. The prevalence of upper respiratory symptoms or incidence of pneumonia did not differ by treatment arms in any of the cohorts. Conclusion. When compared with vitamin A alone, supplementation with zinc, or with zinc and multiple micronutrients, did not reduce diarrhea and respiratory morbidity in rural South African children. Trial Registration. ClinicalTrials.gov NCT00156832	[Bennish, Michael L.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Luabeya, Kany-Kany Angelique] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa; [Mpontshane, Nontobeko] Church Scotland Hosp, Tugela Ferry, South Africa; [Mackay, Malanie] Univ KwaZulu Natal, Dept Med Microbiol, Nelson R Mandela Sch Med, Durban, South Africa; [Ward, Honorine] Tufts Univ New England Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA; [Elson, Inga] Univ KwaZulu Natal, Dept Chem Pathol, Durban, South Africa; [Chhagan, Meera] Univ KwaZulu Natal, Dept Paediat & Child Hlth, Durban, South Africa; [Chhagan, Meera] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Tomkins, Andrew] Univ London, Ctr Int Child Hlth, London, England; [Van den Broeck, Jan] Univ W Indies, Res Inst Trop Med, Kingston 7, Jamaica	University of Oxford; University of Kwazulu Natal; University of Kwazulu Natal; Tufts Medical Center; University of Kwazulu Natal; University of Kwazulu Natal; Tufts University; University of London; University College London; University West Indies Mona Jamaica	Bennish, ML (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Oxford, England.	mbennish@hotmail.com	Luabeya, Angelique Kany Kany/K-2769-2019	Luabeya, Angelique Kany Kany/0000-0001-7379-2836	United States National Institute of Health [1 UO1 AI45508-01, 1 K24 AI/HDO1671-01, D43TW05572-01]; Wellcome Trust [62925]; FOGARTY INTERNATIONAL CENTER [D43TW005572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI001671] Funding Source: NIH RePORTER	United States National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the United States National Institute of Health ( 1 UO1 AI45508-01, 1 K24 AI/HDO1671-01, D43TW05572-01 to Dr. Bennish) and the Wellcome Trust ( Wellcome 62925 to Dr. Bennish and Wellcome 063009 to Dr. Van den Broeck. The National Institutes of Health provided training in good clinical practice to study staff, arranged for the study to be monitored by a contract research organization to ensure compliance with good clinical practice, and established a Data Monitoring and Safety Board to oversee the trial. The sponsor for the study was the host institution, the Africa Centre for Health and Population Studies, which gave discretion in the investigative team in study design, data analysis, manuscript preparation, and decisions on manuscript submission and publication.	Bailey RC, 1999, INT J EPIDEMIOL, V28, P532, DOI 10.1093/ije/28.3.532; Baqui AH, 2003, J NUTR, V133, P4150, DOI 10.1093/jn/133.12.4150; Berger VW, 1999, CONTROL CLIN TRIALS, V20, P319, DOI 10.1016/S0197-2456(99)00014-8; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Bland RM, 2002, ACTA PAEDIATR, V91, P704, DOI 10.1080/080352502760069151; Bobat R, 2005, LANCET, V366, P1862, DOI 10.1016/S0140-6736(05)67756-2; Coldham C, 2000, TROP MED INT HEALTH, V5, P134, DOI 10.1046/j.1365-3156.2000.00505.x; de Romana DL, 2005, AM J CLIN NUTR, V81, P637; de Romana GL, 2005, J NUTR, V135, p646S, DOI 10.1093/jn/135.3.646S; Faber M, 2005, AM J CLIN NUTR, V82, P1032, DOI 10.1093/ajcn/82.5.1032; Faber M, 2005, PUBLIC HEALTH NUTR, V8, P373, DOI 10.1079/PHN2004685; FAWZI WW, 1993, JAMA-J AM MED ASSOC, V269, P898, DOI 10.1001/jama.269.7.898; Gardner JMM, 1998, EUR J CLIN NUTR, V52, P34, DOI 10.1038/sj.ejcn.1600509; Gardner M J, 1989, LONDON BRIT MED J; Garrib A, 2006, TROP MED INT HEALTH, V11, P1841, DOI 10.1111/j.1365-3156.2006.01738.x; HAMILL PVV, 1979, AM J CLIN NUTR, V32, P607, DOI 10.1093/ajcn/32.3.607; Kauchali S, 2004, J TROP PEDIATRICS, V50, P82, DOI 10.1093/tropej/50.2.82; Labadarios D, 2005, PUBLIC HEALTH NUTR, V8, P533, DOI 10.1079/PHN2005816; Lock Gabriela, 2003, Food and Nutrition Bulletin, V24, pS16; Long KZ, 2006, AM J CLIN NUTR, V83, P693, DOI 10.1093/ajcn.83.3.693; Makonnen B, 2003, J TROP PEDIATRICS, V49, P340, DOI 10.1093/tropej/49.6.340; *MICR IN, VIT MIN DEF GLOB PRO; *MIN HLTH S AFR, REG REL FORT CERT FO; Mostert D, 2005, Curationis, V28, P12; Muller O, 2001, BMJ-BRIT MED J, V322, P1567, DOI 10.1136/bmj.322.7302.1567; Ninh NX, 1996, AM J CLIN NUTR, V63, P514, DOI 10.1093/ajcn/63.4.514; Penny ME, 2004, AM J CLIN NUTR, V79, P457; Rosado JL, 1997, AM J CLIN NUTR, V65, P13, DOI 10.1093/ajcn/65.1.13; Roy SK, 1999, EUR J CLIN NUTR, V53, P529, DOI 10.1038/sj.ejcn.1600734; Ruel MT, 1997, PEDIATRICS, V99, P808, DOI 10.1542/peds.99.6.808; *S AFR DEP HLTH, NAT HIV SYPH PREV SU; Sazawal S, 1997, AM J CLIN NUTR, V66, P413, DOI 10.1093/ajcn/66.2.413; Sazawal S, 2007, LANCET, V369, P927, DOI 10.1016/S0140-6736(07)60452-8; Smuts CM, 2005, J NUTR, V135, p653S, DOI 10.1093/jn/135.3.653S; Smuts CM, 2005, J NUTR, V135, p631S; Sur D, 2003, PEDIATRICS, V112, P1327, DOI 10.1542/peds.112.6.1327; Tielsch JM, 2006, LANCET, V367, P144, DOI 10.1016/S0140-6736(06)67963-4; *UNICEF, STAT WORLDS CHILDR U; Untoro J, 2005, J NUTR, V135, p639S, DOI 10.1093/jn/135.3.639S; Walker CF, 2004, ANNU REV NUTR, V24, P255, DOI 10.1146/annurev.nutr.23.011702.073054; *WHO, TECHN UPD GUID INT M; VITAMIN A SUPPLEMENT; PROFILE KWAZULU NATA	44	65	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e541	10.1371/journal.pone.0000541	http://dx.doi.org/10.1371/journal.pone.0000541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593956	Green Published, gold, Green Submitted			2022-12-27	WOS:000207451800001
J	Ster, IC; Ferguson, NM				Ster, Irina Chis; Ferguson, Neil M.			Transmission Parameters of the 2001 Foot and Mouth Epidemic in Great Britain	PLOS ONE			English	Article							ALTERNATIVE CONTROL STRATEGIES; DISEASE EPIDEMIC; MODELS; IMPACT; LIKELIHOOD	Despite intensive ongoing research, key aspects of the spatial-temporal evolution of the 2001 foot and mouth disease (FMD) epidemic in Great Britain (GB) remain unexplained. Here we develop a Markov Chain Monte Carlo (MCMC) method for estimating epidemiological parameters of the 2001 outbreak for a range of simple transmission models. We make the simplifying assumption that infectious farms were completely observed in 2001, equivalent to assuming that farms that were proactively culled but not diagnosed with FMD were not infectious, even if some were infected. We estimate how transmission parameters varied through time, highlighting the impact of the control measures on the progression of the epidemic. We demonstrate statistically significant evidence for assortative contact patterns between animals of the same species. Predictive risk maps of the transmission potential in different geographic areas of GB are presented for the fitted models.	[Ster, Irina Chis; Ferguson, Neil M.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England	Imperial College London	Ster, IC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Norfolk Pl, London, England.	irina.chisster@imperial.ac.uk	Ferguson, Neil/B-8578-2008; Ster, Irina Chis/AAJ-3217-2021	Ferguson, Neil/0000-0002-1154-8093; Ster, Irina Chis/0000-0003-2637-1259	Department of Environmental and Rural Affairs (DEFRA), UK BBRSC, UK	Department of Environmental and Rural Affairs (DEFRA), UK BBRSC, UK(Department for Environment, Food & Rural Affairs (DEFRA))	Department of Environmental and Rural Affairs (DEFRA), UK BBRSC, UK	Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Cressie N.A.C, 1993, WILEY SERIES PROBABI, Vxx, P900; Diggle PJ, 2006, STAT METHODS MED RES, V15, P325, DOI 10.1191/0962280206sm454oa; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Finkenstadt BF, 2005, STAT MED, V24, P3447, DOI 10.1002/sim.2196; Gelman A., 2000, BAYESIAN DATA ANAL; Gibson GJ, 1998, IMA J MATH APPL MED, V15, P19; Gibson GJ, 1997, J R STAT SOC C-APPL, V46, P215, DOI 10.1111/1467-9876.00061; Gibson GJ, 2001, STAT COMPUT, V11, P347, DOI 10.1023/A:1011973120681; Gilks W.R., 1996, MARKOV CHAIN MONTE C; Green LE, 2002, RES VET SCI, V73, P201, DOI 10.1016/S0034-5288(02)00106-6; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Howard SC, 2000, RES VET SCI, V69, P189, DOI 10.1053/rvsc.2000.0415; Kao RR, 2003, P ROY SOC B-BIOL SCI, V270, P2557, DOI 10.1098/rspb.2003.2546; Kao RR, 2002, TRENDS MICROBIOL, V10, P279, DOI 10.1016/S0966-842X(02)02371-5; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 2005, P ROY SOC B-BIOL SCI, V272, P1195, DOI 10.1098/rspb.2004.3046; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Morris RS, 2001, VET REC, V149, P137, DOI 10.1136/vr.149.5.137; O'Neill PD, 1999, J ROY STAT SOC A STA, V162, P121, DOI 10.1111/1467-985X.00125; ONEILL PD, 2003, HIGHLY STRUCTURED ST, P354; ROBERT CP, 2003, HIGHLY STRUCTURED ST, P167; Roberts GO, 1997, ANN APPL PROBAB, V7, P110, DOI 10.1214/aoap/1034625254; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Streftaris G, 2004, P ROY SOC B-BIOL SCI, V271, P1111, DOI 10.1098/rspb.2004.2715; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255	28	78	78	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e502	10.1371/journal.pone.0000502	http://dx.doi.org/10.1371/journal.pone.0000502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551582	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000207451500011
J	Meyers, JH; Justement, JS; Hallahan, CW; Blair, ET; Sun, YMA; O'Shea, MA; Roby, G; Kottilil, S; Moir, S; Kovacs, CM; Chun, TW; Fauci, AS				Meyers, Jennifer Hartt; Justement, J. Shawn; Hallahan, Claire W.; Blair, Eric T.; Sun, Yongming A.; O'Shea, M. Angeline; Roby, Gregg; Kottilil, Shyam; Moir, Susan; Kovacs, Colin M.; Chun, Tae-Wook; Fauci, Anthony S.			Impact of HIV on Cell Survival and Antiviral Activity of Plasmacytoid Dendritic Cells	PLOS ONE			English	Article								Plasmacytoid dendritic cells (pDCs) are important mediators of innate immunity that act mainly through secretion of interferon (IFN)-alpha. Previous studies have found that these cells can suppress HIV in vitro; additionally, pDCs have been shown to be severely reduced in the peripheral blood of HIV-infected individuals. In the present study, we sought to determine the ability of pDCs to directly suppress viral replication ex vivo and to delineate the potential mechanisms whereby pDCs are depleted in HIV-infected individuals. We demonstrate that activated pDCs strongly suppress HIV replication in autologous CD4(+) T cells via a mechanism involving IFN-alpha as well as other antiviral factors. Of note, unstimulated pDCs from infected individuals who maintain low levels of plasma viremia without antiretroviral therapy were able to suppress HIV ex vivo via a mechanism requiring cell-to-cell contact. Our data also demonstrate that death of pDCs by both apoptosis and necrosis is induced by fusion of HIV with pDCs. Taken together, our data suggest that pDCs play an important role in the control of HIV replication and that high levels of viral replication in vivo are associated with pDC cell death via apoptosis and necrosis. Elucidation of the mechanism by which pDCs suppress HIV replication in vivo may have clinically relevant implications for future therapeutic strategies.	[Meyers, Jennifer Hartt; Justement, J. Shawn; O'Shea, M. Angeline; Roby, Gregg; Kottilil, Shyam; Moir, Susan; Chun, Tae-Wook; Fauci, Anthony S.] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Blair, Eric T.; Sun, Yongming A.] Appl Biosyst Inc, Foster City, CA 94404 USA; [Hallahan, Claire W.] NIAID, Biostat Res Branch, NIH, Bethesda, MD 20892 USA; [Kovacs, Colin M.] Univ Toronto, Dept Med, Toronto, ON, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Thermo Fisher Scientific; Applied Biosystems; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Toronto	Chun, TW (corresponding author), NIAID, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	twchun@nih.gov	Chun, Tae-Wook/W-9187-2019; Moir, Susan/AAC-3676-2020; Kottilil, Shyam/ABF-7605-2021; Chun, Tae-Wook/AAC-3101-2020	Chun, Tae-Wook/0000-0001-5153-7340; 	National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000825, Z01AI000885, Z01AI000886, Z01AI000390, ZIAAI000825, ZIAAI000886, ZIAAI000390, Z01AI000851, ZIAAI000851] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Almeida M, 2006, JAIDS-J ACQ IMM DEF, V41, P405, DOI 10.1097/01.qai.0000209896.82255.d3; Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Bjorndal A, 1997, J VIROL, V71, P7478; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bosinger SE, 2004, J IMMUNOL, V173, P6858, DOI 10.4049/jimmunol.173.11.6858; Chehimi J, 2002, J IMMUNOL, V168, P4796, DOI 10.4049/jimmunol.168.9.4796; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Del Corno M, 2005, J VIROL, V79, P12597, DOI 10.1128/JVI.79.19.12597-12601.2005; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Donaghy H, 2001, BLOOD, V98, P2574, DOI 10.1182/blood.V98.8.2574; Donaghy H, 2003, BLOOD, V101, P4505, DOI 10.1182/blood-2002-10-3189; FAKRUDDIN JM, 2006, BLOOD; Fauci AS, 2005, NAT REV IMMUNOL, V5, P835, DOI 10.1038/nri1711; Feldman S, 2001, CLIN IMMUNOL, V101, P201, DOI 10.1006/clim.2001.5111; Finke JS, 2004, J CLIN IMMUNOL, V24, P647, DOI 10.1007/s10875-004-6250-5; Fong L, 2002, J VIROL, V76, P11033, DOI 10.1128/JVI.76.21.11033-11041.2002; Fonteneau JF, 2004, J VIROL, V78, P5223, DOI 10.1128/JVI.78.10.5223-5232.2004; Groot F, 2006, BLOOD, V108, P1957, DOI 10.1182/blood-2006-03-010918; Gurney KB, 2004, J IMMUNOL, V173, P7269, DOI 10.4049/jimmunol.173.12.7269; Kamga I, 2005, J INFECT DIS, V192, P303, DOI 10.1086/430931; Killian MS, 2006, AIDS, V20, P1247, DOI 10.1097/01.aids.0000232231.34253.bd; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Letvin NL, 2003, NAT MED, V9, P861, DOI 10.1038/nm0703-861; MATTHEWS TJ, 1987, P NATL ACAD SCI USA, V84, P5424, DOI 10.1073/pnas.84.15.5424; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Moir S, 1999, J VIROL, V73, P7972, DOI 10.1128/JVI.73.10.7972-7980.1999; Muller-Trutwin M, 2005, IMMUNOL CELL BIOL, V83, P578, DOI 10.1111/j.1440-1711.2005.01394.x; Patterson Bruce K., 2002, Current Molecular Medicine (Hilversum), V2, P713, DOI 10.2174/1566524023361817; Patterson S, 2001, J VIROL, V75, P6710, DOI 10.1128/JVI.75.14.6710-6713.2001; Rothenfusser S, 2002, HUM IMMUNOL, V63, P1111, DOI 10.1016/S0198-8859(02)00749-8; Schmid Gunther, 2006, SOCIO-ECON REV, V4, P1, DOI DOI 10.1093/SER/MWJ029; Schmidt B, 2004, VIROLOGY, V329, P280, DOI 10.1016/j.virol.2004.08.016; Schmidt B, 2005, VIROLOGY, V343, P256, DOI 10.1016/j.virol.2005.09.059; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Soumelis V, 2001, BLOOD, V98, P906, DOI 10.1182/blood.V98.4.906; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Yonezawa A, 2003, J VIROL, V77, P3777, DOI 10.1128/JVI.77.6.3777-3784.2003	40	64	65	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2007	2	5							e458	10.1371/journal.pone.0000458	http://dx.doi.org/10.1371/journal.pone.0000458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DZ	17520017	Green Published, gold, Green Submitted			2022-12-27	WOS:000207446000006
J	Gold, JA; Hoshino, Y; Jones, MB; Hoshino, S; Nolan, A; Weiden, MD				Gold, Jeffrey A.; Hoshino, Yoshihiko; Jones, Marcus B.; Hoshino, Satomi; Nolan, Anna; Weiden, Michael D.			Exogenous Interferon-alpha and Interferon-gamma Increase Lethality of Murine Inhalational Anthrax	PLOS ONE			English	Article								Background. Bacillus anthracis, the etiologic agent of inhalational anthrax, is a facultative intracellular pathogen. Despite appropriate antimicrobial therapy, the mortality from inhalational anthrax approaches 45%, underscoring the need for better adjuvant therapies. The variable latency between exposure and development of disease suggests an important role for the host's innate immune response. Type I and Type II Interferons (IFN) are prominent members of the host innate immune response and are required for control of intracellular pathogens. We have previously described a protective role for exogenous Type I and Type II IFNs in attenuating intracellular B. anthracis germination and macrophage cell death in vitro. Methodology and Principal Findings. We sought to extend these findings in an in vivo model of inhalational anthrax, utilizing the Sterne strain (34F(2)) of B. anthracis. Mice devoid of STAT1, a component of IFN-alpha and IFN-gamma signaling, had a trend towards increased mortality, bacterial germination and extrapulmonary spread of B. anthracis at 24 hrs. This was associated with impaired IL-6, IL-10 and IL-12 production. However, administration of exogenous IFN-gamma, and to a lesser extent IFN-alpha, at the time of infection, markedly increased lethality. While IFNs were able to reduce the fraction of germinated spores within the lung, they increased both the local and systemic inflammatory response manifest by increases in IL-12 and reductions in IL-10. This was associated with an increase in extrapulmonary dissemination. The mechanism of IFN mediated inflammation appears to be in part due to STAT1 independent signaling. Conclusions. In conclusion, while endogenous IFNs are essential for control of B. anthracis germination and lethality, administration of exogenous IFNs appear to increase the local inflammatory response, thereby increasing mortality.	[Gold, Jeffrey A.] Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA; [Hoshino, Yoshihiko; Hoshino, Satomi; Nolan, Anna; Weiden, Michael D.] NYU, Sch Med, Div Pulm & Crit Care, New York, NY USA; [Jones, Marcus B.] J Craig Venter Inst, Rockville, MD USA	Oregon Health & Science University; New York University; J. Craig Venter Institute	Gold, JA (corresponding author), Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA.	goldje@ohsu.edu	Hoshino, Yoshihiko/B-5159-2019; Nolan, Anna/C-2796-2012	Hoshino, Yoshihiko/0000-0002-3132-0715; Nolan, Anna/0000-0002-0631-1171; gold, jeffrey/0000-0001-6683-9907	NIH NCRR GCRC [MO1 RR0096, K08 HL070710, RO1 HL57879]; UNCF/MERCK Graduate Science Research Dissertation Fellowship;  [RO1 GM 63270]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000096] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057879, K23HL084191, K08HL070710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063270] Funding Source: NIH RePORTER	NIH NCRR GCRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); UNCF/MERCK Graduate Science Research Dissertation Fellowship; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH NCRR GCRC MO1 RR0096, K08 HL070710, RO1 HL57879, UNCF/MERCK Graduate Science Research Dissertation Fellowship, David and Lucile Packard Foundation and RO1 GM 63270	ANTHONY LSD, 1989, MICROB PATHOGENESIS, V7, P421, DOI 10.1016/0882-4010(89)90022-3; Chung MP, 2003, AM J RESP CELL MOL, V29, P375, DOI 10.1165/rcmb.2003-0029OC; Condos R, 1997, LANCET, V349, P1513, DOI 10.1016/S0140-6736(96)12273-X; Cui XZ, 2006, J INFECT DIS, V193, P829, DOI 10.1086/500468; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Dang O, 2004, J IMMUNOL, V172, P747, DOI 10.4049/jimmunol.172.2.747; Drysdale M, 2007, INFECT IMMUN, V75, P1757, DOI 10.1128/IAI.01712-06; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; GARNER RE, 1989, INFECT IMMUN, V57, P1800, DOI 10.1128/IAI.57.6.1800-1808.1989; Giosue S, 1998, AM J RESP CRIT CARE, V158, P1156, DOI 10.1164/ajrccm.158.4.9803065; Giosue S, 2000, EUR CYTOKINE NETW, V11, P99; Glomski IJ, 2007, J IMMUNOL, V178, P2646, DOI 10.4049/jimmunol.178.5.2646; Goh KC, 1999, EMBO J, V18, P5601, DOI 10.1093/emboj/18.20.5601; Gold JA, 2004, INFECT IMMUN, V72, P1291, DOI 10.1128/IAI.72.3.1291-1297.2004; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Johnson Christopher P, 2005, Surg Infect (Larchmt), V6, P397, DOI 10.1089/sur.2005.6.397; Lavigne LM, 1998, J IMMUNOL, V160, P284; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; Lyons CR, 2004, INFECT IMMUN, V72, P4801, DOI 10.1128/IAI.72.8.4801-4809.2004; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Palmero D, 1999, INT J TUBERC LUNG D, V3, P214; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Popov SG, 2002, FEBS LETT, V527, P211, DOI 10.1016/S0014-5793(02)03228-3; Remoli ME, 2002, J IMMUNOL, V169, P366, DOI 10.4049/jimmunol.169.1.366; Roy SK, 2005, J BIOL CHEM, V280, P24462, DOI 10.1074/jbc.M413661200; Stoiber D, 2001, J IMMUNOL, V166, P466, DOI 10.4049/jimmunol.166.1.466; Sugawara I, 2004, TOHOKU J EXP MED, V202, P41, DOI 10.1620/tjem.202.41; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Weiden M, 2000, J IMMUNOL, V165, P2028, DOI 10.4049/jimmunol.165.4.2028	34	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e736	10.1371/journal.pone.0000736	http://dx.doi.org/10.1371/journal.pone.0000736			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710136	Green Published, gold			2022-12-27	WOS:000207455200013
J	Martin, TG; Chades, I; Arcese, P; Marra, PP; Possingham, HP; Norris, DR				Martin, Tara G.; Chades, Iadine; Arcese, Peter; Marra, Peter P.; Possingham, Hugh P.; Norris, D. Ryan			Optimal Conservation of Migratory Species	PLOS ONE			English	Article							WINTER	Background. Migratory animals comprise a significant portion of biodiversity worldwide with annual investment for their conservation exceeding several billion dollars. Designing effective conservation plans presents enormous challenges. Migratory species are influenced by multiple events across land and sea-regions that are often separated by thousands of kilometres and span international borders. To date, conservation strategies for migratory species fail to take into account how migratory animals are spatially connected between different periods of the annual cycle (i.e. migratory connectivity) bringing into question the utility and efficiency of current conservation efforts. Methodology/Principal Findings. Here, we report the first framework for determining an optimal conservation strategy for a migratory species. Employing a decision theoretic approach using dynamic optimization, we address the problem of how to allocate resources for habitat conservation for a Neotropical-Nearctic migratory bird, the American redstart Setophaga ruticilla, whose winter habitat is under threat. Our first conservation strategy used the acquisition of winter habitat based on land cost, relative bird density, and the rate of habitat loss to maximize the abundance of birds on the wintering grounds. Our second strategy maximized bird abundance across the entire range of the species by adding the constraint of maintaining a minimum percentage of birds within each breeding region in North America using information on migratory connectivity as estimated from stable-hydrogen isotopes in feathers. We show that failure to take into account migratory connectivity may doom some regional populations to extinction, whereas including information on migratory connectivity results in the protection of the species across its entire range. Conclusions/Significance. We demonstrate that conservation strategies for migratory animals depend critically upon two factors: knowledge of migratory connectivity and the correct statement of the conservation problem. Our framework can be used to identify efficient conservation strategies for migratory taxa worldwide, including insects, birds, mammals, and marine organisms.	[Martin, Tara G.; Arcese, Peter; Norris, D. Ryan] Univ British Columbia, Ctr Appl Conservat Res, Vancouver, BC V5Z 1M9, Canada; [Chades, Iadine] INRA, UR875, Unite Biometrie & Intelligence Artificielle, F-31931 Toulouse, France; [Marra, Peter P.] Smithsonian Migratory Bird Ctr, Washington, DC USA; [Possingham, Hugh P.] Univ Queensland, Ctr Ecol, Brisbane, Qld 4072, Australia; [Possingham, Hugh P.] Univ Queensland, Dept Math, Brisbane, Qld 4072, Australia; [Norris, D. Ryan] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	University of British Columbia; INRAE; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Queensland; University of Queensland; University of Guelph	Martin, TG (corresponding author), Univ British Columbia, Ctr Appl Conservat Res, Vancouver, BC V5Z 1M9, Canada.	Tara.Martin@ubc.ca	Chades, iadine/A-4052-2011; Norris, Ryan/F-4720-2011; Martin, Tara/M-1897-2016; POSSINGHAM, HUGH/R-8310-2019; Possingham, Hugh/B-1337-2008	Chades, iadine/0000-0002-7442-2850; Norris, Ryan/0000-0003-4874-1425; Martin, Tara/0000-0001-7165-9812; POSSINGHAM, HUGH/0000-0001-7755-996X; Possingham, Hugh/0000-0001-7755-996X; Marra, Peter/0000-0002-0508-7577	NSERC; Killam Memorial Foundation; Centre for Applied Conservation Research; Smithsonian Institution; National Science Foundation; Institut National de la Recherche Agronomique; Australian Research Council	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Killam Memorial Foundation; Centre for Applied Conservation Research; Smithsonian Institution(Smithsonian Institution); National Science Foundation(National Science Foundation (NSF)); Institut National de la Recherche Agronomique; Australian Research Council(Australian Research Council)	This work was supported by NSERC ( R.N., P. A., T. G. M.), Killam Memorial Foundation ( R.N.), Centre for Applied Conservation Research ( T. G. M), Smithsonian Institution ( P. P. M., R.N.), National Science Foundation ( P. P. M.), Institut National de la Recherche Agronomique ( I. C.), and the Australian Research Council ( H. P. P).	Cormen T. H., 2001, DIJKSTRAS ALGORITHM, P595, DOI DOI 10.1515/9783110522013; CORMEN TH, 2001, INTRO ALGORITHMS, P595; Costello C, 2004, RESOUR ENERGY ECON, V26, P157, DOI 10.1016/j.reseneeco.2003.11.005; Davis FW, 2006, ECOL SOC, V11; Haight RG, 2004, BIOL CONSERV, V117, P61, DOI 10.1016/S0006-3207(03)00263-5; Marra PP, 2001, AUK, V118, P92, DOI 10.1642/0004-8038(2001)118[0092:CODMHS]2.0.CO;2; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; MARRA PP, MAINTAINING CONNECTI; *MATH WORKS INC, 2002, MATLAB 7 0; Moore J, 2004, BIOL CONSERV, V117, P343, DOI 10.1016/j.biocon.2003.12.013; Nicholson E, 2006, CONSERV BIOL, V20, P871, DOI 10.1111/j.1523-1739.2006.00369.x; Norris D. Ryan, 2006, Ornithological Monographs, V61, P14; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; Possingham HP, 2001, CONSERVATION BIOLOGY: RESEARCH PRIORITIES FOR THE NEXT DECADE, P225; Rappole JH., 1995, ECOLOGY MIGRANT BIRD; Sherry TW, 1997, BIRDS N AM; Studds CE, 2005, ECOLOGY, V86, P2380, DOI 10.1890/04-1145; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Williams PH, 2000, P ROY SOC B-BIOL SCI, V267, P1959, DOI 10.1098/rspb.2000.1236; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; WILSON KA, PLOS BIOL IN PRESS; 2006, 2005 ANN REPORT MIGR; 2003, CONVENTION CONSERVAT	23	253	262	7	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e751	10.1371/journal.pone.0000751	http://dx.doi.org/10.1371/journal.pone.0000751			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710150	Green Published, gold			2022-12-27	WOS:000207455200027
J	Naguib, M; Nemitz, A				Naguib, Marc; Nemitz, Andrea			Living with the Past: Nutritional Stress in Juvenile Males Has Immediate Effects on their Plumage Ornaments and on Adult Attractiveness in Zebra Finches	PLOS ONE			English	Article							EARLY DEVELOPMENTAL STRESS; BROOD SIZE; MATE CHOICE; GREAT TITS; SONG; IMMUNOCOMPETENCE; REPRODUCTION; PHENOTYPE; SELECTION; SURVIVAL	The environmental conditions individuals experience during early development are well known to have fundamental effects on a variety of fitness-relevant traits. Although it is evident that the earliest developmental stages have large effects on fitness, other developmental stages, such as the period when secondary sexual characters develop, might also exert a profound effect on fitness components. Here we show experimentally in male zebra finches, Taeniopygia guttata, that nutritional conditions during this later period have immediate effects on male plumage ornaments and on their attractiveness as adults. Males that had received high quality food during the second month of life, a period when secondary sexual characteristics develop, were significantly more attractive as adults in mate choice tests than siblings supplied with standard food during this period. Preferred males that had experienced better nutritional conditions had larger orange cheek patches when nutritional treatments ended than did unpreferred males. Sexual plumage ornaments of young males thus are honest indicators of nutritional conditions during this period. The mate choice tests with adult birds indicate that nutritional conditions during the period of song learning, brain and gonad development, and moult into adult plumage have persisting effects on male attractiveness. This suggests that the developmental period following nutritional dependence from the parents is just as important in affecting adult attractiveness as are much earlier developmental periods. These findings thus contribute to understanding the origin and consequences of environmentally determined fitness components.	[Naguib, Marc; Nemitz, Andrea] Univ Bielefeld, Fac Biol, Bielefeld, Germany	University of Bielefeld	Naguib, M (corresponding author), Univ Bielefeld, Fac Biol, Bielefeld, Germany.	mnaguib@uni-bielefeld.de	Naguib, Marc/C-2650-2009	Naguib, Marc/0000-0003-0494-4888	German Science Foundation [NA335/6]	German Science Foundation(German Research Foundation (DFG))	The research was funded by the German Science Foundation NA335/6.	Andersson Malte, 1994; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bottjer SW, 2002, J COMP PHYSIOL A, V188, P917, DOI 10.1007/s00359-002-0356-0; Brinkhof MWG, 1999, P ROY SOC B-BIOL SCI, V266, P2315, DOI 10.1098/rspb.1999.0925; Buchanan KL, 2003, P ROY SOC B-BIOL SCI, V270, P1149, DOI 10.1098/rspb.2003.2330; Catchpole CK, 1995, BIRD SONG BIOL THEME; Charmantier A, 2006, TRENDS ECOL EVOL, V21, P417, DOI 10.1016/j.tree.2006.06.001; Cotton S, 2004, P ROY SOC B-BIOL SCI, V271, P771, DOI 10.1098/rspb.2004.2688; DeKogel CH, 1997, J ANIM ECOL, V66, P167; DeKogel CH, 1996, ANIM BEHAV, V51, P699, DOI 10.1006/anbe.1996.0073; Fisher MO, 2006, PLOS BIOL, V4, P1462, DOI 10.1371/journal.pbio.0040251; FORSTMEIER W, 2007, MOL ECOL IN PRESS; Gil D, 2004, J EXP BIOL, V207, P2215, DOI 10.1242/jeb.01013; Gil D, 2006, J NEUROBIOL, V66, P1602, DOI 10.1002/neu.20312; Griffith SC, 1999, NATURE, V400, P358, DOI 10.1038/22536; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; GUSTAFSSON L, 1988, NATURE, V335, P813, DOI 10.1038/335813a0; Hadfield JD, 2006, P ROY SOC B-BIOL SCI, V273, P1347, DOI 10.1098/rspb.2005.3459; Hill GE., 2006, BIRD COLOURATION, P507, DOI [10.4159/9780674273788, DOI 10.4159/9780674273788]; Hodes GE, 2005, HORM BEHAV, V48, P163, DOI 10.1016/j.yhbeh.2005.02.008; Jacot A, 2007, BEHAV ECOL, V18, P34, DOI 10.1093/beheco/arl054; Kaltiala-Heino R, 2003, SOC SCI MED, V57, P1055, DOI 10.1016/S0277-9536(02)00480-X; Leader N, 2006, ANIM BEHAV, V72, P113, DOI 10.1016/j.anbehav.2005.09.013; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Lummaa V, 2002, TRENDS ECOL EVOL, V17, P141, DOI 10.1016/S0169-5347(01)02414-4; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Naguib M, 2004, P ROY SOC B-BIOL SCI, V271, P833, DOI 10.1098/rspb.2003.2673; Naguib M, 2005, BIOL LETT-UK, V1, P95, DOI 10.1098/rsbl.2004.0277; Naguib M, 2006, P ROY SOC B-BIOL SCI, V273, P1901, DOI 10.1098/rspb.2006.3526; Nowicki S, 2002, J COMP PHYSIOL A, V188, P1003, DOI 10.1007/s00359-002-0361-3; Slater P.J.B., 1988, Advances in the Study of Behavior, V18, P1; SOSSINKA R, 1972, Journal fuer Ornithologie, V113, P29, DOI 10.1007/BF01647254; SOSSINKA R, 1980, J EXP ZOOL, V211, P225, DOI 10.1002/jez.1402110211; Spencer KA, 2005, BEHAV ECOL SOCIOBIOL, V58, P423, DOI 10.1007/s00265-005-0927-5; TINBERGEN JM, 1990, J ANIM ECOL, V59, P1113, DOI 10.2307/5035; Wells JCK, 2007, BIOL REV, V82, P143, DOI 10.1111/j.1469-185X.2006.00007.x; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; ZANN R, 1994, IBIS, V136, P136, DOI 10.1111/j.1474-919X.1994.tb01077.x; Zann RA., 1996, ZEBRA FINCH SYNTHESI	39	53	54	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e901	10.1371/journal.pone.0000901	http://dx.doi.org/10.1371/journal.pone.0000901			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878936	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455700009
J	Pagan, I; Alonso-Blanco, C; Garcia-Arenal, F				Pagan, Israel; Alonso-Blanco, Carlos; Garcia-Arenal, Fernando			The Relationship of Within-Host Multiplication and Virulence in a Plant-Virus System	PLOS ONE			English	Article								Background. Virulence does not represent any obvious advantage to parasites. Most models of virulence evolution assume that virulence is an unavoidable consequence of within-host multiplication of parasites, resulting in trade-offs between within-host multiplication and between-host transmission fitness components. Experimental support for the central assumption of this hypothesis, i.e., for a positive correlation between within-host multiplication rates and virulence, is limited for plant-parasite systems. Methodology/Principal Findings. We have addressed this issue in the system Arabidopsis thaliana-Cucumber mosaic virus (CMV). Virus multiplication and the effect of infection on plant growth and on viable seed production were quantified for 21 Arabidopsis wild genotypes infected by 3 CMV isolates. The effect of infection on plant growth and seed production depended of plant architecture and length of postembryonic life cycle, two genetically-determined traits, as well as on the time of infection in the plant's life cycle. A relationship between virus multiplication and virulence was not a general feature of this host-parasite system. This could be explained by tolerance mechanisms determined by the host genotype and operating differently on two components of plant fitness, biomass production and resource allocation to seeds. However, a positive relationship between virus multiplication and virulence was detected for some accessions with short life cycle and high seed weight to biomass ratio, which show lower levels of tolerance to infection. Conclusions/Significance. These results show that genotype-specific tolerance mechanisms may lead to the absence of a clear relationship between parasite multiplication and virulence. Furthermore, a positive correlation between parasite multiplication and virulence may occur only in some genotypes and/or environmental conditions for a given host-parasite system. Thus, our results challenge the general validity of the trade-off hypothesis for virulence evolution, and stress the need of considering the effect of both the host and parasite genotypes in analyses of host-parasite interactions.	[Pagan, Israel; Garcia-Arenal, Fernando] Univ Politecn Madrid, Dept Biotecnol, Madrid, Spain; [Pagan, Israel; Garcia-Arenal, Fernando] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Madrid, Spain; [Alonso-Blanco, Carlos] Univ Autonoma, CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, Madrid, Spain	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Garcia-Arenal, F (corresponding author), Univ Politecn Madrid, Dept Biotecnol, Madrid, Spain.	fernando.garciaar-enal@upm.es	Pagán, Israel/H-1843-2015; Garcia-Arenal, Fernando/H-1603-2015; Alonso-Blanco, Carlos/F-8864-2016	Pagán, Israel/0000-0001-8876-1194; Alonso-Blanco, Carlos/0000-0002-4738-5556; GARCIA-ARENAL RODRIGUEZ, FERNANDO/0000-0002-5327-3200	Plan Nacional de I+D, Spain [AGL2005-01122]; Ministerio de Educacion y Ciencia, Spain	Plan Nacional de I+D, Spain; Ministerio de Educacion y Ciencia, Spain(Spanish Government)	This work was partly supported by grant AGL2005-01122 from Plan Nacional de I+D, Spain, to FGA. IP was supported by a Formacion de Personal Investigador fellowship from Ministerio de Educacion y Ciencia, Spain.	ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Bonnet J, 2005, VIROLOGY, V332, P359, DOI 10.1016/j.virol.2004.11.017; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; BULL JJ, 1992, EVOLUTION, V46, P882, DOI 10.1111/j.1558-5646.1992.tb00606.x; BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.1111/j.1558-5646.1994.tb02185.x; Carr DE, 2006, HEREDITY, V96, P29, DOI 10.1038/sj.hdy.6800743; Carr DE, 2003, EVOL ECOL, V17, P85, DOI 10.1023/A:1022439432213; Clarke D. D., 1986, Advances in Plant Pathology Volume 5., P161; Davies CM, 2001, P ROY SOC B-BIOL SCI, V268, P251, DOI 10.1098/rspb.2000.1367; Day T, 2002, P ROY SOC B-BIOL SCI, V269, P1317, DOI 10.1098/rspb.2002.2021; Ding XS, 2004, MOL PLANT MICROBE IN, V17, P583, DOI 10.1094/MPMI.2004.17.6.583; Dunoyer P, 2005, CURR OPIN PLANT BIOL, V8, P415, DOI 10.1016/j.pbi.2005.05.012; Ebert D, 1996, TRENDS ECOL EVOL, V11, pA79; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; Ebert D, 2003, TRENDS MICROBIOL, V11, P15, DOI 10.1016/S0966-842X(02)00003-3; Ebert D, 1997, EVOLUTION, V51, P1828, DOI [10.2307/2411005, 10.1111/j.1558-5646.1997.tb05106.x]; Escriu F, 2000, PHYTOPATHOLOGY, V90, P1068, DOI 10.1094/PHYTO.2000.90.10.1068; Escriu F, 2000, PHYTOPATHOLOGY, V90, P480, DOI 10.1094/PHYTO.2000.90.5.480; Escriu F, 2003, EVOLUTION, V57, P755, DOI 10.1111/j.0014-3820.2003.tb00287.x; FENNER F, 1965, MIXOMATOSIS; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Gal-On A, 2007, MOL PLANT PATHOL, V8, P139, DOI 10.1111/J.1364-3703.2007.00381.X; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Goss EM, 2006, EVOLUTION, V60, P1562, DOI 10.1111/j.0014-3820.2006.tb00501.x; Handford MG, 2007, J GEN VIROL, V88, P337, DOI 10.1099/vir.0.82376-0; Jaenike J, 1996, EVOLUTION, V50, P2241, DOI [10.1111/j.1558-5646.1996.tb03613.x, 10.2307/2410694]; Jakel T, 2001, INT J PARASITOL, V31, P1639, DOI 10.1016/S0020-7519(01)00289-2; Jensen KH, 2006, PLOS BIOL, V4, P1265, DOI 10.1371/journal.pbio.0040197; Kaltz O, 2002, J EVOLUTION BIOL, V15, P850, DOI 10.1046/j.1420-9101.2002.00433.x; Kover PX, 2002, P NATL ACAD SCI USA, V99, P11270, DOI 10.1073/pnas.102288999; Lambrechts L, 2006, TRENDS PARASITOL, V22, P12, DOI 10.1016/j.pt.2005.11.008; LENSKI RE, 1994, J THEOR BIOL, V169, P253, DOI 10.1006/jtbi.1994.1146; Levin Bruce R., 1994, Trends in Microbiology, V2, P76, DOI 10.1016/0966-842X(94)90538-X; Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6; Little TJ, 2006, EVOLUTION, V60, P31, DOI 10.1111/j.0014-3820.2006.tb01079.x; LOT H, 1972, Annales de Phytopathologie, V4, P25; Mackinnon MJ, 2004, PHILOS T R SOC B, V359, P965, DOI 10.1098/rstb.2003.1414; Martin DP, 2005, PLOS GENET, V1, P475, DOI 10.1371/journal.pgen.0010051; Matthews REF., 2002, PLANT VIROLOGY; Messenger SL, 1999, P ROY SOC B-BIOL SCI, V266, P397, DOI 10.1098/rspb.1999.0651; Miller MR, 2006, EVOLUTION, V60, P945, DOI 10.1111/j.0014-3820.2006.tb01173.x; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Palukaitis P, 2003, ADV VIRUS RES, V62, P241, DOI 10.1016/S0065-3527(03)62005-1; PALUKAITIS P, 1992, ADV VIRUS RES, V41, P281, DOI 10.1016/B978-0-12-394314-9.00013-0; Palukaitis P, 2003, DESCRIPTION PLANT VI; Paul REL, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-30; Peever TL, 2000, APPL ENVIRON MICROB, V66, P4863, DOI 10.1128/AEM.66.11.4863-4869.2000; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Restif O, 2004, AM NAT, V164, pE90, DOI 10.1086/423713; Restif O, 2003, AM NAT, V161, P827, DOI 10.1086/375171; RIZZO TM, 1990, MOL GEN GENET, V222, P249, DOI 10.1007/BF00633825; RODRIGUEZCEREZO E, 1991, P NATL ACAD SCI USA, V88, P9863, DOI 10.1073/pnas.88.21.9863; Sacristan S, 2005, PHYTOPATHOLOGY, V95, P827, DOI 10.1094/PHYTO-95-0827; Salvaudon L, 2005, EVOLUTION, V59, P2518, DOI 10.1111/j.0014-3820.2005.tb00965.x; Sambrook J., 2001, MOL CLONING LAB MANU; SCHAFER JF, 1971, ANNU REV PHYTOPATHOL, V9, P235, DOI 10.1146/annurev.py.09.090171.001315; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; Shi BJ, 2002, MOL PLANT MICROBE IN, V15, P947, DOI 10.1094/MPMI.2002.15.9.947; Sokal RR, 1995, BIOMETRY; Somerville C, 2002, NAT REV GENET, V3, P883, DOI 10.1038/nrg927; Stewart AD, 2005, EVOLUTION, V59, P730, DOI 10.1111/j.0014-3820.2005.tb01749.x; Takahashi H, 2002, PLANT J, V32, P655, DOI 10.1046/j.1365-313X.2002.01453.x; TAKAHASHI H, 1994, PLANT J, V6, P369, DOI 10.1046/j.1365-313X.1994.06030369.x; Wang IN, 2006, GENETICS, V172, P17, DOI 10.1534/genetics.105.045922; Webster JP, 2004, AM NAT, V164, pS33, DOI 10.1086/424607; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Yoon JY, 2006, VIRUS RES, V118, P23, DOI 10.1016/j.virusres.2005.11.004; ZHANG L, 1994, J GEN VIROL, V75, P3185, DOI 10.1099/0022-1317-75-11-3185	69	53	53	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e786	10.1371/journal.pone.0000786	http://dx.doi.org/10.1371/journal.pone.0000786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726516	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455400003
J	Uys, PW; Warren, RM; van Helden, PD				Uys, Pieter W.; Warren, Robin M.; van Helden, Paul D.			A Threshold Value for the Time Delay to TB Diagnosis	PLOS ONE			English	Article								Background. In many communities where TB occurs at high incidence, the major force driving the epidemic is transmission. It is plausible that the typical long delay from the onset of infectious disease to diagnosis and commencement of treatment is almost certainly the major factor contributing to the high rate of transmission. Methodology/Principal Findings. This study is confined to communities which are epidemiologically relatively isolated and which have low HIV incidence. The consequences of delays to diagnosis are analyzed and the existence of a threshold delay value is demonstrated. It is shown that unless a sufficient number of cases are detected before this threshold, the epidemic will escalate. The method used for the analysis avoids the standard computer integration of systems of differential equations since the intention is to present a line of reasoning that reveals the essential dynamics of an epidemic in an intuitively clear way that is nevertheless quantitatively realistic. Conclusions/Significance. The analysis presented here shows that typical delays to diagnosis present a major obstacle to the control of a TB epidemic. Control can be achieved by optimizing the rapid identification of TB cases together with measures to increase the threshold value. A calculated and aggressive program is therefore necessary in order to bring about a reduction in the prevalence of TB in a community by decreasing the time to diagnosis in all its ramifications. Intervention strategies to increase the threshold value relative to the time to diagnosis and which thereby decrease disease incidence are discussed.	[Uys, Pieter W.; Warren, Robin M.; van Helden, Paul D.] Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, Div Mol Biol & Human Genet, MRC Ctr Mol & Cellular Biol,Fac Hlth Sci, Cape Town, Western Cape, South Africa	National Research Foundation - South Africa; Stellenbosch University	van Helden, PD (corresponding author), Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, Div Mol Biol & Human Genet, MRC Ctr Mol & Cellular Biol,Fac Hlth Sci, Cape Town, Western Cape, South Africa.	pvh@sun.ac.za		Warren, Robin/0000-0001-5741-7358	EDCTP	EDCTP	Salary for PU from EDCTP. Sponsor had no role in the study.	Aparicio JP, 2000, J THEOR BIOL, V206, P327, DOI 10.1006/jtbi.2000.2129; Arias-Bouda LMP, 2000, J CLIN MICROBIOL, V38, P2278; Asch S, 1998, AM J RESP CRIT CARE, V157, P1244, DOI 10.1164/ajrccm.157.4.9709071; Bailey WC, 2002, JAMA-J AM MED ASSOC, V287, P996, DOI 10.1001/jama.287.8.996; Boehme C, 2005, T ROY SOC TROP MED H, V99, P893, DOI 10.1016/j.trstmh.2005.04.014; DUBOS J, 1987, WHITE PLAGUE; Golub JE, 2006, INT J TUBERC LUNG D, V10, P24; Hamasur B, 2001, J MICROBIOL METH, V45, P41, DOI 10.1016/S0167-7012(01)00239-1; Koopman J, 2004, ANNU REV PUBL HEALTH, V25, P303, DOI 10.1146/annurev.publhealth.25.102802.124353; LILJEROS F, 2005, CONTACT NETWORK PATI; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Phillips L, 2004, PEDIATRICS, V113, pE514, DOI 10.1542/peds.113.6.e514; Reichler MR, 2002, JAMA-J AM MED ASSOC, V287, P991, DOI 10.1001/jama.287.8.991; SADA E, 1983, LANCET, V2, P651; SADA E, 1992, J CLIN MICROBIOL, V30, P2415, DOI 10.1128/JCM.30.9.2415-2418.1992; Sherman LF, 1999, INT J TUBERC LUNG D, V3, P1088; Tessema TA, 2001, SCAND J INFECT DIS, V33, P279, DOI 10.1080/003655401300077306; Toyota M, 1994, Kekkaku, V69, P375; Verver S, 2004, INT J EPIDEMIOL, V33, P351, DOI 10.1093/ije/dyh021; Wandwalo ER, 2000, INT J TUBERC LUNG D, V4, P133; YANEZ MA, 1986, J CLIN MICROBIOL, V23, P822	22	40	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e757	10.1371/journal.pone.0000757	http://dx.doi.org/10.1371/journal.pone.0000757			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712405	Green Published, gold			2022-12-27	WOS:000207455300005
J	Philippe, H; Brinkmann, H; Martinez, P; Riutort, M; Baguna, J				Philippe, Herve; Brinkmann, Henner; Martinez, Pedro; Riutort, Marta; Baguna, Jaume			Acoel Flatworms Are Not Platyhelminthes: Evidence from Phylogenomics	PLOS ONE			English	Article								Acoel flatworms are small marine worms traditionally considered to belong to the phylum Platyhelminthes. However, molecular phylogenetic analyses suggest that acoels are not members of Platyhelminthes, but are rather extant members of the earliest diverging Bilateria. This result has been called into question, under suspicions of a long branch attraction (LBA) artefact. Here we re-examine this problem through a phylogenomic approach using 68 different protein-coding genes from the acoel Convoluta pulchra and 51 metazoan species belonging to 15 different phyla. We employ a mixture model, named CAT, previously found to overcome LBA artefacts where classical models fail. Our results unequivocally show that acoels are not part of the classically defined Platyhelminthes, making the latter polyphyletic. Moreover, they indicate a deuterostome affinity for acoels, potentially as a sister group to all deuterostomes, to Xenoturbellida, to Ambulacraria, or even to chordates. However, the weak support found for most deuterostome nodes, together with the very fast evolutionary rate of the acoel Convoluta pulchra, call for more data from slowly evolving acoels (or from its sister-group, the Nemertodermatida) to solve this challenging phylogenetic problem.	[Philippe, Herve; Brinkmann, Henner] Univ Montreal, Dept Biochim, Canadian Inst Adv Res, Ctr Robert Cedergren, Montreal, PQ H3C 3J7, Canada; [Martinez, Pedro; Riutort, Marta; Baguna, Jaume] Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain	Canadian Institute for Advanced Research (CIFAR); Universite de Montreal; University of Barcelona	Philippe, H (corresponding author), Univ Montreal, Dept Biochim, Canadian Inst Adv Res, Ctr Robert Cedergren, Montreal, PQ H3C 3J7, Canada.	herve.philippe@umontreal.ca; jbaguna@ub.edu	Martinez, Pedro/O-5025-2014; Riutort, Marta/B-6441-2009	Martinez, Pedro/0000-0003-3956-7541; Riutort, Marta/0000-0002-2134-7674	Genome Quebec; Canadian Research Chair; Universite de Montreal; ICREA; Generalitat de Catalunya; Ministerio de Educacion y Ciencia	Genome Quebec; Canadian Research Chair(Canada Research Chairs); Universite de Montreal; ICREA(ICREA); Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Educacion y Ciencia(Spanish Government)	HP acknowledges Genome Quebec, the Canadian Research Chair and the Universite de Montreal for financial support, PM, MR and JB are supported by grants from ICREA, Generalitat de Catalunya and the Ministerio de Educacion y Ciencia.	Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; AX P, 1996, MULTICELLULAR ANIMAL, V1, P225; Baguna J, 2004, BIOESSAYS, V26, P1046, DOI 10.1002/bies.20113; Baurain D, 2007, MOL BIOL EVOL, V24, P6, DOI 10.1093/molbev/msl137; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Brinkmann H, 2005, SYST BIOL, V54, P743, DOI 10.1080/10635150500234609; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Ehlers U., 1985, Das Phylogenetische System der Plathelminthes.; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Felsenstein J, 2001, PHYLIP PHYLOGENE INF; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; Hyman L., 1951, INVERTEBRATES, VII; Jondelius U, 2002, ZOOL SCR, V31, P201, DOI 10.1046/j.1463-6409.2002.00090.x; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Lundin K, 1998, ZOOL SCR, V27, P263, DOI 10.1111/j.1463-6409.1998.tb00440.x; Marletaz F, 2006, CURR BIOL, V16, pR577, DOI 10.1016/j.cub.2006.07.016; Matus DQ, 2006, CURR BIOL, V16, pR575, DOI 10.1016/j.cub.2006.07.017; Peterson KJ, 2001, EVOL DEV, V3, P170, DOI 10.1046/j.1525-142x.2001.003003170.x; Philippe H, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-50; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Philippe H, 2006, TRENDS ECOL EVOL, V21, P614, DOI 10.1016/j.tree.2006.08.004; Roure B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S2; Ruiz-Trillo I, 2004, MOL PHYLOGENET EVOL, V33, P321, DOI 10.1016/j.ympev.2004.06.002; Ruiz-Trillo I, 2002, P NATL ACAD SCI USA, V99, P11246, DOI 10.1073/pnas.172390199; Ruiz-Trillo I, 1999, SCIENCE, V283, P1919, DOI 10.1126/science.283.5409.1919; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; SMITH JPS, 1986, HYDROBIOLOGIA, V132, P71, DOI 10.1007/BF00046231; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Telford MJ, 2003, P ROY SOC B-BIOL SCI, V270, P1077, DOI 10.1098/rspb.2003.2342; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	37	102	105	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e717	10.1371/journal.pone.0000717	http://dx.doi.org/10.1371/journal.pone.0000717			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684563	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452400020
J	Telschow, A; Flor, M; Kobayashi, Y; Hammerstein, P; Werren, JH				Telschow, Arndt; Flor, Matthias; Kobayashi, Yutaka; Hammerstein, Peter; Werren, John H.			Wolbachia-Induced Unidirectional Cytoplasmic Incompatibility and Speciation: Mainland-Island Model	PLOS ONE			English	Article							REPRODUCTIVE ISOLATION; GENETIC-DIVERGENCE; REINFORCEMENT; POPULATIONS; EVOLUTION; INFECTION; VARIABILITY; PATTERNS; STRAINS; FLOW	Bacteria of the genus Wolbachia are among the most common endosymbionts in the world. In many insect species these bacteria induce a sperm-egg incompatibility between the gametes of infected males and uninfected females, commonly called unidirectional cytoplasmic incompatibility (CI). It is generally believed that unidirectional CI cannot promote speciation in hosts because infection differences between populations will be unstable and subsequent gene flow will eliminate genetic differences between diverging populations. In the present study we investigate this question theoretically in a mainland-island model with migration from mainland to island. Our analysis shows that (a) the infection polymorphism is stable below a critical migration rate, (b) an (initially) uninfected "island'' can better maintain divergence at a selected locus (e.g. can adapt locally) in the presence of CI, and (c) unidirectional CI selects for premating isolation in (initially) uninfected island populations if they receive migration from a Wolbachia-infected mainland. Interestingly, premating isolation is most likely to evolve if levels of incompatibility are intermediate and if either the infection causes fecundity reductions or Wolbachia transmission is incomplete. This is because under these circumstances an infection pattern with an infected mainland and a mostly uninfected island can persist in the face of comparably high migration. We present analytical results for all three findings: (a) a lower estimation of the critical migration rate in the presence of local adaptation, (b) an analytical approximation for the gene flow reduction caused by unidirectional CI, and (c) a heuristic formula describing the invasion success of mutants at a mate preference locus. These findings generally suggest that Wolbachia-induced unidirectional CI can be a factor in divergence and speciation of hosts.	[Telschow, Arndt; Kobayashi, Yutaka] Kyoto Univ, Ctr Ecol Res, Kyoto, Japan; [Telschow, Arndt; Flor, Matthias; Hammerstein, Peter] Humboldt Univ, Inst Theoret Biol, Berlin, Germany; [Werren, John H.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	Kyoto University; Humboldt University of Berlin; University of Rochester	Telschow, A (corresponding author), Kyoto Univ, Ctr Ecol Res, Kyoto, Japan.	a.telschow@ecology.kyoto-u.ac.jp	Flor, Matthias/C-4953-2008; Kobayashi, Yutaka/G-5424-2010	Flor, Matthias/0000-0003-0429-7457; Werren, John/0000-0001-9353-2070	Deutsche Forschungsgemeinschaft [SFB 618]; National Science Foundation [NSF: EF-0328363]; Biodiversity Research [21COE (A14)]; Japanese Society for the Promotion of Science (JSPS)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); Biodiversity Research; Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The study was funded by the Deutsche Forschungsgemeinschaft (SFB 618), the National Science Foundation (NSF: EF-0328363), the Grant of Biodiversity Research 21COE (A14), and the Japanese Society for the Promotion of Science (JSPS).	[Anonymous], 1963, ANIMAL SPECIES EVOLU; BARTON N, 1986, HEREDITY, V57, P357, DOI 10.1038/hdy.1986.135; Baudry E, 2003, MOL ECOL, V12, P1843, DOI 10.1046/j.1365-294X.2003.01855.x; Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; Bordenstein Sr, 2003, CONT T ENT, P283; Bourtzis K, 2003, CONT T ENT, P217; BREEUWER JAJ, 1990, NATURE, V346, P558, DOI 10.1038/346558a0; Clancy DJ, 1996, TRENDS ECOL EVOL, V11, P145, DOI 10.1016/0169-5347(96)30006-2; Coyne J.A., 2004, SPECIATION; COYNE JA, 1989, EVOLUTION, V43, P362, DOI [10.2307/2409213, 10.1111/j.1558-5646.1989.tb04233.x]; Coyne JA, 1997, EVOLUTION, V51, P295, DOI [10.1111/j.1558-5646.1997.tb02412.x, 10.2307/2410984]; De Crespigny FEC, 2005, J EVOLUTION BIOL, V18, P967, DOI 10.1111/j.1420-9101.2005.00909.x; Dobzhansky T, 1940, AM NAT, V74, P312, DOI 10.1086/280899; Engelstadter J, 2004, J THEOR BIOL, V231, P345, DOI 10.1016/j.jtbi.2004.06.029; FINE PEM, 1978, J INVERTEBR PATHOL, V31, P10, DOI 10.1016/0022-2011(78)90102-7; Flor M, 2007, J EVOLUTION BIOL, V20, P696, DOI 10.1111/j.1420-9101.2006.01252.x; GAVRILETS S, 2004, MONOGRAPHS POPULATIO, V41; Guillemaud T, 1997, P ROY SOC B-BIOL SCI, V264, P245, DOI 10.1098/rspb.1997.0035; Hartl D., 1989, PRINCIPLES POPULATIO; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Hurst GDD, 1998, HEREDITY, V80, P2, DOI 10.1046/j.1365-2540.1998.00337.x; Jaenike J, 2006, PLOS BIOL, V4, P1852, DOI 10.1371/journal.pbio.0040325; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Keller GP, 2004, MOL ECOL, V13, P2405, DOI 10.1111/j.1365-294X.2004.02213.x; Kirkpatrick M, 1999, GENETICS, V151, P865; LAVEN H, 1959, COLD SPRING HARB SYM, V24, P166, DOI 10.1101/SQB.1959.024.01.017; Laven H, 1967, GENETICS INSECT VECT, P251; LIOU LW, 1994, EVOLUTION, V48, P1451, DOI 10.1111/j.1558-5646.1994.tb02187.x; MERCOT H, 1995, GENETICS, V141, P1015; PerrotMinnot MJ, 1996, GENETICS, V143, P961; Rasgon JL, 2006, P ROY SOC B-BIOL SCI, V273, P1603, DOI 10.1098/rspb.2006.3493; SANDERSON N, 1989, EVOLUTION, V43, P1223, DOI [10.2307/2409358, 10.1111/j.1558-5646.1989.tb02570.x]; Servedio MR, 2000, EVOLUTION, V54, P21, DOI 10.1111/j.0014-3820.2000.tb00003.x; Shoemaker DD, 2000, INSECT MOL BIOL, V9, P661, DOI 10.1046/j.1365-2583.2000.00233.x; Shoemaker DD, 2003, ENVIRON ENTOMOL, V32, P1329, DOI 10.1603/0046-225X-32.6.1329; Shoemaker DD, 1999, EVOLUTION, V53, P1157, DOI [10.2307/2640819, 10.1111/j.1558-5646.1999.tb04529.x]; SPENCER HG, 1986, AM NAT, V128, P241, DOI 10.1086/284557; Telschow A, 2006, J EVOLUTION BIOL, V19, P869, DOI 10.1111/j.1420-9101.2005.01049.x; Telschow A, 2005, EVOLUTION, V59, P1607, DOI 10.1111/j.0014-3820.2005.tb01812.x; Telschow A, 2005, J THEOR BIOL, V235, P265, DOI 10.1016/j.jtbi.2005.01.008; Telschow A, 2002, INTEGR COMP BIOL, V42, P340, DOI 10.1093/icb/42.2.340; Telschow A, 2002, AM NAT, V160, pS54, DOI 10.1086/342153; TELSCHOW A, 2004, THESIS HUMBOLDT U BE; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; Vala F, 2004, J EVOLUTION BIOL, V17, P692, DOI 10.1046/j.1420-9101.2003.00679.x; Wade MJ, 2001, NATURE, V409, P675, DOI 10.1038/35055648; WEEKS AR, 2002, WOLBACHIA DYNAMICS H; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Werren JH, 1998, ENDLESS FORMS, P245	52	60	62	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e701	10.1371/journal.pone.0000701	http://dx.doi.org/10.1371/journal.pone.0000701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684548	Green Published, gold, Green Submitted			2022-12-27	WOS:000207452400005
J	Arkhipov, SN; Maly, IV				Arkhipov, Sergey N.; Maly, Ivan V.			A Model for the Interplay of Receptor Recycling and Receptor-Mediated Contact in T Cells	PLOS ONE			English	Article								Orientation of organelles inside T cells (TC) toward antigen-presenting cells (APC) ensures that the immune response is properly directed, but the orientation mechanisms remain largely unknown. Structural dynamics of TC are coupled to dynamics of T-cell receptor (TCR), which recognizes antigen on the APC surface. Engagement of the TCR triggers its internalization followed by delayed polarized recycling to the plasma membrane through the submembrane recycling compartment (RC), which organelle shares intracellular location with the TC effector apparatus. TCR engagement also triggers TC-APC interface expansion enabling further receptor engagement. To analyze the interplay of the cell-cell contact and receptor dynamics, we constructed a new numerical model. The new model displays the experimentally observed selective stabilization of the contact initiated next to the RC, and only transient formation of contact diametrically opposed to the RC. In the general case wherein the TC-APC contact is initiated in an arbitrary orientation to the RC, the modeling predicts that the contact dynamics and receptor recycling can interact, resulting effectively in migration of the contact to the TC surface domain adjacent to the submembrane RC. Using three-dimensional live-cell confocal microscopy, we obtain data consistent with this unexpected behavior. We conclude that a TC can stabilize its contact with an APC by aligning it with the polarized intracellular traffic of TCR. The results also suggest that the orientation of TC organelles, such as the RC and the effector apparatus, toward the APC can be achieved without any intracellular translocation of the organelles.	[Arkhipov, Sergey N.; Maly, Ivan V.] Univ Pittsburgh, Sch Med, Dept Computat Biol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Maly, IV (corresponding author), Univ Pittsburgh, Sch Med, Dept Computat Biol, Pittsburgh, PA 15260 USA.	maly@ccbb.pitt.edu	Arkhipov, Sergey/M-6858-2019; Arkhipov, Sergey/E-6293-2014	Arkhipov, Sergey/0000-0003-4707-902X	NIH [GM078332]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078332] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM078332.	ALBERTS B, 1989, MOL BIOL CELL, P1219; Arkhipov SN, 2006, BIOPHYS J, V91, P4306, DOI 10.1529/biophysj.106.083204; Borroto A, 2000, EUR J IMMUNOL, V30, P3403, DOI 10.1002/1521-4141(2000012)30:12<3403::AID-IMMU3403>3.0.CO;2-H; Bray D., 2001, CELL MOVEMENTS MOL M, V2nd, P372; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; BUNNELL SC, 2003, SCI STKE, pPL8; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Burroughs NJ, 2002, BIOPHYS J, V83, P1784, DOI 10.1016/S0006-3495(02)73944-1; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Combs J, 2006, P NATL ACAD SCI USA, V103, P14883, DOI 10.1073/pnas.0600914103; Coombs D, 2002, NAT IMMUNOL, V3, P926, DOI 10.1038/ni838; Das V, 2004, IMMUNITY, V20, P577, DOI 10.1016/S1074-7613(04)00106-2; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; DUNN GA, 1995, J CELL SCI, V108, P1239; Favier B, 2001, INT IMMUNOL, V13, P1525, DOI 10.1093/intimm/13.12.1525; Gakamsky DM, 2005, BIOPHYS J, V89, P2121, DOI 10.1529/biophysj.105.061671; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; Geisler C, 2004, CRIT REV IMMUNOL, V24, P67; Gonzalez PA, 2005, P NATL ACAD SCI USA, V102, P4824, DOI 10.1073/pnas.0500922102; HAMMER DA, 1987, BIOPHYS J, V52, P475, DOI 10.1016/S0006-3495(87)83236-8; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; Kuhne MR, 2003, J IMMUNOL, V171, P860, DOI 10.4049/jimmunol.171.2.860; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; KUPFER A, 1984, J IMMUNOL, V133, P2762; KUPFER A, 1985, J MOL CELL IMMUNOL, V2, P37; Lauffenburger D. A., 1993, RECEPTORS MODELS BIN, P365; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; McGavern DB, 2002, NAT IMMUNOL, V3, P918, DOI 10.1038/ni843; Menne C, 2002, EUR J IMMUNOL, V32, P616, DOI 10.1002/1521-4141(200203)32:3<616::AID-IMMU616>3.3.CO;2-0; MOGILNER A, 2001, PATTERN FORMATION MO, P269; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Moss WC, 2002, P NATL ACAD SCI USA, V99, P15024, DOI 10.1073/pnas.192573999; NICKLAS RB, 1995, J CELL BIOL, V130, P929, DOI 10.1083/jcb.130.4.929; PARSEY MV, 1993, J IMMUNOL, V151, P1881; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Reichert P, 2001, J IMMUNOL, V166, P4278, DOI 10.4049/jimmunol.166.7.4278; Sancho D, 2002, IMMUNOL REV, V189, P84, DOI 10.1034/j.1600-065X.2002.18908.x; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Wofsy C, 2001, BIOPHYS J, V80, P606, DOI 10.1016/S0006-3495(01)76041-9; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266	42	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e633	10.1371/journal.pone.0000633	http://dx.doi.org/10.1371/journal.pone.0000633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653260	Green Published, gold, Green Accepted			2022-12-27	WOS:000207452200002
J	van Weering, JRT; Toonen, RF; Verhage, M				van Weering, Jan R. T.; Toonen, Ruud F.; Verhage, Matthijs			The Role of Rab3a in Secretory Vesicle Docking Requires Association/Dissociation of Guanidine Phosphates and Munc18-1	PLOS ONE			English	Article								Rab3a is a small GTPase that binds selectively to secretory vesicles and switches between active, GTP-bound and inactive, GDP-bound conformations. In yeast, Rab and SM-genes interact genetically to promote vesicle targeting/fusion. We tested different Rab3a conformations and genetic interactions with the SM-gene munc18-1 on the docking function of Rab3a in mammalian chromaffin cells. We expressed Rab3a mutants locked in the GTP-or GDP-bound form in wild-type and munc18-1 null mutant cells and analyzed secretory vesicle distribution. We confirmed that wild-type Rab3a promotes vesicle docking in wild-type cells. Unexpectedly, both GTP- and GDP-locked Rab3a mutants did not promote docking. Furthermore, wildtype Rab3a did not promote docking in munc18-1 null cells and GTP- and GDP-Rab3a both decreased the amount of docked vesicles. The results show that GTP- and GDP-locked conformations do not support a Munc18-1 dependent role of Rab3a in docking. This suggests that nucleotide cycling is required to support docking and that this action of Rab3a is upstream of Munc18-1.	[van Weering, Jan R. T.; Toonen, Ruud F.; Verhage, Matthijs] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Verhage, M (corresponding author), Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands.	matthijs@cncr.vu.nl		van Weering, Jan/0000-0001-5259-4945; Toonen, Ruud/0000-0002-9900-4233; verhage, matthijs/0000-0002-6085-7503	 [ZonMW 903-42-095]		work was supported by ZonMW 903-42-095. No role of ZonMW in any of the mentioned stages of the study.	Ashery U, 1999, EUR J CELL BIOL, V78, P525, DOI 10.1016/S0171-9335(99)80017-X; BRONDYK WH, 1993, J BIOL CHEM, V268, P9410; BURSTEIN ES, 1993, J BIOL CHEM, V268, P22247; Chung SH, 1999, J BIOL CHEM, V274, P18113, DOI 10.1074/jbc.274.25.18113; Coppola T, 2002, MOL BIOL CELL, V13, P1906, DOI 10.1091/mbc.02-02-0025; Darchen F, 2000, BIOCHIMIE, V82, P375, DOI 10.1016/S0300-9084(00)00219-4; DARCHEN F, 1990, P NATL ACAD SCI USA, V87, P5692, DOI 10.1073/pnas.87.15.5692; de Wit H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000126; Leenders AGM, 2001, MOL BIOL CELL, V12, P3095, DOI 10.1091/mbc.12.10.3095; Martinez-Linares J, 2000, PROG T CHEM, V3, P3; MATTEOLI M, 1991, J CELL BIOL, V115, P625, DOI 10.1083/jcb.115.3.625; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Nonet ML, 1997, J NEUROSCI, V17, P8061; Schluter OM, 2006, J NEUROSCI, V26, P1239, DOI 10.1523/JNEUROSCI.3553-05.2006; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; Star EN, 2005, J PHYSIOL-LONDON, V569, P103, DOI 10.1113/jphysiol.2005.092528; Tall GG, 1999, MOL BIOL CELL, V10, P1873, DOI 10.1091/mbc.10.6.1873; Thiagarajan R, 2004, J PHYSIOL-LONDON, V555, P439, DOI 10.1113/jphysiol.2003.056333; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Wang J, 1999, J BIOL CHEM, V274, P28542, DOI 10.1074/jbc.274.40.28542; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	26	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2007	2	7							e616	10.1371/journal.pone.0000616	http://dx.doi.org/10.1371/journal.pone.0000616			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GI	17637832	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452100006
J	Lemeer, S; Jopling, C; Naji, F; Ruijtenbeek, R; Slijper, M; Heck, AJR; den Hertog, J				Lemeer, Simone; Jopling, Chris; Naji, Faris; Ruijtenbeek, Rob; Slijper, Monique; Heck, Albert J. R.; den Hertog, Jeroen			Protein-Tyrosine Kinase Activity Profiling in Knock Down Zebrafish Embryos	PLOS ONE			English	Article								Background. Protein-tyrosine kinases (PTKs) regulate virtually all biological processes. PTKs phosphorylate substrates in a sequence-specific manner and relatively short peptide sequences determine selectivity. Here, we developed new technology to determine PTK activity profiles using peptide arrays. The zebrafish is an excellent model system to investigate signaling in the whole organism, given its wealth of genetic tools, including morpholino-mediated knock down technology. We used zebrafish embryo lysates to determine PTK activity profiles, thus providing the unique opportunity to directly compare the effect of protein knock downs on PTK activity profiles on the one hand and phenotypic changes on the other. Methodology. We used multiplex arrays of 144 distinct peptides, spotted on a porous substrate, allowing the sample to be pumped up and down, optimizing reaction kinetics. Kinase reactions were performed using complex zebrafish embryo lysates or purified kinases. Peptide phosphorylation was detected by fluorescent anti-phosphotyrosine antibody binding and the porous chips allowed semi-continuous recording of the signal. We used morpholinos to knock down protein expression in the zebrafish embryos and subsequently, we determined the effects on the PTK activity profiles. Results and Conclusion. Reproducible PTK activity profiles were derived from one-day-old zebrafiish embryos. Morpholino-mediated knock downs of the Src family kinases, Fyn and Yes, induced characteristic phenotypes and distinct changes in the PTK activity profiles. Interestingly, the peptide substrates that were less phosphorylated upon Fyn and Yes knock down were preferential substrates of purified Fyn and Yes. Previously, we demonstrated that Wnt11 knock down phenocopied Fyn/Yes knock down. Interestingly, Wnt11 knock down induced similar changes in the PTK activity profile as Fyn/Yes knock down. The control Nacre/Mitfa knock down did not affect the PTK activity profile significantly. Our results indicate that the novel peptide chip technology can be used to unravel kinase signaling pathways in vivo.	[Lemeer, Simone; Jopling, Chris; den Hertog, Jeroen] Hubrecht Inst, Utrecht, Netherlands; [Lemeer, Simone; Slijper, Monique; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Lemeer, Simone; Slijper, Monique; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Biomol Mass Spectrometry, Utrecht, Netherlands; [Naji, Faris; Ruijtenbeek, Rob] Pamgene Int BV, sHertogenbosch, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University; PamGene International BV	den Hertog, J (corresponding author), Hubrecht Inst, Utrecht, Netherlands.	hertog@niob.knaw.nl	Jopling, Chris/D-1728-2019; Lemeer, Simone/I-4363-2016; Heck, Albert/D-7098-2011	Heck, Albert/0000-0002-2405-4404; jopling, chris/0000-0003-0950-0063	Netherlands Proteomics Centre (NPC); Netherlands Organisation for Scientific Research (NWO); EU [HPRN-CT-2000-00085]	Netherlands Proteomics Centre (NPC); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); EU(European Commission)	This work was supported in part by the Netherlands Proteomics Centre (NPC), an ASPASIA grant with financial aid from the Netherlands Organisation for Scientific Research (NWO) and an EU research training network (HPRN-CT-2000-00085).	Amatruda JF, 2002, CANCER CELL, V1, P229, DOI 10.1016/S1535-6108(02)00052-1; Bei YX, 2002, DEV CELL, V3, P113, DOI 10.1016/S1534-5807(02)00185-5; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Diks SH, 2004, J BIOL CHEM, V279, P49206, DOI 10.1074/jbc.M405028200; Jopling C, 2005, EMBO REP, V6, P426, DOI 10.1038/sj.embor.7400386; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Lowenberg M, 2005, BLOOD, V106, P1703, DOI 10.1182/blood-2004-12-4790; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Reimer U, 2002, CURR OPIN BIOTECH, V13, P315, DOI 10.1016/S0958-1669(02)00339-7; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; van Baal JWPM, 2006, CANCER RES, V66, P11605, DOI 10.1158/0008-5472.CAN-06-1370; van Beuningen R, 2001, CLIN CHEM, V47, P1931; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; WESTERFIELD M, 1995, ZEBRAFISH BOOK U; Wu Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh118; 2001, GENESIS, V31	17	44	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2007	2	7							e581	10.1371/journal.pone.0000581	http://dx.doi.org/10.1371/journal.pone.0000581			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GG	17611617	Green Published, gold, Green Submitted			2022-12-27	WOS:000207451900001
J	Yurov, YB; Iourov, IY; Vorsanova, SG; Liehr, T; Kolotii, AD; Kutsev, SI; Pellestor, F; Beresheva, AK; Demidova, IA; Kravets, VS; Monakhov, VV; Soloviev, IV				Yurov, Yuri B.; Iourov, Ivan Y.; Vorsanova, Svetlana G.; Liehr, Thomas; Kolotii, Alexei D.; Kutsev, Sergei I.; Pellestor, Franck; Beresheva, Alfia K.; Demidova, Irina A.; Kravets, Viktor S.; Monakhov, Viktor V.; Soloviev, Ilia V.			Aneuploidy and Confined Chromosomal Mosaicism in the Developing Human Brain	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; STRUCTURAL VARIATION; CELL-DEATH; NEURONS; TISSUE; PRINS	Background. Understanding the mechanisms underlying generation of neuronal variability and complexity remains the central challenge for neuroscience. Structural variation in the neuronal genome is likely to be one important mechanism for neuronal diversity and brain diseases. Large-scale genomic variations due to loss or gain of whole chromosomes ( aneuploidy) have been described in cells of the normal and diseased human brain, which are generated from neural stem cells during intrauterine period of life. However, the incidence of aneuploidy in the developing human brain and its impact on the brain development and function are obscure. Methodology/Principal Findings. To address genomic variation during development we surveyed aneuploidy/polyploidy in the human fetal tissues by advanced molecular-cytogenetic techniques at the single-cell level. Here we show that the human developing brain has mosaic nature, being composed of euploid and aneuploid neural cells. Studying over 600,000 neural cells, we have determined the average aneuploidy frequency as 1.25-1.45% per chromosome, with the overall percentage of aneuploidy tending to approach 30-35%. Furthermore, we found that mosaic aneuploidy can be exclusively confined to the brain. Conclusions/Significance. Our data indicates aneuploidization to be an additional pathological mechanism for neuronal genome diversification. These findings highlight the involvement of aneuploidy in the human brain development and suggest an unexpected link between developmental chromosomal instability, intercellural/intertissular genome diversity and human brain diseases.	[Yurov, Yuri B.; Iourov, Ivan Y.; Vorsanova, Svetlana G.; Beresheva, Alfia K.; Demidova, Irina A.; Monakhov, Viktor V.; Soloviev, Ilia V.] Russian Acad Med Sci, Natl Res Ctr Mental Hlth, Moscow, Russia; [Yurov, Yuri B.; Iourov, Ivan Y.; Vorsanova, Svetlana G.; Kolotii, Alexei D.; Beresheva, Alfia K.; Demidova, Irina A.; Kravets, Viktor S.] Inst Pediat & Children Surg, Moscow, Russia; [Liehr, Thomas] Inst Human Genet & Anthropol, Jena, Germany; [Kutsev, Sergei I.] Rostov State Med Univ, Rostov Na Donu, Russia; [Pellestor, Franck] Inst Human Genet, Montpellier, France	Russian Academy of Medical Sciences; Rostov State Medical University; Universite de Montpellier	Yurov, YB (corresponding author), Russian Acad Med Sci, Natl Res Ctr Mental Hlth, Moscow, Russia.	y_yurov@yahoo.com	Kolotii, Alexey/K-8178-2017; Vorsanova, Svetlana/I-2632-2017; Liehr, Thomas/H-2852-2019; Kravets, Victor/L-4055-2017; Shiku, Hiroshi/U-7321-2019; Tikly, Mohammed/R-1885-2019; Iourov, Ivan/O-7684-2014; IA, Demidova/AAA-7598-2019; Kutsev, Sergey I/L-3633-2018; Yurov, Yurii B/D-9051-2016	Kolotii, Alexey/0000-0002-7672-588X; Vorsanova, Svetlana/0000-0002-4869-5361; Liehr, Thomas/0000-0003-1672-3054; Kravets, Victor/0000-0002-0996-3220; Tikly, Mohammed/0000-0001-7850-3538; Iourov, Ivan/0000-0002-4134-8367; IA, Demidova/0000-0002-8143-7604; Kutsev, Sergey I/0000-0002-3133-8018; Yurov, Yurii B/0000-0002-9251-2286	INTAS [03-51-4060]; A-T Children?s Project [1060]; RGNF [060600639a]	INTAS(INTASEuropean Commission); A-T Children?s Project; RGNF	This work was supported by grant from INTAS (03-51-4060), A-T Children?s Project ( 1060) and RGNF (060600639a, Russian Federation). There is no the role of any sponsors or funders in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	BOER GJ, 1994, J NEUROL, V242, P1, DOI 10.1007/BF00920568; Cimini D, 2005, TRENDS CELL BIOL, V15, P442, DOI 10.1016/j.tcb.2005.06.008; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Iourov IY, 2006, CURR GENOMICS, V7, P435, DOI 10.2174/138920206779116756; Iourov IY, 2006, INT REV CYTOL, V249, P143, DOI 10.1016/S0074-7696(06)49003-3; Iourov Ivan Y., 2006, V334, P123; Iourov IY, 2006, CHROMOSOME RES, V14, P223, DOI 10.1007/s10577-006-1037-6; Iourov IY, 2005, J HISTOCHEM CYTOCHEM, V53, P401, DOI 10.1369/jhc.4A6419.2005; KALOUSEK DK, 1983, SCIENCE, V221, P665, DOI 10.1126/science.6867735; Kingsbury MA, 2005, P NATL ACAD SCI USA, V102, P6143, DOI 10.1073/pnas.0408171102; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Liehr T, 2002, INT J MOL MED, V9, P335; Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Pellestor Franck, 2006, V334, P151; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Rakic S, 2000, EUR J NEUROSCI, V12, P2721, DOI 10.1046/j.1460-9568.2000.00153.x; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Watase K, 2003, NAT REV GENET, V4, P296, DOI 10.1038/nrg1045; WILLIAMS RW, 1988, ANNU REV NEUROSCI, V11, P423, DOI 10.1146/annurev.neuro.11.1.423; Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906; Yurov YB, 2001, BRAIN DEV-JPN, V23, pS186, DOI 10.1016/S0387-7604(01)00363-1; Yurov YB, 2005, J HISTOCHEM CYTOCHEM, V53, P385, DOI 10.1369/jhc.4A6430.2005; YUROV YB, 2007, J MED GENET, DOI DOI 10.1135/JMG.2007.049312	29	163	171	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e558	10.1371/journal.pone.0000558	http://dx.doi.org/10.1371/journal.pone.0000558			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593959	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451800004
J	Figuerola, J				Figuerola, Jordi			Climate and Dispersal: Black-Winged Stilts Disperse Further in Dry Springs	PLOS ONE			English	Article								Climate affects the abundance and distribution of many species of wildlife. Nevertheless, the potential effects of climate on dispersive behaviour remain unstudied. Here, I combine data from (i) a long-term Black-winged Stilt (Himantopus himantopus) monitoring program, (ii) a capture-recapture marking program in Donana, and (iii) reports from the Rare Birds Committee in the United Kingdom to analyse at different geographical scales the relationship between climate, survival, philopatry, and dispersive behaviour. Black-winged Stilt populations varied in size in consonance with changes in both the North Atlantic Oscillation (NAO) and local rainfall during the breeding season. Changes in population size are related to changes in philopatry and increases in dispersal beyond the traditional range of the species. The results indicate that climatic conditions influence the dispersive behaviour of individual birds, explaining rapid changes in the local population of this species breeding in unstable Mediterranean wetlands.	CSIC, Estac Biol Donana, Dept Wetland Ecol, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Figuerola, J (corresponding author), CSIC, Estac Biol Donana, Dept Wetland Ecol, E-41080 Seville, Spain.	jordi@ebd.csic.es	Figuerola, Jordi/B-7917-2008	Figuerola, Jordi/0000-0002-4664-9011	Las aves acuaticas de Donana y el cultivo del arroz: la interaccion entre la agricultura y la conservacion de las zonas humedas; Spanish Ministry of Science and Technology	Las aves acuaticas de Donana y el cultivo del arroz: la interaccion entre la agricultura y la conservacion de las zonas humedas; Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The Junta de Andalucia funded this study via the project contract 'Las aves acuaticas de Donana y el cultivo del arroz: la interaccion entre la agricultura y la conservacion de las zonas humedas'. The Spanish Ministry of Science and Technology provides support for my research with a Ramon y Cajal contract for young researchers.	ANDERSON DR, 1994, ECOLOGY, V75, P1780, DOI 10.2307/1939637; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Blums P, 2002, J ANIM ECOL, V71, P438, DOI 10.1046/j.1365-2656.2002.00613.x; Burnham K. P., 1998, MODEL SELECTION INFE; BURNHAM KP, 1987, AM FISH SOC MONOGR, V5; COOCH E, 2004, PROGRAM MARK GENTLE; Danchin E, 2002, BEHAV ECOL SOCIOBIOL, V51, P153, DOI 10.1007/s00265-001-0423-5; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; IPCC, 2002, CLIMATE CHANGE BIODI; IPCC, 2001, ADV CLIM CHANG RES; Kendall WL, 1997, ECOLOGY, V78, P563; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Moller AP, 2006, GLOBAL CHANGE BIOL, V12, P2005, DOI 10.1111/j.1365-2486.2006.01216.x; Saether BE, 2004, ADV ECOL RES, V35, P185, DOI 10.1016/S0065-2504(04)35009-9; Sibley CG, 1990, DISTRIBUTION TAXONOM; Skalski J.R., 1993, P9; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; THORUP O, 2006, BREEDING WATERS EURO; Travis JMJ, 2002, EVOL ECOL RES, V4, P1119; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weatherhead PJ, 2005, OECOLOGIA, V144, P168, DOI 10.1007/s00442-005-0009-4	21	23	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2007	2	6							e539	10.1371/journal.pone.0000539	http://dx.doi.org/10.1371/journal.pone.0000539			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GE	17579713	Green Submitted, Green Published, gold			2022-12-27	WOS:000207451700007
J	Robida, MD; Rahn, A; Singh, R				Robida, Mark D.; Rahn, Andrew; Singh, Ravinder			Genome-Wide Identification of Alternatively Spliced mRNA Targets of Specific RNA-Binding Proteins	PLOS ONE			English	Article								Background. Alternative splicing plays an important role in generating molecular and functional diversity in multi-cellular organisms. RNA binding proteins play crucial roles in modulating splice site choice. The majority of known binding sites for regulatory proteins are short, degenerate consensus sequences that occur frequently throughout the genome. This poses an important challenge to distinguish between functionally relevant sequences and a vast array of those occurring by chance. Methodology/Principal Findings. Here we have used a computational approach that combines a series of biological constraints to identify uridine-rich sequence motifs that are present within relevant biological contexts and thus are potential targets of the Drosophila master sex-switch protein Sex-lethal (SXL). This strategy led to the identification of one novel target. Moreover, our systematic analysis provides a starting point for the molecular and functional characterization of an additional target, which is dependent on SXL activity, either directly or indirectly, for regulation in a germline-specific manner. Conclusions/Significance. This approach has successfully identified previously known, new, and potential SXL targets. Our analysis suggests that only a subset of potential SXL sites are regulated by SXL. Finally, this approach should be directly relevant to the large majority of splicing regulatory proteins for which bonafide targets are unknown.	[Robida, Mark D.; Rahn, Andrew; Singh, Ravinder] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Singh, R (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	rsingh@colorado.edu			National Institutes of Health; American Cancer Society; Butcher Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Butcher Foundation	National Institutes of Health, the American Cancer Society, and the Butcher Foundation	Abaza I, 2006, GENE DEV, V20, P380, DOI 10.1101/gad.371906; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blanchette M, 2005, GENE DEV, V19, P1306, DOI 10.1101/gad.1314205; Bopp D, 1999, DEVELOPMENT, V126, P5785; Burge CB, 1999, RNA WORLD, P525; Deng WM, 1999, J CELL SCI, V112, P3677; Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249; DORER DR, 1990, NUCLEIC ACIDS RES, V18, P5489, DOI 10.1093/nar/18.18.5489; Duncan K, 2006, GENE DEV, V20, P368, DOI 10.1101/gad.371406; Eisen A, 1998, BBA-GENE STRUCT EXPR, V1397, P131, DOI 10.1016/S0167-4781(97)00213-3; Forch P, 2003, Prog Mol Subcell Biol, V31, P127; Fujii S, 2002, EMBO J, V21, P5353, DOI 10.1093/emboj/cdf556; FYRBERG EA, 1980, CELL, V19, P365, DOI 10.1016/0092-8674(80)90511-5; Gawande B, 2006, EMBO J, V25, P1263, DOI 10.1038/sj.emboj.7601022; Hager JH, 1997, DEVELOPMENT, V124, P5033; Hamady M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-1; HERTZ GZ, 1990, COMPUT APPL BIOSCI, V6, P81; Hicks JL, 1999, MOL BIOL CELL, V10, P4341, DOI 10.1091/mbc.10.12.4341; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kabat JL, 2006, PLOS COMPUT BIOL, V2, P734, DOI 10.1371/journal.pcbi.0020086; KANAAR R, 1995, EMBO J, V14, P4530, DOI 10.1002/j.1460-2075.1995.tb00132.x; KELLEY RL, 1995, SCIENCE, V270, P1607, DOI 10.1126/science.270.5242.1607; Lallena MJ, 2002, CELL, V109, P285, DOI 10.1016/S0092-8674(02)00730-4; Lasko P, 2000, J CELL BIOL, V150, pF51, DOI 10.1083/jcb.150.2.F51; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Manak JR, 2006, NAT GENET, V38, P1151, DOI 10.1038/ng1875; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Nagengast AA, 2003, DEVELOPMENT, V130, P463, DOI 10.1242/dev.00274; Nilsen TW, 2002, MOL CELL, V9, P8, DOI 10.1016/S1097-2765(02)00430-6; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Robida MD, 2003, EMBO J, V22, P2924, DOI 10.1093/emboj/cdg301; SAKASHITA E, 1994, NUCLEIC ACIDS RES, V22, P4082, DOI 10.1093/nar/22.20.4082; SALZ HK, 1987, GENETICS, V117, P221; SAMUELS ME, 1994, MOL CELL BIOL, V14, P4975, DOI 10.1128/MCB.14.7.4975; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schroter RH, 2004, DEVELOPMENT, V131, P4501, DOI 10.1242/dev.01309; SCHUPBACH T, 1985, GENETICS, V109, P529; Schutt C, 2000, DEVELOPMENT, V127, P667; Singh R, 2000, RNA, V6, P901, DOI 10.1017/S1355838200000376; Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Singh R, 2006, CURR GENOMICS, V7, P97, DOI 10.2174/138920206777304669; SOSNOWSKI BA, 1989, CELL, V58, P449, DOI 10.1016/0092-8674(89)90426-1; STEINMANNZWICKY M, 1989, CELL, V57, P157, DOI 10.1016/0092-8674(89)90181-5; TAYLOR BJ, 1992, GENETICS, V132, P179; VALCARCEL J, 1993, NATURE, V362, P171, DOI 10.1038/362171a0; VALCARCEL J, 1995, MECH REGULATED PREMR	50	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2007	2	6							e520	10.1371/journal.pone.0000520	http://dx.doi.org/10.1371/journal.pone.0000520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GD	17565373	Green Published, gold, Green Submitted			2022-12-27	WOS:000207451600008
J	Yaghmur, A; Laggner, P; Zhang, SG; Rappolt, M				Yaghmur, Anan; Laggner, Peter; Zhang, Shuguang; Rappolt, Michael			Tuning Curvature and Stability of Monoolein Bilayers by Designer Lipid-Like Peptide Surfactants	PLOS ONE			English	Article							PHASE-BEHAVIOR; CUBIC PHASES; MEMBRANE-PROTEIN; NONBILAYER LIPIDS; LIQUID-CRYSTALS; FORM NANOTUBES; FUSION PEPTIDE; WATER SYSTEMS; X-RAY; CRYSTALLIZATION	This study reports the effect of loading four different charged designer lipid-like short anionic and cationic peptide surfactants on the fully hydrated monoolein (MO)-based Pn3m phase (Q(224)). The studied peptide surfactants comprise seven amino acid residues, namely A(6)D, DA(6), A(6)K, and KA(6). D (aspartic acid) bears two negative charges, K (lysine) bears one positive charge, and A (alanine) constitutes the hydrophobic tail. To elucidate the impact of these peptide surfactants, the ternary MO/peptide/water system has been investigated using small-angle X-ray scattering (SAXS), within a certain range of peptide concentrations (R<0.2) and temperatures (25 to 70 degrees C). We demonstrate that the bilayer curvature and the stability are modulated by: i) the peptide/lipid molar ratio, ii) the peptide molecular structure (the degree of hydrophobicity, the type of the hydrophilic amino acid, and the headgroup location), and iii) the temperature. The anionic peptide surfactants, A(6)D and DA(6), exhibit the strongest surface activity. At low peptide concentrations (R = 0.01), the Pn3m structure is still preserved, but its lattice increases due to the strong electrostatic repulsion between the negatively charged peptide molecules, which are incorporated into the interface. This means that the anionic peptides have the effect of enlarging the water channels and thus they serve to enhance the accommodation of positively charged water-soluble active molecules in the Pn3m phase. At higher peptide concentration (R = 0.10), the lipid bilayers are destabilized and the structural transition from the Pn3m to the inverted hexagonal phase (H-2) is induced. For the cationic peptides, our study illustrates how even minor modifications, such as changing the location of the headgroup (A(6)K vs. KA(6)), affects significantly the peptide's effectiveness. Only KA(6) displays a propensity to promote the formation of H-2, which suggests that KA(6) molecules have a higher degree of incorporation in the interface than those of A(6)K.	[Yaghmur, Anan; Laggner, Peter; Rappolt, Michael] Austrian Acad Sci, Inst Biophys & Nanosyst Res, Graz, Austria; [Zhang, Shuguang] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA	Austrian Academy of Sciences; Massachusetts Institute of Technology (MIT)	Yaghmur, A (corresponding author), Austrian Acad Sci, Inst Biophys & Nanosyst Res, Graz, Austria.	anan.yaghmur@oeaw.ac.at	Yaghmur, Anan/AGU-9381-2022	Yaghmur, Anan/0000-0003-1608-773X; Rappolt, Michael/0000-0001-9942-3035; Zhang, Shuguang/0000-0002-3856-3752				Almsherqi ZA, 2006, J CELL BIOL, V173, P839, DOI 10.1083/jcb.200603055; Andersson AS, 1998, BIOPHYS J, V75, P2877, DOI 10.1016/S0006-3495(98)77730-6; Angelova A, 2005, J PHYS CHEM B, V109, P3089, DOI 10.1021/jp044216p; Barauskas J, 2005, LANGMUIR, V21, P2569, DOI 10.1021/la047590p; Basanez G, 1998, BIOCHEMISTRY-US, V37, P3901, DOI 10.1021/bi9728497; Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001; Borne J, 2000, LANGMUIR, V16, P10044, DOI 10.1021/la000619e; Borne J, 2001, LANGMUIR, V17, P7742, DOI 10.1021/la010650w; Briggs J, 1996, J PHYS II, V6, P723, DOI 10.1051/jp2:1996208; Caboi F, 2001, CHEM PHYS LIPIDS, V109, P47, DOI 10.1016/S0009-3084(00)00200-0; Caboi F, 2002, LANGMUIR, V18, P7916, DOI 10.1021/la0259959; Caboi F, 1997, LANGMUIR, V13, P5476, DOI 10.1021/la9702188; Caffrey M, 2003, J STRUCT BIOL, V142, P108, DOI 10.1016/S1047-8477(03)00043-1; Caffrey M, 2000, CURR OPIN STRUC BIOL, V10, P486, DOI 10.1016/S0959-440X(00)00119-6; Chernik GG, 1999, CURR OPIN COLLOID IN, V4, P381, DOI 10.1016/S1359-0294(00)00023-6; CHUNG H, 1994, NATURE, V368, P224, DOI 10.1038/368224a0; Chupin V, 2003, BIOPHYS J, V84, P2373, DOI 10.1016/S0006-3495(03)75043-7; Colotto A, 1996, BIOCHEMISTRY-US, V35, P980, DOI 10.1021/bi951991+; Colotto A, 1997, BIOCHEMISTRY-US, V36, P7644, DOI 10.1021/bi970382u; de Campo L, 2004, LANGMUIR, V20, P5254, DOI 10.1021/la0499416; deKruijff B, 1997, NATURE, V386, P129, DOI 10.1038/386129a0; Deng YR, 2002, PROTOPLASMA, V219, P160, DOI 10.1007/s007090200017; Drummond CJ, 1999, CURR OPIN COLLOID IN, V4, P449, DOI 10.1016/S1359-0294(00)00020-0; Duesing PM, 1997, LANGMUIR, V13, P351, DOI 10.1021/la960602p; ELLENS H, 1989, BIOCHEMISTRY-US, V28, P3692, DOI 10.1021/bi00435a011; Epand RM, 1997, CURR TOP MEMBR, V44, P237; Garab G, 2000, TRENDS PLANT SCI, V5, P489, DOI 10.1016/S1360-1385(00)01767-2; Gustafsson J, 1996, LANGMUIR, V12, P4611, DOI 10.1021/la960318y; Gustafsson J, 1997, LANGMUIR, V13, P6964, DOI 10.1021/la970566+; Harper PE, 2000, EUR PHYS J E, V2, P217, DOI 10.1007/PL00013660; HYDE S, 1997, ELSEVIER BOOK SERIES; Hyde S. T., 2001, HDB APPL SURFACE COL, P299; Hyde ST, 1996, CURR OPIN SOLID ST M, V1, P653, DOI 10.1016/S1359-0286(96)80047-7; ISRAELACHVILI JN, 1976, J CHEM SOC FARAD T 2, V72, P1525, DOI 10.1039/f29767201525; Kamo T, 2006, J PHYS CHEM B, V110, P24987, DOI 10.1021/jp064988g; Killian JA, 2006, CURR OPIN STRUC BIOL, V16, P473, DOI 10.1016/j.sbi.2006.06.007; KOZLOV MM, 1994, BIOPHYS J, V67, P1603, DOI 10.1016/S0006-3495(94)80633-2; LAGGNER P, 1992, NUCL INSTRUM METH A, V323, P86, DOI 10.1016/0168-9002(92)90273-7; Landau EM, 1997, J PHYS CHEM B, V101, P1935, DOI 10.1021/jp963347q; LANDH T, 1994, J PHYS CHEM-US, V98, P8453, DOI 10.1021/j100085a028; Larsson K, 2000, CURR OPIN COLLOID IN, V5, P64, DOI 10.1016/S1359-0294(00)00040-6; LARSSON K, 1989, J PHYS CHEM-US, V93, P7304, DOI 10.1021/j100358a010; LARSSON K, 1983, NATURE, V304, P664, DOI 10.1038/304664c0; Lewis RNAH, 1997, CURR TOP MEMBR, V44, P25; Li SJ, 2001, BIOPHYS J, V81, P983, DOI 10.1016/S0006-3495(01)75756-6; LINDBLOM G, 1989, BIOCHIM BIOPHYS ACTA, V988, P221, DOI 10.1016/0304-4157(89)90020-8; LINDBLOM G, 1979, J AM CHEM SOC, V101, P5465, DOI 10.1021/ja00513a002; Liu F, 2001, BIOCHEMISTRY-US, V40, P760, DOI 10.1021/bi001942j; LUTTON ES, 1965, J AM OIL CHEM SOC, V42, P1068, DOI 10.1007/BF02636909; Luzzati V, 1997, CURR OPIN STRUC BIOL, V7, P661, DOI 10.1016/S0959-440X(97)80075-9; Lynch ML, 2003, J COLLOID INTERF SCI, V260, P404, DOI 10.1016/S0021-9797(02)00016-4; Masum SM, 2005, LANGMUIR, V21, P5290, DOI 10.1021/la0469607; Masum SM, 2003, LANGMUIR, V19, P4745, DOI 10.1021/la026847l; Misquitta Y, 2001, BIOPHYS J, V81, P1047, DOI 10.1016/S0006-3495(01)75762-1; Morein S, 2000, BIOPHYS J, V78, P2475, DOI 10.1016/S0006-3495(00)76792-0; NILSSON A, 1994, CHEM PHYS LIPIDS, V71, P119, DOI 10.1016/0009-3084(94)90065-5; PATTON JS, 1979, SCIENCE, V204, P145, DOI 10.1126/science.432636; Qiu H, 1998, J PHYS CHEM B, V102, P4819, DOI 10.1021/jp980553k; Qiu H, 2000, BIOMATERIALS, V21, P223, DOI 10.1016/S0142-9612(99)00126-X; Qiu H, 1999, CHEM PHYS LIPIDS, V100, P55, DOI 10.1016/S0009-3084(99)00040-7; Rappolt M, 2006, EUROPHYS LETT, V75, P267, DOI 10.1209/epl/i2006-10104-y; RAPPOLT M, 2006, ELSEVIER BOOK SERIES, V5, P253; Rummel G, 1998, J STRUCT BIOL, V121, P82, DOI 10.1006/jsbi.1997.3952; Sagalowicz L, 2006, J MICROSC-OXFORD, V221, P110, DOI 10.1111/j.1365-2818.2006.01544.x; Santoso S, 2002, NANO LETT, V2, P687, DOI 10.1021/n1025563i; Seddon JM, 1996, BER BUNSEN PHYS CHEM, V100, P380, DOI 10.1002/bbpc.19961000324; Shearman GC, 2006, J PHYS-CONDENS MAT, V18, pS1105, DOI 10.1088/0953-8984/18/28/S01; Siegel DP, 2006, BIOPHYS J, V90, P200, DOI 10.1529/biophysj.105.070466; Siegel DP, 1999, BIOPHYS J, V76, P291, DOI 10.1016/S0006-3495(99)77197-3; Simidjiev I, 2000, P NATL ACAD SCI USA, V97, P1473, DOI 10.1073/pnas.97.4.1473; Spicer PT., 2004, DEKKER ENCY NANOSCIE, P881; Staudegger E, 2000, BBA-BIOMEMBRANES, V1468, P213, DOI 10.1016/S0005-2736(00)00260-1; TATE MW, 1989, BIOCHEMISTRY-US, V28, P4245, DOI 10.1021/bi00436a019; Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599; von Maltzahn G, 2003, LANGMUIR, V19, P4332, DOI 10.1021/la026526+; WIESLANDER A, 1995, EUR J BIOCHEM, V227, P734, DOI 10.1111/j.1432-1033.1995.tb20196.x; Yaghmur A, 2006, LANGMUIR, V22, P517, DOI 10.1021/la052109w; Yaghmur A, 2005, LANGMUIR, V21, P569, DOI 10.1021/la0482711; Yaghmur A, 2006, LANGMUIR, V22, P9919, DOI 10.1021/la061303v; Yang SJ, 2006, SUPRAMOL CHEM, V18, P389, DOI 10.1080/10615800600658586; Yeh JI, 2005, BIOCHEMISTRY-US, V44, P16912, DOI 10.1021/bi051357o; Zhao XJ, 2006, P NATL ACAD SCI USA, V103, P17707, DOI 10.1073/pnas.0607167103; Zhao XJ, 2006, CHEM SOC REV, V35, P1105, DOI 10.1039/b511336a	83	95	97	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2007	2	5							e479	10.1371/journal.pone.0000479	http://dx.doi.org/10.1371/journal.pone.0000479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10FB	17534429	Green Published, Green Submitted, gold			2022-12-27	WOS:000207448800009
J	Bakkali, M				Bakkali, Mohammed			Genome Dynamics of Short Oligonucleotides: The Example of Bacterial DNA Uptake Enhancing Sequences	PLOS ONE			English	Article								Among the many bacteria naturally competent for transformation by DNA uptake-a phenomenon with significant clinical and financial implications-Pasteurellaceae and Neisseriaceae species preferentially take up DNA containing specific short sequences. The genomic overrepresentation of these DNA uptake enhancing sequences (DUES) causes preferential uptake of conspecific DNA, but the function(s) behind this overrepresentation and its evolution are still a matter for discovery. Here I analyze DUES genome dynamics and evolution and test the validity of the results to other selectively constrained oligonucleotides. I use statistical methods and computer simulations to examine DUESs accumulation in Haemophilus influenzae and Neisseria gonorrhoeae genomes. I analyze DUESs sequence and nucleotide frequencies, as well as those of all their mismatched forms, and prove the dependence of DUESs genomic overrepresentation on their preferential uptake by quantifying and correlating both characteristics. I then argue that mutation, uptake bias, and weak selection against DUESs in less constrained parts of the genome combined are sufficient enough to cause DUESs accumulation in susceptible parts of the genome with no need for other DUES function. The distribution of overrepresentation values across sequences with different mismatch loads compared to the DUES suggests a gradual yet not linear molecular drive of DNA sequences depending on their similarity to the DUES. Other genomically overrepresented sequences, both pro-and eukaryotic, show similar distribution of frequencies suggesting that the molecular drive reported above applies to other frequent oligonucleotides. Rare oligonucleotides, however, seem to be gradually drawn to genomic underrepresentation, thus, suggesting a molecular drag. To my knowledge this work provides the first clear evidence of the gradual evolution of selectively constrained oligonucleotides, including repeated, palindromic and protein/transcription factor-binding DNAs.	Univ Nottingham, Inst Genet, Queens Med Ctr, Nottingham NG7 2RD, England	University of Nottingham	Bakkali, M (corresponding author), Univ Nottingham, Inst Genet, Queens Med Ctr, Nottingham NG7 2RD, England.	mbakkali@gmail.com	Sandstedt, Sara A/A-3001-2010; Bakkali, Mohammed/M-1267-2014	Bakkali, Mohammed/0000-0002-9079-8452				Ahmad S, 2006, NUCLEIC ACIDS RES, V34, pW124, DOI 10.1093/nar/gkl104; ALBRITTON WL, 1984, MOL GEN GENET, V193, P358, DOI 10.1007/BF00330693; Bakkali M, 2004, P NATL ACAD SCI USA, V101, P4513, DOI 10.1073/pnas.0306366101; Bianco PR, 1997, P NATL ACAD SCI USA, V94, P6706, DOI 10.1073/pnas.94.13.6706; Bigas A, 2005, VET MICROBIOL, V105, P223, DOI 10.1016/j.vetmic.2004.10.015; BISWAS GD, 1977, J BACTERIOL, V129, P983, DOI 10.1128/JB.129.2.983-992.1977; BISWAS GD, 1981, J BACTERIOL, V145, P638, DOI 10.1128/JB.145.1.638-640.1981; BoyleVavra S, 1996, MICROBIOL-SGM, V142, P2839, DOI 10.1099/13500872-142-10-2839; BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Chen I, 2003, FRONT BIOSCI, V8, pS544; Chu D, 2006, J THEOR BIOL, V238, P157, DOI 10.1016/j.jtbi.2005.05.024; Chu D, 2005, ARTIF LIFE, V11, P317, DOI 10.1162/1064546054407176; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Cohan FM, 2001, SYST BIOL, V50, P513, DOI 10.1080/106351501750435077; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DANNER DB, 1982, P NATL ACAD SCI-BIOL, V79, P2393, DOI 10.1073/pnas.79.7.2393; Davidsen T, 2004, NUCLEIC ACIDS RES, V32, P1050, DOI 10.1093/nar/gkh255; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Elemento O, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r18; ELKINS C, 1991, J BACTERIOL, V173, P3911, DOI 10.1128/JB.173.12.3911-3913.1991; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; Gerland U, 2002, J MOL EVOL, V55, P386, DOI 10.1007/s00239-002-2335-z; Gilsdorf JR, 1997, INFECT IMMUN, V65, P2997, DOI 10.1128/IAI.65.8.2997-3002.1997; Gioia J, 2006, J BACTERIOL, V188, P7257, DOI 10.1128/JB.00675-06; GOODGAL SH, 1984, J BACTERIOL, V157, P785, DOI 10.1128/JB.157.3.785-788.1984; GOODGAL SH, 1961, J GEN PHYSIOL, V44, P1201, DOI 10.1085/jgp.44.6.1201; GOODGAL SH, 1982, ANNU REV GENET, V16, P169, DOI 10.1146/annurev.ge.16.120182.001125; GOODGAL SH, 1990, J BACTERIOL, V172, P5924, DOI 10.1128/jb.172.10.5924-5928.1990; GOODMAN SD, 1988, P NATL ACAD SCI USA, V85, P6982, DOI 10.1073/pnas.85.18.6982; GRAVES JF, 1982, J BACTERIOL, V152, P1071; Hanage WP, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-6; HERRIOTT RM, 1970, J BACTERIOL, V101, P517, DOI 10.1128/JB.101.2.517-524.1970; JONSSON AB, 1991, EMBO J, V10, P477, DOI 10.1002/j.1460-2075.1991.tb07970.x; KARLIN S, 1992, NUCLEIC ACIDS RES, V20, P1363, DOI 10.1093/nar/20.6.1363; Karlin S, 1998, ANNU REV GENET, V32, P185, DOI 10.1146/annurev.genet.32.1.185; Karlin S, 1996, NUCLEIC ACIDS RES, V24, P4263, DOI 10.1093/nar/24.21.4263; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; Konstantinidis KT, 2006, PHILOS T R SOC B, V361, P1929, DOI 10.1098/rstb.2006.1920; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; MATHIS LS, 1982, J GEN MICROBIOL, V128, P1159; MCCREA KW, 1994, INFECT IMMUN, V62, P4922, DOI 10.1128/IAI.62.11.4922-4928.1994; McCrea KW, 1997, J BACTERIOL, V179, P4227, DOI 10.1128/jb.179.13.4227-4231.1997; Moreno E, 1997, REV BIOL TROP, V45, P753; Palchevskiy V, 2006, J BACTERIOL, V188, P3902, DOI 10.1128/JB.01974-05; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Poje Grant, 2003, Methods Mol Med, V71, P57; REDFIELD RJ, 1993, J HERED, V84, P400, DOI 10.1093/oxfordjournals.jhered.a111361; Redfield RJ, 2001, NAT REV GENET, V2, P634, DOI 10.1038/35084593; REDFIELD RJ, 1991, NATURE, V352, P25, DOI 10.1038/352025b0; Redfield RJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-82; ROBINSON NJ, 1995, NUCLEIC ACIDS RES, V23, P729, DOI 10.1093/nar/23.5.729; RUDEL T, 1995, P NATL ACAD SCI USA, V92, P7986, DOI 10.1073/pnas.92.17.7986; RUDEL T, 1995, NATURE, V373, P357, DOI 10.1038/373357a0; Scharnagl M, 1998, J BACTERIOL, V180, P4116, DOI 10.1128/JB.180.16.4116-4122.1998; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SCOCCA JJ, 1974, J BACTERIOL, V118, P369, DOI 10.1128/JB.118.2.369-373.1974; Sengupta AM, 2002, P NATL ACAD SCI USA, V99, P2072, DOI 10.1073/pnas.022388499; Sinha S, 2003, NUCLEIC ACIDS RES, V31, P3586, DOI 10.1093/nar/gkg618; Sinha S, 2002, NUCLEIC ACIDS RES, V30, P5549, DOI 10.1093/nar/gkf669; SMITH HO, 1995, SCIENCE, V269, P538, DOI 10.1126/science.7542802; Smith HO, 1999, RES MICROBIOL, V150, P603, DOI 10.1016/S0923-2508(99)00130-8; Solomon JM, 1996, TRENDS GENET, V12, P150, DOI 10.1016/0168-9525(96)10014-7; StGeme JW, 1996, P NATL ACAD SCI USA, V93, P11913, DOI 10.1073/pnas.93.21.11913; Stormo GD, 1998, TRENDS BIOCHEM SCI, V23, P109, DOI 10.1016/S0968-0004(98)01187-6; STUMPH WE, 1981, NUCLEIC ACIDS RES, V9, P5383, DOI 10.1093/nar/9.20.5383; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; VANHAM SM, 1994, MOL MICROBIOL, V13, P673; Wang Y, 2002, J BACTERIOL, V184, P3442, DOI 10.1128/JB.184.13.3442-3449.2002; Wang Y, 2006, MICROBIOL-SGM, V152, P3319, DOI 10.1099/mic.0.29018-0; Woegerbauer M, 2002, APPL ENVIRON MICROB, V68, P440, DOI 10.1128/AEM.68.1.440-443.2002	72	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e741	10.1371/journal.pone.0000741	http://dx.doi.org/10.1371/journal.pone.0000741			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710141	Green Published, gold			2022-12-27	WOS:000207455200018
J	Fievez, L; Desmet, C; Henry, E; Pajak, B; Hegenbarth, S; Garze, V; Bex, F; Jaspar, F; Boutet, P; Gillet, L; Vanderplasschen, A; Knolle, PA; Leo, O; Moser, M; Lekeux, P; Bureau, F				Fievez, Laurence; Desmet, Christophe; Henry, Emmanuelle; Pajak, Bernard; Hegenbarth, Silke; Garze, Virginie; Bex, Francoise; Jaspar, Fabrice; Boutet, Philippe; Gillet, Laurent; Vanderplasschen, Alain; Knolle, Percy A.; Leo, Oberdan; Moser, Muriel; Lekeux, Pierre; Bureau, Fabrice			STAT5 Is an Ambivalent Regulator of Neutrophil Homeostasis	PLOS ONE			English	Article								Background. Although STAT5 promotes survival of hematopoietic progenitors, STAT5(-/-) mice develop mild neutrophilia. Methodology/Principal findings. Here, we show that in STAT5(-/-) mice, liver endothelial cells (LECs) autonomously secrete high amounts of G-CSF, allowing myeloid progenitors to overcompensate for their intrinsic survival defect. However, when injected with pro-inflammatory cytokines, mutant mice cannot further increase neutrophil production, display a severe deficiency in peripheral neutrophil survival, and are therefore unable to maintain neutrophil homeostasis. In wild-type mice, inflammatory stimulation induces rapid STAT5 degradation in LECs, G-CSF production by LECs and other cell types, and then sustained mobilization and expansion of long-lived neutrophils. Conclusion. We conclude that STAT5 is an ambivalent factor. In cells of the granulocytic lineage, it exerts an antiapoptotic function that is required for maintenance of neutrophil homeostasis, especially during the inflammatory response. In LECs, STAT5 negatively regulates granulopoiesis by directly or indirectly repressing G-CSF expression. Removal of this STAT5-imposed brake contributes to induction of emergency granulopoiesis.	[Fievez, Laurence; Desmet, Christophe; Jaspar, Fabrice; Boutet, Philippe; Lekeux, Pierre; Bureau, Fabrice] Univ Liege, Lab Cellular & Mol Physiol, GIGA Res, Liege, Belgium; [Henry, Emmanuelle; Pajak, Bernard; Garze, Virginie; Leo, Oberdan; Moser, Muriel; Bureau, Fabrice] Univ Libre Bruxelles, Inst Mol Biol & Med, Physiol Anim Lab, Gosselies, Belgium; [Hegenbarth, Silke; Knolle, Percy A.] Univ Bonn, Inst Mol Med & Expt Immunol, D-5300 Bonn, Germany; [Bex, Francoise] Univ Libre Bruxelles, Microbiol Lab, Inst Microbiol Res JM Wiame, Brussels, Belgium; [Vanderplasschen, Alain] Univ Liege, Fac Vet Med, Lab Immunol & Vaccinol, Liege, Belgium	University of Liege; Universite Libre de Bruxelles; University of Bonn; Universite Libre de Bruxelles; University of Liege	Bureau, F (corresponding author), Univ Liege, Lab Cellular & Mol Physiol, GIGA Res, Liege, Belgium.	fabrice.bureau@ulg.ac.be		Gillet, Laurent/0000-0002-1047-2525; Knolle, Percy A./0000-0003-2983-0414	Fonds National de la Recherche Scientifique", FNRS; Fonds de la Formation a la Recherche dans l'Industrie et l'Agriculture", FRIA, Belgium	Fonds National de la Recherche Scientifique", FNRS(Fonds de la Recherche Scientifique - FNRS); Fonds de la Formation a la Recherche dans l'Industrie et l'Agriculture", FRIA, Belgium	This work has been funded by the "Fonds National de la Recherche Scientifique", FNRS, and the "Fonds de la Formation a la Recherche dans l'Industrie et l'Agriculture", FRIA, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Al-Shami A, 1998, J BIOL CHEM, V273, P1058, DOI 10.1074/jbc.273.2.1058; Barreda DR, 2004, DEV COMP IMMUNOL, V28, P509, DOI 10.1016/j.dci.2003.09.010; Basu S, 2000, BLOOD, V95, P3725; Bunting KD, 2002, BLOOD, V99, P479, DOI 10.1182/blood.V99.2.479; Bureau F, 2002, BLOOD, V99, P3683, DOI 10.1182/blood.V99.10.3683; CHATTA GS, 1994, BLOOD, V84, P2923; COLOTTA F, 1992, BLOOD, V80, P2012; Coxon A, 1999, J EXP MED, V190, P923, DOI 10.1084/jem.190.7.923; Croker BA, 2004, IMMUNITY, V20, P153, DOI 10.1016/S1074-7613(04)00022-6; DANCEY JT, 1976, J CLIN INVEST, V58, P705, DOI 10.1172/JCI108517; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; deKoning JP, 1996, BLOOD, V87, P1335, DOI 10.1182/blood.V87.4.1335.bloodjournal8741335; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Edwards SW, 2003, CHEM IMMUNOL, V83, P204; Goh ELK, 2002, ENDOCRINOLOGY, V143, P3590, DOI 10.1210/en.2002-220374; Ilaria RL, 1999, BLOOD, V93, P4154, DOI 10.1182/blood.V93.12.4154.412k15_4154_4166; Kieslinger M, 2000, GENE DEV, V14, P232; Knolle PA, 1999, GASTROENTEROLOGY, V116, P1428, DOI 10.1016/S0016-5085(99)70508-1; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; LORD BI, 1989, P NATL ACAD SCI USA, V86, P9499, DOI 10.1073/pnas.86.23.9499; Luo GY, 2000, MOL ENDOCRINOL, V14, P114, DOI 10.1210/me.14.1.114; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Pajak B, 2000, J CLIN PATHOL, V53, P518, DOI 10.1136/jcp.53.7.518; Semerad CL, 2002, IMMUNITY, V17, P413, DOI 10.1016/S1074-7613(02)00424-7; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; Snow JW, 2002, BLOOD, V99, P95, DOI 10.1182/blood.V99.1.95; SOUZA LM, 1986, SCIENCE, V232, P61, DOI 10.1126/science.2420009; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Tian SS, 1996, BLOOD, V88, P4435, DOI 10.1182/blood.V88.12.4435.bloodjournal88124435; TIAN SS, 1994, BLOOD, V84, P1760; ULICH TR, 1991, BLOOD, V78, P1954; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; VOWELLS SJ, 1995, J IMMUNOL METHODS, V178, P89, DOI 10.1016/0022-1759(94)00247-T; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103	41	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e727	10.1371/journal.pone.0000727	http://dx.doi.org/10.1371/journal.pone.0000727			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710127	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455200004
J	Marques, B; Liguori, L; Paclet, MH; Villegas-Mendez, A; Rothe, R; Morel, F; Lenormand, JL				Marques, Bruno; Liguori, Lavinia; Paclet, Marie-Helene; Villegas-Mendez, Ana; Rothe, Romy; Morel, Francoise; Lenormand, Jean-Luc			Liposome-Mediated Cellular Delivery of Active gp91(phox)	PLOS ONE			English	Article								Background. Gp91(phox) is a transmembrane protein and the catalytic core of the NADPH oxidase complex of neutrophils. Lack of this protein causes chronic granulomatous disease (CGD), a rare genetic disorder characterized by severe and recurrent infections due to the incapacity of phagocytes to kill microorganisms. Methodology. Here we optimize a prokaryotic cell-free expression system to produce integral mammalian membrane proteins. Conclusions. Using this system, we over-express truncated forms of the gp91(phox) protein under soluble form in the presence of detergents or lipids resulting in active proteins with a "native-like'' conformation. All the proteins exhibit diaphorase activity in the presence of cytosolic factors (p67(phox), p47(phox), p40(phox) and Rac) and arachidonic acid. We also produce proteoliposomes containing gp91(phox) protein and demonstrate that these proteins exhibit activities similar to their cellular counterpart. The proteoliposomes induce rapid cellular delivery and relocation of recombinant gp91(phox) proteins to the plasma membrane. Our data support the concept of cell-free expression technology for producing recombinant proteoliposomes and their use for functional and structural studies or protein therapy by complementing deficient cells in gp91(phox) protein.	[Marques, Bruno; Liguori, Lavinia; Villegas-Mendez, Ana; Rothe, Romy; Lenormand, Jean-Luc] Univ Grenoble 1, Lab Enzymol DBPC, Ctr Hosp Univ Grenoble, CNRS,Ctr Hosp Univ,HumProTher,UMR 5525, Grenoble, France; [Paclet, Marie-Helene; Morel, Francoise] Univ Grenoble 1, Lab Enzymol DBPC, Ctr Hosp Univ Grenoble, CNRS,Ctr Hosp Univ,GREPI,TIMC Imag,UMR 5525, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA)	Lenormand, JL (corresponding author), Univ Grenoble 1, Lab Enzymol DBPC, Ctr Hosp Univ Grenoble, CNRS,Ctr Hosp Univ,HumProTher,UMR 5525, BP 217, Grenoble, France.	JLLenormand@chu-grenoble.fr	Lenormand, Jean-Luc/M-6644-2014; Lenormand, Jean-Luc/ABF-3850-2021; Paclet, Marie-Hélène/AAS-5029-2020	villegas-mendez, ana/0000-0002-8363-680X; Lenormand, Jean-Luc/0000-0002-2766-9180				Baniulis D, 2005, BBA-PROTEINS PROTEOM, V1752, P186, DOI 10.1016/j.bbapap.2005.07.018; BEDARD K, 2007, NOX FAMILY NADPH OXI; Berrier C, 2004, BIOCHEMISTRY-US, V43, P12585, DOI 10.1021/bi049049y; Berthier S, 2003, J BIOL CHEM, V278, P25499, DOI 10.1074/jbc.M209755200; Boeckle S, 2006, AAPS J, V8, pE731, DOI 10.1208/aapsj080483; CAMPION Y, 2007, BIOCHIMIE; CROSS AR, 1994, J BIOL CHEM, V269, P21448; Cusi MG, 2004, VACCINE, V22, P735, DOI 10.1016/j.vaccine.2003.08.024; Elbaz Y, 2004, P NATL ACAD SCI USA, V101, P1519, DOI 10.1073/pnas.0306533101; Grisshammer R, 2006, CURR OPIN BIOTECH, V17, P337, DOI 10.1016/j.copbio.2006.06.001; Han CH, 2001, J BIOCHEM-TOKYO, V129, P513, DOI 10.1093/oxfordjournals.jbchem.a002885; Heyworth PG, 2003, CURR OPIN IMMUNOL, V15, P578, DOI 10.1016/S0952-7915(03)00109-2; Ishihara G, 2005, PROTEIN EXPRES PURIF, V41, P27, DOI 10.1016/j.pep.2005.01.013; Jidenko M, 2005, P NATL ACAD SCI USA, V102, P11687, DOI 10.1073/pnas.0503986102; Kim A, 1999, INT J PHARM, V180, P75, DOI 10.1016/S0378-5173(98)00408-6; KLAMMT C, 2007, J STRUCT BIOL; Klammt C, 2006, FEBS J, V273, P4141, DOI 10.1111/j.1742-4658.2006.05432.x; KOSHKIN V, 1993, FEBS LETT, V327, P57, DOI 10.1016/0014-5793(93)81039-3; KOSHKIN V, 1994, FEBS LETT, V338, P285, DOI 10.1016/0014-5793(94)80285-8; Li XJ, 2007, J LEUKOCYTE BIOL, V81, P238, DOI 10.1189/jlb.0905541; Liguori L, 2007, EXPERT REV PROTEOMIC, V4, P79, DOI 10.1586/14789450.4.1.79; Lundstrom Kenneth, 2006, Journal of Structural and Functional Genomics, V7, P77, DOI 10.1007/s10969-006-9011-2; Mizrahi A, 2006, J LEUKOCYTE BIOL, V79, P881, DOI 10.1189/jlb.1005553; Monne M, 2005, PROTEIN SCI, V14, P3048, DOI 10.1110/ps.051689905; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Niegowski D, 2006, INT J BIOL MACROMOL, V39, P83, DOI 10.1016/j.ijbiomac.2006.02.011; Nisimoto Y, 2004, BIOCHEMISTRY-US, V43, P9567, DOI 10.1021/bi0400249; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Paclet MH, 2001, EUR J BIOCHEM, V268, P5197, DOI 10.1046/j.0014-2956.2001.02455.x; PACLET MH, 2007, FASEB J; Park JW, 2001, J CONTROL RELEASE, V74, P95, DOI 10.1016/S0168-3659(01)00315-7; Pessach I, 2006, J LEUKOCYTE BIOL, V80, P630, DOI 10.1189/jlb.1105684; Poinas A, 2002, EUR J BIOCHEM, V269, P1243, DOI 10.1046/j.1432-1033.2002.02764.x; Rentsendorj A, 2006, GENE THER, V13, P821, DOI 10.1038/sj.gt.3302729; Rigaud JL, 2002, BRAZ J MED BIOL RES, V35, P753, DOI 10.1590/S0100-879X2002000700001; ROTROSEN D, 1993, J BIOL CHEM, V268, P14256; Sarfstein R, 2004, J BIOL CHEM, V279, P16007, DOI 10.1074/jbc.M312394200; Sengupta S, 2005, NATURE, V436, P568, DOI 10.1038/nature03794; Taylor RM, 2004, J IMMUNOL, V173, P7349, DOI 10.4049/jimmunol.173.12.7349; Taylor RM, 2006, J BIOL CHEM, V281, P37045, DOI 10.1074/jbc.M607354200; Torchilin VP, 2006, ANNU REV BIOMED ENG, V8, P343, DOI 10.1146/annurev.bioeng.8.061505.095735; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Wallach TM, 1997, BIOCHEM J, V321, P583, DOI 10.1042/bj3210583; WASAN KM, 2006, J PHARM SCI; ZHU Y, 2006, J BIOL CHEM	45	30	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e856	10.1371/journal.pone.0000856	http://dx.doi.org/10.1371/journal.pone.0000856			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848987	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455600003
J	Gillingham, AK; Munro, S				Gillingham, Alison K.; Munro, Sean			Identification of a Guanine Nucleotide Exchange Factor for Arf3, the Yeast Orthologue of Mammalian Arf6	PLOS ONE			English	Article								Small G proteins of the Arf and Rab families are fundamental to the organisation and activity of intracellular membranes. One of the most well characterised of these G proteins is mammalian Arf6, a protein that participates in many cellular processes including endocytosis, actin remodelling and cell adhesion. Exchange of GDP for GTP on Arf6 is performed by a variety of guanine nucleotide exchange factors (GEFs), principally of the cytohesin (PSCD) and EFA6 (PSD) families. In this paper we describe the characterisation of a GEF for the yeast orthologue of Arf6, Arf3, which we have named Yel1 (yeast EFA6-like-1) using yeast genetics, fluorescence microscopy and in vitro nucleotide exchange assays. Yel1 appears structurally related to the EFA6 family of GEFs, having an N-terminal Sec7 domain and C-terminal PH and coiled-coil domains. We find that Yel1 is constitutively targeted to regions of polarised growth in yeast, where it co-localises with Arf3. Moreover the Sec7 domain of Yel1 is required for its membrane targeting and for that of Arf3. Finally we show that the isolated Yel1 Sec7 domain strongly stimulates nucleotide exchange activity specifically on Arf3 in vitro.	[Gillingham, Alison K.; Munro, Sean] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Gillingham, AK (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ag@mrc-lmb.cam.ac.uk		Munro, Sean/0000-0001-6160-5773	U. K. Medical Research Council; MRC [MC_U105178783] Funding Source: UKRI; Medical Research Council [MC_U105178783] Funding Source: researchfish	U. K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the U. K. Medical Research Council.	ACHSTETTER T, 1988, J BIOL CHEM, V263, P11711; Beraud-Dufour S, 2001, METHOD ENZYMOL, V329, P264; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cavenagh MM, 1996, J BIOL CHEM, V271, P21767, DOI 10.1074/jbc.271.36.21767; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Costa R, 2005, BIOCHEM SOC T, V33, P1273, DOI 10.1042/BST0331273; Costa R, 2005, BIOCHEM J, V387, P649, DOI 10.1042/BJ20041729; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; FRANCO M, 1995, J BIOL CHEM, V270, P1337, DOI 10.1074/jbc.270.3.1337; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; GILLINGHAM AK, 2007, ANN REV CEL IN PRESS; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Huang CF, 1999, J BIOL CHEM, V274, P3819, DOI 10.1074/jbc.274.6.3819; Huang CF, 2003, MOL BIOL CELL, V14, P3834, DOI 10.1091/mbc.E03-01-0013; Jackson TR, 2000, TRENDS BIOCHEM SCI, V25, P489, DOI 10.1016/S0968-0004(00)01644-3; Jones S, 1999, GENETICS, V152, P1543; KAHN RA, 2004, ARF FAMILY GTPASES, V1; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; LAMBERT AA, 2007, FEMS YEAST RES; Langille SE, 1999, J BIOL CHEM, V274, P27099, DOI 10.1074/jbc.274.38.27099; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Macia E, 2004, J CELL SCI, V117, P2389, DOI 10.1242/jcs.01090; Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856; Nickel W, 1998, J CELL SCI, V111, P3081; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Shin HW, 2004, J BIOCHEM, V136, P761, DOI 10.1093/jb/mvh185; Shinotsuka C, 2002, BIOCHEM BIOPH RES CO, V294, P254, DOI 10.1016/S0006-291X(02)00456-4; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Togawa A, 1999, J BIOL CHEM, V274, P12308, DOI 10.1074/jbc.274.18.12308; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; Williger BT, 1999, FEBS LETT, V443, P197, DOI 10.1016/S0014-5793(98)01707-4; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Zakrzewska E, 2003, GENETICS, V165, P985	40	21	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e842	10.1371/journal.pone.0000842	http://dx.doi.org/10.1371/journal.pone.0000842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786213	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455500025
J	Chandriani, S; Ganem, D				Chandriani, Sanjay; Ganem, Don			Host Transcript Accumulation during Lytic KSHV Infection Reveals Several Classes of Host Responses	PLOS ONE			English	Article								Lytic infection by Kaposi's sarcoma-associated herpesvirus (KSHV) is associated with an extensive shutoff of host gene expression, mediated chiefly by accelerated mRNA turnover due to expression of the viral SOX protein. We have previously identified a small number of host mRNAs that can escape SOX-mediated degradation. Here we present a detailed, transcriptome-wide analysis of host shutoff, with careful microarray normalization to allow rigorous determination of the magnitude and extent of transcript loss. We find that the extent of transcript reduction represents a continuum of susceptibilities of transcripts to virus-mediated shutoff. Our results affirm that the levels of over 75% of host transcripts are substantially reduced during lytic infection, but also show that another similar to 20% of cellular mRNAs declines only slightly (less than 2-fold) during the course of infection. Approximately 2% of examined cellular genes are strongly upregulated during lytic infection, most likely due to transcriptional induction of mRNAs that display intrinsic SOX-resistance.	[Chandriani, Sanjay; Ganem, Don] Univ Calif San Francisco, George Williams Hooper Fdn, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Ganem, D (corresponding author), Univ Calif San Francisco, George Williams Hooper Fdn, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	ganem@cgl.ucsf.edu		Chandriani, Sanjay/0000-0002-8680-7424	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	All work was funded by the Howard Hughes Medical Institute.	Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bechtel JT, 2003, J VIROL, V77, P6474, DOI 10.1128/JVI.77.11.6474-6481.2003; BOSHOFF C, 1995, NAT MED, V1, P1274, DOI 10.1038/nm1295-1274; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dittmer D, 1998, J VIROL, V72, P8309, DOI 10.1128/JVI.72.10.8309-8315.1998; Fuld S, 2006, J VIROL, V80, P3092, DOI 10.1128/JVI.80.6.3092-3097.2006; GANEM D, 2007, FIELDS VIROLOGY, P2847; Glaunsinger B, 2004, J EXP MED, V200, P391, DOI 10.1084/jem.20031881; Glaunsinger B, 2004, MOL CELL, V13, P713, DOI 10.1016/S1097-2765(04)00091-7; Gwack Y, 2002, J BIOL CHEM, V277, P6438, DOI 10.1074/jbc.M108289200; Joo CH, 2007, J VIROL, V81, P8282, DOI 10.1128/JVI.00235-07; Kirshner JR, 2000, J VIROL, V74, P3586, DOI 10.1128/JVI.74.8.3586-3597.2000; Li M, 2000, MOL CELL BIOL, V20, P8254, DOI 10.1128/MCB.20.21.8254-8263.2000; Liang YY, 2002, GENE DEV, V16, P1977, DOI 10.1101/gad.996502; Lin RT, 2001, ONCOGENE, V20, P800, DOI 10.1038/sj.onc.1204163; Lukac DM, 1998, VIROLOGY, V252, P304, DOI 10.1006/viro.1998.9486; Martin DF, 1999, NEW ENGL J MED, V340, P1063, DOI 10.1056/NEJM199904083401402; McCormick C, 2005, SCIENCE, V307, P739, DOI 10.1126/science.1105779; Miller G, 1997, J VIROL, V71, P314, DOI 10.1128/JVI.71.1.314-324.1997; MOORE PS, 1995, NEW ENGL J MED, V332, P1181, DOI 10.1056/NEJM199505043321801; Nicholas J, 2005, J INTERF CYTOK RES, V25, P373, DOI 10.1089/jir.2005.25.373; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Renne R, 1996, J VIROL, V70, P8151, DOI 10.1128/JVI.70.11.8151-8154.1996; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sarid R, 1999, J VIROL, V73, P1438, DOI 10.1128/JVI.73.2.1438-1446.1999; Schulz TF, 1999, ADV CANCER RES, V76, P121, DOI 10.1016/S0065-230X(08)60775-7; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Staskus KA, 1997, J VIROL, V71, P715, DOI 10.1128/JVI.71.1.715-719.1997; Sturzl M, 1997, INT J CANCER, V72, P68, DOI 10.1002/(SICI)1097-0215(19970703)72:1&lt;68::AID-IJC10&gt;3.0.CO;2-6; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; van de Peppel J, 2003, EMBO REP, V4, P387, DOI 10.1038/sj.embor.embor798; Venetsanakos E, 2002, EXP CELL RES, V273, P21, DOI 10.1006/excr.2001.5424; Wang SE, 2003, J VIROL, V77, P600, DOI 10.1128/JVI.77.1.600-623.2003; Wang SZ, 2001, J VIROL, V75, P11961, DOI 10.1128/JVI.75.24.11961-11973.2001; Wang SZE, 2003, J VIROL, V77, P9590, DOI 10.1128/JVI.77.17.9590-9612.2003; Yang TY, 2000, J EXP MED, V191, P445, DOI 10.1084/jem.191.3.445; Zhong WD, 1996, P NATL ACAD SCI USA, V93, P6641, DOI 10.1073/pnas.93.13.6641; Zhu FX, 2002, P NATL ACAD SCI USA, V99, P5573, DOI 10.1073/pnas.082420599	46	37	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e811	10.1371/journal.pone.0000811	http://dx.doi.org/10.1371/journal.pone.0000811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726541	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455400028
J	Fasano, C; Terce, F; Niel, JP; Nguyen, HTT; Hiol, A; Bertrand-Michel, J; Mallet, N; Collet, X; Miolan, JP				Fasano, Caroline; Terce, Francois; Niel, Jean-Pierre; Nguyen, Hang Thi Thu; Hiol, Abel; Bertrand-Michel, Justine; Mallet, Nicole; Collet, Xavier; Miolan, Jean-Pierre			Neuronal Conduction of Excitation without Action Potentials Based on Ceramide Production	PLOS ONE			English	Article							GPI-ANCHORED PROTEINS; NEUTRAL SPHINGOMYELINASE; LIPID RAFTS; SPHINGOLIPID METABOLISM; MEMBRANE MICRODOMAINS; SIGNAL-TRANSDUCTION; NITRIC-OXIDE; CELL-DEATH; RECEPTOR; TRANSMISSION	Background. Action potentials are the classic mechanism by which neurons convey a state of excitation throughout their length, leading, after synaptic transmission, to the activation of other neurons and consequently to network functioning. Using an in vitro integrated model, we found previously that peripheral networks in the autonomic nervous system can organise an unconventional regulatory reflex of the digestive tract motility without action potentials. Methodology/Principal Findings. In this report, we used combined neuropharmacological and biochemical approaches to elucidate some steps of the mechanism that conveys excitation along the nerves fibres without action potentials. This mechanism requires the production of ceramide in membrane lipid rafts, which triggers in the cytoplasm an increase in intracellular calcium concentration, followed by activation of a neuronal nitric oxide synthase leading to local production of nitric oxide, and then to guanosine cyclic monophosphate. This sequence of second messengers is activated in cascade from rafts to rafts to ensure conduction of the excitation along the nerve fibres. Conclusions/Significance. Our results indicate that second messengers are involved in neuronal conduction of excitation without action potentials. This mechanism represents the first evidence-to our knowledge-that excitation is carried along nerves independently of electrical signals. This unexpected ceramide-based conduction of excitation without action potentials along the autonomic nerve fibres opens up new prospects in our understanding of neuronal functioning.	[Fasano, Caroline; Niel, Jean-Pierre; Miolan, Jean-Pierre] Univ Paul Cezanne, Inst Fed Rech Jean Roche IFR 11, Fac Sci & Tech, Lab Physiol Neurovegetat,UMR CNRS 6153,INRA 1147, Marseille, France; [Terce, Francois; Bertrand-Michel, Justine; Mallet, Nicole] Hop Purpan, INSERM, IFR Toulouse Genopole 30, U563, Toulouse, France; [Nguyen, Hang Thi Thu; Hiol, Abel] Univ Paul Cezanne, Fac Sci & Tech, Lab Chim Biol Appl, UMR INRA 1111, Marseille, France; [Collet, Xavier] Hop Purpan, CPTP, INSERM, Dept Lipoprot & Mediateurs Lipid,IFR 30,U563, Toulouse, France	INRAE; UDICE-French Research Universities; Aix-Marseille Universite; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; UDICE-French Research Universities; Aix-Marseille Universite; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Miolan, JP (corresponding author), Univ Paul Cezanne, Inst Fed Rech Jean Roche IFR 11, Fac Sci & Tech, Lab Physiol Neurovegetat,UMR CNRS 6153,INRA 1147, Marseille, France.	jean-pierre.miolan@univ-cezanne.fr	Tercé, François/M-5863-2018; Collet, Xavier/M-6938-2017; Nguyen, Hang/N-2441-2018	Tercé, François/0000-0003-4488-2167; Nguyen, Hang/0000-0001-7431-5126	Universite Paul Cezanne; Centre National de la Recherche Scientifique; Institut National de la Recherche Agronomique; Institut National de la Sante et de la Recherche Medicale; Toulouse Genopole	Universite Paul Cezanne; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Recherche Agronomique; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Toulouse Genopole	This work was supported by the Universite Paul Cezanne, the Centre National de la Recherche Scientifique, the Institut National de la Recherche Agronomique, the Institut National de la Sante et de la Recherche Medicale, and Toulouse Genopole.	Ballou L.R, 1997, SPHINGOLIPID MEDIATE, P35; BIELAWSKA A, 1993, J BIOL CHEM, V268, P26226; Bottcher CJF, 1961, ANAL CHIM ACTA, V24, P203; Braccia A, 2003, J BIOL CHEM, V278, P15679, DOI 10.1074/jbc.M211228200; BURROWS M, 1981, NEURONES IMPULSES, P199; Czarny M, 2004, AM J PHYSIOL-HEART C, V287, pH1344, DOI 10.1152/ajpheart.00222.2004; Czarny M, 2003, J BIOL CHEM, V278, P4424, DOI 10.1074/jbc.M210375200; de Chaves EP, 2001, J BIOL CHEM, V276, P36207, DOI 10.1074/jbc.M104282200; Dietrich C, 2001, P NATL ACAD SCI USA, V98, P10642, DOI 10.1073/pnas.191168698; FAIN GL, 1981, NEURONES IMPULSES, P29; Fasano C, 2003, NEUROSCIENCE, V116, P753, DOI 10.1016/S0306-4522(02)00760-1; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; GRAUBARD K, 1978, J NEUROPHYSIOL, V41, P1014, DOI 10.1152/jn.1978.41.4.1014; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; Hiol A, 2003, J BIOL CHEM, V278, P19301, DOI 10.1074/jbc.M210123200; Jaffrezou JP, 1998, FASEB J, V12, P999, DOI 10.1096/fasebj.12.11.999; Kito Yoshihiko, 2003, Journal of Smooth Muscle Research, V39, P163, DOI 10.1540/jsmr.39.163; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Kolesnick R, 2002, J CLIN INVEST, V110, P3, DOI 10.1172/JCI200216127; Kolesnick R, 1999, TRENDS BIOCHEM SCI, V24, P224, DOI 10.1016/S0968-0004(99)01408-5; KREULEN DL, 1983, AM J PHYSIOL, V245, pG369, DOI 10.1152/ajpgi.1983.245.3.G369; Kuwabara M, 2003, J RADIAT RES, V44, P203, DOI 10.1269/jrr.44.203; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu GL, 1999, CRIT REV CL LAB SCI, V36, P511, DOI 10.1080/10408369991239240; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Maekawa S, 2001, J BIOCHEM-TOKYO, V129, P691, DOI 10.1093/oxfordjournals.jbchem.a002908; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; MAZET B, 1993, J AUTONOM NERV SYST, V46, P135; Miolan JP, 1996, J AUTONOM NERV SYST, V58, P125, DOI 10.1016/0165-1838(95)00128-X; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Nguyen HTT, 2006, BIOCHEM BIOPH RES CO, V342, P236, DOI 10.1016/j.bbrc.2006.01.141; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; OCHS S, 1987, AXONAL TRANSPORT, P1; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Quinson N, 1999, J PHYSIOL-LONDON, V519, P223, DOI 10.1111/j.1469-7793.1999.0223o.x; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; SIMMERS AJ, 1981, NEURONES IMPULSES, P177; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Szurszewski Joseph H., 1994, P795; TYMIANSKI M, 1994, J CEREBR BLOOD F MET, V14, P911, DOI 10.1038/jcbfm.1994.122; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Vieu C, 2002, J LIPID RES, V43, P510; Vieu C, 1996, J LIPID RES, V37, P1153; Yang SN, 2000, NEUROSCIENCE, V96, P253, DOI 10.1016/S0306-4522(99)00582-5; Zundel W, 2000, MOL CELL BIOL, V20, P1507, DOI 10.1128/MCB.20.5.1507-1514.2000	47	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2007	2	7							e612	10.1371/journal.pone.0000612	http://dx.doi.org/10.1371/journal.pone.0000612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GI	17637828	Green Published, gold			2022-12-27	WOS:000207452100002
J	Campbell, PA; Perez-Iratxeta, C; Andrade-Navarro, MA; Rudnicki, MA				Campbell, Pearl A.; Perez-Iratxeta, Carolina; Andrade-Navarro, Miguel A.; Rudnicki, Michael A.			Oct4 Targets Regulatory Nodes to Modulate Stem Cell Function	PLOS ONE			English	Article							SELF-RENEWAL; ES CELLS; DIFFERENTIATION; EXPRESSION; CHROMATIN; POLYCOMB; NETWORKS; CANCER; CYCLE; REST	Stem cells are characterized by two defining features, the ability to self-renew and to differentiate into highly specialized cell types. The POU homeodomain transcription factor Oct4(Pou5f1) is an essential mediator of the embryonic stem cell state and has been implicated in lineage specific differentiation, adult stem cell identity, and cancer. Recent description of the regulatory networks which maintain 'ES' have highlighted a dual role for Oct4 in the transcriptional activation of genes required to maintain self-renewal and pluripotency while concomitantly repressing genes which facilitate lineage specific differentiation. However, the molecular mechanism by which Oct4 mediates differential activation or repression at these loci to either maintain stem cell identity or facilitate the emergence of alternate transcriptional programs required for the realization of lineage remains to be elucidated. To further investigate Oct4 function, we employed gene expression profiling together with a robust statistical analysis to identify genes highly correlated to Oct4. Gene Ontology analysis to categorize overrepresented genes has led to the identification of themes which may prove essential to stem cell identity, including chromatin structure, nuclear architecture, cell cycle control, DNA repair, and apoptosis. Our experiments have identified previously unappreciated roles for Oct4 for firstly, regulating chromatin structure in a state consistent with self-renewal and pluripotency, and secondly, facilitating the expression of genes that keeps the cell poised to respond to cues that lead to differentiation. Together, these data define the mechanism by which Oct4 orchestrates cellular regulatory pathways to enforce the stem cell state and provides important insight into stem cell function and cancer.	[Campbell, Pearl A.; Perez-Iratxeta, Carolina; Andrade-Navarro, Miguel A.; Rudnicki, Michael A.] Ottawa Hlth Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON, Canada; [Campbell, Pearl A.; Andrade-Navarro, Miguel A.; Rudnicki, Michael A.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Rudnicki, MA (corresponding author), Ottawa Hlth Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON, Canada.	mrudnicki@ohri.ca	Andrade, Miguel A/B-6565-2008	Andrade, Miguel A/0000-0001-6650-1711; Rudnicki, Michael/0000-0002-3866-5249; Campbell, Pearl/0000-0001-9502-7318				Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Broceno C, 2002, P NATL ACAD SCI USA, V99, P14200, DOI 10.1073/pnas.212519499; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Cairns BR, 2005, CURR OPIN GENET DEV, V15, P185, DOI 10.1016/j.gde.2005.01.003; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Fernandez-Capetillo O, 2004, P NATL ACAD SCI USA, V101, P1427, DOI 10.1073/pnas.0307342101; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Furuta S, 2005, P NATL ACAD SCI USA, V102, P9176, DOI 10.1073/pnas.0503793102; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Hemberger M, 2003, DEV BIOL, V257, P371, DOI 10.1016/S0012-1606(03)00097-6; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jin TR, 1999, INT J CANCER, V81, P104, DOI 10.1002/(SICI)1097-0215(19990331)81:1<104::AID-IJC18>3.0.CO;2-Q; Kim JY, 2004, EUR J HAEMATOL, V73, P75, DOI 10.1111/j.1600-0609.2004.00268.x; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Lawinger P, 2000, NAT MED, V6, P826, DOI 10.1038/77565; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Mikkers H, 2005, EMBO J, V24, P2715, DOI 10.1038/sj.emboj.7600749; Monk M, 2001, ONCOGENE, V20, P8085, DOI 10.1038/sj.onc.1205088; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Perez-Iratxeta C, 2005, FEBS LETT, V579, P1795, DOI 10.1016/j.febslet.2005.02.020; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reim G, 2004, DEV CELL, V6, P91, DOI 10.1016/S1534-5807(03)00396-4; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; SELL S, 1994, LAB INVEST, V70, P6; Shimozaki K, 2003, DEVELOPMENT, V130, P2505, DOI 10.1242/dev.00476; Sissons J, 2004, J MED MICROBIOL, V53, P711, DOI 10.1099/jmm.0.45604-0; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Stucki M, 2004, NAT CELL BIOL, V6, P1150, DOI 10.1038/ncb1204-1150; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Tamrakar S, 2000, FRONT BIOSCI-LANDMRK, V5, pD121, DOI 10.2741/Tamrakar; Trounson AO, 2001, REPROD FERT DEVELOP, V13, P523, DOI 10.1071/Rd01101; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Van Eynde A, 2004, MOL CELL BIOL, V24, P5863, DOI 10.1128/MCB.24.13.5863-5874.2004; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; Zimber A, 2004, CELL SIGNAL, V16, P1085, DOI 10.1016/j.cellsig.2004.03.020	58	75	79	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2007	2	6							e553	10.1371/journal.pone.0000553	http://dx.doi.org/10.1371/journal.pone.0000553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GE	17579724	Green Published, gold, Green Submitted			2022-12-27	WOS:000207451700018
J	Chen, PP; Li, WJ; Wang, Y; Zhao, S; Li, DY; Feng, LY; Shi, XL; Koeffler, HP; Tong, XJ; Xie, D				Chen, Ping-Ping; Li, Wen-Jie; Wang, Yan; Zhao, Song; Li, De-Yun; Feng, Li-Yun; Shi, Xiang-Lin; Koeffler, H. Phillip; Tong, Xiang-Jun; Xie, Dong			Expression of Cyr61, CTGF, and WISP-1 Correlates with Clinical Features of Lung Cancer	PLOS ONE			English	Article								Background. CCN family, comprising six members (Cyr61, CTGF, Nov, WISP-1, WISP-2, WISP-3), is involved in the stimulation of cell proliferation, migration, adhesion, angiogenesis, and tumorigenesis. Several studies have shown that expression of Cyr61, CTGF, and WISP-1 affects the tumorigenic potential of lung cancer cells in vitro. However, the correlation of expression of CCN family proteins and clinical features of lung cancer remains unknown. Methodology and Principal Findings. In the present work, we quantified the mRNA levels of Cyr61, CTGF, and WISP-1 in samples from 60 primary lung cancers and their matched normal lung tissues by quantitative real-time PCR assay. Downregulation of the Cyr61 and CTGF genes and upregulation of the WISP-1 gene were found in primary lung cancers compared to the paired normal lung tissues. Immunohistochemistry analysis also disclosed a similar expression pattern of Cyr61, CTGF, and WISP-1 protein in paired lung cancer tissues. Statistical analysis revealed significant associations between expression of either Cyr61 or CTGF with tumor stage, tumor histology, metastasis, smoking, and family history at diagnosis. A significant correlation also existed between WISP-1 expression with tumor histology, and patient age. Moreover, expression levels of Cyr61 and CTGF correlated with survival of the lung-cancer patients. Conclusions. Our results suggest that Cyr61, CTGF, and WISP-1 might be implicated in the development and progression of primary lung cancers, and their levels might serve as valuable prognostic markers, as well as potential targets for therapeutic intervention.	[Chen, Ping-Ping; Wang, Yan; Shi, Xiang-Lin; Tong, Xiang-Jun; Xie, Dong] Chinese Acad Sci, Mol Oncol Lab, Inst Nutr Sci, Shanghai Inst Biol Sci,Grad Sch, Shanghai, Peoples R China; [Chen, Ping-Ping; Li, Wen-Jie] Zhengzhou Univ, Coll Publ Hlth, Zhengzhou, Peoples R China; [Zhao, Song; Feng, Li-Yun] Zhengzhou Univ, Dept Surg, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Li, De-Yun] Inst Med Chron Dis Dis Control & Prevent Sichuan, Chengdu, Sichuan, Peoples R China; [Koeffler, H. Phillip] Univ Calif Los Angeles, Sch Med, Cedars Sinai Med Ctr, Dept Hematol & Oncol, Los Angeles, CA USA; [Tong, Xiang-Jun] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhengzhou University; Zhengzhou University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Peking University	Xie, D (corresponding author), Chinese Acad Sci, Mol Oncol Lab, Inst Nutr Sci, Shanghai Inst Biol Sci,Grad Sch, Shanghai, Peoples R China.	dxie@sibs.ac.cn	Shi, Xianglin/B-8588-2012; Wang, Yan/G-1213-2012; Chen, Pingping/J-9561-2013	Xie, Dong/0000-0002-1150-8657	National Science Foundation of China [30370690, 30470847, 30528003, 30200143]; Chinese Academy of Sciences [KSCX-YW-R73]; Science & Technology Commission of Shanghai Municipality [04DZ14007, 05DJ14009]; China Postdoctoral Science Foundation; Chinese Academy of Sciences	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Science & Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Science Foundation of China (No. 30370690, 30470847, and 30528003 for Xie, D.; No. 30200143 for Tong, X.), Chinese Academy of Sciences (One Hundred Talents Program; Grant KSCX-YW-R73 for Xie, D.), Science & Technology Commission of Shanghai Municipality 04DZ14007 and 05DJ14009 (Xie, D.); China Postdoctoral Science Foundation (Wang, Y.), and Chinese Academy of Sciences K. C. Wong Post-doctoral Fellowships (Wang, Y.).	Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Chang CC, 2004, JNCI-J NATL CANCER I, V96, P364, DOI 10.1093/jnci/djh059; Chien W, 2006, MOL CANCER RES, V4, P591, DOI 10.1158/1541-7786.MCR-06-0029; Chien WW, 2004, J BIOL CHEM, V279, P53087, DOI 10.1074/jbc.M410254200; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Frazier KS, 1997, INT J BIOCHEM CELL B, V29, P153, DOI 10.1016/S1357-2725(96)00127-6; Genini M, 1996, INT J CANCER, V66, P571; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Hashimoto Y, 1996, CANCER RES, V56, P5266; Hashimoto Y, 1998, J EXP MED, V187, P289, DOI 10.1084/jem.187.3.289; Holloway SE, 2005, J AM COLL SURGEONS, V200, P371, DOI 10.1016/j.jamcollsurg.2004.10.005; Igarashi A, 1998, J CUTAN PATHOL, V25, P143, DOI 10.1111/j.1600-0560.1998.tb01706.x; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Kubo M, 1998, BRIT J DERMATOL, V139, P192; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Margalit O, 2003, BRIT J CANCER, V89, P314, DOI 10.1038/sj.bjc.6600977; Nakanishi T, 1997, BIOCHEM BIOPH RES CO, V234, P206, DOI 10.1006/bbrc.1997.6528; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Pepper MS, 2001, CLIN CANCER RES, V7, P462; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P103, DOI 10.1136/mp.54.2.103; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Pilarsky CP, 1998, PROSTATE, V36, P85; Sampath D, 2001, ENDOCRINOLOGY, V142, P2540, DOI 10.1210/en.142.6.2540; Sampath D, 2001, J CLIN ENDOCR METAB, V86, P1707, DOI 10.1210/jc.86.4.1707; Sleeman JP, 2000, RECENT RESULTS CANC, V157, P55; Soon LL, 2003, J BIOL CHEM, V278, P11465, DOI 10.1074/jbc.M210945200; Steffen CL, 1998, GROWTH FACTORS, V15, P199, DOI 10.3109/08977199809002117; Tong XJ, 2004, ONCOGENE, V23, P4847, DOI 10.1038/sj.onc.1207628; Tong XJ, 2001, J BIOL CHEM, V276, P47709, DOI 10.1074/jbc.M107878200; TRAVIS WD, 1995, CANCER-AM CANCER SOC, V75, P191, DOI 10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y; Tsai MS, 2000, CANCER RES, V60, P5603; Wenger C, 1999, ONCOGENE, V18, P1073, DOI 10.1038/sj.onc.1202395; Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666; Xie D, 2004, CLIN CANCER RES, V10, P2072, DOI 10.1158/1078-0432.CCR-0659-03; Xie D, 2001, CANCER RES, V61, P8917; Xie D, 2001, J BIOL CHEM, V276, P14187, DOI 10.1074/jbc.M009755200; Xu LF, 2000, GENE DEV, V14, P585	42	115	120	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2007	2	6							e534	10.1371/journal.pone.0000534	http://dx.doi.org/10.1371/journal.pone.0000534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GE	17579708	Green Submitted, Green Published, gold			2022-12-27	WOS:000207451700002
J	Gray, MA; Harrison, NA; Wiens, S; Critchley, HD				Gray, Marcus A.; Harrison, Neil A.; Wiens, Stefan; Critchley, Hugo D.			Modulation of Emotional Appraisal by False Physiological Feedback during fMRI	PLOS ONE			English	Article							FACIAL EXPRESSIONS; AMYGDALA; CORTEX; FEAR; INTEROCEPTION; AROUSAL; REPRESENTATIONS; DETERMINANTS; RECOGNITION; ATTRIBUTION	Background. James and Lange proposed that emotions are the perception of physiological reactions. Two-level theories of emotion extend this model to suggest that cognitive interpretations of physiological changes shape self-reported emotions. Correspondingly false physiological feedback of evoked or tonic bodily responses can alter emotional attributions. Moreover, anxiety states are proposed to arise from detection of mismatch between actual and anticipated states of physiological arousal. However, the neural underpinnings of these phenomena previously have not been examined. Methodology/Principal Findings. We undertook a functional brain imaging (fMRI) experiment to investigate how both primary and second-order levels of physiological (viscerosensory) representation impact on the processing of external emotional cues. 12 participants were scanned while judging face stimuli during both exercise and non-exercise conditions in the context of true and false auditory feedback of tonic heart rate. We observed that the perceived emotional intensity/salience of neutral faces was enhanced by false feedback of increased heart rate. Regional changes in neural activity corresponding to this behavioural interaction were observed within included right anterior insula, bilateral mid insula, and amygdala. In addition, right anterior insula activity was enhanced during by asynchronous relative to synchronous cardiac feedback even with no change in perceived or actual heart rate suggesting this region serves as a comparator to detect physiological mismatches. Finally, BOLD activity within right anterior insula and amygdala predicted the corresponding changes in perceived intensity ratings at both a group and an individual level. Conclusions/Significance. Our findings identify the neural substrates supporting behavioural effects of false physiological feedback, and highlight mechanisms that underlie subjective anxiety states, including the importance of the right anterior insula in guiding second-order "cognitive" representations of bodily arousal state.	[Gray, Marcus A.; Critchley, Hugo D.] Univ Sussex, Brighton Sussex Med Sch, Clin Imaging Sci Ctr, Brighton, E Sussex, England; [Gray, Marcus A.] UCL, Wellcome Trust Ctr Neuroimaging, Inst Neurol, London, England; [Harrison, Neil A.] UCL, Inst Cognit Neurosci, London, England; [Wiens, Stefan] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden	University of Brighton; University of Sussex; University of London; University College London; University of London; University College London; Stockholm University	Gray, MA (corresponding author), Univ Sussex, Brighton Sussex Med Sch, Clin Imaging Sci Ctr, Brighton, E Sussex, England.	m.gray@bsms.ac.uk	Gray, Marcus/F-6521-2013; critchley, hugo d/G-9267-2011	Gray, Marcus/0000-0001-8671-6939; critchley, hugo d/0000-0002-2445-9284; Harrison, Neil/0000-0002-9584-3769	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported by a Wellcome Trust fellowship grant to HDC and conducted at the Wellcome Trust Centre for Neuroimaging, Institute of Neurology, National Hospital for Neurology and Neurosurgery, University College London, 12 Queen Square, London WC1N 3BG.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BAREFOOT JC, 1971, J PERS SOC PSYCHOL, V2, P154; CANTOR JR, 1975, J PERS SOC PSYCHOL, V32, P69, DOI 10.1037/h0076784; Carver C. S., 1977, MOTIV EMOTION, V1, P61, DOI 10.1007/BF00997581; Corden B, 2006, J COGNITIVE NEUROSCI, V18, P889, DOI 10.1162/jocn.2006.18.6.889; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2005, TRENDS COGN SCI, V9, P566, DOI 10.1016/j.tics.2005.10.005; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2001, NAT NEUROSCI, V4, P207, DOI 10.1038/84048; Critchley HD, 2004, P NATL ACAD SCI USA, V101, P6333, DOI 10.1073/pnas.0401510101; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Critchley HD, 2002, NEURON, V33, P653, DOI 10.1016/S0896-6273(02)00588-3; Crucian GP, 2000, CORTEX, V36, P623, DOI 10.1016/S0010-9452(08)70542-2; Damasio A, 2003, ANN NY ACAD SCI, V1001, P253, DOI 10.1196/annals.1279.014; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Feinstein JS, 2006, SOC COGN AFFECT NEUR, V1, P136, DOI 10.1093/scan/nsl016; Fitzgerald DA, 2004, NEUROSCI LETT, V370, P91, DOI 10.1016/j.neulet.2004.08.007; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; GOLDSTEIN D, 1972, J PERS SOC PSYCHOL, V21, P41, DOI 10.1037/h0031873; Henson RNA, 2005, J COGNITIVE NEUROSCI, V17, P1058, DOI 10.1162/0898929054475208; JAMES W, 1994, PSYCHOL REV, V101, P205, DOI 10.1037/0033-295X.101.2.205; Kano M, 2003, BRAIN, V126, P1474, DOI 10.1093/brain/awg131; Katkin ES, 2001, PSYCHOL SCI, V12, P366, DOI 10.1111/1467-9280.00368; KERBER KW, 1978, J EXP SOC PSYCHOL, V14, P419, DOI 10.1016/0022-1031(78)90039-2; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; Lange C, 1885, EMOTIONS; LIEBHART EH, 1979, EUR J SOC PSYCHOL, V9, P19, DOI 10.1002/ejsp.2420090103; Liu TT, 2004, NEUROIMAGE, V21, P401, DOI 10.1016/j.neuroimage.2003.09.031; Lundqvist D., 1998, KAROLINSKA DIRECTED; MISOVICH S, 1974, J EXP SOC PSYCHOL, V10, P274, DOI 10.1016/0022-1031(74)90073-0; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; PARKINSON B, 1985, PSYCHOL BULL, V98, P471, DOI 10.1037/0033-2909.98.3.471; PARKINSON B, 1981, J PERS SOC PSYCHOL, V40, P239; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Penny W., 2003, HUMAN BRAIN FUNCTION; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Pollatos O, 2004, PSYCHOPHYSIOLOGY, V41, P476, DOI 10.1111/1469-8986.2004.00170.x; Puce A, 1998, J NEUROSCI, V18, P2188; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; ROSENTHAL R, 1965, HUM RELAT, V18, P389, DOI 10.1177/001872676501800407; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Saper CB, 1996, PROG BRAIN RES, V107, P537; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Shaw P, 2005, J COGNITIVE NEUROSCI, V17, P1410, DOI 10.1162/0898929054985491; STERN RM, 1972, PSYCHOPHYSIOLOGY, V9, P21, DOI 10.1111/j.1469-8986.1972.tb00739.x; TAYLOR SE, 1978, ADV EXPT SOCIAL PSYC, V11, P250; THORNTON EW, 1976, BRIT J SOC PSYCHOL, V67, P400; TRUAX SR, 1983, MOTIV EMOTION, V7, P41; VALINS S, 1966, J PERS SOC PSYCHOL, V4, P400, DOI 10.1037/h0023791; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wiens S, 2005, CURR OPIN NEUROL, V18, P442, DOI 10.1097/01.wco.0000168079.92106.99; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004; Yovel G, 2005, CURR BIOL, V15, P2256, DOI 10.1016/j.cub.2005.10.072; ZILLMANN D, 1971, J EXP SOC PSYCHOL, V7, P419, DOI 10.1016/0022-1031(71)90075-8	59	102	102	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2007	2	6							e546	10.1371/journal.pone.0000546	http://dx.doi.org/10.1371/journal.pone.0000546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GE	17579718	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000207451700012
J	Sousa, JC; Costa, MJ; Palha, JA				Sousa, Joao Carlos; Costa, Manuel Joao; Palha, Joana Almeida			Hormone-Mediated Gene Regulation and Bioinformatics: Learning One from the Other	PLOS ONE			English	Article								The ability to manage the constantly growing clinically relevant information in genetics available on the internet is becoming crucial in medical practice. Therefore, training students in teaching environments that develop bioinformatics skills is a particular challenge to medical schools. We present here an instructional approach that potentiates learning of hormone/vitamin mechanisms of action in gene regulation with the acquisition and practice of bioinformatics skills. The activity is integrated within the study of the Endocrine System module. Given a nucleotide sequence of a hormone or vitamin-response element, students use internet databases and tools to find the gene to which it belongs. Subsequently, students search how the corresponding hormone/vitamin influences the expression of that particular gene and how a dysfunctional interaction might cause disease. This activity was presented for four consecutive years to cohorts of 50-60 students/year enrolled in the 2(nd) year of the medical degree. 90% of the students developed a better understanding of the usefulness of bioinformatics and 98% intend to use web-based resources in the future. Since hormones and vitamins regulate genes of all body organ systems, this activity successfully integrates the whole body physiology of the medical curriculum.	[Sousa, Joao Carlos; Costa, Manuel Joao; Palha, Joana Almeida] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal	Universidade do Minho	Sousa, JC (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Campus Gualtar, Braga, Portugal.		Sousa, João C/C-1048-2009; Costa, Manuel Joao/C-3900-2009; Palha, Joana Almeida/C-2745-2009; Sousa, João/T-6628-2019	Sousa, João C/0000-0003-3249-0035; Costa, Manuel Joao/0000-0001-5255-4257; Palha, Joana Almeida/0000-0002-8866-368X; Sousa, João/0000-0003-3249-0035				*ASS AM MED COLL, 2006, CONT ISS MED BAS SCI; Boron W. F., 2003, MED PHYSL; Brenner S, 2003, SCIENCE, V302, P533, DOI 10.1126/science.302.5645.533; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Haga SB, 2006, NAT REV GENET, V7, P223, DOI 10.1038/nrg1803; Magee J, 2001, ACAD MED, V76, P852, DOI 10.1097/00001888-200108000-00022; Sansom CE, 2000, BIOCHEM EDUC, V28, P127, DOI 10.1016/S0307-4412(99)00142-9; Waggoner DJ, 2006, GENET MED, V8, P379, DOI 10.1097/01.gim.0000223543.63104.5a; Waters MJ, 2006, J ENDOCRINOL, V190, P11, DOI 10.1677/joe.1.06843; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158	10	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2007	2	5							e481	10.1371/journal.pone.0000481	http://dx.doi.org/10.1371/journal.pone.0000481			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10FB	17534431	Green Published, gold, Green Submitted			2022-12-27	WOS:000207448800011
J	Hu, D; Bertozzi, SM; Gakidou, E; Sweet, S; Goldie, SJ				Hu, Delphine; Bertozzi, Stefano M.; Gakidou, Emmanuela; Sweet, Steve; Goldie, Sue J.			The Costs, Benefits, and Cost-Effectiveness of Interventions to Reduce Maternal Morbidity and Mortality in Mexico	PLOS ONE			English	Article							LAPAROSCOPY; STRATEGIES; AFGHANISTAN; HEALTH; DEATH; CARE; 2ND	Background. In Mexico, the lifetime risk of dying from maternal causes is 1 in 370 compared to 1 in 2,500 in the U. S. Although national efforts have been made to improve maternal services in the last decade, it is unclear if Millennium Development Goal 5 - to reduce maternal mortality by three-quarters by 2015 - will be met. Methodology/Principal Findings. We developed an empirically calibrated model that simulates the natural history of pregnancy and pregnancy-related complications in a cohort of 15-year-old women followed over their lifetime. After synthesizing national and sub-national trends in maternal mortality, the model was calibrated to current intervention-specific coverage levels and validated by comparing model-projected life expectancy, total fertility rate, crude birth rate and maternal mortality ratio with Mexico-specific data. Using both published and primary data, we assessed the comparative health and economic outcomes of alternative strategies to reduce maternal morbidity and mortality. A dual approach that increased coverage of family planning by 15%, and assured access to safe abortion for all women desiring elective termination of pregnancy, reduced mortality by 43% and was cost saving compared to current practice. The most effective strategy added a third component, enhanced access to comprehensive emergency obstetric care for at least 90% of women requiring referral. At a national level, this strategy reduced mortality by 75%, cost less than current practice, and had an incremental cost-effectiveness ratio of $300 per DALY relative to the next best strategy. Analyses conducted at the state level yielded similar results. Conclusions/Significance. Increasing the provision of family planning and assuring access to safe abortion are feasible, complementary and cost-effective strategies that would provide the greatest benefit within a short-time frame. Incremental improvements in access to high-quality intrapartum and emergency obstetric care will further reduce maternal deaths and disability.	[Hu, Delphine; Sweet, Steve; Goldie, Sue J.] Harvard Univ, Sch Publ Hlth, Program Hlth Decis Sci, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Bertozzi, Stefano M.] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Gakidou, Emmanuela; Goldie, Sue J.] Harvard Initiat Global Hlth, Cambridge, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Instituto Nacional de Salud Publica; Harvard University	Goldie, SJ (corresponding author), Harvard Univ, Sch Publ Hlth, Program Hlth Decis Sci, Dept Hlth Policy & Management, Boston, MA 02115 USA.	sue_goldie@harvard.edu		Bertozzi, Stefano M/0000-0002-1723-7085	John D. and Catherine T. MacArthur Foundation	John D. and Catherine T. MacArthur Foundation	This work was supported by a grant from the John D. and Catherine T. MacArthur Foundation. The MacArthur Foundation had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	ABOUZAHR C, 2004, MATERNAL MORTALITY 2, P24; Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; *AL GUTTMA I, 1996, OV CLAND ABORT LAT A, P4; *AL GUTTMA I, 1999, FACTS BRIEF IND ABOR, P1; Amowitz LL, 2002, JAMA-J AM MED ASSOC, V288, P1284, DOI 10.1001/jama.288.10.1284; [Anonymous], 2000, COCHRANE DATABASE SY; AVILA JL, 2002, INDICE MARGINACION N; Bartlett LA, 2005, LANCET, V365, P864, DOI 10.1016/S0140-6736(05)71044-8; BRIHMER C, 1989, EUR J OBSTET GYN R B, V30, P263, DOI 10.1016/0028-2243(89)90011-7; Cahuana-Hurtado L, 2004, SALUD PUBLICA MEXICO, V46, P316, DOI 10.1590/S0036-36342004000400006; CAHUANAHURTADO L, 2004, APPL MOTHER BAY PACK; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; DRUMMOND M, EC EV HLTH CAR MERG; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; DULEY L, COCHRANE DATABASE SY, V2; DULEY L, COCHRANE DATABASE SY, V2; Ehrnborg C, 2000, PHARMACOECONOMICS, V17, P621, DOI 10.2165/00019053-200017060-00008; *ENG, 2003, OBST FIST NEEDS ASS; French L.M., 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001067.PUB2; FRENCH LM, 2003, CURR WOMENS HLTH REP, V4, P274; Gold MR, 1996, COST EFFECTIVENESS H; Graham WJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P499; Gulmezoglu AM, 2001, LANCET, V358, P689, DOI 10.1016/S0140-6736(01)05835-4; Healy J, 2006, INT J GYNECOL OBSTET, V95, P209, DOI 10.1016/j.ijgo.2006.08.002; Hofmeyr GJ, 2000, COCHRANE DB SYST REV, V2; HOFMEYR GJ, 2003, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD000166; Horton R, 2006, LANCET, V368, P1129, DOI 10.1016/S0140-6736(06)69389-6; Hu D, 2004, ANN INTERN MED, V141, P501, DOI 10.7326/0003-4819-141-7-200410050-00006; JAMISON DT, COST EFFECTIVENESS A, P39; Jha P, 1998, HEALTH POLICY PLANN, V13, P249, DOI 10.1093/heapol/13.3.249; KENT KC, 1995, JAMA-J AM MED ASSOC, V274, P888, DOI 10.1001/jama.274.11.888; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lau CY, 2002, SEX TRANSM DIS, V29, P497, DOI 10.1097/00007435-200209000-00001; Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4; MAINE D, 1981, SAF MOTH PROGR OPT I; Max W, VALUING HUMAN LIFE E; MENKEN J, 2006, INT PUBLIC HLTH DIS, P71; *MIN HLTH, 2001, MORT 2001 CONT ACT A; *MIN HLTH, 1998, CONT ACT ASP REL MEX; MURRAY CJ, HLTH DIMENSIONS SEX; MURRAY CJL, 2004, HLTH DIMENSIONS SEX; Ojha Kamal, 2003, Hum Fertil (Camb), V6, P169, DOI 10.1080/1464770312331369443; *POP REF BUR, 2005, 2005 WOM OUR WORLD; Porter Ian, 1980, HUMAN EMBRYONIC FETA; Prata N, 2004, 2004 POP ASS AM M BO; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Schuitemaker N, 1997, ACTA OBSTET GYN SCAN, V76, P332, DOI 10.1111/j.1600-0412.1997.tb07987.x; SOMMERFELT AE, 2003, REDUCE WORKSH ADD AB; TEISALA K, 1987, OBSTET GYNECOL, V69, P343; UNICEF A, 2007, GLAN MEX STAT; *WHO, 2004, UNS ABORT; *WHO CHOICE, CHOOSING INT COST EF; WOLNERHANSSEN P, 1983, OBSTET GYNECOL, V61, P702; *WORLD BANK, WDI ONL; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, 2001, MACR HLTH INV HLTH E; [No title captured]; WKLY EPIDEMIOL REC, V68, P305	58	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e750	10.1371/journal.pone.0000750	http://dx.doi.org/10.1371/journal.pone.0000750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710149	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455200026
J	Suen, G; Goldman, BS; Welch, RD				Suen, Garret; Goldman, Barry S.; Welch, Roy D.			Predicting Prokaryotic Ecological Niches Using Genome Sequence Analysis	PLOS ONE			English	Article							LATERAL GENE-TRANSFER; BURKHOLDERIA-CEPACIA; EVOLUTION; DATABASE; TAXONOMY; PROPOSAL; SYSTEM; TREE	Automated DNA sequencing technology is so rapid that analysis has become the rate-limiting step. Hundreds of prokaryotic genome sequences are publicly available, with new genomes uploaded at the rate of approximately 20 per month. As a result, this growing body of genome sequences will include microorganisms not previously identified, isolated, or observed. We hypothesize that evolutionary pressure exerted by an ecological niche selects for a similar genetic repertoire in those prokaryotes that occupy the same niche, and that this is due to both vertical and horizontal transmission. To test this, we have developed a novel method to classify prokaryotes, by calculating their Pfam protein domain distributions and clustering them with all other sequenced prokaryotic species. Clusters of organisms are visualized in two dimensions as 'mountains' on a topological map. When compared to a phylogenetic map constructed using 16S rRNA, this map more accurately clusters prokaryotes according to functional and environmental attributes. We demonstrate the ability of this map, which we term a "niche map", to cluster according to ecological niche both quantitatively and qualitatively, and propose that this method be used to associate uncharacterized prokaryotes with their ecological niche as a means of predicting their functional role directly from their genome sequence.	[Suen, Garret; Welch, Roy D.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [Goldman, Barry S.] Monsanto Co, St Louis, MO USA	Syracuse University; Monsanto	Welch, RD (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.	rowelch@syr.edu	Suen, Garret/AAF-2080-2019	Suen, Garret/0000-0002-6170-711X; Welch, Roy/0000-0002-9946-108X				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Badger JH, 2005, INT J SYST EVOL MICR, V55, P1021, DOI 10.1099/ijs.0.63510-0; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; Chen K, 2005, PLOS COMPUT BIOL, V1, P106, DOI 10.1371/journal.pcbi.0010024; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; COHAN FM, 2004, INFEC DIS S, P175; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; DAVIDSON GS, 2001, CLUSTER STABILITY US, P23; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elton C., 1927, ANIMAL ECOLOGY; FELENSTEIN J, 2006, PHYLIP PHYLOGENY INF; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Garrity G. M., 2001, BERGEYS MANUAL SYSTE, V2; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Goldenfeld N, 2007, NATURE, V445, P369, DOI 10.1038/445369a; Grinnell J., 1917, Auk Cambridge Mass, V34; Gupta RS, 2002, THEOR POPUL BIOL, V61, P423, DOI 10.1006/tpbi.2002.1589; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hugenholtz P, 2002, GENOME BIOL, V3; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; Lin J, 2000, GENOME RES, V10, P808, DOI 10.1101/gr.10.6.808; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Martiny JBH, 2005, ECOL LETT, V8, P1334, DOI 10.1111/j.1461-0248.2005.00837.x; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Ochman H, 2005, P NATL ACAD SCI USA, V102, P6595, DOI 10.1073/pnas.0502035102; Ohno S., 1970, EVOLUTION GENE DUPLI; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; PATTEN BC, 1981, AM NAT, V117, P893, DOI 10.1086/283777; Riedel K, 2001, MICROBIOL-SGM, V147, P3249, DOI 10.1099/00221287-147-12-3249; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Simonson AB, 2005, P NATL ACAD SCI USA, V102, P6608, DOI 10.1073/pnas.0501996102; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Tekaia F, 2005, PLOS COMPUT BIOL, V1, P604, DOI 10.1371/journal.pcbi.0010075; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; YABUUCHI E, 1992, MICROBIOL IMMUNOL, V36, P1251, DOI 10.1111/j.1348-0421.1992.tb02129.x; Yang S, 2005, P NATL ACAD SCI USA, V102, P373, DOI 10.1073/pnas.0408810102	49	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e743	10.1371/journal.pone.0000743	http://dx.doi.org/10.1371/journal.pone.0000743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710143	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455200020
J	Coulibaly, MB; Lobo, NF; Fitzpatrick, MC; Kern, M; Grushko, O; Thaner, DV; Traore, SF; Collins, FH; Besansky, NJ				Coulibaly, Mamadou B.; Lobo, Neil F.; Fitzpatrick, Meagan C.; Kern, Marcia; Grushko, Olga; Thaner, Daniel V.; Traore, Sekou F.; Collins, Frank H.; Besansky, Nora J.			Segmental Duplication Implicated in the Genesis of Inversion 2Rj of Anopheles gambiae	PLOS ONE			English	Article								The malaria vector Anopheles gambiae maintains high levels of inversion polymorphism that facilitate its exploitation of diverse ecological settings across tropical Africa. Molecular characterization of inversion breakpoints is a first step toward understanding the processes that generate and maintain inversions. Here we focused on inversion 2Rj because of its association with the assortatively mating Bamako chromosomal form of An. gambiae, whose distinctive breeding sites are rock pools beside the Niger River in Mali and Guinea. Sequence and computational analysis of 2Rj revealed the same 14.6 kb insertion between both breakpoints, which occurred near but not within predicted genes. Each insertion consists of 5.3 kb terminal inverted repeat arms separated by a 4 kb spacer. The insertions lack coding capacity, and are comprised of degraded remnants of repetitive sequences including class I and II transposable elements. Because of their large size and patchwork composition, and as no other instances of these insertions were identified in the An. gambiae genome, they do not appear to be transposable elements. The 14.6 kb modules inserted at both 2Rj breakpoint junctions represent low copy repeats (LCRs, also called segmental duplications) that are strongly implicated in the recent (similar to 0.4N(e) generations) origin of 2Rj. The LCRs contribute to further genome instability, as demonstrated by an imprecise excision event at the proximal breakpoint of 2Rj in field isolates.	[Coulibaly, Mamadou B.; Lobo, Neil F.; Fitzpatrick, Meagan C.; Kern, Marcia; Grushko, Olga; Thaner, Daniel V.; Collins, Frank H.; Besansky, Nora J.] Univ Notre Dame, Dept Biol Sci, Ctr Global Hlth & Infect Dis, Notre Dame, IN 46556 USA; [Coulibaly, Mamadou B.; Traore, Sekou F.] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali	University of Notre Dame; University of Bamako	Besansky, NJ (corresponding author), Univ Notre Dame, Dept Biol Sci, Ctr Global Hlth & Infect Dis, Notre Dame, IN 46556 USA.	nbesansk@nd.edu	Coulibaly, Mamadou/AAE-7006-2019; Fitzpatrick, Meagan C/K-5083-2012	Fitzpatrick, Meagan C/0000-0002-5248-2668	UNDP/World Bank/WHO [A30272]; National Institutes of Health [U01 AI48846, R01 AI48842, R01 AI63508]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI048846, R01AI063508, R01AI048842] Funding Source: NIH RePORTER	UNDP/World Bank/WHO(World Health Organization); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This investigation received financial support from the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (A30272 to NJB), and from the National Institutes of Health (U01 AI48846 to FHC). NJB was supported by NIH R01 AI48842 and R01 AI63508.	Achaz G, 2001, MOL BIOL EVOL, V18, P2280, DOI 10.1093/oxfordjournals.molbev.a003774; Andolfatto P, 1999, GENETICS, V153, P1297; Andolfatto P, 2001, GENET RES, V77, P1, DOI 10.1017/S0016672301004955; Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bingham PM, 1989, MOBILE DNA, P485; Caceres M, 1999, SCIENCE, V285, P415, DOI 10.1126/science.285.5426.415; Caceres M, 2001, GENOME RES, V11, P1353, DOI 10.1101/gr.174001; CIRERA S, 1995, GENETICS, V139, P321; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; COLUZZI M, 1985, B ZOOL, V52, P45, DOI 10.1080/11250008509440343; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Dobzhansky T., 1937; EGNER C, 1981, P NATL ACAD SCI-BIOL, V78, P459, DOI 10.1073/pnas.78.1.459; Gray YHM, 2000, TRENDS GENET, V16, P461, DOI 10.1016/S0168-9525(00)02104-1; Hoffmann AA, 2004, TRENDS ECOL EVOL, V19, P482, DOI 10.1016/j.tree.2004.06.013; Hong YS, 2003, MOL GENET GENOMICS, V268, P720, DOI 10.1007/s00438-003-0813-7; Hua-Van A, 2002, MOL GENET GENOMICS, V267, P79, DOI 10.1007/s00438-002-0638-9; KIDWELL MG, 2002, MOBILE DNA, V2; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Krzywinski J, 2004, GENETICS, V166, P1291, DOI 10.1534/genetics.166.3.1291; Kumar V., 1997, The molecular biology of insect disease vectors: a methods manual., P337; Lobachev KS, 1998, GENETICS, V148, P1507; Mathiopoulos KD, 1998, P NATL ACAD SCI USA, V95, P12444, DOI 10.1073/pnas.95.21.12444; Matzkin LM, 2005, GENETICS, V170, P1143, DOI 10.1534/genetics.104.038810; Mukabayire O, 1996, CHROMOSOMA, V104, P585, DOI 10.1007/BF00352298; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; POTTER S, 1980, CELL, V20, P639, DOI 10.1016/0092-8674(80)90310-4; Powell J. R., 1997, PROGR PROSPECTS EVOL; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; Sharakhov IV, 2006, P NATL ACAD SCI USA, V103, P6258, DOI 10.1073/pnas.0509683103; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Smit A, 1996, REPEATMASKER OPEN 30; Stankiewicz P, 2002, CURR OPIN GENET DEV, V12, P312, DOI 10.1016/S0959-437X(02)00304-0; STEINEMANN M, 1992, P NATL ACAD SCI USA, V89, P7591, DOI 10.1073/pnas.89.16.7591; Torre A. della, 1997, The molecular biology of insect disease vectors: a methods manual., P329; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Wang Y, 2006, FEBS LETT, V580, P1277, DOI 10.1016/j.febslet.2006.01.045; Warburton PE, 2004, GENOME RES, V14, P1861, DOI 10.1101/gr.2542904; WESLEY CS, 1994, P NATL ACAD SCI USA, V91, P3132, DOI 10.1073/pnas.91.8.3132; Wessler SR, 2006, IMPLICIT GENOME, P138	45	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e849	10.1371/journal.pone.0000849	http://dx.doi.org/10.1371/journal.pone.0000849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786220	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455500032
J	Ioannidis, JPA; Patsopoulos, NA; Evangelou, E				Ioannidis, John P. A.; Patsopoulos, Nikolaos A.; Evangelou, Evangelos			Heterogeneity in Meta-Analyses of Genome-Wide Association Investigations	PLOS ONE			English	Article								Background. Meta-analysis is the systematic and quantitative synthesis of effect sizes and the exploration of their diversity across different studies. Meta-analyses are increasingly applied to synthesize data from genome-wide association (GWA) studies and from other teams that try to replicate the genetic variants that emerge from such investigations. Between-study heterogeneity is important to document and may point to interesting leads. Methodology/Principal Findings. To exemplify these issues, we used data from three GWA studies on type 2 diabetes and their replication efforts where meta-analyses of all data using fixed effects methods (not incorporating between-study heterogeneity) have already been published. We considered 11 polymorphisms that at least one of the three teams has suggested as susceptibility loci for type 2 diabetes. The I-2 inconsistency metric (measuring the amount of heterogeneity not due to chance) was different from 0 (no detectable heterogeneity) for 6 of the 11 genetic variants; inconsistency was moderate to very large (I-2 = 32-77%) for 5 of them. For these 5 polymorphisms, random effects calculations incorporating between-study heterogeneity revealed more conservative p-values for the summary effects compared with the fixed effects calculations. These 5 associations were perused in detail to highlight potential explanations for between-study heterogeneity. These include identification of a marker for a correlated phenotype (e.g. FTO rs8050136 being associated with type 2 diabetes through its effect on obesity); differential linkage disequilibrium across studies of the identified genetic markers with the respective culprit polymorphisms (e.g., possibly the case for CDKAL1 polymorphisms or for rs9300039 and markers in linkage disequilibrium, as shown by additional studies); and potential bias. Results were largely similar, when we treated the discovery and replication data from each GWA investigation as separate studies. Significance. Between-study heterogeneity is useful to document in the synthesis of data from GWA investigations and can offer valuable insights for further clarification of gene-disease associations.	[Ioannidis, John P. A.; Patsopoulos, Nikolaos A.; Evangelou, Evangelos] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.] Fdn Res & Technol Hellas, Biomed Res Inst, Ioannina, Greece; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	University of Ioannina; Foundation for Research & Technology - Hellas (FORTH); Tufts University	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Evangelou, Evangelos/C-3033-2013; Ioannidis, John P. A./G-9836-2011	Evangelou, Evangelos/0000-0002-5488-2999; Patsopoulos, Nikolaos/0000-0003-3757-8941	European Union-European Social Fund; Greek Ministry of Development-General Secretariat for Research and Technology	European Union-European Social Fund(European Social Fund (ESF)); Greek Ministry of Development-General Secretariat for Research and Technology(Greek Ministry of Development-GSRT)	NAP and EE are supported by a PENED training grant from the European Union-European Social Fund and the Greek Ministry of Development-General Secretariat for Research and Technology.	Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; BERLIN JA, 1995, AM J EPIDEMIOL, V142, P383, DOI 10.1093/oxfordjournals.aje.a117645; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Egger M, 1998, BRIT MED J, V316, P140; Evangelou E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000196; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; LITTLE J, 2006, HUGENET HUGE REV HDB; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Munafo MR, 2004, PSYCHIAT RES, V129, P39, DOI 10.1016/j.psychres.2004.06.011; Nelson TL, 2007, METABOLISM, V56, P388, DOI 10.1016/j.metabol.2006.10.022; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; SACKS HS, 1987, NEW ENGL J MED, V316, P450, DOI 10.1056/NEJM198702193160806; Salanti G, 2005, GENET MED, V7, P13, DOI 10.1097/01.GIM.0000151839.12032.1A; Salanti G, 2007, STAT MED, V26, P553, DOI 10.1002/sim.2575; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott WJ, 2007, RES J BIOTECHNOL, V2, P5; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; SPIEGELHALTER DJ, 2004, EVIDENCE SYNTHESIS; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Sutton AJAK, 2000, METHODS METAANALYSIS; Todd JA, 2006, NAT GENET, V38, P731, DOI 10.1038/ng0706-731; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	31	239	246	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e841	10.1371/journal.pone.0000841	http://dx.doi.org/10.1371/journal.pone.0000841			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786212	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455500024
J	Saul, A; Fay, MP				Saul, Allan; Fay, Michael P.			Human Immunity and the Design of Multi-Component, Single Target Vaccines	PLOS ONE			English	Article								Background. Inclusion of multiple immunogens to target a single organism is a strategy being pursued for many experimental vaccines, especially where it is difficult to generate a strongly protective response from a single immunogen. Although there are many human vaccines that contain multiple defined immunogens, in almost every case each component targets a different pathogen. As a consequence, there is little practical experience for deciding where the increased complexity of vaccines with multiple defined immunogens vaccines targeting single pathogens will be justifiable. Methodology/Principal Findings. A mathematical model, with immunogenicity parameters derived from a database of human responses to established vaccines, was used to predict the increase in the efficacy and the proportion of the population protected resulting from addition of further immunogens. The gains depended on the relative protection and the range of responses in the population to each immunogen and also to the correlation of the responses between immunogens. In most scenarios modeled, the gain in overall efficacy obtained by adding more immunogens was comparable to gains obtained from a single immunogen through the use of better formulations or adjuvants. Multi-component single target vaccines were more effective at decreasing the proportion of poor responders than increasing the overall efficacy of the vaccine in a population. Conclusions/Significance. Inclusion of limited number of antigens in a vaccine aimed at targeting a single organism will increase efficacy, but the gains are relatively modest and for a practical vaccine there are constraints that are likely to limit multi-component single target vaccines to a small number of key antigens. The model predicts that this type of vaccine will be most useful where the critical issue is the reduction in proportion of poor responders.	[Saul, Allan] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Fay, Michael P.] NIAID, Biostat Res Branch, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Saul, A (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.	ASaul@niaid.nih.gov	Saul, Allan/ABH-2091-2020; Fay, Michael P/A-2974-2008; Saul, Allan J/I-6968-2013	Saul, Allan/0000-0003-0665-4091; Fay, Michael P/0000-0002-8643-9625; Saul, Allan J/0000-0003-0665-4091	National Institute for Allergy and Infectious Diseases, National Institutes of Health	National Institute for Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by the Intramural Research Program of the National Institute for Allergy and Infectious Diseases, National Institutes of Health. The funder played no role in the study or preparation, review or approval of the manuscript.	[Anonymous], 1997, GUIDANCE IND EVALUAT; Bagnoli F, 2006, CURR OPIN INVESTIG D, V7, P695; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Burgess MA, 2001, VACCINE, V19, P4835, DOI 10.1016/S0264-410X(01)00221-3; Coler RN, 2005, TRENDS PARASITOL, V21, P244, DOI 10.1016/j.pt.2005.03.006; Cooper CL, 2004, J CLIN IMMUNOL, V24, P693, DOI 10.1007/s10875-004-6244-3; Dagan R, 2004, INFECT IMMUN, V72, P5383, DOI 10.1128/IAI.72.9.5383-5391.2004; Dickman S, 2003, PLOS BIOL, V1, P144, DOI 10.1371/journal.pbio.0000048; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Goldenthal KL, 2001, CLIN INFECT DIS, V33, pS267, DOI 10.1086/322561; Goto Y, 2007, INFECT IMMUN, V75, P846, DOI 10.1128/IAI.01205-06; GRECO WR, 1995, PHARMACOL REV, V47, P331; Hill A.V., 1910, J PHYSIOL-LONDON, V40, piv; Jack AD, 1999, J INFECT DIS, V179, P489, DOI 10.1086/314578; Knuf M, 2006, VACCINE, V24, P2043, DOI 10.1016/j.vaccine.2005.11.024; Kubler-Kielb J, 2007, P NATL ACAD SCI USA, V104, P293, DOI 10.1073/pnas.0609885104; Kumar S, 2002, TRENDS PARASITOL, V18, P129, DOI 10.1016/S1471-4922(01)02207-3; Li SQ, 2007, VACCINE, V25, P2567, DOI 10.1016/j.vaccine.2006.07.035; Miller LH, 2005, TRENDS PARASITOL, V21, P412, DOI 10.1016/j.pt.2005.07.005; Olin P, 1997, LANCET, V350, P1569, DOI 10.1016/S0140-6736(97)06508-2; REED GF, 1995, PEDIATRICS, V96, P600; Robbins JB, 2005, J INFECT DIS, V191, P81, DOI 10.1086/426454; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Siber GR, 1997, DEV BIOL STAND, V89, P283; Sturgess AW, 1999, VACCINE, V17, P1169, DOI 10.1016/S0264-410X(98)00337-5; Taranger J, 2000, J INFECT DIS, V181, P1010, DOI 10.1086/315318; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Vandepapeliere P, 2005, VACCINE, V23, P2591, DOI 10.1016/j.vaccine.2004.11.034; Wu YM, 2006, P NATL ACAD SCI USA, V103, P18243, DOI 10.1073/pnas.0608545103	29	26	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e850	10.1371/journal.pone.0000850	http://dx.doi.org/10.1371/journal.pone.0000850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786221	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455500033
J	Tang, CT; Nguyen, DT; Ngo, TH; Nguyen, TMP; Le, VT; To, SD; Lindsay, J; Nguyen, TD; Bach, VC; Le, QT; Le, TH; Le, DL; James, C; Nguyen, TKT; Nguyen, VVC; Cockfield, J; Le, TG; Phan, VN; Le, HS; Huynh, TS; Le, VP; Megan, C; Adwoa, BE; Richard, B; James, S; Nguyen, TC; Tran, TH; Jeremy, F; Schultsz, C				Tang Chi Thuong; Nguyen Dac Tho; Ngo Thi Hoa; Nguyen Thi Minh Phuong; Le Van Tuan; To Song Diep; Lindsay, Jodi; Nguyen The Dung; Bach Van Cam; Le Quoc Thinh; Le Thanh Hai; Le Dieu Linh; James Campbell; Nguyen Thi Kim Tien; Nguyen Van Vinh Chau; Cockfield, Joshua; Le Truong Giang; Phan Van Nghiem; Le Hoang Son; Huynh Tan Son; Le Van Phung; Megan Counahan; Adwoa Bentsi-Enchill; Richard Brown; James Simmerman; Nguyen Tran Chinh; Tran Tinh Hien; Jeremy Farrar; Schultsz, Constance			An Outbreak of Severe Infections with Community-Acquired MRSA Carrying the Panton-Valentine Leukocidin Following Vaccination	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; FIELD GEL-ELECTROPHORESIS; METHICILLIN-RESISTANT; SKIN INFECTIONS; STRAINS; SEQUENCE; EPIDEMIOLOGY; PNEUMONIA; PATTERNS; DISEASE	Background. Infections with community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) are emerging worldwide. We investigated an outbreak of severe CA-MRSA infections in children following out-patient vaccination. Methods and Findings. We carried out a field investigation after adverse events following immunization (AEFI) were reported. We reviewed the clinical data from all cases. S. aureus recovered from skin infections and from nasal and throat swabs were analyzed by pulse-field gel electrophoresis, multi locus sequence typing, PCR and microarray. In May 2006, nine children presented with AEFI, ranging from fatal toxic shock syndrome, necrotizing soft tissue infection, purulent abscesses, to fever with rash. All had received a vaccination injection in different health centres in one District of Ho Chi Minh City. Eight children had been vaccinated by the same health care worker (HCW). Deficiencies in vaccine quality, storage practices, or preparation and delivery were not found. Infection control practices were insufficient. CA-MRSA was cultured in four children and from nasal and throat swabs from the HCW. Strains from children and HCW were indistinguishable. All carried the Panton-Valentine leukocidine (PVL), the staphylococcal enterotoxin B gene, the gene complex for staphylococcal-cassette-chromosome mec type V, and were sequence type 59. Strain HCM3A is epidemiologically unrelated to a strain of ST59 prevalent in the USA, although they belong to the same lineage. Conclusions. We describe an outbreak of infections with CA-MRSA in children, transmitted by an asymptomatic colonized HCW during immunization injection. Consistent adherence to injection practice guidelines is needed to prevent CA-MRSA transmission in both in-and outpatient settings.	[Ngo Thi Hoa; Le Dieu Linh; James Campbell; Jeremy Farrar; Schultsz, Constance] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Tang Chi Thuong; Bach Van Cam; Le Quoc Thinh] Pediat Hosp No 1, Ho Chi Minh City, Vietnam; [Nguyen Dac Tho; Le Thanh Hai] Prevent Med Ctr, Ho Chi Minh City, Vietnam; [Nguyen Thi Minh Phuong; Nguyen Thi Kim Tien] Inst Pasteur, Ho Chi Minh City, Vietnam; [Le Van Tuan; Megan Counahan; Adwoa Bentsi-Enchill; Richard Brown; James Simmerman] WHO, Ho Chi Minh City, Vietnam; [To Song Diep; Nguyen Van Vinh Chau; Nguyen Tran Chinh; Tran Tinh Hien] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Lindsay, Jodi; Cockfield, Joshua] St George Hosp, London, England; [Nguyen The Dung; Le Truong Giang; Phan Van Nghiem; Le Hoang Son; Huynh Tan Son] Hlth Serv Ho Chi Minh City, Ho Chi Minh City, Vietnam; [Le Van Phung] Natl Inst Control Vaccines & Biol, Hanoi, Vietnam	University of Oxford; World Health Organization; St Georges University London	Schultsz, C (corresponding author), Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam.	schultsz@gmail.com	Lindsay, Jodi/ABH-8205-2020; Farrar, Jeremy J./HGA-7610-2022; Lindsay, Jodi/B-9565-2008	Lindsay, Jodi/0000-0002-5219-1625; Lindsay, Jodi/0000-0002-5219-1625; Farrar, Jeremy/0000-0002-2700-623X; Ngo, Hoa/0000-0001-9320-4050	Health Service of Ho Chi Minh City; Ministry of Health Viet Nam; World Health Organization; Wellcome Trust UK [064874]	Health Service of Ho Chi Minh City; Ministry of Health Viet Nam; World Health Organization(World Health Organization); Wellcome Trust UK(Wellcome Trust)	This work was supported by the Health Service of Ho Chi Minh City, the Ministry of Health Viet Nam, the World Health Organization and the Wellcome Trust UK. Ngo T. Hoa is a recipient of a Wellcome Trust International Traveling Fellowship (064874).	Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; BANNERMAN TL, 1995, J CLIN MICROBIOL, V33, P551, DOI 10.1128/JCM.33.3.551-555.1995; Bassetti S, 2005, INFECT CONT HOSP EP, V26, P196, DOI 10.1086/502526; Boubaker K, 2004, EMERG INFECT DIS, V10, P121, DOI 10.3201/eid1001.030144; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Bratu S, 2005, EMERG INFECT DIS, V11, P808, DOI 10.3201/eid1106.040885; Chongtrakool P, 2006, ANTIMICROB AGENTS CH, V50, P1001, DOI 10.1128/AAC.50.3.1001-1012.2006; Clinical and Laboratory Standards Institute, 2005, PERF STAND ANT SUS S; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2004, J CLIN MICROBIOL, V42, P2080, DOI 10.1128/JCM.42.5.2080-2084.2004; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Edmiston CE, 2005, SURGERY, V138, P573, DOI 10.1016/j.surg.2005.06.045; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Frazee BW, 2005, ANN EMERG MED, V46, P401, DOI 10.1016/j.annemergmed.2005.05.023; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gonzalez BE, 2005, PEDIATRICS, V115, P642, DOI 10.1542/peds.2004-2300; Hsu LY, 2005, EMERG INFECT DIS, V11, P341, DOI 10.3201/eid1102.040782; Huijsdens XW, 2006, J CLIN MICROBIOL, V44, P2994, DOI 10.1128/JCM.00846-06; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Ma XX, 2005, EMERG INFECT DIS, V11, P973; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Pan ES, 2005, J INFECT DIS, V192, P811, DOI 10.1086/432072; Rutishauser J, 1999, INFECTION, V27, P259, DOI 10.1007/s150100050024; Sax H, 2006, J HOSP INFECT, V63, P93, DOI 10.1016/j.jhin.2005.11.016; SIMON PA, 1993, PEDIATR INFECT DIS J, V12, P368, DOI 10.1097/00006454-199305000-00003; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; *WHO, WHO BEST INF CONTR P; Witney AA, 2005, APPL ENVIRON MICROB, V71, P7504, DOI 10.1128/AEM.71.11.7504-7514.2005; Zhou Weigong, 2003, MMWR Surveill Summ, V52, P1	37	33	33	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e822	10.1371/journal.pone.0000822	http://dx.doi.org/10.1371/journal.pone.0000822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786194	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000207455500006
J	Brenner, JS; Dolmetsch, RE				Brenner, Jacob S.; Dolmetsch, Ricardo E.			TrpC3 Regulates Hypertrophy-Associated Gene Expression without Affecting Myocyte Beating or Cell Size	PLOS ONE			English	Article								Pathological cardiac hypertrophy is associated with an increased risk of heart failure and cardiovascular mortality. Calcium (Ca2+)-regulated gene expression is essential for the induction of hypertrophy, but it is not known how myocytes distinguish between the Ca2+ signals that regulate contraction and those that lead to cardiac hypertrophy. We used in vitro neonatal rat ventricular myocytes to perform an RNA interference (RNAi) screen for ion channels that mediate Ca2+-dependent gene expression in response to hypertrophic stimuli. We identified several ion channels that are linked to hypertrophic gene expression, including transient receptor potential C3 (TrpC3). RNAi-mediated knockdown of TrpC3 decreases expression of hypertrophy-associated genes such as the A- and B-type natriuretic peptides (ANP and BNP) in response to numerous hypertrophic stimuli, while TrpC3 overexpression increases BNP expression. Furthermore, stimuli that induce hypertrophy dramatically increase TrpC3 mRNA levels. Importantly, whereas TrpC3-knockdown strongly reduces gene expression associated with hypertrophy, it has a negligible effect on cell size and on myocyte beating. These results suggest that Ca2+ influx through TrpC3 channels increases transcription of genes associated with hypertrophy but does not regulate the signaling pathways that control cell size or contraction. Thus TrpC3 may represent an important therapeutic target for the treatment of cardiac hypertrophy and heart failure.	[Brenner, Jacob S.; Dolmetsch, Ricardo E.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Brenner, Jacob S.] Stanford Univ, Program Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Dolmetsch, RE (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu			NIH [RO1 NS048564]; Searle Scholars Program; McKnight Endowment for Neuroscience; Burroughs Wellcome Trust; Stanford Medical Scientist Training Program ( MSTP) fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048564] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; McKnight Endowment for Neuroscience; Burroughs Wellcome Trust(Wellcome Trust); Stanford Medical Scientist Training Program ( MSTP) fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH RO1 NS048564, the Searle Scholars Program, the McKnight Endowment for Neuroscience, and the Burroughs Wellcome Trust. J. S. B. is supported by a Stanford Medical Scientist Training Program ( MSTP) fellowship. These studies were designed and executed solely by J. S. B. and R. E. D., without consultation with the agents which funded this work.	Berridge MJ, 2003, BIOCHEM SOC T, V31, P930; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Garcia RL, 1997, BIOCHEM BIOPH RES CO, V239, P279, DOI 10.1006/bbrc.1997.7458; GRUVER CL, 1993, ENDOCRINOLOGY, V133, P376, DOI 10.1210/en.133.1.376; Hunton DL, 2004, AM J PHYSIOL-HEART C, V286, pH1124, DOI 10.1152/ajpheart.00162.2003; Hunton DL, 2002, J BIOL CHEM, V277, P14266, DOI 10.1074/jbc.M107167200; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Jeong MY, 2005, CIRCULATION, V111, P1645, DOI 10.1161/01.CIR.0000160367.99928.87; Kassiri Z, 2002, CIRC RES, V90, P578, DOI 10.1161/01.RES.0000012223.86441.A1; Kawano S, 2005, CARDIOVASC RES, V67, P689, DOI 10.1016/j.cardiores.2005.04.030; Kirchhefer U, 2001, J BIOL CHEM, V276, P4142, DOI 10.1074/jbc.M006443200; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Liang FQ, 2001, CAN J PHYSIOL PHARM, V79, P640, DOI 10.1139/cjpp-79-8-640; MCDONOUGH PM, 1992, J BIOL CHEM, V267, P11665; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Myers JW, 2003, NAT BIOTECHNOL, V21, P324, DOI 10.1038/nbt792; Nakayama H, 2006, FASEB J, V20, P1660, DOI 10.1096/fj.05-5560com; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; SPRENKLE AB, 1995, CIRC RES, V77, P1060, DOI 10.1161/01.RES.77.6.1060; Sugden PH, 1998, J MOL MED, V76, P725, DOI 10.1007/s001090050275; Thebault S, 2005, J CELL PHYSIOL, V204, P320, DOI 10.1002/jcp.20301; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Wolkowicz Roland, 2004, Methods Mol Biol, V246, P391; Zhang L, 2001, J MOL CELL CARDIOL, V33, P233, DOI 10.1006/jmcc.2000.1295; Zobel C, 2002, CIRCULATION, V106, P2385, DOI 10.1161/01.CIR.0000033970.22130.93	34	41	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e802	10.1371/journal.pone.0000802	http://dx.doi.org/10.1371/journal.pone.0000802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726532	Green Published, gold			2022-12-27	WOS:000207455400019
J	Huang, HS; Akbarian, S				Huang, Hsien-Sung; Akbarian, Schahram			GAD1 mRNA Expression and DNA Methylation in Prefrontal Cortex of Subjects with Schizophrenia	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; CHROMATIN; REELIN; INTERNEURONS; DYSFUNCTION; PROMOTER; NEURONS	Dysfunction of prefrontal cortex in schizophrenia includes changes in GABAergic mRNAs, including decreased expression of GAD1, encoding the 67 kDa glutamate decarboxylase (GAD(67)) GABA synthesis enzyme. The underlying molecular mechanisms remain unclear. Alterations in DNA methylation as an epigenetic regulator of gene expression are thought to play a role but this hypothesis is difficult to test because no techniques are available to extract DNA from GAD1 expressing neurons efficiently from human postmortem brain. Here, we present an alternative approach that is based on immunoprecipitation of mononucleosomes with anti-methyl-histone antibodies differentiating between sites of potential gene expression as opposed to repressive or silenced chromatin. Methylation patterns of CpG dinucleotides at the GAD1 proximal promoter and intron 2 were determined for each of the two chromatin fractions separately, using a case-control design for 14 schizophrenia subjects affected by a decrease in prefrontal GAD1 mRNA levels. In controls, the methylation frequencies at CpG dinucleotides, while overall higher in repressive as compared to open chromatin, did not exceed 5% at the proximal GAD1 promoter and 30% within intron 2. Subjects with schizophrenia showed a significant, on average 8-fold deficit in repressive chromatin-associated DNA methylation at the promoter. These results suggest that chromatin remodeling mechanisms are involved in dysregulated GABAergic gene expression in schizophrenia.	[Akbarian, Schahram] Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, Worcester, MA 01655 USA; [Huang, Hsien-Sung] Univ Massachusetts, Sch Med, Grad Sch Biomed Sci, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Akbarian, S (corresponding author), Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, Worcester, MA 01655 USA.	Schahram.akbarian@umassmed.edu		Huang, Hsien-Sung/0000-0003-2657-3635	National Institutes of Mental Health [R01 MH071476]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071476] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by a grant from the National Institutes of Mental Health (R01 MH071476).	Abdolmaleky HM, 2006, HUM MOL GENET, V15, P3132, DOI 10.1093/hmg/ddl253; Addington AM, 2005, MOL PSYCHIATR, V10, P581, DOI 10.1038/sj.mp.4001599; AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; Akbarian S, 2006, BRAIN RES REV, V52, P293, DOI 10.1016/j.brainresrev.2006.04.001; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Dracheva S, 2004, J NEUROSCI RES, V76, P581, DOI 10.1002/jnr.20122; Fatemi SH, 2005, SCHIZOPHR RES, V72, P109, DOI 10.1016/j.schres.2004.02.017; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Huang HS, 2006, J NEUROSCI METH, V156, P284, DOI 10.1016/j.jneumeth.2006.02.018; Iwamoto K, 2005, J NEUROSCI, V25, P5376, DOI 10.1523/JNEUROSCI.0766-05.2005; Laeng P, 2004, J NEUROCHEM, V91, P238, DOI 10.1111/j.1471-4159.2004.02725.x; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Sharma RP, 2005, J PSYCHIATR NEUROSCI, V30, P257; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Stadler F, 2005, J NEUROCHEM, V94, P324, DOI 10.1111/j.1471-4159.2005.03190.x; Straub RE, 2007, MOL PSYCHIATR, V12, P854, DOI 10.1038/sj.mp.4001988; Veldic M, 2005, P NATL ACAD SCI USA, V102, P2152, DOI 10.1073/pnas.0409665102	19	157	159	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e809	10.1371/journal.pone.0000809	http://dx.doi.org/10.1371/journal.pone.0000809			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726539	Green Submitted, gold, Green Published			2022-12-27	WOS:000207455400026
J	Schousboe, JT; Wilson, KE; Hangartner, TN				Schousboe, John T.; Wilson, Kevin E.; Hangartner, Thomas N.			Detection of Aortic Calcification during Vertebral Fracture Assessment (VFA) Compared to Digital Radiography	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; COMPUTED-TOMOGRAPHY; RISK-FACTORS; ATHEROSCLEROSIS; OSTEOPOROSIS; ASSOCIATION; DEPOSITS; STROKE; ARTERY	Background. Cardiovascular disease is the most common cause of mortality among post-menopausal women. Our objective was to determine whether or not lateral spine images obtained on a bone densitometer to detect prevalent vertebral fracture can also accurately detect radiographic abdominal aortic calcification (AAC), an important risk factor for cardiovascular disease independent of clinical risk factors. Methodology/Principal Findings. One hundred seventy four postmenopausal women had bone densitometry, lateral spine densitometry imaging (called vertebral fracture assessment, or VFA), and lateral spine digital radiographs. Radiographs and VFA images were scored for AAC using a previously validated 24 point scale and a simplified, new 8 point scale (AAC-8). One hundred fifty six (90%) of the VFA images were evaluable for AAC. The non-parametric intraclass correlation coefficient between VFA and radiographic 24 point and AAC-8 readings, respectively, were 0.80 (95% C.I. 0.68-0.87) and 0.76 (95% C.I. 0.65-0.84). Areas under receiver operating characteristics (ROC) curves for VFA to detect those with a radiographic 24-point AAC score >= 5 were 0.86 (95% C.I. 0.77-0.94) using the 24 point scale and 0.84 (95% C.I. 0.76-0.92) using the AAC-8 scale. Conclusion/Significance. VFA imaging intended to detect prevalent vertebral fracture can also detect radiographic AAC, an important cardiovascular disease risk factor. Since bone densitometry is recommended for all women age 65 and older, VFA imaging at the time of bone densitometry offers an opportunity to assess this risk factor in the post-menopausal female population at very little incremental time and expense.	[Schousboe, John T.] Pk Nicollet Hlth Serv, Minneapolis, MN USA; [Schousboe, John T.] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN USA; [Wilson, Kevin E.] Hologic, Bedford, MA USA; [Hangartner, Thomas N.] Wright State Univ, BioMed Imaging Lab, Dayton, OH 45435 USA; [Hangartner, Thomas N.] Miami Valley Hosp, Dayton, OH USA	University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; Wright State University Dayton; Miami Valley Hospital	Schousboe, JT (corresponding author), Pk Nicollet Hlth Serv, Minneapolis, MN USA.	john.schousboe@parknicollet.com	Hangartner, Thomas/AAG-4479-2020		Hologic, Inc	Hologic, Inc	Hologic, Inc., funded this study. Kevin Wilson PhD., of Hologic, contributed to study design and manuscript preparation but had no role in data collection or analysis.	American College of Obstetricians and Gynecologists Women's Health Care Physicians, 2004, Obstet Gynecol, V103, P203; Berg AO, 2002, ANN INTERN MED, V137, P526, DOI 10.7326/0003-4819-137-6-200209170-00014; Blake GM, 2006, BONE, V38, P935, DOI 10.1016/j.bone.2005.11.007; Brown JP, 2002, CAN MED ASSOC J, V167, pS1; Greenland P, 2003, NEW ENGL J MED, V349, P465, DOI 10.1056/NEJMcp023197; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Greenland P, 2000, CIRCULATION, V101, P723; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; Hodgson Stephen F, 2003, Endocr Pract, V9, P544; Hollander M, 2003, STROKE, V34, P2367, DOI 10.1161/01.STR.0000091393.32060.0E; Jayalath RW, 2005, EUR J VASC ENDOVASC, V30, P476, DOI 10.1016/j.ejvs.2005.04.030; Kauppila LI, 1997, ATHEROSCLEROSIS, V132, P245, DOI 10.1016/S0021-9150(97)00106-8; Kochanek K.D., 2004, NATL VITAL STAT REP, V52, P1; Kuller Lewis H., 1999, Cardiology Clinics, V17, P51, DOI 10.1016/S0733-8651(05)70056-4; Levitzky YS, 2006, CIRCULATION, V113, pE359; NEAL DJ, 2000, STATA TECHNICAL B RE, V10, P149; *NIH, NIH IM; O'Malley PG, 2003, CIRCULATION, V108, pE169, DOI 10.1161/01.CIR.0000108164.52246.89; Oei HHS, 2002, J AM COLL CARDIOL, V39, P1745, DOI 10.1016/S0735-1097(02)01853-3; Reaven PD, 2005, DIABETOLOGIA, V48, P379, DOI 10.1007/s00125-004-1640-z; Schousboe JT, 2006, J CLIN DENSITOM, V9, P302, DOI 10.1016/j.jocd.2006.05.007; Schousboe JT, 2006, J CLIN DENSITOM, V9, P133, DOI 10.1016/j.jocd.2005.11.004; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tanko LB, 2005, J BONE MINER RES, V20, P1912, DOI 10.1359/JBMR.050711; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; van der Meer IM, 2004, CIRCULATION, V109, P1089, DOI 10.1161/01.CIR.0000120708.59903.1B; Vogt TM, 2000, MAYO CLIN PROC, V75, P888, DOI 10.4065/75.9.888; Vokes T, 2006, J CLIN DENSITOM, V9, P37, DOI 10.1016/j.jocd.2006.05.006; Walsh CR, 2002, AM HEART J, V144, P733, DOI 10.1067/mhj.2002.124404; Wenger NK, 2003, PROG CARDIOVASC DIS, V46, P199, DOI 10.1016/j.pcad.2003.08.003; Wilson PWF, 2001, CIRCULATION, V103, P1529, DOI 10.1161/01.cir.103.11.1529	31	55	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e715	10.1371/journal.pone.0000715	http://dx.doi.org/10.1371/journal.pone.0000715			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684561	gold, Green Published, Green Submitted			2022-12-27	WOS:000207452400018
J	Lawlor, DA; Morton, S; Batty, GD; Macintyre, S; Clark, H; Smith, GD				Lawlor, Debbie A.; Morton, Susan; Batty, G. David; Macintyre, Sally; Clark, Heather; Smith, George Davey			Obstetrician-Assessed Maternal Health at Pregnancy Predicts Offspring Future Health	PLOS ONE			English	Article								Background. We aimed to examine the association between obstetrician assessment of maternal physical health at the time of pregnancy and offspring cardiovascular disease risk. Methods and Principal Findings. We examined this association in a birth cohort of 11,106 individuals, with 245,000 person years of follow-up. We were concerned that any associations might be explained by residual confounding, particularly by family socioeconomic position. In order to explore this we used multivariable regression models in which we adjusted for a range of indicators of socioeconomic position and we explored the specificity of the association. Specificity of association was explored by examining associations with other health related outcomes. Maternal physical health was associated with cardiovascular disease: adjusted (socioeconomic position, complications of pregnancy, birthweight and childhood growth at mean age 5) hazard ratio comparing those described as having poor or very poor health at the time of pregnancy to those with good or very good health was 1.55 (95% CI: 1.05, 2.28) for coronary heart disease, 1.91 (95% CI: 0.99, 3.67) for stroke and 1.57 (95% CI: 1.13, 2.18) for either coronary heart disease or stroke. However, this association was not specific. There were strong associations for other outcomes that are known to be related to socioeconomic position (3.61 (95% CI: 1.04, 12.55) for lung cancer and 1.28 (95% CI: 1.03, 1.58) for unintentional injury), but not for breast cancer (1.10 (95% CI: 0.48, 2.53)). Conclusions and Significance. These findings demonstrate that a simple assessment of physical health (based on the appearance of eyes, skin, hair and teeth) of mothers at the time of pregnancy is a strong indicator of the future health risk of their offspring for common conditions that are associated with poor socioeconomic position and unhealthy behaviours. They do not support a specific biological link between maternal health across her life course and future risk of cardiovascular disease in her offspring.	[Lawlor, Debbie A.; Smith, George Davey] Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Dept Social Med, Bristol BS8 1TH, Avon, England; [Morton, Susan] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand; [Morton, Susan] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Batty, G. David; Macintyre, Sally] Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Batty, G. David] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Clark, Heather] Univ Aberdeen, Dugald Baird Ctr Res Womens Hlth, Aberdeen AB9 1FX, Scotland	University of Bristol; University of Auckland; University of Auckland; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Edinburgh; University of Aberdeen	Lawlor, DA (corresponding author), Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Dept Social Med, Bristol BS8 1TH, Avon, England.	d.a.lawlor@bristol.ac.uk	Batty, GD/Y-4401-2018; Macintyre, Sally/P-6246-2014; Davey Smith, George/A-7407-2013	Batty, GD/0000-0003-1822-5753; Davey Smith, George/0000-0002-1407-8314; s, hema/0000-0002-3440-9475; Morton, Susan/0000-0002-2231-7020; Lawlor, Debbie A/0000-0002-6793-2262; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Medical Research Council [MC_U130059821] Funding Source: Medline; MRC [MC_U130059821] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Batty GD, 2004, PAEDIATR PERINAT EP, V18, P221, DOI 10.1111/j.1365-3016.2004.00552.x; Buka SL, 2003, AM J PSYCHIAT, V160, P1978, DOI 10.1176/appi.ajp.160.11.1978; EMANUEL I, 1992, BRIT J OBSTET GYNAEC, V99, P836, DOI 10.1111/j.1471-0528.1992.tb14416.x; EMANUEL I, 1986, ANN NY ACAD SCI, V477, P27, DOI 10.1111/j.1749-6632.1986.tb40318.x; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Harley K, 1996, Health Bull (Edinb), V54, P410; Hogan JW, 2004, STAT MED, V23, P1455, DOI 10.1002/sim.1728; HUTCHINS V, 1984, PUBLIC HEALTH REP, V99, P162; Hypponen E, 2004, PAEDIATR PERINAT EP, V18, P168, DOI 10.1111/j.1365-3016.2004.00556.x; ILLSLEY R, 1981, PROSPECTIVE LONGITUD, P66; KLEBANOFF MA, 1984, JAMA-J AM MED ASSOC, V252, P2423, DOI 10.1001/jama.252.17.2423; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Lawlor DA, 2005, PAEDIATR PERINAT EP, V19, P377, DOI 10.1111/j.1365-3016.2005.00674.x; Lawlor DA, 2004, LANCET, V363, P1724, DOI 10.1016/S0140-6736(04)16260-0; Lawlor DA, 2003, AM J PUBLIC HEALTH, V93, P266, DOI 10.2105/AJPH.93.2.266; LAWLOR DA, 2004, LIFE COURSE APPROACH, P41; Lawlor DA, 2007, AM J PUBLIC HEALTH, V97, P291, DOI 10.2105/AJPH.2005.080168; Lawlor DA, 2006, AM J EPIDEMIOL, V164, P907, DOI 10.1093/aje/kwj319; Lawlor DA, 2006, AM J PUBLIC HEALTH, V96, P1271, DOI 10.2105/AJPH.2005.066290; Leon DA, 2006, INT J EPIDEMIOL, V35, P549, DOI 10.1093/ije/dyi319; Rich-Edwards J., 2002, LIFE COURSE APPROACH, P23; Royston P, 2005, STATA J, V5, P279, DOI 10.1177/1536867X0500500212; Wang XB, 1995, NEW ENGL J MED, V333, P1744, DOI 10.1056/NEJM199512283332606	23	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e666	10.1371/journal.pone.0000666	http://dx.doi.org/10.1371/journal.pone.0000666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668049	gold, Green Published, Green Accepted			2022-12-27	WOS:000207452300007
J	Huang, YY; Tran, PT; Oliferenko, S; Balasubramanian, MK				Huang, Yinyi; Tran, P. T.; Oliferenko, Snezhana; Balasubramanian, Mohan K.			Assembly of Microtubules and Actomyosin Rings in the Absence of Nuclei and Spindle Pole Bodies Revealed by a Novel Genetic Method	PLOS ONE			English	Article								Background. The nucleus and the centrosomes (spindle pole bodies; SPBs in yeast) are believed to play key roles in the organization of various cellular structures, such as the actomyosin ring and microtubules. The ability to generate cells lacking nuclei and centrosomes (SPBs) is key to the elucidation of the role of these structures in various cellular processes. Methodology/Principal Findings. Here we describe a genetic method, using the Schizosaccharomyces pombe cdc16-116 mutant, to reliably and efficiently generate fission yeast cells lacking nuclei and SPBs. We use this approach to show that the assembly of microtubules does not require nuclear associated microtubule organizing centers and SPBs. We also show that actomyosin rings can assemble albeit inefficiently in the absence of nuclei and SPBs. Conclusion. We conclude that key cytoskeletal elements can be assembled in the absence of nuclei and SPBs. In addition, the approach we describe, taken together with physical approaches such as centrifugation, should facilitate the investigation of the role of the nucleus and SPBs in the assembly and inheritance of various cellular structures and organelles.	[Huang, Yinyi; Oliferenko, Snezhana; Balasubramanian, Mohan K.] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore; [Huang, Yinyi; Balasubramanian, Mohan K.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Tran, P. T.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	National University of Singapore; National University of Singapore; University of Pennsylvania	Balasubramanian, MK (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore.	mohan@tll.org.sg	Tran, Phong/F-1357-2015; Tran, Phong/GZA-8504-2022	Tran, Phong/0000-0002-2410-2277; Balasubramanian, Mohan/0000-0002-1292-8602; Oliferenko, Snezhana/0000-0002-8138-6851	TLL Summer Fellowship; NIH [RO1 GM70899]; Temasek Life Sciences Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070899] Funding Source: NIH RePORTER	TLL Summer Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Temasek Life Sciences Laboratory(National University of Singapore); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a TLL Summer Fellowship and NIH RO1 GM70899 to PTT, and research funds from to the Temasek Life Sciences Laboratory to MKB.	Balasubramanian MK, 1997, METHOD ENZYMOL, V283, P494; Bucciarelli E, 2003, J CELL BIOL, V160, P993, DOI 10.1083/jcb.200211029; Carazo-Salas RE, 2006, NAT CELL BIOL, V8, P1102, DOI 10.1038/ncb1479; Cerutti L, 1999, J CELL SCI, V112, P2313; Daga RR, 2006, NAT CELL BIOL, V8, P1108, DOI 10.1038/ncb1480; Daga RR, 2005, P NATL ACAD SCI USA, V102, P8228, DOI 10.1073/pnas.0409021102; Faruki S, 2002, CELL MOTIL CYTOSKEL, V52, P107, DOI 10.1002/cm.10036; Flory MR, 2002, CELL GROWTH DIFFER, V13, P47; Furge KA, 1998, CURR BIOL, V8, P947, DOI 10.1016/S0960-9822(98)70394-X; Heitz MJ, 2001, J CELL SCI, V114, P4521; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Krapp A, 2004, CURR BIOL, V14, pR722, DOI 10.1016/j.cub.2004.08.049; Li TW, 2000, BIOCHEM BIOPH RES CO, V272, P270, DOI 10.1006/bbrc.2000.2767; MINET M, 1979, J BACTERIOL, V137, P440, DOI 10.1128/JB.137.1.440-446.1979; Mishra M, 2005, CURR BIOL, V15, P1376, DOI 10.1016/j.cub.2005.06.070; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Naqvi NI, 2000, NAT CELL BIOL, V2, P855, DOI 10.1038/35041107; PICARD A, 1988, DEV BIOL, V128, P121, DOI 10.1016/0012-1606(88)90273-4; Rajagopalan S, 2004, CURR BIOL, V14, P69, DOI 10.1016/j.cub.2003.12.027; Schmidt S, 1997, GENE DEV, V11, P1519, DOI 10.1101/gad.11.12.1519; SLUDER G, 1986, J CELL BIOL, V103, P1873, DOI 10.1083/jcb.103.5.1873; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Tran PT, 2004, METHODS, V33, P220, DOI 10.1016/j.ymeth.2003.11.017; West RR, 1998, MOL BIOL CELL, V9, P2839, DOI 10.1091/mbc.9.10.2839; ZHANG DH, 1995, J CELL BIOL, V129, P1287, DOI 10.1083/jcb.129.5.1287; Zhang DH, 1996, NATURE, V382, P466, DOI 10.1038/382466a0	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2007	2	7							e618	10.1371/journal.pone.0000618	http://dx.doi.org/10.1371/journal.pone.0000618			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GI	17637834	Green Published, gold			2022-12-27	WOS:000207452100008
J	Kiselev, AO; Stamm, WE; Yates, JR; Lampe, MF				Kiselev, Andrey O.; Stamm, Walter E.; Yates, John R.; Lampe, Mary F.			Expression, Processing, and Localization of PmpD of Chlamydia trachomatis Serovar L2 during the Chlamydial Developmental Cycle	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; GENOME SEQUENCE; DIFFERENTIAL EXPRESSION; SURFACE-PROTEINS; IN-VITRO; PNEUMONIAE; AUTOTRANSPORTER; IDENTIFICATION; SECRETION; GENES	Background. While families of polymorphic membrane protein (pmp) genes have been identified in several Chlamydia species, their function remains mostly unknown. These proteins are of great interest, however, because of their location in the outer membrane and possible role in chlamydial virulence. Methodology/Principal Finding. We analyzed the relative transcription of the pmpD gene, a member of the pmp gene family in C. trachomatis serovar L2, and its protein product translation and processing during the chlamydial developmental cycle. By real-time reverse transcription polymerase chain reaction, the pmpD gene was found to be upregulated at 16 to 24 four hours after infection. Using polyclonal antibodies generated against the predicted passenger domain of PmpD, we demonstrated that it is initially localized on the surface of reticulate bodies, followed by its secretion outside Chlamydia starting at 24 hours after infection. In elementary bodies, we found a approximate to 157 kDa PmpD only inside the cell. Both events, the upregulation of pmpD gene transcription and PmpD protein processing and secretion, are coincidental with the period of replication and differentiation of RBs into EBs. We also demonstrated that, in the presence of penicillin, the cleavage and secretion of the putative passenger domain was suppressed. Conclusion/Significance. Our results are in agreement with the general concept that PmpD is an autotransporter protein which is post-translationally processed and secreted in the form of the putative passenger domain outside Chlamydia at mid-to- late point after infection, coinciding with the development of RBs into EBs.	[Kiselev, Andrey O.; Lampe, Mary F.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Stamm, Walter E.; Lampe, Mary F.] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA USA; [Yates, John R.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Scripps Research Institute	Lampe, MF (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.	lampe@u.washington.edu	d'Alessandro, Aldo/AAH-6554-2019; Niglio, Tarcisio/K-2496-2018	Niglio, Tarcisio/0000-0001-6555-2453	University of Washington	University of Washington(University of Washington)	This work was supported by a Royalty Research Fund grant from the University of Washington.	BARBOUR AG, 1982, J BACTERIOL, V151, P420, DOI 10.1128/JB.151.1.420-428.1982; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; BIRKELUND S, 1989, INFECT IMMUN, V57, P2683, DOI 10.1128/IAI.57.9.2683-2690.1989; Carlson JH, 2005, INFECT IMMUN, V73, P6407, DOI 10.1128/IAI.73.10.6407-6418.2005; Christiansen G, 2000, J INFECT DIS, V181, pS528, DOI 10.1086/315633; Crane DD, 2006, P NATL ACAD SCI USA, V103, P1894, DOI 10.1073/pnas.0508983103; DALBEY RE, 1985, J BIOL CHEM, V260, P5925; Dautin N, 2007, EMBO J, V26, P1942, DOI 10.1038/sj.emboj.7601638; Desvaux M, 2004, RES MICROBIOL, V155, P53, DOI 10.1016/j.resmic.2003.10.002; Douglas AL, 2000, GENE, V247, P209, DOI 10.1016/S0378-1119(00)00094-9; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Eppens EF, 1997, EMBO J, V16, P4295, DOI 10.1093/emboj/16.14.4295; Fling SP, 2001, P NATL ACAD SCI USA, V98, P1160, DOI 10.1073/pnas.98.3.1160; GATLIN CL, 1998, PROTEIN IDENTIFICATI; Gomes JP, 2005, MICROBES INFECT, V7, P410, DOI 10.1016/j.micinf.2004.11.014; Goodall JC, 2001, EUR J IMMUNOL, V31, P1513, DOI 10.1002/1521-4141(200105)31:5<1513::AID-IMMU1513>3.0.CO;2-U; Grimwood J, 1999, Microb Comp Genomics, V4, P187, DOI 10.1089/omi.1.1999.4.187; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Henderson IR, 2001, TRENDS MICROBIOL, V9, P573, DOI 10.1016/S0966-842X(01)02234-X; Hogan RJ, 2003, MICROB PATHOGENESIS, V34, P11, DOI 10.1016/S0882-4010(02)00187-0; Jose J, 2006, APPL MICROBIOL BIOT, V69, P607, DOI 10.1007/s00253-005-0227-z; Jose J, 2005, BIOCHEM BIOPH RES CO, V333, P1218, DOI 10.1016/j.bbrc.2005.06.028; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; KUO D, 1994, BIOCHEMISTRY-US, V33, P8347, DOI 10.1021/bi00193a023; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPE MF, 1998, P 9 INT S HUM CHLAM, P555; LEE CK, 1978, ANTIMICROB AGENTS CH, V13, P441, DOI 10.1128/AAC.13.3.441; Lindquist EA, 1998, P 9 INT S HUM CHLAM, P259; Longbottom D, 1998, INFECT IMMUN, V66, P1317, DOI 10.1128/IAI.66.4.1317-1324.1998; Mathews SA, 1999, FEBS LETT, V458, P354, DOI 10.1016/S0014-5793(99)01182-5; Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Mygind T, 2004, FEMS IMMUNOL MED MIC, V40, P129, DOI 10.1016/S0928-8244(03)00300-6; Nicholson TL, 2003, J BACTERIOL, V185, P3179, DOI 10.1128/JB.185.10.3179-3189.2003; Niessner A, 2003, J INFECT DIS, V188, P108, DOI 10.1086/375827; Pedersen AS, 2001, FEMS MICROBIOL LETT, V203, P153, DOI 10.1016/S0378-1097(01)00341-X; Read TD, 2003, NUCLEIC ACIDS RES, V31, P2134, DOI 10.1093/nar/gkg321; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; SUCHLAND RJ, 1991, J CLIN MICROBIOL, V29, P1333, DOI 10.1128/JCM.29.7.1333-1338.1991; Tanzer RJ, 2001, J BACTERIOL, V183, P2686, DOI 10.1128/JB.183.8.2686-2690.2001; Tanzer RJ, 2001, INFECT IMMUN, V69, P2428, DOI 10.1128/IAI.69.4.2428-2434.2001; Thomson NR, 2005, GENOME RES, V15, P629, DOI 10.1101/gr.3684805; Vandahl BBS, 2005, CELL MICROBIOL, V7, P825, DOI 10.1111/j.1462-5822.2005.00514.x; Vandahl BB, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-36; Vretou E, 2001, MICROBIOL-SGM, V147, P3303, DOI 10.1099/00221287-147-12-3303; Wehrl W, 2004, MOL MICROBIOL, V51, P319, DOI 10.1046/j.1365-2958.2003.03838.x	48	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e568	10.1371/journal.pone.0000568	http://dx.doi.org/10.1371/journal.pone.0000568			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593967	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451800012
J	Hawkins, RD; Bashiardes, S; Powder, KE; Sajan, SA; Bhonagiri, V; Alvarado, DM; Speck, J; Warchol, ME; Lovett, M				Hawkins, R. David; Bashiardes, Stavros; Powder, Kara E.; Sajan, Samin A.; Bhonagiri, Veena; Alvarado, David M.; Speck, Judith; Warchol, Mark E.; Lovett, Michael			Large Scale Gene Expression Profiles of Regenerating Inner Ear Sensory Epithelia	PLOS ONE			English	Article							HAIR CELL REGENERATION; GROUP PROTEIN EZH2; SIGNAL-TRANSDUCTION; ESTROGEN-RECEPTORS; GUINEA-PIGS; PROLIFERATION; TRANSCRIPTION; HEARING; ADULT; FATE	Loss of inner ear sensory hair cells (HC) is a leading cause of human hearing loss and balance disorders. Unlike mammals, many lower vertebrates can regenerate these cells. We used cross-species microarrays to examine this process in the avian inner ear. Specifically, changes in expression of over 1700 transcription factor (TF) genes were investigated in hair cells of auditory and vestibular organs following treatment with two different damaging agents and regeneration in vitro. Multiple components of seven distinct known signaling pathways were clearly identifiable: TGF beta, PAX, NOTCH, WNT, NFKappaB, INSULIN/IGF1 and AP1. Numerous components of apoptotic and cell cycle control pathways were differentially expressed, including p27(KIP) and TFs that regulate its expression. A comparison of expression trends across tissues and treatments revealed identical patterns of expression that occurred at identical times during regenerative proliferation. Network analysis of the patterns of gene expression in this large dataset also revealed the additional presence of many components (and possible network interactions) of estrogen receptor signaling, circadian rhythm genes and parts of the polycomb complex (among others). Equal numbers of differentially expressed genes were identified that have not yet been placed into any known pathway. Specific time points and tissues also exhibited interesting differences: For example, 45 zinc finger genes were specifically up-regulated at later stages of cochlear regeneration. These results are the first of their kind and should provide the starting point for more detailed investigations of the role of these many pathways in HC recovery, and for a description of their possible interactions.	[Hawkins, R. David; Bashiardes, Stavros; Powder, Kara E.; Sajan, Samin A.; Bhonagiri, Veena; Alvarado, David M.; Lovett, Michael] Washington Univ, Sch Med, Dept Genet, Div Human Genet, St Louis, MO 63110 USA; [Speck, Judith; Warchol, Mark E.] Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Lovett, M (corresponding author), Washington Univ, Sch Med, Dept Genet, Div Human Genet, St Louis, MO 63110 USA.	lovett@genetics.wustl.edu		Powder, Kara/0000-0001-7415-4262	National Organization for Hearing Research Foundation [O1-DC05632, R01 DC006283, P30 DC04665, 5T32HG000045, 5T32GM007067]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005632, P30DC004665, R01DC006283] Funding Source: NIH RePORTER	National Organization for Hearing Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a major grant from the National Organization for Hearing Research Foundation (to ML and MW) and by RO1-DC05632 (ML), R01 DC006283 and P30 DC04665 (MW) and by training grant 5T32HG000045 (supporting DMA) and training grant 5T32GM007067 (supporting KEP).	Antoch MP, 2005, CELL CYCLE, V4, P901, DOI 10.4161/cc.4.7.1792; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bermingham-McDonogh O, 2001, DEV BIOL, V238, P247, DOI 10.1006/dbio.2001.0412; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Chen P, 1999, DEVELOPMENT, V126, P1581; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; Di Palma T, 2003, J BIOL CHEM, V278, P3395, DOI 10.1074/jbc.M205977200; Duncan LJ, 2006, J COMP NEUROL, V499, P691, DOI 10.1002/cne.21114; Etchegaray JP, 2006, J BIOL CHEM, V281, P21209, DOI 10.1074/jbc.M603722200; FORGE A, 1993, SCIENCE, V259, P1616, DOI 10.1126/science.8456284; Fritzsch B, 2003, BRAIN RES BULL, V60, P423, DOI 10.1016/S0361-9230(03)00048-0; Hawkins RD, 2003, HUM MOL GENET, V12, P1261, DOI 10.1093/hmg/ddg150; Hayes KR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-219; Hillier LW, 2005, NATURE, V434, P724, DOI 10.1038/nature03466; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HINCK L, 1994, J CELL BIOL, V124, P729, DOI 10.1083/jcb.124.5.729; Hudspeth AJ, 1997, NEURON, V19, P947, DOI 10.1016/S0896-6273(00)80385-2; Ide T, 2003, MOL ENDOCRINOL, V17, P1255, DOI 10.1210/me.2002-0191; Ikeda S, 2005, MOL GENET METAB, V86, P314, DOI 10.1016/j.ymgme.2005.05.011; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; JHUN BH, 1995, BIOCHEMISTRY-US, V34, P7996, DOI 10.1021/bi00025a005; JORGENSEN JM, 1988, NATURWISSENSCHAFTEN, V75, P319, DOI 10.1007/BF00367330; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kawamoto K, 2003, J NEUROSCI, V23, P4395; Lacorte JM, 1997, J BIOL CHEM, V272, P23578, DOI 10.1074/jbc.272.38.23578; Ledford AW, 2002, DEV BIOL, V245, P157, DOI 10.1006/dbio.2002.0636; Li CG, 2002, J BIOL CHEM, V277, P38399, DOI 10.1074/jbc.M203188200; Li X, 2002, SCIENCE, V297, P1180; Liu Chenglong, 2006, AIDS Res Ther, V3, P6, DOI 10.1186/1742-6405-3-6; Matsui JI, 2004, J NEUROBIOL, V61, P250, DOI 10.1002/neu.20054; Matsui JI, 2000, JARO-J ASSOC RES OTO, V1, P46, DOI 10.1007/s101620010005; Medina KL, 2005, CURR OPIN HEMATOL, V12, P203, DOI 10.1097/01.moh.0000160735.67596.a0; Messina DN, 2004, GENOME RES, V14, P2041, DOI 10.1101/gr.2584104; Oesterle EC, 2003, J COMP NEUROL, V463, P177, DOI 10.1002/cne.10756; Pawar A, 2003, J BIOL CHEM, V278, P40736, DOI 10.1074/jbc.M307973200; RAPHAEL Y, 1988, DEV BIOL, V128, P222, DOI 10.1016/0012-1606(88)90284-9; Reich M, 2004, BIOINFORMATICS, V20, P1797, DOI 10.1093/bioinformatics/bth138; Renn SCP, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-42; ROBERSON DW, 1994, AM J OTOL, V15, P28; RYALS BM, 1988, SCIENCE, V240, P1774, DOI 10.1126/science.3381101; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Sommer S, 2001, SEMIN CANCER BIOL, V11, P339, DOI 10.1006/scbi.2001.0389; Stenberg AE, 2001, HEARING RES, V157, P87, DOI 10.1016/S0378-5955(01)00280-5; Stone JS, 1999, DEVELOPMENT, V126, P961; Stone JS, 2004, DEV DYNAM, V230, P597, DOI 10.1002/dvdy.20087; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Thompson Emma E., 2005, Human Genomics, V2, P168; Trueba SS, 2005, J CLIN ENDOCR METAB, V90, P455, DOI 10.1210/jc.2004-1358; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wagner RA, 2005, DEV BIOL, V288, P595, DOI 10.1016/j.ydbio.2005.09.036; Wang B, 2004, DEVELOPMENT, V131, P4477, DOI 10.1242/dev.01287; Warchol ME, 1996, J NEUROSCI, V16, P5466; Warchol ME, 2001, J NEUROCYTOL, V30, P253, DOI 10.1023/A:1012705925437; Warchol ME, 2002, J NEUROSCI, V22, P2607, DOI 10.1523/JNEUROSCI.22-07-02607.2002; WARCHOL ME, 1993, SCIENCE, V259, P1619, DOI 10.1126/science.8456285; Warchol ME, 1999, J NEUROCYTOL, V28, P889, DOI 10.1023/A:1007026306730; WARCHOL ME, 2007, HEARING RES IN PRESS; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; YAMASHITA H, 1995, P NATL ACAD SCI USA, V92, P3152, DOI 10.1073/pnas.92.8.3152; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; ZHANG W, 1995, MOL CELL BIOL, V15, P6055	66	58	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2007	2	6							e525	10.1371/journal.pone.0000525	http://dx.doi.org/10.1371/journal.pone.0000525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GD	17565378	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451600013
J	Rodriguez-Almazan, C; Torner, FJ; Costas, M; Perez-Montfort, R; de Gomez-Puyou, MT; Puyou, AG				Rodriguez-Almazan, Claudia; Torner, Francisco J.; Costas, Miguel; Perez-Montfort, Ruy; de Gomez-Puyou, Marieta Tuena; Puyou, Armando Gomez			The Stability and Formation of Native Proteins from Unfolded Monomers Is Increased through Interactions with Unrelated Proteins	PLOS ONE			English	Article								The intracellular concentration of protein may be as high as 400 mg per ml; thus it seems inevitable that within the cell, numerous protein-protein contacts are constantly occurring. A basic biochemical principle states that the equilibrium of an association reaction can be shifted by ligand binding. This indicates that if within the cell many protein-protein interactions are indeed taking place, some fundamental characteristics of proteins would necessarily differ from those observed in traditional biochemical systems. Accordingly, we measured the effect of eight different proteins on the formation of homodimeric triosephosphate isomerase from Trypanosoma brucei (TbTIM) from guanidinium chloride unfolded monomers. The eight proteins at concentrations of micrograms per ml induced an important increase on active dimer formation. Studies on the mechanism of this phenomenon showed that the proteins stabilize the dimeric structure of TbTIM, and that this is the driving force that promotes the formation of active dimers. Similar data were obtained with TIM from three other species. The heat changes that occur when TbTIM is mixed with lysozyme were determined by isothermal titration calorimetry; the results provided direct evidence of the weak interaction between apparently unrelated proteins. The data, therefore, are strongly suggestive that the numerous protein-protein interactions that occur in the intracellular space are an additional control factor in the formation and stability of proteins.	[Rodriguez-Almazan, Claudia; Perez-Montfort, Ruy; de Gomez-Puyou, Marieta Tuena; Puyou, Armando Gomez] Univ Nacl Autonoma Mexico, Dept Bioquim, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Torner, Francisco J.; Costas, Miguel] Univ Nacl Autonoma Mexico, Lab Biofisicoquim, Dept Fisicoquim, Fac Quim, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Puyou, AG (corresponding author), Univ Nacl Autonoma Mexico, Dept Bioquim, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	apuyou@ifc.unam.mx		Perez-Montfort, Ruy/0000-0003-0810-1159; Costas, Miguel/0000-0001-8604-6381	PAPIIT UNAM [IN203805]; CONACYT, Mexico [G27551, 42328Q]	PAPIIT UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); CONACYT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grant number IN203805 from PAPIIT UNAM to AGP, and grants G27551 and 42328Q from CONACYT, Mexico to AGP and MC, respectively.	ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; BANERJEE SK, 1975, J BIOL CHEM, V250, P8260; BORCHERT TV, 1993, EUR J BIOCHEM, V211, P703, DOI 10.1111/j.1432-1033.1993.tb17599.x; Bulone D, 2001, BIOPHYS CHEM, V91, P61, DOI 10.1016/S0301-4622(01)00155-7; Chebotareva NA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1239, DOI 10.1007/s10541-005-0070-y; Dhar-Chowdhury P, 2005, J BIOL CHEM, V280, P38464, DOI 10.1074/jbc.M508744200; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Evans MS, 2005, PROTEIN PEPTIDE LETT, V12, P189, DOI 10.2174/0929866053005908; Fedorov AN, 1997, J BIOL CHEM, V272, P32715, DOI 10.1074/jbc.272.52.32715; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; Grallert H, 1998, J BIOL CHEM, V273, P33305, DOI 10.1074/jbc.273.50.33305; Hall D, 2003, BBA-PROTEINS PROTEOM, V1649, P127, DOI 10.1016/S1570-9639(03)00167-5; HAMPE OG, 1982, BIOPHYS J, V40, P77, DOI 10.1016/S0006-3495(82)84460-3; Jaenicke R, 2000, ADV PROTEIN CHEM, V53, P329; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; KNULL HR, 1992, CURR TOP CELL REGUL, V33, P15; KOHL L, 1994, EUR J BIOCHEM, V220, P331, DOI 10.1111/j.1432-1033.1994.tb18629.x; Li J, 2001, J BIOL CHEM, V276, P34396, DOI 10.1074/jbc.M103392200; Maruyama T, 2001, BIOTECHNOL BIOENG, V75, P233, DOI 10.1002/bit.10001; MCVITTIE JD, 1977, EUR J BIOCHEM, V81, P307, DOI 10.1111/j.1432-1033.1977.tb11953.x; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Najera H, 2003, BIOCHEM J, V370, P785, DOI 10.1042/BJ20021439; Orosz F, 2000, P NATL ACAD SCI USA, V97, P1026, DOI 10.1073/pnas.97.3.1026; Orosz F, 2001, BLOOD, V98, P3106, DOI 10.1182/blood.V98.10.3106; OstoaSaloma P, 1997, EUR J BIOCHEM, V244, P700, DOI 10.1111/j.1432-1033.1997.00700.x; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Rakus D, 2004, BIOCHEMISTRY-US, V43, P14948, DOI 10.1021/bi048886x; Ren GP, 2003, J PROTEIN CHEM, V22, P431, DOI 10.1023/B:JOPC.0000005458.08802.11; SCHELLMAN JA, 1975, BIOPOLYMERS, V14, P999, DOI 10.1002/bip.1975.360140509; Srere PA, 2000, TRENDS BIOCHEM SCI, V25, P150, DOI 10.1016/S0968-0004(00)01550-4; SRERE PA, 1990, FEBS LETT, V268, P360, DOI 10.1016/0014-5793(90)81286-W; van den Berg B, 2000, EMBO J, V19, P3870, DOI 10.1093/emboj/19.15.3870; Vazquez-Contreras E, 2000, PROTEIN PEPTIDE LETT, V7, P57; Walden H, 2004, BIOCHEM SOC T, V32, P305, DOI 10.1042/BST0320305; Walden H, 2004, J MOL BIOL, V342, P861, DOI 10.1016/j.jmb.2004.07.067; WALEY SG, 1973, BIOCHEM J, V135, P165, DOI 10.1042/bj1350165; WALSH JL, 1989, BIOCHIM BIOPHYS ACTA, V999, P64, DOI 10.1016/0167-4838(89)90031-9; WANG Z, 1992, PROTEIN SCI, V1, P522; WILLIAMS JC, 1995, BIOCHEMISTRY-US, V34, P8309, DOI 10.1021/bi00026a012; Xiang JY, 2004, BIOCHEMISTRY-US, V43, P11436, DOI 10.1021/bi049208d; ZABORI S, 1980, Z NATURFORSCH C, V35, P999; Zhou BR, 2004, J BIOL CHEM, V279, P55109, DOI 10.1074/jbc.M409086200; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331; Zomosa-Signoret V, 2003, BIOCHEMISTRY-US, V42, P3311, DOI 10.1021/bi0206560	45	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e497	10.1371/journal.pone.0000497	http://dx.doi.org/10.1371/journal.pone.0000497			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551578	gold, Green Submitted, Green Published			2022-12-27	WOS:000207451500007
J	Lunardi, C; Dolcino, M; Peterlana, D; Bason, C; Navone, R; Tamassia, N; Tinazzi, E; Beri, R; Corrocher, R; Puccetti, A				Lunardi, Claudio; Dolcino, Marzia; Peterlana, Dimitri; Bason, Caterina; Navone, Riccardo; Tamassia, Nicola; Tinazzi, Elisa; Beri, Ruggero; Corrocher, Roberto; Puccetti, Antonio			Endothelial Cells' Activation and Apoptosis Induced by a Subset of Antibodies against Human Cytomegalovirus: Relevance to the Pathogenesis of Atherosclerosis	PLOS ONE			English	Article								Background. Human cytomegalovirus (hCMV) is involved in the pathogenesis of atherosclerosis. We have previously shown in patients with atherosclerosis that antibodies directed against the hCMV-derived proteins US28 and UL122 are able to induce endothelial cell damage and apoptosis of non-stressed endothelial cells through cross-rection with normally expressed surface molecules. Our aim was to dissect the molecular basis of such interaction and to investigate mechanisms linking innate immunity to atherosclerosis. Methodology/Principal Findings. We analysed the gene expression profiles in endothelial cells stimulated with antibodies affinity-purified against either the UL122 or the US28 peptides using the microarray technology. Microarray results were validated by quantitative PCR and by detection of proteins in the medium. Supernatant of endothelial cells incubated with antibodies was analysed also for the presence of Heat Shock Protein (HSP)60 and was used to assess stimulation of Toll-Like Receptor-4 (TLR4). Antibodies against UL122 and US28 induced the expression of genes encoding for adhesion molecules, chemokines, growth factors and molecules involved in the apoptotis process together with other genes known to be involved in the initiation and progression of the atherosclerotic process. HSP60 was released in the medium of cells incubated with anti-US28 antibodies and was able to engage TLR4. Conclusions/Significance. Antibodies directed against hCMV modulate the expression of genes coding for molecules involved in activation and apoptosis of endothelial cells, processes known to play a pivotal role in the pathogenesis of atherosclerosis. Moreover, endothelial cells exposed to such antibodies express HSP60 on the cell surface and release HSP60 in the medium able to activate TLR4. These data confirm that antibodies directed against hCMV-derived proteins US28 and UL122 purified from patients with coronary artery disease induce endothelial cell damage and support the hypothesis that hCMV infection may play a crucial role in mediating the atherosclerotic process.	[Lunardi, Claudio; Peterlana, Dimitri; Bason, Caterina; Navone, Riccardo; Tinazzi, Elisa; Beri, Ruggero; Corrocher, Roberto] Univ Verona, Dept Clin & Expt Med, Sect Internal Med, I-37100 Verona, Italy; [Dolcino, Marzia; Puccetti, Antonio] Inst Giannina Gaslini, Genoa, Italy; [Tamassia, Nicola] Univ Verona, Sect Gen Pathol, Dept Pathol, I-37100 Verona, Italy; [Puccetti, Antonio] Univ Genoa, Dept Expt Med, Sect Histol, Genoa, Italy	University of Verona; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Verona; University of Genoa	Lunardi, C (corresponding author), Univ Verona, Dept Clin & Expt Med, Sect Internal Med, I-37100 Verona, Italy.	claudio.lunardi@univr.it	Tinazzi, Elisa/AAB-9450-2020; Tamassia, Nicola/J-8621-2016	Tamassia, Nicola/0000-0003-2990-3003	Italian Ministry for Scientific Research and Technology; Italian Ministry of Health	Italian Ministry for Scientific Research and Technology; Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by grants from the Italian Ministry for Scientific Research and Technology (AP and CL), and from the Italian Ministry of Health (RC). Funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Bason C, 2003, LANCET, V362, P1971, DOI 10.1016/S0140-6736(03)15016-7; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Daley SJ, 1996, AM J PATHOL, V148, P1193; DEGRAAF R, 2006, MICROBES INFECT, V3; Foltz IN, 1998, J BIOL CHEM, V273, P9344, DOI 10.1074/jbc.273.15.9344; Haught WH, 1996, AM HEART J, V132, P1; Hu YH, 2003, J PROTEOME RES, V2, P405, DOI 10.1021/pr0340227; Khurana R, 2005, CIRCULATION, V111, P2828, DOI 10.1161/CIRCULATIONAHA.104.495887; Lee Y, 2002, MOL CELL BIOCHEM, V237, P69, DOI 10.1023/A:1016535217038; Lunardi C, 2006, PLOS MED, V3, P94, DOI 10.1371/journal.pmed.0030002; Lupo G, 2005, BBA-MOL CELL BIOL L, V1735, P135, DOI 10.1016/j.bbalip.2005.05.008; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; Mallat Z, 2000, BRIT J PHARMACOL, V130, P947, DOI 10.1038/sj.bjp.0703407; Mayr M, 1999, CIRCULATION, V99, P1560, DOI 10.1161/01.CIR.99.12.1560; Michelsen KS, 2004, J IMMUNOL, V173, P5901, DOI 10.4049/jimmunol.173.10.5901; Monaco C, 2004, P NATL ACAD SCI USA, V101, P5634, DOI 10.1073/pnas.0401060101; Murakami T, 2000, J Atheroscler Thromb, V7, P39; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Nishiura H, 2005, J CELL BIOCHEM, V94, P540, DOI 10.1002/jcb.20318; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shaw Anthony, 2003, Current Vascular Pharmacology, V1, P41, DOI 10.2174/1570161033386745; Shen YH, 2006, CARDIOVASC RES, V69, P502, DOI 10.1016/j.cardiores.2005.10.007; Smith CL, 2005, PLOS MED, V2, P1031, DOI 10.1371/journal.pmed.0020264; Spratt DE, 2006, FEBS J, V273, P1759, DOI 10.1111/j.1742-4658.2006.05193.x; Tedgui A, 2001, THROMB HAEMOSTASIS, V86, P420; Tuomisto TT, 2005, CURR OPIN LIPIDOL, V16, P201, DOI 10.1097/01.mol.0000162325.85290.e5; Vink A, 2004, CURR OPIN LIPIDOL, V15, P515, DOI 10.1097/00041433-200410000-00004; Wick G, 2004, ANNU REV IMMUNOL, V22, P361, DOI 10.1146/annurev.immunol.22.012703.104644; WILSON PW, 1998, CIRCULATION, V97, P837; Wolvetang EJ, 2003, HUM MOL GENET, V12, P247, DOI 10.1093/hmg/ddg015; Xiao QZ, 2005, STROKE, V36, P2571, DOI 10.1161/01.STR.0000189632.98944.ab; Yang QW, 2005, BIORHEOLOGY, V42, P225; Zhu JH, 2003, ARTERIOSCL THROM VAS, V23, P1055, DOI 10.1161/01.ATV.0000074899.60898.FD	36	25	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2007	2	5							e473	10.1371/journal.pone.0000473	http://dx.doi.org/10.1371/journal.pone.0000473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10FB	17534423	Green Published, gold, Green Submitted			2022-12-27	WOS:000207448800003
J	Young, JM; Waters, H; Dong, C; Fulle, HJ; Liman, ER				Young, Janet M.; Waters, Hang; Dong, Cora; Fuelle, Hans-Juergen; Liman, Emily R.			Degeneration of the Olfactory Guanylyl Cyclase D Gene during Primate Evolution	PLOS ONE			English	Article								Background. The mammalian olfactory system consists of several subsystems that detect specific sets of chemical cues and underlie a variety of behavioral responses. Within the main olfactory epithelium at least three distinct types of chemosensory neurons can be defined by their expression of unique sets of signal transduction components. In rodents, one set of neurons expresses the olfactory-specific guanylyl cyclase (GC)-D gene (Gucy2d, guanylyl cyclase 2d) and other cell-type specific molecules. GC-D-positive neurons project their axons to a small group of atypical "necklace" glomeruli in the olfactory bulb, some of which are activated in response to suckling in neonatal rodents and to atmospheric CO2 in adult mice. Because GC-D is a pseudogene in humans, signaling through this system appears to have been lost at some point in primate evolution. Principal Findings. Here we used a combination of bioinformatic analysis of trace-archive and genome-assembly data and sequencing of PCR-amplified genomic DNA to determine when during primate evolution the functional gene was lost. Our analysis reveals that GC-D is a pseudogene in a large number of primate species, including apes, Old World and New World monkeys and tarsier. In contrast, the gene appears intact and has evolved under purifying selection in mouse, rat, dog, lemur and bushbaby. Conclusions. These data suggest that signaling through GC-D-expressing cells was probably compromised more than 40 million years ago, prior to the divergence of New World monkeys from Old World monkeys and apes, and thus cannot be involved in chemosensation in most primates.	[Waters, Hang; Dong, Cora; Liman, Emily R.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Young, Janet M.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Fuelle, Hans-Juergen] Univ So Calif, Dept Cell & Neurobiol, Keck Sch Med, Los Angeles, CA 90089 USA; Univ So Calif, Dept Ophthalmol, Keck Sch Med, Los Angeles, CA 90089 USA; [Liman, Emily R.] Univ So Calif, Program Neurosci, Los Angeles, CA 90089 USA	University of Southern California; Fred Hutchinson Cancer Center; University of Southern California; University of Southern California; University of Southern California	Liman, ER (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	jayoung@fhcrc.org; Liman@usc.edu	Liman, Emily/AAC-7383-2021	liman, emily/0000-0003-4765-5496	NIH [DC004564, DC004209, DC004281]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004281, R01DC004564, R01DC004209] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding: Our work was funded by three NIH grants: DC004564 to Emily Liman, DC004209 to Barbara Trask and DC004281 to Hans-Jurgen Fulle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Breer H, 2006, CELL MOL LIFE SCI, V63, P1465, DOI 10.1007/s00018-006-6108-5; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; FULLE HJ, 1995, P NATL ACAD SCI USA, V92, P3571, DOI 10.1073/pnas.92.8.3571; Fuss SH, 2005, EUR J NEUROSCI, V22, P2649, DOI 10.1111/j.1460-9568.2005.04468.x; Garbers DL, 2006, TRENDS ENDOCRIN MET, V17, P251, DOI 10.1016/j.tem.2006.06.006; Gilad Y, 2005, GENOME RES, V15, P224, DOI 10.1101/gr.2846405; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Gilad Y, 2003, P NATL ACAD SCI USA, V100, P3324, DOI 10.1073/pnas.0535697100; Gilad Y, 2003, MOL BIOL EVOL, V20, P307, DOI 10.1093/molbev/msg013; Gimelbrant AA, 2004, P NATL ACAD SCI USA, V101, P9019, DOI 10.1073/pnas.0401566101; Giorgi D, 2000, GENOME RES, V10, P1979, DOI 10.1101/gr.10.12.1979; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; GREER CA, 1982, J NEUROSCI, V2, P1744; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Juilfs DM, 1997, P NATL ACAD SCI USA, V94, P3388, DOI 10.1073/pnas.94.7.3388; KIMCHI T, 2007, NATURE IN PRESS; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liman ER, 2006, PFLUG ARCH EUR J PHY, V453, P125, DOI 10.1007/s00424-006-0120-3; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Liman ER, 2003, P NATL ACAD SCI USA, V100, P3328, DOI 10.1073/pnas.0636123100; Lin W, 2007, P NATL ACAD SCI USA, V104, P2471, DOI 10.1073/pnas.0610201104; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Menashe I, 2003, NAT GENET, V34, P143, DOI 10.1038/ng1160; Meyer MR, 2000, P NATL ACAD SCI USA, V97, P10595, DOI 10.1073/pnas.97.19.10595; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Niimura Y, 2006, J HUM GENET, V51, P505, DOI 10.1007/s10038-006-0391-8; Opazo JC, 2006, MOL PHYLOGENET EVOL, V40, P274, DOI 10.1016/j.ympev.2005.11.015; Potter LR, 2005, FRONT BIOSCI-LANDMRK, V10, P1205, DOI 10.2741/1613; Ray DA, 2005, MOL PHYLOGENET EVOL, V35, P117, DOI 10.1016/j.ympev.2004.10.023; RISSER JM, 1987, BRAIN RES BULL, V19, P275, DOI 10.1016/0361-9230(87)90093-1; Rodriguez I, 2000, NAT GENET, V26, P18, DOI 10.1038/79124; Rodriguez I, 2002, CURR BIOL, V12, pR409, DOI 10.1016/S0960-9822(02)00909-0; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Shi P, 2007, GENOME RES, V17, P166, DOI 10.1101/gr.6040007; Smith TD, 2001, ANAT RECORD, V265, P176, DOI 10.1002/ar.1152; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; TEICHER MH, 1980, BRAIN RES, V194, P530, DOI 10.1016/0006-8993(80)91237-8; Tian HK, 2004, J NEUROSCI, V24, P8383, DOI 10.1523/JNEUROSCI.2222-04.2004; Yamagami S, 2005, ZOOL SCI, V22, P819, DOI 10.2108/zsj.22.819; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Young JM, 2007, TRENDS GENET, V23, P212, DOI 10.1016/j.tig.2007.03.004; Zhang JZ, 2003, P NATL ACAD SCI USA, V100, P8337, DOI 10.1073/pnas.1331721100	50	39	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e884	10.1371/journal.pone.0000884	http://dx.doi.org/10.1371/journal.pone.0000884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849013	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455600030
J	Miranda, A; Morgan, M; Jamal, L; Laserson, K; Barreira, D; Silva, G; Santos, J; Wells, C; Paine, P; Garrett, D				Miranda, Abraham; Morgan, Meade; Jamal, Leda; Laserson, Kayla; Barreira, Draurio; Silva, Guida; Santos, Joseney; Wells, Charles; Paine, Patricia; Garrett, Denise			Impact of Antiretroviral Therapy on the Incidence of Tuberculosis: The Brazilian Experience, 1995-2001	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-ASSOCIATED TUBERCULOSIS; RECONSTITUTION INFLAMMATORY SYNDROME; HIV-1-INFECTED PATIENTS; MORTALITY; INFECTION; RISK; ERA; PROPHYLAXIS; MORBIDITY	Background. The human immunodeficiency virus (HIV) fuels tuberculosis (TB) epidemics. In controlled clinical trials, antiretroviral therapy (ART) reduces TB incidence in HIV-infected patients. In this study we determine if, under programmatic conditions, Brazil's policy of universal ART access has impacted TB incidence among HIV-infected patients. Methods. We abstracted clinical information from records of HIV-infected patients managed in the public sector in 11 Brazilian states between 1/1/1995 and 12/31/2001. Case ascertainment (TB and HIV) utilized guidelines (with added stringency) published by Brazil's Ministry of Health. We determined TB incidence and hazards ratio (HR) for ART-naive and ART-treated [including highly active ART (HAART)] patients employing Cox proportional hazards analysis. Results. Information from 463 HIV-infected patients met study criteria. The median age of the study population was 34 years, 70% were male, and mean follow-up to primary endpoints-TB, death, and last clinic visit-was 330, 1059, and 1125 days, respectively. Of the 463 patients, 76 (16%) remained ART-naive. Of the patients who never received HAART (n = 157) 81 were treated with ART non-HAART. Of the patients who received any ART (n = 387), 306 were treated with HAART (includes those patients who later switched from ART non-HAART to HAART). Tuberculosis developed in 39/463 (8%) patients. Compared to HAART- and ART non-HAART-treated patient groups, TB incidence was 10- (p<0.001) and 2.5-fold (p = 0.03) higher in ART-naive patients, respectively. The median baseline absolute CD4+ T-lymphocyte count for patients who developed TB was not significantly different from that of patients who remained TB free. In multivariate analysis, the incidence of TB was statistically significantly lower in HAART- treated [HR 0.2; 95% (CI 0.1, 0.6); p<0.01] compared to ART naive patients. A baseline CD4+ T-lymphocyte count <200 cells/mm(3) [HR 2.5; (95% CI 1.2, 5.4); p<0.01], prior hospitalization [HR 4.2; (95% CI 2.0, 8.8); p<0.001], prior incarceration [HR 4.1; 95% CI 1.6, 10.3); p<0.01], and a positive tuberculin skin test [HR 3.1; (95% CI 1.1, 9.0); p = 0.04] were independently and positively associated with incident TB. Conclusion. In this population-based study we demonstrate an 80% reduction in incident TB, under programmatic conditions, in HAART- treated HIV-infected patients compared to ART-naive patients.	[Miranda, Abraham; Morgan, Meade; Laserson, Kayla] US Ctr Dis Control & Prevent, Global AIDS Program, Atlanta, GA USA; [Miranda, Abraham; Wells, Charles] US Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Jamal, Leda] State Sao Paulo Dept Hlth, Ctr Referencia & Treinamento DST AIDS, STD AIDS Program State Sao Paulo, Sao Paulo, Brazil; [Laserson, Kayla] US Ctr Dis Control & Prevent, Off Director, Off Global Hlth Coordinator, Atlanta, GA USA; [Barreira, Draurio] Brazil Minist Hlth, Programa Nacl DST AIDS, Brasilia, DF, Brazil; [Silva, Guida; Santos, Joseney; Paine, Patricia; Garrett, Denise] Brazil Minist Hlth, Programa Nacl Controle TB, Brasilia, DF, Brazil; [Garrett, Denise] Int Union TB & Lung Dis, Paris, France	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Miranda, A (corresponding author), US Ctr Dis Control & Prevent, Global AIDS Program, Atlanta, GA USA.	aci5@cdc.gov; garrettdo@yahoo.com			The US Agency for International Development (USAID)	The US Agency for International Development (USAID)(United States Agency for International Development (USAID))	The US Agency for International Development (USAID) provided financial support for this project but had no role in the design or conduct of the study, in the collection, analysis, or interpretation of the data, nor in the preparation, review, or approval of the manuscript.	Badri M, 2002, INT J TUBERC LUNG D, V6, P231; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Bleed D, 2000, Curr Opin Pulm Med, V6, P174, DOI 10.1097/00063198-200005000-00002; Bucher HC, 1999, AIDS, V13, P501, DOI 10.1097/00002030-199903110-00009; Carmody ER, 2003, TROP MED INT HEALTH, V8, P378, DOI 10.1046/j.1365-3156.2003.01046.x; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; Dheda K, 2004, J INFECT DIS, V190, P1670, DOI 10.1086/424676; DIPERRI G, 1989, LANCET, V2, P1502; ERON JJ, 1995, NEW ENGL J MED, V333, P1662, DOI 10.1056/NEJM199512213332502; Fitzgerald DW, 2000, LANCET, V356, P1470, DOI 10.1016/S0140-6736(00)02870-1; Girardi E, 2001, J ACQ IMMUN DEF SYND, V26, P326, DOI 10.1097/00126334-200104010-00006; Girardi E, 2000, AIDS, V14, P1985, DOI 10.1097/00002030-200009080-00015; GODREYFAUSSETT P, 2003, TUBERCULOSIS, V83, P68; Grant AD, 1997, AIDS, V11, P1357, DOI 10.1097/00002030-199711000-00010; Hopewell PC, 2000, LUNG BIOL HEALTH DIS, P525; Hung CC, 2003, AIDS, V17, P2615, DOI 10.1097/00002030-200312050-00008; Jones JL, 2000, INT J TUBERC LUNG D, V4, P1026; JORDA R, 2002, BRIT MED J, V325, P757; Lawn SD, 2005, AIDS, V19, P1113, DOI 10.1097/01.aids.0000176211.08581.5a; Levi GC, 2002, AIDS, V16, P2373, DOI 10.1097/00002030-200212060-00001; Lienhardt C, 1997, INT J TUBERC LUNG D, V1, P196; Lipman M, 2006, CURR OPIN INFECT DIS, V19, P20, DOI 10.1097/01.qco.0000200543.80712.01; Maher D, 2005, INT J TUBERC LUNG D, V9, P17; *MIN SAUD BRAS PRO, 2006, REC TER ANT AD AD IN; *MIN SAUD BRAS SEC, 2002, MAN TECN CONTR TUB C; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; MUKADI Y, 1993, LANCET, V342, P143, DOI 10.1016/0140-6736(93)91346-N; NUNN P, 1992, AM REV RESPIR DIS, V146, P849, DOI 10.1164/ajrccm/146.4.849; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Raviglione M C, 1997, AIDS, V11 Suppl B, pS115; Santoro-Lopes G, 2002, CLIN INFECT DIS, V34, P543, DOI 10.1086/338641; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; *WHO, 2006, TUB INF CONTR ER EXP; *WHO, 2002, WHOCDSTB2002296; *WHO, 1995, WHOHTMTB2004336, P27; *WHO, 2002, WHOHTMTB2004330; *WHO, 1990, WKLY EPIDEMIOL REC, V65, P221; WHO, 2007, WHOHTMTB2007376; *WHO, 2004, 3 5 PROGR REP; WHO/UNAIDS, 1999, WEEKLY EPIDEMIOLOGIC, V74, P385; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; Wolday H, 2003, INT J TUBERC LUNG D, V7, P110; World Health Organization, 2002, SCAL ANT THER RES LT	49	63	64	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e826	10.1371/journal.pone.0000826	http://dx.doi.org/10.1371/journal.pone.0000826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786198	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455500010
J	Willberg, CB; Ward, SM; Clayton, RF; Naoumov, NV; McCormick, C; Proto, S; Harris, M; Patel, AH; Klenerman, P				Willberg, Christian B.; Ward, Scott M.; Clayton, Reginald F.; Naoumov, Nikolai V.; McCormick, Christopher; Proto, Sandra; Harris, Mark; Patel, Arvind H.; Klenerman, Paul			Protection of Hepatocytes from Cytotoxic T Cell Mediated Killing by Interferon-Alpha	PLOS ONE			English	Article								Background. Cellular immunity plays a key role in determining the outcome of hepatitis C virus (HCV) infection, although the majority of infections become persistent. The mechanisms behind persistence are still not clear; however, the primary site of infection, the liver, may be critical. We investigated the ability of CD8+ T-cells (CTL) to recognise and kill hepatocytes under cytokine stimulation. Methods/Principle Findings. Resting hepatocytes cell lines expressed low levels of MHC Class I, but remained susceptible to CTL cytotoxicity. IFN-alpha treatment, in vitro, markedly increased hepatocyte MHC Class I expression, however, reduced sensitivity to CTL cytotoxicity. IFN-alpha stimulated hepatocyte lines were still able to present antigen and induce IFN-gamma expression in interacting CTL. Resistance to killing was not due to the inhibition of the FASL/FAS-pathway, as stimulated hepatocytes were still susceptible to FAS-mediated apoptosis. In vitro stimulation with IFN-alpha, or the introduction of a subgenomic HCV replicon into the HepG2 line, upregulated the expression of the granzyme-B inhibitor-proteinase inhibitor 9 (PI-9). PI-9 expression was also observed in liver tissue biopsies from patients with chronic HCV infection. Conclusion/Significance. IFN-alpha induces resistance in hepatocytes to perforin/granzyme mediate CTL killing pathways. One possible mechanism could be through the expression of the PI-9. Hindrance of CTL cytotoxicity could contribute to the chronicity of hepatic viral infections.	[Willberg, Christian B.; Ward, Scott M.; Klenerman, Paul] Univ Oxford, Nuffield Dept Med, Oxford, England; [Clayton, Reginald F.; Patel, Arvind H.] MRC, Virol Unit, Glasgow G11 5JR, Lanark, Scotland; [Naoumov, Nikolai V.; Proto, Sandra] UCL, Inst Hepatol, London, England; [McCormick, Christopher; Harris, Mark] Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England; [Willberg, Christian B.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA; [Ward, Scott M.] Princess Alexandra Hosp, Woolloongabba, Qld 4102, Australia; [McCormick, Christopher] Univ Southampton, Southampton Gen Hosp, Southampton, Hants, England	University of Oxford; University of London; University College London; University of Leeds; University of California System; University of California San Francisco; University of Southampton	Klenerman, P (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.	paul.klenerman@medawar.ox.ac.uk		McCormick, Christopher/0000-0002-6155-9161; Willberg, Christian/0000-0001-5299-9344; Phillips, Sandra/0000-0002-3720-6470; klenerman, paul/0000-0003-4307-9161; Harris, Mark/0000-0002-9821-1003	BBSRC; European Union Virgil Network; Wellcome Trust; Medical Research Council, United Kingdom; MRC [MC_U130184144] Funding Source: UKRI; Medical Research Council [MC_U130184144] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union Virgil Network; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the BBSRC, European Union Virgil Network, Wellcome Trust, and Medical Research Council, United Kingdom.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Balaji KN, 2002, J EXP MED, V196, P493, DOI 10.1084/jem.20011836; Barrie MB, 2004, J IMMUNOL, V172, P6453, DOI 10.4049/jimmunol.172.10.6453; BERTOLETTI A, 1994, J EXP MED, V180, P933, DOI 10.1084/jem.180.3.933; Bertolino P, 2002, IMMUNOL CELL BIOL, V80, P84, DOI 10.1046/j.0818-9641.2001.01048.x; CALNE RY, 1969, NATURE, V223, P472, DOI 10.1038/223472a0; CALNE RY, 1969, LANCET, V2, P940; Chisari FV, 1997, J CLIN INVEST, V99, P1472, DOI 10.1172/JCI119308; Clayton RF, 2005, LIVER INT, V25, P389, DOI 10.1111/j.1478-3231.2005.01017.x; DAAR AS, 1984, TRANSPLANTATION, V38, P287, DOI 10.1097/00007890-198409000-00018; Ehl S, 1998, CELL IMMUNOL, V189, P67, DOI 10.1006/cimm.1998.1344; Eisenberger C F, 1994, Transpl Int, V7 Suppl 1, pS163; Gugenheim J, 1996, EUR SURG RES, V28, P256, DOI 10.1159/000129464; Guidotti LG, 2000, J EXP MED, V191, P1247, DOI 10.1084/jem.191.7.1247; Guidotti LG, 1999, J EXP MED, V189, P1555, DOI 10.1084/jem.189.10.1555; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Hermans IF, 2004, J IMMUNOL METHODS, V285, P25, DOI 10.1016/j.jim.2003.10.017; Jensen ER, 1998, INFECT IMMUN, V66, P4143; Jin YD, 1997, J CLIN IMMUNOL, V17, P140, DOI 10.1023/A:1027326415164; Kafrouni MI, 2001, J IMMUNOL, V167, P1566, DOI 10.4049/jimmunol.167.3.1566; LAU JYN, 1993, DIGEST DIS SCI, V38, P888, DOI 10.1007/BF01295916; Lechner F, 2001, REV MED VIROL, V11, P11, DOI 10.1002/rmv.295; Lechner F, 2000, EUR J IMMUNOL, V30, P2479, DOI 10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Li XK, 2001, TRANSPLANTATION, V71, P503, DOI 10.1097/00007890-200102270-00004; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; McCormick CJ, 2004, J GEN VIROL, V85, P429, DOI 10.1099/vir.0.19676-0; McCormick CJ, 2002, J GEN VIROL, V83, P383, DOI 10.1099/0022-1317-83-2-383; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; SCHOFIELD L, 1987, J IMMUNOL, V139, P2020; Schultz UA, 1999, J VIROL, V73, P3162, DOI 10.1128/JVI.73.4.3162-3168.1999; Sheehy ME, 2001, J IMMUNOL METHODS, V249, P99, DOI 10.1016/S0022-1759(00)00329-X; SO SKS, 1987, TRANSPLANTATION, V43, P79, DOI 10.1097/00007890-198701000-00018; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Sun JR, 1996, J BIOL CHEM, V271, P27802, DOI 10.1074/jbc.271.44.27802; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Timm J, 2004, J EXP MED, V200, P1593, DOI 10.1084/jem.20041006; Tsuzuki S, 2003, BIOCHEM J, V372, P227, DOI 10.1042/BJ20021891; UDA K, 1994, J SURG RES, V57, P563, DOI 10.1006/jsre.1994.1183; WKLY EPIDEMIOL REC, V74, P425	40	17	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e791	10.1371/journal.pone.0000791	http://dx.doi.org/10.1371/journal.pone.0000791			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726521	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000207455400008
J	Grieco, JP; Achee, NL; Chareonviriyaphap, T; Suwonkerd, W; Chauhan, K; Sardelis, MR; Roberts, DR				Grieco, John P.; Achee, Nicole L.; Chareonviriyaphap, Theeraphap; Suwonkerd, Wannapa; Chauhan, Kamal; Sardelis, Michael R.; Roberts, Donald R.			A New Classification System for the Actions of IRS Chemicals Traditionally Used For Malaria Control	PLOS ONE			English	Article							BEHAVIOR; MOSQUITOS; DDT; INSECTICIDES; RESPONSES; DIPTERA; VECTOR	Knowledge of how mosquitoes respond to insecticides is of paramount importance in understanding how an insecticide functions to prevent disease transmission. A suite of laboratory assays was used to quantitatively characterize mosquito responses to toxic, contact irritant, and non-contact spatial repellent actions of standard insecticides. Highly replicated tests of these compounds over a range of concentrations proved that all were toxic, some were contact irritants, and even fewer were non-contact repellents. Of many chemicals tested, three were selected for testing in experimental huts to confirm that chemical actions documented in laboratory tests are also expressed in the field. The laboratory tests showed the primary action of DDT is repellent, alphacypermethrin is irritant, and dieldrin is only toxic. These tests were followed with hut studies in Thailand against marked-released populations. DDT exhibited a highly protective level of repellency that kept mosquitoes outside of huts. Alphacypermethrin did not keep mosquitoes out, but its strong irritant action caused them to prematurely exit the treated house. Dieldrin was highly toxic but showed no irritant or repellent action. Based on the combination of laboratory and confirmatory field data, we propose a new paradigm for classifying chemicals used for vector control according to how the chemicals actually function to prevent disease transmission inside houses. The new classification scheme will characterize chemicals on the basis of spatial repellent, contact irritant and toxic actions.	[Grieco, John P.; Achee, Nicole L.; Sardelis, Michael R.; Roberts, Donald R.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Chareonviriyaphap, Theeraphap] Kasetsart Univ, Dept Entomol, Bangkok, Thailand; [Suwonkerd, Wannapa] Minist Publ Hlth, Off Dis Prevent & Control, Chiang Mai, Thailand; [Chauhan, Kamal] USDA, Chem Affecting Insect Behav Lab, Beltsville, MD 20705 USA	Uniformed Services University of the Health Sciences - USA; Kasetsart University; Ministry of Public Health - Thailand; United States Department of Agriculture (USDA)	Grieco, JP (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA.	jgrieco@usuhs.mil		Achee, Nicole/0000-0001-6939-2055; Grieco, John/0000-0002-2080-8598; Chareonviriyaphap, Theeraphap/0000-0002-7362-5621	National Institutes of Health [5U01AI054777-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI054777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by a grant from the National Institutes of Health entitled "Behavior modifying compounds for disease vector control''(grant no. 5U01AI054777-02).	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; ASCHER K. R. S., 1955, Rivista di Parassitologia, V16, P31; Brogdon WG, 1998, J AM MOSQUITO CONTR, V14, P159; BROWN AWA, 1958, WHO MONOGRAPH SERIES, V38; Chareonviriyaphap T, 1997, J AM MOSQUITO CONTR, V13, P171; DETHIER VG, 1960, J ECON ENTOMOL, V53, P134, DOI 10.1093/jee/53.1.134; DEZULUETA J, 1963, NATURE, V200, P860, DOI [10.1038/200860a0, 10.1038/200861a0]; Grieco JP, 2000, J VECTOR ECOL, V25, P62; Grieco JP, 2005, J AM MOSQUITO CONTR, V21, P404, DOI 10.2987/8756-971X(2006)21[404:ANHSST]2.0.CO;2; KENNEDY JS, 1947, B ENTOMOL RES, V37, P593, DOI 10.1017/S0007485300030091; KRAMER WL, 1979, ENVIRON ENTOMOL, V8, P1111, DOI 10.1093/ee/8.6.1111; MUELLER PH, 1948, NOBEL LECT, P227; MUIRHEADTHOMSON RC, 1953, MOSQUITO BEHAV RELAT, P219; Roberts D R, 1991, Bull Pan Am Health Organ, V25, P210; Roberts DR, 2000, J VECTOR ECOL, V25, P48; *SAS I INC, 1999, BAS SAS SOFTW SAS ON; *SAS I INC, 1999, SAS STAT SOFTW SAS O; SCHRECK CE, 1989, J AM MOSQUITO CONTR, V5, P247; SMITH A, 1969, B ENTOMOL RES, V59, P33, DOI 10.1017/S000748530000300X; TARZWELL CM, 1947, PUBLIC HEALTH REP, V62, P84, DOI 10.2307/4585983; WHO, 2006, WHO TECH REP SER, V936, P1; WHO, 1998, WHOCDSCPCMAL9812	22	163	168	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e716	10.1371/journal.pone.0000716	http://dx.doi.org/10.1371/journal.pone.0000716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684562	gold, Green Submitted, Green Published			2022-12-27	WOS:000207452400019
J	Zhao, W; Pahar, B; Borda, JT; Alvarez, X; Sestak, K				Zhao, Wei; Pahar, Bapi; Borda, Juan T.; Alvarez, Xavier; Sestak, Karol			A Decline in CCL3-5 Chemokine Gene Expression during Primary Simian-Human Immunodeficiency Virus Infection	PLOS ONE			English	Article								Background. The CC-chemokines CCL3, CCL4 and CCL5 have been found to block the entry of CCR5-tropic HIV into host cells and to suppress the viral replication in vitro, but the in vivo role of endogenous CC-chemokines in HIV-1 infection is still incompletely understood. Methodology/Principle Findings. In this study, the primate host CCL3, CCL4 and CCL5 gene expression was evaluated in response to simian-human immunodeficiency virus (SHIV) infection in rhesus macaque model. Five rhesus macaques were inoculated with CCR5-tropic SHIVSF162P4. The mRNA levels of CCL3, CCL4 and CCL5 were measured by real-time PCR at post inoculation day (PID) 0, 7, 14, 21, 35, 56 and 180 in peripheral blood. In addition, a selected subset of samples from CXCR4-tropic SHIVKu1-infected macaques was included with objective to compare the differences in CC-chemokine down-regulation caused by the two SHIVs. Gut-associated lymphoid tissues (GALT) collected from SHIVSF162P4-infected animals were also tested by flow cytometry and confocal microscopy to corroborate the gene expression results. Predictably, higher viral loads and CD4+ T cell losses were observed at PID 14 in macaques infected with SHIVKu1 than with SHIVSF162P4. A decline in CC-chemokine gene expression was also found during primary (PID 7-21), but not chronic (PID 180) stage of infection. Conclusions. It was determined that A) SHIVSF162P4 down-regulated the CC-chemokine gene expression during acute stage of infection to a greater extent (p<0.05) than SHIVKu1, and B) such down-regulation was not paralleled with the CD4+ T cell depletion. Evaluation of CC-chemokine enhancing immunomodulators such as synthetic CpG-oligonucleotides could be explored in future HIV vaccine studies.	[Zhao, Wei; Pahar, Bapi; Borda, Juan T.; Alvarez, Xavier; Sestak, Karol] Tulane Natl Primate Res Ctr, Covington, LA USA; [Alvarez, Xavier; Sestak, Karol] Tulane Univ, Sch Med, New Orleans, LA 70112 USA	Tulane University; Tulane University	Sestak, K (corresponding author), Tulane Natl Primate Res Ctr, Covington, LA USA.	ksestak@tulane.edu	Pahar, Bapi/AFM-3129-2022	Pahar, Bapi/0000-0003-1949-973X; Zhao, Wei/0000-0003-1516-9493	National Institutes of Health [AI54146, RR00164]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI054146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants AI54146 and RR00164 from the National Institutes of Health.	Ahmed RKS, 2002, CLIN EXP IMMUNOL, V129, P11, DOI 10.1046/j.1365-2249.2002.01894.x; Ahmed RKS, 2001, SCAND J IMMUNOL, V53, P245, DOI 10.1046/j.1365-3083.2001.00865.x; Alkhatib G, 1997, VIROLOGY, V234, P340, DOI 10.1006/viro.1997.8673; Belyakov IM, 2001, NAT MED, V7, P1320, DOI 10.1038/nm1201-1320; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Cline AN, 2005, J MED PRIMATOL, V34, P303; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Decrion AZ, 2005, CURR HIV RES, V3, P243, DOI 10.2174/1570162054368057; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Fantuzzi L, 2001, EUR CYTOKINE NETW, V12, P597; Gauduin MC, 1998, J VIROL, V72, P6315, DOI 10.1128/JVI.72.8.6315-6324.1998; Harouse JM, 1998, J MED PRIMATOL, V27, P81, DOI 10.1111/j.1600-0684.1998.tb00230.x; Hofmann-Lehmann R, 2002, AIDS RES HUM RETROV, V18, P627, DOI 10.1089/088922202760019329; Hsu M, 2003, J VIROL, V77, P989, DOI 10.1128/JVI.77.2.989-998.2003; Jennes W, 2002, AIDS RES HUM RETROV, V18, P171, DOI 10.1089/08892220252781220; Joag SV, 1996, J VIROL, V70, P3189, DOI 10.1128/JVI.70.5.3189-3197.1996; Kinter A, 2000, IMMUNOL REV, V177, P88, DOI 10.1034/j.1600-065X.2000.17708.x; LaFranco-Scheuch L, 2004, J VIROL, V78, P6399, DOI 10.1128/JVI.78.12.6399-6408.2004; Lehner T, 2000, IMMUNOLOGY, V99, P569, DOI 10.1046/j.1365-2567.2000.00993.x; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Mackewicz CE, 1996, SCIENCE, V274, P1393, DOI 10.1126/science.274.5291.1393; Mattapallil JJ, 1998, J VIROL, V72, P6421, DOI 10.1128/JVI.72.8.6421-6429.1998; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Moser B, 1997, TRENDS MICROBIOL, V5, P88, DOI 10.1016/S0966-842X(97)01019-6; Muthumani K, 2000, J LEUKOCYTE BIOL, V68, P366; Paxton WA, 1999, IMMUNOL LETT, V66, P71, DOI 10.1016/S0165-2478(98)00154-0; Paxton WA, 1998, VIROLOGY, V244, P66, DOI 10.1006/viro.1998.9082; Ramesh G, 2005, CLIN DIAGN LAB IMMUN, V12, P192, DOI 10.1128/CDLI.12.1.192-197.2005; Rottman JB, 1997, AM J PATHOL, V151, P1341; Stantchev TS, 2001, CYTOKINE GROWTH F R, V12, P219, DOI 10.1016/S1359-6101(00)00033-2; Stein JV, 2005, IMMUNOLOGY, V116, P1, DOI 10.1111/j.1365-2567.2005.02183.x; Veazey RS, 2003, J EXP MED, V198, P1551, DOI 10.1084/jem.20031266; Wen WR, 2005, VIRUS RES, V113, P26, DOI 10.1016/j.virusres.2005.04.002; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681; Zhang LQ, 1998, J VIROL, V72, P5035, DOI 10.1128/JVI.72.6.5035-5045.1998; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	38	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e726	10.1371/journal.pone.0000726	http://dx.doi.org/10.1371/journal.pone.0000726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684570	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452400027
J	Levesque, D; Briere, FP; Perreault, JP				Levesque, Dominique; Briere, Francis P.; Perreault, Jean-Pierre			A Modern Mode of Activation for Nucleic Acid Enzymes	PLOS ONE			English	Article							IN-VITRO SELECTION; RNA; CATALYSIS; RIBOZYMES	Through evolution, enzymes have developed subtle modes of activation in order to ensure the sufficiently high substrate specificity required by modern cellular metabolism. One of these modes is the use of a target-dependent module (i.e. a docking domain) such as those found in signalling kinases. Upon the binding of the target to a docking domain, the substrate is positioned within the catalytic site. The prodomain acts as a target-dependent module switching the kinase from an off state to an on state. As compared to the allosteric mode of activation, there is no need for the presence of a third partner. None of the ribozymes discovered to date have such a mode of activation, nor does any other known RNA. Starting from a specific on/off adaptor for the hepatitis delta virus ribozyme, that differs but has a mechanism reminiscent of this signalling kinase, we have adapted this mode of activation, using the techniques of molecular engineering, to both catalytic RNAs and DNAs exhibiting various activities. Specifically, we adapted three cleaving ribozymes (hepatitis delta virus, hammerhead and hairpin ribozymes), a cleaving 10-23 deoxyribozyme, a ligating hairpin ribozyme and an artificially selected capping ribozyme. In each case, there was a significant gain in terms of substrate specificity. Even if this mode of control is unreported for natural catalytic nucleic acids, its use needs not be limited to proteinous enzymes. We suggest that the complexity of the modern cellular metabolism might have been an important selective pressure in this evolutionary process.	[Levesque, Dominique; Briere, Francis P.; Perreault, Jean-Pierre] Univ Sherbrooke, RNA Grp Grp ARN, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Perreault, JP (corresponding author), Univ Sherbrooke, RNA Grp Grp ARN, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada.	Jean-Pierre.Perreault@usherbrooke.ca			This work was supported by grants from the Canadian Institute of Health Research (CIHR) [MOP-44002, EOP-38322, PRG-80169]; Universite de Sherbrooke	This work was supported by grants from the Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Universite de Sherbrooke	This work was supported by grants from the Canadian Institute of Health Research (CIHR; MOP-44002 and EOP-38322) to J.P.P. The RNA group is supported by grants from the Universite de Sherbrooke and the CIHR (PRG-80169).	Alaoui-Ismaili MH, 2000, ANTIVIR RES, V46, P181, DOI 10.1016/S0166-3542(00)00085-1; BEAUDRY D, 1995, NUCLEIC ACIDS RES, V23, P745, DOI 10.1093/nar/23.5.745; Bergeron LJ, 2005, RNA, V11, P1858, DOI 10.1261/rna.2112705; Bergeron LJ, 2005, NUCLEIC ACIDS RES, V33, P1240, DOI 10.1093/nar/gki278; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Blount KE, 2005, ANNU REV BIOPH BIOM, V34, P415, DOI 10.1146/annurev.biophys.34.122004.184428; Davidson EA, 2007, NAT CHEM BIOL, V3, P23, DOI 10.1038/nchembio846; FERSHT A, 1999, STRUCTURE MECH PROTE, P289; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Jansen JA, 2006, NAT STRUCT MOL BIOL, V13, P517, DOI 10.1038/nsmb1094; Komatsu Y, 1997, BIOORGAN MED CHEM, V5, P1063, DOI 10.1016/S0968-0896(97)00042-4; Levesque D, 2002, RNA, V8, P464, DOI 10.1017/S1355838202020289; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; Penchovsky R, 2005, NAT BIOTECHNOL, V23, P1424, DOI 10.1038/nbt1155; Sakamoto N, 1996, J CLIN INVEST, V98, P2720, DOI 10.1172/JCI119097; Sargueil B, 2003, J BIOL CHEM, V278, P52783, DOI 10.1074/jbc.M306703200; Schubert S, 2004, J MOL BIOL, V339, P355, DOI 10.1016/j.jmb.2004.03.064; Silverman SK, 2005, NUCLEIC ACIDS RES, V33, P6151, DOI 10.1093/nar/gki930; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Tanoue TJ, 2003, CELL SIGNAL, V15, P455, DOI 10.1016/S0898-6568(02)00112-2; Valadkhan S, 2001, NATURE, V413, P701, DOI 10.1038/35099500; Wilson TJ, 2005, BIOCHEM SOC T, V33, P461, DOI 10.1042/BST0330461; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Zaher HS, 2006, RNA, V12, P1949, DOI 10.1261/rna.131306	24	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e673	10.1371/journal.pone.0000673	http://dx.doi.org/10.1371/journal.pone.0000673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653287	gold, Green Published, Green Submitted			2022-12-27	WOS:000207452200029
J	Khan, H; Taqui, AM; Khawaja, MR; Fatmi, Z				Khan, Hassan; Taqui, Ather M.; Khawaja, Muhammad Rizwanulhaq; Fatmi, Zafar			Problem-Based Versus Conventional Curricula: Influence on Knowledge and Attitudes of Medical Students Towards Health Research	PLOS ONE			English	Article								Background. Medical education curricula in developing countries should emphasize training in health research. This study compares the knowledge and attitudes towards health research between undergraduate medical students undertaking Problem Based Learning (PBL) versus conventional Lecture Based Learning (LBL). Methods. Two groups comprising 66 (LBL) and 84 (PBL) 4(th) and 5(th) year students from the medical college of Aga Khan University were administered a structured and validated questionnaire. Knowledge and attitudes of the two groups were recorded on a scale (graduated in percentages) and compared for statistical difference. Results. PBL students scored 54.0% while LBL students scored 55.5% on the knowledge scale [p-value; 0.63]. On the attitudes scale, PBL students scored 75.5% against a 66.7% score of LBL students [p-value; 0.021]. A higher proportion of PBL students (89%) had participated in research activities compared to LBL students (74%) and thus felt more confident in conducting research and writing a scientific paper. Conclusion. The PBL students showed slightly healthier attitudes towards health research compared to LBL students. Both groups demonstrated a similar level of knowledge about health research. The positive impact of the PBL curriculum on attitudes of medical students towards health research may help in improving research output from developing countries in future.	[Khan, Hassan; Taqui, Ather M.; Khawaja, Muhammad Rizwanulhaq] Aga Khan Univ, Coll Med, Karachi, Pakistan; [Fatmi, Zafar] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan	Aga Khan University; Aga Khan University	Khan, H (corresponding author), Aga Khan Univ, Coll Med, Karachi, Pakistan.	drhasankhan@gmail.com	Khan, Hassan/D-6267-2013; Fatmi, Syed Zafar Ahmed/P-4075-2019	Khan, Hassan/0000-0003-1468-8654; Fatmi, Zafar/0000-0001-7212-6858; Khawaja, Muhammad Rizwan/0000-0001-7436-0891				Aslam F, 2004, J Pak Med Assoc, V54, P534; BICKEL J, 1980, J MED EDUC, V55, P567; Birgegard G, 1998, MED EDUC, V32, P46, DOI 10.1046/j.1365-2923.1998.00157.x; BRANCATI FL, 1992, JAMA-J AM MED ASSOC, V267, P1372, DOI 10.1001/jama.267.10.1372; COLES CR, 1985, MED EDUC, V19, P308, DOI 10.1111/j.1365-2923.1985.tb01327.x; Khan H, 2007, JCPSP-J COLL PHYSICI, V17, P59; Khan Hassan, 2006, BMC Med Educ, V6, P54, DOI 10.1186/1472-6920-6-54; Khoo HE, 2003, MED EDUC, V37, P401, DOI 10.1046/j.1365-2923.2003.01489.x; Nandi P. L., 2000, Hong Kong Medical Journal, V6, P301; Rehan N, 2003, J Coll Physicians Surg Pak, V13, P617; Reinders JJ, 2005, MED EDUC, V39, P237, DOI 10.1111/j.1365-2929.2004.02078.x; Sadana R, 2004, BMJ-BRIT MED J, V328, P826, DOI 10.1136/bmj.328.7443.826; Sanson-Fisher RW, 2005, MED J AUSTRALIA, V183, P258, DOI 10.5694/j.1326-5377.2005.tb07032.x; Scaria V, 2004, CALICUT MED J, V2, pe1; SEGAL S, 1990, ACAD MED, V65, P530, DOI 10.1097/00001888-199008000-00010; VERNON DTA, 1993, ACAD MED, V68, P550, DOI 10.1097/00001888-199307000-00015; Vodopivec I, 2002, CROAT MED J, V43, P58; 2005, PLOS MED, V2, pE424	18	46	48	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2007	2	7							e632	10.1371/journal.pone.0000632	http://dx.doi.org/10.1371/journal.pone.0000632			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GI	17637847	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452100021
J	Tang, CSM; Epstein, RJ				Tang, Clara S. M.; Epstein, Richard J.			A Structural Split in the Human Genome	PLOS ONE			English	Article								Background. Promoter-associated CpG islands (PCIs) mediate methylation-dependent gene silencing, yet tend to co-locate to transcriptionally active genes. To address this paradox, we used data mining to assess the behavior of PCI-positive (PCI+) genes in the human genome. Results. PCI+ genes exhibit a bimodal distribution: (1) a 'housekeeping-like' subset characterized by higher GC content and lower intron length/number, and (2) a 'pseudogene paralog' subset characterized by lower GC content and higher intron length/number (p<0.001). These subsets are functionally distinguishable, with the former gene group characterized by higher expression levels and lower evolutionary rate (p<0.001). PCI-negative (PCI-) genes exhibit higher evolutionary rate and narrower expression breadth than PCI+ genes (p<0.001), consistent with more frequent tissue-specific inactivation. Conclusions. Adaptive evolution of the human genome appears driven in part by declining transcription of a subset of PCI+ genes, predisposing to both CpG -> RTpA mutation and intron insertion. We propose a model of evolving biological complexity in which environmentally-selected gains or losses of PCI methylation respectively favor positive or negative selection, thus polarizing PCI+ gene structures around a genomic core of ancestral PCI-genes.	[Tang, Clara S. M.; Epstein, Richard J.] Univ Hong Kong, Dept Med, Lab Computat Oncol, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong	Epstein, RJ (corresponding author), Univ Hong Kong, Dept Med, Lab Computat Oncol, Pokfulam, Hong Kong, Peoples R China.	repstein@hku.hk		Tang, Clara/0000-0003-0265-2638				Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; BEUTLER E, 1989, P NATL ACAD SCI USA, V86, P192, DOI 10.1073/pnas.86.1.192; Brun ME, 2003, GENE, V312, P41, DOI 10.1016/S0378-1119(03)00530-4; Caiafa P, 2005, J CELL BIOCHEM, V94, P257, DOI 10.1002/jcb.20325; Copley RR, 2003, CURR OPIN GENET DEV, V13, P623, DOI 10.1016/j.gde.2003.10.004; Dimitri P, 2003, MOL BIOL EVOL, V20, P503, DOI 10.1093/molbev/msg048; Epstein RJ, 2000, GENE, V245, P291, DOI 10.1016/S0378-1119(00)00042-1; Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100; Frankham R, 2005, J EVOLUTION BIOL, V18, P750, DOI 10.1111/j.1420-9101.2005.00885.x; Horvath JE, 2001, HUM MOL GENET, V10, P2215, DOI 10.1093/hmg/10.20.2215; Jabbari K, 2004, GENE, V333, P143, DOI 10.1016/j.gene.2004.02.043; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Kurek R, 2000, GENETICA, V109, P113, DOI 10.1023/A:1026552604229; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Lin K, 2003, J MOL EVOL, V57, P538, DOI 10.1007/s00239-003-2507-5; Lynch Michael, 2003, Journal of Structural and Functional Genomics, V3, P35, DOI 10.1023/A:1022696612931; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; Meza TJ, 2002, TRANSGENIC RES, V11, P133, DOI 10.1023/A:1015244400941; Nguyen CT, 2001, NUCLEIC ACIDS RES, V29, P4598, DOI 10.1093/nar/29.22.4598; Philippe H, 2003, IUBMB LIFE, V55, P257, DOI 10.1080/1521654031000123330; Reams AB, 2004, ANNU REV MICROBIOL, V58, P119, DOI 10.1146/annurev.micro.58.030603.123806; Rogers SL, 2006, J IMMUNOL, V177, P414, DOI 10.4049/jimmunol.177.1.414; Smith NGC, 1998, GENETICS, V150, P823; TANG CS, 2006, GENOMICS; Vinogradov AE, 2005, TRENDS GENET, V21, P639, DOI 10.1016/j.tig.2005.09.002; VINOGRADOV AE, 2006, NUCL ACIDS RES; Wagner A, 2005, FEBS LETT, V579, P1772, DOI 10.1016/j.febslet.2005.01.063; WOLF SF, 1985, NATURE, V314, P467, DOI 10.1038/314467a0; Yoshikawa T, 2006, BIOL PHARM BULL, V29, P105, DOI 10.1248/bpb.29.105; Yusa K, 2004, MOL CELL BIOL, V24, P4004, DOI 10.1128/MCB.24.9.4004-4018.2004	30	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2007	2	7							e603	10.1371/journal.pone.0000603	http://dx.doi.org/10.1371/journal.pone.0000603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GH	17622348	Green Published, gold, Green Submitted			2022-12-27	WOS:000207452000010
J	Drew, LJ; Rugiero, F; Cesare, P; Gale, JE; Abrahamsen, B; Bowden, S; Heinzmann, S; Robinson, M; Brust, A; Colless, B; Lewis, RJ; Wood, JN				Drew, Liam J.; Rugiero, Francois; Cesare, Paolo; Gale, Jonathan E.; Abrahamsen, Bjarke; Bowden, Sarah; Heinzmann, Sebastian; Robinson, Michelle; Brust, Andreas; Colless, Barbara; Lewis, Richard J.; Wood, John N.			High-Threshold Mechanosensitive Ion Channels Blocked by a Novel Conopeptide Mediate Pressure-Evoked Pain	PLOS ONE			English	Article								Little is known about the molecular basis of somatosensory mechanotransduction in mammals. We screened a library of peptide toxins for effects on mechanically activated currents in cultured dorsal root ganglion neurons. One conopeptide analogue, termed NMB-1 for noxious mechanosensation blocker 1, selectively inhibits (IC50 1 mu M) sustained mechanically activated currents in a subset of sensory neurons. Biotinylated NMB-1 retains activity and binds selectively to peripherin-positive nociceptive sensory neurons. The selectivity of NMB-1 was confirmed by the fact that it has no inhibitory effects on voltage-gated sodium and calcium channels, or ligand-gated channels such as acid-sensing ion channels or TRPA1 channels. Conversely, the tarantula toxin, GsMTx-4, which inhibits stretch-activated ion channels, had no effects on mechanically activated currents in sensory neurons. In behavioral assays, NMB-1 inhibits responses only to high intensity, painful mechanical stimulation and has no effects on low intensity mechanical stimulation or thermosensation. Unexpectedly, NMB-1 was found to also be an inhibitor of rapid FM1-43 loading (a measure of mechanotransduction) in cochlear hair cells. These data demonstrate that pharmacologically distinct channels respond to distinct types of mechanical stimuli and suggest that mechanically activated sustained currents underlie noxious mechanosensation. NMB-1 thus provides a novel diagnostic tool for the molecular definition of channels involved in hearing and pressure-evoked pain.	[Drew, Liam J.; Rugiero, Francois; Abrahamsen, Bjarke; Heinzmann, Sebastian; Robinson, Michelle; Wood, John N.] UCL, Dept Biol, London, England; [Gale, Jonathan E.] UCL, Ear Inst, Ctr Auditory Res, London, England; [Brust, Andreas; Colless, Barbara; Lewis, Richard J.] Xenome Ltd, Indooroopilly, Qld, Australia; [Lewis, Richard J.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Lewis, Richard J.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Cesare, Paolo] Fdn Santa Lucia, Ctr Europeo Ric Cervello, Rome, Italy; [Bowden, Sarah] Ionix Pharmaceut Ltd, Cambridge, England	University of London; University College London; University of London; University College London; University of Queensland; University of Queensland; IRCCS Santa Lucia	Wood, JN (corresponding author), UCL, Dept Biol, London, England.	j.wood@ucl.ac.uk	Gale, Jonathan/AAG-6874-2019; Lewis, Richard J/E-8674-2013; Abrahamsen, Bjarke/ABD-5874-2020; Lewis, Richard/T-8763-2019	Lewis, Richard J/0000-0003-3470-923X; Lewis, Richard/0000-0003-3470-923X; Brust, Andreas/0000-0003-4238-5706; Gale, Jonathan/0000-0003-4678-4878; Abrahamsen, Bjarke/0000-0002-6128-8269; Cesare, Paolo/0000-0003-1324-5974	MRC; Wellcome Trust; MRC [G9717869] Funding Source: UKRI; Medical Research Council [G9717869] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful for the support of The MRC and The in funding this work. We thank Ramin Raouf for help with toxin binding experiments.	Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bode F, 2001, NATURE, V409, P35, DOI 10.1038/35051165; Cho HW, 2002, J NEUROSCI, V22, P1238, DOI 10.1523/JNEUROSCI.22-04-01238.2002; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Drew LJ, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-1; Drew LJ, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-8; Drew LJ, 2004, J PHYSIOL-LONDON, V556, P691, DOI 10.1113/jphysiol.2003.058693; Drew LJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-12-j0001.2002; Ernstrom GG, 2002, ANNU REV GENET, V36, P411, DOI 10.1146/annurev.genet.36.061802.101708; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Gottlieb P, 2006, BIOPHYS J, V90, P1545; Gottlieb P. A., 2004, CURRENT DRUG TARGETS, V3, P61; Hamill OP, 1996, PHARMACOL REV, V48, P231; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; HUSMARK I, 1971, J PHYSIOL-LONDON, V218, P257, DOI 10.1113/jphysiol.1971.sp009616; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lewin G.R., 2000, MOL BASIS PAIN INDUC, P129; Liedtke W, 2005, CELL MOL LIFE SCI, V62, P2985, DOI 10.1007/s00018-005-5181-5; Lin SY, 2005, CURR OPIN NEUROBIOL, V15, P350, DOI 10.1016/j.conb.2005.05.012; LOEWENSTEIN WR, 1966, J PHYSIOL-LONDON, V182, P346, DOI 10.1113/jphysiol.1966.sp007827; MARCOTTI W, 2001, INT J AUDIOL, V41, P231; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; McCarter GC, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-28; Meyers JR, 2003, J NEUROSCI, V23, P4054; NAGY JI, 1983, J NEUROSCI, V3, P1145; SAUMET JL, 1982, PHARMACOL BIOCHEM BE, V16, P241, DOI 10.1016/0091-3057(82)90155-1; Sharpe IA, 2001, NAT NEUROSCI, V4, P902, DOI 10.1038/nn0901-902; SHIR Y, 1990, NEUROSCI LETT, V115, P62, DOI 10.1016/0304-3940(90)90518-E; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P16586, DOI 10.1073/pnas.0606894103; Strassmaier M, 2002, CURR OPIN NEUROBIOL, V12, P380, DOI 10.1016/S0959-4388(02)00344-6; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583	33	56	59	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2007	2	6							e515	10.1371/journal.pone.0000515	http://dx.doi.org/10.1371/journal.pone.0000515			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GD	17565368	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451600003
J	Sumilo, D; Asokliene, L; Bormane, A; Vasilenko, V; Golovljova, I; Randolph, SE				Sumilo, Dana; Asokliene, Loreta; Bormane, Antra; Vasilenko, Veera; Golovljova, Irina; Randolph, Sarah E.			Climate Change Cannot Explain the Upsurge of Tick-Borne Encephalitis in the Baltics	PLOS ONE			English	Article							IXODES-RICINUS ACARI; LYME BORRELIOSIS; TEMPERATURE; FOCI	Background. Pathogens transmitted by ticks cause human disease on a greater scale than any other vector-borne infections in Europe, and have increased dramatically over the past 2-3 decades. Reliable records of tick-borne encephalitis (TBE) since 1970 show an especially sharp upsurge in cases in Eastern Europe coincident with the end of Soviet rule, including the three Baltic countries, Estonia, Latvia and Lithuania, where national incidence increased from 1992 to 1993 by 64, 175 and 1,065%, respectively. At the county level within each country, however, the timing and degree of increase showed marked heterogeneity. Climate has also changed over this period, prompting an almost universal assumption of causality. For the first time, we analyse climate and TBE epidemiology at sufficiently fine spatial and temporal resolution to question this assumption. Methodology/Principal Finding. Detailed analysis of instrumental records of climate has revealed a significant step increase in spring-time daily maximum temperatures in 1989. The seasonal timing and precise level of this warming were indeed such as could promote the transmission of TBE virus between larval and nymphal ticks co-feeding on rodents. These changes in climate, however, are virtually uniform across the Baltic region and cannot therefore explain the marked spatio-temporal heterogeneity in TBE epidemiology. Conclusions/Significance. Instead, it is proposed that climate is just one of many different types of factors, many arising from the socio-economic transition associated with the end of Soviet rule, that have acted synergistically to increase both the abundance of infected ticks and the exposure of humans to these ticks. Understanding the precise differential contribution of each factor as a cause of the observed epidemiological heterogeneity will help direct control strategies.	[Sumilo, Dana; Randolph, Sarah E.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Asokliene, Loreta] Ctr Communicable Dis Prevent & Control, Vilnius, Lithuania; [Bormane, Antra] State Agcy Publ Hlth Agcy, Riga, Latvia; [Vasilenko, Veera; Golovljova, Irina] Natl Inst Hlth Dev, Tallinn, Estonia	University of Oxford; Centre for Communicable Diseases & AIDS (ULAC) - Lithuania; National Institute for Health Development - Estonia	Randolph, SE (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	sarah.randolph@zoo.ox.ac.uk	Randolph, Sarah/AAR-9346-2021		Wellcome Trust [070696/Z/03/Z)]; Estonian Science Foundation [5963]; EU [GOCE-2003-010284]	Wellcome Trust(Wellcome TrustEuropean Commission); Estonian Science Foundation; EU(European Commission)	This study was funded principally by the Wellcome Trust (grant no. 070696/Z/03/Z) and also by the Estonian Science Foundation (grant 5963) and EU grant GOCE-2003-010284 EDEN; it is catalogued by the EDEN Steering Committee as EDEN41 (http://www.eden-fp6project.net/). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission.	Daniel M, 2003, EUR J CLIN MICROBIOL, V22, P327, DOI 10.1007/s10096-003-0918-2; Daniel M., 2006, CLIMATE CHANGE ADAPT, P189; Dautel H, 1997, J INSECT PHYSIOL, V43, P843, DOI 10.1016/S0022-1910(97)00025-5; Davis J.C., 1986, STAT DATA ANAL GEOLO; Epstein PR, 2005, NEW ENGL J MED, V353, P1433, DOI 10.1056/NEJMp058079; Epstein PR, 2001, J URBAN HEALTH, V78, P367, DOI 10.1093/jurban/78.2.367; Gleason ACR, 2002, REMOTE SENS ENVIRON, V79, P147, DOI 10.1016/S0034-4257(01)00269-3; Hossell J, 2006, HDB CLIMATE TRENDS S; Houghton J. T., 2001, CLIMATE CHANGE 2001; Labuda M, 1999, ZBL BAKT-INT J MED M, V289, P513; Lindgren E, 2001, LANCET, V358, P16, DOI 10.1016/S0140-6736(00)05250-8; MacLEOD JOHN, 1935, PARASITOLOGY, V27, P123, DOI 10.1017/S0031182000015006; Menne Bettina, 2006, P1; Patz JA, 2002, P NATL ACAD SCI USA, V99, P12506, DOI 10.1073/pnas.212467899; Perret JL, 2000, PARASITOL RES, V86, P554, DOI 10.1007/s004360000209; Randolph S, 2006, INT J MED MICROBIOL, V296, P84, DOI 10.1016/j.ijmm.2005.12.008; Randolph SE, 2002, INT J PARASITOL, V32, P979, DOI 10.1016/S0020-7519(02)00030-9; Randolph SE, 2001, PHILOS T R SOC B, V356, P1045, DOI 10.1098/rstb.2001.0893; Randolph SE, 2004, PARASITOLOGY, V129, pS37, DOI 10.1017/S0031182004004925; Randolph SE, 2000, PARASITOLOGY, V121, P15, DOI 10.1017/S0031182099006083; REUTERSWARD A, 2003, LABOUR MARKETS SOCIA; Sharma S, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004331; *SKDS MARK PUBL OP, 2001, INV FACT HIND IMM PO; SUMILO D, 2007, EMERG INFEC IN PRESS; Sumilo D, 2006, INT J MED MICROBIOL, V296, P76, DOI 10.1016/j.ijmm.2005.12.006; Suss J, 2003, VACCINE, V21, pS19, DOI 10.1016/S0264-410X(02)00812-5; Suss J, 2002, INT J MED MICROBIOL, V291, P34; Talleklint L, 1998, J MED ENTOMOL, V35, P521, DOI 10.1093/jmedent/35.4.521; WHO, 2003, CLIM CHANG HUM HLTH; Wild M, 2005, SCIENCE, V308, P847, DOI 10.1126/science.1103215	30	111	117	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e500	10.1371/journal.pone.0000500	http://dx.doi.org/10.1371/journal.pone.0000500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551580	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451500009
J	Tchurikov, NA; Kretova, OV				Tchurikov, Nickolai A.; Kretova, Olga V.			Suffix-specific RNAi Leads to Silencing of F Element in Drosophila melanogaster	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; 3 ENDS; TRANSCRIPTION; INTERFERENCE; EXPRESSION; EVOLUTION; SEQUENCE; ORIGIN; FAMILY; GENE	Separate conserved copies of suffix, a short interspersed Drosophila retroelement (SINE), and also divergent copies in the 3' untranslated regions of the three genes, have already been described. Suffix has also been identified on the 3' end of the Drosophila non-LTR F element, where it forms the last conserved domain of the reverse transcriptase (RT). In our current study, we show that the separate copies of suffix are far more actively transcribed than their counterparts on the F element. Transcripts from both strands of suffix are present in RNA preparations during all stages of Drosophila development, providing the potential for the formation of double-stranded RNA and the initiation of RNA interference (RNAi). Using in situ RNA hybridization analysis, we have detected the expression of both sense and antisense suffix transcripts in germinal cells. These sense and antisense transcripts are colocalized in the primary spermatocytes and in the cytoplasm of the nurse cells, suggesting that they form double-stranded RNA. We performed further analyses of suffix-specific small RNAs using northern blotting and SI nuclease protection assays. Among the total RNA preparations isolated from embryos, larvae, pupae and flies, suffix-specific small interfering RNAs (siRNAs) were detected only in pupae. In wild type ovaries, both the siRNAs and longer suffix-specific Piwi-interacting RNAs (piRNAs) were observed, whereas in ovaries of the Dicer-2 mutant, only piRNAs were detected. We further found by 3' RACE that in pupae and ovaries, F element transcripts lacking the suffix sequence are also present. Our data provide direct evidence that suffix-specific RNAi leads to the silencing of the relative LINE (long interspersed element), F element, and suggests that SINE-specific RNA interference could potentially downregulate a set of genes possessing SINE stretches in their 5' or 3' non-coding regions. These data also suggest that double stranded RNAs possessing suffix are processed by both RNAi and an additional silencing mechanism.	[Tchurikov, Nickolai A.; Kretova, Olga V.] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS	Tchurikov, NA (corresponding author), Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow, Russia.	tchurikov@eimb.ru	Tchurikov, Nickolai A./R-4850-2016		Russian Academy of Sciences; Russian Ministry of Education and Science [02.512.11.2066]; Russian Foundation for Basic Research [05-04-48256-?]	Russian Academy of Sciences(Russian Academy of Sciences); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by grants from the Molecular and Cellular Biology Program of the Russian Academy of Sciences, Russian Ministry of Education and Science, 02.512.11.2066 and Russian Foundation for Basic Research, 05-04-48256-?.	Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; DINOCERA PP, 1987, P NATL ACAD SCI USA, V84, P5843; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fuller Margaret T., 1993, P71; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Kerber B, 1996, MOL CELL BIOL, V16, P2998; Kretova O. V., 2002, Genetika, V38, P1090; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li TH, 2001, GENE, V276, P135, DOI 10.1016/S0378-1119(01)00637-0; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; MATERA AG, 1990, MOL CELL BIOL, V10, P5424, DOI 10.1128/MCB.10.10.5424; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; MINCHIOTTI G, 1994, MOL GEN GENET, V245, P152, DOI 10.1007/BF00283262; Nikaido M, 1999, P NATL ACAD SCI USA, V96, P10261, DOI 10.1073/pnas.96.18.10261; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Ohshima K, 1996, MOL CELL BIOL, V16, P3756; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Rubin CM, 2002, NUCLEIC ACIDS RES, V30, P3253, DOI 10.1093/nar/gkf419; Schmid CW, 1996, PROG NUCLEIC ACID RE, V53, P283, DOI 10.1016/S0079-6603(08)60148-8; Shiu PKT, 2002, GENETICS, V161, P1483; Siol O, 2006, MOL CELL BIOL, V26, P8242, DOI 10.1128/MCB.01348-06; TCHURIKOV NA, 1986, EMBO J, V5, P2341, DOI 10.1002/j.1460-2075.1986.tb04502.x; TCHURIKOV NA, 1982, CELL, V28, P365, DOI 10.1016/0092-8674(82)90354-3; TCHURIKOV NA, 1996, TSITOL GENET+, V30, P14; TCHURIKOV NA, 1998, DOKL AKAD NAUK, V360, P124; Tuschl T, 2003, NATURE, V421, P220, DOI 10.1038/421220a; ULLU E, 1985, NATURE, V318, P371, DOI 10.1038/318371a0; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Weiner AM, 2002, CURR OPIN CELL BIOL, V14, P343, DOI 10.1016/S0955-0674(02)00338-1; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	34	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2007	2	5							e476	10.1371/journal.pone.0000476	http://dx.doi.org/10.1371/journal.pone.0000476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10FB	17534426	Green Published, gold, Green Submitted			2022-12-27	WOS:000207448800006
J	Zhang, YHP; Evans, BR; Mielenz, JR; Hopkins, RC; Adams, MWW				Zhang, Y. -H. Percival; Evans, Barbara R.; Mielenz, Jonathan R.; Hopkins, Robert C.; Adams, Michael W. W.			High-Yield Hydrogen Production from Starch and Water by a Synthetic Enzymatic Pathway	PLOS ONE			English	Article								Background. The future hydrogen economy offers a compelling energy vision, but there are four main obstacles: hydrogen production, storage, and distribution, as well as fuel cells. Hydrogen production from inexpensive abundant renewable biomass can produce cheaper hydrogen, decrease reliance on fossil fuels, and achieve zero net greenhouse gas emissions, but current chemical and biological means suffer from low hydrogen yields and/or severe reaction conditions. Methodology/Principal Findings. Here we demonstrate a synthetic enzymatic pathway consisting of 13 enzymes for producing hydrogen from starch and water. The stoichiometric reaction is C(6)H(10)O(5) (l)+7 H(2)O (l)-> 12 H(2) (g)+ 6 CO(2) (g). The overall process is spontaneous and unidirectional because of a negative Gibbs free energy and separation of the gaseous products with the aqueous reactants. Conclusions. Enzymatic hydrogen production from starch and water mediated by 13 enzymes occurred at 30 degrees C as expected, and the hydrogen yields were much higher than the theoretical limit (4 H(2)/glucose) of anaerobic fermentations. Significance. The unique features, such as mild reaction conditions (30 degrees C and atmospheric pressure), high hydrogen yields, likely low production costs ($similar to 2/kg H(2)), and a high energy-density carrier starch (14.8 H(2)-based mass%), provide great potential for mobile applications. With technology improvements and integration with fuel cells, this technology also solves the challenges associated with hydrogen storage, distribution, and infrastructure in the hydrogen economy.	[Zhang, Y. -H. Percival] Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA 24061 USA; [Evans, Barbara R.] Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN USA; [Mielenz, Jonathan R.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Hopkins, Robert C.; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University System of Georgia; University of Georgia	Zhang, YHP (corresponding author), Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA 24061 USA.	ypzhang@vt.edu		Adams, Michael/0000-0002-9796-5014	Southeastern Sun Grant Center, USDA-CSREES [2006-38909-03484]; Oak Ridge Associated Universities; Oak Ridge National Laboratory; Department of Energy [DE-FG02-05ER15710, DE-AC05-00OR22725, FWP CEEB06]; U.S. Department of Energy Office of Energy Efficiency and Renewable Energy	Southeastern Sun Grant Center, USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Oak Ridge Associated Universities; Oak Ridge National Laboratory(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE))	We are grateful for financial support from the Southeastern Sun Grant Center, USDA-CSREES (2006-38909-03484), and Oak Ridge Associated Universities to YHPZ. JRM was supported by Oak Ridge National Laboratory. RCH and MWWA were supported by a grant (DE-FG02-05ER15710) from the Department of Energy under contract DE-AC05-00OR22725. Previous research at Oak Ridge National Laboratory was funded by the U.S. Department of Energy Office of Energy Efficiency and Renewable Energy under FWP CEEB06. Oak Ridge National Laboratory is managed by UT-Battelle, LLC, for the U.S. Department of Energy under contract DE-AC05-00OR22725.	Adams MWW, 1998, SCIENCE, V282, P1842, DOI 10.1126/science.282.5395.1842; Allain EJ, 2007, J CHEM TECHNOL BIOT, V82, P117, DOI 10.1002/jctb.1649; Antal MJ, 2000, IND ENG CHEM RES, V39, P4040, DOI 10.1021/ie0003436; Atkins PW, 2005, ELEMENTS PHYS CHEM, P605; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; Berg J.M., 2002, BIOCHEMISTRY-US, P380; Blennow A, 2002, TRENDS PLANT SCI, V7, P445, DOI 10.1016/S1360-1385(02)02332-4; Cortright RD, 2002, NATURE, V418, P964, DOI 10.1038/nature01009; Das D, 2001, INT J HYDROGEN ENERG, V26, P13, DOI 10.1016/S0360-3199(00)00058-6; Deluga GA, 2004, SCIENCE, V303, P993, DOI 10.1126/science.1093045; *DOE, 2004, BAS RES NEEDS HYDR E; Donahue JL, 2000, J BACTERIOL, V182, P5624, DOI 10.1128/JB.182.19.5624-5627.2000; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Hallenbeck PC, 2002, INT J HYDROGEN ENERG, V27, P1185, DOI 10.1016/S0360-3199(02)00131-3; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; Huber GW, 2003, SCIENCE, V300, P2075, DOI 10.1126/science.1085597; Jung GY, 2004, SCIENCE, V304, P428, DOI 10.1126/science.1096920; Lynd LR, 1999, BIOTECHNOL PROGR, V15, P777, DOI 10.1021/bp990109e; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; MA K, 1993, P NATL ACAD SCI USA, V90, P5341, DOI 10.1073/pnas.90.11.5341; MA KS, 1994, FEMS MICROBIOL LETT, V122, P245, DOI 10.1016/0378-1097(94)00330-0; Matsumura Y, 2005, BIOMASS BIOENERG, V29, P269, DOI 10.1016/j.biombioe.2005.04.006; Millsaps JF, 2001, PHOTOCHEM PHOTOBIOL, V73, P630, DOI 10.1562/0031-8655(2001)073<0630:NPPPOH>2.0.CO;2; Moore RB, 1998, INT J HYDROGEN ENERG, V23, P617, DOI 10.1016/S0360-3199(97)00061-X; Morris D, 2006, J SCI FOOD AGR, V86, P1743, DOI 10.1002/jsfa.2561; MUIR M, 1985, J BACTERIOL, V163, P1237, DOI 10.1128/JB.163.3.1237-1242.1985; Ohno A, 2000, J ORG CHEM, V65, P6381, DOI 10.1021/jo000262j; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Ramos A, 1997, APPL ENVIRON MICROB, V63, P4020, DOI 10.1128/AEM.63.10.4020-4025.1997; Salge JR, 2006, SCIENCE, V314, P801, DOI 10.1126/science.1131244; Schlapbach L, 2001, NATURE, V414, P353, DOI 10.1038/35104634; SMIL V, 1999, ENERGIES ILLUSTRATED, P1; Steele BCH, 2001, NATURE, V414, P345, DOI 10.1038/35104620; Stephanopoulos G., 1998, METAB ENG; *US DEP EN HYDR PR, 2005, DOE ANN NEW HYDR COS; Wheals AE, 1999, TRENDS BIOTECHNOL, V17, P482, DOI 10.1016/S0167-7799(99)01384-0; Woodward J, 2000, NATURE, V405, P1014, DOI 10.1038/35016633; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003; Zhang YHP, 2005, P NATL ACAD SCI USA, V102, P7321, DOI 10.1073/pnas.0408734102; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282; Zhang YHP, 2004, APPL ENVIRON MICROB, V70, P1563, DOI 10.1128/AEM.70.3.1563-1569.2004	43	202	223	3	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2007	2	5							e456	10.1371/journal.pone.0000456	http://dx.doi.org/10.1371/journal.pone.0000456			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DZ	17520015	Green Published, gold			2022-12-27	WOS:000207446000004
J	Janniere, L; Canceill, D; Suski, C; Kanga, S; Dalmais, B; Lestini, R; Monnier, AF; Chapuis, J; Bolotin, A; Marina, T; Le Chatelier, E; Ehrlich, SD				Janniere, Laurent; Canceill, Danielle; Suski, Catherine; Kanga, Sophie; Dalmais, Berengere; Lestini, Roxane; Monnier, Anne-Francoise; Chapuis, Jerome; Bolotin, Alexander; Marina, Titok; Le Chatelier, Emmanuelle; Ehrlich, S. Dusko			Genetic Evidence for a Link Between Glycolysis and DNA Replication	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACILLUS-SUBTILIS; INITIATION FREQUENCY; STRINGENT RESPONSE; CELL-DIVISION; PROTEIN; TRANSCRIPTION; COMPLEX; CHROMOSOME; MUTANTS	Background. A challenging goal in biology is to understand how the principal cellular functions are integrated so that cells achieve viability and optimal fitness in a wide range of nutritional conditions. Methodology/Principal Findings. We report here a tight link between glycolysis and DNA synthesis. The link, discovered during an analysis of suppressors of thermosensitive replication mutants in bacterium Bacillus subtilis, is very strong as some metabolic alterations fully restore viability to replication mutants in which a lethal arrest of DNA synthesis otherwise occurs at a high, restrictive, temperature. Full restoration of viability by such alterations was limited to cells with mutations in three elongation factors ( the lagging strand DnaE polymerase, the primase and the helicase) out of a large set of thermosensitive mutants affected in most of the replication proteins. Restoration of viability resulted, at least in part, from maintenance of replication protein activity at high temperature. Physiological studies suggested that this restoration depended on the activity of the three-carbon part of the glycolysis/gluconeogenesis pathway and occurred in both glycolytic and gluconeogenic regimens. Restoration took place abruptly over a narrow range of expression of genes in the three-carbon part of glycolysis. However, the absolute value of this range varied greatly with the allele in question. Finally, restoration of cell viability did not appear to be the result of a decrease in growth rate or an induction of major stress responses. Conclusions/Significance. Our findings provide the first evidence for a genetic system that connects DNA chain elongation to glycolysis. Its role may be to modulate some aspect of DNA synthesis in response to the energy provided by the environment and the underlying mechanism is discussed. It is proposed that related systems are ubiquitous.	[Janniere, Laurent; Canceill, Danielle; Suski, Catherine; Kanga, Sophie; Dalmais, Berengere; Lestini, Roxane; Monnier, Anne-Francoise; Chapuis, Jerome; Bolotin, Alexander; Marina, Titok; Le Chatelier, Emmanuelle; Ehrlich, S. Dusko] INRA, Lab Genet Microbienne, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Janniere, L (corresponding author), INRA, Lab Genet Microbienne, Jouy En Josas, France.	laurent.janniere@jouy.inra.fr	LE CHATELIER, Emmanuelle/O-1243-2017; Lestini, Roxane/R-9285-2017; Ehrlich, S./Y-2423-2019; Bolotine, Alexandre/AAW-1156-2020	LE CHATELIER, Emmanuelle/0000-0002-2724-0536; Lestini, Roxane/0000-0001-7377-4734; Ehrlich, S./0000-0002-7563-4046; Bolotine, Alexandre/0000-0002-5878-8270; Titok, Marina/0000-0002-8623-5083; Suski Grabowski, Catherine/0000-0002-4892-6633; Janniere, Laurent/0000-0003-2353-3160				Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blinkova A, 2003, J BACTERIOL, V185, P3583, DOI 10.1128/JB.185.12.3583-3595.2003; BOYLAN SA, 1993, J BACTERIOL, V175, P7931, DOI 10.1128/JB.175.24.7931-7937.1993; Bruck I, 2000, J BIOL CHEM, V275, P28971, DOI 10.1074/jbc.M003565200; BUCHER T, 1955, METHOD ENZYMOL, V1, P435, DOI 10.1016/0076-6879(55)01071-9; Canback B, 2002, P NATL ACAD SCI USA, V99, P6097, DOI 10.1073/pnas.082112499; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Chang VK, 2004, MOL CELL BIOL, V24, P6514, DOI 10.1128/MCB.24.14.6514-6524.2004; Chang VK, 2003, J BIOL CHEM, V278, P6093, DOI 10.1074/jbc.M209827200; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; CHEN YR, 1995, MOL CELL BIOL, V15, P4631; Cho YH, 2006, CELL, V127, P579, DOI 10.1016/j.cell.2006.09.028; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Dauner M, 2001, J BACTERIOL, V183, P7308, DOI 10.1128/JB.183.24.7308-7317.2001; Dervyn E, 2001, SCIENCE, V294, P1716, DOI 10.1126/science.1066351; Doan T, 2003, MOL MICROBIOL, V47, P1709, DOI 10.1046/j.1365-2958.2003.03404.x; Erbse A, 2004, BIOCHEM SOC T, V32, P617, DOI 10.1042/BST0320617; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; Fillinger S, 2000, J BIOL CHEM, V275, P14031, DOI 10.1074/jbc.275.19.14031; Fitch MJ, 2003, J BIOL CHEM, V278, P25408, DOI 10.1074/jbc.M300699200; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; FOTHERGILLGILMORE LA, 1993, PROG BIOPHYS MOL BIO, V59, P105, DOI 10.1016/0079-6107(93)90001-Z; Foti JJ, 2005, MOL CELL, V17, P549, DOI 10.1016/j.molcel.2005.01.012; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Giraldo R, 2003, FEMS MICROBIOL REV, V26, P533, DOI 10.1111/j.1574-6976.2003.tb00629.x; Gon S, 2006, EMBO J, V25, P1137, DOI 10.1038/sj.emboj.7600990; Guzman EC, 2002, MOL MICROBIOL, V43, P487, DOI 10.1046/j.1365-2958.2002.02761.x; Hardy CD, 2005, MOL MICROBIOL, V57, P1636, DOI 10.1111/j.1365-2958.2005.04799.x; Hartl B, 2001, J BACTERIOL, V183, P2696, DOI 10.1128/JB.183.8.2696-2699.2001; HARWOOD CR, MOL BIOL METHODS BAC; HELMSTETTER CE, 1996, ESCHERICHIA COLI SAL, P1627; HENSON JM, 1979, GENETICS, V92, P1041; JINDAL HK, 1990, J BIOL CHEM, V265, P6540; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Katayama T, 2001, MOL MICROBIOL, V41, P9, DOI 10.1046/j.1365-2958.2001.02483.x; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Laschet JJ, 2004, J NEUROSCI, V24, P7614, DOI 10.1523/JNEUROSCI.0868-04.2004; Lay AJ, 2000, NATURE, V408, P869, DOI 10.1038/35048596; Le Chatelier E, 2004, J BIOL CHEM, V279, P1757, DOI 10.1074/jbc.M310719200; LEVINE A, 1991, J MOL BIOL, V219, P605, DOI 10.1016/0022-2836(91)90657-R; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; MAHER M, 1995, MOL CELL BIOL, V15, P3129; Mai B, 2002, MOL CELL BIOL, V22, P430, DOI 10.1128/MCB.22.2.430-441.2002; MAINE GT, 1984, GENETICS, V106, P365; MATHEWS CK, 1993, PROG NUCLEIC ACID RE, V44, P167, DOI 10.1016/S0079-6603(08)60220-2; McHenry CS, 2003, MOL MICROBIOL, V49, P1157, DOI 10.1046/j.1365-2958.2003.03645.x; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Michelsen O, 2003, MICROBIOL-SGM, V149, P1001, DOI 10.1099/mic.0.26058-0; Mijakovic I, 2006, NUCLEIC ACIDS RES, V34, P1588, DOI 10.1093/nar/gkj514; Molina F, 2004, MOL MICROBIOL, V52, P1597, DOI 10.1111/j.1365-2958.2004.04097.x; Moreno MS, 2001, MOL MICROBIOL, V39, P1366, DOI 10.1046/j.1365-2958.2001.02328.x; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; Norris V, 2007, MICROBIOL MOL BIOL R, V71, P230, DOI 10.1128/MMBR.00035-06; Ortenberg R, 2004, P NATL ACAD SCI USA, V101, P7439, DOI 10.1073/pnas.0401965101; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Peter BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r87; Petersen C, 2000, J BIOL CHEM, V275, P3931, DOI 10.1074/jbc.275.6.3931; PETIT MA, 1990, J BACTERIOL, V172, P6736, DOI 10.1128/jb.172.12.6736-6740.1990; Petit MA, 1998, MOL MICROBIOL, V29, P261, DOI 10.1046/j.1365-2958.1998.00927.x; Popanda O, 1998, BBA-GENE STRUCT EXPR, V1397, P102, DOI 10.1016/S0167-4781(97)00229-7; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; REEVE JN, 1970, J BACTERIOL, V104, P1052, DOI 10.1128/JB.104.3.1052-1064.1970; RICARD M, 1973, J BACTERIOL, V116, P314, DOI 10.1128/JB.116.1.314-322.1973; Riedinger HJ, 2001, J BIOL CHEM, V276, P47122, DOI 10.1074/jbc.M106938200; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; Schneider DA, 2004, J BIOL CHEM, V279, P8262, DOI 10.1074/jbc.M311996200; SCHREIBER G, 1995, CURR MICROBIOL, V30, P27, DOI 10.1007/BF00294520; SCHUMANN W, FUNCTIONAL ANAL BACT; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Skovgaard O, 2005, MICROBIOL-SGM, V151, P963, DOI 10.1099/mic.0.27630-0; Sutera VA, 2006, MOL MICROBIOL, V60, P229, DOI 10.1111/j.1365-2958.2006.05093.x; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Titok M, 2006, MICROBIOL-SGM, V152, P1471, DOI 10.1099/mic.0.28693-0; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Tuominen F W, 1975, Methods Enzymol, V42, P157; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Velten M, 2003, MOL CELL, V11, P1009, DOI 10.1016/S1097-2765(03)00130-8; WALKER JR, 1982, P NATL ACAD SCI-BIOL, V79, P3340, DOI 10.1073/pnas.79.10.3340; Walker JR, 2006, BIOCHIMIE, V88, P1, DOI 10.1016/j.biochi.2005.08.009; Wegrzyn G, 2002, MICROB CELL FACT, V1, DOI 10.1186/1475-2859-1-2; Westers H, 2003, MOL BIOL EVOL, V20, P2076, DOI 10.1093/molbev/msg219; Yao DC, 2006, CELL, V124, P275, DOI 10.1016/j.cell.2005.11.024; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x; Zhang SY, 2005, J BACTERIOL, V187, P7554, DOI 10.1128/JB.187.22.7554-7560.2005; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X; ZYSKIND JW, 1992, CELL, V69, P5, DOI 10.1016/0092-8674(92)90112-P	96	56	57	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2007	2	5							e447	10.1371/journal.pone.0000447	http://dx.doi.org/10.1371/journal.pone.0000447			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DY	17505547	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445900007
J	Beadell, JS; Atkins, C; Cashion, E; Jonker, M; Fleischer, RC				Beadell, Jon S.; Atkins, Colm; Cashion, Erin; Jonker, Michelle; Fleischer, Robert C.			Immunological Change in a Parasite-Impoverished Environment: Divergent Signals from Four Island Taxa	PLOS ONE			English	Article							GENETIC-VARIATION; AVIAN MALARIA; MICROSATELLITE LOCI; REPRODUCTIVE EFFORT; IMMUNE-RESPONSE; INFECTIOUS-DISEASES; NATURAL ANTIBODIES; FOUNDER EVENTS; HOUSE SPARROWS; TRADE-OFFS	Dramatic declines of native Hawaiian avifauna due to the human-mediated emergence of avian malaria and pox prompted an examination of whether island taxa share a common altered immunological signature, potentially driven by reduced genetic diversity and reduced exposure to parasites. We tested this hypothesis by characterizing parasite prevalence, genetic diversity and three measures of immune response in two recently-introduced species (Neochmia temporalis and Zosterops lateralis) and two island endemics (Acrocephalus aequinoctialis and A. rimitarae) and then comparing the results to those observed in closely-related mainland counterparts. The prevalence of blood parasites was significantly lower in 3 of 4 island taxa, due in part to the absence of certain parasite lineages represented in mainland populations. Indices of genetic diversity were unchanged in the island population of N. temporalis; however, allelic richness was significantly lower in the island population of Z. lateralis while both allelic richness and heterozygosity were significantly reduced in the two island-endemic species examined. Although parasite prevalence and genetic diversity generally conformed to expectations for an island system, we did not find evidence for a pattern of uniformly altered immune responses in island taxa, even amongst endemic taxa with the longest residence times. The island population of Z. lateralis exhibited a significantly reduced inflammatory cell-mediated response while levels of natural antibodies remained unchanged for this and the other recently introduced island taxon. In contrast, the island endemic A. rimitarae exhibited a significantly increased inflammatory response as well as higher levels of natural antibodies and complement. These measures were unchanged or lower in A. aequinoctialis. We suggest that small differences in the pathogenic landscape and the stochastic history of mutation and genetic drift are likely to be important in shaping the unique immunological profiles of small isolated populations. Consequently, predicting the impact of introduced disease on the many other endemic faunas of the remote Pacific will remain a challenge.	[Beadell, Jon S.; Atkins, Colm; Cashion, Erin; Fleischer, Robert C.] Smithsonian Inst, Natl Zool Pk, Genet Program, Washington, DC 20008 USA; [Beadell, Jon S.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Jonker, Michelle] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University System of Maryland; University of Maryland College Park; Australian Institute of Marine Science	Beadell, JS (corresponding author), Smithsonian Inst, Natl Zool Pk, Genet Program, Washington, DC 20008 USA.	beadellj@si.edu	Jonker, Michelle/P-8910-2019; Jonker, Michelle/A-4563-2016	Jonker, Michelle/0000-0002-0876-6081; Jonker, Michelle/0000-0002-0876-6081; Atkins, Colm/0000-0003-4110-161X	National Science Foundation [0508754]; Smithsonian Institution (Abbott Fund); Cosmos Club; American Ornithologists' Union	National Science Foundation(National Science Foundation (NSF)); Smithsonian Institution (Abbott Fund)(Smithsonian InstitutionSmithsonian National Museum of Natural History); Cosmos Club; American Ornithologists' Union	This project was supported by the National Science Foundation ( Grant No. 0508754), Smithsonian Institution (Abbott Fund grant and graduate fellowship), Cosmos Club, and the American Ornithologists' Union.	Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; Adamo SA, 2004, ANIM BEHAV, V68, P1443, DOI 10.1016/j.anbehav.2004.05.005; Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Atkinson Carter T., 2006, Pacific Conservation Biology, V12, P229; Atkinson CT, 1995, PARASITOLOGY, V111, pS59, DOI 10.1017/S003118200007582X; Atkinson CT, 2000, J WILDLIFE DIS, V36, P197, DOI 10.7589/0090-3558-36.2.197; Atkinson CT, 2001, CONDOR, V103, P209, DOI 10.1650/0010-5422(2001)103[0209:PSRADO]2.0.CO;2; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; BAKER AJ, 1987, EVOLUTION, V41, P525, DOI 10.1111/j.1558-5646.1987.tb05823.x; Beadell JS, 2006, P ROY SOC B-BIOL SCI, V273, P2935, DOI 10.1098/rspb.2006.3671; Beadell JS, 2004, MOL ECOL, V13, P3829, DOI 10.1111/j.1365-294X.2004.02363.x; Beadell JS, 2005, J PARASITOL, V91, P683, DOI 10.1645/GE-3412RN; BENNETT GF, 1993, J NAT HIST, V27, P993, DOI 10.1080/00222939300770621; BLAKERS M, 1985, ATLAS AUSTR BIRDS, P738; Blondel J, 2000, VIE MILIEU, V50, P205; Boots M, 2004, P ROY SOC B-BIOL SCI, V271, P715, DOI 10.1098/rspb.2003.2655; Clegg SM, 2002, P NATL ACAD SCI USA, V99, P8127, DOI 10.1073/pnas.102583399; Clifford DL, 2006, BIOL CONSERV, V131, P230, DOI 10.1016/j.biocon.2006.04.029; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; COOPER JE, 1993, J ZOO WILDLIFE MED, V24, P256; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Deerenberg C, 1997, P ROY SOC B-BIOL SCI, V264, P1021, DOI 10.1098/rspb.1997.0141; Degnan SM, 1999, MOL ECOL, V8, P159; DOBSON A P, 1988, Conservation Biology, V2, P31, DOI 10.1111/j.1523-1739.1988.tb00333.x; Fleischer RC, 1998, MOL ECOL, V7, P533, DOI 10.1046/j.1365-294x.1998.00364.x; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Frentiu FD, 2003, MOL ECOL NOTES, V3, P462, DOI 10.1046/j.1471-8286.2003.00484.x; Friend M, 2001, AUK, V118, P290, DOI 10.1642/0004-8038(2001)118[0290:DEIBCF]2.0.CO;2; Fromont E, 2001, PARASITOLOGY, V123, P143, DOI 10.1017/S0031182001008277; Goltsman M, 2005, J ZOOL, V267, P405, DOI 10.1017/S0952836905007557; Goltsman M., 1996, Oryx, V30, P251; Gonzalez G, 1999, J ANIM ECOL, V68, P1225, DOI 10.1046/j.1365-2656.1999.00364.x; Gottdenker NL, 2005, BIOL CONSERV, V126, P429, DOI 10.1016/j.biocon.2005.06.025; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GUSTAFSSON L, 1994, PHILOS T R SOC B, V346, P323, DOI 10.1098/rstb.1994.0149; Hale KA, 2007, ANIM CONSERV, V10, P2, DOI 10.1111/j.1469-1795.2006.00059.x; Hansson B, 2000, MOL ECOL, V9, P1529, DOI 10.1046/j.1365-294x.2000.01028.x; Hansson B, 2005, ANIM CONSERV, V8, P83, DOI 10.1017/S1367943004001878; Hawley DM, 2005, BIOL LETTERS, V1, P326, DOI 10.1098/rsbl.2005.0303; Hillgarth Nigella, 1997, P78; Hochberg ME, 2001, J EVOLUTION BIOL, V14, P539, DOI 10.1046/j.1420-9101.2001.00312.x; Humphrey B. D., 2002, Nutritional biotechnology in the feed and food industries. Proceedings of Alltech's 18th Annual Symposium: from niche markets to mainstream, Lexington, Kentucky, USA, 13-15 May 2002, P69; Janeway CA, 2005, IMMUNOBIOLOGY; Jarvi SI, 2003, CONSERV GENET, V4, P629, DOI 10.1023/A:1025626529806; Jarvi SI, 2001, STUD AVIAN BIOL-SER, P254; KLASING KC, 1988, J NUTR, V118, P1158, DOI 10.1093/jn/118.9.1158; Lindstrom KM, 2004, P ROY SOC B-BIOL SCI, V271, P1513, DOI 10.1098/rspb.2004.2752; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Long JL, 1981, INTRO BIRDS WORLD; LYLES AM, 1993, J ZOO WILDLIFE MED, V24, P315; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Martin TE, 2001, P NATL ACAD SCI USA, V98, P2071, DOI 10.1073/pnas.98.4.2071; Martinez MC, 2006, EDUC POLICY, V20, P299, DOI 10.1177/0895904805285017; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; Matson KD, 2006, P ROY SOC B-BIOL SCI, V273, P2267, DOI 10.1098/rspb.2006.3590; Merino S, 2000, P ROY SOC B-BIOL SCI, V267, P2507, DOI 10.1098/rspb.2000.1312; MILDER S L, 1982, Bulletin of the British Ornithologists' Club, V102, P20; Millien V, 2006, PLOS BIOL, V4, P1863, DOI 10.1371/journal.pbio.0040321; Moller AP, 2004, OIKOS, V104, P299, DOI 10.1111/j.0030-1299.2004.12844.x; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nordling D, 1998, P ROY SOC B-BIOL SCI, V265, P1291, DOI 10.1098/rspb.1998.0432; OBRIEN SJ, 1985, SCIENCE, V227, P1428, DOI 10.1126/science.2983425; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; Parker Patricia G, 2006, Auk, V123, P625, DOI 10.1093/auk/123.3.625; Parmentier HK, 2004, DEV COMP IMMUNOL, V28, P39, DOI 10.1016/S0145-305X(03)00087-9; Pearman PB, 2005, ECOL LETT, V8, P401, DOI 10.1111/j.1461-0248.2005.00735.x; Peters A, 2004, AM NAT, V164, P51, DOI 10.1086/421302; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reid JM, 2003, P ROY SOC B-BIOL SCI, V270, P2151, DOI 10.1098/rspb.2003.2480; Richard FA, 2002, J PARASITOL, V88, P819, DOI 10.1645/0022-3395(2002)088[0819:ACAOPB]2.0.CO;2; Richardson DS, 2000, MOL ECOL, V9, P2226; ROELKE ME, 1993, CURR BIOL, V3, P340, DOI 10.1016/0960-9822(93)90197-V; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; SCRIMSHAW NS, 1991, JPEN-PARENTER ENTER, V15, P589, DOI 10.1177/0148607191015006589; Sefc KM, 2001, MOL ECOL NOTES, V1, P252, DOI 10.1046/j.1471-8278.2001.00095.x; Smits JE, 2005, VET PATHOL, V42, P59, DOI 10.1354/vp.42-1-59; Smits JE, 1999, FUNCT ECOL, V13, P567, DOI 10.1046/j.1365-2435.1999.00338.x; Spielman D, 2004, CONSERV GENET, V5, P439, DOI 10.1023/B:COGE.0000041030.76598.cd; Steadman DW, 1997, J BIOGEOGR, V24, P737, DOI 10.1046/j.1365-2699.1997.00157.x; Tarr CL, 1998, MOL ECOL, V7, P719, DOI 10.1046/j.1365-294x.1998.00385.x; Tompkins DM, 2006, J ROY SOC NEW ZEAL, V36, P51, DOI 10.1080/03014223.2006.9517799; Valkiunas, 2005, AVIAN MALARIA PARASI, P932; Viney ME, 2005, TRENDS ECOL EVOL, V20, P665, DOI 10.1016/j.tree.2005.10.003; WARNER RE, 1968, CONDOR, V70, P101, DOI 10.2307/1365954; Whiteman NK, 2006, P ROY SOC B-BIOL SCI, V273, P797, DOI 10.1098/rspb.2005.3396; Wiggins DA, 1998, OECOLOGIA, V115, P478, DOI 10.1007/s004420050544; Wikelski M, 2004, ECOL SOC, V9; Wright S, 1931, GENETICS, V16, P0097; Yorinks N, 2000, AUK, V117, P731, DOI 10.1642/0004-8038(2000)117[0731:EOMOAB]2.0.CO;2; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	93	24	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e896	10.1371/journal.pone.0000896	http://dx.doi.org/10.1371/journal.pone.0000896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878931	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455700004
J	Greene, E				Greene, Ernest			Retinal Encoding of Ultrabrief Shape Recognition Cues	PLOS ONE			English	Article								Shape encoding mechanisms can be probed by the sequential brief display of dots that mark the boundary of the shape, and delays of less that a millisecond between successive dots can impair recognition. It is not entirely clear whether this is accomplished by preserving stimulus timing in the signal being sent to the brain, or calls for a retinal binding mechanism. Two experiments manipulated the degree of simultaneity among and within dot pairs, requiring also that the pair members be in the same half of the visual field or on opposite halves, i.e., across the midline from one another. Recognition performance was impaired the same for these two conditions. The results make it likely that simultaneity of cues is being registered within the retina. A potential mechanism is suggested, calling for linkage of stimulated sites through activation of PA1 cells. A third experiment confirmed a prior finding that the overall level of recognition deficit is partly a function of display-set size, and affirmed submillisecond resolution in binding dot pairs into effective shape-recognition cues.	[Greene, Ernest] Univ So Calif, Dept Psychol, Lab Neurometr Res, Los Angeles, CA 90089 USA; [Greene, Ernest] Neuropsychol Fdn, Sun Valley, CA USA	University of Southern California	Greene, E (corresponding author), Univ So Calif, Dept Psychol, Lab Neurometr Res, Los Angeles, CA 90089 USA.	egreene@usc.edu						Ackert JM, 2006, J NEUROSCI, V26, P4206, DOI 10.1523/JNEUROSCI.0496-06.2006; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; AMMERMULLER J, 1988, J COMP NEUROL, V273, P137, DOI 10.1002/cne.902730202; Amthor FR, 2005, VISUAL NEUROSCI, V22, P769, DOI 10.1017/S0952523805226081; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; CHATTERJEE S, 2006, J VISION, V6, pA62; COLTHEART M, 1980, PERCEPT PSYCHOPHYS, V27, P183, DOI 10.3758/BF03204258; DACEY DM, 1993, J NEUROSCI, V13, P5334, DOI 10.1523/JNEUROSCI.13-12-05334.1993; DACEY DM, 1989, J COMP NEUROL, V284, P275, DOI 10.1002/cne.902840210; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P9136, DOI 10.1073/pnas.88.20.9136; FAMIGLIETTI EV, 1992, J COMP NEUROL, V316, P391, DOI 10.1002/cne.903160402; FAMIGLIETTI EV, 1992, J COMP NEUROL, V316, P406, DOI 10.1002/cne.903160403; Freed MA, 1996, J COMP NEUROL, V364, P556; Gray CM, 1999, NEURON, V24, P31, DOI 10.1016/S0896-6273(00)80820-X; Greene Ernest, 2006, Behav Brain Funct, V2, P38, DOI 10.1186/1744-9081-2-38; Greene E, 2007, PERCEPT PSYCHOPHYS, V69, P772, DOI 10.3758/BF03193778; Greene E, 2007, PERCEPT MOTOR SKILL, V104, P1043, DOI 10.2466/PMS.104.4.1043-1059; Greene E, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-15; Greene E, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-27; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Kohler W, 1928, PSYCHOL FORSCH, V11, P188, DOI 10.1007/BF00410257; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; LONG GM, 1980, PSYCHOL BULL, V88, P785, DOI 10.1037/0033-2909.88.3.785; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P325, DOI 10.1152/jn.1983.49.2.325; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P350, DOI 10.1152/jn.1983.49.2.350; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; MAUNSELL JHR, VIS NEUROSCI, V16, P1; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Montani F, 2007, J NEUROSCI, V27, P2338, DOI 10.1523/JNEUROSCI.3417-06.2007; Murphy GJ, 2006, NEURON, V52, P511, DOI 10.1016/j.neuron.2006.09.014; NISLY SJ, 1989, PSYCHOL BULL, V106, P483, DOI 10.1037/0033-2909.106.3.483; Reinagel P, 2002, J NEUROSCI, V22, P6837; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; RODIECK RW, 1998, COMP PRIMATE BIOL, V5, P203; Samonds JM, 2006, J NEUROPHYSIOL, V95, P2602, DOI 10.1152/jn.01070.2005; Schall R., 1991, BIOMETRIKA, V40, P917, DOI 10.1093/biomet/78.4.719; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Stafford DK, 1997, VISUAL NEUROSCI, V14, P507, DOI 10.1017/S0952523800012165; STANFORD LR, 1987, SCIENCE, V238, P358, DOI 10.1126/science.3659918; Taylor WR, 1996, VISUAL NEUROSCI, V13, P599, DOI 10.1017/S0952523800008506; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Uzzell VJ, 2004, J NEUROPHYSIOL, V92, P780, DOI 10.1152/jn.01171.2003; Volgyi B, 2001, J COMP NEUROL, V440, P109, DOI 10.1002/cne.1373; von der Malsburg C, 1999, NEURON, V24, P95, DOI 10.1016/S0896-6273(00)80825-9; von der Malsburg C., 1994, MODELS NEURAL NETWOR, P95, DOI [DOI 10.1007/978-1-4612-4320-5_2, 10.1007/978-1-4612-4320-5_2]; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; Wright LL, 2004, VISUAL NEUROSCI, V21, P145, DOI 10.1017/S0952523804042063	52	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e871	10.1371/journal.pone.0000871	http://dx.doi.org/10.1371/journal.pone.0000871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849001	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455600018
J	Meister, IG; Iacoboni, M				Meister, Ingo G.; Iacoboni, Marco			No Language-Specific Activation during Linguistic Processing of Observed Actions	PLOS ONE			English	Article								Background. It has been suggested that cortical neural systems for language evolved from motor cortical systems, in particular from those fronto-parietal systems responding also to action observation. While previous studies have shown shared cortical systems for action - or action observation - and language, they did not address the question of whether linguistic processing of visual stimuli occurs only within a subset of fronto-parietal areas responding to action observation. If this is true, the hypothesis that language evolved from fronto-parietal systems matching action execution and action observation would be strongly reinforced. Methodology/Principal Findings. We used functional magnetic resonance imaging (fMRI) while subjects watched video stimuli of hand-object-interactions and control photo stimuli of the objects and performed linguistic (conceptual and phonological), and perceptual tasks. Since stimuli were identical for linguistic and perceptual tasks, differential activations had to be related to task demands. The results revealed that the linguistic tasks activated left inferior frontal areas that were subsets of a large bilateral fronto-parietal network activated during action perception. Not a single cortical area demonstrated exclusive - or even simply higher - activation for the linguistic tasks compared to the action perception task. Conclusions. These results show that linguistic tasks do not only share common neural representations but essentially activate a subset of the action observation network if identical stimuli are used. Our findings strongly support the evolutionary hypothesis that fronto-parietal systems matching action execution and observation were co-opted for language, a process known as exaptation.	[Meister, Ingo G.; Iacoboni, Marco] Univ Calif Los Angeles, David Geffen Sch Med, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA; [Iacoboni, Marco] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90095 USA; [Meister, Ingo G.; Iacoboni, Marco] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Iacoboni, Marco] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; [Meister, Ingo G.] Univ Cologne, Dept Neurol, Cologne, Germany; [Meister, Ingo G.] Univ Cologne, Fac Med, Cologne, Germany; [Meister, Ingo G.] Univ Cologne, Klaus Joachim Zulch Labs, Max Planck Soc, Max Planck Inst Neurol Res, Cologne, Germany	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Cologne; University of Cologne; Max Planck Society; University of Cologne	Meister, IG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA.	igmeister@gmx.de; iacoboni@loni.ucla.edu	Meister, Ingo/A-3642-2008		Brain Mapping Medical Research Organization; Brain Mapping Support Foundation; Pierson-Lovelace Foundation; The Ahmanson Foundation; William M. and Linda R. Dietel Philanthropic Fund at the Northern Piedmont Community Foundation; Tamkin Foundation; Jennifer Jones-Simon Foundation; Capital Group Companies Charitable Foundation; Robson Family and Northstar Fund; National Institute of Mental Health [MH68630]; National Center for Research Resources (NCRR) [RR12169, RR13642, RR00865]; National Institutes of Health (NIH); Deutsche Forschungsgemeinschaft [ME 2104/3-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012169, P41RR013642, M01RR000865] Funding Source: NIH RePORTER	Brain Mapping Medical Research Organization; Brain Mapping Support Foundation; Pierson-Lovelace Foundation; The Ahmanson Foundation; William M. and Linda R. Dietel Philanthropic Fund at the Northern Piedmont Community Foundation; Tamkin Foundation; Jennifer Jones-Simon Foundation; Capital Group Companies Charitable Foundation; Robson Family and Northstar Fund; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding: For generous support the authors wish to thank the Brain Mapping Medical Research Organization, Brain Mapping Support Foundation, Pierson-Lovelace Foundation, The Ahmanson Foundation, William M. and Linda R. Dietel Philanthropic Fund at the Northern Piedmont Community Foundation, Tamkin Foundation, Jennifer Jones-Simon Foundation, Capital Group Companies Charitable Foundation, Robson Family and Northstar Fund. The project described was supported by Grant Numbers MH68630 from the National Institute of Mental Health, and RR12169, RR13642 and RR00865 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH); its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIMH, NCRR or NIH. IGM is funded by the Deutsche Forschungsgemeinschaft (Grant ME 2104/3-1).	Andrews PW, 2002, BEHAV BRAIN SCI, V25, P489; Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Aziz-Zadeh L, 2004, EUR J NEUROSCI, V19, P2609, DOI 10.1111/j.0953-816X.2004.03348.x; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; CHENG Y, 2006, CEREBR IN PRESS 1031; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; Floel A, 2003, EUR J NEUROSCI, V18, P704, DOI 10.1046/j.1460-9568.2003.02774.x; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2007, PHILOS T R SOC B, V362, P659, DOI 10.1098/rstb.2006.2002; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Hamzei F, 2003, NEUROIMAGE, V19, P637, DOI 10.1016/S1053-8119(03)00087-9; Heiser M, 2003, EUR J NEUROSCI, V17, P1123, DOI 10.1046/j.1460-9568.2003.02530.x; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Liberman AM, 2000, TRENDS COGN SCI, V4, P187, DOI 10.1016/S1364-6613(00)01471-6; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; Meister IG, 2003, NEUROPSYCHOLOGIA, V41, P401, DOI 10.1016/S0028-3932(02)00179-3; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Sparing R, 2007, EUR J NEUROSCI, V25, P319, DOI 10.1111/j.1460-9568.2006.05252.x; Tokimura H, 1996, ANN NEUROL, V40, P628, DOI 10.1002/ana.410400413; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002	28	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e891	10.1371/journal.pone.0000891	http://dx.doi.org/10.1371/journal.pone.0000891			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849020	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455600037
J	Somenzi, G; Sala, G; Rossetti, S; Ren, MQ; Ghidoni, R; Sacchi, N				Somenzi, Giulia; Sala, Giusy; Rossetti, Stefano; Ren, MingQiang; Ghidoni, Riccardo; Sacchi, Nicoletta			Disruption of Retinoic Acid Receptor Alpha Reveals the Growth Promoter Face of Retinoic Acid	PLOS ONE			English	Article							BREAST-CANCER CELLS; NUCLEAR RECEPTORS; VITAMIN-A; EXTRACELLULAR RELEASE; CARCINOMA-CELLS; BETA-CAROTENE; LUNG-CANCER; KINASE; ACTIVATION; EXPRESSION	Background. Retinoic acid (RA), the bioactive derivative of Vitamin A, by epigenetically controlling transcription through the RA-receptors (RARs), exerts a potent antiproliferative effect on human cells. However, a number of studies show that RA can also promote cell survival and growth. In the course of one of our studies we observed that disruption of RA-receptor alpha, RAR alpha, abrogates the RA-mediated growth-inhibitory effects and unmasks the growth-promoting face of RA (Ren et al., Mol. Cell. Biol., 2005, 25: 10591). The objective of this study was to investigate whether RA can differentially govern cell growth, in the presence and absence of RAR alpha, through differential regulation of the "rheostat'' comprising ceramide (CER), the sphingolipid with growth-inhibitory activity, and sphingosine-1-phosphate (S1P), the sphingolipid with prosurvival activity. Methodology/Principal Findings. We found that functional inhibition of endogenous RAR alpha in breast cancer cells by using either RAR alpha specific antagonists or a dominant negative RAR alpha mutant hampers on one hand the RA-induced upregulation of neutral sphingomyelinase (nSMase)-mediated CER synthesis, and on the other hand the RA-induced downregulation of sphingosine kinase 1, SK1, pivotal for S1P synthesis. In association with RA inability to regulate the sphingolipid rheostat, cells not only survive, but also grow more in response to RA both in vitro and in vivo. By combining genetic, pharmacological and biochemical approaches, we mechanistically demonstrated that RA-induced growth is, at least in part, due to non-RAR-mediated activation of the SK1-S1P signaling. Conclusions/Significance. In the presence of functional RAR alpha, RA inhibits cell growth by concertedly, and inversely, modulating the CER and S1P synthetic pathways. In the absence of a functional RAR alpha, RA-in a non-RAR-mediated fashion-promotes cell growth by activating the prosurvival S1P signaling. These two distinct, yet integrated processes apparently concur to the growth-promoter effects of RA.	[Sala, Giusy; Ghidoni, Riccardo] Univ Milan, Sch Med, San Paolo Univ Hosp, Biochem & Mol Biol Lab, Milan, Italy; [Somenzi, Giulia; Rossetti, Stefano; Ren, MingQiang; Sacchi, Nicoletta] Roswell Pk Canc Inst, Dept Canc Biol, Canc Genet Program, Buffalo, NY 14263 USA	University of Milan; Roswell Park Cancer Institute	Ghidoni, R (corresponding author), Univ Milan, Sch Med, San Paolo Univ Hosp, Biochem & Mol Biol Lab, Milan, Italy.	riccardo.ghidoni@unimi.it; nicoletta.sacchi@roswellpark.org		GHIDONI, RICCARDO/0000-0002-6300-5867	MIUR, Italy [PRIN 20011065545]; Cariplo Foundation Award (Italy); Roswell Park Alliance Foundation Award; U. S. Army [DAMD 17-02-01-0432]; Graduate Program of Molecular Medicine, University of Milan, Italy	MIUR, Italy(Ministry of Education, Universities and Research (MIUR)); Cariplo Foundation Award (Italy); Roswell Park Alliance Foundation Award; U. S. Army; Graduate Program of Molecular Medicine, University of Milan, Italy	This work was funded by the PRIN 20011065545 grant "Lipids as effectors and mediators of growth, differentiation and apoptosis in cancer cells'' (MIUR, Italy) (RG and NS), a Cariplo Foundation Award (Italy) (RG and NS), a Roswell Park Alliance Foundation Award (NS), the U. S. Army DAMD 17-02-01-0432 (NS), the Graduate Program of Molecular Medicine, University of Milan, Italy (G. Somenzi and G. Sala).	Albright CD, 2004, J NUTR, V134, P1139, DOI 10.1093/jn/134.5.1139; Altucci L, 2001, TRENDS ENDOCRIN MET, V12, P460, DOI 10.1016/S1043-2760(01)00502-1; AMES BN, 1960, J BIOL CHEM, V235, P769; Anelli V, 2005, J NEUROCHEM, V92, P1204, DOI 10.1111/j.1471-4159.2004.02955.x; APFEL C, 1992, P NATL ACAD SCI USA, V89, P7129, DOI 10.1073/pnas.89.15.7129; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Bistulfi G, 2006, CANCER RES, V66, P10308, DOI 10.1158/0008-5472.CAN-06-1052; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Decensi A, 2007, NAT CLIN PRACT ONCOL, V4, P64, DOI 10.1038/ncponc0735; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Guo XJ, 2002, CANCER RES, V62, P1654; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; HENION PD, 1994, DEV BIOL, V161, P243, DOI 10.1006/dbio.1994.1024; Jing YK, 1996, FASEB J, V10, P1064, DOI 10.1096/fasebj.10.9.8801168; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; KANG SW, 1995, J INVEST DERMATOL, V105, P549, DOI 10.1111/1523-1747.ep12323445; Khuri FR, 2006, JNCI-J NATL CANCER I, V98, P441, DOI 10.1093/jnci/djj091; Kihara A, 2003, J BIOL CHEM, V278, P14578, DOI 10.1074/jbc.M211416200; Kikuchi K, 2001, BIOORG MED CHEM LETT, V11, P1215, DOI 10.1016/S0960-894X(01)00177-9; Koivunen J, 2006, CANCER LETT, V235, P1, DOI 10.1016/j.canlet.2005.03.033; Kroesen BJ, 2001, J BIOL CHEM, V276, P13606, DOI 10.1074/jbc.M009517200; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; MERRILL AH, 1992, METHOD ENZYMOL, V209, P427; Mikkelsen S, 1998, CARCINOGENESIS, V19, P663, DOI 10.1093/carcin/19.4.663; Mira-y-Lopez R, 2000, J CELL PHYSIOL, V185, P302, DOI 10.1002/1097-4652(200011)185:2<302::AID-JCP15>3.0.CO;2-#; Mollersen L, 2004, CARCINOGENESIS, V25, P149, DOI 10.1093/carcin/bgg176; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Napoli JL, 1996, FASEB J, V10, P993, DOI 10.1096/fasebj.10.9.8801182; Ochoa WF, 2003, BIOCHEMISTRY-US, V42, P8774, DOI 10.1021/bi034713g; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Perry DK, 2000, METHOD ENZYMOL, V312, P22; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; Pozzi S, 2006, ONCOGENE, V25, P1400, DOI 10.1038/sj.onc.1209173; REN M, 2005, P AM ASSOC CANC RES, V46, P300; REN M, 2006, P AM ASSOC CANC RES, V47, P1625; REN M, 2007, P AM ASSOC CANC RES, V48, P1660; Ren MQ, 2005, MOL CELL BIOL, V25, P10591, DOI 10.1128/MCB.25.23.10591-10603.2005; Ren MQ, 2004, ANTICANCER RES, V24, P2879; Rexer BN, 2001, CANCER RES, V61, P7065; ROMAN SD, 1992, CANCER RES, V52, P2236; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; SHEIKH MS, 1993, J CELL BIOCHEM, V53, P394, DOI 10.1002/jcb.240530417; Sirchia SM, 2002, CANCER RES, V62, P2455; TSAI S, 1992, GENE DEV, V6, P2258, DOI 10.1101/gad.6.12a.2258; VANDERBURG B, 1993, MOL CELL ENDOCRINOL, V91, P149, DOI 10.1016/0303-7207(93)90267-N; VANVELDHOVEN PP, 1995, BIOCHEM MOL BIOL INT, V36, P21; Wang HT, 2003, UROLOGY, V61, P1047, DOI 10.1016/S0090-4295(02)02511-6; Wang HT, 2001, CANCER RES, V61, P5102; Zanardi S, 2006, ENDOCR-RELAT CANCER, V13, P51, DOI 10.1677/erc.1.00938; Zelent A, 2001, ONCOGENE, V20, P7186, DOI 10.1038/sj.onc.1204766	52	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e836	10.1371/journal.pone.0000836	http://dx.doi.org/10.1371/journal.pone.0000836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786207	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455500019
J	Churamani, D; Boulware, MJ; Geach, TJ; Martin, ACR; Moy, GW; Su, YH; Vacquier, VD; Marchant, JS; Dale, L; Patel, S				Churamani, Dev; Boulware, Michael J.; Geach, Timothy J.; Martin, Andrew C. R.; Moy, Gary W.; Su, Yi-Hsien; Vacquier, Victor D.; Marchant, Jonathan S.; Dale, Leslie; Patel, Sandip			Molecular Characterization of a Novel Intracellular ADP-Ribosyl Cyclase	PLOS ONE			English	Article								Background. ADP-ribosyl cyclases are remarkable enzymes capable of catalyzing multiple reactions including the synthesis of the novel and potent intracellular calcium mobilizing messengers, cyclic ADP-ribose and NAADP. Not all ADP-ribosyl cyclases however have been characterized at the molecular level. Moreover, those that have are located predominately at the outer cell surface and thus away from their cytosolic substrates. Methodology/Principal Findings. Here we report the molecular cloning of a novel expanded family of ADP-ribosyl cyclases from the sea urchin, an extensively used model organism for the study of inositol trisphosphate-independent calcium mobilization. We provide evidence that one of the isoforms (SpARC1) is a soluble protein that is targeted exclusively to the endoplasmic reticulum lumen when heterologously expressed. Catalytic activity of the recombinant protein was readily demonstrable in crude cell homogenates, even under conditions where luminal continuity was maintained. Conclusions/Significance. Our data reveal a new intracellular location for ADP-ribosyl cyclases and suggest that production of calcium mobilizing messengers may be compartmentalized.	[Churamani, Dev; Patel, Sandip] UCL, Dept Physiol, London, England; [Boulware, Michael J.; Marchant, Jonathan S.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Geach, Timothy J.; Dale, Leslie] UCL, Dept Anat & Dev Biol, London, England; [Martin, Andrew C. R.] UCL, Dept Biochem & Mol Biol, London, England; [Moy, Gary W.; Su, Yi-Hsien; Vacquier, Victor D.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA	University of London; University College London; University of Minnesota System; University of Minnesota Twin Cities; University of London; University College London; University of London; University College London; University of California System; University of California San Diego; Scripps Institution of Oceanography	Patel, S (corresponding author), UCL, Dept Physiol, London, England.	patel.s@ucl.ac.uk	Marchant, Jonathan/Q-5484-2019; Su, Yi-Hsien/F-2910-2014; MARCHANT, Jonathan/B-8051-2009; Patel, Sandip/O-9591-2015	Marchant, Jonathan/0000-0001-6592-0877; MARCHANT, Jonathan/0000-0001-6592-0877; Martin, Andrew/0000-0002-2835-2572; Patel, Sandip/0000-0001-7247-2013	BBSRC [BB/D018110/1, BBS/B/0661X]; NIH [HD12986, NS046783]; NSF [0237946]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD012986, R01HD012986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046783] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/D018110/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC grants BB/D018110/1 ( DC and SP) and BBS/B/0661X ( TJG and LD), NIH grants HD12986 ( Y-HS, GWM and VDD) and NS046783 ( MJB and JSM), and NSF grant 0237946 ( MJB and JSM).	Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; Adebanjo OA, 1999, NAT CELL BIOL, V1, P409, DOI 10.1038/15640; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Berridge G, 2002, BIOCHEM J, V365, P295, DOI 10.1042/BJ20020180; Berridge G, 2002, J BIOL CHEM, V277, P43717, DOI 10.1074/jbc.M203224200; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Billington RA, 2006, FASEB J, V20, P521, DOI 10.1096/fj.05-5058fje; Billington RA, 2002, J PHYSIOL-LONDON, V544, P107, DOI 10.1113/jphysiol.2002.030098; Billington RA, 2006, FERTIL STERIL, V86, P891, DOI 10.1016/j.fertnstert.2006.03.030; Boulware MJ, 2005, CURR BIOL, V15, P765, DOI 10.1016/j.cub.2005.02.065; Brailoiu E, 2005, J BIOL CHEM, V280, P5646, DOI 10.1074/jbc.M408746200; Brailoiu E, 2001, MOL PHARMACOL, V60, P718; Brailoiu E, 2006, J BIOL CHEM, V281, P15923, DOI 10.1074/jbc.M602249200; Bruzzone S, 2003, BIOCHEM J, V375, P395, DOI 10.1042/BJ20030556; Ceni C, 2003, J BIOL CHEM, V278, P40670, DOI 10.1074/jbc.M301196200; Chameau P, 2001, PFLUG ARCH EUR J PHY, V443, P289, DOI 10.1007/s004240100691; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chini EN, 1997, AM J PHYSIOL-CELL PH, V272, pC416, DOI 10.1152/ajpcell.1997.272.2.C416; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; Dickinson GD, 2003, BIOCHEM J, V375, P805, DOI 10.1042/BJ20030672; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Fukushi Y, 2001, J BIOL CHEM, V276, P649, DOI 10.1074/jbc.M004469200; Galione A, 2000, BIOL CELL, V92, P197, DOI 10.1016/S0248-4900(00)01070-4; Galione A, 2005, MOL INTERV, V5, P73, DOI 10.1124/mi.5.2.4; GALIONE A, 1993, SCIENCE, V261, P348, DOI 10.1126/science.8392748; GALIONE A, 1993, NATURE, V365, P456, DOI 10.1038/365456a0; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Genazzani AA, 1996, J BIOL CHEM, V271, P11599, DOI 10.1074/jbc.271.20.11599; GLICK DL, 1991, CELL REGUL, V2, P211, DOI 10.1091/mbc.2.3.211; Goodrich SP, 2005, BIOCHEMISTRY-US, V44, P11082, DOI 10.1021/bi050704r; Graeff RM, 1998, J BIOL CHEM, V273, P118, DOI 10.1074/jbc.273.1.118; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Guida L, 2002, J BIOL CHEM, V277, P47097, DOI 10.1074/jbc.M207793200; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; Heidemann AC, 2005, J BIOL CHEM, V280, P35630, DOI 10.1074/jbc.M507338200; HIRATA Y, 1994, FEBS LETT, V356, P244, DOI 10.1016/0014-5793(94)01279-2; Hohenegger M, 2002, BIOCHEM J, V367, P423, DOI 10.1042/BJ20020584; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; Kuhn I, 2006, BIOCHEMISTRY-US, V45, P11867, DOI 10.1021/bi060930g; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee HC, 2000, CHEM IMMUNOL, V75, P39; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; LEE HC, 1989, J BIOL CHEM, V264, P1608; LEE HC, 1993, SCIENCE, V261, P352, DOI 10.1126/science.8392749; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee HC, 1996, BIOL SIGNAL, V5, P101; Lim D, 2001, FASEB J, V15, P2257, DOI 10.1096/fj.01-0157com; Mani RS, 1998, J BIOL CHEM, V273, P30818, DOI 10.1074/jbc.273.46.30818; Matsumura N, 1998, BIOCHEM BIOPH RES CO, V253, P246, DOI 10.1006/bbrc.1998.9752; Meszaros LG, 1997, BIOCHEM BIOPH RES CO, V234, P252, DOI 10.1006/bbrc.1997.6620; Moreno-Garcia ME, 2005, MOL IMMUNOL, V42, P703, DOI 10.1016/j.molimm.2004.09.019; Munshi C, 1999, J BIOL CHEM, V274, P30770, DOI 10.1074/jbc.274.43.30770; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Patel S, 2001, TRENDS BIOCHEM SCI, V26, P482, DOI 10.1016/S0968-0004(01)01896-5; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SOARES S, 2006, AM J PHYSL CELL PHYS; Sternfeld L, 2003, J BIOL CHEM, V278, P33629, DOI 10.1074/jbc.M301043200; Subramanian VS, 2001, AM J PHYSIOL-GASTR L, V281, pG1477, DOI 10.1152/ajpgi.2001.281.6.G1477; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; TERASAKI M, 1991, J CELL BIOL, V114, P929, DOI 10.1083/jcb.114.5.929; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Wilson HL, 2001, J BIOL CHEM, V276, P11180, DOI 10.1074/jbc.M004849200; Wilson HL, 1998, BIOCHEM J, V331, P837, DOI 10.1042/bj3310837; Xie GH, 2005, BIOCHEM BIOPH RES CO, V330, P1290, DOI 10.1016/j.bbrc.2005.03.114; Yamada M, 1997, BRAIN RES, V756, P52, DOI 10.1016/S0006-8993(97)00117-0; Zhang F, 2006, AM J PHYSIOL-HEART C, V291, pH274, DOI 10.1152/ajpheart.01064.2005; Zocchi E, 1996, FEBS LETT, V396, P327, DOI 10.1016/0014-5793(96)01125-8	73	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e797	10.1371/journal.pone.0000797	http://dx.doi.org/10.1371/journal.pone.0000797			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726527	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455400014
J	Tabach, Y; Brosh, R; Buganim, Y; Reiner, A; Zuk, O; Yitzhaky, A; Koudritsky, M; Rotter, V; Domany, E				Tabach, Yuval; Brosh, Ran; Buganim, Yossi; Reiner, Anat; Zuk, Or; Yitzhaky, Assif; Koudritsky, Mark; Rotter, Varda; Domany, Eytan			Wide-Scale Analysis of Human Functional Transcription Factor Binding Reveals a Strong Bias towards the Transcription Start Site	PLOS ONE			English	Article							NF-KAPPA-B; DNA REGULATORY MOTIFS; FALSE DISCOVERY RATE; GENE-EXPRESSION; CELL-CYCLE; IDENTIFICATION; MYOCARDIN; ELEMENTS; CONSERVATION; SEQUENCES	Background. Transcription factors (TF) regulate expression by binding to specific DNA sequences. A binding event is functional when it affects gene expression. Functionality of a binding site is reflected in conservation of the binding sequence during evolution and in over represented binding in gene groups with coherent biological functions. Functionality is governed by several parameters such as the TF-DNA binding strength, distance of the binding site from the transcription start site (TSS), DNA packing, and more. Understanding how these parameters control functionality of different TFs in different biological contexts is a must for identifying functional TF binding sites and for understanding regulation of transcription. Methodology/Principal Findings. We introduce a novel method to screen the promoters of a set of genes with shared biological function (obtained from the functional Gene Ontology (GO) classification) against a precompiled library of motifs, and find those motifs which are statistically over-represented in the gene set. More than 8000 human (and 23,000 mouse) genes, were assigned to one of 134 GO sets. Their promoters were searched (from 200 bp downstream to 1000 bp upstream the TSS) for 414 known DNA motifs. We optimized the sequence similarity score threshold, independently for every location window, taking into account nucleotide heterogeneity along the promoters of the target genes. The method, combined with binding sequence and location conservation between human and mouse, identifies with high probability functional binding sites for groups of functionally-related genes. We found many location-sensitive functional binding events and showed that they clustered close to the TSS. Our method and findings were tested experimentally. Conclusions/Significance. We identified reliably functional TF binding sites. This is an essential step towards constructing regulatory networks. The promoter region proximal to the TSS is of central importance for regulation of transcription in human and mouse, just as it is in bacteria and yeast.	[Tabach, Yuval; Reiner, Anat; Zuk, Or; Yitzhaky, Assif; Koudritsky, Mark; Domany, Eytan] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Tabach, Yuval; Brosh, Ran; Buganim, Yossi; Rotter, Varda] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Domany, E (corresponding author), Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel.	eytan.domany@weizmann.ac.il	Tabach, Yuval/Q-8488-2019; Reiner-Benaim, Anat/HGQ-1183-2022; DOMANY, EYTAN/K-1560-2012; Brosh, Ran/H-7309-2019; Brosh, Ran/HDL-9562-2022	Reiner-Benaim, Anat/0000-0001-8709-3112; Brosh, Ran/0000-0001-9714-8623; 	Ridgefield Foundation; NIH [5 P01 CA 65930-06]; EC [FP6]; NATIONAL CANCER INSTITUTE [P01CA065930] Funding Source: NIH RePORTER	Ridgefield Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EC(European CommissionEuropean Commission Joint Research Centre); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by grants from the Ridgefield Foundation, the NIH grant # 5 P01 CA 65930-06 and by EC FP6 funding.	Aerts S, 2003, NUCLEIC ACIDS RES, V31, P1753, DOI 10.1093/nar/gkg268; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Ambesi-Impiombato A, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S8; Amir-Zilberstein L, 2007, MOL CELL BIOL, V27, P5246, DOI 10.1128/MCB.00586-07; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BARASH Y, 2001, SIMPLE HYPER GEOMETR; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Buckland PR, 2005, HUM MUTAT, V26, P214, DOI 10.1002/humu.20207; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Emberly E, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-57; Eto A, 2003, BIOCHEM BIOPH RES CO, V301, P495, DOI 10.1016/S0006-291X(02)03082-6; Frech K, 1997, TRENDS BIOCHEM SCI, V22, P103; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gerland U, 2002, P NATL ACAD SCI USA, V99, P12015, DOI 10.1073/pnas.192693599; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Haverty PM, 2004, NUCLEIC ACIDS RES, V32, P179, DOI 10.1093/nar/gkh183; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Howard ML, 2004, DEV BIOL, V271, P109, DOI 10.1016/j.ydbio.2004.03.031; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kimura-Yoshida C, 2004, DEVELOPMENT, V131, P57, DOI 10.1242/dev.00877; Lam AL, 2005, CHROMOSOMA, V114, P242, DOI 10.1007/s00412-005-0001-0; Li H, 2002, P NATL ACAD SCI USA, V99, P11772, DOI 10.1073/pnas.112341999; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Liu RX, 2003, GENOME RES, V13, P654, DOI 10.1101/gr.911803; Lodish H., 2000, MOL CELL BIOL WH FRE; MacIsaac KD, 2006, PLOS COMPUT BIOL, V2, P201, DOI 10.1371/journal.pcbi.0020036; Marino-Ramirez L, 2005, CYTOGENET GENOME RES, V110, P333, DOI 10.1159/000084965; McCue LA, 2001, NUCLEIC ACIDS RES, V29, P774, DOI 10.1093/nar/29.3.774; McGuire AM, 2000, GENOME RES, V10, P744, DOI 10.1101/gr.10.6.744; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Nobrega MA, 2004, NATURE, V431, P988, DOI 10.1038/nature03022; Pfeifer D, 1999, AM J HUM GENET, V65, P111, DOI 10.1086/302455; Pipes GCT, 2005, DEV BIOL, V288, P502, DOI 10.1016/j.ydbio.2005.10.014; Plessy C, 2005, TRENDS GENET, V21, P207, DOI 10.1016/j.tig.2005.02.006; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rajewsky N, 2002, GENOME RES, V12, P298, DOI 10.1101/gr.207502. Article published online before print in January 2002; Rashi-Elkeles S, 2006, ONCOGENE, V25, P1584, DOI 10.1038/sj.onc.1209189; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sharan R, 2004, NUCLEIC ACIDS RES, V32, pW253, DOI 10.1093/nar/gkh385; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Tabach Y, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100030; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; Yao GQ, 2000, ENDOCRINOLOGY, V141, P2914, DOI 10.1210/en.141.8.2914; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zheng JS, 2003, NUCLEIC ACIDS RES, V31, P1995, DOI 10.1093/nar/gkg287	65	49	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e807	10.1371/journal.pone.0000807	http://dx.doi.org/10.1371/journal.pone.0000807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726537	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455400024
J	Palmqvist, L; Pineault, N; Wasslavik, C; Humphries, RK				Palmqvist, Lars; Pineault, Nicolas; Wasslavik, Carina; Humphries, R. Keith			Candidate Genes for Expansion and Transformation of Hematopoietic Stem Cells by NUP98-HOX Fusion Genes	PLOS ONE			English	Article								Background. Hox genes are implicated in hematopoietic stem cell (HSC) regulation as well as in leukemia development through translocation with the nucleoporin gene NUP98. Interestingly, an engineered NUP98-HOXA10 (NA10) fusion can induce a several hundred-fold expansion of HSCs in vitro and NA10 and the AML-associated fusion gene NUP98-HOXD13 (ND13) have a virtually indistinguishable ability to transform myeloid progenitor cells in vitro and to induce leukemia in collaboration with MEIS1 in vivo. Methodology/Principal Findings. These findings provided a potentially powerful approach to identify key pathways mediating Hox-induced expansion and transformation of HSCs by identifying gene expression changes commonly induced by ND13 and NA10 but not by a NUP98-Hox fusion with a non-DNA binding homedomain mutation (N51S). The gene expression repertoire of purified murine bone marrow Sca-1+Lin-cells transduced with retroviral vectors encoding for these genes was established using the Affymetrix GeneChip MOE430A. Approximately seventy genes were differentially expressed in ND13 and NA10 cells that were significantly changed by both compared to the ND13(N51S) mutant. Intriguingly, several of these potential Hox target genes have been implicated in HSC expansion and self-renewal, including the tyrosine kinase receptor Flt3, the prion protein, Prnp, hepatic leukemia factor, Hlf and Jagged-2, Jag2. Consistent with these results, FLT3, HLF and JAG2 expression correlated with HOX A cluster gene expression in human leukemia samples. Conclusions. In conclusion this study has identified several novel Hox downstream target genes and provides important new leads to key regulators of the expansion and transformation of hematopoietic stem cells by Hox.	[Palmqvist, Lars; Pineault, Nicolas; Humphries, R. Keith] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Palmqvist, Lars; Wasslavik, Carina] Sahlgrens Univ Hosp, Inst Biomed, Gothenburg, Sweden; [Humphries, R. Keith] Univ British Columbia, Dept Med, Vancouver, BC, Canada	British Columbia Cancer Agency; Sahlgrenska University Hospital; University of British Columbia	Humphries, RK (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	khumphri@bccrc.ca		Humphries, Richard/0000-0003-0540-7005	National Cancer Institute of Canada; Terry Fox Foundation; Canadian Stem Cell Network; Genome Canada/British Columbia; Canadian Institutes of Health; National Institutes of Health; Swedish Cancer Society; ALF/LUA at the Sahlgrenska University Hospital	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Terry Fox Foundation; Canadian Stem Cell Network; Genome Canada/British Columbia(Genome Canada); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Cancer Society(Swedish Cancer Society); ALF/LUA at the Sahlgrenska University Hospital	This work was supported in part by the National Cancer Institute of Canada, with funds from the Terry Fox Foundation and by grants from the Canadian Stem Cell Network and Genome Canada/British Columbia, the Canadian Institutes of Health and National Institutes of Health to RKH. LP held a postdoctoral fellowship funded by the Swedish Cancer Society and his work is supported by ALF/LUA at the Sahlgrenska University Hospital.	Abramovich C, 2005, ANN NY ACAD SCI, V1044, P109, DOI 10.1196/annals.1349.014; Abramovich C, 2005, CURR OPIN HEMATOL, V12, P210, DOI 10.1097/01.moh.0000160737.52349.aa; Arai Y, 1997, BLOOD, V89, P3936, DOI 10.1182/blood.V89.11.3936; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Calvo KR, 2002, ONCOGENE, V21, P4247, DOI 10.1038/sj.onc.1205516; Chung KY, 2006, CANCER RES, V66, P11781, DOI 10.1158/0008-5472.CAN-06-0706; Dodelet VC, 1998, BLOOD, V91, P1556, DOI 10.1182/blood.V91.5.1556.1556_1556_1561; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; Gal H, 2006, LEUKEMIA, V20, P2147, DOI 10.1038/sj.leu.2404401; Gervais C, 2005, LEUKEMIA, V19, P145, DOI 10.1038/sj.leu.2403565; Ghannam G, 2004, J BIOL CHEM, V279, P866, DOI 10.1074/jbc.M307280200; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grier DG, 2005, J PATHOL, V205, P154, DOI 10.1002/path.1710; INABA T, 1992, SCIENCE, V257, P531, DOI 10.1126/science.1386162; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kalberer CP, 2000, P NATL ACAD SCI USA, V97, P5411, DOI 10.1073/pnas.100082597; Kroon E, 2001, EMBO J, V20, P350, DOI 10.1093/emboj/20.3.350; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Kumar AR, 2004, BLOOD, V103, P1823, DOI 10.1182/blood-2003-07-2582; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohmann I, 2002, CURR BIOL, V12, pR514, DOI 10.1016/S0960-9822(02)01025-4; MANN RS, 1995, BIOESSAYS, V17, P855, DOI 10.1002/bies.950171007; Moore MAS, 2005, EXP HEMATOL, V33, P719, DOI 10.1016/j.exphem.2005.04.011; Nakamura T, 1999, BLOOD, V94, P741, DOI 10.1182/blood.V94.2.741.414k04_741_747; Nakamura T, 1996, NAT GENET, V12, P154, DOI 10.1038/ng0296-154; Ohta H, 2007, EXP HEMATOL, V35, P817, DOI 10.1016/j.exphem.2007.02.012; Ozeki K, 2004, BLOOD, V103, P1901, DOI 10.1182/blood-2003-06-1845; Palmqvist L, 2006, BLOOD, V108, P1030, DOI 10.1182/blood-2005-12-007005; Panagopoulos L, 2003, GENE CHROMOSOME CANC, V36, P107, DOI 10.1002/gcc.10139; PAWLIUK R, 1994, BLOOD, V84, P2868, DOI 10.1182/blood.V84.9.2868.bloodjournal8492868; Pineault N, 2002, EXP HEMATOL, V30, P49, DOI 10.1016/S0301-472X(01)00757-3; Pineault N, 2004, MOL CELL BIOL, V24, P1907, DOI 10.1128/MCB.24.5.1907-1917.2004; Pineault N, 2003, BLOOD, V101, P4529, DOI 10.1182/blood-2002-08-2484; PINEAULT N, 2005, LEUKEMIA; Quentmeier H, 2004, LEUKEMIA LYMPHOMA, V45, P567, DOI 10.1080/10428190310001609942; Raza-Egilmez SZ, 1998, CANCER RES, V58, P4269; Roche J, 2004, LEUKEMIA, V18, P1059, DOI 10.1038/sj.leu.2403366; Sauvageau G, 1997, IMMUNITY, V6, P13, DOI 10.1016/S1074-7613(00)80238-1; Shanmugam K, 1999, MOL CELL BIOL, V19, P7577; Shojaei F, 2005, DEV CELL, V8, P651, DOI 10.1016/j.devcel.2005.03.004; Slape C, 2004, LEUKEMIA LYMPHOMA, V45, P1341, DOI 10.1080/10428190310001659325; Suzuki A, 2002, BRIT J HAEMATOL, V116, P170, DOI 10.1046/j.1365-2141.2002.03246.x; Takacs-Vellai K, 2007, DEV BIOL, V302, P661, DOI 10.1016/j.ydbio.2006.09.049; Taketani T, 2002, CANCER RES, V62, P4571; Taketani T, 2002, GENE CHROMOSOME CANC, V34, P437, DOI 10.1002/gcc.10077; Taketani T, 2002, CANCER RES, V62, P33; Thornhill S, 1997, PHYS WORLD, V10, P17; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; van Oostveen JW, 1999, LEUKEMIA, V13, P1675, DOI 10.1038/sj.leu.2401562; WANG GG, 2005, BLOOD; Wiellette EL, 1999, DEVELOPMENT, V126, P1985; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103	56	51	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e768	10.1371/journal.pone.0000768	http://dx.doi.org/10.1371/journal.pone.0000768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712416	Green Published, gold			2022-12-27	WOS:000207455300016
J	Marshall, JL				Marshall, Jeremy L.			Rapid Evolution of Spermathecal Duct Length in the Allonemobius socius Complex of Crickets: Species, Population and Wolbachia Effects	PLOS ONE			English	Article							REPRODUCTIVE ISOLATION; SPERM; ZONE; HYBRIDIZATION; COADAPTATION; COEVOLUTION; SPECIATION; PIPIENTIS; DYNAMICS; FEMALES	The three species in the Allonemobius socius complex of crickets have recently diverged and radiated across North America. Interestingly, the only barriers to gene flow between these species in zones of secondary contact appear to be associated with fertilization traits - e.g., conspecific sperm precedence and the ability of males to induce females to lay eggs. Other traits, such as the length of female's reproductive tract, may also influence fertilization success and be associated with species boundaries. However, the underlying variation in this duct has not been assessed across populations and species. Moreover, the effects of reproductive parasites like Wolbachia on these morphological features have yet to be addressed, even though its infections are concentrated in reproductive tissues. I evaluated both the natural variation in and the effects of Wolbachia infection on spermathecal duct length among several populations of two species in the Allonemobius socius complex. My results suggest the following: (1) spermathecal duct length varies between species and is associated with species boundaries, (2) there is considerable variation among populations within species, (3) there is a Wolbachia infection-by-population interaction effect on the length of the spermathecal duct, and (4) experimental curing of Wolbachia recovers the uninfected morphology. These findings suggest the following hypotheses: (1) spermathecal duct length, like other fertilization traits in Allonemobius, is evolving rapidly and influences reproductive isolation and (2) Wolbachia-induced modifications of this duct could influence the dynamics of male-female coevolution. Further experiments are needed, however, to explicitly test these latter two hypotheses.	Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA	Kansas State University	Marshall, JL (corresponding author), Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.	cricket@ksu.edu	Marshall, Jeremy/D-1436-2013		Texas [ARP 003656-0067-2001]; Kansas Agricultural Experiment Station [07-242-J]	Texas; Kansas Agricultural Experiment Station	This work was supported by a grant from the Advanced Research Program of Texas (ARP 003656-0067-2001) and the Kansas Agricultural Experiment Station (contribution # 07-242-J)	BANDI C, 1994, P ROY SOC B-BIOL SCI, V257, P43, DOI 10.1098/rspb.1994.0092; BIRKHEAD TR, 1993, J THEOR BIOL, V161, P51, DOI 10.1006/jtbi.1993.1039; BIRKHEAD TR, 2000, PROMISCUITY, P272; Braswell WE, 2006, GENOME, V49, P1069, DOI 10.1139/G06-061; Briskie JV, 1997, EVOLUTION, V51, P937, DOI 10.1111/j.1558-5646.1997.tb03674.x; Britch SC, 2001, MOL ECOL, V10, P627, DOI 10.1046/j.1365-294x.2001.01215.x; Broughton RE, 2003, GENETICS, V163, P1389; Casiraghi M, 2001, PARASITOLOGY, V122, P93, DOI 10.1017/S0031182000007149; Coyne J.A., 2004, SPECIATION; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Doherty JA, 1996, ANIM BEHAV, V51, P981, DOI 10.1006/anbe.1996.0101; DYBAS LK, 1981, EVOLUTION, V35, P168, DOI 10.1111/j.1558-5646.1981.tb04869.x; EBERHARD WG, 1996, FEMALE CONTROL SEXUA, P472; GREGORY PG, 1994, EVOLUTION, V48, P705, DOI [10.2307/2410480, 10.1111/j.1558-5646.1994.tb01355.x]; Gregory PG, 1998, ENTOMOL EXP APPL, V87, P263, DOI 10.1023/A:1003280322549; HOWARD DJ, 1991, EVOLUTION, V45, P1120, DOI 10.1111/j.1558-5646.1991.tb04379.x; Howard DJ, 1998, EVOLUTION, V52, P511, DOI 10.1111/j.1558-5646.1998.tb01650.x; HOWARD DJ, 1986, EVOLUTION, V40, P34, DOI 10.1111/j.1558-5646.1986.tb05715.x; Howard DJ, 1998, ENDLESS FORMS, P439; Ilango K, 2000, J MED ENTOMOL, V37, P653, DOI 10.1603/0022-2585-37.5.653; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; KELLER L, 1995, ADV STUD BEHAV, V24, P291, DOI 10.1016/S0065-3454(08)60397-6; Marshall JL, 2004, EVOLUTION, V58, P2409, DOI 10.1111/j.0014-3820.2004.tb00871.x; McGraw EA, 2004, CURR OPIN MICROBIOL, V7, P67, DOI 10.1016/j.mib.2003.12.003; Miller GT, 2002, SCIENCE, V298, P1230, DOI 10.1126/science.1076968; Miller GT, 2003, J EVOLUTION BIOL, V16, P114, DOI 10.1046/j.1420-9101.2003.00476.x; Morrow EH, 2000, P ROY SOC B-BIOL SCI, V267, P307, DOI 10.1098/rspb.2000.1001; Pitnick S, 1999, EVOLUTION, V53, P1804, DOI [10.2307/2640442, 10.1111/j.1558-5646.1999.tb04564.x]; Presgraves DC, 1999, P ROY SOC B-BIOL SCI, V266, P1041, DOI 10.1098/rspb.1999.0741; Simmons LW, 1999, AM NAT, V153, P302, DOI 10.1086/303171; Sokal R. R., 1995, BIOMETRY; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Swanson WJ, 1998, SCIENCE, V281, P710, DOI 10.1126/science.281.5377.710; Vacquier VD, 1993, ZYGOTE, V1, P181, DOI 10.1017/S0967199400001465; Weeks AR, 2002, TRENDS ECOL EVOL, V17, P257, DOI 10.1016/S0169-5347(02)02480-1; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587	36	17	17	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e720	10.1371/journal.pone.0000720	http://dx.doi.org/10.1371/journal.pone.0000720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684565	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452400022
J	Ramachandran, S; Xie, LH; John, SA; Subramaniam, S; Lal, R				Ramachandran, Srinivasan; Xie, Lai-Hua; John, Scott A.; Subramaniam, Shankar; Lal, Ratnesh			A Novel Role for Connexin Hemichannel in Oxidative Stress and Smoking-Induced Cell Injury	PLOS ONE			English	Article							GAP-JUNCTIONAL HEMICHANNELS; HORIZONTAL CELLS; PLASMA-MEMBRANE; CHANNELS; APOPTOSIS; PERMEABILITY; PROTEIN; MECHANISMS; TRANSPORT; PATHWAYS	Oxidative stress is linked to many pathological conditions, including ischemia, atherosclerosis and neurodegenerative disorders. The molecular mechanisms of oxidative stress induced pathophysiology and cell death are currently poorly understood. Our present work demonstrates that oxidative stress induced by reactive oxygen species and cigarette smoke extract depolarize the cell membrane and open connexin hemichannels. Under oxidative stress, connexin expression and connexin silencing resulted in increased and reduced cell deaths, respectively. Morphological and live/dead assays indicate that cell death is likely through apoptosis. Our studies provide new insights into the mechanistic role of hemichannels in oxidative stress induced cell injury.	[Subramaniam, Shankar] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Ramachandran, Srinivasan; Lal, Ratnesh] Univ Chicago, Ctr Nanomed, Chicago, IL 60637 USA; [Xie, Lai-Hua; John, Scott A.] Univ Calif Los Angeles, Cardiovasc Res Lab, Los Angeles, CA USA	University of California System; University of California San Diego; University of Chicago; University of California System; University of California Los Angeles	Subramaniam, S (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	shankar@sdsc.edu; rlal@uchicago.edu	Lal, Ratnesh/AAG-5424-2019; Ramachandran, Srinivasan/G-5300-2010	Ramachandran, Srinivasan/0000-0002-6155-4002; John, Scott/0000-0002-1232-9140; Xie, Lai-Hua/0000-0003-0613-6286	NIH; Philip Morris	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris	The work was supported by grants from NIH and Philip Morris External Grant Program.	Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Bruzzone S, 2001, FASEB J, V15, P10; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Das Sarma J, 2002, J BIOL CHEM, V277, P20911, DOI 10.1074/jbc.M111498200; DEVRIES SH, 1992, J PHYSIOL-LONDON, V445, P201, DOI 10.1113/jphysiol.1992.sp018920; EBIHARA L, 1993, J GEN PHYSIOL, V102, P59, DOI 10.1085/jgp.102.1.59; Ek-Vitorin JF, 2005, AM J PHYSIOL-CELL PH, V289, pC1535, DOI 10.1152/ajpcell.00182.2005; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; George CH, 1999, J BIOL CHEM, V274, P8678, DOI 10.1074/jbc.274.13.8678; Gomes P, 2005, INVEST OPHTH VIS SCI, V46, P1208, DOI 10.1167/iovs.04-1181; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hirsch T, 1998, CELL BIOL TOXICOL, V14, P141, DOI 10.1023/A:1007486022411; John SA, 1999, J BIOL CHEM, V274, P236, DOI 10.1074/jbc.274.1.236; Kalvelyte A, 2003, BIOCHEM PHARMACOL, V66, P1661, DOI 10.1016/S0006-2952(03)00540-9; Kourie JI, 1998, AM J PHYSIOL-CELL PH, V275, pC1, DOI 10.1152/ajpcell.1998.275.1.C1; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Li HY, 1996, J CELL BIOL, V134, P1019, DOI 10.1083/jcb.134.4.1019; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Lin JHC, 2003, J NEUROSCI, V23, P430, DOI 10.1523/JNEUROSCI.23-02-00430.2003; Liu PL, 2005, AM J PHYSIOL-LUNG C, V289, pL739, DOI 10.1152/ajplung.00099.2005; Locke D, 2004, EXP CELL RES, V298, P643, DOI 10.1016/j.yexcr.2004.05.003; MALCHOW RP, 1993, J NEUROSCI RES, V35, P237, DOI 10.1002/jnr.490350303; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mattson MP, 2001, APOPTOSIS, V6, P69, DOI 10.1023/A:1009676112184; MUSIL LS, 1993, CELL, V74, P1065, DOI 10.1016/0092-8674(93)90728-9; Napoli C, 2005, NEUROBIOL AGING, V26, P293, DOI 10.1016/j.neurobiolaging.2004.02.031; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; Quist AP, 2000, J CELL BIOL, V148, P1063, DOI 10.1083/jcb.148.5.1063; Richter C, 1996, FEBS LETT, V378, P107, DOI 10.1016/0014-5793(95)01431-4; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Saez JC, 2003, ACTA PHYSIOL SCAND, V179, P9, DOI 10.1046/j.1365-201X.2003.01196.x; Shao Q, 2005, CANCER RES, V65, P2705, DOI 10.1158/0008-5472.CAN-04-2367; SILVERSTEIN SC, 1977, ANNU REV BIOCHEM, V46, P669, DOI 10.1146/annurev.bi.46.070177.003321; Thimm J, 2005, J BIOL CHEM, V280, P10646, DOI 10.1074/jbc.M412749200; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; TRUMP B F, 1992, Current Opinion in Cell Biology, V4, P227; VanSlyke JK, 2000, METHODS, V20, P156, DOI 10.1006/meth.1999.0933; Vayssier-Taussat M, 2001, AM J PHYSIOL-HEART C, V280, pH1293, DOI 10.1152/ajpheart.2001.280.3.H1293; Verselis VK, 2000, BRAZ J MED BIOL RES, V33, P379, DOI 10.1590/S0100-879X2000000400003; YANCEY SB, 1989, J CELL BIOL, V108, P2241, DOI 10.1083/jcb.108.6.2241; Zhao HB, 2005, EUR J NEUROSCI, V21, P1859, DOI 10.1111/j.1460-9568.2005.04031.x	51	122	124	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e712	10.1371/journal.pone.0000712	http://dx.doi.org/10.1371/journal.pone.0000712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684558	Green Published, gold, Green Submitted			2022-12-27	WOS:000207452400015
J	Scheer, FAJL; Wright, KP; Kronauer, RE; Czeisler, CA				Scheer, Frank A. J. L.; Wright, Kenneth P., Jr.; Kronauer, Richard E.; Czeisler, Charles A.			Plasticity of the Intrinsic Period of the Human Circadian Timing System	PLOS ONE			English	Article							SLEEP-PHASE SYNDROME; BRIGHT LIGHT; MELATONIN SUPPRESSION; RHYTHMS; ENTRAINMENT; PACEMAKER; CLOCK; WAKEFULNESS; ADAPTATION; ASSOCIATION	Human expeditions to Mars will require adaptation to the 24.65-h Martian solar day-night cycle (sol), which is outside the range of entrainment of the human circadian pacemaker under lighting intensities to which astronauts are typically exposed. Failure to entrain the circadian time-keeping system to the desired rest-activity cycle disturbs sleep and impairs cognitive function. Furthermore, differences between the intrinsic circadian period and Earth's 24-h light-dark cycle underlie human circadian rhythm sleep disorders, such as advanced sleep phase disorder and non-24-hour sleep-wake disorders. Therefore, first, we tested whether exposure to a model-based lighting regimen would entrain the human circadian pacemaker at a normal phase angle to the 24.65-h Martian sol and to the 23.5-h day length often required of astronauts during short duration space exploration. Second, we tested here whether such prior entrainment to non-24-h light-dark cycles would lead to subsequent modification of the intrinsic period of the human circadian timing system. Here we show that exposure to moderately bright light (similar to 450 lux; similar to 1.2 W/m(2)) for the second or first half of the scheduled wake episode is effective for entraining individuals to the 24.65-h Martian sol and a 23.5-h day length, respectively. Estimations of the circadian periods of plasma melatonin, plasma cortisol, and core body temperature rhythms collected under forced desynchrony protocols revealed that the intrinsic circadian period of the human circadian pacemaker was significantly longer following entrainment to the Martian sol as compared to following entrainment to the 23.5-h day. The latter finding of after-effects of entrainment reveals for the first time plasticity of the period of the human circadian timing system. Both findings have important implications for the treatment of circadian rhythm sleep disorders and human space exploration.	[Scheer, Frank A. J. L.] Harvard Univ, Brigham & Womens Hosp, Div Sleep Med, Sch Med,Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Sleep Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Scheer, FAJL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Sleep Med, Sch Med,Dept Med, Boston, MA 02115 USA.	fscheer@rics.bwh.harvard.edu	Scheer, Frank A.J.L./C-2795-2012	Scheer, Frank A.J.L./0000-0002-2014-7582; Czeisler, Charles Andrew/0000-0002-7408-1849	National Institute of Neurological Disorders and Stroke [R01-NS41886]; National Centers for Research Resources [M01-RR02635]; National Sleep Foundation; NASA [NCC 9-58];  [R01 HL081761]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002635] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041886] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Centers for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Sleep Foundation; NASA(National Aeronautics & Space Administration (NASA)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from the National Institute of Neurological Disorders and Stroke (R01-NS41886) and the National Centers for Research Resources (M01-RR02635). FAJLS is supported by a Pickwick Fellowship from the National Sleep Foundation. KPW is supported by R01 HL081761. CAC is supported by NASA Cooperation Agreement NCC 9-58 with the National Space Biomedical Research Institute. The sponsors or funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Archer SN, 2003, SLEEP, V26, P413, DOI 10.1093/sleep/26.4.413; ASCHOFF J, 1962, NATURWISSENSCHAFTEN, V49, P337; Aton SJ, 2004, J BIOL RHYTHM, V19, P198, DOI 10.1177/0748730404264156; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Boivin DB, 1996, NATURE, V379, P540, DOI 10.1038/379540a0; Borbely A A, 1982, Hum Neurobiol, V1, P195; CZEISLER CA, 1989, SCIENCE, V244, P1328, DOI 10.1126/science.2734611; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; DeCoursey PJ, 1989, CIRCADIAN CLOCKS ECO, P187; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; Dijk DJ, 2001, AM J PHYSIOL-REG I, V281, pR1647, DOI 10.1152/ajpregu.2001.281.5.R1647; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; EASTMAN CI, 1990, AM J PHYSIOL, V259, pR1189, DOI 10.1152/ajpregu.1990.259.6.R1189; Ebisawa T, 2001, EMBO REP, V2, P342, DOI 10.1093/embo-reports/kve070; ESKINA, 1971, BIOCHRONOMETRY, P55; Gronfier C, 2007, P NATL ACAD SCI USA, V104, P9081, DOI 10.1073/pnas.0702835104; Hebert M, 2002, J PINEAL RES, V33, P198, DOI 10.1034/j.1600-079X.2002.01885.x; HONMA KI, 1992, AM J PHYSIOL, V262, pR885, DOI 10.1152/ajpregu.1992.262.5.R885; IBUKA N, 1975, BRAIN RES, V96, P76, DOI 10.1016/0006-8993(75)90574-0; Jasser SA, 2006, J BIOL RHYTHM, V21, P394, DOI 10.1177/0748730406292391; Jones CR, 1999, NAT MED, V5, P1062, DOI 10.1038/12502; Kelly TL, 1999, J BIOL RHYTHM, V14, P190, DOI 10.1177/074873099129000597; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; KLEIN T, 1993, SLEEP, V16, P333, DOI 10.1093/sleep/16.4.333; Klerman EB, 1999, J BIOL RHYTHM, V14, P260, DOI 10.1177/074873099129000678; Kronauer RE, 1999, J BIOL RHYTHM, V14, P500, DOI 10.1177/074873099129001073; Lockley SW, 2000, J ENDOCRINOL, V164, pR1, DOI 10.1677/joe.0.164R001; Lockley SW, 1997, J BIOL RHYTHM, V12, P16, DOI 10.1177/074873049701200104; Lockley SW, 1997, J CLIN ENDOCR METAB, V82, P3763, DOI 10.1210/jc.82.11.3763; Lockley SW, 2003, J CLIN ENDOCR METAB, V88, P4502, DOI 10.1210/jc.2003-030570; Nelson DE, 1999, AM J PHYSIOL-REG I, V277, pR1351, DOI 10.1152/ajpregu.1999.277.5.R1351; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Richter C. P., 1968, Communications in Behavioral Biology (Ser A), V1, P305; Sack RL, 2000, NEW ENGL J MED, V343, P1070, DOI 10.1056/NEJM200010123431503; Shen HM, 1997, J NEUROSCI, V17, P5221; Smith KA, 2004, J CLIN ENDOCR METAB, V89, P3610, DOI 10.1210/jc.2003-032100; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; vandenPol AN, 1996, J NEUROSCI, V16, P5883; WEVER RA, 1989, J BIOL RHYTHM, V4, P161; WEVER RA, 1979, CIRCADIAN SYSTEM MAN, P276; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; Wright KP, 2006, J COGNITIVE NEUROSCI, V18, P508, DOI 10.1162/jocn.2006.18.4.508; Wright KP, 2001, P NATL ACAD SCI USA, V98, P14027, DOI 10.1073/pnas.201530198; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Zeitzer JM, 2000, J PHYSIOL-LONDON, V526, P695, DOI 10.1111/j.1469-7793.2000.00695.x	48	88	102	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e721	10.1371/journal.pone.0000721	http://dx.doi.org/10.1371/journal.pone.0000721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684566	gold, Green Submitted, Green Published			2022-12-27	WOS:000207452400023
J	Zumdieck, A; Kruse, K; Bringmann, H; Hyman, AA; Julicher, F				Zumdieck, Alexander; Kruse, Karsten; Bringmann, Henrik; Hyman, Anthony A.; Juelicher, Frank			Stress Generation and Filament Turnover during Actin Ring Constriction	PLOS ONE			English	Article								We present a physical analysis of the dynamics and mechanics of contractile actin rings. In particular, we analyze the dynamics of ring contraction during cytokinesis in the Caenorhabditis elegans embryo. We present a general analysis of force balances and material exchange and estimate the relevant parameter values. We show that on a microscopic level contractile stresses can result from both the action of motor proteins, which cross-link filaments, and from the polymerization and depolymerization of filaments in the presence of end-tracking cross-linkers.	[Zumdieck, Alexander; Kruse, Karsten; Juelicher, Frank] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Bringmann, Henrik; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Max Planck Society; Max Planck Society	Julicher, F (corresponding author), Max Planck Inst Phys Komplexer Syst, Dresden, Germany.	julicher@pks.mpg.de	Julicher, Frank/B-1828-2009; Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011; Kruse, Karsten/GOG-8298-2022	Julicher, Frank/0000-0003-4731-9185; Hyman, Anthony A/0000-0003-3664-154X; Kruse, Karsten/0000-0001-8665-2349	Max Planck Society	Max Planck Society(Max Planck Society)	This work was funded by the Max Planck Society.	Biron D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098102; BRENNER S, 1974, GENETICS, V77, P71; Bringmann H, 2005, NATURE, V436, P731, DOI 10.1038/nature03823; Dickinson RB, 2004, BIOPHYS J, V87, P2838, DOI 10.1529/biophysj.104.045211; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Gerisch G, 2000, CURR OPIN CELL BIOL, V12, P126, DOI 10.1016/S0955-0674(99)00066-6; He XY, 1997, EXP CELL RES, V233, P252, DOI 10.1006/excr.1997.3585; HUXLEY AF, 1954, NATURE, V173, P971, DOI 10.1038/173971a0; KANBE T, 1989, J CELL SCI, V94, P647; Kruse K, 2000, PHYS REV LETT, V85, P1778, DOI 10.1103/PhysRevLett.85.1778; Kruse K, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051913; Kruse K, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.031904; Kruse K, 2003, EUROPHYS LETT, V64, P716, DOI 10.1209/epl/i2003-00618-2; Kruse K, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.138101; Kruse K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.078101; Kruse K, 2005, EUR PHYS J E, V16, P5, DOI 10.1140/epje/e2005-00002-5; MABUCHI I, 1977, J CELL BIOL, V74, P251, DOI 10.1083/jcb.74.1.251; Matzke R, 2001, NAT CELL BIOL, V3, P607, DOI 10.1038/35078583; MAUPIN P, 1986, J ULTRA MOL STRUCT R, V94, P92, DOI 10.1016/0889-1605(86)90055-8; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Park S, 2005, BIOPHYS J, V89, P4330, DOI 10.1529/biophysj.104.053462; Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999; RAPPAPORT R, 1967, SCIENCE, V156, P1241, DOI 10.1126/science.156.3779.1241; Rappaport R., 1996, CYTOKINESIS ANIMAL C; Schroeder T E, 1975, Soc Gen Physiol Ser, V30, P305; SCHROEDER TE, 1990, ANN NY ACAD SCI, V582, P78; TAKIGUCHI K, 1991, J BIOCHEM-TOKYO, V109, P520, DOI 10.1093/oxfordjournals.jbchem.a123414; Tanaka-Takiguchi Y, 2004, J MOL BIOL, V341, P467, DOI 10.1016/j.jmb.2004.06.019; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Zhang WD, 2005, P NATL ACAD SCI USA, V102, P7186, DOI 10.1073/pnas.0502545102	32	85	85	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e696	10.1371/journal.pone.0000696	http://dx.doi.org/10.1371/journal.pone.0000696			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684545	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452400002
J	Merrin, J; Leibler, S; Chuang, JS				Merrin, Jack; Leibler, Stanislas; Chuang, John S.			Printing Multistrain Bacterial Patterns with a Piezoelectric Inkjet Printer	PLOS ONE			English	Article								Many studies involving interacting microorganisms would benefit from simple devices able to deposit cells in precisely defined patterns. We describe an inexpensive bacterial piezoelectric inkjet printer (adapted from the design of the POSaM oligonucleotide microarrayer) that can be used to "print out" different strains of bacteria or chemicals in small droplets onto a flat surface at high resolution. The capabilities of this device are demonstrated by printing ordered arrays comprising two bacterial strains labeled with different fluorescent proteins. We also characterized several properties of this piezoelectric printer, such as the droplet volume (of the order of tens of pl), the distribution of number of cells in each droplet, and the dependence of droplet volume on printing frequency. We established the limits of the printing resolution, and determined that the printed viability of Escherichia coli exceeded 98.5%.	[Chuang, John S.] Rockefeller Univ, Lab Living Matter, New York, NY 10021 USA; Rockefeller Univ, Ctr Phys & Biol, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Chuang, JS (corresponding author), Rockefeller Univ, Lab Living Matter, 1230 York Ave, New York, NY 10021 USA.	chuangj@mail.rockefeller.edu			NIH [F32]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: JSC was supported by an NIH F32 postdoctoral fellowship.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Hasman H, 2000, J BACTERIOL, V182, P1089, DOI 10.1128/JB.182.4.1089-1095.2000; Lausted C, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r58; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; NAGELMAEKER PM, 2006, THESIS EINDHOVEN U T; Pardo L, 2003, LANGMUIR, V19, P1462, DOI 10.1021/la026171u; Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052; Sanjana NE, 2004, J NEUROSCI METH, V136, P151, DOI 10.1016/j.jneumeth.2004.01.011; Shimoda T, 2003, MRS BULL, V28, P821, DOI 10.1557/mrs2003.231; Sirringhaus H, 2000, SCIENCE, V290, P2123, DOI 10.1126/science.290.5499.2123; Wang Y, 2004, P SOC PHOTO-OPT INS, V5374, P628, DOI 10.1117/12.541711; Watanabe K, 2003, ZOOL SCI, V20, P429, DOI 10.2108/zsj.20.429; Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011; Xu T, 2004, BIOTECHNOL BIOENG, V85, P29, DOI 10.1002/bit.10768	15	49	50	6	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e663	10.1371/journal.pone.0000663	http://dx.doi.org/10.1371/journal.pone.0000663			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653283	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452200025
J	Pelozuelo, L; Meusnier, S; Audiot, P; Bourguet, D; Ponsard, S				Pelozuelo, Laurent; Meusnier, Serge; Audiot, Philippe; Bourguet, Denis; Ponsard, Sergine			Assortative Mating between European Corn Borer Pheromone Races: Beyond Assortative Meeting	PLOS ONE			English	Article							OSTRINIA-NUBILALIS HUBNER; CABBAGE-LOOPER MOTH; HOST-PLANT RACES; SEX-PHEROMONE; LEPIDOPTERA-PYRALIDAE; COMMUNICATION-SYSTEM; BLEND DISCRIMINATION; GENETIC ISOLATION; EVOLUTION; STRAINS	Background. Sex pheromone communication systems may be a major force driving moth speciation by causing behavioral reproductive isolation via assortative meeting of conspecific individuals. The 'E' and 'Z' pheromone races of the European corn borer (ECB) are a textbook example in this respect. 'Z' females produce and 'Z' males preferentially respond to a 'Z' pheromone blend, while the 'E' race communicates via an 'E' blend. Both races do not freely hybridize in nature and their populations are genetically differentiated. A straightforward explanation would be that their reproductive isolation is a mere consequence of "assortative meeting" resulting from their different pheromones specifically attracting males towards same-race females at long range. However, previous laboratory experiments and those performed here show that even when moths are paired in a small box - i.e., when the meeting between sexual partners is forced - inter-race couples still have a lower mating success than intra-race ones. Hence, either the difference in attractivity of E vs. Z pheromones for males of either race still holds at short distance or the reproductive isolation between E and Z moths may not only be favoured by assortative meeting, but must also result from an additional mechanism ensuring significant assortative mating at close range. Here, we test whether this close-range mechanism is linked to the E/Z female sex pheromone communication system. Methodology/Principal Findings. Using crosses and backcrosses of E and Z strains, we found no difference in mating success between full-sisters emitting different sex pheromones. Conversely, the mating success of females with identical pheromone types but different coefficients of relatedness to the two parental strains was significantly different, and was higher when their genetic background was closer to that of their male partner's pheromone race. Conclusions/Significance. We conclude that the close-range mechanism ensuring assortative mating between the E and Z ECB pheromone races is unrelated to the difference in female sex pheromone. Although the nature of this mechanism remains elusive, our results show that it is expressed in females, acts at close range, segregates independently of the autosome carrying Pher and of both sex chromosomes, and is widely distributed since it occurs both in France and in the USA.	[Ponsard, Sergine] Univ Toulouse 3, CNRS, UMR 5172, Lab Dynam Biodiversite, F-31062 Toulouse, France; [Pelozuelo, Laurent] Univ Tokyo, Grad Sch Agr & Life Sci, Appl Entomol Lab, Tokyo, Japan; [Meusnier, Serge; Audiot, Philippe; Bourguet, Denis] INRA, CBGP, UMR 1062, Montferrier Sur Lez, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Tokyo; INRAE; Institut de Recherche pour le Developpement (IRD)	Ponsard, S (corresponding author), Univ Toulouse 3, CNRS, UMR 5172, Lab Dynam Biodiversite, F-31062 Toulouse, France.	ponsard@cict.fr		Bourguet, Denis/0000-0002-2109-5323	Institut Francais de la Biodiversite; Centre National de la Recherche Scientifique; French Ministere de l'education nationale, de l'enseignement superieur et de la recherche	Institut Francais de la Biodiversite; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French Ministere de l'education nationale, de l'enseignement superieur et de la recherche	Funding sources were the Institut Francais de la Biodiversite (AO "Biodiversite et Changement Global''), the Centre National de la Recherche Scientifique (AO "Impact des Biotechnologies sur les Agroecosystemes) and the French Ministere de l'education nationale, de l'enseignement superieur et de la recherche (AO "Fonctionnement et Dynamique de la Biosphere Continentale").	Bartels DW, 1997, J ECON ENTOMOL, V90, P449, DOI 10.1093/jee/90.2.449; Bethenod MT, 2005, HEREDITY, V94, P264, DOI 10.1038/sj.hdy.6800611; Bontemps A, 2004, P ROY SOC B-BIOL SCI, V271, P2179, DOI 10.1098/rspb.2004.2851; Bourguet D, 2000, P ROY SOC B-BIOL SCI, V267, P1177, DOI 10.1098/rspb.2000.1126; Butlin RK, 1997, INSECT PHEROMONE RESEARCH, P548; Byers JA, 2005, J THEOR BIOL, V235, P199, DOI 10.1016/j.jtbi.2005.01.003; CARDE RT, 1978, SCIENCE, V199, P555, DOI 10.1126/science.199.4328.555; CARDE RT, 1975, ENVIRON ENTOMOL, V4, P413, DOI 10.1093/ee/4.3.413; Coracini M, 2003, NATURWISSENSCHAFTEN, V90, P419, DOI 10.1007/s00114-003-0456-x; CORNFORD ME, 1973, ANN ENTOMOL SOC AM, V66, P1079, DOI 10.1093/aesa/66.5.1079; Coyne J.A., 2004, SPECIATION; Dopman EB, 2005, P NATL ACAD SCI USA, V102, P14706, DOI 10.1073/pnas.0502054102; Dopman EB, 2004, GENETICS, V167, P301, DOI 10.1534/genetics.167.1.301; Dugdale JS, 1997, INSECT PHEROMONE RESEARCH, P463; Ellegren H, 2005, TRENDS ECOL EVOL, V20, P180, DOI 10.1016/j.tree.2005.01.015; Emelianov I, 2001, EVOLUTION, V55, P2002, DOI 10.1111/j.0014-3820.2001.tb01317.x; ESHEL I, 1982, P NATL ACAD SCI-BIOL, V79, P1331, DOI 10.1073/pnas.79.4.1331; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Fisher R.A., 1992, BREAKTHROUGHS STAT, P66, DOI DOI 10.1007/978-1-4612-4380-9_6; Foster SP, 1997, INSECT PHEROMONE RESEARCH, P514; GAHUKAR R T, 1975, Annales de Zoologie Ecologie Animale, V7, P491; GLOVER T, 1990, ARCH INSECT BIOCHEM, V15, P67, DOI 10.1002/arch.940150202; GLOVER T, 1991, ENV ENTOMOL, V20; GLOVER TJ, 1987, J CHEM ECOL, V13, P143, DOI 10.1007/BF01020358; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; HANSSON BS, 1987, NATURWISSENSCHAFTEN, V74, P497, DOI 10.1007/BF00447935; HARRISON RG, 1977, ANN ENTOMOL SOC AM, V70, P717, DOI 10.1093/aesa/70.5.717; HARTIGAN PM, 1985, J R STAT SOC C-APPL, V34, P320; Haynes KF, 1997, INSECT PHEROMONE RESEARCH, P525; KLUN JA, 1973, SCIENCE, V181, P661, DOI 10.1126/science.181.4100.661; KLUN JA, 1979, ENVIRON ENTOMOL, V8, P423, DOI 10.1093/ee/8.3.423; Kochansky J, 1975, J CHEM ECOL, V1, P225, DOI 10.1007/BF00987871; LASSANCE JM, 2006, 22 ANN M INT SOC CHE, P151; LIEBHERR J, 1975, ANN ENTOMOL SOC AM, V68, P305, DOI 10.1093/aesa/68.2.305; Linn CE, 1997, PHYSIOL ENTOMOL, V22, P212, DOI 10.1111/j.1365-3032.1997.tb01161.x; LIU YB, 1992, J CHEM ECOL, V18, P299, DOI 10.1007/BF00994233; LOFSTEDT C, 1993, PHILOS T R SOC B, V340, P167, DOI 10.1098/rstb.1993.0055; LOFSTEDT C, 1986, NATURE, V323, P621, DOI 10.1038/323621a0; LOFSTEDT C, 1985, J CHEM ECOL, V11, P649, DOI 10.1007/BF00988574; Lofstedt C., 1991, Chemoecology, V2, P20, DOI 10.1007/BF01240662; LOFSTEDT C, 1989, GENETICS, V123, P553; Malausa T, 2005, SCIENCE, V308, P258, DOI 10.1126/science.1107577; Marcotte M, 2003, J INSECT PHYSIOL, V49, P81, DOI 10.1016/S0022-1910(02)00251-2; Martel C, 2003, HEREDITY, V90, P141, DOI 10.1038/sj.hdy.6800186; NAGAI T, 1997, J INSECT PHYSL, V23, P591; Nakano R, 2006, NATURWISSENSCHAFTEN, V93, P292, DOI 10.1007/s00114-006-0100-7; Newcomb RD, 1998, BIOCHEM SYST ECOL, V26, P473, DOI 10.1016/S0305-1978(98)00015-5; Ngollo ED, 2000, J ECON ENTOMOL, V93, P256, DOI 10.1603/0022-0493-93.2.256; PATERSON HEH, 1978, S AFR J SCI, V74, P369; Pelozuelo L, 2004, J CHEM ECOL, V30, P335, DOI 10.1023/B:JOEC.0000017981.03762.ed; PENA A, 1988, J CHEM ECOL, V14, P1359, DOI 10.1007/BF01020140; Robinson R, 1971, LEPIDOPTERA GENETICS; ROELOFS W, 1987, P NATL ACAD SCI USA, V84, P7585, DOI 10.1073/pnas.84.21.7585; Roelofs WL, 2003, P NATL ACAD SCI USA, V100, P9179, DOI 10.1073/pnas.1233767100a; ROELOFS WL, 1982, ANNU REV ECOL SYST, V13, P395, DOI 10.1146/annurev.es.13.110182.002143; ROYER L, 1993, FUNCT ECOL, V7, P209, DOI 10.2307/2389889; ROYER L, 1992, CAN ENTOMOL, V124, P113, DOI 10.4039/Ent124113-1; Schlaepfer MA, 2000, CAN J ZOOL, V78, P2045, DOI 10.1139/cjz-78-11-2045; SHOWERS WB, 1976, ENVIRON ENTOMOL, V5, P1099, DOI 10.1093/ee/5.6.1099; Sorenson CE, 2005, ENVIRON ENTOMOL, V34, P1057, DOI 10.1603/0046-225X(2005)034[1057:GVIPRO]2.0.CO;2; SPERLING FAH, 1995, CAN ENTOMOL, V127, P277, DOI 10.4039/Ent127277-3; Sturtevant AH, 1915, AM NAT, V49, P42, DOI 10.1086/279453; Takanashi T, 2005, BIOL J LINN SOC, V84, P143, DOI 10.1111/j.1095-8312.2005.00421.x; Teal PEA, 1997, INSECT PHEROMONE RESEARCH, P535; Thomas Y, 2003, EVOLUTION, V57, P261; Valeur PG, 1996, ENTOMOL EXP APPL, V79, P51, DOI 10.1007/BF00333821; WHITE CS, 1995, SPECIATION RECOGNITI; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; WIZGALL P, 1991, J CHEM ECOL, V17, P1355; Zhu JW, 1996, GENETICS, V144, P757; Zhu JW, 1997, J INSECT BEHAV, V10, P805, DOI 10.1023/B:JOIR.0000010414.28494.9a	71	27	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2007	2	6							e555	10.1371/journal.pone.0000555	http://dx.doi.org/10.1371/journal.pone.0000555			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GE	17579726	gold, Green Published			2022-12-27	WOS:000207451700020
J	Benoit, M; Fenollar, F; Raoult, D; Mege, JL				Benoit, Marie; Fenollar, Florence; Raoult, Didier; Mege, Jean-Louis			Increased Levels of Circulating IL-16 and Apoptosis Markers Are Related to the Activity of Whipple's Disease	PLOS ONE			English	Article								Background. Whipple's disease (WD) is an infectious disease caused by Tropheryma whipplei, which replicates in macrophages and induces the release of interleukin (IL)-16, a substrate of caspase 3, and macrophage apoptosis. The disease is characterized by intestinal, cardiac or neurological manifestations; its diagnosis is based on invasive analysis requiring tissue biopsies or cerebrospinal fluid puncture. The disease progression is slow and often complicated by relapses despite empirical antibiotic treatment. Methodology/Principal findings. We monitored circulating levels of IL-16 and nucleosomes in 36 French patients with WD; among them, some patients were enrolled in a longitudinal follow-up. As compared to control subjects, the circulating levels of both IL-16 and nucleosomes were increased in untreated patients with WD presenting as intestinal, cardiac or neurological manifestations. This finding was specific to WD since the circulating levels of IL-16 and nucleosomes were not increased in patients with unrelated inflammatory diseases such as inflammatory bowel disease or Q fever endocarditis. We also found that increased levels of IL-16 and nucleosomes were related to the activity of the disease. Indeed, successful antibiotic treatment decreased those levels down to those of control subjects. In contrast, patients who suffered from relapses exhibited circulating levels of IL-16 and nucleosomes as high as those of untreated patients. Conclusions/Significance. Circulating levels of both IL-16 and nucleosomes were increased in WD. This finding provides simple and non-invasive tools for the diagnosis and the prognosis of WD.	[Benoit, Marie; Fenollar, Florence; Raoult, Didier; Mege, Jean-Louis] Univ Aix Marseille 2, Unite Rickettsies, CNRS,Fac Med, Unite Mixte Rech 6020,Inst Federatif Rech 48, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Mege, JL (corresponding author), Univ Aix Marseille 2, Unite Rickettsies, CNRS,Fac Med, Unite Mixte Rech 6020,Inst Federatif Rech 48, Marseille, France.	Jean-Louis.Mege@medecine.univ-mrs.fr	MEGE, JEAN-LOUIS/O-6063-2016; RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974				Beller E, 2006, FUTURE CHILD, V16, P19, DOI 10.1353/foc.2006.0012; Bentley SD, 2003, LANCET, V361, P637, DOI 10.1016/S0140-6736(03)12597-4; Blaschke S, 2001, J RHEUMATOL, V28, P12; Capo C, 1999, J IMMUNOL, V163, P6078; Cruikshank WW, 2000, J LEUKOCYTE BIOL, V67, P757, DOI 10.1002/jlb.67.6.757; Desnues B, 2005, J INFECT DIS, V192, P1642, DOI 10.1086/491745; Desnues B, 2005, J IMMUNOL, V175, P4575, DOI 10.4049/jimmunol.175.7.4575; Durand DV, 1997, MEDICINE, V76, P170, DOI 10.1097/00005792-199705000-00003; Ehrbar HU, 1999, LANCET, V353, P2214, DOI 10.1016/S0140-6736(99)01776-6; Elssner A, 2004, J IMMUNOL, V172, P7721, DOI 10.4049/jimmunol.172.12.7721; Fenollar F, 2001, CLIN DIAGN LAB IMMUN, V8, P1, DOI 10.1128/CDLI.8.1.1-8.2001; Fenollar F, 2004, J CLIN MICROBIOL, V42, P401, DOI 10.1128/JCM.42.1.401-403.2004; Fenollar F, 2003, J INFECT DIS, V188, P828, DOI 10.1086/378093; Fenollar F, 2007, NEW ENGL J MED, V356, P55, DOI 10.1056/NEJMra062477; Fournier PE, 1998, J CLIN MICROBIOL, V36, P1823, DOI 10.1128/JCM.36.7.1823-1834.1998; Holdenrieder S, 2005, CLIN CHEM, V51, P1544, DOI 10.1373/clinchem.2005.049320; La Scola B, 2001, INT J SYST EVOL MICR, V51, P1471, DOI 10.1099/00207713-51-4-1471; LABERGE S, 1995, J IMMUNOL, V155, P2902; Lepidi H, 2004, J INFECT DIS, V190, P935, DOI 10.1086/422845; Lepidi H, 2003, HUM PATHOL, V34, P589, DOI 10.1016/S0046-8177(03)00126-6; Lim KG, 1996, J IMMUNOL, V156, P2566; Mahnel R, 2004, CLIN EXP MED, V4, P39, DOI 10.1007/s10238-004-0036-1; Maiwald M, 1998, APPL ENVIRON MICROB, V64, P760; MAIZEL H, 1970, MEDICINE, V49, P175, DOI 10.1097/00005792-197005000-00001; Marth T, 2003, LANCET, V361, P239, DOI 10.1016/S0140-6736(03)12274-X; Marth T, 1996, LANCET, V348, P66, DOI 10.1016/S0140-6736(05)64400-5; Middel P, 2001, GUT, V49, P795, DOI 10.1136/gut.49.6.795; Raoult D, 2000, NEW ENGL J MED, V342, P620, DOI 10.1056/NEJM200003023420903; Raoult D, 2003, GENOME RES, V13, P1800, DOI 10.1101/gr.1474603; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; Rumsaeng V, 1997, J IMMUNOL, V159, P2904; Seegert D, 2001, GUT, V48, P326, DOI 10.1136/gut.48.3.326; Singer R, 1998, DRUGS, V55, P699, DOI 10.2165/00003495-199855050-00007; Skundric DS, 2005, J AUTOIMMUN, V25, P206, DOI 10.1016/j.jaut.2005.09.016; Skundric DS, 2005, J NEUROSCI RES, V79, P680, DOI 10.1002/jnr.20377; Skundric DS, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-13; Street S, 1999, LANCET, V354, P1178, DOI 10.1016/S0140-6736(99)03065-2; Travis SPL, 2006, GUT, V55, DOI 10.1136/gut.2005.081950b; Whipple GH, 1907, B JOHNS HOPKINS HOSP, V18, P382; Wu DMH, 1999, J IMMUNOL, V162, P1287; YARDLEY JH, 1961, B JOHNS HOPKINS HOSP, V109, P80; Zhang YJ, 1998, J BIOL CHEM, V273, P1144, DOI 10.1074/jbc.273.2.1144	42	26	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e494	10.1371/journal.pone.0000494	http://dx.doi.org/10.1371/journal.pone.0000494			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551575	gold, Green Published			2022-12-27	WOS:000207451500004
J	Guest, CB; Hartman, ME; O'Connor, JC; Chakour, KS; Sovari, AA; Freund, GG				Guest, Christopher B.; Hartman, Matthew E.; O'Connor, Jason C.; Chakour, Kenneth S.; Sovari, Ali A.; Freund, Gregory G.			Phagocytosis of Cholesteryl Ester Is Amplified in Diabetic Mouse Macrophages and Is Largely Mediated by CD36 and SR-A	PLOS ONE			English	Article								Type 2 diabetes (T2D) is associated with accelerated atherosclerosis, which accounts for approximately 75% of all diabetes-related deaths. Here we investigate the link between diabetes and macrophage cholesteryl ester accumulation. When diabetic (db/db) mice are given cholesteryl ester intraperitoneally (IP), peritoneal macrophages (PerM Phi s) recovered from these animals showed a 58% increase in intracellular cholesteryl ester accumulation over PerM Phi s from heterozygote control (db/+) mice. Notably, PerM Phi fluid-phase endocytosis and large particle phagocytosis was equivalent in db/+ and db/db mice. However, IP administration of CD36 and SR-A blocking antibodies led to 37% and 25% reductions in cholesteryl ester accumulation in PerM Phi. Finally, in order to determine if these scavenger receptors (SRs) were part of the mechanism responsible for the increased accumulation of cholesteryl esters observed in the diabetic mouse macrophages, receptor expression was quantified by flow cytometry. Importantly, db/db PerM Phi s showed a 43% increase in CD36 expression and an 80% increase in SR-A expression. Taken together, these data indicate that direct cholesteryl ester accumulation in mouse macrophages is mediated by CD36 and SR-A, and the magnitude of accumulation is increased in db/db macrophages due to increased scavenger receptor expression.	[Guest, Christopher B.; O'Connor, Jason C.; Freund, Gregory G.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Hartman, Matthew E.; Freund, Gregory G.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Freund, Gregory G.] Univ Illinois, Dept Pathol, Urbana, IL 61801 USA; [Guest, Christopher B.; Chakour, Kenneth S.; Sovari, Ali A.; Freund, Gregory G.] Univ Illinois, Coll Med, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Freund, GG (corresponding author), Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA.	freun@uiuc.edu		Hartman, Matt/0000-0002-6238-1887	National Institutes of Health [DK064862, NS046227]; Ruth Kirschstein Institutional NRSA [5T32 DK59802]; American Heart Association; University of Illinois Agricultural Experiment Station; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK059802, R01DK064862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS046227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth Kirschstein Institutional NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Illinois Agricultural Experiment Station; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the National Institutes of Health (DK064862 to G. G. F, NS046227 to M. E. H., Ruth Kirschstein Institutional NRSA 5T32 DK59802 to the Division of Nutritional Sciences and Predoctoral Fellowship to C. B. G.), American Heart Association (Established Investigator Award to G. G. F and Predoctoral Fellowship to J. C. O.), University of Illinois Agricultural Experiment Station (to G. G. F.).	Aronson D, 2002, CARDIOVASC DIABETOL, V1, DOI 10.1186/1475-2840-1-1; Askari B, 2002, HISTOL HISTOPATHOL, V17, P1317, DOI 10.14670/HH-17.1317; BALL RY, 1995, ATHEROSCLEROSIS, V114, P45, DOI 10.1016/0021-9150(94)05463-S; BROWN MS, 1980, J BIOL CHEM, V255, P9344; Ceddia MA, 1999, J APPL PHYSIOL, V87, P2253, DOI 10.1152/jappl.1999.87.6.2253; de Villiers WJS, 1999, J LEUKOCYTE BIOL, V66, P740, DOI 10.1002/jlb.66.5.740; Deszo EL, 2001, J BIOL CHEM, V276, P10212, DOI 10.1074/jbc.M010589200; EPPS DE, 1995, CHEM PHYS LIPIDS, V77, P51, DOI 10.1016/0009-3084(95)02454-Q; Gargalovic P, 2003, J LIPID RES, V44, P11, DOI 10.1194/jlr.R200005-JLR200; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; GORDON D, 1990, P NATL ACAD SCI USA, V87, P4600, DOI 10.1073/pnas.87.12.4600; Greaves DR, 1998, CURR OPIN LIPIDOL, V9, P425, DOI 10.1097/00041433-199810000-00006; Guyton JR, 1996, ARTERIOSCL THROM VAS, V16, P4, DOI 10.1161/01.ATV.16.1.4; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hiltunen TP, 1998, ATHEROSCLEROSIS, V137, pS81, DOI 10.1016/S0021-9150(97)00307-9; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hurst RT, 2003, ANN INTERN MED, V139, P824, DOI 10.7326/0003-4819-139-10-200311180-00010; Jagasia Dinesh, 2003, Congest Heart Fail, V9, P133, DOI 10.1111/j.1527-5299.2002.00901.x; KATZ S S, 1976, Journal of Clinical Investigation, V58, P200; Kellner-Weibel G, 1998, ARTERIOSCL THROM VAS, V18, P423, DOI 10.1161/01.ATV.18.3.423; LESNIK P, 1992, P NATL ACAD SCI USA, V89, P10370, DOI 10.1073/pnas.89.21.10370; Liang CP, 2004, J CLIN INVEST, V113, P764, DOI [10.1172/JCI200419528, 10.1172/JCI19528]; MAHLBERG FH, 1990, BIOCHIM BIOPHYS ACTA, V1045, P291, DOI 10.1016/0005-2760(90)90133-I; MCGOOKEY DJ, 1983, J CELL BIOL, V97, P1156, DOI 10.1083/jcb.97.4.1156; ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043; Sampson MJ, 2003, ATHEROSCLEROSIS, V167, P129, DOI 10.1016/S0021-9150(02)00421-5; Silverstein RL, 2000, CURR OPIN LIPIDOL, V11, P483, DOI 10.1097/00041433-200010000-00006; SNOW JW, 1988, BIOCHEMISTRY-US, V27, P3640, DOI 10.1021/bi00410a018; Stangl H, 1998, J BIOL CHEM, V273, P31002, DOI 10.1074/jbc.273.47.31002; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Takahashi Kiyoshi, 2002, Medical Electron Microscopy, V35, P179, DOI 10.1007/s007950200023; TANGIRALA RK, 1993, J BIOL CHEM, V268, P9653; Tyteca D, 2002, EXP CELL RES, V281, P86, DOI 10.1006/excr.2002.5613; WILLIAMS G, 1999, HDB DIABETES	34	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e511	10.1371/journal.pone.0000511	http://dx.doi.org/10.1371/journal.pone.0000511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551591	Green Submitted, gold, Green Published			2022-12-27	WOS:000207451500020
J	Lima, MMS; Andersen, ML; Reksidler, AB; Vital, MABF; Tufik, S				Lima, Marcelo M. S.; Andersen, Monica L.; Reksidler, Angela B.; Vital, Maria A. B. F.; Tufik, Sergio			The Role of the Substantia Nigra Pars Compacta in Regulating Sleep Patterns in Rats	PLOS ONE			English	Article								Background. As of late, dopaminergic neurotransmission has been recognized to be involved in the generation of sleep disturbances. Increasing evidence shows that sleep disturbances in Parkinson's disease (PD) patients are mostly related to the disease itself, rather than being a secondary phenomenon. Evidence contained in the literature lends support to the hypothesis that the dopaminergic nigrostriatal pathway is closely involved in the regulation of sleep patterns. Methodology/Principal Findings. To test this hypothesis we examined the electrophysiological activity along the sleep-wake cycle of rats submitted to a surgically induced lesion of the SNpc by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). We demonstrated that a 50% lesion of the substantia nigra pars compacta (SNpc) suffices to produce disruptions of several parameters in the sleep-wake pattern of rats. A robust and constant decrease in the latency to the onset of slow wave sleep (SWS) was detected throughout the five days of recording in both light [F-(22.16) = 72.46, p<0.0001] and dark [F-(22.16) = 75.0, p<0.0001] periods. Also found was a pronounced increase in the percentage of sleep efficiency during the first four days of recording [F-(21.15) = 21.48, p<0.0001], in comparison to the sham group. Additionally, the reduction in the SNpc dopaminergic neurons provoked an ablation in the percentage of rapid eye movement sleep (REM) during three days of the sleep-wake recording period with a strong correlation (r = 0.91; p<0.0001) between the number of dopaminergic neurons lost and the percentage decrease of REM sleep on the first day of recording. On day 4, the percentage of REM sleep during the light and dark periods was increased, [F-(22.16) = 2.46, p<0.0007], a phenomenon consistent with REM rebound. Conclusions/Significance. We propose that dopaminergic neurons present in the SNpc possess a fundamental function in the regulation of sleep processes, particularly in promoting REM sleep.	[Lima, Marcelo M. S.; Andersen, Monica L.; Tufik, Sergio] Univ Fed Sao Paulo, Dept Psicobiol, Sao Paulo, Brazil; [Reksidler, Angela B.; Vital, Maria A. B. F.] Univ Fed Parana, Dept Farmacol, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Parana	Lima, MMS (corresponding author), Univ Fed Sao Paulo, Dept Psicobiol, Sao Paulo, Brazil.	mmeirasantoslima@psicobio.epm.br	Tufik, Sergio/D-7606-2012; Andersen, Monica L/C-7616-2012	Andersen, Monica L/0000-0002-1894-6748; M. S. Lima, Marcelo/0000-0001-9602-4880	AFIP; CAPES; FAPESP-CEPID [98/14.303-3]	AFIP; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP-CEPID(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by AFIP, CAPES, FAPESP-CEPID (98/14.303-3 to ST). ST and MABFV are recipient of CNPq fellowships.	Adler CH, 2005, MOVEMENT DISORD, V20, pS23, DOI 10.1002/mds.20460; Arnulf I, 2002, NEUROLOGY, V58, P1019, DOI 10.1212/WNL.58.7.1019; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; CHIBA K, 1984, BIOCHEM BIOPH RES CO, V120, P574, DOI 10.1016/0006-291X(84)91293-2; DAHAN L, 2006, NEUROPSYCHOPHARMACOL, P1; De Cock VC, 2007, BRAIN, V130, P450, DOI 10.1093/brain/awl363; Lima MDS, 2006, BRAIN RES, V1101, P117, DOI 10.1016/j.brainres.2006.05.016; DZIRASA K, 2006, J NEUROSCI, V26, P1; Gagnon JF, 2002, NEUROLOGY, V59, P585, DOI 10.1212/WNL.59.4.585; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Hobson DE, 2002, JAMA-J AM MED ASSOC, V287, P455, DOI 10.1001/jama.287.4.455; Hobson JA, 1998, CURR OPIN NEUROBIOL, V8, P239, DOI 10.1016/S0959-4388(98)80146-3; JONES BE, 1973, BRAIN RES, V58, P157, DOI 10.1016/0006-8993(73)90830-5; JONES BE, 1969, CR SOC BIOL, V163, P176; JOUVET M, 1967, SCI AM, V216, P62, DOI 10.1038/scientificamerican0267-62; Larsen JP, 2001, CNS DRUGS, V15, P267, DOI 10.2165/00023210-200115040-00002; Lev N, 2003, PROG NEURO-PSYCHOPH, V27, P245, DOI 10.1016/S0278-5846(03)00019-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marsden CA, 2006, BRIT J PHARMACOL, V147, pS136, DOI 10.1038/sj.bjp.0706473; Monti JM, 2007, SLEEP MED REV, V11, P113, DOI 10.1016/j.smrv.2006.08.003; NUNES GP, 1994, BRAIN RES BULL, V34, P453, DOI 10.1016/0361-9230(94)90018-3; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Poewe Werner, 2000, Current Opinion in Neurology, V13, P423, DOI 10.1097/00019052-200008000-00009; PUNGOR K, 1990, BRAIN RES, V525, P310, DOI 10.1016/0006-8993(90)90880-K; Reksidler AB, 2007, EUR J PHARMACOL, V560, P163, DOI 10.1016/j.ejphar.2006.12.032; Rye DB, 2002, NEUROLOGY, V58, P341, DOI 10.1212/WNL.58.3.341; Sandyk R, 1997, INT J NEUROSCI, V90, P75, DOI 10.3109/00207459709000627; TIMOIARIA C, 1970, PHYSIOL BEHAV, V5, P1057, DOI 10.1016/0031-9384(70)90162-9; TUFIK S, 1978, PHARMACOLOGY, V16, P98, DOI 10.1159/000136753; TUFIK S, 1981, PSYCHOPHARMACOLOGY, V72, P257, DOI 10.1007/BF00431826; Ulivelli M, 2002, NEUROLOGY, V58, P462, DOI 10.1212/WNL.58.3.462; WAUQUIER A, 1995, HDB EXPT PHARM	32	76	78	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e513	10.1371/journal.pone.0000513	http://dx.doi.org/10.1371/journal.pone.0000513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551593	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451500022
J	Ignoul, S; Simaels, J; Hermans, D; Annaert, W; Eggermont, J				Ignoul, Sofie; Simaels, Jeannine; Hermans, Diane; Annaert, Wim; Eggermont, Jan			Human ClC-6 Is a Late Endosomal Glycoprotein that Associates with Detergent-Resistant Lipid Domains	PLOS ONE			English	Article							LYSOSOMAL STORAGE DISEASE; CHLORIDE CHANNEL; N-GLYCOSYLATION; CELL-SURFACE; BETA-SUBUNIT; TRANSPORT; EXPRESSION; LOCALIZATION; KIDNEY; LEADS	Background. The mammalian CLC protein family comprises nine members (ClC-1 to -7 and ClC-Ka, -Kb) that function either as plasma membrane chloride channels or as intracellular chloride/proton antiporters, and that sustain a broad spectrum of cellular processes, such as membrane excitability, transepithelial transport, endocytosis and lysosomal degradation. In this study we focus on human ClC-6, which is structurally most related to the late endosomal/lysomal ClC-7. Principal Findings. Using a polyclonal affinity-purified antibody directed against a unique epitope in the ClC-6 COOH-terminal tail, we show that human ClC-6, when transfected in COS-1 cells, is N-glycosylated in a region that is evolutionary poorly conserved between mammalian CLC proteins and that is located between the predicted helices K and M. Three asparagine residues (N410, N422 and N432) have been defined by mutagenesis as acceptor sites for N-glycosylation, but only two of the three sites seem to be simultaneously N-glycosylated. In a differentiated human neuroblastoma cell line (SH-SY5Y), endogenous ClC-6 colocalizes with LAMP-1, a late endosomal/lysosomal marker, but not with early/recycling endosomal markers such as EEA-1 and transferrin receptor. In contrast, when transiently expressed in COS-1 or HeLa cells, human ClC-6 mainly overlaps with markers for early/recycling endosomes (transferrin receptor, EEA-1, Rab5, Rab4) and not with late endosomal/lysosomal markers (LAMP1, Rab7). Analogously, overexpression of human ClC-6 in SH-SY5Y cells also leads to an early/recycling endosomal localization of the exogenously expressed ClC-6 protein. Finally, in transiently transfected COS-1 cells, ClC-6 copurifies with detergent-resistant membrane fractions, suggesting its partitioning in lipid rafts. Mutating a juxtamembrane string of basic amino acids (amino acids 71-75: KKGRR) disturbs the association with detergent-resistant membrane fractions and also affects the segregation of ClC-6 and ClC-7 when cotransfected in COS-1 cells. Conclusions. We conclude that human ClC-6 is an endosomal glycoprotein that partitions in detergent resistant lipid domains. The differential sorting of endogenous (late endosomal) versus overexpressed (early and recycling endosomal) ClC-6 is reminiscent of that of other late endosomal/lysosomal membrane proteins (e. g. LIMP II), and is consistent with a rate-limiting sorting step for ClC-6 between early endosomes and its final destination in late endosomes.	[Ignoul, Sofie; Simaels, Jeannine; Hermans, Diane; Eggermont, Jan] Univ Louvain, Dept Mol Cell Biol, Lab Membrane Transport, Louvain, Belgium; [Annaert, Wim] Univ Louvain, Dept Human Genet, Lab Membrane Trafficking, Louvain, Belgium; [Annaert, Wim] VIB 11, Louvain, Belgium	Flanders Institute for Biotechnology (VIB)	Eggermont, J (corresponding author), Univ Louvain, Dept Mol Cell Biol, Lab Membrane Transport, Louvain, Belgium.	Jan.Eggermont@med.kuleuven.be	Ignoul, Sofie/AAF-4758-2019	Ignoul, Sofie/0000-0002-4154-785X; Eggermont, Jan/0000-0002-8497-1159	Forton Foundation (Koning Boudewijn Stichting, Belgium); Fund for Scientific Research-Flanders (FWO-Vlaanderen) [G. 0243.04, G. 0217.03]; Bijzonder Onderzoeksfonds [OT/03/42]	Forton Foundation (Koning Boudewijn Stichting, Belgium); Fund for Scientific Research-Flanders (FWO-Vlaanderen)(FWO); Bijzonder Onderzoeksfonds	Research in the authors' laboratory is supported by the Forton Foundation (Koning Boudewijn Stichting, Belgium), the Fund for Scientific Research-Flanders (FWO-Vlaanderen; G. 0243.04 to WA and G. 0217.03 to JE) and the Bijzonder Onderzoeksfonds (BOF; OT/03/42 to JE) of the K. U. Leuven.	Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; BARRIOCANAL JG, 1986, J BIOL CHEM, V261, P6755; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Brandt S, 1995, FEBS LETT, V377, P15, DOI 10.1016/0014-5793(95)01298-2; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Buyse G, 1998, BIOCHEM J, V330, P1015, DOI 10.1042/bj3301015; Buyse G, 1997, J BIOL CHEM, V272, P3615, DOI 10.1074/jbc.272.6.3615; Bykova EA, 2006, NAT STRUCT MOL BIOL, V13, P1115, DOI 10.1038/nsmb1176; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Christensen EI, 2003, P NATL ACAD SCI USA, V100, P8472, DOI 10.1073/pnas.1432873100; de Wit H, 2001, MOL BIOL CELL, V12, P3703, DOI 10.1091/mbc.12.11.3703; Devuyst O, 1999, HUM MOL GENET, V8, P247, DOI 10.1093/hmg/8.2.247; Dowland LK, 2000, J BIOL CHEM, V275, P37765, DOI 10.1074/jbc.M004840200; DWEK RA, 1993, ANNU REV BIOCHEM, V62, P65, DOI 10.1146/annurev.bi.62.070193.000433; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hinzpeter A, 2007, J BIOL CHEM, V282, P2423, DOI 10.1074/jbc.M608251200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Jones J, 2005, BBA-GEN SUBJECTS, V1726, P121, DOI 10.1016/j.bbagen.2005.07.003; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kuronita T, 2002, J CELL SCI, V115, P4117, DOI 10.1242/jcs.00075; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Popik W, 2004, J BIOL CHEM, V279, P704, DOI 10.1074/jbc.M306380200; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Sakamoto H, 1999, AM J PHYSIOL-RENAL, V277, pF957, DOI 10.1152/ajprenal.1999.277.6.F957; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; SchmidtRose T, 1997, P NATL ACAD SCI USA, V94, P7633, DOI 10.1073/pnas.94.14.7633; Schmieder S, 2001, BIOCHEM BIOPH RES CO, V286, P635, DOI 10.1006/bbrc.2001.5407; Schmieder S, 2007, J CELL PHYSIOL, V210, P479, DOI 10.1002/jcp.20882; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Suzuki T, 2006, J CELL PHYSIOL, V206, P792, DOI 10.1002/jcp.20516; Trouet D, 1997, PFLUG ARCH EUR J PHY, V434, P632, DOI 10.1007/s004240050445; Trouet D, 2001, AM J PHYSIOL-CELL PH, V281, pC248, DOI 10.1152/ajpcell.2001.281.1.C248; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; VERBOOMEN H, 1992, BIOCHEM J, V286, P591, DOI 10.1042/bj2860591; Voets T, 1996, J PHYSIOL-LONDON, V495, P441, DOI 10.1113/jphysiol.1996.sp021605; Weylandt KH, 2001, J BIOL CHEM, V276, P17461, DOI 10.1074/jbc.M011667200	53	22	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2007	2	5							e474	10.1371/journal.pone.0000474	http://dx.doi.org/10.1371/journal.pone.0000474			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10FB	17534424	Green Submitted, gold, Green Published			2022-12-27	WOS:000207448800004
J	Nunes, A; Gomes, JP; Mead, S; Florindo, C; Correia, H; Borrego, MJ; Dean, D				Nunes, Alexandra; Gomes, Joao P.; Mead, Sally; Florindo, Carlos; Correia, Helena; Borrego, Maria J.; Dean, Deborah			Comparative Expression Profiling of the Chlamydia trachomatis pmp Gene Family for Clinical and Reference Strains	PLOS ONE			English	Article								Background. Chlamydia trachomatis, an obligate intracellular pathogen, is a leading worldwide cause of ocular and urogenital diseases. Advances have been made in our understanding of the nine-member polymorphic membrane protein (Pmp) gene (pmp) family of C. trachomatis. However, there is only limited information on their biologic role, especially for biological variants (biovar) and clinical strains. Methodology/Principal Findings. We evaluated expression for pmps throughout development for reference strains E/Bour and L-2/434, representing different biovars, and for clinical E and L-2 strains. Immunoreactivity of patient sera to recombinant (r) Pmps was also determined. All pmps were expressed at two hours. pmpA had the lowest expression but was up-regulated at 12 h for all strains, indicating involvement in reticulate body development. For pmpD, expression peaked at 36 h. Additionally, 57.7% of sera from infected and 0% from uninfected adolescents were reactive to rPmpD (p = 0.001), suggesting a role in immunogenicity. pmpF had the highest expression levels for all clinical strains and L-2/434 with differential expression of the pmpFE operon for the same strains. Sera were nonreactive to rPmpF despite immunoreactivity to rMOMP and rPmpD, suggesting that PmpF is not associated with humoral immune responses. pmpFE sequences for clinical strains were identical to those of the respective reference strains. We identified the putative pmpFE promoter, which was, surprisingly, 100% conserved for all strains. Analyses of ribosomal binding sites, RNase E, and hairpin structures suggested complex regulatory mechanism(s) for this > 6 Kb operon. Conclusions/Significance. The dissimilar expression of the same pmp for different C. trachomatis strains may explain different strain-specific needs and phenotypic distinctions. This is further supported by the differential immunoreactivity to rPmpD and rPmpF of sera from patients infected with different strains. Furthermore, clinical E strains did not correlate with the E reference strain at the gene expression level, reinforcing the need for expansive studies of clinical strains.	[Nunes, Alexandra; Gomes, Joao P.; Mead, Sally; Dean, Deborah] Childrens Hosp Oakland, Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA; [Nunes, Alexandra; Gomes, Joao P.; Florindo, Carlos; Correia, Helena; Borrego, Maria J.] Inst Nacl Saude, Dept Bacteriol, Lisbon, Portugal; [Dean, Deborah] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Dean, Deborah] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Instituto Nacional de Saude Dr. Ricardo Jorge; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Dean, D (corresponding author), Childrens Hosp Oakland, Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA.	ddean@chori.org	Nunes, Alexandra/ABE-3699-2020	Borrego, Maria Jose/0000-0002-8604-8800; Nunes, Alexandra/0000-0001-6449-8053; Gomes, Joao Paulo/0000-0002-2697-2399	NIAID NIH HHS [R01-AI39499, R01-AI059647, R01 AI059647, R01 AI039499] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039499, R01AI059647] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Afonyushkin T, 2005, NUCLEIC ACIDS RES, V33, P1678, DOI 10.1093/nar/gki313; ALLEN JE, 1989, J BACTERIOL, V171, P285, DOI 10.1128/jb.171.1.285-291.1989; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Caldwell HD, 2003, J CLIN INVEST, V111, P1757, DOI [10.1172/JCI200317993, 10.1172/JCI17993]; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Carlson JH, 2005, INFECT IMMUN, V73, P6407, DOI 10.1128/IAI.73.10.6407-6418.2005; Carlson JH, 2004, INFECT IMMUN, V72, P7063, DOI 10.1128/IAI.72.12.7063-7072.2004; CHELLADURAI BS, 1991, NUCLEIC ACIDS RES, V19, P1759, DOI 10.1093/nar/19.8.1759; Crane DD, 2006, P NATL ACAD SCI USA, V103, P1894, DOI 10.1073/pnas.0508983103; DANILITION SL, 1990, INFECT IMMUN, V58, P189, DOI 10.1128/IAI.58.1.189-196.1990; de Hoon MJL, 2005, PLOS COMPUT BIOL, V1, P212, DOI 10.1371/journal.pcbi.0010025; Dean D, 2001, INFECT IMMUN, V69, P2442, DOI 10.1128/IAI.69.4.2442-2447.2001; Dean D, 1997, J CLIN INVEST, V99, P475, DOI 10.1172/JCI119182; Dean D, 2000, J INFECT DIS, V182, P909, DOI 10.1086/315778; Dean D, 1997, PATHOLOGY INFECT DIS, P473; Deana A, 2005, GENE DEV, V19, P2526, DOI 10.1101/gad.1348805; DELAMAZA LM, 1991, INFECT IMMUN, V59, P1196, DOI 10.1128/IAI.59.3.1196-1201.1991; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; Douglas AL, 1996, J BACTERIOL, V178, P5573, DOI 10.1128/jb.178.19.5573-5578.1996; EHRETSMANN CP, 1992, GENE DEV, V6, P149, DOI 10.1101/gad.6.1.149; Fields P. I., 1992, The Prokaryotes. A handbook on the biology of bacteria: ecophysiology, isolation, identification, applications. Volume IV.., P3691; FITCH WM, 1993, MOL BIOL EVOL, V10, P892; Gomes JP, 2007, GENOME RES, V17, P50, DOI 10.1101/gr.5674706; Gomes JP, 2006, J BACTERIOL, V188, P275, DOI 10.1128/JB.188.1.275-286.2006; Gomes JP, 2005, MICROBES INFECT, V7, P410, DOI 10.1016/j.micinf.2004.11.014; Gomes JP, 2004, J BACTERIOL, V186, P4295, DOI 10.1128/JB.186.13.4295-4306.2004; Grimwood J, 1999, Microb Comp Genomics, V4, P187, DOI 10.1089/omi.1.1999.4.187; Henderson IR, 2001, TRENDS MICROBIOL, V9, P573, DOI 10.1016/S0966-842X(01)02234-X; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Hessel T, 2001, INFECT IMMUN, V69, P4996, DOI 10.1128/IAI.69.8.4996-5000.2001; Huntzinger E, 2005, EMBO J, V24, P824, DOI 10.1038/sj.emboj.7600572; Kennell D, 2002, J BACTERIOL, V184, P4645, DOI 10.1128/JB.184.17.4645-4657.2002; Kiselev AO, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000568; KISELEV AO, 2002, SAN FRANC INT CHLAM, P567; Kushner SR, 2004, IUBMB LIFE, V56, P585, DOI 10.1080/15216540400022441; Liang FT, 2004, MICROB PATHOGENESIS, V37, P35, DOI 10.1016/j.micpath.2004.02.007; LINDQUIST EA, 1998, CHLAMYDIAL INFECT, P259; Mader U, 2004, J BACTERIOL, V186, P2240, DOI 10.1128/JB.186.8.2240-2252.2004; Meinken C, 2003, MICROBIOL-SGM, V149, P751, DOI 10.1099/mic.0.26078-0; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; Miyairi I, 2006, J INFECT DIS, V194, P350, DOI 10.1086/505432; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Mygind PH, 2000, FEMS MICROBIOL LETT, V186, P163, DOI 10.1111/j.1574-6968.2000.tb09098.x; Ramamoorthy R, 2005, J BACTERIOL, V187, P2592, DOI 10.1128/JB.187.8.2592-2600.2005; ROBERTSON HD, 1977, P NATL ACAD SCI USA, V74, P822, DOI 10.1073/pnas.74.3.822; SaNogueira I, 1997, MICROBIOL-SGM, V143, P957, DOI 10.1099/00221287-143-3-957; Schaumburg CS, 2000, J BACTERIOL, V182, P5167, DOI 10.1128/JB.182.18.5167-5171.2000; Schaumburg CS, 2003, NUCLEIC ACIDS RES, V31, P551, DOI 10.1093/nar/gkg150; Shaw AC, 2002, PROTEOMICS, V2, P164, DOI 10.1002/1615-9861(200202)2:2<164::AID-PROT164>3.0.CO;2-U; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Skipp P, 2005, PROTEOMICS, V5, P1558, DOI 10.1002/pmic.200401044; STEPHENS RS, 1988, J BACTERIOL, V170, P744, DOI 10.1128/jb.170.2.744-750.1988; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stothard DR, 2003, INFECT IMMUN, V71, P1200, DOI 10.1128/IAI.71.3.1200-1208.2003; Tan M, 1998, J BACTERIOL, V180, P2359, DOI 10.1128/JB.180.9.2359-2366.1998; Tanzer RJ, 2001, J BACTERIOL, V183, P2686, DOI 10.1128/JB.183.8.2686-2690.2001; Vandahl BB, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-36; Ward ME, 1988, MICOBIOLOGY CHLAMYDI, P71; Washio T, 1998, NUCLEIC ACIDS RES, V26, P5456, DOI 10.1093/nar/26.23.5456; Wehrl W, 2004, MOL MICROBIOL, V51, P319, DOI 10.1046/j.1365-2958.2003.03838.x; Wei XM, 2004, MICROBIOL-SGM, V150, P1869, DOI 10.1099/mic.0.26785-0; YAJNIK V, 1993, J BIOL CHEM, V268, P13253	62	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e878	10.1371/journal.pone.0000878	http://dx.doi.org/10.1371/journal.pone.0000878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849007	Green Published, gold			2022-12-27	WOS:000207455600024
J	Alvarez, BV; Gilmour, GS; Mema, SC; Martin, BT; Shull, GE; Casey, JR; Sauve, Y				Alvarez, Bernardo V.; Gilmour, Gregory S.; Mema, Silvina C.; Martin, Brent T.; Shull, Gary E.; Casey, Joseph R.; Sauve, Yves			Blindness Caused by Deficiency in AE3 Chloride/Bicarbonate Exchanger	PLOS ONE			English	Article								Background. Vision is initiated by phototransduction in the outer retina by photoreceptors, whose high metabolic rate generates large CO2 loads. Inner retina cells then process the visual signal and CO2. The anion exchanger 3 gene (AE3/Slc4a3) encodes full-length AE3 (AE3fl) and cardiac AE3 (AE3c) isoforms, catalyzing plasma membrane Cl-/HCO3- exchange in Muller (AE3fl) and horizontal (AE3c) cells. AE3 thus maintains acid-balance by removing photoreceptor-generated CO2 waste. Methodology/Principal Findings. We report that Slc4a3(-/-) null mice have inner retina defects (electroretinogram b-wave reduction, optic nerve and retinal vessel anomalies). These pathologic features are common to most human vitreoretinal degenerations. Immunobloting analysis revealed that Na+/HCO3- co-transporter (NBC1), and carbonic anhydrase II and CAXIV, protein expression were elevated in Slc4a3(-/-) mouse retinas, suggesting compensation for loss of AE3. TUNEL staining showed increased numbers of apoptotic nuclei from 4-6 months of age, in Slc4a3(-/-) mice, indicating late onset photoreceptor death. Conclusions/Significance. Identification of Slc4a3 as underlying a previously unrecognized cause of blindness suggests this gene as a new candidate for a subset of hereditary vitreoretinal retinal degeneration.	[Alvarez, Bernardo V.; Martin, Brent T.; Casey, Joseph R.; Sauve, Yves] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Alvarez, Bernardo V.; Casey, Joseph R.] Univ Alberta, Dept Biochem, Membrane Prot Res Grp, Edmonton, AB, Canada; [Gilmour, Gregory S.; Mema, Silvina C.; Sauve, Yves] Univ Alberta, Dept Ophthalmol, Edmonton, AB, Canada; [Shull, Gary E.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University of Alberta; University of Alberta; University of Alberta; University of Cincinnati	Sauve, Y (corresponding author), Univ Alberta, Dept Physiol, Edmonton, AB, Canada.	ysauve@ualberta.ca	Casey, Joseph/A-8888-2013; Mema, Silvina/J-5416-2019	Casey, Joseph/0000-0002-9890-5056; Mema, Silvina/0000-0001-5895-9159	Canadian Institutes of Health Research; NIH [HL61974]; Barbara Tuck/MacPhee Family Vision Research Award; Canadian Cystic Fibrosis Foundation; NSERC Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061974] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barbara Tuck/MacPhee Family Vision Research Award; Canadian Cystic Fibrosis Foundation; NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Canadian Institutes of Health Research Grants to YS and JRC and NIH grant HL61974 to GES. YS is a recipient of the Barbara Tuck/MacPhee Family Vision Research Award in Macular Degeneration. JRC is a Scientist of the Alberta Heritage Foundation for Medical Research. BVA was supported by a Postdoctoral Fellowship from the Canadian Cystic Fibrosis Foundation, and BTM by a NSERC Canada Graduate Scholarship (Masters level).	Alvarez BV, 2003, BIOCHEMISTRY-US, V42, P12321, DOI 10.1021/bi0353124; ALVAREZ BV, 2007, ARVO; Bok D, 2001, AM J PHYSIOL-RENAL, V281, pF920, DOI 10.1152/ajprenal.2001.281.5.F920; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; BROWN DM, 1995, ARCH OPHTHALMOL-CHIC, V113, P671, DOI 10.1001/archopht.1995.01100050139045; CABANTCHIK ZI, 1992, AM J PHYSIOL, V262, pC803, DOI 10.1152/ajpcell.1992.262.4.C803; Chang B, 2006, VISUAL NEUROSCI, V23, P11, DOI 10.1017/S095252380623102X; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; DOERING C, 2007, NEUROSCIENC IN PRESS; EVERETT WG, 1968, AM J OPHTHALMOL, V65, P229, DOI 10.1016/0002-9394(68)93592-7; Hentschke M, 2006, MOL CELL BIOL, V26, P182, DOI 10.1128/MCB.26.1.182-191.2006; HIROSE T, 1980, ANN OPHTHALMOL, V12, P1135; Igarashi T, 1999, NAT GENET, V23, P264, DOI 10.1038/15440; IWASAKI M, 1987, GRAEF ARCH CLIN EXP, V225, P177, DOI 10.1007/BF02175446; JACOBSON SG, 1991, AM J OPHTHALMOL, V111, P446, DOI 10.1016/S0002-9394(14)72379-7; Jiao XD, 2004, INVEST OPHTH VIS SCI, V45, P4498, DOI 10.1167/iovs.04-0722; Kellner U, 1998, BRIT J OPHTHALMOL, V82, P650, DOI 10.1136/bjo.82.6.650; Kniep EM, 2006, INVEST OPHTH VIS SCI, V47, P1185, DOI 10.1167/iovs.05-0555; KOBAYASHI S, 1994, J NEUROSCI, V14, P6266; Kopito R R, 1990, Int Rev Cytol, V123, P177, DOI 10.1016/S0074-7696(08)60674-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MM, 2003, OPHTHALMOLOGY, V110, P2418, DOI 10.1016/S0161-6420(03)00828-5; MAUMENEE IH, 1979, AM J OPHTHALMOL, V88, P432, DOI 10.1016/0002-9394(79)90645-7; McMurtrie HL, 2004, J ENZYM INHIB MED CH, V19, P231, DOI 10.1080/14756360410001704443; MEYERTHOLEN EP, 1986, VISION RES, V26, P521, DOI 10.1016/0042-6989(86)90001-5; Nagelhus EA, 2005, P NATL ACAD SCI USA, V102, P8030, DOI 10.1073/pnas.0503021102; OAKLEY B, 1989, J PHYSIOL-LONDON, V419, P353, DOI 10.1113/jphysiol.1989.sp017876; Ochrietor JD, 2005, EXP EYE RES, V81, P492, DOI 10.1016/j.exer.2005.03.010; OGILVIE JM, 2007, P NATL ACAD SCI US; Parkkila S, 2001, P NATL ACAD SCI USA, V98, P1918, DOI 10.1073/pnas.98.4.1918; Peachey NS, 1997, VISUAL NEUROSCI, V14, P627, DOI 10.1017/S0952523800012591; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; ROMERO MF, 2004, PFLUGERS ARCH, V14, P14; RUETZ S, 1993, J CELL BIOL, V121, P37, DOI 10.1083/jcb.121.1.37; Sander T, 2002, EPILEPSY RES, V51, P249, DOI 10.1016/S0920-1211(02)00152-3; Sauer CG, 1997, NAT GENET, V17, P164, DOI 10.1038/ng1097-164; Shah GN, 2005, P NATL ACAD SCI USA, V102, P16771, DOI 10.1073/pnas.0508449102; SILLMAN AJ, 1972, VISION RES, V12, P1519, DOI 10.1016/0042-6989(72)90177-0; Snead MP, 1996, EYE, V10, P653, DOI 10.1038/eye.1996.158; Snead MP, 1996, ANN NY ACAD SCI, V785, P331, DOI 10.1111/j.1749-6632.1996.tb56300.x; Sterling D, 1999, BIOCHEM J, V344, P221, DOI 10.1042/0264-6021:3440221; Sterling D, 2002, J BIOL CHEM, V277, P25239, DOI 10.1074/jbc.M202562200; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; SU YR, 1994, GENOMICS, V22, P605, DOI 10.1006/geno.1994.1433; Svichar N, 2006, GLIA, V53, P241, DOI 10.1002/glia.20277; TAKAHASHI KI, 1993, J GEN PHYSIOL, V101, P695, DOI 10.1085/jgp.101.5.695; Vessey JP, 2005, J NEUROSCI, V25, P4108, DOI 10.1523/JNEUROSCI.5253-04.2005; WALLS G L, 1949, Am J Ophthalmol, V32, P1409; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667	49	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e839	10.1371/journal.pone.0000839	http://dx.doi.org/10.1371/journal.pone.0000839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786210	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455500022
J	Crevel, G; Hashimoto, R; Vass, S; Sherkow, J; Yamaguchi, M; Heck, MMS; Cotterill, S				Crevel, Gilles; Hashimoto, Reina; Vass, Sharron; Sherkow, Jake; Yamaguchi, Masamitsu; Heck, Margarete M. S.; Cotterill, Sue			Differential Requirements for MCM Proteins in DNA Replication in Drosophila S2 Cells	PLOS ONE			English	Article								Background. The MCM2-7 proteins are crucial components of the pre replication complex (preRC) in eukaryotes. Since they are significantly more abundant than other preRC components, we were interested in determining whether the entire cellular content was necessary for DNA replication in vivo. Methodology/Principle Findings. We performed a systematic depletion of the MCM proteins in Drosophila S2 cells using dsRNA-interference. Reducing MCM2-6 levels by >95-99% had no significant effect on cell cycle distribution or viability. Depletion of MCM7 however caused an S-phase arrest. MCM2-7 depletion produced no change in the number of replication forks as measured by PCNA loading. We also depleted MCM8. This caused a 30% reduction in fork number, but no significant effect on cell cycle distribution or viability. No additive effects were observed by co-depleting MCM8 and MCM5. Conclusions/Significance. These studies suggest that, in agreement with what has previously been observed for Xenopus in vitro, not all of the cellular content of MCM2-6 proteins is needed for normal cell cycling. They also reveal an unexpected unique role for MCM7. Finally they suggest that MCM8 has a role in DNA replication in S2 cells.	[Crevel, Gilles; Cotterill, Sue] St Georges Univ London, London, England; [Hashimoto, Reina; Yamaguchi, Masamitsu] Kyoto Inst Technol, Dept Appl Biol, Insect Biomed Res Ctr, Kyoto 606, Japan; [Vass, Sharron; Sherkow, Jake; Heck, Margarete M. S.] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland	St Georges University London; Kyoto Institute of Technology; University of Edinburgh	Cotterill, S (corresponding author), St Georges Univ London, London, England.	s.cotterill@sgul.ac.uk		Sherkow, Jacob/0000-0002-9724-9261; Yamaguchi, Masamitsu/0000-0002-6321-9750; Vass, Sharron/0000-0003-4201-2002	AICR; Wellcome Trust	AICR; Wellcome Trust(Wellcome TrustEuropean Commission)	This research in the Cotterill lab was funded by the AICR. Research in the Heck laboratory is funded by a Senior Research Fellowship from the Wellcome Trust.	Christensen TW, 2003, MOL BIOL CELL, V14, P2206, DOI 10.1091/mbc.E02-11-0706; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Crevel G, 2005, J CELL SCI, V118, P2451, DOI 10.1242/jcs.02361; Crevel G, 2001, NUCLEIC ACIDS RES, V29, P4834, DOI 10.1093/nar/29.23.4834; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; FEGER G, 1995, EMBO J, V14, P5387, DOI 10.1002/j.1460-2075.1995.tb00223.x; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Gozuacik D, 2003, NUCLEIC ACIDS RES, V31, P570, DOI 10.1093/nar/gkg136; Kearsey SE, 2003, MOL CELL, V12, P1067, DOI 10.1016/S1097-2765(03)00441-6; Kelman Z, 2003, NAT STRUCT BIOL, V10, P148, DOI 10.1038/nsb0303-148; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Labib K, 2001, MOL BIOL CELL, V12, P3658, DOI 10.1091/mbc.12.11.3658; Labib K, 2001, CURR OPIN GENET DEV, V11, P64, DOI 10.1016/S0959-437X(00)00158-1; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Loupart ML, 2000, CURR BIOL, V10, P1547, DOI 10.1016/S0960-9822(00)00844-7; Mahbubani HM, 1997, J CELL BIOL, V136, P125, DOI 10.1083/jcb.136.1.125; Maiorano D, 2000, J BIOL CHEM, V275, P8426, DOI 10.1074/jbc.275.12.8426; Maiorano D, 2005, CELL, V120, P315, DOI 10.1016/j.cell.2004.12.010; Matsubayashi H, 2003, GENES GENET SYST, V78, P363, DOI 10.1266/ggs.78.363; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Oehlmann M, 2004, J CELL BIOL, V165, P181, DOI 10.1083/jcb.200311044; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Pflumm MF, 2001, DEVELOPMENT, V128, P1697; Prokhorova TA, 2000, J BIOL CHEM, V275, P2491, DOI 10.1074/jbc.275.4.2491; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Schwed G, 2002, MOL BIOL CELL, V13, P607, DOI 10.1091/mbc.01-08-0400; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Volkening M, 2005, MOL CELL BIOL, V25, P1560, DOI 10.1128/MCB.25.4.1560-1568.2005; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; You ZY, 1999, MOL CELL BIOL, V19, P8003	35	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e833	10.1371/journal.pone.0000833	http://dx.doi.org/10.1371/journal.pone.0000833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786205	Green Published, Green Accepted, gold			2022-12-27	WOS:000207455500017
J	Kugimiya, F; Kawaguchi, H; Ohba, S; Kawamura, N; Hirata, M; Chikuda, H; Azuma, Y; Woodgett, JR; Nakamura, K; Chung, U				Kugimiya, Fumitaka; Kawaguchi, Hiroshi; Ohba, Shinsuke; Kawamura, Naohiro; Hirata, Makoto; Chikuda, Hirotaka; Azuma, Yoshiaki; Woodgett, James R.; Nakamura, Kozo; Chung, Ung-il			GSK-3 beta Controls Osteogenesis through Regulating Runx2 Activity	PLOS ONE			English	Article								Despite accumulated knowledge of various signalings regulating bone formation, the molecular network has not been clarified sufficiently to lead to clinical application. Here we show that heterozygous glycogen synthase kinase-3 beta (GSK-3 beta)-deficient mice displayed an increased bone formation due to an enhanced transcriptional activity of Runx2 by suppressing the inhibitory phosphorylation at a specific site. The cleidocranial dysplasia in heterozygous Runx2-deficient mice was significantly rescued by the genetic insufficiency of GSK-3 beta or the oral administration of lithium chloride, a selective inhibitor of GSK-3 beta. These results establish GSK-3 beta as a key attenuator of Runx2 activity in bone formation and as a potential molecular target for clinical treatment of bone catabolic disorders like cleidocranial dysplasia.	[Kugimiya, Fumitaka; Ohba, Shinsuke; Chung, Ung-il] Univ Tokyo, Ctr Dis Biol & Integrat Med, Tokyo, Japan; [Kugimiya, Fumitaka; Kawaguchi, Hiroshi; Kawamura, Naohiro; Hirata, Makoto; Chikuda, Hirotaka; Nakamura, Kozo] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Azuma, Yoshiaki] Teijin Inst Biomed Res, Tokyo, Japan; [Woodgett, James R.] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada	University of Tokyo; University of Tokyo; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Chung, U (corresponding author), Univ Tokyo, Ctr Dis Biol & Integrat Med, Tokyo, Japan.	uichung-tky@umin.ac.jp	Kawamura, Naohiro/J-8372-2019; Woodgett, Jim/F-1087-2010	Woodgett, Jim/0000-0003-3731-5797; Ohba, Shinsuke/0000-0002-6874-8539	Japanese Ministry of Education, Culture, Sports, Science, and Technology [17390410]; Terumo Life Science Foundation	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Terumo Life Science Foundation(Terumo Life Science Foundation)	This study was supported by a Grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (#17390410) and Terumo Life Science Foundation. The sponsor had no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript.	Akune T, 2002, J CELL BIOL, V159, P147, DOI 10.1083/jcb.200204046; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; CANALIS E, 1993, BONE, V14, P273, DOI 10.1016/8756-3282(93)90151-Y; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Cohen Y, 1998, MED ONCOL, V15, P32, DOI 10.1007/BF02787342; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; Dixon JF, 1998, P NATL ACAD SCI USA, V95, P8363, DOI 10.1073/pnas.95.14.8363; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Ito Y, 1999, GENES CELLS, V4, P685, DOI 10.1046/j.1365-2443.1999.00298.x; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kim BG, 2006, PROTEOMICS, V6, P1166, DOI 10.1002/pmic.200500289; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Patel S, 2004, BIOCHEM SOC T, V32, P803, DOI 10.1042/BST0320803; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037; Thrailkill KM, 2005, AM J PHYSIOL-ENDOC M, V289, pE735, DOI 10.1152/ajpendo.00159.2005; Wee HJ, 2002, EMBO REP, V3, P967, DOI 10.1093/embo-reports/kvf193; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200	41	114	117	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e837	10.1371/journal.pone.0000837	http://dx.doi.org/10.1371/journal.pone.0000837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786208	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455500020
J	Zikopoulos, B; Barbas, H				Zikopoulos, Basilis; Barbas, Helen			Parallel Driving and Modulatory Pathways Link the Prefrontal Cortex and Thalamus	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LATERAL GENICULATE-NUCLEUS; PRIMARY AUDITORY-CORTEX; PRIMARY VISUAL-CORTEX; NEURONS-IN-VITRO; RHESUS-MONKEY; MACAQUE MONKEY; BASAL GANGLIA; CORTICOCORTICAL COMMUNICATION; CORTICOTHALAMIC PROJECTIONS	Pathways linking the thalamus and cortex mediate our daily shifts from states of attention to quiet rest, or sleep, yet little is known about their architecture in high-order neural systems associated with cognition, emotion and action. We provide novel evidence for neurochemical and synaptic specificity of two complementary circuits linking one such system, the prefrontal cortex with the ventral anterior thalamic nucleus in primates. One circuit originated from the neurochemical group of parvalbumin-positive thalamic neurons and projected focally through large terminals to the middle cortical layers, resembling 'drivers' in sensory pathways. Parvalbumin thalamic neurons, in turn, were innervated by small 'modulatory' type cortical terminals, forming asymmetric (presumed excitatory) synapses at thalamic sites enriched with the specialized metabotropic glutamate receptors. A second circuit had a complementary organization: it originated from the neurochemical group of calbindin-positive thalamic neurons and terminated through small 'modulatory' terminals over long distances in the superficial prefrontal layers. Calbindin thalamic neurons, in turn, were innervated by prefrontal axons through small and large terminals that formed asymmetric synapses preferentially at sites with ionotropic glutamate receptors, consistent with a driving pathway. The largely parallel thalamo-cortical pathways terminated among distinct and laminar-specific neurochemical classes of inhibitory neurons that differ markedly in inhibitory control. The balance of activation of these parallel circuits that link a high-order association cortex with the thalamus may allow shifts to different states of consciousness, in processes that are disrupted in psychiatric diseases.	[Zikopoulos, Basilis; Barbas, Helen] Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA; [Barbas, Helen] Boston Univ, Program Neurosci, Boston, MA 02215 USA; [Barbas, Helen] Harvard Univ, Sch Med, New England Primate Res Ctr, Boston, MA USA; [Barbas, Helen] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02215 USA	Boston University; Boston University; Harvard University; Harvard Medical School; Boston University	Barbas, H (corresponding author), Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA.	barbas@bu.edu	Zikopoulos, Basilis/K-2443-2012	Zikopoulos, Vasileios/0000-0002-8834-5104; Barbas, Helen/0000-0003-0825-0832	NIMH; NINDS	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH grants from NIMH and NINDS. The authors declare no financial interest in this manuscript.	Abbott LF, 2005, PROG BRAIN RES, V149, P147, DOI 10.1016/S0079-6123(05)49011-1; ABRAMSON BP, 1985, NEUROSCIENCE, V15, P81, DOI 10.1016/0306-4522(85)90125-3; BARBAS H, 1991, J COMP NEUROL, V313, P65, DOI 10.1002/cne.903130106; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Barbas H, 2005, CEREB CORTEX, V15, P1356, DOI 10.1093/cercor/bhi018; Barbas H, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-25; Becherer U, 2006, CELL TISSUE RES, V326, P393, DOI 10.1007/s00441-006-0243-z; CASAGRANDE VA, 2005, PROG BRAIN RES, V149; CIPOLLONI PB, 1989, BRAIN RES, V492, P347, DOI 10.1016/0006-8993(89)90918-9; Conn PJ, 2005, NAT REV NEUROSCI, V6, P787, DOI 10.1038/nrn1763; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dombrowski SM, 2001, CEREB CORTEX, V11, P975, DOI 10.1093/cercor/11.10.975; Eaton SA, 1996, NEUROSCIENCE, V73, P1, DOI 10.1016/0306-4522(96)00123-6; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Gabbott PLA, 1996, J COMP NEUROL, V364, P609; Garcia-Cabezas MA, 2007, NEUROIMAGE, V34, P965, DOI 10.1016/j.neuroimage.2006.07.032; Germuska M, 2006, CEREB CORTEX, V16, P865, DOI 10.1093/cercor/bhj030; Godwin DW, 1996, J NEUROSCI, V16, P8181; GOLDMANRAKIC PS, 1992, J NEURAL TRANSM-GEN, P163; Golshani P, 1998, J NEUROPHYSIOL, V80, P143, DOI 10.1152/jn.1998.80.1.143; Guillery RW, 2005, PROG BRAIN RES, V149, P235, DOI 10.1016/S0079-6123(05)49017-2; Guillery RW, 1995, J ANAT, V187, P583; Guillery RW, 2003, J NEUROPHYSIOL, V90, P539, DOI 10.1152/jn.00337.2003; Guillery RW, 2002, PHILOS T R SOC B, V357, P1809, DOI 10.1098/rstb.2002.1171; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; HASHIKAWA T, 1995, J COMP NEUROL, V362, P195, DOI 10.1002/cne.903620204; Herbert MR, 2004, ANN NEUROL, V55, P530, DOI 10.1002/ana.20032; HOOVER JE, 1993, SCIENCE, V259, P819, DOI 10.1126/science.7679223; Howard C, 1998, UNBIASED STEREOLOGY; ILINSKY IA, 1990, J COMP NEUROL, V294, P455, DOI 10.1002/cne.902940313; Jones E G, 1998, Adv Neurol, V77, P49; Jones EG, 1998, J COMP NEUROL, V397, P371, DOI 10.1002/(SICI)1096-9861(19980803)397:3<371::AID-CNE5>3.0.CO;2-#; Jones EG, 2002, PHILOS T R SOC B, V357, P1659, DOI 10.1098/rstb.2002.1168; JONES EG, 1989, EUR J NEUROSCI, V1, P222, DOI 10.1111/j.1460-9568.1989.tb00791.x; Jones EG, 1998, NEUROSCIENCE, V85, P331, DOI 10.1016/S0306-4522(97)00581-2; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; Jones EG, 1985, THALAMUS; Kao CQ, 1997, J NEUROPHYSIOL, V77, P2661, DOI 10.1152/jn.1997.77.5.2661; Kubota Y, 2007, J NEUROSCI, V27, P1139, DOI 10.1523/JNEUROSCI.3846-06.2007; Kwegyir-Afful EE, 2005, J NEUROSCI, V25, P5926, DOI 10.1523/JNEUROSCI.1360-05.2005; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; LEE CC, 2006, 2006 NEUR M PLANN AT; LEWIS DA, 1988, BRAIN RES, V449, P225, DOI 10.1016/0006-8993(88)91040-2; Lewis DA, 2001, AM J PSYCHIAT, V158, P1411, DOI 10.1176/appi.ajp.158.9.1411; Li JL, 2003, J NEUROPHYSIOL, V90, P3429, DOI 10.1152/jn.00456.2003; LIU XB, 1995, J COMP NEUROL, V352, P69, DOI 10.1002/cne.903520106; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; LUND JS, 1975, J COMP NEUROL, V164, P287, DOI 10.1002/cne.901640303; MADARASZ M, 1981, ANAT EMBRYOL, V162, P363, DOI 10.1007/BF00299979; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; McFarland NR, 2002, J NEUROSCI, V22, P8117; MEDALLA M, 2007, CEREB CORTE IN PRESS; Melchitzky DS, 1999, J COMP NEUROL, V408, P11; Mizuno A, 2006, BRAIN RES, V1104, P160, DOI 10.1016/j.brainres.2006.05.064; MONTERO VM, 1991, EXP BRAIN RES, V86, P257; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Negyessy L, 2005, EXP BRAIN RES, V164, P148, DOI 10.1007/s00221-005-2237-6; OJIMA H, 1994, CEREB CORTEX, V4, P646, DOI 10.1093/cercor/4.6.646; olszewski j, 1952, THALAMUS MACACA MULA; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; Peters A., 1991, FINE STRUCTURE NERVO; PIERCE JP, 1993, J NEUROSCI, V13, P4748; PIERCE JP, 1994, NEUROSCIENCE, V58, P441, DOI 10.1016/0306-4522(94)90071-X; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Ramcharan EJ, 2005, P NATL ACAD SCI USA, V102, P12236, DOI 10.1073/pnas.0502843102; Reichova I, 2004, J NEUROPHYSIOL, V92, P2185, DOI 10.1152/jn.00322.2004; Reiner A, 2000, J NEUROSCI METH, V103, P23, DOI 10.1016/S0165-0270(00)00293-4; RICHMOND FJR, 1994, J NEUROSCI METH, V53, P35, DOI 10.1016/0165-0270(94)90142-2; Rockland KS, 1999, J COMP NEUROL, V406, P221, DOI 10.1002/(SICI)1096-9861(19990405)406:2<221::AID-CNE7>3.0.CO;2-K; Rockland KS, 1996, J COMP NEUROL, V368, P57, DOI 10.1002/(SICI)1096-9861(19960422)368:1<57::AID-CNE5>3.0.CO;2-J; Rollenhagen A, 2006, CELL TISSUE RES, V326, P221, DOI 10.1007/s00441-006-0288-z; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROUILLER EM, 1991, EXP BRAIN RES, V86, P483, DOI 10.1007/BF00230523; Rouiller EM, 2000, BRAIN RES BULL, V53, P727, DOI 10.1016/S0361-9230(00)00364-6; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; SCHWARTZ ML, 1991, J COMP NEUROL, V309, P289, DOI 10.1002/cne.903090302; Schweizer FE, 2006, CURR OPIN NEUROBIOL, V16, P298, DOI 10.1016/j.conb.2006.05.006; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Shipp S, 2003, PHILOS T R SOC B, V358, P1605, DOI 10.1098/rstb.2002.1213; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Steriade M, 2004, NEURON, V41, P493, DOI 10.1016/S0896-6273(04)00076-5; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 1997, THALAMUS ORG FUNCTIO; Thomson AM, 2000, PROG NEUROBIOL, V62, P159, DOI 10.1016/S0301-0082(00)00008-3; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; Van Horn SC, 2000, J COMP NEUROL, V416, P509; VEENMAN CL, 1992, J NEUROSCI METH, V41, P239, DOI 10.1016/0165-0270(92)90089-V; Vidnyanszky Z, 1996, EUR J NEUROSCI, V8, P1061, DOI 10.1111/j.1460-9568.1996.tb01273.x; Volk DW, 2003, BIOL PSYCHIAT, V53, P385, DOI 10.1016/S0006-3223(02)01547-0; Walker AE, 1940, J COMP NEUROL, V73, P59, DOI 10.1002/cne.900730106; Wang S, 2002, J COMP NEUROL, V454, P482, DOI 10.1002/cne.10453; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wurtz RH, 2005, PROG BRAIN RES, V149, P207, DOI 10.1016/S0079-6123(05)49015-9; Xiao D., 2002, Thalamus & Related Systems, V2, P33; Xiao Danqing, 2004, Thalamus & Related Systems, V2, P325, DOI 10.1016/j.tharel.2004.03.001; ZIKOPOULOS B, 2007, REV NEUROSC IN PRESS; Zikopoulos B, 2006, J NEUROSCI, V26, P7348, DOI 10.1523/JNEUROSCI.5511-05.2006	105	86	86	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e848	10.1371/journal.pone.0000848	http://dx.doi.org/10.1371/journal.pone.0000848			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786219	Green Submitted, gold, Green Published			2022-12-27	WOS:000207455500031
J	Chandalia, M; Lin, P; Seenivasan, T; Livingston, EH; Snell, PG; Grundy, SM; Abate, N				Chandalia, Manisha; Lin, Ping; Seenivasan, Thanalakshmi; Livingston, Edward H.; Snell, Peter G.; Grundy, Scott M.; Abate, Nicola			Insulin Resistance and Body Fat Distribution in South Asian Men Compared to Caucasian Men	PLOS ONE			English	Article							ADIPOSE-TISSUE; OBESITY	Objective. South Asians are susceptible to insulin resistance even without obesity. We examined the characteristics of body fat content, distribution and function in South Asian men and their relationships to insulin resistance compared to Caucasians. Research Design and Methods. Twenty-nine South Asian and 18 Caucasian non-diabetic men (age 27+/-3 and 27+/-3 years, respectively) underwent euglycemic-hyperinsulinemic clamp for insulin sensitivity, underwater weighing for total body fat, MRI of entire abdomen for intraperitoneal (IP) and subcutaneous abdominal (SA) fat and biopsy of SA fat for adipocyte size. Results. Compared to Caucasians, in spite of similar BMI, South Asians had higher total body fat (22+/-6 and 15+/-4% of body weight; p-value<0.0001), higher SA fat (3.5+/-1.9 and 2.2+/-1.3 kg, respectively; p-value=0.004), but no differences in IP fat (1.0+/-0.5 and 1.0+/-0.7 kg, respectively; p-value=0.4). SA adipocyte cell size was significantly higher in South Asians (3491+/-1393 and 1648+/-864 mu m(2); p-value=0.0001) and was inversely correlated with both glucose disposal rate (r-value=20.57; p-value=0.0008) and plasma adiponectin concentrations (r-value=20.71; p-value<0.0001). Adipocyte size differences persisted even when SA was matched between South Asians and Caucasians. Conclusions. Insulin resistance in young South Asian men can be observed even without increase in IP fat mass and is related to large SA adipocytes size. Hence ethnic excess in insulin resistance in South Asians appears to be related more to excess truncal fat and dysfunctional adipose tissue than to excess visceral fat.	[Chandalia, Manisha; Snell, Peter G.; Grundy, Scott M.; Abate, Nicola] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Chandalia, Manisha; Abate, Nicola] Univ Texas SW Med Ctr Dallas, Div Endocrinol & Metab, Dallas, TX 75390 USA; [Chandalia, Manisha; Lin, Ping; Seenivasan, Thanalakshmi; Grundy, Scott M.; Abate, Nicola] Univ Texas SW Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA; [Livingston, Edward H.] Univ Texas SW Med Ctr Dallas, Div Gastrointestinal & Endocrine Surg, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chandalia, M (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	Manisha.chandalia@utsouthwestern.edu; Nicola.abate@utsouthwestern.edu			NIDDK [RO1 DK072158-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072158] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIDDK RO1 DK072158-01 (N.A. and M.C.)	Abate N, 2003, J DIABETES COMPLICAT, V17, P39, DOI 10.1016/S1056-8727(02)00190-3; ABATE N, 1995, J CLIN INVEST, V96, P88, DOI 10.1172/JCI118083; Abate N, 2004, J CLIN ENDOCR METAB, V89, P2750, DOI 10.1210/jc.2003-031843; Abate N, 2003, J CLIN ENDOCR METAB, V88, P5927, DOI 10.1210/jc.2003-030453; ABATE N, 1994, J LIPID RES, V35, P1490; Bajaj Mandeep, 2004, Curr Diab Rep, V4, P213, DOI 10.1007/s11892-004-0026-4; Chandalia M, 1999, J CLIN ENDOCR METAB, V84, P2329, DOI 10.1210/jc.84.7.2329; Lundgren M, 2007, DIABETOLOGIA, V50, P625, DOI 10.1007/s00125-006-0572-1; MCKEIGUE PM, 1992, DIABETOLOGIA, V35, P785; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Miles JM, 2005, DIABETES CARE, V28, P2326, DOI 10.2337/diacare.28.9.2326; Raji A, 2001, J CLIN ENDOCR METAB, V86, P5366, DOI 10.1210/jc.86.11.5366; RUSH E, 2004, N Z MED J, V7, pU1203; THOMAS LW, 1962, Q J EXP PHYSIOL CMS, V47, P179, DOI 10.1113/expphysiol.1962.sp001589; Vague J, 1999, Nutrition, V15, P89; Vega GL, 2006, J CLIN ENDOCR METAB, V91, P4459, DOI 10.1210/jc.2006-0814; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560	17	173	175	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e812	10.1371/journal.pone.0000812	http://dx.doi.org/10.1371/journal.pone.0000812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726542	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455400029
J	Persoon, ACM; Jager, PL; Sluiter, WJ; Plukker, JTM; Wolffenbuttel, BHR; Links, TP				Persoon, Adrienne C. M.; Jager, Pieter L.; Sluiter, Wim J.; Plukker, John T. M.; Wolffenbuttel, Bruce H. R.; Links, Thera P.			A Sensitive Tg Assay or rhTSH Stimulated Tg: What's the Best in the Long-Term Follow-Up of Patients with Differentiated Thyroid Carcinoma?	PLOS ONE			English	Article								Sensitivity of thyroglobulin (Tg) measurement in the follow-up of differentiated thyroid carcinoma (DTC) can be optimized by using a sensitive Tg assay and rhTSH stimulation. We evaluated the diagnostic yield of a sensitive Tg assay and rhTSH stimulated Tg in the detection of recurrences in the follow-up of DTC. Additionally the value of imaging techniques for the localization of recurrences was evaluated. We included 121 disease free patients in long-term follow-up for DTC (median 10 years, range 1-34). Tg during thyroid hormone suppression therapy (Tg-on) and rhTSH stimulated Tg were measured with a sensitive Tg assay. Patients with rhTSH stimulated Tg >= 1.0 ng/ml underwent imaging with neck ultrasound, FDG-PET and post therapy I-131 WBS. Sensitive Tg measurement resulted in 3 patients with Tg-on >= 1.0 ng/ml, recurrence could be localized in 2 of them. RhTSH stimulation resulted in Tg >= 1.0 ng/ml in another 17 of 118 patients. Recurrence could be localized in only 1 additional patient (1 out of 118 patients). Recurrence was localized by neck ultrasound in 1 of 3, by FDG-PET in 2 of 3 and by post therapy I-131 WBS in 2 of 3 patients. In the detection of recurrences in DTC, rhTSH stimulation had very limited additional value in comparison to Tg-on measurement with a sensitive Tg assay. We consider this too low to justify rhTSH stimulation in all patients during long-term follow up. Neck ultrasound, FDG-PET and post therapy I-131 WBS showed complementary value in localization of disease, but were only positive in a small fracture of all procedures.	[Persoon, Adrienne C. M.; Sluiter, Wim J.; Wolffenbuttel, Bruce H. R.; Links, Thera P.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, NL-9700 AB Groningen, Netherlands; [Plukker, John T. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, NL-9700 AB Groningen, Netherlands; [Jager, Pieter L.] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med, NL-9700 AB Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Links, TP (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, NL-9700 AB Groningen, Netherlands.	t.p.links@int.umcg.nl	Jager, Pieter/A-3672-2017; Wolffenbuttel, Bruce/A-8419-2011	Jager, Pieter/0000-0003-4033-7559; Wolffenbuttel, Bruce/0000-0001-9262-6921	University Medical Center Groningen	University Medical Center Groningen	This study was funded by an effectiveness studies grant from University Medical Center Groningen. The funding source had no role in the study design, data collection, data analysis and interpretation or writing of the report.	Ahuja AT, 2001, CLIN RADIOL, V56, P284, DOI 10.1053/crad.2000.0632; DEMERS CM, 2002, NATL ACAD CLIN BIOCH; do Rosario PWS, 2005, CLIN ENDOCRINOL, V62, P121, DOI 10.1111/j.1365-2265.2005.02212.x; Eustatia-Rutten CFA, 2006, J CLIN ENDOCR METAB, V91, P313, DOI 10.1210/jc.2005-1322; FeldtRasmussen U, 1996, ANN BIOL CLIN-PARIS, V54, P337; FeldtRasmussen U, 1996, ANN BIOL CLIN-PARIS, V54, P343; Frasoldati A, 2003, CANCER-AM CANCER SOC, V97, P90, DOI 10.1002/cncr.11031; Haugen BR, 1999, J CLIN ENDOCR METAB, V84, P3877, DOI 10.1210/jc.84.11.3877; Hermanek P., 1992, TNM CLASSIFICATION M, P35; Kessler A, 2003, J CLIN ULTRASOUND, V31, P21, DOI 10.1002/jcu.10130; Ladenson PW, 1997, NEW ENGL J MED, V337, P888, DOI 10.1056/NEJM199709253371304; Lind P, 2006, SEMIN NUCL MED, V36, P194, DOI 10.1053/j.semnuclmed.2006.03.002; Links TP, 2005, ENDOCR-RELAT CANCER, V12, P273, DOI 10.1677/erc.1.00892; LINKS TP, 2006, J CLIN ENDOCRINOL ME; LOGERFO P, 1980, J SURG ONCOL, V14, P195; Mazzaferri EL, 2001, J CLIN ENDOCR METAB, V86, P1447, DOI 10.1210/jc.86.4.1447; Mazzaferri EL, 2002, ENDOCR-RELAT CANCER, V9, P227, DOI 10.1677/erc.0.0090227; Mazzaferri EL, 2003, J CLIN ENDOCR METAB, V88, P1433, DOI 10.1210/jc.2002-021702; MEIER CA, 1994, J CLIN ENDOCR METAB, V78, P188, DOI 10.1210/jc.78.1.188; Morgenthaler NG, 2002, CLIN CHEM, V48, P1077; Nanni C, 2006, BIOMED PHARMACOTHER, V60, P409, DOI 10.1016/j.biopha.2006.07.008; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Persoon ACM, 2006, CLIN CHEM, V52, P686, DOI 10.1373/clinchem.2005.060095; Persoon ACM, 2006, CLIN CHEM, V52, P1196, DOI 10.1373/clinchem.2005.060103; Schlumberger M, 2000, EUR J ENDOCRINOL, V143, P557, DOI 10.1530/eje.0.1430557; Schlumberger MJ, 1998, NEW ENGL J MED, V338, P297, DOI 10.1056/NEJM199801293380506; Smallridge RC, 2007, J CLIN ENDOCR METAB, V92, P82, DOI 10.1210/jc.2006-0993; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Spencer CA, 1999, THYROID, V9, P435, DOI 10.1089/thy.1999.9.435; Spencer CA, 2005, J CLIN ENDOCR METAB, V90, P5566, DOI 10.1210/jc.2005-0671; Torlontano M, 2004, J CLIN ENDOCR METAB, V89, P3402, DOI 10.1210/jc.2003-031521; Torlontano M, 2003, EUR J ENDOCRINOL, V148, P19, DOI 10.1530/eje.0.1480019; Wartofsky L, 2002, J CLIN ENDOCR METAB, V87, P1486, DOI 10.1210/jc.87.4.1486; Zanotti-Fregonara P, 2007, EUR J NUCL MED MOL I, V34, P541, DOI 10.1007/s00259-006-0279-z	34	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e816	10.1371/journal.pone.0000816	http://dx.doi.org/10.1371/journal.pone.0000816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726546	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455400033
J	Kullberg, M; Hallstrom, B; Arnason, U; Janke, A				Kullberg, Morgan; Hallstrom, Bjorn; Arnason, Ulfur; Janke, Axel			Expressed Sequence Tags as a Tool for Phylogenetic Analysis of Placental Mammal Evolution	PLOS ONE			English	Article							MITOCHONDRIAL-DNA SEQUENCE; POSITIVE SELECTION; LIKELIHOOD METHOD; PROTEIN FAMILIES; GENES; IDENTIFICATION; SUBFAMILIES; SYSTEMATICS; INFERENCE; PATTERNS	Background. We investigate the usefulness of expressed sequence tags, ESTs, for establishing divergences within the tree of placental mammals. This is done on the example of the established relationships among primates (human), lagomorphs (rabbit), rodents (rat and mouse), artiodactyls (cow), carnivorans (dog) and proboscideans (elephant). Methodology/Principal Findings. We have produced 2000 ESTs (1.2 mega bases) from a marsupial mouse and characterized the data for their use in phylogenetic analysis. The sequences were used to identify putative orthologous sequences from whole genome projects. Although most ESTs stem from single sequence reads, the frequency of potential sequencing errors was found to be lower than allelic variation. Most of the sequences represented slowly evolving housekeeping-type genes, with an average amino acid distance of 6.6% between human and mouse. Positive Darwinian selection was identified at only a few single sites. Phylogenetic analyses of the EST data yielded trees that were consistent with those established from whole genome projects. Conclusions. The general quality of EST sequences and the general absence of positive selection in these sequences make ESTs an attractive tool for phylogenetic analysis. The EST approach allows, at reasonable costs, a fast extension of data sampling from species outside the genome projects.	[Kullberg, Morgan; Hallstrom, Bjorn; Arnason, Ulfur; Janke, Axel] Lund Univ, Dept Cell & Organism Biol, Div Evolutionary Mol Systemat, Lund, Sweden	Lund University	Kullberg, M (corresponding author), Lund Univ, Dept Cell & Organism Biol, Div Evolutionary Mol Systemat, Lund, Sweden.	morgan.kullberg@cob.lu.se	Janke, Axel/M-2135-2013	Janke, Axel/0000-0002-9394-1904	Swedish Science Council; Jorgen Lindstrom Foundation; Royal Physiographic Society (Nilsson-Ehle)	Swedish Science Council; Jorgen Lindstrom Foundation; Royal Physiographic Society (Nilsson-Ehle)	The Swedish Science Council, the Jorgen Lindstrom Foundation, and the Royal Physiographic Society (Nilsson-Ehle) supported the study.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ADACHI J, 1993, J MOL EVOL, V36, P270, DOI 10.1007/BF00160483; Adachi J., 1996, COMPUT SCI MONOGR, V28, P1; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Amrine-Madsen H, 2003, MOL PHYLOGENET EVOL, V28, P186, DOI 10.1016/S1055-7903(03)00122-2; [Anonymous], NCBI REFSEQ DAT; Arnason U, 2002, CYTOGENET GENOME RES, V96, P20, DOI 10.1159/000063023; ARNASON U, 1992, J MOL EVOL, V34, P493, DOI 10.1007/BF00160463; Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Arnason U, 1996, J MOL EVOL, V43, P650, DOI 10.1007/BF02202113; BAURAIN D, 2006, MOL BIOL EV IN PRESS; BENTON MJ, 2006, PALEONTOLOGICAL EVID; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Cannarozzi G, 2007, PLOS COMPUT BIOL, V3, P9, DOI 10.1371/journal.pcbi.0030002; Cao Y, 1998, MOL BIOL EVOL, V15, P1637, DOI 10.1093/oxfordjournals.molbev.a025891; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; de la Torre JEB, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-48; DeBry RW, 2003, SYST BIOL, V52, P604, DOI 10.1080/10635150390235403; DEJONG WW, 1981, NATURE, V292, P538, DOI 10.1038/292538a0; Endo T, 1996, MOL BIOL EVOL, V13, P685, DOI 10.1093/oxfordjournals.molbev.a025629; *ENSEMBL, ENSEMBL PUBL FTP; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; GU X, 1995, MOL BIOL EVOL, V12, P546; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes AL, 2007, MOL PHYLOGENET EVOL, V45, P81, DOI 10.1016/j.ympev.2007.04.022; Hughes J, 2006, MOL BIOL EVOL, V23, P268, DOI 10.1093/molbev/msj041; HUTTLEY GA, 2007, MOL BIOL EV IN PRESS; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; JANKE A, 1994, GENETICS, V137, P243; Jansa SA, 2006, MOL PHYLOGENET EVOL, V38, P363, DOI 10.1016/j.ympev.2005.06.007; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jorgensen FG, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-2; Kjer KM, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-8; Kriegs JO, 2006, PLOS BIOL, V4, P537, DOI 10.1371/journal.pbio.0040091; Kullberg M, 2006, MOL BIOL EVOL, V23, P1493, DOI 10.1093/molbev/msl027; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nikolaev S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030002; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; Parkinson J, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-31; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Pie MR, 2006, MOL BIOL EVOL, V23, P2274, DOI 10.1093/molbev/msl116; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A., 1996, SE ALV2 0A11 SEQUENC; Reyes A, 2004, MOL BIOL EVOL, V21, P397, DOI 10.1093/molbev/msh033; Reyes A, 2000, GENE, V259, P177, DOI 10.1016/S0378-1119(00)00438-8; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Strugnell J, 2005, MOL PHYLOGENET EVOL, V37, P426, DOI 10.1016/j.ympev.2005.03.020; Sullivan Jack, 1997, Journal of Mammalian Evolution, V4, P77, DOI 10.1023/A:1027314112438; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Waters PD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000158; Watson J. D., 1965, MOL BIOL GENE; YANG Z, 2006, COMPUTIONAL MOL EVOL; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zheng XH, 2005, BIOINFORMATICS, V21, P703, DOI 10.1093/bioinformatics/bti045	69	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e775	10.1371/journal.pone.0000775	http://dx.doi.org/10.1371/journal.pone.0000775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712423	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455300023
J	Reig, R; Sanchez-Vives, MV				Reig, Ramon; Sanchez-Vives, Maria V.			Synaptic Transmission and Plasticity in an Active Cortical Network	PLOS ONE			English	Article								Background. The cerebral cortex is permanently active during both awake and sleep states. This ongoing cortical activity has an impact on synaptic transmission and short-term plasticity. An activity pattern generated by the cortical network is a slow rhythmic activity that alternates up (active) and down (silent) states, a pattern occurring during slow wave sleep, anesthesia and even in vitro. Here we have studied 1) how network activity affects short term synaptic plasticity and, 2) how synaptic transmission varies in up versus down states. Methodology/Principal Findings. Intracellular recordings obtained from cortex in vitro and in vivo were used to record synaptic potentials, while presynaptic activation was achieved either with electrical or natural stimulation. Repetitive activation of layer 4 to layer 2/3 synaptic connections from ferret visual cortex slices displayed synaptic augmentation that was larger and longer lasting in active than in silent slices. Paired-pulse facilitation was also significantly larger in an active network and it persisted for longer intervals (up to 200 ms) than in silent slices. Intracortical synaptic potentials occurring during up states in vitro increased their amplitude while paired-pulse facilitation disappeared. Both intracortical and thalamocortical synaptic potentials were also significantly larger in up than in down states in the cat visual cortex in vivo. These enhanced synaptic potentials did not further facilitate when pairs of stimuli were given, thus paired-pulse facilitation during up states in vivo was virtually absent. Visually induced synaptic responses displayed larger amplitudes when occurring during up versus down states. This was further tested in rat barrel cortex, where a sensory activated synaptic potential was also larger in up states. Conclusions/Significance. These results imply that synaptic transmission in an active cortical network is more secure and efficient due to larger amplitude of synaptic potentials and lesser short term plasticity.	[Reig, Ramon; Sanchez-Vives, Maria V.] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alacant, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Sanchez-Vives, MV (corresponding author), Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alacant, Spain.	mavi.sanchez@umh.es	Sanchez-Vives, Maria/J-8526-2014; Reig, Ramon/A-6925-2017	Sanchez-Vives, Maria/0000-0002-8437-9083; Reig, Ramon/0000-0002-6475-4181	Ministerio de Educacion y Ciencia de Espana; Human Frontier Science Program	Ministerio de Educacion y Ciencia de Espana(Spanish Government); Human Frontier Science Program(Human Frontier Science Program)	This work has been sponsored by Ministerio de Educacion y Ciencia de Espana and Human Frontier Science Program to MVSV. No role in the study played by the sponsors.	AGHAJANIAN GK, 1989, SYNAPSE, V3, P331, DOI 10.1002/syn.890030406; Andersen P., 1968, PHYSIOLOGICAL BASIS; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Azouz R, 1999, J NEUROSCI, V19, P2209; Bazhenov M, 2002, J NEUROSCI, V22, P8691; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Boudreau CE, 2005, J NEUROSCI, V25, P7179, DOI 10.1523/JNEUROSCI.1445-05.2005; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V539, P567, DOI 10.1113/jphysiol.2001.013283; CastroAlamancos MA, 1996, J NEUROSCI, V16, P7742; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chen DF, 2005, J NEUROPHYSIOL, V94, P2713, DOI 10.1152/jn.00024.2005; COMPTE A, 2003, FAST SYNCHRONIZED OS; Crochet S, 2006, CEREB CORTEX, V16, P618, DOI 10.1093/cercor/bhj008; Crochet S, 2005, EUR J NEUROSCI, V21, P1030, DOI 10.1111/j.1460-9568.2005.03932.x; De No RL, 1938, J NEUROPHYSIOL, V1, P207; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; EVARTS EV, 1964, J NEUROPHYSIOL, V27, P152, DOI 10.1152/jn.1964.27.2.152; Fuentealba P, 2004, J NEUROPHYSIOL, V91, P1990, DOI 10.1152/jn.01105.2003; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; HAIDER B, 2007, J NEUROPHYSIOL; HOBSON JA, 1971, ELECTROEN CLIN NEURO, V30, P97, DOI 10.1016/0013-4694(71)90271-9; Kerr JND, 2002, J NEUROSCI, V22, P1499, DOI 10.1523/JNEUROSCI.22-05-01499.2002; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Massimini M, 2001, J NEUROPHYSIOL, V85, P1346, DOI 10.1152/jn.2001.85.3.1346; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Nowak LG, 1998, EXP BRAIN RES, V118, P477, DOI 10.1007/s002210050304; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Paxinos G., 2005, RAT BRAIN STEREOTAXI, Vxliii; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Reig R, 2006, CEREB CORTEX, V16, P688, DOI 10.1093/cercor/bhj014; Rudolph M, 2005, J NEUROPHYSIOL, V94, P2805, DOI 10.1152/jn.01313.2004; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; SANCHEZVIVES MV, 1998, IS SYNAPTIC DEPRESSI, P896; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Shu YS, 2003, J NEUROSCI, V23, P10388; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; STERIADE M, 1984, BRAIN RES REV, V8, P1, DOI 10.1016/0165-0173(84)90017-1; STERIADE M, 1993, J NEUROSCI, V13, P3284; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; Steriade M, 1996, J NEUROSCI, V16, P392, DOI 10.1523/jneurosci.16-01-00392.1996; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; Timofeev I, 1996, J PHYSIOL-LONDON, V494, P265, DOI 10.1113/jphysiol.1996.sp021489; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Varela JA, 1997, J NEUROSCI, V17, P7926; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Waters J, 2006, J NEUROSCI, V26, P8267, DOI 10.1523/JNEUROSCI.2152-06.2006; Wilson CJ, 1996, J NEUROSCI, V16, P2397; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	56	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e670	10.1371/journal.pone.0000670	http://dx.doi.org/10.1371/journal.pone.0000670			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668052	Green Published, gold, Green Submitted			2022-12-27	WOS:000207452300010
J	Thedieck, C; Kalbacher, H; Kuczyk, M; Muller, GA; Muller, CA; Klein, G				Thedieck, Cornelia; Kalbacher, Hubert; Kuczyk, Markus; Mueller, Gerhard A.; Mueller, Claudia A.; Klein, Gerd			Cadherin-9 Is a Novel Cell Surface Marker for the Heterogeneous Pool of Renal Fibroblasts	PLOS ONE			English	Article								Background. Interstitial fibroblasts are a minor, but nevertheless very important, component of the kidney. They secrete and remodel extracellular matrix and they produce active compounds such as erythropoietin. However, studying human renal fibroblasts has been hampered by the lack of appropriate surface markers. Methods and Findings. The expression of cadherin-9 in various human renal cell lines and tissues was studied on the mRNA level by RT-PCR and on the protein level with the help of newly generated cadherin-9 antibodies. The classical type II cadherin-9, so far only described in the neural system, was identified as a reliable surface marker for renal fibroblasts. Compared to FSP1, a widely-used cytosolic renal fibroblast marker, cadherin-9 showed a more restricted expression pattern in human kidney. Under pathological conditions, cadherin-9 was expressed in the stroma of renal cell carcinoma, but not in the tumor cells themselves, and in renal fibrosis the percentage of cadherin-9-positive cells was clearly elevated 3 to 5 times compared to healthy kidney tissue. Induction of epithelial mesenchymal transition in renal epithelial cells with cyclosporin-A, which causes renal fibrosis as a side effect, induced cadherin-9 expression. Functional studies following siRNA-mediated knockdown of cadherin-9 revealed that it acts in the kidney like a typical classical cadherin. It was found to be associated with catenins and to mediate homophilic but not heterophilic cell interactions. Conclusions. Cadherin-9 represents a novel and reliable cell surface marker for fibroblasts in healthy and diseased kidneys. Together with the established marker molecules FSP1, CD45 and alpha smooth muscle actin, cadherin-9 can now be used to differentiate the heterogenic pool of renal fibroblasts into resident and activated fibroblasts, immigrated bone marrow derived fibroblast precursors and cells in different stages of epithelial mesenchymal transition.	[Thedieck, Cornelia; Mueller, Claudia A.; Klein, Gerd] Univ Med Clin, Sect Transplantat Immunol & Immunohematol, Med Res Ctr, Tubingen, Germany; [Kalbacher, Hubert] Univ Tubingen, Med & Nat Sci Res Ctr, Tubingen, Germany; [Kuczyk, Markus] Univ Med Clin, Dept Urol, Tubingen, Germany; [Mueller, Gerhard A.] Univ Gottingen, Dept Nephrol & Rheumatol, Med Ctr, Gottingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Gottingen	Klein, G (corresponding author), Univ Med Clin, Sect Transplantat Immunol & Immunohematol, Med Res Ctr, Tubingen, Germany.	gerd.klein@uni-tuebingen.de	Klein, Gerd/C-8499-2013; Lee-Thedieck, Cornelia/H-2835-2013	Lee-Thedieck, Cornelia/0000-0001-8863-5403	DFG (German Research Society) [GK 794]	DFG (German Research Society)(German Research Foundation (DFG))	This project was supported by a grant of the Doctoral Program GK 794 of the DFG (German Research Society) and in part by institutional funding.	Angst BD, 2001, J CELL SCI, V114, P629; BACHMANN S, 1993, J HISTOCHEM CYTOCHEM, V41, P335, DOI 10.1177/41.3.8429197; Bekirov IH, 2002, NEUROSCIENCE, V115, P213, DOI 10.1016/S0306-4522(02)00375-5; Blaschke S, 2002, INT J CANCER, V101, P327, DOI 10.1002/ijc.10623; BOHLE A, 1994, NEPHROL DIAL TRANSPL, V9, P4; Dahl U, 2002, MOL CELL BIOL, V22, P1474, DOI 10.1128/MCB.22.5.1474-1487.2002; DAVIES M, 1995, DNA CELL BIOL, V14, P825, DOI 10.1089/dna.1995.14.825; Dekel B, 2006, J AM SOC NEPHROL, V17, P3300, DOI 10.1681/ASN.2005020195; Dudley AT, 1999, GENE DEV, V13, P1601, DOI 10.1101/gad.13.12.1601; EKBLOM P, 1989, FASEB J, V3, P2141, DOI 10.1096/fasebj.3.10.2666230; Forino M, 2006, INT J EXP PATHOL, V87, P197, DOI 10.1111/j.1365-2613.2006.00479.x; Gooch JL, 2007, TRANSPLANTATION, V83, P439, DOI 10.1097/01.tp.0000251423.78124.51; Goto S, 1998, J AM SOC NEPHROL, V9, P1234; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Igarashi P, 2003, NEPHRON EXP NEPHROL, V94, pE1, DOI 10.1159/000070812; Inoue T, 2005, KIDNEY INT, V67, P2488, DOI 10.1111/j.1523-1755.2005.00358.x; Iwano M, 2004, CURR OPIN NEPHROL HY, V13, P279, DOI 10.1097/00041552-200405000-00003; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Le Hir M, 2005, KIDNEY INT, V68, P2400, DOI 10.1111/j.1523-1755.2005.00704_1.x; Le Hir M, 2005, HISTOCHEM CELL BIOL, V123, P335, DOI 10.1007/s00418-005-0788-z; LONNEMANN G, 1995, KIDNEY INT, V47, P845, DOI 10.1038/ki.1995.127; MAXWELL PH, 1993, KIDNEY INT, V44, P1149, DOI 10.1038/ki.1993.362; Mazzucchelli L, 2002, AM J PATHOL, V160, P7, DOI 10.1016/S0002-9440(10)64342-8; McMorrow T, 2005, NEPHROL DIAL TRANSPL, V20, P2215, DOI 10.1093/ndt/gfh967; MULLER GA, 1995, EXP NEPHROL, V3, P127; Munro SB, 1996, CELL IMMUNOL, V169, P309, DOI 10.1006/cimm.1996.0123; Munro SB, 1996, BIOL REPROD, V55, P822, DOI 10.1095/biolreprod55.4.822; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; NOUWEN EJ, 1993, KIDNEY INT, V44, P147, DOI 10.1038/ki.1993.225; Okada H, 1997, AM J PHYSIOL-RENAL, V273, pF563, DOI 10.1152/ajprenal.1997.273.4.F563; Paul R, 1997, CANCER RES, V57, P2741; Plotkin MD, 2006, AM J PHYSIOL-RENAL, V291, pF902, DOI 10.1152/ajprenal.00396.2005; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552; Sariola H, 1998, BIOCHEM CELL BIOL, V76, P1009, DOI 10.1139/bcb-76-6-1009; Schuttert JB, 2003, PFLUG ARCH EUR J PHY, V446, P387, DOI 10.1007/s00424-003-1026-y; SCHWINZER R, 1989, LEUKOCYTE TYPING, V4, P628; Shimoyama Y, 2000, BIOCHEM J, V349, P159, DOI 10.1042/0264-6021:3490159; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Strutz F, 1996, EXP NEPHROL, V4, P267; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; TAKENAGA K, 1994, BIOCHEM BIOPH RES CO, V202, P94, DOI 10.1006/bbrc.1994.1898; Thedieck C, 2005, BRIT J CANCER, V92, P2010, DOI 10.1038/sj.bjc.6602597; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135	47	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e657	10.1371/journal.pone.0000657	http://dx.doi.org/10.1371/journal.pone.0000657			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668045	Green Published, gold			2022-12-27	WOS:000207452300003
J	Hsiau, THC; Diaconu, C; Myers, CA; Lee, J; Cepko, CL; Corbo, JC				Hsiau, Timothy H. -C.; Diaconu, Claudiu; Myers, Connie A.; Lee, Jongwoo; Cepko, Constance L.; Corbo, Joseph C.			The Cis-regulatory Logic of the Mammalian Photoreceptor Transcriptional Network	PLOS ONE			English	Article								The photoreceptor cells of the retina are subject to a greater number of genetic diseases than any other cell type in the human body. The majority of more than 120 cloned human blindness genes are highly expressed in photoreceptors. In order to establish an integrative framework in which to understand these diseases, we have undertaken an experimental and computational analysis of the network controlled by the mammalian photoreceptor transcription factors, Crx, Nrl, and Nr2e3. Using microarray and in situ hybridization datasets we have produced a model of this network which contains over 600 genes, including numerous retinal disease loci as well as previously uncharacterized photoreceptor transcription factors. To elucidate the connectivity of this network, we devised a computational algorithm to identify the photoreceptor-specific cis-regulatory elements (CREs) mediating the interactions between these transcription factors and their target genes. In vivo validation of our computational predictions resulted in the discovery of 19 novel photoreceptor-specific CREs near retinal disease genes. Examination of these CREs permitted the definition of a simple cis-regulatory grammar rule associated with high-level expression. To test the generality of this rule, we used an expanded form of it as a selection filter to evolve photoreceptor CREs from random DNA sequences in silico. When fused to fluorescent reporters, these evolved CREs drove strong, photoreceptor-specific expression in vivo. This study represents the first systematic identification and in vivo validation of CREs in a mammalian neuronal cell type and lays the groundwork for a systems biology of photoreceptor transcriptional regulation.	[Cepko, Constance L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; [Hsiau, Timothy H. -C.; Diaconu, Claudiu; Myers, Connie A.; Lee, Jongwoo; Corbo, Joseph C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Washington University (WUSTL)	Cepko, CL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA.	cepko@genetics.harvard.edu; jcorbo@pathology.wustl.edu		Corbo, Joseph/0000-0002-9323-7140	NIH [K08EY014822, R01EY009676]; Foundation for Retina Research, Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [K08EY014822, R01EY009676] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Retina Research, Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding: This work was supported by funds from NIH grant, K08EY014822, to JCC and by funds from the Foundation for Retina Research, Howard Hughes Medical Institute and an NIH grant, R01EY009676, to CLC.	Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; AHMAD I, 1994, J NEUROCHEM, V62, P396; Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Alfano G, 2005, HUM MOL GENET, V14, P913, DOI 10.1093/hmg/ddi084; Bessant DAR, 1999, NAT GENET, V21, P355, DOI 10.1038/7678; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Chang LW, 2006, GENOME RES, V16, P405, DOI 10.1101/gr.4303406; Chen CMA, 2000, MECH DEVELOP, V90, P293; CHEN J, 1994, P NATL ACAD SCI USA, V91, P2611, DOI 10.1073/pnas.91.7.2611; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Chen SM, 1996, J BIOL CHEM, V271, P28549, DOI 10.1074/jbc.271.45.28549; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; CORBO JC, 2007, P NATL AC A IN PRESS; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; De-Leon SBT, 2007, ANNU REV BIOPH BIOM, V36, P191, DOI 10.1146/annurev.biophys.35.040405.102002; Dlakic M, 2001, EMBO J, V20, P828, DOI 10.1093/emboj/20.4.828; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa A, 2002, J NEUROSCI, V22, P1640, DOI 10.1523/JNEUROSCI.22-05-01640.2002; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Haider NB, 2001, HUM MOL GENET, V10, P1619, DOI 10.1093/hmg/10.16.1619; Huber BR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-229; Kamachi Y, 1998, DEVELOPMENT, V125, P2521; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; KIKUCHI T, 1993, MOL CELL BIOL, V13, P4400, DOI 10.1128/MCB.13.7.4400; LEM J, 1991, NEURON, V6, P201, DOI 10.1016/0896-6273(91)90356-5; Lenhard B, 2002, BIOINFORMATICS, V18, P1135, DOI 10.1093/bioinformatics/18.8.1135; Lerner LE, 2002, J BIOL CHEM, V277, P25877, DOI 10.1074/jbc.M201407200; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luo JM, 1997, NATURE, V388, P778, DOI 10.1038/42022; Martinez-Morales JR, 2003, J BIOL CHEM, V278, P21721, DOI 10.1074/jbc.M301708200; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mitsunaga K, 2004, MECH DEVELOP, V121, P237, DOI 10.1016/j.mod.2004.01.006; Mitton KP, 2000, J BIOL CHEM, V275, P29794, DOI 10.1074/jbc.M003658200; Morris TA, 1997, INVEST OPHTH VIS SCI, V38, P196; Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pawlyk BS, 2005, INVEST OPHTH VIS SCI, V46, P3039, DOI 10.1167/iovs.05-0371; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pennesi ME, 2003, J NEUROSCI, V23, P453; Pittler SJ, 2004, J BIOL CHEM, V279, P19800, DOI 10.1074/jbc.M401864200; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Qian J, 2005, NUCLEIC ACIDS RES, V33, P3479, DOI 10.1093/nar/gki658; Roberts MR, 2005, INVEST OPHTH VIS SCI, V46, P2897, DOI 10.1167/iovs.05-0093; Rozen S, 2000, Methods Mol Biol, V132, P365; Schneider TD, 2000, NUCLEIC ACIDS RES, V28, P2794, DOI 10.1093/nar/28.14.2794; Schroeder MD, 2004, PLOS BIOL, V2, P1396, DOI 10.1371/journal.pbio.0020271; Senger K, 2004, MOL CELL, V13, P19, DOI 10.1016/S1097-2765(03)00500-8; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shimada N, 2003, MECH DEVELOP, V120, P455, DOI 10.1016/S0925-4773(03)00002-9; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SRINIVAS M, 2006, MOL ENDOCRINOL; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160; Young JE, 2003, INVEST OPHTH VIS SCI, V44, P4076, DOI 10.1167/iovs.03-0197; ZACK DJ, 1991, NEURON, V6, P187, DOI 10.1016/0896-6273(91)90355-4	70	107	109	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e643	10.1371/journal.pone.0000643	http://dx.doi.org/10.1371/journal.pone.0000643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653270	gold, Green Published			2022-12-27	WOS:000207452200012
J	Nie, CL; Wei, Y; Chen, XY; Liu, YY; Dui, W; Liu, Y; Davies, MC; Tendler, SJB; He, RG				Nie, Chun Lai; Wei, Yan; Chen, Xinyong; Liu, Yan Ying; Dui, Wen; Liu, Ying; Davies, Martyn C.; Tendler, Saul J. B.; He, Rong Giao			Formaldehyde at Low Concentration Induces Protein Tau into Globular Amyloid-Like Aggregates In Vitro and In Vivo	PLOS ONE			English	Article								Recent studies have shown that neurodegeneration is closely related to misfolding and aggregation of neuronal tau. Our previous results show that neuronal tau aggregates in formaldehyde solution and that aggregated tau induces apoptosis of SH-SY5Y and hippocampal cells. In the present study, based on atomic force microscopy (AFM) observation, we have found that formaldehyde at low concentrations induces tau polymerization whilst acetaldehyde does not. Neuronal tau misfolds and aggregates into globular-like polymers in 0.01-0.1% formaldehyde solutions. Apart from globular-like aggregation, no fibril-like polymerization was observed when the protein was incubated with formaldehyde for 15 days. SDS-PAGE results also exhibit tau polymerizing in the presence of formaldehyde. Under the same experimental conditions, polymerization of bovine serum albumin (BSA) or alpha-synuclein was not markedly detected. Kinetic study shows that tau significantly misfolds and polymerizes in 60 minutes in 0.1% formaldehyde solution. However, presence of 10% methanol prevents protein tau from polymerization. This suggests that formaldehyde polymerization is involved in tau aggregation. Such aggregation process is probably linked to the tau's special "worm-like'' structure, which leaves the epsilon-amino groups of Lys and thiol groups of Cys exposed to the exterior. Such a structure can easily bond to formaldehyde molecules in vitro and in vivo. Polymerizing of formaldehyde itself results in aggregation of protein tau. Immunocytochemistry and thioflavin S staining of both endogenous and exogenous tau in the presence of formaldehyde at low concentrations in the cell culture have shown that formaldehyde can induce tau into amyloid-like aggregates in vivo during apoptosis. The significant protein tau aggregation induced by formaldehyde and the severe toxicity of the aggregated tau to neural cells may suggest that toxicity of methanol and formaldehyde ingestion is related to tau misfolding and aggregation.	[Nie, Chun Lai; Wei, Yan; Liu, Yan Ying; Dui, Wen; Liu, Ying; He, Rong Giao] Chinese Acad Sci, Inst Biophys, Grad Sch, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Chen, Xinyong; Davies, Martyn C.; Tendler, Saul J. B.] Univ Nottingham, Sch Pharm, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Chinese Academy of Sciences, CAS; University of Nottingham	He, RG (corresponding author), Chinese Acad Sci, Inst Biophys, Grad Sch, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	herq@sun5.ibp.ac.cn	Liu, Ying/D-8933-2013	Liu, Ying/0000-0003-0802-3832; Davies, Martyn/0000-0001-7695-0596	NSFB [06J11]; NSFC [90206041, 30570536, 30621004];  [2006CB500703];  [2006CB911003]	NSFB(Beijing Natural Science Foundation); NSFC(National Natural Science Foundation of China (NSFC)); ; 	This project was supported by NSFB (06J11), the NSFC (Nos. 90206041, 30570536 and 30621004) and 973- Project (2006CB500703 and 2006CB911003).	Alonso AD, 2001, J BIOL CHEM, V276, P37967; Atlas R, 2004, J NEUROCHEM, V89, P613, DOI 10.1111/j.1471-4159.2004.02371.x; Barceloux DG, 2002, J TOXICOL-CLIN TOXIC, V40, P415; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Burns M, 2002, ANN NY ACAD SCI, V977, P367, DOI 10.1111/j.1749-6632.2002.tb04839.x; Chen K, 2006, J NEUROCHEM, V99, P1413, DOI 10.1111/j.1471-4159.2006.04181.x; Chen XP, 2000, CHEM COMMUN, P233, DOI 10.1039/a909162i; Cohen FE, 1999, J MOL BIOL, V293, P313, DOI 10.1006/jmbi.1999.2990; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; CULLEN KM, 1995, NEUROPATH APPL NEURO, V21, P312, DOI 10.1111/j.1365-2990.1995.tb01065.x; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; Davi G, 2005, ANTIOXID REDOX SIGN, V7, P256, DOI 10.1089/ars.2005.7.256; Dayan AD, 2001, HUM EXP TOXICOL, V20, P439, DOI 10.1191/096032701682693062; DUNTEN RL, 1989, J BIOL CHEM, V264, P16739; Eells JT, 2000, NEUROTOXICOLOGY, V21, P321; ERKRATH KD, 1981, Z RECHTSMED, V87, P233; ESTERBAUER H, 1992, FREE RADICAL BIO MED, V13, P341, DOI 10.1016/0891-5849(92)90181-F; Feng Z, 2006, FREE RADICAL BIO MED, V40, P101, DOI 10.1016/j.freeradbiomed.2005.08.014; Floyd RA, 2002, NEUROBIOL AGING, V23, P795, DOI 10.1016/S0197-4580(02)00019-2; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; GARNER CD, 1995, TOXICOL APPL PHARM, V130, P101, DOI 10.1006/taap.1995.1014; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gubisne-Haberle D, 2004, J PHARMACOL EXP THER, V310, P1125, DOI 10.1124/jpet.104.068601; HALLIWELL B, 1988, HUM TOXICOL, V7, P7, DOI 10.1177/096032718800700102; Heck HD, 1999, TOXICOL APPL PHARM, V160, P86, DOI 10.1006/taap.1999.8764; Hua Q, 2003, CELL MOL LIFE SCI, V60, P413, DOI 10.1007/s000180300034; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; Jiang WL, 2000, BIOTECHNOL BIOENG, V70, P507, DOI 10.1002/1097-0290(20001205)70:5<507::AID-BIT5>3.3.CO;2-3; KHATOON S, 1992, J NEUROCHEM, V59, P750, DOI 10.1111/j.1471-4159.1992.tb09432.x; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; MCLAUGHLIN AC, 1974, J BIOL CHEM, V249, P1445; Mirzaei H, 2006, J CHROMATOGR A, V1134, P122, DOI 10.1016/j.chroma.2006.08.096; Moreno-Herrero F, 2004, BIOPHYS J, V86, P517, DOI 10.1016/S0006-3495(04)74130-2; Nie Chun Lai, 2007, BMC Neurosci, V8, P9, DOI 10.1186/1471-2202-8-9; Nie CL, 2005, PROTEIN PEPTIDE LETT, V12, P75, DOI 10.2174/0929866053405931; Niemela Onni, 1999, Frontiers in Bioscience, V4, pD506, DOI 10.2741/Niemela; Paudel HK, 1997, J BIOL CHEM, V272, P28328, DOI 10.1074/jbc.272.45.28328; PLUMMER TH, 1963, J BIOL CHEM, V238, P1396; POMERANTZ M, 1982, J ORG CHEM, V47, P2217, DOI 10.1021/jo00132a056; Qu MH, 2004, NEUROREPORT, V15, P2723; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Rait VK, 2004, LAB INVEST, V84, P292, DOI 10.1038/labinvest.3700045; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Rohn TT, 2001, NEUROBIOL DIS, V8, P1006, DOI 10.1006/nbdi.2001.0449; Rohn TT, 2001, AM J PATHOL, V158, P189, DOI 10.1016/S0002-9440(10)63957-0; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; SHCHERBAKOVA L N, 1986, Byulleten' Eksperimental'noi Biologii i Meditsiny, V102, P573; Sung JY, 2005, J BIOL CHEM, V280, P25216, DOI 10.1074/jbc.M503341200; Taubes G, 1996, SCIENCE, V271, P1493, DOI 10.1126/science.271.5255.1493; TSOU CL, 1988, BIOCHEMISTRY-US, V27, P1809, DOI 10.1021/bi00406a001; VALENTINE WM, 1990, VET CLIN N AM-SMALL, V20, P515, DOI 10.1016/S0195-5616(90)50042-X; Von B. M., 2000, P NATL ACAD SCI USA, V97, P5129; Yu PH, 2006, AM J PATHOL, V168, P718, DOI 10.2353/ajpath.2006.050970; Yu PH, 2001, MED HYPOTHESES, V57, P175, DOI 10.1054/mehy.2001.1329	56	65	69	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2007	2	7							e629	10.1371/journal.pone.0000629	http://dx.doi.org/10.1371/journal.pone.0000629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GI	17637844	Green Submitted, gold, Green Published			2022-12-27	WOS:000207452100018
J	Kress, CL; Konopleva, M; Martinez-Garcia, V; Krajewska, M; Lefebvre, S; Hyer, ML; McQueen, T; Andreeff, M; Reed, JC; Zapata, JM				Kress, Christina L.; Konopleva, Marina; Martinez-Garcia, Vanesa; Krajewska, Maryla; Lefebvre, Sophie; Hyer, Marc L.; McQueen, Teresa; Andreeff, Michael; Reed, John C.; Zapata, Juan M.			Triterpenoids Display Single Agent Anti-tumor Activity in a Transgenic Mouse Model of Chronic Lymphocytic Leukemia and Small B Cell Lymphoma	PLOS ONE			English	Article								Background. The synthetic triterpenoid 2-Cyano-3,12-Dioxooleana-1,9-Dien-28-Oic Acid ( CDDO) and derivatives display antitumor activity against a variety of cultured tumor cell lines and in mouse xenografts. In this report, we have studied the effects of CDDO and its imidazolide derivative (CDDO-Im) on chronic lymphocytic leukemia (CLL), using patients' CLL cells and a mouse model of CLL and small B cell lymphoma (SBL). Principal Findings. CDDO and CDDO-Im efficiently induced apoptosis of malignant human and mouse B-cells ex vivo, although CDDO-Im was over 10-fold more potent than CDDO. Treating mice with CLL/SBL with liposome-formulated CDDO or CDDO-Im resulted in significant reductions of B cells in blood, spleen and lung. CDDO-Im was shown to be more potent than CDDO, while treatment with empty liposomes had no impact on disease. CDDO-Im treatment initially resulted in an increase of circulating B cells, which correlates with a reduction in resident lymphocytes in spleen, and lungs, suggesting that CDDO-Im induces mobilization of tumor cells from lymphoid organs and infiltrated tissues into the circulation. Analysis of blood cells recovered from treated mice also showed that CDDO-Im is a potent inducer of tumor cells death in vivo. Furthermore, CDDO-Im efficiently eradicated mouse CLL/SBL cells but had little effect on the viability of normal B and T cells in vivo. Significance. The presented data demonstrate that triterpenoids CDDO and CDDO-Im reduce leukemia and lymphoma burden in vivo in a transgenic mouse model of CLL/SBL, and support the clinical testing of CDDO-based synthetic triterpenoids in patients with CLL.	[Kress, Christina L.; Martinez-Garcia, Vanesa; Krajewska, Maryla; Lefebvre, Sophie; Hyer, Marc L.; Reed, John C.; Zapata, Juan M.] Burnham Inst Med Res, La Jolla, CA USA; [Konopleva, Marina; McQueen, Teresa; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA; [Martinez-Garcia, Vanesa; Zapata, Juan M.] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Sanford Burnham Prebys Medical Discovery Institute; University of Texas System; UTMD Anderson Cancer Center; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Zapata, JM (corresponding author), Burnham Inst Med Res, La Jolla, CA USA.	jmzapata@cbm.uam.es	Zapata, Juan M/J-6304-2014	Zapata, Juan M/0000-0002-0110-0009	National Institutes of Health [AI070859, CA81534, CA089346, CA100632]; Leukemia and Lymphoma Society of America [SAF2004-7675]; Spanish Ministerio de Educacion y Ciencia; NATIONAL CANCER INSTITUTE [P50CA100632, R01CA089346, P01CA081534, P20CA081534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); Spanish Ministerio de Educacion y Ciencia(Spanish Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants AI070859, CA81534, CA089346, CA100632, Leukemia Specialized Programs of Research Excellence ( SPORE), the Leukemia and Lymphoma Society of America, SAF2004-7675, Programa Ramon y Cajal and a fellowship from the Spanish Ministerio de Educacion y Ciencia.	Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; Chauhan D, 2004, BLOOD, V103, P3158, DOI 10.1182/blood-2003-08-2873; Chintharlapalli S, 2005, MOL PHARMACOL, V68, P119, DOI 10.1124/mol.105.011437; Dzubak P, 2006, NAT PROD REP, V23, P394, DOI 10.1039/b515312n; Elter T, 2006, EXPERT OPIN PHARMACO, V7, P1641, DOI 10.1517/14656566.7.12.1641; Han SS, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-22; Honda T, 1998, BIOORG MED CHEM LETT, V8, P2711, DOI 10.1016/S0960-894X(98)00479-X; Honda T, 2002, BIOORG MED CHEM LETT, V12, P1027, DOI 10.1016/S0960-894X(02)00105-1; Honda T, 2000, J MED CHEM, V43, P4233, DOI 10.1021/jm0002230; Hyer ML, 2005, CANCER RES, V65, P4799, DOI 10.1158/0008-5472.CAN-04-3319; Ikeda T, 2004, MOL CANCER THER, V3, P39, DOI 10.2463/mrms.3.39; Inoue S, 2004, LEUKEMIA, V18, P948, DOI 10.1038/sj.leu.2403328; Ito Y, 2000, CELL GROWTH DIFFER, V11, P261; Kay NE, 2006, SEMIN HEMATOL, V43, pS50, DOI 10.1053/j.seminhematol.2005.12.011; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Kipps T J, 1997, Curr Opin Hematol, V4, P268; Kitada S, 2002, ONCOGENE, V21, P3459, DOI 10.1038/sj.onc.1205327; Konopleva M, 2006, MOL CANCER THER, V5, P317, DOI 10.1158/1535-7163.MCT-05-0350; Konopleva M, 2005, LEUKEMIA, V19, P1350, DOI 10.1038/sj.leu.2403828; Konopleva M, 2004, CANCER RES, V64, P7927, DOI 10.1158/0008-5472.CAN-03-2402; Konopleva M, 2002, BLOOD, V99, P326, DOI 10.1182/blood.V99.1.326; Lapillonne H, 2003, CANCER RES, V63, P5926; Melichar B, 2004, GYNECOL ONCOL, V93, P149, DOI 10.1016/j.ygyno.2004.01.008; Place AE, 2003, CLIN CANCER RES, V9, P2798; REED JC, 2001, CHRONIC LYMPHOID LEU, P111; Samudio I, 2006, MOL PHARMACOL, V69, P1182, DOI 10.1124/mol.105.018051; Samudio I, 2005, J BIOL CHEM, V280, P36273, DOI 10.1074/jbc.M507518200; Shishodia S, 2006, CLIN CANCER RES, V12, P1828, DOI 10.1158/1078-0432.CCR-05-2044; STADHEIM TA, 2002, J BIOL CHEM IN PRESS; Suh NJ, 1999, CANCER RES, V59, P336; Suh WS, 2003, LEUKEMIA, V17, P2122, DOI 10.1038/sj.leu.2403112; Yue P, 2006, CANCER BIOL THER, V5, P492, DOI 10.4161/cbt.5.5.2565; Zapata JM, 2000, J IMMUNOL, V165, P5084, DOI 10.4049/jimmunol.165.9.5084; Zapata JM, 2004, P NATL ACAD SCI USA, V101, P16600, DOI 10.1073/pnas.0407541101; Zapata JM, 2003, EXPERT OPIN THER TAR, V7, P411, DOI 10.1517/14728222.7.3.411; ZAPATA JM, 2002, TRAF1 LORD RING; Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238	37	25	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e559	10.1371/journal.pone.0000559	http://dx.doi.org/10.1371/journal.pone.0000559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593960	Green Submitted, gold, Green Published			2022-12-27	WOS:000207451800005
J	Santos-Lopes, SS; Pereira, RW; Wilson, IJ; Pena, SDJ				Santos-Lopes, Simone S.; Pereira, Rinaldo W.; Wilson, Ian J.; Pena, Sergio D. J.			A Worldwide Phylogeography for the Human X Chromosome	PLOS ONE			English	Article							HUMAN GENOME; HUMAN-POPULATIONS; LINKAGE DISEQUILIBRIUM; MAP; MICROSATELLITES; RECOMBINATION; DIVERSITY; INFERENCE; HOTSPOTS; HISTORY	Background. We reasoned that by identifying genetic markers on human X chromosome regions where recombination is rare or absent, we should be able to construct X chromosome genealogies analogous to those based on Y chromosome and mitochondrial DNA polymorphisms, with the advantage of providing information about both male and female components of the population. Methodology/Principal Findings. We identified a 47 Kb interval containing an Alu insertion polymorphism (DXS225) and four microsatellites in complete linkage disequilibrium in a low recombination rate region of the long arm of the human X chromosome. This haplotype block was studied in 667 males from the HGDP-CEPH Human Genome Diversity Panel. The haplotypic diversity was highest in Africa (0.99260.0025) and lowest in the Americas (0.839 +/- 0.0378), where no insertion alleles of DXS225 were observed. Africa shared few haplotypes with other geographical areas, while those exhibited significant sharing among themselves. Median joining networks revealed that the African haplotypes were numerous, occupied the periphery of the graph and had low frequency, whereas those from the other continents were few, central and had high frequency. Altogether, our data support a single origin of modern man in Africa and migration to occupy the other continents by serial founder effects. Coalescent analysis permitted estimation of the time of the most recent common ancestor as 182,000 years ( 56,700-479,000) and the estimated time of the DXS225 Alu insertion of 94,400 years ( 24,300-310,000). These dates are fully compatible with the current widely accepted scenario of the origin of modern mankind in Africa within the last 195,000 years and migration out-of-Africa circa 55,000-65,000 years ago. Conclusions/Significance. A haplotypic block combining an Alu insertion polymorphism and four microsatellite markers on the human X chromosome is a useful marker to evaluate genetic diversity of human populations and provides a highly informative tool for evolutionary studies.	[Santos-Lopes, Simone S.; Pereira, Rinaldo W.; Pena, Sergio D. J.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Pereira, Rinaldo W.] Univ Catolica Brasilia, Programa Posgrad Ciencias Genom & Biotecnol, Brasilia, DF, Brazil; [Wilson, Ian J.] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England	Universidade Federal de Minas Gerais; Universidade Catolica de Brasilia; Newcastle University - UK	Pena, SDJ (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	spena@dcc.ufmg.br	Pereira, Rinaldo W/B-9255-2011	Pereira, Rinaldo W/0000-0003-3704-2848; Wilson, Ian/0000-0001-6893-2873	CNPq-Brazil; Royal Society Relocation Fellowship	CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Royal Society Relocation Fellowship	Supported by CNPq-Brazil through the Universal Grants program and the "Institutos do Milenio'' program. Further support to Ian Wilson from the Royal Society Relocation Fellowship scheme.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EXCOFFIER L, 1992, GENETICS, V131, P491; HEDRICK PW, 1987, GENETICS, V117, P331; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Leopoldino AM, 2003, HUM MUTAT, V21, P71, DOI 10.1002/humu.10153; Li N, 2003, GENETICS, V165, P2213; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mountain JL, 2002, GENOME RES, V12, P1766, DOI 10.1101/gr.238602; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nagaraja R, 1997, GENOME RES, V7, P210, DOI 10.1101/gr.7.3.210; PENA SDJ, 2007, PHARMACOGENOMICS ADM; Pereira RW, 2006, GENET MOL RES, V5, P63; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242; Schaffner SF, 2004, NAT REV GENET, V5, P43, DOI 10.1038/nrg1247; Schneider S., 2000, ARLEQUIN SOFTWARE PO; STORTO L, 2005, POVOS INDIGENAS BRAS; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Wilkins JF, 2006, BIOESSAYS, V28, P290, DOI 10.1002/bies.20378; Wilson IJ, 1998, GENETICS, V150, P499; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Xu HY, 2005, GENETICS, V170, P305, DOI 10.1534/genetics.104.036855; Yu N, 2002, GENETICS, V161, P269	35	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e557	10.1371/journal.pone.0000557	http://dx.doi.org/10.1371/journal.pone.0000557			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593958	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451800003
J	Sullivan, PS; Campsmith, ML; Nakamura, GV; Begley, EB; Schulden, J; Nakashima, AK				Sullivan, Patrick S.; Campsmith, Michael L.; Nakamura, Glenn V.; Begley, Elin B.; Schulden, Jeffrey; Nakashima, Allyn K.			Patient and Regimen Characteristics Associated with Self-Reported Nonadherence to Antiretroviral Therapy	PLOS ONE			English	Article							HIV BEHAVIORAL SURVEILLANCE; MEDICATION ADHERENCE; VIRAL SUPPRESSION; CLINICAL-TRIALS; DRUG-USE; INFECTION; IMPACT; RISK; OUTCOMES; INDIVIDUALS	Background. Nonadherence to antiretroviral therapy (ARVT) is an important behavioral determinant of the success of ARVT. Nonadherence may lead to virological failure, and increases the risk of development of drug resistance. Understanding the prevalence of nonadherence and associated factors is important to inform secondary HIV prevention efforts. Methodology/Principal Findings. We used data from a cross-sectional interview study of persons with HIV conducted in 18 U. S. states from 2000-2004. We calculated the proportion of nonadherent respondents (took <95% of prescribed doses in the past 48 hours), and the proportion of doses missed. We used multivariate logistic regression to describe factors associated with nonadherence. Nine hundred and fifty-eight (16%) of 5,887 respondents reported nonadherence. Nonadherence was significantly (p<0.05) associated with black race and Hispanic ethnicity; age <40 years; alcohol or crack use in the prior 12 months; being prescribed >= 4 medications; living in a shelter or on the street; and feeling "blue" >= 14 of the past 30 days. We found weaker associations with having both male-male sex and injection drug use risks for HIV acquisition; being prescribed ARVT for >= 21 months; and being prescribed a protease inhibitor (PI)-based regimen not boosted with ritonavir. The median proportion of doses missed was 50%. The most common reasons for missing doses were forgetting and side effects. Conclusions/Significance. Self-reported recent nonadherence was high in our study. Our data support increased emphasis on adherence in clinical settings, and additional research on how providers and patients can overcome barriers to adherence.	[Sullivan, Patrick S.; Campsmith, Michael L.; Nakamura, Glenn V.; Begley, Elin B.; Schulden, Jeffrey; Nakashima, Allyn K.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Sullivan, PS (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	pss0@cdc.gov		Sullivan, Patrick Sean/0000-0002-7728-0587	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding support for data collection was provided to the project sites by the Centers for Disease Control and Prevention. No external funding was used to support the analysis of these data.	Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008; Ammassari A, 2004, PSYCHOSOMATICS, V45, P394, DOI 10.1176/appi.psy.45.5.394; Ammassari A, 2002, JAIDS, V31, pS123, DOI 10.1097/00126334-200212153-00007; Antinori A, 2004, ANTIVIR THER, V9, P291; Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1007/s11606-002-0044-3; Bartenstein P, 2002, AKTUEL NEUROL, V29, P1, DOI 10.1055/s-2002-20000; Berg KM, 2004, J GEN INTERN MED, V19, P1111, DOI 10.1111/j.1525-1497.2004.30445.x; Bottonari KA, 2005, AIDS PATIENT CARE ST, V19, P719, DOI 10.1089/apc.2005.19.719; Buehler JW, 1996, PUBLIC HEALTH REP, V111, P133; Carpenter CCJ, 1998, JAMA-J AM MED ASSOC, V280, P78, DOI 10.1001/jama.280.1.78; Carrieri MP, 2006, JAIDS-J ACQ IMM DEF, V41, P477, DOI 10.1097/01.qai.0000186364.27587.0e; Chander G, 2006, DRUGS, V66, P769, DOI 10.2165/00003495-200666060-00004; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; COHEN M, 2006, 13 C RETR OPP INF DE; Fairley CK, 2005, HIV MED, V6, P366, DOI 10.1111/j.1468-1293.2005.00322.x; FARIZO KM, 1992, JAMA-J AM MED ASSOC, V267, P1798, DOI 10.1001/jama.267.13.1798; Fletcher CV, 2005, JAIDS-J ACQ IMM DEF, V40, P301, DOI 10.1097/01.qai.0000180078.53321.6a; Gallagher KM, 2007, PUBLIC HEALTH REP, V122, P32, DOI 10.1177/00333549071220S106; Glass TR, 2006, JAIDS-J ACQ IMM DEF, V41, P385, DOI 10.1097/01.qai.0000186371.95301.52; Gordillo V, 1999, AIDS, V13, P1763, DOI 10.1097/00002030-199909100-00021; GROSS R, 2006, 13 C RETR OPP INF DE; Hirsch MS, 1998, JAMA-J AM MED ASSOC, V279, P1984, DOI 10.1001/jama.279.24.1984; Holmes WC, 2002, J GEN INTERN MED, V17, P677, DOI 10.1046/j.1525-1497.2002.00746.x; Howard AA, 2002, AIDS, V16, P2175, DOI 10.1097/00002030-200211080-00010; Kerr Thomas, 2005, Curr HIV/AIDS Rep, V2, P200, DOI 10.1007/s11904-005-0017-3; Lafeuillade A, 2001, INT J STD AIDS, V12, P18, DOI 10.1258/0956462011924290; Lansky A, 2007, PUBLIC HEALTH REP, V122, P16, DOI 10.1177/00333549071220S104; Lichtenstein KA, 2005, JAIDS-J ACQ IMM DEF, V39, P395, DOI 10.1097/01.qai.0000167478.28051.3a; Maggiolo F, 2005, CLIN INFECT DIS, V40, P158, DOI 10.1086/426595; Maisto SA, 2003, AM J ADDICTION, V12, pS12, DOI 10.1111/j.1521-0391.2003.tb00493.x; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; Martini M, 2004, EUR J EPIDEMIOL, V19, P585, DOI 10.1023/B:EJEP.0000032353.03967.ef; Moss AR, 2004, CLIN INFECT DIS, V39, P1190, DOI 10.1086/424008; Murri R, 2004, J GEN INTERN MED, V19, P1104, DOI 10.1111/j.1525-1497.2004.30248.x; Nieuwkerk PT, 2005, JAIDS-J ACQ IMM DEF, V38, P445, DOI 10.1097/01.qai.0000147522.34369.12; NILSSON SL, 2006, AIDS CARE, V18, P246; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Piliero Peter J, 2003, J Am Acad Nurse Pract, V15, P305, DOI 10.1111/j.1745-7599.2003.tb01313.x; Reynolds NR, 2004, CURR HIV RES, V2, P207, DOI 10.2174/1570162043351309; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Santos CP, 2005, AIDS, V19, pS14, DOI 10.1097/01.aids.0000191485.92285.c7; Selnes OA, 2002, JAIDS-J ACQ IMM DEF, V31, pS132, DOI 10.1097/00126334-200212153-00009; Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684; Simoni JM, 2006, AIDS BEHAV, V10, P227, DOI 10.1007/s10461-006-9078-6; Sledjeski EM, 2005, AIDS PATIENT CARE ST, V19, P728, DOI 10.1089/apc.2005.19.728; Smith RJ, 2006, P ROY SOC B-BIOL SCI, V273, P617, DOI 10.1098/rspb.2005.3352; Starace F, 2002, JAIDS, V31, pS136, DOI 10.1097/00126334-200212153-00010; Stirratt MJ, 2006, AIDS BEHAV, V10, P483, DOI 10.1007/s10461-006-9106-6; Trotta MP, 2003, AIDS, V17, P1099, DOI 10.1097/00002030-200305020-00026; *US DEP HHS, 2006, GUID US ANT AG HIV 1; Van Wijngaerden E, 2002, AIDS RES HUM RETROV, V18, P327, DOI 10.1089/088922202753519098; Vlahov D, 2001, AIDS, V15, P2311, DOI 10.1097/00002030-200111230-00013; Vrijens B, 2005, STAT MED, V24, P2719, DOI 10.1002/sim.2130; Wagner G, 2004, JAIDS-J ACQ IMM DEF, V35, P203, DOI 10.1097/00126334-200402010-00016; Wagner GJ, 2002, AIDS PATIENT CARE ST, V16, P599, DOI 10.1089/108729102761882134; Walsh JC, 2002, AIDS, V16, P269, DOI 10.1097/00002030-200201250-00017; Walster C. I., 1999, Fish Veterinary Journal, P54; WEISER B, 1994, P NATL ACAD SCI USA, V91, P8037, DOI 10.1073/pnas.91.17.8037; Weiser SD, 2004, HIV CLIN TRIALS, V5, P278, DOI 10.1310/LNHD-K1R7-HQP5-HJCQ; Wood E, 2004, JAIDS-J ACQ IMM DEF, V35, P261, DOI 10.1097/00126334-200403010-00006	60	54	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2007	2	6							e552	10.1371/journal.pone.0000552	http://dx.doi.org/10.1371/journal.pone.0000552			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GE	17579723	Green Published, gold, Green Submitted			2022-12-27	WOS:000207451700017
J	Plant, EP; Nguyen, P; Russ, JR; Pittman, YR; Nguyen, T; Quesinberry, JT; Kinzy, TG; Dinman, JD				Plant, Ewan P.; Nguyen, Phuc; Russ, Jonathan R.; Pittman, Yvette R.; Nguyen, Thai; Quesinberry, Jack T.; Kinzy, Terri Goss; Dinman, Jonathan D.			Differentiating between Near- and Non-Cognate Codons in Saccharomyces cerevisiae	PLOS ONE			English	Article								Background. Decoding of mRNAs is performed by aminoacyl tRNAs (aa-tRNAs). This process is highly accurate, however, at low frequencies (10(-3)-10(-4)) the wrong aa-tRNA can be selected, leading to incorporation of aberrant amino acids. Although our understanding of what constitutes the correct or cognate aa-tRNA: mRNA interaction is well defined, a functional distinction between near-cognate or single mismatched, and unpaired or non-cognate interactions is lacking. Methodology/Principal Findings. Misreading of several synonymous codon substitutions at the catalytic site of firefly luciferase was assayed in Saccharomyces cerevisiae. Analysis of the results in the context of current kinetic and biophysical models of aa-tRNA selection suggests that the defining feature of near-cognate aa-tRNAs is their potential to form mini-helical structures with A-site codons, enabling stimulation of GTPase activity of eukaryotic Elongation Factor 1A (eEF1A). Paromomycin specifically stimulated misreading of near-cognate but not of non-cognate aa-tRNAs, providing a functional probe to distinguish between these two classes. Deletion of the accessory elongation factor eEF1B gamma promoted increased misreading of near-cognate, but hyperaccurate reading of non-cognate codons, suggesting that this factor also has a role in tRNA discrimination. A mutant of eEF1B alpha, the nucleotide exchange factor for eEF1A, promoted a general increase in fidelity, suggesting that the decreased rates of elongation may provide more time for discrimination between aa-tRNAs. A mutant form of ribosomal protein L5 promoted hyperaccurate decoding of both types of codons, even though it is topologically distant from the decoding center. Conclusions/Signficance. It is important to distinguish between near-cognate and non-cognate mRNA: tRNA interactions, because such a definition may be important for informing therapeutic strategies for suppressing these two different categories of mutations underlying many human diseases. This study suggests that the defining feature of near-cognate aa-tRNAs is their potential to form mini-helical structures with A-site codons in the ribosomal decoding center. An aminoglycoside and a ribosomal factor can be used to distinguish between near-cognate and non-cognate interactions.	[Plant, Ewan P.; Nguyen, Phuc; Russ, Jonathan R.; Dinman, Jonathan D.] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; [Pittman, Yvette R.; Kinzy, Terri Goss] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA; [Nguyen, Thai] Eleanor Roosevelt High Sch, Ctr Sci & Technol, Greenbelt, MD USA; [Quesinberry, Jack T.] Huntington High Sch, Huntington, MD USA	University System of Maryland; University of Maryland College Park; Rutgers State University New Brunswick; Rutgers State University Medical Center	Dinman, JD (corresponding author), Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA.	dinman@umd.edu	Plant, Ewan/AAB-1911-2020	Plant, Ewan/0000-0003-0166-5939; Dinman, Jonathan/0000-0002-2402-9698; Kinzy, Terri/0000-0003-1394-9226	National Institutes of Health [GM058859, AI064307]; TGK [GM057483]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057483, R01GM058859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TGK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health to JDD (GM058859 and AI064307), and to TGK (GM057483).	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; AGRIS PF, 1991, BIOCHIMIE, V73, P1345, DOI 10.1016/0300-9084(91)90163-U; Anand M, 2003, J BIOL CHEM, V278, P6985, DOI 10.1074/jbc.M209224200; Anand M, 2001, COLD SPRING HARB SYM, V66, P439, DOI 10.1101/sqb.2001.66.439; Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; BELCOURT MF, 1990, CELL, V62, P339, DOI 10.1016/0092-8674(90)90371-K; BOUADLOUN F, 1983, EMBO J, V2, P1351, DOI 10.1002/j.1460-2075.1983.tb01591.x; Carr-Schmid A, 1999, MOL CELL BIOL, V19, P5257; Carr-Schmid A, 1999, J BIOL CHEM, V274, P30297, DOI 10.1074/jbc.274.42.30297; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cochella L, 2005, CURR BIOL, V15, pR536, DOI 10.1016/j.cub.2005.07.018; Cochella L, 2007, NAT STRUCT MOL BIOL, V14, P30, DOI 10.1038/nsmb1183; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Daviter T, 2006, BIOCHIMIE, V88, P1001, DOI 10.1016/j.biochi.2006.04.013; DESHMUKH M, 1995, J BIOL CHEM, V270, P30148; Dinman JD, 1997, RNA, V3, P870; DINMAN JD, 1994, GENETICS, V136, P75; Gromadski KB, 2006, MOL CELL, V21, P369, DOI 10.1016/j.molcel.2005.12.018; Hani J, 1998, NUCLEIC ACIDS RES, V26, P689, DOI 10.1093/nar/26.3.689; Harger JW, 2003, RNA, V9, P1019, DOI 10.1261/rna.5930803; HIRAGA K, 1993, FEBS LETT, V316, P165, DOI 10.1016/0014-5793(93)81208-H; Hobbie SN, 2006, BIOCHIMIE, V88, P1033, DOI 10.1016/j.biochi.2006.04.008; IKEMURA T, 1982, J MOL BIOL, V158, P573, DOI 10.1016/0022-2836(82)90250-9; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jacobs JL, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh157; Jeppesen MG, 2003, J BIOL CHEM, V278, P47190, DOI 10.1074/jbc.M306630200; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Lim VI, 2005, J MOL BIOL, V351, P470, DOI 10.1016/j.jmb.2005.06.019; Meskauskas A, 2001, RNA, V7, P1084, DOI 10.1017/S1355838201001480; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Najafabadi HS, 2007, GENE, V387, P150, DOI 10.1016/j.gene.2006.09.004; NIERHAUS KH, 1990, BIOCHEMISTRY-US, V29, P4997, DOI 10.1021/bi00473a001; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; OLAREWAJU O, 2004, RNA BIOL, V1, P12; Percudani R, 1997, J MOL BIOL, V268, P322, DOI 10.1006/jmbi.1997.0942; PLEWNIAK F, 2007, GCG DOCUMENTATION; Rakwalska M, 2004, MOL CELL BIOL, V24, P9186, DOI 10.1128/MCB.24.20.9186-9197.2004; Rodnina MV, 2005, FEBS LETT, V579, P938, DOI 10.1016/j.febslet.2004.11.048; Salas-Marco J, 2005, J MOL BIOL, V348, P801, DOI 10.1016/j.jmb.2005.03.025; Sanbonmatsu KY, 2006, BIOCHIMIE, V88, P1075, DOI 10.1016/j.biochi.2006.07.002; Sanbonmatsu KY, 2006, BIOCHIMIE, V88, P1053, DOI 10.1016/j.biochi.2006.06.012; Sanbonmatsu KY, 2003, J MOL BIOL, V328, P33, DOI 10.1016/S0022-2836(03)00236-5; SANDBAKEN MG, 1988, GENETICS, V120, P923; Stansfield I, 1998, J MOL BIOL, V282, P13, DOI 10.1006/jmbi.1998.1976; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P20473, DOI 10.1074/jbc.270.35.20473; Tumer NE, 1998, J VIROL, V72, P1036, DOI 10.1128/JVI.72.2.1036-1042.1998	53	41	41	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2007	2	6							e517	10.1371/journal.pone.0000517	http://dx.doi.org/10.1371/journal.pone.0000517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GD	17565370	Green Published, gold, Green Submitted			2022-12-27	WOS:000207451600005
J	Shankar, PR; Palaian, S; Gyawali, S; Mishra, P; Mohan, L				Shankar, P. Ravi; Palaian, Subish; Gyawali, Sudesh; Mishra, Pranaya; Mohan, Lalit			Personal Drug Selection: Problem-Based Learning in Pharmacology: Experience from a Medical School in Nepal	PLOS ONE			English	Article								Background. At the Manipal College of Medical Sciences, Pokhara, Nepal, Pharmacology is taught during the first four semesters of the undergraduate medical course. Personal or P-drug selection is an important exercise. The present study was carried out to obtain student opinion about the P-drug learning sessions, the assessment examinations, and on the small group dynamics. Method. The practical sessions on P-drug selection are carried out in small groups. Student feedback about the session was obtained using focus group discussions. The focus groups were selected to represent both genders and the three main nationalities, Nepalese, Indians, and Sri Lankans. There were four Nepalese, five Indians, and three Sri Lankans. Within each nationality and gender category the students were randomly selected. The respondents were explained the objectives of the study and were invited to participate. Written informed consent was obtained. The discussion lasted around two hours and was conducted in the afternoon in two groups of six students each. The first author (PRS) acted as a facilitator. The responses were recorded and analyzed qualitatively. Results. The overall student opinion was positive. Around 25% (3 respondents) of respondents were confused about whether P-drugs were for a disease or a patient. Group consensus was commonly used to give numerical values for the different criteria. The large number of brands created problems in calculating cost. The students wanted more time for the exercise in the examination. Formative assessment during the learning sessions may be considered. The group members usually got along well. Absenteeism was a problem and not all members put in their full effort. The physical working environment should be improved. Conclusions. Based on what the students say, the sessions on P-drugs should be continued and strengthened. Modifications in the sessions are required. Sessions during the clinical years and internship training can be considered.	[Shankar, P. Ravi; Palaian, Subish; Gyawali, Sudesh; Mishra, Pranaya; Mohan, Lalit] Manipal Coll Med Sci, Dept Pharmacol, Pokhara, Nepal		Shankar, PR (corresponding author), Manipal Coll Med Sci, Dept Pharmacol, Pokhara, Nepal.	ravi.dr.shankar@gmail.com	Palaian, Subish/AAU-1424-2020; Palaian, Subish/K-9680-2019; Shankar, P Ravi/H-3117-2019	Palaian, Subish/0000-0002-9323-3940; Palaian, Subish/0000-0002-9323-3940; Shankar, P Ravi/0000-0001-6105-5636				[Anonymous], GUIDE GOOD PRESCRIBI; DEVRIES TPGM, 1995, LANCET, V346, P1454, DOI 10.1016/S0140-6736(95)92472-8; HARRIES CS, 2006, BULIDING SUCCESSFUL; HOGERZEIL HV, 2001, TEACHERS GUIDE GOOD, P98; Joshi MP, 1996, MED TEACH, V18, P75, DOI 10.3109/01421599609040269; Joshi MP, 1996, ESSENTIALS MED ED, P51; Michel MC, 2002, N-S ARCH PHARMACOL, V366, P64, DOI 10.1007/s00210-002-0570-x; Shakib Sepehr, 2003, Aust Fam Physician, V32, P35; Shankar P.R., 2004, PHARM ED, V4, P51; Shankar PR, 2003, PHARM ED, V3, P97, DOI DOI 10.1080/1560221031000089507; Tisonova J, 2005, Bratisl Lek Listy, V106, P83; Tofovic SP, 1998, J CLIN PHARMACOL, V38, P670, DOI 10.1002/j.1552-4604.1998.tb04805.x; Walley T, 1993, POSTGRADUATE ED GENE, V4, P50; Ward F, 2002, MED TEACH, V24, P628, DOI 10.1080/0142159021000063952; WHO Policy Perspectives on Medicines, 2002, PROM RAT US MED COR	15	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2007	2	6							e524	10.1371/journal.pone.0000524	http://dx.doi.org/10.1371/journal.pone.0000524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GD	17565377	Green Published, gold, Green Submitted			2022-12-27	WOS:000207451600012
J	Deagle, BE; Gales, NJ; Evans, K; Jarman, SN; Robinson, S; Trebilco, R; Hindell, MA				Deagle, Bruce E.; Gales, Nick J.; Evans, Karen; Jarman, Simon N.; Robinson, Sarah; Trebilco, Rowan; Hindell, Mark A.			Studying Seabird Diet through Genetic Analysis of Faeces: A Case Study on Macaroni Penguins (Eudyptes chrysolophus)	PLOS ONE			English	Article							SEALS PHOCA-VITULINA; CHRYSOCOME-CHRYSOCOME; SALMONID PREY; GUT CONTENTS; DNA; ISLAND; IDENTIFICATION; IDENTIFY; FOOD; SEGREGATION	Background. Determination of seabird diet usually relies on the analysis of stomach-content remains obtained through stomach flushing; this technique is both invasive and logistically difficult. We evaluate the usefulness of DNA-based faecal analysis in a dietary study on chick-rearing macaroni penguins (Eudyptes chrysolophus) at Heard Island. Conventional stomach-content data was also collected, allowing comparison of the approaches. Methodology/Principal Findings. Prey-specific PCR tests were used to detect dietary DNA in faecal samples and amplified prey DNA was cloned and sequenced. Of the 88 faecal samples collected, 39 contained detectable DNA from one or more of the prey groups targeted with PCR tests. Euphausiid DNA was most commonly detected in the early (guard) stage of chick-rearing, and detection of DNA from the myctophid fish Krefftichthys anderssoni and amphipods became more common in samples collected in the later (creche) stage. These trends followed those observed in the penguins' stomach contents. In euphausiid-specific clone libraries the proportion of sequences from the two dominant euphausiid prey species (Euphausia vallentini and Thysanoessa macrura) changed over the sampling period; again, this reflected the trend in the stomach content data. Analysis of prey sequences in universal clone libraries revealed a higher diversity of fish prey than identified in the stomachs, but non-fish prey were not well represented. Conclusions/Significance. The present study is one of the first to examine the full breadth of a predator's diet using DNA-based faecal analysis. We discuss methodological difficulties encountered and suggest possible refinements. Overall, the ability of the DNA-based approach to detect temporal variation in the diet of macaroni penguins indicates this non-invasive method will be generally useful for monitoring population-level dietary trends in seabirds.	[Deagle, Bruce E.; Evans, Karen; Trebilco, Rowan; Hindell, Mark A.] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Deagle, Bruce E.; Gales, Nick J.; Jarman, Simon N.; Robinson, Sarah] Australian Govt Antarctic Div, Kingston, Tas, Australia	University of Tasmania; Australian Antarctic Division	Deagle, BE (corresponding author), Univ Tasmania, Sch Zool, Hobart, Tas, Australia.	bedeagle@utas.edu.au	evans, karen/D-7110-2012; Deagle, Bruce E/A-9854-2008; Hindell, Mark A/C-8368-2013; Deagle, Bruce E/R-2999-2019; Trebilco, Rowan/I-5311-2012; Hindell, Mark A/K-1131-2013; Jarman, Simon/H-9265-2016	Deagle, Bruce E/0000-0001-7651-3687; Trebilco, Rowan/0000-0001-9712-8016; Evans, Karen/0000-0003-2205-4264; Jarman, Simon/0000-0002-0792-9686; Hindell, Mark/0000-0002-7823-7185	Australian Government Antarctic Division	Australian Government Antarctic Division(Australian Government)	The research was funded by the Australian Government Antarctic Division.	Abraham CL, 2006, MAR ECOL PROG SER, V313, P271, DOI 10.3354/meps313271; Agusti N, 2003, MOL ECOL, V12, P3467, DOI 10.1046/j.1365-294X.2003.02014.x; Ainley DG, 1998, POLAR BIOL, V20, P311, DOI 10.1007/s003000050308; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barlow KE, 2002, MAR BIOL, V140, P205, DOI 10.1007/s00227-001-0691-7; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Blankenship LE, 2005, MOL ECOL, V14, P891, DOI 10.1111/j.1365-294X.2005.02448.x; Bocher P, 2000, MAR ECOL PROG SER, V208, P249, DOI 10.3354/meps208249; Brooke MD, 2004, P ROY SOC B-BIOL SCI, V271, pS246, DOI 10.1098/rsbl.2003.0153; BROWN CR, 1987, J ZOOL, V212, P7, DOI 10.1111/j.1469-7998.1987.tb05111.x; Cherel Y, 2000, OECOLOGIA, V122, P155, DOI 10.1007/PL00008843; Chiaradia A, 2003, EMU, V103, P43, DOI 10.1071/MU02020; Clarke J, 2006, MAR ECOL PROG SER, V310, P247, DOI 10.3354/meps310247; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; CLARKE MR, 1985, HDB IDENTIFICATION S; COOPER J, 1990, PENGUIN BIOL; Crawford RJM, 2003, AFR J MAR SCI, V25, P475, DOI 10.2989/18142320309504036; CROXALL JP, 1985, J ZOOL, V206, P485; CROXALL JP, 1980, IBIS, V122, P245, DOI 10.1111/j.1474-919X.1980.tb02665.x; Deagle BE, 2005, J HERED, V96, P417, DOI 10.1093/jhered/esi036; Deagle BE, 2005, MOL ECOL, V14, P1831, DOI 10.1111/j.1365-294X.2005.02531.x; DEAGLE BE, 2006, FRONTIERS ZOOLOGY, pE11; Deagle BE, 2007, CONSERV GENET, V8, P743, DOI 10.1007/s10592-006-9197-7; EALEY E. H. M., 1954, EMU, V54, P204; Fischer W, 1985, SO OCEAN FISHING ARE; GALES RP, 1988, IBIS, V130, P418, DOI 10.1111/j.1474-919X.1988.tb00999.x; Gauthier-Clerc M, 2000, NATURE, V408, P928, DOI 10.1038/35050163; Green K., 1998, Marine Ornithology, V26, P27; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; HARTLEY PHT, 1948, IBIS, V90, P361, DOI 10.1111/j.1474-919X.1948.tb01700.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedd A, 2006, MAR ECOL PROG SER, V309, P263, DOI 10.3354/meps309263; HINDELL MA, 1988, EMU, V88, P219, DOI 10.1071/MU9880219; Hull CL, 1999, J ZOOL, V247, P507, DOI 10.1111/j.1469-7998.1999.tb01013.x; Jarman SN, 2006, MOL ECOL NOTES, V6, P268, DOI 10.1111/j.1471-8286.2005.01172.x; Jarman SN, 2004, MOL ECOL, V13, P1313, DOI 10.1111/j.1365-294X.2004.02109.x; Jarman SN, 2002, MOL ECOL, V11, P2679, DOI 10.1046/j.1365-294X.2002.01641.x; KLAGES NTW, 1989, AUST WILDLIFE RES, V16, P599; Kvitrud MA, 2005, MAR BIOL, V147, P1459, DOI 10.1007/s00227-005-0047-9; Lea MA, 2002, MAR ECOL PROG SER, V245, P281, DOI 10.3354/meps245281; OLESIUK PF, 1993, FISH B-NOAA, V91, P491; Palumbi Stephen R., 1996, P205; Parsons KM, 2005, J ZOOL, V266, P275, DOI 10.1017/S0952836905006904; Purcell M, 2004, FISH B-NOAA, V102, P213; Ropert-Coudert Y, 2007, MAR ECOL PROG SER, V333, P281, DOI 10.3354/meps333281; ROSEL PE, 2002, J EXPT MARINE BIOL E, V42, P75; Scribner KT, 1998, MOL ECOL, V7, P1401, DOI 10.1046/j.1365-294x.1998.00434.x; SUTHERLAND RM, 2000, THESIS U OXFORD OXFO; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; TREBILCO R, 2004, THESIS U TASMANIA; VENCES M, 2005, FRONTIERS ZOOLOGY, pE5; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Williams R., 1990, ANARE RES NOTES, V75, P1; WILLIAMS TD, 1991, J ZOOL, V223, P189, DOI 10.1111/j.1469-7998.1991.tb04759.x; WILSON RP, 1984, J FIELD ORNITHOL, V55, P109; WOEHLER EJ, 2006, HEARD ISLAND SO OCEA, P128	56	153	157	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e831	10.1371/journal.pone.0000831	http://dx.doi.org/10.1371/journal.pone.0000831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786203	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000207455500015
J	Shaw, SD; Chakrabarti, S; Ghosh, G; Krainer, AR				Shaw, Stephanie D.; Chakrabarti, Sutapa; Ghosh, Gourisankar; Krainer, Adrian R.			Deletion of the N-terminus of SF2/ASF Permits RS-Domain-Independent Pre-mRNA Splicing	PLOS ONE			English	Article								Serine/arginine-rich (SR) proteins are essential splicing factors with one or two RNA-recognition motifs (RRMs) and a C-terminal arginine- and serine-rich (RS) domain. SR proteins bind to exonic splicing enhancers via their RRM(s), and from this position are thought to promote splicing by antagonizing splicing silencers, recruiting other components of the splicing machinery through RS-RS domain interactions, and/or promoting RNA base-pairing through their RS domains. An RS domain tethered at an exonic splicing enhancer can function as a splicing activator, and RS domains play prominent roles in current models of SR protein functions. However, we previously reported that the RS domain of the SR protein SF2/ASF is dispensable for in vitro splicing of some pre-mRNAs. We have now extended these findings via the identification of a short inhibitory domain at the SF2/ASF N-terminus; deletion of this segment permits splicing in the absence of this SR protein's RS domain of an IgM pre-mRNA substrate previously classified as RS-domain-dependent. Deletion of the N-terminal inhibitory domain increases the splicing activity of SF2/ASF lacking its RS domain, and enhances its ability to bind pre-mRNA. Splicing of the IgM pre-mRNA in S100 complementation with SF2/ASF lacking its RS domain still requires an exonic splicing enhancer, suggesting that an SR protein RS domain is not always required for ESE-dependent splicing activation. Our data provide additional evidence that the SF2/ASF RS domain is not strictly required for constitutive splicing in vitro, contrary to prevailing models for how the domains of SR proteins function to promote splicing.	[Shaw, Stephanie D.; Krainer, Adrian R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Chakrabarti, Sutapa; Ghosh, Gourisankar] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Shaw, Stephanie D.] SUNY Stony Brook, Mol & Cellular Biol Program, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; University of California System; University of California San Diego; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Krainer, AR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	krainer@cshl.edu		Krainer, Adrian/0000-0001-9024-9501	NIH [GM42699]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042699] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM42699 to ARK.	Allain FHT, 1996, NATURE, V380, P646, DOI 10.1038/380646a0; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Bouck J, 1998, J BIOL CHEM, V273, P15169, DOI 10.1074/jbc.273.24.15169; CACERES JF, 1993, EMBO J, V12, P4715, DOI 10.1002/j.1460-2075.1993.tb06160.x; Canadillas JMP, 2003, EMBO J, V22, P2821, DOI 10.1093/emboj/cdg259; CAO W, 1988, J BIOL CHEM, V273, P20629; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NAT STRUCT BIOL, V10, P120, DOI 10.1038/nsb887; Chew SL, 1999, P NATL ACAD SCI USA, V96, P10655, DOI 10.1073/pnas.96.19.10655; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Eperon IC, 2000, MOL CELL BIOL, V20, P8303, DOI 10.1128/MCB.20.22.8303-8318.2000; FU XD, 1995, RNA, V1, P663; GORLACH M, 1994, J BIOL CHEM, V269, P23074; Graveley BR, 2001, RNA, V7, P806, DOI 10.1017/S1355838201010317; Graveley BR, 1998, EMBO J, V17, P6747, DOI 10.1093/emboj/17.22.6747; Graveley BR, 1998, MOL CELL, V1, P765, DOI 10.1016/S1097-2765(00)80076-3; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; GUI JF, 1994, P NATL ACAD SCI USA, V91, P10824, DOI 10.1073/pnas.91.23.10824; Guth S, 1999, MOL CELL BIOL, V19, P8263; Guth S, 2001, MOL CELL BIOL, V21, P7673, DOI 10.1128/MCB.21.22.7673-7681.2001; Hargous Y, 2006, EMBO J, V25, P5126, DOI 10.1038/sj.emboj.7601385; HE F, 2005, SOLUTION STRUCTURE R; Hertel KJ, 2005, TRENDS BIOCHEM SCI, V30, P115, DOI 10.1016/j.tibs.2005.01.002; Jacks A, 2003, STRUCTURE, V11, P833, DOI 10.1016/S0969-2126(03)00121-7; JESSEN TH, 1991, EMBO J, V10, P3447, DOI 10.1002/j.1460-2075.1991.tb04909.x; Kan JLC, 1999, GENE DEV, V13, P462, DOI 10.1101/gad.13.4.462; Kanopka A, 1998, NATURE, V393, P185, DOI 10.1038/30277; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Li Y, 1999, J BIOL CHEM, V274, P35074, DOI 10.1074/jbc.274.49.35074; Liu HX, 2000, MOL CELL BIOL, V20, P1063, DOI 10.1128/MCB.20.3.1063-1071.2000; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; MAYEDA A, 1988, MOL CELL BIOL, V8, P4484, DOI 10.1128/MCB.8.10.4484; Mayeda A, 1999, MOL CELL BIOL, V19, P1853; Mayeda A, 1999, METH MOL B, V118, P315; Mayeda A, 1999, METH MOL B, V118, P309; MERRILL BM, 1988, J BIOL CHEM, V263, P3307; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Philipps D, 2003, NUCLEIC ACIDS RES, V31, P6502, DOI 10.1093/nar/gkg845; Pont-Kingdon Genevieve, 2003, Methods Mol Biol, V226, P511; Pozzoli U, 2005, CELL MOL LIFE SCI, V62, P1579, DOI 10.1007/s00018-005-5030-6; Prasad J, 1999, MOL CELL BIOL, V19, P6991; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; QUERY CC, 1989, CELL, V57, P89, DOI 10.1016/0092-8674(89)90175-X; Reed R, 1996, CURR OPIN GENET DEV, V6, P215, DOI 10.1016/S0959-437X(96)80053-0; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Rudner DZ, 1998, GENE DEV, V12, P1010, DOI 10.1101/gad.12.7.1010; Rudner DZ, 1998, MOL CELL BIOL, V18, P4004, DOI 10.1128/MCB.18.7.4004; Sanford JR, 1999, GENE DEV, V13, P1513, DOI 10.1101/gad.13.12.1513; SCHNEIDER D, 1992, J MOL BIOL, V228, P862, DOI 10.1016/0022-2836(92)90870-P; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Shen HH, 2006, GENE DEV, V20, P1755, DOI 10.1101/gad.1422106; Shen HH, 2004, MOL CELL, V13, P367, DOI 10.1016/S1097-2765(04)00025-5; Shen HH, 2004, MOL CELL, V16, P363, DOI 10.1016/j.molcel.2004.10.021; Shen HH, 2004, RNA, V10, P787, DOI 10.1261/rna.5229704; Simpson PJ, 2004, STRUCTURE, V12, P1631, DOI 10.1016/j.str.2004.07.008; STAKNIS D, 1994, MOL CELL BIOL, V14, P7670, DOI 10.1128/MCB.14.11.7670; TIAN M, 1994, GENE DEV, V8, P1703, DOI 10.1101/gad.8.14.1703; Wang J, 1998, GENE DEV, V12, P2222, DOI 10.1101/gad.12.14.2222; WANG Z, 1995, RNA, V1, P21; WATAKABE A, 1993, GENE DEV, V7, P407, DOI 10.1101/gad.7.3.407; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; Zhu J, 2001, NANO LETT, V1, P8, DOI 10.1021/nl005512q; Zhu J, 2000, GENE DEV, V14, P3166, DOI 10.1101/gad.189500; Zuo P, 1996, GENE DEV, V10, P1356, DOI 10.1101/gad.10.11.1356; ZUO P, 1993, EMBO J, V12, P4727, DOI 10.1002/j.1460-2075.1993.tb06161.x	79	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e854	10.1371/journal.pone.0000854	http://dx.doi.org/10.1371/journal.pone.0000854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786225	Green Accepted, Green Published, gold			2022-12-27	WOS:000207455500037
J	Malone, JH; Chrzanowski, TH; Michalak, P				Malone, John H.; Chrzanowski, Thomas H.; Michalak, Pawel			Sterility and Gene Expression in Hybrid Males of Xenopus laevis and X. muelleri	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; INTERSPECIFIC DROSOPHILA HYBRIDS; POLYMERASE I TRANSCRIPTION; SOMATIC-CELL HYBRIDS; GENOME-WIDE PATTERNS; HORDEUM-VULGARE-L; NUCLEOLAR DOMINANCE; SEX DETERMINATION; CLAWED FROGS; CYTOSINE METHYLATION	Background. Reproductive isolation is a defining characteristic of populations that represent unique biological species, yet we know very little about the gene expression basis for reproductive isolation. The advent of powerful molecular biology tools provides the ability to identify genes involved in reproductive isolation and focuses attention on the molecular mechanisms that separate biological species. Herein we quantify the sterility pattern of hybrid males in African Clawed Frogs (Xenopus) and apply microarray analysis of the expression pattern found in testes to identify genes that are misexpressed in hybrid males relative to their two parental species (Xenopus laevis and X. muelleri). Methodology/Principal Findings. Phenotypic characteristics of spermatogenesis in sterile male hybrids (X. laevis x X. muelleri) were examined using a novel sperm assay that allowed quantification of live, dead, and undifferentiated sperm cells, the number of motile vs. immotile sperm, and sperm morphology. Hybrids exhibited a dramatically lower abundance of mature sperm relative to the parental species. Hybrid spermatozoa were larger in size and accompanied by numerous undifferentiated sperm cells. Microarray analysis of gene expression in testes was combined with a correction for sequence divergence derived from genomic hybridizations to identify candidate genes involved in the sterility phenotype. Analysis of the transcriptome revealed a striking asymmetric pattern of misexpression. There were only about 140 genes misexpressed in hybrids compared to X. laevis but nearly 4,000 genes misexpressed in hybrids compared to X. muelleri. Conclusions/Significance. Our results provide an important correlation between phenotypic characteristics of sperm and gene expression in sterile hybrid males. The broad pattern of gene misexpression suggests intriguing mechanisms creating the dominance pattern of the X. laevis genome in hybrids. These findings significantly contribute to growing evidence for allelic dominance in hybrids and have implications for the mechanism of species differentiation at the transcriptome level.	[Malone, John H.; Chrzanowski, Thomas H.; Michalak, Pawel] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA	University of Texas System; University of Texas Arlington	Michalak, P (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.	michalak@uta.edu			National Science Foundation Dissertation Improvement [DEB-0508882]; Texas Academy of Science Student Research	National Science Foundation Dissertation Improvement(National Science Foundation (NSF)); Texas Academy of Science Student Research	Funding was provided by a National Science Foundation Dissertation Improvement Grant (DEB-0508882) and Texas Academy of Science Student Research Grant to JHM.	Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; APPELS R, 1982, THEOR APPL GENET, V63, P337, DOI 10.1007/BF00303905; Auger DL, 2005, GENETICS, V169, P389, DOI 10.1534/genetics.104.032987; BARBASH DA, 2006, J EXP ZOOL MOL DEV B, V306; BAUERDANTOIN AC, 1992, ENDOCRINOLOGY, V131, P2946, DOI 10.1210/en.131.6.2946; Birchler JA, 2005, TRENDS GENET, V21, P219, DOI 10.1016/j.tig.2005.02.010; BLACKLER AW, 1972, DEV BIOL, V27, P385, DOI 10.1016/0012-1606(72)90177-7; BOLSTAD B, 2005, RMAEXPRESS; BOSELEY P, 1979, CELL, V17, P19, DOI 10.1016/0092-8674(79)90291-5; BRAMWELL ME, 1971, BIOCHIM BIOPHYS ACTA, V232, P580, DOI 10.1016/0005-2787(71)90611-3; Brandeis M, 1998, P NATL ACAD SCI USA, V95, P4344, DOI 10.1073/pnas.95.8.4344; BROWN DD, 1977, DEV BIOL, V59, P266, DOI 10.1016/0012-1606(77)90263-9; BRUN LO, 1995, P NATL ACAD SCI USA, V92, P9861, DOI 10.1073/pnas.92.21.9861; BUSBY SJ, 1983, CELL, V34, P989, DOI 10.1016/0092-8674(83)90556-1; CASSIDY DM, 1974, DEV BIOL, V41, P84, DOI 10.1016/0012-1606(74)90285-1; Chain FJJ, 2006, PLOS GENET, V2, P478, DOI 10.1371/journal.pgen.0020056; Chen ZJ, 1997, P NATL ACAD SCI USA, V94, P3442, DOI 10.1073/pnas.94.7.3442; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Chen ZJ, 1998, P NATL ACAD SCI USA, V95, P14891, DOI 10.1073/pnas.95.25.14891; Christensen JR, 2004, CAN J ZOOL, V82, P555, DOI 10.1139/Z04-021; Comai L, 2003, PHILOS T R SOC B, V358, P1149, DOI 10.1098/rstb.2003.1305; CROCE CM, 1977, P NATL ACAD SCI USA, V74, P694, DOI 10.1073/pnas.74.2.694; CROSBY AR, 1957, AM J BOT, V44, P813, DOI 10.2307/2438902; CROUSE HV, 1960, GENETICS, V45, P1429; de la Casa-Esperon E, 2003, ANNU REV GENET, V37, P349, DOI 10.1146/annurev.genet.37.110801.143741; DEROBERTIS EM, 1979, DEV BIOL, V68, P334, DOI 10.1016/0012-1606(79)90267-7; Diederichs S, 2005, INT J CANCER, V116, P207, DOI 10.1002/ijc.21034; Dobson SL, 1998, GENETICS, V149, P233; Doelling JH, 1996, NUCLEIC ACIDS RES, V24, P4725, DOI 10.1093/nar/24.23.4725; DOVER GA, 1984, CELL, V38, P622, DOI 10.1016/0092-8674(84)90255-1; DURICA DS, 1978, GENETICS, V89, P37; DURICA DS, 1977, DEV BIOL, V59, P62, DOI 10.1016/0012-1606(77)90240-8; ELICEIRI GL, 1969, J MOL BIOL, V41, P253, DOI 10.1016/0022-2836(69)90390-8; Evans BJ, 2005, MOL BIOL EVOL, V22, P1193, DOI 10.1093/molbev/msi104; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; FAN H, 1995, PLANT J, V8, P295, DOI 10.1046/j.1365-313X.1995.08020295.x; Fischer WJ, 2000, J ZOOL, V252, P99, DOI 10.1017/S0952836900009110; FLAVELL RB, 1988, J MOL BIOL, V204, P523, DOI 10.1016/0022-2836(88)90352-X; Frieman M, 1999, GENETICS, V152, P451; Galili N, 2000, DEV DYNAM, V218, P102, DOI 10.1002/(SICI)1097-0177(200005)218:1<102::AID-DVDY9>3.3.CO;2-1; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gilad Y, 2005, GENOME RES, V15, P674, DOI 10.1101/gr.3335705; Gilad Y, 2006, CURR OPIN GENET DEV, V16, P553, DOI 10.1016/j.gde.2006.09.005; Goday C, 2001, BIOESSAYS, V23, P242, DOI 10.1002/1521-1878(200103)23:3&lt;242::AID-BIES1034&gt;3.0.CO;2-P; GRAVES PR, 1993, J BIOL CHEM, V268, P6394; GRUMMT I, 1982, NATURE, V296, P173, DOI 10.1038/296173a0; Gye MC, 2004, REPROD DOMEST ANIM, V39, P43, DOI 10.1046/j.1439-0531.2003.00474.x; Haerty W, 2006, MOL BIOL EVOL, V23, P1707, DOI 10.1093/molbev/msl033; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hammond JP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-10; Hayes TB, 1998, J EXP ZOOL, V281, P373, DOI 10.1002/(SICI)1097-010X(19980801)281:5<373::AID-JEZ4>3.0.CO;2-L; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Hegarty MJ, 2006, CURR BIOL, V16, P1652, DOI 10.1016/j.cub.2006.06.071; HENEEN WK, 1962, HEREDITAS, V48, P471; HONJO T, 1973, J MOL BIOL, V80, P217, DOI 10.1016/0022-2836(73)90168-X; Hsu LC, 2000, BBA-GENE STRUCT EXPR, V1492, P289, DOI 10.1016/S0167-4781(00)00108-1; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JIN Y, 2007, MOL REPROD DEV; Josefsson C, 2006, CURR BIOL, V16, P1322, DOI 10.1016/j.cub.2006.05.045; Kajiura-Kobayashi H, 2004, BIOCHEM BIOPH RES CO, V323, P288, DOI 10.1016/j.bbrc.2004.08.097; Kanzaki M, 1996, ENDOCRINOLOGY, V137, P1249, DOI 10.1210/en.137.4.1249; KASHA KJ, 1971, CHROMOSOMA, V35, P264, DOI 10.1007/BF00326278; KAULEN H, 1991, MOL CELL BIOL, V11, P412, DOI 10.1128/MCB.11.1.412; KEEP E, 1962, CAN J GENET CYTOL, V4, P206, DOI 10.1139/g62-025; KEEP E, 1960, NATURE, V188, P339, DOI 10.1038/188339a0; KNOX KL, 1995, ENDOCRINOLOGY, V136, P187, DOI 10.1210/en.136.1.187; KOBEL HR, 1981, J ZOOL, V194, P317, DOI 10.1111/j.1469-7998.1981.tb04584.x; KOBEL HR, 1985, S AFR J SCI, V81, P205; KOBEL HR, 1986, TRENDS GENET, V2, P310, DOI 10.1016/0168-9525(86)90286-6; KOBEL HR, 1975, IMMUNOGENETICS, V2, P87, DOI 10.1007/BF01572278; KOBEL HR, 1996, BIOL XENOPUS, P391; KOBEL HR, 1996, BIOL XENOPUS, P9; LABHART P, 1984, CELL, V37, P285, DOI 10.1016/0092-8674(84)90324-6; Lai Z, 2006, MOL ECOL, V15, P1213, DOI 10.1111/j.1365-294X.2006.02775.x; Landry CR, 2005, GENETICS, V171, P1813, DOI 10.1534/genetics.105.047449; LANGE W, 1976, GENETICA, V46, P217, DOI 10.1007/BF00121038; Mable BK, 1995, J HERED, V86, P432, DOI 10.1093/oxfordjournals.jhered.a111617; Malone JH, 2006, J MOL EVOL, V63, P427, DOI 10.1007/s00239-005-0263-4; McStay B, 2006, GENE DEV, V20, P1207, DOI 10.1101/gad.1436906; Michalak P, 2006, J EVOLUTION BIOL, V19, P1768, DOI 10.1111/j.1420-9101.2006.01141.x; Michalak P, 2003, MOL BIOL EVOL, V20, P1070, DOI 10.1093/molbev/msg119; MIESFELD R, 1984, MOL CELL BIOL, V4, P221, DOI 10.1128/MCB.4.2.221; MIESFELD R, 1984, MOL CELL BIOL, V4, P1306, DOI 10.1128/MCB.4.7.1306; MIKAMO K, 1964, EXPERIENTIA, V20, P622, DOI 10.1007/BF02144823; MIKAMO K, 1963, GENETICS, V48, P1411; MILLER OJ, 1976, P NATL ACAD SCI USA, V73, P4531, DOI 10.1073/pnas.73.12.4531; Missirlis F, 2006, P NATL ACAD SCI USA, V103, P5893, DOI 10.1073/pnas.0601471103; Miyata S, 1999, ZOOL SCI, V16, P335, DOI 10.2108/zsj.16.335; Moehring AJ, 2007, MOL BIOL EVOL, V24, P137, DOI 10.1093/molbev/msl142; MOSS T, 1983, NATURE, V302, P223, DOI 10.1038/302223a0; NAVASHIN M., 1934, CYTOLOGIA, V5, P169, DOI 10.1508/cytologia.5.169; NICOLOFF H, 1979, THEOR APPL GENET, V55, P247, DOI 10.1007/BF00265358; Nielsen MG, 2006, EVOL DEV, V8, P23, DOI 10.1111/j.1525-142X.2006.05072.x; Nuzhdin SV, 2004, MOL BIOL EVOL, V21, P1308, DOI 10.1093/molbev/msh128; ONISHI T, 1984, P NATL ACAD SCI-BIOL, V81, P484, DOI 10.1073/pnas.81.2.484; Ortiz-Barrientos D, 2007, GENETICA, V129, P71, DOI 10.1007/s10709-006-0034-1; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Picker M. D., 1996, BIOL XENOPUS, P61; PICKER MD, 1989, BIOL CONSERV, V49, P169, DOI 10.1016/0006-3207(89)90034-7; PICKER MD, 1985, COPEIA, P574, DOI 10.2307/1444746; Pikaard CS, 2000, PLANT MOL BIOL, V43, P163, DOI 10.1023/A:1006471009225; PIKAARD CS, 1988, MOL CELL BIOL, V8, P4282, DOI 10.1128/MCB.8.10.4282; Pilder SH, 1997, J ANDROL, V18, P663; Porter AH, 2002, EVOLUTION, V56, P2103; Pozzi AG, 2006, J EXP ZOOL PART A, V305A, P96, DOI 10.1002/jez.a.254; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Presgraves DC, 1998, SCIENCE, V282, P952, DOI 10.1126/science.282.5390.952; Presgraves DC, 2002, EVOLUTION, V56, P1168, DOI 10.1111/j.0014-3820.2002.tb01430.x; Ranz JM, 2004, GENOME RES, V14, P373, DOI 10.1101/gr.2019804; REEDER RH, 1984, CELL, V38, P39, DOI 10.1016/0092-8674(84)90524-5; REEDER RH, 1985, J CELL BIOL, V101, P2013, DOI 10.1083/jcb.101.5.2013; REEDER RH, 1984, CELL, V38, P349, DOI 10.1016/0092-8674(84)90489-6; REEDER RH, 1983, CELL, V35, P449, DOI 10.1016/0092-8674(83)90178-2; Reiland J, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-16; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Rosemblit C, 2006, J COMP PHYSIOL B, V176, P559, DOI 10.1007/s00360-006-0078-7; SARDANA R, 1993, MOL GEN GENET, V236, P155, DOI 10.1007/BF00277107; Scheltinga David M., 2003, P119; SCHMID M, 1991, CHROMOSOMA, V101, P123, DOI 10.1007/BF00357062; SCHNAPP A, 1991, MOL CELL BIOCHEM, V104, P137; SCHUBERT I, 1990, CHROMOSOMA, V99, P352, DOI 10.1007/BF01731723; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Siu MKY, 2005, J BIOL CHEM, V280, P25029, DOI 10.1074/jbc.M501049200; Smith JM, 2004, DEV DYNAM, V230, P366, DOI 10.1002/dvdy.20053; Smith RC, 2007, INSECT MOL BIOL, V16, P61, DOI 10.1111/j.1365-2583.2006.00701.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SOLLNERWEBB B, 1979, CELL, V18, P485, DOI 10.1016/0092-8674(79)90066-7; SOPRANO KJ, 1979, P NATL ACAD SCI USA, V76, P3885, DOI 10.1073/pnas.76.8.3885; SOPRANO KJ, 1980, P NATL ACAD SCI-BIOL, V77, P1566, DOI 10.1073/pnas.77.3.1566; Terado M, 2006, ASIAN J ANDROL, V8, P443, DOI 10.1111/j.1745-7262.2006.00166.x; THOMPSON WF, 1988, J MOL BIOL, V204, P535, DOI 10.1016/0022-2836(88)90353-1; TYMOWSKA J, 1972, CYTOGENETICS, V11, P270, DOI 10.1159/000130197; Viegas W., 2002, Current Genomics, V3, P563, DOI 10.2174/1389202023350237; VINOGRADOV AE, 1990, GENOME, V33, P619, DOI 10.1139/g90-092; VONWYL E, 1983, COMP BIOCHEM PHYS B, V76, P17, DOI 10.1016/0305-0491(83)90164-5; WALL DA, 1974, DEV BIOL, V36, P379, DOI 10.1016/0012-1606(74)90059-1; WALLACE H, 1971, HEREDITY, V27, P1, DOI 10.1038/hdy.1971.66; Wang JL, 2004, GENETICS, V167, P1961, DOI 10.1534/genetics.104.027896; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wang R, 2005, J HISTOCHEM CYTOCHEM, V53, P1235, DOI 10.1369/jhc.5A6688.2005; Wassersug R., 1996, BIOL XENOPUS, P143; Wilkinson J, 1944, ANN BOT-LONDON, V8, P269, DOI 10.1093/oxfordjournals.aob.a088566; Witschi E, 1971, HORMONES DEV, P601; Wu CI, 1996, TRENDS ECOL EVOL, V11, P281, DOI 10.1016/0169-5347(96)10033-1; WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534; YEH BY, 1965, AM J BOT, V52, P626, DOI 10.2307/2440131	148	49	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e781	10.1371/journal.pone.0000781	http://dx.doi.org/10.1371/journal.pone.0000781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712429	gold, Green Submitted, Green Published			2022-12-27	WOS:000207455300029
J	Strasburg, JL; Kearney, M; Moritz, C; Templeton, AR				Strasburg, Jared L.; Kearney, Michael; Moritz, Craig; Templeton, Alan R.			Combining Phylogeography with Distribution Modeling: Multiple Pleistocene Range Expansions in a Parthenogenetic Gecko from the Australian Arid Zone	PLOS ONE			English	Article							HETERONOTIA-BINOEI GEKKONIDAE; GEOGRAPHIC PARTHENOGENESIS; MITOCHONDRIAL-DNA; STATISTICAL PHYLOGEOGRAPHY; MOLECULAR PHYLOGENETICS; POPULATION-GROWTH; GENETIC-EVIDENCE; SPECIES GROUP; ORIGIN; EVOLUTION	Phylogenetic and geographic evidence suggest that many parthenogenetic organisms have evolved recently and have spread rapidly. These patterns play a critical role in our understanding of the relative merits of sexual versus asexual reproductive modes, yet their interpretation is often hampered by a lack of detail. Here we present a detailed phylogeographic study of a vertebrate parthenogen, the Australian gecko Heteronotia binoei, in combination with statistical and biophysical modeling of its distribution during the last glacial maximum. Parthenogenetic H. binoei occur in the Australian arid zone and have the widest range of any known vertebrate parthenogen. They are broadly sympatric with their sexual counterparts, from which they arose via hybridization. We have applied nested clade phylogeographic, effective migration, and mismatch distribution analyses to mitochondrial DNA ( mtDNA) sequences obtained for 319 individuals sampled throughout the known geographic ranges of two parthenogenetic mitochondrial lineages. These analyses provide strong evidence for past range expansion events from west to east across the arid zone, and for continuing eastward range expansion. Parthenogen formation and range expansion events date to the late Pleistocene, with one lineage expanding from the northwest of its present range around 240,000 years ago and the second lineage expanding from the far west around 70,000 years ago. Statistical and biophysical distribution models support these inferences of recent range expansion, with suitable climatic conditions during the last glacial maximum most likely limited to parts of the arid zone north and west of much of the current ranges of these lineages. Combination of phylogeographic analyses and distribution modeling allowed considerably stronger inferences of the history of this complex than either would in isolation, illustrating the power of combining complementary analytical approaches.	[Strasburg, Jared L.; Templeton, Alan R.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Kearney, Michael] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia; [Kearney, Michael] Univ Melbourne, Ctr Environm Stress & Adaptat Res, Parkville, Vic 3052, Australia; [Moritz, Craig] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	Washington University (WUSTL); University of Melbourne; University of Melbourne; University of California System; University of California Berkeley	Strasburg, JL (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	jstrasbu@indiana.edu	Kearney, Michael/R-3404-2017; Templeton, Alan R./F-5963-2011	Kearney, Michael/0000-0002-3349-8744; Templeton, Alan/0000-0002-0167-845X	Howard Hughes Medical Institute; Ethel Mary Read Fund; Peter Rankin Trust Fund for Herpetology; Australian Research Council	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ethel Mary Read Fund; Peter Rankin Trust Fund for Herpetology; Australian Research Council(Australian Research Council)	This work was supported by a Howard Hughes Medical Institute predoctoral fellowship to JLS and by grants from the Ethel Mary Read Fund, Peter Rankin Trust Fund for Herpetology, and Australian Research Council to MK.	Adamowicz SJ, 2002, MOL ECOL, V11, P1209, DOI 10.1046/j.1365-294X.2002.01517.x; Adams M, 2003, EVOLUTION, V57, P2619; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bell G, 1982, MASTERPIECE NATURE E; BIERZYCHUDEK P, 1985, EXPERIENTIA, V41, P1255, DOI 10.1007/BF01952068; Brisson JA, 2005, EVOLUTION, V59, P1046; BROWN WM, 1979, SCIENCE, V203, P1247, DOI 10.1126/science.424751; Butlin R, 2002, NAT REV GENET, V3, P311, DOI 10.1038/nrg749; Chaplin JA, 1997, HEREDITY, V78, P57; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COLE C J, 1988, American Museum Novitates, P1; De Gelas K, 2005, MOL ECOL, V14, P753, DOI 10.1111/j.1365-294X.2004.02434.x; De Iorio M, 2004, ADV APPL PROBAB, V36, P417, DOI 10.1239/aap/1086957579; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fu JZ, 2000, COPEIA, P432, DOI 10.1643/0045-8511(2000)000[0432:DOTCBG]2.0.CO;2; Fu YX, 1997, GENETICS, V147, P915; GLESENER RR, 1978, AM NAT, V112, P659, DOI 10.1086/283308; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; Hesse PP, 2004, QUATERN INT, V118, P87, DOI 10.1016/S1040-6182(03)00132-0; HEWITT GM, 1993, EVOLUTIONARY PATTERN, P95; Hugall A, 2002, P NATL ACAD SCI USA, V99, P6112, DOI 10.1073/pnas.092538699; Janzen FJ, 2002, MOL ECOL, V11, P1739, DOI 10.1046/j.1365-294X.2002.01571.x; Kearney M, 2006, OIKOS, V115, P186, DOI 10.1111/j.2006.0030-1299.14908.x; Kearney M, 2005, TRENDS ECOL EVOL, V20, P495, DOI 10.1016/j.tree.2005.06.005; Kearney M, 2005, PHYSIOL BIOCHEM ZOOL, V78, P316, DOI 10.1086/430033; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Kearney M, 2003, EVOL ECOL RES, V5, P953; Kearney M, 2006, MOL ECOL, V15, P1743, DOI 10.1111/j.1365-294X.2006.02898.x; Kearney MR, 2003, TRENDS ECOL EVOL, V18, P605, DOI 10.1016/j.tree.2003.09.021; KIMURA M, 1970, GENET RES, V15, P131, DOI 10.1017/S0016672300001439; Knowles LL, 2002, MOL ECOL, V11, P2623, DOI 10.1046/j.1365-294X.2002.01637.x; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Law JH, 2002, MOL ECOL, V11, P1471, DOI 10.1046/j.1365-294X.2002.01547.x; LYNCH M, 1984, Q REV BIOL, V59, P257, DOI 10.1086/413902; Macey JR, 2001, MOL PHYLOGENET EVOL, V19, P131, DOI 10.1006/mpev.2000.0908; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; MANTEL N, 1967, CANCER RES, V27, P209; Miller GH, 1997, NATURE, V385, P241, DOI 10.1038/385241a0; MORITZ C, 1989, EVOLUTION, V43, P994, DOI 10.1111/j.1558-5646.1989.tb02545.x; MORITZ C, 1993, GENETICA, V90, P269, DOI 10.1007/BF01435044; MORITZ C, 1993, SYST BIOL, V42, P293, DOI 10.2307/2992465; MORITZ C, 1991, GENETICS, V129, P211; MORITZ C, 1991, P ROY SOC B-BIOL SCI, V244, P145, DOI 10.1098/rspb.1991.0063; MORITZ C, 1984, CHROMOSOMA, V89, P151, DOI 10.1007/BF00292899; Moritz C., 1989, EVOLUTION ECOLOGY UN, P87; Nei M., 1987, MOL EVOLUTIONARY GEN; Paland S, 2005, EVOLUTION, V59, P800; Panchal M, 2007, EVOLUTION, V61, P1466, DOI 10.1111/j.1558-5646.2007.00124.x; Peck JR, 1998, NATURE, V391, P889, DOI 10.1038/36099; Pfenninger M, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-8; Pongratz N, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-23; Posada D, 2000, MOL ECOL, V9, P487, DOI 10.1046/j.1365-294x.2000.00887.x; ROGERS AR, 1995, HUM BIOL, V67, P1; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SLATKIN M, 1991, GENETICS, V129, P555; Strasburg JL, 2005, MOL ECOL, V14, P2755, DOI 10.1111/j.1365-294X.2005.02627.X; TAJIMA F, 1989, GENETICS, V123, P585; Templeton A.R., 1982, P75; Templeton AR, 2004, MOL ECOL, V13, P789, DOI 10.1046/j.1365-294X.2003.02041.x; TEMPLETON AR, 1992, GENETICS, V132, P619; TEMPLETON AR, 2003, EVOLUTIONARY THEORY, P1; VANDEL A., 1928, BULL BIOL FRANCE ET BELGIQUE, V62, P164; VRIJENHOEK RC, EVOLUTION ECOLOGY UN, P19; Weisrock DW, 2001, MOL PHYLOGENET EVOL, V18, P434, DOI 10.1006/mpev.2000.0905; White M.J.D., 1978, MODES SPECIATION	65	44	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e760	10.1371/journal.pone.0000760	http://dx.doi.org/10.1371/journal.pone.0000760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712408	Green Published, gold			2022-12-27	WOS:000207455300008
J	Winter, D; Vinegar, B; Nahal, H; Ammar, R; Wilson, GV; Provart, NJ				Winter, Debbie; Vinegar, Ben; Nahal, Hardeep; Ammar, Ron; Wilson, Greg V.; Provart, Nicholas J.			An "Electronic Fluorescent Pictograph" Browser for Exploring and Analyzing Large-Scale Biological Data Sets	PLOS ONE			English	Article								Background. The exploration of microarray data and data from other high-throughput projects for hypothesis generation has become a vital aspect of post-genomic research. For the non-bioinformatics specialist, however, many of the currently available tools provide overwhelming amounts of data that are presented in a non-intuitive way. Methodology/Principal Findings. In order to facilitate the interpretation and analysis of microarray data and data from other large-scale data sets, we have developed a tool, which we have dubbed the electronic Fluorescent Pictograph - or eFP - Browser, available at http://www.bar.utoronto.ca/, for exploring microarray and other data for hypothesis generation. This eFP Browser engine paints data from large-scale data sets onto pictographic representations of the experimental samples used to generate the data sets. We give examples of using the tool to present Arabidopsis gene expression data from the AtGenExpress Consortium (Arabidopsis eFP Browser), data for subcellular localization of Arabidopsis proteins (Cell eFP Browser), and mouse tissue atlas microarray data ( Mouse eFP Browser). Conclusions/Significance. The eFP Browser software is easily adaptable to microarray or other large-scale data sets from any organism and thus should prove useful to a wide community for visualizing and interpreting these data sets for hypothesis generation.	[Winter, Debbie; Nahal, Hardeep; Ammar, Ron; Provart, Nicholas J.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Vinegar, Ben; Wilson, Greg V.] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada	University of Toronto; University of Toronto	Provart, NJ (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	nicholas.provart@utoronto.ca	Winter, Deborah R./AAQ-9253-2020	Winter, Deborah R./0000-0003-1806-673X; Wilson, Greg/0000-0001-8659-8979; Ammar, Ron/0000-0002-6006-7392	Genome Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)	Genome Canada(Genome Canada); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project was funded in part with grants from Genome Canada and NSERC, the Natural Sciences and Engineering Research Council of Canada (NSERC). Debbie Winter is an NSERC Undergraduate Student Research Award recipient.	Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Casson S, 2005, PLANT J, V42, P111, DOI 10.1111/j.1365-313X.2005.02355.x; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Garcia-Hernandez Margarita, 2002, Funct Integr Genomics, V2, P239, DOI 10.1007/s10142-002-0077-z; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KILIAN J, ATGENEXPRESS G UNPUB; Lee SC, 2002, GENE DEV, V16, P646, DOI 10.1101/gad.969002; Mueller LA, 2003, PLANT PHYSIOL, V132, P453, DOI 10.1104/pp.102.017236; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P224, DOI 10.1093/nar/gkg076; Rocca-Serra P, 2003, CR BIOL, V326, P1075, DOI 10.1016/j.crvi.2003.09.026; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; Shin H, 2004, PLANT J, V39, P629, DOI 10.1111/j.1365-313X.2004.02161.x; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; THURSTON G, 2006, ETHYLENE RECEP UNPUB; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Yu H, 2004, P NATL ACAD SCI USA, V101, P7827, DOI 10.1073/pnas.0402377101; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	23	1795	1832	2	210	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e718	10.1371/journal.pone.0000718	http://dx.doi.org/10.1371/journal.pone.0000718			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684564	Green Submitted, gold, Green Published			2022-12-27	WOS:000207452400021
J	Funicello, M; Novelli, M; Ragni, M; Vottari, T; Cocuzza, C; Soriano-Lopez, J; Chiellini, C; Boschi, F; Marzola, P; Masiello, P; Saftig, P; Santini, F; St-Jacques, R; Desmarais, S; Morin, N; Mancini, J; Percival, MD; Pinchera, A; Maffei, M				Funicello, Marcella; Novelli, Michela; Ragni, Maurizio; Vottari, Teresa; Cocuzza, Cesare; Soriano-Lopez, Joaquin; Chiellini, Chiara; Boschi, Federico; Marzola, Pasquina; Masiello, Pellegrino; Saftig, Paul; Santini, Ferruccio; St-Jacques, Rene; Desmarais, Sylvie; Morin, Nicolas; Mancini, Joseph; Percival, M. David; Pinchera, Aldo; Maffei, Margherita			Cathepsin K Null Mice Show Reduced Adiposity during the Rapid Accumulation of Fat Stores	PLOS ONE			English	Article								Growing evidences indicate that proteases are implicated in adipogenesis and in the onset of obesity. We previously reported that the cysteine protease cathepsin K (ctsk) is overexpressed in the white adipose tissue (WAT) of obese individuals. We herein characterized the WAT and the metabolic phenotype of ctsk deficient animals (ctsk-/-). When the growth rate of ctsk-/- was compared to that of the wild type animals (WT), we could establish a time window (5-8 weeks of age) within which ctsk-/- display significantly lower body weight and WAT size as compared to WT. Such a difference was not observable in older mice. Upon treatment with high fat diet (HFD) for 12 weeks ctsk-/- gained significantly less weight than WT and showed reduced brown adipose tissue, liver mass and a lower percentage of body fat. Plasma triglycerides, cholesterol and leptin were significantly lower in HFD-fed-ctsk-/- as compared to HFD-fed WT animals. Adipocyte lipolysis rates were increased in both young and HFD-fed-ctsk-/-, as compared to WT. Carnitine palmitoyl transferase-1 activity, was higher in mitochondria isolated from the WAT of HFD treated ctsk-/- as compared to WT. Together, these data indicate that ctsk ablation in mice results in reduced body fat content under conditions requiring a rapid accumulation of fat stores. This observation could be partly explained by an increased release and/or utilization of FFA and by an augmented ratio of lipolysis/lipogenesis. These results also demonstrate that under a HFD, ctsk deficiency confers a partial resistance to the development of dyslipidemia.	[Funicello, Marcella; Ragni, Maurizio; Vottari, Teresa; Cocuzza, Cesare; Soriano-Lopez, Joaquin; Chiellini, Chiara; Maffei, Margherita] Univ Hosp Pisa, Dulbecco Telethon Inst, Dept Endocrinol & Metab, Pisa, Italy; [Novelli, Michela; Masiello, Pellegrino] Univ Pisa, Dept Expt Pathol Med Biotechnol Infectivol & Epid, Pisa, Italy; [Boschi, Federico; Marzola, Pasquina] Univ Verona, Fac Med, Dept Morphol Biomed Sci, Human Anat & Histol Sect, I-37100 Verona, Italy; [Saftig, Paul] Univ Kiel, Inst Biochem, D-2300 Kiel, Germany; [St-Jacques, Rene] Merck Frosst Ctr Therapeut Res, Dept Pharmacol, Kirkland, PQ, Canada; [Desmarais, Sylvie; Morin, Nicolas; Mancini, Joseph; Percival, M. David] Merck Frosst Ctr Therapeut Res, Dept Biochem & Mol Biol, Kirkland, PQ, Canada	Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Pisa; University of Verona; University of Kiel; Merck & Company; Merck & Company	Maffei, M (corresponding author), Univ Hosp Pisa, Dulbecco Telethon Inst, Dept Endocrinol & Metab, Pisa, Italy.	mmaffei@dti.telethon.it	Saftig, Paul/A-7966-2010; Ragni, Maurizio/AAB-1527-2020; Santini, Ferruccio/J-9272-2018	Ragni, Maurizio/0000-0001-6548-741X; Santini, Ferruccio/0000-0002-1706-0822; MARZOLA, Pasquina/0000-0001-6936-8901	Telethon Foundation [TCP99016]; Compagnia di San Paolo	Telethon Foundation(Fondazione Telethon); Compagnia di San Paolo(Compagnia di San Paolo)	Margherita Maffei is an Assistant Telethon Scientist. MF, MR, TV, CC, JSL were supported by a Telethon fellowship. This work was supported by Telethon Foundation (grant TCP99016) and Compagnia di San Paolo.	BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Boord JB, 2002, CURR OPIN LIPIDOL, V13, P141, DOI 10.1097/00041433-200204000-00005; Bouloumie A, 2001, DIABETES, V50, P2080, DOI 10.2337/diabetes.50.9.2080; Brubaker KD, 2003, J BONE MINER RES, V18, P222, DOI 10.1359/jbmr.2003.18.2.222; Buhling F, 2001, J PATHOL, V195, P375; Buhling F, 2000, ADV EXP MED BIOL, V477, P281; CASTIGLIONI T, 1994, HUM PATHOL, V25, P857, DOI 10.1016/0046-8177(94)90003-5; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Chiellini C, 2003, J CELL PHYSIOL, V195, P309, DOI 10.1002/jcp.10253; Cock TA, 2003, LANCET, V362, P1572, DOI 10.1016/S0140-6736(03)14747-2; Corisdeo S, 2001, BIOCHEM BIOPH RES CO, V285, P335, DOI 10.1006/bbrc.2001.5127; Dodds RA, 1999, ARTHRITIS RHEUM, V42, P1588, DOI 10.1002/1529-0131(199908)42:8<1588::AID-ANR4>3.0.CO;2-S; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friedrichs B, 2003, J CLIN INVEST, V111, P1733, DOI 10.1172/JCI200315990; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Grabowska UB, 2005, CURR OPIN DRUG DISC, V8, P619; HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375; Herrera E, 2000, DIABETES-METAB RES, V16, P202, DOI 10.1002/1520-7560(200005/06)16:3<202::AID-DMRR116>3.3.CO;2-R; Hummel KM, 1998, J RHEUMATOL, V25, P1887; Lazner F, 1999, MOL MED TODAY, V5, P413, DOI 10.1016/S1357-4310(99)01563-4; Lecaille F, 2002, BIOCHEMISTRY-US, V41, P8447, DOI 10.1021/bi025638x; Levine JA, 1998, J CLIN INVEST, V101, P1557, DOI 10.1172/JCI2293; Li CY, 2006, J BONE MINER RES, V21, P865, DOI 10.1359/JBMR.060313; Lijnen HR, 2002, ARTERIOSCL THROM VAS, V22, P374, DOI 10.1161/hq0302.104522; Lipton A, 2005, EXPERT OPIN BIOL TH, V5, P817, DOI 10.1517/14712598.5.6.817; LittlewoodEvans AJ, 1997, CANCER RES, V57, P5386; Lutgens E, 2006, CIRCULATION, V113, P98, DOI 10.1161/CIRCULATIONAHA.105.561449; Maquoi E, 2002, DIABETES, V51, P1093, DOI 10.2337/diabetes.51.4.1093; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; RODBELL M, 1964, J BIOL CHEM, V239, P375; Rodgers KJ, 2006, ARTERIOSCL THROM VAS, V26, P851, DOI 10.1161/01.ATV.0000203526.75772.4b; RUNGER TM, 2006, J INVEST DERMATOL; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Sell H, 2004, INT J BIOCHEM CELL B, V36, P2098, DOI 10.1016/j.biocel.2004.04.003; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Taleb S, 2005, FASEB J, V19, P1540, DOI 10.1096/fj.05-3673fje; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Turk S, 2003, BIOCHEM SOC SYMP, V70, P15; Yasuda Y, 2005, ADV DRUG DELIVER REV, V57, P973, DOI 10.1016/j.addr.2004.12.013; Xiao Y, 2006, J CLIN ENDOCR METAB, V91, P4520, DOI 10.1210/jc.2005-2486	43	45	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e683	10.1371/journal.pone.0000683	http://dx.doi.org/10.1371/journal.pone.0000683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668061	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452300019
J	Lenoir, M; Serre, F; Cantin, L; Ahmed, SH				Lenoir, Magalie; Serre, Fuschia; Cantin, Lauriane; Ahmed, Serge H.			Intense Sweetness Surpasses Cocaine Reward	PLOS ONE			English	Article							EXTRACELLULAR DOPAMINE CONCENTRATIONS; NUCLEUS-ACCUMBENS; DRUG-ADDICTION; INTRAVENOUS COCAINE; RHESUS-MONKEYS; FOOD-INTAKE; CHOICE; MORPHINE; OBESITY; SUGAR	Background. Refined sugars (e.g., sucrose, fructose) were absent in the diet of most people until very recently in human history. Today overconsumption of diets rich in sugars contributes together with other factors to drive the current obesity epidemic. Overconsumption of sugar-dense foods or beverages is initially motivated by the pleasure of sweet taste and is often compared to drug addiction. Though there are many biological commonalities between sweetened diets and drugs of abuse, the addictive potential of the former relative to the latter is currently unknown. Methodology/Principal findings. Here we report that when rats were allowed to choose mutually-exclusively between water sweetened with saccharin-an intense calorie-free sweetener-and intravenous cocaine-a highly addictive and harmful substance-the large majority of animals (94%) preferred the sweet taste of saccharin. The preference for saccharin was not attributable to its unnatural ability to induce sweetness without calories because the same preference was also observed with sucrose, a natural sugar. Finally, the preference for saccharin was not surmountable by increasing doses of cocaine and was observed despite either cocaine intoxication, sensitization or intake escalation-the latter being a hallmark of drug addiction. Conclusions. Our findings clearly demonstrate that intense sweetness can surpass cocaine reward, even in drug-sensitized and -addicted individuals. We speculate that the addictive potential of intense sweetness results from an inborn hypersensitivity to sweet tastants. In most mammals, including rats and humans, sweet receptors evolved in ancestral environments poor in sugars and are thus not adapted to high concentrations of sweet tastants. The supranormal stimulation of these receptors by sugar-rich diets, such as those now widely available in modern societies, would generate a supranormal reward signal in the brain, with the potential to override self-control mechanisms and thus to lead to addiction.	[Lenoir, Magalie; Serre, Fuschia; Cantin, Lauriane; Ahmed, Serge H.] Univ Bordeaux 2, CNRS, Univ Bordeaux 1, UMR 5227, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Ahmed, SH (corresponding author), Univ Bordeaux 2, CNRS, Univ Bordeaux 1, UMR 5227, F-33076 Bordeaux, France.	sahmed@u--bordeaux2.fr	SERRE, Fuschia/AAU-3161-2020; AHMED, Serge H/D-5236-2014; Lenoir, Magalie/E-5797-2019	SERRE, Fuschia/0000-0002-0228-3572; Lenoir, Magalie/0000-0001-7983-1824; Ahmed, Serge/0000-0002-1225-9234	Universite Victor-Segalen Bordeaux 2; French Research Council (CNRS); Conseil Regional Aquitaine; National Research Agency (ANR); Fondation pour la Recherche Medicale (FRM)	Universite Victor-Segalen Bordeaux 2; French Research Council (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Conseil Regional Aquitaine(Region Nouvelle-Aquitaine); National Research Agency (ANR)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by grants from the Universite Victor-Segalen Bordeaux 2, the French Research Council (CNRS), the Conseil Regional Aquitaine, the National Research Agency (ANR) and the Fondation pour la Recherche Medicale (FRM).	Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Ahmed SH, 2002, NAT NEUROSCI, V5, P625, DOI 10.1038/nn872; AIGNER TG, 1978, SCIENCE, V201, P534, DOI 10.1126/science.96531; Avena NM, 2006, NEUROSCIENCE, V139, P813, DOI 10.1016/j.neuroscience.2005.12.037; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Berthoud HR, 2004, PHYSIOL BEHAV, V81, P781, DOI 10.1016/j.physbeh.2004.04.034; Blundell JE, 2001, OBES RES, V9, p263S, DOI 10.1038/oby.2001.129; CARROLL ME, 1989, PSYCHOPHARMACOLOGY, V97, P23, DOI 10.1007/BF00443407; CARROLL ME, 1993, PSYCHOPHARMACOLOGY, V110, P5, DOI 10.1007/BF02246944; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Colantuoni C, 2002, OBES RES, V10, P478, DOI 10.1038/oby.2002.66; Collier G, 1967, J Comp Physiol Psychol, V64, P401; DAnci KE, 1996, PHARMACOL BIOCHEM BE, V54, P693, DOI 10.1016/0091-3057(96)00016-0; Di Chiara G, 1999, EUR J PHARMACOL, V375, P13, DOI 10.1016/S0014-2999(99)00372-6; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; DICIANO P, 1995, BEHAV PHARMACOL, V6, P311; Doyon WM, 2004, ALCOHOL, V34, P261, DOI 10.1016/j.alcohol.2004.10.004; Drewnowski A, 1997, ANNU REV NUTR, V17, P237, DOI 10.1146/annurev.nutr.17.1.237; ETTENBERG A, 1991, PSYCHOPHARMACOLOGY, V103, P455, DOI 10.1007/BF02244244; Hajnal A, 2004, AM J PHYSIOL-REG I, V286, pR31, DOI 10.1152/ajpregu.00282.2003; Hajnal A, 2002, NEUROREPORT, V13, P2213, DOI 10.1097/00001756-200212030-00010; Hajnal A, 2001, BRAIN RES, V904, P76, DOI 10.1016/S0006-8993(01)02451-9; HAJNAL A, COMMUNICATION; Hemby SE, 1999, J PHARMACOL EXP THER, V288, P274; Hemby SE, 1997, PSYCHOPHARMACOLOGY, V133, P7, DOI 10.1007/s002130050365; Herrnstein RJ, 1970, J EXP ANAL BEHAV, V13, P243, DOI 10.1901/jeab.1970.13-243; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kanarek RB, 1997, PHARMACOL BIOCHEM BE, V57, P377, DOI 10.1016/S0091-3057(96)00337-1; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Kelley AE, 2003, EUR J NEUROSCI, V18, P2592, DOI 10.1046/j.1460-9568.2003.02991.x; Kelley AE, 2002, PHYSIOL BEHAV, V76, P365, DOI 10.1016/S0031-9384(02)00751-5; Kilner RM, 1999, NATURE, V397, P667, DOI 10.1038/17746; Koob GF, 1999, ANN NY ACAD SCI, V897, P27, DOI 10.1111/j.1749-6632.1999.tb07876.x; Koob GF, 2006, NEUR ADD; Levine AS, 2003, AM J CLIN NUTR, V78, p834S, DOI 10.1093/ajcn/78.4.834S; LIEBLICH I, 1983, SCIENCE, V221, P871, DOI 10.1126/science.6879185; Malik VS, 2006, AM J CLIN NUTR, V84, P274; MARK GP, 1991, BRAIN RES, V551, P308, DOI 10.1016/0006-8993(91)90946-S; Mateo Y, 2004, EUR J NEUROSCI, V20, P2838, DOI 10.1111/j.1460-9568.2004.03736.x; MEIL WM, 1995, PSYCHOPHARMACOLOGY, V118, P338, DOI 10.1007/BF02245964; Melendez RI, 2002, ALCOHOL CLIN EXP RES, V26, P318; MINTZ S, 1985, SWEETNESS POWER PLAC, P274; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; NADER MA, 1991, PSYCHOPHARMACOLOGY, V105, P169, DOI 10.1007/BF02244304; Negus SS, 2003, NEUROPSYCHOPHARMACOL, V28, P919, DOI 10.1038/sj.npp.1300096; Norgren R, 2006, PHYSIOL BEHAV, V89, P531, DOI 10.1016/j.physbeh.2006.05.024; Nutt D, 2007, LANCET, V369, P1047, DOI 10.1016/S0140-6736(07)60464-4; Pecina S, 2006, NEUROSCIENTIST, V12, P500, DOI 10.1177/1073858406293154; Pelchat ML, 2002, PHYSIOL BEHAV, V76, P347, DOI 10.1016/S0031-9384(02)00757-6; PETTIT HO, 1991, BRAIN RES, V539, P94, DOI 10.1016/0006-8993(91)90690-W; Pontieri FE, 1995, P NATL ACAD SCI USA, V92, P12304, DOI 10.1073/pnas.92.26.12304; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Popkin BM, 2003, OBES RES, V11, P1325, DOI 10.1038/oby.2003.179; Rada P, 2005, NEUROSCIENCE, V134, P737, DOI 10.1016/j.neuroscience.2005.04.043; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Robbins TW, 1999, NATURE, V398, P567, DOI 10.1038/19208; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Rudski JM, 1997, PHARMACOL BIOCHEM BE, V58, P679, DOI 10.1016/S0091-3057(97)00019-1; Sclafani A, 2004, PHYSIOL BEHAV, V81, P773, DOI 10.1016/j.physbeh.2004.04.031; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Sizemore GM, 2000, PSYCHOPHARMACOLOGY, V150, P391, DOI 10.1007/s002130000456; Smith JC, 2002, APPETITE, V38, P155, DOI 10.1006/appe.2001.0467; Spangler R, 2004, MOL BRAIN RES, V124, P134, DOI 10.1016/j.molbrainres.2004.02.013; Steiner J E, 1979, Adv Child Dev Behav, V13, P257, DOI 10.1016/S0065-2407(08)60349-3; Tinbergen, 1951, STUDY INSTINCT; Ulijaszek SJ, 2006, ANNU REV ANTHROPOL, V35, P337, DOI 10.1146/annurev.anthro.35.081705.123301; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Wang GJ, 2006, P NATL ACAD SCI USA, V103, P15641, DOI 10.1073/pnas.0601977103; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; WEISS F, 1993, J PHARMACOL EXP THER, V267, P250; Williams G. C., 1966, P307; Williams KL, 2000, ALCOHOL CLIN EXP RES, V24, P980, DOI 10.1111/j.1530-0277.2000.tb04640.x; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; WISE RA, 1995, PSYCHOPHARMACOLOGY, V120, P10, DOI 10.1007/BF02246140; WOOLVERTON WL, 1979, COMMUN PSYCHOPHARMAC, V3, P309; Zittel-Lazarini A, 2007, PSYCHOPHARMACOLOGY, V192, P337, DOI 10.1007/s00213-007-0724-0	78	371	373	1	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e698	10.1371/journal.pone.0000698	http://dx.doi.org/10.1371/journal.pone.0000698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668074	gold, Green Submitted, Green Published			2022-12-27	WOS:000207452300032
J	Man, O; Willhite, DC; Crasto, CJ; Shepherd, GM; Gilad, Y				Man, Orna; Willhite, David C.; Crasto, Chiquito J.; Shepherd, Gordon M.; Gilad, Yoav			A Framework for Exploring Functional Variability in Olfactory Receptor Genes	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; ODORANT RECEPTORS; MOLECULAR-BASIS; MOUSE; ACID; PROTEINS; REPERTOIRES; SUPERFAMILY; EXPRESSION; PRIMATES	Background. Olfactory receptors (ORs) are the largest gene family in mammalian genomes. Since nearly all OR genes are orphan receptors, inference of functional similarity or differences between odorant receptors typically relies on sequence comparisons. Based on the alignment of entire coding region sequence, OR genes are classified into families and subfamilies, a classification that is believed to be a proxy for OR gene functional variability. However, the assumption that overall protein sequence diversity is a good proxy for functional properties is untested. Methodology. Here, we propose an alternative sequence-based approach to infer the similarities and differences in OR binding capacity. Our approach is based on similarities and differences in the predicted binding pockets of OR genes, rather than on the entire OR coding region. Conclusions. Interestingly, our approach yields markedly different results compared to the analysis based on the entire OR coding-regions. While neither approach can be tested at this time, the discrepancy between the two calls into question the assumption that the current classification reliably reflects OR gene functional variability.	[Man, Orna] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Man, Orna] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Willhite, David C.; Crasto, Chiquito J.; Shepherd, Gordon M.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Gilad, Yoav] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	Weizmann Institute of Science; Weizmann Institute of Science; Yale University; University of Chicago	Man, O (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	orna.man@weizmann.ac.il; gilad@uchicago.edu			NIH [DC00086]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000086] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	GMS, CC, and DCW were supported by NIH grant DC00086 (GMS).	Antikainen NM, 2003, BIOCHEMISTRY-US, V42, P1603, DOI 10.1021/bi0267285; Balasubramanian M, 2002, SCIENCE, V295; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gilad Y, 2005, GENOME RES, V15, P224, DOI 10.1101/gr.2846405; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Gilad Y, 2003, P NATL ACAD SCI USA, V100, P3324, DOI 10.1073/pnas.0535697100; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; GRIFF IC, 1995, CELL, V83, P407, DOI 10.1016/0092-8674(95)90118-3; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Kawashima S, 1999, NUCLEIC ACIDS RES, V27, P368, DOI 10.1093/nar/27.1.368; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; LANCET D, 1993, P NATL ACAD SCI USA, V90, P3715, DOI 10.1073/pnas.90.8.3715; Lapidot M, 2001, GENOMICS, V71, P296, DOI 10.1006/geno.2000.6431; Laska M, 2000, CHEM SENSES, V25, P47, DOI 10.1093/chemse/25.1.47; Lo LW, 2003, P NATL ACAD SCI USA, V100, P4463, DOI 10.1073/pnas.0737647100; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Man O, 2004, PROTEIN SCI, V13, P240, DOI 10.1110/ps.03296404; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Mirny LA, 2002, J MOL BIOL, V321, P7, DOI 10.1016/S0022-2836(02)00587-9; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; Niimura Y, 2005, P NATL ACAD SCI USA, V102, P6039, DOI 10.1073/pnas.0501922102; OCONNELL RJ, 1994, CHEM SENSES, V19, P197, DOI 10.1093/chemse/19.3.197; Olender T, 2004, GENOMICS, V83, P361, DOI 10.1016/j.ygeno.2003.08.009; Olender Tsviya, 2004, Genet Mol Res, V3, P545; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Quignon P, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r80; Reed RR, 2004, CELL, V116, P329, DOI 10.1016/S0092-8674(04)00047-9; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; SALVADOR S, 2004, DETERMINING NUMBER C, P576; Schneider K, 2003, P NATL ACAD SCI USA, V100, P8601, DOI 10.1073/pnas.1430550100; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Young JM, 2002, HUM MOL GENET, V11, P1153, DOI 10.1093/hmg/11.10.1153; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zozulya S, 2001, GENOME BIOL, V2	45	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e682	10.1371/journal.pone.0000682	http://dx.doi.org/10.1371/journal.pone.0000682			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668060	gold, Green Published, Green Submitted			2022-12-27	WOS:000207452300018
J	Michos, AG; Syriopoulou, VP; Hadjichristodoulou, C; Daikos, GL; Lagona, E; Douridas, P; Mostrou, G; Theodoridou, M				Michos, Athanasios G.; Syriopoulou, Vassiliki P.; Hadjichristodoulou, Christos; Daikos, George L.; Lagona, Evagelia; Douridas, Panagiotis; Mostrou, Glykeria; Theodoridou, Maria			Aseptic Meningitis in Children: Analysis of 506 Cases	PLOS ONE			English	Article								Background. Non-polio human enteroviruses are the leading cause of aseptic meningitis in children. The role of enterovirus PCR for diagnosis and management of aseptic meningitis has not been fully explored. Methodology/Principal Findings. A retrospective study was conducted to determine the epidemiological, clinical, and laboratory characteristics of aseptic meningitis and to evaluate the role of enterovirus PCR for the diagnosis and management of this clinical entity. The medical records of children who had as discharge diagnosis aseptic or viral meningitis were reviewed. A total of 506 children, median age 5 years, were identified. The annual incidence rate was estimated to be 17/100,000 children less than 14 years of age. Most of the cases occurred during summer (38%) and autumn (24%). The dominant clinical symptoms were fever (98%), headache (94%) and vomiting (67%). Neck stiffness was noted in 60%, and irritation in 46% of the patients. The median number of CSF cell count was 201/mm(3) with polymorphonuclear predominance (>50%) in 58.3% of the cases. Enterovirus RNA was detected in CSF in 47 of 96 (48.9%) children tested. Children with positive enterovirus PCR had shorter hospitalization stay as compared to children who had negative PCR or to children who were not tested (P = 0.01). There were no serious complications or deaths. Conclusions. Enteroviruses accounted for approximately one half of cases of aseptic meningitis. PCR may reduce the length of hospitalization and plays important role in the diagnosis and management of children with aseptic meningitis.	[Michos, Athanasios G.; Syriopoulou, Vassiliki P.; Lagona, Evagelia; Douridas, Panagiotis; Mostrou, Glykeria; Theodoridou, Maria] Univ Athens, Dept Pediat 1, Aghia Sophia Childrens Hosp, Athens, Greece; [Hadjichristodoulou, Christos] Univ Thessaly, Dept Hyg & Epidemiol, Fac Med, Larisa, Greece; [Daikos, George L.] Univ Athens, Laiko Gen Hosp, Dept Propaedeut Med 1, Athens, Greece	National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; University of Thessaly; Laiko General Hospital; National & Kapodistrian University of Athens	Syriopoulou, VP (corresponding author), Univ Athens, Dept Pediat 1, Aghia Sophia Childrens Hosp, Athens, Greece.	vsyriop@med.uoa.gr	Michos, Athanasios/H-2389-2012; Daikos, George L./ABD-8378-2021	Michos, Athanasios/0000-0003-1745-1118; Hadjichristodoulou, Christos/0000-0002-4769-8376				Ahmed A, 1997, J PEDIATR-US, V131, P393, DOI 10.1016/S0022-3476(97)80064-9; AMIR J, 1991, J PEDIATR-US, V119, P938, DOI 10.1016/S0022-3476(05)83049-5; BERLIN LE, 1993, J INFECT DIS, V168, P888, DOI 10.1093/infdis/168.4.888; Hamilton MS, 1999, PEDIATR INFECT DIS J, V18, P533, DOI 10.1097/00006454-199906000-00011; Ishiko H, 2002, J INFECT DIS, V185, P744, DOI 10.1086/339298; Lee BE, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-68; Marshall GS, 1997, PEDIATR INFECT DIS J, V16, P1086, DOI 10.1097/00006454-199711000-00015; Nigrovic LE, 2000, ARCH PEDIAT ADOL MED, V154, P817, DOI 10.1001/archpedi.154.8.817; Nigrovic LE, 2007, JAMA-J AM MED ASSOC, V297, P52, DOI 10.1001/jama.297.1.52; Ramers C, 2000, JAMA-J AM MED ASSOC, V283, P2680, DOI 10.1001/jama.283.20.2680; RICE SK, 1995, CLIN INFECT DIS, V20, P931, DOI 10.1093/clinids/20.4.931; Robinson CC, 2002, PEDIATR INFECT DIS J, V21, P283, DOI 10.1097/00006454-200204000-00005; Rotbart HA, 1997, PEDIATR INFECT DIS J, V16, P409, DOI 10.1097/00006454-199704000-00014; ROTBART HA, 1995, CLIN INFECT DIS, V20, P971, DOI 10.1093/clinids/20.4.971; SAWYER MH, 1994, PEDIATR INFECT DIS J, V13, P177, DOI 10.1097/00006454-199403000-00002; Sawyer MH, 1999, PEDIATR INFECT DIS J, V18, P1033, DOI 10.1097/00006454-199912000-00002; SCHLESINGER Y, 1994, PEDIATRICS, V94, P157; Siafakas N, 2004, MOL CELL PROBE, V18, P389, DOI 10.1016/j.mcp.2004.06.005; Spicher VM, 2000, CLIN PEDIATR, V39, P203, DOI 10.1177/000992280003900402; STRIKAS RA, 1986, J INFECT DIS, V153, P346, DOI 10.1093/infdis/153.2.346; Syriopoulou VP, 2002, J HOSP INFECT, V51, P275, DOI 10.1053/jhin.2002.1253; van Vliet KE, 1998, J CLIN MICROBIOL, V36, P2652, DOI 10.1128/JCM.36.9.2652-2657.1998; WILDIN S, 1987, AM J DIS CHILD, V141, P454, DOI 10.1001/archpedi.1987.04460040112030	23	90	99	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e674	10.1371/journal.pone.0000674	http://dx.doi.org/10.1371/journal.pone.0000674			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668054	Green Published, gold			2022-12-27	WOS:000207452300012
J	Panagiotakos, G; Alshamy, G; Chan, B; Abrams, R; Greenberg, E; Saxena, A; Bradbury, M; Edgar, M; Gutin, P; Tabar, V				Panagiotakos, Georgia; Alshamy, George; Chan, Bill; Abrams, Rory; Greenberg, Edward; Saxena, Amit; Bradbury, Michelle; Edgar, Mark; Gutin, Philip; Tabar, Viviane			Long-Term Impact of Radiation on the Stem Cell and Oligodendrocyte Precursors in the Brain	PLOS ONE			English	Article								Background. The cellular basis of long term radiation damage in the brain is not fully understood. Methods and Findings. We administered a dose of 25Gy to adult rat brains while shielding the olfactory bulbs. Quantitative analyses were serially performed on different brain regions over 15 months. Our data reveal an immediate and permanent suppression of SVZ proliferation and neurogenesis. The olfactory bulb demonstrates a transient but remarkable SVZ-independent ability for compensation and maintenance of the calretinin interneuron population. The oligodendrocyte compartment exhibits a complex pattern of limited proliferation of NG2 progenitors but steady loss of the oligodendroglial antigen O4. As of nine months post radiation, diffuse demyelination starts in all irradiated brains. Counts of capillary segments and length demonstrate significant loss one day post radiation but swift and persistent recovery of the vasculature up to 15 months post XRT. MRI imaging confirms loss of volume of the corpus callosum and early signs of demyelination at 12 months. Ultrastructural analysis demonstrates progressive degradation of myelin sheaths with axonal preservation. Areas of focal necrosis appear beyond 15 months and are preceded by widespread demyelination. Human white matter specimens obtained post-radiation confirm early loss of oligodendrocyte progenitors and delayed onset of myelin sheath fragmentation with preserved capillaries. Conclusions. This study demonstrates that long term radiation injury is associated with irreversible damage to the neural stem cell compartment in the rodent SVZ and loss of oligodendrocyte precursor cells in both rodent and human brain. Delayed onset demyelination precedes focal necrosis and is likely due to the loss of oligodendrocyte precursors and the inability of the stem cell compartment to compensate for this loss.	[Panagiotakos, Georgia; Alshamy, George; Chan, Bill; Abrams, Rory; Greenberg, Edward; Saxena, Amit; Gutin, Philip; Tabar, Viviane] Sloan Kettering Inst Canc Res, Dept Neurosurg, New York, NY USA; [Bradbury, Michelle] Sloan Kettering Inst Canc Res, Dept Radiol, New York, NY USA; [Edgar, Mark] Sloan Kettering Inst Canc Res, Dept Pathol, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Tabar, V (corresponding author), Sloan Kettering Inst Canc Res, Dept Neurosurg, New York, NY USA.	tabarv@mskcc.org	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Abrams, Rory/0000-0002-9675-4012; PANAGIOTAKOS, GEORGIA/0000-0001-9444-2480; Saxena, Amit/0000-0003-0098-1083	NINDS; NIH; Michael T. McCarthy Foundation	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael T. McCarthy Foundation	Funding provided in part by grants from the NINDS, NIH and the Michael T. McCarthy Foundation.	Aguirre A, 2004, J NEUROSCI, V24, P10530, DOI 10.1523/JNEUROSCI.3572-04.2004; Bansal R, 1997, ADV EXP MED BIOL, V429, P69; Belka C, 2001, BRIT J CANCER, V85, P1233, DOI 10.1054/bjoc.2001.2100; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Blakemore WF, 2000, J NEUROSCI RES, V61, P288, DOI 10.1002/1097-4547(20000801)61:3<288::AID-JNR6>3.0.CO;2-#; Bu J, 2004, GLIA, V48, P51, DOI 10.1002/glia.20055; CAVANAGH JB, 1972, J NEUROL SCI, V15, P471, DOI 10.1016/0022-510X(72)90172-4; Chari DM, 2002, GLIA, V37, P307, DOI 10.1002/glia.10038; DEANGELIS LM, 2002, INTRACRANIAL TUMORS; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; DUFFNER PK, 1985, CANCER-AM CANCER SOC, V56, P1841, DOI 10.1002/1097-0142(19851001)56:7+<1841::AID-CNCR2820561325>3.0.CO;2-C; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FIKE JR, 1988, INT J RADIAT ONCOL, V14, P63, DOI 10.1016/0360-3016(88)90052-1; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Gensert JM, 2001, J NEUROBIOL, V48, P75, DOI 10.1002/neu.1043.abs; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Hodges H, 1998, BEHAV BRAIN RES, V91, P99, DOI 10.1016/S0166-4328(97)00108-3; Hopewell JW, 1999, FRONT RADIAT THER ON, V33, P265; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.3.CO;2-Z; Lee GD, 2005, BRAIN RES BULL, V65, P317, DOI 10.1016/j.brainresbull.2004.11.024; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Little JB, 2003, ONCOGENE, V22, P6978, DOI 10.1038/sj.onc.1206988; LJUBIMOVA NV, 1991, BRIT J RADIOL, V64, P934, DOI 10.1259/0007-1285-64-766-934; Lyubimova N, 2004, BRIT J RADIOL, V77, P488, DOI 10.1259/bjr/15169876; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Mouton PR, 2002, J MICROSC-OXFORD, V206, P54, DOI 10.1046/j.1365-2818.2002.01006.x; OI S, 1990, Neurologia Medico-Chirurgica, V30, P36, DOI 10.2176/nmc.30.36; Otsuka S, 2006, RADIAT RES, V165, P582, DOI 10.1667/RR3539.1; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Polito A, 2005, J ANAT, V207, P707, DOI 10.1111/j.1469-7580.2005.00454.x; REINHOLD HS, 1990, INT J RADIAT ONCOL, V18, P37, DOI 10.1016/0360-3016(90)90264-K; ROMAN DD, 1995, INT J RADIAT ONCOL, V31, P983, DOI 10.1016/0360-3016(94)00550-8; Sano K, 2000, NEUROL MED-CHIR, V40, P495, DOI 10.2176/nmc.40.495; Schmitz C, 2005, NEUROSCIENCE, V130, P935, DOI 10.1016/j.neuroscience.2004.08.034; Suzuki K, 2003, ONCOGENE, V22, P6988, DOI 10.1038/sj.onc.1206881; Tada E, 2000, NEUROSCIENCE, V99, P33, DOI 10.1016/S0306-4522(00)00151-2; Tada E, 1999, EXP NEUROL, V160, P66, DOI 10.1006/exnr.1999.7172; VANDERKOGEL AJ, 2001, RAD INJURY NERVOUS S, P91	42	127	134	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2007	2	7							e588	10.1371/journal.pone.0000588	http://dx.doi.org/10.1371/journal.pone.0000588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GH	17622341	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452000003
J	Sonkoly, E; Wei, TL; Janson, PCJ; Saaf, A; Lundeberg, L; Tengvall-Linder, M; Norstedt, G; Alenius, H; Homey, B; Scheynius, A; Stahle, M; Pivarcsi, A				Sonkoly, Eniko; Wei, Tianling; Janson, Peter C. J.; Saaf, Annika; Lundeberg, Lena; Tengvall-Linder, Maria; Norstedt, Gunnar; Alenius, Harri; Homey, Bernhard; Scheynius, Annika; Stahle, Mona; Pivarcsi, Andor			MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis?	PLOS ONE			English	Article								MicroRNAs are a recently discovered class of posttranscriptional regulators of gene expression with critical functions in health and disease. Psoriasis is the most prevalent chronic inflammatory skin disease in adults, with a substantial negative impact on the patients' quality of life. Here we show for the first time that psoriasis-affected skin has a specific microRNA expression profile when compared with healthy human skin or with another chronic inflammatory skin disease, atopic eczema. Among the psoriasis-specific microRNAs, we identified leukocyte-derived microRNAs and one keratinocyte-derived microRNA, miR-203. In a panel of 21 different human organs and tissues, miR-203 showed a highly skin-specific expression profile. Among the cellular constituents of the skin, it was exclusively expressed by keratinocytes. The up-regulation of miR-203 in psoriatic plaques was concurrent with the down-regulation of an evolutionary conserved target of miR-203, suppressor of cytokine signaling 3 (SOCS-3), which is involved in inflammatory responses and keratinocyte functions. Our results suggest that microRNA deregulation is involved in the pathogenesis of psoriasis and contributes to the dysfunction of the cross talk between resident and infiltrating cells. Taken together, a new layer of regulatory mechanisms is involved in the pathogenesis of chronic inflammatory skin diseases.	[Sonkoly, Eniko; Wei, Tianling; Lundeberg, Lena; Stahle, Mona; Pivarcsi, Andor] Karolinska Inst, Dept Med, Dermatol & Venereol Unit, Stockholm, Sweden; [Janson, Peter C. J.; Tengvall-Linder, Maria; Scheynius, Annika] Karolinska Inst, Dept Med, Clin Allergy Res Unit, Stockholm, Sweden; [Saaf, Annika; Norstedt, Gunnar] Karolinska Inst, Ctr Mol Med, Dept Mol Med & Surg, Stockholm, Sweden; [Alenius, Harri] Finnish Inst Occupat Hlth, Unit Excellence Immunotoxicol, Helsinki, Finland; [Homey, Bernhard] Univ Dusseldorf, Dept Dermatol, D-4000 Dusseldorf, Germany	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Finnish Institute of Occupational Health; Heinrich Heine University Dusseldorf	Sonkoly, E (corresponding author), Karolinska Inst, Dept Med, Dermatol & Venereol Unit, Stockholm, Sweden.	eniko.sonkoly@ki.se; andor.pivarcsi@ki.se	Pivarcsi, Andor/J-5801-2017	Pivarcsi, Andor/0000-0003-2196-1102; Alenius, Harri/0000-0003-0106-8923; Sonkoly, Eniko/0000-0002-4909-5413; Norstedt, Gunnar/0000-0002-7759-3241	Swedish Medical Research Council; Stockholm County Council; Karolinska Institutet; Cancer and Allergy Foundation; Edvard Welanders Foundation; Swedish Psoriasis Association; Sigurd och Elsa Goljes Minne Foundation; Tore Nilsons Foundation; Hesselman Foundation; Konsul ThC Bergh Foundation; Wenner-Gren Foundation; Marie Curie Intra-European	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Cancer and Allergy Foundation; Edvard Welanders Foundation; Swedish Psoriasis Association; Sigurd och Elsa Goljes Minne Foundation; Tore Nilsons Foundation; Hesselman Foundation; Konsul ThC Bergh Foundation; Wenner-Gren Foundation; Marie Curie Intra-European(European Commission)	Financial support is acknowledged from the Swedish Medical Research Council, Stockholm County Council, and the Karolinska Institutet, the Cancer and Allergy Foundation, Edvard Welanders Foundation, the Swedish Psoriasis Association, Sigurd och Elsa Goljes Minne, Tore Nilsons, Hesselman, and the Konsul ThC Bergh Foundations. Moreover, E. S. and A. P. were supported by the Wenner-Gren Foundation, and A. P. was supported by the Marie Curie Intra-European Fellowship.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carlen LM, 2005, J INVEST DERMATOL, V124, P63, DOI 10.1111/j.0022-202X.2004.23501.x; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Czech MP, 2006, NEW ENGL J MED, V354, P1194, DOI 10.1056/NEJMcibr060065; Dimon-Gadal S, 2000, J INVEST DERMATOL, V114, P984, DOI 10.1046/j.1523-1747.2000.00962.x; Fischer M, 2006, J CLIN INVEST, V116, P2748, DOI 10.1172/JCI24274; Goren I, 2006, J INVEST DERMATOL, V126, P477, DOI 10.1038/sj.jid.5700063; Homey B, 2000, J IMMUNOL, V164, P3465, DOI 10.4049/jimmunol.164.7.3465; Lebwohl M, 2003, LANCET, V361, P1197, DOI 10.1016/S0140-6736(03)12954-6; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Nickoloff BJ, 1999, AM J PATHOL, V155, P145, DOI 10.1016/S0002-9440(10)65109-7; Nomura L, 2003, J ALLERGY CLIN IMMUN, V112, P1195, DOI 10.1016/j.jaci.2003.08.049; Pivarcsi A, 2003, INT IMMUNOL, V15, P721, DOI 10.1093/intimm/dxg068; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Stratis A, 2006, J CLIN INVEST, V116, P2094, DOI 10.1172/JCI27179; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	22	573	636	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2007	2	7							e610	10.1371/journal.pone.0000610	http://dx.doi.org/10.1371/journal.pone.0000610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GH	17622355	Green Submitted, gold, Green Published			2022-12-27	WOS:000207452000017
J	Boulay, JL; Miserez, AR; Zweifel, C; Sivasankaran, B; Kana, V; Ghaffari, A; Luyken, C; Sabel, M; Zerrouqi, A; Wasner, M; Van Meir, E; Tolnay, M; Reifenberger, G; Merlo, A				Boulay, Jean-Louis; Miserez, Andre R.; Zweifel, Christian; Sivasankaran, Balasubramanian; Kana, Veronika; Ghaffari, Anthony; Luyken, Cordelia; Sabel, Michael; Zerrouqi, Abdessamad; Wasner, Morten; Van Meir, Erwin; Tolnay, Markus; Reifenberger, Guido; Merlo, Adrian			Loss of NOTCH2 Positively Predicts Survival in Subgroups of Human Glial Brain Tumors	PLOS ONE			English	Article								The structural complexity of chromosome 1p centromeric region has been an obstacle for fine mapping of tumor suppressor genes in this area. Loss of heterozygosity (LOH) on chromosome 1p is associated with the longer survival of oligodendroglioma ( OD) patients. To test the clinical relevance of 1p loss in glioblastomas (GBM) patients and identifiy the underlying tumor suppressor locus, we constructed a somatic deletion map on chromosome 1p in 26 OG and 118 GBM. Deletion hotspots at 4 microsatellite markers located at 1p36.3, 1p36.1, 1p22 and 1p11 defined 10 distinct haplotypes that were related to patient survival. We found that loss of 1p centromeric marker D1S2696 within NOTCH2 intron 12 was associated with favorable prognosis in OD ( P = 0.0007) as well as in GBM ( P = 0.0175), while 19q loss, concomitant with 1p LOH in OD, had no influence on GBM survival ( P = 0.918). Assessment of the intra-chromosomal ratio between NOTCH2 and its 1q21 pericentric duplication N2N (N2/N2N-test) allowed delineation of a consistent centromeric breakpoint in OD that also contained a minimally lost area in GBM. OD and GBM showed distinct deletion patterns that converged to the NOTCH2 gene in both glioma subtypes. Moreover, the N2/N2N-test disclosed homozygous deletions of NOTCH2 in primary OD. The N2/N2N test distinguished OD from GBM with a specificity of 100% and a sensitivity of 97%. Combined assessment of NOTCH2 genetic markers D1S2696 and N2/N2N predicted 24-month survival with an accuracy (0.925) that is equivalent to histological classification combined with the D1S2696 status (0.954) and higher than current genetic evaluation by 1p/19q LOH (0.762). Our data propose NOTCH2 as a powerful new molecular test to detect prognostically favorable gliomas.	[Boulay, Jean-Louis; Zweifel, Christian; Sivasankaran, Balasubramanian; Kana, Veronika; Ghaffari, Anthony; Merlo, Adrian] Univ Hosp, Mol Neurooncol Lab, Dept Res, Basel, Switzerland; [Miserez, Andre R.] Diagene Inc, Res Labs, Reinach, Switzerland; [Zweifel, Christian; Ghaffari, Anthony; Wasner, Morten; Merlo, Adrian] Univ Hosp, Neurosurg Clin, Basel, Switzerland; [Luyken, Cordelia; Sabel, Michael; Reifenberger, Guido] Univ Dusseldorf, Dept Neuropathol, Dusseldorf, Germany; [Luyken, Cordelia; Sabel, Michael; Reifenberger, Guido] Univ Dusseldorf, Dept Neurosurg, Dusseldorf, Germany; [Zerrouqi, Abdessamad; Van Meir, Erwin] Emory Univ, Mol Neurooncol Lab, Dept Neurosurg, Atlanta, GA 30322 USA; [Tolnay, Markus] Univ Hosp, Inst Pathol, Basel, Switzerland	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Emory University	Merlo, A (corresponding author), Univ Hosp, Mol Neurooncol Lab, Dept Res, Basel, Switzerland.	amerlo@uhbs.ch	Reifenberger, Guido/AAE-3599-2019; Sivasankaran, Balasubramanian/D-1527-2015; Miserez, André R./A-8581-2008	Sivasankaran, Balasubramanian/0000-0001-6207-5516; Van Meir, Erwin G./0000-0003-2444-7707; Zerrouqi, Abdessamad/0000-0002-2628-473X; Kana, Veronika/0000-0002-9362-3156	Swiss National Cancer League / Oncosuisse [OCS-01613-12-2004]; Regional Cancer League of both Basel-Stadt and Baselland [7-2004]; German Cancer Aid [70-3088-Sa1]	Swiss National Cancer League / Oncosuisse; Regional Cancer League of both Basel-Stadt and Baselland; German Cancer Aid(Deutsche Krebshilfe)	This work was supported by the Swiss National Cancer League / Oncosuisse (OCS-01613-12-2004), the Regional Cancer League of both Basel-Stadt and Baselland ( No. 7-2004) and the German Cancer Aid (70-3088-Sa1).	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Bello MJ, 2000, CANCER GENET CYTOGEN, V116, P142, DOI 10.1016/S0165-4608(99)00122-3; Bigner SH, 1999, AM J PATHOL, V155, P375, DOI 10.1016/S0002-9440(10)65134-6; Cairncross G, 2006, J CLIN ONCOL, V24, P2707, DOI 10.1200/JCO.2005.04.3414; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Duan ZJ, 2004, MOL CELL BIOL, V24, P58, DOI 10.1128/MCB.24.1.58-70.2004; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Felsberg J, 2004, BRAIN PATHOL, V14, P121, DOI 10.1111/j.1750-3639.2004.tb00044.x; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Griffin CA, 2006, J NEUROPATH EXP NEUR, V65, P988, DOI 10.1097/01.jnen.0000235122.98052.8f; GRIGORIEV A, 1994, GENOMICS, V22, P482, DOI 10.1006/geno.1994.1416; Hubmann R, 2002, BLOOD, V99, P3742, DOI 10.1182/blood.V99.10.3742; Husemann K, 1999, J NEUROPATH EXP NEUR, V58, P1041, DOI 10.1097/00005072-199910000-00002; Irvin DK, 2001, J COMP NEUROL, V436, P167, DOI 10.1002/cne.1059.abs; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Kleihues P, 2000, CANCER, V88, P2887, DOI 10.1002/1097-0142(20000615)88:12<2887::AID-CNCR32>3.0.CO;2-F; Kraus JA, 2001, ACTA NEUROPATHOL, V101, P311; Lebrun C, 2004, NEUROLOGY, V62, P1783, DOI 10.1212/01.WNL.0000125196.88449.89; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Mai M, 1998, GENOMICS, V51, P359, DOI 10.1006/geno.1998.5387; Maier D, 1997, ONCOGENE, V15, P997, DOI 10.1038/sj.onc.1201209; Merlo A, 2003, NEUROSURG REV, V26, P145, DOI 10.1007/s10143-003-0267-8; Mirimanoff RO, 2006, J CLIN ONCOL, V24, P2563, DOI 10.1200/JCO.2005.04.5963; Mukasa A, 2002, ONCOGENE, V21, P3961, DOI 10.1038/sj.onc.1205495; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Reifenberger G, 2003, J NEUROPATH EXP NEUR, V62, P111, DOI 10.1093/jnen/62.2.111; REIFENBERGER J, 1994, AM J PATHOL, V145, P1175; SHAW EG, 1992, J NEUROSURG, V76, P428, DOI 10.3171/jns.1992.76.3.0428; Tanaka M, 2003, NEUROSCI LETT, V353, P87, DOI 10.1016/j.neulet.2003.08.080	35	54	55	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e576	10.1371/journal.pone.0000576	http://dx.doi.org/10.1371/journal.pone.0000576			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593975	Green Submitted, Green Published, gold			2022-12-27	WOS:000207451800020
J	Ozden, S; Huerre, M; Riviere, JP; Coffey, LL; Afonso, PV; Mouly, V; de Monredon, J; Roger, JC; El Amrani, M; Yvin, JL; Jaffar, MC; Frenkiel, MP; Sourisseau, M; Schwartz, O; Butler-Browne, G; Despres, P; Gessain, A; Ceccaldi, PE				Ozden, Simona; Huerre, Michel; Riviere, Jean-Pierre; Coffey, Lark L.; Afonso, Philippe V.; Mouly, Vincent; de Monredon, Jean; Roger, Jean-Christophe; El Amrani, Mohamed; Yvin, Jean-Luc; Jaffar, Marie-Christine; Frenkiel, Marie-Pascale; Sourisseau, Marion; Schwartz, Olivier; Butler-Browne, Gillian; Despres, Philippe; Gessain, Antoine; Ceccaldi, Pierre-Emmanuel			Human Muscle Satellite Cells as Targets of Chikungunya Virus Infection	PLOS ONE			English	Article								Background. Chikungunya (CHIK) virus is a mosquito-transmitted alphavirus that causes in humans an acute infection characterised by fever, polyarthralgia, head-ache, and myalgia. Since 2005, the emergence of CHIK virus was associated with an unprecedented magnitude outbreak of CHIK disease in the Indian Ocean. Clinically, this outbreak was characterized by invalidating poly-arthralgia, with myalgia being reported in 97.7% of cases. Since the cellular targets of CHIK virus in humans are unknown, we studied the pathogenic events and targets of CHIK infection in skeletal muscle. Methodology/Principal Findings. Immunohistology on muscle biopsies from two CHIK virus-infected patients with myositic syndrome showed that viral antigens were found exclusively inside skeletal muscle progenitor cells (designed as satelllite cells), and not in muscle fibers. To evaluate the ability of CHIK virus to replicate in human satellite cells, we assessed virus infection on primary human muscle cells; viral growth was observed in CHIK virus-infected satellite cells with a cytopathic effect, whereas myotubes were essentially refractory to infection. Conclusions/Significance. This report provides new insights into CHIK virus pathogenesis, since it is the first to identify a cellular target of CHIK virus in humans and to report a selective infection of muscle satellite cells by a viral agent in humans.	[Ozden, Simona; Afonso, Philippe V.; Gessain, Antoine; Ceccaldi, Pierre-Emmanuel] Inst Pasteur, CNRS, Unite Epidemiol & Physiopathol Virus Oncogenes, URA1930, Paris, France; [Huerre, Michel] Inst Pasteur, Unite Rech & Expertise Histotechnol & Pathol, Paris, France; [Riviere, Jean-Pierre] CHD Felix Guyon, Serv Anatomopathol, St Denis, Reunion, France; [Coffey, Lark L.; Frenkiel, Marie-Pascale; Despres, Philippe] Inst Pasteur, Unite Interact Mol Flavivirus Hotes, Paris, France; [Mouly, Vincent; Butler-Browne, Gillian] Univ Paris 06, INSERM, Inst Myol, U787, Paris, France; [de Monredon, Jean; Roger, Jean-Christophe; El Amrani, Mohamed] CHD Felix Guyon, Serv Neurol, St Denis, Reunion, France; [Yvin, Jean-Luc] CHD Felix Guyon, Serv Med Interne, St Denis, Reunion, France; [Jaffar, Marie-Christine] CHD Felix Guyon, Biol Lab, St Denis, Reunion, France; [Sourisseau, Marion; Schwartz, Olivier] Inst Pasteur, Unite Virus & Immunite, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CHU Reunion; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU Reunion; CHU Reunion; CHU Reunion; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ceccaldi, PE (corresponding author), Inst Pasteur, CNRS, Unite Epidemiol & Physiopathol Virus Oncogenes, URA1930, Paris, France.	ceccaldi@pasteur.fr	CECCALDI, Pierre-Emmanuel/J-6628-2017; Mouly, Gillian/G-6595-2017; Afonso, Philippe/D-2234-2014; Afonso, Philippe V/ABB-5692-2021; Schwartz, Olivier/AAZ-3765-2021	CECCALDI, Pierre-Emmanuel/0000-0002-2736-2314; Afonso, Philippe/0000-0002-4828-3797; Afonso, Philippe V/0000-0002-4828-3797; Schwartz, Olivier/0000-0002-0729-1475; Mouly, Vincent/0000-0003-3809-4033; butler-browne, gillian/0000-0002-3431-242X; Coffey, Lark/0000-0002-0718-5146	French Minsitry of Research; Association Francaise contre les Myopathies; University Pierre-et-Marie Curie; Centre National de la Recherche Scientifique; ANR/MIME; INSERM; MYORES Network of Excellence; European Commission [511978]; Programmme Transversal de Recherches ``Chikungunya''	French Minsitry of Research; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); University Pierre-et-Marie Curie; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); ANR/MIME(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); MYORES Network of Excellence; European Commission(European CommissionEuropean Commission Joint Research Centre); Programmme Transversal de Recherches ``Chikungunya''	P. V. A. is a recipient from the French Minsitry of Research. This work is supported by the Association Francaise contre les Myopathies, the University Pierre-et-Marie Curie, the Centre National de la Recherche Scientifique, the ANR/MIME, INSERM, MYORES Network of Excellence from the European Commission (6thFP; contract 511978), and the Programmme Transversal de Recherches ``Chikungunya'' of the Pasteur Institute.	[Anonymous], 2006, Wkly Epidemiol Rec, V81, P409; BACHELET T, 2006, B SOC PATHOL EXOT, V99, P144; BISCHOFF R, 1975, ANAT REC, V182, P215, DOI 10.1002/ar.1091820207; Bodenmann P, 2006, LANCET, V368, P258, DOI 10.1016/S0140-6736(06)69046-6; Decary S, 1997, HUM GENE THER, V8, P1429, DOI 10.1089/hum.1997.8.12-1429; FINKELSTEIN S, 1987, PATHOLOGY INFECT DIS; GREISERWILKE I, 1989, J GEN VIROL, V70, P743, DOI 10.1099/0022-1317-70-3-743; Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001; HIRUMA M, 1990, JPN J VET SCI, V52, P767; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Morrison TE, 2006, J VIROL, V80, P737, DOI 10.1128/JVI.80.2.737-749.2006; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; Outbreak news, 2006, WKLY EPIDEMIOL REC, V81, P106; Ozden S, 2005, AM J PATHOL, V167, P1609, DOI 10.1016/S0002-9440(10)61245-X; Paquet C, 2006, EUROSURVEILLANCE, V11; PATTYN SR, 1975, ARCH VIROL, V49, P33, DOI 10.1007/BF02175593; Pfeffer M., 2006, EUROSURVEILLANCE, V11; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; SEAY AR, 1981, NEUROLOGY, V31, P656, DOI 10.1212/WNL.31.6.656; SOURISSEAU M, 2007, PLOS PATHOG IN PRESS; Taylor SF, 2005, SOUTH MED J, V98, P484, DOI 10.1097/01.SMJ.0000145879.14102.F4; TESH RB, 1982, ANNU REV MED, V33, P31, DOI 10.1146/annurev.me.33.020182.000335; Trgovcich J, 1996, VIROLOGY, V224, P73, DOI 10.1006/viro.1996.0508; UBOL S, 1991, J VIROL, V65, P6913, DOI 10.1128/JVI.65.12.6913-6921.1991; Villoing S, 2000, J VIROL, V74, P173, DOI 10.1128/JVI.74.1.173-183.2000; WEAVER SC, 2005, TOPLEY WILSONS MICRO, P1010	26	201	204	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2007	2	6							e527	10.1371/journal.pone.0000527	http://dx.doi.org/10.1371/journal.pone.0000527			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GD	17565380	Green Published, gold			2022-12-27	WOS:000207451600015
J	Watson, LE; Kuo, SR; Katki, K; Dang, TY; Park, SK; Dostal, DE; Tang, WJ; Leppla, SH; Frankel, AE				Watson, Linley E.; Kuo, Shu-ru; Katki, Khurshed; Dang, Tongyun; Park, Seong Kyu; Dostal, David E.; Tang, Wei-jen; Leppla, Stephen H.; Frankel, Arthur E.			Anthrax Toxins Induce Shock in Rats by Depressed Cardiac Ventricular Function	PLOS ONE			English	Article								Anthrax infections are frequently associated with severe and often irreversible hypotensive shock. The isolated toxic proteins of Bacillus anthracis produce a non-cytokine-mediated hypotension in rats by unknown mechanisms. These observations suggest the anthrax toxins have direct cardiovascular effects. Here, we characterize these effects. As a first step, we administered systemically anthrax lethal toxin (LeTx) and edema toxin (EdTx) to cohorts of three to twelve rats at different doses and determined the time of onset, degree of hypotension and mortality. We measured serum concentrations of the protective antigen (PA) toxin component at various time points after infusion. Peak serum levels of PA were in the mg/mL range with half-lives of 10-20 minutes. With doses that produced hypotension with delayed lethality, we then gave bolus intravenous infusions of toxins to groups of four to six instrumented rats and continuously monitored blood pressure by telemetry. Finally, the same doses used in the telemetry experiments were given to additional groups of four rats, and echocardiography was performed pretreatment and one, two, three and twenty-four hours post-treatment. LeTx and EdTx each produced hypotension. We observed a doubling of the velocity of propagation and 20% increases in left ventricular diastolic and systolic areas in LeTx-treated rats, but not in EdTx-treated rats. EdTx-but not LeTx-treated rats showed a significant increase in heart rate. These results indicate that LeTx reduced left ventricular systolic function and EdTx reduced preload. Uptake of toxins occurs readily into tissues with biological effects occurring within minutes to hours of serum toxin concentrations in the mu g/mL range. LeTx and EdTx yield an irreversible shock with subsequent death. These findings should provide a basis for the rational design of drug interventions to reduce the dismal prognosis of systemic anthrax infections.	[Watson, Linley E.] Scott & White Mem Hosp & Clin, Div Cardiol, Scott Sherwood & Brindley Fdn, Temple, TX 76508 USA; [Watson, Linley E.; Katki, Khurshed; Dostal, David E.; Frankel, Arthur E.] Texas A&M Univ Syst, Hlth Sci Ctr, Coll Med, Dept Med, Temple, TX USA; [Kuo, Shu-ru; Dang, Tongyun; Park, Seong Kyu; Frankel, Arthur E.] Scott & White Canc Res Inst, Temple, TX USA; [Watson, Linley E.; Dostal, David E.] Texas A&M Univ Syst, Div Mol Cardiol, Hlth Sci Ctr, Coll Med, Temple, TX USA; [Watson, Linley E.; Dostal, David E.] Cent Texas Vet Hlth Care Syst, Temple, TX USA; [Tang, Wei-jen] Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; [Leppla, Stephen H.] NIAID, Bacterial Toxins & Therapeut Sect, Bethesda, MD 20892 USA	Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Frankel, AE (corresponding author), Scott & White Mem Hosp & Clin, Div Cardiol, Scott Sherwood & Brindley Fdn, Temple, TX 76508 USA.	AFRANKEL@swmail.sw.org		Tang, Wei-Jen/0000-0002-8267-8995	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001032, ZIAAI000929, Z01AI001032, Z01AI000929] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abi-Habib RJ, 2005, MOL CANCER THER, V4, P1303, DOI 10.1158/1535-7163.MCT-05-0145; Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Borio L, 2001, JAMA-J AM MED ASSOC, V286, P2554, DOI 10.1001/jama.286.20.2554; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Cui XZ, 2007, J INFECT DIS, V195, P572, DOI 10.1086/510856; Cui XZ, 2005, J INFECT DIS, V191, P422, DOI 10.1086/427189; Cui XZ, 2004, AM J PHYSIOL-REG I, V286, pR699, DOI 10.1152/ajpregu.00593.2003; Culley NC, 2005, INFECT IMMUN, V73, P7006, DOI 10.1128/IAI.73.10.7006-7010.2005; DIPETTE DJ, 1989, AM J MED SCI, V297, P65, DOI 10.1097/00000441-198902000-00001; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; EZZELL JW, 1984, INFECT IMMUN, V45, P761, DOI 10.1128/IAI.45.3.761-767.1984; Firoved AM, 2007, INFECT IMMUN, V75, P2120, DOI 10.1128/IAI.01781-06; Firoved AM, 2005, AM J PATHOL, V167, P1309, DOI 10.1016/S0002-9440(10)61218-7; Hong J, 2005, BIOCHEM BIOPH RES CO, V335, P850, DOI 10.1016/j.bbrc.2005.07.132; Kobiler D, 2006, INFECT IMMUN, V74, P5871, DOI 10.1128/IAI.00792-06; LoRusso PM, 2005, J CLIN ONCOL, V23, P5281, DOI 10.1200/JCO.2005.14.415; Mabry R, 2006, CLIN VACCINE IMMUNOL, V13, P671, DOI 10.1128/CVI.00023-06; Marcus H, 2004, INFECT IMMUN, V72, P3471, DOI 10.1128/IAI.72.6.3471-3477.2004; Mayer TA, 2001, JAMA-J AM MED ASSOC, V286, P2549, DOI 10.1001/jama.286.20.2549; Mina B, 2002, JAMA-J AM MED ASSOC, V287, P858, DOI 10.1001/jama.287.7.858; Moayeri M, 2005, INFECT IMMUN, V73, P4238, DOI 10.1128/IAI.73.7.4238-4244.2005; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Mogridge J, 2002, BIOCHEMISTRY-US, V41, P1079, DOI 10.1021/bi015860m; Ogawa Toshihiro, 2005, Cardiovasc Ultrasound, V3, P24, DOI 10.1186/1476-7120-3-24; OH JK, 1999, ECHO MANUAL; Paccani SR, 2005, J EXP MED, V201, P325, DOI 10.1084/jem.20041557; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Plehm Ralph, 2006, V129, P115; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Ramirez DM, 2002, J IND MICROBIOL BIOT, V28, P232, DOI 10.1038/sj/jim/700239; Rosovitz MJ, 2003, J BIOL CHEM, V278, P30936, DOI 10.1074/jbc.M301154200; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Scobie HM, 2006, PLOS PATHOG, V2, P949, DOI 10.1371/journal.ppat.0020111; Soelaiman S, 2003, J BIOL CHEM, V278, P25990, DOI 10.1074/jbc.M301232200; Trujillo C, 2006, NEUROTOX RES, V9, P63, DOI 10.1007/BF03033924; Watson LE, 2004, J AM SOC ECHOCARDIOG, V17, P161, DOI 10.1016/j.echo.2003.10.010	37	48	49	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2007	2	5							e466	10.1371/journal.pone.0000466	http://dx.doi.org/10.1371/journal.pone.0000466			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DZ	17520025	Green Published, gold, Green Submitted			2022-12-27	WOS:000207446000014
J	Harkonen, T; Harding, K; Rasmussen, TD; Teilmann, J; Dietz, R				Harkonen, Tero; Harding, Karin; Rasmussen, Thomas Dau; Teilmann, Jonas; Dietz, Rune			Age- and Sex-Specific Mortality Patterns in an Emerging Wildlife Epidemic: The Phocine Distemper in European Harbour Seals	PLOS ONE			English	Article							SCOTTISH GREY SEALS; VITULINA; VIRUS; IDENTIFICATION; ANTIBODIES	Analyses of the dynamics of diseases in wild populations typically assume all individuals to be identical. However, profound effects on the long-term impact on the host population can be expected if the disease has age and sex dependent dynamics. The Phocine Distemper Virus (PDV) caused two mass mortalities in European harbour seals in 1988 and in 2002. We show the mortality patterns were highly age specific on both occasions, where young of the year and adult (>4 yrs) animals suffered extremely high mortality, and sub-adult seals (1-3 yrs) of both sexes experienced low mortality. Consequently, genetic differences cannot have played a main role explaining why some seals survived and some did not in the study region, since parents had higher mortality levels than their progeny. Furthermore, there was a conspicuous absence of animals older than 14 years among the victims in 2002, which strongly indicates that the survivors from the previous disease outbreak in 1988 had acquired and maintained immunity to PDV. These specific mortality patterns imply that contact rates and susceptibility to the disease are strongly age and sex dependent variables, underlining the need for structured epidemic models for wildlife diseases. Detailed data can thus provide crucial information about a number of vital parameters such as functional herd immunity. One of many future challenges in understanding the epidemiology of the PDV and other wildlife diseases is to reveal how immune system responses differ among animals in different stages during their life cycle. The influence of such underlying mechanisms may also explain the limited evidence for abrupt disease thresholds in wild populations.	[Harkonen, Tero] Swedish Museum Nat Hist, S-10405 Stockholm, Sweden; [Harding, Karin] Univ Gothenburg, Dept Marine Ecol, Gothenburg, Sweden; [Rasmussen, Thomas Dau; Teilmann, Jonas; Dietz, Rune] Natl Environm Res Inst, Roskilde, Denmark	Swedish Museum of Natural History; University of Gothenburg; Aarhus University	Harkonen, T (corresponding author), Swedish Museum Nat Hist, S-10405 Stockholm, Sweden.	tero.harkonen@swipnet.se	Teilmann, Jonas/J-7828-2013; Dietz, Rune/F-9154-2015; Harding, Karin/F-9957-2013; Dietz, Rune/L-4640-2013	Teilmann, Jonas/0000-0002-4376-4700; Dietz, Rune/0000-0001-9652-317X; Harding, Karin/0000-0003-1527-0903	Swedish Environmental Protection Agency; The Danish Ministry of Environment	Swedish Environmental Protection Agency; The Danish Ministry of Environment	Funding: This study was financed by the Swedish Environmental Protection Agency and The Danish Ministry of Environment.	Caswell, 2000, MATRIX POPULATION MO; COHEN JE, 1979, SIAM J APPL MATH, V36, P169, DOI 10.1137/0136015; DIETZ R, 1989, AMBIO, V18, P258; DIETZ R, 1991, SARSIA, V76, P17, DOI 10.1080/00364827.1991.10413461; Duignan PJ, 1997, J WILDLIFE DIS, V33, P7, DOI 10.7589/0090-3558-33.1.7; GALVANI AP, 2003, P ROY SOC LOND B BIO, V271, P171; Hammond JA, 2005, J GEN VIROL, V86, P2563, DOI 10.1099/vir.0.80962-0; Harding KC, 2003, ECOL LETT, V6, P894, DOI 10.1046/j.1461-0248.2003.00507.x; Harding KC, 2002, ECOL LETT, V5, P727, DOI 10.1046/j.1461-0248.2002.00390.x; Harding KC, 2005, AM NAT, V166, P722, DOI 10.1086/497580; Harkonen T, 2002, CAN J ZOOL, V80, P1498, DOI 10.1139/Z02-141; Harkonen T, 1999, J APPL ECOL, V36, P825, DOI 10.1046/j.1365-2664.1999.00434.x; HARKONEN T, 1990, OPHELIA, V32, P211; Harkonen T, 2006, DIS AQUAT ORGAN, V68, P115, DOI 10.3354/dao068115; HEIDEJORGENSEN MP, 1992, AMBIO, V21, P511; Jensen T, 2002, SCIENCE, V297, P209, DOI 10.1126/science.1075343; KENNEDY S, 1990, VET REC, V127, P563; KEYFITZ N, 1971, DEMOGRAPHY, V8, P71, DOI 10.2307/2060339; LESLIE PH, 1948, BIOMETRIKA, V35, P213, DOI 10.2307/2332342; Lonergan M, 2003, ECOL LETT, V6, P889, DOI 10.1046/j.1461-0248.2003.00510.x; OSTERHAUS ADME, 1988, NATURE, V335, P20, DOI 10.1038/335020a0; Pomeroy PP, 2005, MAR ECOL PROG SER, V287, P241, DOI 10.3354/meps287241; Thompson D, 2005, J APPL ECOL, V42, P638, DOI 10.1111/j.1365-2664.2005.01025.x; Thompson PM, 2002, VET REC, V151, P609, DOI 10.1136/vr.151.20.609; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009	25	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e887	10.1371/journal.pone.0000887	http://dx.doi.org/10.1371/journal.pone.0000887			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849016	Green Published, gold			2022-12-27	WOS:000207455600033
J	Marinescu, V; Loomis, PA; Ehmann, S; Beales, M; Potashkin, JA				Marinescu, Victor; Loomis, Patricia A.; Ehmann, Svetlana; Beales, Mitchell; Potashkin, Judith A.			Regulation of Retention of FosB Intron 4 by PTB	PLOS ONE			English	Article								One effect of stressors such as chronic drug administration is that sequence within the terminal exon of the transcription factor FosB is recognized as intronic and removed by alternative splicing. This results in an open-reading-frame shift that produces a translation stop codon and ultimately a truncated protein, termed Delta FosB. In vitro splicing assays with control and mutated transcripts generated from a fosB mini-gene construct indicated a CU-rich sequence at the 39 end of intron 4 (I4) plays an important role in regulating fosB pre-mRNA splicing due to its binding of polypyrimidine tract binding protein (PTB). PTB binding to this sequence is dependent upon phosphorylation by protein kinase A and is blocked if the CU-rich sequence is mutated to a U-rich region. When this mutated fosB minigene is expressed in HeLa cells, the splicing efficiency of its product is increased compared to wild type. Moreover, transient transfection of PTB-1 in HeLa cells decreased the splicing efficiency of a wild type fosB minigene transcript. Depletion of PTB from nuclear extracts facilitated U2AF(65) binding to wild type sequence in vitro, suggesting these proteins function in a dynamic equilibrium to modulate fosB pre-mRNA alternative splicing. These results demonstrate for the first time that phosphorylated PTB promotes intron retention and thereby silences the splicing of fosB I4.	[Marinescu, Victor; Loomis, Patricia A.; Ehmann, Svetlana; Beales, Mitchell; Potashkin, Judith A.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cellular & Mol Pharmacol, N Chicago, IL USA	Chicago Medical School; Rosalind Franklin University Medical & Science	Potashkin, JA (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cellular & Mol Pharmacol, N Chicago, IL USA.	judy.potashkin@rosalindfranklin.edu			National Institutes of Health [DA-13703, DA-15367]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA013703, R01DA015367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants DA-13703 and DA-15367 to JP.	Acquaviva C, 2001, ONCOGENE, V20, P7563, DOI 10.1038/sj.onc.1204880; Alibhai IN, 2007, BRAIN RES, V1143, P22, DOI 10.1016/j.brainres.2007.01.069; Ashiya M, 1997, RNA, V3, P996; BLACK DL, 1992, CELL, V69, P795, DOI 10.1016/0092-8674(92)90291-J; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; CHEN JS, 1995, MOL PHARMACOL, V48, P880; Chen JS, 1997, J NEUROSCI, V17, P4933; Chou MY, 2000, MOL CELL, V5, P949, DOI 10.1016/S1097-2765(00)80260-9; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Dredge BK, 2001, NAT REV NEUROSCI, V2, P43, DOI 10.1038/35049061; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Grabowski PJ, 2001, PROG NEUROBIOL, V65, P289, DOI 10.1016/S0301-0082(01)00007-7; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; HAMPSON RK, 1987, P NATL ACAD SCI USA, V84, P2673, DOI 10.1073/pnas.84.9.2673; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Hiroi N, 1998, J NEUROSCI, V18, P6952; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Kikuchi T, 2000, J BIOCHEM, V128, P811, DOI 10.1093/oxfordjournals.jbchem.a022819; Ladd AN, 2002, GENOME BIOL, V3; LIN CH, 1995, RNA, V1, P234; Lou H, 1999, MOL CELL BIOL, V19, P78; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; MATLIN AJ, 2007, RNA; Mayeda A, 1999, METH MOL B, V118, P315; Mayeda A, 1999, METH MOL B, V118, P309; Miyata S, 2001, MOL BRAIN RES, V90, P39, DOI 10.1016/S0169-328X(01)00072-9; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; MUMBERG D, 1991, GENE DEV, V5, P1212, DOI 10.1101/gad.5.7.1212; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 1999, BRAIN RES, V835, P10, DOI 10.1016/S0006-8993(98)01191-3; PARADIS C, 2007, RNA; Perez-Otano I, 1998, MOL BRAIN RES, V53, P41, DOI 10.1016/S0169-328X(97)00269-6; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Sharma S, 2005, MOL CELL, V19, P485, DOI 10.1016/j.molcel.2005.07.014; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Southby J, 1999, MOL CELL BIOL, V19, P2699; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; SUN Q, 1993, GENE DEV, V7, P2598, DOI 10.1101/gad.7.12b.2598; Ulery PG, 2007, EUR J NEUROSCI, V25, P224, DOI 10.1111/j.1460-9568.2006.05262.x; Ulery PG, 2006, J NEUROSCI, V26, P5131, DOI 10.1523/JNEUROSCI.4970-05.2006; Valcarcel J, 1997, CURR BIOL, V7, pR705, DOI 10.1016/S0960-9822(06)00361-7; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Zavolan M, 2006, CURR OPIN STRUC BIOL, V16, P362, DOI 10.1016/j.sbi.2006.05.002; Zhang L, 1999, RNA, V5, P117, DOI 10.1017/S1355838299981530; Zhang L, 1996, RNA, V2, P682	53	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e828	10.1371/journal.pone.0000828	http://dx.doi.org/10.1371/journal.pone.0000828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786200	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455500012
J	Sobo, K; Le Blanc, I; Luyet, PP; Fivaz, M; Ferguson, C; Parton, RG; Gruenberg, J; van der Goot, FG				Sobo, Komla; Le Blanc, Isabelle; Luyet, Pierre-Philippe; Fivaz, Marc; Ferguson, Charles; Parton, Robert G.; Gruenberg, Jean; van der Goot, F. Gisou			Late Endosomal Cholesterol Accumulation Leads to Impaired Intra-Endosomal Trafficking	PLOS ONE			English	Article								Background. Pathological accumulation of cholesterol in late endosomes is observed in lysosomal storage diseases such as Niemann-Pick type C. We here analyzed the effects of cholesterol accumulation in NPC cells, or as phenocopied by the drug U18666A, on late endosomes membrane organization and dynamics. Methodology/Principal Findings. Cholesterol accumulation did not lead to an increase in the raft to non-raft membrane ratio as anticipated. Strikingly, we observed a 23 fold increase in the size of the compartment. Most importantly, properties and dynamics of late endosomal intralumenal vesicles were altered as revealed by reduced late endosomal vacuolation induced by the mutant pore-forming toxin ASSP, reduced intoxication by the anthrax lethal toxin and inhibition of infection by the Vesicular Stomatitis Virus. Conclusions/Significance. These results suggest that back fusion of intralumenal vesicles with the limiting membrane of late endosomes is dramatically perturbed upon cholesterol accumulation.	[Sobo, Komla; Fivaz, Marc; van der Goot, F. Gisou] Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland; [Le Blanc, Isabelle; Luyet, Pierre-Philippe; Gruenberg, Jean] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Ferguson, Charles; Parton, Robert G.] Univ Queensland, Sch Biomed Sci, Ctr Microscopy & Microanal, Inst Mol Biosci, Brisbane, Qld, Australia; [van der Goot, F. Gisou] Ecole Polytech Fed Lausanne, Lausanne, Switzerland	University of Geneva; University of Geneva; University of Queensland; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	van der Goot, FG (corresponding author), Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland.	gisou.vandergoot@epfl.ch	Parton, Robert G/C-5673-2009; van der Goot, Gisou G/B-2279-2012	Parton, Robert G/0000-0002-7494-5248; van der Goot, Gisou G/0000-0002-8522-274X; Fivaz, Marc/0000-0003-1003-7934	Swiss National Science Foundation; National Health and Medical Research Council of Australia; Roche Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Roche Research Foundation	This work was supported by a grant from the Swiss National Science Foundation to JG and to GvdG and a grant from the National Health and Medical Research Council of Australia to RP. ILB was a recipient of a fellowship from the Roche Research Foundation. GvdG is an international Fellow of the Howard Hughes Medical Institute.	Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Abrami L, 1998, J BIOL CHEM, V273, P32656, DOI 10.1074/jbc.273.49.32656; Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Carozzi AJ, 2000, TRAFFIC, V1, P326, DOI 10.1034/j.1600-0854.2000.010406.x; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; Chen FW, 2005, BIOCHEM J, V390, P549, DOI 10.1042/BJ20050236; Cruz JC, 2000, J BIOL CHEM, V275, P4013, DOI 10.1074/jbc.275.6.4013; Desnick RJ, 2002, NAT REV GENET, V3, P954, DOI 10.1038/nrg963; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; GRUENBERG J, 1989, ANNU REV CELL BIOL, V5, P453; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; GRUENBERG J, 2006, NAT REV MOL CELL BIO; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; Hui C, 2006, CELL SIGNAL, V18, P1844, DOI 10.1016/j.cellsig.2006.04.006; Ikonen E, 2004, SEMIN CELL DEV BIOL, V15, P445, DOI 10.1016/j.semcdb.2004.03.001; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Kopitz J, 1996, AM J MED GENET, V63, P198; Lange Y, 1998, J BIOL CHEM, V273, P18915, DOI 10.1074/jbc.273.30.18915; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Leventhal AR, 2001, J BIOL CHEM, V276, P44976, DOI 10.1074/jbc.M106455200; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Miaczynska M, 2002, EXP CELL RES, V272, P8, DOI 10.1006/excr.2001.5401; PARTON RG, 1989, J CELL BIOL, V109, P3259, DOI 10.1083/jcb.109.6.3259; Puri V, 1999, NAT CELL BIOL, V1, P386, DOI 10.1038/14084; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000391; Sturley SL, 2004, BBA-MOL CELL BIOL L, V1685, P83, DOI 10.1016/j.bbalip.2004.08.014; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Zhang M, 2001, P NATL ACAD SCI USA, V98, P4466, DOI 10.1073/pnas.081070898	46	108	109	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e851	10.1371/journal.pone.0000851	http://dx.doi.org/10.1371/journal.pone.0000851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786222	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455500034
J	Zeller, SL; Brandl, H; Schmid, B				Zeller, Simon L.; Brandl, Helmut; Schmid, Bernhard			Host-Plant Selectivity of Rhizobacteria in a Crop/Weed Model System	PLOS ONE			English	Article							RHIZOSPHERE BACTERIA; CYANIDE PRODUCTION; SP NOV.; SOIL	Belowground microorganisms are known to influence plants' performance by altering the soil environment. Plant pathogens such as cyanide-producing strains of the rhizobacterium Pseudomonas may show strong host-plant selectivity. We analyzed interactions between different host plants and Pseudomonas strains and tested if these can be linked to the cyanide sensitivity of host plants, the cyanide production of bacterial strains or the plant identity from which strains had been isolated. Eight strains (four cyanide producing) were isolated from roots of four weed species and then re-inoculated on the four weed and two additional crop species. Bacterial strain composition varied strongly among the four weed species. Although all six plant species showed different reductions in root growth when cyanide was artificially applied to seedlings, they were generally not negatively affected by inoculation with cyanide-producing bacterial strains. We found a highly significant plant species x bacterial strain interaction. Partitioning this interaction into contrasts showed that it was entirely due to a strongly negative effect of a bacterial strain (Pseudomonas kilonensis/brassicacearum, isolated from Galium mollugo) on Echinochloa crus-galli. This exotic weed may not have become adapted to the bacterial strain isolated from a native weed. Our findings suggest that host-specific rhizobacteria hold some promise as biological weed-control agents.	[Zeller, Simon L.; Brandl, Helmut; Schmid, Bernhard] Univ Zurich, Inst Environm Sci, Zurich, Switzerland	University of Zurich	Zeller, SL (corresponding author), Univ Zurich, Inst Environm Sci, Zurich, Switzerland.	zellsim@uwinst.uzh.ch	Schmid, Bernhard/C-8625-2009; Zeller, Simon/A-7396-2010	Schmid, Bernhard/0000-0002-8430-3214; 				Achouak W, 2000, INT J SYST EVOL MICR, V50, P9, DOI 10.1099/00207713-50-1-9; ALSTROM S, 1989, BIOL FERT SOILS, V7, P232, DOI 10.1007/BF00709654; ASTROM B, 1988, PLANT SOIL, V109, P263, DOI 10.1007/BF02202093; BAKKER AW, 1987, SOIL BIOL BIOCHEM, V19, P451, DOI 10.1016/0038-0717(87)90037-X; BEGONIA MFT, 1994, FEMS MICROBIOL ECOL, V15, P227, DOI 10.1111/j.1574-6941.1994.tb00246.x; Brandl H, 2005, J APPL MICROBIOL, V99, P1099, DOI 10.1111/j.1365-2672.2005.02700.x; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; CASTRIC KF, 1983, APPL ENVIRON MICROB, V45, P701, DOI 10.1128/AEM.45.2.701-702.1983; Faramarzi MA, 2004, J BIOTECHNOL, V113, P321, DOI 10.1016/j.jbiotec.2004.03.031; Flores-Vargas RD, 2006, J APPL MICROBIOL, V100, P946, DOI 10.1111/j.1365-2672.2006.02851.x; FREDRICKSON JK, 1985, PLANT SOIL, V83, P399, DOI 10.1007/BF02184452; HETRICK BAD, 1988, SOIL BIOL BIOCH, V20; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; KENNEDY AC, 1991, SOIL SCI SOC AM J, V55, P722, DOI 10.2136/sssaj1991.03615995005500030014x; Kremer RJ, 2001, CURR MICROBIOL, V43, P182, DOI 10.1007/s002840010284; KREMER RJ, 1990, APPL ENVIRON MICROB, V56, P1649, DOI 10.1128/AEM.56.6.1649-1655.1990; Li SH, 2005, ENVIRON GEOL, V47, P1150, DOI 10.1007/s00254-005-1253-y; McCrady MH, 1915, J INFECT DIS, V17, P183, DOI 10.1093/infdis/17.1.183; Nehl DB, 1997, APPL SOIL ECOL, V5, P1, DOI 10.1016/S0929-1393(96)00124-2; SANDS DC, 1970, APPL MICROBIOL, V20, P513, DOI 10.1128/AEM.20.3.513-514.1970; SCHIPPERS B, 1987, ANNU REV PHYTOPATHOL, V25, P339, DOI 10.1146/annurev.py.25.090187.002011; SCHROTH MN, 1982, SCIENCE, V216, P1376, DOI 10.1126/science.216.4553.1376; Sikorski J, 2001, INT J SYST EVOL MICR, V51, P1549, DOI 10.1099/00207713-51-4-1549; Westover KM, 1997, J ECOL, V85, P863, DOI 10.2307/2960607; Wieland G, 2001, APPL ENVIRON MICROB, V67, P5849, DOI 10.1128/AEM.67.12.5849-5854.2001; WOLTZ SS, 1978, ANNU REV PHYTOPATHOL, V16, P403, DOI 10.1146/annurev.py.16.090178.002155	26	36	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e846	10.1371/journal.pone.0000846	http://dx.doi.org/10.1371/journal.pone.0000846			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786217	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455500029
J	Hotta, K; Ogura, T; Nishii, K; Kodani, T; Onishi, M; Shimizu, Y; Kanehiro, A; Kiura, K; Tanimoto, M; Tobe, K				Hotta, Katsuyuki; Ogura, Toshio; Nishii, Kenji; Kodani, Tsuyoshi; Onishi, Masaru; Shimizu, Yukito; Kanehiro, Arihiko; Kiura, Katsuyuki; Tanimoto, Mitsune; Tobe, Kazuo			Whole Blood Interferon-Gamma Assay for Baseline Tuberculosis Screening among Japanese Healthcare Students	PLOS ONE			English	Article								Background. The whole blood interferon-gamma assay (QuantiFERON-TB-2G; QFT) has not been fully evaluated as a baseline tuberculosis screening test in Japanese healthcare students commencing clinical contact. The aim of this study was to compare the results from the QFT with those from the tuberculin skin test (TST) in a population deemed to be at a low risk for infection with Mycobacterium tuberculosis. Methodology/Principal Findings. Healthcare students recruited at Okayama University received both the TST and the QFT to assess the level of agreement between these two tests. The interleukin-10 levels before and after exposure to M tuberculosis-specific antigens (early-secreted antigenic target 6-kDa protein [ESAT-6] and culture filtrate protein 10 [CFP-10]) were also measured. Of the 536 healthcare students, most of whom had been vaccinated with bacillus-Calmette-Guerin (BCG), 207 (56%) were enrolled in this study. The agreement between the QFT and the TST results was poor, with positive result rates of 1.4% vs. 27.5%, respectively. A multivariate analysis also revealed that the induration diameter of the TST was not affected by the interferon-gamma concentration after exposure to either of the antigens but was influenced by the number of BCG needle scars (p = 0.046). The whole blood interleukin-10 assay revealed that after antigen exposure, the median increases in interleukin-10 concentration was higher in the subgroup with the small increase in interferon-gamma concentration than in the subgroup with the large increase in interferon-gamma concentration (0.3 vs. 0 pg/mL; p = 0.004). Conclusions/Significance. As a baseline screening test for low-risk Japanese healthcare students at their course entry, QFT yielded quite discordant results, compared with the TST, probably because of the low specificity of the TST results in the BCG-vaccinated population. We also found, for the first time, that the change in the interleukin-10 level after exposure to specific antigens was inversely associated with that in the interferon-gamma level in a low-risk population.	[Hotta, Katsuyuki; Ogura, Toshio; Onishi, Masaru; Shimizu, Yukito; Tobe, Kazuo] Okayama Univ, Hlth & Environm Ctr, Okayama, Japan; [Nishii, Kenji; Kodani, Tsuyoshi] Okayama Inst Hlth & Prevent, Dept Resp Med, Okayama, Japan; [Kanehiro, Arihiko; Kiura, Katsuyuki; Tanimoto, Mitsune] Okayama Univ Hosp, Dept Resp Med, Okayama, Japan	Okayama University; Okayama University	Hotta, K (corresponding author), Okayama Univ, Hlth & Environm Ctr, Okayama, Japan.	khotta@md.okayama-u.ac.jp	KANEHIRO, Arihiko/B-1926-2011; KIURA, Katsuyuki/B-1991-2011	Kiura, Katsuyuki/0000-0002-9172-9379	Ministry of Education, Culture, Sports, Science and Technology of Japan [18790397]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by a Grant-in-Aid for Young Scientists ( B) ( No. 18790397) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aliberti J, 2005, PROSTAG LEUKOTR ESS, V73, P283, DOI 10.1016/j.plefa.2005.05.018; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Graham M, 2006, MED J AUSTRALIA, V185, P324, DOI 10.5694/j.1326-5377.2006.tb00587.x; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358; Johnson PDR, 1999, CLIN DIAGN LAB IMMUN, V6, P934, DOI 10.1128/CDLI.6.6.934-937.1999; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Minion FC, 2003, INFECT IMMUN, V71, P2239, DOI 10.1128/IAI.71.4.2239-2243.2003; Mori T, 2000, EMERG INFECT DIS, V6, P566, DOI 10.3201/eid0606.000602; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Trajkovic V, 2002, INFECT IMMUN, V70, P6558, DOI 10.1128/IAI.70.12.6558-6566.2002; *WHO, WHO GLOB TB CONTR 20; YAMAUCHI Y, 1994, KEKKAKU, V74, P819	20	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e803	10.1371/journal.pone.0000803	http://dx.doi.org/10.1371/journal.pone.0000803			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726533	Green Submitted, gold, Green Published			2022-12-27	WOS:000207455400020
J	Joshi, R; Patil, S; Kalantri, S; Schwartzman, K; Menzies, D; Pai, M				Joshi, Rajnish; Patil, Samir; Kalantri, Shriprakash; Schwartzman, Kevin; Menzies, Dick; Pai, Madhukar			Prevalence of Abnormal Radiological Findings in Health Care Workers with Latent Tuberculosis Infection and Correlations with T Cell Immune Response	PLOS ONE			English	Article							INTERFERON-GAMMA ASSAY; PULMONARY TUBERCULOSIS; SCREENING-PROGRAMS; IMMIGRANTS; DIAGNOSIS; MANIFESTATIONS; CHILDHOOD; REFUGEES; DISEASE; INDIA	Background. More than half of all health care workers (HCWs) in high TB-incidence, low and middle income countries are latently infected with tuberculosis (TB). We determined radiological lesions in a cohort of HCWs with latent TB infection (LTBI) in India, and determined their association with demographic, occupational and T-cell immune response variables. Methodology. We obtained chest radiographs of HCWs who had undergone tuberculin skin test (TST) and QuantiFERON-TB Gold In Tube (QFT), an interferon-gamma release assay, in a previous cross-sectional study, and were diagnosed to have LTBI because they were positive by either TST or QFT, but had no evidence of clinical disease. Two observers independently interpreted these radiographs using a standardized data form and any discordance between them resolved by a third observer. The radiological diagnostic categories (normal, suggestive of inactive TB, and suggestive of active TB) were compared with results of TST, QFT assay, demographic, and occupational covariates. Results. A total of 330 HCWs with positive TST or QFT underwent standard chest radiography. Of these 330, 113 radiographs (34.2%) were finally classified as normal, 206 (62.4%) had lesions suggestive of inactive TB, and 11 (3.4%) had features suggestive of active TB. The mean TST indurations and interferon-gamma levels in the HCWs in these three categories were not significantly different. None of the demographic or occupational covariates was associated with prevalence of inactive TB lesions on chest radiography. Conclusion/Significance. In a high TB incidence setting, nearly two-thirds of HCWs with latent TB infection had abnormal radiographic findings, and these findings had no clear correlation with T cell immune responses. Further studies are needed to verify these findings and to identify the causes and prognosis of radiologic abnormalities in health care workers.	[Schwartzman, Kevin; Menzies, Dick; Pai, Madhukar] McGill Univ, Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Schwartzman, Kevin; Menzies, Dick; Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Patil, Samir] Parmanand D Hinduja Hosp, Bombay, Maharashtra, India; [Patil, Samir] Med Res Ctr, Bombay, Maharashtra, India; [Joshi, Rajnish; Kalantri, Shriprakash] Mahatma Gandhi Inst Med Sci, Dept Med, Sevagram, Maharashtra, India; [Joshi, Rajnish] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA	McGill University; McGill University; Mahatma Gandhi Institute of Medical Sciences, Sevagram; University of California System; University of California Berkeley	Pai, M (corresponding author), McGill Univ, Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada.	madhukar.pai@mcgill.ca	Kalantri, Shriprakash/ABG-9318-2021; PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021	Kalantri, Shriprakash/0000-0002-1633-1029; PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; Patil, Samir/0000-0003-3898-3594; Joshi, Rajnish/0000-0002-4702-0522	Canadian Institutes of Health Research (CIHR) [MOP-81362]; Fogarty AIDS International Training Program [AITRP] [1-D43-TW00003-17]; Fonds de la Recherche en Sante du Quebec (FRSQ); CIHR New Investigator Career Award; FOGARTY INTERNATIONAL CENTER [D43TW000003] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fogarty AIDS International Training Program [AITRP](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); CIHR New Investigator Career Award(Canadian Institutes of Health Research (CIHR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported in part by a grant from the Canadian Institutes of Health Research (CIHR), grant MOP-81362. RJ is a recipient of a training fellowship from the Fogarty AIDS International Training Program [AITRP] (grant 1-D43-TW00003-17), USA. KS is the recipient of a Chercheur-Boursier Clinicien career award from the Fonds de la Recherche en Sante du Quebec (FRSQ). DM is the recipient of a Chercheur National career award from the FRSQ. MP is a recipient of a CIHR New Investigator Career Award. The CIHR, Fogarty AITRP and FRSQ had no role in the design, conduct or review of this manuscript.	Al Zahrani K, 2000, AM J RESP CRIT CARE, V162, P1419, DOI 10.1164/ajrccm.162.4.9912048; Andreu J, 2004, EUR J RADIOL, V51, P139, DOI 10.1016/j.ejrad.2004.03.009; Balabanova Y, 2005, BMJ-BRIT MED J, V331, P379, DOI 10.1136/bmj.331.7513.379; BLUM RN, 1993, CHEST, V103, P1670, DOI 10.1378/chest.103.6.1670; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; DALEY CL, 2003, RADIOGRAPHIC MANIFES; DANNENBERG AM, 1982, AM REV RESPIR DIS, V125, P25; Den Boon S, 2005, INT J TUBERC LUNG D, V9, P1088; DeRiemer K, 1998, ARCH INTERN MED, V158, P753, DOI 10.1001/archinte.158.7.753; Geng E, 2005, JAMA-J AM MED ASSOC, V293, P2740, DOI 10.1001/jama.293.22.2740; GOTHI G. D., 1982, Indian Journal of Tuberculosis, V29, P134; Graham S, 2002, INT J TUBERC LUNG D, V6, P137; HAQUE AK, 1990, J THORAC IMAG, V5, P8, DOI 10.1097/00005382-199004000-00004; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; HORWITZ O, 1976, PUBLIC HEALTH REP, V91, P146; *ILO, 2002, OCC SAF HLTH SER, V22; Jenssen HK, 2005, INDIANA U MATH J, V54, P1, DOI 10.1512/iumj.2005.54.2685; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; LoBue PA, 2004, CHEST, V126, P1777, DOI 10.1378/chest.126.6.1777; Magkanas E, 2005, INT J TUBERC LUNG D, V9, P865; Maloney SA, 2006, ARCH INTERN MED, V166, P234, DOI 10.1001/archinte.166.2.234; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; MCADAMS HP, 1995, RADIOL CLIN N AM, V33, P655; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-7; Pai M, 2006, EMERG INFECT DIS, V12, P1311, DOI 10.3201/eid1209.051663; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Pang SC, 2000, INT J TUBERC LUNG D, V4, P232; REICHMAN LB, 1974, HEALTH SERV REP, V89, P177, DOI 10.2307/4595006; REIDER HI, 1999, EPIDEMIOLOGICAL BASI; Richards B, 2005, INT J TUBERC LUNG D, V9, P858; SACKETT DL, 1992, JAMA-J AM MED ASSOC, V267, P2638, DOI 10.1001/jama.267.19.2638; Schwartzman K, 2000, AM J RESP CRIT CARE, V161, P780, DOI 10.1164/ajrccm.161.3.9902005; Seah GT, 2000, J INFECT DIS, V181, P385, DOI 10.1086/315200; Sodhi A, 1997, CLIN INFECT DIS, V25, P617, DOI 10.1086/513769; STEINBRUCK P, 1972, B INT UNION TUBERC, V47; Wilcke JTR, 1998, INT J TUBERC LUNG D, V2, P219; Zellweger JP, 2006, INT J TUBERC LUNG D, V10, P1123	45	31	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e805	10.1371/journal.pone.0000805	http://dx.doi.org/10.1371/journal.pone.0000805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726535	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455400022
J	Meulemans, D; Bronner-Fraser, M				Meulemans, Daniel; Bronner-Fraser, Marianne			Insights from Amphioxus into the Evolution of Vertebrate Cartilage	PLOS ONE			English	Article								Central to the story of vertebrate evolution is the origin of the vertebrate head, a problem difficult to approach using paleontology and comparative morphology due to a lack of unambiguous intermediate forms. Embryologically, much of the vertebrate head is derived from two ectodermal tissues, the neural crest and cranial placodes. Recent work in protochordates suggests the first chordates possessed migratory neural tube cells with some features of neural crest cells. However, it is unclear how and when these cells acquired the ability to form cellular cartilage, a cell type unique to vertebrates. It has been variously proposed that the neural crest acquired chondrogenic ability by recruiting proto-chondrogenic gene programs deployed in the neural tube, pharynx, and notochord. To test these hypotheses we examined the expression of 11 amphioxus orthologs of genes involved in neural crest chondrogenesis. Consistent with cellular cartilage as a vertebrate novelty, we find that no single amphioxus tissue co-expresses all or most of these genes. However, most are variously co-expressed in mesodermal derivatives. Our results suggest that neural crest-derived cartilage evolved by serial cooption of genes which functioned primitively in mesoderm.	[Meulemans, Daniel; Bronner-Fraser, Marianne] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Meulemans, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	dm@caltech.edu		MEDEIROS, DANIEL/0000-0002-8182-6028; Bronner, Marianne/0000-0003-4274-1862	NIH [DE017911]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017911] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding for this work was provided by NIH grant DE017911 to MBF.	Amore G, 2006, DEV BIOL, V293, P555, DOI 10.1016/j.ydbio.2006.02.024; AZARIAH J, 1973, ACTA HISTOCHEM, V46, P10; Baker CVH, 1997, MECH DEVELOP, V69, P13, DOI 10.1016/S0925-4773(97)00129-9; Barlow AJ, 1999, DEV DYNAM, V214, P291, DOI 10.1002/(SICI)1097-0177(199904)214:4<291::AID-AJA2>3.0.CO;2-E; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Beverdam A, 2001, DEVELOPMENT, V128, P3975; Bruneau S, 1997, MECH DEVELOP, V65, P163, DOI 10.1016/S0925-4773(97)00072-5; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; COULY GF, 1993, DEVELOPMENT, V117, P409; Ettensohn CA, 2003, DEVELOPMENT, V130, P2917, DOI 10.1242/dev.00511; Flores MV, 2006, DEV DYNAM, V235, P3166, DOI 10.1002/dvdy.20957; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; HOPWOOD ND, 1989, CELL, V59, P893, DOI 10.1016/0092-8674(89)90612-0; Jeffery WR, 2004, NATURE, V431, P696, DOI 10.1038/nature02975; Jones FS, 1997, P NATL ACAD SCI USA, V94, P2632, DOI 10.1073/pnas.94.6.2632; Kang JS, 2004, MECH DEVELOP, V121, P301, DOI 10.1016/j.mod.2004.01.007; Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lettice LA, 1999, P NATL ACAD SCI USA, V96, P9695, DOI 10.1073/pnas.96.17.9695; Mallatt J, 2003, J MORPHOL, V258, P1, DOI 10.1002/jmor.10081; Martinez-Morales JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r36; McCauley DW, 2006, NATURE, V441, P750, DOI 10.1038/nature04691; Meech R, 2005, DEVELOPMENT, V132, P2135, DOI 10.1242/dev.01811; Meulemans D, 2005, J EXP ZOOL PART B, V304B, P298, DOI 10.1002/jez.b.21047; Meulemans D, 2003, DEV BIOL, V264, P430, DOI 10.1016/j.ydbio.2003.09.006; Meulemans D, 2002, DEVELOPMENT, V129, P4953; Miller CT, 2000, DEVELOPMENT, V127, P3815; Miller CT, 2003, DEVELOPMENT, V130, P1353, DOI 10.1242/dev.00339; NORTHCUTT RG, 1983, Q REV BIOL, V58, P1, DOI 10.1086/413055; Perez-Alcala S, 2004, DEVELOPMENT, V131, P4455, DOI 10.1242/dev.01329; RAHR H, 1982, ZOOMORPHOLOGY, V99, P167, DOI 10.1007/BF00310308; Rodrigo I, 2003, DEVELOPMENT, V130, P473, DOI 10.1242/dev.00240; RYCHEL AL, 2005, MOL BIOL EVOL; Rychel AL, 2007, J EXP ZOOL PART B, V308B, P325, DOI 10.1002/jez.b.21157; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; Smits P, 2003, DEVELOPMENT, V130, P1135, DOI 10.1242/dev.00331; Soo K, 2002, DEV BIOL, V247, P251, DOI 10.1006/dbio.2002.0699; Spokony RF, 2002, DEVELOPMENT, V129, P421; STOKES MD, 1995, ACTA ZOOL-STOCKHOLM, V76, P105, DOI 10.1111/j.1463-6395.1995.tb00986.x; Stone JR, 2004, EVOL DEV, V6, P123, DOI 10.1111/j.1525-142X.2004.04014.x; Tahtakran SA, 2003, GENE EXPR PATTERNS, V3, P455, DOI 10.1016/S1567-133X(03)00065-6; ten Berge D, 1998, DEV BIOL, V199, P11, DOI 10.1006/dbio.1998.8921; Tribioli C, 1999, DEVELOPMENT, V126, P5699; Wada H, 2006, EVOL DEV, V8, P370, DOI 10.1111/j.1525-142X.2006.00109.x; Walshe J, 2003, DEV BIOL, V264, P522, DOI 10.1016/j.ydbio.2003.08.010; Wenke AK, 2006, BIOCHEM BIOPH RES CO, V345, P495, DOI 10.1016/j.bbrc.2006.04.123; Wilson J, 2004, DEV BIOL, V266, P138, DOI 10.1016/j.ydbio.2003.10.012; YAN YL, 1995, DEV DYNAM, V203, P363, DOI 10.1002/aja.1002030308; Yan YL, 2002, DEVELOPMENT, V129, P5065; Yasui K, 1998, DEV BIOL, V195, P49, DOI 10.1006/dbio.1997.8834; Yoshida CA, 2005, CRIT REV EUKAR GENE, V15, P243, DOI 10.1615/CritRevEukarGeneExpr.v15.i3.60; Yu JK, 2002, DEV DYNAM, V225, P289, DOI 10.1002/dvdy.10173; Zhang GJ, 2006, P NATL ACAD SCI USA, V103, P3180, DOI 10.1073/pnas.0508313103; Zhang GJ, 2006, P NATL ACAD SCI USA, V103, P16829, DOI 10.1073/pnas.0605630103; Zhao Q, 1996, NAT GENET, V13, P275, DOI 10.1038/ng0796-275	55	97	101	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e787	10.1371/journal.pone.0000787	http://dx.doi.org/10.1371/journal.pone.0000787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726517	Green Published, gold, Green Accepted			2022-12-27	WOS:000207455400004
J	Regales, L; Balak, MN; Gong, YX; Politi, K; Sawai, A; Le, C; Koutcher, JA; Solit, DB; Rosen, N; Zakowski, MF; Pao, W				Regales, Lucia; Balak, Marissa N.; Gong, Yixuan; Politi, Katerina; Sawai, Ayana; Le, Carl; Koutcher, Jason A.; Solit, David B.; Rosen, Neal; Zakowski, Maureen F.; Pao, William			Development of New Mouse Lung Tumor Models Expressing EGFR T790M Mutants Associated with Clinical Resistance to Kinase Inhibitors	PLOS ONE			English	Article								Background. The EGFR T790M mutation confers acquired resistance to kinase inhibitors in human EGFR mutant lung adenocarcinoma, is occasionally detected before treatment, and may confer genetic susceptibility to lung cancer. Methodology/Principal Findings. To study further its role in lung tumorigenesis, we developed mice with inducible expression in type II pneumocytes of EGFR(T790M) alone or together with a drug-sensitive L858R mutation. Both transgenic lines develop lung adenocarcinomas that require mutant EGFR for tumor maintenance but are resistant to an EGFR kinase inhibitor. EGFR(L858R+T790M)-driven tumors are transiently targeted by hsp90 inhibition. Notably, EGFR(T790M)-expressing animals develop tumors with longer latency than EGFR(L858R+T790M)-bearing mice and in the absence of additional kinase domain mutations. Conclusions/Significance. These new mouse models of mutant EGFR-dependent lung adenocarcinomas provide insight into clinical observations. The models should also be useful for developing improved therapies for patients with lung cancers harboring EGFR(T790M) alone or in conjunction with drug-sensitive EGFR kinase domain mutations.	[Regales, Lucia; Balak, Marissa N.; Gong, Yixuan; Pao, William] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, Pao Lab, New York, NY 10021 USA; [Politi, Katerina] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, Varmus Lab, New York, NY 10021 USA; [Sawai, Ayana; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, Rosen Lab, New York, NY 10021 USA; [Le, Carl; Koutcher, Jason A.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, Imaging & Spectroscop Phys Serv, New York, NY 10021 USA; [Solit, David B.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, Solit Lab, New York, NY 10021 USA; [Zakowski, Maureen F.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Pao, William] Cornell Univ, Weill Med Coll, Dept Med 7, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Pao, W (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, Pao Lab, 1275 York Ave, New York, NY 10021 USA.	paow@mskcc.org	Le, Hongbiao/H-4735-2011; Rosen, Neal/ABF-2677-2020; Solit, David B./AAC-5309-2019		American Cancer Society-Davidson Sinai Research Foundation [PF-05-078-01-MGO]; Labrecque Foundation; NIH [R24CA83084, P30 CA08748]; Byrne Fund; The Joan Scarangello Foundation [K08-CA097980, R01-CA121210, R01-CA120247]; MSKCC TIMRF fund; Carmel Hill Fund; NATIONAL CANCER INSTITUTE [P30CA008748, R24CA083084] Funding Source: NIH RePORTER	American Cancer Society-Davidson Sinai Research Foundation; Labrecque Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Byrne Fund; The Joan Scarangello Foundation; MSKCC TIMRF fund; Carmel Hill Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the American Cancer Society-Davidson Sinai Research Foundation (PF-05-078-01-MGO) (KP), the Labrecque Foundation (KP); NIH grants R24CA83084 and P30 CA08748 (JAK); The Byrne Fund (DBS); Joan's Legacy: The Joan Scarangello Foundation to Conquer Lung Cancer (WP), K08-CA097980 (WP), R01-CA121210 (WP), R01-CA120247 (KP, awarded to HV); the MSKCC TIMRF fund (WP), and The Carmel Hill Fund (KP, awarded to HV; WP). KP and WP are part of a pending application on EGFR T790M mutations. WP is the incumbent of the Miner Family Chair for Intrathoracic Cancers.	Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Bell DW, 2005, NAT GENET, V37, P1315, DOI 10.1038/ng1671; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Inukai M, 2006, CANCER RES, V66, P7854, DOI 10.1158/0008-5472.CAN-06-1951; JI H, 2006, CANC CELL; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Mulloy R, 2007, CANCER RES, V67, P2325, DOI 10.1158/0008-5472.CAN-06-4293; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Roche-Lestienne C, 2003, NEW ENGL J MED, V348, P2265, DOI 10.1056/NEJMc035089; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Skaggs BJ, 2006, P NATL ACAD SCI USA, V103, P19466, DOI 10.1073/pnas.0609239103; Solit DB, 2006, CURR TOP MED CHEM, V6, P1205, DOI 10.2174/156802606777812068; Solit DB, 2003, CANCER RES, V63, P2139; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Tichelaar JW, 2000, J BIOL CHEM, V275, P11858, DOI 10.1074/jbc.275.16.11858; Vikis H, 2007, CANCER RES, V67, P4665, DOI 10.1158/0008-5472.CAN-07-0217; Yang SC, 2006, CANCER RES, V66, P6990, DOI 10.1158/0008-5472.CAN-06-1042	24	96	101	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e810	10.1371/journal.pone.0000810	http://dx.doi.org/10.1371/journal.pone.0000810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726540	Green Published, gold			2022-12-27	WOS:000207455400027
J	Kamradt, J; Jung, V; Wahrheit, K; Tolosi, L; Rahnenfuehrer, J; Schilling, M; Walker, R; Davis, S; Stoeckle, M; Meltzer, P; Wullich, B				Kamradt, Joern; Jung, Volker; Wahrheit, Kerstin; Tolosi, Laura; Rahnenfuehrer, Joerg; Schilling, Martin; Walker, Robert; Davis, Sean; Stoeckle, Michael; Meltzer, Paul; Wullich, Bernd			Detection of Novel Amplicons in Prostate Cancer by Comprehensive Genomic Profiling of Prostate Cancer Cell Lines Using Oligonucleotide-Based ArrayCGH	PLOS ONE			English	Article								Background. The purpose of this study was to prove the feasibility of a longmer oligonucleotide microarray platform to profile gene copy number alterations in prostate cancer cell lines and to quickly indicate novel candidate genes, which may play a role in carcinogenesis. Methods/Results and Findings. Genome-wide screening for regions of genetic gains and losses on nine prostate cancer cell lines (PC3, DU145, LNCaP, CWR22, and derived sublines) was carried out using comparative genomic hybridization on a 35,000 feature oligonucleotide microarray (arrayCGH). Compared to conventional chromosomal CGH, more deletions and small regions of gains, particularly in pericentromeric regions and regions next to the telomeres, were detected. As validation of the high-resolution of arrayCGH we further analyzed a small amplicon of 1.7 MB at 9p13.3, which was found in CWR22 and CWR22-Rv1. Increased copy number was confirmed by fluorescence in situ hybridization using the BAC clone RP11-165H19 from the amplified region comprising the two genes interleukin 11 receptor alpha (IL11-RA) and dynactin 3 (DCTN3). Using quantitative real time PCR (qPCR) we could demonstrate that IL11-RA is the gene with the highest copy number gain in the cell lines compared to DCTN3 suggesting IL11-RA to be the amplification target. Screening of 20 primary prostate carcinomas by qPCR revealed an IL11-RA copy number gain in 75% of the tumors analyzed. Gain of DCTN3 was only found in two cases together with a gain of IL11-RA. Conclusions/Significance. ArrayCGH using longmer oligonucleotide microarrays is feasible for high-resolution analysis of chomosomal imbalances. Characterization of a small gained region at 9p13.3 in prostate cancer cell lines and primary prostate cancer samples by fluorescence in situ hybridization and quantitative PCR has revealed interleukin 11 receptor alpha gene as a candidate target of amplification with an amplification frequency of 75% in prostate carcinomas. Frequent amplification of IL11-RA in prostate cancer is a potential mechanism of IL11-RA overexpression in this tumor type.	[Kamradt, Joern; Jung, Volker; Wahrheit, Kerstin; Stoeckle, Michael; Wullich, Bernd] Univ Saarland, Dept Urol & Pediat Urol, D-6650 Homburg, Germany; [Tolosi, Laura] Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, Saarbrucken, Germany; [Rahnenfuehrer, Joerg] Univ Dortmund, Stat Methoden Genet & Chemometrie Fachbereich Sta, Dortmund, Germany; [Schilling, Martin] Univ Saarland, Dept Gen Visceral Vasc & Pediat Surg, D-6650 Homburg, Germany; [Walker, Robert; Davis, Sean; Meltzer, Paul] NCI, Genet Lab, NIH, Bethesda, MD 20892 USA	Saarland University; Max Planck Society; Dortmund University of Technology; Saarland University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kamradt, J (corresponding author), Univ Saarland, Dept Urol & Pediat Urol, D-6650 Homburg, Germany.	joern.kamradt@uks.eu	Davis, Sean/AAD-1801-2021	Davis, Sean/0000-0002-8991-6458; Walker, Robert/0000-0001-8235-4686; Rahnenfuhrer, Jorg/0000-0002-8947-440X	Deutsche Forschungsgemeinschaft [KA1793/1-1]; Bundesministerium fur Bildung und Forschung [01GR0453]; BioSapiens Network of Excellence; EU [LSHG-CT-2003-503265]; NATIONAL CANCER INSTITUTE [ZIABC010759, Z01BC010759] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); BioSapiens Network of Excellence; EU(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Deutsche Forschungsgemeinschaft, grant number KA1793/1-1, Bundesministerium fur Bildung und Forschung, grant number 01GR0453, BioSapiens Network of Excellence, EU contract number LSHG-CT-2003-503265	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; Bex A, 2001, CANCER GENET CYTOGEN, V124, P98, DOI 10.1016/S0165-4608(00)00332-0; Brennan C, 2004, CANCER RES, V64, P4744, DOI 10.1158/0008-5472.CAN-04-1241; Campbell CL, 2001, AM J PATHOL, V158, P25, DOI 10.1016/S0002-9440(10)63940-5; Chen Y, 1997, J Biomed Opt, V2, P364, DOI 10.1117/12.281504; Clark J, 2003, ONCOGENE, V22, P1247, DOI 10.1038/sj.onc.1206247; Edwards J, 2005, BJU INT, V95, P1320, DOI 10.1111/j.1464-410X.2005.05526.x; Gao LF, 2005, CLIN CANCER RES, V11, P6333, DOI 10.1158/1078-0432.CCR-05-0148; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hermans KG, 2004, GENE CHROMOSOME CANC, V39, P171, DOI 10.1002/gcc.10311; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Jung V, 1999, J NEUROPATH EXP NEUR, V58, P993, DOI 10.1097/00005072-199909000-00009; Jung V, 2006, MOL CANCER RES, V4, P169, DOI 10.1158/1541-7786.MCR-05-0165; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Kindich R, 2005, CLIN CHEM, V51, P649, DOI 10.1373/clinchem.2004.045013; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; Lensch R, 2002, INT J ONCOL, V21, P695; Paris PL, 2003, AM J PATHOL, V162, P763, DOI 10.1016/S0002-9440(10)63873-4; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Rahnenfuhrer J, 2005, BIOINFORMATICS, V21, P2438, DOI 10.1093/bioinformatics/bti312; Rembrink K, 1997, PROSTATE, V31, P168; Saramaki OR, 2006, INT J CANCER, V119, P1322, DOI 10.1002/ijc.21976; Sattler HP, 1999, PROSTATE, V39, P79; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Strohmeyer DM, 2004, PROSTATE, V59, P43, DOI 10.1002/pros.20028; van Dekken H, 2004, GENE CHROMOSOME CANC, V39, P249, DOI 10.1002/gcc.20001; Yano S, 2004, CANCER GENET CYTOGEN, V150, P122, DOI 10.1016/j.cancergencyto.2003.09.004; Zhao HJ, 2005, PROSTATE, V63, P187, DOI 10.1002/pros.20158; Zurita AJ, 2004, CANCER RES, V64, P435, DOI 10.1158/0008-5472.CAN-03-2675	33	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e769	10.1371/journal.pone.0000769	http://dx.doi.org/10.1371/journal.pone.0000769			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712417	gold, Green Submitted, Green Published			2022-12-27	WOS:000207455300017
J	Bala, ADS; Spitzer, MW; Takahashi, TT				Bala, Avinash D. S.; Spitzer, Matthew W.; Takahashi, Terry T.			Auditory Spatial Acuity Approximates the Resolving Power of Space-Specific Neurons	PLOS ONE			English	Article							INTERAURAL LEVEL DIFFERENCE; SOUND-LOCALIZATION EXPERIMENTS; BARN OWL; RECEPTIVE-FIELDS; INFERIOR COLLICULUS; TIME DIFFERENCE; BRAIN-STEM; SINGLE NEURONS; VIRTUAL SPACE; NEURAL MAP	The relationship between neuronal acuity and behavioral performance was assessed in the barn owl (Tyto alba), a nocturnal raptor renowned for its ability to localize sounds and for the topographic representation of auditory space found in the midbrain. We measured discrimination of sound-source separation using a newly developed procedure involving the habituation and recovery of the pupillary dilation response. The smallest discriminable change of source location was found to be about two times finer in azimuth than in elevation. Recordings from neurons in its midbrain space map revealed that their spatial tuning, like the spatial discrimination behavior, was also better in azimuth than in elevation by a factor of about two. Because the PDR behavioral assay is mediated by the same circuitry whether discrimination is assessed in azimuth or in elevation, this difference in vertical and horizontal acuity is likely to reflect a true difference in sensory resolution, without additional confounding effects of differences in motor performance in the two dimensions. Our results, therefore, are consistent with the hypothesis that the acuity of the midbrain space map determines auditory spatial discrimination.	[Bala, Avinash D. S.; Spitzer, Matthew W.; Takahashi, Terry T.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Spitzer, Matthew W.] Monash Univ, Sch Psychol Psychiat & Psychol Med, Clayton, Vic 3800, Australia	University of Oregon; Monash University	Bala, ADS (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	avinash@uoneuro.uoregon.edu	Bala, Avinash/B-7923-2013	Bala, Avinash/0000-0002-8531-5110	National Institute of Deafness and Communication Disorders [DC03925]; Medical Research Foundation of Oregon; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003925] Funding Source: NIH RePORTER	National Institute of Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Medical Research Foundation of Oregon; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the National Institute of Deafness and Communication Disorders (DC03925) and the Medical Research Foundation of Oregon.	Bala ADS, 2003, NATURE, V424, P771, DOI 10.1038/nature01835; Bala ADS, 2000, J COMP PHYSIOL A, V186, P425, DOI 10.1007/s003590050442; BALDI P, 1988, BIOL CYBERN, V59, P313, DOI 10.1007/BF00332921; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Britten KH, 1999, J NEUROSCI, V19, P5074; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Carr CE, 1999, NEURAL COMPUT, V11, P1, DOI 10.1162/089976699300016773; COHEN YE, 1995, J NEUROSCI, V15, P5152; DULAC S, 1990, J NEUROPHYSIOL, V63, P131, DOI 10.1152/jn.1990.63.1.131; Eurich CW, 1997, BIOL CYBERN, V76, P357, DOI 10.1007/s004220050349; Euston DR, 2002, J NEUROSCI, V22, P284, DOI 10.1523/JNEUROSCI.22-01-00284.2002; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; FAREL PB, 1976, J NEUROPHYSIOL, V39, P661, DOI 10.1152/jn.1976.39.4.661; Green DM, 1966, SIGNAL DETECTION THE; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; Keller CH, 1998, HEARING RES, V118, P13, DOI 10.1016/S0378-5955(98)00014-8; KNUDSEN EI, 1978, SCIENCE, V200, P795, DOI 10.1126/science.644324; KNUDSEN EI, 1977, SCIENCE, V198, P1278, DOI 10.1126/science.929202; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; KNUDSEN EI, 1993, J NEUROSCI, V13, P2837; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P1, DOI 10.1007/BF00663105; KONISHI M, 1973, AM NAT, V107, P775, DOI 10.1086/282875; MANLEY GA, 1988, J NEUROSCI, V8, P2665; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; MOISEFF A, 1983, J NEUROSCI, V3, P2553; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; Pena JL, 2004, J NEUROSCI, V24, P8907, DOI 10.1523/JNEUROSCI.2924-04.2004; Pena JL, 2001, SCIENCE, V292, P249, DOI 10.1126/science.1059201; Poganiatz I, 2001, J COMP PHYSIOL A, V187, P225, DOI 10.1007/s003590100193; Poganiatz I, 2001, JARO, V2, P1; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2723, DOI 10.1152/jn.2000.83.5.2723; ROLLS ET, 1989, EUR J NEUROSCI, V1, P53, DOI 10.1111/j.1460-9568.1989.tb00774.x; SAKITT B, 1973, NATURE, V241, P133, DOI 10.1038/241133a0; Shackleton TM, 2003, J NEUROSCI, V23, P716, DOI 10.1523/JNEUROSCI.23-02-00716.2003; Skottun BC, 2001, P NATL ACAD SCI USA, V98, P14050, DOI 10.1073/pnas.241513998; Sokolov EN, 1958, ORIENTING REFLEX EXP, P141; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; Spezio ML, 2003, J NEUROSCI, V23, P4677; Spitzer MW, 2004, J NEUROPHYSIOL, V92, P2051, DOI 10.1152/jn.01235.2003; SULLIVAN WE, 1984, J NEUROSCI, V4, P1787; TAKAHASHI T, 1984, J NEUROSCI, V4, P1781; TAKAHASHI TT, 1992, J COMP PHYSIOL A, V170, P161; TAKAHASHI TT, 1988, J COMP NEUROL, V274, P190, DOI 10.1002/cne.902740206; WAGNER H, 1993, J NEUROSCI, V13, P371; WATHEY JC, 1989, BRAIN BEHAV EVOLUT, V33, P279, DOI 10.1159/000115936	47	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e675	10.1371/journal.pone.0000675	http://dx.doi.org/10.1371/journal.pone.0000675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668055	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452300013
J	Jean, L; Thomas, B; Tahiri-Alaoui, A; Shaw, M; Vaux, DJ				Jean, Letitia; Thomas, Benjamin; Tahiri-Alaoui, Abdessamad; Shaw, Michael; Vaux, David J.			Heterologous Amyloid Seeding: Revisiting the Role of Acetylcholinesterase in Alzheimer's Disease	PLOS ONE			English	Article								Neurodegenerative diseases associated with abnormal protein folding and ordered aggregation require an initial trigger which may be infectious, inherited, post-inflammatory or idiopathic. Proteolytic cleavage to generate vulnerable precursors, such as amyloid-beta peptide (A beta) production via beta and gamma secretases in Alzheimer's Disease (AD), is one such trigger, but the proteolytic removal of these fragments is also aetiologically important. The levels of A beta in the central nervous system are regulated by several catabolic proteases, including insulysin (IDE) and neprilysin (NEP). The known association of human acetylcholinesterase (hAChE) with pathological aggregates in AD together with its ability to increase A beta fibrilization prompted us to search for proteolytic triggers that could enhance this process. The hAChE C-terminal domain (T40, AChE(575- 614)) is an exposed amphiphilic alpha-helix involved in enzyme oligomerisation, but it also contains a conformational switch region (CSR) with high propensity for conversion to non-native (hidden) beta-strand, a property associated with amyloidogenicity. A synthetic peptide (AChE(586- 599)) encompassing the CSR region shares homology with A beta and forms beta-sheet amyloid fibrils. We investigated the influence of IDE and NEP proteolysis on the formation and degradation of relevant hAChE beta-sheet species. By combining reverse-phase HPLC and mass spectrometry, we established that the enzyme digestion profiles on T40 versus AChE(586- 599), or versus A beta, differed. Moreover, IDE digestion of T40 triggered the conformational switch from alpha- to beta-structures, resulting in surfactant CSR species that self-assembled into amyloid fibril precursors (oligomers). Crucially, these CSR species significantly increased A beta fibril formation both by seeding the energetically unfavorable formation of amyloid nuclei and by enhancing the rate of amyloid elongation. Hence, these results may offer an explanation for observations that implicate hAChE in the extent of A beta deposition in the brain. Furthermore, this process of heterologous amyloid seeding by a proteolytic fragment from another protein may represent a previously underestimated pathological trigger, implying that the abundance of the major amyloidogenic species (A beta in AD, for example) may not be the only important factor in neurodegeneration.	[Thomas, Benjamin; Vaux, David J.] Univ Oxford, Sir William Dunn Sch Pathol, Cent Prote Facil, Oxford OX1 3RE, England	University of Oxford	Vaux, DJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Cent Prote Facil, S Parks Rd, Oxford OX1 3RE, England.	david.vaux@path.ox.ac.uk		Vaux, David/0000-0002-4901-9795; Jean, Letitia/0000-0002-6450-7148	Synaptica Ltd.; Wellcome Trust	Synaptica Ltd.; Wellcome Trust(Wellcome TrustEuropean Commission)	Funding: This work was supported by a research grant from Synaptica Ltd. and BT was supported by the Wellcome Trust. Synaptica Ltd had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation or review of the manuscript. The company approved the manuscript without modification.	Alvarez A, 1998, J NEUROSCI, V18, P3213; Atwood CS, 2002, PEPTIDES, V23, P1343, DOI 10.1016/S0196-9781(02)00070-0; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Bitan G, 2004, ACCOUNTS CHEM RES, V37, P357, DOI 10.1021/ar000214l; Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960; Bourne Y, 1999, J BIOL CHEM, V274, P30370, DOI 10.1074/jbc.274.43.30370; Caccamo A, 2005, NEUROBIOL AGING, V26, P645, DOI 10.1016/j.neurobiolaging.2004.06.013; Carson JA, 2002, J NEUROCHEM, V81, P1, DOI 10.1046/j.1471-4159.2002.00855.x; Cottingham MG, 2004, LAB INVEST, V84, P523, DOI 10.1038/labinvest.3700054; Cottingham MG, 2003, BIOCHEMISTRY-US, V42, P10863, DOI 10.1021/bi034768i; Cottingham MG, 2002, BIOCHEMISTRY-US, V41, P13539, DOI 10.1021/bi0260334; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Diamant S, 2006, P NATL ACAD SCI USA, V103, P8628, DOI 10.1073/pnas.0602922103; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Dvir H, 2004, EMBO J, V23, P4394, DOI 10.1038/sj.emboj.7600425; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; GEULA C, 1989, BRAIN RES, V498, P185, DOI 10.1016/0006-8993(89)90419-8; Giacobini E, 2002, J NEURAL TRANSM, V109, P1053, DOI 10.1007/s007020200089; Guillozet AL, 1997, ANN NEUROL, V42, P909, DOI 10.1002/ana.410420613; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Harrison PM, 1997, CURR OPIN STRUC BIOL, V7, P53, DOI 10.1016/S0959-440X(97)80007-3; Inestrosa NC, 1996, NEURON, V16, P881, DOI 10.1016/S0896-6273(00)80108-7; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jaikaran ETAS, 2001, J MOL BIOL, V308, P515, DOI 10.1006/jmbi.2001.4593; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Kanemitsu H, 2003, NEUROSCI LETT, V350, P113, DOI 10.1016/S0304-3940(03)00898-X; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; LIAO J, 1994, J NEUROCHEM, V63, P1446; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Massoulie J, 2002, NEUROSIGNALS, V11, P130, DOI 10.1159/000065054; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; McLaurin J, 2000, J BIOL CHEM, V275, P18495, DOI 10.1074/jbc.M906994199; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mesulam MM, 2002, NEUROSCIENCE, V110, P627, DOI 10.1016/S0306-4522(01)00613-3; MESULAM MM, 1987, ANN NEUROL, V22, P683, DOI 10.1002/ana.410220603; Mihara H, 1998, BIOPOLYMERS, V47, P83, DOI 10.1002/(SICI)1097-0282(1998)47:1<83::AID-BIP9>3.0.CO;2-T; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Pedersen JS, 2004, J MOL BIOL, V341, P575, DOI 10.1016/j.jmb.2004.06.020; Perez A, 2000, NEUROCHEM RES, V25, P247, DOI 10.1023/A:1007527721160; PERRY EK, 1978, NEUROPATH APPL NEURO, V4, P273, DOI 10.1111/j.1365-2990.1978.tb00545.x; Qiu WQ, 1997, J BIOL CHEM, V272, P6641, DOI 10.1074/jbc.272.10.6641; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Rees T, 2003, NEUROBIOL AGING, V24, P777, DOI 10.1016/S0197-4580(02)00230-0; Rees Tina M., 2005, Current Alzheimer Research, V2, P291, DOI 10.2174/1567205054367847; Saez-Valero J, 1999, J NEUROCHEM, V72, P1600, DOI 10.1046/j.1471-4159.1999.721600.x; Seilheimer B, 1997, J STRUCT BIOL, V119, P59, DOI 10.1006/jsbi.1997.3859; SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Shaw KTY, 2001, P NATL ACAD SCI USA, V98, P7605, DOI 10.1073/pnas.131152998; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Song ES, 2001, J BIOL CHEM, V276, P1152, DOI 10.1074/jbc.M008702200; SOREGHAN B, 1994, J BIOL CHEM, V269, P28551; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Vekrellis K, 2000, J NEUROSCI, V20, P1657; WRIGHT CI, 1993, ANN NEUROL, V34, P373, DOI 10.1002/ana.410340312; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X; Yoon S, 2004, PROTEIN SCI, V13, P2149, DOI 10.1110/ps.04790604	64	19	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e652	10.1371/journal.pone.0000652	http://dx.doi.org/10.1371/journal.pone.0000652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653279	Green Published, gold, Green Submitted			2022-12-27	WOS:000207452200021
J	Sangster, TA; Bahrami, A; Wilczek, A; Watanabe, E; Schellenberg, K; McLellan, C; Kelley, A; Kong, SW; Queitsch, C; Lindquist, S				Sangster, Todd A.; Bahrami, Adam; Wilczek, Amity; Watanabe, Etsuko; Schellenberg, Kurt; McLellan, Catherine; Kelley, Alicia; Kong, Sek Won; Queitsch, Christine; Lindquist, Susan			Phenotypic Diversity and Altered Environmental Plasticity in Arabidopsis thaliana with Reduced Hsp90 Levels	PLOS ONE			English	Article								The molecular chaperone HSP90 aids the maturation of a diverse but select set of metastable protein clients, many of which are key to a variety of signal transduction pathways. HSP90 function has been best investigated in animal and fungal systems, where inhibition of the chaperone has exceptionally diverse effects, ranging from reversing oncogenic transformation to preventing the acquisition of drug resistance. Inhibition of HSP90 in the model plant Arabidopsis thaliana uncovers novel morphologies dependent on normally cryptic genetic variation and increases stochastic variation inherent to developmental processes. The biochemical activity of HSP90 is strictly conserved between animals and plants. However, the substrates and pathways dependent on HSP90 in plants are poorly understood. Progress has been impeded by the necessity of reliance on light-sensitive HSP90 inhibitors due to redundancy in the A. thaliana HSP90 gene family. Here we present phenotypic and genome-wide expression analyses of A. thaliana with constitutively reduced HSP90 levels achieved by RNAi targeting. HSP90 reduction affects a variety of quantitative life-history traits, including flowering time and total seed set, increases morphological diversity, and decreases the developmental stability of repeated characters. Several morphologies are synergistically affected by HSP90 and growth temperature. Genome-wide expression analyses also suggest a central role for HSP90 in the genesis and maintenance of plastic responses. The expression results are substantiated by examination of the response of HSP90-reduced plants to attack by caterpillars of the generalist herbivore Trichoplusia ni. HSP90 reduction potentiates a more robust herbivore defense response. In sum, we propose that HSP90 exerts global effects on the environmental responsiveness of plants to many different stimuli. The comprehensive set of HSP90-reduced lines described here is a vital instrument to further examine the role of HSP90 as a central interface between organism, development, and environment.	[Sangster, Todd A.] Univ Chicago, Comm Genet, Chicago, IL 60637 USA; [Sangster, Todd A.; Kelley, Alicia; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Bahrami, Adam; Wilczek, Amity] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Watanabe, Etsuko; Schellenberg, Kurt; McLellan, Catherine; Queitsch, Christine] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Kong, Sek Won] Childrens Hosp Boston, Informat Program, Boston, MA USA	University of Chicago; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Harvard University; Harvard University; Boston Children's Hospital	Queitsch, C (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	queitsch@u.washing-ton.edu	Bahrami, Adam/J-2736-2013	Bahrami, Adam/0000-0003-3039-6854	G. Harold and Lelia Y. Mathers Foundation; Howard Hughes Medical Institute	G. Harold and Lelia Y. Mathers Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Funding: Funding for this project was provided by the G. Harold and Lelia Y. Mathers Foundation to S.L. TAS was supported by a Howard Hughes Medical Institute pre-doctoral fellowship.	ABBOTT RJ, 1989, HEREDITY, V62, P411, DOI 10.1038/hdy.1989.56; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; *AR INF RES, 2007, TAIR7 GEN REL; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azevedo C, 2006, EMBO J, V25, P2007, DOI 10.1038/sj.emboj.7601084; Bechtold N, 1998, METH MOL B, V82, P259; BHATTARAI KK, 2007, PLANT PHYSL; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Campisi L, 1999, PLANT J, V17, P699, DOI 10.1046/j.1365-313X.1999.00409.x; Cao DS, 2003, PLANT J, V33, P107, DOI 10.1046/j.1365-313X.2003.016011.x; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Cui J, 2005, P NATL ACAD SCI USA, V102, P1791, DOI 10.1073/pnas.0409450102; Cui JP, 2002, PLANT PHYSIOL, V129, P551, DOI 10.1104/pp.010815; Duina AA, 1998, J BIOL CHEM, V273, P18974, DOI 10.1074/jbc.273.30.18974; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grenert JP, 1999, J BIOL CHEM, V274, P17525, DOI 10.1074/jbc.274.25.17525; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; Heil M, 2002, ANN BOT-LONDON, V89, P503, DOI 10.1093/aob/mcf076; HOAGLAND DR, 1950, 347 CAL AGR EXP STA; Holt BF, 2005, SCIENCE, V309, P929, DOI 10.1126/science.1109977; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; Ishiguro S, 2002, EMBO J, V21, P898, DOI 10.1093/emboj/21.5.898; Kanzaki H, 2003, MOL PLANT PATHOL, V4, P383, DOI [10.1046/j.1364-3703.2003.00186.x, 10.1046/J.1364-3703.2003.00186.X]; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Krishna P, 1997, PLANT MOL BIOL, V33, P457, DOI 10.1023/A:1005709308096; Krishna P, 2001, CELL STRESS CHAPERON, V6, P238, DOI 10.1379/1466-1268(2001)006<0238:THFOPI>2.0.CO;2; Krizek BA, 1996, P NATL ACAD SCI USA, V93, P4063, DOI 10.1073/pnas.93.9.4063; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Liu YL, 2004, J BIOL CHEM, V279, P2101, DOI 10.1074/jbc.M310029200; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; MCBRIDE KE, 1990, PLANT MOL BIOL, V14, P269, DOI 10.1007/BF00018567; Milton CC, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000075; MURAKAMI Y, 1991, EXP CELL RES, V195, P338, DOI 10.1016/0014-4827(91)90382-5; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Pratt WB, 2006, HANDB EXP PHARM, V172, P111; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Sangster TA, 2004, BIOESSAYS, V26, P348, DOI 10.1002/bies.20020; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Stancato LF, 1996, BIOCHEMISTRY-US, V35, P554, DOI 10.1021/bi9511649; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; YABE N, 1994, PLANT CELL PHYSIOL, V35, P1207, DOI 10.1093/oxfordjournals.pcp.a078715; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhao RM, 2007, ADV EXP MED BIOL, V594, P27	53	115	123	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e648	10.1371/journal.pone.0000648	http://dx.doi.org/10.1371/journal.pone.0000648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653275	Green Published, gold, Green Submitted			2022-12-27	WOS:000207452200017
J	Shaish, L; Abelson, A; Rinkevich, B				Shaish, Lee; Abelson, Avigdor; Rinkevich, Baruch			How Plastic Can Phenotypic Plasticity Be? The Branching Coral Stylophora pistillata as a Model System	PLOS ONE			English	Article							REEF-CORAL; POCILLOPORA-DAMICORNIS; PATTERN-FORMATION; GROWTH FORMS; WATER MOTION; ORGANISMS; ORGANIZATION; RESTORATION; COMPETITION; EXPRESSION	Phenotypic plasticity enables multicellular organisms to adjust morphologies and various life history traits to variable environmental challenges. Here, we elucidate fixed and plastic architectural rules for colony astogeny in multiple types of colonial ramets, propagated by cutting from genets of the branching coral Stylophora pistillata from Eilat, the Red Sea. We examined 16 morphometric parameters on 136 one-year old S. pistillata colonies (of seven genotypes), originating from small fragments belonging, each, to one of three single-branch types (single tips, start-up, and advanced bifurcating tips) or to structural preparative manipulations (representing a single or two growth axes). Experiments were guided by the rationale that in colonial forms, complexity of evolving phenotypic plasticity can be associated with a degree of structural modularity, where shapes are approached by erecting iterative growth patterns at different levels of coral-colony organization. Analyses revealed plastic morphometric characters at branch level, and predetermined morphometric traits at colony level (only single trait exhibited plasticity under extreme manipulation state). Therefore, under the experimental manipulations of this study, phenotypic plasticity in S. pistillata appears to be related to branch level of organization, whereas colony traits are controlled by predetermined genetic architectural rules. Each level of organization undergoes its own mode of astogeny. However, depending on the original ramet structure, the spherical 3-D colonial architecture in this species is orchestrated and assembled by both developmental trajectories at the branch level, and traits at the colony level of organization. In nature, branching colonial forms are often subjected to harsh environmental conditions that cause fragmentation of colony into ramets of different sizes and structures. Developmental traits that are plastic, responding to fragment structure and are not predetermine in controlling astogeny, allow formation of species-specific architecture product through integrated but variable developmental routes. This adaptive plasticity or regeneration is an efficient mechanism by which isolated fragments of branching coral species cope with external environmental forces.	[Shaish, Lee; Abelson, Avigdor; Rinkevich, Baruch] Tel Aviv Univ, Dept Zool, Ramat Aviv, Israel; [Shaish, Lee] Natl Inst Oceanog, IL-31080 Haifa, Israel	Tel Aviv University; Israel Oceanographic & Limnological Research Institute	Rinkevich, B (corresponding author), Tel Aviv Univ, Dept Zool, Ramat Aviv, Israel.	buki@ocean.org.il			EC-INCO-DEV; GEF/World Bank; EC collective research	EC-INCO-DEV; GEF/World Bank; EC collective research	Funding: The study was supported by the EC-INCO-DEV (REEFRES project), by the GEF/World Bank (Remediation and Restoration working Group project), and by the EC collective research (CORALZOO) project.	Abraham ER, 2001, MAR BIOL, V138, P503, DOI 10.1007/s002270000479; Ball EE, 2004, NAT REV GENET, V5, P567, DOI 10.1038/nrg1402; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; BRAZEAU DA, 1988, CORAL REEFS, V7, P139, DOI 10.1007/BF00300973; Bruno JF, 1997, ECOLOGY, V78, P2177, DOI 10.2307/2265954; Callahan HS, 1997, BIOESSAYS, V19, P519, DOI 10.1002/bies.950190611; Cartwright P, 2006, J EXP ZOOL PART B, V306B, P460, DOI 10.1002/jez.b.21106; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; DAUGET JM, 1991, CR ACAD SCI III-VIE, V313, P45; DAUGET JM, 1991, MAR BIOL, V111, P157, DOI 10.1007/BF01986357; Dunn CW, 2005, DEV DYNAM, V234, P835, DOI 10.1002/dvdy.20483; Epstein N, 2001, BASIC APPL ECOL, V2, P219, DOI 10.1078/1439-1791-00045; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; Foster A.B., 1983, Coral Reefs, V2, P19, DOI 10.1007/BF00304728; Gateno D, 1998, BIOL BULL, V194, P178, DOI 10.2307/1543048; GRAUS RR, 1976, SCIENCE, V193, P895, DOI 10.1126/science.193.4256.895; Hageman SJ, 2003, INTEGR COMP BIOL, V43, P87, DOI 10.1093/icb/43.1.87; JACKSON JBC, 1979, BIOL SYSTEMATICS COL, V2, P499; Kaandorp JA, 1999, MAR BIOL, V134, P295, DOI 10.1007/s002270050547; Kaandorp JA, 2005, P ROY SOC B-BIOL SCI, V272, P127, DOI 10.1098/rspb.2004.2934; Kaandorp JA, 2001, VIRTUAL LAB, P1; Kim K, 1997, J EXP MAR BIOL ECOL, V215, P49, DOI 10.1016/S0022-0981(97)00015-4; Kizner Z, 2001, ECOL MODEL, V141, P227, DOI 10.1016/S0304-3800(01)00276-9; Lasker HR, 1999, AM ZOOL, V39, P92; Lasker HR, 2003, BIOL BULL-US, V205, P319, DOI 10.2307/1543295; LESSER MP, 1994, J EXP MAR BIOL ECOL, V178, P153, DOI 10.1016/0022-0981(94)90034-5; LIDDLE MJ, 1987, BIOL CONSERV, V42, P1, DOI 10.1016/0006-3207(87)90049-8; Marfenin NN, 1997, HYDROBIOLOGIA, V355, P153, DOI 10.1023/A:1003069831832; Marshall PA, 2000, MAR ECOL PROG SER, V200, P177, DOI 10.3354/meps200177; Matus DQ, 2006, CURR BIOL, V16, P499, DOI 10.1016/j.cub.2006.01.052; Merks RMH, 2004, J THEOR BIOL, V228, P559, DOI 10.1016/j.jtbi.2004.02.020; MERKS RMH, 2003, THESIS U AMSTERDAM N; MILLER KJ, 1994, MAR ECOL PROG SER, V110, P19, DOI 10.3354/meps110019; Muko S, 2000, B MAR SCI, V66, P225; NAKAMURA T, 2006, P 10 INT COR REEF S, P872; Permata WD, 2005, ZOOL SCI, V22, P1197, DOI 10.2108/zsj.22.1197; Pigliucci M, 1996, TRENDS ECOL EVOL, V11, P168, DOI 10.1016/0169-5347(96)10008-2; PIGLIUCCI M, 1995, ECOLOGY, V76, P2134, DOI 10.2307/1941688; RINKEVICH B, 1985, B MAR SCI, V36, P319; Rinkevich B, 2000, MAR BIOL, V136, P807, DOI 10.1007/s002270000293; RINKEVICH B, 1985, OECOLOGIA, V66, P100, DOI 10.1007/BF00378559; RINKEVICH B, 1986, EXPERIENTIA, V42, P320, DOI 10.1007/BF01942521; Rinkevich B, 2002, ISRAEL J ZOOL, V48, P71, DOI 10.1560/BCPA-UM3A-MKBP-HGL2; RINKEVICH B, 1984, MAR BIOL, V80, P7, DOI 10.1007/BF00393121; RYLAND JS, 1986, PHILOS T ROY SOC B, V313, P53; Sanchez JA, 2004, AM NAT, V163, pE24, DOI 10.1086/382139; Sanchez JA, 2003, P ROY SOC B-BIOL SCI, V270, P2039, DOI 10.1098/rspb.2003.2471; Sebens KP, 1997, J EXP MAR BIOL ECOL, V211, P1, DOI 10.1016/S0022-0981(96)02636-6; Shaish L, 2006, DEV DYNAM, V235, P2111, DOI 10.1002/dvdy.20861; Sokal RR, 1984, BIOMETRY PRINCIPLES; Todd PA, 2004, MAR ECOL PROG SER, V271, P167, DOI 10.3354/meps271167; Underwood A.J., 1981, Oceanography and Marine Biology an Annual Review, V19, P513; VOSBURG F, 1977, P 3 INT COR REEF S, P177; West JM, 1997, BIOL BULL, V192, P279, DOI 10.2307/1542721; Wolpert L, 1996, TRENDS GENET, V12, P359, DOI 10.1016/S0168-9525(96)80019-9	56	45	46	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e644	10.1371/journal.pone.0000644	http://dx.doi.org/10.1371/journal.pone.0000644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653271	gold, Green Published, Green Submitted			2022-12-27	WOS:000207452200013
J	Teske, PR; Papadopoulos, I; McQuaid, CD; Newman, BK; Barker, NP				Teske, Peter R.; Papadopoulos, Isabelle; McQuaid, Christopher D.; Newman, Brent K.; Barker, Nigel P.			Climate Change, Genetics or Human Choice: Why Were the Shells of Mankind's Earliest Ornament Larger in the Pleistocene Than in the Holocene?	PLOS ONE			English	Article							RANGE EXPANSION; SOUTH-AFRICA; DNA; TEMPERATURE; PATTERNS; ENVIRONMENTS; BOUNDARIES; EVOLUTION; PROGRAM; HISTORY	Background. The southern African tick shell, Nassarius kraussianus (Dunker, 1846), has been identified as being the earliest known ornamental object used by human beings. Shell beads dated from similar to 75,000 years ago (Pleistocene era) were found in a cave located on South Africa's south coast. Beads made from N. kraussianus shells have also been found in deposits in this region dating from the beginning of the Holocene era (<10,000 years ago). These younger shells were significantly smaller, a phenomenon that has been attributed to a change in human preference. Methodology/Principal Findings. We investigated two alternative hypotheses explaining the difference in shell size: a) N. kraussianus comprises at least two genetic lineages that differ in size; b) the difference in shell size is due to phenotypic plasticity and is a function of environmental conditions. To test these hypotheses, we first reconstructed the species' phylogeographic history, and second, we measured the shell sizes of extant individuals throughout South Africa. Although two genetic lineages were identified, the sharing of haplotypes between these suggests that there is no genetic basis for the size differences. Extant individuals from the cool temperate west coast had significantly larger shells than populations in the remainder of the country, suggesting that N. kraussianus grows to a larger size in colder water. Conclusion/Significance. The decrease in fossil shell size from Pleistocene to Holocene was likely due to increased temperatures as a result of climate change at the beginning of the present interglacial period. We hypothesise that the sizes of N. kraussianus fossil shells can therefore serve as indicators of the climatic conditions that were prevalent in a particular region at the time when they were deposited. Moreover, N. kraussianus could serve as a biomonitor to study the impacts of future climate change on coastal biota in southern Africa.	[Teske, Peter R.; Papadopoulos, Isabelle; Barker, Nigel P.] Rhodes Univ, Dept Bot, Mol Ecol & Systemat Grp, ZA-6140 Grahamstown, South Africa; [McQuaid, Christopher D.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa; [Newman, Brent K.] CSIR, Durban, South Africa	Rhodes University; Rhodes University; Council for Scientific & Industrial Research (CSIR) - South Africa	Teske, PR (corresponding author), Rhodes Univ, Dept Bot, Mol Ecol & Systemat Grp, ZA-6140 Grahamstown, South Africa.	P.Teske@ru.ac.za	McQuaid, Christopher/AAT-3725-2020; Teske, Peter R/C-3337-2008; Teske, Peter/B-1564-2019	McQuaid, Christopher/0000-0002-3473-8308; Teske, Peter/0000-0002-2838-7804; Newman, Brent/0000-0001-6544-8234; Barker, Nigel/0000-0002-4612-1399	Claude Harris Leon Foundation; National Research Foundation [GUN 2069119]	Claude Harris Leon Foundation; National Research Foundation	PRT was supported by a Postdoctoral Research Fellowship from the Claude Harris Leon Foundation. This work was funded by a National Research Foundation Grant ( GUN 2069119) to NPB.	ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Atkinson D, 1997, TRENDS ECOL EVOL, V12, P235, DOI 10.1016/S0169-5347(97)01058-6; BOLTON JJ, 1990, BOT MAR, V33, P447, DOI 10.1515/botm.1990.33.5.447; BULLOCK TH, 1955, BIOL REV, V30, P311, DOI 10.1111/j.1469-185X.1955.tb01211.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Compton JS, 2001, HOLOCENE, V11, P395, DOI 10.1191/095968301678302832; Cooper J.A.G., 1989, South African Journal of Geology, V92, P73; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; DEACON J, 1988, LATE QUATERNARY PALA, P220; Duda TF, 2001, BIOL J LINN SOC, V73, P391, DOI 10.1006/bijl.2001.0544; EMANUEL BP, 1992, S AFR J MARINE SCI, V12, P341; Evans BS, 2004, MAR ECOL PROG SER, V270, P163, DOI 10.3354/meps270163; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Harrison TD, 2002, MAR FRESHWATER RES, V53, P479, DOI 10.1071/MF01121; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Henshilwood C, 2004, SCIENCE, V304, P404, DOI 10.1126/science.1095905; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hood G. M., 2004, POPTOOLS VERSION 2 6; KENSLEY B, 1977, Annals of the South African Museum, V72, P189; Kilburn R, 1982, SEA SHELLS SO AFRICA; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; PALMER CG, THESIS RHODES U GRAH; Palumbi Stephen R., 1996, P205; PARTRIDGE L, 1994, EVOLUTION, V48, P1269, DOI 10.1111/j.1558-5646.1994.tb05311.x; Posada D, 2000, MOL ECOL, V9, P487, DOI 10.1046/j.1365-294x.2000.00887.x; RAY CARLETON, 1960, JOUR MORPHOL, V106, P85, DOI 10.1002/jmor.1051060104; Ridgway TM, 1998, J ZOOL, V245, P317, DOI 10.1111/j.1469-7998.1998.tb00107.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SLATKIN M, 1991, GENETICS, V129, P555; TANKARD A J, 1975, Annals of the South African Museum, V69, P17; Templeton AR, 2004, MOL ECOL, V13, P789, DOI 10.1046/j.1365-294X.2003.02041.x; TEMPLETON AR, 1992, GENETICS, V132, P619; Teske PR, 2006, MAR ECOL PROG SER, V314, P283, DOI 10.3354/meps314283; Teske PR, 2004, MOL PHYLOGENET EVOL, V30, P273, DOI 10.1016/S1055-7903(03)00214-8; TESKE PR, J MOLLUSCAN IN PRESS; TESKE PR, AFR J MAR S IN PRESS; TESKE PR, MAR BIOL IN PRESS; Teusch Kristin P., 2002, Palaios, V17, P366, DOI 10.1669/0883-1351(2002)017<0366:MVITGF>2.0.CO;2; Trussell GC, 2000, EVOLUTION, V54, P151, DOI 10.1111/j.0014-3820.2000.tb00016.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Zardi GI, 2007, MAR ECOL PROG SER, V337, P135, DOI 10.3354/meps337135	45	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2007	2	7							e614	10.1371/journal.pone.0000614	http://dx.doi.org/10.1371/journal.pone.0000614			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GI	17637830	Green Published, gold			2022-12-27	WOS:000207452100004
J	Faria, CA; Wackers, FL; Pritchard, J; Barrett, DA; Turlings, TCJ				Faria, Cristina A.; Waeckers, Felix L.; Pritchard, Jeremy; Barrett, David A.; Turlings, Ted C. J.			High Susceptibility of Bt Maize to Aphids Enhances the Performance of Parasitoids of Lepidopteran Pests	PLOS ONE			English	Article								Concerns about possible undesired environmental effects of transgenic crops have prompted numerous evaluations of such crops. So-called Bt crops receive particular attention because they carry bacteria-derived genes coding for insecticidal proteins that might negatively affect non-target arthropods. Here we show a remarkable positive effect of Bt maize on the performance of the corn leaf aphid Rhopalosiphum maidis, which in turn enhanced the performance of parasitic wasps that feed on aphid honeydew. Within five out of six pairs that were evaluated, transgenic maize lines were significantly more susceptible to aphids than their near-isogenic equivalents, with the remaining pair being equally susceptible. The aphids feed from the phloem sieve element content and analyses of this sap in selected maize lines revealed marginally, but significantly higher amino acid levels in Bt maize, which might partially explain the observed increased aphid performance. Larger colony densities of aphids on Bt plants resulted in an increased production of honeydew that can be used as food by beneficial insects. Indeed, Cotesia marginiventris, a parasitoid of lepidopteran pests, lived longer and parasitized more pest caterpillars in the presence of aphid-infested Bt maize than in the presence of aphid-infested isogenic maize. Hence, depending on aphid pest thresholds, the observed increased susceptibility of Bt maize to aphids may be either a welcome or an undesirable side effect.	[Faria, Cristina A.; Turlings, Ted C. J.] Univ Neuchatel, Inst Zool, CH-2007 Neuchatel, Switzerland; [Waeckers, Felix L.] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Pritchard, Jeremy] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Barrett, David A.] Univ Nottingham, Sch Pharm, Ctr Analyt Biosci, Nottingham NG7 2RD, England	University of Neuchatel; Lancaster University; University of Birmingham; University of Nottingham	Turlings, TCJ (corresponding author), Univ Neuchatel, Inst Zool, CH-2007 Neuchatel, Switzerland.	ted.turlings@unine.ch	Barrett, David A/C-9922-2011; Turlings, Ted CJ/E-8671-2012	Barrett, David A/0000-0001-6900-9474; Turlings, Ted CJ/0000-0002-8315-785X	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the Swiss National Centre of Competence in Research "Plant Survival'', research program of the Swiss National Science Foundation.	ADAMS JB, 1972, APHID TECHNOLOGY, P48; Ashouri A, 2001, ENVIRON ENTOMOL, V30, P524, DOI 10.1603/0046-225X-30.3.524; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Awmack CS, 2004, GLOBAL CHANGE BIOL, V10, P1414, DOI 10.1111/j.1365-2486.2004.00800.x; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Bernal CC, 2002, ENTOMOL EXP APPL, V102, P21, DOI 10.1023/A:1015278618586; Bourguet Denis, 2002, Environmental Biosafety Research, V1, P49, DOI 10.1051/ebr:2002005; Conner AJ, 2003, PLANT J, V33, P19, DOI 10.1046/j.0960-7412.2002.001607.x; DREYER DL, 1987, PLANT CELL ENVIRON, V10, P353; Dutton A, 2003, BIOCONTROL, V48, P611, DOI 10.1023/A:1026313719424; Dutton A, 2002, ECOL ENTOMOL, V27, P441, DOI 10.1046/j.1365-2311.2002.00436.x; England S, 1997, ENVIRON ENTOMOL, V26, P1437, DOI 10.1093/ee/26.6.1437; Evans EW, 2000, ENTOMOL EXP APPL, V94, P141, DOI 10.1023/A:1003914509181; FARIA CA, 2006, BASIC APPL ECOLOGY; FERGUSON JE, 1979, PLANT PHYSIOL, V63, P416, DOI 10.1104/pp.63.3.416; GIROUSSE C, 1994, ENTOMOL EXP APPL, V70, P227, DOI 10.1007/BF02380556; GIVOVICH A, 1994, J CHEM ECOL, V20, P1923, DOI 10.1007/BF02066233; Head G, 2001, ENTOMOL EXP APPL, V99, P37, DOI 10.1023/A:1018913429026; HOCKING H, 1966, J AUSTR ENTOMOLOGICA, V6, P83; HOFTE H, 1989, MICROBIOL REV, V53, P242; Jauset AM, 2000, ANN ENTOMOL SOC AM, V93, P1116, DOI 10.1603/0013-8746(2000)093[1116:KOAHPO]2.0.CO;2; Karley AJ, 2002, J EXP BIOL, V205, P3009; KAZEMI MH, 1992, ANN APPL BIOL, V121, P1, DOI 10.1111/j.1744-7348.1992.tb03981.x; Kok EJ, 2003, TRENDS BIOTECHNOL, V21, P439, DOI 10.1016/j.tibtech.2003.08.003; KRING TJ, 1986, CROP PROT, V5, P125, DOI 10.1016/0261-2194(86)90093-1; Krober T., 1991, Biocontrol News and Information, V12, P357; Lee JC, 2004, ENTOMOL EXP APPL, V111, P189, DOI 10.1111/j.0013-8703.2004.00165.x; LESZCZYNSKI B, 1995, ENTOMOL EXP APPL, V76, P157, DOI 10.1007/BF02383213; Lovei GL, 2005, ENTOMOL EXP APPL, V114, P1, DOI 10.1111/j.0013-8703.2005.00235.x; Lozzia G. C., 1998, Bollettino di Zoologia Agraria e di Bachicoltura, V30, P153; Lumbierres B, 2004, ECOL ENTOMOL, V29, P309, DOI 10.1111/j.0307-6946.2004.00597.x; MACINTOSH SC, 1990, J INVERTEBR PATHOL, V56, P258, DOI 10.1016/0022-2011(90)90109-J; MARKWELL TJ, 1993, NEW ZEAL J ECOL, V17, P85; MOLLER H, 1987, NEW ZEAL J ECOL, V10, P167; Nie CR, 2005, AUST J AGR RES, V56, P833, DOI 10.1071/AR04321; NIEMEYER HM, 1988, PHYTOCHEMISTRY, V27, P3349, DOI 10.1016/0031-9422(88)80731-3; NIRAZ S, 1985, INSECT SCI APPL, V6, P253, DOI 10.1017/S1742758400004513; Pons X, 2005, EUR J ENTOMOL, V102, P73, DOI 10.14411/eje.2005.010; Raps A, 2001, MOL ECOL, V10, P525, DOI 10.1046/j.1365-294x.2001.01236.x; ROBERTS JJ, 1983, J ECON ENTOMOL, V76, P1320, DOI 10.1093/jee/76.6.1320; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; SANDSTROM J, 1994, J INSECT PHYSIOL, V40, P947, DOI 10.1016/0022-1910(94)90133-3; SHAW JR, 1984, PLANT PHYSIOL, V75, P207, DOI 10.1104/pp.75.1.207; Tosh CR, 2001, ENTOMOL EXP APPL, V99, P121, DOI 10.1023/A:1019267205797; UNWIN DM, 1978, PHYSIOL ENTOMOL, V3, P71, DOI 10.1111/j.1365-3032.1978.tb00135.x; VANDENWOLLENBERG AL, 1977, PSYCHOMETRIKA, V42, P207, DOI 10.1007/BF02294050; Wackers FL, 2000, OIKOS, V90, P197, DOI 10.1034/j.1600-0706.2000.900124.x; Wackers FL, 2001, J INSECT PHYSIOL, V47, P1077, DOI 10.1016/S0022-1910(01)00088-9; WEBSTER JA, 1994, J ECON ENTOMOL, V87, P231, DOI 10.1093/jee/87.1.231; WEIBULL J, 1987, ANN APPL BIOL, V111, P729, DOI 10.1111/j.1744-7348.1987.tb02031.x; Wilkinson TL, 2003, ENTOMOL EXP APPL, V106, P103, DOI 10.1046/j.1570-7458.2003.00014.x; Zhu XL, 2005, ELECTROPHORESIS, V26, P911, DOI 10.1002/elps.200410259	52	78	87	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2007	2	7							e600	10.1371/journal.pone.0000600	http://dx.doi.org/10.1371/journal.pone.0000600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GH	17622345	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452000007
J	Lutz, NW; Viola, A; Malikova, I; Confort-Gouny, S; Audoin, B; Ranjeva, JP; Pelletier, J; Cozzone, PJ				Lutz, Norbert W.; Viola, Angele; Malikova, Irina; Confort-Gouny, Sylviane; Audoin, Bertrand; Ranjeva, Jean-Philippe; Pelletier, Jean; Cozzone, Patrick J.			Inflammatory Multiple-Sclerosis Plaques Generate Characteristic Metabolic Profiles in Cerebrospinal Fluid	PLOS ONE			English	Article								Background. Multiple sclerosis (MS), an inflammatory disease of the central nervous system, manifests itself in numerous forms and stages. A number of brain metabolic alterations have been reported for MS patients vs. control subjects. However, metabolite profiles of cerebrospinal fluid (CSF) are not consistent among the published MS studies, most probably due to variations in the patient cohorts studied. We undertook the first investigation of highly homogeneous MS patient cohorts to determine characteristic effects of inflammatory MS plaques on the CSF metabolome, including only patients with clinically isolated syndrome (CIS) with or without inflammatory brain plaques, and controls. Methodology/Principal Findings. CSF obtained by lumbar puncture was analyzed by proton magnetic resonance spectroscopy. 27 metabolites were quantified. Differences between groups of control subjects (n = 10), CIS patients with (n = 21) and without (n = 12) inflammatory plaques were evaluated by univariate statistics and principal component analysis (PCA). Seven metabolites showed statistically significant inter-group differences (p < 0.05). Interestingly, a significant increase in beta-hydroxyisobutyrate (BHIB) was detected in CIS with vs. without active plaques, but not when comparing either CIS group with control subjects. Moreover, a significant correlation was found, for the first time, between CSF lactate concentration and the number of inflammatory MS brain plaques. In contrast, fructose concentrations were equally enhanced in CIS with or without active plaques. PCA based on all 27 metabolites yielded group-specific clusters. Conclusions/Significance. CSF metabolic profiles suggest a close link between MS plaque activity in CIS patients on the one hand and organic-acid metabolism on the other. Our detection of increased BHIB levels points to a hitherto unsuspected role for this compound in MS with active plaques, and serves as a basis for further investigation. The metabolic effects described in our study are crucial elements in the explanation of biochemical mechanisms involved in specific MS manifestations.	[Lutz, Norbert W.; Viola, Angele; Malikova, Irina; Confort-Gouny, Sylviane; Audoin, Bertrand; Ranjeva, Jean-Philippe; Pelletier, Jean; Cozzone, Patrick J.] Univ Aix Marseille 2, CNRS, UMR 6612, Ctr Resonance Magnet Biol & Med,Fac Med Timone, Marseille, France; [Malikova, Irina; Audoin, Bertrand; Pelletier, Jean] Hop Enfants La Timone, Serv Neurol, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Lutz, NW (corresponding author), Univ Aix Marseille 2, CNRS, UMR 6612, Ctr Resonance Magnet Biol & Med,Fac Med Timone, Marseille, France.	Norbert.Lutz@medecine.univ-mrs.fr		Ranjeva, Jean-Philippe/0000-0001-8073-102X	ARSEP; Serono France; CNRS [CNRS 6612]	ARSEP; Serono France; CNRS(Centre National de la Recherche Scientifique (CNRS))	Financial support from ARSEP (2005 award), Serono France and CNRS (UMR CNRS 6612) is gratefully acknowledged.	Aasly J, 1997, ACTA NEUROL SCAND, V95, P9, DOI 10.1111/j.1600-0404.1997.tb00060.x; Bernard-Helary K, 2002, GLIA, V37, P379, DOI 10.1002/glia.10046; Bruck W, 2005, CURR OPIN NEUROL, V18, P221; Caudie C, 2000, ANN BIOL CLIN-PARIS, V58, P376; Desplat S, 2000, REV NEUROL-FRANCE, V156, P885; Filippi M, 2001, J NEUROL, V248, P1019, DOI 10.1007/s004150170020; Fishman R. A, 1993, CEREBROSPINAL FLUID; FUJISHIMA M, 1984, J NEUROL, V231, P71, DOI 10.1007/BF00313719; Ghosh A, 2005, J BIOL CHEM, V280, P11114, DOI 10.1074/jbc.M410894200; HOFFMANN GF, 1995, J INHERIT METAB DIS, V18, P189, DOI 10.1007/BF00711763; Kirschenlohr HL, 2006, NAT MED, V12, P705, DOI 10.1038/nm1432; KOSCHOREK F, 1993, NEUROSURG REV, V16, P307, DOI 10.1007/BF00383842; Lassmann H, 2003, J NEUROL SCI, V206, P187, DOI 10.1016/S0022-510X(02)00421-5; LEE SHC, 1986, BIOCHEM J, V233, P621, DOI 10.1042/bj2330621; LETTO J, 1986, BIOCHEM J, V240, P909, DOI 10.1042/bj2400909; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Loder C, 2002, MED HYPOTHESES, V59, P594, DOI 10.1016/S0306-9877(02)00261-X; LOPEZVILLEGAS D, 1995, MAGNET RESON MED, V34, P32, DOI 10.1002/mrm.1910340107; Lutz NW, 2007, BIOCHEM BIOPH RES CO, V354, P160, DOI 10.1016/j.bbrc.2006.12.169; Lutz NW, 1998, FEBS LETT, V425, P345, DOI 10.1016/S0014-5793(98)00262-2; Maillet S, 1998, BRAIN RES PROTOC, V3, P123, DOI 10.1016/S1385-299X(98)00033-6; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McEwen BS, 2004, EUR J PHARMACOL, V490, P13, DOI 10.1016/j.ejphar.2004.02.041; Nicoli F, 1996, CR ACAD SCI III-VIE, V319, P623; POSNER JB, 1967, ARCH NEUROL-CHICAGO, V16, P492, DOI 10.1001/archneur.1967.00470230044005; REIBER H, 1987, CLIN CHIM ACTA, V163, P319, DOI 10.1016/0009-8981(87)90250-6; SHARMA R, 2000, INT SOC MAGN RES MED, P623; SIMON J, 1999, GIT SPEZIAL SEPARATI, V1, P20; Simone IL, 1996, J NEUROL SCI, V144, P182, DOI 10.1016/S0022-510X(96)00224-9; Sokal RR, 1995, BIOMETRY; Srinivasan R, 2005, BRAIN, V128, P1016, DOI 10.1093/brain/awh467; Viola A, 2002, AM J NEURORADIOL, V23, P480; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Wray H L, 1966, Diabetologia, V2, P82, DOI 10.1007/BF00423014; Wuerfel J, 2004, BRAIN, V127, P111, DOI 10.1093/brain/awh007; ZUPPING R, 1971, ARCH NEUROL-CHICAGO, V25, P33, DOI 10.1001/archneur.1971.00490010043006	36	72	74	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2007	2	7							e595	10.1371/journal.pone.0000595	http://dx.doi.org/10.1371/journal.pone.0000595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GG	17611627	gold, Green Published, Green Submitted			2022-12-27	WOS:000207451900012
J	McBride, SM; Fischetti, VA; LeBlanc, DJ; Moellering, RC; Gilmore, MS				McBride, Shonna M.; Fischetti, Vincent A.; LeBlanc, Donald J.; Moellering, Robert C., Jr.; Gilmore, Michael S.			Genetic Diversity among Enterococcus faecalis	PLOS ONE			English	Article							VANCOMYCIN-RESISTANT ENTEROCOCCI; HIGH-LEVEL RESISTANCE; LACTAMASE-PRODUCING ENTEROCOCCI; PLASMIDS DETERMINING HEMOLYSIN; GRAM-POSITIVE BACTERIA; BILE-SALT HYDROLASE; STREPTOCOCCUS-FAECALIS; BETA-LACTAMASE; ANTIBIOTIC-RESISTANCE; GLYCOPEPTIDE-RESISTANCE	Enterococcus faecalis, a ubiquitous member of mammalian gastrointestinal flora, is a leading cause of nosocomial infections and a growing public health concern. The enterococci responsible for these infections are often resistant to multiple antibiotics and have become notorious for their ability to acquire and disseminate antibiotic resistances. In the current study, we examined genetic relationships among 106 strains of E. faecalis isolated over the past 100 years, including strains identified for their diversity and used historically for serotyping, strains that have been adapted for laboratory use, and isolates from previously described E. faecalis infection outbreaks. This collection also includes isolates first characterized as having novel plasmids, virulence traits, antibiotic resistances, and pathogenicity island (PAI) components. We evaluated variation in factors contributing to pathogenicity, including toxin production, antibiotic resistance, polymorphism in the capsule (cps) operon, pathogenicity island (PAI) gene content, and other accessory factors. This information was correlated with multi-locus sequence typing (MLST) data, which was used to define genetic lineages. Our findings show that virulence and antibiotic resistance traits can be found within many diverse lineages of E. faecalis. However, lineages have emerged that have caused infection outbreaks globally, in which several new antibiotic resistances have entered the species, and in which virulence traits have converged. Comparing genomic hybridization profiles, using a microarray, of strains identified by MLST as spanning the diversity of the species, allowed us to identify the core E. faecalis genome as consisting of an estimated 2057 unique genes.	[McBride, Shonna M.; Gilmore, Michael S.] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02115 USA; [Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10021 USA; [LeBlanc, Donald J.] Pfizer Inc, Global Res & Dev, Antibacterial Mol Sci, Ann Arbor, MI USA; [Moellering, Robert C., Jr.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Rockefeller University; Pfizer; Harvard University; Beth Israel Deaconess Medical Center	Gilmore, MS (corresponding author), Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02115 USA.	michael.gilmore@schepens.harvard.edu	McBride, Shonna/H-6174-2013	McBride, Shonna/0000-0001-6221-714X				Aanensen DM, 2005, NUCLEIC ACIDS RES, V33, pW728, DOI 10.1093/nar/gki415; ACKERMANN HW, 1975, CAN J MICROBIOL, V21, P571, DOI 10.1139/m75-080; Anfinsen C.B., 1971, ENZYMES, V4; ARENDT EK, 1994, APPL ENVIRON MICROB, V60, P1875, DOI 10.1128/AEM.60.6.1875-1883.1994; Arthur M, 1996, J INFECTION, V32, P11, DOI 10.1016/S0163-4453(96)80003-X; Avery OT, 1919, J EXP MED, V29, P215, DOI 10.1084/jem.29.2.215; BANAI M, 1983, J BACTERIOL, V155, P1094, DOI 10.1128/JB.155.3.1094-1104.1983; Begley M, 2005, INFECT IMMUN, V73, P894, DOI 10.1128/IAI.73.2.894-904.2005; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; BENVENISTE R, 1973, ANNU REV BIOCHEM, V42, P471, DOI 10.1146/annurev.bi.42.070173.002351; Birkeauc KE, 1927, P SOC EXP BIOL MED, V24, P541; Birkhaug KE, 1927, J INFECT DIS, V40, P549, DOI 10.1093/infdis/40.5.549; BLEIWEIS AS, 1964, J BACTERIOL, V88, P653, DOI 10.1128/JB.88.3.653-659.1964; Booth MC, 2001, INFECT IMMUN, V69, P345, DOI 10.1128/IAI.69.1.345-352.2001; BRIDGE PD, 1982, INT J SYST BACTERIOL, V32, P410, DOI 10.1099/00207713-32-4-410; BROCK TD, 1963, J BACTERIOL, V86, P708, DOI 10.1128/JB.86.4.708-712.1963; BROCK TD, 1963, J BACTERIOL, V86, P702, DOI 10.1128/JB.86.4.702-707.1963; CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; CLEWELL DB, 1974, J BACTERIOL, V117, P283, DOI 10.1128/JB.117.1.283-289.1974; CLEWELL DB, 1982, J BACTERIOL, V152, P1220; Coburn PS, 2003, CELL MICROBIOL, V5, P661, DOI 10.1046/j.1462-5822.2003.00310.x; COBURN PS, 2006, MOL MICROBIOL   1205; COLLINS MD, 1984, INT J SYST BACTERIOL, V34, P220, DOI 10.1099/00207713-34-2-220; DASHKEVICZ MP, 1989, APPL ENVIRON MICROB, V55, P11, DOI 10.1128/AEM.55.1.11-16.1989; DUNNY GM, 1975, J BACTERIOL, V124, P784, DOI 10.1128/JB.124.2.784-790.1975; DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479; DUNNY GM, 1979, PLASMID, V2, P454, DOI 10.1016/0147-619X(79)90029-5; Dussurget O, 2002, MOL MICROBIOL, V45, P1095, DOI 10.1046/j.1365-2958.2002.03080.x; DUTKAMALEN S, 1995, J CLIN MICROBIOL, V33, P1434, DOI 10.1128/JCM.33.5.1434-1434.1995; DUTKAMALEN S, 1990, MOL GEN GENET, V224, P364, DOI 10.1007/BF00262430; DUTKAMALEN S, 1990, ANTIMICROB AGENTS CH, V34, P1875, DOI 10.1128/AAC.34.10.1875; Engelbert M, 2004, INFECT IMMUN, V72, P3628, DOI 10.1128/IAI.72.6.3628-3633.2004; EVANS AC, 1947, J BACTERIOL, V54, P495, DOI 10.1128/JB.54.4.495-512.1947; EVERS S, 1993, GENE, V124, P143, DOI 10.1016/0378-1119(93)90779-3; FACKLAM RR, 1989, J CLIN MICROBIOL, V27, P731, DOI 10.1128/JCM.27.4.731-734.1989; FERRETTI JJ, 1986, J BACTERIOL, V167, P631, DOI 10.1128/jb.167.2.631-638.1986; FINLAND M, 1950, AM J CLIN PATHOL, V20, P208; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; FLETCHER C, 1984, BRIT MED J, V289, P1721, DOI 10.1136/bmj.289.6460.1721; FONTANA R, 1992, CLIN INFECT DIS, V15, P486, DOI 10.1093/clind/15.3.486; Francia MV, 2002, J BACTERIOL, V184, P5187, DOI 10.1128/JB.184.18.5187-5193.2002; GARDNER P, 1969, LANCET, V2, P774; Giard JC, 2002, FEMS MICROBIOL LETT, V206, P235, DOI 10.1111/j.1574-6968.2002.tb11015.x; Giard JC, 2000, J BACTERIOL, V182, P4512, DOI 10.1128/JB.182.16.4512-4520.2000; GILMORE MS, 1994, J BACTERIOL, V176, P7335, DOI 10.1128/JB.176.23.7335-7344.1994; GOLD OG, 1975, ARCH ORAL BIOL, V20, P473, DOI 10.1016/0003-9969(75)90236-8; Hancock L, 2002, J BACTERIOL, V184, P5819, DOI 10.1128/JB.184.21.5819-5825.2002; Hancock L. E., 2006, Gram-positive pathogens, P299; Hancock LE, 2003, J BACTERIOL, V185, P4393, DOI 10.1128/JB.185.15.4393-4401.2003; Hancock LE, 2002, P NATL ACAD SCI USA, V99, P1574, DOI 10.1073/pnas.032448299; Hancock LE, 2004, J BACTERIOL, V186, P5629, DOI 10.1128/JB.186.17.5629-5639.2004; HANCOCK LE, 2001, IDENTIFICATION CHARA; Harrington SM, 2004, J CLIN MICROBIOL, V42, P5895, DOI 10.1128/JCM.42.12.5895-5898.2004; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Hufnagel M, 2005, CLIN DIAGN LAB IMMUN, V12, P930, DOI 10.1128/CDLI.12.8.930-934.2005; Hufnagel M, 2004, J CLIN MICROBIOL, V42, P2548, DOI 10.1128/JCM.42.6.2548-2557.2004; HUYCKE MM, 1991, ANTIMICROB AGENTS CH, V35, P1626, DOI 10.1128/AAC.35.8.1626; Hwang MSH, 2005, APPL ENVIRON MICROB, V71, P5182, DOI 10.1128/AEM.71.9.5182-5191.2005; IKE Y, 1992, J BACTERIOL, V174, P8172, DOI 10.1128/JB.174.24.8172-8177.1992; IKE Y, 1984, J BACTERIOL, V158, P777, DOI 10.1128/JB.158.3.777-783.1984; JACOB AE, 1974, J BACTERIOL, V117, P360, DOI 10.1128/JB.117.2.360-372.1974; JACOB AE, 1975, J BACTERIOL, V121, P863, DOI 10.1128/JB.121.3.863-872.1975; Jefferies JMC, 2004, J CLIN MICROBIOL, V42, P5681, DOI 10.1128/JCM.42.12.5681-5688.2004; JETT BD, 1994, CLIN MICROBIOL REV, V7, P462, DOI 10.1128/CMR.7.4.462-478.1994; Johnston JW, 2004, INFECT IMMUN, V72, P5858, DOI 10.1128/IAI.72.10.5858-5867.2004; Kayaoglu G, 2004, CRIT REV ORAL BIOL M, V15, P308, DOI 10.1177/154411130401500506; KORNBERG HA, 1948, ANAL CHEM, V20, P81, DOI 10.1021/ac60013a022; Kozlowicz BK, 2006, INT J MED MICROBIOL, V296, P141, DOI 10.1016/j.ijmm.2006.01.040; LEBLANC DJ, 1983, INFECT IMMUN, V40, P1015, DOI 10.1128/IAI.40.3.1015-1022.1983; LEBLANC DJ, 1982, J BACTERIOL, V150, P835, DOI 10.1128/JB.150.2.835-843.1982; LECLERCQ R, 1988, NEW ENGL J MED, V319, P157, DOI 10.1056/NEJM198807213190307; Luan SL, 2005, J CLIN MICROBIOL, V43, P3727, DOI 10.1128/JCM.43.8.3727-3733.2005; Lucchini S, 1999, J VIROL, V73, P8647, DOI 10.1128/JVI.73.10.8647-8656.1999; LUGINBUHL LM, 1987, PEDIATR INFECT DIS J, V6, P1022, DOI 10.1097/00006454-198706110-00003; MACCALLUM WG, 1899, J EXP MED, V4, P421; Macovei L, 2006, APPL ENVIRON MICROB, V72, P4028, DOI 10.1128/AEM.00034-06; Maekawa S, 1996, Kansenshogaku Zasshi, V70, P168; MAEKAWA S, 1992, MICROBIOL IMMUNOL, V36, P671, DOI 10.1111/j.1348-0421.1992.tb02070.x; MAKI DG, 1988, MEDICINE, V67, P248, DOI 10.1097/00005792-198807000-00005; Manson JM, 2003, J CLIN MICROBIOL, V41, P3331, DOI 10.1128/JCM.41.7.3331-3333.2003; Manson JM, 2003, ANTIMICROB AGENTS CH, V47, P204, DOI 10.1128/AAC.47.1.204-210.2003; Mathur S, 2005, INT J FOOD MICROBIOL, V105, P281, DOI 10.1016/j.ijfoodmicro.2005.03.008; MCDONALD JS, 1975, P AM ASS VET LAB DIA, V18, P251; MEDERSKISAMORAJ BD, 1983, J INFECT DIS, V147, P751, DOI 10.1093/infdis/147.4.751; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; MIELE A, 1995, ANTIMICROB AGENTS CH, V39, P1772, DOI 10.1128/AAC.39.8.1772; MOELLERI.RC, 1971, J CLIN INVEST, V50, P2580, DOI 10.1172/JCI106758; Moellering R C Jr, 1970, Antimicrob Agents Chemother (Bethesda), V10, P335; MOELLERING RC, 1979, J INFECT DIS, V140, P203, DOI 10.1093/infdis/140.2.203; MOELLERING RC, 1971, J LAB CLIN MED, V77, P821; Moellering RC, 2006, CLIN INFECT DIS, V42, pS3, DOI 10.1086/491708; MOELLERING RC, 1983, AM J MED, V75, P4, DOI 10.1016/0002-9343(83)90088-8; MOELLERING RC, 1992, CLIN INFECT DIS, V14, P1173, DOI 10.1093/clinids/14.6.1173; Mundy LM, 2000, CLIN MICROBIOL REV, V13, P513, DOI 10.1128/CMR.13.4.513-522.2000; MURRAY BE, 1991, J INFECT DIS, V163, P780, DOI 10.1093/infdis/163.4.780; MURRAY BE, 1983, J CLIN INVEST, V72, P1168, DOI 10.1172/JCI111042; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; Mylonakis E, 2002, INFECT IMMUN, V70, P4678, DOI 10.1128/IAI.70.8.4678-4681.2002; Nallapareddy SR, 2005, J BACTERIOL, V187, P5709, DOI 10.1128/JB.187.16.5709-5718.2005; Nallapareddy SR, 2002, J CLIN MICROBIOL, V40, P868, DOI 10.1128/JCM.40.3.868-876.2002; Oh TG, 1998, J BACTERIOL, V180, P5788, DOI 10.1128/JB.180.21.5788-5791.1998; OLIVER DR, 1977, J BACTERIOL, V130, P948, DOI 10.1128/JB.130.2.948-950.1977; Oprea SF, 2004, J ANTIMICROB CHEMOTH, V53, P626, DOI 10.1093/jac/dkh138; PATTERSON JE, 1988, ANTIMICROB AGENTS CH, V32, P122, DOI 10.1128/AAC.32.1.122; PATTERSON JE, 1988, J INFECT DIS, V158, P212, DOI 10.1093/infdis/158.1.212; PATTERSON JE, 1990, ANTIMICROB AGENTS CH, V34, P302, DOI 10.1128/AAC.34.2.302; PATTERSON JE, 1989, ANTIMICROB AGENTS CH, V33, P251, DOI 10.1128/AAC.33.2.251; PATTERSON JE, 1988, J INFECT DIS, V158, P1144, DOI 10.1093/infdis/158.5.1144; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Perreten V, 1997, SYST APPL MICROBIOL, V20, P27, DOI 10.1078/072320204322970944; Peset V, 2000, EUR J CLIN MICROBIOL, V19, P742, DOI 10.1007/s100960000360; Qin X, 2000, INFECT IMMUN, V68, P2579, DOI 10.1128/IAI.68.5.2579-2586.2000; RICE LB, 1991, ANTIMICROB AGENTS CH, V35, P272, DOI 10.1128/AAC.35.2.272; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Rince A, 2003, INT J FOOD MICROBIOL, V88, P207, DOI 10.1016/S0168-1605(03)00182-X; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; ROBERTS IS, 1995, MICROBIOL-SGM, V141, P2023, DOI 10.1099/13500872-141-9-2023; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Roberts MC, 1999, ANTIMICROB AGENTS CH, V43, P2823, DOI 10.1128/AAC.43.12.2823; ROSAN B, 1964, ARCH ORAL BIOL, V9, P291, DOI 10.1016/0003-9969(64)90061-5; Ruiz-Garbajosa P, 2006, J CLIN MICROBIOL, V44, P2220, DOI 10.1128/JCM.02596-05; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; SAMBROOKJOSEPH RW, 2001, MOL CLONING, P999; Schatz A, 1944, P SOC EXP BIOL MED, V55, P66, DOI 10.3181/00379727-55-14461; Schwarz FV, 2001, PLASMID, V46, P170, DOI 10.1006/plas.2001.1544; Schwarz S, 2004, FEMS MICROBIOL REV, V28, P519, DOI 10.1016/j.femsre.2004.04.001; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Shankar N, 2006, J CLIN MICROBIOL, V44, P4200, DOI 10.1128/JCM.01218-06; SHARPE ME, 1964, J GEN MICROBIOL, V36, P151, DOI 10.1099/00221287-36-1-151; SHARPE ME, 1952, J GEN MICROBIOL, V6, P150; SHATTOCK PMF, 1949, J GEN MICROBIOL, V3, P80, DOI 10.1099/00221287-3-1-80; Shattock PMF, 1943, J HYG-CAMBRIDGE, V43, P173, DOI 10.1017/S0022172400012791; Shepard BD, 2002, MICROBES INFECT, V4, P215, DOI 10.1016/S1286-4579(01)01530-1; Shepard BD, 2002, INFECT IMMUN, V70, P4344, DOI 10.1128/IAI.70.8.4344-4352.2002; Singh KV, 1998, J INFECT DIS, V178, P1416, DOI 10.1086/314453; SPEER BS, 1992, CLIN MICROBIOL REV, V5, P387, DOI 10.1128/CMR.5.4.387-399.1992; SU YA, 1991, INFECT IMMUN, V59, P415, DOI 10.1128/IAI.59.1.415-420.1991; THAL LA, 1993, ANTIMICROB AGENTS CH, V37, P134, DOI 10.1128/AAC.37.1.134; THAL LA, 1994, ANTIMICROB AGENTS CH, V38, P1152, DOI 10.1128/AAC.38.5.1152; TOALA P, 1969, AM J MED SCI, V258, P416, DOI 10.1097/00000441-196912000-00006; Todd EW, 1934, J PATHOL BACTERIOL, V39, P299, DOI 10.1002/path.1700390207; TOMICH PK, 1980, J BACTERIOL, V141, P1366, DOI 10.1128/JB.141.3.1366-1374.1980; TOMICH PK, 1979, ANTIMICROB AGENTS CH, V15, P828, DOI 10.1128/AAC.15.6.828; TRIEUCUOT P, 1983, GENE, V23, P331, DOI 10.1016/0378-1119(83)90022-7; TRIEUCUOT P, 1993, ANTIMICROB AGENTS CH, V37, P2593, DOI 10.1128/AAC.37.12.2593; UTTLEY AHC, 1988, LANCET, V1, P57; UTTLEY AHC, 1989, EPIDEMIOL INFECT, V103, P173, DOI 10.1017/S0950268800030478; Waar K, 2002, J INFECT DIS, V185, P1121, DOI 10.1086/339682; WALKER JC, 1958, BIOGRAPHICAL MEMOIRS, P113; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; WHEELER SM, 1945, AM J DIS CHILD, V70, P207, DOI 10.1001/archpedi.1945.02020220008002; YAGI Y, 1983, J GEN MICROBIOL, V129, P1207; Yoshioka M, 1995, Kansenshogaku Zasshi, V69, P189; Yoshioka M, 1995, Kansenshogaku Zasshi, V69, P181; ZERVOS MJ, 1987, J CLIN MICROBIOL, V25, P2443, DOI 10.1128/JCM.25.12.2443-2444.1987; ZERVOS MJ, 1986, ANTIMICROB AGENTS CH, V30, P78, DOI 10.1128/AAC.30.1.78; ZSCHECK KK, 1991, ANTIMICROB AGENTS CH, V35, P1736, DOI 10.1128/AAC.35.9.1736	159	207	209	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2007	2	7							e582	10.1371/journal.pone.0000582	http://dx.doi.org/10.1371/journal.pone.0000582			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GG	17611618	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451900002
J	Krishnan, A; Giuliani, A; Tomita, M				Krishnan, Arun; Giuliani, Alessandro; Tomita, Masaru			Indeterminacy of Reverse Engineering of Gene Regulatory Networks: The Curse of Gene Elasticity	PLOS ONE			English	Article							CELLULAR CONTROL PROCESSES; STEADY-STATES; FEEDBACK; CANALIZATION; MATHEMATICS; SIMULATION; EVOLUTION; SYSTEMS	Background. Gene Regulatory Networks (GRNs) have become a major focus of interest in recent years. A number of reverse engineering approaches have been developed to help uncover the regulatory networks giving rise to the observed gene expression profiles. However, this is an overspecified problem due to the fact that more than one genotype ( network wiring) can give rise to the same phenotype. We refer to this phenomenon as "gene elasticity.'' In this work, we study the effect of this particular problem on the pure, data-driven inference of gene regulatory networks. Methodology. We simulated a four-gene network in order to produce "data'' ( protein levels) that we use in lieu of real experimental data. We then optimized the network connections between the four genes with a view to obtain the original network that gave rise to the data. We did this for two different cases: one in which only the network connections were optimized and the other in which both the network connections as well as the kinetic parameters ( given as reaction probabilities in our case) were estimated. We observed that multiple genotypes gave rise to very similar protein levels. Statistical experimentation indicates that it is impossible to differentiate between the different networks on the basis of both equilibrium as well as dynamic data. Conclusions. We show explicitly that reverse engineering of GRNs from pure expression data is an indeterminate problem. Our results suggest the unsuitability of an inferential, purely data-driven approach for the reverse engineering transcriptional networks in the case of gene regulatory networks displaying a certain level of complexity.	[Krishnan, Arun; Tomita, Masaru] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Giuliani, Alessandro] Ist Super Sanita, Environm & Hlth Dept, I-00161 Rome, Italy	Keio University; Istituto Superiore di Sanita (ISS)	Krishnan, A (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.	krishnan@ttck.keio.ac.jp	Giuliani, Alessandro/AAF-1740-2020; Giuliani, Alessandro/K-7589-2016	Giuliani, Alessandro/0000-0002-4640-804X; Giuliani, Alessandro/0000-0002-4640-804X	Tsuruoka city and Yamagata prefecture governments	Tsuruoka city and Yamagata prefecture governments	Arun Krishnan and Masaru Tomita would like to acknowledge the Tsuruoka city and Yamagata prefecture governments for funding for this project.	Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; BARJOSEPH Z, 2003, NAT BIOTECHNOL, V21, P1295; BODEN J, 1997, J THEOR BIOL, V188, P391; BROOMHEAD DS, 1986, PHYSICA D, V20, P217, DOI 10.1016/0167-2789(86)90031-X; CHIPPERFIELD A, 2001, GENETIC ALGORITHM TO; DARROCH JN, 1985, BIOMETRIKA, V72, P241, DOI 10.2307/2336077; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gardner TS, 2005, PHYS LIFE REV, V2, P65, DOI 10.1016/j.plrev.2005.01.001; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.0.CO;2-J; GRIFFITH JS, 1968, J THEOR BIOL, V20, P202, DOI 10.1016/0022-5193(68)90189-6; GRIFFITH JS, 1968, J THEOR BIOL, V20, P209, DOI 10.1016/0022-5193(68)90190-2; Hayot F, 2005, J THEOR BIOL, V234, P133, DOI 10.1016/j.jtbi.2004.11.010; Ingram PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-108; Le Novere N, 2001, BIOINFORMATICS, V17, P575, DOI 10.1093/bioinformatics/17.6.575; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Liang Shoudan, 1998, REVEAL GEN REVERSE E; McAdams HH, 1998, ANNU REV BIOPH BIOM, V27, P199, DOI 10.1146/annurev.biophys.27.1.199; Mestl T, 1996, PHYSICA D, V98, P33, DOI 10.1016/0167-2789(96)00086-3; MESTL T, 1995, J THEOR BIOL, V176, P291, DOI 10.1006/jtbi.1995.0199; Plahte E, 1998, J MATH BIOL, V36, P321, DOI 10.1007/s002850050103; Preisendorfer R.W., 1988, DEV ATMOS SCI, V17; Qi Yuan, 2006, PLoS Comput Biol, V2, pe174, DOI 10.1371/journal.pcbi.0020174; Rice SH, 1998, EVOLUTION, V52, P647, DOI 10.1111/j.1558-5646.1998.tb03690.x; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Schmalhausen II., 1986, FACTORS EVOLUTION TH; SMITH H, 1987, J MATH BIOL, V25, P169, DOI 10.1007/BF00276388; Smolen P, 2000, B MATH BIOL, V62, P247, DOI 10.1006/bulm.1999.0155; SNOUSSI E, 1993, B MATH BIOL, V55, P973, DOI 10.1016/S0092-8240(05)80199-5; Soinov LA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r6; Somogyi R, 1996, COMPLEXITY, V1, P45, DOI DOI 10.1002/CPLX.6130010612; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; THOMAS R, 1995, B MATH BIOL, V57, P247, DOI 10.1007/BF02460618; Tyson J., 1978, PROG THEOR BIOL, V5, P1; VONFOERSTER H, 1981, OBSERVING SYSTEMS SE; Waddington C., 1957, STRATEGY GENES; Wen XL, 1998, P NATL ACAD SCI USA, V95, P334, DOI 10.1073/pnas.95.1.334; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896	38	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e562	10.1371/journal.pone.0000562	http://dx.doi.org/10.1371/journal.pone.0000562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593963	Green Published, gold, Green Submitted			2022-12-27	WOS:000207451800008
J	Hardee, ME; Cao, YT; Fu, P; Jiang, XH; Zhao, YL; Rabbani, ZN; Vujaskovic, Z; Dewhirst, MW; Arcasoy, MO				Hardee, Matthew E.; Cao, Yiting; Fu, Ping; Jiang, Xiaohong; Zhao, Yulin; Rabbani, Zahid N.; Vujaskovic, Zeljko; Dewhirst, Mark W.; Arcasoy, Murat O.			Erythropoietin Blockade Inhibits the Induction of Tumor Angiogenesis and Progression	PLOS ONE			English	Article								Background. The induction of tumor angiogenesis, a pathologic process critical for tumor progression, is mediated by multiple regulatory factors released by tumor and host cells. We investigated the role of the hematopoietic cytokine erythropoietin as an angiogenic factor that modulates tumor progression. Methodology/Principal Findings. Fluorescently-labeled rodent mammary carcinoma cells were injected into dorsal skin-fold window chambers in mice, an angiogenesis model that allows direct, non-invasive, serial visualization and real-time assessment of tumor cells and neovascularization simultaneously using intravital microscopy and computerized image analysis during the initial stages of tumorigenesis. Erythropoietin or its antagonist proteins were co-injected with tumor cells into window chambers. In vivo growth of cells engineered to stably express a constitutively active erythropoietin receptor EPOR-R129C or the erythropoietin antagonist R103A-EPO were analyzed in window chambers and in the mammary fat pads of athymic nude mice. Co-injection of erythropoietin with tumor cells or expression of EPOR-R129C in tumor cells significantly stimulated tumor neovascularization and growth in window chambers. Co-injection of erythropoietin antagonist proteins (soluble EPOR or anti-EPO antibody) with tumor cells or stable expression of antagonist R103A-EPO protein secreted from tumor cells inhibited angiogenesis and impaired tumor growth. In orthotopic tumor xenograft studies, EPOR-R129C expression significantly promoted tumor growth associated with increased expression of Ki67 proliferation antigen, enhanced microvessel density, decreased tumor hypoxia, and increased phosphorylation of extracellular-regulated kinases ERK1/2. R103A-EPO antagonist expression in mammary carcinoma cells was associated with near-complete disruption of primary tumor formation in the mammary fat pad. Conclusions/Significance. These data indicate that erythropoietin is an important angiogenic factor that regulates the induction of tumor cell-induced neovascularization and growth during the initial stages of tumorigenesis. The suppression of tumor angiogenesis and progression by erythropoietin blockade suggests that erythropoietin may constitute a potential target for the therapeutic modulation of angiogenesis in cancer.	[Fu, Ping; Jiang, Xiaohong; Arcasoy, Murat O.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Hardee, Matthew E.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Cao, Yiting; Zhao, Yulin; Rabbani, Zahid N.; Vujaskovic, Zeljko; Dewhirst, Mark W.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA	Duke University; Duke University; Duke University	Arcasoy, MO (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	arcas001@mc.duke.edu	Dewhirst, Mark/Q-1302-2019	Dewhirst, Mark/0000-0003-3459-6546; Rabbani, zahid/0000-0002-4101-7947	National Institutes of Health (NCI) [CA40355, CA100844]; Department of Defense [DAMD17-03-1-0968, DAMD17-05-1-0294]; NATIONAL CANCER INSTITUTE [R01CA100844, R01CA040355] Funding Source: NIH RePORTER	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by grants from the National Institutes of Health (NCI) Duke SPORE in breast cancer CA40355 and CA100844, and the Department of Defense DAMD17-03-1-0968 and DAMD17-05-1-0294.	Arcasoy MO, 1997, MOL CELL BIOL, V17, P2076, DOI 10.1128/MCB.17.4.2076; Arcasoy MO, 2002, BLOOD, V99, P3066, DOI 10.1182/blood.V99.8.3066; Bahlmann FH, 2004, BLOOD, V103, P921, DOI 10.1182/blood-2003-04-1284; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Blackwell KL, 2003, CANCER RES, V63, P6162; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Burns S, 2002, BLOOD, V99, P4400, DOI 10.1182/blood.V99.12.4400; Cao YT, 2005, CANCER RES, V65, P5498, DOI 10.1158/0008-5472.CAN-04-4553; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Feldman L, 2006, PROSTATE, V66, P135, DOI 10.1002/pros.20310; Folkman J, 2006, EXP CELL RES, V312, P594, DOI 10.1016/j.yexcr.2005.11.015; Folkman J, 2000, JNCI-J NATL CANCER I, V92, P94, DOI 10.1093/jnci/92.2.94; Gewirtz DA, 2006, CLIN CANCER RES, V12, P2232, DOI 10.1158/1078-0432.CCR-05-2287; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; Hanlon PR, 2005, FASEB J, V19, P1323, DOI 10.1096/fj.04-3545fje; Hardee ME, 2006, CLIN CANCER RES, V12, P332, DOI 10.1158/1078-0432.CCR-05-1771; Hardee ME, 2005, BRIT J CANCER, V93, P1350, DOI 10.1038/sj.bjc.6602846; HARDEE ME, 2006, MOL CANCER THER, V5, P536; Haroon ZSA, 2003, AM J PATHOL, V163, P993, DOI 10.1016/S0002-9440(10)63459-1; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Henke M, 2006, J CLIN ONCOL, V24, P4708, DOI 10.1200/JCO.2006.06.2737; Huang Q, 1999, NAT BIOTECHNOL, V17, P1033, DOI 10.1038/13736; Jaquet K, 2002, MICROVASC RES, V64, P326, DOI 10.1006/mvre.2002.2426; Kertesz N, 2004, DEV BIOL, V276, P101, DOI 10.1016/j.ydbio.2004.08.025; LaMontagne KR, 2006, MOL CANCER THER, V5, P347, DOI 10.1158/1535-7163.MCT-05-0203; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Lester RD, 2005, J BIOL CHEM, V280, P39273, DOI 10.1074/jbc.M509446200; Leyland-Jones B, 2005, J CLIN ONCOL, V23, P5960, DOI 10.1200/JCO.2005.06.150; Li CY, 2000, JNCI-J NATL CANCER I, V92, P143, DOI 10.1093/jnci/92.2.143; Lin PN, 1998, CELL GROWTH DIFFER, V9, P49; Longmore GD, 1998, BLOOD, V91, P870, DOI 10.1182/blood.V91.3.870.870_870_878; LONGMORE GD, 1994, MOL CELL BIOL, V14, P2266, DOI 10.1128/MCB.14.4.2266; LONGMORE GD, 1991, CELL, V67, P1089, DOI 10.1016/0092-8674(91)90286-8; Matthews DJ, 1996, P NATL ACAD SCI USA, V93, P9471, DOI 10.1073/pnas.93.18.9471; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; MIURA Y, 1994, J BIOL CHEM, V269, P29962; Moucadel V, 2005, J BIOL CHEM, V280, P13364, DOI 10.1074/jbc.M407326200; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; PHARR PN, 1993, P NATL ACAD SCI USA, V90, P938, DOI 10.1073/pnas.90.3.938; Qiu HW, 1998, J BIOL CHEM, V273, P11173, DOI 10.1074/jbc.273.18.11173; Ribatti D, 1999, BLOOD, V93, P2627, DOI 10.1182/blood.V93.8.2627.408k21_2627_2636; Shan SQ, 2003, FASEB J, V17, P326, DOI 10.1096/fj.03-0765fje; Shikama Y, 1996, BLOOD, V88, P455, DOI 10.1182/blood.V88.2.455.bloodjournal882455; Tovari J, 2005, CANCER RES, V65, P7186, DOI 10.1158/0008-5472.CAN-04-2498; Watanabe D, 2005, NEW ENGL J MED, V353, P782, DOI 10.1056/NEJMoa041773; Wright JR, 2007, J CLIN ONCOL, V25, P1027, DOI 10.1200/JCO.2006.07.1514; Yasuda Y, 2003, CARCINOGENESIS, V24, P1021, DOI 10.1093/carcin/bgg060; Yasuda Y, 2002, CARCINOGENESIS, V23, P1797, DOI 10.1093/carcin/23.11.1797; Yasuda Y, 2001, BRIT J CANCER, V84, P836, DOI 10.1054/bjoc.2000.1666; Yasuda Y, 1998, J BIOL CHEM, V273, P25381, DOI 10.1074/jbc.273.39.25381; YOSHIMURA A, 1990, NATURE, V348, P647, DOI 10.1038/348647a0	51	83	86	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2007	2	6							e549	10.1371/journal.pone.0000549	http://dx.doi.org/10.1371/journal.pone.0000549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GE	17579721	Green Submitted, gold, Green Published			2022-12-27	WOS:000207451700015
J	Nickle, DC; Heath, L; Jensen, MA; Gilbert, PB; Mullins, JI; Pond, SLK				Nickle, David C.; Heath, Laura; Jensen, Mark A.; Gilbert, Peter B.; Mullins, James I.; Pond, Sergei L. Kosakovsky			HIV-Specific Probabilistic Models of Protein Evolution	PLOS ONE			English	Article								Comparative sequence analyses, including such fundamental bioinformatics techniques as similarity searching, sequence alignment and phylogenetic inference, have become a mainstay for researchers studying type 1 Human Immunodeficiency Virus (HIV-1) genome structure and evolution. Implicit in comparative analyses is an underlying model of evolution, and the chosen model can significantly affect the results. In general, evolutionary models describe the probabilities of replacing one amino acid character with another over a period of time. Most widely used evolutionary models for protein sequences have been derived from curated alignments of hundreds of proteins, usually based on mammalian genomes. It is unclear to what extent these empirical models are generalizable to a very different organism, such as HIV-1-the most extensively sequenced organism in existence. We developed a maximum likelihood model fitting procedure to a collection of HIV-1 alignments sampled from different viral genes, and inferred two empirical substitution models, suitable for describing between-and within-host evolution. Our procedure pools the information from multiple sequence alignments, and provided software implementation can be run efficiently in parallel on a computer cluster. We describe how the inferred substitution models can be used to generate scoring matrices suitable for alignment and similarity searches. Our models had a consistently superior fit relative to the best existing models and to parameter-rich data-driven models when benchmarked on independent HIV-1 alignments, demonstrating evolutionary biases in amino-acid substitution that are unique to HIV, and that are not captured by the existing models. The scoring matrices derived from the models showed a marked difference from common amino-acid scoring matrices. The use of an appropriate evolutionary model recovered a known viral transmission history, whereas a poorly chosen model introduced phylogenetic error. We argue that our model derivation procedure is immediately applicable to other organisms with extensive sequence data available, such as Hepatitis C and Influenza A viruses.	[Pond, Sergei L. Kosakovsky] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Nickle, David C.; Heath, Laura; Jensen, Mark A.; Mullins, James I.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Gilbert, Peter B.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of California System; University of California San Diego; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Pond, SLK (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	spond@ucsd.edu	Nickle, David/ABF-2727-2020; Pond, Sergei LK/G-9830-2012	Pond, Sergei LK/0000-0003-4817-4029; Jensen, Mark/0000-0001-5215-101X	National Institutes of Health [AI43638, AI47745, AI57167, R01-GM66276, 5R01AI058894-03, 5P01AI057005-04, 2 RO1 AI054165-04]; University of California University wide AIDS Research Program [IS 02-SD-701]; University of California, San Diego Center for AIDS Research/NIAID Developmental Award [AI36214]; University of Washington Center for AIDS Research and STDs [P30-AI-27757]; Boeing Corporation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI043638, R01AI054165, P30AI027757, R56AI047745, P01AI057005, R01AI058894, R21AI047745, P30AI036214, R01AI057167, R01AI047745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California University wide AIDS Research Program(University of California System); University of California, San Diego Center for AIDS Research/NIAID Developmental Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Washington Center for AIDS Research and STDs; Boeing Corporation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by the National Institutes of Health (AI43638, AI47745, and AI57167, R01-GM66276), the University of California University wide AIDS Research Program (IS 02-SD-701), and by a University of California, San Diego Center for AIDS Research/NIAID Developmental Award to SLKP (AI36214). Additional support came from the National Institutes of Health (5R01AI058894-03, 5P01AI057005-04) and from the University of Washington Center for AIDS Research and STDs (P30-AI-27757) and a gift from Boeing Corporation all awarded to JIM and NIH award 2 RO1 AI054165-04 awarded to PBG. The funders had no influence on the preparation, review, or approval of the manuscript.	Adachi J, 1996, J MOL EVOL, V42, P459; Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Dimmic MW, 2002, J MOL EVOL, V55, P65, DOI 10.1007/s00239-001-2304-y; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FENG DF, 1985, J MOL EVOL, V21, P112, DOI 10.1007/BF02100085; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; GEORGE DG, 1990, METHOD ENZYMOL, V183, P333; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Herbeck JT, 2006, J VIROL, V80, P1637, DOI 10.1128/JVI.80.4.1637-1644.2006; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KARLIN S, 1985, P NATL ACAD SCI USA, V82, P8597, DOI 10.1073/pnas.82.24.8597; Pond SLK, 2007, MOL BIOL EVOL, V24, P159, DOI 10.1093/molbev/msl144; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Leitner T, 1996, P NATL ACAD SCI USA, V93, P10864, DOI 10.1073/pnas.93.20.10864; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Mansky LM, 1996, VIROLOGY, V222, P391, DOI 10.1006/viro.1996.0436; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Nachman MW, 2000, GENETICS, V156, P297; Nickle DC, 2003, SCIENCE, V299, P1515; Pond SLK, 2005, MOL BIOL EVOL, V22, P223, DOI 10.1093/molbev/msi009; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; POND SLK, 2006, MOL BIOL EVOL; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Stanfel LE, 1996, J THEOR BIOL, V183, P195, DOI 10.1006/jtbi.1996.0213; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tang H, 2004, MOL BIOL EVOL, V21, P1548, DOI 10.1093/molbev/msh158; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yampolsky LY, 2005, GENETICS, V170, P1459, DOI 10.1534/genetics.104.039107; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888	37	72	75	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e503	10.1371/journal.pone.0000503	http://dx.doi.org/10.1371/journal.pone.0000503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551583	gold, Green Published, Green Submitted			2022-12-27	WOS:000207451500012
J	Przewloka, MR; Zhang, W; Costa, P; Archambault, V; D'Avino, PP; Lilley, KS; Laue, ED; McAinsh, AD; Glover, DM				Przewloka, Marcin R.; Zhang, Wei; Costa, Patricia; Archambault, Vincent; D'Avino, Pier Paolo; Lilley, Kathryn S.; Laue, Ernest D.; McAinsh, Andrew D.; Glover, David M.			Molecular Analysis of Core Kinetochore Composition and Assembly in Drosophila melanogaster	PLOS ONE			English	Article							KH-DOMAIN PROTEIN; CENP-A; NDC80 COMPLEX; CENTROMERE FORMATION; OUTER KINETOCHORE; TOPOISOMERASE-II; CELL-CYCLE; HETEROCHROMATIN; CHROMATIN; DNA	Background. Kinetochores are large multiprotein complexes indispensable for proper chromosome segregation. Although Drosophila is a classical model organism for studies of chromosome segregation, little is known about the organization of its kinetochores. Methodology/Principal Findings. We employed bioinformatics, proteomics and cell biology methods to identify and analyze the interaction network of Drosophila kinetochore proteins. We have shown that three Drosophila proteins highly diverged from human and yeast Ndc80, Nuf2 and Mis12 are indeed their orthologues. Affinity purification of these proteins from cultured Drosophila cells identified a further five interacting proteins with weak similarity to subunits of the SPC105/KNL-1, MIND/MIS12 and NDC80 kinetochore complexes together with known kinetochore associated proteins such as dynein/dynactin, spindle assembly checkpoint components and heterochromatin proteins. All eight kinetochore complex proteins were present at the kinetochore during mitosis and MIND/MIS12 complex proteins were also centromeric during interphase. Their down-regulation led to dramatic defects in chromosome congression/segregation frequently accompanied by mitotic spindle elongation. The systematic depletion of each individual protein allowed us to establish dependency relationships for their recruitment onto the kinetochore. This revealed the sequential recruitment of individual members of first, the MIND/MIS12 and then, NDC80 complex. Conclusions/Significance. The Drosophila MIND/MIS12 and NDC80 complexes and the Spc105 protein, like their counterparts from other eukaryotic species, are essential for chromosome congression and segregation, but are highly diverged in sequence. Hierarchical dependence relationships of individual proteins regulate the assembly of Drosophila kinetochore complexes in a manner similar, but not identical, to other organisms.	[Przewloka, Marcin R.; Costa, Patricia; Archambault, Vincent; D'Avino, Pier Paolo; Glover, David M.] Univ Cambridge, Dept Genet, Cell Cycle Genet Res Grp, Canc Res UK, Cambridge CB2 3EH, England; [Zhang, Wei; Lilley, Kathryn S.; Laue, Ernest D.] Univ Cambridge, Dept Biochem, Cambridge CB2 3EH, England; [Lilley, Kathryn S.] Univ Cambridge, Cambridge Ctr Prote, Cambridge CB2 3EH, England; [McAinsh, Andrew D.] Marie Curie Res Inst, Chromosome Segregat Lab, Oxted, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; University of Cambridge	Przewloka, MR (corresponding author), Univ Cambridge, Dept Genet, Cell Cycle Genet Res Grp, Canc Res UK, Downing St, Cambridge CB2 3EH, England.	mrp50@cam.ac.uk; dmg25@cam.ac.uk	McAinsh, Andrew/C-6438-2012; D'Avino, Pier Paolo/AAU-4577-2020; Lilley, Kathryn/ABF-5787-2020; Przewloka, Marcin R./AAA-5137-2020	Lilley, Kathryn/0000-0003-0594-6543; Przewloka, Marcin R./0000-0002-0329-9162; Laue, Ernest/0000-0002-7476-4148; D'Avino, Pier Paolo/0000-0002-4773-6950; McAinsh, Andrew/0000-0001-6808-0711; Glover, David/0000-0003-0956-0103	BBSRC [BB/C508926/1, BB/E011586/1]; EC [HPRN-CT-2006-00260]; Human Frontier Science Program; Cancer Research UK; Marie Curie Cancer Care; MRC [G0501718] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C508926/1, BB/E011586/1] Funding Source: researchfish; Medical Research Council [G0501718] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EC(European CommissionEuropean Commission Joint Research Centre); Human Frontier Science Program(Human Frontier Science Program); Cancer Research UK(Cancer Research UK); Marie Curie Cancer Care; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work presented here was supported by BBSRC grants BB/C508926/1 and BB/E011586/1. P. C. was supported by funding from the EC FW5 Network "Molecular analysis of Drosophila cell division'' (HPRN-CT-2006-00260). V. A. holds a long-term fellowship from the Human Frontier Science Program. Programme grant support from Cancer Research UK to D. M. G. also helped support this work. A. D. M was supported by Marie Curie Cancer Care.	Arnaud L, 1998, CHROMOSOMA, V107, P424, DOI 10.1007/s004120050326; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Carroll CW, 2006, TRENDS CELL BIOL, V16, P70, DOI 10.1016/j.tcb.2005.12.008; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Chen F, 2007, CURR BIOL, V17, P293, DOI 10.1016/j.cub.2007.01.068; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Cortes A, 2000, MOL CELL BIOL, V20, P3860, DOI 10.1128/MCB.20.11.3860-3869.2000; Dawe RK, 2006, TRENDS BIOCHEM SCI, V31, P662, DOI 10.1016/j.tibs.2006.10.004; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Glover DM, 2005, ONCOGENE, V24, P230, DOI 10.1038/sj.onc.1208279; Goshima G, 1999, GENE DEV, V13, P1664, DOI 10.1101/gad.13.13.1664; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Heeger S, 2005, GENE DEV, V19, P2041, DOI 10.1101/gad.347805; Heit R, 2006, BIOCHEM CELL BIOL, V84, P605, DOI 10.1139/O06-080; Huertas D, 2004, CURR BIOL, V14, P1611, DOI 10.1016/j.cub.2004.09.024; Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003; King JM, 2000, J CELL BIOL, V151, P739, DOI 10.1083/jcb.151.4.739; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Maiato H, 2006, CHROMOSOMA, V115, P469, DOI 10.1007/s00412-006-0076-2; May KM, 2006, J CELL SCI, V119, P4139, DOI 10.1242/jcs.03165; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; McAinsh AD, 2006, EMBO J, V25, P4033, DOI 10.1038/sj.emboj.7601293; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; McCleland ML, 2003, GENE DEV, V17, P101, DOI 10.1101/gad.1040903; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Morris CA, 2007, CELL, V128, P647, DOI 10.1016/j.cell.2007.02.002; Morrison EE, 2007, CELL MOL LIFE SCI, V64, P307, DOI 10.1007/s00018-007-6360-3; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Porter ACG, 2004, CHROMOSOME RES, V12, P569, DOI 10.1023/B:CHRO.0000036608.91085.d1; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rattner JB, 1996, J CELL BIOL, V134, P1097, DOI 10.1083/jcb.134.5.1097; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Salina D, 2003, J CELL BIOL, V162, P991, DOI 10.1083/jcb.200304080; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tirnauer JS, 2002, MOL BIOL CELL, V13, P4308, DOI 10.1091/mbc.e02-04-0236; Vos LJ, 2006, BIOCHEM CELL BIOL, V84, P619, DOI 10.1139/O06-078; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Worby C A, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.95.pl1; Yucel JK, 2000, J CELL BIOL, V150, P1, DOI 10.1083/jcb.150.1.1	55	105	107	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2007	2	5							e478	10.1371/journal.pone.0000478	http://dx.doi.org/10.1371/journal.pone.0000478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10FB	17534428	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000207448800008
J	Lacaille, F; Hiroi, M; Twele, R; Inoshita, T; Umemoto, D; Maniere, G; Marion-Poll, F; Ozaki, M; Francke, W; Cobb, M; Everaerts, C; Tanimura, T; Ferveur, JF				Lacaille, Fabien; Hiroi, Makoto; Twele, Robert; Inoshita, Tsuyoshi; Umemoto, Daisuke; Maniere, Gerard; Marion-Poll, Frederic; Ozaki, Mamiko; Francke, Wittko; Cobb, Matthew; Everaerts, Claude; Tanimura, Teiichi; Ferveur, Jean-Francois			An Inhibitory Sex Pheromone Tastes Bitter for Drosophila Males	PLOS ONE			English	Article								Sexual behavior requires animals to distinguish between the sexes and to respond appropriately to each of them. In Drosophila melanogaster, as in many insects, cuticular hydrocarbons are thought to be involved in sex recognition and in mating behavior, but there is no direct neuronal evidence of their pheromonal effect. Using behavioral and electrophysiological measures of responses to natural and synthetic compounds, we show that Z-7-tricosene, a Drosophila male cuticular hydrocarbon, acts as a sex pheromone and inhibits male-male courtship. These data provide the first direct demonstration that an insect cuticular hydrocarbon is detected as a sex pheromone. Intriguingly, we show that a particular type of gustatory neurons of the labial palps respond both to Z-7-tricosene and to bitter stimuli. Cross-adaptation between Z-7-tricosene and bitter stimuli further indicates that these two very different substances are processed by the same neural pathways. Furthermore, the two substances induced similar behavioral responses both in courtship and feeding tests. We conclude that the inhibitory pheromone tastes bitter to the fly.	[Lacaille, Fabien; Maniere, Gerard; Everaerts, Claude; Ferveur, Jean-Francois] Univ Bourgogne, CNRS, UMR5548, Dijon, France; [Hiroi, Makoto; Marion-Poll, Frederic] INRA, UMR1272, F-78026 Versailles, France; [Twele, Robert; Francke, Wittko] Univ Hamburg, Hamburg, Germany; [Hiroi, Makoto; Inoshita, Tsuyoshi; Tanimura, Teiichi] Kyushu Univ, Grad Sch Sci, Dept Biol, Fukuoka 812, Japan; [Umemoto, Daisuke; Ozaki, Mamiko] Kyoto Inst Technol, Dept Appl Biol, Fac Text Sci, Kyoto 606, Japan; [Cobb, Matthew] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Hamburg; Kyushu University; Kyoto Institute of Technology; University of Manchester	Ferveur, JF (corresponding author), Univ Bourgogne, CNRS, UMR5548, Dijon, France.	jean-francois.ferveur@u-bourgogne.fr	Hiroi, Makoto/B-6834-2008; Frederic, Marion-Poll/I-1358-2019	Hiroi, Makoto/0000-0002-0136-5891; Frederic, Marion-Poll/0000-0001-6824-0180; Cobb, Matthew/0000-0002-8258-4913; Maniere, Gerard/0000-0003-1308-7291				ANTONY C, 1982, J INSECT PHYSIOL, V28, P873, DOI 10.1016/0022-1910(82)90101-9; Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; Darwin C., 1871, P423; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; FERVEUR JF, 1995, SCIENCE, V267, P902, DOI 10.1126/science.7846534; Ferveur JF, 1996, P ROY SOC B-BIOL SCI, V263, P967, DOI 10.1098/rspb.1996.0143; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hiroi M, 2004, J NEUROBIOL, V61, P333, DOI 10.1002/neu.20063; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; KIMURA K, 1986, J EXP ZOOL, V239, P393, DOI 10.1002/jez.1402390310; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Marcillac F, 2005, GENETICS, V171, P1617, DOI 10.1534/genetics.104.033159; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Park SK, 2006, CURR BIOL, V16, P1154, DOI 10.1016/j.cub.2006.04.028; Rezaval C, 2007, EUR J NEUROSCI, V25, P683, DOI 10.1111/j.1460-9568.2007.05317.x; Savarit F, 1999, P NATL ACAD SCI USA, V96, P9015, DOI 10.1073/pnas.96.16.9015; Schmitt U., 1991, Chemoecology, V2, P35, DOI 10.1007/BF01240664; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Svetec N, 2005, J EXP BIOL, V208, P891, DOI 10.1242/jeb.01454; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Xu A, 2002, CELL TISSUE RES, V307, P381, DOI 10.1007/s00441-002-0524-0; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	31	101	101	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e661	10.1371/journal.pone.0000661	http://dx.doi.org/10.1371/journal.pone.0000661			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710124	Green Published, gold			2022-12-27	WOS:000207455200001
J	Soares, EAJM; Santos, AFA; Sousa, TM; Sprinz, E; Martinez, AMB; Silveira, J; Tanuri, A; Soares, MA				Soares, Esmeralda A. J. M.; Santos, Andre F. A.; Sousa, Thatiana M.; Sprinz, Eduardo; Martinez, Ana M. B.; Silveira, Jussara; Tanuri, Amilcar; Soares, Marcelo A.			Differential Drug Resistance Acquisition in HIV-1 of Subtypes B and C	PLOS ONE			English	Article								Background. Subtype C is the most prevalent HIV-1 subtype in the world, mainly in countries with the highest HIV prevalence. However, few studies have evaluated the impact of antiretroviral therapy on this subtype. In southern Brazil, the first developing country to offer free and universal treatment, subtypes B and C co-circulate with equal prevalence, allowing for an extensive evaluation of this issue. Methods and Findings. Viral RNA of 160 HIV-1+ patients was extracted, and the protease and reverse transcriptase genes were sequenced, subtyped and analyzed for ARV mutations. Sequences were grouped by subtype, and matched to type (PI, NRTI and NNRTI) and time of ARV exposure. Statistical analyses were performed to compare differences in the frequency of ARV-associated mutations. There were no significant differences in time of treatment between subtypes B and C groups, although they showed distinct proportions of resistant strains at different intervals for two of three ARV classes. For PI, 26% of subtype B strains were resistant, compared to only 8% in subtype C (p = 0.0288, Fisher's exact test). For NRTI, 54% of subtype B strains were resistant versus 23% of subtype C (p = 0.0012). Differences were significant from 4 years of exposure, and remained so until the last time point analyzed. The differences observed between both subtypes were independent of time under rebound viremia in cases of virologic failure and of the number of HAART regimens used by treated patients. Conclusions. Our results pointed out to a lower rate of accumulation of mutations conferring resistance to ARV in subtype C than in subtype B. These findings are of crucial importance for current initiatives of ARV therapy roll-out in developing countries, where subtype is C prevalent.	[Soares, Esmeralda A. J. M.; Santos, Andre F. A.; Sousa, Thatiana M.; Tanuri, Amilcar; Soares, Marcelo A.] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil; [Sprinz, Eduardo] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Martinez, Ana M. B.; Silveira, Jussara] Fundacao Univ Fed Rio Grande Sul, Dept Patol, Rio Grande, RS, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Soares, MA (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil.	masoares@biologia.ufrj.br	Tanuri, Amilcar/AAM-8601-2021; sprinz, eduardo/V-7961-2019; Santos, Andre FA/I-5734-2016; Soares, Marcelo A/G-5662-2010	sprinz, eduardo/0000-0003-4343-8304; 	Brazilian Ministry of Science and Technology (CNPq) [403589/2004-5]; Rio de Janeiro State Science Foundation (FAPERJ) [E-26/171.337/2002]; Brazilian Ministry of Health (PN-DST/AIDS) [322/2005]	Brazilian Ministry of Science and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Science Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian Ministry of Health (PN-DST/AIDS)	Financial support by the Brazilian Ministry of Science and Technology (CNPq) grant no. 403589/2004-5, Rio de Janeiro State Science Foundation (FAPERJ) grant no. E-26/171.337/2002 and the Brazilian Ministry of Health (PN-DST/AIDS) grant no. 322/2005. The sponsors had no role in any step of the study design, data analysis or manuscript preparation.	Abecasis AB, 2005, AIDS, V19, P1799, DOI 10.1097/01.aids.0000188422.95162.b7; Abecasis AB, 2006, ANTIVIR THER, V11, P581; Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005; Brenner B, 2003, AIDS, V17, pF1, DOI 10.1097/00002030-200301030-00001; Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016; Carmona R, 2005, J CLIN VIROL, V32, P248, DOI 10.1016/j.jcv.2004.11.009; Dumans AT, 2004, J INFECT DIS, V189, P1232, DOI 10.1086/382483; Gonzalez LMF, 2004, ANTIMICROB AGENTS CH, V48, P3552, DOI 10.1128/AAC.48.9.3552-3555.2004; Gonzalez LMF, 2003, ANTIMICROB AGENTS CH, V47, P2817, DOI 10.1128/AAC.47.9.2817-2822.2003; Grossman Z, 2004, AIDS, V18, P909, DOI 10.1097/00002030-200404090-00008; Grossman Z, 2001, AIDS, V15, P1453, DOI 10.1097/00002030-200108170-00001; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Holguin A, 2004, J CLIN VIROL, V31, P215, DOI 10.1016/j.jcv.2004.03.015; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; Johnson Victoria A, 2006, Top HIV Med, V14, P125; Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112; Kantor R, 2006, CURR OPIN INFECT DIS, V19, P594, DOI 10.1097/QCO.0b013e3280109122; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Pieniazek D, 2000, AIDS, V14, P1489, DOI 10.1097/00002030-200007280-00004; Renjifo B, 2004, AIDS, V18, P1629, DOI 10.1097/01.aids.0000131392.68597.34; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Salemi M, 2005, J MOL EVOL, V60, P598, DOI 10.1007/s00239-004-0206-5; Shankarappa R, 2001, J VIROL, V75, P10479, DOI 10.1128/JVI.75.21.10479-10487.2001; Soares EAJM, 2005, AIDS, V19, pS81, DOI 10.1097/01.aids.0000191497.00928.e4; Soares EAJM, 2003, JAIDS-J ACQ IMM DEF, V34, P520, DOI 10.1097/00126334-200312150-00012; Soares MA, 2003, AIDS, V17, P11, DOI 10.1097/00002030-200301030-00004; Stuyver L, 1997, ANTIMICROB AGENTS CH, V41, P284, DOI 10.1128/AAC.41.2.284; Teixeira PR, 2004, AIDS, V18, pS5, DOI 10.1097/00002030-200406003-00002; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van de Vijver DA, 2006, JAIDS-J ACQ IMM DEF, V41, P352, DOI 10.1097/01.qai.0000209899.05126.e4; Van Harmelen JH, 1999, AIDS RES HUM RETROV, V15, P395; Vergne L, 2006, J CLIN VIROL, V36, P43, DOI 10.1016/j.jcv.2006.01.012	34	48	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e730	10.1371/journal.pone.0000730	http://dx.doi.org/10.1371/journal.pone.0000730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710130	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455200007
J	Streitz, M; Tesfa, L; Yildirim, V; Yahyazadeh, A; Ulrichs, T; Lenkei, R; Quassem, A; Liebetrau, G; Nomura, L; Maecker, H; Volk, HD; Kern, F				Streitz, Mathias; Tesfa, Lydia; Yildirim, Vedat; Yahyazadeh, Ali; Ulrichs, Timo; Lenkei, Rodica; Quassem, Ali; Liebetrau, Gerd; Nomura, Laurel; Maecker, Holden; Volk, Hans-Dieter; Kern, Florian			Loss of Receptor on Tuberculin-Reactive T-Cells Marks Active Pulmonary Tuberculosis	PLOS ONE			English	Article								Background. Tuberculin-specific T-cell responses have low diagnostic specificity in BCG vaccinated populations. While subunit-antigen (e. g. ESAT-6, CFP-10) based tests are useful for diagnosing latent tuberculosis infection, there is no reliable immunological test for active pulmonary tuberculosis. Notably, all existing immunological tuberculosis-tests are based on T-cell response size, whereas the diagnostic potential of T-cell response quality has never been explored. This includes surface marker expression and functionality of mycobacterial antigen specific T-cells. Methodology/Principal Findings. Flow-cytometry was used to examine over-night antigen-stimulated T-cells from tuberculosis patients and controls. Tuberculin and/or the relatively M. tuberculosis specific ESAT-6 protein were used as stimulants. A set of classic surface markers of T-cell naive/memory differentiation was selected and IFN-gamma production was used to identify T-cells recognizing these antigens. The percentage of tuberculin-specific T-helper-cells lacking the surface receptor CD27, a state associated with advanced differentiation, varied considerably between individuals (from less than 5% to more than 95%). Healthy BCG vaccinated individuals had significantly fewer CD27-negative tuberculin-reactive CD4 T-cells than patients with smear and/or culture positive pulmonary tuberculosis, discriminating these groups with high sensitivity and specificity, whereas individuals with latent tuberculosis infection exhibited levels in between. Conclusions/Significance. Smear and/or culture positive pulmonary tuberculosis can be diagnosed by a rapid and reliable immunological test based on the distribution of CD27 expression on peripheral blood tuberculin specific T-cells. This test works very well even in a BCG vaccinated population. It is simple and will be of great utility in situations where sputum specimens are difficult to obtain or sputum-smear is negative. It will also help avoid unnecessary hospitalization and patient isolation.	[Streitz, Mathias; Tesfa, Lydia; Yildirim, Vedat; Yahyazadeh, Ali; Volk, Hans-Dieter; Kern, Florian] Charite, Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Ulrichs, Timo] Max Planck Inst Infekt Biol, Immunol Abt, Berlin, Germany; [Lenkei, Rodica] St Gorans Univ Hosp, Capio Diagnost AB, Stockholm, Sweden; [Quassem, Ali; Liebetrau, Gerd] Lungenklin Lostau, Lostau, Germany; [Nomura, Laurel; Maecker, Holden] BD Biosci, San Jose, CA USA; [Kern, Florian] Brighton & Sussex Med Sch, Div Med, Brighton, E Sussex, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Saint Goran's Hospital; University of Brighton; University of Sussex	Kern, F (corresponding author), Charite, Charite, Inst Med Immunol, D-13353 Berlin, Germany.	f.kern@bsms.ac.uk	volk, hans-dieter/AAV-8053-2021; Kern, Florian/AAE-6784-2022	volk, hans-dieter/0000-0002-7743-6668; Kern, Florian/0000-0002-0368-8408	Charite-Universitatsmedizin Berlin	Charite-Universitatsmedizin Berlin	The work was funded by Charite-Universitatsmedizin Berlin. The funding source was not involved in study design, data collection, analysis, interpretation, writing the report, or the decision to submit.	Antas PRZ, 2005, T ROY SOC TROP MED H, V99, P699, DOI 10.1016/j.trstmh.2005.05.002; Appay V, 2002, J IMMUNOL, V168, P5954, DOI 10.4049/jimmunol.168.11.5954; Barry SM, 2003, J INFECT DIS, V187, P243, DOI 10.1086/346112; Bienenstock J, 2005, IMMUNOL REV, V206, P22, DOI 10.1111/j.0105-2896.2005.00299.x; Cardoso FLL, 2002, INFECT IMMUN, V70, P6707, DOI 10.1128/IAI.70.12.6707-6714.2002; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hamann D, 1999, IMMUNOL TODAY, V20, P177, DOI 10.1016/S0167-5699(99)01444-9; Hughes AJ, 2005, CLIN EXP IMMUNOL, V142, P132, DOI 10.1111/j.1365-2249.2005.02884.x; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Kern F, 2005, TRENDS IMMUNOL, V26, P477, DOI 10.1016/j.it.2005.07.005; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lyadova IV, 2004, CLIN EXP IMMUNOL, V138, P21, DOI 10.1111/j.1365-2249.2004.02573.x; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Means TK, 1999, J IMMUNOL, V163, P3920; Means TK, 2001, J IMMUNOL, V166, P4074, DOI 10.4049/jimmunol.166.6.4074; Murray RA, 2006, J IMMUNOL, V177, P5647, DOI 10.4049/jimmunol.177.8.5647; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Ravn P, 2005, CLIN DIAGN LAB IMMUN, V12, P491, DOI 10.1128/CDLI.12.4.491-496.2005; Rowland-Jones SL, 2001, IMMUNOL LETT, V79, P15, DOI 10.1016/S0165-2478(01)00261-9; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2000, CURR TOP MICROBIOL, V251, P167; Tesfa L, 2004, CYTOM PART B-CLIN CY, V60B, P47, DOI 10.1002/cyto.b.20007; TJARNLUND A, 2006, MICROBES INFECT; Vekemans J, 2001, INFECT IMMUN, V69, P6554, DOI 10.1128/IAI.69.10.6554-6557.2001; Wills MR, 2002, J IMMUNOL, V168, P5455, DOI 10.4049/jimmunol.168.11.5455	29	71	75	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e735	10.1371/journal.pone.0000735	http://dx.doi.org/10.1371/journal.pone.0000735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710135	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455200012
J	Chen, LT; Ko, TP; Chang, YW; Lin, KA; Wang, AHJ; Wang, TF				Chen, Li-Tzu; Ko, Tzu-Ping; Chang, Yu-Wei; Lin, Kuei-An; Wang, Andrew H. -J.; Wang, Ting-Fang			Structural and Functional Analyses of Five Conserved Positively Charged Residues in the L1 and N-Terminal DNA Binding Motifs of Archaeal RadA Protein	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; RECA PROTEIN; METHANOCOCCUS-VOLTAE; RECOMBINATION; COMPLEXES; HOMOLOG; DOMAIN; DMC1; GLYCOSYLASE; INSIGHTS	RecA family proteins engage in an ATP-dependent DNA strand exchange reaction that includes a ssDNA nucleoprotein helical filament and a homologous dsDNA sequence. In spite of more than 20 years of efforts, the molecular mechanism of homology pairing and strand exchange is still not fully understood. Here we report a crystal structure of Sulfolobus solfataricus RadA overwound right-handed filament with three monomers per helical pitch. This structure reveals conformational details of the first ssDNA binding disordered loop (denoted L1 motif) and the dsDNA binding N-terminal domain (NTD). L1 and NTD together form an outwardly open palm structure on the outer surface of the helical filament. Inside this palm structure, five conserved basic amino acid residues (K27, K60, R117, R223 and R229) surround a 25 A pocket that is wide enough to accommodate anionic ssDNA, dsDNA or both. Biochemical analyses demonstrate that these five positively charged residues are essential for DNA binding and for RadA-catalyzed D-loop formation. We suggest that the overwound right-handed RadA filament represents a functional conformation in the homology search and pairing reaction. A new structural model is proposed for the homologous interactions between a RadA-ssDNA nucleoprotein filament and its dsDNA target.	[Chen, Li-Tzu; Chang, Yu-Wei; Wang, Andrew H. -J.; Wang, Ting-Fang] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [Wang, Andrew H. -J.] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Chen, Li-Tzu; Ko, Tzu-Ping; Chang, Yu-Wei; Lin, Kuei-An; Wang, Andrew H. -J.; Wang, Ting-Fang] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Wang, Andrew H. -J.] Acad Sinica, Natl Core Facil High Throughput Prot Crystallog, Taipei 115, Taiwan	National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Wang, AHJ (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan.	ahjwang@gate.sinica.edu.tw; tfwang@gate.sinica.edu.tw	Wang, Ting-Fang/ABI-3818-2020	Wang, Ting-Fang/0000-0001-6306-9505				Aihara H, 1999, J MOL BIOL, V290, P495, DOI 10.1006/jmbi.1999.2904; Ariza A, 2005, NUCLEIC ACIDS RES, V33, P1465, DOI 10.1093/nar/gki288; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen LT, 2007, NUCLEIC ACIDS RES, V35, P1787, DOI 10.1093/nar/gkl1131; Chen LW, 2002, CHEM BIOL, V9, P345, DOI 10.1016/S1074-5521(02)00120-5; Chen YK, 2004, P NATL ACAD SCI USA, V101, P10572, DOI 10.1073/pnas.0404195101; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; De Zutter SK, 1999, J MOL BIOL, V293, P769, DOI 10.1006/jmbi.1999.3200; Henning W, 2003, TOXICOLOGY, V193, P91, DOI 10.1016/S0300-483X(03)00291-9; Hollis T, 2000, EMBO J, V19, P758, DOI 10.1093/emboj/19.4.758; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kinebuchi T, 2005, J BIOL CHEM, V280, P28382, DOI 10.1074/jbc.M503372200; Kinebuchi T, 2004, MOL CELL, V14, P363, DOI 10.1016/S1097-2765(04)00218-7; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.biochem.63.1.991; Lee MH, 2004, BIOCHEM BIOPH RES CO, V323, P845, DOI 10.1016/j.bbrc.2004.08.163; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Qian XG, 2005, BIOCHEMISTRY-US, V44, P13753, DOI 10.1021/bi051222i; ROCKMILL B, 1995, GENE DEV, V9, P2684, DOI 10.1101/gad.9.21.2684; Seitz EM, 1998, GENE DEV, V12, P1248, DOI 10.1101/gad.12.9.1248; Shao XG, 2000, NUCLEIC ACIDS RES, V28, P2643, DOI 10.1093/nar/28.14.2643; Shi WX, 2005, NANO LETT, V5, P2476, DOI 10.1021/nl051783v; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Thorslund T, 2007, EMBO J, V26, P2915, DOI 10.1038/sj.emboj.7601739; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wu Y, 2004, MOL CELL, V15, P423, DOI 10.1016/j.molcel.2004.07.014; Wu Y, 2005, J BIOL CHEM, V280, P722, DOI 10.1074/jbc.M411093200; YU X, 1990, BIOPHYS J, V57, P555, DOI 10.1016/S0006-3495(90)82571-6; Zhang XP, 2005, J BIOL CHEM, V280, P26303, DOI 10.1074/jbc.M503244200	37	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e858	10.1371/journal.pone.0000858	http://dx.doi.org/10.1371/journal.pone.0000858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848989	gold, Green Submitted, Green Published			2022-12-27	WOS:000207455600005
J	Muller, J; Tsuji, LA				Mueller, Johannes; Tsuji, Linda A.			Impedance-Matching Hearing in Paleozoic Reptiles: Evidence of Advanced Sensory Perception at an Early Stage of Amniote Evolution	PLOS ONE			English	Article								Background. Insights into the onset of evolutionary novelties are key to the understanding of amniote origins and diversification. The possession of an impedance-matching tympanic middle ear is characteristic of all terrestrial vertebrates with a sophisticated hearing sense and an adaptively important feature of many modern terrestrial vertebrates. Whereas tympanic ears seem to have evolved multiple times within tetrapods, especially among crown-group members such as frogs, mammals, squamates, turtles, crocodiles, and birds, the presence of true tympanic ears has never been recorded in a Paleozoic amniote, suggesting they evolved fairly recently in amniote history. Methodology/Principal Findings. In the present study, we performed a morphological examination and a phylogenetic analysis of poorly known parareptiles from the Middle Permian of the Mezen River Basin in Russia. We recovered a well-supported clade that is characterized by a unique cheek morphology indicative of a tympanum stretching across large parts of the temporal region to an extent not seen in other amniotes, fossil or extant, and a braincase specialized in showing modifications clearly related to an increase in auditory function, unlike the braincase of any other Paleozoic tetrapod. In addition, we estimated the ratio of the tympanum area relative to the stapedial footplate for the basalmost taxon of the clade, which, at 23:1, is in close correspondence to that of modern amniotes capable of efficient impedance-matching hearing. Conclusions/Significance. Using modern amniotes as analogues, the possession of an impedance-matching middle ear in these parareptiles suggests unique ecological adaptations potentially related to living in dim-light environments. More importantly, our results demonstrate that already at an early stage of amniote diversification, and prior to the Permo-Triassic extinction event, the complexity of terrestrial vertebrate ecosystems had reached a level that proved advanced sensory perception to be of notable adaptive significance.	[Mueller, Johannes; Tsuji, Linda A.] Humboldt Univ, Museum Naturkunde, Berlin, Germany	Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Muller, J (corresponding author), Humboldt Univ, Museum Naturkunde, Berlin, Germany.	johannes.mueller@museum.hu-berlin.de	Müller, Johannes/A-6293-2017	Müller, Johannes/0000-0001-5801-856X	Deutsche Forschungsgemeinschaft (DFG) [Mu 1760/2-3]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding: The study was funded by a grant of the Deutsche Forschungsgemeinschaft (DFG Mu 1760/2-3).	[Anonymous], 1987, T PALEONTOLOGICHESKO; Brazeau MD, 2006, NATURE, V439, P318, DOI 10.1038/nature04196; Carroll R.L, 1988, VERTEBRATE PALEONTOL, P698; CARROLL RL, 1985, CAN J EARTH SCI, V22, P1571, DOI 10.1139/e85-166; Chang BSW, 2002, MOL BIOL EVOL, V19, P1483, DOI 10.1093/oxfordjournals.molbev.a004211; CLACK JA, 1993, ACTA BIOTHEOR, V41, P391, DOI 10.1007/BF00709373; Clack JA, 2002, J NEUROBIOL, V53, P251, DOI 10.1002/neu.10129; CLACK JA, 1989, NATURE, V342, P425, DOI 10.1038/342425a0; Clack JA., 2002, GAINING GROUND ORIGI, P369; Clark JA, 1997, BRAIN BEHAV EVOLUT, V50, P198, DOI 10.1159/000113334; Damiani R, 2003, P ROY SOC B-BIOL SCI, V270, P1747, DOI 10.1098/rspb.2003.2427; deBraga M, 2003, CAN J EARTH SCI, V40, P527, DOI 10.1139/E02-082; EFREMOV IA, 1938, DOKL AKAD NAUK SSSR, V19, P771; Frey E, 1997, SCIENCE, V275, P1450, DOI 10.1126/science.275.5305.1450; HEMILA S, 1995, HEARING RES, V85, P31, DOI 10.1016/0378-5955(95)00031-X; Ivakhnenko MF, 1997, PALEONTOL J, V31, P552; Iwaniuk AN, 2006, BEHAV BRAIN RES, V167, P305, DOI 10.1016/j.bbr.2005.09.015; LAURIN M, 1995, ZOOL J LINN SOC-LOND, V113, P165, DOI 10.1111/j.1096-3642.1995.tb00932.x; Laurin M, 1998, ANN SCI NAT ZOOL, V19, P1, DOI 10.1016/S0003-4339(98)80132-9; Lombard R. Eric, 1993, P241; Maddison W., 2003, MACCLADE 4 06; MANLEY GA, 1972, J COMP PHYSIOL, V81, P239, DOI 10.1007/BF00693629; Mason MJ, 2001, J ZOOL, V255, P467; Meyer A, 2003, ANNU REV ECOL EVOL S, V34, P311, DOI 10.1146/annurev.ecolsys.34.011802.132351; Modesto S, 2001, P ROY SOC B-BIOL SCI, V268, P2047, DOI 10.1098/rspb.2001.1766; Modesto SP, 2006, ZOOL J LINN SOC-LOND, V146, P345, DOI 10.1111/j.1096-3642.2006.00205.x; Muller J, 2003, NATURWISSENSCHAFTEN, V90, P473, DOI 10.1007/s00114-003-0461-0; Narins PM, 1997, BRAIN RES BULL, V44, P641, DOI 10.1016/S0361-9230(97)00286-4; NORBERG RA, 1978, PHILOS T R SOC B, V282, P325, DOI 10.1098/rstb.1978.0014; Nummela S, 2006, J ZOOL, V270, P256, DOI 10.1111/j.1469-7998.2006.00126.x; Reisz RR, 2007, ZOOL J LINN SOC-LOND, V151, P191, DOI 10.1111/j.1096-3642.2007.00312.x; Reisz RR, 1997, TRENDS ECOL EVOL, V12, P218, DOI 10.1016/S0169-5347(97)01060-4; Reisz RR, 2001, GEOL SOC AM BULL, V113, P1229, DOI 10.1130/0016-7606(2001)113<1229:TRMFVE>2.0.CO;2; Rieppel O, 1999, ANNU REV ECOL SYST, V30, P1, DOI 10.1146/annurev.ecolsys.30.1.1; Robinson J, 2005, ZOOL J LINN SOC-LOND, V143, P577, DOI 10.1111/j.1096-3642.2005.00156.x; Rybczynski N, 2001, NATURE, V411, P684, DOI 10.1038/35079567; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tsuji LA, 2006, J VERTEBR PALEONTOL, V26, P849, DOI 10.1671/0272-4634(2006)26[849:CAAPAO]2.0.CO;2; Werner YL, 2005, ANAT REC PART A, V283A, P212, DOI 10.1002/ar.a.20142; WEVER EG, 1970, J EXP ZOOL, V175, P327, DOI 10.1002/jez.1401750307; WEVER EG, 1978, REPTILE EAR ITS STRU, P1025	41	66	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e889	10.1371/journal.pone.0000889	http://dx.doi.org/10.1371/journal.pone.0000889			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849018	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455600035
J	Tuljapurkar, SD; Puleston, CO; Gurven, MD				Tuljapurkar, Shripad D.; Puleston, Cedric O.; Gurven, Michael D.			Why Men Matter: Mating Patterns Drive Evolution of Human Lifespan	PLOS ONE			English	Article							FERTILITY	Evolutionary theory predicts that senescence, a decline in survival rates with age, is the consequence of stronger selection on alleles that affect fertility or mortality earlier rather than later in life. Hamilton quantified this argument by showing that a rare mutation reducing survival is opposed by a selective force that declines with age over reproductive life. He used a female-only demographic model, predicting that female menopause at age ca. 50 yrs should be followed by a sharp increase in mortality, a "wall of death.'' Human lives obviously do not display such a wall. Explanations of the evolution of lifespan beyond the age of female menopause have proven difficult to describe as explicit genetic models. Here we argue that the inclusion of males and mating patterns extends Hamilton's theory and predicts the pattern of human senescence. We analyze a general two-sex model to show that selection favors survival for as long as men reproduce. Male fertility can only result from matings with fertile females, and we present a range of data showing that males much older than 50 yrs have substantial realized fertility through matings with younger females, a pattern that was likely typical among early humans. Thus old-age male fertility provides a selective force against autosomal deleterious mutations at ages far past female menopause with no sharp upper age limit, eliminating the wall of death. Our findings illustrate the evolutionary importance of males and mating preferences, and show that one-sex demographic models are insufficient to describe the forces that shape human senescence.	[Tuljapurkar, Shripad D.; Puleston, Cedric O.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Gurven, Michael D.] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA	Stanford University; University of California System; University of California Santa Barbara	Tuljapurkar, SD (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	tulja@stanford.edu		Tuljapurkar, Shripad/0000-0001-5549-4245; Gurven, Michael/0000-0002-5661-527X	U.S. National Institute [1 PO1 AG22500-01]; NIA [R01 AG024119-01]; NATIONAL INSTITUTE ON AGING [R01AG024119, P01AG022500] Funding Source: NIH RePORTER	U.S. National Institute; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by U.S. National Institute on Aging grant 1 PO1 AG22500-01 and NIA grant R01 AG024119-01.	[Anonymous], 1997, ZEUS SALMON BIODEMOG; CASTERLINE JB, 1986, POP STUD-J DEMOG, V40, P353, DOI 10.1080/0032472031000142296; Charlesworth B, 1997, CURR BIOL, V7, pR440, DOI 10.1016/S0960-9822(06)00213-2; Charlesworth B, 2001, J THEOR BIOL, V210, P47, DOI 10.1006/jtbi.2001.2296; CHARLESWORTH B, 2004, EVOLUTION AGE STRUCT; Dupanloup I, 2003, J MOL EVOL, V57, P85, DOI 10.1007/s00239-003-2458-x; FELDMAN MW, 1983, GENETICS, V105, P1003; *GOV PAK, 1984, CAM DEM HLTH SURV PA; GURVEN M, 2007, HUNTER GATHERER LONG; GURVEN M, 2007, AM J HUM BI IN PRESS; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; Hawkes K, 2003, AM J HUM BIOL, V15, P380, DOI 10.1002/ajhb.10156; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; HOWELL N, 1979, DEMOGRAPHY DOBE 1KUN; Kaplan HS, 2002, P NATL ACAD SCI USA, V99, P10221, DOI 10.1073/pnas.152502899; Kuhnert B, 2004, HUM REPROD UPDATE, V10, P327, DOI 10.1093/humupd/dmh030; Lardoux S, 2003, POPULATION, V58, P807, DOI 10.2307/3271283; Lee RD, 2003, P NATL ACAD SCI USA, V100, P9637, DOI 10.1073/pnas.1530303100; Marlowe FW, 2000, HUM NATURE-INT BIOS, V11, P27, DOI 10.1007/s12110-000-1001-7; Marlowe FW, 2005, EVOL ANTHROPOL, V14, P54, DOI 10.1002/evan.20046; Medawar P., 1952, UNSOLVED PROBLEM BIO; Melancon T., 1982, THESIS PENNSYLVANIA; MULDER MB, 1988, REPROD SUCCESS, pCH26; *NAT I STAT, CAM DEM HLTH SURV; PAGET WJ, 1994, POP STUD-J DEMOG, V48, P333, DOI 10.1080/0032472031000147826; POLLAK RA, 1987, THEOR POPUL BIOL, V32, P176, DOI 10.1016/0040-5809(87)90046-3; POLLAK RA, 1990, J POLIT ECON, V98, P399, DOI 10.1086/261683; Ratcliffe AA, 2000, B WORLD HEALTH ORGAN, V78, P570; RAVANERA ZR, 2003, ANN M POP ASS AM MIN; ROGERS AR, 1993, EVOL ECOL, V7, P406, DOI 10.1007/BF01237872; ROGERS AR, 1994, HUMAN REPROD DECISIO, P76; SCHOEN R, 1981, DEMOGRAPHY, V18, P201, DOI 10.2307/2061093; Shanley DP, 2001, BIOESSAYS, V23, P282, DOI 10.1002/1521-1878(200103)23:3<282::AID-BIES1038>3.0.CO;2-9; *UN STAT DIV, 2006, SOC IND IND HLTH; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	36	83	83	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e785	10.1371/journal.pone.0000785	http://dx.doi.org/10.1371/journal.pone.0000785			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726515	Green Published, gold			2022-12-27	WOS:000207455400002
J	Launay, O; Durier, C; Desaint, C; Silbermann, B; Jackson, A; Pialoux, G; Bonnet, B; Poizot-Martin, I; Gonzalez-Canali, G; Cuzin, L; Figuereido, S; Surenaud, M; Ben Hamouda, N; Gahery, H; Choppin, J; Salmon, D; Guerin, C; Villada, IB; Guillet, JG				Launay, Odile; Durier, Christine; Desaint, Corinne; Silbermann, Benjamin; Jackson, Angela; Pialoux, Gilles; Bonnet, Benedicte; Poizot-Martin, Isabelle; Gonzalez-Canali, Gustavo; Cuzin, Lise; Figuereido, Suzanne; Surenaud, Mathieu; Ben Hamouda, Nadine; Gahery, Hanne; Choppin, Jeannine; Salmon, Dominique; Guerin, Corinne; Villada, Isabelle Bourgault; Guillet, Jean-Gerard		ANRS VAC16 Study Grp	Cellular Immune Responses Induced with Dose-Sparing Intradermal Administration of HIV Vaccine to HIV-Uninfected Volunteers in the ANRS VAC16 Trial	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; IMMUNODEFICIENCY-VIRUS; INTRAMUSCULAR VACCINATION; DENDRITIC CELLS; IN-VIVO; LIPOPEPTIDE; IMMUNIZATION; EPITOPES; INDUCTION; CD4(+)	Objective. The objective was to compare the safety and cellular immunogenicity of intradermal versus intramuscular immunization with an HIV-lipopeptide candidate vaccine (LIPO-4) in healthy volunteers. Methodology. A randomized, open-label trial with 24 weeks of follow-up was conducted in France at six HIV-vaccine trial sites. Sixty-eight healthy 21-to 55-year-old HIV-uninfected subjects were randomized to receive the LIPO-4 vaccine (four HIV lipopeptides linked to a T-helper-stimulating epitope of tetanus-toxin protein) at weeks 0, 4 and 12, either intradermally (0.1 ml, 100 mu g of each peptide) or intramuscularly (0.5 ml, 500 mu g of each peptide). Comparative safety of both routes was evaluated. CD8(+) T-cell immune responses to HIV epitopes (ELISpot interferon-gamma assay) and tetanus toxin-specific CD4(+) T-cell responses (lymphoproliferation) were assessed at baseline, two weeks after each injection, and at week 24. Results and Conclusion. No severe, serious or life-threatening adverse events were observed. Local pain was significantly more frequent after intramuscular injection, but local inflammatory reactions were more frequent after intradermal immunization. At weeks 2, 6, 14 and 24, the respective cumulative percentages of induced CD8(+) T-cell responses to at least one HIV peptide were 9, 33, 39 and 52 (intradermal group) or 14, 20, 26 and 37 (intramuscular group), and induced tetanus toxin-specific CD4(+) T-cell responses were 6, 27, 33 and 39 (intradermal), or 9, 46, 54 and 63 (intramuscular). In conclusion, intradermal LIPO-4 immunization was well tolerated, required one-fifth of the intramuscular dose, and induced similar HIV-specific CD8(+) T-cell responses. Moreover, the immunization route influenced which antigen-specific T-cells (CD4(+) or CD8(+)) were induced. Trial Registration. ClinicalTrials. gov NCT00121121	[Launay, Odile; Salmon, Dominique] Univ Paris 05, Fac Med, Paris, France; [Launay, Odile; Desaint, Corinne; Silbermann, Benjamin] Grp Hosp Cochin St Vincent de Paul, AP HP, CIC Vaccinol Cochin Pasteur, Paris, France; [Launay, Odile; Desaint, Corinne; Silbermann, Benjamin] INSERM, CIC Vaccinol Cochin Pasteur, Paris, France; [Durier, Christine] INSERM, SC10, Villejuif, France; [Jackson, Angela; Figuereido, Suzanne; Surenaud, Mathieu; Ben Hamouda, Nadine; Gahery, Hanne; Choppin, Jeannine; Villada, Isabelle Bourgault; Guillet, Jean-Gerard] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Jackson, Angela; Figuereido, Suzanne; Surenaud, Mathieu; Ben Hamouda, Nadine; Gahery, Hanne; Choppin, Jeannine; Villada, Isabelle Bourgault; Guillet, Jean-Gerard] INSERM, U567, Paris, France; [Pialoux, Gilles] Hop Tenon, AP HP, Serv Malad Infect, F-75970 Paris, France; [Bonnet, Benedicte] CHU Nantes, Hotel Dieu, Serv Malad Infect, F-44035 Nantes 01, France; [Poizot-Martin, Isabelle] Hop St Marguerite, Unite CISIH Sud Hematol VIH, Marseille, France; [Gonzalez-Canali, Gustavo] Hop Europe Georges Pompidou, AP HP, Serv Immunol Clin, Paris, France; [Cuzin, Lise] Hop Purpan, Serv Malad Infect, Toulouse, France; [Guerin, Corinne] Hop Cochin, AP HP, F-75674 Paris, France; [Villada, Isabelle Bourgault] Hop Ambroise Pare, AP HP, Serv Dermatol, Boulogne, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Nantes Universite; CHU de Nantes; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Launay, O (corresponding author), Univ Paris 05, Fac Med, Paris, France.	odile.launay@cch.aphp.fr		BEN HAMOUDA, Nadine/0000-0002-0438-924X; SURENAUD, Mathieu/0000-0002-3312-7871	French National Agency for Research on Aids; Viral Hepatitis (ANRS)	French National Agency for Research on Aids(ANRS); Viral Hepatitis (ANRS)(ANRS)	The French National Agency for Research on Aids and Viral Hepatitis (ANRS) sponsored the trial. After giving its approval of the protocol, the ANRS was not involved in the collection, analysis or interpretation of the data, writing of the report or the decision to submit the paper for publication. All authors declare that they have no conflicts of interest.	Andrieu M, 2000, EUR J IMMUNOL, V30, P3256, DOI 10.1002/1521-4141(200011)30:11<3256::AID-IMMU3256>3.0.CO;2-H; Belshe RB, 2004, NEW ENGL J MED, V351, P2286, DOI 10.1056/NEJMoa043555; BenMohamed L, 1997, EUR J IMMUNOL, V27, P1242, DOI 10.1002/eji.1830270528; BenMohamed L, 2002, LANCET INFECT DIS, V2, P425, DOI 10.1016/S1473-3099(02)00318-3; BOURGAULT I, 1994, J IMMUNOL, V152, P2530; Briggs DJ, 2000, B WORLD HEALTH ORGAN, V78, P693; BRYAN JP, 1992, CLIN INFECT DIS, V14, P697, DOI 10.1093/clinids/14.3.697; Coutsinos Z, 2005, FEMS IMMUNOL MED MIC, V43, P357, DOI 10.1016/j.femsim.2004.09.003; DERES K, 1989, NATURE, V342, P561, DOI 10.1038/342561a0; Durier C, 2006, AIDS, V20, P1039, DOI 10.1097/01.aids.0000222077.68243.22; Fischer E, 2005, MEM I OSWALDO CRUZ, V100, P79, DOI 10.1590/S0074-02762005000100015; Flanagan KL, 2001, J IMMUNOL, V167, P4729, DOI 10.4049/jimmunol.167.8.4729; FREY S, 2005, AIDS VACC 2005 C MON; Gahery H, 2006, AIDS RES HUM RETROV, V22, P684, DOI 10.1089/aid.2006.22.684; Gahery-Segard H, 2003, J VIROL, V77, P11220, DOI 10.1128/JVI.77.20.11220-11231.2003; Gahery-Segard H, 2000, J VIROL, V74, P1694, DOI 10.1128/JVI.74.4.1694-1703.2000; Hosmalin A, 2001, IMMUNOL LETT, V79, P97, DOI 10.1016/S0165-2478(01)00271-1; Keating SM, 2005, J IMMUNOL, V175, P5675, DOI 10.4049/jimmunol.175.9.5675; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; Klinguer C, 1999, VACCINE, V18, P259, DOI 10.1016/S0264-410X(99)00196-6; Le Gal FA, 2002, INT J CANCER, V98, P221, DOI 10.1002/ijc.10186; Levy Y, 2005, AIDS, V19, P279; Livingston BD, 1997, J IMMUNOL, V159, P1383; Markel H, 2005, NEW ENGL J MED, V353, P753, DOI 10.1056/NEJMp058146; MARTINON F, 1992, J IMMUNOL, V149, P3416; Mortara L, 1999, J VIROL, V73, P4447, DOI 10.1128/JVI.73.5.4447-4451.1999; Pialoux G, 2001, AIDS, V15, P1239, DOI 10.1097/00002030-200107060-00005; Rahman F, 2000, HEPATOLOGY, V31, P521, DOI 10.1002/hep.510310237; REDFIELD RR, 1985, JAMA-J AM MED ASSOC, V254, P3203, DOI 10.1001/jama.254.22.3203; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; SAUZET JP, 1995, VACCINE, V13, P1339, DOI 10.1016/0264-410X(94)00087-4; VITIELLO A, 1995, J CLIN INVEST, V95, P341, DOI 10.1172/JCI117662; Zhang XL, 2005, J VIROL, V79, P15289, DOI 10.1128/JVI.79.24.15289-15301.2005; Zhu XM, 2004, EUR J IMMUNOL, V34, P3102, DOI 10.1002/eji.200425166	34	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e725	10.1371/journal.pone.0000725	http://dx.doi.org/10.1371/journal.pone.0000725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712402	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455300002
J	Towner, JS; Pourrut, X; Albarino, CG; Nkogue, CN; Bird, BH; Grard, G; Ksiazek, TG; Gonzalez, JP; Nichol, ST; Leroy, EM				Towner, Jonathan S.; Pourrut, Xavier; Albarino, Cesar G.; Nkogue, Chimene Nze; Bird, Brian H.; Grard, Gilda; Ksiazek, Thomas G.; Gonzalez, Jean-Paul; Nichol, Stuart T.; Leroy, Eric M.			Marburg Virus Infection Detected in a Common African Bat	PLOS ONE			English	Article							HEMORRHAGIC-FEVER	Marburg and Ebola viruses can cause large hemorrhagic fever (HF) outbreaks with high case fatality (80-90%) in human and great apes. Identification of the natural reservoir of these viruses is one of the most important topics in this field and a fundamental key to understanding their natural history. Despite the discovery of this virus family almost 40 years ago, the search for the natural reservoir of these lethal pathogens remains an enigma despite numerous ecological studies. Here, we report the discovery of Marburg virus in a common species of fruit bat (Rousettus aegyptiacus) in Gabon as shown by finding virus-specific RNA and IgG antibody in individual bats. These Marburg virus positive bats represent the first naturally infected non-primate animals identified. Furthermore, this is the first report of Marburg virus being present in this area of Africa, thus extending the known range of the virus. These data imply that more areas are at risk for MHF outbreaks than previously realized and correspond well with a recently published report in which three species of fruit bats were demonstrated to be likely reservoirs for Ebola virus.	[Pourrut, Xavier; Nkogue, Chimene Nze; Grard, Gilda; Leroy, Eric M.] Ctr Int Rech Med Franceville, Franceville, Gabon; [Towner, Jonathan S.; Albarino, Cesar G.; Bird, Brian H.; Ksiazek, Thomas G.; Nichol, Stuart T.] Ctr Dis Control & Prevent, Special Pathogens Branch, Atlanta, GA USA; [Pourrut, Xavier; Leroy, Eric M.] Inst Rech Dev, UR178, Franceville, Gabon; [Bird, Brian H.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Gonzalez, Jean-Paul] Inst Rech Dev, UR178, Nakhon Pathom, Thailand	Centers for Disease Control & Prevention - USA; Institut de Recherche pour le Developpement (IRD); University of California System; University of California Davis; Institut de Recherche pour le Developpement (IRD)	Leroy, EM (corresponding author), Ctr Int Rech Med Franceville, BP 769, Franceville, Gabon.	eric.leroy@ird.fr	Gonzalez, J-P/C-3077-2013; Towner, Jonathan/ABC-3780-2020; LEROY, Eric M/I-4347-2016	Gonzalez, J-P/0000-0003-3063-1770; LEROY, Eric M/0000-0003-0022-0890	Government of the United States of America; Government of Gabon, Total-Fina-Elf Gabon; Ministere de la Cooperation Francaise; Ministere des Affaires Etrangeres de la France [FSP ndegrees 2002005700]	Government of the United States of America; Government of Gabon, Total-Fina-Elf Gabon; Ministere de la Cooperation Francaise; Ministere des Affaires Etrangeres de la France	CDC is supported by the Government of the United States of America. CIRMF is supported by the Government of Gabon, Total-Fina-Elf Gabon, and the Ministere de la Cooperation Francaise. This work was also supported by a Fonds de Solidarite Prioritaire grant from the Ministere des Affaires Etrangeres de la France (FSP n degrees 2002005700).	Bausch DG, 2006, NEW ENGL J MED, V355, P909, DOI 10.1056/NEJMoa051465; Bausch DG, 2003, EMERG INFECT DIS, V9, P1531, DOI 10.3201/eid0912.030355; BERGMANS W, 1989, Beaufortia, V39, P89; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P308; Feldmann H, 2007, FIELDS VIROLOGY, P1409; Johnson ED, 1996, ARCH VIROL, P101; KINGDON J, 1974, E AFRICAN MAMMALS, P341; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Swanepoel R, 1996, EMERG INFECT DIS, V2, P321, DOI 10.3201/eid0204.960407; Towner JS, 2006, J VIROL, V80, P6497, DOI 10.1128/JVI.00069-06; TOWNER JS, 2007, J INFECT DI IN PRESS; *WHO, 2005, WKLY EPIDEMIOL REC, V80, P115	14	255	268	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e764	10.1371/journal.pone.0000764	http://dx.doi.org/10.1371/journal.pone.0000764			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712412	Green Submitted, gold, Green Published			2022-12-27	WOS:000207455300012
J	Lafourcade, M; Elezgarai, I; Mato, S; Bakiri, Y; Grandes, P; Manzoni, OJ				Lafourcade, Mathieu; Elezgarai, Izaskun; Mato, Susana; Bakiri, Yamina; Grandes, Pedro; Manzoni, Olivier J.			Molecular Components and Functions of the Endocannabinoid System in Mouse Prefrontal Cortex	PLOS ONE			English	Article								Background. Cannabinoids have deleterious effects on prefrontal cortex (PFC)-mediated functions and multiple evidences link the endogenous cannabinoid (endocannabinoid) system, cannabis use and schizophrenia, a disease in which PFC functions are altered. Nonetheless, the molecular composition and the physiological functions of the endocannabinoid system in the PFC are unknown. Methodology/Principal Findings. Here, using electron microscopy we found that key proteins involved in endocannabinoid signaling are expressed in layers V/VI of the mouse prelimbic area of the PFC: presynaptic cannabinoid CB1 receptors (CB1R) faced postsynaptic mGluR5 while diacylglycerol lipase alpha (DGL-alpha), the enzyme generating the endocannabinoid 2-arachidonoyl-glycerol (2-AG) was expressed in the same dendritic processes as mGluR5. Activation of presynaptic CB1R strongly inhibited evoked excitatory post-synaptic currents. Prolonged synaptic stimulation at 10Hz induced a profound long-term depression (LTD) of layers V/VI excitatory inputs. The endocannabinoid -LTD was presynaptically expressed and depended on the activation of postsynaptic mGluR5, phospholipase C and a rise in postsynaptic Ca2+ as predicted from the localization of the different components of the endocannabinoid system. Blocking the degradation of 2-AG (with URB 602) but not of anandamide (with URB 597) converted subthreshold tetanus to LTD-inducing ones. Moreover, inhibiting the synthesis of 2-AG with Tetrahydrolipstatin, blocked endocannabinoid-mediated LTD. All together, our data show that 2-AG mediates LTD at these synapses. Conclusions/Significance. Our data show that the endocannabinoid -retrograde signaling plays a prominent role in long-term synaptic plasticity at the excitatory synapses of the PFC. Alterations of endocannabinoid -mediated synaptic plasticity may participate to the etiology of PFC-related pathologies.	[Lafourcade, Mathieu; Mato, Susana; Bakiri, Yamina; Manzoni, Olivier J.] INSERM, U862, Equipe Physiopathol Plasticite Synapt, Bordeaux, France; [Elezgarai, Izaskun; Mato, Susana; Grandes, Pedro] Univ Basque Country, Dept Neurosci, Fac Med & Dent, Bilbao, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Basque Country	Manzoni, OJ (corresponding author), INSERM, U862, Equipe Physiopathol Plasticite Synapt, Bordeaux, France.	manzoni@bordeaux.inserm.fr	Grandes, Pedro/H-7494-2015; Elezgarai, Izaskun/H-7076-2015; Mato, Susana/AAU-3129-2020; Manzoni, Olivier/M-7899-2016; Grandes, Pedro/AAA-1627-2019	Grandes, Pedro/0000-0003-3947-4230; Elezgarai, Izaskun/0000-0003-0880-8058; Mato, Susana/0000-0002-2005-9793; Manzoni, Olivier/0000-0002-5579-6208; Lafourcade, Mathieu/0000-0001-6117-1194	INSERM; Region Aquitaine; ANR 2006 Neurosciences, Neurologie et Psychiatrie [RPV06092GSA]; MCYT [BFI2002-01474]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Aquitaine(Region Nouvelle-Aquitaine); ANR 2006 Neurosciences, Neurologie et Psychiatrie(French National Research Agency (ANR)); MCYT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Work in O.J.M.'s laboratory is supported by grants from INSERM, Region Aquitaine and "ANR 2006 Neurosciences, Neurologie et Psychiatrie n degrees RPV06092GSA''. P. Grandes' laboratory is supported by MCYT grant BFI2002-01474.	Ade KK, 2007, J NEUROSCI, V27, P2403, DOI 10.1523/JNEUROSCI.2916-06.2007; ANDREASSON S, 1988, LANCET, V1, P1000; Auclair N, 2000, J NEUROPHYSIOL, V83, P3287, DOI 10.1152/jn.2000.83.6.3287; Barbara JG, 2003, EUR J NEUROSCI, V17, P981, DOI 10.1046/j.1460-9568.2003.02533.x; Carelli RM, 2000, BRAIN RES, V866, P44, DOI 10.1016/S0006-8993(00)02217-4; Chang JY, 2000, NEUROSCIENCE, V99, P433, DOI 10.1016/S0306-4522(00)00218-9; Charpier S, 1999, NEUROSCIENCE, V91, P1209, DOI 10.1016/S0306-4522(98)00719-2; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Chhatwal JP, 2005, NEUROPSYCHOPHARMACOL, V30, P516, DOI 10.1038/sj.npp.1300655; D'Souza DC, 2005, BIOL PSYCHIAT, V57, P594, DOI 10.1016/j.biopsych.2004.12.006; De Marchi Nicola, 2003, Lipids Health Dis, V2, P5, DOI 10.1186/1476-511X-2-5; Dean B, 2001, NEUROSCIENCE, V103, P9, DOI 10.1016/S0306-4522(00)00552-2; Doherty J, 2003, CURR OPIN PHARMACOL, V3, P46, DOI 10.1016/S1471-4892(02)00014-0; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Fellous JM, 2003, NEUROSCIENCE, V122, P811, DOI 10.1016/j.neuroscience.2003.08.027; Fortin DA, 2007, CEREB CORTEX, V17, P163, DOI 10.1093/cercor/bhj133; Fourgeaud L, 2004, J NEUROSCI, V24, P6939, DOI 10.1523/JNEUROSCI.0671-04.2004; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Fride E, 2005, CNS NEUROL DISORD-DR, V4, P633, DOI 10.2174/156800705774933069; Giuffrida A, 2004, NEUROPSYCHOPHARMACOL, V29, P2108, DOI 10.1038/sj.npp.1300558; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Haller J, 2005, BEHAV PHARMACOL, V16, P415, DOI 10.1097/00008877-200509000-00014; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Hashimotodani Y, 2007, J NEUROSCI, V27, P1211, DOI 10.1523/JNEUROSCI.4159-06.2007; Hoffman AF, 2003, J NEUROSCI, V23, P4815; Hoffman AF, 2001, J NEUROPHYSIOL, V85, P72, DOI 10.1152/jn.2001.85.1.72; Howlett AC, 2002, PROSTAG OTH LIPID M, V68-9, P619, DOI 10.1016/S0090-6980(02)00060-6; Jung KM, 2005, MOL PHARMACOL, V68, P1196, DOI 10.1124/mol.105.013961; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Laviolette SR, 2006, CELL MOL LIFE SCI, V63, P1597, DOI 10.1007/s00018-006-6027-5; Laviolette SR, 2006, J NEUROSCI, V26, P6458, DOI 10.1523/JNEUROSCI.0707-06.2006; Leroy S, 2001, AM J MED GENET, V105, P749, DOI 10.1002/ajmg.10038; Leweke FM, 1999, NEUROREPORT, V10, P1665, DOI 10.1097/00001756-199906030-00008; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Makara JK, 2005, NAT NEUROSCI, V8, P1139, DOI 10.1038/nn1521; Makara JK, 2007, NAT NEUROSCI, V10, P134, DOI 10.1038/nn0107-134a; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Mateos JM, 2000, J NEUROCHEM, V74, P1301; MATHERS DC, 1992, BRIT J PSYCHIAT, V161, P648, DOI 10.1192/bjp.161.5.648; Mato S, 2005, J NEUROSCI, V25, P11619, DOI 10.1523/JNEUROSCI.2294-05.2005; Mato S, 2004, NAT NEUROSCI, V7, P585, DOI 10.1038/nn1251; Melis M, 2004, J NEUROSCI, V24, P10707, DOI 10.1523/JNEUROSCI.3502-04.2004; Myers KM, 2002, NEURON, V36, P340, DOI 10.1016/S0896-6273(02)01017-6; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Piomelli Daniele, 2005, Curr Opin Investig Drugs, V6, P672; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Robbe D, 2001, J NEUROSCI, V21, P109, DOI 10.1523/JNEUROSCI.21-01-00109.2001; Ronesi J, 2005, J PHYSIOL-LONDON, V562, P245, DOI 10.1113/jphysiol.2004.068460; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Straiker A, 2005, J PHYSIOL-LONDON, V569, P501, DOI 10.1113/jphysiol.2005.091918; Szabo B, 2006, J PHYSIOL-LONDON, V577, P263, DOI 10.1113/jphysiol.2006.119362; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; UCHIGASHIMA M, 2007, J NEUROSCI IN PRESS; Ujike H, 2004, J PHARMACOL SCI, V96, P376, DOI 10.1254/jphs.FMJ04003X4; Ujike H, 2002, MOL PSYCHIATR, V7, P515, DOI 10.1038/sj.mp.4001029; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006; Zavitsanou K, 2004, PROG NEURO-PSYCHOPH, V28, P355, DOI 10.1016/j.pnpbp.2003.11.005	61	180	181	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e709	10.1371/journal.pone.0000709	http://dx.doi.org/10.1371/journal.pone.0000709			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684555	Green Published, gold			2022-12-27	WOS:000207452400012
J	Jakob, W; Schierwater, B				Jakob, Wolfgang; Schierwater, Bernd			Changing Hydrozoan Bauplans by Silencing Hox-Like Genes	PLOS ONE			English	Article							HYDRACTINIA-SYMBIOLONGICARPUS CNIDARIA; HOMEOBOX GENES; ONCOPELTUS-FASCIATUS; EXPRESSION; MORPHOLINO; ORIGINS; CNOX-2; HYDRA; EVOLUTION; CONSERVATION	Regulatory genes of the Antp class have been a major factor for the invention and radiation of animal bauplans. One of the most diverse animal phyla are the Cnidaria, which are close to the root of metazoan life and which often appear in two distinct generations and a remarkable variety of body forms. Hox-like genes have been known to be involved in axial patterning in the Cnidaria and have been suspected to play roles in the genetic control of many of the observed bauplan changes. Unfortunately RNAi mediated gene silencing studies have not been satisfactory for marine invertebrate organisms thus far. No direct evidence supporting Hox-like gene induced bauplan changes in cnidarians have been documented as of yet. Herein, we report a protocol for RNAi transfection of marine invertebrates and demonstrate that knock downs of Hox-like genes in Cnidaria create substantial bauplan alterations, including the formation of multiple oral poles ("heads'') by Cnox-2 and Cnox-3 inhibition, deformation of the main body axis by Cnox-5 inhibition and duplication of tentacles by Cnox-1 inhibition. All phenotypes observed in the course of the RNAi studies were identical to those obtained by morpholino antisense oligo experiments and are reminiscent of macroevolutionary bauplan changes. The reported protocol will allow routine RNAi studies in marine invertebrates to be established.	[Jakob, Wolfgang; Schierwater, Bernd] Stiftung Tieraerztliche Hsch Hannover, Div Ecol & Evolut, Hannover, Germany; [Schierwater, Bernd] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA	University of Veterinary Medicine Hannover, Foundation; Yale University	Jakob, W (corresponding author), Stiftung Tieraerztliche Hsch Hannover, Div Ecol & Evolut, Hannover, Germany.	wolfgang.jakob@ecolevol.de			DFG [Schi-277/20-1]	DFG(German Research Foundation (DFG))	DFG Schi-277/20-1	AERNE BL, 1995, DEV BIOL, V169, P547, DOI 10.1006/dbio.1995.1168; Amali AA, 2004, DEV DYNAM, V229, P847, DOI 10.1002/dvdy.10454; Blackstone NW, 2003, J EXP ZOOL PART B, V297B, P35, DOI 10.1002/jez.b.00016; Bode HR, 2001, AM ZOOL, V41, P621, DOI 10.1668/0003-1569(2001)041[0621:TROHGI]2.0.CO;2; Boero F, 1997, ITAL J ZOOL, V64, P359, DOI 10.1080/11250009709356223; BOUILLON J, 2006, INTRO HYDROZOA, P591; BOUILLON J, 2000, PHYLOGENY CLASSIFICA, P296; Buchon N, 2006, HEREDITY, V96, P195, DOI 10.1038/sj.hdy.6800789; Cartwright P, 1999, P NATL ACAD SCI USA, V96, P2183, DOI 10.1073/pnas.96.5.2183; Cartwright P, 1999, J EXP ZOOL, V285, P57, DOI 10.1002/(SICI)1097-010X(19990415)285:1<57::AID-JEZ7>3.0.CO;2-P; CARTWRIGHT P, 2006, J EXP ZOOL PART B, V306, P1; Deutsch J, 2005, BIOESSAYS, V27, P673, DOI 10.1002/bies.20260; Endl I, 1999, P NATL ACAD SCI USA, V96, P1445, DOI 10.1073/pnas.96.4.1445; Ferrier DEK, 2001, EVOL DEV, V3, P263, DOI 10.1046/j.1525-142x.2001.003004263.x; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; Finnerty JR, 1998, CURR TOP DEV BIOL, V40, P211, DOI 10.1016/S0070-2153(08)60368-3; Finnerty JR, 1997, BIOL BULL-US, V193, P62, DOI 10.2307/1542736; Finnerty JR, 1999, EVOL DEV, V1, P16, DOI 10.1046/j.1525-142x.1999.99010.x; Finnerty JR, 2003, INT J DEV BIOL, V47, P523; Finnerty JR, 2003, EVOL DEV, V5, P331, DOI 10.1046/j.1525-142X.2003.03041.x; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Galliot B, 2002, INT J DEV BIOL, V46, P39; Gauchat D, 2000, P NATL ACAD SCI USA, V97, P4493, DOI 10.1073/pnas.97.9.4493; HAUENSCHILD C, 1957, Z NATURFORSCH B, V12, P7; HAUENSCHILD C, 1957, Z NATURFORSCH B, V12, P6; HAUENSCHILD C, 1956, Z NATURFORSCH B, V11, P7; Hayward DC, 2001, DEV GENES EVOL, V211, P10; Herke SW, 2005, DEVELOPMENT, V132, P27, DOI 10.1242/dev.01561; Hughes CL, 2000, DEVELOPMENT, V127, P3683; Jakob W, 2004, DEV GENES EVOL, V214, P170, DOI 10.1007/s00427-004-0390-8; Kamm K, 2006, CURR BIOL, V16, P920, DOI 10.1016/j.cub.2006.03.036; Kuhn K, 1996, MOL PHYLOGENET EVOL, V6, P30, DOI 10.1006/mpev.1996.0055; Li M, 2006, CELL RES, V16, P99, DOI 10.1038/sj.cr.7310013; Li YX, 2000, DEV BIOL, V217, P394, DOI 10.1006/dbio.1999.9540; Lohmann JU, 1999, DEV BIOL, V214, P211, DOI 10.1006/dbio.1999.9407; Mokady O, 1998, P NATL ACAD SCI USA, V95, P3673, DOI 10.1073/pnas.95.7.3673; Momose T, 2007, PLOS BIOL, V5, P889, DOI 10.1371/journal.pbio.0050070; Morcos PA, 2001, GENESIS, V30, P94, DOI 10.1002/gene.1039; MURTHA MT, 1991, P NATL ACAD SCI USA, V88, P10711, DOI 10.1073/pnas.88.23.10711; NAITO M, 1993, FEBS LETT, V333, P271, DOI 10.1016/0014-5793(93)80668-K; Partridge M, 1996, ANTISENSE NUCLEIC A, V6, P169, DOI 10.1089/oli.1.1996.6.169; Ryan JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000153; SCHIERWATER B, 1989, J MORPHOL, V200, P255, DOI 10.1002/jmor.1052000304; SCHIERWATER B, 1991, J EXP ZOOL, V260, P413, DOI 10.1002/jez.1402600316; Schierwater B, 1998, MOL PHYLOGENET EVOL, V9, P375, DOI 10.1006/mpev.1998.0489; Schubert M, 2006, DEV BIOL, V296, P190, DOI 10.1016/j.ydbio.2006.04.457; SCHUMMER M, 1992, EMBO J, V11, P1815, DOI 10.1002/j.1460-2075.1992.tb05233.x; SHENK MA, 1993, DEV BIOL, V160, P108, DOI 10.1006/dbio.1993.1290; SHENK MA, 1993, DEVELOPMENT, V117, P657; Smith KM, 2000, DEVELOPMENT, V127, P4743; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P63, DOI 10.1089/oli.1.1997.7.63; Van Auken K, 2000, P NATL ACAD SCI USA, V97, P4499, DOI 10.1073/pnas.97.9.4499; Wikramanayake AH, 2004, GENESIS, V39, P194, DOI 10.1002/gene.20045; Yamada L, 2003, DEVELOPMENT, V130, P6485, DOI 10.1242/dev.00847; Yanze N, 2001, DEV BIOL, V236, P89, DOI 10.1006/dbio.2001.0299	56	22	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e694	10.1371/journal.pone.0000694	http://dx.doi.org/10.1371/journal.pone.0000694			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668071	gold, Green Published, Green Submitted			2022-12-27	WOS:000207452300029
J	Brockhurst, MA				Brockhurst, Michael A.			Population Bottlenecks Promote Cooperation in Bacterial Biofilms	PLOS ONE			English	Article								Population bottlenecks are assumed to play a key role in the maintenance of social traits in microbes. Ecological parameters such as colonisation or disturbances can favour cooperation through causing population bottlenecks that enhance genetic structuring (relatedness). However, the size of the population bottleneck is likely to play a crucial role in determining the success of cooperation. Relatedness is likely to increase with decreasing bottleneck size thus favouring the evolution of cooperation. I used an experimental evolution approach to test this prediction with biofilm formation by the bacterium Pseudomonas fluorescens as the cooperative trait. Replicate populations were exposed to disturbance events every four days under one of six population bottleneck treatments (from 10 3 to 10 8 bacterial cells). In line with predictions, the frequency of evolved cheats within the populations increased with increasing bottleneck size. This result highlights the importance of ecologically mediated population bottlenecks in the maintenance of social traits in microbes.	Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Brockhurst, MA (corresponding author), Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England.	michael.brockhurst@liv.ac.uk	Brockhurst, Michael A/A-6247-2009	Brockhurst, Michael/0000-0003-0362-820X	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	Funding: Funded by the Wellcome Trust through the Research Development Fund of the University of Liverpool.	Brockhurst MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000193; Brockhurst MA, 2007, CURR BIOL, V17, P761, DOI 10.1016/j.cub.2007.02.057; Brockhurst MA, 2006, CURR BIOL, V16, P2030, DOI 10.1016/j.cub.2006.08.068; Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Frank, 1998, FDN SOCIAL EVOLUTION; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HAMILTON WD, 1997, NARROW ROADS GENE LA, V1; Harrison F, 2005, CURR BIOL, V15, P1968, DOI 10.1016/j.cub.2005.09.048; Hodgson DJ, 2002, P ROY SOC B-BIOL SCI, V269, P2277, DOI 10.1098/rspb.2002.2146; MacLean RC, 2006, NATURE, V441, P498, DOI 10.1038/nature04624; MacLean RC, 2004, P NATL ACAD SCI USA, V101, P8072, DOI 10.1073/pnas.0307195101; MAYNARDSMITH J, 2000, BIOESSAYS, V22, P1115; Mitteldorf J, 2000, J THEOR BIOL, V204, P481, DOI 10.1006/jtbi.2000.2007; Parr LA, 1999, NATURE, V399, P647, DOI 10.1038/21345; PETRAITIS PS, 1989, Q REV BIOL, V64, P393, DOI 10.1086/416457; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Sharp SP, 2005, NATURE, V434, P1127, DOI 10.1038/nature03522; Spiers AJ, 2002, GENETICS, V161, P33; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; Velicer GJ, 1998, P NATL ACAD SCI USA, V95, P12376, DOI 10.1073/pnas.95.21.12376; Velicer GJ, 2003, TRENDS MICROBIOL, V11, P330, DOI 10.1016/S0966-842X(03)00152-5; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969	31	30	32	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e634	10.1371/journal.pone.0000634	http://dx.doi.org/10.1371/journal.pone.0000634			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653261	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452200003
J	Yoo, SY; Kim, Y; Kim, SY; Lee, JS; Ahn, JH				Yoo, So Yeon; Kim, Yunhee; Kim, Soo Young; Lee, Jong Seob; Ahn, Ji Hoon			Control of Flowering Time and Cold Response by a NAC-Domain Protein in Arabidopsis	PLOS ONE			English	Article								Background. Plants must integrate complex signals from environmental and endogenous cues to fine-tune the timing of flowering. Low temperature is one of the most common environmental stresses that affect flowering time; however, molecular mechanisms underlying the cold temperature regulation of flowering time are not fully understood. Methodology/Principal Findings. We report the identification of a novel regulator, LONG VEGETATIVE PHASE 1 (LOV1), that controls flowering time and cold response. An Arabidopsis mutant, long v egetative phase 1-1D (lov1-1D) showing the late-flowering phenotype, was isolated by activation tagging screening. Subsequent analyses demonstrated that the phenotype of the mutant resulted from the overexpression of a NAC-domain protein gene (At2g02450). Both gain-and loss-of-function alleles of LOV1 affected flowering time predominantly under long-day but not short-day conditions, suggesting that LOV1 may act within the photoperiod pathway. The expression of CONSTANS (CO), a floral promoter, was affected by LOV1 level, suggesting that LOV1 controls flowering time by negatively regulating CO expression. The epistatic relationship between CO and LOV1 was consistent with this proposed regulatory pathway. Physiological analyses to elucidate upstream signalling pathways revealed that LOV1 regulates the cold response in plants. Loss of LOV1 function resulted in hypersensitivity to cold temperature, whereas a gain-of-function allele conferred cold tolerance. The freezing tolerance was accompanied by upregulation of cold response genes, COLD-REGULATED 15A (COR15A) and COLD INDUCED 1 (KIN1) without affecting expression of the C-repeat-binding factor/dehydration responsive element-binding factor 1 (CBF/DREB1) family of genes. Conclusions. Our study shows that LOV1 functions as a floral repressor that negatively regulates CO expression under long-day conditions and acts as a common regulator of two intersecting pathways that regulate flowering time and the cold response, respectively. Our results suggest an overlapping pathway for controlling cold stress response and flowering time in plants.	[Kim, Soo Young] Chonnam Natl Univ, Dept Mol Biotechnol, Kwangju, South Korea; [Kim, Soo Young] Chonnam Natl Univ, Kumho Life Sci Lab, Coll Agr & Life Sci, Kwangju, South Korea; [Yoo, So Yeon; Ahn, Ji Hoon] Korea Univ, Plant Signaling Network Res Ctr, Sch Life Sci & Biotechnol, Seoul, South Korea; [Kim, Yunhee; Lee, Jong Seob] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea	Chonnam National University; Chonnam National University; Korea University; Seoul National University (SNU)	Kim, SY (corresponding author), Chonnam Natl Univ, Dept Mol Biotechnol, Kwangju, South Korea.	sooykim@chonnam.ac.kr; jongslee@plaza.snu.ac.kr; jahn@korea.ac.kr	Ahn, Ji Hoon/A-4141-2011	Ahn, Ji Hoon/0000-0003-0347-3922	Crop Functional Genomics Center; Plant Signaling Network Research Center of Korea University; Korea Research Foundation	Crop Functional Genomics Center; Plant Signaling Network Research Center of Korea University; Korea Research Foundation(National Research Foundation of Korea)	Funding: This work was supported by the Crop Functional Genomics Center of the 21C Frontier Program (J.S.L.) and the Plant Signaling Network Research Center of Korea University (J.H.A.). S.Y.Y. was supported by BK21 program and a grant for pre-doctoral students of Korea Research Foundation.	Ahn JH, 2007, PLANT CELL PHYSIOL, V48, P169, DOI 10.1093/pcp/pcl052; Artus NN, 1996, P NATL ACAD SCI USA, V93, P13404, DOI 10.1073/pnas.93.23.13404; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Boyce JM, 2003, PLANT J, V34, P395, DOI 10.1046/j.1365-313X.2003.01734.x; Cao SQ, 2005, PLANT CELL REP, V24, P683, DOI 10.1007/s00299-005-0061-x; Chen MJ, 2006, PLANT J, V46, P823, DOI 10.1111/j.1365-313X.2006.02740.x; CHOUARD P, 1960, ANNU REV PLANT PHYS, V11, P191, DOI 10.1146/annurev.pp.11.060160.001203; Davis SJ, 1998, PLANT MOL BIOL, V36, P521, DOI 10.1023/A:1005991617182; Fittinghoff K, 2006, PLANT J, V47, P577, DOI 10.1111/j.1365-313X.2006.02812.x; Henderson IR, 2004, DEVELOPMENT, V131, P3829, DOI 10.1242/dev.01294; Hepworth SR, 2002, EMBO J, V21, P4327, DOI 10.1093/emboj/cdf432; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P550, DOI 10.1016/j.tplants.2006.09.004; Johnson CH, 2001, ANNU REV PHYSIOL, V63, P695, DOI 10.1146/annurev.physiol.63.1.695; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Knight H, 1999, PLANT CELL, V11, P875, DOI 10.1105/tpc.11.5.875; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Koornneef M, 1998, ANNU REV PLANT PHYS, V49, P345, DOI 10.1146/annurev.arplant.49.1.345; KURKELA S, 1992, PLANT MOL BIOL, V19, P689, DOI 10.1007/BF00026794; KURKELA S, 1990, PLANT MOL BIOL, V15, P137, DOI 10.1007/BF00017731; Laubinger S, 2006, DEVELOPMENT, V133, P3213, DOI 10.1242/dev.02481; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Mizoguchi T, 2005, PLANT CELL, V17, P2255, DOI 10.1105/tpc.105.033464; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Qu LJ, 2006, CURR OPIN PLANT BIOL, V9, P544, DOI 10.1016/j.pbi.2006.07.005; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Sessions A, 2000, SCIENCE, V289, P779, DOI 10.1126/science.289.5480.779; Sharma P, 2005, BIOESSAYS, V27, P1048, DOI 10.1002/bies.20307; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; STONE JM, 1993, P NATL ACAD SCI USA, V90, P7869, DOI 10.1073/pnas.90.16.7869; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Sung S, 2005, ANNU REV PLANT BIOL, V56, P491, DOI 10.1146/annurev.arplant.56.032604.144307; TEUTONICO RA, 1995, MOL BREEDING, V1, P329, DOI 10.1007/BF01248410; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; YAMAGUCHISHINOZAKI K, 1993, MOL GEN GENET, V236, P331, DOI 10.1007/BF00277130; Yoo SY, 2005, PLANTA, V221, P523, DOI 10.1007/s00425-004-1466-4; Zhu JH, 2004, P NATL ACAD SCI USA, V101, P9873, DOI 10.1073/pnas.0403166101	49	127	157	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e642	10.1371/journal.pone.0000642	http://dx.doi.org/10.1371/journal.pone.0000642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653269	Green Published, gold, Green Submitted			2022-12-27	WOS:000207452200011
J	Sequeira, SJ; Ranganathan, AC; Adam, AP; Iglesias, BV; Farias, EF; Aguirre-Ghiso, JA				Sequeira, Sharon J.; Ranganathan, Aparna C.; Adam, Alejandro P.; Iglesias, Bibiana V.; Farias, Eduardo F.; Aguirre-Ghiso, Julio A.			Inhibition of Proliferation by PERK Regulates Mammary Acinar Morphogenesis and Tumor Formation	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; INDUCED GENE-EXPRESSION; EPITHELIAL-CELL LINE; MESSENGER-RNA; ALPHA(6)BETA(4) INTEGRIN; TRANSLATIONAL CONTROL; BREAST-CANCER; ACTIVATION; APOPTOSIS; KINASE	Endoplasmic reticulum ( ER) stress signaling can be mediated by the ER kinase PERK, which phosphorylates its substrate eIF2 alpha. This in turn, results in translational repression and the activation of downstream programs that can limit cell growth through cell cycle arrest and/or apoptosis. These responses can also be initiated by perturbations in cell adhesion. Thus, we hypothesized that adhesion-dependent regulation of PERK signaling might determine cell fate. We tested this hypothesis in a model of mammary acini development, a morphogenetic process regulated in part by adhesion signaling. Here we report a novel role for PERK in limiting MCF10A mammary epithelial cell proliferation during acinar morphogenesis in 3D Matrigel culture as well as in preventing mammary tumor formation in vivo. We show that loss of adhesion to a suitable substratum induces PERK-dependent phosphorylation of eIF2a and selective upregulation of ATF4 and GADD153. Further, inhibition of endogenous PERK signaling during acinar morphogenesis, using two dominant-negative PERK mutants (PERK-Delta C or PERK-K618A), does not affect apoptosis but results instead in hyper-proliferative and enlarged lumen-filled acini, devoid of proper architecture. This phenotype correlated with an adhesion-dependent increase in translation initiation, Ki67 staining and upregulation of Laminin-5, ErbB1 and ErbB2 expression. More importantly, the MCF10A cells expressing PERK Delta C, but not a vector control, were tumorigenic in vivo upon orthotopic implantation in denuded mouse mammary fat pads. Our results reveal that the PERK pathway is responsive to adhesion-regulated signals and that it is essential for proper acinar morphogenesis and in preventing mammary tumor formation. The possibility that deficiencies in PERK signaling could lead to hyperproliferation of the mammary epithelium and increase the likelihood of tumor formation, is of significance to the understanding of breast cancer.	[Sequeira, Sharon J.; Ranganathan, Aparna C.; Adam, Alejandro P.; Iglesias, Bibiana V.; Aguirre-Ghiso, Julio A.] SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Rensselaer, NY USA; [Sequeira, Sharon J.; Ranganathan, Aparna C.; Adam, Alejandro P.; Iglesias, Bibiana V.; Aguirre-Ghiso, Julio A.] SUNY Albany, Ctr Excellence Canc Genom, Rensselaer, NY USA; [Farias, Eduardo F.] Mt Sinai Sch Med, Dept Med, Div Hematol Oncol, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Icahn School of Medicine at Mount Sinai	Aguirre-Ghiso, JA (corresponding author), SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Rensselaer, NY USA.	jaguirre-ghiso@albany.edu	Adam, Alejandro/M-6541-2013	Adam, Alejandro/0000-0001-6285-7235; Aguirre-Ghiso, Julio/0000-0002-6694-6507	Samuel Waxman Cancer Research Foundation; NIH/National Cancer Institute [CA109182]; Ruth L. Kirschstein National Research Service Award; NIH [CA119018]; NATIONAL CANCER INSTITUTE [R01CA119018, R01CA109182] Funding Source: NIH RePORTER	Samuel Waxman Cancer Research Foundation; NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by grants from the Samuel Waxman Cancer Research Foundation Tumor Dormancy Program and an NIH/National Cancer Institute grant CA109182 (to JAAG), a Ruth L. Kirschstein National Research Service Award (NIH/National Cancer Institute) Fellowship (to ACR) and an NIH grant CA119018 (to EFF).	Bagheri-Yarmand R, 2003, J BIOL CHEM, V278, P17421, DOI 10.1074/jbc.M300761200; BARONE MV, 1994, GENE DEV, V8, P453, DOI 10.1101/gad.8.4.453; BENECKE BJ, 1978, CELL, V14, P931, DOI 10.1016/0092-8674(78)90347-1; BENECKE BJ, 1980, J CELL PHYSIOL, V103, P247, DOI 10.1002/jcp.1041030209; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Biason-Lauber A, 2002, DIABETES, V51, P2301, DOI 10.2337/diabetes.51.7.2301; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boudreau N, 1998, CURR OPIN CELL BIOL, V10, P640, DOI 10.1016/S0955-0674(98)80040-9; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; BROOKS RF, 1977, CELL, V12, P311, DOI 10.1016/0092-8674(77)90209-4; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CHEN JJ, 1995, TRENDS BIOCHEM SCI, V20, P105, DOI 10.1016/S0968-0004(00)88975-6; Chipuk JE, 2005, NAT REV MOL CELL BIO, V6, P268, DOI [10.1038/nrm1573, 10.1038/nrm2239]; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Collins NL, 2005, MOL CELL BIOL, V25, P5282, DOI 10.1128/MCB.25.12.5282-5291.2005; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; DONZE O, 1995, EMBO J, V14, P3828, DOI 10.1002/j.1460-2075.1995.tb00052.x; Faraldo MM, 2001, EMBO REP, V2, P431, DOI 10.1093/embo-reports/kve086; FARMER SR, 1978, CELL, V15, P627, DOI 10.1016/0092-8674(78)90031-4; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gan BY, 2006, J BIOL CHEM, V281, P37321, DOI 10.1074/jbc.M605241200; Gorrini C, 2005, P NATL ACAD SCI USA, V102, P9200, DOI 10.1073/pnas.0409513102; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harris J, 1999, DIS BREAST; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Muraoka-Cook RS, 2005, CLIN CANCER RES, V11, p937S; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Ranganathan AC, 2006, CANCER BIOL THER, V5, P729, DOI 10.4161/cbt.5.7.2968; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Siegel J, 1998, INT J ONCOL, V13, P1259; Sonenberg N, 2000, TRANSLATIONAL CONTRO; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; SOULE HD, 1990, CANCER RES, V50, P6075; Talukder AH, 2002, ONCOGENE, V21, P4289, DOI 10.1038/sj.onc.1205529; Valentijn AJ, 2004, J BIOL CHEM, V279, P32848, DOI 10.1074/jbc.M313375200; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Yoon SO, 2006, CANCER RES, V66, P2732, DOI 10.1158/0008-5472.CAN-05-2941; Zahir N, 2003, J CELL BIOL, V163, P1397, DOI 10.1083/jcb.200302023; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365	64	59	58	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2007	2	7							e615	10.1371/journal.pone.0000615	http://dx.doi.org/10.1371/journal.pone.0000615			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GI	17637831	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452100005
J	Reyes, CL; Rutenber, E; Walter, P; Stroud, RM				Reyes, Christopher L.; Rutenber, Earl; Walter, Peter; Stroud, Robert M.			X-ray Structures of the Signal Recognition Particle Receptor Reveal Targeting Cycle Intermediates	PLOS ONE			English	Article							MEMBRANE ASSOCIATION; CRYSTAL-STRUCTURE; GTP HYDROLYSIS; NG DOMAIN; SRP; FTSY; PROTEIN; FFH; DIFFRACTION; MECHANISM	The signal recognition particle (SRP) and its conjugate receptor (SR) mediate cotranslational targeting of a subclass of proteins destined for secretion to the endoplasmic reticulum membrane in eukaryotes or to the plasma membrane in prokaryotes. Conserved active site residues in the GTPase domains of both SRP and SR mediate discrete conformational changes during formation and dissociation of the SRP? SR complex. Here, we describe structures of the prokaryotic SR, FtsY, as an apo protein and in two different complexes with a non-hydrolysable GTP analog (GMPPNP). These structures reveal intermediate conformations of FtsY containing GMPPNP and explain how the conserved active site residues position the nucleotide into a non-catalytic conformation. The basis for the lower specificity of binding of nucleotide in FtsY prior to heterodimerization with the SRP conjugate Ffh is also shown. We propose that these structural changes represent discrete conformational states assumed by FtsY during targeting complex formation and dissociation.	[Reyes, Christopher L.; Stroud, Robert M.] Univ Calif San Francisco, Dept Biochem & Biophys, Grad Grp Biophys, San Francisco, CA 94143 USA; [Rutenber, Earl; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Stroud, RM (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Grad Grp Biophys, San Francisco, CA 94143 USA.	stroud@msg.ucsf.edu			National Institutes of Health [GM 60641, GM 32384]; Ford Foundation; NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032384, R37GM032384, R01GM060641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ford Foundation; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM 60641 to RMS and is by GM 32384 to PW. PW is an investigator of the Howard Hughes Medical Institute. Christopher Reyes was supported by a Ford Foundation Minority Fellowship and the NIGMS Minority Graduate Fellowship.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CONNOLLY T, 1991, SCIENCE, V252, P1171, DOI 10.1126/science.252.5009.1171; CONNOLLY T, 1989, CELL, V57, P599, DOI 10.1016/0092-8674(89)90129-3; de Leeuw E, 2000, EMBO J, V19, P531, DOI 10.1093/emboj/19.4.531; deLeeuw E, 1997, FEBS LETT, V416, P225, DOI 10.1016/S0014-5793(97)01238-6; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Focia PJ, 2006, J MOL BIOL, V360, P631, DOI 10.1016/j.jmb.2006.05.031; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Freymann DM, 1997, NATURE, V385, P361, DOI 10.1038/385361a0; Freymann DM, 1999, NAT STRUCT BIOL, V6, P793, DOI 10.1038/11572; Gariani T, 2006, J STRUCT BIOL, V153, P85, DOI 10.1016/j.jsb.2005.10.003; GAWRONSKISALERN.J, 2006, PROTEINS; GAWRONSKISALERN.J, 2006, J STRUCT BIOL; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Jagath JR, 2000, J MOL BIOL, V295, P745, DOI 10.1006/jmbi.1999.3427; *JOINT CTR STRUCT, 2007, CRYST STRUCT CELL DI; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Montoya G, 1997, PROTEINS, V28, P285, DOI 10.1002/(SICI)1097-0134(199706)28:2<285::AID-PROT15>3.0.CO;2-E; Montoya G, 1997, NATURE, V385, P365, DOI 10.1038/385365a0; Moser C, 1997, P NATL ACAD SCI USA, V94, P11339, DOI 10.1073/pnas.94.21.11339; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padmanabhan S, 2001, STRUCTURE, V9, P859, DOI 10.1016/S0969-2126(01)00641-4; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; POWERS T, 1995, SCIENCE, V269, P1422, DOI 10.1126/science.7660124; Shan SO, 2004, PLOS BIOL, V2, P1572, DOI 10.1371/journal.pbio.0020320; Shan SO, 2003, P NATL ACAD SCI USA, V100, P4480, DOI 10.1073/pnas.0737693100; Shepotinovskaya IV, 2002, BBA-PROTEIN STRUCT M, V1597, P107, DOI 10.1016/S0167-4838(02)00287-X; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Zelazny A, 1997, P NATL ACAD SCI USA, V94, P6025, DOI 10.1073/pnas.94.12.6025; Zhang JT, 2000, BIOCHEM J, V348, P597, DOI 10.1042/0264-6021:3480597	33	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2007	2	7							e607	10.1371/journal.pone.0000607	http://dx.doi.org/10.1371/journal.pone.0000607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GH	17622352	Green Published, gold			2022-12-27	WOS:000207452000014
J	Holst, CR; Bou-Reslan, H; Gore, BB; Wong, K; Grant, D; Chalasani, S; Carano, RA; Frantz, GD; Tessier-Lavigne, M; Bolon, B; French, DM; Ashkenazi, A				Holst, Charles R.; Bou-Reslan, Hani; Gore, Bryan B.; Wong, Karen; Grant, Deanna; Chalasani, Sreedevi; Carano, Richard A.; Frantz, Gretchen D.; Tessier-Lavigne, Marc; Bolon, Brad; French, Dorothy M.; Ashkenazi, Avi			Secreted Sulfatases Sulf1 and Sulf2 Have Overlapping yet Essential Roles in Mouse Neonatal Survival	PLOS ONE			English	Article								Background. Heparan sulfate proteoglycans (HSPGs) use highly sulfated polysaccharide side-chains to interact with several key growth factors and morphogens, thereby regulating their accessibility and biological activity. Various sulfotransferases and sulfatases with differing specificities control the pattern of HSPG sulfation, which is functionally critical. Among these enzymes in the mouse are two secreted 6-O-endosulfatases, Sulf1 and Sulf2, which modify HSPGs in the extracellular matrix and on the cell surface. The roles of Sulf1 and Sulf2 during normal development are not well understood. Methods/Results. To investigate the importance of Sulf1 and Sulf2 for embryonic development, we generated mice genetically deficient in these genes and assessed the phenotypes of the resulting secreted sulfatase-deficient mice. Surprisingly, despite the established crucial role of HSPG interactions during development, neither Sulf1- nor Sulf2-deficient mice showed significant developmental flaws. In contrast, mice deficient in both Sulf1and Sulf2 exhibited highly penetrant neonatal lethality. Loss of viability was associated with multiple, although subtle, developmental defects, including skeletal and renal abnormalities. Conclusions. These results show that Sulf1 and Sulf2 play overlapping yet critical roles in mouse development and are redundant and essential for neonatal survival.	[Holst, Charles R.; Ashkenazi, Avi] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; [Bou-Reslan, Hani; Carano, Richard A.] Genentech Inc, Dept Biomed Imaging, San Francisco, CA 94080 USA; [Gore, Bryan B.; Wong, Karen; Tessier-Lavigne, Marc] Genentech Inc, Dept Res Drug Discovery, San Francisco, CA 94080 USA; [Grant, Deanna] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Chalasani, Sreedevi; Frantz, Gretchen D.; French, Dorothy M.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Gore, Bryan B.] Stanford Univ, Grad Program Neurosci, Stanford, CA 94305 USA; [Bolon, Brad] GEMpath Inc, Cedar City, UT USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Stanford University	Ashkenazi, A (corresponding author), Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA.	aa@gene.com	Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589; Holst, Charles/0000-0001-8010-1677	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	Genentech, Inc. funded this research project.	Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Bink RJ, 2003, J BIOL CHEM, V278, P31118, DOI 10.1074/jbc.M213124200; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Chen E, 2005, DEV BIOL, V284, P364, DOI 10.1016/j.ydbio.2005.05.032; Cole F, 2003, CURR BIOL, V13, P411, DOI 10.1016/S0960-9822(03)00088-5; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; Fan GP, 2000, FEBS LETT, V467, P7, DOI 10.1016/S0014-5793(00)01111-X; Forsberg E, 2001, J CLIN INVEST, V108, P175, DOI 10.1172/JCI13561; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Hajihosseini MK, 2004, DEVELOPMENT, V131, P325, DOI 10.1242/dev.00940; Jena N, 1997, EXP CELL RES, V230, P28, DOI 10.1006/excr.1996.3411; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Katagiri T, 1998, DEV GENET, V22, P340, DOI 10.1002/(SICI)1520-6408(1998)22:4<340::AID-DVG4>3.0.CO;2-6; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Lai JP, 2004, ONCOGENE, V23, P1439, DOI 10.1038/sj.onc.1207258; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lum DH, 2007, MOL CELL BIOL, V27, P678, DOI 10.1128/MCB.01279-06; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; McLaughlin D, 2003, MECH DEVELOP, V120, P1481, DOI 10.1016/j.mod.2003.08.008; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nagamine S, 2005, DEV BRAIN RES, V159, P135, DOI 10.1016/j.devbrainres.2005.07.006; Ohto T, 2002, GENES CELLS, V7, P173, DOI 10.1046/j.1356-9597.2001.00502.x; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Solloway MJ, 1998, DEV GENET, V22, P321, DOI 10.1002/(SICI)1520-6408(1998)22:4<321::AID-DVG3>3.3.CO;2-7; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Uchimura Kenji, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-2; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wang O, 2001, DEVELOPMENT, V128, P3867; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; YAGI T, 1993, NATURE, V366, P742, DOI 10.1038/366742a0; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	46	98	99	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e575	10.1371/journal.pone.0000575	http://dx.doi.org/10.1371/journal.pone.0000575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593974	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451800019
J	Liu, Y; Li, ZJ; Lin, QS; Kosinski, J; Seetharaman, J; Bujnicki, JM; Sivaraman, J; Hew, CL				Liu, Yang; Li, Zhengjun; Lin, Qingsong; Kosinski, Jan; Seetharaman, J.; Bujnicki, Janusz M.; Sivaraman, J.; Hew, Choy-Leong			Structure and Evolutionary Origin of Ca2+-Dependent Herring Type II Antifreeze Protein	PLOS ONE			English	Article								In order to survive under extremely cold environments, many organisms produce antifreeze proteins (AFPs). AFPs inhibit the growth of ice crystals and protect organisms from freezing damage. Fish AFPs can be classified into five distinct types based on their structures. Here we report the structure of herring AFP (hAFP), a Ca2+-dependent fish type II AFP. It exhibits a fold similar to the C-type (Ca2+-dependent) lectins with unique ice-binding features. The 1.7 angstrom crystal structure of hAFP with bound Ca2+ and site-directed mutagenesis reveal an ice-binding site consisting of Thr96, Thr98 and Ca2+-coordinating residues Asp94 and Glu99, which initiate hAFP adsorption onto the [10-10] prism plane of the ice lattice. The hAFP-ice interaction is further strengthened by the bound Ca2+ through the coordination with a water molecule of the ice lattice. This Ca2+-coordinated ice-binding mechanism is distinct from previously proposed mechanisms for other AFPs. However, phylogenetic analysis suggests that all type II AFPs evolved from the common ancestor and developed different ice-binding modes. We clarify the evolutionary relationship of type II AFPs to sugar-binding lectins.	[Liu, Yang; Li, Zhengjun; Lin, Qingsong; Sivaraman, J.; Hew, Choy-Leong] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Kosinski, Jan; Bujnicki, Janusz M.] Int Inst Mol & Cell Biol, Warsaw, Poland; [Kosinski, Jan; Bujnicki, Janusz M.] Brookhaven Natl Lab, Upton, NY 11973 USA	National University of Singapore; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; United States Department of Energy (DOE); Brookhaven National Laboratory	Sivaraman, J (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsjayar@nus.edu.sg; dbshewcl@nus.edu.sg	Sivaraman, J/H-8028-2012; Hew, Choy Leong/I-1501-2012; Kosinski, Jan/G-9971-2012; Kosinski, Jan/V-8540-2019; Lin, Qingsong/H-9794-2012	Hew, Choy Leong/0000-0002-9441-0064; Kosinski, Jan/0000-0002-3641-0322; Lin, Qingsong/0000-0001-9117-8514	National University of Singapore	National University of Singapore(National University of Singapore)	This work was supported by the office of life sciences and Academic research Fund (ARF), National University of Singapore (C. L. H and J. S.*).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bertrand JA, 1996, EMBO J, V15, P2678, DOI 10.1002/j.1460-2075.1996.tb00628.x; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAKRABARTTY A, 1989, J BIOL CHEM, V264, P11307; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ewart KV, 1999, CELL MOL LIFE SCI, V55, P271, DOI 10.1007/s000180050289; Ewart KV, 1996, J BIOL CHEM, V271, P16627, DOI 10.1074/jbc.271.28.16627; EWART KV, 1993, THESIS MEMORIAL U NE; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; Fletcher GL, 1999, CHEMTECH, V29, P17; FORTELLE EDL, 1997, METHOD ENZYMOL, P472; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; *FSANZ, 2006, TECHN REP SER, V42; Gilbert JA, 2005, FEMS MICROBIOL LETT, V245, P67, DOI 10.1016/j.femsle.2005.02.022; Graham LA, 2005, SCIENCE, V310, P461, DOI 10.1126/science.1115145; Gronwald W, 1998, BIOCHEMISTRY-US, V37, P4712, DOI 10.1021/bi972788c; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hew Choy L., 1992, Molecular Marine Biology and Biotechnology, V1, P309; Jia ZC, 2002, TRENDS BIOCHEM SCI, V27, P101, DOI 10.1016/S0968-0004(01)02028-X; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Khanna HK, 2006, PLANT CELL REP, V25, P1336, DOI 10.1007/s00299-006-0191-9; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li ZJ, 2004, BIOCHEMISTRY-US, V43, P14547, DOI 10.1021/bi048485h; Li ZJ, 2001, PROTEIN EXPRES PURIF, V21, P438, DOI 10.1006/prep.2001.1395; Loewen MC, 1998, BIOCHEMISTRY-US, V37, P17745, DOI 10.1021/bi9820513; Marshall CB, 2004, NATURE, V429, P153, DOI 10.1038/429153a; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SONNICHSEN FD, 1995, PROTEIN SCI, V4, P460; Taylor JS, 2001, CURR BIOL, V11, pR1005, DOI 10.1016/S0960-9822(01)00610-8; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Wang Renxue, 1995, Molecular Marine Biology and Biotechnology, V4, P20; Yamashita Y, 2003, BIOSCI BIOTECH BIOCH, V67, P461, DOI 10.1271/bbb.67.461; Zeng H, 2006, J AM CHEM SOC, V128, P2844, DOI 10.1021/ja0548182	41	52	55	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2007	2	6							e548	10.1371/journal.pone.0000548	http://dx.doi.org/10.1371/journal.pone.0000548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GE	17579720	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451700014
J	Hrus, A; Lau, G; Hutter, H; Schenk, S; Ferralli, J; Brown-Luedi, M; Chiquet-Ehrismann, R; Canevascini, S				Hrus, Ana; Lau, Gordon; Hutter, Harald; Schenk, Susanne; Ferralli, Jacqueline; Brown-Luedi, Marianne; Chiquet-Ehrismann, Ruth; Canevascini, Stefano			C. elegans Agrin Is Expressed in Pharynx, IL1 Neurons and Distal Tip Cells and Does Not Genetically Interact with Genes Involved in Synaptogenesis or Muscle Function	PLOS ONE			English	Article							DYSTROPHIN-GLYCOPROTEIN COMPLEX; CAENORHABDITIS-ELEGANS; LEVAMISOLE RESISTANCE; STRUCTURAL PROTEINS; NERVOUS-SYSTEM; BASAL LAMINA; UNC-52 GENE; DYSTROGLYCAN; BINDING; MUSK	Agrin is a basement membrane protein crucial for development and maintenance of the neuromuscular junction in vertebrates. The C. elegans genome harbors a putative agrin gene agr-1. We have cloned the corresponding cDNA to determine the primary structure of the protein and expressed its recombinant fragments to raise specific antibodies. The domain organization of AGR-1 is very similar to the vertebrate orthologues. C. elegans agrin contains a signal sequence for secretion, seven follistatin domains, three EGF-like repeats and two laminin G domains. AGR-1 loss of function mutants did not exhibit any overt phenotypes and did not acquire resistance to the acetylcholine receptor agonist levamisole. Furthermore, crossing them with various mutants for components of the dystrophin-glycoprotein complex with impaired muscle function did not lead to an aggravation of the phenotypes. Promoter-GFP translational fusion as well as immunostaining of worms revealed expression of agrin in buccal epithelium and the protein deposition in the basal lamina of the pharynx. Furthermore, dorsal and ventral IL1 head neurons and distal tip cells of the gonad arms are sources of agrin production, but no expression was detectable in body muscles or in the motoneurons innervating them. Recombinant worm AGR-1 fragment is able to cluster vertebrate dystroglycan in cultured cells, implying a conservation of this interaction, but since neither of these proteins is expressed in muscle of C. elegans, this interaction may be required in different tissues. The connections between muscle cells and the basement membrane, as well as neuromuscular junctions, are structurally distinct between vertebrates and nematodes.	[Hrus, Ana; Lau, Gordon; Schenk, Susanne; Ferralli, Jacqueline; Brown-Luedi, Marianne; Chiquet-Ehrismann, Ruth; Canevascini, Stefano] Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Hutter, Harald] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada	Friedrich Miescher Institute for Biomedical Research; Novartis; Simon Fraser University	Chiquet-Ehrismann, R (corresponding author), Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	Ruth.Chiquet@fmi.ch			Novartis Research Foundation	Novartis Research Foundation	This work was supported by the Novartis Research Foundation.	Ackley BD, 2003, J NEUROSCI, V23, P3577; Ackley BD, 2001, J CELL BIOL, V152, P1219, DOI 10.1083/jcb.152.6.1219; ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; Batchelor CL, 2006, TRENDS CELL BIOL, V16, P198, DOI 10.1016/j.tcb.2006.02.001; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bessereau JL, 2001, NATURE, V413, P70, DOI 10.1038/35092567; Bessou C, 1998, NEUROGENETICS, V2, P61, DOI 10.1007/s100480050053; Bezakova G, 2001, J CELL BIOL, V153, P1453, DOI 10.1083/jcb.153.7.1453; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; BRENNER S, 1974, GENETICS, V77, P71; Brown NH, 2000, MATRIX BIOL, V19, P191, DOI 10.1016/S0945-053X(00)00064-0; Burgess RW, 2002, J NEUROCHEM, V83, P271, DOI 10.1046/j.1471-4159.2002.01102.x; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; CHEN L, 1992, SCIENCE, V256, P240, DOI 10.1126/science.1314423; Cheusova T, 2006, GENE DEV, V20, P1800, DOI 10.1101/gad.375206; Chow DK, 2006, EXP GERONTOL, V41, P252, DOI 10.1016/j.exger.2005.12.004; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671; DENZER AJ, 1995, J CELL BIOL, V131, P1547, DOI 10.1083/jcb.131.6.1547; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; FISCHER D, 1995, J BIOL CHEM, V270, P3378, DOI 10.1074/jbc.270.7.3378; Fleming JT, 1997, J NEUROSCI, V17, P5843; Forrester WC, 1999, NATURE, V400, P881, DOI 10.1038/23722; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Gally C, 2004, NATURE, V431, P578, DOI 10.1038/nature02893; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600; Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; Gieseler K, 1999, NEUROGENETICS, V2, P87, DOI 10.1007/s100480050057; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; GODFREY EW, 1984, J CELL BIOL, V99, P615, DOI 10.1083/jcb.99.2.615; Grewal PK, 2003, HUM MOL GENET, V12, pR259, DOI 10.1093/hmg/ddg272; Groffen AJA, 1998, EUR J BIOCHEM, V254, P123, DOI 10.1046/j.1432-1327.1998.2540123.x; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Hobert O, 2003, CURR OPIN NEUROBIOL, V13, P70, DOI 10.1016/S0959-4388(03)00002-3; Hobert O, 2005, WORMBOOK; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; Hutter H, 2000, SCIENCE, V287, P989, DOI 10.1126/science.287.5455.989; Johnson RP, 2006, DEVELOPMENT, V133, P1911, DOI 10.1242/dev.02363; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Kammerer RA, 1999, EMBO J, V18, P6762, DOI 10.1093/emboj/18.23.6762; Kang SH, 2000, MOL BIOL CELL, V11, P3911, DOI 10.1091/mbc.11.11.3911; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Koga M, 1999, DEVELOPMENT, V126, P5387; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; KRAMER JM, 2005, WORMBOOK; Krause M, 1995, METHOD CELL BIOL, V48, P513; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee M, 2001, J BIOL CHEM, V276, P36404, DOI 10.1074/jbc.M105795200; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; LEWIS JA, 1980, GENETICS, V95, P905; LHernault SW, 1995, METHOD CELL BIOL, V48, P273; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; MAGILLSOLC C, 1990, J PHYSIOL-PARIS, V84, P78; MAGILLSOLC C, 1990, J EXP BIOL, V153, P1; MAGILLSOLC C, 1988, J CELL BIOL, V107, P1825, DOI 10.1083/jcb.107.5.1825; Martin PT, 2003, GLYCOBIOLOGY, V13, p55R, DOI 10.1093/glycob/cwg076; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Merz DC, 2003, DEV BIOL, V256, P173, DOI 10.1016/S0012-1606(03)00014-9; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Millet ACM, 2004, CURR OPIN IMMUNOL, V16, P4, DOI 10.1016/j.coi.2003.11.005; Mullen GP, 1999, MOL BIOL CELL, V10, P3205, DOI 10.1091/mbc.10.10.3205; Neumann FR, 2001, MOL CELL NEUROSCI, V17, P208, DOI 10.1006/mcne.2000.0932; NGUYEN M, 1995, GENETICS, V140, P527; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Pagni M, 2004, NUCLEIC ACIDS RES, V32, pW332, DOI 10.1093/nar/gkh479; PEARSON CA, 1988, EMBO J, V7, P2977, DOI 10.1002/j.1460-2075.1988.tb03160.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Riddle DL, 1997, C ELEGANS; ROGALSKI TM, 1995, GENETICS, V139, P159; ROGALSKI TM, 1993, GENE DEV, V7, P1471, DOI 10.1101/gad.7.8.1471; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; Ruegg MA, 1998, TRENDS NEUROSCI, V21, P22, DOI 10.1016/S0166-2236(97)01154-5; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHEDL T, 1997, C ELEGANS, V2, P241; SCOTTON P, 2006, J BIOL CHEM; SMITH MA, 1992, MOL CELL NEUROSCI, V3, P406, DOI 10.1016/1044-7431(92)90052-4; STROME S, 1986, J CELL BIOL, V103, P2241, DOI 10.1083/jcb.103.6.2241; SULSTON JE, 1974, GENETICS, V77, P95; THOMAS JH, 1990, CELL, V62, P1041, DOI 10.1016/0092-8674(90)90382-O; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; TSEN G, 1995, J BIOL CHEM, V270, P3392, DOI 10.1074/jbc.270.7.3392; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; Winzen U, 2003, J BIOL CHEM, V278, P30106, DOI 10.1074/jbc.M212676200; Zhang JP, 2006, FASEB J, V20, P50, DOI 10.1096/fj.04-3303com; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431	104	15	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e731	10.1371/journal.pone.0000731	http://dx.doi.org/10.1371/journal.pone.0000731			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710131	Green Submitted, gold, Green Published			2022-12-27	WOS:000207455200008
J	Shieh, JC; Cheng, YC; Su, MC; Moore, M; Choo, Y; Klug, A				Shieh, Jia-Ching; Cheng, Yu-Che; Su, Mao-Chang; Moore, Michael; Choo, Yen; Klug, Aaron			Tailor-Made Zinc-Finger Transcription Factors Activate FLO11 Gene Expression with Phenotypic Consequences in the Yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							DNA-BINDING; INVASIVE GROWTH; MAP KINASE; PSEUDOHYPHAL DIFFERENTIATION; NUCLEIC-ACIDS; PROTEINS; PROMOTER; DESIGN; SEQUENCE; FAMILY	Cys(2)His(2) zinc fingers are eukaryotic DNA-binding motifs, capable of distinguishing different DNA sequences, and are suitable for engineering artificial transcription factors. In this work, we used the budding yeast Saccharomyces cerevisiae to study the ability of tailor-made zinc finger proteins to activate the expression of the FLO11 gene, with phenotypic consequences. Two three-finger peptides were identified, recognizing sites from the 5' UTR of the FLO11 gene with nanomolar DNA-binding affinity. The three-finger domains and their combined six-finger motif, recognizing an 18-bp site, were fused to the activation domain of VP16 or VP64. These transcription factor constructs retained their DNA-binding ability, with the six-finger ones being the highest in affinity. However, when expressed in haploid yeast cells, only one three-finger recombinant transcription factor was able to activate the expression of FLO11 efficiently. Unlike in the wild-type, cells with such transcriptional activation displayed invasive growth and biofilm formation, without any requirement for glucose depletion. The VP16 and VP64 domains appeared to act equally well in the activation of FLO11 expression, with comparable effects in phenotypic alteration. We conclude that the functional activity of tailor-made transcription factors in cells is not easily predicted by the in vitro DNA-binding activity.	[Shieh, Jia-Ching; Cheng, Yu-Che] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan; [Shieh, Jia-Ching; Moore, Michael; Choo, Yen; Klug, Aaron] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Su, Mao-Chang] Chung Shan Med Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Taichung, Taiwan	Chung Shan Medical University; MRC Laboratory Molecular Biology; Chung Shan Medical University; Chung Shan Medical University Hospital	Shieh, JC (corresponding author), Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan.	jcs@csmu.edu.tw		Choo, Yen/0000-0002-3348-9602	Medical Research Council of the United Kingdom; National Science Council, Republic of China [NSC91-2745-P-040-002, NSC 92-2311-B-040-007]; Chung Shan Medical University, Republic of China [CSMU93-OM-B-017]	Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); Chung Shan Medical University, Republic of China	This work was supported by the Medical Research Council of the United Kingdom and grants from National Science Council (NSC91-2745-P-040-002; NSC 92-2311-B-040-007) of the Republic of China, and Chung Shan Medical University (CSMU93-OM-B-017) of the Republic of China.	Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Bae KH, 2003, NAT BIOTECHNOL, V21, P275, DOI 10.1038/nbt796; Bartsevich VV, 2003, STEM CELLS, V21, P632, DOI 10.1634/stemcells.21-6-632; Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Blancafort P, 2005, P NATL ACAD SCI USA, V102, P11716, DOI 10.1073/pnas.0501162102; BROWN RS, 1985, FEBS LETT, V186, P271, DOI 10.1016/0014-5793(85)80723-7; CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11168, DOI 10.1073/pnas.91.23.11168; CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11163, DOI 10.1073/pnas.91.23.11163; Choo Y, 2000, CURR OPIN STRUC BIOL, V10, P411, DOI 10.1016/S0959-440X(00)00107-X; Chou S, 2004, CELL, V119, P981, DOI 10.1016/j.cell.2004.11.053; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; Dai QS, 2004, CIRCULATION, V110, P2467, DOI 10.1161/01.CIR.0000145139.53840.49; Dreier B, 2001, J BIOL CHEM, V276, P29466, DOI 10.1074/jbc.M102604200; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Fidalgo M, 2006, P NATL ACAD SCI USA, V103, P11228, DOI 10.1073/pnas.0601713103; Gagiano M, 1999, MOL MICROBIOL, V31, P103, DOI 10.1046/j.1365-2958.1999.01151.x; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Greisman HA, 1997, SCIENCE, V275, P657, DOI 10.1126/science.275.5300.657; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Isalan M, 2001, METHOD ENZYMOL, V340, P593; Isalan M, 2001, NAT BIOTECHNOL, V19, P656, DOI 10.1038/90264; Jamieson AC, 2003, NAT REV DRUG DISCOV, V2, P361, DOI 10.1038/nrd1087; JOHNSTON LH, 1987, NUCLEIC ACIDS RES, V15, P5017, DOI 10.1093/nar/15.13.5017; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kim JS, 1998, P NATL ACAD SCI USA, V95, P2812, DOI 10.1073/pnas.95.6.2812; Klug A, 1999, J MOL BIOL, V293, P215, DOI 10.1006/jmbi.1999.3007; Kohler T, 2002, EUKARYOT CELL, V1, P673, DOI 10.1128/EC.1.5.673-686.2002; Lambrechts MG, 1996, P NATL ACAD SCI USA, V93, P8419, DOI 10.1073/pnas.93.16.8419; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEE MS, 1989, SCIENCE, V245, P635, DOI 10.1126/science.2503871; Li FY, 2007, NUCLEIC ACIDS RES, V35, P100, DOI 10.1093/nar/gkl1035; Liu Q, 1997, P NATL ACAD SCI USA, V94, P5525, DOI 10.1073/pnas.94.11.5525; Lo WS, 1996, J BACTERIOL, V178, P7144, DOI 10.1128/jb.178.24.7144-7151.1996; Lo WS, 1998, MOL BIOL CELL, V9, P161, DOI 10.1091/mbc.9.1.161; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Moore M, 2001, P NATL ACAD SCI USA, V98, P1432, DOI 10.1073/pnas.98.4.1432; Moore M, 2001, P NATL ACAD SCI USA, V98, P1437, DOI 10.1073/pnas.98.4.1437; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Palecek SP, 2002, MICROBIOL-SGM, V148, P893, DOI 10.1099/00221287-148-4-893; Papworth M, 2003, P NATL ACAD SCI USA, V100, P1621, DOI 10.1073/pnas.252773399; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Rebar EJ, 2004, EXPERT OPIN INV DRUG, V13, P829, DOI 10.1517/13543784.13.7.829; Ren DL, 2002, GENE DEV, V16, P27, DOI 10.1101/gad.953802; Reynolds L, 2003, P NATL ACAD SCI USA, V100, P1615, DOI 10.1073/pnas.252770699; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; SEIPEL K, 1992, EMBO J, V11, P4961, DOI 10.1002/j.1460-2075.1992.tb05603.x; Sengupta N, 2007, BIOPHYS CHEM, V125, P59, DOI 10.1016/j.bpc.2006.06.012; Tan WJ, 2004, J VIROL, V78, P1301, DOI 10.1128/JVI.78.3.1301-1313.2004; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Voynov V, 2006, P NATL ACAD SCI USA, V103, P14423, DOI 10.1073/pnas.0606546103	65	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e746	10.1371/journal.pone.0000746	http://dx.doi.org/10.1371/journal.pone.0000746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710146	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455200023
J	Stoeck, T; Kasper, J; Bunge, J; Leslin, C; Ilyin, V; Epstein, S				Stoeck, Thorsten; Kasper, Jennifer; Bunge, John; Leslin, Chesley; Ilyin, Valya; Epstein, Slava			Protistan Diversity in the Arctic: A Case of Paleoclimate Shaping Modern Biodiversity?	PLOS ONE			English	Article								Background. The impact of climate on biodiversity is indisputable. Climate changes over geological time must have significantly influenced the evolution of biodiversity, ultimately leading to its present pattern. Here we consider the paleoclimate data record, inferring that present-day hot and cold environments should contain, respectively, the largest and the smallest diversity of ancestral lineages of microbial eukaryotes. Methodology/Principal Findings. We investigate this hypothesis by analyzing an original dataset of 18S rRNA gene sequences from Western Greenland in the Arctic, and data from the existing literature on 18S rRNA gene diversity in hydrothermal vent, temperate sediments, and anoxic water column communities. Unexpectedly, the community from the cold environment emerged as one of the richest observed to date in protistan species, and most diverse in ancestral lineages. Conclusions/Significance. This pattern is consistent with natural selection sweeps on aerobic non-psychrophilic microbial eukaryotes repeatedly caused by low temperatures and global anoxia of snowball Earth conditions. It implies that cold refuges persisted through the periods of greenhouse conditions, which agrees with some, although not all, current views on the extent of the past global cooling and warming events. We therefore identify cold environments as promising targets for microbial discovery.	[Leslin, Chesley; Ilyin, Valya; Epstein, Slava] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Stoeck, Thorsten; Kasper, Jennifer] Univ Kaiserslautern, Dept Ecol, Kaiserslautern, Germany; [Bunge, John] Cornell Univ, Dept Stat Sci, Ithaca, NY USA; [Epstein, Slava] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA	Northeastern University; University of Kaiserslautern; Cornell University; Northeastern University	Epstein, S (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	s.epstein@neu.edu			US NSF [OPP-0214231]; Deutsche Forschungsgemeinschaft [STO414/2-2, STO 414/2-3]	US NSF(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by the US NSF grant OPP-0214231 to SSE and Deutsche Forschungsgemeinschaft grants STO414/2-2 and STO 414/2-3 to TS. The research was conducted using the computing facilities of the Northeastern University, and resources of the Cornell Theory Center, which receives funding from Cornell University, New York State, federal agencies, foundations, and corporate partners.	Ahlberg A, 2002, GFF, V124, P197, DOI 10.1080/11035890201244197; Akhmanova A, 1999, MOL MICROBIOL, V32, P1103, DOI 10.1046/j.1365-2958.1999.01434.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaral Zettler Linda A., 2002, Nature (London), V417, P137, DOI 10.1038/417137a; BARGER KJA, 2006, MIXTURES EXPONENTIAL; Behnke A, 2006, APPL ENVIRON MICROB, V72, P3626, DOI 10.1128/AEM.72.5.3626-3636.2006; Bodiselitsch B, 2005, SCIENCE, V308, P239, DOI 10.1126/science.1104657; Cameron A, 2004, J BIOL CHEM, V279, P31429, DOI 10.1074/jbc.M402433200; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; Cuny J, 2002, J PHYS OCEANOGR, V32, P627, DOI 10.1175/1520-0485(2002)032<0627:LSBCAT>2.0.CO;2; Dawson SC, 2002, P NATL ACAD SCI USA, V99, P8324, DOI 10.1073/pnas.062169599; Edgcomb VP, 2002, P NATL ACAD SCI USA, V99, P7658, DOI 10.1073/pnas.062186399; ELWOOD HJ, 1985, MOL BIOL EVOL, V2, P399; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Fried J, 2002, SYST APPL MICROBIOL, V25, P555, DOI 10.1078/07232020260517706; Gingerich PD, 2006, TRENDS ECOL EVOL, V21, P246, DOI 10.1016/j.tree.2006.03.006; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Hong SH, 2006, P NATL ACAD SCI USA, V103, P117, DOI 10.1073/pnas.0507245102; Jenkyns HC, 2004, NATURE, V432, P888, DOI 10.1038/nature03143; Jensen DB, 2003, 55 GRONL NAT, P165; Jeon SO, 2006, APPL ENVIRON MICROB, V72, P6578, DOI 10.1128/AEM.00787-06; Johnson MD, 2004, PROTIST, V155, P347, DOI 10.1078/1434461041844222; Kirschvink J. L., 1992, PROTEROZOIC BIOSPHER, P51; Kirschvink JL, 2000, P NATL ACAD SCI USA, V97, P1400, DOI 10.1073/pnas.97.4.1400; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kuvardina ON, 2002, J EUKARYOT MICROBIOL, V49, P498, DOI 10.1111/j.1550-7408.2002.tb00235.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; Lang-Unnasch N, 1998, ANNU REV MICROBIOL, V52, P561, DOI 10.1146/annurev.micro.52.1.561; Lawley B, 2004, APPL ENVIRON MICROB, V70, P5963, DOI 10.1128/AEM.70.10.5963-5972.2004; Leander BS, 2006, PROTIST, V157, P45, DOI 10.1016/j.protis.2005.10.002; Leander BS, 2003, J EUKARYOT MICROBIOL, V50, P334, DOI 10.1111/j.1550-7408.2003.tb00145.x; LEIPE DD, 1994, PHYCOLOGIA, V33, P369, DOI 10.2216/i0031-8884-33-5-369.1; Lomolino MV, 2006, BIOGEOGRAPHY, P845; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lopez-Garcia P, 2003, P NATL ACAD SCI USA, V100, P697, DOI 10.1073/pnas.0235779100; Lopez-Garcia P, 2001, FEMS MICROBIOL ECOL, V36, P193, DOI 10.1016/S0168-6496(01)00133-7; Lovejoy C, 2006, APPL ENVIRON MICROB, V72, P3085, DOI 10.1128/AEM.72.5.3085-3095.2006; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; Martin AP, 2004, EVOLUTION, V58, P946; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; MILLER SL, 1988, NATURE, V334, P609, DOI 10.1038/334609a0; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moran K, 2006, NATURE, V441, P601, DOI 10.1038/nature04800; Naviaux RK, 2005, MAR ECOL PROG SER, V301, P9, DOI 10.3354/meps301009; OKELLY CJ, 1993, J EUKARYOT MICROBIOL, V40, P627, DOI 10.1111/j.1550-7408.1993.tb06120.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; ROBISONCOX JF, 1995, APPL ENVIRON MICROB, V61, P1240, DOI 10.1128/AEM.61.4.1240-1245.1995; Schrag DP, 2001, NATURE, V409, P306, DOI 10.1038/35053170; Shen TJ, 2003, ECOLOGY, V84, P798, DOI 10.1890/0012-9658(2003)084[0798:PTNONS]2.0.CO;2; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Simpson AGB, 1996, SYST PARASITOL, V33, P187, DOI 10.1007/BF01531200; Sluijs A, 2006, NATURE, V441, P610, DOI 10.1038/nature04668; Steenkamp ET, 2006, MOL BIOL EVOL, V23, P93, DOI 10.1093/molbev/msj011; Stoeck T, 2006, PROTIST, V157, P31, DOI 10.1016/j.protis.2005.10.004; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P5656, DOI 10.1128/AEM.69.9.5656-5663.2003; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P2657, DOI 10.1128/AEM.69.5.2657-2663.2003; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Swofford DL., 2001, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripati A, 2005, NATURE, V436, P341, DOI 10.1038/nature03874; Voncken F, 2002, MOL MICROBIOL, V44, P1441, DOI 10.1046/j.1365-2958.2002.02959.x; Wilson PA, 2001, NATURE, V412, P425, DOI 10.1038/35086553; Wuyts J, 2004, NUCLEIC ACIDS RES, V32, pD101, DOI 10.1093/nar/gkh065; Zuendorf A, 2006, FEMS MICROBIOL ECOL, V58, P476, DOI 10.1111/j.1574-6941.2006.00171.x	68	58	59	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e728	10.1371/journal.pone.0000728	http://dx.doi.org/10.1371/journal.pone.0000728			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710128	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455200005
J	Tremblay, C; Champoux, F; Voss, P; Bacon, BA; Lepore, F; Theoret, H				Tremblay, Corinne; Champoux, Francois; Voss, Patrice; Bacon, Benoit A.; Lepore, Franco; Theoret, Hugo			Speech and Non-Speech Audio-Visual Illusions: A Developmental Study	PLOS ONE			English	Article							HEARING LIPS; HUMAN BRAIN; PERCEPTION; INTEGRATION	It is well known that simultaneous presentation of incongruent audio and visual stimuli can lead to illusory percepts. Recent data suggest that distinct processes underlie non-specific intersensory speech as opposed to non-speech perception. However, the development of both speech and non-speech intersensory perception across childhood and adolescence remains poorly defined. Thirty-eight observers aged 5 to 19 were tested on the McGurk effect (an audio-visual illusion involving speech), the Illusory Flash effect and the Fusion effect (two audio-visual illusions not involving speech) to investigate the development of audio-visual interactions and contrast speech vs. non-speech developmental patterns. Whereas the strength of audio-visual speech illusions varied as a direct function of maturational level, performance on non-speech illusory tasks appeared to be homogeneous across all ages. These data support the existence of independent maturational processes underlying speech and non-speech audio-visual illusory effects.	[Tremblay, Corinne; Voss, Patrice; Lepore, Franco; Theoret, Hugo] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Tremblay, Corinne; Lepore, Franco; Theoret, Hugo] St Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Bacon, Benoit A.] Bishops Univ, Dept Psychol, Sherbrooke, PQ, Canada	Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Bishops University	Theoret, H (corresponding author), Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada.	hugo.theoret@umontreal.ca	voss, patrice/I-7026-2019	voss, patrice/0000-0001-8698-7130; Theoret, Hugo/0000-0002-7458-8797	Canadian Institutes of Health Research, Fonds de Recherche en Sante du Quebec	Canadian Institutes of Health Research, Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du QuebecCanadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research, Fonds de Recherche en Sante du Quebec. Funders did not contribute to the study or to the mansucript.	Andersen TS, 2004, COGNITIVE BRAIN RES, V21, P301, DOI 10.1016/j.cogbrainres.2004.06.004; Burnham D, 2004, DEV PSYCHOBIOL, V45, P204, DOI 10.1002/dev.20032; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Champoux F, 2006, NEUROREPORT, V17, P1607, DOI 10.1097/01.wnr.0000236856.93586.94; Colin C, 2002, CLIN NEUROPHYSIOL, V113, P495, DOI 10.1016/S1388-2457(02)00024-X; DEKLE DJ, 1992, PERCEPT PSYCHOPHYS, V51, P355, DOI 10.3758/BF03211629; Desjardins RN, 2004, DEV PSYCHOBIOL, V45, P187, DOI 10.1002/dev.20033; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; Hnath-Chisolm TE, 1998, J SPEECH LANG HEAR R, V41, P94, DOI 10.1044/jslhr.4101.94; Holmes NP, 2005, CURR BIOL, V15, pR762, DOI 10.1016/j.cub.2005.08.058; Kaiser J, 2005, CEREB CORTEX, V15, P646, DOI 10.1093/cercor/bhh166; Lewkowicz DJ, 2002, COGNITIVE BRAIN RES, V14, P41, DOI 10.1016/S0926-6410(02)00060-5; Macaluso E, 2004, NEUROIMAGE, V21, P725, DOI 10.1016/j.neuroimage.2003.09.049; Massaro D.W., 1998, PERCEIVING TALKING F; MASSARO DW, 1990, PSYCHOL SCI, V1, P55, DOI 10.1111/j.1467-9280.1990.tb00068.x; MASSARO DW, 1984, CHILD DEV, V55, P1777, DOI 10.2307/1129925; MASSARO DW, 1986, J EXP CHILD PSYCHOL, V41, P93, DOI 10.1016/0022-0965(86)90053-6; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Musacchia G, 2006, EXP BRAIN RES, V168, P1, DOI 10.1007/s00221-005-0071-5; Rosenblum LD, 1997, PERCEPT PSYCHOPHYS, V59, P347, DOI 10.3758/BF03211902; Rosenblum LD, 1996, J EXP PSYCHOL HUMAN, V22, P318, DOI 10.1037/0096-1523.22.2.318; Scheier C, 2003, DEVELOPMENTAL SCI, V6, P233, DOI 10.1111/1467-7687.00276; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; SESTIERI C, 2006, COGN PROCESS, V7, P138; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Shams L, 2002, COGNITIVE BRAIN RES, V14, P147, DOI 10.1016/S0926-6410(02)00069-1; Shams L, 2001, NEUROREPORT, V12, P3849, DOI 10.1097/00001756-200112040-00049; Shimojo S, 2001, CURR OPIN NEUROBIOL, V11, P505, DOI 10.1016/S0959-4388(00)00241-5; Stein BE, 2005, EXP BRAIN RES, V166, P305, DOI 10.1007/s00221-005-2372-0; Teder-Salejarvi WA, 2002, COGNITIVE BRAIN RES, V14, P106, DOI 10.1016/S0926-6410(02)00065-4; Tiippana K, 2004, EUR J COGN PSYCHOL, V16, P457, DOI 10.1080/09541440340000268; Tuomainen J, 2005, COGNITION, V96, pB13, DOI 10.1016/j.cognition.2004.10.004; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Welch RB, 1999, PRESENCE-TELEOP VIRT, V8, P574, DOI 10.1162/105474699566387	35	81	81	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e742	10.1371/journal.pone.0000742	http://dx.doi.org/10.1371/journal.pone.0000742			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710142	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455200019
J	van der Sande, MAB; Waight, PA; Mendy, M; Zaman, S; Kaye, S; Sam, O; Kahn, A; Jeffries, D; Akum, AA; Hall, AJ; Bah, E; McConkey, SJ; Hainaut, P; Whittle, HC				van der Sande, Marianne A. B.; Waight, Pauline A.; Mendy, Maimuna; Zaman, Syed; Kaye, Steve; Sam, Omar; Kahn, Abi; Jeffries, David; Akum, Aveika A.; Hall, Andrew J.; Bah, Ebrima; McConkey, Samuel J.; Hainaut, Pierre; Whittle, Hilton C.			Long-Term Protection against HBV Chronic Carriage of Gambian Adolescents Vaccinated in Infancy and Immune Response in HBV Booster Trial in Adolescence	PLOS ONE			English	Article							HEPATITIS-B-VACCINE; RECOMBINANT; ANTIBODY; IMMUNOGENICITY; REGIMEN; 2-DOSE	Background. Chronic infection with hepatitis B virus (HBV) arising in childhood is associated with hepatocellular carcinoma in adult life. Between 1986 and 1990, approximately 120,000 Gambian newborns were enrolled in a randomised controlled trial to assess the effectiveness of infant HBV vaccination on the prevention of hepatocellular carcinoma in adulthood. These children are now in adolescence and approaching adulthood, when the onset of sexual activity may challenge their hepatitis B immunity. Thus a booster dose in adolescence could be important to maintain long-term protection. Methods. Fifteen years after the start of the HBV infant vaccination study, 492 vaccinated and 424 unvaccinated children were identified to determine vaccine efficacy against infection and carriage in adolescence. At the same time, 297 of the 492 infant-vaccinated subjects were randomly offered a booster dose of HBV vaccine. Anti-HBs was measured before the booster, and two weeks and 1 year afterwards (ISRCTN71271385). Results. Vaccine efficacy 15 years after vaccination was 67.0% against infection as manifest by anti-HBc positivity (95% CI 58.2-74.6%), and 96.6% against HBsAg carriage (95% CI 91.5-100%). 31.2% of participants had detectable anti-HBs with a GMC of 32 IU/l. For 168 boosted participants GMC anti-HBs responses were 38 IU/l prior to vaccination, 524 IU/l two weeks after boosting, and 101 IU/l after 1 year. Conclusions. HBV vaccination in infants confers very good protection against carriage up to 15 years of age, although a large proportion of vaccinated subjects did not have detectable anti-HBs at this age. The response to boosting persisted for at least a year.	[van der Sande, Marianne A. B.; Waight, Pauline A.; Mendy, Maimuna; Zaman, Syed; Kaye, Steve; Jeffries, David; Akum, Aveika A.; McConkey, Samuel J.; Whittle, Hilton C.] MRC Labs, Fajara, Gambia; [Mendy, Maimuna; Bah, Ebrima; Hainaut, Pierre] Int Agcy Res Canc, Gambia Hepatitis Intervent Study, F-69372 Lyon, France; [Sam, Omar; Kahn, Abi] Dept State Hlth, Banjul, Gambia; [Hall, Andrew J.] London Sch Hyg & Trop Med, London WC1, England	MRC Laboratory Molecular Biology; World Health Organization; International Agency for Research on Cancer (IARC); University of London; London School of Hygiene & Tropical Medicine	van der Sande, MAB (corresponding author), Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands.	Marianne.van.der.sande@rivm.nl	Hainaut, Pierre/B-6018-2012; McConkey, Samuel/E-7307-2012; Mendy, Maimuna/ABD-5038-2021	Hainaut, Pierre/0000-0002-1303-1610; van der Sande, Marianne AB/0000-0002-4778-6739; McConkey, Samuel/0000-0001-9085-7793	MRC UK; MRC [MC_U190071425] Funding Source: UKRI	MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the MRC UK. The sponsor had no role in the design and conduct of the study, analysis, interpretation of data, nor in the drafting of the manuscript.	Akram DS, 2005, VACCINE, V23, P5792, DOI 10.1016/j.vaccine.2005.06.013; [Anonymous], 1987, CANCER RES, V47, P5782; Banatvala J, 2000, LANCET, V355, P561, DOI 10.1016/S0140-6736(99)07239-6; Banatvala J, 2000, VACCINE, V19, P877, DOI 10.1016/S0264-410X(00)00224-3; Bulkow LR, 1998, CLIN INFECT DIS, V26, P933, DOI 10.1086/513939; Cassidy WM, 2001, PEDIATRICS, V107, P626, DOI 10.1542/peds.107.4.626; COURSAGET P, 1994, J HEPATOL, V21, P250, DOI 10.1016/S0168-8278(05)80404-0; Gellin BG, 1997, J INFECT DIS, V175, P1494, DOI 10.1086/516485; Heron LG, 2002, VACCINE, V20, P3472, DOI 10.1016/S0264-410X(02)00346-8; Jack AD, 1999, J INFECT DIS, V179, P489, DOI 10.1086/314578; JILG W, 1988, J MED VIROL, V24, P377, DOI 10.1002/jmv.1890240404; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Levie K, 2002, SCAND J INFECT DIS, V34, P610, DOI 10.1080/00365540110080881; Liao SS, 1999, VACCINE, V17, P2661, DOI 10.1016/S0264-410X(99)00031-6; Marsano LS, 1998, VACCINE, V16, P624, DOI 10.1016/S0264-410X(97)00233-8; van der Sande MAB, 2006, J INFECT DIS, V193, P1528, DOI 10.1086/503433; Viviani S, 1999, VACCINE, V17, P2946, DOI 10.1016/S0264-410X(99)00178-4; WHITTLE HC, 1991, LANCET, V337, P747, DOI 10.1016/0140-6736(91)91367-4; WHITTLE HC, 2004, BMJ-BRIT MED J, V325, P569; Williams IT, 2003, PEDIATR INFECT DIS J, V22, P157; Wistrom J, 1999, VACCINE, V17, P2162, DOI 10.1016/S0264-410X(99)00012-2	21	55	57	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e753	10.1371/journal.pone.0000753	http://dx.doi.org/10.1371/journal.pone.0000753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710152	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000207455200029
J	Li, G; Wang, JH; Rossiter, SJ; Jones, G; Zhang, SY				Li, Gang; Wang, Jinhong; Rossiter, Stephen J.; Jones, Gareth; Zhang, Shuyi			Accelerated FoxP2 Evolution in Echolocating Bats	PLOS ONE			English	Article							COMBINATION-SENSITIVE NEURONS; DETECTING POSITIVE SELECTION; MEDIAL GENICULATE-BODY; LIKELIHOOD METHOD; MOUSTACHED BAT; SEVERE SPEECH; TARGET RANGE; NOSED BAT; PROTEIN; GENE	FOXP2 is a transcription factor implicated in the development and neural control of orofacial coordination, particularly with respect to vocalisation. Observations that orthologues show almost no variation across vertebrates yet differ by two amino acids between humans and chimpanzees have led to speculation that recent evolutionary changes might relate to the emergence of language. Echolocating bats face especially challenging sensorimotor demands, using vocal signals for orientation and often for prey capture. To determine whether mutations in the FoxP2 gene could be associated with echolocation, we sequenced FoxP2 from echolocating and non-echolocating bats as well as a range of other mammal species. We found that contrary to previous reports, FoxP2 is not highly conserved across all nonhuman mammals but is extremely diverse in echolocating bats. We detected divergent selection (a change in selective pressure) at FoxP2 between bats with contrasting sonar systems, suggesting the intriguing possibility of a role for FoxP2 in the evolution and development of echolocation. We speculate that observed accelerated evolution of FoxP2 in bats supports a previously proposed function in sensorimotor coordination.	[Rossiter, Stephen J.] Univ London, Sch Biol & Chem Sci, London, England; [Li, Gang; Wang, Jinhong; Zhang, Shuyi] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Li, Gang] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Li, Gang] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Jones, Gareth] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of London; East China Normal University; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Bristol	Rossiter, SJ (corresponding author), Univ London, Sch Biol & Chem Sci, London, England.	s.j.rossiter@qmul.ac.uk; syzhang@bio.ecnu.edu.cn	Rossiter, Stephen J/E-2111-2011; Zhang, Shuyi/B-5117-2011; li, gang/E-5640-2014	li, gang/0000-0001-7400-5486; Rossiter, Stephen/0000-0002-3881-4515; Jones, Gareth/0000-0002-1904-3735	East China Normal University [14-008]	East China Normal University	This work was funded by a special grant from East China Normal University to SZ and a Darwin Initiative grant (14-008) to GJ.	ALDRIDGE HDJN, 1990, J MAMMAL, V71, P242, DOI 10.2307/1382175; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Bielawski Joseph P., 2003, Journal of Structural and Functional Genomics, V3, P201, DOI 10.1023/A:1022642807731; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; BIRKY CW, 1988, P NATL ACAD SCI USA, V85, P6414, DOI 10.1073/pnas.85.17.6414; Boughman JW, 1998, P ROY SOC B-BIOL SCI, V265, P227, DOI 10.1098/rspb.1998.0286; Brenowitz EA, 1997, J NEUROBIOL, V33, P517, DOI 10.1002/(SICI)1097-4695(19971105)33:5<517::AID-NEU3>3.0.CO;2-7; Choi JH, 2000, BIOINFORMATICS, V16, P1056, DOI 10.1093/bioinformatics/16.11.1056; COVEY E, 1995, LOWER BRAINSTEM AUDI, P235; Eick GN, 2005, MOL BIOL EVOL, V22, P1869, DOI 10.1093/molbev/msi180; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; ESSER KH, 1994, NEUROREPORT, V5, P1718, DOI 10.1097/00001756-199409080-00007; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fisher SE, 2006, NAT REV GENET, V7, P9, DOI 10.1038/nrg1747; Fitzgerald EMG, 2006, P ROY SOC B-BIOL SCI, V273, P2955, DOI 10.1098/rspb.2006.3664; Foote AD, 2006, BIOL LETT-UK, V2, P509, DOI 10.1098/rsbl.2006.0525; Griffin DR, 1958, LISTENING DARK; Grothe B, 2000, MICROSC RES TECHNIQ, V51, P382, DOI 10.1002/1097-0029(20001115)51:4<382::AID-JEMT7>3.0.CO;2-7; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; HERZING DL, 2004, ECHOLOCATION BATS DO; Hiryu S, 2006, J COMP PHYSIOL A, V192, P807, DOI 10.1007/s00359-006-0118-5; Hu KL, 2006, NEUROREPORT, V17, P1743, DOI 10.1097/01.wnr.0000239959.91190.c8; Hughes M, 1998, BEHAV ECOL SOCIOBIOL, V42, P437, DOI 10.1007/s002650050458; Hutcheon JM, 1998, PHILOS T R SOC B, V353, P607, DOI 10.1098/rstb.1998.0229; Janik VM, 1997, ADV STUD BEHAV, V26, P59, DOI 10.1016/S0065-3454(08)60377-0; Janik VM, 2000, SCIENCE, V289, P1355, DOI 10.1126/science.289.5483.1355; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; JOHNSON F, 1995, J COMP NEUROL, V358, P260, DOI 10.1002/cne.903580208; JONES G, 1993, P ROY SOC B-BIOL SCI, V252, P125, DOI 10.1098/rspb.1993.0055; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Marczyk G. R., 2003, INT J FORENSIC MENT, V2, P7, DOI DOI 10.1080/14999013.2003.10471175; Mercado E, 2005, ANIM COGN, V8, P93, DOI 10.1007/s10071-004-0238-7; Moss C. F., 1995, BEHAV STUDIES AUDITO, P87; Moss CF, 2003, CURR OPIN NEUROBIOL, V13, P751, DOI 10.1016/j.conb.2003.10.016; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nelson DA, 2000, P NATL ACAD SCI USA, V97, P13348, DOI 10.1073/pnas.240457797; Nummela S, 2004, NATURE, V430, P776, DOI 10.1038/nature02720; OLSEN JF, 1991, J NEUROPHYSIOL, V65, P1254, DOI 10.1152/jn.1991.65.6.1254; OLSEN JF, 1991, J NEUROPHYSIOL, V65, P1275, DOI 10.1152/jn.1991.65.6.1275; PAULIN MG, 1993, BRAIN BEHAV EVOLUT, V41, P39, DOI 10.1159/000113822; POLLAK G, 1977, SCIENCE, V196, P675, DOI 10.1126/science.857318; Pollak G.D., 1989, NEURAL BASIS ECHOLOC; Poole JH, 2005, NATURE, V434, P455, DOI 10.1038/434455a; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Scharff C, 2005, CURR OPIN NEUROBIOL, V15, P694, DOI 10.1016/j.conb.2005.10.004; Schuddekopf K, 1996, P NATL ACAD SCI USA, V93, P9661, DOI 10.1073/pnas.93.18.9661; Shriberg LD, 2006, J SPEECH LANG HEAR R, V49, P500, DOI 10.1044/1092-4388(2006/038); Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Springer MS, 2001, P NATL ACAD SCI USA, V98, P6241, DOI 10.1073/pnas.111551998; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; SUGA N, 1979, SCIENCE, V206, P351, DOI 10.1126/science.482944; Teeling EC, 2000, NATURE, V403, P188, DOI 10.1038/35003188; Teeling EC, 2002, P NATL ACAD SCI USA, V99, P1431, DOI 10.1073/pnas.022477199; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van den Bussche RA, 2004, J MAMMAL, V85, P321, DOI 10.1644/1545-1542(2004)085<0321:PRARCF>2.0.CO;2; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Wang XM, 2007, J COMP PHYSIOL A, V193, P13, DOI 10.1007/s00359-006-0167-9; Webb DM, 2005, J HERED, V96, P212, DOI 10.1093/jhered/esi025; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Zeesman S, 2006, AM J MED GENET A, V140A, P509, DOI 10.1002/ajmg.a.31110; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang JZ, 2002, GENETICS, V162, P1825	74	107	111	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e900	10.1371/journal.pone.0000900	http://dx.doi.org/10.1371/journal.pone.0000900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878935	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455700008
J	Hansen, T; Olsen, L; Lindow, M; Jakobsen, KD; Ullum, H; Jonsson, E; Andreassen, OA; Djurovic, S; Melle, I; Agartz, I; Hall, H; Timm, S; Wang, AG; Werge, T				Hansen, Thomas; Olsen, Line; Lindow, Morten; Jakobsen, Klaus D.; Ullum, Henrik; Jonsson, Erik; Andreassen, Ole A.; Djurovic, Srdjan; Melle, Ingrid; Agartz, Ingrid; Hall, Hakan; Timm, Sally; Wang, August G.; Werge, Thomas			Brain Expressed microRNAs Implicated in Schizophrenia Etiology	PLOS ONE			English	Article								Background. Protein encoding genes have long been the major targets for research in schizophrenia genetics. However, with the identification of regulatory microRNAs ( miRNAs) as important in brain development and function, miRNAs genes have emerged as candidates for schizophrenia-associated genetic factors. Indeed, the growing understanding of the regulatory properties and pleiotropic effects that miRNA have on molecular and cellular mechanisms, suggests that alterations in the interactions between miRNAs and their mRNA targets may contribute to phenotypic variation. Methodology/Principal Findings. We have studied the association between schizophrenia and genetic variants of miRNA genes associated with brain-expression using a case-control study design on three Scandinavian samples. Eighteen known SNPs within or near brain-expressed miRNAs in three samples (Danish, Swedish and Norwegian: 420/163/257 schizophrenia patients and 1006/177/293 control subjects), were analyzed. Subsequently, joint analysis of the three samples was performed on SNPs showing marginal association. Two SNPs rs17578796 and rs1700 in hsa-mir-206 (mir-206) and hsa-mit-198 (mir-198) showed nominal significant allelic association to schizophrenia in the Danish and Norwegian sample respectively (P = 0.0021 & p = 0.038), of which only rs17578796 was significant in the joint sample. In-silico analysis revealed that 8 of the 15 genes predicted to be regulated by both mir-206 and mir-198, are transcriptional targets or interaction partners of the JUN, ATF2 and TAF1 connected in a tight network. JUN and two of the miRNA targets (CCND2 and PTPN1) in the network have previously been associated with schizophrenia. Conclusions/Significance. We found nominal association between brain-expressed miRNAs and schizophrenia for rs17578796 and rs1700 located in mir-206 and mir-198 respectively. These two miRNAs have a surprising large number (15) of targets in common, eight of which are also connected by the same transcription factors.	[Hansen, Thomas; Olsen, Line; Jakobsen, Klaus D.; Werge, Thomas] SCT Hans Mental Hosp, Res Inst Biol Psychiat, Roskilde, Denmark; [Lindow, Morten] Univ Copenhagen, Bioinformat Ctr, Inst Mol Biol, Copenhagen, Denmark; [Ullum, Henrik] Rigshosp, Dept Clin Immunol, DK-2100 Copenhagen, Denmark; [Jonsson, Erik; Agartz, Ingrid; Hall, Hakan] Karolinska Hosp & Inst, Psychiat Sect, Dept Clin Neurosci, Stockholm, Sweden; [Andreassen, Ole A.; Djurovic, Srdjan; Melle, Ingrid] Ullevaal Univ Hosp, TOP Project, Dept Psychiat, Oslo, Norway; [Timm, Sally] Univ Dept Psychiat, Psychiat Ctr Frederiksberg, Frederiksberg, Denmark; [Wang, August G.] Univ Dept Psychiat, Psychiat Ctr Amager, Copenhagen, Denmark; [Hansen, Thomas] Univ Copenhagen, Ctr Pharmacogenom, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; Karolinska Institutet; Karolinska University Hospital; University of Oslo; University of Copenhagen	Werge, T (corresponding author), SCT Hans Mental Hosp, Res Inst Biol Psychiat, Roskilde, Denmark.	thomas.werge@shh.regionh.dk	Hansen, Thomas/GWZ-2858-2022; Hansen, Thomas Folkmann/O-5965-2014; Melle, Ingrid S/B-4858-2011; Andreassen, Ole A./AAY-7531-2020; Werge, Thomas/G-7263-2012; Hall, Hakan/A-5197-2009	Hansen, Thomas Folkmann/0000-0001-6703-7762; Melle, Ingrid S/0000-0002-9783-548X; Ullum, Henrik/0000-0001-7306-9058; Djurovic, Srdjan/0000-0002-8140-8061; Agartz, Ingrid/0000-0002-9839-5391; Wang, August G./0000-0003-4518-0466; Andreassen, Ole A./0000-0002-4461-3568				Arnold SE, 2005, PROG BRAIN RES, V147, P319, DOI 10.1016/S0079-6123(04)47023-X; Aston C, 2004, J NEUROSCI RES, V77, P858, DOI 10.1002/jnr.20208; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Davidsson P, 1999, SCHIZOPHR RES, V40, P23, DOI 10.1016/S0920-9964(99)00037-7; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Ekholm B, 2005, NORD J PSYCHIAT, V59, P457, DOI 10.1080/08039480500360906; Falush D, 2003, GENETICS, V164, P1567; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Freedman R, 2001, AM J MED GENET, V105, P794, DOI 10.1002/ajmg.10100; Frith MC, 2005, EUR J HUM GENET, V13, P894, DOI 10.1038/sj.ejhg.5201459; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Jakobsen KD, 2006, PSYCHOPATHOLOGY, V39, P269, DOI 10.1159/000095731; Jakobsen KD, 2005, NORD J PSYCHIAT, V59, P209, DOI 10.1080/08039480510027698; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Jonsson EG, 2006, PROG NEURO-PSYCHOPH, V30, P924, DOI 10.1016/j.pnpbp.2006.02.008; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; Makino S, 2007, AM J HUM GENET, V80, P393, DOI 10.1086/512129; MCGUFFIN P, 1994, SEMINARS PSYCHIAT GE, P100; Mehler MF, 2006, J PHYSIOL-LONDON, V575, P333, DOI 10.1113/jphysiol.2006.113191; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Perkins DO, 2005, MOL PSYCHIATR, V10, P69, DOI 10.1038/sj.mp.4001577; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rogaev EI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1404, DOI 10.1007/s10541-005-0276-z; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tamminga CA, 2005, MOL PSYCHIATR, V10, P27, DOI 10.1038/sj.mp.4001563; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vares M, 2006, PSYCHOPATHOLOGY, V39, P286, DOI 10.1159/000095733; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; [No title captured]	44	213	229	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e873	10.1371/journal.pone.0000873	http://dx.doi.org/10.1371/journal.pone.0000873			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849003	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455600020
J	Buskila, Y; Abu-Ghanem, Y; Levi, Y; Moran, A; Grauer, E; Amitai, Y				Buskila, Yossi; Abu-Ghanem, Yasmin; Levi, Yifat; Moran, Arie; Grauer, Ettie; Amitai, Yael			Enhanced Astrocytic Nitric Oxide Production and Neuronal Modifications in the Neocortex of a NOS2 Mutant Mouse	PLOS ONE			English	Article							SYNTHASE MESSENGER-RNA; EXPRESSION; RECEPTOR; ACTIVATION; STRESS; MODEL; ROLES; MICE; POTENTIATION; INHIBITORS	Background. It has been well accepted that glial cells in the central nervous system (CNS) produce nitric oxide (NO) through the induction of a nitric oxide synthase isoform (NOS2) only in response to various insults. Recently we described rapid astroglial, NOS2-dependent, NO production in the neocortex of healthy mice on a time scale relevant to neuronal activity. To explore a possible role for astroglial NOS2 in normal brain function we investigated a NOS2 knockout mouse (B6; 129P2-Nos2(tm1Lau)/J, Jackson Laboratory). Previous studies of this mouse strain revealed mainly altered immune responses, but no compensatory pathways and no CNS abnormalities have been reported. Methodology/Principal Findings. To our surprise, using NO imaging in brain slices in combination with biochemical methods we uncovered robust NO production by neocortical astrocytes of the NOS2 mutant. These findings indicate the existence of an alternative pathway that increases basal NOS activity. In addition, the astroglial mutation instigated modifications of neuronal attributes, shown by changes in the membrane properties of pyramidal neurons, and revealed in distinct behavioral abnormalities characterized by an increase in stress-related parameters. Conclusions/Significance. The results strongly indicate the involvement of astrocytic-derived NO in modifying the activity of neuronal networks. In addition, the findings corroborate data linking NO signaling with stress-related behavior, and highlight the potential use of this genetic model for studies of stress-susceptibility. Lastly, our results beg re-examination of previous studies that used this mouse strain to examine the pathophysiology of brain insults, assuming lack of astrocytic nitrosative reaction.	[Buskila, Yossi; Abu-Ghanem, Yasmin; Levi, Yifat; Moran, Arie; Amitai, Yael] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, Beer Sheva, Israel; [Grauer, Ettie] Israel Inst Biol Res, Dept Pharmacol, IL-70450 Ness Ziona, Israel	Ben Gurion University	Amitai, Y (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, Beer Sheva, Israel.	yaela@bgu.ac.il	Amitai, Yael/G-2791-2013; MORAN, ARIE/F-1210-2012; Buskila, Yossi/Y-1041-2019	Buskila, Yossi/0000-0001-8500-469X; Amitai, Yael/0000-0001-6664-8705; Abu-Ghanem, Yasmin/0000-0003-3682-5963	Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	The study was supported by a grant from the Israel Science Foundation to Yael Amitai.	Aguado F, 2002, J NEUROSCI, V22, P9430; Araque A, 2001, ANNU REV PHYSIOL, V63, P795, DOI 10.1146/annurev.physiol.63.1.795; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broillet MC, 2001, FEBS LETT, V491, P227, DOI 10.1016/S0014-5793(01)02206-2; Brown LA, 1999, J NEUROSCI METH, V92, P101, DOI 10.1016/S0165-0270(99)00098-9; Burette A, 2002, J NEUROSCI, V22, P8961; Buskila Y, 2005, GLIA, V52, P169, DOI 10.1002/glia.20217; Chen LC, 2003, BRAIN RES, V973, P214, DOI 10.1016/S0006-8993(03)02484-3; CHIANG LW, 1994, MOL BRAIN RES, V27, P183, DOI 10.1016/0169-328X(94)90202-X; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Colton CA, 2006, P NATL ACAD SCI USA, V103, P12867, DOI 10.1073/pnas.0601075103; de Oliveira RMW, 2000, NEUROSCI LETT, V289, P123, DOI 10.1016/S0304-3940(00)01287-8; Dehmer T, 2000, J NEUROCHEM, V74, P2213, DOI 10.1046/j.1471-4159.2000.0742213.x; Demas GE, 1999, J NEUROSCI, V19; Demas GE, 1997, MOL MED, V3, P610, DOI 10.1007/BF03401818; DINERMAN JL, 1994, P NATL ACAD SCI USA, V91, P4214, DOI 10.1073/pnas.91.10.4214; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Garthwaite G, 2006, J NEUROSCI, V26, P7730, DOI 10.1523/JNEUROSCI.1528-06.2006; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Gil Z, 1996, J NEUROSCI, V16, P6567; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Guimaraes FS, 2005, NEUROSCI BIOBEHAV R, V29, P1313, DOI 10.1016/j.neubiorev.2005.03.026; GUIMARAES FS, 1994, NEUROREPORT, V5, P1929, DOI 10.1097/00001756-199410000-00022; Ikeda H, 2004, J NEUROSCI, V24, P9888, DOI 10.1523/JNEUROSCI.2608-04.2004; Isaksson J, 2005, SPINAL CORD, V43, P167, DOI 10.1038/sj.sc.3101672; Kara P, 1999, J NEUROSCI, V19, P5528; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Liberatore GT, 1999, NAT MED, V5, P1403; Licinio J, 1999, MOL MED TODAY, V5, P225, DOI 10.1016/S1357-4310(99)01453-7; Lopez-Figueroa MO, 2000, BRAIN RES, V852, P239, DOI 10.1016/S0006-8993(99)02241-6; Martin LJ, 2005, J NEUROSCI, V25, P6449, DOI 10.1523/JNEUROSCI.0911-05.2005; Mashimo H, 1999, AM J PHYSIOL-GASTR L, V277, pG745, DOI 10.1152/ajpgi.1999.277.4.G745; Moreira FD, 2003, PHARMACOL BIOCHEM BE, V76, P35, DOI 10.1016/S0091-3057(03)00186-2; Moreno-Lopez B, 2004, J NEUROSCI, V24, P85, DOI 10.1523/JNEUROSCI.1574-03.2004; Moro MA, 2004, CELL CALCIUM, V36, P265, DOI 10.1016/j.ceca.2004.02.011; Mungrue IN, 2003, ACTA PHYSIOL SCAND, V179, P123, DOI 10.1046/j.1365-201X.2003.01182.x; Murphy S, 2000, GLIA, V29, P1, DOI 10.1002/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Olivenza R, 2000, J NEUROCHEM, V74, P785, DOI 10.1046/j.1471-4159.2000.740785.x; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Perea G, 2005, CELL CALCIUM, V38, P375, DOI 10.1016/j.ceca.2005.06.015; Pokk P, 2002, PROG NEURO-PSYCHOPH, V26, P241, DOI 10.1016/S0278-5846(01)00261-5; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; Przedborski S, 1996, P NATL ACAD SCI USA, V93, P4565, DOI 10.1073/pnas.93.10.4565; Roychowdhury S, 2002, GLIA, V38, P103, DOI 10.1002/glia.10024; Schafe GE, 2005, EUR J NEUROSCI, V22, P201, DOI 10.1111/j.1460-9568.2005.04209.x; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Vruwink M, 2001, J COMP NEUROL, V441, P288, DOI 10.1002/cne.1413; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Wang QW, 2004, J NEUROSCI, V24, P6049, DOI 10.1523/JNEUROSCI.0233-04.2004; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002	55	33	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e843	10.1371/journal.pone.0000843	http://dx.doi.org/10.1371/journal.pone.0000843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786214	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455500026
J	Phillips, KA; Sherwood, CC; Lilak, AL				Phillips, Kimberley A.; Sherwood, Chet C.; Lilak, Alayna L.			Corpus Callosum Morphology in Capuchin Monkeys Is Influenced by Sex and Handedness	PLOS ONE			English	Article								Sex differences have been reported in both overall corpus callosum area and its regional subdivisions in humans. Some have suggested this reflects a unique adaptation in humans, as similar sex differences in corpus callosum morphology have not been reported in any other species of primate examined to date. Furthermore, an association between various measurements of corpus callosum morphology and handedness has been found in humans and chimpanzees. In the current study, we report measurements of corpus callosum cross-sectional area from midsagittal MR images collected in vivo from 14 adult capuchin monkeys, 9 of which were also characterized for hand preference on a coordinated bimanual task. Adult females were found to have a significantly larger corpus callosum: brain volume ratio, rostral body, posterior midbody, isthmus, and splenium than adult males. Left-handed individuals had a larger relative overall corpus callosum area than did right-handed individuals. Additionally, a significant sex and handedness interaction was found for anterior midbody, with right-handed males having a significantly smaller area than right-handed females. These results suggest that sex and handedness influences on corpus callosum morphology are not restricted to Homo sapiens.	[Phillips, Kimberley A.; Lilak, Alayna L.] Hiram Coll, Dept Psychol, Hiram, OH USA; [Sherwood, Chet C.] George Washington Univ, Dept Anthropol, Washington, DC USA	Hiram College; George Washington University	Phillips, KA (corresponding author), Hiram Coll, Dept Psychol, Hiram, OH USA.	phillipsk@hiram.edu	Phillips, Kimberley/P-1212-2016	Phillips, Kimberley/0000-0002-5517-3596	Howard Hughes Medical Institute, NIH [NS42867, NS24328, MH56661]; NSF [BCS-0515484, BCS0549117]; Wenner-Gren Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024328, R01NS042867] Funding Source: NIH RePORTER	Howard Hughes Medical Institute, NIH(Howard Hughes Medical InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Wenner-Gren Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the Howard Hughes Medical Institute, NIH ( NS42867, NS24328, MH56661), NSF ( BCS-0515484, BCS0549117) and the Wenner-Gren Foundation.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Bishop KM, 1997, NEUROSCI BIOBEHAV R, V21, P581, DOI 10.1016/S0149-7634(96)00049-8; BROADFIELD DC, 2001, THESIS COLUMBIA U; Dadda M, 2006, NEUROPSYCHOLOGIA, V44, P2582, DOI 10.1016/j.neuropsychologia.2006.03.037; Davatzikos C, 1998, CEREB CORTEX, V8, P635, DOI 10.1093/cercor/8.7.635; DELACOSTE MC, 1988, BRAIN BEHAV EVOLUT, V31, P318, DOI 10.1159/000116598; DELACOSTE MC, 1986, HUM NEUROBIOL, V5, P93; DRIESEN NR, 1995, PSYCHOBIOLOGY, V23, P240; Dunham LA, 2006, BEHAV NEUROSCI, V120, P1025, DOI 10.1037/0735-7044.120.5.1025; Fragaszy D. M., 2004, COMPLETE CAPUCHIN; Fragaszy DM, 1990, J COMP PSYCHOL, V104, P272; HABIB M, 1991, BRAIN COGNITION, V16, P41, DOI 10.1016/0278-2626(91)90084-L; HOLLOWAY RL, 1992, AM J PHYS ANTHROPOL, V87, P349, DOI 10.1002/ajpa.1330870309; HOLLOWAY RL, 1993, AM J PHYS ANTHROPOL, V92, P481, DOI 10.1002/ajpa.1330920407; HOLLOWAY RL, 1986, HUM NEUROBIOL, V5, P87; HOLLOWAY RL, 1990, APES ANGELS ESSAYS A, P221; Hopkins WD, 2004, BEHAV NEUROSCI, V118, P659, DOI 10.1037/0735-7044.118.3.659; Hopkins WD, 2003, J COMP PSYCHOL, V117, P302, DOI 10.1037/0735-7036.117.3.302; HOPKINS WD, 1995, J COMP PSYCHOL, V109, P291, DOI 10.1037/0735-7036.109.3.291; Hopkins WD, 2000, BEHAV NEUROSCI, V114, P739, DOI 10.1037//0735-7044.114.4.739; Jack K., 2007, PRIMATES PERSPECTIVE, P107; JOHNSON SC, 1994, BRAIN RES BULL, V35, P373, DOI 10.1016/0361-9230(94)90116-3; LACOSTEUTAMSING C, 1982, SCIENCE, V216, P1431; LAMANTIA AS, 1990, J COMP NEUROL, V291, P520, DOI 10.1002/cne.902910404; LEMAY M, 1976, ANN NY ACAD SCI, V280, P349, DOI 10.1111/j.1749-6632.1976.tb25499.x; Limongelli L., 1994, P9; Lonsdorf EV, 2005, P NATL ACAD SCI USA, V102, P12634, DOI 10.1073/pnas.0505806102; PARKER ST, 1977, J HUM EVOL, V6, P623, DOI 10.1016/S0047-2484(77)80135-8; Phillips KA, 2005, BEHAV NEUROSCI, V119, P1701, DOI 10.1037/0735-7044.119.6.1701; Phillips KA, 2007, NEUROPSYCHOLOGIA, V45, P2333, DOI 10.1016/j.neuropsychologia.2007.02.010; Schoenemann PT, 2006, ANNU REV ANTHROPOL, V35, P379, DOI 10.1146/annurev.anthro.35.081705.123210; Serrien DJ, 2006, NAT REV NEUROSCI, V7, P160, DOI 10.1038/nrn1849; Smith RJ, 2005, CURR ANTHROPOL, V46, P249, DOI 10.1086/427117; Spinozzi G, 1998, J COMP PSYCHOL, V112, P183, DOI 10.1037/0735-7036.112.2.183; Sussman RW, 2000, NEW WORLD MONKEYS, V2; Vauclair J, 2005, COGNITIVE BRAIN RES, V25, P210, DOI 10.1016/j.cogbrainres.2005.05.012; WESTERGAARD GC, 1993, PRIMATES, V34, P295, DOI 10.1007/BF02382624; WESTERGAARD GC, 1993, FOLIA PRIMATOL, V61, P38, DOI 10.1159/000156726; Westergaard GC, 1996, J COMP PSYCHOL, V110, P406, DOI 10.1037/0735-7036.110.4.406; WITELSON SF, 1985, SCIENCE, V229, P665, DOI 10.1126/science.4023705; WITELSON SF, 1991, BRAIN RES, V545, P175, DOI 10.1016/0006-8993(91)91284-8; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Wundrum I. J., 1986, HUMAN EVOLUTION, V1, P183, DOI [10.1007/BF02437494, DOI 10.1007/BF02437494]	43	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e792	10.1371/journal.pone.0000792	http://dx.doi.org/10.1371/journal.pone.0000792			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726522	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455400009
J	Bolzoni, L; Real, L; De Leo, G				Bolzoni, Luca; Real, Leslie; De Leo, Giulio			Transmission Heterogeneity and Control Strategies for Infectious Disease Emergence	PLOS ONE			English	Article								Background. The control of emergence and spread of infectious diseases depends critically on the details of the genetic makeup of pathogens and hosts, their immunological, behavioral and ecological traits, and the pattern of temporal and spatial contacts among the age/stage-classes of susceptible and infectious host individuals. Methods and Findings. We show that failing to acknowledge the existence of heterogeneities in the transmission rate among age/stage-classes can make traditional eradication and control strategies ineffective, and in some cases, policies aimed at controlling pathogen emergence can even increase disease incidence in the host. When control strategies target for reduction in numbers those subsets of the population that effectively limit the production of new susceptible individuals, then control can produce a flush of new susceptibles entering the population. The availability of a new cohort of susceptibles may actually increase disease incidence. We illustrate these general points using Classical Swine Fever as a reference disease. Conclusion. Negative effects of culling are robust to alternative formulations of epidemiological processes and underline the importance of better assessing transmission structure in the design of wildlife disease control strategies.	[Bolzoni, Luca; De Leo, Giulio] Univ Parma, Dipartimento Sci Ambientali, I-43100 Parma, Italy; [Real, Leslie] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	University of Parma; Emory University	Bolzoni, L (corresponding author), Univ Parma, Dipartimento Sci Ambientali, I-43100 Parma, Italy.	luca.bolzoni@nemo.unipr.it	De Leo, Giulio/AAC-5098-2019; Bolzoni, Luca/F-5061-2011	De Leo, Giulio/0000-0002-4186-3369; Bolzoni, Luca/0000-0001-8523-4460	Italian Minister of Research [II04CE49G8]; US National Institutes of Health [RO1 AI1047498]; Emory University	Italian Minister of Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University	This work was supported in part by the Italian Minister of Research prot. II04CE49G8 (LB and GDL) and by a US National Institutes of Health RO1 AI1047498 and an International and Comparative Studies grant from Emory University ( to LAR).	ANDERSON RM, 1981, NATURE, V289, P765, DOI 10.1038/289765a0; CASTILLOCHAVEZ C, 1989, MATH STAT APPROACHES; Choisy M, 2006, P ROY SOC B-BIOL SCI, V273, P2025, DOI 10.1098/rspb.2006.3554; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; COYNE MJ, 1989, AM J VET RES, V50, P2148; Dobson A, 1996, ECOLOGY, V77, P1026, DOI 10.2307/2265573; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; Galvani AP, 2005, NATURE, V438, P293, DOI 10.1038/438293a; Gilbert M, 2005, NATURE, V435, P491, DOI 10.1038/nature03548; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; Haydon DT, 2004, NAT REV MICROBIOL, V2, P675, DOI 10.1038/nrmicro960; Heesterbeek J. A. P., 1995, P90, DOI 10.1017/CBO9780511629396.004; Hethcote HW, 1992, MODELING HIV TRANSMI; Kaden V, 2005, EUR J WILDLIFE RES, V51, P101, DOI 10.1007/s10344-005-0083-2; Laddomada A, 2000, VET MICROBIOL, V73, P121, DOI 10.1016/S0378-1135(00)00139-5; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103; Oliver JH, 2003, P NATL ACAD SCI USA, V100, P11642, DOI 10.1073/pnas.1434553100; Pluimers FH, 1999, PREV VET MED, V42, P139, DOI 10.1016/S0167-5877(99)00085-9; REAL LA, 2005, J HEREDITY, V96; Saatkamp HW, 1997, PREV VET MED, V30, P121, DOI 10.1016/S0167-5877(96)01104-X; Shirley MDF, 2005, EPIDEMIOL INFECT, V133, P1023, DOI 10.1017/S095026880500453X; Sidwa TJ, 2005, JAVMA-J AM VET MED A, V227, P785, DOI 10.2460/javma.2005.227.785; Woodroffe R, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P123	27	44	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e747	10.1371/journal.pone.0000747	http://dx.doi.org/10.1371/journal.pone.0000747			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712403	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455300003
J	Mirambeau, G; Lyonnais, S; Coulaud, D; Hameau, L; Lafosse, S; Jeusset, J; Borde, I; Reboud-Ravaux, M; Restle, T; Gorelick, RJ; Le Cam, E				Mirambeau, Gilles; Lyonnais, Sebastien; Coulaud, Dominique; Hameau, Laurence; Lafosse, Sophie; Jeusset, Josette; Borde, Isabelle; Reboud-Ravaux, Michele; Restle, Tobias; Gorelick, Robert J.; Le Cam, Eric			HIV-1 Protease and Reverse Transcriptase Control the Architecture of Their Nucleocapsid Partner	PLOS ONE			English	Article								The HIV-1 nucleocapsid is formed during protease (PR)-directed viral maturation, and is transformed into pre-integration complexes following reverse transcription in the cytoplasm of the infected cell. Here, we report a detailed transmission electron microscopy analysis of the impact of HIV-1 PR and reverse transcriptase (RT) on nucleocapsid plasticity, using in vitro reconstitutions. After binding to nucleic acids, NCp15, a proteolytic intermediate of nucleocapsid protein (NC), was processed at its C-terminus by PR, yielding premature NC (NCp9) followed by mature NC (NCp7), through the consecutive removal of p6 and p1. This allowed NC co-aggregation with its single-stranded nucleic-acid substrate. Examination of these co-aggregates for the ability of RT to catalyse reverse transcription showed an effective synthesis of double-stranded DNA that, remarkably, escaped from the aggregates more efficiently with NCp7 than with NCp9. These data offer a compelling explanation for results from previous virological studies that focused on i) Gag processing leading to nucleocapsid condensation, and ii) the disappearance of NCp7 from the HIV-1 pre-integration complexes. We propose that HIV-1 PR and RT, by controlling the nucleocapsid architecture during the steps of condensation and dismantling, engage in a successive nucleoprotein-remodelling process that spatiotemporally coordinates the pre-integration steps of HIV-1. Finally we suggest that nucleoprotein remodelling mechanisms are common features developed by mobile genetic elements to ensure successful replication.	[Mirambeau, Gilles; Lyonnais, Sebastien; Coulaud, Dominique; Hameau, Laurence; Lafosse, Sophie; Jeusset, Josette; Le Cam, Eric] Univ Paris 11, Inst Cancerol Gustave Roussy, CNRS, UMR Interact Mol & Canc 8126,Lab Microscopie Mol, Villejuif, France; [Mirambeau, Gilles] Univ Paris 06, Div Biochim, UFR Sci Vie, Paris, France; [Borde, Isabelle] Univ Paris 06, Lab Biol & Multimedia, Paris, France; [Reboud-Ravaux, Michele] Univ Paris 06, CNRS, Inst Jacques Monod, Lab Enzymol Mol & Fonct,FRE 2852, Paris, France; [Restle, Tobias] Univ Klinikum Schleswig Holstein, Inst Mol Med, D-23538 Lubeck, Germany; [Restle, Tobias] ZMSB, Lubeck, Germany; [Gorelick, Robert J.] NCI, AIDS Vaccine Program, Basic Res Program, Sci Applicat Int Corp Frederick, Frederick, MD 21701 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Kiel; Schleswig Holstein University Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Mirambeau, G (corresponding author), Univ Paris 11, Inst Cancerol Gustave Roussy, CNRS, UMR Interact Mol & Canc 8126,Lab Microscopie Mol, Villejuif, France.	gilles.mirambeau@free.fr; elecam@igr.fr		Mirambeau, Gilles/0000-0001-8308-4948; Le cam, Eric/0000-0002-6832-6117; Lyonnais, Sebastien/0000-0002-3154-8568	ANRS; EC [LSHG-CT-2003-503480]; National Cancer Institute, National Institutes of Health [N01-CO-12400]	ANRS(ANRSFrench National Research Agency (ANR)); EC(European CommissionEuropean Commission Joint Research Centre); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	SL and LH were supported by fellowships from Agence Nationale de Recherches sur le SIDA (ANRS). This work was supported by grants from ANRS (GM and EL), by EC-grant LSHG-CT-2003-503480 (TR) and with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400 (RG). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U. S. Government.	AlGhusein H, 1996, BIOCHEM BIOPH RES CO, V224, P191, DOI 10.1006/bbrc.1996.1006; Anthony RM, 2007, J MOL BIOL, V365, P310, DOI 10.1016/j.jmb.2006.10.007; Apolloni A, 2003, J VIROL, V77, P9912, DOI 10.1128/JVI.77.18.9912-9921.2003; Arhel N, 2006, NAT METHODS, V3, P817, DOI 10.1038/nmeth928; Bannwarth L, 2006, J MED CHEM, V49, P4657, DOI 10.1021/jm060576k; Beloin C, 2003, J BIOL CHEM, V278, P5333, DOI 10.1074/jbc.M207489200; Benjamin J, 2005, J MOL BIOL, V346, P577, DOI 10.1016/j.jmb.2004.11.064; BILLICH A, 1990, BIOL CHEM H-S, V371, P265, DOI 10.1515/bchm3.1990.371.1.265; Briggs JAG, 2006, STRUCTURE, V14, P15, DOI 10.1016/j.str.2005.09.010; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Carteau S, 1999, J VIROL, V73, P6670, DOI 10.1128/JVI.73.8.6670-6679.1999; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Cruceanu M, 2006, NUCLEIC ACIDS RES, V34, P593, DOI 10.1093/nar/gkj458; de Rocquigny H, 1997, J BIOL CHEM, V272, P30753, DOI 10.1074/jbc.272.49.30753; Dettenhofer M, 1999, J VIROL, V73, P4696, DOI 10.1128/JVI.73.6.4696-4704.1999; Dismuke DJ, 2006, J VIROL, V80, P3712, DOI 10.1128/JVI.80.8.3712-3720.2006; DUBOCHET J, 1971, J ULTRA MOL STRUCT R, V35, P147, DOI 10.1016/S0022-5320(71)80148-X; Fassati A, 2001, J VIROL, V75, P3626, DOI 10.1128/JVI.75.8.3626-3635.2001; Fisher RJ, 2006, NUCLEIC ACIDS RES, V34, P472, DOI 10.1093/nar/gkj442; Forshey BM, 2003, J VIROL, V77, P4409, DOI 10.1128/JVI.77.7.4409-4414.2003; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Fu W, 2006, J VIROL, V80, P1242, DOI 10.1128/JVI.80.3.1242-1249.2006; Gao K, 2003, J VIROL, V77, P1598, DOI 10.1128/JVI.77.2.1598-1603.2003; Guo JH, 2000, J VIROL, V74, P8980, DOI 10.1128/JVI.74.19.8980-8988.2000; Hameau L, 2001, J VIROL, V75, P3301, DOI 10.1128/JVI.75.7.3301-3313.2001; Henriet S, 2005, J MOL BIOL, V354, P55, DOI 10.1016/j.jmb.2005.09.025; Hill MK, 2002, J VIROL, V76, P11245, DOI 10.1128/JVI.76.22.11245-11253.2002; Hsu M, 2000, J HUMAN VIROL, V3, P16; Iordanskiy S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-4; Jenkins Y, 2001, J VIROL, V75, P10537, DOI 10.1128/JVI.75.21.10537-10542.2001; JOANICOT M, 1987, BIOPOLYMERS, V26, P315, DOI 10.1002/bip.360260211; KHAN R, 1994, J BIOL CHEM, V269, P22538; Kleiman L, 2004, CURR HIV RES, V2, P163, DOI 10.2174/1570162043484988; Kotov A, 1999, J VIROL, V73, P8824, DOI 10.1128/JVI.73.10.8824-8830.1999; Krishnamoorthy G, 2003, NUCLEIC ACIDS RES, V31, P5425, DOI 10.1093/nar/gkg738; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Le Cam E, 1998, BIOPOLYMERS, V45, P217, DOI 10.1002/(SICI)1097-0282(199803)45:3&lt;217::AID-BIP4&gt;3.0.CO;2-U; Lee BM, 1998, J MOL BIOL, V279, P633, DOI 10.1006/jmbi.1998.1766; Lehmann-Che J, 2004, AIDS REV, V6, P199; Lener D, 1998, J BIOL CHEM, V273, P33781, DOI 10.1074/jbc.273.50.33781; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Liu BD, 1999, J VIROL, V73, P2901, DOI 10.1128/JVI.73.4.2901-2908.1999; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Lyonnais S, 2003, NUCLEIC ACIDS RES, V31, P5754, DOI 10.1093/nar/gkg716; Lyonnais S, 2002, NUCLEIC ACIDS RES, V30, P5276, DOI 10.1093/nar/gkf644; Mirambeau G, 2006, J MOL BIOL, V364, P496, DOI 10.1016/j.jmb.2006.08.065; MULLER B, 1989, J BIOL CHEM, V264, P13975; Nermut MV, 2003, J VIROL, V77, P8196, DOI 10.1128/JVI.77.15.8196-8206.2003; Nijhuis M, 2007, PLOS MED, V4, P152, DOI 10.1371/journal.pmed.0040036; Nisole Sebastien, 2004, Retrovirology, V1, P9, DOI 10.1186/1742-4690-1-9; Pettit SC, 1998, ADV EXP MED BIOL, V436, P15; Pettit SC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-66; Prabu-Jeyabalan M, 2004, J VIROL, V78, P12446, DOI 10.1128/JVI.78.22.12446-12454.2004; Schultz SJ, 2006, J BIOL CHEM, V281, P1943, DOI 10.1074/jbc.M510504200; Shehu-Xhilaga M, 2002, J VIROL, V76, P4331, DOI 10.1128/JVI.76.9.4331-4340.2002; Shehu-Xhilaga M, 2001, J VIROL, V75, P9156, DOI 10.1128/JVI.75.19.9156-9164.2001; Sheng NJ, 1997, J VIROL, V71, P5723, DOI 10.1128/JVI.71.8.5723-5732.1997; SHENG NJ, 1994, J VIROL, V68, P6207, DOI 10.1128/JVI.68.10.6207-6214.1994; Shi J, 2006, VIROLOGY, V350, P493, DOI 10.1016/j.virol.2006.03.013; THOMAS JA, 2006, VIROLOGY; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998; Wisniewski M, 2000, P NATL ACAD SCI USA, V97, P11978, DOI 10.1073/pnas.210392297; Yamashita M, 2005, PLOS PATHOG, V1, P170, DOI 10.1371/journal.ppat.0010018; Zhu K, 2004, J VIROL, V78, P5045, DOI 10.1128/JVI.78.10.5045-5055.2004; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100	67	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e669	10.1371/journal.pone.0000669	http://dx.doi.org/10.1371/journal.pone.0000669			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712401	Green Published, gold			2022-12-27	WOS:000207455300001
J	Tang, J; Park, JG; Millard, CB; Schmidt, JJ; Pang, YP				Tang, Jing; Park, Jewn Giew; Millard, Charles B.; Schmidt, James J.; Pang, Yuan-Ping			Computer-Aided Lead Optimization: Improved Small-Molecule Inhibitor of the Zinc Endopeptidase of Botulinum Neurotoxin Serotype A	PLOS ONE			English	Article							PROTON DISSOCIATION-ENERGIES; SUBSTRATE-SPECIFICITY; DYNAMICS SIMULATIONS; COUPLING REACTION; ARYL; IDENTIFICATION; IMIDAZOLE; MECHANISM; POTENT; IMP-1	Optimization of a serotype-selective, small-molecule inhibitor of botulinum neurotoxin serotype A (BoNTA) endopeptidase is a formidable challenge because the enzyme-substrate interface is unusually large and the endopeptidase itself is a large, zinc-binding protein with a complex fold that is difficult to simulate computationally. We conducted multiple molecular dynamics simulations of the endopeptidase in complex with a previously described inhibitor (K-i(app) of 7+/-2.4 mu M) using the cationic dummy atom approach. Based on our computational results, we hypothesized that introducing a hydroxyl group to the inhibitor could improve its potency. Synthesis and testing of the hydroxyl-containing analog as a BoNTA endopeptidase inhibitor showed a twofold improvement in inhibitory potency (K-i(app) of 3.8+/-0.8 mu M) with a relatively small increase in molecular weight (16 Da). The results offer an improved template for further optimization of BoNTA endopeptidase inhibitors and demonstrate the effectiveness of the cationic dummy atom approach in the design and optimization of zinc protease inhibitors.	[Schmidt, James J.] USA, Med Res Inst Infect Dis, Dept Cell Biol & Biochem, Frederick, MD USA; [Tang, Jing; Park, Jewn Giew; Pang, Yuan-Ping] Mayo Clin, Comp Aided Mol Design Lab, Rochester, MN USA; [Millard, Charles B.] Walter Reed Army Inst Res, Div Biochem, Silver Spring, MD USA	Mayo Clinic; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Schmidt, JJ (corresponding author), USA, Med Res Inst Infect Dis, Dept Cell Biol & Biochem, Frederick, MD USA.	james.schmidt@det.amedd.army.mil; pang@mayo.edu		Pang, Yuan-Ping/0000-0003-0838-2560	Advanced Research Projects Agency [DAAD19-01-10322]; U.S. Army Medical Research Acquisition Activity [W81XWH-04-2-0001]; National Institutes of Health/National Institute of Allergy and Infectious Diseases [5R01AI054574-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054574] Funding Source: NIH RePORTER	Advanced Research Projects Agency; U.S. Army Medical Research Acquisition Activity; National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by Advanced Research Projects Agency (DAAD19-01-10322), the U.S. Army Medical Research Acquisition Activity (W81XWH-04-2-0001), and the National Institutes of Health/National Institute of Allergy and Infectious Diseases (5R01AI054574-03).	Ariffin A, 2004, SYNTHETIC COMMUN, V34, P4439, DOI 10.1081/SCC-200043164; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boldt GE, 2006, ORG LETT, V8, P1729, DOI 10.1021/ol0603211; Boldt GE, 2006, J COMB CHEM, V8, P513, DOI 10.1021/cc060010h; Boldt GE, 2006, CHEM COMMUN, P3063, DOI 10.1039/b603099h; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Burnett JC, 2007, J BIOL CHEM, V282, P5004, DOI 10.1074/jbc.M608166200; Burnett JC, 2003, BIOCHEM BIOPH RES CO, V310, P84, DOI 10.1016/j.bbrc.2003.08.112; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dickerson TJ, 2006, ACS CHEM BIOL, V1, P359, DOI 10.1021/cb600179d; DIECK HA, 1975, J ORGANOMET CHEM, V93, P259, DOI 10.1016/S0022-328X(00)94049-X; El Yazal J, 2000, J PHYS CHEM B, V104, P6662, DOI 10.1021/jp994283x; El Yazal J, 1999, J PHYS CHEM B, V103, P8773, DOI 10.1021/jp991787m; El Yazal J, 2001, J MOL STRUC-THEOCHEM, V545, P271, DOI 10.1016/S0166-1280(01)00405-5; EUBANKS LM, 2007, P NATL ACAD SCI US; Frisch M J, 1999, GAUSSIAN 98 REVISION; GUPTA RR, 1999, HETEROCYCLIC CHEM, V2, P145; Ho CY, 2005, J ORG CHEM, V70, P4873, DOI 10.1021/jo050036f; Johnson SL, 2006, CURR TOP MED CHEM, V6, P317, DOI 10.2174/156802606776287072; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JOULE JA, 1998, HETEROCYCLIC CHEM, P261; Kessler KR, 1997, NEUROTOXICOLOGY, V18, P761; Meegalla SK, 2004, BIOORG MED CHEM LETT, V14, P4949, DOI 10.1016/j.bmcl.2004.07.033; Merino I, 2006, BIOORGAN MED CHEM, V14, P3583, DOI 10.1016/j.bmc.2006.01.015; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; MIYAURA N, 1979, J CHEM SOC CHEM COMM, P866, DOI 10.1039/c39790000866; MOOTOO DR, 1989, TETRAHEDRON LETT, V30, P2363, DOI 10.1016/S0040-4039(01)80399-3; Oelschlaeger P, 2003, BIOCHEMISTRY-US, V42, P8945, DOI 10.1021/bi0300332; Oelschlaeger P, 2003, PROTEIN ENG, V16, P341, DOI 10.1093/protein/gzg049; Pang YP, 2000, PROTEIN SCI, V9, P1857; Pang YP, 2004, PROTEINS, V57, P747, DOI 10.1002/prot.20249; Pang YP, 1999, J MOL MODEL, V5, P196, DOI 10.1007/s008940050119; Pang YP, 2004, BIOORGAN MED CHEM, V12, P3063, DOI 10.1016/j.bmc.2004.02.026; Pang YP, 2001, PROTEINS, V45, P183, DOI 10.1002/prot.1138; Pang YP, 1996, J BIOL CHEM, V271, P23646, DOI 10.1074/jbc.271.39.23646; Pang YP, 1999, J AM CHEM SOC, V121, P1717, DOI 10.1021/ja9828410; Park JG, 2006, BIOORGAN MED CHEM, V14, P395, DOI 10.1016/j.bmc.2005.08.018; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Roe RR, 1999, J MOL MODEL, V5, P134, DOI 10.1007/s008940050113; Sakai N, 2004, ORG LETT, V6, P1527, DOI 10.1021/ol036499u; Schmidt JJ, 2003, APPL ENVIRON MICROB, V69, P297, DOI 10.1128/AEM.69.1.297-303.2003; Schmidt JJ, 1997, J PROTEIN CHEM, V16, P19, DOI 10.1023/A:1026386710428; SHAPIRO R, 1984, BIOCHEMISTRY-US, V23, P5225, DOI 10.1021/bi00317a021; Shapiro RL, 1998, ANN INTERN MED, V129, P221, DOI 10.7326/0003-4819-129-3-199808010-00011; SHONE CC, 1994, EUR J BIOCHEM, V225, P263, DOI 10.1111/j.1432-1033.1994.00263.x; SIMPSON LL, 1981, PHARMACOL REV, V33, P155; Singh BR, 2000, NAT STRUCT BIOL, V7, P617, DOI 10.1038/77900; SPRINGEN K, 2002, BOTOX BOOM NEWSWEEK, P50; SUZUKI A, 1991, PURE APPL CHEM, V63, P419, DOI 10.1351/pac199163030419; Todhunter J A, 1979, Methods Enzymol, V63, P383	52	44	45	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e761	10.1371/journal.pone.0000761	http://dx.doi.org/10.1371/journal.pone.0000761			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712409	Green Published, gold			2022-12-27	WOS:000207455300009
J	Niimura, Y; Nei, M				Niimura, Yoshihito; Nei, Masatoshi			Extensive Gains and Losses of Olfactory Receptor Genes in Mammalian Evolution	PLOS ONE			English	Article								Odor perception in mammals is mediated by a large multigene family of olfactory receptor ( OR) genes. The number of OR genes varies extensively among different species of mammals, and most species have a substantial number of pseudogenes. To gain some insight into the evolutionary dynamics of mammalian OR genes, we identified the entire set of OR genes in platypuses, opossums, cows, dogs, rats, and macaques and studied the evolutionary change of the genes together with those of humans and mice. We found that platypuses and primates have,400 functional OR genes while the other species have 800-1,200 functional OR genes. We then estimated the numbers of gains and losses of OR genes for each branch of the phylogenetic tree of mammals. This analysis showed that (i) gene expansion occurred in the placental lineage each time after it diverged from monotremes and from marsupials and (ii) hundreds of gains and losses of OR genes have occurred in an order-specific manner, making the gene repertoires highly variable among different orders. It appears that the number of OR genes is determined primarily by the functional requirement for each species, but once the number reaches the required level, it fluctuates by random duplication and deletion of genes. This fluctuation seems to have been aided by the stochastic nature of OR gene expression.	[Niimura, Yoshihito] Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat, Tokyo, Japan; [Niimura, Yoshihito; Nei, Masatoshi] Penn State Univ, Inst Mol Evolutionary Genet, University Pk, PA 16802 USA; [Niimura, Yoshihito; Nei, Masatoshi] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Tokyo Medical & Dental University (TMDU); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Niimura, Y (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat, Tokyo, Japan.	niimura@bioinfo.tmd.ac.jp			US NIH [GM020293]; Ministry of Education, Culture, Sports, Science and Technology, Japan [17710162]; Genome Information Integration Project of the Ministry of Economy; Trade and Industry of Japan; Japan Biological Informatics Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020293] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Genome Information Integration Project of the Ministry of Economy; Trade and Industry of Japan; Japan Biological Informatics Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by US NIH grant GM020293 to M.N. and by grant 17710162 from Ministry of Education, Culture, Sports, Science and Technology, Japan and by the Genome Information Integration Project of the Ministry of Economy, Trade and Industry of Japan and the Japan Biological Informatics Consortium to Y.N.	Aloni R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r88; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cannarozzi G, 2007, PLOS COMPUT BIOL, V3, P9, DOI 10.1371/journal.pcbi.0030002; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Go Y, 2006, MOL BIOL EVOL, V23, P964, DOI 10.1093/molbev/msj106; GOODMAN M, 1979, SYST ZOOL, V28, P132, DOI 10.2307/2412519; Grus WE, 2005, P NATL ACAD SCI USA, V102, P5767, DOI 10.1073/pnas.0501589102; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kriegs JO, 2006, PLOS BIOL, V4, P537, DOI 10.1371/journal.pbio.0040091; Kullberg M, 2006, MOL BIOL EVOL, V23, P1493, DOI 10.1093/molbev/msl027; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; Nam J, 2005, MOL BIOL EVOL, V22, P2386, DOI 10.1093/molbev/msi229; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; NEI M, 2000, MOL EVOLUTION PHYLOG, P175; NEI M, 2007, P NATL ACAD IN PRESS; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; Niimura Y, 2005, GENE, V346, P23, DOI 10.1016/j.gene.2004.09.027; Niimura Y, 2005, P NATL ACAD SCI USA, V102, P6039, DOI 10.1073/pnas.0501922102; Niimura Y, 2005, GENE, V346, P13, DOI 10.1016/j.gene.2004.09.025; Niimura Y, 2003, P NATL ACAD SCI USA, V100, P12235, DOI 10.1073/pnas.1635157100; Niimura Y, 2006, J HUM GENET, V51, P505, DOI 10.1007/s10038-006-0391-8; Nozawa M, 2007, P NATL ACAD SCI USA, V104, P7122, DOI 10.1073/pnas.0702133104; Page RDM, 1997, MOL PHYLOGENET EVOL, V7, P231, DOI 10.1006/mpev.1996.0390; Pettigrew JD, 1999, J EXP BIOL, V202, P1447; Quignon P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r83; Ray A, 2007, NEURON, V53, P353, DOI 10.1016/j.neuron.2006.12.010; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shepherd GM, 2004, PLOS BIOL, V2, P572, DOI 10.1371/journal.pbio.0020146; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zozulya S, 2001, GENOME BIOL, V2	44	216	223	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e708	10.1371/journal.pone.0000708	http://dx.doi.org/10.1371/journal.pone.0000708			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684554	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452400011
J	Karpathy, SE; Qin, X; Gioia, J; Jiang, HY; Liu, YM; Petrosino, JF; Yerrapragada, S; Fox, GE; Haake, SK; Weinstock, GM; Highlander, SK				Karpathy, Sandor E.; Qin, Xiang; Gioia, Jason; Jiang, Huaiyang; Liu, Yamei; Petrosino, Joseph F.; Yerrapragada, Shailaja; Fox, George E.; Haake, Susan Kinder; Weinstock, George M.; Highlander, Sarah K.			Genome Sequence of Fusobacterium nucleatum Subspecies Polymorphum - a Genetically Tractable Fusobacterium	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; GROUP-I INTRONS; ESCHERICHIA-COLI; PORPHYROMONAS-GINGIVALIS; CLOSTRIDIUM-PERFRINGENS; SHIGELLA-FLEXNERI; BACTERIAL GENOMES; OXIDATIVE STRESS; STREPTOCOCCUS-PYOGENES; SUBGINGIVAL PLAQUE	Fusobacterium nucleatum is a prominent member of the oral microbiota and is a common cause of human infection. F. nucleatum includes five subspecies: polymorphum, nucleatum, vincentii, fusiforme, and animalis. F. nucleatum subsp. polymorphum ATCC 10953 has been well characterized phenotypically and, in contrast to previously sequenced strains, is amenable to gene transfer. We sequenced and annotated the 2,429,698 bp genome of F. nucleatum subsp. polymorphum ATCC 10953. Plasmid pFN3 from the strain was also sequenced and analyzed. When compared to the other two available fusobacterial genomes (F. nucleatum subsp. nucleatum, and F. nucleatum subsp. vincentii) 627 open reading frames unique to F. nucleatum subsp. polymorphum ATCC 10953 were identified. A large percentage of these mapped within one of 28 regions or islands containing five or more genes. Seventeen percent of the clustered proteins that demonstrated similarity were most similar to proteins from the clostridia, with others being most similar to proteins from other gram-positive organisms such as Bacillus and Streptococcus. A ten kilobase region homologous to the Salmonella typhimurium propanediol utilization locus was identified, as was a prophage and integrated conjugal plasmid. The genome contains five composite ribozyme/transposons, similar to the Cd/St IStrons described in Clostridium difficile. IStrons are not present in the other fusobacterial genomes. These findings indicate that F. nucleatum subsp. polymorphum is proficient at horizontal gene transfer and that exchange with the Firmicutes, particularly the Clostridia, is common.	[Karpathy, Sandor E.; Qin, Xiang; Jiang, Huaiyang; Petrosino, Joseph F.; Yerrapragada, Shailaja; Weinstock, George M.; Highlander, Sarah K.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Karpathy, Sandor E.; Weinstock, George M.] Univ Texas Houston, Sch Med, Dept Microbiol & Mol Genet, Houston, TX USA; [Gioia, Jason; Petrosino, Joseph F.; Weinstock, George M.; Highlander, Sarah K.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Liu, Yamei; Fox, George E.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Haake, Susan Kinder] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Houston System; University of Houston; University of California System; University of California Los Angeles	Highlander, SK (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	sarahh@bcm.tmc.edu	Willson, richard/AAD-4832-2019; Petrosino, Joseph F./AAF-1621-2019; Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592	National Institute of Dental and Craniofacial [R01 DE013759]; Susan Kinder Haake [R01 DEO15348]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015348, R01DE013759] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Susan Kinder Haake; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This project was supported by a grant from the National Institute of Dental and Craniofacial Research to George Weinstock. (R01 DE013759). Susan Kinder Haake was supported by R01 DEO15348.	Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Bearfield C, 2002, BJOG-INT J OBSTET GY, V109, P527, DOI 10.1016/S1470-0328(02)01349-6; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Bobik TA, 1997, J BACTERIOL, V179, P6633, DOI 10.1128/jb.179.21.6633-6639.1997; Bolstad AI, 1996, CLIN MICROBIOL REV, V9, P55, DOI 10.1128/CMR.9.1.55; Bradshaw DJ, 1998, INFECT IMMUN, V66, P4729, DOI 10.1128/IAI.66.10.4729-4732.1998; Braun V, 2000, MOL MICROBIOL, V36, P1447, DOI 10.1046/j.1365-2958.2000.01965.x; Brenot A, 2004, INFECT IMMUN, V72, P408, DOI 10.1128/IAI.72.1.408-413.2004; Brook I, 1998, J MED MICROBIOL, V47, P1075, DOI 10.1099/00222615-47-12-1075; Brown L J, 1993, Periodontol 2000, V2, P57; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Cahill RJ, 2005, MOL HUM REPROD, V11, P761, DOI 10.1093/molehr/gah234; CARSIOTIS M, 1989, INFECT IMMUN, V57, P3276, DOI 10.1128/IAI.57.11.3276-3280.1989; CECH TR, 1994, NAT STRUCT BIOL, V1, P273, DOI 10.1038/nsb0594-273; Chaudhry R, 1998, BRIT J NEUROSURG, V12, P127, DOI 10.1080/02688699845258; Cheng ZF, 1998, J BIOL CHEM, V273, P14077, DOI 10.1074/jbc.273.23.14077; Christie PJ, 2004, BBA-MOL CELL RES, V1694, P219, DOI 10.1016/j.bbamcr.2004.02.013; Chryssagi AM, 2001, CLIN RHEUMATOL, V20, P229, DOI 10.1007/s100670170072; CIVEN R, 1995, CLIN INFECT DIS, V20, pS224, DOI 10.1093/clinids/20.Supplement_2.S224; Conrads G, 2002, INT J SYST EVOL MICR, V52, P493, DOI 10.1099/00207713-52-2-493; Demuth DR, 1996, INFECT IMMUN, V64, P1335, DOI 10.1128/IAI.64.4.1335-1341.1996; Desvaux M, 2005, BBA-BIOMEMBRANES, V1713, P92, DOI 10.1016/j.bbamem.2005.05.002; Diaz PI, 2002, MICROBIOL-SGM, V148, P467, DOI 10.1099/00221287-148-2-467; Diaz PI, 2000, FEMS MICROBIOL LETT, V187, P31, DOI 10.1016/S0378-1097(00)00174-9; DZINK JL, 1990, INT J SYST BACTERIOL, V40, P74, DOI 10.1099/00207713-40-1-74; Ebersole JL, 1997, MICROB PATHOGENESIS, V23, P23, DOI 10.1006/mpat.1996.0129; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Feuille F, 1996, INFECT IMMUN, V64, P2095, DOI 10.1128/IAI.64.6.2094-2100.1996; Frias J, 2001, INFECT IMMUN, V69, P3431, DOI 10.1128/IAI.69.5.3431-3434.2001; Gerardo SH, 2002, ORAL MICROBIOL IMMUN, V17, P315; Gmur R, 2006, SYST APPL MICROBIOL, V29, P120, DOI 10.1016/j.syapm.2005.07.011; GOLDSTEIN EJC, 1995, CLIN INFECT DIS, V20, P797, DOI 10.1093/clinids/20.4.797; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Haake SK, 1997, ARCH ORAL BIOL, V42, P19, DOI 10.1016/S0003-9969(96)00105-7; Haake SK, 2000, J BACTERIOL, V182, P1176, DOI 10.1128/JB.182.4.1176-1180.2000; Han YPW, 2004, INFECT IMMUN, V72, P2272, DOI 10.1128/IAI.72.4.2272-2279.2004; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; HASE S, 1977, J BACTERIOL, V129, P9, DOI 10.1128/JB.129.1.9-14.1977; Havlak P, 2004, GENOME RES, V14, P721, DOI 10.1101/gr.2264004; Hayes WS, 1998, GENOME RES, V8, P1154, DOI 10.1101/gr.8.11.1154; Hill G B, 1998, Ann Periodontol, V3, P222, DOI 10.1902/annals.1998.3.1.222; HOLST E, 1994, J CLIN MICROBIOL, V32, P176, DOI 10.1128/JCM.32.1.176-186.1994; ILYINA TV, 1992, NUCLEIC ACIDS RES, V20, P3279, DOI 10.1093/nar/20.13.3279; Jaeger T, 2004, ARCH BIOCHEM BIOPHYS, V423, P182, DOI 10.1016/j.abb.2003.11.021; Jean D, 2004, MICROBIOL-SGM, V150, P1649, DOI 10.1099/mic.0.27017-0; Jewett A, 2000, INFECT IMMUN, V68, P1893, DOI 10.1128/IAI.68.4.1893-1898.2000; JOUSIMIESSOMER H, 1993, CLIN INFECT DIS, V16, pS292, DOI 10.1093/clinids/16.Supplement_4.S292; Kapatral V, 2003, GENOME RES, V13, P1180, DOI 10.1101/gr.566003; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; KAUFMAN J, 1989, INFECT IMMUN, V57, P331, DOI 10.1128/IAI.57.2.331-337.1989; Kersulyte D, 1998, GENE, V223, P175, DOI 10.1016/S0378-1119(98)00164-4; King KY, 2000, J BACTERIOL, V182, P5290, DOI 10.1128/JB.182.19.5290-5299.2000; KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993; Kononen E, 2000, ANN MED, V32, P107, DOI 10.3109/07853890009011759; Kuriyama T, 2000, MICROBES INFECT, V2, P1425, DOI 10.1016/S1286-4579(00)01296-X; LAWRENCE JG, 1992, GENETICS, V131, P753; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; LEACH SA, 1966, NATURE, V209, P506, DOI 10.1038/209506a0; Lehmann Y, 1996, J BACTERIOL, V178, P7152, DOI 10.1128/jb.178.24.7152-7158.1996; Li KY, 2004, J BACTERIOL, V186, P6800, DOI 10.1128/JB.186.20.6800-6808.2004; LIN ECC, 1996, ESCHERICHIA COLI SAL, P307; LINDAHL L, 1986, ANNU REV GENET, V20, P297; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; MCKAY TL, 1995, PLASMID, V33, P15, DOI 10.1006/plas.1995.1003; McLeod MP, 2004, J BACTERIOL, V186, P5842, DOI 10.1128/JB.186.17.5842-5855.2004; MEDIGUE C, 1991, J MOL BIOL, V222, P851, DOI 10.1016/0022-2836(91)90575-Q; Mikamo H, 1999, AM J OBSTET GYNECOL, V180, P378, DOI 10.1016/S0002-9378(99)70217-6; Mikamo H, 1998, AM J OBSTET GYNECOL, V179, P1579, DOI 10.1016/S0002-9378(98)70028-6; Mira A, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-50; Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x; Morris ML, 1996, ORAL MICROBIOL IMMUN, V11, P15, DOI 10.1111/j.1399-302X.1996.tb00331.x; Moszer I, 1999, CURR OPIN MICROBIOL, V2, P524, DOI 10.1016/S1369-5274(99)00011-9; Mrazek J, 1999, ANN NY ACAD SCI, V870, P314, DOI 10.1111/j.1749-6632.1999.tb08893.x; Niederman R, 1997, CRIT REV ORAL BIOL M, V8, P269, DOI 10.1177/10454411970080030301; OZAKI M, 1990, J PERIODONTAL RES, V25, P129, DOI 10.1111/j.1600-0765.1990.tb01034.x; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Philippe H, 2003, CURR OPIN MICROBIOL, V6, P498, DOI 10.1016/j.mib.2003.09.008; Ragan MA, 2001, FEMS MICROBIOL LETT, V201, P187, DOI 10.1111/j.1574-6968.2001.tb10755.x; Ribeiro-Sobrinho AP, 2005, J MED MICROBIOL, V54, P413, DOI 10.1099/jmm.0.45728-0; ROBRISH SA, 1987, J BACTERIOL, V169, P3891, DOI 10.1128/jb.169.9.3891-3897.1987; ROBRISH SA, 1990, J BACTERIOL, V172, P5714, DOI 10.1128/jb.172.10.5714-5723.1990; ROGERS AH, 1991, ORAL MICROBIOL IMMUN, V6, P250, DOI 10.1111/j.1399-302X.1991.tb00486.x; ROGERS AH, 1992, ORAL MICROBIOL IMMUN, V7, P299, DOI 10.1111/j.1399-302X.1992.tb00592.x; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; SHENKER BJ, 1995, INFECT IMMUN, V63, P4830, DOI 10.1128/IAI.63.12.4830-4836.1995; Siefert JL, 1997, J MOL EVOL, V45, P467, DOI 10.1007/PL00006251; SUKUPOLVI S, 1990, MICROBIOL REV, V54, P331, DOI 10.1128/MMBR.54.4.331-341.1990; SUZUKI T, 1994, MOL MICROBIOL, V11, P31, DOI 10.1111/j.1365-2958.1994.tb00287.x; TAKADA H, 1988, INFECT IMMUN, V56, P855, DOI 10.1128/IAI.56.4.855-863.1988; Takemoto T, 1997, J CLIN MICROBIOL, V35, P1378, DOI 10.1128/JCM.35.6.1378-1381.1997; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOBE T, 1992, J BACTERIOL, V174, P6359, DOI 10.1128/JB.174.20.6359-6367.1992; TUTTLE RS, 1992, ORAL MICROBIOL IMMUN, V7, P78, DOI 10.1111/j.1399-302X.1992.tb00513.x; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P648, DOI 10.1034/j.1600-051x.2000.027009648.x; Yoshida A, 2005, APPL ENVIRON MICROB, V71, P2372, DOI 10.1128/AEM.71.5.2372-2380.2005; Zhang R, 2004, BIOINFORMATICS, V20, P612, DOI 10.1093/bioinformatics/btg453; Zimmer M, 2002, J BACTERIOL, V184, P4359, DOI 10.1128/JB.184.16.4359-4368.2002	101	49	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e659	10.1371/journal.pone.0000659	http://dx.doi.org/10.1371/journal.pone.0000659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668047	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452300005
J	Garman, R; Rubin, C; Judex, S				Garman, Russell; Rubin, Clinton; Judex, Stefan			Small Oscillatory Accelerations, Independent of Matrix Deformations, Increase Osteoblast Activity and Enhance Bone Morphology	PLOS ONE			English	Article								A range of tissues have the capacity to adapt to mechanical challenges, an attribute presumed to be regulated through deformation of the cell and/or surrounding matrix. In contrast, it is shown here that extremely small oscillatory accelerations, applied as unconstrained motion and inducing negligible deformation, serve as an anabolic stimulus to osteoblasts in vivo. Habitual background loading was removed from the tibiae of 18 female adult mice by hindlimb-unloading. For 20 min/d, 5 d/wk, the left tibia of each mouse was subjected to oscillatory 0.6 g accelerations at 45 Hz while the right tibia served as control. Sham-loaded (n = 9) and normal age-matched control (n = 18) mice provided additional comparisons. Oscillatory accelerations, applied in the absence of weight bearing, resulted in 70% greater bone formation rates in the trabeculae of the metaphysis, but similar levels of bone resorption, when compared to contralateral controls. Quantity and quality of trabecular bone also improved as a result of the acceleration stimulus, as evidenced by a significantly greater bone volume fraction (17%) and connectivity density (33%), and significantly smaller trabecular spacing (-6%) and structural model index (-11%). These in vivo data indicate that mechanosensory elements of resident bone cell populations can perceive and respond to acceleratory signals, and point to an efficient means of introducing intense physical signals into a biologic system without putting the matrix at risk of overloading. In retrospect, acceleration, as opposed to direct mechanical distortion, represents a more generic and safe, and perhaps more fundamental means of transducing physical challenges to the cells and tissues of an organism.	[Garman, Russell; Rubin, Clinton; Judex, Stefan] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Judex, S (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.	stefan.judex@sunysb.edu			Wallace H. Coulter Foundation; Whitaker Foundation; NASA; NIH	Wallace H. Coulter Foundation; Whitaker Foundation; NASA(National Aeronautics & Space Administration (NASA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: Financial support from the Wallace H. Coulter Foundation (SJ), Whitaker Foundation (SJ), NASA ( SJ), and NIH (CTR), is gratefully acknowledged. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacabac RG, 2006, FASEB J, V20, P858, DOI 10.1096/fj.05-4966.com; Burr DB, 1996, BONE, V18, P405, DOI 10.1016/8756-3282(96)00028-2; Fritton SP, 2000, J BIOMECH, V33, P317, DOI 10.1016/S0021-9290(99)00210-9; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; GALILEO G, 1638, DISCORSI DIMONSTRAZI; Garman R, 2007, J ORTHOP RES, V25, P732, DOI 10.1002/jor.20354; Gilsanz V, 2006, J BONE MINER RES, V21, P1464, DOI 10.1359/JBMR.060612; Gross TS, 2002, J BONE MINER RES, V17, P493, DOI 10.1359/jbmr.2002.17.3.493; Han YF, 2004, P NATL ACAD SCI USA, V101, P16689, DOI 10.1073/pnas.0407429101; Judex S, 2002, FASEB J, V16, P1280, DOI 10.1096/fj.01-0913fje; Judex S, 2004, J BONE MINER RES, V19, P600, DOI 10.1359/JBMR.040101; Judex S, 2007, J BIOMECH, V40, P1333, DOI 10.1016/j.jbiomech.2006.05.014; Kaab MJ, 1998, J ORTHOP RES, V16, P743, DOI 10.1002/jor.1100160617; LAFORTUNE MA, 1991, J BIOMECH, V24, P877, DOI 10.1016/0021-9290(91)90166-K; MALONE A, 2007, AM J PHYSL CELL PHYS; MCLEOD KJ, 1992, J BONE JOINT SURG AM, V74A, P920, DOI 10.2106/00004623-199274060-00014; Morey-Holton E, 1981, PHYSIOLOGIST, V24, P545; NUNAMAKER DM, 1990, J ORTHOPAED RES, V8, P604, DOI 10.1002/jor.1100080417; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Qin YX, 2003, J BIOMECH, V36, P1427, DOI 10.1016/S0021-9290(03)00127-1; Rubin C, 2002, J BONE MINER RES, V17, P349, DOI 10.1359/jbmr.2002.17.2.349; Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122; Rubin C, 2002, BONE, V30, P445, DOI 10.1016/S8756-3282(01)00689-5; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; RUBIN CT, 1982, J EXP BIOL, V101, P187; RUBIN CT, 1985, CALCIFIED TISSUE INT, V37, P411, DOI 10.1007/BF02553711; Rubin J, 2003, J BIOL CHEM, V278, P34018, DOI 10.1074/jbc.M302822200; Schaer BLD, 2006, EQUINE VET J, V38, P664, DOI 10.2746/042516406X156389; Spalazzi JP, 2006, J ORTHOP RES, V24, P2001, DOI 10.1002/jor.20260; STEPHENS PR, 1989, AM J VET RES, V50, P1089; TURNER CH, 1994, J BONE MINER RES, V9, P87; Xie LQ, 2006, BONE, V39, P1059, DOI 10.1016/j.bone.2006.05.012; You J, 2000, J BIOMECH ENG-T ASME, V122, P387, DOI 10.1115/1.1287161	33	51	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e653	10.1371/journal.pone.0000653	http://dx.doi.org/10.1371/journal.pone.0000653			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653280	Green Published, gold			2022-12-27	WOS:000207452200022
J	Kelly, KA; Carson, J; McCarthy, JR; Weissleder, R				Kelly, Kimberly A.; Carson, Jonathan; McCarthy, Jason R.; Weissleder, Ralph			Novel Peptide Sequence ("IQ-tag'') with High Affinity for NIR Fluorochromes Allows Protein and Cell Specific Labeling for In Vivo Imaging	PLOS ONE			English	Article								Background. Probes that allow site-specific protein labeling have become critical tools for visualizing biological processes. Methods. Here we used phage display to identify a novel peptide sequence with nanomolar affinity for near infrared (NIR) (benz) indolium fluorochromes. The developed peptide sequence ("IQ-tag'') allows detection of NIR dyes in a wide range of assays including ELISA, flow cytometry, high throughput screens, microscopy, and optical in vivo imaging. Significance. The described method is expected to have broad utility in numerous applications, namely site-specific protein imaging, target identification, cell tracking, and drug development.	[Kelly, Kimberly A.; Carson, Jonathan; McCarthy, Jason R.; Weissleder, Ralph] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Mol Imaging Res, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Weissleder, R (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Mol Imaging Res, Boston, MA 02115 USA.	weissleder@helix.mgh.harvard.edu		/0000-0003-0828-4143	NIH [R24-CA92782, P50-CA86355]; Sandler Foundation; NATIONAL CANCER INSTITUTE [R24CA092782, P50CA086355] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH R24-CA92782 and P50-CA86355, Sandler Foundation (R.W.)	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Chen I, 2005, CURR OPIN BIOTECH, V16, P35, DOI 10.1016/j.copbio.2004.12.003; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Farinas J, 1999, J BIOL CHEM, V274, P7603, DOI 10.1074/jbc.274.12.7603; George N, 2004, J AM CHEM SOC, V126, P8896, DOI 10.1021/ja048396s; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Guignet EG, 2004, NAT BIOTECHNOL, V22, P440, DOI 10.1038/nbt954; Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101; Lisenbee CS, 2003, TRAFFIC, V4, P491, DOI 10.1034/j.1600-0854.2003.00107.x; Marguet D, 1999, IMMUNITY, V11, P231, DOI 10.1016/S1074-7613(00)80098-9; Montet X, 2005, CANCER RES, V65, P6330, DOI 10.1158/0008-5472.CAN-05-0382; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Panchal RG, 2003, P NATL ACAD SCI USA, V100, P15936, DOI 10.1073/pnas.2533915100; SASSO SP, 1994, BBA-PROTEIN STRUCT M, V1207, P74, DOI 10.1016/0167-4838(94)90053-1; Stroffekova K, 2001, PFLUG ARCH EUR J PHY, V442, P859, DOI 10.1007/s004240100619; Tannous BA, 2006, NAT METHODS, V3, P391, DOI 10.1038/NMETH875; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198; Yin J, 2004, J AM CHEM SOC, V126, P7754, DOI 10.1021/ja047749k	19	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e665	10.1371/journal.pone.0000665	http://dx.doi.org/10.1371/journal.pone.0000665			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653285	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452200027
J	Villard, V; Agak, GW; Frank, G; Jafarshad, A; Servis, C; Nebie, I; Sirima, SB; Felger, I; Arevalo-Herrera, M; Herrera, S; Heitz, F; Backer, V; Druilhe, P; Kajava, AV; Corradin, G				Villard, Viviane; Agak, George W.; Frank, Geraldine; Jafarshad, Ali; Servis, Catherine; Nebie, Issa; Sirima, Sodiomon B.; Felger, Ingrid; Arevalo-Herrera, Myriam; Herrera, Socrates; Heitz, Frederic; Baecker, Volker; Druilhe, Pierre; Kajava, Andrey V.; Corradin, Giampietro			Rapid Identification of Malaria Vaccine Candidates Based on alpha-Helical Coiled Coil Protein Motif	PLOS ONE			English	Article								To identify malaria antigens for vaccine development, we selected alpha-helical coiled coil domains of proteins predicted to be present in the parasite erythrocytic stage. The corresponding synthetic peptides are expected to mimic structurally "native" epitopes. Indeed the 95 chemically synthesized peptides were all specifically recognized by human immune sera, though at various prevalence. Peptide specific antibodies were obtained both by affinity-purification from malaria immune sera and by immunization of mice. These antibodies did not show significant cross reactions, i.e., they were specific for the original peptide, reacted with native parasite proteins in infected erythrocytes and several were active in inhibiting in vitro parasite growth. Circular dichroism studies indicated that the selected peptides assumed partial or high alpha-helical content. Thus, we demonstrate that the bioinformatics/chemical synthesis approach described here can lead to the rapid identification of molecules which target biologically active antibodies, thus identifying suitable vaccine candidates. This strategy can be, in principle, extended to vaccine discovery in a wide range of other pathogens.	[Villard, Viviane; Agak, George W.; Frank, Geraldine; Servis, Catherine; Corradin, Giampietro] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Jafarshad, Ali; Druilhe, Pierre] Inst Pasteur, Paris, France; [Nebie, Issa; Sirima, Sodiomon B.] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Felger, Ingrid] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Arevalo-Herrera, Myriam; Herrera, Socrates] Univ Valle, Inst Immunol, Cali, Colombia; [Heitz, Frederic; Baecker, Volker; Kajava, Andrey V.] Univ Montpellier, CNRS, CRBM, F-34059 Montpellier, France	University of Lausanne; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Basel; Swiss Tropical & Public Health Institute; Universidad del Valle; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Corradin, G (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	giampietro.corradin@unil.ch	Agak, George/AAN-2246-2021; Baecker, Volker/AFT-9035-2022; Kajava, Andrey V/E-1107-2014	Kajava, Andrey V/0000-0002-2342-6886; Agak, George/0000-0002-3356-9864; Felger, Ingrid/0000-0003-1255-2606; Nebie, Issa/0000-0003-3051-3600; SIRIMA, Sodiomon Bienvenu/0000-0002-0972-4211	Swiss National Science Foundation [310000-112244]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding: The work was supported by the Swiss National Science Foundation grant 310000-112244.	ALPERS MP, 1992, PAPUA NEW GUINEA MED, V35, P285; Audran R, 2005, INFECT IMMUN, V73, P8017, DOI 10.1128/IAI.73.12.8017-8026.2005; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Betts JC, 2002, IUBMB LIFE, V53, P239, DOI 10.1080/15216540212651; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; Cooper JA, 1997, MOL IMMUNOL, V34, P433, DOI 10.1016/S0161-5890(97)00056-4; Daubersies P, 2000, NAT MED, V6, P1258, DOI 10.1038/81366; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; FIDOCK DA, 1994, J IMMUNOL, V153, P190; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Guda C, 2005, BIOINFORMATICS, V21, P3963, DOI 10.1093/bioinformatics/bti650; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hodges RS, 1996, BIOCHEM CELL BIOL, V74, P133, DOI 10.1139/o96-015; Hofmann K., 1993, BIOL CHEM HOPPESEYLE, V374; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lopez JA, 2001, EUR J IMMUNOL, V31, P1989, DOI 10.1002/1521-4141(200107)31:7&lt;1989::AID-IMMU1989&gt;3.0.CO;2-M; Lu SM, 2002, J BIOL CHEM, V277, P23515, DOI 10.1074/jbc.M201981200; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Merino EF, 2006, MOL BIOCHEM PARASIT, V149, P10, DOI 10.1016/j.molbiopara.2006.04.002; MOELANS IIMD, 1992, PARASITOL TODAY, V8, P118, DOI 10.1016/0169-4758(92)90278-A; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Rappuoli R, 2003, SCIENCE, V302, P602, DOI 10.1126/science.1092329; Singh S, 2005, INFECT IMMUN, V73, P1235, DOI 10.1128/IAI.73.2.1235-1238.2005; STOUTE JA, 2005, VACCINE; Tripet B, 2006, J STRUCT BIOL, V155, P176, DOI 10.1016/j.jsb.2006.03.019; Vincensini L, 2005, MOL CELL PROTEOMICS, V4, P582, DOI 10.1074/mcp.M400176-MCP200	33	55	116	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e645	10.1371/journal.pone.0000645	http://dx.doi.org/10.1371/journal.pone.0000645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653272	Green Published, gold			2022-12-27	WOS:000207452200014
J	Kalderon, N; Muruganandham, M; Koutcher, JA; Potuzak, M				Kalderon, Nurit; Muruganandham, Manickam; Koutcher, Jason A.; Potuzak, Melissa			Therapeutic Strategy for Acute Spinal Cord Contusion Injury: Cell Elimination Combined with Microsurgical Intervention	PLOS ONE			English	Article								Background. No cure is available for human spinal cord injury. Cell elimination by localized radiation therapy that is timed within 2-3 weeks postinjury can facilitate repair of structure and function in transected rat spinal cord. In pilot studies in contusion spinal cord injury, a model similar to crush/fracture injury in human, we did not observe the expected beneficial effects of radiation therapy. Long forgotten data show that in contusion/crush injury, fluid accumulation from hemorrhage is critical. Alfred Reginald Allen observed that the most devastating sequelae in contusive injury are secondary to fluid accumulation which could be alleviated by surgical intervention, midline slits (myelotomy) at the lesion site. Methods and Findings. Here, we tested whether release of fluid buildup by microsurgery (partial myelotomy) would affect the structural outcome of radiation therapy in the severely contused rat spinal cord. Surgical intervention alone significantly enhanced tissue and functional preservation in the contused cord, thus confirming Allen's observations. Combining partial myelotomy with radiation therapy that is specifically timed postinjury elicited substantial beneficial therapeutic outcome; it led to significant increase in tissue repair/preservation compared with the group that received surgical intervention only, as determined by histology and in vivo MRI. Altogether, the combined treatments led to a 1.8 fold increase in tissue repair/preservation as compared with the contused group. Conclusions. The data suggest that a clinical protocol could be developed to treat acute human spinal cord injury through conventional clinical procedures, a combination of microsurgical manipulation and radiation therapy. These also suggest it is imperative to first prevent the secondary damage caused by fluid accumulation for a cure to be possible.	[Kalderon, Nurit; Potuzak, Melissa] Sloan Kettering Inst Canc Res, Mol Pharmacol & Chem Program, New York, NY USA; [Muruganandham, Manickam; Koutcher, Jason A.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Koutcher, Jason A.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Kalderon, N (corresponding author), Spinal Cord Injury Repair Lab, New York, NY USA.	kalderon@spinalcordcure.org			NIH/NINDS [RO1 NS39375]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039375] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH/NINDS grant RO1 NS39375 (N.K.). No sponsors or funders.	Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002; Allen AR, 1911, JAMA 57, P878, DOI [10.1001/jama.1911.04260090100008, DOI 10.1001/JAMA.1911.04260090100008]; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bilgen M, 2001, MAGNET RESON MED, V45, P614, DOI 10.1002/mrm.1083; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Campbell J B, 1973, Surg Neurol, V1, P102; COOPER PR, 1985, J NEUROSURG, V63, P492, DOI 10.3171/jns.1985.63.4.0492; Corbetta M, 2002, P NATL ACAD SCI USA, V99, P17066, DOI 10.1073/pnas.262669099; de Leon RD, 2002, BRAIN RES REV, V40, P267, DOI 10.1016/S0165-0173(02)00209-6; FALCONER JC, 1994, MAGNET RESON MED, V32, P484, DOI 10.1002/mrm.1910320410; FREEMAN LW, 1953, ANN SURG, V137, P433, DOI 10.1097/00000658-195304000-00001; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Kalderon N, 1996, P NATL ACAD SCI USA, V93, P11185, DOI 10.1073/pnas.93.20.11185; Kalderon N, 2005, CURR PHARM DESIGN, V11, P1237, DOI 10.2174/1381612053507477; Kalderon N, 2001, BRAIN RES, V904, P199, DOI 10.1016/S0006-8993(01)02402-7; Kalderon N, 1996, P NATL ACAD SCI USA, V93, P11179, DOI 10.1073/pnas.93.20.11179; Khan DC, 1999, CANCER INVEST, V17, P110; LOVELY RG, 1986, EXP NEUROL, V92, P421, DOI 10.1016/0014-4886(86)90094-4; Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168; MARCUS RB, 1990, INT J RADIAT ONCOL, V19, P3, DOI 10.1016/0360-3016(90)90126-5; Markham JW., 1951, HIST NEUROLOGICAL SU, P364; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Merola A, 2002, J ORTHOP TRAUMA, V16, P155, DOI 10.1097/00005131-200203000-00003; Narayana P, 1999, MAGN RESON MED, V41, P315, DOI 10.1002/(SICI)1522-2594(199902)41:2<315::AID-MRM15>3.0.CO;2-B; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Popovich PG, 1996, EXP NEUROL, V142, P258, DOI 10.1006/exnr.1996.0196; Qi HX, 2004, SOMATOSENS MOT RES, V21, P229, DOI 10.1080/08990220400012588; Rabchevsky AG, 2002, J NEUROSCI RES, V68, P7, DOI 10.1002/jnr.10187; SCHULTHEISS TE, 1990, INT J RADIAT ONCOL, V19, P219, DOI 10.1016/0360-3016(90)90157-F; Stokes BT, 2002, SPINAL CORD, V40, P101, DOI 10.1038/sj.sc.3101254; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; Timoszyk WK, 2002, J NEUROPHYSIOL, V88, P3108, DOI 10.1152/jn.01050.2001; Wu CWH, 2000, NEURON, V28, P967, DOI 10.1016/S0896-6273(00)00167-7; Zeman RJ, 2001, EXP NEUROL, V172, P228, DOI 10.1006/exnr.2001.7803	36	22	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2007	2	7							e565	10.1371/journal.pone.0000565	http://dx.doi.org/10.1371/journal.pone.0000565			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GI	17637827	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452100001
J	Brown, SP; Taddei, F				Brown, Sam P.; Taddei, Francois			The Durability of Public Goods Changes the Dynamics and Nature of Social Dilemmas	PLOS ONE			English	Article							EVOLUTION; COOPERATION; ALTRUISM; PUNISHMENT; BEHAVIOR	An implicit assumption underpins basic models of the evolution of cooperation, mutualism and altruism: The benefits (or payoffs) of cooperation and defection are defined by the current frequency or distribution of cooperators. In social dilemmas involving durable public goods (group resources that can persist in the environment-ubiquitous from microbes to humans) this assumption is violated. Here, we examine the consequences of relaxing this assumption, allowing pay-offs to depend on both current and past numbers of cooperators. We explicitly trace the dynamic of a public good created by cooperators, and define pay-offs in terms of the current public good. By raising the importance of cooperative history in determining the current fate of cooperators, durable public goods cause novel dynamics (e. g., transient increases in cooperation in Prisoner's Dilemmas, oscillations in Snowdrift Games, or shifts in invasion thresholds in Stag-hunt Games), while changes in durability can transform one game into another, by moving invasion thresholds for cooperation or conditions for coexistence with defectors. This enlarged view challenges our understanding of social cheats. For instance, groups of cooperators can do worse than groups of defectors, if they inherit fewer public goods, while a rise in defectors no longer entails a loss of social benefits, at least not in the present moment (as highlighted by concerns over environmental lags). Wherever durable public goods have yet to reach a steady state (for instance due to external perturbations), the history of cooperation will define the ongoing dynamics of cooperators.	[Brown, Sam P.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Taddei, Francois] Univ Paris 05, INSERM, U571, Paris, France	University of Texas System; University of Texas Austin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Brown, SP (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	sam.brown@cantab.net	Brown, Sam/B-5234-2009	Brown, Sam/0000-0003-1892-9275; Taddei, Francois/0000-0002-7894-0647	Human Frontier Science Program; EURYI	Human Frontier Science Program(Human Frontier Science Program); EURYI(European Science Foundation (ESF))	The work presented was financially supported by the Human Frontier Science Program (S. P. B.) and EURYI (F. T.).	[Anonymous], 1965, LOGIC COLLECTIVE ACT; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Brown SP, 2006, CURR BIOL, V16, P2048, DOI 10.1016/j.cub.2006.08.089; Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; Brown SP, 2001, P ROY SOC B-BIOL SCI, V268, P961, DOI 10.1098/rspb.2001.1609; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Dionisio F, 2006, EVOL ECOL RES, V8, P321; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Dugatkin LA, 2005, P ROY SOC B-BIOL SCI, V272, P79, DOI 10.1098/rspb.2004.2916; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Foster KR, 2006, J EVOLUTION BIOL, V19, P1283, DOI 10.1111/j.1420-9101.2005.01073.x; Frank, 1998, FDN SOCIAL EVOLUTION; Gardner A, 2004, AM NAT, V164, P753, DOI 10.1086/425623; GRIEG D, 2004, P R SOC B, V271, pS25; Guyer Melvin J., 1976, 2 2 GAME; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2006, J THEOR BIOL, V239, P195, DOI 10.1016/j.jtbi.2005.08.040; Hauert C, 2006, P R SOC B, V273, P2565, DOI 10.1098/rspb.2006.3600; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Jansen VAA, 2006, NATURE, V440, P663, DOI 10.1038/nature04387; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; Ostrom E., 1990, GOVERNING COMMONS EV; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143	34	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2007	2	7							e593	10.1371/journal.pone.0000593	http://dx.doi.org/10.1371/journal.pone.0000593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GG	17611625	Green Submitted, Green Published, gold			2022-12-27	WOS:000207451900010
J	Talbott, JR				Talbott, John R.			Size Matters: The Number of Prostitutes and the Global HIV/AIDS Pandemic	PLOS ONE			English	Article							MALE CIRCUMCISION; HIV-INFECTION; SEX; PREVALENCE; RISK; AFRICA	Background. HIV/AIDS prevalence rates across countries of the world vary more than 500-fold from .06% in Hungary to 33.4% in Swaziland. One of the most cited research papers in the field, utilizing cross country regression analysis to analyze other correlates with this HIV prevalence data, is flawed in that it weights each country's results by the country's population. Methodology/Principal Findings. Based on cross-country linear and multiple regressions using newly gathered data from UNAIDS, the number of female commercial sex workers as a percentage of the female adult population is robustly positively correlated with countrywide HIV/AIDS prevalence levels. Confirming earlier studies, female illiteracy levels, gender illiteracy differences and income inequality within countries are also significantly positively correlated with HIV/AIDS levels. Muslims as a percentage of the population, itself highly correlated with country circumcision rates and previously found to be negatively correlated with HIV/AIDS prevalence, is insignificant when the percentage of commercial sex workers in a population is included in the analysis. Conclusions/Significance. This paper provides strong evidence that when conducted properly, cross country regression data does not support the theory that male circumcision is the key to slowing the AIDS epidemic. Rather, it is the number of infected prostitutes in a country that is highly significant and robust in explaining HIV prevalence levels across countries. An explanation is offered for why Africa has been hit the hardest by the AIDS pandemic and why there appears to be very little correlation between HIV/AIDS infection rates and country wealth.	Africans Aids Inc, New York, NY USA		Talbott, JR (corresponding author), Africans Aids Inc, New York, NY USA.	johntalbs@hotmail.com						[Anonymous], 1985, THEORY PRACTICE ECON; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Cote AM, 2004, AIDS, V18, P917, DOI [10.1097/01.aids.0000111475.61782.98, 10.1097/00002030-200404090-00009]; Darby R, 2005, ARCH SEX BEHAV, V34, P707, DOI 10.1007/s10508-005-7930-9; DRAIN JK, 2004, J ACQUIR IMMUNE DEFI, V35; DRAIN PK, 2004, J ACQUIR IMMUNE DEFI, V35; EPSTEIN H, 2004, NY TIMES MAGAZI 0613, P54; Ferry B, 2001, AIDS, V15, pS41, DOI 10.1097/00002030-200108004-00005; Ghys PD, 2001, AIDS, V15, pS33, DOI 10.1097/00002030-200104003-00005; Gray PB, 2004, SOC SCI MED, V58, P1751, DOI 10.1016/S0277-9536(03)00367-8; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; Halperin DT, 1999, LANCET, V354, P1813, DOI 10.1016/S0140-6736(99)03421-2; Harcourt C, 2005, SEX TRANSM INFECT, V81, P201, DOI 10.1136/sti.2004.012468; POTTERAT JJ, 1990, J SEX RES, V27, P233, DOI 10.1080/00224499009551554; Reynolds SJ, 2004, LANCET, V363, P1039, DOI 10.1016/S0140-6736(04)15840-6; ROLL R, 2002, END CLASS WARFARE EX; Siegfried N, 2005, LANCET INFECT DIS, V5, P165, DOI 10.1016/S1473-3099(05)01309-5; U.S. Census Bureau, 2006, HIV AIDS SURV DAT BA; *UN, 2005, DEV PROGR REP, P270; *UN STAT DIV, 2006, DEM SOC IND; UNAIDS, 2006, REP GLOB AIDS EP; United States Central Intelligence Agency, 2006, WORLD FACTB 2006; *USAID UNAIDS WHO, 2006, ANN TABL 6 PREV SERV; Vandepitte J, 2006, SEX TRANSM INFECT, V82, pIII18, DOI 10.1136/sti.2006.020081; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; WESSA P, 2006, STAT SOFTWARE; *WORLD BANK, 2006, WORLD DEV IND 2006 D	27	52	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2007	2	6							e543	10.1371/journal.pone.0000543	http://dx.doi.org/10.1371/journal.pone.0000543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GE	17579715	Green Published, gold, Green Submitted			2022-12-27	WOS:000207451700009
J	Ayoub, NA; Garb, JE; Tinghitella, RM; Collin, MA; Hayashi, CY				Ayoub, Nadia A.; Garb, Jessica E.; Tinghitella, Robin M.; Collin, Matthew A.; Hayashi, Cheryl Y.			Blueprint for a High-Performance Biomaterial: Full-Length Spider Dragline Silk Genes	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; NEPHILA-CLAVIPES TETRAGNATHIDAE; UTR SEQUENCE MOTIF; BLACK-WIDOW SPIDER; EGG CASE SILK; MECHANICAL-PROPERTIES; LATRODECTUS-HESPERUS; REGULATORY ELEMENTS; PROTEIN-COMPONENTS; MOLECULAR CLOCK	Spider dragline (major ampullate) silk outperforms virtually all other natural and manmade materials in terms of tensile strength and toughness. For this reason, the mass-production of artificial spider silks through transgenic technologies has been a major goal of biomimetics research. Although all known arthropod silk proteins are extremely large (> 200 kiloDaltons), recombinant spider silks have been designed from short and incomplete cDNAs, the only available sequences. Here we describe the first full-length spider silk gene sequences and their flanking regions. These genes encode the MaSp1 and MaSp2 proteins that compose the black widow's high-performance dragline silk. Each gene includes a single enormous exon (> 9000 base pairs) that translates into a highly repetitive polypeptide. Patterns of variation among sequence repeats at the amino acid and nucleotide levels indicate that the interaction of selection, intergenic recombination, and intragenic recombination governs the evolution of these highly unusual, modular proteins. Phylogenetic footprinting revealed putative regulatory elements in non-coding flanking sequences. Conservation of both upstream and downstream flanking sequences was especially striking between the two paralogous black widow major ampullate silk genes. Because these genes are co-expressed within the same silk gland, there may have been selection for similarity in regulatory regions. Our new data provide complete templates for synthesis of recombinant silk proteins that significantly improve the degree to which artificial silks mimic natural spider dragline fibers.	[Ayoub, Nadia A.; Garb, Jessica E.; Tinghitella, Robin M.; Collin, Matthew A.; Hayashi, Cheryl Y.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Ayoub, NA (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	nadiaa@ucr.edu	Garb, Jessica E/J-4566-2015	Tinghitella, Robin/0000-0002-0049-5539; Ayoub, Nadia/0000-0003-4404-1472	Army Research Office [DAAD19-02-1-0358, W911NF-06-1-0455]; National Science Foundation [DEB-0236020]	Army Research Office; National Science Foundation(National Science Foundation (NSF))	The research was funded by the Army Research Office (DAAD19-02-1-0358 and W911NF-06-1-0455) and the National Science Foundation (DEB-0236020).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSEN SO, 1970, COMP BIOCHEM PHYSIOL, V35, P705, DOI 10.1016/0010-406X(70)90988-6; Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133; Arnason U, 2000, HEREDITAS, V133, P217, DOI 10.1111/j.1601-5223.2000.00217.x; Ayoub NA, 2007, MOL PHYLOGENET EVOL, V42, P394, DOI 10.1016/j.ympev.2006.07.018; BECKWITT R, 1994, J BIOL CHEM, V269, P6661; Beckwitt R, 1998, INSECT BIOCHEM MOLEC, V28, P121, DOI 10.1016/S0965-1748(97)00083-0; BENTON MJ, 1990, J MOL EVOL, V30, P409, DOI 10.1007/BF02101113; Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877; Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275; Blackledge TA, 2005, ZOOLOGY, V108, P41, DOI 10.1016/j.zool.2004.11.001; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Bram A, 1997, J APPL CRYSTALLOGR, V30, P390, DOI 10.1107/S0021889896012344; Bray N, 2003, GENOME RES, V13, P97, DOI 10.1101/gr.789803; CABRERA CV, 1991, EMBO J, V10, P2965, DOI 10.1002/j.1460-2075.1991.tb07847.x; Casem ML, 1999, INT J BIOL MACROMOL, V24, P103, DOI 10.1016/S0141-8130(98)00078-6; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Coy JF, 1999, HUM MOL GENET, V8, P1253, DOI 10.1093/hmg/8.7.1253; Craig CL, 2000, MOL BIOL EVOL, V17, P1904, DOI 10.1093/oxfordjournals.molbev.a026292; De Bodt S, 2006, MOL BIOL EVOL, V23, P1293, DOI 10.1093/molbev/msk016; DELIDAKIS C, 1992, P NATL ACAD SCI USA, V89, P8731, DOI 10.1073/pnas.89.18.8731; Dicko C, 2004, BIOMACROMOLECULES, V5, P704, DOI 10.1021/bm034307c; DONG ZY, 1991, ARCH BIOCHEM BIOPHYS, V284, P53, DOI 10.1016/0003-9861(91)90262-H; Foelix R.F., 1996, BIOL SPIDERS, P336; Foo CWP, 2006, APPL PHYS A-MATER, V82, P193, DOI 10.1007/s00339-005-3425-8; Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102; Garb JE, 2006, SCIENCE, V312, P1762, DOI 10.1126/science.1127946; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; Goodwin EB, 1997, DEVELOPMENT, V124, P749; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9; Gosline JM, 1999, J EXP BIOL, V202, P3295; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Gregory TR, 2003, J HERED, V94, P285, DOI 10.1093/jhered/esg070; Griswold CE, 1998, ZOOL J LINN SOC-LOND, V123, P1; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; Hardison RC, 2003, PLOS BIOL, V1, P156, DOI 10.1371/journal.pbio.0000058; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204; Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477; Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478; HINMAN M, 1992, SPIDER SILK MYSTERY, P227; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5; Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q; Inada DC, 2003, GENOME RES, V13, P2030, DOI 10.1101/gr.1280703; Ittah S, 2006, BIOMACROMOLECULES, V7, P1790, DOI 10.1021/bm060120k; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kohler K, 2005, DNA CELL BIOL, V24, P371, DOI 10.1089/dna.2005.24.371; Kummerlen J, 1996, MACROMOLECULES, V29, P2920, DOI 10.1021/ma951098i; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lai EC, 1997, DEVELOPMENT, V124, P4847; Lai EC, 1998, DEVELOPMENT, V125, P4077; Lawrence BA, 2004, BIOMACROMOLECULES, V5, P689, DOI 10.1021/bm0342640; Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780; Lee MSY, 1999, J MOL EVOL, V49, P385, DOI 10.1007/PL00006562; Leviten MW, 1997, DEVELOPMENT, V124, P4039; LOMBARDI SJ, 1990, J ARACHNOL, V18, P297; Marais G, 2005, GENETICS, V170, P481, DOI 10.1534/genetics.104.037333; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b; O'Brien JP, 1998, ADV MATER, V10, P1185, DOI 10.1002/(SICI)1521-4095(199810)10:15<1185::AID-ADMA1185>3.0.CO;2-T; Parkhe AD, 1997, J MOL RECOGNIT, V10, P1, DOI 10.1002/(SICI)1099-1352(199701/02)10:1<1::AID-JMR338>3.0.CO;2-7; Pollard DA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-376; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prakash A, 2005, NAT BIOTECHNOL, V23, P1249, DOI 10.1038/nbt1140; Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x; Rombauts S, 2003, PLANT PHYSIOL, V132, P1162, DOI 10.1104/pp.102.017715; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; RUIZGOMEZ M, 1993, EMBO J, V12, P1121, DOI 10.1002/j.1460-2075.1993.tb05753.x; Sakharkar MK, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-67; Sakharkar MK, 2002, BIOINFORMATICS, V18, P1266, DOI 10.1093/bioinformatics/18.9.1266; Sambrook J., 2001, MOL CLONING LAB MANU; Scheller J, 2004, TRANSGENIC RES, V13, P51, DOI 10.1023/B:TRAG.0000017175.78809.7a; Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; SELDEN PA, 1990, PALAEONTOLOGY, V33, P257; SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060; Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84; Sinha S, 2005, MOL BIOL EVOL, V22, P874, DOI 10.1093/molbev/msi090; Sponner A, 2005, BIOCHEM BIOPH RES CO, V338, P897, DOI 10.1016/j.bbrc.2005.10.048; Sponner A, 2005, NAT MATER, V4, P772, DOI 10.1038/nmat1493; Sponner A, 2005, BIOCHEMISTRY-US, V44, P4727, DOI 10.1021/bi047671k; SPRAGUE KU, 1975, BIOCHEMISTRY-US, V14, P925, DOI 10.1021/bi00676a008; Swanson BO, 2006, APPL PHYS A-MATER, V82, P213, DOI 10.1007/s00339-005-3427-6; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Tian MZ, 2005, BIOCHEMISTRY-US, V44, P8006, DOI 10.1021/bi050366u; Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103; van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wong WSW, 2004, GENETICS, V167, P949, DOI 10.1534/genetics.102.010959; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhao AC, 2006, BIOCHEMISTRY-US, V45, P3348, DOI 10.1021/bi052414g	108	272	295	5	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2007	2	6							e514	10.1371/journal.pone.0000514	http://dx.doi.org/10.1371/journal.pone.0000514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GD	17565367	Green Published, gold, Green Submitted			2022-12-27	WOS:000207451600002
J	Greenstein, RJ; Su, LY; Shahidi, A; Brown, ST				Greenstein, Robert J.; Su, Liya; Shahidi, Azra; Brown, Sheldon T.			On the Action of 5-Amino-Salicylic Acid and Sulfapyridine on M. avium including Subspecies paratuberculosis	PLOS ONE			English	Article								Background. Introduced in 1942, sulfasalazine (a conjugate of 5-aminosalicylic acid (5-ASA) and sulfapyridine) is the most prescribed medication used to treat ``inflammatory'' bowel disease (IBD.) Although controversial, there are increasingly compelling data that Mycobacterium avium subspecies paratuberculosis (MAP) may be an etiological agent in some or all of IBD. We have shown that two other agents used in the therapy of IBD (methotrexate and 6-MP) profoundly inhibit MAP growth. We concluded that their most plausible mechanism of action is as antiMAP antibiotics. We herein hypothesize that the mechanism of action of 5-ASA and/or sulfapyridine may also simply be to inhibit MAP growth. Methodology. The effect on MAP growth kinetics by sulfasalazine and its components were evaluated in bacterial culture of two strains each of MAP and M. avium, using a radiometric ((CO2)-C-14 BACTEC (R)) detection system that quantifies mycobacterial growth as arbitrary ``growth index units'' (GI). Efficacy data are presented as ``percent decrease in cumulative GI'' (%-Delta cGI). Principal Findings. There are disparate responses to 5-ASA and sulfapyridine in the two subspecies. Against MAP, 5-ASA is inhibitory in a dose-dependent manner (MAP ATCC 19698 46%-Delta DcGI at 64 mu g/ml), whereas sulfapyridine has virtually no effect. In contrast, against M. avium ATCC 25291, 5-ASA has no effect, whereas sulfapyridine (88%-Delta cGI at 4 mu g/ml) is as effective as methotrexate, our positive control (88%-Delta cGI at 4 mu g/ml). Conclusions. 5-ASA inhibits MAP growth in culture. We posit that, unknowingly, the medical profession has been treating MAP infections since sulfasalazine's introduction in 1942. These observations may explain, in part, why MAP has not previously been identified as a human pathogen. We conclude that henceforth in clinical trials evaluating antiMAP agents in IBD, if considered ethical, the use of 5-ASA (as well as methotrexate and 6-MP) should be excluded from control groups.	[Greenstein, Robert J.] VA Med Ctr, Dept Surg, Bronx, NY USA; [Greenstein, Robert J.; Su, Liya] VA Med Ctr, Lab Mol Surg Res, Bronx, NY USA		Greenstein, RJ (corresponding author), VA Med Ctr, Dept Surg, Bronx, NY USA.	BGAxis@aol.com			VAMC Bronx	VAMC Bronx	There was no extramural funding for this study. Financial support was from the VAMC Bronx, which provided facilities and in-house or personal funds.	BERARDI RR, 1996, TXB THERAPEUTICS DRU, P483; BERTRAM MA, 1986, J INFECT DIS, V154, P194, DOI 10.1093/infdis/154.1.194; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; CHIODINI RJ, 1986, J CLIN MICROBIOL, V24, P357, DOI 10.1128/JCM.24.3.357-363.1986; CHOI PM, 1994, DIGEST DIS SCI, V39, P1885, DOI 10.1007/BF02088121; DAMATO JJ, 1990, VET MICROBIOL, V22, P31, DOI 10.1016/0378-1135(90)90122-C; Evans GM, 1938, LANCET, V2, P14; FEAGAN BG, 1995, NEW ENGL J MED, V332, P292, DOI 10.1056/NEJM199502023320503; Green JRB, 1998, ALIMENT PHARM THERAP, V12, P1207; Greenstein RJ, 2004, LANCET, V364, P396, DOI 10.1016/S0140-6736(04)16781-0; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Greenstein RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000161; Hermon-Taylor J, 2004, PATHOGENIC MYCOBACTE, P74; KHAN AKA, 1977, LANCET, V2, P829; Mishina D, 1996, P NATL ACAD SCI USA, V93, P9816, DOI 10.1073/pnas.93.18.9816; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; RASTOGI N, 1992, ANTIMICROB AGENTS CH, V36, P2843, DOI 10.1128/AAC.36.12.2843; Rutgeerts P, 1998, DIGESTION, V59, P453, DOI 10.1159/000007523; STENSON WF, 2003, TXB GASTROENTEROLOGY, P1727; Svartz N, 1942, ACTA MED SCAND, V110, P577; Travis SPL, 2002, GUT, V51, P548, DOI 10.1136/gut.51.4.548; Whitby LEH, 1938, LANCET, V1, P1210; World Medical Association, 1964, ETH PRINC MED RES IN; Zanetti Stefania, 2006, Ann Clin Microbiol Antimicrob, V5, P27, DOI 10.1186/1476-0711-5-27	24	47	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2007	2	6							e516	10.1371/journal.pone.0000516	http://dx.doi.org/10.1371/journal.pone.0000516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GD	17565369	gold, Green Submitted, Green Published			2022-12-27	WOS:000207451600004
J	Henderson, GP; Gan, L; Jensen, GJ				Henderson, Gregory P.; Gan, Lu; Jensen, Grant J.			3-D Ultrastructure of O. tauri: Electron Cryotomography of an Entire Eukaryotic Cell	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; MITOCHONDRIAL INNER MEMBRANE; CRYOELECTRON TOMOGRAPHY; 3-DIMENSIONAL STRUCTURE; ARCHITECTURE; MICROSCOPY; ORGANIZATION; DYNAMICS; MAGNETOSOMES; CHLOROPHYTA	The hallmark of eukaryotic cells is their segregation of key biological functions into discrete, membrane-bound organelles. Creating accurate models of their ultrastructural complexity has been difficult in part because of the limited resolution of light microscopy and the artifact-prone nature of conventional electron microscopy. Here we explored the potential of the emerging technology electron cryotomography to produce three-dimensional images of an entire eukaryotic cell in a near-native state. Ostreococcus tauri was chosen as the specimen because as a unicellular picoplankton with just one copy of each organelle, it is the smallest known eukaryote and was therefore likely to yield the highest resolution images. Whole cells were imaged at various stages of the cell cycle, yielding 3-D reconstructions of complete chloroplasts, mitochondria, endoplasmic reticula, Golgi bodies, peroxisomes, microtubules, and putative ribosome distributions in-situ. Surprisingly, the nucleus was seen to open long before mitosis, and while one microtubule (or two in some predivisional cells) was consistently present, no mitotic spindle was ever observed, prompting speculation that a single microtubule might be sufficient to segregate multiple chromosomes.	[Henderson, Gregory P.; Gan, Lu; Jensen, Grant J.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Jensen, GJ (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	jensen@caltech.edu	Gan, Lu/F-8317-2011	Gan, Lu/0000-0002-8685-4896	NIH [R01 AI067548, PO1 GM66521]; DOE [DE-FG02-04ER63785]; Searle Scholar Award; Beckman Institute at Caltech; Damon Runyon Cancer Research Foundation [DRG-194007]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM066521] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); Searle Scholar Award; Beckman Institute at Caltech; Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grants R01 AI067548 and PO1 GM66521 and DOE grant DE-FG02-04ER63785 to GJJ, a Searle Scholar Award to GJJ, the Beckman Institute at Caltech, and gifts to Caltech from the Gordon and Betty Moore Foundation and Agouron Institute. Lu Gan was supported by a fellowship from the Damon Runyon Cancer Research Foundation (DRG-194007). These sponsors/funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1; Al-Amoudi A, 2004, EMBO J, V23, P3583, DOI 10.1038/sj.emboj.7600366; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Briegel A, 2006, MOL MICROBIOL, V62, P5, DOI 10.1111/j.1365-2958.2006.05355.x; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; CHRETIENNOTDINET MJ, 1995, PHYCOLOGIA, V34, P285, DOI 10.2216/i0031-8884-34-4-285.1; Comolli LR, 2005, J STRUCT BIOL, V152, P149, DOI 10.1016/j.jsb.2005.08.004; COURTIES C, 1994, NATURE, V370, P255, DOI 10.1038/370255a0; Courties C, 1998, J PHYCOL, V34, P844, DOI 10.1046/j.1529-8817.1998.340844.x; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Drummond SP, 2006, CAN J PHYSIOL PHARM, V84, P423, DOI 10.1139/Y05-148; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Farinas B, 2006, PLANT MOL BIOL, V60, P277, DOI 10.1007/s11103-005-4066-1; Frangakis AS, 2002, P NATL ACAD SCI USA, V99, P14153, DOI 10.1073/pnas.172520299; Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406; Gaietta GM, 2006, P NATL ACAD SCI USA, V103, P17777, DOI 10.1073/pnas.0608509103; Grimm R, 1997, BIOPHYS J, V72, P482, DOI 10.1016/S0006-3495(97)78689-2; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Henderson GP, 2006, MOL MICROBIOL, V60, P376, DOI 10.1111/j.1365-2958.2006.05113.x; Heymann JB, 2006, J STRUCT BIOL, V153, P312, DOI 10.1016/j.jsb.2005.11.012; Hoog JL, 2007, DEV CELL, V12, P349, DOI 10.1016/j.devcel.2007.01.020; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Iancu CV, 2006, NAT PROTOC, V1, P2813, DOI 10.1038/nprot.2006.432; Iancu CV, 2005, J STRUCT BIOL, V151, P288, DOI 10.1016/j.jsb.2005.07.004; Jensen GJ, 2007, CURR OPIN STRUC BIOL, V17, P260, DOI 10.1016/j.sbi.2007.03.002; JOHNSTON GC, 1979, J BACTERIOL, V137, P1; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Kurner J, 2005, SCIENCE, V307, P436, DOI 10.1126/science.1104031; Leong PA, 2005, STRUCTURE, V13, P505, DOI 10.1016/j.str.2005.01.015; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001; MANNELLA CA, 1994, MICROSC RES TECHNIQ, V27, P278, DOI 10.1002/jemt.1070270403; Mannella CA, 2001, IUBMB LIFE, V52, P93, DOI 10.1080/15216540152845885; Mannella CA, 2006, BBA-MOL CELL RES, V1763, P542, DOI 10.1016/j.bbamcr.2006.04.006; Marko M, 2007, NAT METHODS, V4, P215, DOI 10.1038/nmeth1014; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; McDonald KL, 2006, BIOTECHNIQUES, V41, P137, DOI 10.2144/000112226; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Mullen RT, 2006, BBA-MOL CELL RES, V1763, P1655, DOI 10.1016/j.bbamcr.2006.09.011; Nevo R, 2007, EMBO J, V26, P1467, DOI 10.1038/sj.emboj.7601594; Nicastro D, 2000, J STRUCT BIOL, V129, P48, DOI 10.1006/jsbi.1999.4204; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Perkins G, 1997, J STRUCT BIOL, V119, P260, DOI 10.1006/jsbi.1997.3885; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Ral JP, 2004, PLANT PHYSIOL, V136, P3333, DOI 10.1104/pp.104.044131; Robbens S, 2005, MOL BIOL EVOL, V22, P589, DOI 10.1093/molbev/msi044; Scheffel A, 2006, NATURE, V440, P110, DOI 10.1038/nature04382; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Shimoni E, 2005, PLANT CELL, V17, P2580, DOI 10.1105/tpc.105.035030; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Staehelin LA, 1997, PLANT J, V11, P1151, DOI 10.1046/j.1365-313X.1997.11061151.x; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; STOPPIN V, 1994, PLANT CELL, V6, P1099, DOI 10.1105/tpc.6.8.1099; Storrie B, 2002, TRAFFIC, V3, P521, DOI 10.1034/j.1600-0854.2002.30802.x; Subramaniam S, 2004, ANNU REV BIOPH BIOM, V33, P141, DOI 10.1146/annurev.biophys.33.110502.140339; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; van de Meene AML, 2006, ARCH MICROBIOL, V184, P259, DOI 10.1007/s00203-005-0027-y; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Vothknecht UC, 2001, BBA-MOL CELL RES, V1541, P91, DOI 10.1016/S0167-4889(01)00153-7; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wright ER, 2006, J STRUCT BIOL, V153, P241, DOI 10.1016/j.jsb.2005.12.003; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075; Zadrag R, 2006, ACTA BIOCHIM POL, V53, P747, DOI 10.18388/abp.2006_3302; Zheng QXS, 2004, J STRUCT BIOL, V147, P91, DOI 10.1016/j.jsb.2004.02.005	65	101	102	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e749	10.1371/journal.pone.0000749	http://dx.doi.org/10.1371/journal.pone.0000749			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710148	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000207455200025
J	Spiers, AJ				Spiers, Andrew J.			Wrinkly-Spreader Fitness in the Two-Dimensional Agar Plate Microcosm: Maladaptation, Compensation and Ecological Success	PLOS ONE			English	Article								Bacterial adaptation to new environments often leads to the establishment of new genotypes with significantly altered phenotypes. In the Wrinkly Spreader (WS), ecological success in static liquid microcosms was through the rapid colonisation of the air-liquid interface by the production of a cellulose-based biofilm. Rapid surface spreading was also seen on agar plates, but in this two-dimensional environment the WS appears maladapted and rapidly reverts to the ancestral smooth (SM)-like colony genotype. In this work, the fitness of WS relative to SM in mixed colonies was found to be low, confirming the WS instability on agar plates. By examining defined WS mutants, the maladaptive characteristic was found to be the expression of cellulose. SM-like revertants had a higher growth rate than WS and no longer expressed significant amounts of cellulose, further confirming that the expression of this high-cost polymer was the basis of maladaptation and the target of compensatory mutation in developing colonies. However, examination of the fate of WS-founded populations in either multiple-colony or single mega-colony agar plate microcosms demonstrated that the loss of WS lineages could be reduced under conditions in which the rapid spreading colony phenotype could dominate nutrient and oxygen access more effectively than competing SM/SM-like genotypes. WS-like isolates recovered from such populations showed increased WS phenotype stability as well as changes in the degree of colony spreading, confirming that the WS was adapting to the two-dimensional agar plate microcosm.	[Spiers, Andrew J.] Univ Oxford, Dept Plant Sci, Oxford, England	University of Oxford	Spiers, AJ (corresponding author), Univ Abertay Dundee, Scottish Informat Math Biol & Stat Ctr, Dundee, Scotland.	a.spiers@abertay.ac.uk	Spiers, Andrew/I-3535-2012	Spiers, Andrew/0000-0003-0463-8629	Department of Plant Sciences, University of Oxford; SIMBIOS Centre, University of Abertay Dundee	Department of Plant Sciences, University of Oxford; SIMBIOS Centre, University of Abertay Dundee	Support for this research came from the Department of Plant Sciences, University of Oxford, and the SIMBIOS Centre, University of Abertay Dundee.	Bailey MJ, 1995, MOL ECOL, V4, P755, DOI 10.1111/j.1365-294X.1995.tb00276.x; Bantinaki E, 2007, GENETICS, V176, P441, DOI 10.1534/genetics.106.069906; Ben-Jacob E, 2003, PHILOS T R SOC A, V361, P1283, DOI 10.1098/rsta.2003.1199; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; D'Argenio DA, 2004, MICROBIOL-SGM, V150, P2497, DOI 10.1099/mic.0.27099-0; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Fux CA, 2005, TRENDS MICROBIOL, V13, P58, DOI 10.1016/j.tim.2004.11.001; Goymer P, 2006, GENETICS, V173, P515, DOI 10.1534/genetics.106.055863; GOYMER PJ, 2002, THESIS U OXFORD; Grondin A, 1999, ARCH MICROBIOL, V172, P59, DOI 10.1007/s002030050740; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007; KING EO, 1954, J LAB CLIN MED, V44, P301; Knight CG, 2006, NAT GENET, V38, P1015, DOI 10.1038/ng1867; KORONA R, 1994, P NATL ACAD SCI USA, V91, P9037, DOI 10.1073/pnas.91.19.9037; Krebs JR, 1993, INTRO BEHAV ECOLOGY; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1995, SYMP SOC GEN MICROBI, V52, P193; MacLean RC, 2004, P NATL ACAD SCI USA, V101, P8072, DOI 10.1073/pnas.0307195101; Miller J.H., 1972, EXPT MOL GENETICS; Rainey PB, 2000, TRENDS ECOL EVOL, V15, P243, DOI 10.1016/S0169-5347(00)01871-1; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rainey PB, 1996, MOL MICROBIOL, V19, P521, DOI 10.1046/j.1365-2958.1996.391926.x; ROBINSON TP, 1991, J GEN MICROBIOL, V137, P2885, DOI 10.1099/00221287-137-12-2885; Sambrook J., 2002, MOL CLONING LAB MANU; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; SHAPIRO JA, 1995, BIOESSAYS, V17, P597, DOI 10.1002/bies.950170706; Spiers AJ, 2002, GENETICS, V161, P33; Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x; Spiers AJ, 2005, MICROBIOL-SGM, V151, P2829, DOI 10.1099/mic.0.27984-0; Ude S, 2006, ENVIRON MICROBIOL, V8, P1997, DOI 10.1111/j.1462-2920.2006.01080.x; WIMPENNY JWT, 1983, J GEN MICROBIOL, V129, P1239	33	9	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e740	10.1371/journal.pone.0000740	http://dx.doi.org/10.1371/journal.pone.0000740			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710140	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455200017
J	Martyniuk, CJ; Aris-Brosou, S; Drouin, G; Cahn, J; Trudeau, VL				Martyniuk, Christopher J.; Aris-Brosou, Stephane; Drouin, Guy; Cahn, Joel; Trudeau, Vance L.			Early Evolution of Ionotropic GABA Receptors and Selective Regimes Acting on the Mammalian-Specific Theta and Epsilon Subunits	PLOS ONE			English	Article								Background. The amino acid neurotransmitter GABA is abundant in the central nervous system (CNS) of both invertebrates and vertebrates. Receptors of this neurotransmitter play a key role in important processes such as learning and memory. Yet, little is known about the mode and tempo of evolution of the receptors of this neurotransmitter. Here, we investigate the phylogenetic relationships of GABA receptor subunits across the chordates and detail their mode of evolution among mammals. Principal Findings. Our analyses support two major monophyletic clades: one clade containing GABA(A) receptor alpha, gamma, and epsilon subunits, and another one containing GABA(A) receptor rho, beta, delta, theta, and pi subunits. The presence of GABA receptor subunits from each of the major clades in the Ciona intestinalis genome suggests that these ancestral duplication events occurred before the divergence of urochordates. However, while gene divergence proceeded at similar rates on most receptor subunits, we show that the mammalian-specific subunits theta and epsilon experienced an episode of positive selection and of relaxed constraints, respectively, after the duplication event. Sites putatively under positive selection are placed on a three-dimensional model obtained by homology-modeling. Conclusions. Our results suggest an early divergence of the GABA receptor subunits, before the split from urochordates. We show that functional changes occurred in the lineages leading to the mammalian-specific subunit theta, and we identify the amino acid sites putatively responsible for the functional divergence. We discuss potential consequences for the evolution of mammals and of their CNS.	[Martyniuk, Christopher J.; Aris-Brosou, Stephane; Drouin, Guy; Cahn, Joel; Trudeau, Vance L.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Martyniuk, Christopher J.; Aris-Brosou, Stephane; Drouin, Guy; Cahn, Joel; Trudeau, Vance L.] Univ Ottawa, Ctr Adv Res Environm Gen, Ottawa, ON, Canada; [Aris-Brosou, Stephane] Univ Ottawa, Dept Math & Stat, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa	Aris-Brosou, S (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	sarisbro@uottawa.ca	Trudeau, Vance L./P-5542-2019	Trudeau, Vance L./0000-0002-0845-9444; Aris-Brosou, Stephane/0000-0003-4987-0296; Martyniuk, Christopher J./0000-0003-0921-4796	Ontario Graduate Scholarship; Natural Sciences and Engineering Research Council	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an Ontario Graduate Scholarship to CJM, and by Natural Sciences and Engineering Research Council Discovery Grants to VLT, SAB and GD.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anadon R, 1998, J COMP NEUROL, V401, P293; AnselmoFranci JA, 1997, BRAIN RES, V767, P289, DOI 10.1016/S0006-8993(97)00613-6; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arvat E, 2002, J ENDOCRINOL INVEST, V25, P735, DOI 10.1007/BF03345110; Bates PA, 2001, PROTEINS, P39; Bielawski Joseph P., 2003, Journal of Structural and Functional Genomics, V3, P201, DOI 10.1023/A:1022642807731; Bormann J, 2000, TRENDS PHARMACOL SCI, V21, P16, DOI 10.1016/S0165-6147(99)01413-3; BORMANN J, 1995, TRENDS NEUROSCI, V18, P515, DOI 10.1016/0166-2236(95)98370-E; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Costa E, 2002, NEUROPHARMACOLOGY, V43, P925, DOI 10.1016/S0028-3908(02)00199-5; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; CUTTING GR, 1992, GENOMICS, V12, P801, DOI 10.1016/0888-7543(92)90312-G; Darlison MG, 2005, CELL MOL NEUROBIOL, V25, P607, DOI 10.1007/s10571-005-4004-4; DARLISON MG, 1992, TRENDS NEUROSCI, V15, P469, DOI 10.1016/0166-2236(92)90091-L; Dent JA, 2006, J MOL EVOL, V62, P523, DOI 10.1007/s00239-005-0018-2; Derry JMC, 2004, J NEUROCHEM, V88, P1431, DOI 10.1046/j.1471-4159.2003.02264.x; ERIKSSON KS, 1994, J COMP NEUROL, V345, P528, DOI 10.1002/cne.903450405; Galperin MY, 1999, GENETICA, V106, P159, DOI 10.1023/A:1003705601428; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HEBEBRAND J, 1987, J NEUROCHEM, V48, P1103, DOI 10.1111/j.1471-4159.1987.tb05633.x; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Huelsenbeck JP, 2004, MOL BIOL EVOL, V21, P1123, DOI 10.1093/molbev/msh123; Irwin DM, 2005, J HERED, V96, P205, DOI 10.1093/jhered/esi024; Johnston Graham A. R., 2002, Current Topics in Medicinal Chemistry, V2, P903, DOI 10.2174/1568026023393453; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kass-Simon G, 2003, COMP BIOCHEM PHYS A, V136, P329, DOI 10.1016/S1095-6433(03)00168-5; Kellogg CK, 1998, PERSPECT DEV NEUROBI, V5, P219; Koulen P, 1997, J COMP NEUROL, V380, P520, DOI 10.1002/(SICI)1096-9861(19970421)380:4<520::AID-CNE8>3.0.CO;2-3; Moragues N, 2003, BRAIN RES, V967, P285, DOI 10.1016/S0006-8993(02)04270-1; Myhrer T, 2003, BRAIN RES REV, V41, P268, DOI 10.1016/S0165-0173(02)00268-0; Newell JG, 2004, J NEUROSCI, V24, P11226, DOI 10.1523/JNEUROSCI.3746-04.2004; NIELSEN M, 1978, BRAIN RES, V141, P342, DOI 10.1016/0006-8993(78)90203-2; Nielsen R, 1998, GENETICS, V148, P929; OHTA T, 1989, GENOME, V31, P304, DOI 10.1139/g89-048; Okamura Y, 2005, PHYSIOL GENOMICS, V22, P269, DOI 10.1152/physiolgenomics.00229.2004; ORONA E, 1990, J COMP NEUROL, V294, P633, DOI 10.1002/cne.902940410; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; Ranna Martin, 2006, BMC Pharmacology, V6, P1, DOI 10.1186/1471-2210-6-1; Rocha AA, 2006, NEUROPEPTIDES, V40, P57, DOI 10.1016/j.npep.2005.10.005; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russek SJ, 1999, GENE, V227, P213, DOI 10.1016/S0378-1119(98)00594-0; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Simon J, 2004, J BIOL CHEM, V279, P41422, DOI 10.1074/jbc.M401354200; Sinkkonen ST, 2000, J NEUROSCI, V20, P3588, DOI 10.1523/JNEUROSCI.20-10-03588.2000; Tsang SY, 2007, MOL BIOL EVOL, V24, P599, DOI 10.1093/molbev/msl188; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Venclovas C, 2005, PROTEINS, V61, P99, DOI 10.1002/prot.20725; Whiting PJ, 1999, NEUROCHEM INT, V34, P387, DOI 10.1016/S0197-0186(99)00048-0; Xue H, 1998, J MOL EVOL, V47, P323, DOI 10.1007/PL00006390; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZZ, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P63; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	62	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e894	10.1371/journal.pone.0000894	http://dx.doi.org/10.1371/journal.pone.0000894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878929	Green Published, gold			2022-12-27	WOS:000207455700002
J	de Napoles, M; Nesterova, T; Brockdorff, N				de Napoles, Mariana; Nesterova, Tatyana; Brockdorff, Neil			Early Loss of Xist RNA Expression and Inactive X Chromosome Associated Chromatin Modification in Developing Primordial Germ Cells	PLOS ONE			English	Article								Background. The inactive X chromosome characteristic of female somatic lineages is reactivated during development of the female germ cell lineage. In mouse, analysis of protein products of X-linked genes and/or transgenes located on the X chromosome has indicated that reactivation occurs after primordial germ cells reach the genital ridges. Principal Findings/Methodology. We present evidence that the epigenetic reprogramming of the inactive X-chromosome is initiated earlier than was previously thought, around the time that primordial germ cells (PGCs) migrate through the hindgut. Specifically, we find that Xist RNA expression, the primary signal for establishment of chromosome silencing, is extinguished in migrating PGCs. This is accompanied by displacement of Polycomb-group repressor proteins Eed and Suz(12), and loss of the inactive X associated histone modification, methylation of histone H3 lysine 27. Conclusions/Significance. We conclude that X reactivation in primordial germ cells occurs progressively, initiated by extinction of Xist RNA around the time that germ cells migrate through the hindgut to the genital ridges. The events that we observe are reminiscent of X reactivation of the paternal X chromosome in inner cell mass cells of mouse pre-implantation embryos and suggest a unified model in which execution of the pluripotency program represses Xist RNA thereby triggering progressive reversal of epigenetic silencing of the X chromosome.	[de Napoles, Mariana; Nesterova, Tatyana; Brockdorff, Neil] Hammersmith Hosp, MRC, Ctr Clin Sci, Imperial Coll,Fac Med, London, England	Imperial College London	Brockdorff, N (corresponding author), Hammersmith Hosp, MRC, Ctr Clin Sci, Imperial Coll,Fac Med, London, England.	neil.brockdorff@csc.mrc.ac.uk		Brockdorff, Neil/0000-0003-4838-2653; Nesterova, Tatyana/0000-0001-7740-4386	MRC [MC_U120031757] Funding Source: UKRI; Medical Research Council [MC_U120031757] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Blackwell TK, 2004, CURR BIOL, V14, pR229, DOI 10.1016/j.cub.2004.02.052; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; Chuma S, 2001, DEV BIOL, V229, P468, DOI 10.1006/dbio.2000.9989; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Duthie SM, 1999, HUM MOL GENET, V8, P195, DOI 10.1093/hmg/8.2.195; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; EPSTEIN CJ, 1969, SCIENCE, V163, P1078, DOI 10.1126/science.163.3871.1078; GRANT M, 1992, NAT GENET, V2, P161, DOI 10.1038/ng1092-161; JOHNSTON PG, 1981, GENET RES, V37, P317, DOI 10.1017/S0016672300020322; Kalantry S, 2006, NAT CELL BIOL, V8, P195, DOI 10.1038/ncb1351; Keohane AM, 1996, DEV BIOL, V180, P618, DOI 10.1006/dbio.1996.0333; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Mermoud JE, 1999, J CELL BIOL, V147, P1399, DOI 10.1083/jcb.147.7.1399; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; MONK M, 1981, J EMBRYOL EXP MORPH, V63, P75; Nesterova TB, 2002, DIFFERENTIATION, V69, P216, DOI 10.1046/j.1432-0436.2002.690415.x; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Saitou M, 2003, PHILOS T R SOC B, V358, P1363, DOI 10.1098/rstb.2003.1324; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; SINGERSAM J, 1992, P NATL ACAD SCI USA, V89, P1413, DOI 10.1073/pnas.89.4.1413; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; TAKAGI N, 1983, CELL, V34, P1053, DOI 10.1016/0092-8674(83)90563-9; TAM PPL, 1994, DEVELOPMENT, V120, P2925; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675	35	75	75	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e860	10.1371/journal.pone.0000860	http://dx.doi.org/10.1371/journal.pone.0000860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848991	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455600007
J	Gururajan, M; Jacob, J; Pulendran, B				Gururajan, Murali; Jacob, Joshy; Pulendran, Bali			Toll-Like Receptor Expression and Responsiveness of Distinct Murine Splenic and Mucosal B-Cell Subsets	PLOS ONE			English	Article								Background. Toll-like receptors (TLRs) are pattern recognition receptors that recognize pathogen associated molecular patterns and trigger innate immunity leading to initiation of adaptive immunity. TLR-mediated activation of dendritic cells (DCs) is known to be a critical event in the initiation of cellular and humoral immune responses. Recent work however suggests that B cells also express TLRs, and that they can be activated via TLR ligands. However, whether such B cell activation occurs only on memory B cells, or whether it can also occur on truly naive B cells remains controversial. Furthermore, the expression and functional relevance of TLRs on distinct subsets of B cells, which are known to play differential roles in humoral responses is not known. Methodology/Principal Findings. In this study, we investigated the expression pattern of different TLRs in distinct subsets of murine B cells (naive, memory, follicular, marginal zone, B-1 and peyer's patch). In contrast to the reported restricted expression pattern of TLRs in human peripheral blood naive B cells, murine splenic naive B cells express a variety of TLRs with the exception of TLR5 and 8. Consistent with this relatively broad expression pattern, murine naive B cells proliferate and secrete antibody to a variety of TLR agonists in vitro, in the absence of B-cell receptor cross-linking. In addition, we observed subtle differences in the antibody secretion pattern of follicular, marginal zone, B-1 and peyer's patch B-cell subsets. Conclusions/Significance. Thus various B cell subsets, including truly naive B cells, express multiple TLRs, and signaling via such TLRs results in their robust proliferation and antibody secretion, even in the absence of dendritic cell activation, or T-cell help.	[Gururajan, Murali; Jacob, Joshy; Pulendran, Bali] Emory Univ, Vaccine Res Ctr, Atlanta, GA 30322 USA; [Pulendran, Bali] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Jacob, Joshy] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Pulendran, B (corresponding author), Emory Univ, Vaccine Res Ctr, Atlanta, GA 30322 USA.	bpulend@rmy.emory.edu	Pulendran, Bali/AAW-9550-2021		NIAID NIH HHS [U19AI057266, R01 AI056499, R01 AI048638, R01 AI48638-01, R01 AI056499-01, U19 AI057266] Funding Source: Medline; NIDDK NIH HHS [R01 DK57665-01, R01 DK057665] Funding Source: Medline; PHS HHS [N01 A150025, N01-A1-50019] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266, R01AI056499, R01AI048638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057665] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Beutler B, 2005, IMMUNOGENETICS, V57, P385, DOI 10.1007/s00251-005-0011-3; Chappell CP, 2006, J IMMUNOL, V176, P4706, DOI 10.4049/jimmunol.176.8.4706; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Fink K, 2006, EUR J IMMUNOL, V36, P2094, DOI 10.1002/eji.200635993; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Huggins J, 2007, BLOOD, V109, P1611, DOI 10.1182/blood-2006-03-008441; Ito T, 2005, INT J HEMATOL, V81, P188, DOI 10.1532/IJH97.05012; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Janeway CA, 1999, CURR BIOL, V9, pR879, DOI 10.1016/S0960-9822(00)80073-1; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Mansson A, 2006, IMMUNOLOGY, V118, P539, DOI 10.1111/j.1365-2567.2006.02392.x; Martin D, 2002, BRILLS TIBET STU LIB, V2, P335; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; VITETTA ES, 1975, J IMMUNOL, V115, P603; Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032; WHITLOCK CA, 1979, J EXP MED, V150, P1483, DOI 10.1084/jem.150.6.1483	29	147	154	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e863	10.1371/journal.pone.0000863	http://dx.doi.org/10.1371/journal.pone.0000863			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848994	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455600010
J	Horibe, T; Hoogenraad, NJ				Horibe, Tomohisa; Hoogenraad, Nicholas J.			The Chop Gene Contains an Element for the Positive Regulation of the Mitochondrial Unfolded Protein Response	PLOS ONE			English	Article							STRESS-RESPONSE; IDENTIFICATION; ACTIVATION; EXPRESSION; INDUCTION; ATF6	We have previously reported on the discovery of a mitochondrial specific unfolded protein response (mtUPR) in mammalian cells, in which the accumulation of unfolded protein within the mitochondrial matrix results in the transcriptional activation of nuclear genes encoding mitochondrial stress proteins such as chaperonin 60, chaperonin 10, mtDnaJ, and ClpP, but not those encoding stress proteins of the endoplasmic reticulum (ER) or the cytosol. Analysis of the chaperonin 60/10 bidirectional promoter showed that the CHOP element was required for the mtUPR and that the transcription of the chop gene is activated by mtUPR. In order to investigate the role of CHOP in the mtUPR, we carried out a deletion analysis of the chop promoter. This revealed that the transcriptional activation of the chop gene by mtUPR is through an AP-1 (activator protein-1) element. This site lies alongside an ERSE element through which chop transcription is activated in response to the ER stress response (erUPR). Thus CHOP can be induced separately in response to 2 different stress response pathways. We also discuss the potential signal pathway between mitochondria and the nucleus for the mtUPR.	[Horibe, Tomohisa; Hoogenraad, Nicholas J.] La Trobe Univ, Dept Biochem, Melbourne, Vic, Australia	La Trobe University	Hoogenraad, NJ (corresponding author), La Trobe Univ, Dept Biochem, Melbourne, Vic, Australia.	n.hoogenraad@latrobe.edu.au	Hoogenraad, Nicholas J/C-7505-2011					ALDRIDGE J, 2007, PLOS ONE UNPUB; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Dietrich AJ, 2004, ANN FAM MED, V2, P301, DOI 10.1370/afm.102; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Goffart S, 2003, EXP PHYSIOL, V88, P33, DOI 10.1113/eph8802500; GOODSELL DS, 1991, TRENDS BIOCHEM SCI, V16, P203, DOI 10.1016/0968-0004(91)90083-8; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Martinus RD, 1996, EUR J BIOCHEM, V240, P98, DOI 10.1111/j.1432-1033.1996.0098h.x; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Roy B, 1996, J BIOL CHEM, V271, P28995, DOI 10.1074/jbc.271.46.28995; RYAN MT, 2007, ANN REV BIO IN PRESS; Schroder M, 2006, MOL BIOTECHNOL, V34, P279, DOI 10.1385/MB:34:2:279; SRERE PA, 1980, TRENDS BIOCHEM SCI, V5, P120, DOI 10.1016/0968-0004(80)90051-1; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	32	149	151	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e835	10.1371/journal.pone.0000835	http://dx.doi.org/10.1371/journal.pone.0000835			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848986	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455600002
J	Ligios, C; Cancedda, GM; Margalith, I; Santucciu, C; Madau, L; Maestrale, C; Basagni, M; Saba, M; Heikenwalder, M				Ligios, Ciriaco; Cancedda, Giovanna Maria; Margalith, Ilan; Santucciu, Cinzia; Madau, Laura; Maestrale, Caterina; Basagni, Massimo; Saba, Mariangela; Heikenwalder, Mathias			Intraepithelial and Interstitial Deposition of Pathological Prion Protein in Kidneys of Scrapie-Affected Sheep	PLOS ONE			English	Article								Prions have been documented in extra-neuronal and extra-lymphatic tissues of humans and various ruminants affected by Transmissible Spongiform Encephalopathy (TSE). The presence of prion infectivity detected in cervid and ovine blood tempted us to reason that kidney, the organ filtrating blood derived proteins, may accumulate disease associated PrP(Sc). We collected and screened kidneys of experimentally, naturally scrapie-affected and control sheep for renal deposition of PrP(Sc) from distinct, geographically separated flocks. By performing Western blot, PET blot analysis and immunohistochemistry we found intraepithelial (cortex, medulla and papilla) and occasional interstitial (papilla) deposition of PrP(Sc) in kidneys of scrapie-affected sheep. Interestingly, glomerula lacked detectable signals indicative of PrP(Sc). PrP(Sc) was also detected in kidneys of subclinical sheep, but to significantly lower degree. Depending on the stage of the disease the incidence of PrP(Sc) in kidney varied from approximately 27% (subclinical) to 73.6% (clinical) in naturally scrapie-affected sheep. Kidneys from flocks without scrapie outbreak were devoid of PrP(Sc). Here we demonstrate unexpectedly frequent deposition of high levels of PrP(Sc) in ovine kidneys of various flocks. Renal deposition of PrP(Sc) is likely to be a pre-requisite enabling prionuria, a possible co-factor of horizontal prion-transmission in sheep.	[Ligios, Ciriaco; Cancedda, Giovanna Maria; Santucciu, Cinzia; Madau, Laura; Maestrale, Caterina; Saba, Mariangela] Ist Zooprofilatt Sperimentale Sardegna, Sassari, Italy; [Margalith, Ilan; Heikenwalder, Mathias] Univ Spital Zurich, Inst Neuropathol, Dept Pathol, Zurich, Switzerland	IZS Della Sardegna; University of Zurich; University Zurich Hospital	Ligios, C (corresponding author), Ist Zooprofilatt Sperimentale Sardegna, Sassari, Italy.	ciriaco.ligios@izs-sardegna.it; mathias.heikenwalder@usz.ch	Santucciu, Cinzia/D-1229-2012; Heikenwalder, Mathias/AAA-2269-2020	Santucciu, Cinzia/0000-0001-9699-3745; 				Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Aguzzi A, 2003, ADV IMMUNOL, V81, P123, DOI 10.1016/S0065-2776(03)81004-0; Andreoletti O, 2002, J HISTOCHEM CYTOCHEM, V50, P1357, DOI 10.1177/002215540205001009; Andreoletti O, 2000, J GEN VIROL, V81, P3115, DOI 10.1099/0022-1317-81-12-3115; Andreoletti O, 2004, NAT MED, V10, P591, DOI 10.1038/nm1055; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; Bosque PJ, 2002, P NATL ACAD SCI USA, V99, P3812, DOI 10.1073/pnas.052707499; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Hamir AN, 2006, VET PATHOL, V43, P367, DOI 10.1354/vp.43-3-367; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; Herzog C, 2005, J VIROL, V79, P14339, DOI 10.1128/JVI.79.22.14339-14345.2005; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Kariv-Inbal Z, 2006, NEURODEGENER DIS, V3, P123, DOI 10.1159/000094770; Kovacs GG, 2004, ANN NEUROL, V55, P121, DOI 10.1002/ana.10813; Lezmi S, 2003, HISTOCHEM CELL BIOL, V119, P415, DOI 10.1007/s00418-003-0524-5; Ligios C, 2005, NAT MED, V11, P1137, DOI 10.1038/nm1105-1137; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Lupi O, 2005, MED HYPOTHESES, V65, P47, DOI 10.1016/j.mehy.2005.01.039; MAESTRALE C, 2004, P 16 C NAZ SOC IT PA, P178; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Peden AH, 2006, AM J PATHOL, V168, P927, DOI 10.2353/ajpath.2006.050788; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ryder SJ, 2001, VET REC, V148, P437, DOI 10.1136/vr.148.14.437; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; Siso S, 2006, VET REC, V159, P327, DOI 10.1136/vr.159.10.327-b; Thuring CMA, 2004, J CLIN MICROBIOL, V42, P972, DOI 10.1128/JCM.42.3.972-980.2004; Tuo WB, 2002, P NATL ACAD SCI USA, V99, P6310, DOI 10.1073/pnas.072071199; vanKeulen LJM, 1996, J CLIN MICROBIOL, V34, P1228, DOI 10.1128/JCM.34.5.1228-1231.1996; Vascellari M, 2007, J VIROL, V81, P4872, DOI 10.1128/JVI.02148-06; Wisniewski HM, 1996, LANCET, V347, P1114, DOI 10.1016/S0140-6736(96)90310-4; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8	35	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e859	10.1371/journal.pone.0000859	http://dx.doi.org/10.1371/journal.pone.0000859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848990	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455600006
J	Gingras, S; Pelletier, S; Boyd, K; Ihle, JN				Gingras, Sebastien; Pelletier, Stephane; Boyd, Kelli; Ihle, James N.			Characterization of a Family of Novel Cysteine- Serine-Rich Nuclear Proteins (CSRNP)	PLOS ONE			English	Article								Gene array analysis has been widely used to identify genes induced during T cell activation. Our studies identified an immediate early gene that is strongly induced in response to IL-2 in mouse T cells which we named cysteine- serine-rich nuclear protein-1 (CSRNP-1). The human ortholog was previously identified as an AXIN1 induced gene (AXUD1). The protein does not contain sequence defined domains or motifs annotated in public databases, however the gene is a member of a family of three mammalian genes that share conserved regions, including cysteine- and serine-rich regions and a basic domain, they encode nuclear proteins, possess transcriptional activation domain and bind the sequence AGAGTG. Consequently we propose the nomenclature of CSRNP-1, -2 and -3 for the family. To elucidate the physiological functions of CSRNP-1, -2 and -3, we generated mice deficient for each of these genes by homologous recombination in embryonic stem cells. Although the CSRNP proteins have the hallmark of transcription factors and CSRNP-1 expression is highly induced by IL-2, deletion of the individual genes had no obvious consequences on normal mouse development, hematopoiesis or T cell functions. However, combined deficiencies cause partial neonatal lethality suggesting that the genes have redundant functions.	[Gingras, Sebastien; Pelletier, Stephane; Ihle, James N.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; [Boyd, Kelli] St Jude Childrens Res Hosp, Anim Resource Ctr, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Ihle, JN (corresponding author), St Jude Childrens Res Hosp, Dept Biochem, 332 N Lauderdale St, Memphis, TN 38105 USA.	james.ihle@stjude.org		Pelletier, Stephane/0000-0002-1127-0212	Cancer Center CORE [CA21765]; American Lebanese Syrian Associated Charities ( ALSAC);  [RO1 DK42932];  [PO1 HL53740]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042932] Funding Source: NIH RePORTER	Cancer Center CORE; American Lebanese Syrian Associated Charities ( ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Cancer Center CORE grant CA21765, by grants RO1 DK42932 and PO1 HL53740 to J. N. I., and by the American Lebanese Syrian Associated Charities ( ALSAC).	Beadling Carol, 2002, Med Immunol, V1, P2, DOI 10.1186/1476-9433-1-2; Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306; Gatzka M, 2006, CYTOKINE, V34, P143, DOI 10.1016/j.cyto.2006.04.003; Gingras S, 1999, NUCLEIC ACIDS RES, V27, P2722, DOI 10.1093/nar/27.13.2722; Hoffmeyer A, 2001, MOL CELL BIOL, V21, P3137, DOI 10.1128/MCB.21.9.3137-3143.2001; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Hsu W, 2001, J CELL BIOL, V155, P1055, DOI 10.1083/jcb.200107066; Hutton JJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-82; Ishiguro H, 2001, ONCOGENE, V20, P5062, DOI 10.1038/sj.onc.1204603; Kovanen PE, 2005, INT IMMUNOL, V17, P1009, DOI 10.1093/intimm/dxh283; Kovanen PE, 2003, J BIOL CHEM, V278, P5205, DOI 10.1074/jbc.M209015200; LAHTI JM, 1994, NAT GENET, V7, P370, DOI 10.1038/ng0794-370; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Lin Jian-Xin, 1997, Cytokine and Growth Factor Reviews, V8, P313; Malek TR, 2003, J LEUKOCYTE BIOL, V74, P961, DOI 10.1189/jlb.0603272; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Morikawa Y, 2004, J NEUROSCI, V24, P1941, DOI 10.1523/JNEUROSCI.4975-03.2004; Nakamura T, 2004, ONCOGENE, V23, P2385, DOI 10.1038/sj.onc.1207392; Nishidate T, 2004, INT J ONCOL, V25, P797; Obama K, 2005, HEPATOLOGY, V41, P1339, DOI 10.1002/hep.20718; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Thomas DM, 2005, FASEB J, V19, P515, DOI 10.1096/fj.05-4873fje; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; VANDEURSEN J, 1993, CELL, V74, P621, DOI 10.1016/0092-8674(93)90510-W; WALDMANN TA, 1989, ANNU REV BIOCHEM, V58, P875, DOI 10.1146/annurev.bi.58.070189.004303; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; Yi XM, 2006, AM J PHYSIOL-HEART C, V290, pH1098, DOI 10.1152/ajpheart.00832.2005; Zamorano J, 1998, J IMMUNOL, V160, P3502	34	27	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e808	10.1371/journal.pone.0000808	http://dx.doi.org/10.1371/journal.pone.0000808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726538	Green Published, gold			2022-12-27	WOS:000207455400025
J	Kelter, G; Steinbach, D; Konkimalla, VB; Tahara, T; Taketani, S; Fiebig, HH; Efferth, T				Kelter, Gerhard; Steinbach, Daniel; Konkimalla, Venkata Badireenath; Tahara, Tsuyoshi; Taketani, Shigeru; Fiebig, Heinz-Herbert; Efferth, Thomas			Role of Transferrin Receptor and the ABC Transporters ABCB6 and ABCB7 for Resistance and Differentiation of Tumor Cells towards Artesunate	PLOS ONE			English	Article								The anti-malarial artesunate also exerts profound anti-cancer activity. The susceptibility of tumor cells to artesunate can be enhanced by ferrous iron. The transferrin receptor (TfR) is involved in iron uptake by internalization of transferrin and is over-expressed in rapidly growing tumors. The ATP-binding cassette (ABC) transporters ABCB6 and ABCB7 are also involved in iron homeostasis. To investigate whether these proteins play a role for sensitivity towards artesunate, Oncotest's 36 cell line panel was treated with artesunate or artesunate plus iron(II) glycine sulfate (Ferrosanol (R)). The majority of cell lines showed increased inhibition rates, for the combination of artesunate plus iron(II) glycine sulfate compared to artesunate alone. However, in 11 out of the 36 cell lines the combination treatment was not superior. Cell lines with high TfR expression significantly correlated with high degrees of modulation indicating that high TfR expressing tumor cells would be more efficiently inhibited by this combination treatment than low TfR expressing ones. Furthermore, we found a significant relationship between cellular response to artesunate and TfR expression in 55 cell lines of the National Cancer Institute (NCI), USA. A significant correlation was also found for ABCB6, but not for ABCB7 in the NCI panel. Artesunate treatment of human CCRF-CEM leukemia and MCF7 breast cancer cells induced ABCB6 expression but repressed ABCB7 expression. Finally, artesunate inhibited proliferation and differentiation of mouse erythroleukemia (MEL) cells. Down-regulation of ABCB6 by antisense oligonucleotides inhibited differentiation of MEL cells indicating that artesunate and ABCB6 may cooperate. In conclusion, our results indicate that ferrous iron improves the activity of artesunate in some but not all tumor cell lines. Several factors involved in iron homeostasis such as TfR and ABCB6 may contribute to this effect.	[Konkimalla, Venkata Badireenath; Efferth, Thomas] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Kelter, Gerhard; Fiebig, Heinz-Herbert] Oncotest GmbH, Inst Expt Oncol, Freiburg, Germany; [Steinbach, Daniel] Univ Ulm, Dept Pediat, D-7900 Ulm, Germany; [Tahara, Tsuyoshi; Taketani, Shigeru] Kyoto Inst Technol, Dept Biotechnol, Kyoto 606, Japan	Helmholtz Association; German Cancer Research Center (DKFZ); Oncotest GmbH; Ulm University; Kyoto Institute of Technology	Efferth, T (corresponding author), German Canc Res Ctr, Pharmaceut Biol C015, D-6900 Heidelberg, Germany.	t.efferth@dkfz.de	Konkimalla, Badireenath/A-7473-2011; Konkimalla, VB/K-7496-2019; Tahara, Tsuyoshi/E-4024-2010	Efferth, Thomas/0000-0002-3096-3292; Konkimalla, Badireenath/0000-0003-3699-7490	intramural grants	intramural grants	This work was funded by intramural grants.	ALLEY MC, 1988, CANCER RES, V48, P589; Ashley EA, 2005, CURR OPIN INFECT DIS, V18, P531, DOI 10.1097/01.qco.0000186848.46417.6c; Berger TG, 2005, ONCOL REP, V14, P1599; Boonstra R, 2004, BRIT J CANCER, V90, P2411, DOI 10.1038/sj.bjc.6601863; BOUSTOS MD, 1994, B WORLD HEALTH ORGAN, V72, P729; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; DENGLER WA, 1995, ANTI-CANCER DRUG, V6, P522, DOI 10.1097/00001813-199508000-00005; Efferth T, 2004, FREE RADICAL BIO MED, V37, P998, DOI 10.1016/j.freeradbiomed.2004.06.023; Efferth T, 2003, MOL PHARMACOL, V64, P382, DOI 10.1124/mol.64.2.382; Efferth T, 1996, ARZNEIMITTEL-FORSCH, V46, P196; Efferth T, 2001, INT J ONCOL, V18, P767; Efferth T, 2007, PLANTA MED, V73, P299, DOI 10.1055/s-2007-967138; Efferth T, 2006, MOL CANCER THER, V5, P1986, DOI 10.1158/1535-7163.MCT-06-0086; Efferth Thomas, 2001, Current Molecular Medicine (Hilversum), V1, P45, DOI 10.2174/1566524013364194; FIEBIG HH, 1992, IMMUNODEFICIENT MICE, V42, P321; Gillet JP, 2007, BBA-REV CANCER, V1775, P237, DOI 10.1016/j.bbcan.2007.05.002; Gillet Jean-Pierre, 2006, Cancer Genomics & Proteomics, V3, P97; Gillet JP, 2004, CANCER RES, V64, P8987, DOI 10.1158/0008-5472.CAN-04-1978; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; Meshnick S R, 1998, Med Trop (Mars), V58, P13; Moore JC, 1995, CANCER LETT, V98, P83, DOI 10.1016/0304-3835(95)90207-4; Park S, 2006, BREAST CANCER RES TR, V99, P9, DOI 10.1007/s10549-006-9175-2; POSNER GH, 1995, J AM CHEM SOC, V117, P5885, DOI 10.1021/ja00126a042; POSNER GH, 2000, CARBON CTR RADICALS, P289; Robert A, 2002, ACCOUNTS CHEM RES, V35, P167, DOI 10.1021/ar990164o; ROTH T, 1999, CONTRIB ONCOL, V54, P145; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Shirihai OS, 2000, EMBO J, V19, P2492, DOI 10.1093/emboj/19.11.2492; SHTERMAN N, 1991, PATHOBIOLOGY, V59, P19, DOI 10.1159/000163611; Singh NP, 2001, LIFE SCI, V70, P49, DOI 10.1016/S0024-3205(01)01372-8; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Steinbach D, 2003, BLOOD, V102, P4493, DOI 10.1182/blood-2002-11-3461; Steinbach D, 2006, CLIN CANCER RES, V12, P4357, DOI 10.1158/1078-0432.CCR-05-2587; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Taketani S, 2003, BLOOD, V101, P3274, DOI 10.1182/blood-2002-04-1212; Ucar T, 2003, BRIT J NEUROSURG, V17, P525, DOI 10.1080/02688690310001627759; Volm Manfred, 2004, Cancer Genomics & Proteomics, V1, P157; WHITNEY JF, 1995, CANCER, V76, P20, DOI 10.1002/1097-0142(19950701)76:1<20::AID-CNCR2820760104>3.0.CO;2-3; Wirth GJ, 2006, ONCOLOGY-BASEL, V71, P86, DOI 10.1159/000100476; WOERDENBAG HJ, 1993, J NAT PROD, V56, P849, DOI 10.1021/np50096a007; Yang DC, 2001, ANTICANCER RES, V21, P541; Yasui K, 2004, CANCER RES, V64, P1403, DOI 10.1158/0008-5472.CAN-3263-2; ZHANG F, 1992, BIOCHEM PHARMACOL, V43, P1805, DOI 10.1016/0006-2952(92)90713-S	46	81	90	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e798	10.1371/journal.pone.0000798	http://dx.doi.org/10.1371/journal.pone.0000798			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726528	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455400015
J	Matsuura, K; Tamura, T; Kobayashi, N; Yashiro, T; Tatsumi, S				Matsuura, Kenji; Tamura, Takashi; Kobayashi, Norimasa; Yashiro, Toshihisa; Tatsumi, Shingo			The Antibacterial Protein Lysozyme Identified as the Termite Egg Recognition Pheromone	PLOS ONE			English	Article							ISOPTERA; SEQUENCE; FUNGUS; ANTS	Social insects rely heavily on pheromone communication to maintain their sociality. Egg protection is one of the most fundamental social behaviours in social insects. The recent discovery of the termite-egg mimicking fungus 'termite-ball' and subsequent studies on termite egg protection behaviour have shown that termites can be manipulated by using the termite egg recognition pheromone (TERP), which strongly evokes the egg-carrying and -grooming behaviours of workers. Despite the great scientific and economic importance, TERP has not been identified because of practical difficulties. Herein we identified the antibacterial protein lysozyme as the TERP. We isolated the target protein using ion-exchange and hydrophobic interaction chromatography, and the MALDI-TOF MS analysis showed a molecular size of 14.5 kDa. We found that the TERP provided antibacterial activity against a gram-positive bacterium. Among the currently known antimicrobial proteins, the molecular size of 14.5 kDa limits the target to lysozyme. Termite lysozymes obtained from eggs and salivary glands, and even hen egg lysozyme, showed a strong termite egg recognition activity. Besides eggs themselves, workers also supply lysozyme to eggs through frequent egg-grooming, by which egg surfaces are coated with saliva containing lysozyme. Reverse transcript PCR analysis showed that mRNA of termite lysozyme was expressed in both salivary glands and eggs. Western blot analysis confirmed that lysozyme production begins in immature eggs in queen ovaries. This is the first identification of proteinaceous pheromone in social insects. Researchers have focused almost exclusively on hydrocarbons when searching for recognition pheromones in social insects. The present finding of a proteinaceous pheromone represents a major step forward in, and result in the broadening of, the search for recognition pheromones. This novel function of lysozyme as a termite pheromone illuminates the profound influence of pathogenic microbes on the evolution of social behaviour in termites.	[Matsuura, Kenji; Kobayashi, Norimasa; Yashiro, Toshihisa; Tatsumi, Shingo] Okayama Univ, Grad Sch Environm Sci, Okayama, Japan; [Matsuura, Kenji] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Tamura, Takashi] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan	Okayama University; Harvard University; Okayama University	Matsuura, K (corresponding author), Okayama Univ, Grad Sch Environm Sci, Okayama, Japan.	kenjijpn@cc.okayama-u.ac.jp	Tamura, Takashi/B-2097-2011; Matsuura, Kenji/B-1573-2011; Yashiro, Toshihisa/J-3120-2015; Matsuura, Kenji/H-8364-2019	Yashiro, Toshihisa/0000-0002-9582-4605; Matsuura, Kenji/0000-0002-9099-6694	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	This work was funded by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN). PROBRAIN provides full financial support for this research and publication of the achievement.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; D'Ettorre P, 2006, NATURWISSENSCHAFTEN, V93, P136, DOI 10.1007/s00114-005-0075-9; de Bruijn PJA, 2006, J CHEM ECOL, V32, P1599, DOI 10.1007/s10886-006-9092-1; Endler A, 2006, BEHAV ECOL SOCIOBIOL, V59, P490, DOI 10.1007/s00265-005-0073-0; Fujita A, 2002, INSECT BIOCHEM MOLEC, V32, P1615, DOI 10.1016/S0965-1748(02)00100-5; Gorman MJ, 2004, INSECT MOL BIOL, V13, P19, DOI 10.1111/j.1365-2583.2004.00454.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Holldobler B., 1990, pi; Hultmark D., 1996, Experientia Supplementum (Basel), V75, P87; JOLLES P, 1996, MODEL ENZYMES BIOCH; Koganesawa N, 2001, PROTEIN ENG, V14, P705, DOI 10.1093/protein/14.9.705; LOCKEY KH, 1988, COMP BIOCHEM PHYS B, V89, P595, DOI 10.1016/0305-0491(88)90305-7; MATSUMURA F, 1968, NATURE, V219, P963, DOI 10.1038/219963a0; Matsuura K, 2005, APPL ENTOMOL ZOOL, V40, P53, DOI 10.1303/aez.2005.53; Matsuura K, 2003, CONT T ENT, P131; Matsuura K, 2002, ANIM BEHAV, V64, P167, DOI 10.1006/anbe.2002.3062; Matsuura K, 2000, ECOL RES, V15, P405, DOI 10.1046/j.1440-1703.2000.00361.x; MATSUURA K, 2002, THESIS KYOTO U KYOTO; MATSUURA K, 2000, Patent No. 2000342149; Matsuura K, 2007, POPUL ECOL, V49, P179, DOI 10.1007/s10144-006-0030-4; Matsuura K, 2006, NATURWISSENSCHAFTEN, V93, P506, DOI 10.1007/s00114-006-0136-8; Matsuura K, 2006, P ROY SOC B-BIOL SCI, V273, P1203, DOI 10.1098/rspb.2005.3434; Pankewitz F, 2006, J CHEM ECOL, V32, P2067, DOI 10.1007/s10886-006-9129-5; Rosengaus RB, 2001, BEHAV ECOL SOCIOBIOL, V50, P546, DOI 10.1007/s002650100394; Shellman-Reeve Janet S., 1997, P52; Singer TL, 1998, AM ZOOL, V38, P394; Su NY, 2002, SOCIOBIOLOGY, V40, P95; Tallamy DW, 2005, ANNU REV ENTOMOL, V50, P347, DOI 10.1146/annurev.ento.50.071803.130424; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vander Meer RK., 1998, PHEROMONE COMMUNICAT, P159; Watanabe H, 1998, NATURE, V394, P330, DOI 10.1038/28527; Zhou XG, 2006, P NATL ACAD SCI USA, V103, P4499, DOI 10.1073/pnas.0508866103	33	55	61	2	527	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e813	10.1371/journal.pone.0000813	http://dx.doi.org/10.1371/journal.pone.0000813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726543	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455400030
J	Bretscher, MS; Clotworthy, M				Bretscher, Mark S.; Clotworthy, Margaret			Using Single loxP Sites to Enhance Homologous Recombination: ts Mutants in Sec1 of Dictyostelium discoideum	PLOS ONE			English	Article								Background. Dictyostelium discoideum amoebae are haploid and, as they share many features with animal cells, should be an ideal creature for studying basic processes such as cell locomotion. Isolation of mutants in this amoeba has largely been limited to non-essential genes: nsfA-the gene for NEM-sensitive factor-remains the only essential gene for which conditional (ts) mutants exist. These ts mutants were generated by gene replacement using a library of mutagenised nsfA containing a selectable marker: transformants were then screened for temperature sensitivity. The success of this approach depended on the high level of homologous recombination prevailing at this locus: similar to 95% of selected clones were homologous recombinants. This is unusually high for Dictyostelium: homologous recombination at other loci is usually much less, usually between 0-30%, making the isolation of ts mutants much more tedious. Methodology/Principal Findings. In trying to make ts mutants in sec1A, homologous recombination was found to be only similar to 25%. A new approach, involving single loxP sites, was investigated. LoxP sites are 34 bp sequences recognised by Cre recombinase and between which this enzyme catalyses recombination. A Dictyostelium line containing a single loxP site adjacent to the 39 end of the sec1A gene was engineered. A sec1A replacement DNA also containing a single loxP site in a homologous position was then introduced into this cell line. In the presence of CRE recombinase, homologous recombination increased to similar to 80% at this locus, presumably largely driven by intermolecular recombination between the two single loxP sites. Conclusions/Significance. A route to increase the rate of homologous recombination at a specific locus, sec1A, is described which enabled the isolation of 30 ts mutants in sec1A. One of these, sec1Ats1, has been studied and found to cease moving at the restrictive temperature. The approach described here may be valuable for enhancing homologous recombination at specified loci and thus for introducing mutations into specific genes in Dictyostelium and other creatures.	[Bretscher, Mark S.; Clotworthy, Margaret] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Bretscher, MS (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	msb@mrc-lmb.cam.ac.uk			Medical Research Council; Medical Research Council [MC_U105178788] Funding Source: researchfish; MRC [MC_U105178788] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Medical Research Council.	BRETSCHER MS, 1984, SCIENCE, V224, P681, DOI 10.1126/science.6719108; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Burgoyne RD, 2007, CURR BIOL, V17, pR255, DOI 10.1016/j.cub.2007.02.006; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; CLOTWORTHY M, 2006, STUDIES DICTYOSTELIU; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; Knecht D, 1995, Methods Mol Biol, V47, P321; MANSTEIN DJ, 1989, EMBO J, V8, P923, DOI 10.1002/j.1460-2075.1989.tb03453.x; Noegel AA, 2000, J CELL SCI, V113, P759; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Thompson CRL, 2002, DEVELOPMENT, V129, P4185	12	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e724	10.1371/journal.pone.0000724	http://dx.doi.org/10.1371/journal.pone.0000724			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684569	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452400026
J	Echegoyen, J; Neu, A; Graber, KD; Soltesz, I				Echegoyen, Julio; Neu, Axel; Graber, Kevin D.; Soltesz, Ivan			Homeostatic Plasticity Studied Using In Vivo Hippocampal Activity-Blockade: Synaptic Scaling, Intrinsic Plasticity and Age-Dependence	PLOS ONE			English	Article								Homeostatic plasticity is thought to be important in preventing neuronal circuits from becoming hyper- or hypoactive. However, there is little information concerning homeostatic mechanisms following in vivo manipulations of activity levels. We investigated synaptic scaling and intrinsic plasticity in CA1 pyramidal cells following 2 days of activity-blockade in vivo in adult ( postnatal day 30; P30) and juvenile (P15) rats. Chronic activity-blockade in vivo was achieved using the sustained release of the sodium channel blocker tetrodotoxin (TTX) from the plastic polymer Elvax 40W implanted directly above the hippocampus, followed by electrophysiological assessment in slices in vitro. Three sets of results were in general agreement with previous studies on homeostatic responses to in vitro manipulations of activity. First, Schaffer collateral stimulation-evoked field responses were enhanced after 2 days of in vivo TTX application. Second, miniature excitatory postsynaptic current (mEPSC) amplitudes were potentiated. However, the increase in mEPSC amplitudes occurred only in juveniles, and not in adults, indicating age-dependent effects. Third, intrinsic neuronal excitability increased. In contrast, three sets of results sharply differed from previous reports on homeostatic responses to in vitro manipulations of activity. First, miniature inhibitory postsynaptic current (mIPSC) amplitudes were invariably enhanced. Second, multiplicative scaling of mEPSC and mIPSC amplitudes was absent. Third, the frequencies of adult and juvenile mEPSCs and adult mIPSCs were increased, indicating presynaptic alterations. These results provide new insights into in vivo homeostatic plasticity mechanisms with relevance to memory storage, activity-dependent development and neurological diseases.	[Echegoyen, Julio; Neu, Axel; Soltesz, Ivan] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Graber, Kevin D.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	University of California System; University of California Irvine; Stanford University	Echegoyen, J (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA.	jechegoy@uci.edu		Neu, Axel/0000-0001-7045-7194	National Institutes of Health [NS35915 (IS), NS02167 (KDG)]; University of California; Deutsche Forschungsgemeinschaft [NE1185/1-1 (AN)]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS035915, R29NS035915, R01NS035915] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant NS35915 (IS), NS02167 (KDG); by the University of California Irvine Medical Scientist Training Program (JE); and by Deutsche Forschungsgemeinschaft Grant NE1185/1-1 (AN).	Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; Aptowicz CO, 2004, BRAIN RES, V998, P155, DOI 10.1016/j.brainres.2003.11.035; Bacci A, 2001, J NEUROSCI, V21, P6588, DOI 10.1523/JNEUROSCI.21-17-06588.2001; Bausch SB, 2006, J NEUROPHYSIOL, V96, P2151, DOI 10.1152/jn.00355.2006; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Chen K, 1999, NAT MED, V5, P888, DOI 10.1038/11330; CHIAIA NL, 1994, DEV BRAIN RES, V79, P301, DOI 10.1016/0165-3806(94)90136-8; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Galvan CD, 2000, J NEUROSCI, V20, P2904; Galvan CD, 2003, EUR J NEUROSCI, V18, P1861, DOI 10.1046/j.1460-9568.2003.02920.x; Golowasch J, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0004.1999; Graber KD, 1999, ANN NEUROL, V46, P234, DOI 10.1002/1531-8249(199908)46:2<234::AID-ANA13>3.0.CO;2-Q; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hong SJ, 1997, J NEUROPHYSIOL, V77, P76, DOI 10.1152/jn.1997.77.1.76; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Howard AL, 2007, J NEUROPHYSIOL, V97, P2394, DOI 10.1152/jn.00509.2006; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Karmarkar UR, 2006, EUR J NEUROSCI, V23, P1575, DOI 10.1111/j.1460-9568.2006.04692.x; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kirov SA, 2004, NEUROPHARMACOLOGY, V47, P640, DOI 10.1016/j.neuropharm.2004.07.039; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Marder E, 2003, NEURON, V37, P2, DOI 10.1016/S0896-6273(02)01173-X; Marder E, 2002, BIOESSAYS, V24, P1145, DOI 10.1002/bies.10185; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Moldakarimov SB, 2006, P NATL ACAD SCI USA, V103, P16526, DOI 10.1073/pnas.0607589103; Moulder KL, 2006, J NEUROSCI, V26, P6618, DOI 10.1523/JNEUROSCI.5498-05.2006; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Neu A, 2007, J PHYSIOL-LONDON, V578, P233, DOI 10.1113/jphysiol.2006.115691; Petrak LJ, 2005, J COMP NEUROL, V484, P183, DOI 10.1002/cne.20468; Samsonovich AV, 2006, P NATL ACAD SCI USA, V103, P1569, DOI 10.1073/pnas.0510057103; Santhakumar V, 2004, TRENDS NEUROSCI, V27, P504, DOI 10.1016/j.tins.2004.06.002; Santhakumar V, 2003, J NEUROSCI, V23, P5865; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; SILBERSTEIN GB, 1982, DEV BIOL, V93, P272, DOI 10.1016/0012-1606(82)90259-7; SOLTESZ I, 2005, DIVERSITY NEUROANAL; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; Sullivan TJ, 2006, NEURAL NETWORKS, V19, P734, DOI 10.1016/j.neunet.2006.05.006; Swanwick CC, 2006, MOL CELL NEUROSCI, V31, P481, DOI 10.1016/j.mcn.2005.11.002; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Trasande CA, 2007, J CLIN NEUROPHYSIOL, V24, P154, DOI 10.1097/WNP.0b013e318033787f; TURRIGIANO G, 1995, J NEUROSCI, V15, P3640; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Wierenga CJ, 2006, J NEUROPHYSIOL, V96, P2127, DOI 10.1152/jn.00107.2006; Williams H, 2007, BIOSYSTEMS, V87, P252, DOI 10.1016/j.biosystems.2006.09.020	55	98	99	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e700	10.1371/journal.pone.0000700	http://dx.doi.org/10.1371/journal.pone.0000700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684547	Green Published, gold			2022-12-27	WOS:000207452400004
J	Orr, A; Dube, MP; Marcadier, J; Jiang, HY; Federico, A; George, S; Seamone, C; Andrews, D; Dubord, P; Holland, S; Provost, S; Mongrain, V; Evans, S; Higgins, B; Bowman, S; Guernsey, D; Samuels, M				Orr, Andrew; Dube, Marie-Pierre; Marcadier, Julien; Jiang, Haiyan; Federico, Antonio; George, Stanley; Seamone, Christopher; Andrews, David; Dubord, Paul; Holland, Simon; Provost, Sylvie; Mongrain, Vanessa; Evans, Susan; Higgins, Brent; Bowman, Sharen; Guernsey, Duane; Samuels, Mark			Mutations in the UBIAD1 Gene, Encoding a Potential Prenyltransferase, Are Causal for Schnyder Crystalline Corneal Dystrophy	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; FUNCTIONAL REGIONS; IDENTIFICATION; SEQUENCE; CONSURF; TERE1; ASSOCIATION; PROTEINS; DISEASE; FAMILY	Schnyder crystalline corneal dystrophy (SCCD, MIM 121800) is a rare autosomal dominant disease characterized by progressive opacification of the cornea resulting from the local accumulation of lipids, and associated in some cases with systemic dyslipidemia. Although previous studies of the genetics of SCCD have localized the defective gene to a 1.58 Mbp interval on chromosome 1p, exhaustive sequencing of positional candidate genes has thus far failed to reveal causal mutations. We have ascertained a large multigenerational family in Nova Scotia affected with SCCD in which we have confirmed linkage to the same general area of chromosome 1. Intensive fine mapping in our family revealed a 1.3 Mbp candidate interval overlapping that previously reported. Sequencing of genes in our interval led to the identification of five putative causal mutations in gene UBIAD1, in our family as well as in four other small families of various geographic origins. UBIAD1 encodes a potential prenyltransferase, and is reported to interact physically with apolipoprotein E. UBIAD1 may play a direct role in intracellular cholesterol biochemistry, or may prenylate other proteins regulating cholesterol transport and storage.	[Orr, Andrew; Jiang, Haiyan; Guernsey, Duane; Samuels, Mark] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Orr, Andrew; George, Stanley; Seamone, Christopher; Andrews, David] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada; [Dube, Marie-Pierre; Provost, Sylvie] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Marcadier, Julien; Mongrain, Vanessa; Evans, Susan] Dalhousie Univ, Fac Med, Halifax, NS, Canada; [Federico, Antonio] Univ Siena, Dipartimento Sci Neurol & Comportamento, I-53100 Siena, Italy; [Dubord, Paul; Holland, Simon] Univ British Columbia, Fac Med, Dept Ophthalmol, Vancouver, BC, Canada; [Higgins, Brent; Bowman, Sharen] Canada Inst Marine Biol, Natl Res Council, Halifax, NS, Canada; [Samuels, Mark] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Dalhousie University; Dalhousie University; Universite de Montreal; Dalhousie University; University of Siena; University of British Columbia; National Research Council Canada; Universite de Montreal	Samuels, M (corresponding author), Dalhousie Univ, Dept Pathol, Halifax, NS, Canada.	mark.e.samuels@umontreal.ca	Dubé, Marie-Pierre/B-9364-2008	Dubé, Marie-Pierre/0000-0001-8442-4393; Orr, Andrew/0000-0002-9388-9034	Queen Elizabeth II Health Science Centre; Dalhousie University; IWK Health Centre; Dalhousie Medical Research Foundation; Capital District Health Authority; Genome Atlantic and Genomic Canada; Genome Canada/Genome Atlantic; Fonds de Recherche en Sante du Quebec (FRSQ)	Queen Elizabeth II Health Science Centre; Dalhousie University; IWK Health Centre; Dalhousie Medical Research Foundation; Capital District Health Authority; Genome Atlantic and Genomic Canada; Genome Canada/Genome Atlantic(Genome Canada); Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	AO was supported by the Queen Elizabeth II Health Science Centre Research Fund. MES was supported by Dalhousie University, the IWK Health Centre, the Dalhousie Medical Research Foundation, the Capital District Health Authority, Genome Atlantic and Genomic Canada. SB was supported by Genome Canada/Genome Atlantic. MPD was supported by the Fonds de Recherche en Sante du Quebec (FRSQ).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aldave AJ, 2005, MOL VIS, V11, P713; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Ashburner M, 1999, GENETICS, V153, P179; BARCHIESI BJ, 1991, SURV OPHTHALMOL, V36, P1, DOI 10.1016/0039-6257(91)90205-T; Battisti C, 1998, AM J MED GENET, V75, P35, DOI 10.1002/(SICI)1096-8628(19980106)75:1<35::AID-AJMG8>3.0.CO;2-P; Brauer L, 2004, J MOL MODEL, V10, P317, DOI 10.1007/s00894-004-0197-6; BRON AJ, 1972, BRIT J OPHTHALMOL, V56, P383, DOI 10.1136/bjo.56.5.383; BRON AJ, 1989, CORNEA, V8, P135; BROWNSTEIN S, 1991, CAN J OPHTHALMOL, V26, P273; Burns R P, 1978, Trans Am Ophthalmol Soc, V76, P184; Crispin S, 2002, PROG RETIN EYE RES, V21, P169, DOI 10.1016/S1350-9462(02)00004-6; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gaynor PM, 1996, ARTERIOSCL THROM VAS, V16, P992, DOI 10.1161/01.ATV.16.8.992; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Kajinami K, 1988, Nihon Naika Gakkai Zasshi, V77, P1017; Kohnen T, 1997, KLIN MONATSBL AUGENH, V211, P135, DOI 10.1055/s-2008-1035112; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Magnuson VL, 1996, BIOTECHNIQUES, V21, P700, DOI 10.2144/96214rr03; MCCARTHY M, 1994, OPHTHALMOLOGY, V101, P895; McGarvey TW, 2005, J CELL BIOCHEM, V95, P419, DOI 10.1002/jcb.20432; McGarvey TW, 2003, PROSTATE, V54, P144, DOI 10.1002/pros.10174; McGarvey TW, 2001, ONCOGENE, V20, P1042, DOI 10.1038/sj.onc.1204143; Meier U, 1998, KLIN MONATSBL AUGENH, V212, P405, DOI 10.1055/s-2008-1034920; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OLEYNIKOV YS, 2007, EXCLUSION CHROSOME 1; PALMER M, 1985, ARCH OPHTHALMOL-CHIC, V103, P817, DOI 10.1001/archopht.1985.01050060077030; Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Riebeling P, 2003, OPHTHALMOLOGE, V100, P979, DOI 10.1007/s00347-003-0883-2; Rozen S, 2000, Methods Mol Biol, V132, P365; SAMUELS M, 2007, NEW TECHNOL IN PRESS; SAMUELS ME, 2005, LINKAGE MAPPING ENCY; Schnyder WF., 1929, SCHWEIZ MED WSCHR, V10, P559; Shearman AM, 1996, HUM MOL GENET, V5, P1667, DOI 10.1093/hmg/5.10.1667; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Theendakara V, 2004, HUM GENET, V114, P594, DOI 10.1007/s00439-004-1110-1; THIEL HJ, 1977, KLIN MONATSBL AUGENH, V171, P678; Thomas PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/pnas.0404380101; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Van Went JM., 1924, NIEDERL TIJDSCHR GEN, V68, P2996; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; WEISS JS, 1992, CORNEA, V11, P93, DOI 10.1097/00003226-199203000-00001; WEISS JS, 1992, OPHTHALMOLOGY, V99, P1072; Weiss JS, 1996, OPHTHALMOLOGY, V103, P465; Yamada M, 1998, BRIT J OPHTHALMOL, V82, P444, DOI 10.1136/bjo.82.4.444	54	94	103	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e685	10.1371/journal.pone.0000685	http://dx.doi.org/10.1371/journal.pone.0000685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668063	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452300021
J	Nashev, LG; Chandsawangbhuwana, C; Balazs, Z; Atanasov, AG; Dick, B; Frey, FJ; Baker, ME; Odermatt, A				Nashev, Lyubomir G.; Chandsawangbhuwana, Charlie; Balazs, Zoltan; Atanasov, Atanas G.; Dick, Bernhard; Frey, Felix J.; Baker, Michael E.; Odermatt, Alex			Hexose-6-phosphate Dehydrogenase Modulates 11 beta-Hydroxysteroid Dehydrogenase Type 1-Dependent Metabolism of 7-keto- and 7 beta-hydroxy-neurosteroids	PLOS ONE			English	Article								Background. The role of 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) in the regulation of energy metabolism and immune system by locally reactivating glucocorticoids has been extensively studied. Experiments determining initial rates of enzyme activity revealed that 11 beta-HSD1 can catalyze both the reductase and the dehydrogenase reaction in cell lysates, whereas it predominantly catalyzes the reduction of cortisone to cortisol in intact cells that also express hexose-6-phosphate dehydrogenase (H6PDH), which provides cofactor NADPH. Besides its role in glucocorticoid metabolism, there is evidence that 11 beta-HSD1 is involved in the metabolism of 7-keto- and 7-hydroxy-steroids; however the impact of H6PDH on this alternative function of 11 beta-HSD1 has not been assessed. Methodology. We investigated the 11 beta-HSD1-dependent metabolism of the neurosteroids 7-keto-, 7 alpha-hydroxy- and 7 beta-hydroxy-dehydroepiandrosterone ( DHEA) and 7-keto- and 7 beta-hydroxy-pregnenolone, respectively, in the absence or presence of H6PDH in intact cells. 3D-structural modeling was applied to study the binding of ligands in 11 beta-HSD1. Principal Findings. We demonstrated that 11 beta-HSD1 functions in a reversible way and efficiently catalyzed the interconversion of these 7-keto- and 7-hydroxy-neurosteroids in intact cells. In the presence of H6PDH, 11 beta-HSD1 predominantly converted 7-keto-DHEA and 7-ketopregnenolone into their corresponding 7 beta-hydroxy metabolites, indicating a role for H6PDH and 11 beta-HSD1 in the local generation of 7 beta-hydroxy-neurosteroids. 3D-structural modeling offered an explanation for the preferred formation of 7-hydroxy-neurosteroids. Conclusions. Our results from experiments determining the steady state concentrations of glucocorticoids or 7-oxygenated neurosteroids suggested that the equilibrium between cortisone and cortisol and between 7-keto- and 7-hydroxy-neurosteroids is regulated by 11 beta-HSD1 and greatly depends on the coexpression with H6PDH. Thus, the impact of H6PDH on 11 beta-HSD1 activity has to be considered for understanding both glucocorticoid and neurosteroid action in different tissues.	[Nashev, Lyubomir G.; Balazs, Zoltan; Odermatt, Alex] Univ Basel, Inst Mol & Syst Toxicol, Basel, Switzerland; [Nashev, Lyubomir G.; Balazs, Zoltan; Dick, Bernhard; Frey, Felix J.; Odermatt, Alex] Univ Bern, Dept Hypertens & Nephrol, Bern, Switzerland; [Chandsawangbhuwana, Charlie; Baker, Michael E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Atanasov, Atanas G.] Univ Bern, Inst Pathol, Div Immunopathol, Bern, Switzerland	University of Basel; University of Bern; University of California System; University of California San Diego; University of Bern	Odermatt, A (corresponding author), Univ Basel, Inst Mol & Syst Toxicol, Basel, Switzerland.	alex.odermatt@unibas.ch	Atanasov, Atanas G./C-5535-2013	Atanasov, Atanas G./0000-0003-2545-0967; Baker, Michael/0000-0003-4387-3269; Odermatt, Alex/0000-0002-6820-2712	Cloetta Research Foundation; Swiss National Science Foundation [310000-112279]; Roche Research Foundation [2004-276]; Novartis Research Foundation	Cloetta Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche Research Foundation; Novartis Research Foundation	This study was supported by the Cloetta Research Foundation, the Swiss National Science Foundation ( No 310000-112279) and the Roche Research Foundation ( No 2004-276). A.O. is a Novartis Research Foundation Professor. Financial support was obtained for salaries, coverage of infrastructure and consumables. There was no influence of the funding institution on the research performed.	AGARWAL AK, 1990, MOL ENDOCRINOL, V4, P1827, DOI 10.1210/mend-4-12-1827; Agarwal AK, 2005, ENDOCRINOLOGY, V146, P2531, DOI 10.1210/en.2005-0061; AGARWAL AK, 1989, J BIOL CHEM, V264, P18939; Apostolova G, 2005, AM J PHYSIOL-ENDOC M, V288, pE957, DOI 10.1152/ajpendo.00442.2004; Arampatzis S, 2005, J MOL ENDOCRINOL, V35, P89, DOI 10.1677/jme.1.01736; Arnold P, 2003, MOL CELL ENDOCRINOL, V201, P177, DOI 10.1016/S0303-7207(02)00304-0; Atanasov AG, 2004, FEBS LETT, V571, P129, DOI 10.1016/j.febslet.2004.06.065; ATANASOV AG, 2007, ENDOCR META IN PRESS; Banhegyi G, 2004, J BIOL CHEM, V279, P27017, DOI 10.1074/jbc.M404159200; Baulieu EE, 1998, P NATL ACAD SCI USA, V95, P4089, DOI 10.1073/pnas.95.8.4089; Bujalska IJ, 2005, J MOL ENDOCRINOL, V34, P675, DOI 10.1677/jme.1.01718; Bujalska IJ, 2002, J CLIN ENDOCR METAB, V87, P1205, DOI 10.1210/jc.87.3.1205; Chalbot S, 2002, STEROIDS, V67, P1121, DOI 10.1016/S0039-128X(02)00072-7; Compagnone NA, 1998, P NATL ACAD SCI USA, V95, P4678, DOI 10.1073/pnas.95.8.4678; de Quervain DJF, 2004, HUM MOL GENET, V13, P47, DOI 10.1093/hmg/ddg361; Draper N, 2003, NAT GENET, V34, P434, DOI 10.1038/ng1214; Frick C, 2004, J BIOL CHEM, V279, P31131, DOI 10.1074/jbc.M313666200; Hampl, 1997, Endocr Regul, V31, P211; Hermanowski-Vosatka A, 2005, J EXP MED, V202, P517, DOI 10.1084/jem.20050119; Hewitt KN, 2005, ENDOCRINOLOGY, V146, P2539, DOI 10.1210/en.2005-0117; Hult M, 2004, CELL MOL LIFE SCI, V61, P992, DOI 10.1007/s00018-003-3476-y; Jamieson PM, 2000, J ENDOCRINOL, V165, P685, DOI 10.1677/joe.0.1650685; Khan N, 2004, ARCH BIOCHEM BIOPHYS, V429, P50, DOI 10.1016/j.abb.2004.05.023; Kim SB, 2003, J CLIN ENDOCR METAB, V88, P5199, DOI 10.1210/jc.2003-030646; LARDY H, 1995, P NATL ACAD SCI USA, V92, P6617, DOI 10.1073/pnas.92.14.6617; Lathe R, 2002, STEROIDS, V67, P967, DOI 10.1016/S0039-128X(02)00044-2; Lavery GG, 2006, J BIOL CHEM, V281, P6546, DOI 10.1074/jbc.M512635200; Maser E, 2006, MOL CELL ENDOCRINOL, V248, P34, DOI 10.1016/j.mce.2005.10.019; Matsunaga M, 2004, P NATL ACAD SCI USA, V101, P17282, DOI 10.1073/pnas.0407176101; Miller WL, 2002, MOL CELL ENDOCRINOL, V198, P7, DOI 10.1016/S0303-7207(02)00363-5; Muller C, 2006, J STEROID BIOCHEM, V100, P95, DOI 10.1016/j.jsbmb.2006.03.001; Muller C, 2006, J STEROID BIOCHEM, V99, P215, DOI 10.1016/j.jsbmb.2005.12.001; Nobel CSI, 2002, PROTEIN EXPRES PURIF, V26, P349, DOI 10.1016/S1046-5928(02)00547-8; Odermatt A, 1999, J BIOL CHEM, V274, P28762, DOI 10.1074/jbc.274.40.28762; Pringle AK, 2003, EUR J NEUROSCI, V18, P117, DOI 10.1046/j.1460-9568.2003.02734.x; Robinzon B, 2005, ARCH BIOCHEM BIOPHYS, V442, P33, DOI 10.1016/j.abb.2005.07.010; Robinzon B, 2003, ARCH BIOCHEM BIOPHYS, V412, P251, DOI 10.1016/S0003-9861(03)00056-0; Rose K, 2001, J BIOL CHEM, V276, P23937, DOI 10.1074/jbc.M011564200; Schuster D, 2006, J MED CHEM, V49, P3454, DOI 10.1021/jm0600794; Schweizer RAS, 2004, J BIOL CHEM, V279, P18415, DOI 10.1074/jbc.M313615200; Shi J, 2000, STEROIDS, V65, P124, DOI 10.1016/S0039-128X(99)00094-X; Song W, 1998, J BIOL CHEM, V273, P16223, DOI 10.1074/jbc.273.26.16223; TANAHASHI K, 1980, J HISTOCHEM CYTOCHEM, V28, P1175, DOI 10.1177/28.11.7430614; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; Wang MH, 2006, CURR OPIN INVEST DR, V7, P319; Weill-Engerer S, 2003, BRAIN RES, V969, P117, DOI 10.1016/S0006-8993(03)02288-1; Wolf OT, 1999, BRAIN RES REV, V30, P264, DOI 10.1016/S0165-0173(99)00021-1; Yau JLW, 2003, NEUROSCIENCE, V121, P307, DOI 10.1016/S0306-4522(03)00438-X; Zhang JD, 2005, BIOCHEMISTRY-US, V44, P6948, DOI 10.1021/bi047599q	49	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e561	10.1371/journal.pone.0000561	http://dx.doi.org/10.1371/journal.pone.0000561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593962	gold, Green Published, Green Submitted			2022-12-27	WOS:000207451800007
J	Yamamoto, H; Kawada, M; Takeda, A; Igarashi, H; Matano, T				Yamamoto, Hiroyuki; Kawada, Miki; Takeda, Akiko; Igarashi, Hiroko; Matano, Tetsuro			Post-Infection Immunodeficiency Virus Control by Neutralizing Antibodies	PLOS ONE			English	Article								Background. Unlike most acute viral infections controlled with the appearance of virus-specific neutralizing antibodies (NAbs), primary HIV infections are not met with such potent and early antibody responses. This brings into question if or how the presence of potent antibodies can contribute to primary HIV control, but protective efficacies of antiviral antibodies in primary HIV infections have remained elusive; and, it has been speculated that even NAb induction could have only a limited suppressive effect on primary HIV replication once infection is established. Here, in an attempt to answer this question, we examined the effect of passive NAb immunization post-infection on primary viral replication in a macaque AIDS model. Methods and Findings. The inoculums for passive immunization with simian immunodeficiency virus mac239 (SIVmac239)-specific neutralizing activity were prepared by purifying polyclonal immunoglobulin G from pooled plasma of six SIVmac239-infected rhesus macaques with NAb induction in the chronic phase. Passive immunization of rhesus macaques with the NAbs at day 7 after SIVmac239 challenge resulted in significant reduction of set-point plasma viral loads and preservation of central memory CD4 T lymphocyte counts, despite the limited detection period of the administered NAb responses. Peripheral lymph node dendritic cell (DC)-associated viral RNA loads showed a remarkable peak with the NAb administration, and DCs stimulated in vitro with NAb-preincubated SIV activated virus-specific CD4 T lymphocytes in an Fc-dependent manner, implying antibody-mediated virion uptake by DCs and enhanced T cell priming. Conclusions. Our results present evidence indicating that potent antibody induction post-infection can result in primary immunodeficiency virus control and suggest direct and indirect contribution of its absence to initial control failure in HIV infections. Although difficulty in achieving requisite neutralizing titers for sterile HIV protection by prophylactic vaccination has been suggested, this study points out a possibility of non-sterile HIV control by prophylactic vaccine-induced, sub-sterile titers of NAbs post-infection, providing a rationale of vaccine-based NAb induction for primary HIV control.	[Yamamoto, Hiroyuki; Kawada, Miki; Takeda, Akiko; Matano, Tetsuro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo, Japan; [Yamamoto, Hiroyuki; Kawada, Miki; Igarashi, Hiroko; Matano, Tetsuro] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Matano, Tetsuro] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Matano, Tetsuro] Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Ibaraki, Japan	University of Tokyo; University of Tokyo; National Institute of Infectious Diseases (NIID); National Institute of Health Sciences - Japan	Matano, T (corresponding author), Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo, Japan.	matano@m.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology; Japan Health Sciences Foundation; Ministry of Health, Labor, and Welfare in Japan	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Health Sciences Foundation; Ministry of Health, Labor, and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, grants from the Japan Health Sciences Foundation, and grants from the Ministry of Health, Labor, and Welfare in Japan.	Arguello JR, 1998, TISSUE ANTIGENS, V52, P57, DOI 10.1111/j.1399-0039.1998.tb03024.x; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; CHAKRABARTI L, 1994, AM J PATHOL, V144, P1226; Eitner F, 2000, AM J PATHOL, V156, P1197, DOI 10.1016/S0002-9440(10)64990-5; Frankel SS, 1998, J VIROL, V72, P9788, DOI 10.1128/JVI.72.12.9788-9794.1998; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Haigwood NL, 1996, IMMUNOL LETT, V51, P107, DOI 10.1016/0165-2478(96)02563-1; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Huber M, 2006, PLOS MED, V3, P2078, DOI 10.1371/journal.pmed.0030441; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kawada M, 2006, J VIROL, V80, P1949, DOI 10.1128/JVI.80.4.1949-1958.2006; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Lore K, 2005, J EXP MED, V201, P2023, DOI 10.1084/jem.20042413; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Matano T, 2004, J EXP MED, V199, P1709, DOI 10.1084/jem.20040432; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Nishimura Y, 2004, P NATL ACAD SCI USA, V101, P12324, DOI 10.1073/pnas.0404620101; Nishimura Y, 2003, P NATL ACAD SCI USA, V100, P15131, DOI 10.1073/pnas.2436476100; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Picker LJ, 2005, NAT IMMUNOL, V6, P430, DOI 10.1038/ni0505-430; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schuurhuis DH, 2002, J IMMUNOL, V168, P2240, DOI 10.4049/jimmunol.168.5.2240; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Thomas PG, 2006, P NATL ACAD SCI USA, V103, P2764, DOI 10.1073/pnas.0511185103; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470	39	38	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2007	2	6							e540	10.1371/journal.pone.0000540	http://dx.doi.org/10.1371/journal.pone.0000540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GE	17579714	Green Submitted, Green Published, gold			2022-12-27	WOS:000207451700008
J	Tian, KG; Yu, XL; Zhao, TZ; Feng, YJ; Cao, Z; Wang, CB; Hu, Y; Chen, XZ; Hu, DM; Tian, XS; Liu, D; Zhang, SO; Deng, XY; Ding, YQ; Yang, L; Zhang, YX; Xiao, HX; Qiao, MM; Wang, B; Hou, LL; Wang, XY; Yang, XY; Kang, LP; Sun, M; Jin, P; Wang, SJ; Kitamura, Y; Yan, JH; Gao, GF				Tian, Kegong; Yu, Xiuling; Zhao, Tiezhu; Feng, Youjun; Cao, Zhen; Wang, Chuanbin; Hu, Yan; Chen, Xizhao; Hu, Dongmei; Tian, Xinsheng; Liu, Di; Zhang, Shuo; Deng, Xiaoyu; Ding, Yinqiao; Yang, Lu; Zhang, Yunxia; Xiao, Haixia; Qiao, Mingming; Wang, Bin; Hou, Lili; Wang, Xiaoying; Yang, Xinyan; Kang, Liping; Sun, Ming; Jin, Ping; Wang, Shujuan; Kitamura, Yoshihiro; Yan, Jinghua; Gao, George F.			Emergence of Fatal PRRSV Variants: Unparalleled Outbreaks of Atypical PRRS in China and Molecular Dissection of the Unique Hallmark	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; PORCINE EPIDEMIC ABORTION; MYSTERY SWINE DISEASE; CDNA INFECTIOUS CLONE; NORTH-AMERICAN; LELYSTAD VIRUS; GENOMIC CHARACTERIZATION; GENETIC-VARIATION; PROTEIN; VIRULENT	Porcine reproductive and respiratory syndrome (PRRS) is a severe viral disease in pigs, causing great economic losses worldwide each year. The causative agent of the disease, PRRS virus (PRRSV), is a member of the family Arteriviridae. Here we report our investigation of the unparalleled large-scale outbreaks of an originally unknown, but so-called ``high fever'' disease in China in 2006 with the essence of PRRS, which spread to more than 10 provinces (autonomous cities or regions) and affected over 2,000,000 pigs with about 400,000 fatal cases. Different from the typical PRRS, numerous adult sows were also infected by the ``high fever'' disease. This atypical PRRS pandemic was initially identified as a hog cholera-like disease manifesting neurological symptoms (e. g., shivering), high fever (40-42 degrees C), erythematous blanching rash, etc. Autopsies combined with immunological analyses clearly showed that multiple organs were infected by highly pathogenic PRRSVs with severe pathological changes observed. Whole-genome analysis of the isolated viruses revealed that these PRRSV isolates are grouped into Type II and are highly homologous to HB-1, a Chinese strain of PRRSV (96.5% nucleotide identity). More importantly, we observed a unique molecular hallmark in these viral isolates, namely a discontinuous deletion of 30 amino acids in nonstructural protein 2 (NSP2). Taken together, this is the first comprehensive report documenting the 2006 epidemic of atypical PRRS outbreak in China and identifying the 30 amino-acid deletion in NSP2, a novel determining factor for virulence which may be implicated in the high pathogenicity of PRRSV, and will stimulate further study by using the infectious cDNA clone technique.	[Tian, Kegong; Yu, Xiuling; Zhao, Tiezhu; Cao, Zhen; Wang, Chuanbin; Hu, Yan; Chen, Xizhao; Hu, Dongmei; Zhang, Shuo; Deng, Xiaoyu; Ding, Yinqiao; Yang, Lu; Zhang, Yunxia; Qiao, Mingming; Wang, Bin; Hou, Lili; Wang, Xiaoying; Yang, Xinyan; Kang, Liping; Sun, Ming; Jin, Ping] China Anim Dis Control Ctr, Beijing, Peoples R China; [Feng, Youjun; Tian, Xinsheng; Liu, Di; Xiao, Haixia; Wang, Shujuan; Kitamura, Yoshihiro; Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, Ctr Mol Immunol, Beijing, Peoples R China; [Feng, Youjun; Tian, Xinsheng; Xiao, Haixia] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Zhang, Yunxia; Qiao, Mingming; Wang, Bin; Hou, Lili; Wang, Shujuan] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Kitamura, Yoshihiro; Gao, George F.] Chinese Acad Sci, Inst Microbiol, China Japan Joint Lab Mol Immunol & Mol Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; China Agricultural University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Tian, KG (corresponding author), China Anim Dis Control Ctr, Beijing, Peoples R China.	tiankg@263.net; gaof@im.ac.cn	Gao, George Fu/ABD-5229-2021; Feng, Youjun/E-8386-2010; Liu, Di/ABD-2729-2021; Xiao, Haixia/AAZ-3374-2020; Liu, Di/G-6135-2014; yang, xin/HGU-9981-2022; Feng, Youjun/I-4134-2012	Liu, Di/0000-0003-3693-2726; Xiao, Haixia/0000-0003-0032-5430; Liu, Di/0000-0003-3693-2726; 	National Basic Research Program of China [2005CB523001]; National Key Technologies RD Programs [2006BAD06A04, 2006BAD06A01]; Natural Science Foundation in Beijing [5062028]; Japan MEXT (Ministry of Education, Culture, Sports, Science and Technology); National Natural Science Foundation of China [30525010]	National Basic Research Program of China(National Basic Research Program of China); National Key Technologies RD Programs(National Key Technology R&D Program); Natural Science Foundation in Beijing; Japan MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program (Project 973) of China (2005CB523001), National Key Technologies R&D Programs (2006BAD06A04 & 2006BAD06A01) and Natural Science Foundation in Beijing (5062028). The China-Japan Joint Laboratory of Molecular Immunology and Molecular Microbiology is, in part, supported by Japan MEXT (Ministry of Education, Culture, Sports, Science and Technology). GEG is a distinguised young investigator of National Natural Science Foundation of China (NSFC) (Grant No.30525010).	Albina E, 1997, VET MICROBIOL, V55, P309, DOI 10.1016/S0378-1135(96)01322-3; Allende R, 1999, J GEN VIROL, V80, P307, DOI 10.1099/0022-1317-80-2-307; Blaha T, 2000, VET RES, V31, P77, DOI 10.1051/vetres:2000058; Botner A, 1999, VET MICROBIOL, V68, P187, DOI 10.1016/S0378-1135(99)00053-X; Botner A, 1997, VET REC, V141, P497, DOI 10.1136/vr.141.19.497; BROUWER J, 1994, VET QUART, V16, P95, DOI 10.1080/01652176.1994.9694427; Cavanagh D, 1997, ARCH VIROL, V142, P629; Chen J, 2006, BIOCHEM GENET, V44, P425, DOI 10.1007/s10528-006-9039-9; Dea S, 2000, ARCH VIROL, V145, P659, DOI 10.1007/s007050050662; Done SH, 1996, BRIT VET J, V152, P153, DOI 10.1016/S0007-1935(96)80071-6; ELAZHARY Y, 1991, VET REC, V129, P495, DOI 10.1136/vr.129.22.495-b; Faaberg KS, 2006, ADV EXP MED BIOL, V581, P73; Fang Y, 2004, VIRUS RES, V100, P229, DOI 10.1016/j.virusres.2003.12.026; Fang Y, 2006, ADV EXP MED BIOL, V581, P605; Fang Y, 2006, J VIROL, V80, P11447, DOI 10.1128/JVI.01032-06; GALINA L, 1994, VET REC, V134, P60, DOI 10.1136/vr.134.3.60; Gao ZQ, 2004, ARCH VIROL, V149, P1341, DOI 10.1007/s00705-004-0292-0; Grebennikova TV, 2004, VIROLOGY, V321, P383, DOI 10.1016/j.virol.2004.01.001; Han J, 2006, VIRUS RES, V122, P175, DOI 10.1016/j.virusres.2006.06.003; Hermann J, 2007, VET RES, V38, P81, DOI 10.1051/vetres:2006044; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Johnson W, 2004, VET IMMUNOL IMMUNOP, V102, P233, DOI 10.1016/j.vetimm.2004.09.010; Key KF, 2001, VET MICROBIOL, V83, P249, DOI 10.1016/S0378-1135(01)00427-8; Kwon B, 2006, VACCINE, V24, P7071, DOI 10.1016/j.vaccine.2006.07.010; Li H, 2003, VET MICROBIOL, V95, P295, DOI 10.1016/S0378-1135(03)00158-5; Mateu E, 2006, VIRUS RES, V115, P198, DOI 10.1016/j.virusres.2005.09.008; MEULENBERG JJM, 1993, VIROLOGY, V192, P62, DOI 10.1006/viro.1993.1008; MURAKAMI Y, 1994, J VET MED SCI, V56, P891, DOI 10.1292/jvms.56.891; MURTAUGH MP, 1995, ARCH VIROL, V140, P1451, DOI 10.1007/BF01322671; Nelsen CJ, 1999, J VIROL, V73, P270, DOI 10.1128/JVI.73.1.270-280.1999; Nelson E A, 1995, Adv Exp Med Biol, V380, P321; NELSON EA, 1993, J CLIN MICROBIOL, V31, P3184, DOI 10.1128/JCM.31.12.3184-3189.1993; Nielsen HS, 2003, J VIROL, V77, P3702, DOI 10.1128/JVI.77.6.3702-3711.2003; Nielsen HS, 2001, J GEN VIROL, V82, P1263, DOI 10.1099/0022-1317-82-6-1263; Nielsen J, 2002, VET MICROBIOL, V84, P1, DOI 10.1016/S0378-1135(01)00450-3; Nodelijk G, 2003, PREV VET MED, V60, P37, DOI 10.1016/S0167-5877(03)00081-3; PATON DJ, 1991, VET REC, V128, P617, DOI 10.1136/vr.128.26.617; Pesch S, 2005, VET MICROBIOL, V107, P31, DOI 10.1016/j.vetmic.2005.01.028; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schommer SK, 2006, ADV EXP MED BIOL, V581, P435; Shen S, 2000, ARCH VIROL, V145, P871, DOI 10.1007/s007050050680; SHIMIZU M, 1994, J VET MED SCI, V56, P389, DOI 10.1292/jvms.56.389; Stadejek T, 2002, J GEN VIROL, V83, P1861, DOI 10.1099/0022-1317-83-8-1861; Storgaard T, 1999, ARCH VIROL, V144, P2389, DOI 10.1007/s007050050652; Suarez P, 2000, VET RES, V31, P47, DOI 10.1051/vetres:2000056; TANG J, 2006, PLOS MED, V3; Thiel H J, 1993, Arch Virol Suppl, V7, P41; Wasilk A, 2004, J CLIN MICROBIOL, V42, P4453, DOI 10.1128/JCM.42.10.4453-4461.2004; WENSVOORT G, 1993, VET RES, V24, P117; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Yang L, 1999, ARCH VIROL, V144, P525, DOI 10.1007/s007050050523; Yang L, 2000, ARCH VIROL, V145, P1599, DOI 10.1007/s007050070079; Yoshii M, 2005, ARCH VIROL, V150, P2313, DOI 10.1007/s00705-005-0549-2; Zimmerman JJ, 1997, VET MICROBIOL, V55, P187, DOI 10.1016/S0378-1135(96)01330-2	54	730	914	5	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2007	2	6							e526	10.1371/journal.pone.0000526	http://dx.doi.org/10.1371/journal.pone.0000526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GD	17565379	gold, Green Published, Green Submitted			2022-12-27	WOS:000207451600014
J	Balcan, D; Kabakcioglu, A; Mungan, M; Erzan, A				Balcan, Duygu; Kabakcioglu, Alkan; Mungan, Muhittin; Erzan, Ayse			The Information Coded in the Yeast Response Elements Accounts for Most of the Topological Properties of Its Transcriptional Regulation Network	PLOS ONE			English	Article								The regulation of gene expression in a cell relies to a major extent on transcription factors, proteins which recognize and bind the DNA at specific binding sites (response elements) within promoter regions associated with each gene. We present an information theoretic approach to modeling transcriptional regulatory networks, in terms of a simple "sequence-matching" rule and the statistics of the occurrence of binding sequences of given specificity in random promoter regions. The crucial biological input is the distribution of the amount of information coded in these cognate response elements and the length distribution of the promoter regions. We provide an analysis of the transcriptional regulatory network of yeast Saccharomyces cerevisiae, which we extract from the available databases, with respect to the degree distributions, clustering coefficient, degree correlations, rich-club coefficient and the k-core structure. We find that these topological features are in remarkable agreement with those predicted by our model, on the basis of the amount of information coded in the interaction between the transcription factors and response elements.	[Balcan, Duygu; Erzan, Ayse] Istanbul Tech Univ, Dept Phys, Fac Sci & Letters, TR-80626 Istanbul, Turkey; [Kabakcioglu, Alkan] Koc Univ, Dept Phys, Fac Arts & Sci, Istanbul, Turkey; [Mungan, Muhittin] Bogazici Univ, Dept Phys, Fac Arts & Sci, Istanbul, Turkey; [Mungan, Muhittin; Erzan, Ayse] Gursey Inst, Istanbul, Turkey	Istanbul Technical University; Koc University; Bogazici University; Bogazici University; Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)	Balcan, D (corresponding author), Istanbul Tech Univ, Dept Phys, Fac Sci & Letters, TR-80626 Istanbul, Turkey.	balcand@indiana.edu	Mungan, Muhittin/M-7991-2015	Mungan, Muhittin/0000-0002-0352-5422; Kabakcioglu, Alkan/0000-0002-9831-3632	Turkish Academy of Sciences	Turkish Academy of Sciences(Turkish Academy of Sciences)	AE is grateful for partial support from the Turkish Academy of Sciences.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; ALBERTS B, 2002, MOL BIOL CELL, pCH9; Almirantis Y, 1999, J STAT PHYS, V97, P233, DOI 10.1023/A:1004671119400; Balcan D, 2004, EUR PHYS J B, V38, P253, DOI 10.1140/epjb/e2004-00055-7; Banzhaf Wolfgang, 2004, Journal of Biological Physics and Chemistry, V4, P85, DOI 10.4024/2040405.jbpc.04.02; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Bollobas B., 1998, MODERN GRAPH THEORY; Caldarelli G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.258702; CARMI S, 2006, CONDMAT0601240ARXIV; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Colizza V, 2005, PHYSICA A, V352, P1, DOI 10.1016/j.physa.2004.12.030; Dobrin R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-10; Dorogovtsev SN, 2002, ADV PHYS, V51, P1079, DOI 10.1080/00018730110112519; GEARD N, 2003, P 2003 C EV COMP CEC; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Huang Sui, 2004, Briefings in Functional Genomics & Proteomics, V2, P279, DOI 10.1093/bfgp/2.4.279; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Kauffman S, 2004, J THEOR BIOL, V230, P581, DOI 10.1016/j.jtbi.2003.12.017; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; KINIKOGLU B, 2006, IDENTIFYING PE UNPUB; KLEFFE J, 1992, COMPUT APPL BIOSCI, V8, P433; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Mungan M, 2005, J PHYS A-MATH GEN, V38, P9599, DOI 10.1088/0305-4470/38/44/001; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Perelson AS, 1997, REV MOD PHYS, V69, P1219, DOI 10.1103/RevModPhys.69.1219; Reil T, 1999, LECT NOTES ARTIF INT, V1674, P457; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; SOLE RV, 2002, HDB GRAPHS NETWORKS; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; van Noort V, 2004, EMBO REP, V5, P280, DOI 10.1038/sj.embor.7400090; Vazquez A, 2004, P NATL ACAD SCI USA, V101, P17940, DOI 10.1073/pnas.0406024101; WAGNER A, 1994, P NATL ACAD SCI USA, V91, P4387, DOI 10.1073/pnas.91.10.4387; Wagner A, 2001, MOL BIOL EVOL, V18, P1283, DOI 10.1093/oxfordjournals.molbev.a003913; Watson J, 2004, BIOSYSTEMS, V76, P239, DOI 10.1016/j.biosystems.2004.05.016; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhou S, 2004, IEEE COMMUN LETT, V8, P180, DOI 10.1109/LCOMM.2004.823426	48	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e501	10.1371/journal.pone.0000501	http://dx.doi.org/10.1371/journal.pone.0000501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551581	Green Submitted, Green Published, gold			2022-12-27	WOS:000207451500010
J	Bernardinelli, L; Murgia, SB; Bitti, PP; Foco, L; Ferrai, R; Musu, L; Prokopenko, I; Pastorino, R; Saddi, V; Ticca, A; Piras, ML; Cox, DR; Berzuini, C				Bernardinelli, Luisa; Murgia, Salvatore Bruno; Bitti, Pier Paolo; Foco, Luisa; Ferrai, Raffaela; Musu, Luigina; Prokopenko, Inga; Pastorino, Roberta; Saddi, Valeria; Ticca, Anna; Piras, Maria Luisa; Cox, David Roxbee; Berzuini, Carlo			Association between the ACCN1 Gene and Multiple Sclerosis in Central East Sardinia	PLOS ONE			English	Article							SENSING ION CHANNELS; LINKAGE DISEQUILIBRIUM; CATION CHANNEL; DEGENERIN MDEG; POPULATION; RISK; SUSCEPTIBILITY; GENOTYPE; SUBUNIT; BRAIN	Multiple genome screens have been performed to identify regions in linkage or association with Multiple Sclerosis (MS, OMIM 126200), but little overlap has been found among them. This may be, in part, due to a low statistical power to detect small genetic effects and to genetic heterogeneity within and among the studied populations. Motivated by these considerations, we studied a very special population, namely that of Nuoro, Sardinia, Italy. This is an isolated, old, and genetically homogeneous population with high prevalence of MS. Our study sample includes both nuclear families and unrelated cases and controls. A multi-stage study design was adopted. In the first stage, microsatellites were typed in the 17q11.2 region, previously independently found to be in linkage with MS. One significant association was found at microsatellite D17S798. Next, a bioinformatic screening of the region surrounding this marker highlighted an interesting candidate MS susceptibility gene: the Amiloride-sensitive Cation Channel Neuronal 1 (ACCN1) gene. In the second stage of the study, we resequenced the exons and the 39 untranslated (UTR) region of ACCN1, and investigated the MS association of Single Nucleotide Polymorphisms (SNPs) identified in that region. For this purpose, we developed a method of analysis where complete, phase-solved, posterior-weighted haplotype assignments are imputed for each study individual from incomplete, multi-locus, genotyping data. The imputed assignments provide an input to a number of proposed procedures for testing association at a microsatellite level or of a sequence of SNPs. These include a Mantel-Haenszel type test based on expected frequencies of pseudocase/pseudocontrol haplotypes, as well as permutation based tests, including a combination of permutation and weighted logistic regression analysis. Application of these methods allowed us to find a significant association between MS and the SNP rs28936 located in the 39 UTR segment of ACCN1 with p = 0.0004 (p = 0.002, after adjusting for multiple testing). This result is in tune with several recent experimental findings which suggest that ACCN1 may play an important role in the pathogenesis of MS.	[Bernardinelli, Luisa; Foco, Luisa; Prokopenko, Inga; Pastorino, Roberta] Univ Pavia, Dipartimento Sci Sanit Applicate & Psicocomportam, I-27100 Pavia, Italy; [Bernardinelli, Luisa; Berzuini, Carlo] Univ Forvie Site, Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England; [Murgia, Salvatore Bruno; Ferrai, Raffaela; Musu, Luigina; Saddi, Valeria; Ticca, Anna; Piras, Maria Luisa] ASL N 3 Nuoro, Presidio Osped S Francesco, Div Neurol, Nuoro, Italy; [Bitti, Pier Paolo] ASL N 3 Nuoro, Presidio Osped S Francesco, SIT, Ctr Tipizzaz Tissutale, Nuoro, Italy; [Cox, David Roxbee] Univ Oxford Nuffield Coll, Oxford OX1 1NF, England; [Cox, David Roxbee] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Berzuini, Carlo] Univ Pavia, Dipartimento Informat & Sistemist, I-27100 Pavia, Italy	University of Pavia; MRC Biostatistics Unit; University of Cambridge; University of Oxford; University of Oxford; University of Pavia	Bernardinelli, L (corresponding author), Univ Pavia, Dipartimento Sci Sanit Applicate & Psicocomportam, Via Palestro 3, I-27100 Pavia, Italy.	luisa.bernardinelli@mrc-bsu.cam.ac.uk	Bernardinelli, Luisa/AAL-5750-2021; Prokopenko, Inga/AAU-9895-2020; Prokopenko, Inga/H-3241-2014; Berzuini, Carlo/AAA-7023-2019; PASTORINO, Roberta/AAC-1866-2022	Prokopenko, Inga/0000-0003-1624-7457; Berzuini, Carlo/0000-0001-6056-0489; PASTORINO, Roberta/0000-0001-5013-0733	Fondazione Cariplo, Milano, Italy [1428/2004]; Azienda Sanitaria Locale Ndegrees3, Nuoro, Italy; MRC [MC_U105260799] Funding Source: UKRI; Medical Research Council [MC_U105260799] Funding Source: researchfish	Fondazione Cariplo, Milano, Italy(Fondazione Cariplo); Azienda Sanitaria Locale Ndegrees3, Nuoro, Italy; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant from the Fondazione Cariplo, Project Number 1428/2004, Milano, Italy, and by the Azienda Sanitaria Locale N degrees 3, Nuoro, Italy.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Biernacka JM, 2006, GENET EPIDEMIOL, V30, P582, DOI 10.1002/gepi.20167; Coraddu F, 1998, NEUROGENETICS, V2, P24, DOI 10.1007/s100480050048; Cordell HJ, 2006, GENET EPIDEMIOL, V30, P259, DOI 10.1002/gepi.20142; Deval E, 2004, J BIOL CHEM, V279, P19531, DOI 10.1074/jbc.M313078200; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; HOLM S, 1979, SCAND J STAT, V6, P65; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jagodic M, 2004, J IMMUNOL, V173, P1366, DOI 10.4049/jimmunol.173.2.1366; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Montomoli C, 2002, GENET EPIDEMIOL, V22, P265, DOI 10.1002/gepi.0173; Morahan G, 2001, NAT GENET, V27, P218, DOI 10.1038/84872; Pericak-Vance MA, 2001, MULT SCLER, V7, P3; Poser CM, 2001, CLIN NEUROL NEUROSUR, V103, P1, DOI 10.1016/S0303-8467(00)00125-6; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Prokopenko I, 2003, NEUROEPIDEMIOLOGY, V22, P290, DOI 10.1159/000071192; PUFFENBERGER EG, 1994, HUM MOL GENET, V3, P1217; Saarela J, 2006, PLOS GENET, V2, P364, DOI 10.1371/journal.pgen.0020042; Sawcer S, 2005, AM J HUM GENET, V77, P454; SELF SG, 1991, BIOMETRICS, V47, P53, DOI 10.2307/2532495; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Spielman RS, 1996, AM J HUM GENET, V59, P983; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 1996, GENOMICS, V37, P269, DOI 10.1006/geno.1996.0558; Waxman SG, 2001, NAT REV NEUROSCI, V2, P652, DOI 10.1038/35090026; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; WESTFALL PH, 1993, RESAMPLING BASED MUL, P320; Zavattari P, 2000, HUM MOL GENET, V9, P2947, DOI 10.1093/hmg/9.20.2947; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006; Zody MC, 2006, NATURE, V440, P1045, DOI 10.1038/nature04689	36	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2007	2	5							e480	10.1371/journal.pone.0000480	http://dx.doi.org/10.1371/journal.pone.0000480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10FB	17534430	gold, Green Published, Green Submitted			2022-12-27	WOS:000207448800010
J	Moll, K; Chene, A; Ribacke, U; Kaneko, O; Nilsson, S; Winter, G; Haeggstrom, M; Pan, WQ; Berzins, K; Wahlgren, M; Chen, Q				Moll, Kirsten; Chene, Arnaud; Ribacke, Ulf; Kaneko, Osamu; Nilsson, Sandra; Winter, Gerhard; Haeggstrom, Malin; Pan, Weiqing; Berzins, Klavs; Wahlgren, Mats; Chen, Qijun			A Novel DBL-Domain of the P. falciparum 332 Molecule Possibly Involved in Erythrocyte Adhesion	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODY; RED-BLOOD-CELLS; PLASMODIUM-FALCIPARUM; INFECTED ERYTHROCYTES; MALARIA PARASITES; PF332 GENE; HOST-CELL; IN-VITRO; INVASION; MEMBRANE	Plasmodium falciparum malaria is brought about by the asexual stages of the parasite residing in human red blood cells (RBC). Contact between the erythrocyte surface and the merozoite is the first step for successful invasion and proliferation of the parasite. A number of different pathways utilised by the parasite to adhere and invade the host RBC have been characterized, but the complete biology of this process remains elusive. We here report the identification of an open reading frame (ORF) representing a hitherto unknown second exon of the Pf332 gene that encodes a cysteine-rich polypeptide with a high degree of similarity to the Duffy-binding-like (DBL) domain of the erythrocyte-binding-ligand (EBL) family. The sequence of this DBL-domain is conserved and expressed in all parasite clones/strains investigated. In addition, the expression level of Pf332 correlates with proliferation efficiency of the parasites in vitro. Antibodies raised against the DBL-domain are able to reduce the invasion efficiency of different parasite clones/strains. Analysis of the DBL-domain revealed its ability to bind to uninfected human RBC, and moreover demonstrated association with the iRBC surface. Thus, Pf332 is a molecule with a potential role to support merozoite invasion. Due to the high level of conservation in sequence, the novel DBL-domain of Pf332 is of possible importance for development of novel anti-malaria drugs and vaccines.	[Moll, Kirsten; Chene, Arnaud; Ribacke, Ulf; Nilsson, Sandra; Winter, Gerhard; Haeggstrom, Malin; Wahlgren, Mats; Chen, Qijun] Karolinska Inst, Swedish Inst Infect Dis Control SMI, Dept Parasitol Mycol & Environm Microbiol PMV, Stockholm, Sweden; [Moll, Kirsten; Chene, Arnaud; Ribacke, Ulf; Nilsson, Sandra; Winter, Gerhard; Haeggstrom, Malin; Wahlgren, Mats; Chen, Qijun] Karolinska Inst, Dept Microbiol Tumour & Cell Biol MTC, Stockholm, Sweden; [Chene, Arnaud] Karolinska Inst, Ctr Infect Med, Stockholm, Sweden; [Kaneko, Osamu] Ehime Univ, Grad Sch Med, Dept Mol Parasitol, Matsuyama, Ehime 790, Japan; [Pan, Weiqing] Second Mil Med Univ, Dept Etiol Biol, Shanghai, Peoples R China; [Berzins, Klavs] Stockholm Univ, Wenner Gren Inst, Dept Immunol, S-10691 Stockholm, Sweden	Karolinska Institutet; Swedish Institute for Infectious Disease Control; Karolinska Institutet; Karolinska Institutet; Ehime University; Naval Medical University; Stockholm University	Chen, Q (corresponding author), Karolinska Inst, Swedish Inst Infect Dis Control SMI, Dept Parasitol Mycol & Environm Microbiol PMV, Stockholm, Sweden.	Qijun.Chen@smi.ki.se	Chene, Arnaud/O-4397-2017	Chene, Arnaud/0000-0002-6551-4382	European Malaria Consortium (BioMalPar); Swedish Research Council [348-2003-4845]; SIDA/SAREC [SWE2003-241]	European Malaria Consortium (BioMalPar); Swedish Research Council(Swedish Research CouncilEuropean Commission); SIDA/SAREC	This work was funded by grants from the European Malaria Consortium (BioMalPar), the Swedish Research Council (348-2003-4845), SIDA/SAREC (SWE2003-241).	AHLBORG N, 1991, MOL BIOCHEM PARASIT, V46, P89, DOI 10.1016/0166-6851(91)90202-H; ANDERS RF, 1986, PARASITE IMMUNOL, V8, P529, DOI 10.1111/j.1365-3024.1986.tb00867.x; Baum J, 2005, PLOS PATHOG, V1, P299, DOI 10.1371/journal.ppat.0010037; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Chen QJ, 2004, VACCINE, V22, P2701, DOI 10.1016/j.vaccine.2004.02.015; Chitnis CE, 2000, PARASITOL TODAY, V16, P411, DOI 10.1016/S0169-4758(00)01756-7; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Flick K, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-50; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; Glushakova S, 2005, CURR BIOL, V15, P1645, DOI 10.1016/j.cub.2005.07.067; Haeggstrom M, 2004, MOL BIOCHEM PARASIT, V133, P1, DOI 10.1016/j.molbiopara.2003.07.006; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; HINTERBERG K, 1994, EMBO J, V13, P4174, DOI 10.1002/j.1460-2075.1994.tb06735.x; HINTERBERG K, 1994, EXP PARASITOL, V79, P279, DOI 10.1006/expr.1994.1091; Howell DPG, 2006, MOL BIOCHEM PARASIT, V148, P1, DOI 10.1016/j.molbiopara.2006.03.004; Liang H, 1997, MOL BIOCHEM PARASIT, V84, P241, DOI 10.1016/S0166-6851(96)02791-0; Ljungstr?m I., 2004, METHODS MALARIA RES; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; MATTEI D, 1992, GENE, V110, P71, DOI 10.1016/0378-1119(92)90446-V; MATTEI D, 1992, MEM I OSWALDO CRUZ, V87, P163, DOI 10.1590/S0074-02761992000700026; MATTEI D, 1989, PARASITE IMMUNOL, V11, P15, DOI 10.1111/j.1365-3024.1989.tb00645.x; MERCEREAUPUIJAL.O, 1987, UCLA S MOL CELLULAR, V42, P343; MERCEREAUPUIJALON O, 1991, ACTA TROP, V49, P281, DOI 10.1016/0001-706X(91)90079-Y; O'Donnell RA, 2000, NAT MED, V6, P91, DOI 10.1038/71595; Pan WQ, 2004, J IMMUNOL, V172, P6167, DOI 10.4049/jimmunol.172.10.6167; Pasvol G, 2003, TRENDS PARASITOL, V19, P430, DOI 10.1016/j.pt.2003.08.005; PERKINS M, 1981, J CELL BIOL, V90, P563, DOI 10.1083/jcb.90.3.563; Pettersson F, 2005, INFECT IMMUN, V73, P7736, DOI 10.1128/IAI.73.11.7736-7746.2005; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; UDOMSANGPETCH R, 1989, J IMMUNOL, V142, P3620; UDOMSANGPETCH R, 1989, NATURE, V338, P763, DOI 10.1038/338763a0; UHLEMANN AC, 2000, MACS MORE, V4, P7; WAHLGREN M, 1989, PARASITOL TODAY, V5, P183, DOI 10.1016/0169-4758(89)90141-5; WAHLIN B, 1992, INFECT IMMUN, V60, P443; Winter G, 2005, J EXP MED, V201, P1853, DOI 10.1084/jem.20041392	39	26	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2007	2	5							e477	10.1371/journal.pone.0000477	http://dx.doi.org/10.1371/journal.pone.0000477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10FB	17534427	Green Published, Green Submitted, gold			2022-12-27	WOS:000207448800007
J	Lo, WS; Xu, ZW; Yu, ZL; Pun, FW; Ng, SK; Chen, JH; Tong, KL; Zhao, CY; Xu, XJ; Tsang, SY; Harano, M; Stober, G; Nimgaonkar, VL; Xue, H				Lo, Wing-Sze; Xu, Zhiwen; Yu, Zhiliang; Pun, Frank W.; Ng, Siu-Kin; Chen, Jianhuan; Tong, Ka-Lok; Zhao, Cunyou; Xu, Xiaojing; Tsang, Shui-Ying; Harano, Mutsuo; Stoeber, Gerald; Nimgaonkar, Vishwajit L.; Xue, Hong			Positive Selection within the Schizophrenia-Associated GABA(A) Receptor beta(2) Gene	PLOS ONE			English	Article							REGULATING BRAIN SIZE; NUCLEOTIDE SUBSTITUTIONS; GABRB2 ASSOCIATION; STATISTICAL-METHOD; MTDNA VARIATION; HOMO-SAPIENS; ALU REPEATS; EVOLUTION; POPULATION; SEQUENCE	The gamma-aminobutyric acid type-A (GABA(A)) receptor plays a major role in inhibitory neurotransmissions. Intronic SNPs and haplotypes in GABRB2, the gene for GABA(A) receptor beta(2) subunit, are associated with schizophrenia and correlated with the expression of two alternatively spliced beta(2) isoforms. In the present study, using chimpanzee as an ancestral reference, high frequencies were observed for the derived (D) alleles of the four SNPs rs6556547, rs187269, rs1816071 and rs1816072 in GABRB2, suggesting the occurrence of positive selection for these derived alleles. Coalescence-based simulation showed that the population frequency spectra and the frequencies of H56, the haplotype having all four D alleles, significantly deviated from neutral-evolution expectation in various demographic models. Haplotypes containing the derived allele of rs1816072 displayed significantly less diversity compared to haplotypes containing its ancestral allele, further supporting positive selection. The variations in DD-genotype frequencies in five human populations provided a snapshot of the evolutionary history, which suggested that the positive selections of the D alleles are recent and likely ongoing. The divergence between the DD-genotype profiles of schizophrenic and control samples pointed to the schizophrenia-relevance of positive selections, with the schizophrenic samples showing weakened selections compared to the controls. These DD-genotypes were previously found to increase the expression of beta(2), especially its long isoform. Electrophysiological analysis showed that this long beta(2) isoform favored by the positive selections is more sensitive than the short isoform to the inhibition of GABAA receptor function by energy depletion. These findings represent the first demonstration of positive selection in a schizophrenia-associated gene.	[Lo, Wing-Sze; Xu, Zhiwen; Pun, Frank W.; Chen, Jianhuan; Tong, Ka-Lok; Tsang, Shui-Ying; Xue, Hong] Hong Kong Univ Sci & Technol, Dept Biochem, Appl Genom Lab, Hong Kong, Hong Kong, Peoples R China; [Lo, Wing-Sze; Xu, Zhiwen; Pun, Frank W.; Chen, Jianhuan; Tong, Ka-Lok; Tsang, Shui-Ying; Xue, Hong] Hong Kong Univ Sci & Technol, HKH Bioinformat Ctr, Hong Kong, Hong Kong, Peoples R China; [Yu, Zhiliang] Hong Kong Univ Sci & Technol, Grad Program Atmospher Marine & Coastal Environm, Hong Kong, Hong Kong, Peoples R China; [Ng, Siu-Kin; Zhao, Cunyou; Xu, Xiaojing] Hong Kong Univ Sci & Technol, Grad Program Bioengn, Hong Kong, Hong Kong, Peoples R China; [Harano, Mutsuo] Kurume Univ, Sch Med, Dept Neuropsychiat, Fukuka, Japan; [Stoeber, Gerald] Univ Wurzburg, Dept Psychiat & Psychotherapy, Wurzburg, Germany; [Nimgaonkar, Vishwajit L.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Nimgaonkar, Vishwajit L.] Univ Pittsburgh, Dept Human Genet, Sch Med, Pittsburgh, PA USA; [Nimgaonkar, Vishwajit L.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Kurume University; University of Wurzburg; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xue, H (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Appl Genom Lab, Hong Kong, Hong Kong, Peoples R China.	hxue@ust.hk	Chen, Jian-Huan/L-7188-2017; Lo, Cario Wing Sze/DGZ-8810-2022; Chen, Jian-Huan/ABB-9660-2021; ZHAO, Cunyou/Q-5076-2016	Chen, Jian-Huan/0000-0001-8714-2543; Chen, Jian-Huan/0000-0001-8714-2543; ZHAO, Cunyou/0000-0001-6116-4584; Xue, Hong/0000-0002-8133-9828	Research Grants Council; Innovation and Technology Fund of Hong Kong	Research Grants Council(Hong Kong Research Grants Council); Innovation and Technology Fund of Hong Kong	We thank the Research Grants Council and the Innovation and Technology Fund of Hong Kong for financial support.	Abou Jamra R, 2007, PSYCHIAT GENET, V17, P43, DOI 10.1097/YPG.0b013e32801118cd; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Austin Jehannine, 2005, J Genet Couns, V14, P329, DOI 10.1007/s10897-005-1622-4; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bird CP, 2006, CURR OPIN GENET DEV, V16, P559, DOI 10.1016/j.gde.2006.10.003; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Chowdari KV, 2002, HUM MOL GENET, V11, P1373, DOI 10.1093/hmg/11.12.1373; Cohen MN, 1984, PALEOPATHOLOGY ORIGI, P585; Currat M, 2006, SCIENCE, V313, P172, DOI 10.1126/science.1122712; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Evans PD, 2005, SCIENCE, V309, P1717, DOI 10.1126/science.1113722; Fay JC, 2000, GENETICS, V155, P1405; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Forster P, 1996, AM J HUM GENET, V59, P935; FU YX, 1993, GENETICS, V133, P693; Garrigan D, 2006, NAT REV GENET, V7, P669, DOI 10.1038/nrg1941; GLEIBERMANN L., 1973, Ecology of Food and Nutrition, V2, P143, DOI 10.1080/03670244.1973.9990329; GOTTESMAN II, 1989, SCHIZOPHRENIA BULL, V15, P5, DOI 10.1093/schbul/15.1.5; Greenfield LJ, 2002, NEUROPHARMACOLOGY, V42, P502, DOI 10.1016/S0028-3908(01)00196-4; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Huang RQ, 1998, J PHARMACOL EXP THER, V286, P243; HUDSON RR, 1987, GENETICS, V116, P153; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Ikeda M, 2005, BIOL PSYCHIAT, V58, P440, DOI 10.1016/j.biopsych.2005.05.002; Kimura M., 1983, NEUTRAL THEORY MOL E; Korpi ER, 2006, PHARMACOL THERAPEUT, V109, P12, DOI 10.1016/j.pharmthera.2005.05.009; Leonhard K., 1999, CLASSIFICATION ENDOG, V2nd; Liu JX, 2005, BIOCHEM BIOPH RES CO, V334, P817, DOI 10.1016/j.bbrc.2005.06.167; Lo WS, 2007, BIOL PSYCHIAT, V61, P653, DOI 10.1016/j.biopsych.2006.05.003; Lo WS, 2004, MOL PSYCHIATR, V9, P603, DOI 10.1038/sj.mp.4001461; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Nakajima T, 2004, AM J HUM GENET, V74, P898, DOI 10.1086/420793; NEEL JV, 1962, AM J HUM GENET, V14, P353; NEI M, 1983, GENETICS, V105, P207; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Otto SP, 1997, GENETICS, V147, P879; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PARNAS J, 1988, PSYCHIATRY, V51, P58, DOI 10.1080/00332747.1988.11024380; Petryshen TL, 2005, MOL PSYCHIATR, V10, P1074, DOI 10.1038/sj.mp.4001739; Pike RL, 2006, AM J HUM BIOL, V18, P729, DOI 10.1002/ajhb.20548; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozen S, 2000, Methods Mol Biol, V132, P365; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Salem AH, 2003, MOL BIOL EVOL, V20, P1349, DOI 10.1093/molbev/msg150; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Sapolsky RM, 2004, PLOS BIOL, V2, P534, DOI 10.1371/journal.pbio.0020106; Smit A.F.A, 1996, REPEATMASKER OPEN 3; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Vander Molen J, 2005, AM J HUM GENET, V76, P548, DOI 10.1086/428784; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Yu ZL, 2006, CLIN BIOCHEM, V39, P210, DOI 10.1016/j.clinbiochem.2006.01.009; Zhao C, 2006, MOL PSYCHIATR, V11, P1092, DOI 10.1038/sj.mp.4001899	70	31	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2007	2	5							e462	10.1371/journal.pone.0000462	http://dx.doi.org/10.1371/journal.pone.0000462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DZ	17520021	Green Published, gold, Green Accepted			2022-12-27	WOS:000207446000010
J	Zayed, A; Constantin, SA; Packer, L				Zayed, Amro; Constantin, Serban A.; Packer, Laurence			Successful Biological Invasion despite a Severe Genetic Load	PLOS ONE			English	Article							POPULATION BIOLOGY; SEX DETERMINATION; GEOGRAPHIC DISTANCE; PROPAGULE PRESSURE; COLONY STRUCTURE; ARGENTINE ANTS; FIRE ANT; HYMENOPTERA; BEE; EVOLUTION	Understanding the factors that influence the success of ecologically and economically damaging biological invasions is of prime importance. Recent studies have shown that invasive populations typically exhibit minimal, if any, reductions in genetic diversity, suggesting that large founding populations and/or multiple introductions are required for the success of biological invasions, consistent with predictions of the propagule pressure hypothesis. Through population genetic analysis of neutral microsatellite markers and a gene experiencing balancing selection, we demonstrate that the solitary bee Lasioglossum leucozonium experienced a single and severe bottleneck during its introduction from Europe. Paradoxically, the success of L. leucozonium in its introduced range occurred despite the severe genetic load caused by single-locus complementary sex-determination that still turns 30% of female-destined eggs into sterile diploid males, thereby substantially limiting the growth potential of the introduced population. Using stochastic modeling, we show that L. leucozonium invaded North America through the introduction of a very small number of propagules, most likely a singly-mated female. Our results suggest that chance events and ecological traits of invaders are more important than propagule pressure in determining invasion success, and that the vigilance required to prevent invasions may be considerably greater than has been previously considered.	[Zayed, Amro; Constantin, Serban A.; Packer, Laurence] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	York University - Canada	Zayed, A (corresponding author), Univ Illinois, Dept Entomol, 320 Morrill Hall, Urbana, IL 61801 USA.	azayed@life.uiuc.edu	Zayed, Amro/G-6405-2011	Zayed, Amro/0000-0003-3233-4585; packer, laurence/0000-0002-1711-8203	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Graduate Scholarship (CGS); Ontario Genomics Institute; NSERC	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Graduate Scholarship (CGS)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Genomics Institute; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The study was funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) grant to LP and a Canada Graduate Scholarship (CGS) to AZ. Support for sequencing was obtained through funding to the Canadian Barcode of Life Network from Genome Canada through the Ontario Genomics Institute, NSERC, and other sponsors listed at www.BOLNET.ca. The funding sources played no role in the design, analysis, and interpretation of the data or in the preparation of the manuscript.	Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; ATWOOD C. E., 1933, CANADIAN JOUR RES, V9, P443; Beveridge M, 2006, MOL ECOL, V15, P951, DOI 10.1111/j.1365-294X.2006.02846.x; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; Brohede J, 1999, P ROY SOC B-BIOL SCI, V266, P825, DOI 10.1098/rspb.1999.0712; Buczkowski G, 2004, MOL ECOL, V13, P2235, DOI 10.1111/j.1365-294X.2004.02261.x; CANC JH, 2003, NONNATIVE CROPS WHEN, P113; Clausen C.P., 1978, INTRO PARASITES PRED; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; Cornuet JM, 1996, GENETICS, V144, P2001; Crawley M.J., 1989, BIOL INVASIONS GLOBA, P407; Danforth BN, 1999, SYST ENTOMOL, V24, P377, DOI 10.1046/j.1365-3113.1999.00087.x; Danforth BN, 2003, J KANSAS ENTOMOL SOC, V76, P221; EICKWORT GC, 1980, ANNU REV ENTOMOL, V25, P421, DOI 10.1146/annurev.en.25.010180.002225; Frankham R, 2005, HEREDITY, V94, P385, DOI 10.1038/sj.hdy.6800634; Giles V, 2006, J HYMENOPT RES, V15, P208; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; Goodisman MAD, 2001, MOL ECOL, V10, P1423, DOI 10.1046/j.1365-294X.2001.01291.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grevstad Fritzi S., 1999, Biological Invasions, V1, P313, DOI 10.1023/A:1010037912369; Grixti JC, 2006, CAN ENTOMOL, V138, P147; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedrick PW, 2006, TRENDS ECOL EVOL, V21, P55, DOI 10.1016/j.tree.2005.11.014; Henshaw MT, 2005, AUST J ENTOMOL, V44, P37, DOI 10.1111/j.1440-6055.2005.00421.x; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Johnson RN, 2004, ANN ENTOMOL SOC AM, V97, P732, DOI 10.1603/0013-8746(2004)097[0732:ASLOGD]2.0.CO;2; KNERER G, 1969, Entomological News, V80, P141; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; LINDROTH CH, 1957, FAUNAL CONNECTIONS E, P135; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; MCGINLEY RJ, 1986, SMITHSONIAN CONTRIBU, V429, P1, DOI DOI 10.5479/SI.00810282.429; Memmott J, 2005, J ANIM ECOL, V74, P50, DOI 10.1111/j.1365-2656.2004.00896.x; Neumann K, 2006, APIDOLOGIE, V37, P75, DOI 10.1051/apido:2005060; OWEN RE, 1994, HEREDITY, V72, P219, DOI 10.1038/hdy.1994.31; Packer L, 2001, CONSERV ECOL, V5; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROSS KG, 1993, GENETICS, V135, P843; Schierup MH, 2000, GENET RES, V76, P51, DOI 10.1017/S0016672300004535; SIMBERLOFF D, 1989, BIOL INVASIONS, P00061; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Suarez AV, 2005, P NATL ACAD SCI USA, V102, P17032, DOI 10.1073/pnas.0506119102; Tsutsui ND, 2003, CONSERV BIOL, V17, P48, DOI 10.1046/j.1523-1739.2003.02018.x; Tsutsui ND, 2003, P NATL ACAD SCI USA, V100, P1078, DOI 10.1073/pnas.0234412100; Tsutsui ND, 2001, EVOLUTION, V55, P976, DOI 10.1554/0014-3820(2001)055[0976:PGACSO]2.0.CO;2; VANWILGENBURG E, 2006, FRONT ZOOL, V3; Wares JP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P229; YOKOYAMA S, 1979, GENETICS, V91, P609; Zar J.H., 2010, BIOSTAT ANAL; Zayed A, 2007, HEREDITY, V99, P397, DOI 10.1038/sj.hdy.6801013; Zayed A, 2005, CONSERV GENET, V6, P1017, DOI 10.1007/s10592-005-9094-5; Zayed A, 2005, P NATL ACAD SCI USA, V102, P10742, DOI 10.1073/pnas.0502271102; Zayed A, 2004, HEREDITY, V93, P627, DOI 10.1038/sj.hdy.6800588; Zayed A, 2006, MOL ECOL NOTES, V6, P1154, DOI 10.1111/j.1471-8286.2006.01469.x	61	81	83	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e868	10.1371/journal.pone.0000868	http://dx.doi.org/10.1371/journal.pone.0000868			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848999	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455600015
J	Mizrahi, S; Markel, G; Porgador, A; Bushkin, Y; Mandelboim, O				Mizrahi, Sa'ar; Markel, Gal; Porgador, Angel; Bushkin, Yuri; Mandelboim, Ofer			CD100 on NK Cells Enhance IFN gamma Secretion and Killing of Target Cells Expressing CD72	PLOS ONE			English	Article								Background. NK cells are able to kill tumor and virus-infected cells without the need of prior antigen stimulation. The killing of these target cells is regulated by inhibitory, lysis and co-stimulatory receptors that are expressed on the surface of NK cells. Principal Findings. CD100 (Semaphorin 4D), a 150kD transmembrane protein, is expressed on the surface of activated NK cells as a homodimer, mediates the killing of target cells by binding to CD72. CD100 is not involved directly in the killing process but is rather increases NK cytotoxicity by enhancing the adhesion between NK cells and their targets. This increased adhesion leads to a more efficient killing and enhanced IFN gamma secretion. Significance. Since CD72 is expressed on antigen presenting cells (APC) and the CD100-CD72 interaction lead to the shading of CD100, we suggest that NK interacting with APC cells could be the early source of soluble CD100 which is crucial for the formation of antigen specific immune response. CD100-CD72 interaction can be the mechanism by which NK cell communicate with B cells.	[Mizrahi, Sa'ar; Markel, Gal; Mandelboim, Ofer] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, Jerusalem, Israel; [Porgador, Angel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol & Immunol, Canc Res Ctr, IL-84105 Beer Sheva, Israel; [Bushkin, Yuri] NJMS UMDNJ, Publ Hlth Res Inst, Newark, NJ USA	Hebrew University of Jerusalem; Ben Gurion University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Mandelboim, O (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, Jerusalem, Israel.	oferm@ekmd.huji.ac.il		Mandelboim, Ofer/0000-0002-9354-1855; Porgador, Angel/0000-0003-1540-4449	US-Israel Bi-national Science Foundation; The Israeli Cancer Research Foundation; Israel Science Foundation; AICR; European consortium [MRTN-CT-2005, LSCH-CT-2005-518178]; NIH [AI 045761]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045761] Funding Source: NIH RePORTER	US-Israel Bi-national Science Foundation(US-Israel Binational Science Foundation); The Israeli Cancer Research Foundation; Israel Science Foundation(Israel Science Foundation); AICR; European consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the US-Israel Bi-national Science Foundation, by a grant from The Israeli Cancer Research Foundation, by a grant from the Israel Science Foundation, by a grant from the AICR, by grants from the European consortium MRTN-CT-2005 and LSCH-CT-2005-518178, and by NIH AI 045761 for Yuri Bushkin.	Arnold D, 2001, COMMUN ACM, V44, P30, DOI 10.1145/379300.379306; Basile JR, 2006, P NATL ACAD SCI USA, V103, P9017, DOI 10.1073/pnas.0508825103; Billard C, 2000, BLOOD, V95, P965, DOI 10.1182/blood.V95.3.965.003k39_965_972; BISMUTH G, 2002, SCI STKE, pRE4; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BOUGERET C, 1992, J IMMUNOL, V148, P318; Braud VM, 1999, CURR TOP MICROBIOL, V244, P85; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Chabbert-de Ponnat I, 2005, INT IMMUNOL, V17, P439, DOI 10.1093/intimm/dxh224; Colonna M, 1999, J LEUKOCYTE BIOL, V66, P375, DOI 10.1002/jlb.66.3.375; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; DANDREA A, 1995, J IMMUNOL, V155, P2306; Delaire S, 1998, CELL MOL LIFE SCI, V54, P1265, DOI 10.1007/s000180050252; Delaire S, 2001, J IMMUNOL, V166, P4348, DOI 10.4049/jimmunol.166.7.4348; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Elhabazi A, 2001, J IMMUNOL, V166, P4341, DOI 10.4049/jimmunol.166.7.4341; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; GARAND R, 1994, LEUKEMIA RES, V18, P651, DOI 10.1016/0145-2126(94)90050-7; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; Hanna J, 2004, J IMMUNOL, V173, P6547, DOI 10.4049/jimmunol.173.11.6547; HAUSER WE, 1982, CELL IMMUNOL, V69, P330, DOI 10.1016/0008-8749(82)90076-4; Herold C, 1996, J IMMUNOL, V157, P5262; Ishida I, 2003, INT IMMUNOL, V15, P1027, DOI 10.1093/intimm/dxg098; Kikutani H, 2003, NAT REV IMMUNOL, V3, P159, DOI 10.1038/nri1003; Kumanogoh A, 2005, INT IMMUNOL, V17, P1277, DOI 10.1093/intimm/dxh307; Kumanogoh A, 2003, J CELL SCI, V116, P3463, DOI 10.1242/jcs.00674; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; Kumanogoh A, 2001, TRENDS IMMUNOL, V22, P670, DOI 10.1016/S1471-4906(01)02087-7; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Li M, 2006, J IMMUNOL, V177, P3406, DOI 10.4049/jimmunol.177.5.3406; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Mandelboim O, 1999, P NATL ACAD SCI USA, V96, P5640, DOI 10.1073/pnas.96.10.5640; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; MYERS DE, 1995, LEUKEMIA LYMPHOMA, V18, P119, DOI 10.3109/10428199509064931; PESANDO JM, 1990, HUM IMMUNOL, V27, P193, DOI 10.1016/0198-8859(90)90050-Y; ROBERTSON MJ, 1992, J EXP MED, V175, P779, DOI 10.1084/jem.175.3.779; SCHWARTING R, 1992, AM J HEMATOL, V41, P151, DOI 10.1002/ajh.2830410303; SHAH PD, 1985, J EXP MED, V162, P625, DOI 10.1084/jem.162.2.625; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1; Wang XS, 2001, BLOOD, V97, P3498, DOI 10.1182/blood.V97.11.3498; Watanabe C, 2001, J IMMUNOL, V167, P4321, DOI 10.4049/jimmunol.167.8.4321	51	21	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e818	10.1371/journal.pone.0000818	http://dx.doi.org/10.1371/journal.pone.0000818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786190	Green Published, gold			2022-12-27	WOS:000207455500002
J	Burki, F; Shalchian-Tabrizi, K; Minge, M; Skjaeveland, A; Nikolaev, SI; Jakobsen, KS; Pawlowski, J				Burki, Fabien; Shalchian-Tabrizi, Kamran; Minge, Marianne; Skjaeveland, Asmund; Nikolaev, Sergey I.; Jakobsen, Kjetill S.; Pawlowski, Jan			Phylogenomics Reshuffles the Eukaryotic Supergroups	PLOS ONE			English	Article							COMMON ORIGIN; MISSING DATA; SEQUENCES; CERCOZOA; GENE; TREE; CLASSIFICATION; DINOFLAGELLATE; DIVERSITY; SELECTION	Background. Resolving the phylogenetic relationships between eukaryotes is an ongoing challenge of evolutionary biology. In recent years, the accumulation of molecular data led to a new evolutionary understanding, in which all eukaryotic diversity has been classified into five or six supergroups. Yet, the composition of these large assemblages and their relationships remain controversial. Methodology/Principle Findings. Here, we report the sequencing of expressed sequence tags (ESTs) for two species belonging to the supergroup Rhizaria and present the analysis of a unique dataset combining 29908 amino acid positions and an extensive taxa sampling made of 49 mainly unicellular species representative of all supergroups. Our results show a very robust relationship between Rhizaria and two main clades of the supergroup chromalveolates: stramenopiles and alveolates. We confirm the existence of consistent affinities between assemblages that were thought to belong to different supergroups of eukaryotes, thus not sharing a close evolutionary history. Conclusions. This well supported phylogeny has important consequences for our understanding of the evolutionary history of eukaryotes. In particular, it questions a single red algal origin of the chlorophyll-c containing plastids among the chromalveolates. We propose the abbreviated name 'SAR' (Stramenopiles+Alveolates+Rhizaria) to accommodate this new super assemblage of eukaryotes, which comprises the largest diversity of unicellular eukaryotes.	[Burki, Fabien; Pawlowski, Jan] Univ Geneva, Dept Zool & Anim Biol, Geneva, Switzerland; [Nikolaev, Sergey I.] Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland; [Shalchian-Tabrizi, Kamran; Minge, Marianne; Skjaeveland, Asmund; Jakobsen, Kjetill S.] Univ Oslo, Dept Biol, Oslo, Norway	University of Geneva; University of Geneva; University of Oslo	Burki, F (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Geneva, Switzerland.	Fabien.Burki@zoo.unige.ch	Nikolaev, Sergey/F-3148-2012; Burki, Fabien/F-4818-2010	Skjaeveland, Asmund Steen/0000-0002-2375-381X	Swiss National Science Foundation [3100A0-100415, 3100A0-112645]; Norwegian Research Council [118894/431]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Norwegian Research Council(Research Council of NorwayEuropean Commission)	This research was supported by the Swiss National Science Foundation grant 3100A0-100415 and 3100A0-112645 ( JP); and by research grant ( grant no 118894/431) from the Norwegian Research Council ( KSJ).	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Bachvaroff TR, 2005, MOL BIOL EVOL, V22, P1772, DOI 10.1093/molbev/msi172; BHATTACHARYA D, 1995, J EUKARYOT MICROBIOL, V42, P65, DOI 10.1111/j.1550-7408.1995.tb01541.x; Bodyl A, 2005, J PHYCOL, V41, P712, DOI 10.1111/j.1529-8817.2005.00091.x; Burki F, 2002, PROTIST, V153, P251, DOI 10.1078/1434-4610-00102; Burki F, 2006, GENOME, V49, P882, DOI 10.1139/G06-048; Burki F, 2006, MOL BIOL EVOL, V23, P1922, DOI 10.1093/molbev/msl055; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Cavalier-Smith T, 2003, PROTIST, V154, P341, DOI 10.1078/143446103322454112; CAVALIERSMITH T, 2004, ORGANELLES GENOMES E, P32; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; HACKETT JD, 2007, MOL BIOL EVOL, pSM89; Harper JT, 2005, INT J SYST EVOL MICR, V55, P487, DOI 10.1099/ijs.0.63216-0; Harper JT, 2003, MOL BIOL EVOL, V20, P1730, DOI 10.1093/molbev/msg195; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Keeling PJ, 2004, AM J BOT, V91, P1481, DOI 10.3732/ajb.91.10.1481; Keeling PJ, 2001, P NATL ACAD SCI USA, V98, P10745, DOI 10.1073/pnas.191337098; Keeling PJ, 2001, MOL BIOL EVOL, V18, P1551, DOI 10.1093/oxfordjournals.molbev.a003941; Li SL, 2006, MOL BIOL EVOL, V23, P663, DOI 10.1093/molbev/msj075; Longet D, 2003, INT J SYST EVOL MICR, V53, P1735, DOI 10.1099/ijs.0.02597-0; McMahon MM, 2006, SYST BIOL, V55, P818, DOI 10.1080/10635150600999150; Nikolaev SI, 2004, P NATL ACAD SCI USA, V101, P8066, DOI 10.1073/pnas.0308602101; Nikolaev SI, 2003, ACTA PROTOZOOL, V42, P183; NOZAKI H, 2007, MOL BIOL EVOL; Parfrey LW, 2006, PLOS GENET, V2, P2062, DOI 10.1371/journal.pgen.0020220; Patron NJ, 2007, CURR BIOL, V17, P887, DOI 10.1016/j.cub.2007.03.069; Patron NJ, 2004, EUKARYOT CELL, V3, P1169, DOI 10.1128/EC.3.5.1169-1175.2004; Patterson DJ, 1999, AM NAT, V154, pS96, DOI 10.1086/303287; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Polet S, 2004, PROTIST, V155, P53, DOI 10.1078/1434461000164; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Robinson-Rechavi M, 2000, BIOINFORMATICS, V16, P296, DOI 10.1093/bioinformatics/16.3.296; Rodriguez-Ezpeleta N, 2005, CURR BIOL, V15, P1325, DOI 10.1016/j.cub.2005.06.040; Rogers MB, 2007, MOL BIOL EVOL, V24, P54, DOI 10.1093/molbev/msl129; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roure B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S2; Shalchian-Tabrizi K, 2006, P ROY SOC B-BIOL SCI, V273, P1833, DOI 10.1098/rspb.2006.3515; Shalchian-Tabrizi K, 2007, PROTIST, V158, P173, DOI 10.1016/j.protis.2006.10.003; Shalchian-Tabrizi K, 2006, MOL BIOL EVOL, V23, P1504, DOI 10.1093/molbev/msl011; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Wiens JJ, 2005, SYST BIOL, V54, P731, DOI 10.1080/10635150500234583	50	279	289	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e790	10.1371/journal.pone.0000790	http://dx.doi.org/10.1371/journal.pone.0000790			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726520	gold, Green Submitted, Green Published			2022-12-27	WOS:000207455400007
J	Michael, TP; Park, S; Kim, TS; Booth, J; Byer, A; Sun, Q; Chory, J; Lee, K				Michael, Todd P.; Park, Sohyun; Kim, Tae-Sung; Booth, Jim; Byer, Amanda; Sun, Qi; Chory, Joanne; Lee, Kwangwon			Simple Sequence Repeats Provide a Substrate for Phenotypic Variation in the Neurospora crassa Circadian Clock	PLOS ONE			English	Article							BLUE-LIGHT PHOTORECEPTOR; WHITE COLLAR-1; AERIAL DISPERSAL; GENETIC-ANALYSIS; TRANSCRIPTION; ENTRAINMENT; BINDING; CONIDIATION; ARABIDOPSIS; MECHANISMS	Background. WHITE COLLAR-1 (WC-1) mediates interactions between the circadian clock and the environment by acting as both a core clock component and as a blue light photoreceptor in Neurospora crassa. Loss of the amino-terminal polyglutamine (NpolyQ) domain in WC-1 results in an arrhythmic circadian clock; this data is consistent with this simple sequence repeat (SSR) being essential for clock function. Methodology/Principal Findings. Since SSRs are often polymorphic in length across natural populations, we reasoned that investigating natural variation of the WC-1 NpolyQ may provide insight into its role in the circadian clock. We observed significant phenotypic variation in the period, phase and temperature compensation of circadian regulated asexual conidiation across 143 N. crassa accessions. In addition to the NpolyQ, we identified two other simple sequence repeats in WC-1. The sizes of all three WC-1 SSRs correlated with polymorphisms in other clock genes, latitude and circadian period length. Furthermore, in a cross between two N. crassa accessions, the WC-1 NpolyQ co-segregated with period length. Conclusions/Significance. Natural variation of the WC-1 NpolyQ suggests a mechanism by which period length can be varied and selected for by the local environment that does not deleteriously affect WC-1 activity. Understanding natural variation in the N. crassa circadian clock will facilitate an understanding of how fungi exploit their environments.	[Michael, Todd P.; Park, Sohyun; Kim, Tae-Sung; Lee, Kwangwon] Cornell Univ, Dept Plant Pathol, Ithaca, NY 14853 USA; [Michael, Todd P.; Byer, Amanda; Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA USA; [Booth, Jim] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Sun, Qi] Cornell Univ, Cornell Theory Ctr, Ithaca, NY USA; [Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Cornell University; Salk Institute; Cornell University; Cornell University; Howard Hughes Medical Institute; Salk Institute	Lee, K (corresponding author), Cornell Univ, Dept Plant Pathol, Ithaca, NY 14853 USA.	kl272@cornell.edu	Lee, Kwangwon/AAC-8060-2021	Lee, Kwangwon/0000-0001-8225-4220; Michael, Todd/0000-0001-6272-2875	NIH [5 F32 GM068381, R01GM062932, R01GM052413]; College of Agriculture and Life Science, Cornell University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062932, R01GM052413, F32GM068381] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Agriculture and Life Science, Cornell University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	TPM is supported by a NIH fellowship 5 F32 GM068381 and NIH grant R01GM062932 to JC. AB is supported by NIH grant R01GM052413 to JC. JC is an investigator of the Howard Hughes Medical Institute. KL is supported by the College of Agriculture and Life Science, Cornell University.	AYLOR DE, 1982, P NATL ACAD SCI USA, V79, P697, DOI 10.1073/pnas.79.2.697; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; Bhat A, 2003, GENETICS, V164, P947; Borstnik B, 2002, GENOME RES, V12, P909, DOI 10.1101/gr.138802; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Brown SA, 2005, PLOS BIOL, V3, P1813, DOI 10.1371/journal.pbio.0030338; Cheng P, 2003, J BIOL CHEM, V278, P3801, DOI 10.1074/jbc.M209592200; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Davis R.H., 2000, NEUROSPORA CONTRIBUT; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dunlap JC, 2006, J BIOL CHEM, V281, P28489, DOI 10.1074/jbc.R600018200; Dunlap JC, 2004, J BIOL RHYTHM, V19, P414, DOI 10.1177/0748730404269116; Edwards KD, 2005, GENETICS, V170, P387, DOI 10.1534/genetics.104.035238; Elvin M, 2005, GENE DEV, V19, P2593, DOI 10.1101/gad.349305; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Hotta CT, 2007, PLANT CELL ENVIRON, V30, P333, DOI 10.1111/j.1365-3040.2006.01627.x; Jacobson DJ, 2006, MYCOLOGIA, V98, P550, DOI 10.3852/mycologia.98.4.550; Jacobson DJ, 2004, MYCOLOGIA, V96, P66, DOI 10.2307/3761989; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kaldi K, 2006, EMBO REP, V7, P199, DOI 10.1038/sj.embor.7400595; Karaoglu H, 2005, MOL BIOL EVOL, V22, P639, DOI [10.1093/molbev/mis057, 10.1093/molbev/msi057]; KIM C K, 1990, Annals of the Phytopathological Society of Japan, V56, P315, DOI 10.3186/jjphytopath.56.315; Kurosawa G, 2006, J THEOR BIOL, V242, P478, DOI 10.1016/j.jtbi.2006.03.016; Lakin-Thomas PL, 2004, ANNU REV MICROBIOL, V58, P489, DOI 10.1146/annurev.micro.58.030603.123744; Lee K, 2003, GENETICS, V163, P103; Lee K, 2004, FUNGAL GENETICS NEWS, V51, P12; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Liu Y, 2003, J BIOL RHYTHM, V18, P195, DOI 10.1177/0748730403018003002; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; Merrow M, 2006, CHRONOBIOL INT, V23, P71, DOI 10.1080/07420520500545888; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Nadkarni NA, 2005, J BIOL RHYTHM, V20, P490, DOI 10.1177/0748730405281332; Oke T.R., 1987, BOUNDARY LAYER CLIMA, DOI DOI 10.4324/9780203407219; PITTENDRIGH CS, 1989, J BIOL RHYTHM, V4, P217; Pregueiro AM, 2006, SCIENCE, V313, P644, DOI 10.1126/science.1121716; Roenneberg T, 2000, METHOD ENZYMOL, V305, P104; Rozen S, 1998, PRIMER3; Ruoff P., 2000, COMMENTS THEOR BIOL, V5, P361; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; SARGENT ML, 1972, PLANT PHYSIOL, V50, P171, DOI 10.1104/pp.50.1.171; Sawyer LA, 1997, SCIENCE, V278, P2117, DOI 10.1126/science.278.5346.2117; Schmale DG, 2006, CAN J PLANT PATHOL, V28, P100, DOI 10.1080/07060660609507276; SPRINGER ML, 1993, BIOESSAYS, V15, P365, DOI 10.1002/bies.950150602; SPRINGER ML, 1989, GENE DEV, V3, P559, DOI 10.1101/gad.3.4.559; TAJIMA F, 1989, GENETICS, V123, P585; Terashima K, 2005, GENETICS, V171, P101, DOI 10.1534/genetics.104.040048; Toyota K, 2002, MOL GENET GENOMICS, V268, P56, DOI 10.1007/s00438-002-0722-1; Turner BC, 2001, FUNGAL GENET BIOL, V32, P67, DOI 10.1006/fgbi.2001.1247; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	54	52	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e795	10.1371/journal.pone.0000795	http://dx.doi.org/10.1371/journal.pone.0000795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726525	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455400012
J	Clark, JL; Caceres, CF; Lescano, AG; Konda, KA; Leon, SR; Jones, FR; Kegeles, SM; Klausner, JD; Coates, TJ				Clark, Jesse L.; Caceres, Carlos F.; Lescano, Andres G.; Konda, Kelika A.; Leon, Segundo R.; Jones, Franca R.; Kegeles, Susan M.; Klausner, Jeffrey D.; Coates, Thomas J.		NIMH STD HIV Collaborative Prevent	Prevalence of Same-Sex Sexual Behavior and Associated Characteristics among Low-Income Urban Males in Peru	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RISK-FACTORS; TYPE-2 INFECTION; LATIN-AMERICA; HIV-INFECTION; MEN; GAY; EPIDEMIOLOGY; TRANSMISSION; POPULATIONS	Background. Peru has a concentrated HIV epidemic in which men who have sex with men are particularly vulnerable. We describe the lifetime prevalence of same-sex sexual contact and associated risk behaviors of men in Peru's general population, regardless of their sexual identity. Methods and Results. A probability sample of males from low-income households in three Peruvian cities completed an epidemiologic survey addressing their sexual risk behavior, including sex with other men. Serum was tested for HSV-2, HIV, and syphilis. Urine was tested for chlamydia and gonorrhea. A total of 2,271 18-30 year old men and women were contacted, of whom 1,645 (72.4%) agreed to participate in the study. Among the sexually experienced men surveyed, 15.2% (85/558, 95% CI: 12.2%-18.2%) reported a history of sex with other men. Men ever reporting sex with men (MESM) had a lower educational level, had greater numbers of sex partners, and were more likely to engage in risk behaviors including unprotected sex with casual partners, paying for or providing compensated sex, and using illegal drugs. MESM were also more likely to have had previous STI symptoms or a prior STI diagnosis, and had a greater prevalence of HSV-2 seropositivity. Conclusions. Many low-income Peruvian men have engaged in same-sex sexual contact and maintain greater behavioral and biological risk factors for HIV/STI transmission than non-MESM. Improved surveillance strategies for HIV and STIs among MESM are necessary to better understand the epidemiology of HIV in Latin America and to prevent its further spread.	[Clark, Jesse L.; Konda, Kelika A.; Coates, Thomas J.] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Caceres, Carlos F.; Leon, Segundo R.] Univ Peruana Cayetano Heredia, Unidad Salud Sexualidad & Desarrollo Humano, Lima, Peru; [Lescano, Andres G.] USN, Med Ctr Res Detachment, Lima, Peru; [Jones, Franca R.] USN, Med Res Ctr, Biol Def Res Directorate, Silver Spring, MD USA; [Kegeles, Susan M.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Klausner, Jeffrey D.] San Francisco Dept Publ Hlth, San Francisco, CA USA; [NIMH STD HIV Collaborative Prevent] NIMH, Multisite Int Grp, Bethesda, MD 20892 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universidad Peruana Cayetano Heredia; United States Department of Defense; United States Navy; University of California System; University of California San Francisco; San Francisco Department of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Clark, JL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA.	jlclark@mednet.ucla.edu	Lescano, Andres G./M-9849-2019; Leon, Segundo Ramos/J-3058-2019; Oliveira, Claudia DL/G-8618-2011; Lescano, Andres G/B-8479-2008	Lescano, Andres G./0000-0001-9779-633X; Leon, Segundo Ramos/0000-0002-5630-5714; Lescano, Andres G/0000-0001-9779-633X; Clark, Jesse/0000-0001-5862-6530; Caceres, Carlos F./0000-0002-8101-0790	NIH/NIMH [U10 MH61536]; LP-CRADA [NM-04-1787]; FOGARTY INTERNATIONAL CENTER [D43TW007393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U10MH061536] Funding Source: NIH RePORTER	NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); LP-CRADA; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by NIH/NIMH grant number U10 MH61536 which is a five-country Cooperative Agreement being conducted in China, India, Peru, Russia, and Zimbabwe. Each site has selected a different venue and population with which to implement the prevention program entitled Community Public Opinion Leader (C-POL) Intervention. This article is based on a pre-baseline study conducted in all the sites to prepare for initiation of the intervention. This study was partially supported by LP-CRADA NM-04-1787. The supporting institutions supervised design and execution of the study, including data collection, and approved the final version of the manuscript.	Agronick G, 2004, AIDS BEHAV, V8, P185, DOI 10.1023/B:AIBE.0000030249.11679.d0; Almaguer T, 1991, DIFFERENCES, V3, P75; Bautista CT, 2004, SEX TRANSM INFECT, V80, P498, DOI 10.1136/sti.2004.013094; BEYRER C, 1995, AIDS, V9, P171, DOI 10.1097/00002030-199509020-00009; Caceres C, 2006, SEX TRANSM INFECT, V82, pIII3, DOI 10.1136/sti.2005.019489; CACERES C, 2004, NEEDS ARE IDENTIFYIN; Caceres C F, 1999, Cult Health Sex, V1, P261, DOI 10.1080/136910599301012; Caceres CF, 2003, INT J EPIDEMIOL, V32, P740, DOI 10.1093/ije/dyg214; Caceres CF, 2002, AIDS, V16, pS23, DOI 10.1097/00002030-200212003-00005; CACERES CF, 1999, RECONFIGURACION UNIV; Carballo-Dieguez A., 1994, J PSYCHOL HUMAN SEXU, V6, P41; CARBALLODIEGUEZ A, 2000, J PSYCHOL HUMAN SEXU, V12, P49; CARCAMO C, 2003, SEXUALLY TRANSMITTED; Catania JA, 2001, AM J PUBLIC HEALTH, V91, P907, DOI 10.2105/AJPH.91.6.907; Chng CL, 2000, AIDS EDUC PREV, V12, P326; *COM EC AM LAT CAR, 1993, CENS POBL VIV 1993; Dodds JP, 2006, SEX TRANSM INFECT, V82, P86, DOI 10.1136/sti.2005.015248; Dûíaz RM., 1998, LATINO GAY MEN HIV C; Finlinson HA, 2006, AIDS BEHAV, V10, P531, DOI 10.1007/s10461-006-9107-5; Goodreau SM, 2005, J INFECT DIS, V191, pS147, DOI 10.1086/425268; Gutierrez JP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-152; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heimer R, 2005, AIDS BEHAV, V9, P403, DOI 10.1007/s10461-005-9030-1; *I NAC EST INF, 1994, PER MAP NEC BAS INS; Jarama SL, 2005, AIDS BEHAV, V9, P513, DOI 10.1007/s10461-005-9022-1; Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) Working Group on Global HIV/AIDS and STI Surveillance, 2004, UNAIDS WHO EP FACT S; Konda KA, 2005, SEX TRANSM DIS, V32, P534, DOI 10.1097/01.olq.0000175413.89733.ae; KONDA KA, 2007, AIDS BEHAV IN PRESS; Lama JR, 2006, J INFECT DIS, V194, P1459, DOI 10.1086/508548; Liu H, 2006, SEX TRANSM DIS, V33, P68, DOI 10.1097/01.olq.0000187266.29927.11; McFarland W, 2001, AIDS, V15, pS23, DOI 10.1097/00002030-200104003-00004; MILLER M, 2005, J URBAN HLTH S1, V82, P26; Montano SM, 2005, JAIDS-J ACQ IMM DEF, V40, P57, DOI 10.1097/01.qai.0000159667.72584.8b; O'Donnell L, 2002, AIDS EDUC PREV, V14, P457, DOI 10.1521/aeap.14.8.457.24109; Pando MA, 2006, SEX TRANSM DIS, V33, P307, DOI 10.1097/01.olq.0000194578.06795.2d; Ramirez-Valles J, 2005, AIDS BEHAV, V9, P387, DOI 10.1007/s10461-005-9012-3; Salazar X, 2005, CULT HEALTH SEX, V7, P375, DOI 10.1080/13691050500100849; Salazar Ximena, 2006, Cad. Saúde Pública, V22, P2097, DOI 10.1590/S0102-311X2006001000015; SANCHEZ J, 2007, J ACQUIR IMMUNE DEFI; Stueve A, 2001, AM J PUBLIC HEALTH, V91, P922, DOI 10.2105/AJPH.91.6.922; Sutmoller Frits, 2002, International Journal of Infectious Diseases, V6, P259, DOI 10.1016/S1201-9712(02)90158-X; Tabet S, 2002, AIDS, V16, P1271, DOI 10.1097/00002030-200206140-00010; Tabet SR, 1996, AIDS, V10, P201, DOI 10.1097/00002030-199602000-00011	44	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e778	10.1371/journal.pone.0000778	http://dx.doi.org/10.1371/journal.pone.0000778			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712426	gold, Green Submitted, Green Published			2022-12-27	WOS:000207455300026
J	Heinicke, S; Livstone, MS; Lu, C; Oughtred, R; Kang, F; Angiuoli, SV; White, O; Botstein, D; Dolinski, K				Heinicke, Sven; Livstone, Michael S.; Lu, Charles; Oughtred, Rose; Kang, Fan; Angiuoli, Samuel V.; White, Owen; Botstein, David; Dolinski, Kara			The Princeton Protein Orthology Database (P-POD): A Comparative Genomics Analysis Tool for Biologists	PLOS ONE			English	Article							DOLICHOL-PHOSPHATE-MANNOSE; DYSTONIA PEPTIDE-1 DDP1; HAILEY-HAILEY-DISEASE; GTP-CYCLOHYDROLASE-I; GENE ONTOLOGY TERMS; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; FUNCTIONAL COMPLEMENTATION; PLASMODIUM-FALCIPARUM; CONGENITAL-DISORDER	Many biological databases that provide comparative genomics information and tools are now available on the internet. While certainly quite useful, to our knowledge none of the existing databases combine results from multiple comparative genomics methods with manually curated information from the literature. Here we describe the Princeton Protein Orthology Database (P-POD, http://ortholog.princeton.edu), a user-friendly database system that allows users to find and visualize the phylogenetic relationships among predicted orthologs (based on the OrthoMCL method) to a query gene from any of eight eukaryotic organisms, and to see the orthologs in a wider evolutionary context (based on the Jaccard clustering method). In addition to the phylogenetic information, the database contains experimental results manually collected from the literature that can be compared to the computational analyses, as well as links to relevant human disease and gene information via the OMIM, model organism, and sequence databases. Our aim is for the P-POD resource to be extremely useful to typical experimental biologists wanting to learn more about the evolutionary context of their favorite genes. P-POD is based on the commonly used Generic Model Organism Database (GMOD) schema and can be downloaded in its entirety for installation on one's own system. Thus, bioinformaticians and software developers may also find P-POD useful because they can use the P-POD database infrastructure when developing their own comparative genomics resources and database tools.	[Heinicke, Sven; Livstone, Michael S.; Lu, Charles; Oughtred, Rose; Kang, Fan; Botstein, David; Dolinski, Kara] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Angiuoli, Samuel V.; White, Owen] Inst Genom Res, Rockville, MD USA; [Angiuoli, Samuel V.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	Princeton University; J. Craig Venter Institute; University System of Maryland; University of Maryland College Park	Dolinski, K (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	kara@genomics.princeton.edu	Angiuoli, Samuel V/H-7340-2014; Dolinski, Kara/GPP-4026-2022	Angiuoli, Samuel/0000-0001-9525-4350; Livstone, Michael/0000-0001-5386-5823; Dolinski, Kara/0000-0002-7010-0264; Oughtred, Rose/0000-0002-6475-3373	NIH [5R01HG003471, P50 GM071508, NO1-AI-40038]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH grant 5R01HG003471 awarded to DB (PI) and KD (co-investigator), by NIH grant P50 GM071508 awarded to DB, and by NIH contract NO1-AI-40038 awarded to OW.	Agarwal AK, 2003, HUM MOL GENET, V12, P1995, DOI 10.1093/hmg/ddg213; ALEXEYENKO A, 2006, DRUG DISCOV TODAY, V11, P137; Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; ARCHAMBAULT J, 1993, MICROBIOL REV, V57, P703, DOI 10.1128/MMBR.57.3.703-724.1993; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Boyum R, 1997, BIOCHEM BIOPH RES CO, V230, P22, DOI 10.1006/bbrc.1996.5913; Brzeski J, 1999, NUCLEIC ACIDS RES, V27, P2393, DOI 10.1093/nar/27.11.2393; Bussey H, 1997, NATURE, V387, P103, DOI 10.1038/387s103; Catoni Elisabetta, 2003, BMC Plant Biology, V3, P1, DOI 10.1186/1471-2229-3-1; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Chatterjee A, 2001, NUCLEIC ACIDS RES, V29, P4935, DOI 10.1093/nar/29.24.4935; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Chen Y, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-12; Clark AB, 1999, NUCLEIC ACIDS RES, V27, P736, DOI 10.1093/nar/27.3.736; Colussi PA, 1997, P NATL ACAD SCI USA, V94, P7873, DOI 10.1073/pnas.94.15.7873; Covic L, 1996, BBA-GENE STRUCT EXPR, V1305, P125, DOI 10.1016/0167-4781(95)00233-2; Desmyter L, 2004, EXP GERONTOL, V39, P707, DOI 10.1016/j.exger.2004.01.008; Dutcher SK, 2003, CURR OPIN MICROBIOL, V6, P634, DOI 10.1016/j.mib.2003.10.016; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; FEILER HS, 1995, EMBO J, V14, P5626, DOI 10.1002/j.1460-2075.1995.tb00250.x; Forsgren M, 2004, BIOCHEM J, V382, P519, DOI 10.1042/BJ20040261; Frank CG, 2004, AM J HUM GENET, V75, P146, DOI 10.1086/422367; Gao XD, 2005, FEBS J, V272, P2497, DOI 10.1111/j.1742-4658.2005.04670.x; Garavaglia B, 2004, J INHERIT METAB DIS, V27, P455, DOI 10.1023/B:BOLI.0000037349.08483.96; Garbers C, 1996, EMBO J, V15, P2115, DOI 10.1002/j.1460-2075.1996.tb00565.x; Gecz J, 2003, GENE, V320, P137, DOI 10.1016/S0378-1119(03)00819-9; Geisler M, 2000, PLANT PHYSIOL, V124, P1814, DOI 10.1104/pp.124.4.1814; Geraghty MT, 1998, HUM MOL GENET, V7, P1411, DOI 10.1093/hmg/7.9.1411; Gowda DC, 1997, J BIOL CHEM, V272, P6428, DOI 10.1074/jbc.272.10.6428; Grubenmann CE, 2002, HUM MOL GENET, V11, P2331, DOI 10.1093/hmg/11.19.2331; GUZDER SN, 1995, J BIOL CHEM, V270, P17660, DOI 10.1074/jbc.270.30.17660; HEINISCH JJ, 1993, FEBS LETT, V328, P35, DOI 10.1016/0014-5793(93)80960-3; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hofmann S, 2002, J BIOL CHEM, V277, P23287, DOI 10.1074/jbc.M201154200; Hsi G, 2004, GENOMICS, V83, P473, DOI 10.1016/j.ygeno.2003.08.022; Hu CA, 1996, J BIOL CHEM, V271, P9795, DOI 10.1074/jbc.271.16.9795; Jantti J, 1999, P NATL ACAD SCI USA, V96, P909, DOI 10.1073/pnas.96.3.909; Johnstone O, 2005, DEV BIOL, V277, P92, DOI 10.1016/j.ydbio.2004.09.009; Jothi R, 2006, BIOINFORMATICS, V22, P779, DOI 10.1093/bioinformatics/btl009; KATAOKA T, 1985, CELL, V40, P19, DOI 10.1016/0092-8674(85)90304-6; Kedees MH, 2002, EXP PARASITOL, V101, P64, DOI 10.1016/S0014-4894(02)00030-9; Keeling PJ, 1996, MOL BIOL EVOL, V13, P1297, DOI 10.1093/oxfordjournals.molbev.a025576; KELLEHER DJ, 1994, J BIOL CHEM, V269, P12908; Kellermayer R, 2005, FEBS LETT, V579, P2021, DOI 10.1016/j.febslet.2005.03.003; Kida Y, 2001, HISTOCHEM CELL BIOL, V115, P189; Kleinow T, 2000, PLANT J, V23, P115, DOI 10.1046/j.1365-313x.2000.00809.x; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; KRON SJ, 1992, P NATL ACAD SCI USA, V89, P4466, DOI 10.1073/pnas.89.10.4466; KRUMPELMAN PM, 1995, PLANT PHYSIOL, V107, P1479, DOI 10.1104/pp.107.4.1479; Kulikova T, 2007, NUCLEIC ACIDS RES, V35, pD16, DOI 10.1093/nar/gkl913; Lai K, 2000, BIOCHEM BIOPH RES CO, V271, P392, DOI 10.1006/bbrc.2000.2629; Lanterman MM, 1996, HUM MOL GENET, V5, P1643, DOI 10.1093/hmg/5.10.1643; Lattimore BS, 2005, COMPUT BIOL CHEM, V29, P354, DOI 10.1016/j.compbiolchem.2005.07.002; Lee Y, 2002, GENOME RES, V12, P493, DOI 10.1101/gr.212002; Lenffer J, 2006, NUCLEIC ACIDS RES, V34, pD599, DOI 10.1093/nar/gkj152; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liang F, 1997, P NATL ACAD SCI USA, V94, P8579, DOI 10.1073/pnas.94.16.8579; Lillard-Wetherell K, 2005, CANCER RES, V65, P5520, DOI 10.1158/0008-5472.CAN-05-0632; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Lucas ME, 2003, MOL GENET METAB, V80, P227, DOI 10.1016/S1096-7192(03)00137-9; Lumbreras V, 2001, EMBO REP, V2, P55, DOI 10.1093/embo-reports/kve001; Mamiya N, 1999, J BIOL CHEM, V274, P15751, DOI 10.1074/jbc.274.22.15751; Mancini R, 1999, BIOCHEM BIOPH RES CO, V255, P521, DOI 10.1006/bbrc.1998.9951; Mayordomo I, 2001, YEAST, V18, P1309, DOI 10.1002/yea.780; McEwen RK, 1999, J BIOL CHEM, V274, P33905, DOI 10.1074/jbc.274.48.33905; Mercer JFB, 2003, BIOMETALS, V16, P175, DOI 10.1023/A:1020719016675; Morgante PG, 2005, GENE, V344, P93, DOI 10.1016/j.gene.2004.10.006; MORITA T, 1993, P NATL ACAD SCI USA, V90, P6577, DOI 10.1073/pnas.90.14.6577; Neff NF, 1999, MOL BIOL CELL, V10, P665, DOI 10.1091/mbc.10.3.665; Nomoto S, 1997, GENES CELLS, V2, P601, DOI 10.1046/j.1365-2443.1997.1470346.x; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; O'Brien KP, 2004, HUM MUTAT, V24, P112, DOI 10.1002/humu.20068; Okada K, 2004, PLANT MOL BIOL, V55, P567, DOI 10.1007/s11103-004-1298-4; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Payne AS, 1998, J BIOL CHEM, V273, P3765, DOI 10.1074/jbc.273.6.3765; Pearce DA, 1998, P NATL ACAD SCI USA, V95, P6915, DOI 10.1073/pnas.95.12.6915; Peng Z, 1996, MOL GEN GENET, V253, P334, DOI 10.1007/s004380050329; Penkett CJ, 2006, NUCLEIC ACIDS RES, V34, pW330, DOI 10.1093/nar/gkl311; Portmann R, 2005, FEBS LETT, V579, P3589, DOI 10.1016/j.febslet.2005.05.042; POULLET P, 1994, MOL CELL BIOL, V14, P815, DOI 10.1128/MCB.14.1.815; RABEN N, 1995, AM J HUM GENET, V56, P131; RAYMOND M, 1992, SCIENCE, V256, P232, DOI 10.1126/science.1348873; Raymond RK, 1999, ARCH BIOCHEM BIOPHYS, V372, P300, DOI 10.1006/abbi.1999.1498; Roje S, 1999, J BIOL CHEM, V274, P36089, DOI 10.1074/jbc.274.51.36089; Rothbauer U, 2001, J BIOL CHEM, V276, P37327, DOI 10.1074/jbc.M105313200; Sambongi Y, 1997, J BIOCHEM-TOKYO, V121, P1169, DOI 10.1093/oxfordjournals.jbchem.a021711; Saunders RDC, 2000, FEBS LETT, V467, P337, DOI 10.1016/S0014-5793(00)01148-0; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Schiott M, 2004, P NATL ACAD SCI USA, V101, P9502, DOI 10.1073/pnas.0401542101; Schmidt PJ, 1999, J BIOL CHEM, V274, P36952, DOI 10.1074/jbc.274.52.36952; Schmidt WK, 2000, J BIOL CHEM, V275, P6227, DOI 10.1074/jbc.275.9.6227; Schwarz M, 2004, AM J HUM GENET, V74, P472, DOI 10.1086/382492; Shaag A, 2005, HUM MOL GENET, V14, P555, DOI 10.1093/hmg/ddi052; Sone T, 2004, J BIOL CHEM, V279, P28807, DOI 10.1074/jbc.M403165200; Song WY, 2004, PLANT PHYSIOL, V135, P1027, DOI 10.1104/pp.103.037739; Srinivasan C, 2000, J BIOL CHEM, V275, P29187, DOI 10.1074/jbc.M004239200; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; Takeuchi M, 1998, PLANT CELL PHYSIOL, V39, P590, DOI 10.1093/oxfordjournals.pcp.a029409; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomita S, 1998, J BIOL CHEM, V273, P9249, DOI 10.1074/jbc.273.15.9249; Tommasini R, 1998, PLANT J, V13, P773, DOI 10.1046/j.1365-313X.1998.00076.x; Ton VK, 2004, J INVEST DERMATOL, V123, P1192, DOI 10.1111/j.0022-202X.2004.23437.x; Ton VK, 2002, J BIOL CHEM, V277, P6422, DOI 10.1074/jbc.M110612200; van Wilpe S, 1999, EUR J BIOCHEM, V264, P825, DOI 10.1046/j.1432-1327.1999.00673.x; Vonarx EJ, 2002, GENE, V296, P1, DOI 10.1016/S0378-1119(02)00869-7; Wagner N, 2004, J CELL SCI, V117, P2015, DOI 10.1242/jcs.01052; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Yamagata K, 1998, P NATL ACAD SCI USA, V95, P8733, DOI 10.1073/pnas.95.15.8733	115	64	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e766	10.1371/journal.pone.0000766	http://dx.doi.org/10.1371/journal.pone.0000766			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712414	Green Submitted, gold, Green Published			2022-12-27	WOS:000207455300014
J	Bruno, JF; Selig, ER				Bruno, John F.; Selig, Elizabeth R.			Regional Decline of Coral Cover in the Indo-Pacific: Timing, Extent, and Subregional Comparisons	PLOS ONE			English	Article								Background. A number of factors have recently caused mass coral mortality events in all of the world's tropical oceans. However, little is known about the timing, rate or spatial variability of the loss of reef-building corals, especially in the Indo-Pacific, which contains 75% of the world's coral reefs. Methodology/Principle Findings. We compiled and analyzed a coral cover database of 6001 quantitative surveys of 2667 Indo-Pacific coral reefs performed between 1968 and 2004. Surveys conducted during 2003 indicated that coral cover averaged only 22.1% (95% CI: 20.7, 23.4) and just 7 of 390 reefs surveyed that year had coral cover > 60%. Estimated yearly coral cover loss based on annually pooled survey data was approximately 1% over the last twenty years and 2% between 1997 and 2003 (or 3,168 km(2) per year). The annual loss based on repeated measures regression analysis of a subset of reefs that were monitored for multiple years from 1997 to 2004 was 0.72% (n = 476 reefs, 95% CI: 0.36, 1.08). Conclusions/Significance. The rate and extent of coral loss in the Indo-Pacific are greater than expected. Coral cover was also surprisingly uniform among subregions and declined decades earlier than previously assumed, even on some of the Pacific's most intensely managed reefs. These results have significant implications for policy makers and resource managers as they search for successful models to reverse coral loss.	[Bruno, John F.; Selig, Elizabeth R.] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27515 USA; [Selig, Elizabeth R.] Univ N Carolina, Curriculum Ecol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Bruno, JF (corresponding author), Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27515 USA.	jbruno@unc.edu			National Science Foundation [OCE-0326983]; EPA; University of North Carolina	National Science Foundation(National Science Foundation (NSF)); EPA(United States Environmental Protection Agency); University of North Carolina	This research was funded in part by the National Science Foundation (OCE-0326983 to J.F.B.), an EPA Star Fellowship to E.R.S, and the University of North Carolina at Chapel Hill.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Aronson RB, 2000, NATURE, V405, P36, DOI 10.1038/35011132; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkelmans R, 1999, CORAL REEFS, V18, P55, DOI 10.1007/s003380050154; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Bruno JF, 2001, CORAL REEFS, V20, P127, DOI 10.1007/s003380100151; Bruno JF, 2001, MARINE COMMUNITY ECOLOGY, P201; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; CHESHER RH, 1969, SCIENCE, V165, P280, DOI 10.1126/science.165.3890.280; COLGAN MW, 1987, ECOLOGY, V68, P1592, DOI 10.2307/1939851; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Cote IM, 2005, PHILOS T R SOC B, V360, P385, DOI 10.1098/rstb.2004.1591; Dana T. F., 1979, ATOLL RES B, V228, P1; DONE T, 1992, AM ZOOL, V32, P655; Edmunds PJ, 2007, ECOL MONOGR, V77, P3, DOI 10.1890/05-1081; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; Endean R., 1973, Atoll Res Bull, VNo. 168, P1; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; GOMEZ ED, 1981, 4TH P INT COR REEF S, V1, P275; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Grigg R.W., 1990, P439; Grigg RW, 2005, SCIENCE, V308, P1740; Guinotte JM, 2003, CORAL REEFS, V22, P551, DOI 10.1007/s00338-003-0331-4; HARMELINVIVIEN ML, 1986, CORAL REEFS, V5, P55, DOI 10.1007/BF00270353; Hodgson G, 1999, MAR POLLUT BULL, V38, P345, DOI 10.1016/S0025-326X(99)00002-8; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Idjadi JA, 2006, MAR ECOL PROG SER, V319, P117, DOI 10.3354/meps319117; Idjadi JA, 2006, CORAL REEFS, V25, P209, DOI 10.1007/s00338-006-0088-7; *ISRS, 2004, EFF TERR RUN SED NUT, P18; Jokiel Paul L., 2004, Pacific Science, V58, P159, DOI 10.1353/psc.2004.0018; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lourey MJ, 2000, MAR ECOL PROG SER, V196, P179, DOI 10.3354/meps196179; Mcmanus JW, 1997, ENVIRON MANAGE, V21, P69, DOI 10.1007/s002679900006; Miller I, 1999, CORAL REEFS, V18, P353, DOI 10.1007/s003380050212; MILLER I, 1997, P 8 INT COR REEF S, V2, P1475; Miller IR, 1996, MAR FRESHWATER RES, V47, P19, DOI 10.1071/MF9960019; MONTEBON ARF, 1997, P 8 INT COR REEF S, V1, P295; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Ninio R, 2000, MAR ECOL PROG SER, V194, P65, DOI 10.3354/meps194065; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Salvat B, 2002, STATUS CORAL REEFS W, P203; SEBENS KP, 1994, AM ZOOL, V34, P115; Selig ER., 2006, ANALYZING RELATIONSH, P111; Silliman BR, 2005, SCIENCE, V310, P1803, DOI 10.1126/science.1118229; Spalding M, 2002, REEFS RISK SE ASIA, P72; STODDART DR, 1974, 2ND P INT COR REEF S, V2, P473; SWEATMAN H, 2003, 6 AUSTR I MAR SCI; Wilkinson C., 2002, STATUS CORAL REEFS W, P378; Wilkinson CR, 2003, P 7 INT COR REEF S G, V1, P11; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Wing SR, 2001, CORAL REEFS, V20, P1	63	814	843	6	201	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e711	10.1371/journal.pone.0000711	http://dx.doi.org/10.1371/journal.pone.0000711			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684557	gold, Green Published			2022-12-27	WOS:000207452400014
J	Ivanov, AI; Bachar, M; Babbin, BA; Adelstein, RS; Nusrat, A; Parkos, CA				Ivanov, Andrei I.; Bachar, Moshe; Babbin, Brian A.; Adelstein, Robert S.; Nusrat, Asma; Parkos, Charles A.			A Unique Role for Nonmuscle Myosin Heavy Chain IIA in Regulation of Epithelial Apical Junctions	PLOS ONE			English	Article							CELL-CELL JUNCTIONS; TIGHT JUNCTIONS; E-CADHERIN; ACTIN POLYMERIZATION; LIGHT-CHAIN; ADHESION; MECHANISM; COMPONENTS; EXPRESSION; DYNAMICS	The integrity and function of the epithelial barrier is dependent on the apical junctional complex (AJC) composed of tight and adherens junctions and regulated by the underlying actin filaments. A major F-actin motor, myosin II, was previously implicated in regulation of the AJC, however direct evidence of the involvement of myosin II in AJC dynamics are lacking and the molecular identity of the myosin II motor that regulates formation and disassembly of apical junctions in mammalian epithelia is unknown. We investigated the role of nonmuscle myosin II (NMMII) heavy chain isoforms, A, B, and C in regulation of epithelial AJC dynamics and function. Expression of the three NMMII isoforms was observed in model intestinal epithelial cell lines, where all isoforms accumulated within the perijunctional F-actin belt. siRNA-mediated downregulation of NMMIIA, but not NMMIIB or NMMIIC expression in SK-CO15 colonic epithelial cells resulted in profound changes of cell morphology and cell-cell adhesions. These changes included acquisition of a fibroblast-like cell shape, defective paracellular barrier, and substantial attenuation of the assembly and disassembly of both adherens and tight junctions. Impaired assembly of the AJC observed after NMMIIA knock-down involved dramatic disorganization of perijunctional actin filaments. These findings provide the first direct non-pharmacological evidence of myosin II-dependent regulation of AJC dynamics in mammalian epithelia and highlight a unique role of NMMIIA in junctional biogenesis.	[Ivanov, Andrei I.; Bachar, Moshe; Babbin, Brian A.; Nusrat, Asma; Parkos, Charles A.] Emory Univ, Dept Pathol & Lab Med, Epithelial Pathobiol Res Unit, Atlanta, GA 30322 USA; [Adelstein, Robert S.] NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA	Emory University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Ivanov, AI (corresponding author), Emory Univ, Dept Pathol & Lab Med, Epithelial Pathobiol Res Unit, Atlanta, GA 30322 USA.	aiivano@emory.edu	Ivanov, Andrei/V-1672-2019	Adelstein, Robert/0000-0002-8683-2144	Crohn's and Colitis Foundation of America; National Institute of Health [DK 61379, DK 72564, HL72124, DK 55679, DK 59888]; Digestive Diseases Minicenter [DK64399]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072124, Z01HL004218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061379, R01DK055679, R29DK055679, R01DK059888, R24DK064399, R01DK072564] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Minicenter; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Career Development Award from Crohn's and Colitis Foundation of America (to AII) and by National Institute of Health grants DK 61379, DK 72564 and HL72124 (to CAP), DK 55679, and DK 59888 (to AN) and a Digestive Diseases Minicenter grant DK64399 (epithelial tissue culture and morphology cores).	Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Aijaz S, 2006, INT REV CYTOL, V248, P261, DOI 10.1016/S0074-7696(06)48005-0; Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; Bershadsky A, 2004, TRENDS CELL BIOL, V14, P589, DOI 10.1016/j.tcb.2004.09.009; Blaschuk OW, 2002, MOL MEMBR BIOL, V19, P75, DOI 10.1080/09687680210132467; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Cramer LP, 2002, CELL MOTIL CYTOSKEL, V51, P27, DOI 10.1002/cm.10013; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; Gandhi S, 1997, AM J PHYSIOL-RENAL, V272, pF214, DOI 10.1152/ajprenal.1997.272.2.F214; Gloushankova NA, 1998, P NATL ACAD SCI USA, V95, P4362, DOI 10.1073/pnas.95.8.4362; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Goodwin M, 2004, J MOL HISTOL, V35, P839, DOI 10.1007/s10735-004-1833-2; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; Hecht G, 1996, AM J PHYSIOL-CELL PH, V271, pC1678, DOI 10.1152/ajpcell.1996.271.5.C1678; Hossain MM, 2005, J BIOL CHEM, V280, P42442, DOI 10.1074/jbc.M509952200; Ivanov AI, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-12; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Ivanov AI, 2004, MOL BIOL CELL, V15, P2639, DOI 10.1091/mbc.E04-02-0163; Jana SS, 2006, J BIOL CHEM, V281, P24662, DOI 10.1074/jbc.M604606200; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Krendel MF, 1999, CELL MOTIL CYTOSKEL, V43, P296, DOI 10.1002/(SICI)1097-0169(1999)43:4<296::AID-CM3>3.0.CO;2-U; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; Lecuit T, 2005, TRENDS CELL BIOL, V15, P34, DOI 10.1016/j.tcb.2004.11.007; LITTEN RZ, 1982, CIRC RES, V50, P856, DOI 10.1161/01.RES.50.6.856; Ma TY, 2000, MICROSC RES TECHNIQ, V51, P156, DOI 10.1002/1097-0029(20001015)51:2<156::AID-JEMT7>3.0.CO;2-J; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; Mandell KJ, 2005, J BIOL CHEM, V280, P11665, DOI 10.1074/jbc.M412650200; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; MOOSEKER MS, 1985, ANNU REV CELL BIOL, V1, P209, DOI 10.1146/annurev.cellbio.1.1.209; Ogita H, 2006, IUBMB LIFE, V58, P334, DOI 10.1080/15216540600719622; Ostap EM, 2002, J MUSCLE RES CELL M, V23, P305, DOI 10.1023/A:1022047102064; PHILLIPS CL, 1995, J MUSCLE RES CELL M, V16, P379, DOI 10.1007/BF00114503; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Rosenfeld SS, 2003, J BIOL CHEM, V278, P27449, DOI 10.1074/jbc.M302555200; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Shu S, 2005, P NATL ACAD SCI USA, V102, P1472, DOI 10.1073/pnas.0409528102; STEVENSON BR, 1994, J CELL SCI, V107, P367; Togo T, 2004, MOL BIOL CELL, V15, P688, DOI 10.1091/mbc.E03-06-0430; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Utech M, 2005, MOL BIOL CELL, V16, P5040, DOI 10.1091/mbc.E05-03-0193; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Weis WI, 2006, J BIOL CHEM, V281, P35593, DOI 10.1074/jbc.R600027200; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yarrow JC, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-5; Zhang JK, 2005, J CELL SCI, V118, P5549, DOI 10.1242/jcs.02639	62	125	128	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e658	10.1371/journal.pone.0000658	http://dx.doi.org/10.1371/journal.pone.0000658			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668046	gold, Green Published, Green Submitted			2022-12-27	WOS:000207452300004
J	Srinivasan, S; Santiago, P; Lubrano, C; Vaisse, C; Conklin, BR				Srinivasan, Supriya; Santiago, Pamela; Lubrano, Cecile; Vaisse, Christian; Conklin, Bruce R.			Engineering the Melanocortin-4 Receptor to Control Constitutive and Ligand-Mediated G(s) Signaling In Vivo	PLOS ONE			English	Article							ENERGY HOMEOSTASIS; OBESITY; MUTATIONS; PROLIFERATION; AGONIST; MC4R; PROOPIOMELANOCORTIN; ACTIVATION; EXPRESSION; SWEET	The molecular and functional diversity of G protein-coupled receptors is essential to many physiological processes. However, this diversity presents a significant challenge to understanding the G protein-mediated signaling events that underlie a specific physiological response. To increase our understanding of these processes, we sought to gain control of the timing and specificity of G(s) signaling in vivo. We used naturally occurring human mutations to develop two G(s)-coupled engineered receptors that respond solely to a synthetic ligand (RASSLs). Our G(s)-coupled RASSLs are based on the melanocortin-4 receptor, a centrally expressed receptor that plays an important role in the regulation of body weight. These RASSLs are not activated by the endogenous hormone alpha-melanocyte-stimulating hormone but respond potently to a selective synthetic ligand, tetrahydroisoquinoline. The RASSL variants reported here differ in their intrinsic basal activities, allowing the separation of the effects of basal signaling from ligand-mediated activation of the G(s) pathway in vivo. These RASSLs can be used to activate G(s) signaling in any tissue, but would be particularly useful for analyzing downstream events that mediate body weight regulation in mice. Our study also demonstrates the use of human genetic variation for protein engineering.	[Srinivasan, Supriya] Univ Calif San Francisco, Dept Physiol, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94143 USA; [Vaisse, Christian; Conklin, Bruce R.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Lubrano, Cecile; Vaisse, Christian] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Srinivasan, S (corresponding author), Univ Calif San Francisco, Dept Physiol, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94143 USA.	supriya.srinivasan@ucsf.edu; bconklin@gladstone.ucsf.edu	Vaisse, Christian/F-1067-2011; Conklin, Bruce/E-4738-2019	Conklin, Bruce/0000-0003-1463-6061	National Institutes of Health [HL60664-06]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant HL60664-06 (to B. R. C.) and an American Heart Association Postdoctoral Fellowship (to S. S.).	Barb CR, 2004, J ENDOCRINOL, V181, P39, DOI 10.1677/joe.0.1810039; Blau CA, 1997, P NATL ACAD SCI USA, V94, P3076, DOI 10.1073/pnas.94.7.3076; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; Challis BG, 2004, P NATL ACAD SCI USA, V101, P4695, DOI 10.1073/pnas.0306931101; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; Claeysen S, 2003, J BIOL CHEM, V278, P699, DOI 10.1074/jbc.C200588200; Cone RD, 2000, RECEPTORS, P405; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611; Gaillard I, 2004, CELL MOL LIFE SCI, V61, P456, DOI 10.1007/s00018-003-3273-7; Goodfellow VS, 2003, CURR TOP MED CHEM, V3, P855, DOI 10.2174/1568026033452212; HAGA T, 2000, G PROTEIN COUPLED RE; Harrold JA, 2003, PEPTIDES, V24, P397, DOI 10.1016/S0196-9781(03)00054-8; Haskell-Luevano C, 2000, PEPTIDES, V21, P49, DOI 10.1016/S0196-9781(99)00167-9; Haskell-Luevano C, 2001, REGUL PEPTIDES, V99, P1, DOI 10.1016/S0167-0115(01)00234-8; Haskell-Luevano C, 2001, BIOCHEMISTRY-US, V40, P6164, DOI 10.1021/bi010025q; Hermans E, 2003, PHARMACOL THERAPEUT, V99, P25, DOI 10.1016/S0163-7258(03)00051-2; Ho GY, 1999, J BIOL CHEM, V274, P35816, DOI 10.1074/jbc.274.50.35816; Holst PJ, 2001, J CLIN INVEST, V108, P1789, DOI 10.1172/JCI13622; Houshmand P, 2003, CURR OPIN CHEM BIOL, V7, P457, DOI 10.1016/S1367-5931(03)00086-3; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jain RK, 2004, P NATL ACAD SCI USA, V101, P111, DOI 10.1073/pnas.2534352100; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Li ZY, 2002, MOL THER, V5, P420, DOI 10.1006/mthe.2002.0565; Lubrano-Berthelier C, 2003, ANN NY ACAD SCI, V994, P49, DOI 10.1111/j.1749-6632.2003.tb03161.x; Lubrano-Berthelier C, 2003, HUM MOL GENET, V12, P145, DOI 10.1093/hmg/ddg016; Luttrell LM, 2002, CAN J PHYSIOL PHARM, V80, P375, DOI 10.1139/Y02-045; MacNeil DJ, 2002, EUR J PHARMACOL, V440, P141, DOI 10.1016/S0014-2999(02)01425-5; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; Millington GWM, 2001, NEUROSCIENCE, V108, P437, DOI 10.1016/S0306-4522(01)00428-6; Moldrich RX, 2003, CNS NEUROL DISORD-DR, V2, P109, DOI 10.2174/1568007033482922; Myslivecek J, 2003, GEN PHYSIOL BIOPHYS, V22, P3; Nijenhuis WAJ, 2003, J BIOL CHEM, V278, P22939, DOI 10.1074/jbc.M211326200; Raffin-Sanson ML, 2003, EUR J ENDOCRINOL, V149, P79, DOI 10.1530/eje.0.1490079; Redfern CH, 1999, NAT BIOTECHNOL, V17, P165, DOI 10.1038/6165; Scearce-Levie K, 2001, TRENDS PHARMACOL SCI, V22, P414, DOI 10.1016/S0165-6147(00)01743-0; SCEARCELEVIE K, 2002, SOC NEUROSCIENCE; Sebhat IK, 2002, J MED CHEM, V45, P4589, DOI 10.1021/jm025539h; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Shinyama H, 2003, ENDOCRINOLOGY, V144, P1301, DOI 10.1210/en.2002-220931; Small KM, 2001, J BIOL CHEM, V276, P31596, DOI 10.1074/jbc.M102734200; Srinivasan S, 2003, ANN NY ACAD SCI, V994, P225, DOI 10.1111/j.1749-6632.2003.tb03184.x; SRINIVASAN S, 2004, ACTIVATION IN PRESS; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Whitney ML, 2001, J BIOL CHEM, V276, P41191, DOI 10.1074/jbc.M103191200; Yang Suh-Yung, 2000, Korean Journal of Biological Sciences, V4, P39; Yang YK, 2002, J BIOL CHEM, V277, P20328, DOI 10.1074/jbc.M201343200; Yeo GSH, 2003, HUM MOL GENET, V12, P561, DOI 10.1093/hmg/ddg057; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	54	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2007	2	8							e668	10.1371/journal.pone.0000668	http://dx.doi.org/10.1371/journal.pone.0000668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GK	17668051	gold, Green Published			2022-12-27	WOS:000207452300009
J	Boyles, JG; Storm, JJ				Boyles, Justin G.; Storm, Jonathan J.			The Perils of Picky Eating: Dietary Breadth Is Related to Extinction Risk in Insectivorous Bats	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; FECAL ANALYSIS; RARITY; SPECIALIZATION; CHIROPTERA; PHYLOGENY; FOOD	Several recent papers evaluate the relationship between ecological characteristics and extinction risk in bats. These studies report that extinction risk is negatively related to geographic range size and positively related to habitat specialization. Here, we evaluate the hypothesis that extinction risk is also related to dietary specialization in insectivorous vespertilionid bats using both traditional and phylogenetically-controlled analysis of variance. We collected dietary data and The World Conservation Union (IUCN) rankings for 44 Australian, European, and North American bat species. Our results indicate that species of conservation concern (IUCN ranking near threatened or above) are more likely to have a specialized diet than are species of least concern. Additional analyses show that dietary breadth is not correlated to geographic range size or wing morphology, characteristics previously found to correlate with extinction risk. Therefore, there is likely a direct relationship between dietary specialization and extinction risk; however, the large variation in dietary breadth within species of least concern suggests that diet alone cannot explain extinction risk. Our results may have important implications for the development of predictive models of extinction risk and for the assignment of extinction risk to insectivorous bat species. Similar analyses should be conducted on additional bat families to assess the generality of this relationship between niche breadth and extinction risk.	[Boyles, Justin G.] Indiana State Univ, Ctr N Amer Bat Res & Conservat, Dept Ecol & Organismal Biol, Terre Haute, IN 47809 USA; [Storm, Jonathan J.] Indiana State Univ, Dept Ecol & Organismal Biol, Terre Haute, IN 47809 USA	Indiana State University; Indiana State University	Boyles, JG (corresponding author), Indiana State Univ, Ctr N Amer Bat Res & Conservat, Dept Ecol & Organismal Biol, Terre Haute, IN 47809 USA.	jboyles3@mymail.indstate.edu	Boyles, Justin G/A-5152-2010					ARITA HT, 1993, ECOL APPL, V3, P506, DOI 10.2307/1941919; Boots M, 2002, AM NAT, V159, P706, DOI 10.1086/339996; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Garland T, 1999, AM ZOOL, V39, P374; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; Goulson D, 2005, BIOL CONSERV, V122, P1, DOI 10.1016/j.biocon.2004.06.017; Harcourt AH, 2002, J BIOGEOGR, V29, P445, DOI 10.1046/j.1365-2699.2002.00685.x; Hoofer SR, 2003, ACTA CHIROPTEROL, V5, P1, DOI 10.3161/001.005.s101; HUMPHREY SR, 1975, J MAMMAL, V56, P321, DOI 10.2307/1379364; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; IUCN, 2006, IUCN RED LIST THREAT; Jones KE, 2003, AM NAT, V161, P601, DOI 10.1086/368289; Jonsson T, 2006, ECOL MODEL, V199, P93, DOI 10.1016/j.ecolmodel.2006.06.012; Kotiaho JS, 2005, P NATL ACAD SCI USA, V102, P1963, DOI 10.1073/pnas.0406718102; KUNZ TH, 1983, CAN J ZOOL, V61, P1317, DOI 10.1139/z83-177; KURTA A, 1992, ECOGRAPHY, V15, P257, DOI 10.1111/j.1600-0587.1992.tb00032.x; LAURANCE WF, 1991, CONSERV BIOL, V5, P79, DOI 10.1111/j.1523-1739.1991.tb00390.x; MacArthur R.H., 1972, pvii; Martins E. P., 2004, COMPARE VERSION 4 6B; Mickleburgh SP, 2002, ORYX, V36, P18, DOI 10.1017/S0030605301000011; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Purvis A, 2000, BIOESSAYS, V22, P1123, DOI 10.1002/1521-1878(200012)22:12<1123::AID-BIES10>3.0.CO;2-C; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; ROBINSON MF, 1993, J ZOOL, V231, P239, DOI 10.1111/j.1469-7998.1993.tb01915.x; Ruedi M, 2001, MOL PHYLOGENET EVOL, V21, P436, DOI 10.1006/mpev.2001.1017; Safi K, 2004, CONSERV BIOL, V18, P1293, DOI 10.1111/j.1523-1739.2004.00155.x; Schoener TW, 2001, NATURE, V412, P183, DOI 10.1038/35084071; Sierro A, 1997, ACTA OECOL, V18, P91, DOI 10.1016/S1146-609X(97)80067-7; Stadelmann B, 2007, MOL PHYLOGENET EVOL, V43, P32, DOI 10.1016/j.ympev.2006.06.019; Stadelmann B, 2004, ACTA CHIROPTEROL, V6, P177, DOI 10.3161/001.006.0201; Walker JS, 2006, BIOL CONSERV, V130, P60, DOI 10.1016/j.biocon.2005.12.002; Williams P, 2005, BIOL CONSERV, V122, P33, DOI 10.1016/j.biocon.2004.06.019; Zar JH, 1999, BIOSTATISTICAL ANAL	33	67	71	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e672	10.1371/journal.pone.0000672	http://dx.doi.org/10.1371/journal.pone.0000672			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653286	gold, Green Published			2022-12-27	WOS:000207452200028
J	Catic, A; Fiebiger, E; Korbel, GA; Blom, D; Galardy, PJ; Ploegh, HL				Catic, Andre; Fiebiger, Edda; Korbel, Gregory A.; Blom, Daniel; Galardy, Paul J.; Ploegh, Hidde L.			Screen for ISG15-crossreactive Deubiquitinases	PLOS ONE			English	Article							UBIQUITIN-LIKE PROTEIN; FUNCTIONAL PROTEOMICS; ANTIVIRAL MOLECULE; STIMULATED GENE-15; UBP43 USP18; ATAXIA MICE; ISG15; ENZYME; CONJUGATION; IDENTIFICATION	Background. The family of ubiquitin-like molecules (UbLs) comprises several members, each of which has sequence, structural, or functional similarity to ubiquitin. ISG15 is a homolog of ubiquitin in vertebrates and is strongly upregulated following induction by type I interferon. ISG15 can be covalently attached to proteins, analogous to ubiquitination and with actual support of ubiquitin conjugating factors. Specific proteases are able to reverse modification with ubiquitin or UbLs by hydrolyzing the covalent bond between their C-termini and substrate proteins. The tail regions of ubiquitin and ISG15 are identical and we therefore hypothesized that promiscuous deubiquitinating proteases (DUBs) might exist, capable of recognizing both ubiquitin and ISG15. Results. We have cloned and expressed 22 human DUBs, representing the major clades of the USP protease family. Utilizing suicide inhibitors based on ubiquitin and ISG15, we have identified USP2, USP5 (IsoT1), USP13 (IsoT3), and USP14 as ISG15-reactive proteases, in addition to the bona fide ISG15-specific protease USP18 (UBP43). USP14 is a proteasome-associated DUB, and its ISG15 isopeptidase activity increases when complexed with the proteasome. Conclusions. By evolutionary standards, ISG15 is a newcomer among the UbLs and it apparently not only utilizes the conjugating but also the deconjugating machinery of its more established relative ubiquitin. Functional overlap between these two posttranslational modifiers might therefore be more extensive than previously appreciated and explain the rather innocuous phenotype of ISG15 null mice.	[Galardy, Paul J.] Mayo Clin Pediat & Adolescent Med, Rochester, MN USA; [Catic, Andre] Harvard Univ, Sch Med, Program Immunol, Boston, MA USA; [Catic, Andre; Korbel, Gregory A.; Ploegh, Hidde L.] MIT, Whitehead Inst Biomed Res, Cambridge, MA USA; [Fiebiger, Edda] Childrens Hosp, GI Cell Biol, Boston, MA 02115 USA; [Blom, Daniel] Merck, Rahway, NJ USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Boston Children's Hospital; Merck & Company	Galardy, PJ (corresponding author), Mayo Clin Pediat & Adolescent Med, Rochester, MN USA.	Galardy.Paul@mayo.edu; Ploegh@wi.mit.edu	Galardy, Paul/AAE-9297-2019	Catic, Andre/0000-0002-3572-7598	NIH [GM072352-02]; AstraZeneca; Charles A. King Trust; Mayo Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM072352] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AstraZeneca(AstraZeneca); Charles A. King Trust; Mayo Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH and from AstraZeneca. E. F. was supported by the Charles A. King Trust. G. A. K. was supported by an NIH postdoctoral fellowship (GM072352-02). P.J.G. is the Harriet H. Samuelsson Clinical Translational Research Scientist and is also supported by the Mayo Foundation.	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Borodovsky A, 2005, CHEMBIOCHEM, V6, P287, DOI 10.1002/cbic.200400236; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Catic A, 2005, TRENDS BIOCHEM SCI, V30, P600, DOI 10.1016/j.tibs.2005.09.002; Crimmins S, 2006, J NEUROSCI, V26, P11423, DOI 10.1523/JNEUROSCI.3600-06.2006; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Fiebiger E, 2005, J EXP MED, V201, P267, DOI 10.1084/jem.20041384; Fiebiger E, 2002, EMBO J, V21, P1041, DOI 10.1093/emboj/21.5.1041; Gabriel JM, 2002, BIOCHEMISTRY-US, V41, P13755, DOI 10.1021/bi026096m; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guterman A, 2004, CURR PROTEIN PEPT SC, V5, P201, DOI 10.2174/1389203043379756; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hemelaar J, 2004, J PROTEOME RES, V3, P268, DOI 10.1021/pr0341080; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hipp MS, 2005, MOL CELL BIOL, V25, P3483, DOI 10.1128/MCB.25.9.3483-3491.2005; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jamaluddin M, 2001, AM J PHYSIOL-LUNG C, V280, pL248, DOI 10.1152/ajplung.2001.280.2.L248; Kessler B, 2003, J BIOL CHEM, V278, P10013, DOI 10.1074/jbc.M211221200; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; KNIGHT E, 1991, J IMMUNOL, V146, P2280; Knobeloch KP, 2005, MOL CELL BIOL, V25, P11030, DOI 10.1128/MCB.25.24.11030-11034.2005; Kroismayr R, 2004, J CELL SCI, V117, P4749, DOI 10.1242/jcs.01338; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; Lindner HA, 2005, J VIROL, V79, P15199, DOI 10.1128/JVI.79.24.15199-15208.2005; Liu MJ, 2003, J BIOL CHEM, V278, P1594, DOI 10.1074/jbc.M208123200; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; MISAGHI S, 2004, J BIOL CHEM; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nakamura M, 1996, J IMMUNOL, V156, P533; Nakamura M, 1998, BIOCHEM J, V330, P683, DOI 10.1042/bj3300683; Narasimhan J, 2005, J BIOL CHEM, V280, P27356, DOI 10.1074/jbc.M502814200; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Ritchie KJ, 2004, NAT MED, V10, P1374, DOI 10.1038/nm1133; Ritchie KJ, 2004, SEMIN CELL DEV BIOL, V15, P237, DOI 10.1016/j.semcdb.2003.12.005; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; SCHEID MP, 1975, SCIENCE, V190, P1211, DOI 10.1126/science.1081736; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Schwer H, 2000, GENOMICS, V65, P44, DOI 10.1006/geno.2000.6148; Segal S, 2003, TRENDS MICROBIOL, V11, P445, DOI 10.1016/S0966-842X(03)00207-5; Soboleva TA, 2004, CURR PROTEIN PEPT SC, V5, P191, DOI 10.2174/1389203043379765; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Takeuchi T, 2006, BIOCHEM BIOPH RES CO, V348, P473, DOI 10.1016/j.bbrc.2006.07.076; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102	69	68	70	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e679	10.1371/journal.pone.0000679	http://dx.doi.org/10.1371/journal.pone.0000679			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653289	gold, Green Published, Green Submitted			2022-12-27	WOS:000207452200031
J	Moradian, MM; Beglaryan, D; Skozylas, JM; Kerikorian, V				Moradian, Mike M.; Beglaryan, Denis; Skozylas, Jill M.; Kerikorian, Varand			Complete Mitochondrial Genome Sequence of Three Tetrahymena Species Reveals Mutation Hot Spots and Accelerated Nonsynonymous Substitutions in Ymf Genes	PLOS ONE			English	Article							DNA; ALIGNMENT; PROGRAM; RATES; THERMOPHILA; EVOLUTION; CLUSTAL; PACKAGE	The ciliate Tetrahymena, a model organism, contains divergent mitochondrial (Mt) genome with unusual properties, where half of its 44 genes still remain without a definitive function. These genes could be categorized into two major groups of KPC (known protein coding) and Ymf (genes without an identified function). To gain insights into the mechanisms underlying gene divergence and molecular evolution of Tetrahymena (T.) Mt genomes, we sequenced three Mt genomes of T. paravorax, T. pigmentosa, and T. malaccensis. These genomes were aligned and the analyses were carried out using several programs that calculate distance, nucleotide substitution (dn/ds), and their rate ratios (omega) on individual codon sites and via a sliding window approach. Comparative genomic analysis indicated a conserved putative transcription control sequence, a GC box, in a region where presumably transcription and replication initiate. We also found distinct features in Mt genome of T. paravorax despite similar genome organization among these similar to 47 kb long linear genomes. Another significant finding was the presence of at least one or more highly variable regions in Ymf genes where majority of substitutions were concentrated. These regions were mutation hotspots where elevated distances and the dn/ds ratios were primarily due to an increase in the number of nonsynonymous substitutions, suggesting relaxed selective constraint. However, in a few Ymf genes, accelerated rates of nonsynonymous substitutions may be due to positive selection. Similarly, on protein level the majority of amino acid replacements occurred in these regions. Ymf genes comprise half of the genes in Tetrahymena Mt genomes, so understanding why they have not been assigned definitive functions is an important aspect of molecular evolution. Importantly, nucleotide substitution types and rates suggest possible reasons for not being able to find homologues for Ymf genes. Additionally, comparative genomic analysis of complete Mt genomes is essential in identifying biologically significant motifs such as control regions.	[Moradian, Mike M.; Beglaryan, Denis; Skozylas, Jill M.; Kerikorian, Varand] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Moradian, MM (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90024 USA.	mmoradia@ucla.edu			NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: IGERT training program fellowship from NIH.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSEN AH, 1985, NUCLEIC ACIDS RES, V13, P1543, DOI 10.1093/nar/13.5.1543; Ballard JWO, 2000, J MOL EVOL, V51, P64, DOI 10.1007/s002390010067; Bleyman Lea K., 1996, P291; Blouin MS, 1998, MOL BIOL EVOL, V15, P1719, DOI 10.1093/oxfordjournals.molbev.a025898; Brunk CF, 2003, NUCLEIC ACIDS RES, V31, P1673, DOI 10.1093/nar/gkg270; BRUNK CF, 1969, EXP CELL RES, V54, P143, DOI 10.1016/0014-4827(69)90225-0; Burger G, 2000, J MOL BIOL, V297, P365, DOI 10.1006/jmbi.2000.3529; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Chiang YC, 2003, AM J BOT, V90, P561, DOI 10.3732/ajb.90.4.561; CLAYTON DA, 1992, INT REV CYTOL, V141, P217, DOI 10.1016/S0074-7696(08)62067-7; Crandall KA, 1997, NATURE, V387, P667, DOI 10.1038/42628; Dagan T, 2002, MOL BIOL EVOL, V19, P1022, DOI 10.1093/oxfordjournals.molbev.a004161; Denver DR, 2000, SCIENCE, V289, P2342, DOI 10.1126/science.289.5488.2342; DOOLITTLE RF, 1990, METHOD ENZYMOL, V183, P99; Edqvist J, 2000, J MOL BIOL, V297, P381, DOI 10.1006/jmbi.2000.3530; ENGBERG J, 1990, NUCLEIC ACIDS RES, V18, P6915, DOI 10.1093/nar/18.23.6915; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fares MA, 2004, BIOINFORMATICS, V20, P2867, DOI 10.1093/bioinformatics/bth303; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gray MW, 1998, NUCLEIC ACIDS RES, V26, P865, DOI 10.1093/nar/26.4.865; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; Hu Yin-gang, 2003, Xibei Zhiwu Xuebao, V23, P875; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KORBER B, 2001, HIV SIGNATURE SEQUEN, P55; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; LI WH, 1997, MOL EVOLUTION, P216; Lopez R, 2003, NUCLEIC ACIDS RES, V31, P3795, DOI 10.1093/nar/gkg573; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MORIN GB, 1988, CELL, V52, P367, DOI 10.1016/S0092-8674(88)80029-1; MORIN GB, 1988, MOL CELL BIOL, V8, P4450, DOI 10.1128/MCB.8.10.4450; MOUNT DW, 2001, BIOINFORMATICS SEQUE, P96; NANNY DL, 2000, LAB EVOLUTIONARY HIS, P4; NEI M, 1986, MOL BIOL EVOL, V3, P418; ORIAS E, 1976, METHOD CELL BIOL, V8, P247; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shao RF, 2003, MOL BIOL EVOL, V20, P362, DOI 10.1093/molbev/msg045; Siltberg J, 2002, J EVOLUTION BIOL, V15, P588, DOI 10.1046/j.1420-9101.2002.00416.x; TAJIMA F, 1989, GENETICS, V123, P585; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thorstenson YR, 1998, GENOME RES, V8, P848, DOI 10.1101/gr.8.8.848; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Yokoyama S, 1996, ANNU REV ECOL SYST, V27, P543, DOI 10.1146/annurev.ecolsys.27.1.543; Yu FL, 2005, PLOS GENET, V1, P404, DOI 10.1371/journal.pgen.0010041; Zhang JZ, 2000, J MOL EVOL, V50, P56, DOI 10.1007/s002399910007	54	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e650	10.1371/journal.pone.0000650	http://dx.doi.org/10.1371/journal.pone.0000650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653277	gold, Green Submitted, Green Published			2022-12-27	WOS:000207452200019
J	Mikenberg, I; Widera, D; Kaus, A; Kaltschmidt, B; Kaltschmidt, C				Mikenberg, Ilja; Widera, Darius; Kaus, Aljoscha; Kaltschmidt, Barbara; Kaltschmidt, Christian			Transcription Factor NF-kappa B Is Transported to the Nucleus via Cytoplasmic Dynein/Dynactin Motor Complex in Hippocampal Neurons	PLOS ONE			English	Article								Background. Long-term changes in synaptic plasticity require gene transcription, indicating that signals generated at the synapse must be transported to the nucleus. Synaptic activation of hippocampal neurons is known to trigger retrograde transport of transcription factor NF-kappa B. Transcription factors of the NF-kappa B family are widely expressed in the nervous system and regulate expression of several genes involved in neuroplasticity, cell survival, learning and memory. Principal Findings. In this study, we examine the role of the dynein/dynactin motor complex in the cellular mechanism targeting and transporting activated NF-kappa B to the nucleus in response to synaptic stimulation. We demonstrate that overexpression of dynamitin, which is known to dissociate dynein from microtubules, and treatment with microtubule-disrupting drugs inhibits nuclear accumulation of NF-kappa B p65 and reduces NF-kappa B-dependent transcription activity. In this line, we show that p65 is associated with components of the dynein/dynactin complex in vivo and in vitro and that the nuclear localization sequence (NLS) within NF-kappa B p65 is essential for this binding. Conclusion. This study shows the molecular mechanism for the retrograde transport of activated NF-kappa B from distant synaptic sites towards the nucleus.	[Mikenberg, Ilja; Widera, Darius; Kaus, Aljoscha; Kaltschmidt, Barbara; Kaltschmidt, Christian] Univ Witten Herdecke, Inst Neurobiochem, Witten, Germany	Witten Herdecke University	Kaltschmidt, C (corresponding author), Univ Bielefeld, Fak Biol, Lehrstuhl Zellbiol Tiere, D-4800 Bielefeld, Germany.	c.kaltschmidt@uni-bielefeld.de	Widera, Darius/J-4237-2012	Widera, Darius/0000-0003-1686-130X	Deutsche Forschungsgemeinschaft (DFG); Gerhard C. Starck Stiftung; Institute for Biochemistry, University of Giessen, Germany [pBI-EGFP-TAP-p65]; Columbia University Medical Center	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Gerhard C. Starck Stiftung; Institute for Biochemistry, University of Giessen, Germany; Columbia University Medical Center	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) and by Gerhard C. Starck Stiftung.; We acknowledge the kind gifts of pBI-EGFP-TAP-p65 from Lienhard M. Schmitz, Institute for Biochemistry, University of Giessen, Germany and pCMV beta-Dynamitin from Richard Vallee, Columbia University Medical Center. Expert technical assistance by Maria Prullage and Julia Pfeiffer is gratefully acknowledged. We thank Marina Rodnina, Hans-Joachim Lipps and Wolfgang Wintermeyer for helpful and essential advice on the biochemical assays.	Ahmad FJ, 1998, J CELL BIOL, V140, P391, DOI 10.1083/jcb.140.2.391; Albensi BC, 2000, SYNAPSE, V35, P151; AMBRON RT, 1992, J NEUROSCI, V12, P2813; BASKIN LS, 1982, BIOCHIM BIOPHYS ACTA, V684, P263, DOI 10.1016/0005-2736(82)90015-3; Bhakar AL, 2002, J NEUROSCI, V22, P8466; BLANK V, 1991, EMBO J, V10, P4159, DOI 10.1002/j.1460-2075.1991.tb04994.x; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Boylan K, 2000, MOL BIOL CELL, V11, P3791, DOI 10.1091/mbc.11.11.3791; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Campbell EA, 2003, ADV DRUG DELIVER REV, V55, P761, DOI 10.1016/S0169-409X(03)00049-8; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; GUERRINI L, 1995, P NATL ACAD SCI USA, V92, P9077, DOI 10.1073/pnas.92.20.9077; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Hamanoue M, 1999, MOL CELL NEUROSCI, V14, P28, DOI 10.1006/mcne.1999.0770; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hanz S, 2004, NEUROSCIENTIST, V10, P404, DOI 10.1177/1073858404267884; HOLZBAUR ELF, 1991, NATURE, V351, P579, DOI 10.1038/351579a0; HORDERN JS, 1979, VIROLOGY, V97, P131, DOI 10.1016/0042-6822(79)90379-9; JOSHI S, 1990, J BIOL CHEM, V265, P14518; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; KALTSCHMIDT C, 1993, MECH DEVELOP, V43, P135, DOI 10.1016/0925-4773(93)90031-R; KALTSCHMIDT C, 1994, MOL CELL BIOL, V14, P3981, DOI 10.1128/MCB.14.6.3981; KALTSCHMIDT C, 1995, P NATL ACAD SCI USA, V92, P9618, DOI 10.1073/pnas.92.21.9618; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Lam MHC, 2002, MOL ENDOCRINOL, V16, P390, DOI 10.1210/me.16.2.390; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lilienbaum A, 2003, MOL CELL BIOL, V23, P2680, DOI 10.1128/MCB.23.8.2680-2698.2003; Meberg PJ, 1996, MOL BRAIN RES, V38, P179, DOI 10.1016/0169-328X(95)00229-L; Meffert MK, 2005, TRENDS NEUROSCI, V28, P37, DOI 10.1016/j.tins.2004.11.002; MEFFERT MK, 2003, NAT NEUROSCI; MELLONI RH, 1995, J COMP NEUROL, V357, P15, DOI 10.1002/cne.903570103; Merlo E, 2005, LEARN MEMORY, V12, P23, DOI 10.1101/lm.82705; Merlo E, 2002, NEUROSCIENCE, V112, P161, DOI 10.1016/S0306-4522(02)00049-0; Mesika A, 2005, HUM GENE THER, V16, P200, DOI 10.1089/hum.2005.16.200; Mikenberg I, 2006, EUR J CELL BIOL, V85, P529, DOI 10.1016/j.ejcb.2006.02.007; O'Mahony A, 2006, MOL CELL BIOL, V26, P7283, DOI 10.1128/MCB.00510-06; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Romano A, 2006, EUR J NEUROSCI, V24, P1507, DOI 10.1111/j.1460-9568.2006.05022.x; Salman H, 2005, BIOPHYS J, V89, P2134, DOI 10.1529/biophysj.105.060160; SCHWEIZER E, 1982, BIOCHEMISTRY-US, V21, P6807, DOI 10.1021/bi00269a029; Shah JV, 2000, MOL BIOL CELL, V11, P3495, DOI 10.1091/mbc.11.10.3495; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; Tokito MK, 1996, MOL BIOL CELL, V7, P1167, DOI 10.1091/mbc.7.8.1167; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Wellmann H, 2001, J BIOL CHEM, V276, P11821, DOI 10.1074/jbc.M009253200; Yeh SH, 2004, MOL PHARMACOL, V65, P1286, DOI 10.1124/mol.65.5.1286; Yeh SH, 2002, J BIOL CHEM, V277, P46720, DOI 10.1074/jbc.M206258200	60	84	86	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2007	2	7							e589	10.1371/journal.pone.0000589	http://dx.doi.org/10.1371/journal.pone.0000589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GH	17622342	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000207452000004
J	Schrambach, S; Ardizzone, M; Leymarie, V; Sibilia, J; Bahram, S				Schrambach, Stephanie; Ardizzone, Marc; Leymarie, Vincent; Sibilia, Jean; Bahram, Seiamak			In Vivo Expression Pattern of MICA and MICB and Its Relevance to Auto-Immunity and Cancer	PLOS ONE			English	Article								Non-conventional MHC class I MIC molecules interact not with the TCR, but with NKG2D, a C-type lectin activatory receptor present on most NK, gamma delta and CD8(+) alpha beta T cells. While this interaction is critical in triggering/calibrating the cytotoxic activity of these cells, the actual extent of its in vivo involvement, in man, in infection, cancer or autoimmunity, needs further assessment. The latter has gained momentum along with the reported expansion of peripheral CD4(+)CD28(-) NKG2D(+) T cells in rheumatoid arthritis (RA). We first initiated to extend this report to a larger cohort of not only RA patients, but also those affected by systemic lupus erythematosus (SLE) and Sjogren's syndrome (SS). In RA and SS, this initial observation was further tested in target tissues: the joint and the salivary glands, respectively. In conclusion and despite occasional and indiscriminate expansion of the previously incriminated T cell subpopulation, no correlation could be observed between the CD4(+)CD28(-)NKG2D(+) and auto-immunity. Moreover, in situ, the presence of NKG2D matched that of CD8(+), but not that of CD4(+) T cells. In parallel, a total body tissue scan of both MICA and MICB transcription clearly shows that despite original presumptions, and with the exception of the central nervous system, both genes are widely transcribed and therefore possibly translated and membrane-bound. Extending this analysis to a number of human tumors did not reveal a coherent pattern of expression vs. normal tissues. Collectively these data question previous assumptions, correlating a tissue-specific expression/induction of MIC in relevance to auto-immune or tumor processes.	[Schrambach, Stephanie; Ardizzone, Marc; Bahram, Seiamak] Hop Univ Strasbourg, Lab Cent Immunol, Strasbourg, France; [Schrambach, Stephanie; Ardizzone, Marc; Sibilia, Jean] Hop Univ Strasbourg, Serv Rhumatol, Strasbourg, France; [Schrambach, Stephanie; Ardizzone, Marc; Bahram, Seiamak] Fac Med Strasbourg, Ctr Rech Immunol & Hematol, Strasbourg, France; [Leymarie, Vincent] Hop Univ Strasbourg, Hematol Lab, Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bahram, S (corresponding author), Hop Univ Strasbourg, Lab Cent Immunol, Strasbourg, France.	siamak@hemato-ulp.u-strasbg.fr	Bahram, Seiamak/GZA-7150-2022	Bahram, Seiamak/0000-0002-6928-9952; Sibilia, Jean/0000-0002-1601-4795	Universite Louis Pasteur; Hopitaux Universitaires de Strasbourg; Association Francaise du Gougerot Sjogren et des syndromes secs; Ligue contre le Cancer; Association pour la recherche sur le Cancer (ARC)	Universite Louis Pasteur; Hopitaux Universitaires de Strasbourg; Association Francaise du Gougerot Sjogren et des syndromes secs; Ligue contre le Cancer(Ligue nationale contre le cancer); Association pour la recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by the Universite Louis Pasteur, the Hopitaux Universitaires de Strasbourg, the Association Francaise du Gougerot Sjogren et des syndromes secs, the Ligue contre le Cancer, the Association pour la recherche sur le Cancer (ARC).	Amezaga N, 2006, TRANSPL IMMUNOL, V17, P39, DOI 10.1016/j.trim.2006.09.016; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bahram S, 2005, CURR OPIN IMMUNOL, V17, P505, DOI 10.1016/j.coi.2005.07.016; Bahram S, 1996, IMMUNOGENETICS, V43, P230, DOI 10.1007/BF00587305; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Bahram S, 2000, Adv Immunol, V76, P1; Benoist C, 2000, ARTHRITIS RES, V2, P90, DOI 10.1186/ar73; Busche A, 2006, HUM GENE THER, V17, P135, DOI 10.1089/hum.2006.17.135; Carbone E, 2005, BLOOD, V105, P251, DOI 10.1182/blood-2004-04-1422; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Cervera R, 2006, AUTOIMMUN REV, V5, P180, DOI 10.1016/j.autrev.2005.06.004; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Das H, 2001, IMMUNITY, V15, P83, DOI 10.1016/S1074-7613(01)00168-6; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Fodil N, 1999, IMMUNOGENETICS, V49, P557, DOI 10.1007/s002510050536; Friese MA, 2003, CANCER RES, V63, P8996; Girlanda S, 2005, CANCER RES, V65, P7502, DOI 10.1158/0008-5472.CAN-05-0731; Goronzy JJ, 2005, IMMUNOL REV, V204, P55, DOI 10.1111/j.0105-2896.2005.00245.x; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Hansen A, 2003, CURR OPIN RHEUMATOL, V15, P563, DOI 10.1097/00002281-200309000-00007; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; James JA, 2001, CURR OPIN RHEUMATOL, V13, P370, DOI 10.1097/00002281-200109000-00005; JANEWAY C, 2004, IMMUNOBIOLOGY IMMUNE, P800; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Klareskog L, 2006, CURR OPIN IMMUNOL, V18, P650, DOI 10.1016/j.coi.2006.06.004; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lindahl KF, 1997, ANNU REV IMMUNOL, V15, P851; Lohr J, 2005, IMMUNOL REV, V204, P116, DOI 10.1111/j.0105-2896.2005.00241.x; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; McCann FE, 2007, J IMMUNOL, V178, P3418, DOI 10.4049/jimmunol.178.6.3418; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Monach PA, 2004, ADV IMMUNOL, V82, P217, DOI 10.1016/S0065-2776(04)82005-4; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; Ogasawara K, 2005, J CLIN IMMUNOL, V25, P534, DOI 10.1007/s10875-005-8786-4; Orchard TR, 2001, CLIN EXP IMMUNOL, V126, P437, DOI 10.1046/j.1365-2249.2001.01662.x; Perera L, 2007, INFLAMM BOWEL DIS, V13, P298, DOI 10.1002/ibd.20026; Radosavljevic M, 2002, GENOMICS, V79, P114, DOI 10.1006/geno.2001.6673; Rioux JD, 2005, NATURE, V435, P584, DOI 10.1038/nature03723; Romero P, 2006, ADV IMMUNOL, V92, P187, DOI 10.1016/S0065-2776(06)92005-7; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Saez-Borderias A, 2006, EUR J IMMUNOL, V36, P3198, DOI 10.1002/eji.200636682; Schmidt D, 1996, J CLIN INVEST, V97, P2027, DOI 10.1172/JCI118638; SHAWAR SM, 1994, ANNU REV IMMUNOL, V12, P839, DOI 10.1146/annurev.immunol.12.1.839; Strong RK, 2002, MOL IMMUNOL, V38, P1029, DOI 10.1016/S0161-5890(02)00032-9; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wagner U, 2003, EUR J IMMUNOL, V33, P79, DOI 10.1002/immu.200390010; Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701	50	69	76	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2007	2	6							e518	10.1371/journal.pone.0000518	http://dx.doi.org/10.1371/journal.pone.0000518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GD	17565371	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451600006
J	Patel, A; Fondrk, MK; Kaftanoglu, O; Emore, C; Hunt, G; Frederick, K; Amdam, GV				Patel, Avani; Fondrk, M. Kim; Kaftanoglu, Osman; Emore, Christine; Hunt, Greg; Frederick, Katy; Amdam, Gro V.			The Making of a Queen: TOR Pathway Is a Key Player in Diphenic Caste Development	PLOS ONE			English	Article							HONEY-BEE; APIS-MELLIFERA; SIGNALING PATHWAY; VITELLOGENIN; DIFFERENTIATION; EXPRESSION; INSECT; NUMBER; TARGET; GROWTH	Background. Honey bees (Apis mellifera) provide a principal example of diphenic development. Excess feeding of female larvae results in queens (large reproductives). Moderate diet yields workers (small helpers). The signaling pathway that links provisioning to female developmental fate is not understood, yet we reasoned that it could include TOR (target of rapamycin), a nutrient-and energy-sensing kinase that controls organismal growth. Methodology/Principal Findings. Here, the role of Apis mellifera TOR (amTOR) in caste determination is examined by rapamycin/FK506 pharmacology and RNA interference (RNAi) gene knockdown. We show that in queen-destined larvae, the TOR inhibitor rapamycin induces the development of worker characters that are blocked by the antagonist FK506. Further, queen fate is associated with elevated activity of the Apis mellifera TOR encoding gene, amTOR, and amTOR gene knockdown blocks queen fate and results in individuals with worker morphology. Conclusions/Significance. A much-studied insect dimorphism, thereby, can be governed by the TOR pathway. Our results present the first evidence for a role of TOR in diphenic development, and suggest that adoption of this ancestral nutrient-sensing cascade is one evolutionary pathway for morphological caste differentiation in social insects.	[Patel, Avani; Fondrk, M. Kim; Kaftanoglu, Osman; Frederick, Katy; Amdam, Gro V.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Emore, Christine; Hunt, Greg] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Amdam, Gro V.] Norwegian Univ Life Sci, Anim & Aquacultural Sci Dept, As, Norway	Arizona State University; Arizona State University-Tempe; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Norwegian University of Life Sciences	Amdam, GV (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	Gro.Amdam@asu.edu			Norwegian Research Council [171958, 175413]; U.S. National Science Foundation [0615502]; National Institute on Aging [PO1 AG22500]; Pew Foundation; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER	Norwegian Research Council(Research Council of NorwayEuropean Commission); U.S. National Science Foundation(National Science Foundation (NSF)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Pew Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support was provided by the Norwegian Research Council # 171958, # 175413, U.S. National Science Foundation # 0615502, National Institute on Aging PO1 AG22500 and the Pew Foundation.	Aase ALTO, 2005, APIDOLOGIE, V36, P293, DOI 10.1051/apido:2005003; Amdam GV, 2006, BEHAV BRAIN RES, V169, P201, DOI 10.1016/j.bbr.2006.01.006; Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; Aronstein K, 2006, J APICULT RES, V45, P20, DOI 10.1080/00218839.2006.11101307; Berrigan D, 1998, EVOL ECOL, V12, P535, DOI 10.1023/A:1006552608754; BERRIGAN D, 1991, OIKOS, V60, P313, DOI 10.2307/3545073; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Cristino AS, 2006, INSECT MOL BIOL, V15, P703, DOI 10.1111/j.1365-2583.2006.00696.x; Dedej S, 1998, J APICULT RES, V37, P183, DOI 10.1080/00218839.1998.11100970; ENGELS W, 1990, SOCIAL INSECTS EVOLU, P264; Guertin DA, 2006, CURR BIOL, V16, P958, DOI 10.1016/j.cub.2006.03.084; Guidugli KR, 2005, ARCH INSECT BIOCHEM, V59, P211, DOI 10.1002/arch.20061; Hafen E, 2003, CURR TOP MICROBIOL, V279, P153; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; Maeterlinck Maurice, 1901, LIFE BEE; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Page RE, 2007, BIOESSAYS, V29, P334, DOI 10.1002/bies.20549; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Reiss M.J., 1989, ALLOMETRY GROWTH REP; REMBOLD H, 1981, J APICULT RES, V20, P165, DOI 10.1080/00218839.1981.11100492; Rembold H, 1964, Hoppe Seylers Z Physiol Chem, V339, P251, DOI 10.1515/bchm2.1964.339.1.251; REMBOLD H, 1974, J INSECT PHYSIOL, V20, P1193, DOI 10.1016/0022-1910(74)90225-X; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; VANDENBERG JD, 1987, J APICULT RES, V26, P90, DOI 10.1080/00218839.1987.11100743; West-Eberhard M.J., 1987, P35; Wheeler DE, 2006, INSECT MOL BIOL, V15, P597, DOI 10.1111/j.1365-2583.2006.00681.x; Winston M.L., 1991, BIOL HONEY BEE; WIRTZ P, 1972, ENTOMOL EXP APPL, V15, P517, DOI 10.1007/BF00293616; WOYKE J, 1977, J APICULT RES, V16, P84, DOI 10.1080/00218839.1977.11099866	35	209	227	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e509	10.1371/journal.pone.0000509	http://dx.doi.org/10.1371/journal.pone.0000509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551589	gold, Green Published, Green Submitted			2022-12-27	WOS:000207451500018
J	Sampath, R; Russell, KL; Massire, C; Eshoo, MW; Harpin, V; Blyn, LB; Melton, R; Ivy, C; Pennella, T; Li, F; Levene, H; Hall, TA; Libby, B; Fan, N; Walcott, DJ; Ranken, R; Pear, M; Schink, A; Gutierrez, J; Drader, J; Moore, D; Metzgar, D; Addington, L; Rothman, R; Gaydos, CA; Yang, S; St George, K; Fuschino, ME; Dean, AB; Stallknecht, DE; Goekjian, G; Yingst, S; Monteville, M; Saad, MD; Whitehouse, CA; Baldwin, C; Rudnick, KH; Hofstadler, SA; Lemon, SM; Ecker, DJ				Sampath, Rangarajan; Russell, Kevin L.; Massire, Christian; Eshoo, Mark W.; Harpin, Vanessa; Blyn, Lawrence B.; Melton, Rachael; Ivy, Cristina; Pennella, Thuy; Li, Feng; Levene, Harold; Hall, Thomas A.; Libby, Brian; Fan, Nancy; Walcott, Demetrius J.; Ranken, Raymond; Pear, Michael; Schink, Amy; Gutierrez, Jose; Drader, Jared; Moore, David; Metzgar, David; Addington, Lynda; Rothman, Richard; Gaydos, Charlotte A.; Yang, Samuel; St. George, Kirsten; Fuschino, Meghan E.; Dean, Amy B.; Stallknecht, David E.; Goekjian, Ginger; Yingst, Samuel; Monteville, Marshall; Saad, Magdi D.; Whitehouse, Chris A.; Baldwin, Carson; Rudnick, Karl H.; Hofstadler, Steven A.; Lemon, Stanley M.; Ecker, David J.			Global Surveillance of Emerging Influenza Virus Genotypes by Mass Spectrometry	PLOS ONE			English	Article								Background. Effective influenza surveillance requires new methods capable of rapid and inexpensive genomic analysis of evolving viral species for pandemic preparedness, to understand the evolution of circulating viral species, and for vaccine strain selection. We have developed one such approach based on previously described broad-range reverse transcription PCR/electrospray ionization mass spectrometry (RT-PCR/ESI-MS) technology. Methods and Principal Findings. Analysis of base compositions of RT-PCR amplicons from influenza core gene segments (PB1, PB2, PA, M, NS, NP) are used to provide subspecies identification and infer influenza virus H and N subtypes. Using this approach, we detected and correctly identified 92 mammalian and avian influenza isolates, representing 30 different H and N types, including 29 avian H5N1 isolates. Further, direct analysis of 656 human clinical respiratory specimens collected over a seven-year period (1999-2006) showed correct identification of the viral species and subtypes with >97% sensitivity and specificity. Base composition derived clusters inferred from this analysis showed 100% concordance to previously established clades. Ongoing surveillance of samples from the recent influenza virus seasons (2005-2006) showed evidence for emergence and establishment of new genotypes of circulating H3N2 strains worldwide. Mixed viral quasispecies were found in approximately 1% of these recent samples providing a view into viral evolution. Conclusion/Significance. Thus, rapid RT-PCR/ESI-MS analysis can be used to simultaneously identify all species of influenza viruses with clade-level resolution, identify mixed viral populations and monitor global spread and emergence of novel viral genotypes. This high-throughput method promises to become an integral component of influenza surveillance.	[Sampath, Rangarajan; Massire, Christian; Eshoo, Mark W.; Harpin, Vanessa; Blyn, Lawrence B.; Melton, Rachael; Ivy, Cristina; Pennella, Thuy; Li, Feng; Levene, Harold; Hall, Thomas A.; Libby, Brian; Fan, Nancy; Walcott, Demetrius J.; Ranken, Raymond; Pear, Michael; Schink, Amy; Gutierrez, Jose; Drader, Jared; Moore, David; Hofstadler, Steven A.; Ecker, David J.] Ibis Biosci Inc, Carlsbad, CA USA; [Russell, Kevin L.; Metzgar, David; Addington, Lynda] USN, Hlth Res Ctr, Resp Dis Lab, San Diego, CA 92152 USA; [Rothman, Richard; Gaydos, Charlotte A.; Yang, Samuel] Johns Hopkins Med Inst, Dept Emergency Med & Med, Baltimore, MD 21205 USA; [St. George, Kirsten; Fuschino, Meghan E.; Dean, Amy B.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Stallknecht, David E.; Goekjian, Ginger] Univ Georgia, Coll Vet Med, Athens, GA USA; [Yingst, Samuel; Monteville, Marshall; Saad, Magdi D.] Naval Med Res Unit 3, Cairo, Egypt; [Whitehouse, Chris A.; Baldwin, Carson] USA, Ft Detrick, MD USA; [Rudnick, Karl H.] Sci Applicat Int Corp, San Diego, CA 92121 USA; [Lemon, Stanley M.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX USA	United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); Johns Hopkins University; Johns Hopkins Medicine; State University of New York (SUNY) System; Wadsworth Center; University System of Georgia; University of Georgia; Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3); Science Applications International Corporation (SAIC); University of Texas System; University of Texas Medical Branch Galveston	Sampath, R (corresponding author), Ibis Biosci Inc, Carlsbad, CA USA.	rsampath@ibisbio.com	Saad, Magdi/H-5561-2013; Gaydos, Charlotte A./E-9937-2010	Saad, Magdi/0000-0003-2111-8115; Ecker, David/0000-0003-4350-9037; Yang, Samuel/0000-0003-1123-9036; Rothman, Richard/0000-0002-1017-9505	DARPA; U.S. Department of Defense; CDC [R01-CI-000099]; NIAID, NIH [IUCIAI067232-01]	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); U.S. Department of Defense(United States Department of Defense); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The RT-PCR/ESI-MS technology development was funded by DARPA, a division of the U.S. Department of Defense. Funding from the CDC and NIAID supported the influenza surveillance assay development and screening described here. The sponsors had no role in the design, implementation or conlusions of the assay.; The author thank the CDC (Extramural Grant: R01-CI-000099) and NIAID (NIH Grant IUCIAI067232-01) for financial support.	Barr IG, 2005, J MED VIROL, V76, P391, DOI 10.1002/jmv.20374; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Ecker D, 2006, J ASS LAB AUTOM, P341; Ecker DJ, 2005, P NATL ACAD SCI USA, V102, P8012, DOI 10.1073/pnas.0409920102; Hofstadler SA, 2005, INT J MASS SPECTROM, V242, P23, DOI 10.1016/j.ijms.2004.09.014; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Jiang Y, 2003, ANAL BIOCHEM, V316, P50, DOI 10.1016/S0003-2697(03)00024-1; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Kilbourne ED, 2004, VIRAL IMMUNOL, V17, P350, DOI 10.1089/0882824041857076; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Muddiman DC, 1997, ANAL CHEM, V69, P1543, DOI 10.1021/ac961134r; Puthavathana P, 2005, J GEN VIROL, V86, P423, DOI 10.1099/vir.0.80368-0; Ruest A, 2003, J CLIN MICROBIOL, V41, P3487, DOI 10.1128/JCM.41.8.3487-3493.2003; Sampath R, 2005, EMERG INFECT DIS, V11, P373, DOI 10.3201/eid1103.040629; Sampath R, 2007, ANN NY ACAD SCI, V1102, P109, DOI 10.1196/annals.1408.008; Schweiger B, 2000, J CLIN MICROBIOL, V38, P1552, DOI 10.1128/JCM.38.4.1552-1558.2000; Simonsen L, 2000, J INFECT DIS, V181, P831, DOI 10.1086/315320; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; van Elden LJR, 2001, BRIT J GEN PRACT, V51, P630; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001; WRIGHT KE, 1995, J CLIN MICROBIOL, V33, P1180, DOI 10.1128/JCM.33.5.1180-1184.1995; Xu XY, 2002, J INFECT DIS, V186, P1490, DOI 10.1086/344738	26	107	152	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2007	2	5							e489	10.1371/journal.pone.0000489	http://dx.doi.org/10.1371/journal.pone.0000489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10FB	17534439	Green Published, Green Submitted, gold			2022-12-27	WOS:000207448800019
J	Dadachova, E; Bryan, RA; Huang, XC; Moadel, T; Schweitzer, AD; Aisen, P; Nosanchuk, JD; Casadevall, A				Dadachova, Ekaterina; Bryan, Ruth A.; Huang, Xianchun; Moadel, Tiffany; Schweitzer, Andrew D.; Aisen, Philip; Nosanchuk, Joshua D.; Casadevall, Arturo			Ionizing Radiation Changes the Electronic Properties of Melanin and Enhances the Growth of Melanized Fungi	PLOS ONE			English	Article							VIRULENCE; RESISTANCE; ROLES	Background. Melanin pigments are ubiquitous in nature. Melanized microorganisms are often the dominating species in certain extreme environments, such as soils contaminated with radionuclides, suggesting that the presence of melanin is beneficial in their life cycle. We hypothesized that ionizing radiation could change the electronic properties of melanin and might enhance the growth of melanized microorganisms. Methodology/Principal Findings. Ionizing irradiation changed the electron spin resonance (ESR) signal of melanin, consistent with changes in electronic structure. Irradiated melanin manifested a 4-fold increase in its capacity to reduce NADH relative to non-irradiated melanin. HPLC analysis of melanin from fungi grown on different substrates revealed chemical complexity, dependence of melanin composition on the growth substrate and possible influence of melanin composition on its interaction with ionizing radiation. XTT/MTT assays showed increased metabolic activity of melanized C. neoformans cells relative to non-melanized cells, and exposure to ionizing radiation enhanced the electron-transfer properties of melanin in melanized cells. Melanized Wangiella dermatitidis and Cryptococcus neoformans cells exposed to ionizing radiation approximately 500 times higher than background grew significantly faster as indicated by higher CFUs, more dry weight biomass and 3-fold greater incorporation of 14 C-acetate than non-irradiated melanized cells or irradiated albino mutants. In addition, radiation enhanced the growth of melanized Cladosporium sphaerospermum cells under limited nutrients conditions. Conclusions/Significance. Exposure of melanin to ionizing radiation, and possibly other forms of electromagnetic radiation, changes its electronic properties. Melanized fungal cells manifested increased growth relative to non-melanized cells after exposure to ionizing radiation, raising intriguing questions about a potential role for melanin in energy capture and utilization.	[Dadachova, Ekaterina; Bryan, Ruth A.; Huang, Xianchun; Moadel, Tiffany; Schweitzer, Andrew D.] Albert Einstein Coll Med, Dept Nucl Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Dadachova, E (corresponding author), Albert Einstein Coll Med, Dept Nucl Med, Bronx, NY 10467 USA.	edadacho@aecom.yu.edu	Nosanchuk, Joshua/AAS-7801-2021; Dadachova, Ekaterina/I-7838-2013; Schweitzer, Andrew/M-3702-2013	Schweitzer, Andrew/0000-0001-9538-8076	NIH [AI52733]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052733] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was partially supported by NIH grant AI52733 (AC and JN). Funders played no role in this study.	Beatty JT, 2005, P NATL ACAD SCI USA, V102, P9306, DOI 10.1073/pnas.0503674102; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Boomer SM, 2000, ARCH MICROBIOL, V174, P152, DOI 10.1007/s002030000189; Casadevall A, 2005, FUNGAL GENET BIOL, V42, P98, DOI 10.1016/j.fgb.2004.11.008; CONTER A, 1986, ARCH MICROBIOL, V144, P286, DOI 10.1007/BF00410964; CROUTE F, 1982, RADIAT RES, V92, P560, DOI 10.2307/3575928; DAVIS M, 1985, NATURE, V313, P503, DOI 10.1038/313503a0; Eisenman HC, 2005, BIOCHEMISTRY-US, V44, P3683, DOI 10.1021/bi047731m; ENOCHS WS, 1993, PIGM CELL RES, V6, P91, DOI 10.1111/j.1600-0749.1993.tb00587.x; Feng B, 2001, INFECT IMMUN, V69, P1781, DOI 10.1128/IAI.69.3.1781-1794.2001; Frases S, 2006, APPL ENVIRON MICROB, V72, P1542, DOI 10.1128/AEM.72.2.1542-1550.2006; GAN EV, 1976, ARCH BIOCHEM BIOPHYS, V173, P666, DOI 10.1016/0003-9861(76)90304-0; Garcia-Rivera J, 2005, FUNGAL GENET BIOL, V42, P989, DOI 10.1016/j.fgb.2005.09.003; Hicks JK, 2004, EUKARYOT CELL, V3, P14, DOI 10.1128/EC.3.1.14-26.2004; HILL HZ, 1992, BIOESSAYS, V14, P49, DOI 10.1002/bies.950140111; Hulot G, 2003, EARTH PLANET SC LETT, V210, P191, DOI 10.1016/S0012-821X(03)00130-4; ITO S, 1985, ANAL BIOCHEM, V144, P527, DOI 10.1016/0003-2697(85)90150-2; Jacobson ES, 2000, CLIN MICROBIOL REV, V13, P708, DOI 10.1128/CMR.13.4.708-717.2000; Jansonius J., 2000, Palynology, V24, P37, DOI 10.2113/0240037; Kuhn DM, 2003, J CLIN MICROBIOL, V41, P506, DOI 10.1128/JCM.41.1.506-508.2003; Lin LH, 2006, SCIENCE, V314, P479, DOI 10.1126/science.1127376; MIRCHINK TG, 1972, MIKROBIOLOGIYA, V41, P83; Nicolaus R.A., 1968, MELANINS, Vfirst; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; Robinson CH, 2001, NEW PHYTOL, V151, P341, DOI 10.1046/j.1469-8137.2001.00177.x; SALEH YG, 1988, APPL ENVIRON MICROB, V54, P2134, DOI 10.1128/AEM.54.8.2134-2135.1988; Sorenson JA, 1987, PHYS NUCL MED; Starratt AN, 2002, CAN J MICROBIOL, V48, P320, DOI 10.1139/w02-017; Steenbergen JN, 2001, P NATL ACAD SCI USA, V98, P15245, DOI 10.1073/pnas.261418798; Taylor TN, 2005, MYCOLOGIA, V97, P269, DOI 10.3852/mycologia.97.1.269; Vember V V, 2001, Mikrobiol Z, V63, P3; Wakamatsu K, 2002, PIGM CELL RES, V15, P174, DOI 10.1034/j.1600-0749.2002.02017.x; Wang YL, 1996, INFECT IMMUN, V64, P2420, DOI 10.1128/IAI.64.7.2420-2424.1996; WILCZOK T, 1984, ARCH BIOCHEM BIOPHYS, V231, P257, DOI 10.1016/0003-9861(84)90386-2; Zhdanova N N, 2002, Mikrobiol Z, V64, P47; ZHDANOVA N N, 1991, Mikrobiologicheskii Zhurnal (Kiev), V53, P9; Zhdanova NN, 2004, MYCOL RES, V108, P1089, DOI 10.1017/S0953756204000966	38	273	291	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2007	2	5							e457	10.1371/journal.pone.0000457	http://dx.doi.org/10.1371/journal.pone.0000457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DZ	17520016	gold, Green Published, Green Submitted			2022-12-27	WOS:000207446000005
J	Froula, JL; Francino, MP				Froula, Jeffrey L.; Francino, M. Pilar			Selection against Spurious Promoter Motifs Correlates with Translational Efficiency across Bacteria	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GENE-EXPRESSION LEVEL; TRANSFER-RNA GENES; ESCHERICHIA-COLI; CODON USAGE; SIGMA(70) SUBUNIT; TRANSCRIPTION; EVOLUTION; PROTEIN; POLYMERASE	Because binding of RNAP to misplaced sites could compromise the efficiency of transcription, natural selection for the optimization of gene expression should regulate the distribution of DNA motifs capable of RNAP-binding across the genome. Here we analyze the distribution of the -10 promoter motifs that bind the sigma(70) subunit of RNAP in 42 bacterial genomes. We show that selection on these motifs operates across the genome, maintaining an over-representation of -10 motifs in regulatory sequences while eliminating them from the nonfunctional and, in most cases, from the protein coding regions. In some genomes, however, -10 sites are over-represented in the coding sequences; these sites could induce pauses effecting regulatory roles throughout the length of a transcriptional unit. For nonfunctional sequences, the extent of motif under-representation varies across genomes in a manner that broadly correlates with the number of tRNA genes, a good indicator of translational speed and growth rate. This suggests that minimizing the time invested in gene transcription is an important selective pressure against spurious binding. However, selection against spurious binding is detectable in the reduced genomes of host-restricted bacteria that grow at slow rates, indicating that components of efficiency other than speed may also be important. Minimizing the number of RNAP molecules per cell required for transcription, and the corresponding energetic expense, may be most relevant in slow growers. These results indicate that genome-level properties affecting the efficiency of transcription and translation can respond in an integrated manner to optimize gene expression. The detection of selection against promoter motifs in nonfunctional regions also confirms previous results indicating that no sequence may evolve free of selective constraints, at least in the relatively small and unstructured genomes of bacteria.	[Froula, Jeffrey L.; Francino, M. Pilar] DOE Joint Genome Inst, Evolutionary Genom Program, Walnut Creek, CA USA	United States Department of Energy (DOE)	Francino, MP (corresponding author), DOE Joint Genome Inst, Evolutionary Genom Program, Walnut Creek, CA USA.	mpfrancino@lbl.gov	Francino, M.Pilar/H-9090-2015	Francino, M.Pilar/0000-0002-4510-5653	US Department of Energy's Office of Science; University of California, Lawrence Berkeley National Laboratory [DE-AC03-76SF00098]	US Department of Energy's Office of Science(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory(University of California System)	This work has been performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program and by the University of California, Lawrence Berkeley National Laboratory under contract No. DE-AC03-76SF00098.	ALTSCHUL SF, 1985, MOL BIOL EVOL, V2, P526; Babu MM, 2003, TRENDS MICROBIOL, V11, P59, DOI 10.1016/S0966-842X(02)00031-8; BENSON DA, 2005, NUCLEIC ACIDS RES, V38, P33; Brodolin K, 2004, NAT STRUCT MOL BIOL, V11, P551, DOI 10.1038/nsmb768; BULMER M, 1991, GENETICS, V129, P897; Clark MA, 1999, MOL BIOL EVOL, V16, P1586, DOI 10.1093/oxfordjournals.molbev.a026071; Dhandayuthapani S, 1998, GENE, V215, P213, DOI 10.1016/S0378-1119(98)00260-1; Dhiman A, 2000, J BACTERIOL, V182, P5076, DOI 10.1128/JB.182.18.5076-5081.2000; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Hahn MW, 2003, MOL BIOL EVOL, V20, P901, DOI 10.1093/molbev/msg096; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; HELMANN JD, 1995, NUCLEIC ACIDS RES, V23, P2351, DOI 10.1093/nar/23.13.2351; Herbeck JT, 2003, GENETICS, V165, P1651; Herbeck JT, 2003, MICROBIOL-SGM, V149, P2585, DOI 10.1099/mic.0.26381-0; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huerta AM, 2006, MOL BIOL EVOL, V23, P997, DOI 10.1093/molbev/msk004; Huerta AM, 2003, J MOL BIOL, V333, P261, DOI 10.1016/j.jmb.2003.07.017; Huerta AM, 2006, PLOS GENET, V2, P1740, DOI 10.1371/journal.pgen.0020185; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; KUMAR A, 1993, J MOL BIOL, V232, P406, DOI 10.1006/jmbi.1993.1400; Lewin B., 2000, GENES; LISSER S, 1993, NUCLEIC ACIDS RES, V21, P1507, DOI 10.1093/nar/21.7.1507; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; MAKINO K, 1988, J MOL BIOL, V203, P85, DOI 10.1016/0022-2836(88)90093-9; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; Mooney RA, 2003, GENE DEV, V17, P2839, DOI 10.1101/gad.1142203; Moran NA, 2004, CURR OPIN GENET DEV, V14, P627, DOI 10.1016/j.gde.2004.09.003; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Moran NA, 2005, J BACTERIOL, V187, P4229, DOI 10.1128/JB.187.12.4229-4237.2005; Moreno-Hagelsieb Gabriel, 2002, Bioinformatics, V18 Suppl 1, pS329; MOYLE H, 1991, J BACTERIOL, V173, P1944, DOI 10.1128/jb.173.6.1944-1950.1991; Nickels BE, 2004, NAT STRUCT MOL BIOL, V11, P544, DOI 10.1038/nsmb757; Ozoline ON, 1997, NUCLEIC ACIDS RES, V25, P4703, DOI 10.1093/nar/25.23.4703; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Salgado H, 2004, NUCLEIC ACIDS RES, V32, pD303, DOI 10.1093/nar/gkh140; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; Stone JR, 2001, MOL BIOL EVOL, V18, P1764, DOI 10.1093/oxfordjournals.molbev.a003964; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P2890, DOI 10.1093/nar/gkg398; Wade JT, 2004, P NATL ACAD SCI USA, V101, P17777, DOI 10.1073/pnas.0404305101; Weiner J, 2000, NUCLEIC ACIDS RES, V28, P4488, DOI 10.1093/nar/28.22.4488; WEISBURG WG, 1985, SCIENCE, V230, P556, DOI 10.1126/science.3931222; Wernegreen JJ, 1999, MOL BIOL EVOL, V16, P83, DOI 10.1093/oxfordjournals.molbev.a026040; Wilcox JL, 2003, MOL MICROBIOL, V48, P1491, DOI 10.1046/j.1365-2958.2003.03522.x	51	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e745	10.1371/journal.pone.0000745	http://dx.doi.org/10.1371/journal.pone.0000745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710145	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455200022
J	Williamson, P; Halleck, MS; Malowitz, J; Ng, S; Fan, XX; Krahling, S; Remaley, AT; Schlegel, RA				Williamson, Patrick; Halleck, Margaret S.; Malowitz, Jonathan; Ng, Susan; Fan, Xiaoxuan; Krahling, Stephen; Remaley, Alan T.; Schlegel, Robert A.			Transbilayer Phospholipid Movements in ABCA1-Deficient Cells	PLOS ONE			English	Article								Tangier disease is an inherited disorder that results in a deficiency in circulating levels of HDL. Although the disease is known to be caused by mutations in the ABCA1 gene, the mechanism by which lesions in the ABCA1 ATPase effect this outcome is not known. The inability of ABCA1 knockout mice (ABCA1(-/-)) to load cholesterol and phospholipids onto apoA1 led to a proposal that ABCA1 mediates the transbilayer externalization of phospholipids, an activity integral not only to the formation of HDL particles but also to another, distinct process: the recognition and clearance of apoptotic cells by macrophages. Expression of phosphatidylserine (PS) on the surface of both macrophages and their apoptotic targets is required for efficient engulfment of the apoptotic cells, and it has been proposed that ABCA1 is required for transbilayer externalization of PS to the surface of both cell types. To determine whether ABCA1 is responsible for any of the catalytic activities known to control transbilayer phospholipid movements, these activities were measured in cells from ABCA1(-/-) mice and from Tangier individuals as well as ABCA1-expressing HeLa cells. Phospholipid movements in either normal or apoptotic lymphocytes or in macrophages were not inhibited when cells from knockout and wildtype mice or immortalized cells from Tangier individuals vs normal individuals were compared. Exposure of PS on the surface of normal thymocytes, apoptotic thymocytes and elicited peritoneal macrophages from wildtype and knockout mice or B lymphocytes from normal and Tangier individuals, as measured by annexin V binding, was also unchanged. No evidence was found of ABCA1-stimulated active PS export, and spontaneous PS movement to the outer leaflet in the presence or absence of apoA1 was unaffected by the presence or absence of ABCA1. Normal or Tangier B lymphocytes and macrophages were also identical in their ability to serve as targets or phagocytes, respectively, in apoptotic cell clearance assays. No evidence was found to support the suggestion that ABCA1 is involved in transport to the macrophage cell surface of annexins I and II, known to enhance phagocytosis of apoptotic cells. These results show that mutations in ABCA1 do not measurably reduce the rate of transbilayer movements of phospholipids in either the engulfing macrophage or the apoptotic target, thus discounting catalysis of transbilayer movements of phospholipids as the mechanism by which ABCA1 facilitates loading of phospholipids and cholesterol onto apoA1.	[Williamson, Patrick; Malowitz, Jonathan; Ng, Susan] Amherst Coll, Dept Biol, Amherst, MA 01002 USA; [Halleck, Margaret S.; Fan, Xiaoxuan; Krahling, Stephen; Schlegel, Robert A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Remaley, Alan T.] NHLBI, NIH, Bethesda, MD 20892 USA	Amherst College; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Williamson, P (corresponding author), Amherst Coll, Dept Biol, Amherst, MA 01002 USA.	plwilliamson@amherst.edu	Eckhardt, Erik/G-1567-2010		American Heart Association, Pennsylvania; Faculty Research Awards Program of Amherst College; Howard Hughes Medical Institute	American Heart Association, Pennsylvania(American Heart Association); Faculty Research Awards Program of Amherst College; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Supported by the American Heart Association, Pennsylvania Affiliate (to RAS), the Faculty Research Awards Program of Amherst College (to PLW) and the Howard Hughes Medical Institute through an Undergraduate Biological Sciences Education Program award to Amherst College. Study sponsors had no role in either study design; collection, analysis, and interpretation of the data; writing of the paper; or decision to submit for publication.	Albrecht C, 2005, BLOOD, V106, P542, DOI 10.1182/blood-2004-05-2056; Alder-Baerens N, 2005, J BIOL CHEM, V280, P26321, DOI 10.1074/jbc.M413993200; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; BASSE F, 1993, BIOCHEMISTRY-US, V32, P2337, DOI 10.1021/bi00060a027; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Bortnick AE, 2000, J BIOL CHEM, V275, P28634, DOI 10.1074/jbc.M003407200; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Callahan MK, 2003, J LEUKOCYTE BIOL, V74, P846, DOI 10.1189/jlb.0902433; Callahan MK, 2000, CELL DEATH DIFFER, V7, P645, DOI 10.1038/sj.cdd.4400690; Chambenoit O, 2001, J BIOL CHEM, V276, P9955, DOI 10.1074/jbc.M010265200; Chapman LP, 2003, ENDOCRINOLOGY, V144, P1062, DOI 10.1210/en.2002-220650; Chau PL, 2006, BIOCHEMISTRY-US, V45, P3981, DOI 10.1021/bi052535g; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; ELLIS RE, 1991, GENETICS, V129, P79; FADOK VA, 1992, J IMMUNOL, V149, P4029; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fan XX, 2004, MOL BIOL CELL, V15, P2863, DOI 10.1091/mbc.E03-09-0670; Fielding PE, 2000, BIOCHEMISTRY-US, V39, P14113, DOI 10.1021/bi0004192; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Hamon Y, 2002, BBA-MOL CELL BIOL L, V1585, P64, DOI 10.1016/S1388-1981(02)00325-6; Kielar D, 2001, CLIN CHEM, V47, P2089; Krahling S, 1999, CELL DEATH DIFFER, V6, P183, DOI 10.1038/sj.cdd.4400473; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Locher KP, 2004, CURR OPIN STRUC BIOL, V14, P426, DOI 10.1016/j.sbi.2004.06.005; Luciani MF, 1996, EMBO J, V15, P226, DOI 10.1002/j.1460-2075.1996.tb00353.x; Marcil M, 1999, LANCET, V354, P1341, DOI 10.1016/S0140-6736(99)07026-9; Marguet D, 1999, NAT CELL BIOL, V1, P454, DOI 10.1038/15690; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Oram JF, 1999, J LIPID RES, V40, P1769; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; Pradhan D, 1997, MOL BIOL CELL, V8, P767, DOI 10.1091/mbc.8.5.767; Remaley AT, 2003, J LIPID RES, V44, P828, DOI 10.1194/jlr.M200475-JLR200; Remaley AT, 2001, BIOCHEM BIOPH RES CO, V280, P818, DOI 10.1006/bbrc.2000.4219; Remaley AT, 1999, P NATL ACAD SCI USA, V96, P12685, DOI 10.1073/pnas.96.22.12685; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schlegel RA, 1999, CELL DEATH DIFFER, V6, P583, DOI 10.1038/sj.cdd.4400529; Schlegel RA, 2001, CELL DEATH DIFFER, V8, P551, DOI 10.1038/sj.cdd.4400817; Smith JD, 2002, J BIOL CHEM, V277, P17797, DOI 10.1074/jbc.M201594200; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; Verhoven B, 1999, CELL DEATH DIFFER, V6, P262, DOI 10.1038/sj.cdd.4400491; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; WILLIAMSON P, 1995, BIOCHEMISTRY-US, V34, P10448, DOI 10.1021/bi00033a017; WILLIAMSON P, 1992, BIOCHEMISTRY-US, V31, P6355, DOI 10.1021/bi00142a027; Williamson P, 2002, BBA-MOL CELL BIOL L, V1585, P53, DOI 10.1016/S1388-1981(02)00324-4; Williamson P, 2001, BIOCHEMISTRY-US, V40, P8065, DOI 10.1021/bi001929z; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; Zwaal RFA, 2005, CELL MOL LIFE SCI, V62, P971, DOI 10.1007/s00018-005-4527-3; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003	53	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e729	10.1371/journal.pone.0000729	http://dx.doi.org/10.1371/journal.pone.0000729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710129	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455200006
J	Ben-Shachar, D; Karry, R				Ben-Shachar, Dorit; Karry, Rachel			Sp1 Expression Is Disrupted in Schizophrenia; A Possible Mechanism for the Abnormal Expression of Mitochondrial Complex I Genes, NDUFV1 and NDUFV2	PLOS ONE			English	Article							PHOSPHORYLATION; ACTIVATION; PROMOTER; BRAIN; SUBUNIT; INVOLVEMENT; DYSFUNCTION; PLATELETS; DOPAMINE; REVEALS	Background. The prevailing hypothesis regards schizophrenia as a polygenic disease, in which multiple genes combine with each other and with environmental stimuli to produce the variance of its clinical symptoms. We investigated whether the ubiquitous transcription factor Sp1 is abnormally expressed in schizophrenia, and consequently can affect the expression of genes implicated in this disorder. Methodology/Principal Findings. mRNA of Sp1 and of mitochondrial complex I subunits (NDUFV1, NDUFV2) was analyzed in three postmortem brain regions obtained from the Stanley Foundation Brain Collection, and in lymphocytes of schizophrenic patients and controls. Sp1 role in the transcription of these genes was studied as well. Sp1 was abnormally expressed in schizophrenia in both brain and periphery. Its mRNA alteration pattern paralleled that of NDUFV1 and NDUFV2, decreasing in the prefrontal cortex and the striatum, while increasing in the parieto-occipital cortex and in lymphocytes of schizophrenic patients as compared with controls. Moreover, a high and significant correlation between these genes existed in normal subjects, but was distorted in patients. Sp1 role in the regulation of complex I subunits, was demonstrated by the ability of the Sp1/DNA binding inhibitor, mithramycin, to inhibit the transcription of NDUFV1 and NDUFV2, in neuroblastoma cells. In addition, Sp1 activated NDUFV2 promoter by binding to its three GC-boxes. Both activation and binding were inhibited by mithramycin. Conclusions/Significance. These findings suggest that abnormality in Sp1, which can be the main activator/repressor or act in combination with additional transcription factors and is subjected to environmental stimuli, can contribute to the polygenic and clinically heterogeneous nature of schizophrenia.	[Ben-Shachar, Dorit; Karry, Rachel] Technion Israel Inst Technol, Rambam Med Ctr, Ruth & Bruce Rappaport Fac Med, Psychobiol Lab,Dept Psychiat, Haifa, Israel; [Ben-Shachar, Dorit; Karry, Rachel] Technion Israel Inst Technol, Rambam Med Ctr, Ruth & Bruce Rappaport Fac Med, Mol Med Lab, Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Ben-Shachar, D (corresponding author), Technion Israel Inst Technol, Rambam Med Ctr, Ruth & Bruce Rappaport Fac Med, Psychobiol Lab,Dept Psychiat, Haifa, Israel.	shachar@tx.technion.ac.il	Ben-Shachar, Dorit/D-4703-2015	Ben-Shachar, Dorit/0000-0003-2317-1489	Israel Chief Scientist Ministry of Health; The Stanley Medical Research Institute	Israel Chief Scientist Ministry of Health; The Stanley Medical Research Institute	This work was supported in part by a grant from Israel Chief Scientist Ministry of Health, and in part by a grant from The Stanley Medical Research Institute.	Altar CA, 2005, BIOL PSYCHIAT, V58, P85, DOI 10.1016/j.biopsych.2005.03.031; Bahn S, 2001, J CHEM NEUROANAT, V22, P79, DOI 10.1016/S0891-0618(01)00099-0; Banchio C, 2004, J BIOL CHEM, V279, P40220, DOI 10.1074/jbc.M406468200; BELOGRUDOV G, 1994, BIOCHEMISTRY-US, V33, P4571, DOI 10.1021/bi00181a018; Ben-Shachar D, 1999, INT J NEUROPSYCHOPH, V2, P245, DOI 10.1017/S1461145799001649; Ben-Shachar D, 2002, J NEUROCHEM, V83, P1241, DOI 10.1046/j.1471-4159.2002.01263.x; Ben-Shachar D, 2004, INT REV NEUROBIOL, V59, P273; Caruncho Hector J., 2004, Critical Reviews in Neurobiology, V16, P25, DOI 10.1615/CritRevNeurobiol.v16.i12.20; CHEN ML, 2005, J PSYCHIAT RES; Chen Y, 2002, NUCLEIC ACIDS RES, V30, P2930, DOI 10.1093/nar/gkf401; Cook T, 1998, J BIOL CHEM, V273, P25929, DOI 10.1074/jbc.273.40.25929; Daniel S, 1996, J BIOL CHEM, V271, P1385, DOI 10.1074/jbc.271.3.1385; Datta PK, 2000, J BIOL CHEM, V275, P40014, DOI 10.1074/jbc.C000508200; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dror N, 2002, MOL PSYCHIATR, V7, P995, DOI 10.1038/sj.mp.4001116; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Eastwood SL, 2001, BRAIN RES BULL, V55, P569, DOI 10.1016/S0361-9230(01)00530-5; Ferno J, 2005, PHARMACOGENOMICS J, V5, P298, DOI 10.1038/sj.tpj.6500323; Glantz LA, 1997, ARCH GEN PSYCHIAT, V54, P943; Goffart S, 2003, EXP PHYSIOL, V88, P33, DOI 10.1113/eph8802500; Goldberg HJ, 2000, DIABETES, V49, P863, DOI 10.2337/diabetes.49.5.863; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Karry R, 2004, BIOL PSYCHIAT, V55, P676, DOI 10.1016/j.biopsych.2003.12.012; Knable MB, 2002, MOL PSYCHIATR, V7, P392, DOI 10.1038/sj.mp.4001034; Li JZ, 2004, HUM MOL GENET, V13, P609, DOI 10.1093/hmg/ddh065; Liu AG, 2003, J BIOL CHEM, V278, P26423, DOI 10.1074/jbc.M211165200; Ma LM, 2004, J BIOL CHEM, V279, P40451, DOI 10.1074/jbc.M406827200; Mancama D, 2003, CURR OPIN MOL THER, V5, P642; Matsumoto N, 1998, J BIOL CHEM, V273, P28229, DOI 10.1074/jbc.273.43.28229; Maurer I, 2001, SCHIZOPHR RES, V48, P125, DOI 10.1016/S0920-9964(00)00075-X; MCGLASHAN TH, 1988, SCHIZOPHRENIA BULL, V14, P515, DOI 10.1093/schbul/14.4.515; MCGLASHAN TH, 1992, ARCH GEN PSYCHIAT, V49, P63; MEHLERWEX C, 2004, MITROCHONDRIAL COMPL; Middleton FA, 2002, J NEUROSCI, V22, P2718, DOI 10.1523/JNEUROSCI.22-07-02718.2002; Okamoto S, 2002, MOL BRAIN RES, V107, P89, DOI 10.1016/S0169-328X(02)00440-0; Pearlson GD, 2000, ANN NEUROL, V48, P556, DOI 10.1002/1531-8249(200010)48:4<556::AID-ANA2>3.3.CO;2-U; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; SAFFER JD, 1990, GENE DEV, V4, P659, DOI 10.1101/gad.4.4.659; SHIH JC, 1993, J PSYCHIATR NEUROSCI, V18, P25; Stefansson H, 2004, ANN MED, V36, P62, DOI 10.1080/07853890310017585; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Szabo G, 1996, DNA CELL BIOL, V15, P1081, DOI 10.1089/dna.1996.15.1081; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Trisciuoglio D, 2004, J BIOL CHEM, V279, P6737, DOI 10.1074/jbc.M308938200; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; Winterer G, 2004, TRENDS NEUROSCI, V27, P683, DOI 10.1016/j.tins.2004.08.002; Young CE, 1998, CEREB CORTEX, V8, P261, DOI 10.1093/cercor/8.3.261; Zaid A, 1999, J BIOENERG BIOMEMBR, V31, P129, DOI 10.1023/A:1005499727732; Zornoza T, 2005, NEUROPHARMACOLOGY, V49, P1067, DOI 10.1016/j.neuropharm.2005.06.005	55	61	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e817	10.1371/journal.pone.0000817	http://dx.doi.org/10.1371/journal.pone.0000817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786189	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455500001
J	Wang, Q; Pang, YP				Wang, Qi; Pang, Yuan-Ping			Preference of Small Molecules for Local Minimum Conformations when Binding to Proteins	PLOS ONE			English	Article								It is well known that small molecules (ligands) do not necessarily adopt their lowest potential energy conformations when binding to proteins. Analyses of protein-bound ligand crystal structures have reportedly shown that many of them do not even adopt the conformations at local minima of their potential energy surfaces (local minimum conformations). The results of these analyses raise a concern regarding the validity of virtual screening methods that use ligands in local minimum conformations. Here we report a normal-mode-analysis (NMA) study of 100 crystal structures of protein-bound ligands. Our data show that the energy minimization of a ligand alone does not automatically stop at a local minimum conformation if the minimum of the potential energy surface is shallow, thus leading to the folding of the ligand. Furthermore, our data show that all 100 ligand conformations in their protein-bound ligand crystal structures are nearly identical to their local minimum conformations obtained from NMA-monitored energy minimization, suggesting that ligands prefer to adopt local minimum conformations when binding to proteins. These results both support virtual screening methods that use ligands in local minimum conformations and caution about possible adverse effect of excessive energy minimization when generating a database of ligand conformations for virtual screening.	[Wang, Qi; Pang, Yuan-Ping] Mayo Clin, Comp Aided Mol Design Lab, Rochester, MI USA	Mayo Clinic	Pang, YP (corresponding author), Mayo Clin, Comp Aided Mol Design Lab, Rochester, MI USA.	pang@mayo.edu		Pang, Yuan-Ping/0000-0003-0838-2560	U. S. Army Medical Research Acquisition Activity [W81XWH-04-2-0001]; National Institutes of Health [5R01AI054574-03, 5R01GM061300-06]; Mayo Graduate School; Mayo Foundation for Medical Education and Research	U. S. Army Medical Research Acquisition Activity; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Graduate School; Mayo Foundation for Medical Education and Research	This work was supported by the U. S. Army Medical Research Acquisition Activity (W81XWH-04-2-0001), the National Institutes of Health (5R01AI054574-03 and 5R01GM061300-06), Mayo Graduate School, and the Mayo Foundation for Medical Education and Research.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bostrom J, 1998, J COMPUT AID MOL DES, V12, P383, DOI 10.1023/A:1008007507641; Bruns RF, 1996, TRENDS PHARMACOL SCI, V17, P189, DOI 10.1016/0165-6147(96)20027-6; BURGEN ASV, 1981, FED PROC, V40, P2723; Case D.A, 1999, MOL BIOL+, V18, P329, DOI [10.1007/0-306-47089-6, DOI 10.1007/0-306-47089-6]; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; CORNELL WD, 1995, J AM CHEM SOC, V117, P5197; Dooley AJ, 2006, BIOORG MED CHEM LETT, V16, P830, DOI 10.1016/j.bmcl.2005.11.018; Frisch M J, 1999, GAUSSIAN 98 REVISION; Hinsen Konrad, 2006, P1; JENSEN F, 1998, INTRO COMPUTATIONAL, P312; JORGENSEN WL, 1991, SCIENCE, V254, P954, DOI 10.1126/science.1719636; Kenakin T, 1996, TRENDS PHARMACOL SCI, V17, P190, DOI 10.1016/0165-6147(96)20026-4; KOSHLAND DE, 1994, ANGEW CHEM INT EDIT, V33, P2375; NICKLAUS MC, 1995, BIOORGAN MED CHEM, V3, P411, DOI 10.1016/0968-0896(95)00031-B; Pang YP, 2007, CLIN PHARMACOL THER, V81, P30, DOI 10.1038/sj.clpt.6100030; Pang YP, 2001, J COMPUT CHEM, V22, P1750, DOI 10.1002/jcc.1129; Pang YP, 2004, PROTEINS, V57, P747, DOI 10.1002/prot.20249; Pang YP, 1997, J MOL MODEL, V3, P240, DOI 10.1007/s008940050036; PANG YP, 2007, IBM J RES D IN PRESS; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Perola E, 2004, J MED CHEM, V47, P2499, DOI 10.1021/jm030563w; Pornillos O, 2002, NAT STRUCT BIOL, V9, P812, DOI 10.1038/nsb856; Vieth M, 1998, J COMPUT AID MOL DES, V12, P563, DOI 10.1023/A:1008055202136; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang Q, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000531	27	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e820	10.1371/journal.pone.0000820	http://dx.doi.org/10.1371/journal.pone.0000820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786192	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455500004
J	Beres, SB; Musser, JM				Beres, Stephen B.; Musser, James M.			Contribution of Exogenous Genetic Elements to the Group A Streptococcus Metagenome	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; ERYTHROMYCIN RESISTANCE GENES; POPULATION-BASED SURVEILLANCE; MATRIX-BINDING PROTEINS; GRAM-POSITIVE BACTERIA; ACUTE RHEUMATIC-FEVER; PILUS-LIKE STRUCTURES; STAPHYLOCOCCUS-AUREUS; MACROLIDE-RESISTANCE; MYCOBACTERIUM-TUBERCULOSIS	Variation in gene content among strains of a bacterial species contributes to biomedically relevant differences in phenotypes such as virulence and antimicrobial resistance. Group A Streptococcus (GAS) causes a diverse array of human infections and sequelae, and exhibits a complex pathogenic behavior. To enhance our understanding of genotype-phenotype relationships in this important pathogen, we determined the complete genome sequences of four GAS strains expressing M protein serotypes (M2, M4, and 2 M12) that commonly cause noninvasive and invasive infections. These sequences were compared with eight previously determined GAS genomes and regions of variably present gene content were assessed. Consistent with the previously determined genomes, each of the new genomes is similar to 1.9 Mb in size, with similar to 10% of the gene content of each encoded on variably present exogenous genetic elements. Like the other GAS genomes, these four genomes are polylysogenic and prophage encode the majority of the variably present gene content of each. In contrast to most of the previously determined genomes, multiple exogenous integrated conjugative elements (ICEs) with characteristics of conjugative transposons and plasmids are present in these new genomes. Cumulatively, 242 new GAS metagenome genes were identified that were not present in the previously sequenced genomes. Importantly, ICEs accounted for 41% of the new GAS metagenome gene content identified in these four genomes. Two large ICEs, designated 2096-RD.2 (63 kb) and 10750-RD.2 (49 kb), have multiple genes encoding resistance to antimicrobial agents, including tetracycline and erythromycin, respectively. Also resident on these ICEs are three genes encoding inferred extracellular proteins of unknown function, including a predicted cell surface protein that is only present in the genome of the serotype M12 strain cultured from a patient with acute poststreptococcal glomerulonephritis. The data provide new information about the GAS metagenome and will assist studies of pathogenesis, antimicrobial resistance, and population genomics.	[Beres, Stephen B.; Musser, James M.] Methodist Hosp, Res Inst, Ctr Mol & Translat Human Infect Dis Res, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston	Musser, JM (corresponding author), Methodist Hosp, Res Inst, Ctr Mol & Translat Human Infect Dis Res, 6535 Fannin, Houston, TX 77030 USA.	jmmusser@tmh.tmc.edu		Beres, Stephen/0000-0003-3041-0185	National Institute of Allergy and Infectious Diseases [UO1-60595]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by grant UO1-60595 from the National Institute of Allergy and Infectious Diseases ( to JMM).	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Alberti S, 2003, J CLIN MICROBIOL, V41, P2385, DOI 10.1128/JCM.41.6.2385-2390.2003; ALLIGNET J, 1995, ANTIMICROB AGENTS CH, V39, P2027, DOI 10.1128/AAC.39.9.2027; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aracil B, 2001, J ANTIMICROB CHEMOTH, V48, P592, DOI 10.1093/jac/48.4.592; Areschoug T, 2004, VACCINE, V22, pS9, DOI 10.1016/j.vaccine.2004.08.010; Arpin C, 1999, ANTIMICROB AGENTS CH, V43, P2335, DOI 10.1128/AAC.43.9.2335; Banks DJ, 2004, J INFECT DIS, V190, P727, DOI 10.1086/422697; Banks DJ, 2003, J INFECT DIS, V188, P1898, DOI 10.1086/379897; Banks DJ, 2002, TRENDS MICROBIOL, V10, P515, DOI 10.1016/S0966-842X(02)02461-7; Beres SB, 2006, P NATL ACAD SCI USA, V103, P7059, DOI 10.1073/pnas.0510279103; Beres SB, 2004, P NATL ACAD SCI USA, V101, P11833, DOI 10.1073/pnas.0404163101; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; BERRIOS X, 1986, J LAB CLIN MED, V108, P535; Bessen DE, 2002, INFECT IMMUN, V70, P1159, DOI 10.1128/IAI.70.3.1159-1167.2002; Bingen E, 2002, ANTIMICROB AGENTS CH, V46, P1199, DOI 10.1128/AAC.46.5.1199-1203.2002; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; BISNO AL, 1991, NEW ENGL J MED, V325, P783, DOI 10.1056/NEJM199109123251106; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; Brandt CM, 2001, MICROB DRUG RESIST, V7, P165, DOI 10.1089/10766290152045039; Brenciani A, 2004, J ANTIMICROB CHEMOTH, V54, P991, DOI 10.1093/jac/dkh481; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Burrus V, 2002, MOL MICROBIOL, V46, P601, DOI 10.1046/j.1365-2958.2002.03191.x; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Chuang I, 2002, CLIN INFECT DIS, V35, P665, DOI 10.1086/342062; Clancy J, 1996, MOL MICROBIOL, V22, P867, DOI 10.1046/j.1365-2958.1996.01521.x; CLEWELL DB, 1974, ANTIMICROB AGENTS CH, V5, P534, DOI 10.1128/AAC.5.5.534; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLMAN G, 1993, J MED MICROBIOL, V39, P165, DOI 10.1099/00222615-39-3-165; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; De Azavedo JCS, 1999, ANTIMICROB AGENTS CH, V43, P2144, DOI 10.1128/AAC.43.9.2144; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El-Bouri KW, 1998, EPIDEMIOL INFECT, V121, P515, DOI 10.1017/S095026889800168X; Enright MC, 2001, INFECT IMMUN, V69, P2416, DOI 10.1128/IAI.69.4.2416-2427.2001; Eriksson BKG, 2003, CLIN INFECT DIS, V37, P1189, DOI 10.1086/379013; Facklam RF, 2002, CLIN INFECT DIS, V34, P28, DOI 10.1086/324621; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Fitzgerald JR, 2001, TRENDS MICROBIOL, V9, P547, DOI 10.1016/S0966-842X(01)02228-4; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; GAWORZEWSKA E, 1988, EPIDEMIOL INFECT, V100, P257, DOI 10.1017/S095026880006739X; Ghai R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-198; Giovanetti E, 2002, J ANTIMICROB CHEMOTH, V50, P249, DOI 10.1093/jac/dkf122; Giovanetti E, 2003, ANTIMICROB AGENTS CH, V47, P2844, DOI 10.1128/AAC.47.9.2844-2849.2003; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Green NM, 2005, J CLIN MICROBIOL, V43, P4083, DOI 10.1128/JCM.43.8.4083-4091.2005; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Hammerum AM, 2004, J ANTIMICROB CHEMOTH, V53, P118, DOI 10.1093/jac/dkh043; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; HYDER SL, 1978, J INFECT DIS, V138, P281, DOI 10.1093/infdis/138.3.281; JOHNSTON KH, 1986, J EXP MED, V163, P697, DOI 10.1084/jem.163.3.697; Kataja J, 2000, J ANTIMICROB CHEMOTH, V46, P789, DOI 10.1093/jac/46.5.789; Kataja J, 1999, ANTIMICROB AGENTS CH, V43, P48, DOI 10.1128/AAC.43.1.48; Kataja J, 2002, EUR J CLIN MICROBIOL, V21, P589, DOI 10.1007/s10096-002-0771-8; Kaul R, 1997, AM J MED, V103, P18, DOI 10.1016/S0002-9343(97)00160-5; Kreikemeyer B, 2005, J BIOL CHEM, V280, P33228, DOI 10.1074/jbc.M502896200; Kreikemeyer B, 2004, INT J MED MICROBIOL, V294, P177, DOI 10.1016/j.ijmm.2004.06.017; Kreikemeyer B, 2004, J BIOL CHEM, V279, P15850, DOI 10.1074/jbc.M313613200; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Leclercq R, 2002, CLIN INFECT DIS, V34, P482, DOI 10.1086/324626; Li ZY, 2003, J INFECT DIS, V188, P1587, DOI 10.1086/379050; Lindsay JA, 2004, TRENDS MICROBIOL, V12, P378, DOI 10.1016/j.tim.2004.06.004; LINTON KJ, 1994, MOL MICROBIOL, V11, P777, DOI 10.1111/j.1365-2958.1994.tb00355.x; Luna VA, 1999, J ANTIMICROB CHEMOTH, V44, P19, DOI 10.1093/jac/44.1.19; Luna VA, 2002, ANTIMICROB AGENTS CH, V46, P2513, DOI 10.1128/AAC.46.8.2513-2517.2002; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; MALKE H, 1974, MOL GEN GENET, V135, P349, DOI 10.1007/BF00271149; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Martin JM, 2002, NEW ENGL J MED, V346, P1200, DOI 10.1056/NEJMoa013169; Molinari G, 2001, MOL MICROBIOL, V40, P99, DOI 10.1046/j.1365-2958.2001.02373.x; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; MURPHY E, 1985, J BACTERIOL, V162, P633, DOI 10.1128/JB.162.2.633-640.1985; MUSSER JM, 1995, INFECT IMMUN, V63, P994, DOI 10.1128/IAI.63.3.994-1003.1995; Musser JM, 1998, BIOMED RES REP, P185; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Nakata M, 2005, MOL MICROBIOL, V57, P786, DOI 10.1111/j.1365-2958.2005.04730.x; Nielsen HUK, 2004, MICROB DRUG RESIST, V10, P231, DOI 10.1089/mdr.2004.10.231; O'Brien KL, 2002, CLIN INFECT DIS, V35, P268, DOI 10.1086/341409; Overbeek R, 2003, NUCLEIC ACIDS RES, V31, P164, DOI 10.1093/nar/gkg148; Palavecino EL, 2001, ANTIMICROB AGENTS CH, V45, P339, DOI 10.1128/AAC.45.1.339-341.2001; PATTI JM, 1992, J BIOL CHEM, V267, P4766; Perez-Trallero E, 2001, J ANTIMICROB CHEMOTH, V48, P225, DOI 10.1093/jac/48.2.225; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Podbielski A, 1999, MOL MICROBIOL, V31, P1051, DOI 10.1046/j.1365-2958.1999.01241.x; POONKING R, 1993, J EXP MED, V178, P759, DOI 10.1084/jem.178.2.759; Rastogi P A, 2000, Methods Mol Biol, V132, P47; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Santagati M, 2003, MICROB DRUG RESIST, V9, P243, DOI 10.1089/107662903322286445; Schmitz FJ, 2003, J INFECT DIS, V188, P1578, DOI 10.1086/379230; SCOTT RJD, 1989, EPIDEMIOL INFECT, V102, P85, DOI 10.1017/S095026880002971X; Seppala H, 1998, ANTIMICROB AGENTS CH, V42, P257; Sharkawy A, 2002, CLIN INFECT DIS, V34, P454, DOI 10.1086/338466; Shulman ST, 2004, CLIN INFECT DIS, V39, P325, DOI 10.1086/421949; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; Snodgrass JL, 1999, INFECT IMMUN, V67, P3952, DOI 10.1128/IAI.67.8.3952-3959.1999; Stalhammar-Carlemalm M, 1999, MOL MICROBIOL, V33, P208, DOI 10.1046/j.1365-2958.1999.01470.x; STOLLERMAN GH, 1971, CIRCULATION, V43, P915, DOI 10.1161/01.CIR.43.6.915; Subtil A, 2004, CURR OPIN MICROBIOL, V7, P85, DOI 10.1016/j.mib.2003.12.012; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P1817, DOI 10.1128/AAC.40.8.1817; Suter TM, 1997, ANTIMICROB AGENTS CH, V41, P1385, DOI 10.1128/AAC.41.6.1385; Syrogiannopoulos GA, 2001, PEDIATR INFECT DIS J, V20, P863, DOI 10.1097/00006454-200109000-00008; Tanz RR, 2004, CLIN INFECT DIS, V39, P1794, DOI 10.1086/426025; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Thompson PR, 1998, J BIOL CHEM, V273, P14788, DOI 10.1074/jbc.273.24.14788; Tyrrell GJ, 2002, J CLIN MICROBIOL, V40, P4466, DOI 10.1128/JCM.40.12.4466-4471.2002; UBUKATA K, 1975, J ANTIBIOT, V28, P681, DOI 10.7164/antibiotics.28.681; VILLARREAL H, 1979, J EXP MED, V149, P459, DOI 10.1084/jem.149.2.459; Vlaminckx B, 2004, EUR J CLIN MICROBIOL, V23, P434, DOI 10.1007/s10096-004-1147-z; Vlaminckx BJM, 2003, J CLIN MICROBIOL, V41, P4941, DOI 10.1128/JCM.41.11.4941-4949.2003; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wescombe PA, 2006, APPL ENVIRON MICROB, V72, P1459, DOI 10.1128/AEM.72.2.1459-1466.2006; Wescombe PA, 2003, APPL ENVIRON MICROB, V69, P2737, DOI 10.1128/AEM.69.5.2737-2747.2003; WIDDOWSON JP, 1971, J GEN MICROBIOL, V65, P69, DOI 10.1099/00221287-65-1-69; WIDDOWSON JP, 1970, J GEN MICROBIOL, V61, P343, DOI 10.1099/00221287-61-3-343; Yan JJ, 2000, J CLIN MICROBIOL, V38, P2475, DOI 10.1128/JCM.38.7.2475-2479.2000; Zampaloni C, 2003, J CLIN MICROBIOL, V41, P1307, DOI 10.1128/JCM.41.3.1307-1310.2003; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang S, 2006, INFECT IMMUN, V74, P4200, DOI 10.1128/IAI.00493-06	130	128	136	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e800	10.1371/journal.pone.0000800	http://dx.doi.org/10.1371/journal.pone.0000800			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726530	Green Submitted, Green Published, gold			2022-12-27	WOS:000207455400017
J	Passamaneck, YJ; Hadjantonakis, AK; Di Gregorio, A				Passamaneck, Yale J.; Hadjantonakis, Anna-Katerina; Di Gregorio, Anna			Dynamic and Polarized Muscle Cell Behaviors Accompany Tail Morphogenesis in the Ascidian Ciona intestinalis	PLOS ONE			English	Article								Background. Axial elongation is a key morphogenetic process that serves to shape developing organisms. Tail extension in the ascidian larva represents a striking example of this process, wherein paraxially positioned muscle cells undergo elongation and differentiation independent of the segmentation process that characterizes the formation of paraxial mesoderm in vertebrates. Investigating the cell behaviors underlying the morphogenesis of muscle in ascidians may therefore reveal the evolutionarily conserved mechanisms operating during this process. Methodology/Principle Findings. A live cell imaging approach utilizing subcellularly-localized fluorescent proteins was employed to investigate muscle cell behaviors during tail extension in the ascidian Ciona intestinalis. Changes in the position and morphology of individual muscle cells were analyzed in vivo in wild type embryos undergoing tail extension and in embryos in which muscle development was perturbed. Muscle cells were observed to undergo elongation in the absence of positional reorganization. Furthermore, high-speed high-resolution live imaging revealed that the onset and progression of tail extension were characterized by the presence of dynamic and polarized actin-based protrusive activity at the plasma membrane of individual muscle cells. Conclusions/Significance. Our results demonstrate that in the Ciona muscle, tissue elongation resulted from gradual and coordinated changes in cell geometry and not from changes in cell topology. Proper formation of muscle cells was found to be necessary not only for muscle tissue elongation, but also more generally for completion of tail extension. Based upon the characterized dynamic changes in cell morphology and plasma membrane protrusive activity, a three-phase model is proposed to describe the cell behavior operating during muscle morphogenesis in the ascidian embryo.	[Passamaneck, Yale J.; Di Gregorio, Anna] Cornell Univ, Dept Cell & Dev Biol, Weill Med Coll, New York, NY 10021 USA; [Hadjantonakis, Anna-Katerina] Sloan Kettering Inst, Dev Biol Program, New York, NY USA	Cornell University; Memorial Sloan Kettering Cancer Center	Di Gregorio, A (corresponding author), Cornell Univ, Dept Cell & Dev Biol, Weill Med Coll, New York, NY 10021 USA.	hadj@mskcc.org; and2015@med.cornell.edu	Di Gregorio, Anna/C-4766-2008	Hadjantonakis, Anna-Katerina/0000-0002-7580-5124	March of Dimes Birth Defects Foundation [5-FY03-153]; National Institutes of Health [RO1-HD050704, RO1-HD052115]; Irma T. Hirschl Career Scientist Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052115] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050704] Funding Source: NIH RePORTER	March of Dimes Birth Defects Foundation(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl Career Scientist Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Basil O'Connor Starter Scholar Research Award Grant Number 5-FY03-153 from the March of Dimes Birth Defects Foundation, National Institutes of Health RO1-HD050704, Irma T. Hirschl Career Scientist Award to A.D.G, Charles H. Revson postdoctoral fellowship to Y.J.P. and National Institutes of Health RO1-HD052115 to A.-K.H.	Afonin B, 2006, DEV DYNAM, V235, P3268, DOI 10.1002/dvdy.20979; Coisy-Quivy M, 2006, BIOL CELL, V98, P577, DOI 10.1042/BC20060032; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Corbo JC, 1997, DEVELOPMENT, V124, P589; Corbo JC, 2001, CELL, V106, P535, DOI 10.1016/S0092-8674(01)00481-0; Di Gregorio A, 2002, DEV BIOL, V244, P385, DOI 10.1006/dbio.2002.0582; Di Gregorio A, 2006, BIOESSAYS, V28, P874, DOI 10.1002/bies.20453; Erives A, 1998, DEV BIOL, V194, P213, DOI 10.1006/dbio.1997.8810; Fraser ST, 2005, GENESIS, V42, P162, DOI 10.1002/gene.20139; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Hadjantonakis AK, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-33; Hadjantonakis AK, 2003, NAT REV GENET, V4, P613, DOI 10.1038/nrg1126; Jiang D, 2005, CURR BIOL, V15, P79; Kondoh G, 1999, FEBS LETT, V458, P299, DOI 10.1016/S0014-5793(99)01172-2; Lemmon MA, 2002, FEBS LETT, V513, P71, DOI 10.1016/S0014-5793(01)03243-4; Meedel TH, 2007, DEV BIOL, V302, P333, DOI 10.1016/j.ydbio.2006.09.043; Miki H, 1998, BIOCHEM BIOPH RES CO, V243, P73, DOI 10.1006/bbrc.1997.8064; Munro EM, 2002, DEVELOPMENT, V129, P1; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakatani Y, 1999, DEVELOPMENT, V126, P3293; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6; Passamaneck YJ, 2006, MICROSC RES TECHNIQ, V69, P160, DOI 10.1002/jemt.20284; Passamaneck YJ, 2005, DEV DYNAM, V233, P1, DOI 10.1002/dvdy.20300; Plusa B, 2005, NATURE, V434, P391, DOI 10.1038/nature03388; Rhee JM, 2006, GENESIS, V44, P202, DOI 10.1002/dvg.20203; Rhee JM, 2005, GENESIS, V43, P136, DOI 10.1002/gene.20164; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Satoh N., 1994, DEV BIOL ASCIDIANS; SWALLA BJ, 1993, MICROSC RES TECHNIQ, V26, P274, DOI 10.1002/jemt.1070260403; SWALLA BJ, 1990, DEV BIOL, V142, P319, DOI 10.1016/0012-1606(90)90353-K; Tada M, 1998, DEVELOPMENT, V125, P3997; Tall EG, 2000, CURR BIOL, V10, P743, DOI 10.1016/S0960-9822(00)00541-8; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; WHITTAKER JR, 1977, J EXP ZOOL, V202, P139, DOI 10.1002/jez.1402020202; Wissmann A, 1997, GENE DEV, V11, P409, DOI 10.1101/gad.11.4.409; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7; Zeller RW, 2006, DEV DYNAM, V235, P456, DOI 10.1002/dvdy.20644	37	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e714	10.1371/journal.pone.0000714	http://dx.doi.org/10.1371/journal.pone.0000714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684560	gold, Green Published, Green Submitted			2022-12-27	WOS:000207452400017
J	Evans, SR; Simpson, DM; Kitch, DW; King, A; Clifford, DB; Cohen, BA; McArthur, JC				Evans, Scott R.; Simpson, David M.; Kitch, Douglas W.; King, Agnes; Clifford, David B.; Cohen, Bruce A.; McArthur, Justin C.		Neurologic AIDS Res Consortium; AIDS Clinical Trials Grp	A Randomized Trial Evaluating Prosaptide (TM) for HIV-Associated Sensory Neuropathies: Use of an Electronic Diary to Record Neuropathic Pain	PLOS ONE			English	Article								Objectives. To examine the efficacy and safety of Prosaptide (TM) (PRO) for the treatment of painful HIV-associated sensory neuropathies (HIV-SN). Design. A randomized, double-blind, placebo-controlled, multicenter study in participants with sensory neuropathy. Pain modulating therapy was discontinued prior to baseline. Participants were stratified by sural sensory nerve action potential (SNAP) amplitude. Participants were trained to use an electronic diary (ED) to record pain. Setting. Peripheral neuropathies are common complications of HIV infection. The pathogenesis is unknown and currently treatments are restricted to symptomatic measures. We examined PRO against placebo (PBO) for treatment of painful HIV-SN and performed a post-hoc evaluation of an electronic diary (ED) to record HIV-associated neuropathic pain. Participants. Eligible participants included adults with neurologist-confirmed painful HIV-SN. Interventions. 2, 4, 8, or 16 mg/d PRO or PBO administered via subcutaneous (SC) injection for six weeks. Neurotoxic antiretroviral drug usage was held constant. Outcome Measures. Changes from baseline in the weekly average of evaluable daily random prompts measuring pain using the Gracely pain scale and adverse events. Results. 237 participants were randomized. The study was stopped after a planned futility analysis. There were no between-group differences in the frequency of adverse events or laboratory toxicities. The 6-week mean (sd) Gracely pain scale changes were -0.12 (0.23), -0.24 (0.35), -0.15 (0.32), 20.18 (0.34), and -0.18 (0.32) for the 2, 4, 8, 16 mg, and PBO arms respectively. A similar variability of pain changes recorded using the ED were noted compared to previous trials that used paper collection methods. Conclusions. 6-week treatment with PRO was safe but not effective at reducing HIV-associated neuropathic pain. Use of an ED to record neuropathic pain is novel in HIV-SN, resulted in reasonable compliance in recording pain data, but did not decrease the variability of pain scores compared to historical paper collection methods. Trial Registration.ClinicalTrials. gov NCT00286377	[Evans, Scott R.; Kitch, Douglas W.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Simpson, David M.] Mt Sinai Sch Med, New York, NY USA; [King, Agnes; McArthur, Justin C.] Johns Hopkins Univ, Baltimore, MD USA; [Clifford, David B.] Washington Univ, St Louis, MO USA; [Cohen, Bruce A.] Northwestern Univ, Chicago, IL 60611 USA	Harvard University; Harvard T.H. Chan School of Public Health; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Washington University (WUSTL); Northwestern University	Evans, SR (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	evans@sdac.harvard.edu		Nunn, Michael/0000-0002-6771-9912	Neurologic AIDS Research Consortium (NARC) [NS 32228]; Savient Pharmaceuticals, Inc.; National Institute of Allergy and Infectious Diseases [AI38858]; National Center for Research Resources; NIH [NS044807, NS049465, MH075673]; University of California, Los Angeles (A0601) [AI27660-18S2]; University of California, San Diego (A0701) [AI27670]; Washington University, St. Louis [AI25903, NS32228]; University of Pennsylvania [UOI AI32783-13]; Mt. Sinai Medical Center [NINDS NS002253, NCRR RR000071]; University of Miami [AI27675]; University of Rochester [AI27658]; Cornell University [AI46386]; University of Texas, Southwestern Med Ctr [AI46376-05]; University of Puerto Rico [1U54NS43011, 1P20RR11126]	Neurologic AIDS Research Consortium (NARC); Savient Pharmaceuticals, Inc.; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, Los Angeles (A0601)(University of California System); University of California, San Diego (A0701); Washington University, St. Louis; University of Pennsylvania; Mt. Sinai Medical Center; University of Miami; University of Rochester; Cornell University; University of Texas, Southwestern Med Ctr; University of Puerto Rico	Funding: Supported in part by the Neurologic AIDS Research Consortium (NARC) grant NS 32228, Savient Pharmaceuticals, Inc., the Adult AIDS Clinical Trials Group (ACTG) funded by the National Institute of Allergy and Infectious Diseases grant AI38858, and by the General Clinical Research Center Units funded by the National Center for Research Resources. Dr McArthur has received NIH support for this manuscript from NS044807, NS049465, and MH075673. The NARC led study design, collection, analysis, data interpretation, and manuscript writing, and made the decision to submit the paper for publication. The ACTG supported data collection and manuscript writing. Savient Pharmaceuticals, Inc. participated in the design and collection of data. The General Clinical Research Center Units supported data collection. Dr. Evans had access to all data described in this paper and acts as the guarantor for the study.; The authors wish to thank the study participants, investigators, and coordinators for their participation in this trial. The authors further acknowledge Invivodata, Inc. and Jason Eger for their assistance with the ED data. NARC DSMB members included Dr. Burk Jubelt, Dr. Norman Latov, Dr. Howard Gendelman, and Dr. David Glidden. Associated NINDS staff included Dr. Mike Nunn and Dr. Peter Gilbert.; The following persons and institutions were instrumental in this study: Kay Carter, PA- C, and Diane Thomas, MD-Johns Hopkins University (A0201) Grants: AI-27668, RR-00052; Elyse Singer, MD- University of California, Los Angeles (A0601) Grant: AI27660-18S2; Mallory Witt and Ruben Lopez-Apodaca-Harbor General (A0603); Richard K. Olney, MD and Jeffrey W. Ralph, MD- University of California, San Francisco; Joseph C. Gathe, MD and Ataher Syed, MD- Physicians Research Network; Bruce Cohen, MD and Linda Reisberg, RN- Northwestern University (A2701); Taryn Exter, MP and Kathleen Nuffer, NP- University of California, San Diego (A0701) Grant: AI27670; Mary Gould, RN and Teresa Spitz, RN- Washington University, St. Louis (A2101) Grants: AI25903, NS32228; Michael S. Somero, MD and Kelly A. Morris, CCRC- Michael Somero Research Center; Daniel Feinberg, MD and Pablo Tebas, MD- University of Pennsylvania (A6201) Grant # UOI AI32783-13; Susama Verma, MD and Edwin Nunez- Mt. Sinai Medical Center Grant # NINDS NS002253 and NCRR RR000071; Vilma M. Vega, MD and Mauricio Concha, MD-Infectious Diseases Associates; Jose G. Castro, MD and Lillian Colon, RN, BSN- University of Miami (A0901) Grant: AI27675; Dr. Yuen So and Debbie Slamowitz, RN-Stanford University (A0501); Trevor Hawkins, MD and Wenoah Veikley, ACRN-Southwest C. A. R. E. Center; Giovanni Schifitto, MD and Carol Greisberger, RN- University of Rochester (A1101) Grants: AI27658, RR00044; Michael Rubin, MD and Ivanka Zaprianova- Cornell University (A7803) Grant: AI46386; Ramon DiazArrastia, MD, PhD and Tianna Petersen, MS- University of Texas, Southwestern Med Ctr (A3751) Grant: AI46376-05; Daniel J. Skiest, MD and Tim Sumarll, RN- University of Texas, Southwestern Medical Center; Tania Ginebra, RN, MS and Moraima Rivera, BS, MPH- University of Puerto Rico Grant # 1U54NS43011 and 1P20RR11126; Yunanan Mootoor, MD and Julie Gurwell, PhD- University of Kentucky; Ronald G. Nahass, MD- I.D. Care, Inc.	BACELLAR H, 1994, NEUROLOGY, V44, P1892, DOI 10.1212/WNL.44.10.1892; BAROHN RJ, 1993, ARCH NEUROL-CHICAGO, V50, P167, DOI 10.1001/archneur.1993.00540020045016; Brew BJ, 2003, AIDS, V17, P1094, DOI 10.1097/00002030-200305020-00024; Brinkman K, 1998, AIDS, V12, P1735, DOI 10.1097/00002030-199814000-00004; Calcutt NA, 1999, J NEUROPATH EXP NEUR, V58, P628, DOI 10.1097/00005072-199906000-00007; Calcutt NA, 2000, ANESTHESIOLOGY, V93, P1271, DOI 10.1097/00000542-200011000-00021; Campana WM, 1998, NEUROTOXICOLOGY, V19, P237; Cherry CL, 2002, J ACQ IMMUN DEF SYND, V30, P271, DOI [10.1097/01.QAI.0000017962.22053.0E, 10.1097/00126334-200207010-00002]; CORNBLATH D, 1988, NEUROLOGY, V1938, P794; Griffin JW, 1998, NEUROLOGY AIDS, P275; JANSSEN RS, 1991, NEUROLOGY, V41, P778; Keswani SC, 2002, AIDS, V16, P2105, DOI 10.1097/00002030-200211080-00002; Kieburtz K, 1998, NEUROLOGY, V51, P1682, DOI 10.1212/WNL.51.6.1682; McArthur JC, 2000, NEUROLOGY, V54, P1080, DOI 10.1212/WNL.54.5.1080; McArthur JC, 2005, LANCET NEUROL, V4, P543, DOI 10.1016/S1474-4422(05)70165-4; Mizisin AP, 2001, J NEUROPATH EXP NEUR, V60, P953, DOI 10.1093/jnen/60.10.953; Otero DAC, 1999, NEUROSCI LETT, V270, P29, DOI 10.1016/S0304-3940(99)00461-9; Pettersen JA, 2006, ANN NEUROL, V59, P816, DOI 10.1002/ana.20816; Sacktor N, 2001, NEUROLOGY, V56, P257, DOI 10.1212/WNL.56.2.257; Simpson DM, 2003, NEUROLOGY, V60, P1508, DOI 10.1212/01.WNL.0000063304.88470.D9; Stone AA, 2002, BMJ-BRIT MED J, V324, P1193, DOI 10.1136/bmj.324.7347.1193; Wagner R, 1998, NEUROREPORT, V9, P2827, DOI 10.1097/00001756-199808240-00026; WEI LJ, 1985, BIOMETRIKA, V72, P359; Wulff EA, 2000, DRUGS, V59, P1251, DOI 10.2165/00003495-200059060-00005	24	32	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e551	10.1371/journal.pone.0000551	http://dx.doi.org/10.1371/journal.pone.0000551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653259	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452200001
J	Kiani, F; Schwarzl, S; Fischer, S; Efferth, T				Kiani, Farooq; Schwarzl, Sonja; Fischer, Stefan; Efferth, Thomas			Three-Dimensional Modeling of Glucose-6-phosphate Dehydrogenase-Deficient Variants from German Ancestry	PLOS ONE			English	Article								Background. Loss of function of dimeric glucose-6-phosphate dehydrogenase (G6PD) represents the most common inborn error of metabolism throughout the world affecting an estimated 400 million people. In Germany, this enzymopathy is very rare. Methodology/Principal Findings. On the basis of G6PD crystal structures, we have analyzed six G6PD variants of German ancestry by three-dimensional modeling. All mutations present in the German population are either close to one of the three G6P or NADP(+) units or to the interface of the two monomers. Two of the three mutated amino acids of G6PD Vancouver are closer to the binding site of NADP+. The G6PD Aachen mutation is also closer to the second NADP+ unit. The G6PD Wayne mutation is closer to the G6P binding region. These mutations may affect the binding of G6P and NADP+ units. Three mutations, i.e. G6PD Munich, G6PD Riverside and G6PD Gastonia, lie closer to the interface of the two monomers. These may also affect the interface of two monomers. Conclusion. None of these G6PD variants share mutations with the common G6PD variants known from the Mediterranean, Near East, or Africa indicating that they have developed independently. The G6PD variants have been compared with mutants from other populations and the implications for survival of G6PD variants from natural selection have been discussed.	[Efferth, Thomas] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Kiani, Farooq; Schwarzl, Sonja; Fischer, Stefan] Heidelberg Univ, Interdisciplinary Ctr Biocomp, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Efferth, T (corresponding author), German Canc Res Ctr, D-6900 Heidelberg, Germany.	t.efferth@dkfz.de		Efferth, Thomas/0000-0002-3096-3292; Kiani, Farooq/0000-0001-8773-3634	intramural grants	intramural grants	This work has been funded by intramural grants.	ALALI AK, 1989, ANN CLIN BIOCHEM, V26, P477, DOI 10.1177/000456328902600603; Au SWN, 2000, STRUCTURE, V8, P293, DOI 10.1016/S0969-2126(00)00104-0; Bannert N, 1969, Monatsschr Kinderheilkd, V117, P675; BENOHR HC, 1970, KLIN WOCHENSCHR, V48, P71, DOI 10.1007/BF01484619; BENOHR HC, 1971, DEUT MED WOCHENSCHR, V96, P1029, DOI 10.1055/s-0028-1108377; BEUTLER E, 1991, ACTA HAEMATOL-BASEL, V86, P179; Beutler E, 2002, BLOOD CELL MOL DIS, V28, P93, DOI 10.1006/bcmd.2002.0490; BEUTLER E, 1991, J BIOL CHEM, V266, P4145; BEUTLER E, 1991, NEW ENGL J MED, V324, P169; BUSCH D, 1970, KLIN WOCHENSCHR, V48, P74, DOI 10.1007/BF01484620; CALABRO V, 1990, HUM GENET, V86, P49; CANCEDDA R, 1973, EUR J BIOCHEM, V34, P199, DOI 10.1111/j.1432-1033.1973.tb02746.x; EBER SW, 1985, BLUT, V51, P109, DOI 10.1007/BF00320119; Efferth T, 2004, BLOOD, V104, P2608, DOI 10.1182/blood-2004-06-2135; Efferth T, 2000, BLOOD CELL MOL DIS, V26, P101, DOI 10.1006/bcmd.2000.0281; GAHR M, 1974, EUR J CLIN INVEST, V4, P187, DOI 10.1111/j.1365-2362.1974.tb00390.x; GAHR M, 1976, BRIT J HAEMATOL, V33, P363, DOI 10.1111/j.1365-2141.1976.tb03552.x; GAHR M, 1977, KLIN WOCHENSCHR, V55, P379, DOI 10.1007/BF01488623; GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456; GLORIABOTTINI F, 1980, EXPERIENTIA, V36, P541, DOI 10.1007/BF01965786; GRAY GR, 1973, LANCET, V2, P530; HELGE H, 1966, DEUT MED WOCHENSCHR, V91, P1584, DOI 10.1055/s-0028-1111556; HIRONO A, 1994, BLOOD, V83, P3363; HIRONO A, 1989, P NATL ACAD SCI USA, V86, P10015, DOI 10.1073/pnas.86.24.10015; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JablonskaSkwiecinska E, 1997, EUR J HUM GENET, V5, P22, DOI 10.1159/000484727; KAHN A, 1976, HUM GENET, V32, P171, DOI 10.1007/BF00291500; Kotaka M, 2005, ACTA CRYSTALLOGR D, V61, P495, DOI 10.1107/S0907444905002350; KURDIHAIDAR B, 1990, AM J HUM GENET, V47, P1013; MAEDA M, 1992, AM J HUM GENET, V51, P386; Miwa S, 1996, AM J HEMATOL, V51, P122, DOI 10.1002/(SICI)1096-8652(199602)51:2<122::AID-AJH5>3.0.CO;2-#; NAFA K, 1994, HUM GENET, V94, P513; NOWICKI L, 1974, KLIN WOCHENSCHR, V52, P478, DOI 10.1007/BF01468536; PAI GS, 1980, P NATL ACAD SCI-BIOL, V77, P2810, DOI 10.1073/pnas.77.5.2810; PEKRUN A, 1989, BLUT, V58, P11, DOI 10.1007/BF00320229; RAVINDRANATH Y, 1987, AM J HEMATOL, V24, P357, DOI 10.1002/ajh.2830240405; Ruwende C, 1998, J MOL MED, V76, P581, DOI 10.1007/s001090050253; Scopes DA, 1998, EUR J BIOCHEM, V251, P382, DOI 10.1046/j.1432-1327.1998.2510382.x; SMITH JE, 1966, P SOC EXP BIOL MED, V122, P671; Vulliamy T, 1997, BLOOD CELL MOL DIS, V23, P302, DOI 10.1006/bcmd.1997.0147; VUOPIO P, 1975, SCAND J HAEMATOL, V15, P145; WALLER HD, 1966, KLIN WOCHENSCHR, V44, P122, DOI 10.1007/BF01746562; WEIDTMAN V, 1966, KLIN WOCHENSCHR, V44, P446, DOI 10.1007/BF01727460; WEINREICH J, 1968, KLIN WOCHENSCHR, V46, P146, DOI 10.1007/BF01727373; WITT I, 1972, KLIN WOCHENSCHR, V50, P205, DOI 10.1007/BF01487145; XU WM, 1995, BLOOD, V85, P257, DOI 10.1182/blood.V85.1.257.bloodjournal851257; GERBER MOL DESIGN	47	10	11	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2007	2	7							e625	10.1371/journal.pone.0000625	http://dx.doi.org/10.1371/journal.pone.0000625			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GI	17637841	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452100015
J	Thuy, TT; Shah, NS; Mai, HA; Do, TN; Duong, T; Truong, L; Dinh, NS; Bui, DD; Luu, TMC; Phung, TPM; Wells, CD; Laserson, KF; Varma, JK				Thuy, Trinh Thanh; Shah, N. Sarita; Mai Hoang Anh; Do Trong Nghia; Duong Thom; Truong Linh; Dinh Ngoc Sy; Bui Duc Duong; Luu Thi Minh Chau; Phung Thi Phuong Mai; Wells, Charles D.; Laserson, Kayla F.; Varma, Jay K.			HIV-Associated TB in An Giang Province, Vietnam, 2001-2004: Epidemiology and TB Treatment Outcomes	PLOS ONE			English	Article								Background. Mortality is high in HIV-infected TB patients, but few studies from Southeast Asia have documented the benefits of interventions, such as co-trimoxazole (CTX), in reducing mortality during TB treatment. To help guide policy in Vietnam, we studied the epidemiology of HIV-associated TB in one province and examined factors associated with outcomes, including the impact of CTX use. Methodology/Principal Findings. We retrospectively abstracted data for all HIV-infected persons diagnosed with TB from 2001-2004 in An Giang, a province in southern Vietnam in which TB patients receive HIV counseling and testing. We used standard WHO definitions to classify TB treatment outcomes. We conducted multivariate analysis to identify risk factors for the composite outcome of death, default, or treatment failure during TB treatment. From 2001-2004, 637 HIV-infected TB patients were diagnosed in An Giang. Of these, 501 (79%) were male, 321 (50%) were aged 25-34 years, and the most common self-reported HIV risk factor was sex with a commercial sex worker in 221 (35%). TB was classified as smear-positive in 531 (83%). During TB treatment, 167 (26%) patients died, 9 (1%) defaulted, and 6 (1%) failed treatment. Of 454 patients who took CTX, 116 (26%) had an unsuccessful outcome compared with 33 (70%) of 47 patients who did not take CTX (relative risk, 0.4; 95% confidence interval [CI], 0.3-0.5). Adjusting for male sex, rural residence, TB smear status and disease location, and the occurrence of adverse events during TB treatment in multivariate analysis, the benefit of CTX persisted (adjusted odds ratio for unsuccessful outcome 0.1; CI, 0.1-0.3). Conclusions/Significance. In An Giang, Vietnam, HIV-associated TB was associated with poor TB treatment outcomes. Outcomes were significantly better in those taking CTX. This finding suggests that Vietnam should consider applying WHO recommendations to prescribe CTX to all HIV-infected TB patients.	[Thuy, Trinh Thanh] US Ctr Dis Control & Prevent, Global AIDS Program, Hanoi, Vietnam; [Shah, N. Sarita; Wells, Charles D.; Laserson, Kayla F.; Varma, Jay K.] US Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Mai Hoang Anh; Duong Thom; Truong Linh] An Giang Prov Prevent Med Ctr, Long Xuyen City, Vietnam; [Do Trong Nghia; Dinh Ngoc Sy; Bui Duc Duong] Minist Hlth, Vietnam Natl TB Program, Natl Hosp TB & Lung Dis, Hanoi, Vietnam; [Luu Thi Minh Chau; Phung Thi Phuong Mai] Minist Hlth, LIFE GAP Off, Hanoi, Vietnam; [Varma, Jay K.] US Ctr Dis Control Collaborat, Thailand Minist Publ Hlth, Bangkok, Thailand	Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand	Varma, JK (corresponding author), US Ctr Dis Control & Prevent, Global AIDS Program, Hanoi, Vietnam.	jvarma@cdc.gov			U.S. Agency for International Development; U.S. Centers for Disease Control and Prevention	U.S. Agency for International Development(United States Agency for International Development (USAID)); U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	U.S. Agency for International Development and U.S. Centers for Disease Control and Prevention. USAID was not involved in: study design, collection, analysis, interpretation of data; or the decision to submit for publication.	Apers L, 2004, INT J TUBERC LUNG D, V8, P945; Boeree MJ, 2005, TROP MED INT HEALTH, V10, P723, DOI 10.1111/j.1365-3156.2005.01433.x; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Dean GL, 2002, AIDS, V16, P75, DOI 10.1097/00002030-200201040-00010; Dheda K, 2004, J INFECT DIS, V190, P1670, DOI 10.1086/424676; Freudenberg N, 2006, AM J PUBLIC HEALTH, V96, P424, DOI 10.2105/AJPH.2005.063511; Grimwade K, 2005, AIDS, V19, P163, DOI 10.1097/00002030-200501280-00008; GRIMWADE K, 2004, COCHRANE LIB; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; *JOINT UN PROGR HI, 2006, REP GLOB AIDS EP 200; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; MWAUNGULU FB, 2004, B WORLD HEALTH ORGAN, V82, P854; Quy HT, 2006, INT J TUBERC LUNG D, V10, P45; Tuan NA, 2007, B WORLD HEALTH ORGAN, V85, P35, DOI 10.2471/BLT.05.026153; *WHO, 2006, GLOB TUB CONTR SURV; *WHO, 2004, INT POL COLL TB HIV; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2	18	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e507	10.1371/journal.pone.0000507	http://dx.doi.org/10.1371/journal.pone.0000507			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551587	gold, Green Published			2022-12-27	WOS:000207451500016
J	Edwards, KA; Doescher, LT; Kaneshiro, KY; Yamamoto, D				Edwards, Kevin A.; Doescher, Linden T.; Kaneshiro, Kenneth Y.; Yamamoto, Daisuke			A Database of Wing Diversity in the Hawaiian Drosophila	PLOS ONE			English	Article								Background. Within genus Drosophila, the endemic Hawaiian species offer some of the most dramatic examples of morphological and behavioral evolution. The advent of the Drosophila grimshawi genome sequence permits genes of interest to be readily cloned from any of the hundreds of species of Hawaiian Drosophila, offering a powerful comparative approach to defining molecular mechanisms of species evolution. A key step in this process is to survey the Hawaiian flies for characters whose variation can be associated with specific candidate genes. The wings provide an attractive target for such studies: Wings are essentially two dimensional, and genes controlling wing shape, vein specification, pigment production, and pigment pattern evolution have all been identified in Drosophila. Methodology/Principal Findings. We present a photographic database of over 180 mounted, adult wings from 73 species of Hawaiian Drosophila. The image collection, available at FlyBase.org, includes 53 of the 112 known species of "picture wing'' Drosophila, and several species from each of the other major Hawaiian groups, including the modified mouthparts, modified tarsus, antopocerus, and haleakalae (fungus feeder) groups. Direct image comparisons show that major wing shape changes can occur even between closely related species, and that pigment pattern elements can vary independently of each other. Among the 30 species closest to grimshawi, diverse visual effects are achieved by altering a basic pattern of seven wing spots. Finally, we document major pattern variations within species, which appear to result from reduced diffusion of pigment precursors through the wing blade. Conclusions/Significance. The database highlights the striking variation in size, shape, venation, and pigmentation in Hawaiian Drosophila, despite their generally low levels of DNA sequence divergence. In several independent lineages, highly complex patterns are derived from simple ones. These lineages offer a promising model system to study the evolution of complexity.	[Edwards, Kevin A.] Illinois State Univ, Dept Biol Sci, Normal, IL 61761 USA; [Doescher, Linden T.; Kaneshiro, Kenneth Y.] Univ Hawaii Manoa, Ctr Conservat Res & Training, Honolulu, HI 96822 USA; [Yamamoto, Daisuke] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan	Illinois State University; University of Hawaii System; University of Hawaii Manoa; Tohoku University	Edwards, KA (corresponding author), Illinois State Univ, Dept Biol Sci, Normal, IL 61761 USA.	kaedwar@ilstu.edu	Edwards, Kevin Andrew/GOE-3539-2022; Vanrolleghem, Peter A/E-1784-2011	Edwards, Kevin Andrew/0000-0003-4721-5626; Vanrolleghem, Peter A/0000-0003-1695-1313; , Daisuke/0000-0002-4623-0106	ERATO; Japan Science and Technology; NIH [GM062185]; Illinois State University; MEXT [1802012]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM062185] Funding Source: NIH RePORTER	ERATO(Japan Science & Technology Agency (JST)); Japan Science and Technology(Japan Science & Technology Agency (JST)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Illinois State University; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by Yamamoto Behavior Genes Project, ERATO, Japan Science and Technology (to DY); NIH GM062185 (to KAE); and Illinois State University. DY was supported by Specially Promoted Research grant # 1802012 from MEXT.	Ashburner M., 2004, DROSOPHILA LAB HDB; Boake CRB, 1998, HEREDITY, V80, P642, DOI 10.1046/j.1365-2540.1998.00317.x; Bonacum J, 2005, MOL PHYLOGENET EVOL, V37, P73, DOI 10.1016/j.ympev.2005.03.008; BRENNAN MD, 1984, CELL, V38, P147, DOI 10.1016/0092-8674(84)90535-X; Carson Hampton L., 1995, P14; Carson Hampton L., 1992, P407; CARSON HL, 1976, ANNU REV ECOL SYST, V7, P311, DOI 10.1146/annurev.es.07.110176.001523; CARSON HL, 1970, SCIENCE, V168, P1414, DOI 10.1126/science.168.3938.1414; Carson HL, 1997, J HERED, V88, P343, DOI 10.1093/oxfordjournals.jhered.a023115; CARSON HL, 1967, P NATL ACAD SCI USA, V57, P1280, DOI 10.1073/pnas.57.5.1280; CARSON HL, 1983, GENETICS, V103, P465; Craddock EM, 2000, EVOL BIOL, V31, P1; Crosby MA, 2007, NUCLEIC ACIDS RES, V35, pD486, DOI 10.1093/nar/gkl827; Davis T, 2000, HEREDITAS, V132, P67, DOI 10.1111/j.1601-5223.2000.00067.x; Davis T, 2000, HEREDITAS, V132, P257, DOI 10.1111/j.1601-5223.2000.00257.x; de Celis JF, 2003, BIOESSAYS, V25, P443, DOI 10.1002/bies.10258; Dworkin I, 2006, GENETICS, V173, P1417, DOI 10.1534/genetics.105.053868; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; GREENE E, 1987, SCIENCE, V236, P310, DOI 10.1126/science.236.4799.310; GRIMSHAW PH, 1901, FAUNA HAWAIIENSIS, V3, P1; Grumbling G, 2006, NUCLEIC ACIDS RES, V34, pD484, DOI 10.1093/nar/gkj068; Handler AM, 2001, INSECT BIOCHEM MOLEC, V31, P111, DOI 10.1016/S0965-1748(00)00159-4; Hardy D.E., 1972, U TEXAS PUBLICATION, V7213, P155; HARDY DE, 1979, P HAWAII ENTOMOL SOC, V13, P71; HARDY DE, 1968, U TEXAS PUBL, V6818, P171; HARDY DE, 1971, U TEXAS PUBL 2, V7103, P151; HARDY DE, 1965, DIPTERA CYCLORRAPHA, V2; Hardy DE., 1969, U TEXAS PUBLICATION, V6918, P39; Held LI., 2002, IMAGINAL DISCS GENET; HOY RR, 1988, SCIENCE, V240, P217, DOI 10.1126/science.3127882; Joron M, 2006, PLOS BIOL, V4, P1831, DOI 10.1371/journal.pbio.0040303; KAMBYSELLIS MP, 1995, CURR BIOL, V5, P1129, DOI 10.1016/S0960-9822(95)00229-6; Kaneshiro K, 2005, J HERED, V96, P285, DOI 10.1093/jhered/esi049; KANESHIRO KY, 1988, BIOSCIENCE, V38, P258, DOI 10.2307/1310849; KANESHIRO KY, 1987, TRENDS ECOL EVOL, V2, P207, DOI 10.1016/0169-5347(87)90022-X; KANESHIRO KY, 1977, DROS INFORM SERV, V52, P85; Kopp A, 2002, EVOL DEV, V4, P278, DOI 10.1046/j.1525-142X.2002.02017.x; Mezey JG, 2005, GENETICS, V169, P2101, DOI 10.1534/genetics.104.036988; O'Connor MB, 2006, DEVELOPMENT, V133, P183; O'Grady P.M., 2002, Bishop Museum Occasional Papers, V69, P36; O'Grady Patrick M., 2004, Bishop Museum Bulletins in Entomology, V12, P117; O'Grady PM, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-6; O'Grady PM, 2003, ANN ENTOMOL SOC AM, V96, P12, DOI 10.1603/0013-8746(2003)096[0012:ROTDMS]2.0.CO;2; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Remsen J, 1998, MOL PHYLOGENET EVOL, V9, P225, DOI 10.1006/mpev.1997.0484; SPIETH HT, 1975, ANN ENTOMOL SOC AM, V68, P506, DOI 10.1093/aesa/68.3.506; Stark J, 1999, ANNU REV ENTOMOL, V44, P97, DOI 10.1146/annurev.ento.44.1.97; True JR, 1999, CURR BIOL, V9, P1382, DOI 10.1016/S0960-9822(00)80083-4; VAL FC, 1977, EVOLUTION, V31, P611, DOI 10.1111/j.1558-5646.1977.tb01051.x; Weber K, 2005, GENETICS, V169, P1461, DOI 10.1534/genetics.104.027748; Wheeler M.R., 1965, DROS INFORM SERV, V40, P98; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/s0065-2660(08)60008-5; YANG H, 1969, U TEXAS PUBL, V6918, P133; Yeh SD, 2006, HEREDITY, V96, P383, DOI 10.1038/sj.hdy.6800814; ASSEMBLY ALIGNMENT A	57	39	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2007	2	5							e487	10.1371/journal.pone.0000487	http://dx.doi.org/10.1371/journal.pone.0000487			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10FB	17534437	Green Published, gold, Green Submitted			2022-12-27	WOS:000207448800017
J	Hehl, AB; Regos, A; Schraner, E; Schneider, A				Hehl, Adrian B.; Regos, Attila; Schraner, Elisabeth; Schneider, Andre			Bax Function in the Absence of Mitochondria in the Primitive Protozoan Giardia lamblia	PLOS ONE			English	Article								Bax-induced permeabilization of the mitochondrial outer membrane and release of cytochrome c are key events in apoptosis. Although Bax can compromise mitochondria in primitive unicellular organisms that lack a classical apoptotic machinery, it is still unclear if Bax alone is sufficient for this, or whether additional mitochondrial components are required. The protozoan parasite Giardia lamblia is one of the earliest branching eukaryotes and harbors highly degenerated mitochondrial remnant organelles (mitosomes) that lack a genome. Here we tested whether human Bax expressed in Giardia can be used to ablate mitosomes. We demonstrate that these organelles are neither targeted, nor compromised, by Bax. However, specialized compartments of the regulated secretory pathway are completely ablated by Bax. As a consequence, maturing cyst wall proteins that are sorted into these organelles are released into the cytoplasm, causing a developmental arrest and cell death. Interestingly, this ectopic cargo release is dependent on the carboxy-terminal 22 amino acids of Bax, and can be prevented by the Bax-inhibiting peptide Ku70. A C-terminally truncated Bax variant still localizes to secretory organelles, but is unable to permeabilize these membranes, uncoupling membrane targeting and cargo release. Even though mitosomes are too diverged to be recognized by Bax, off-target membrane permeabilization appears to be conserved and leads to cell death completely independently of mitochondria.	[Hehl, Adrian B.; Regos, Attila] Univ Zurich, Inst Parasitol, CH-8057 Zurich, Switzerland; [Schraner, Elisabeth] Univ Zurich, Inst Vet Anat, CH-8057 Zurich, Switzerland; [Schneider, Andre] Univ Fribourg, Dept Cell & Dev Biol, CH-1700 Fribourg, Switzerland	University of Zurich; University of Zurich; University of Fribourg	Hehl, AB (corresponding author), Univ Zurich, Inst Parasitol, Winterthurerstr 266A, CH-8057 Zurich, Switzerland.	Adrian.Hehl@access.uzh.ch		Hehl, Adrian/0000-0002-2110-4445	Swiss National Science Foundation [31-100270/1, 3100A0112327]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Swiss National Science Foundation, Grants nr. 31-100270/1 and 3100A0112327	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; AMEISEN JC, 1995, CELL DEATH DIFFER, V2, P285; Arisue N, 2002, PARASITOL INT, V51, P9, DOI 10.1016/S1383-5769(01)00093-9; Cartron PF, 2002, FEBS LETT, V512, P95, DOI 10.1016/S0014-5793(02)02227-5; Chanez AL, 2006, J CELL SCI, V119, P2968, DOI 10.1242/jcs.03023; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Dolezal P, 2005, P NATL ACAD SCI USA, V102, P10924, DOI 10.1073/pnas.0500349102; Epand RF, 2002, BIOCHEM BIOPH RES CO, V298, P744, DOI 10.1016/S0006-291X(02)02544-5; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Esseiva AC, 2004, EMBO REP, V5, P268, DOI 10.1038/sj.embor.7400095; Ferrier DEK, 2001, EVOL DEV, V3, P263, DOI 10.1046/j.1525-142x.2001.003004263.x; Figarella K, 2005, CELL DEATH DIFFER, V12, P335, DOI 10.1038/sj.cdd.4401564; Gerwig GJ, 2002, GLYCOBIOLOGY, V12, P499, DOI 10.1093/glycob/cwf059; Hedges SB, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-4; Hehl AB, 2000, MOL BIOL CELL, V11, P1789, DOI 10.1091/mbc.11.5.1789; Lanfredi-Rangel A, 1998, J STRUCT BIOL, V123, P225, DOI 10.1006/jsbi.1998.4035; Lee N, 2002, CELL DEATH DIFFER, V9, P53, DOI 10.1038/sj.cdd.4400952; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; LUJAN HD, 1995, J BIOL CHEM, V270, P4612, DOI 10.1074/jbc.270.9.4612; Manon S, 1997, FEBS LETT, V415, P29, DOI 10.1016/S0014-5793(97)01087-9; Marti M, 2003, TRENDS PARASITOL, V19, P440, DOI 10.1016/S1471-4922(03)00201-0; Marti M, 2003, J BIOL CHEM, V278, P24837, DOI 10.1074/jbc.M302082200; Marti M, 2003, MOL BIOL CELL, V14, P1433, DOI 10.1091/mbc.E02-08-0467; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nohynkova E, 2006, EUKARYOT CELL, V5, P753, DOI 10.1128/EC.5.4.753-761.2006; Priault M, 2003, CELL DEATH DIFFER, V10, P1068, DOI 10.1038/sj.cdd.4401270; Regoes A, 2005, J BIOL CHEM, V280, P30557, DOI 10.1074/jbc.M500787200; REINER DS, 1990, EUR J CELL BIOL, V53, P142; Roger AJ, 1998, P NATL ACAD SCI USA, V95, P229, DOI 10.1073/pnas.95.1.229; Sagolla MS, 2006, J CELL SCI, V119, P4889, DOI 10.1242/jcs.03276; Sawada M, 2003, NAT CELL BIOL, V5, P352, DOI 10.1038/ncb955; Silberman JD, 2002, MOL BIOL EVOL, V19, P777, DOI 10.1093/oxfordjournals.molbev.a004135; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; Sun CH, 2003, J BIOL CHEM, V278, P21701, DOI 10.1074/jbc.M302023200; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zha HB, 1996, MOL CELL BIOL, V16, P6494	39	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2007	2	5							e488	10.1371/journal.pone.0000488	http://dx.doi.org/10.1371/journal.pone.0000488			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10FB	17534438	gold, Green Published, Green Submitted			2022-12-27	WOS:000207448800018
J	Lombardo, MV; Barnes, JL; Wheelwright, SJ; Baron-Cohen, S				Lombardo, Michael V.; Barnes, Jennifer L.; Wheelwright, Sally J.; Baron-Cohen, Simon			Self-Referential Cognition and Empathy in Autism	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; ASPERGER-SYNDROME; FOCUSED ATTENTION; FRONTAL-CORTEX; BRAIN; MIND; CHILDREN; ADULTS; CONSCIOUSNESS; SCALE	Background. Individuals with autism spectrum conditions (ASC) have profound impairments in the interpersonal social domain, but it is unclear if individuals with ASC also have impairments in the intrapersonal self-referential domain. We aimed to evaluate across several well validated measures in both domains, whether both self-referential cognition and empathy are impaired in ASC and whether these two domains are related to each other. Methodology/Principal Findings. Thirty adults aged 19-45, with Asperger Syndrome or high-functioning autism and 30 age, sex, and IQ matched controls participated in the self-reference effect (SRE) paradigm. In the SRE paradigm, participants judged adjectives in relation to the self, a similar close other, a dissimilar non-close other, or for linguistic content. Recognition memory was later tested. After the SRE paradigm, several other complimentary self- referential cognitive measures were taken. Alexithymia and private self-consciousness were measured via self- report. Self-focused attention was measured on the Self-Focus Sentence Completion task. Empathy was measured with 3 self-report instruments and 1 performance measure of mentalizing (Eyes test). Self-reported autistic traits were also measured with the Autism Spectrum Quotient (AQ). Although individuals with ASC showed a significant SRE in memory, this bias was decreased compared to controls. Individuals with ASC also showed reduced memory for the self and a similar close other and also had concurrent impairments on measures of alexithymia, self- focused attention, and on all 4 empathy measures. Individual differences in self- referential cognition predicted mentalizing ability and self-reported autistic traits. More alexithymia and less self memory was predictive of larger mentalizing impairments and AQ scores regardless of diagnosis. In ASC, more self- focused attention is associated with better mentalizing ability and lower AQ scores, while in controls, more self- focused attention is associated with decreased mentalizing ability and higher AQ scores. Increasing private self- consciousness also predicted better mentalizing ability, but only for individuals with ASC. Conclusions/Significance. We conclude that individuals with ASC have broad impairments in both self-referential cognition and empathy. These two domains are also intrinsically linked and support predictions made by simulation theory. Our results also highlight a specific dysfunction in ASC within cortical midlines structures of the brain such as the medial prefrontal cortex.	[Lombardo, Michael V.; Barnes, Jennifer L.; Wheelwright, Sally J.; Baron-Cohen, Simon] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England	University of Cambridge	Lombardo, MV (corresponding author), Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England.	ml437@cam.ac.uk	Lombardo, Michael V/J-1773-2012	Lombardo, Michael V/0000-0001-6780-8619; Ramon-Valls, Montserrat/0000-0001-6596-3105; Wheelwright, Sally/0000-0003-0657-2483	Shirley Foundation; Cambridge Overseas Trust; Fulbright Foundation; Medical Research Council (MRC); MRC [G0600977] Funding Source: UKRI; Medical Research Council [G0600977] Funding Source: researchfish	Shirley Foundation; Cambridge Overseas Trust; Fulbright Foundation; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: MVL was supported by the Shirley Foundation and the Cambridge Overseas Trust. JLB was supported by the Fulbright Foundation. SJW and SBC were supported by the Medical Research Council (MRC) during the period of this work.	Aiken L. S., 1991, MULTIPLE REGRESSION; Ames DR, 2004, J PERS SOC PSYCHOL, V87, P340, DOI 10.1037/0022-3514.87.3.340; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; ANDERSON NH, 1968, J PERS SOC PSYCHOL, V9, P272, DOI 10.1037/h0025907; ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; ARON A, 1991, J PERS SOC PSYCHOL, V60, P241, DOI 10.1037/0022-3514.60.2.241; Association AP, 1994, DIAGN STAT MAN MENT, V4th; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Berthoz S, 2005, EUR PSYCHIAT, V20, P291, DOI 10.1016/j.eurpsy.2004.06.013; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; DAVIS D, 1975, J EXP SOC PSYCHOL, V11, P381, DOI 10.1016/0022-1031(75)90017-7; Davis M.H., 1980, JSAS CATALOGUE SELEC, V10; Doherty RW, 1997, J NONVERBAL BEHAV, V21, P131, DOI 10.1023/A:1024956003661; EXNER JE, 1973, J PERS ASSESS, V37, P437, DOI 10.1080/00223891.1973.10119902; FENIGSTEIN A, 1975, J CONSULT CLIN PSYCH, V43, P522, DOI 10.1037/h0076760; Frith U., 2003, AUTISM EXPLAINING EN; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; Happe F, 1996, NEUROREPORT, V8, P197, DOI 10.1097/00001756-199612200-00040; HEAL J, 1986, THEORIES THEORIES MI, P75; Hill E, 2004, J AUTISM DEV DISORD, V34, P229, DOI 10.1023/B:JADD.0000022613.41399.14; Hobson RP, 2006, MONOGR SOC RES CHILD, V71, pI; HULL JG, 1988, J PERS SOC PSYCHOL, V54, P452, DOI 10.1037/0022-3514.54.3.452; Humphrey N., 1984, NEW SCI; HURLBURT RT, 1994, PSYCHOL MED, V24, P385, DOI 10.1017/S0033291700027367; INGRAM RE, 1988, J PERS SOC PSYCHOL, V55, P967, DOI 10.1037/0022-3514.55.6.967; JORDAN RR, 1989, BRIT J DISORD COMMUN, V24, P169; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kana RK, 2007, BIOL PSYCHIAT, V62, P198, DOI 10.1016/j.biopsych.2006.08.004; Kanner L, 1943, NERV CHILD, V2, P217; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; KLEIN SB, 1988, J PERS SOC PSYCHOL, V55, P5, DOI 10.1037/0022-3514.55.1.5; KLEIN SB, 1986, J EXP PSYCHOL GEN, V115, P26, DOI 10.1037/0096-3445.115.1.26; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Lee A, 1998, J CHILD PSYCHOL PSYC, V39, P1131, DOI 10.1111/1469-7610.00417; LEE A, 1994, J AUTISM DEV DISORD, V24, P155, DOI 10.1007/BF02172094; LEE PS, 2007, ATYPICAL NEURAL SUBS; LOVELAND KA, 1986, J AUTISM DEV DISORD, V16, P335, DOI 10.1007/BF01531663; Macrae CN, 2004, CEREB CORTEX, V14, P647, DOI 10.1093/cercor/bhh025; Manjaly ZM, 2007, NEUROIMAGE, V35, P283, DOI 10.1016/j.neuroimage.2006.11.036; McIntosh DN, 2006, DEVELOPMENTAL SCI, V9, P295, DOI 10.1111/j.1467-7687.2006.00492.x; MINIOPALUELLO I, ABSENCE SENSORIMOTOR; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Mor N, 2002, PSYCHOL BULL, V128, P638, DOI 10.1037//0033-2909.128.4.638; Moriguchi Y, 2006, NEUROIMAGE, V32, P1472, DOI 10.1016/j.neuroimage.2006.04.186; Murias M, 2007, BIOL PSYCHIAT, V62, P270, DOI 10.1016/j.biopsych.2006.11.012; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Pennebaker J. W., 2001, LINGUISTIC INQUIRY W; Pennington BF, 1996, J CHILD PSYCHOL PSYC, V37, P51, DOI 10.1111/j.1469-7610.1996.tb01380.x; Pfeifer JH, 2007, J COGNITIVE NEUROSCI, V19, P1323, DOI 10.1162/jocn.2007.19.8.1323; Ring HA, 1999, BRAIN, V122, P1305, DOI 10.1093/brain/122.7.1305; ROGERS TB, 1977, J PERS SOC PSYCHOL, V35, P677, DOI 10.1037/0022-3514.35.9.677; Rude SS, 2004, COGNITION EMOTION, V18, P1121, DOI 10.1080/02699930441000030; Saxe R, 2006, SOC COGN AFFECT NEUR, V1, P229, DOI 10.1093/scan/nsl034; Symons CS, 1997, PSYCHOL BULL, V121, P371, DOI 10.1037/0033-2909.121.3.371; Toichi M, 2002, AM J PSYCHIAT, V159, P1422, DOI 10.1176/appi.ajp.159.8.1422; Wang AT, 2007, ARCH GEN PSYCHIAT, V64, P698, DOI 10.1001/archpsyc.64.6.698; Wang AT, 2006, BRAIN, V129, P932, DOI 10.1093/brain/awl032; Welchew DE, 2005, BIOL PSYCHIAT, V57, P991, DOI 10.1016/j.biopsych.2005.01.028; Weschler D, 1999, WECHSLER ABBREVIATED; World Health Organization, 1994, ICD 10 INT CLASS DIS	73	286	293	4	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e883	10.1371/journal.pone.0000883	http://dx.doi.org/10.1371/journal.pone.0000883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849012	Green Published, gold			2022-12-27	WOS:000207455600029
J	Troein, C; Ahren, D; Krogh, M; Peterson, C				Troein, Carl; Ahren, Dag; Krogh, Morten; Peterson, Carsten			Is Transcriptional Regulation of Metabolic Pathways an Optimal Strategy for Fitness?	PLOS ONE			English	Article							GENE-REGULATION; DEMAND THEORY; BISTABILITY; EXPRESSION; EVOLUTION; LACTOSE; OPERONS	Background. Transcriptional regulation of the genes in metabolic pathways is a highly successful strategy, which is virtually universal in microorganisms. The lac operon of E. coli is but one example of how enzyme and transporter production can be made conditional on the presence of a nutrient to catabolize. Methodology. With a minimalist model of metabolism, cell growth and transcriptional regulation in a microorganism, we explore how the interaction between environmental conditions and gene regulation set the growth rate of cells in the phase of exponential growth. This in silico model, which is based on biochemical rate equations, does not describe a specific organism, but the magnitudes of its parameters are chosen to match realistic values. Optimizing the parameters of the regulatory system allows us to quantify the fitness benefit of regulation. When a second nutrient and its metabolic pathway are introduced, the system must further decide whether and how to activate both pathways. Conclusions. Even the crudest transcriptional network is shown to substantially increase the fitness of the organism, and this effect persists even when the range of nutrient levels is kept very narrow. We show that maximal growth is achieved when pathway activation is a more or less steeply graded function of the nutrient concentration. Furthermore, we predict that bistability of the system is a rare phenomenon in this context, but outline a situation where it may be selected for.	[Troein, Carl; Krogh, Morten; Peterson, Carsten] Lund Univ, Dept Theoret Phys, S-22362 Lund, Sweden; [Ahren, Dag] Lund Univ, Dept Ecol, S-22362 Lund, Sweden	Lund University; Lund University	Troein, C (corresponding author), Lund Univ, Dept Theoret Phys, Solvegatan 14A, S-22362 Lund, Sweden.	carl@thep.lu.se			Swedish National Research School in Genomics and Bioinformatics; Knut and Alice Wallenberg foundation; Swedish Foundation for Strategic Research	Swedish National Research School in Genomics and Bioinformatics; Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	CT acknowledges support from the Swedish National Research School in Genomics and Bioinformatics. DA was supported by the Knut and Alice Wallenberg foundation. CP and MK were supported by the Swedish Foundation for Strategic Research (Senior Individual Grant). MK was also supported by the Knut and Alice Wallenberg Foundation through the Swegene consortium and the Strategic Science Foundation (Lund Strategic Center for Clinical Cancer Research).	BARFORD JP, 1992, BIOPROCESS ENG, V7, P297, DOI 10.1007/BF00705158; Briggs GE, 1925, BIOCHEM J, V19, P338, DOI 10.1042/bj0190338; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; KOCH AL, 1983, J MOL EVOL, V19, P455, DOI 10.1007/BF02102321; Kolkman A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100069; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Moran NA, 2005, J BACTERIOL, V187, P4229, DOI 10.1128/JB.187.12.4229-4237.2005; Nelson P., 2004, BIOL PHYS; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; SAVAGEAU MA, 1977, P NATL ACAD SCI USA, V74, P5647, DOI 10.1073/pnas.74.12.5647; Savageau MA, 1998, GENETICS, V149, P1677; Savageau MA, 1998, GENETICS, V149, P1665; Shoemaker J, 2003, J THEOR BIOL, V222, P307, DOI 10.1016/S0022-5193(03)00036-5; Soyer OS, 2006, P NATL ACAD SCI USA, V103, P16337, DOI 10.1073/pnas.0604449103; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Thattai M, 2003, BIOPHYS J, V85, P744, DOI 10.1016/S0006-3495(03)74517-2; van Hoek MJA, 2006, BIOPHYS J, V91, P2833, DOI [10.1529/biophysj.105.077420, 10.1529/biophysj.106.077420]; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	26	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e855	10.1371/journal.pone.0000855	http://dx.doi.org/10.1371/journal.pone.0000855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786226	gold, Green Published, Green Submitted			2022-12-27	WOS:000207455500038
J	Johnson, JA; Li, JF; Wei, XR; Lipscomb, J; Bennett, D; Brant, A; Cong, ME; Spira, T; Shafer, RW; Heneine, W				Johnson, Jeffrey A.; Li, Jin-Fen; Wei, Xierong; Lipscomb, Jonathan; Bennett, Diane; Brant, Ashley; Cong, Mian-er; Spira, Thomas; Shafer, Robert W.; Heneine, Walid			Simple PCR Assays Improve the Sensitivity of HIV-1 Subtype B Drug Resistance Testing and Allow Linking of Resistance Mutations	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SINGLE-DOSE NEVIRAPINE; FITNESS; POPULATIONS; PERSISTENCE; MULTIPLE; WOMEN	Background. The success of antiretroviral therapy is known to be compromised by drug-resistant HIV-1 at frequencies detectable by conventional bulk sequencing. Currently, there is a need to assess the clinical consequences of low-frequency drug resistant variants occurring below the detection limit of conventional genotyping. Sensitive detection of drug-resistant subpopulations, however, requires simple and practical methods for routine testing. Methodology. We developed highly-sensitive and simple real-time PCR assays for nine key drug resistance mutations and show that these tests overcome substantial sequence heterogeneity in HIV-1 clinical specimens. We specifically used early wildtype virus samples from the pre-antiretroviral drug era to measure background reactivity and were able to define highly-specific screening cut-offs that are up to 67-fold more sensitive than conventional genotyping. We also demonstrate that sequencing the mutation-specific PCR products provided a direct and novel strategy to further detect and link associated resistance mutations, allowing easy identification of multi-drug-resistant variants. Resistance mutation associations revealed in mutation-specific amplicon sequences were verified by clonal sequencing. Significance. Combined, sensitive real-time PCR testing and mutation-specific amplicon sequencing provides a powerful and simple approach that allows for improved detection and evaluation of HIV-1 drug resistance mutations.	[Johnson, Jeffrey A.; Li, Jin-Fen; Wei, Xierong; Lipscomb, Jonathan; Brant, Ashley; Cong, Mian-er; Heneine, Walid] Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Bennett, Diane] Ctr Dis Control & Prevent, HIV Incidence & Case Surveillance Branch, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Spira, Thomas] Ctr Dis Control & Prevent, Global AIDS Program, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Shafer, Robert W.] Stanford Univ, Med Ctr, Stanford, CA 94305 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Stanford University	Johnson, JA (corresponding author), Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	JJohnson1@cdc.gov						Cai FP, 2007, NAT METHODS, V4, P123, DOI 10.1038/nmeth995; Collins JA, 2004, J VIROL, V78, P603, DOI 10.1128/JVI.78.2.603-611.2004; Cong ME, 2007, J VIROL, V81, P3037, DOI 10.1128/JVI.02712-06; Flys T, 2005, J INFECT DIS, V192, P24, DOI 10.1086/430742; Ghosn J, 2006, AIDS, V20, P159, DOI 10.1097/01.aids.0000199820.47703.a0; Goudsmit J, 1996, J VIROL, V70, P5662, DOI 10.1128/JVI.70.8.5662-5664.1996; Halvas EK, 2006, J CLIN MICROBIOL, V44, P2612, DOI 10.1128/JCM.00449-06; Hance AJ, 2001, J VIROL, V75, P6410, DOI 10.1128/JVI.75.14.6410-6417.2001; Havlir DV, 1996, J VIROL, V70, P7894, DOI 10.1128/JVI.70.11.7894-7899.1996; Johnson JA, 2005, J INFECT DIS, V192, P16, DOI 10.1086/430741; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MELLORS J, 2006, ANTIVIR THER S, V8, pS150; Palmer S, 2006, P NATL ACAD SCI USA, V103, P7094, DOI 10.1073/pnas.0602033103; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Shi CJ, 2004, NAT METHODS, V1, P141, DOI 10.1038/NMETH713; Sturmer M, 2002, J CLIN VIROL, V25, pS65; *US DEP HHS, 2006, GUID US ANT AG HIV 1; Villahermosa ML, 2001, J HUMAN VIROL, V4, P238; Weinstock HS, 2004, J INFECT DIS, V189, P2174, DOI 10.1086/420789	20	59	63	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e638	10.1371/journal.pone.0000638	http://dx.doi.org/10.1371/journal.pone.0000638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653265	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452200007
J	White, CR; Day, N; Butler, PJ; Martin, GR				White, Craig R.; Day, Norman; Butler, Patrick J.; Martin, Graham R.			Vision and Foraging in Cormorants: More like Herons than Hawks?	PLOS ONE			English	Article								Background. Great cormorants (Phalacrocorax carbo L.) show the highest known foraging yield for a marine predator and they are often perceived to be in conflict with human economic interests. They are generally regarded as visually-guided, pursuit-dive foragers, so it would be expected that cormorants have excellent vision much like aerial predators, such as hawks which detect and pursue prey from a distance. Indeed cormorant eyes appear to show some specific adaptations to the amphibious life style. They are reported to have a highly pliable lens and powerful intraocular muscles which are thought to accommodate for the loss of corneal refractive power that accompanies immersion and ensures a well focussed image on the retina. However, nothing is known of the visual performance of these birds and how this might influence their prey capture technique. Methodology/ Principal Findings. We measured the aquatic visual acuity of great cormorants under a range of viewing conditions (illuminance, target contrast, viewing distance) and found it to be unexpectedly poor. Cormorant visual acuity under a range of viewing conditions is in fact comparable to unaided humans under water, and very inferior to that of aerial predators. We present a prey detectability model based upon the known acuity of cormorants at different illuminances, target contrasts and viewing distances. This shows that cormorants are able to detect individual prey only at close range (less than 1 m). Conclusions/Significance. We conclude that cormorants are not the aquatic equivalent of hawks. Their efficient hunting involves the use of specialised foraging techniques which employ brief short-distance pursuit and/or rapid neck extension to capture prey that is visually detected or flushed only at short range. This technique appears to be driven proximately by the cormorant's limited visual capacities, and is analogous to the foraging techniques employed by herons.	[White, Craig R.; Day, Norman; Butler, Patrick J.; Martin, Graham R.] Univ Birmingham, Sch Biosci, Ctr Ornithol, Birmingham, W Midlands, England	University of Birmingham	Martin, GR (corresponding author), Univ Birmingham, Sch Biosci, Ctr Ornithol, Birmingham, W Midlands, England.	g.r.martin@bham.ac.uk	White, Craig R/F-9062-2010	White, Craig R/0000-0002-0200-2187	UK Natural Environment Research Council [NER/A/2003/00542]	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding: This research was supported by the UK Natural Environment Research Council: Grant NER/A/2003/00542.	Carss DN, 2003, VOGELWELT, V124, P299; DICKMAN M, 1995, HYDROBIOLOGIA, V312, P27, DOI 10.1007/BF00018884; Engstrom H, 2003, VOGELWELT S, V124, P187; Gaffney MF, 2003, VISION RES, V43, P2053, DOI 10.1016/S0042-6989(03)00304-3; Gislen A, 2003, CURR BIOL, V13, P833, DOI 10.1016/S0960-9822(03)00290-2; GLASSER A, 1996, Q REV BIOL, V79, P475; Gremillet D, 2006, MAR BIOL, V148, P1081, DOI 10.1007/s00227-005-0130-2; Gremillet D, 2005, BIOL LETTERS, V1, P469, DOI 10.1098/rsbl.2005.0356; Gremillet D, 2004, FUNCT ECOL, V18, P793, DOI 10.1111/j.0269-8463.2004.00914.x; HALSEY LG, 2007, BIOL LETT IN PRESS; HESS C, 1913, HDB VERGLEICHENDEN P, P789; Hess Carl, 1909, Archiv fuer Augenheilkunde Wiesbaden, V63; Hliwa P., 2003, VOGELWELT, V124, P217; JABLONSKI PG, 2002, CONDOR, V60, P2633; Jerlov N. G., 1976, MARINE OPTICS; JOHNSGARD P.A., 1993, CORMORANTS DARTERS P; Katzir G, 2003, J EXP BIOL, V206, P833, DOI 10.1242/jeb.00142; Lilliendahl K, 2006, MAR BIOL, V149, P979, DOI 10.1007/s00227-006-0259-7; Lythgoe J.N., 1979, ECOLOGY VISION; MARTIN GR, 1991, BRAIN BEHAV EVOLUT, V37, P65, DOI 10.1159/000114347; Martin GR, 1999, IBIS, V141, P444, DOI 10.1111/j.1474-919X.1999.tb04413.x; MARTIN GR, 1974, VISION RES, V14, P1393, DOI 10.1016/0042-6989(74)90014-5; MCFALLNGAI MJ, 1990, AM ZOOL, V30, P175; ORTA J, 1992, HDB BIRDS WORLD, P00326; REYMOND L, 1987, VISION RES, V27, P1859, DOI 10.1016/0042-6989(87)90114-3; REYMOND L, 1985, VISION RES, V25, P1477, DOI 10.1016/0042-6989(85)90226-3; Ropert-Coudert Y, 2006, MAR BIOL, V149, P415, DOI 10.1007/s00227-005-0242-8; SCHLAER R, 1972, SCIENCE, V176, P920; Strod T, 2004, CURR BIOL, V14, pR376, DOI 10.1016/j.cub.2004.05.009; VANEERDEN MR, 1995, ARDEA, V83, P199; VOISIN C, 1991, HERONS EUROPE; VOSLAMBER B, 1995, ARDEA, V83, P213; Wanless S, 1999, MAR ECOL PROG SER, V188, P219, DOI 10.3354/meps188219; WATANUKI Y, BRIT BIRDS IN PRESS	34	52	54	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e639	10.1371/journal.pone.0000639	http://dx.doi.org/10.1371/journal.pone.0000639			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653266	Green Published, gold, Green Submitted			2022-12-27	WOS:000207452200008
J	Baena, A; Mootnick, AR; Falvo, JV; Tsytsykova, AV; Ligeiro, F; Diop, OM; Brieva, C; Gagneux, P; O'Brien, SJ; Ryder, OA; Goldfeld, AE				Baena, Andres; Mootnick, Alan R.; Falvo, James V.; Tsytsykova, Alla V.; Ligeiro, Filipa; Diop, Ousmane M.; Brieva, Claudia; Gagneux, Pascal; O'Brien, Stephen J.; Ryder, Oliver A.; Goldfeld, Anne E.			Primate TNF Promoters Reveal Markers of Phylogeny and Evolution of Innate Immunity	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA GENE; SINGLE-NUCLEOTIDE POLYMORPHISMS; COMPARATIVE SEQUENCE-ANALYSIS; TRANSCRIPTION FACTOR-BINDING; MONKEY SAIMIRI-SCIUREUS; NEW-WORLD MONKEYS; DNA EVIDENCE; EXPRESSION PATTERNS; MOLECULAR PHYLOGENY	Background. Tumor necrosis factor (TNF) is a critical cytokine in the immune response whose transcriptional activation is controlled by a proximal promoter region that is highly conserved in mammals and, in particular, primates. Specific single nucleotide polymorphisms (SNPs) upstream of the proximal human TNF promoter have been identified, which are markers of human ancestry. Methodology/Principal findings. Using a comparative genomics approach we show that certain fixed genetic differences in the TNF promoter serve as markers of primate speciation. We also demonstrate that distinct alleles of most human TNF promoter SNPs are identical to fixed nucleotides in primate TNF promoters. Furthermore, we identify fixed genetic differences within the proximal TNF promoters of Asian apes that do not occur in African ape or human TNF promoters. Strikingly, protein-DNA binding assays and gene reporter assays comparing these Asian ape TNF promoters to African ape and human TNF promoters demonstrate that, unlike the fixed differences that we define that are associated with primate phylogeny, these Asian ape-specific fixed differences impair transcription factor binding at an Sp1 site and decrease TNF transcription induced by bacterial stimulation of macrophages. Conclusions/significance. Here, we have presented the broadest interspecies comparison of a regulatory region of an innate immune response gene to date. We have characterized nucleotide positions in Asian ape TNF promoters that underlie functional changes in cell type-and stimulus-specific activation of the TNF gene. We have also identified ancestral TNF promoter nucleotide states in the primate lineage that correspond to human SNP alleles. These findings may reflect evolution of Asian and African apes under a distinct set of infectious disease pressures involving the innate immune response and TNF.	[Baena, Andres; Falvo, James V.; Tsytsykova, Alla V.; Ligeiro, Filipa; Goldfeld, Anne E.] Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; [Mootnick, Alan R.] Gibbon Conservat Ctr, Santa Clarita, CA USA; [Diop, Ousmane M.] Inst Pasteur, Lab Retrovirol, Dakar, Senegal; [Brieva, Claudia] Univ Nacl Colombia, Fac Med Vet & Zootecn, Unidad Rescate & Rehabil Anim Silvestres, Bogota, Colombia; [Gagneux, Pascal] Univ Calif San Diego, Dept Med & Cellular & Mol Med, Project Explaining Origin Humans, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [O'Brien, Stephen J.] NCI, Lab Genom Divers, Frederick, MD 21701 USA; [Ryder, Oliver A.] Zool Soc San Diego, San Diego, CA USA; [Ryder, Oliver A.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Universidad Nacional de Colombia; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Zoological Society of San Diego; University of California System; University of California San Diego	Goldfeld, AE (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA.	goldfeld@cbrinstitute.org	Goldfeld, Anne/AAF-1818-2019; OBRIEN, STEPHEN/ABD-1346-2020	Baena, Andres/0000-0003-1309-1020; OBRIEN, STEPHEN/0000-0001-7857-0757	NIH [GM076685, HL59838]; NSF [0094993]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076685] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH to A. E. G. (GM076685 and HL59838) and an NSF grant (0094993) to O.A.R.	Ackerman HC, 2003, GENES IMMUN, V4, P476, DOI 10.1038/sj.gene.6364008; Aguillon JC, 2006, IMMUNOBIOLOGY, V211, P75, DOI 10.1016/j.imbio.2005.09.005; Allen RD, 1999, MOL IMMUNOL, V36, P1017, DOI 10.1016/S0161-5890(99)00127-3; ALPER CA, 1982, CLIN IMMUNOL IMMUNOP, V24, P276, DOI 10.1016/0090-1229(82)90238-0; Baena A, 2002, GENES IMMUN, V3, P482, DOI 10.1038/sj.gene.6363898; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Barthel R, 2003, MOL CELL BIOL, V23, P526, DOI 10.1128/MCB.23.2.526-533.2003; Bayley JP, 2004, GENES IMMUN, V5, P315, DOI 10.1038/sj.gene.6364055; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Brandon-Jones D, 2004, INT J PRIMATOL, V25, P97, DOI 10.1023/B:IJOP.0000014647.18720.32; BRINKMAN BMN, 1995, HUM GENET, V96, P493; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Carroll SB, 2003, NATURE, V422, P849, DOI 10.1038/nature01495; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Cooper GM, 2003, CURR OPIN GENET DEV, V13, P604, DOI 10.1016/j.gde.2003.10.001; DALFONSO S, 1994, IMMUNOGENETICS, V39, P150; Delgado JC, 2003, IMMUNOGENETICS, V55, P497, DOI 10.1007/s00251-003-0604-7; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2004, ANNU REV GENOM HUM G, V5, P351, DOI 10.1146/annurev.genom.5.061903.180040; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Falvo JV, 2000, MOL CELL BIOL, V20, P2239, DOI 10.1128/MCB.20.6.2239-2247.2000; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Fischer A, 2006, CURR BIOL, V16, P1133, DOI 10.1016/j.cub.2006.04.033; Gagneux P, 2001, MOL PHYLOGENET EVOL, V18, P2, DOI 10.1006/mpev.2000.0799; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Gilad Y, 2003, P NATL ACAD SCI USA, V100, P3324, DOI 10.1073/pnas.0535697100; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; Goldfeld AE, 2000, GENE, V261, P19, DOI 10.1016/S0378-1119(00)00477-7; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; GROVES C, MAMMAL SPECIES WORLD; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; Hacia JG, 2001, TRENDS GENET, V17, P637, DOI 10.1016/S0168-9525(01)02494-5; Hahn MW, 2004, GENETICS, V167, P867, DOI 10.1534/genetics.103.025726; Hajeer AH, 2001, HUM IMMUNOL, V62, P1191, DOI 10.1016/S0198-8859(01)00322-6; HAMANN A, 1995, BIOCHEM BIOPH RES CO, V211, P833, DOI 10.1006/bbrc.1995.1887; Harland W.B., 1990, GEOLOGIC TIME SCALE; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Haudek SB, 1997, MOL IMMUNOL, V34, P1041, DOI 10.1016/S0161-5890(97)00124-7; Haudek SB, 1998, IMMUNOGENETICS, V48, P202, DOI 10.1007/s002510050424; Heissig F, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r57; Hellmann I, 2003, GENOME RES, V13, P831, DOI 10.1101/gr.944903; Heraud JM, 2002, IMMUNOGENETICS, V54, P20, DOI 10.1007/s00251-002-0443-y; Hernandez EC, 2002, IMMUNOGENETICS, V54, P645, DOI 10.1007/s00251-002-0512-2; Higuchi T, 1998, TISSUE ANTIGENS, V51, P605, DOI 10.1111/j.1399-0039.1998.tb03002.x; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hollegaard MV, 2006, GENES IMMUN, V7, P269, DOI 10.1038/sj.gene.6364301; Karaman MW, 2003, GENOME RES, V13, P1619, DOI 10.1101/gr.1289803; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; KLEIN J, 1986, NATURAL HIST MAJOR H; Kumar S, 2005, P NATL ACAD SCI USA, V102, P18842, DOI 10.1073/pnas.0509585102; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Leung JY, 2000, P NATL ACAD SCI USA, V97, P6614, DOI 10.1073/pnas.97.12.6614; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; McConkey EH, 2000, SCIENCE, V289, P1295; Merien F, 2003, VET IMMUNOL IMMUNOP, V92, P37, DOI 10.1016/S0165-2427(03)00018-7; Mittermeier Russell A., 2006, Primate Conservation, V20, P1, DOI 10.1896/0898-6207.20.1.1; Mootnick A, 2005, INT J PRIMATOL, V26, P971, DOI 10.1007/s10764-005-5332-4; Mootnick Alan R., 2006, Primate Conservation, V21, P103, DOI 10.1896/0898-6207.21.1.103; Muir CC, 2000, J MOL EVOL, V51, P471, DOI 10.1007/s002390010110; Muller S, 2003, HUM GENET, V113, P493, DOI 10.1007/s00439-003-0997-2; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Olson MV, 2003, NAT REV GENET, V4, P20, DOI 10.1038/nrg981; Opazo JC, 2006, MOL PHYLOGENET EVOL, V40, P274, DOI 10.1016/j.ympev.2005.11.015; Ovcharenko I, 2004, GENOME RES, V14, P1191, DOI 10.1101/gr.1773104; Page SL, 2001, MOL PHYLOGENET EVOL, V18, P14, DOI 10.1006/mpev.2000.0895; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Posch PE, 2003, GENES IMMUN, V4, P547, DOI 10.1038/sj.gene.6364023; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Richardson A, 2001, GENES IMMUN, V2, P343, DOI 10.1038/sj.gene.6363789; Rockman MV, 2005, PLOS BIOL, V3, P2208, DOI 10.1371/journal.pbio.0030387; Rockman MV, 2003, CURR BIOL, V13, P2118, DOI 10.1016/j.cub.2003.11.025; Roos C, 2001, MOL PHYLOGENET EVOL, V19, P486, DOI 10.1006/mpev.2001.0939; Ruvolo M, 1997, MOL BIOL EVOL, V14, P248, DOI 10.1093/oxfordjournals.molbev.a025761; Schrago CG, 2003, MOL BIOL EVOL, V20, P1620, DOI 10.1093/molbev/msg172; SCHRAGO CG, 2006, AM J PHYS ANTHR; Stauffer RL, 2001, J HERED, V92, P469, DOI 10.1093/jhered/92.6.469; Stedman HH, 2004, NATURE, V428, P415, DOI 10.1038/nature02358; Swofford D., 1998, PAUP PHYLOGENETIC AN; TAGLE DA, 1988, J MOL BIOL, V203, P439, DOI 10.1016/0022-2836(88)90011-3; Takacs Z, 2005, MOL PHYLOGENET EVOL, V36, P456, DOI 10.1016/j.ympev.2005.03.032; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsai EY, 1996, MOL CELL BIOL, V16, P5232; Tsai EY, 1996, MOL CELL BIOL, V16, P459; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Tsytsykova AV, 2007, J BIOL CHEM, V282, P11629, DOI 10.1074/jbc.M611418200; Tsytsykova AV, 2002, MOL CELL BIOL, V22, P2620, DOI 10.1128/MCB.22.8.2620-2631.2002; Uglialoro AM, 1998, TISSUE ANTIGENS, V52, P359, DOI 10.1111/j.1399-0039.1998.tb03056.x; Varki A, 2005, GENOME RES, V15, P1746, DOI 10.1101/gr.3737405; VILLINGER F, 1995, J IMMUNOL, V155, P3946; Waldron-Lynch F, 2001, GENES IMMUN, V2, P82, DOI 10.1038/sj.gene.6363738; Webster MT, 2003, MOL BIOL EVOL, V20, P278, DOI 10.1093/molbev/msg037; Wienberg J, 2004, CURR OPIN GENET DEV, V14, P657, DOI 10.1016/j.gde.2004.10.001; Wildman DE, 2003, P NATL ACAD SCI USA, V100, P7181, DOI 10.1073/pnas.1232172100; Wilson A. G., 1992, Human Molecular Genetics, V1, P353, DOI 10.1093/hmg/1.5.353; WILSON AG, 1993, J EXP MED, V177, P557, DOI 10.1084/jem.177.2.557; Wimmer R, 2002, CHROMOSOME RES, V10, P55, DOI 10.1023/A:1014222311431; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Xu XF, 1996, J MOL EVOL, V43, P431, DOI 10.1007/PL00006103; Yunis EJ, 2003, TISSUE ANTIGENS, V62, P1, DOI 10.1034/j.1399-0039.2003.00098.x; Zhang YW, 2001, J MOL EVOL, V52, P516, DOI 10.1007/s002390010182; Zhi L, 1996, CURR BIOL, V6, P1326, DOI 10.1016/S0960-9822(02)70719-7; Zimmerman PA, 1996, IMMUNOGENETICS, V44, P485, DOI 10.1007/BF02602813	111	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2007	2	7							e621	10.1371/journal.pone.0000621	http://dx.doi.org/10.1371/journal.pone.0000621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GI	17637837	gold, Green Submitted, Green Published			2022-12-27	WOS:000207452100011
J	Amengual, B; Bourhy, H; Lopez-Roig, M; Serra-Cobo, J				Amengual, Blanca; Bourhy, Herve; Lopez-Roig, Marc; Serra-Cobo, Jordi			Temporal Dynamics of European Bat Lyssavirus Type 1 and Survival of Myotis myotis Bats in Natural Colonies	PLOS ONE			English	Article							RABIES VIRUS; INFECTION; POPULATIONS; EVOLUTION; EXCRETION; RACCOONS	Many emerging RNA viruses of public health concern have recently been detected in bats. However, the dynamics of these viruses in natural bat colonies is presently unknown. Consequently, prediction of the spread of these viruses and the establishment of appropriate control measures are hindered by a lack of information. To this aim, we collected epidemiological, virological and ecological data during a twelve-year longitudinal study in two colonies of insectivorous bats (Myotis myotis) located in Spain and infected by the most common bat lyssavirus found in Europe, the European bat lyssavirus subtype 1 (EBLV-1). This active survey demonstrates that cyclic lyssavirus infections occurred with periodic oscillations in the number of susceptible, immune and infected bats. Persistence of immunity for more than one year was detected in some individuals. These data were further used to feed models to analyze the temporal dynamics of EBLV-1 and the survival rate of bats. According to these models, the infection is characterized by a predicted low basic reproductive rate (R-0 = 1.706) and a short infectious period ( D = 5.1 days). In contrast to observations in most non-flying animals infected with rabies, the survival model shows no variation in mortality after EBLV-1 infection of M. myotis. These findings have considerable public health implications in terms of management of colonies where lyssavirus-positive bats have been recorded and confirm the potential risk of rabies transmission to humans. A greater understanding of the dynamics of lyssavirus in bat colonies also provides a model to study how bats contribute to the maintenance and transmission of other viruses of public health concern.	[Amengual, Blanca; Lopez-Roig, Marc; Serra-Cobo, Jordi] Univ Barcelona, Fac Biol, Dept Biol Anim, Barcelona, Spain; [Amengual, Blanca; Bourhy, Herve] Inst Pasteur, WHO Collaborating Ctr Reference & Res Rabies, UPRE Lyssavirus Dynam & Host Adaptat, Paris, France	University of Barcelona; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Serra-Cobo, J (corresponding author), Univ Barcelona, Fac Biol, Dept Biol Anim, Barcelona, Spain.	serracobo@areambiental.com	Serra-Cobo, Jordi/G-4673-2016; Bourhy, Hervé/F-5272-2010		Conselleria de Sanitat i Consum (Govern Illes Balears, Spain)	Conselleria de Sanitat i Consum (Govern Illes Balears, Spain)	The Conselleria de Sanitat i Consum (Govern Illes Balears, Spain) financed this study.	Aguilar-Setien A, 2005, EPIDEMIOL INFECT, V133, P517, DOI 10.1017/S0950268805003705; Amengual B, 1997, J GEN VIROL, V78, P2319, DOI 10.1099/0022-1317-78-9-2319; ANDERSON R M, 1991; AUBERT MFA, 1991, ANN RECH VET, V22, P77; Bacon P.J., 1985, P109; BAER GM, 1967, J INFECT DIS, V117, P82, DOI 10.1093/infdis/117.1.82; Bickham JW, 2004, MOL PHYLOGENET EVOL, V33, P333, DOI 10.1016/j.ympev.2004.06.012; BIGLER WJ, 1973, AM J EPIDEMIOL, V98, P326, DOI 10.1093/oxfordjournals.aje.a121562; Bourhy H, 2005, Euro Surveill, V10, P213, DOI 10.2807/esm.10.11.00575-en; BOURHY H, 1992, J CLIN MICROBIOL, V30, P2419, DOI 10.1128/JCM.30.9.2419-2426.1992; Brookes SM, 2005, EMERG INFECT DIS, V11, P572, DOI 10.3201/eid1104.040920; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Childs JE, 2000, P NATL ACAD SCI USA, V97, P13666, DOI 10.1073/pnas.240326697; COX FEG, 1993, MODERN PARASITOLOGY, P288; COYNE MJ, 1989, AM J VET RES, V50, P2148; Davis PL, 2006, INFECT GENET EVOL, V6, P464, DOI 10.1016/j.meegid.2006.02.007; Davis PL, 2005, J VIROL, V79, P10487, DOI 10.1128/JVI.79.16.10487-10497.2005; Echevarria JE, 2001, J CLIN MICROBIOL, V39, P3678, DOI 10.1128/JCM.39.10.3678-3683.2001; FEKADU M, 1988, REV INFECT DIS, V10, pS678; Fooks AR, 2003, J MED VIROL, V71, P281, DOI 10.1002/jmv.10481; Grenfell B, 2002, P NATL ACAD SCI USA, V99, P3365, DOI 10.1073/pnas.062049599; HARRIS S, 2004, RABIES EUROPE MEDITE, P221; Harris SL, 2006, BIOL CONSERV, V131, P193, DOI 10.1016/j.biocon.2006.04.006; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lina PHC, 2006, DEV BIOLOGICALS, V125, P245; Mitchell-Jones AJ, 1999, ATLAS EUROPEAN MAMMA, P484; Muller T, 2004, J VET MED B, V51, P49, DOI 10.1111/j.1439-0450.2003.00725.x; Pollock KH, 1990, WILDLIFE MONOGR, V107, P3; Reynes JM, 2004, EMERG INFECT DIS, V10, P2231, DOI 10.3201/eid1012.040459; RONSHOLT L, 2002, RABIES B EUROPE, V2, P15; Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6; Serra-Cobo J, 2002, EMERG INFECT DIS, V8, P413, DOI 10.3201/eid0804.010263; Shankar V, 2004, J WILDLIFE DIS, V40, P403, DOI 10.7589/0090-3558-40.3.403; Tepsumethanon V, 2004, CLIN INFECT DIS, V39, P278, DOI 10.1086/421556; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van der Poel WHM, 2005, EMERG INFECT DIS, V11, P1854, DOI 10.3201/eid1112.041200; VAUGHN JB, 1965, J AMER MED ASSOC, V193, P363, DOI 10.1001/jama.1965.03090050039010; Vazquez S, 2006, DEV BIOLOGICALS, V125, P257; Wellenberg GJ, 2002, ARCH VIROL, V147, P349, DOI 10.1007/s705-002-8324-3; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; 2003, RABIES B EUROPE, V27, P1	41	69	71	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e566	10.1371/journal.pone.0000566	http://dx.doi.org/10.1371/journal.pone.0000566			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593965	gold, Green Submitted, Green Published			2022-12-27	WOS:000207451800010
J	Liska, D; Dufour, S; Zern, TL; Taksali, S; Cali, AMG; Dziura, J; Shulman, GI; Pierpont, BM; Caprio, S				Liska, David; Dufour, Sylvie; Zern, Tosca L.; Taksali, Sara; Cali, Anna M. G.; Dziura, James; Shulman, Gerald I.; Pierpont, Bridget M.; Caprio, Sonia			Interethnic Differences in Muscle, Liver and Abdominal Fat Partitioning in Obese Adolescents	PLOS ONE			English	Article								The prevalence of insulin resistance and type 2 diabetes (T2D) in obese youth is rapidly increasing, especially in Hispanics and African Americans compared to Caucasians. Insulin resistance is known to be associated with increases in intramyocellular (IMCL) and hepatic fat content. We determined if there are ethnic differences in IMCL and hepatic fat content in a multiethnic cohort of 55 obese adolescents. We used 1 H magnetic resonance spectroscopy (MRS) to quantify IMCL levels in the soleus muscle, oral glucose tolerance testing to estimate insulin sensitivity, magnetic resonance imaging (MRI) to measure abdominal fat distribution. Liver fat content was measured by fast-MRI. Despite similar age and % total body fat among the groups, IMCL was significantly higher in the Hispanics (1.71% [1.43%, 2.0%]) than in the African-Americans (1.04% [0.75%, 1.34%], p = 0.013) and the Caucasians (1.2% [0.94%, 1.5%], p = 0.04). Liver fat content was undetectable in the African Americans whereas it was two fold higher than normal in both Caucasians and Hispanics. Visceral fat was significantly lower in African Americans (41.5 cm(2) [34.6, 49.6]) and was similar in Caucasians (65.2 cm(2) [55.9, 76.0]) and Hispanics (70.5 cm(2) [59.9, 83.1]). In a multiple regression analysis, we found that ethnicity independent of age, gender and % body fat accounts for 10% of the difference in IMCL. Our study indicates that obese Hispanic adolescents have a greater IMCL lipid content than both Caucasians and African Americans, of comparable weight, age and gender. Excessive accumulation of fat in the liver was found in both Caucasian and Hispanic groups as opposed to virtually undetectable levels in the African Americans. Thus, irrespective of obesity, there seem to be some clear ethnic differences in the amount of lipid accumulated in skeletal muscle, liver and abdominal cavity.	[Caprio, Sonia] Yale Univ, Sch Med, Dept Pediat, Howard Hughes Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Gen Clin Res Ctr, New Haven, CT USA	Howard Hughes Medical Institute; Yale University; Yale University	Caprio, S (corresponding author), Yale Univ, Sch Med, Dept Pediat, Howard Hughes Inst, New Haven, CT 06510 USA.	sonia.caprio@yale.edu	Shulman, Gerald I./P-7176-2019; Liska, David/L-9180-2019	Shulman, Gerald I./0000-0003-1529-5668; Liska, David/0000-0002-8632-6065	National Institutes of Health (NIH) [R01-HD40787, R01-HD28016, K24-HD01464, P01-DK068229]; Yale General Clinical Research Center [M01-RR00125, R01-EB006494]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD028016, R01HD040787] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001464] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK068229] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the National Institutes of Health (NIH) R01-HD40787, R01-HD28016, and K24-HD01464 to Dr. Caprio, P01-DK068229 American Distinguished Clinical Investigator Award to Dr. Shulman, and M01-RR00125 to the Yale General Clinical Research Center, and R01-EB006494 (Bioimage Suite).	Abate N, 2003, J DIABETES COMPLICAT, V17, P39, DOI 10.1016/S1056-8727(02)00190-3; Arslanian SA, 2002, DIABETES, V51, P3014, DOI 10.2337/diabetes.51.10.3014; Arslanian SA, 2002, J PEDIATR ENDOCR MET, V15, P509; Bacha F, 2005, PEDIATR DIABETES, V6, P100, DOI 10.1111/j.1399-543X.2005.00108.x; Beha A, 2006, AM J PHYSIOL-ENDOC M, V290, pE989, DOI 10.1152/ajpendo.00459.2005; Carey DGP, 1996, INT J OBESITY, V20, P722; Dabelea D, 1999, ENDOCRIN METAB CLIN, V28, P709, DOI 10.1016/S0889-8529(05)70098-0; Fishbein MH, 1997, MAGN RESON IMAGING, V15, P287, DOI 10.1016/S0730-725X(96)00224-X; Goran MI, 2002, DIABETES CARE, V25, P2184, DOI 10.2337/diacare.25.12.2184; Gower BA, 1999, DIABETES, V48, P1515, DOI 10.2337/diabetes.48.8.1515; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; PAPADEMETRIS X, BIOIMAGE SUITE INTEG; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Roden M, 2005, INT J OBESITY, V29, pS111, DOI 10.1038/sj.ijo.0803102; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Schwimmer JB, 2005, PEDIATRICS, V115, pE561, DOI 10.1542/peds.2004-1832; Shen J, 1997, MAGNET RESON MED, V38, P834, DOI 10.1002/mrm.1910380521; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; SZCEZPANIAK LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462; United States Census Bureau, 2004, US INT PROJ AG SEX R; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Yeckel CW, 2004, J CLIN ENDOCR METAB, V89, P1096, DOI 10.1210/jc.2003-031503	23	97	97	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e569	10.1371/journal.pone.0000569	http://dx.doi.org/10.1371/journal.pone.0000569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593968	gold, Green Published, Green Submitted			2022-12-27	WOS:000207451800013
J	Meisel, RP; Schaeffer, SW				Meisel, Richard P.; Schaeffer, Stephen W.			Meiotic Transmission of Drosophila pseudoobscura Chromosomal Arrangements	PLOS ONE			English	Article								Drosophila pseudoobscura harbors a rich gene arrangement polymorphism on the third chromosome generated by a series of overlapping paracentric inversions. The arrangements suppress recombination in heterokaryotypic individuals, which allows for the selective maintenance of coadapted gene complexes. Previous mapping experiments used to determine the degree to which recombination is suppressed in gene arrangement heterozygotes produced non-recombinant progeny in non-Mendelian ratios. The deviations from Mendelian expectations could be the result of viability differences between wild and mutant chromosomes, meiotic drive because of achiasmate pairing of homologues in heterokaryotypic females during meiosis, or a combination of both mechanisms. The possibility that the frequencies of the chromosomal arrangements in natural populations are affected by mechanisms other than adaptive selection led us to consider these hypotheses. We performed reciprocal crosses involving both heterozygous males and females to determine if the frequency of the non-recombinant progeny deviates significantly from Mendelian expectations and if the frequencies deviate between reciprocal crosses. We failed to observe non-Mendelian ratios in multiple crosses, and the frequency of the non-recombinant classes differed in only one of five pairs of reciprocal crosses despite sufficient power to detect these differences in all crosses. Our results indicate that deviations from Mendelian expectations in recombination experiments involving the D. pseudoobscura inversion system are most likely due to fitness differences of gene arrangement karyotypes in different environments.	[Meisel, Richard P.] Penn State Univ, Inst Mol Evolutionary Genet, Intercoll Grad Program Genet, University Pk, PA 16802 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Meisel, RP (corresponding author), Penn State Univ, Inst Mol Evolutionary Genet, Intercoll Grad Program Genet, University Pk, PA 16802 USA.	meisel@psu.edu	Meisel, Richard/J-3410-2013; Schaeffer, Stephen W/B-1662-2010; Schaeffer, Stephen/AAA-2303-2021	Meisel, Richard/0000-0002-7362-9307; Schaeffer, Stephen/0000-0003-2070-5342				ANDERSON WW, 1991, P NATL ACAD SCI USA, V88, P10367, DOI 10.1073/pnas.88.22.10367; ANDERSON WW, 1968, GENET RES, V12, P317, DOI 10.1017/S0016672300011903; DOBZHANSKY T, 1948, GENETICS, V33, P158; DOBZHANSKY T, 1948, P NATL ACAD SCI USA, V34, P137, DOI 10.1073/pnas.34.4.137; DOBZHANSKY T, 1950, GENETICS, V35, P288; HAWLEY RS, 1993, ANNU REV GENET, V27, P281; Kovacevic M, 2000, GENETICS, V156, P155; LEVINE L, 1955, GENETICS, V40, P832; LEVINE RP, 1955, GENETICS, V40, P399; LEVINE RP, 1956, AM NAT, V90, P41, DOI 10.1086/281905; ORRWEAVER TL, 1995, P NATL ACAD SCI USA, V92, P10443, DOI 10.1073/pnas.92.23.10443; Popadic A, 1996, MOL BIOL EVOL, V13, P883, DOI 10.1093/oxfordjournals.molbev.a025648; Powell Jeffrey R., 1992, P73; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; RILEY MA, 1989, GENETICS, V123, P359; Schaeffer SW, 2005, GENETICS, V171, P1729, DOI 10.1534/genetics.105.041947; Schaeffer SW, 2003, P NATL ACAD SCI USA, V100, P8319, DOI 10.1073/pnas.1432900100; SCHAEFFER SW, 1992, GENETICS, V132, P471; Sokal RR, 1995, BIOMETRY; STRICKBERGER MW, 1963, EVOLUTION, V17, P40, DOI 10.2307/2406334; Sturtevant AH, 1937, J GENET, V34, P415, DOI 10.1007/BF02982303; Sturtevant AH, 1936, GENETICS, V21, P444; WATANABE T, 1970, GENET RES, V15, P123, DOI 10.1017/S0016672300001427; WRIGHT S, 1946, GENETICS, V31, P125	24	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2007	2	6							e530	10.1371/journal.pone.0000530	http://dx.doi.org/10.1371/journal.pone.0000530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GD	17565383	Green Submitted, Green Published, gold			2022-12-27	WOS:000207451600018
J	Kress, WJ; Erickson, DL				Kress, W. John; Erickson, David L.			A Two-Locus Global DNA Barcode for Land Plants: The Coding rbcL Gene Complements the Non-Coding trnH-psbA Spacer Region	PLOS ONE			English	Article							SEQUENCES; NUCLEAR; IDENTIFY; RATES	Background. A useful DNA barcode requires sufficient sequence variation to distinguish between species and ease of application across a broad range of taxa. Discovery of a DNA barcode for land plants has been limited by intrinsically lower rates of sequence evolution in plant genomes than that observed in animals. This low rate has complicated the trade-off in finding a locus that is universal and readily sequenced and has sufficiently high sequence divergence at the species-level. Methodology/Principal Findings. Here, a global plant DNA barcode system is evaluated by comparing universal application and degree of sequence divergence for nine putative barcode loci, including coding and non-coding regions, singly and in pairs across a phylogenetically diverse set of 48 genera (two species per genus). No single locus could discriminate among species in a pair in more than 79% of genera, whereas discrimination increased to nearly 88% when the non-coding trnH-psbA spacer was paired with one of three coding loci, including rbcL. In silico trials were conducted in which DNA sequences from GenBank were used to further evaluate the discriminatory power of a subset of these loci. These trials supported the earlier observation that trnH-psbA coupled with rbcL can correctly identify and discriminate among related species. Conclusions/Significance. A combination of the non-coding trnH-psbA spacer region and a portion of the coding rbcL gene is recommended as a two-locus global land plant barcode that provides the necessary universality and species discrimination.	[Kress, W. John; Erickson, David L.] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Kress, WJ (corresponding author), Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA.	kressj@si.edu			Smithsonian's National Museum of Natural History; United States Botanic Garden	Smithsonian's National Museum of Natural History(Smithsonian InstitutionSmithsonian National Museum of Natural History); United States Botanic Garden	This work was supported by the Smithsonian's National Museum of Natural History and the United States Botanic Garden.	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asmussen CB, 2001, AM J BOT, V88, P1103, DOI 10.2307/2657094; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Cho Y, 1998, P NATL ACAD SCI USA, V95, P14244, DOI 10.1073/pnas.95.24.14244; Cowan RS, 2006, TAXON, V55, P611, DOI 10.2307/25065638; GIVNISH TJ, 2006, MONOCOTS COMP BIOL E, P28; Goremykin VV, 2005, MOL BIOL EVOL, V22, P1813, DOI 10.1093/molbev/msi173; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kellogg EA, 1997, AM J BOT, V84, P413, DOI 10.2307/2446015; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Renner SS, 1999, AM J BOT, V86, P1301, DOI 10.2307/2656778; Rogers MB, 2007, MOL BIOL EVOL, V24, P54, DOI 10.1093/molbev/msl129; Rubinoff D, 2006, TRENDS ECOL EVOL, V21, P1, DOI 10.1016/j.tree.2005.10.019; Salazar GA, 2003, AM J BOT, V90, P777, DOI 10.3732/ajb.90.5.777; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Soltis DE, 2001, ANN MO BOT GARD, V88, P669, DOI 10.2307/3298639; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; The Angiosperm Phylogeny Group II, 2003, BOT J LINN SOC, V141, P399, DOI [DOI 10.1046/J.1095-8339.2003.T01-1-00158.X, 10.1046/j.1095-8339.2003.t01-1-00158.x]; Treutlein J, 2005, PLANT BIOLOGY, V7, P79, DOI 10.1055/s-2004-830478; WIERSEMA JH, 2007, WORLD EC PLANTS; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Yamaguchi A, 2006, PHYCOL RES, V54, P317, DOI 10.1111/j.1440-1835.2006.00438.x; Zar J.H., 2010, BIOSTAT ANAL	34	927	1100	7	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e508	10.1371/journal.pone.0000508	http://dx.doi.org/10.1371/journal.pone.0000508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551588	Green Published, gold			2022-12-27	WOS:000207451500017
J	Amrein, I; Dechmann, DKN; Winter, Y; Lipp, HP				Amrein, Irmgard; Dechmann, Dina K. N.; Winter, York; Lipp, Hans-Peter			Absent or Low Rate of Adult Neurogenesis in the Hippocampus of Bats (Chiroptera)	PLOS ONE			English	Article								Bats are the only flying mammals and have well developed navigation abilities for 3D-space. Even bats with comparatively small home ranges cover much larger territories than rodents, and long-distance migration by some species is unique among small mammals. Adult proliferation of neurons, i.e., adult neurogenesis, in the dentate gyrus of rodents is thought to play an important role in spatial memory and learning, as indicated by lesion studies and recordings of neurons active during spatial behavior. Assuming a role of adult neurogenesis in hippocampal function, one might expect high levels of adult neurogenesis in bats, particularly among fruit-and nectar-eating bats in need of excellent spatial working memory. The dentate gyrus of 12 tropical bat species was examined immunohistochemically, using multiple antibodies against proteins specific for proliferating cells (Ki-67, MCM2), and migrating and differentiating neurons (Doublecortin, NeuroD). Our data show a complete lack of hippocampal neurogenesis in nine of the species (Glossophaga soricina, Carollia perspicillata, Phyllostomus discolor, Nycteris macrotis, Nycteris thebaica, Hipposideros cyclops, Neoromicia rendalli, Pipistrellus guineensis, and Scotophilus leucogaster), while it was present at low levels in three species (Chaerephon pumila, Mops condylurus and Hipposideros caffer). Although not all antigens were recognized in all species, proliferation activity in the subventricular zone and rostral migratory stream was found in all species, confirming the appropriateness of our methods for detecting neurogenesis. The small variation of adult hippocampal neurogenesis within our sample of bats showed no indication of a correlation with phylogenetic relationship, foraging strategy, type of hunting habitat or diet. Our data indicate that the widely accepted notion of adult neurogenesis supporting spatial abilities needs to be considered carefully. Given their astonishing longevity, certain bat species may be useful subjects to compare adult neurogenesis with other long-living species, such as monkeys and humans, showing low rates of adult hippocampal neurogenesis.	[Amrein, Irmgard; Dechmann, Dina K. N.; Lipp, Hans-Peter] Univ Zurich, Inst Anat, Div Neuroanat & Behav, Zurich, Switzerland; [Winter, York] Univ Munich, Dept Biol, Munich, Germany	University of Zurich; University of Munich	Lipp, HP (corresponding author), Univ Zurich, Inst Anat, Div Neuroanat & Behav, Zurich, Switzerland.	hplipp@anatom.uzh.ch	Dechmann, Dina/A-1827-2010	Winter, York/0000-0002-7828-1872; Dechmann, Dina/0000-0003-0043-8267	Swiss National Science Foundation; NCCR "Neural Plasticity and Repair" (Switzerland); Volkswagen Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR "Neural Plasticity and Repair" (Switzerland)(Swiss National Science Foundation (SNSF)); Volkswagen Foundation(Volkswagen)	Fundings through Swiss National Science Foundation, NCCR "Neural Plasticity and Repair" (Switzerland), and by a grant of the Volkswagen Foundation to WY. All fundings were given for the collection (African) and breeding (Neotropical) of the bat species.	AlvarezBuylla A, 1997, J NEUROBIOL, V33, P585, DOI 10.1002/(SICI)1097-4695(19971105)33:5<585::AID-NEU7>3.0.CO;2-0; Amrein I, 2004, EUR J NEUROSCI, V20, P3342, DOI 10.1111/j.1460-9568.2004.03795.x; Amrein I, 2004, HIPPOCAMPUS, V14, P1000, DOI 10.1002/hipo.20018; Anthony E.L.P., 1988, P47; Baron G, 1996, COMP NEUROBIOLOGY CH; Bedard A, 2004, DEV BRAIN RES, V151, P159, DOI 10.1016/j.devbrainres.2004.03.021; Belsky J.K, 1990, PSYCHOL AGING THEORY; Boekhoorn K, 2006, NEUROBIOL DIS, V24, P1, DOI 10.1016/j.nbd.2006.04.017; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Curtis MA, 2005, NEUROSCIENCE, V132, P777, DOI 10.1016/j.neuroscience.2004.12.051; Decher Jan, 2005, Mammalian Species, P1; Del Bigio MR, 1999, MICROSC RES TECHNIQ, V45, P353, DOI 10.1002/(SICI)1097-0029(19990615)45:6<353::AID-JEMT3>3.3.CO;2-D; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fahrner A, 2007, EXP NEUROL, V203, P320, DOI 10.1016/j.expneurol.2006.08.023; Fleming TH, 2003, BAT ECOLOGY, P156; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Hayes NL, 2002, DEV BRAIN RES, V134, P77, DOI 10.1016/S0165-3806(01)00324-8; Horn J. L., 1970, LIFE SPAN DEV PSYCH, V1, P423, DOI DOI 10.1016/B978-0-12-293850-4.50022-4; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lavenex P, 2000, EUR J NEUROSCI, V12, P643, DOI 10.1046/j.1460-9568.2000.00949.x; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Lichtenwalner RJ, 2006, J CEREBR BLOOD F MET, V26, P1, DOI 10.1038/sj.jcbfm.9600170; LIPP HP, 1991, BEHAV BRAIN RES, V45, P135, DOI 10.1016/S0166-4328(05)80079-8; Matsuo N, 1998, BIOCHEM BIOPH RES CO, V252, P571, DOI 10.1006/bbrc.1998.9698; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Safi K, 2005, P ROY SOC B-BIOL SCI, V272, P179, DOI 10.1098/rspb.2004.2924; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seress L, 2001, NEUROSCIENCE, V105, P831, DOI 10.1016/S0306-4522(01)00156-7; Starborg M, 1996, J CELL SCI, V109, P143; Stich KP, 2006, J EXP BIOL, V209, P4802, DOI 10.1242/jeb.02574; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Thiele J, 2005, ANIM BEHAV, V69, P315, DOI 10.1016/j.anbehav.2004.05.012; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Winter Y, 2005, J EXP BIOL, V208, P539, DOI 10.1242/jeb.01416	43	95	95	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2007	2	5							e455	10.1371/journal.pone.0000455	http://dx.doi.org/10.1371/journal.pone.0000455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DZ	17520014	Green Published, Green Submitted, gold			2022-12-27	WOS:000207446000003
J	Kwezi, L; Meier, S; Mungur, L; Ruzvidzo, O; Irving, H; Gehring, C				Kwezi, Lusisizwe; Meier, Stuart; Mungur, Lyndon; Ruzvidzo, Oziniel; Irving, Helen; Gehring, Chris			The Arabidopsis thaliana Brassinosteroid Receptor (AtBRI1) Contains a Domain that Functions as a Guanylyl Cyclase In Vitro	PLOS ONE			English	Article								Background. Guanylyl cyclases (GCs) catalyze the formation of the second messenger guanosine 3',5'-cyclic monophosphate (cGMP) from guanosine 5'-triphosphate (GTP). Cyclic GMP has been implicated in an increasing number of plant processes, including responses to abiotic stresses such as dehydration and salt, as well as hormones. Principle Findings. Here we used a rational search strategy based on conserved and functionally assigned residues in the catalytic centre of annotated GCs to identify candidate GCs in Arabidopsis thaliana and show that one of the candidates is the brassinosteroid receptor AtBR1, a leucine rich repeat receptor like kinase. We have cloned and expressed a 114 amino acid recombinant protein (AtBR1-GC) that harbours the putative catalytic domain, and demonstrate that this molecule can convert GTP to cGMP in vitro. Conclusions. Our results suggest that AtBR1 may belong to a novel class of GCs that contains both a cytosolic kinase and GC domain, and thus have a domain organisation that is not dissimilar to that of atrial natriuretic peptide receptors, NPR1 and NPR2. The findings also suggest that cGMP may have a role as a second messenger in brassinosteroid signalling. In addition, it is conceivable that other proteins containing the extended GC search motif may also have catalytic activity, thus implying that a significant number of GCs, both in plants and animals, remain to be discovered, and this is in keeping with the fact that the single cellular green alga Chlamydomonas reinhardtii contains over 90 annotated putative CGs.	[Kwezi, Lusisizwe; Meier, Stuart; Mungur, Lyndon; Ruzvidzo, Oziniel; Gehring, Chris] Univ Western Cape, Dept Biotechnol, ZA-7535 Bellville, South Africa; [Irving, Helen] Monash Univ, Dept Pharmaceut Biol, Victorian Coll Pharm, Melbourne, Vic 3004, Australia	University of the Western Cape; Monash University	Gehring, C (corresponding author), Univ Western Cape, Dept Biotechnol, ZA-7535 Bellville, South Africa.	cgehring@uwc.ac.za	Irving, Helen/B-4425-2019	Irving, Helen/0000-0002-1514-0909; Gehring, Christoph/0000-0003-4355-4591	NRF (South Africa); ARC (Australia)	NRF (South Africa)(National Research Foundation - South Africa); ARC (Australia)(Australian Research Council)	This work was supported by the NRF (South Africa) and the ARC (Australia).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bouquin T, 2001, PLANT PHYSIOL, V127, P450, DOI 10.1104/pp.010173; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; Chory J, 1996, P NATL ACAD SCI USA, V93, P12066, DOI 10.1073/pnas.93.22.12066; Clouse SD, 2002, PLANT CELL, V14, P1995, DOI 10.1105/tpc.140930; Donaldson L, 2004, FEBS LETT, V569, P317, DOI 10.1016/j.febslet.2004.06.016; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; GARBERS DL, 1994, J BIOL CHEM, V269, P30741; GEHRING CA, 1990, P NATL ACAD SCI USA, V87, P9645, DOI 10.1073/pnas.87.24.9645; Gehring CA, 2003, INT J BIOCHEM CELL B, V35, P1318, DOI 10.1016/S1357-2725(03)00032-3; GODA H, 2002, PLANT PHYSIOL, V130, P700; Haubrick LL, 2006, PLANT CELL ENVIRON, V29, P446, DOI 10.1111/j.1365-3040.2005.01481.x; Hu XY, 2005, PLANT PHYSIOL, V137, P663, DOI 10.1104/pp.104.054494; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Kende H, 1997, PLANT CELL, V9, P1197, DOI 10.1105/tpc.9.7.1197; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Leyser O, 2005, CURR OPIN GENET DEV, V15, P468, DOI 10.1016/j.gde.2005.06.010; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Lindsey K, 2002, TRENDS PLANT SCI, V7, P78, DOI 10.1016/S1360-1385(01)02194-X; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; Ludidi N, 2003, J BIOL CHEM, V278, P6490, DOI 10.1074/jbc.M210983200; Maathuis FJM, 2006, PLANT J, V45, P700, DOI 10.1111/j.1365-313X.2005.02616.x; McCue LA, 2000, GENOME RES, V10, P204, DOI 10.1101/gr.10.2.204; Meier S, 2006, AFR J BIOTECHNOL, V5, P1687; Mussig C, 2006, PLANT BIOLOGY, V8, P291, DOI 10.1055/s-2005-873043; Nam KH, 2004, PLANT CELL, V16, P2406, DOI 10.1105/tpc.104.023903; Newton RP, 2004, PHYTOCHEMISTRY, V65, P2423, DOI 10.1016/j.phytochem.2004.07.026; Newton RP, 1999, NEW PHYTOL, V143, P427, DOI 10.1046/j.1469-8137.1999.00478.x; Pagnussat GC, 2004, PLANT PHYSIOL, V135, P279, DOI 10.1104/pp.103.038554; Penson SP, 1996, PLANT CELL, V8, P2325, DOI 10.1105/tpc.8.12.2325; Pharmawati M, 1998, PLANT SCI, V137, P107, DOI 10.1016/S0168-9452(98)00135-6; Pharmawati M, 2001, PLANT PHYSIOL BIOCH, V39, P385, DOI 10.1016/S0981-9428(01)01252-9; Prado AM, 2004, DEVELOPMENT, V131, P2707, DOI 10.1242/dev.01153; Schaap P, 2005, FRONT BIOSCI-LANDMRK, V10, P1485, DOI 10.2741/1633; Tang WJ, 1998, MOL PHARMACOL, V54, P231, DOI 10.1124/mol.54.2.231; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THORPE DS, 1990, J BIOL CHEM, V265, P14717; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597	39	100	105	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2007	2	5							e449	10.1371/journal.pone.0000449	http://dx.doi.org/10.1371/journal.pone.0000449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DZ	17520012	gold, Green Published, Green Submitted			2022-12-27	WOS:000207446000001
J	Smith, MD; Rosenow, MA; Wang, MT; Allen, JP; Szostak, JW; Chaput, JC				Smith, Matthew D.; Rosenow, Matthew A.; Wang, Meitian; Allen, James P.; Szostak, Jack W.; Chaput, John C.			Structural Insights into the Evolution of a Non-Biological Protein: Importance of Surface Residues in Protein Fold Optimization	PLOS ONE			English	Article							IN-VITRO SELECTION; BINDING; SEQUENCES; STABILIZATION; DETERMINANTS; STABILITY	Phylogenetic profiling of amino acid substitution patterns in proteins has led many to conclude that most structural information is carried by interior core residues that are solvent inaccessible. This conclusion is based on the observation that buried residues generally tolerate only conserved sequence changes, while surface residues allow more diverse chemical substitutions. This notion is now changing as it has become apparent that both core and surface residues play important roles in protein folding and stability. Unfortunately, the ability to identify specific mutations that will lead to enhanced stability remains a challenging problem. Here we discuss two mutations that emerged from an in vitro selection experiment designed to improve the folding stability of a non-biological ATP binding protein. These mutations alter two solvent accessible residues, and dramatically enhance the expression, solubility, thermal stability, and ligand binding affinity of the protein. The significance of both mutations was investigated individually and together, and the X-ray crystal structures of the parent sequence and double mutant protein were solved to a resolution limit of 2.8 and 1.65 angstrom, respectively. Comparative structural analysis of the evolved protein to proteins found in nature reveals that our non-biological protein evolved certain structural features shared by many thermophilic proteins. This experimental result suggests that protein fold optimization by in vitro selection offers a viable approach to generating stable variants of many naturally occurring proteins whose structures and functions are otherwise difficult to study.	[Smith, Matthew D.; Rosenow, Matthew A.; Chaput, John C.] Arizona State Univ, Ctr BioOpt Nanotechnol, Biodesign Inst, Tempe, AZ 85287 USA; [Smith, Matthew D.; Rosenow, Matthew A.; Wang, Meitian; Allen, James P.; Chaput, John C.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA; [Szostak, Jack W.] Massachusetts Gen Hosp, Dept Mol Biol, Howard Hughes Med Inst, Boston, MA 02114 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Chaput, JC (corresponding author), Arizona State Univ, Ctr BioOpt Nanotechnol, Biodesign Inst, Tempe, AZ 85287 USA.	john.chaput@asu.edu	Wang, Meitian/D-3208-2013		Biodesign Institute; NIH; NASA Astrobiology Institute	Biodesign Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA Astrobiology Institute	This work was supported by new laboratory start-up funds from the The Biodesign Institute to JCC and grants from the NIH and NASA Astrobiology Institute to JWS. JWS is an Investigator, and J.C.C. was a Research Associate of the Howard Hughes Medical Institute.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; BOWIE JU, 1989, P NATL ACAD SCI USA, V86, P2152, DOI 10.1073/pnas.86.7.2152; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; Cappello V, 2002, PROTEINS, V47, P106, DOI 10.1002/prot.10070; Carothers JM, 2006, J AM CHEM SOC, V128, P7929, DOI 10.1021/ja060952q; Chaput JC, 2004, CHEM BIOL, V11, P865, DOI 10.1016/j.chembiol.2004.04.006; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; Chothia C, 1998, J MOL BIOL, V278, P457, DOI 10.1006/jmbi.1998.1653; Dauter Z, 2002, ACTA CRYSTALLOGR D, V58, P494, DOI 10.1107/S090744490200118X; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DELANO WL, 2002, PYMOL MOL GRAPHICS P; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hecht MH, 2004, PROTEIN SCI, V13, P1711, DOI 10.1110/ps.04690804; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; Jung S, 1999, J MOL BIOL, V294, P163, DOI 10.1006/jmbi.1999.3196; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; Kimura M., 1983, NEUTRAL THEORY MOL E; Krishna SS, 2004, STRUCTURE, V12, P1125, DOI 10.1016/j.str.2004.06.004; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Lo Surdo P, 2004, NAT STRUCT MOL BIOL, V11, P382, DOI 10.1038/nsmb745; LOVELL SC, 2003, PROTEINS STRUCTURE F, V50; Martin A, 2001, J MOL BIOL, V309, P717, DOI 10.1006/jmbi.2001.4698; Matsuura T, 2003, FEBS LETT, V539, P24, DOI 10.1016/S0014-5793(03)00178-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OLIPHANT AR, 1986, GENE, V44, P177, DOI 10.1016/0378-1119(86)90180-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERUTZ MF, 1968, NATURE, V219, P902, DOI 10.1038/219902a0; PERUTZ MF, 1965, J MOL BIOL, V13, P669, DOI 10.1016/S0022-2836(65)80134-6; Petsko GA, 2001, METHOD ENZYMOL, V334, P469; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; REIDHAAROLSON JF, 1988, SCIENCE, V241, P53, DOI 10.1126/science.3388019; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Roodveldt C, 2005, CURR OPIN STRUC BIOL, V15, P50, DOI 10.1016/j.sbi.2005.01.001; Sauer RT, 1996, FOLD DES, V1, pR27, DOI 10.1016/S1359-0278(96)00015-6; Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174; Strickler SS, 2006, BIOCHEMISTRY-US, V45, P2761, DOI 10.1021/bi0600143; Takahashi TT, 2003, TRENDS BIOCHEM SCI, V28, P159, DOI 10.1016/S0968-0004(03)00036-7; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang QH, 2000, J MOL BIOL, V298, P917, DOI 10.1006/jmbi.2000.3716; WILSON D, 2000, CURRENT PROTOCOLS MO; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Wunderlich M, 2005, J MOL BIOL, V347, P1063, DOI 10.1016/j.jmb.2005.02.014	47	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2007	2	5							e467	10.1371/journal.pone.0000467	http://dx.doi.org/10.1371/journal.pone.0000467			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DZ	17520026	gold, Green Submitted, Green Published			2022-12-27	WOS:000207446000015
J	Liang, J; Fu, MG; Ciociola, E; Chandalia, M; Abate, N				Liang, Jian; Fu, Mingui; Ciociola, Ester; Chandalia, Manisha; Abate, Nicola			Role of ENPP1 on Adipocyte Maturation	PLOS ONE			English	Article								Background. It is recognized that the ability of adipose tissue to expand in response to energy excess, i.e. adipocyte maturation, is important in determining systemic abnormalities in glucose and lipid metabolism. Ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1, also known as PC-1) has been recently reported to be involved in the pathogenesis of insulin resistance and related diseases. However, its role on adipose tissue physiology as a mechanism of systemic insulin resistance is not understood. This study was performed to evaluate whether ENPP1 is regulated during adipogenesis and whether over-expression in adipocytes can affect adipocyte maturation, a potential novel mechanism of ENPP1-related insulin resistance. Methodology/Principal Findings. ENPP1 expression was found down-regulated during 3T3-L1 maturation, and over-expression of human ENPP1 in 3T3-L1 (pQCXIP-ENPP1 vector) resulted in adipocyte insulin resistance and in defective adipocyte maturation. Adipocyte maturation was more efficient in mesenchymal embryonal cells from ENPP1 knockout mice than from wild-type. Conclusions. We identify ENPP1 as a novel mechanism of defective adipocyte maturation. This mechanism could contribute to the pathogenesis of insulin resistance in absence of obesity.	[Chandalia, Manisha; Abate, Nicola] Univ Texas SW Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA; [Ciociola, Ester; Chandalia, Manisha; Abate, Nicola] Univ Texas SW Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA; [Liang, Jian; Fu, Mingui] Univ Cent Florida, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; State University System of Florida; University of Central Florida	Chandalia, M (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA.	Manisha.Chandalia@utsouthwestern.edu; Nicola.Abate@UTSouthwestern.edu			NIDDK [RO1 DK072158-01]; ADA [7-03-JF-18]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072158] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ADA(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: NIDDK RO1 DK072158-01 (NA and MC); ADA 7-03-JF-18 (MF)	Abate N, 2005, DIABETES, V54, P1207, DOI 10.2337/diabetes.54.4.1207; Abate N, 2003, J CLIN ENDOCR METAB, V88, P5927, DOI 10.1210/jc.2003-030453; Belfiore A, 1996, MOL ENDOCRINOL, V10, P1318, DOI 10.1210/me.10.11.1318; CHANEY B, 2007, US NEWS WORLD REP, V143, P8; Chen N, 2005, DIABETES, V54, P3379, DOI 10.2337/diabetes.54.12.3379; Costanzo BV, 2001, DIABETES, V50, P831, DOI 10.2337/diabetes.50.4.831; Dong HJ, 2005, DIABETES, V54, P367, DOI 10.2337/diabetes.54.2.367; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Garg A, 2004, ENDOCRIN METAB CLIN, V33, P305, DOI 10.1016/j.ecl.2004.03.003; GIRARD J, 1994, FASEB J, V8, P36, DOI 10.1096/fasebj.8.1.7905448; Johnson K, 2005, ARTERIOSCL THROM VAS, V25, P686, DOI 10.1161/01.ATV.0000154774.71187.f0; KOUTSARI C, 2006, J LIPID RES     0510; Laustsen PG, 2002, GENE DEV, V16, P3213, DOI 10.1101/gad.1034802; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI15924; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; Maddux BA, 2006, AM J PHYSIOL-ENDOC M, V290, pE746, DOI 10.1152/ajpendo.00298.2005; MADDUX BA, 1995, NATURE, V373, P448, DOI 10.1038/373448a0; Maddux BA, 2000, DIABETES, V49, P13, DOI 10.2337/diabetes.49.1.13; MATSUOKA N, 2005, INT J OBESITY, V11, P1; Matsuzawa Y, 2006, FEBS LETT, V580, P2917, DOI 10.1016/j.febslet.2006.04.028; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Miles JM, 2004, DIABETES, V53, P521, DOI 10.2337/diabetes.53.3.521; Prudente S, 2007, OBESITY, V15, P1, DOI 10.1038/oby.2007.636; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rosen ED, 2000, GENE DEV, V14, P1293; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; RUDERMAN NB, 1981, AM J CLIN NUTR, V34, P1617, DOI 10.1093/ajcn/34.8.1617; Sakoda H, 1999, DIABETES, V48, P1365, DOI 10.2337/diabetes.48.7.1365; Zhang Weidong, 2004, Genet Vaccines Ther, V2, P8, DOI 10.1186/1479-0556-2-8	30	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e882	10.1371/journal.pone.0000882	http://dx.doi.org/10.1371/journal.pone.0000882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849011	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455600028
J	Mahfooz, N; Turchyn, N; Mihajlovic, M; Hrycaj, S; Popadic, A				Mahfooz, Najmus; Turchyn, Nataliya; Mihajlovic, Michelle; Hrycaj, Steven; Popadic, Aleksandar			Ubx Regulates Differential Enlargement and Diversification of Insect Hind Legs	PLOS ONE			English	Article								Differential enlargement of hind (T3) legs represents one of the hallmarks of insect evolution. However, the actual mechanism(s) responsible are yet to be determined. To address this issue, we have now studied the molecular basis of T3 leg enlargement in Oncopeltus fasciatus (milkweed bug) and Acheta domesticus (house cricket). In Oncopeltus, the T3 tibia displays a moderate increase in size, whereas in Acheta, the T3 femur, tibia, and tarsus are all greatly enlarged. Here, we show that the hox gene Ultrabithorax (Ubx) is expressed in the enlarged segments of hind legs. Furthermore, we demonstrate that depletion of Ubx during embryogenesis has a primary effect in T3 legs and causes shortening of leg segments that are enlarged in a wild type. This result shows that Ubx is regulating the differential growth and enlargement of T3 legs in both Oncopeltus and Acheta. The emerging view suggests that Ubx was co-opted for a novel role in regulating leg growth and that the transcriptional modification of its expression may be a universal mechanism for the evolutionary diversification of insect hind legs.	[Mahfooz, Najmus; Turchyn, Nataliya; Mihajlovic, Michelle; Hrycaj, Steven; Popadic, Aleksandar] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Popadic, A (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	apopadic@biology.biosci.wayne.edu			NIGMS NIH HHS [GM071927, R01 GM071927] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071927] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abzhanov A, 1999, EVOL DEV, V1, P77, DOI 10.1046/j.1525-142x.1999.99014.x; Akam M, 1998, CURR BIOL, V8, pR676, DOI 10.1016/S0960-9822(98)70433-6; Angelini DR, 2005, DEV BIOL, V287, P440, DOI 10.1016/j.ydbio.2005.08.010; Averof M, 1997, NATURE, V388, P682, DOI 10.1038/41786; Bennett RL, 1999, DEV GENES EVOL, V209, P608, DOI 10.1007/s004270050295; Brodu V, 2002, DEVELOPMENT, V129, P2957; Carroll S.B., 2001, DNA DIVERSITY; CASTELLIGAIR J, 1995, DEVELOPMENT, V121, P2973; Damen WGM, 1998, P NATL ACAD SCI USA, V95, P10665, DOI 10.1073/pnas.95.18.10665; Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717; GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8; Heming BS., 2003, INSECT DEV EVOLUTION; Hughes CL, 2002, EVOL DEV, V4, P459, DOI 10.1046/j.1525-142X.2002.02034.x; Hughes CL, 2002, DEVELOPMENT, V129, P1225; Hughes CL, 2000, DEVELOPMENT, V127, P3683; KELSH R, 1994, DEV GENET, V15, P19, DOI 10.1002/dvg.1020150104; Lewis DL, 2000, P NATL ACAD SCI USA, V97, P4504, DOI 10.1073/pnas.97.9.4504; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li H, 2004, EVOL DEV, V6, P310, DOI 10.1111/j.1525-142X.2004.04039.x; Liu PZ, 2004, DEVELOPMENT, V131, P1515, DOI 10.1242/dev.01046; Lohmann I, 2002, CURR BIOL, V12, pR514, DOI 10.1016/S0960-9822(02)01025-4; Mahfooz NS, 2004, P NATL ACAD SCI USA, V101, P4877, DOI 10.1073/pnas.0401216101; MIHAJLOVIC M, 2005, UTILIZING MOL PROBES; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Peterson MD, 1999, DEV GENES EVOL, V209, P77, DOI 10.1007/s004270050230; Popadic A, 2001, EVOL DEV, V3, P391, DOI 10.1046/j.1525-142X.2001.01049.x; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Rozowski M, 2002, GENE DEV, V16, P1150, DOI 10.1101/gad.219302; Snodgrass R.E., 1952, TXB ARTHROPOD ANATOM; Stern DL, 1999, DEVELOPMENT, V126, P1091; Stern DL, 2003, DEV BIOL, V256, P355, DOI 10.1016/S0012-1606(03)00035-6; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; Telford MJ, 1998, P NATL ACAD SCI USA, V95, P10671, DOI 10.1073/pnas.95.18.10671; Tomoyasu Y, 2005, NATURE, V433, P643, DOI 10.1038/nature03272; Wilkins A.S., 2002, EVOLUTION DEV PATHWA; Zhang HJ, 2005, GENE EXPR PATTERNS, V5, P491, DOI 10.1016/j.modgep.2004.12.006; Zheng Z, 1999, DEV GENES EVOL, V209, P460, DOI 10.1007/s004270050279	37	38	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e866	10.1371/journal.pone.0000866	http://dx.doi.org/10.1371/journal.pone.0000866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17848997	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455600013
J	Hartmannsgruber, V; Heyken, WT; Kacik, M; Kaistha, A; Grgic, I; Harteneck, C; Liedtke, W; Hoyer, J; Kohler, R				Hartmannsgruber, Veronika; Heyken, Willm-Thomas; Kacik, Michael; Kaistha, Anuradha; Grgic, Ivica; Harteneck, Christian; Liedtke, Wolfgang; Hoyer, Joachim; Koehler, Ralf			Arterial Response to Shear Stress Critically Depends on Endothelial TRPV4 Expression	PLOS ONE			English	Article								Background. In blood vessels, the endothelium is a crucial signal transduction interface in control of vascular tone and blood pressure to ensure energy and oxygen supply according to the organs' needs. In response to vasoactive factors and to shear stress elicited by blood flow, the endothelium secretes vasodilating or vasocontracting autacoids, which adjust the contractile state of the smooth muscle. In endothelial sensing of shear stress, the osmo- and mechanosensitive Ca2+-permeable TRPV4 channel has been proposed to be candidate mechanosensor. Using TRPV4(-/-) mice, we now investigated whether the absence of endothelial TRPV4 alters shear-stress-induced arterial vasodilation. Methodology/Principal Findings. In TRPV4(-/-) mice, loss of the TRPV4 protein was confirmed by Western blot, immunohistochemistry and by in situ-patch-clamp techniques in carotid artery endothelial cells (CAEC). Endothelium-dependent vasodilation was determined by pressure myography in carotid arteries (CA) from TRPV4(-/-) mice and wild-type littermates (WT). In WT CAEC, TRPV4 currents could be elicited by TRPV4 activators 4 alpha-phorbol-12,13-didecanoate (4 alpha PDD), arachidonic acid ( AA), and by hypotonic cell swelling (HTS). In striking contrast, in TRPV4(-/-) mice, 4 alpha PDD did not produce currents and currents elicited by AA and HTS were significantly reduced. 4 alpha PDD caused a robust and endothelium-dependent vasodilation in WT mice, again conspicuously absent in TRPV4(-/-) mice. Shear stress-induced vasodilation could readily be evoked in WT, but was completely eliminated in TRPV4(-/-) mice. In addition, flow/reperfusion-induced vasodilation was significantly reduced in TRPV4(-/-) vs. WT mice. Vasodilation in response to acetylcholine, vasoconstriction in response to phenylephrine, and passive mechanical compliance did not differ between genotypes, greatly underscoring the specificity of the above trpv4-dependent phenotype for physiologically relevant shear stress. Conclusions/Significance. Genetically encoded loss-of-function of trpv4 results in a loss of shear stress-induced vasodilation, a response pattern critically dependent on endothelial TRPV4 expression. Thus, Ca2+-influx through endothelial TRPV4 channels is a molecular mechanism contributing significantly to endothelial mechanotransduction.	[Hartmannsgruber, Veronika; Heyken, Willm-Thomas; Kacik, Michael; Kaistha, Anuradha; Grgic, Ivica; Hoyer, Joachim; Koehler, Ralf] Univ Marburg, Dept Internal Med Nephrol, Marburg, Germany; [Harteneck, Christian] Charite Campus Benjamin Franklin, Inst Pharmakol, Berlin, Germany; [Liedtke, Wolfgang] Duke Univ, Ctr Translat Neurosci, Durham, NC USA	Philipps University Marburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Duke University	Kohler, R (corresponding author), Univ Marburg, Dept Internal Med Nephrol, Marburg, Germany.	rkoehler@med.uni-marburg.de	Liedtke, Wolfgang B/G-4633-2011; Liedtke, Wolfgang/GNH-1878-2022; Hoyer, Joachim/GQB-1090-2022	Kohler, Ralf/0000-0001-9563-2913	Deutsche Forschungsgemeinschaft [SFB593, FOR 667]; National Institute of Mental Health (Bethesda, MD, USA); Whitehall Foundation; Klingenstein Fund; Duke University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute of Mental Health (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Whitehall Foundation; Klingenstein Fund(Klingenstein Philanthropies); Duke University	RK, JH and CH were supported by the Deutsche Forschungsgemeinschaft (P A11 of the SFB593 (JH, RK) and P4 of the FOR 667; CH); WL was supported by a K08 Career Development Award of the National Institute of Mental Health (Bethesda, MD, USA), by funding from the Whitehall Foundation (Palm Springs, FL, USA), the Klingenstein Fund (New York, NY, USA) and by the Duke University (Durham, NC, USA). All funders had no influence in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Alessandri-Haber N, 2006, J NEUROSCI, V26, P3864, DOI 10.1523/JNEUROSCI.5385-05.2006; Alessandri-Haber N, 2005, PAIN, V118, P70, DOI 10.1016/j.pain.2005.07.016; Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Alvarez DF, 2006, CIRC RES, V99, P988, DOI 10.1161/01.RES.0000247065.11756.19; Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Clapham DE, 2003, PHARMACOL REV, V55, P591, DOI 10.1124/pr.55.4.6; Eichler I, 2003, BRIT J PHARMACOL, V138, P594, DOI 10.1038/sj.bjp.0705075; FALCONE JC, 1993, AM J PHYSIOL, V264, pH653, DOI 10.1152/ajpheart.1993.264.2.H653; Feletou M, 2006, ARTERIOSCL THROM VAS, V26, P1215, DOI 10.1161/01.ATV.0000217611.81085.c5; Fleming I, 1998, CIRC RES, V82, P686, DOI 10.1161/01.RES.82.6.686; Flockerzi V., 2007, V179, P1; Fukunaga R, 2006, AM J PHYSIOL-HEART C, V291, pH2388, DOI 10.1152/ajpheart.01313.2005; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Garry A, 2007, EMBO REP, V8, P354, DOI 10.1038/sj.embor.7400916; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; Gudermann T, 2005, N-S ARCH PHARMACOL, V371, P241, DOI 10.1007/s00210-005-1029-7; Guler AD, 2002, J NEUROSCI, V22, P6408; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Kohler R, 2007, KIDNEY INT, V72, P145, DOI 10.1038/sj.ki.5002303; Kohler R, 2006, ARTERIOSCL THROM VAS, V26, P1495, DOI 10.1161/01.ATV.0000225698.36212.6a; Kohler R, 2001, CIRC RES, V89, P174, DOI 10.1161/hh1401.093460; Liedtke W., 2007, V179, P473; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2005, CELL MOL LIFE SCI, V62, P2985, DOI 10.1007/s00018-005-5181-5; Liedtke Wolfgang B., 2007, P303; Maier T, 2005, DEUT MED WOCHENSCHR, V130, P2637, DOI 10.1055/s-2005-922047; Marrelli SP, 2007, AM J PHYSIOL-HEART C, V292, pH1390, DOI 10.1152/ajpheart.01006.2006; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Muller JM, 1999, AM J PHYSIOL-HEART C, V276, pH1706, DOI 10.1152/ajpheart.1999.276.5.H1706; Mutai H, 2003, CELL CALCIUM, V33, P471, DOI 10.1016/S0143-4160(03)00062-9; Nilius B, 2003, ENDOTHELIUM-J ENDOTH, V10, P5, DOI 10.1080/10623320303356; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; O'Neil RG, 2005, PFLUG ARCH EUR J PHY, V451, P193, DOI 10.1007/s00424-005-1424-4; Oancea E, 2006, CIRC RES, V98, P245, DOI 10.1161/01.RES.0000200179.29375.cc; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Reiter B, 2006, FASEB J, V20, P1802, DOI 10.1096/fj.06-5772com; Rosa JC, 1998, J MED CHEM, V41, P2, DOI 10.1021/jm970571a; Si H, 2006, CIRC RES, V99, P537, DOI 10.1161/01.RES.0000238377.08219.0c; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Taniguchi J, 2007, AM J PHYSIOL-RENAL, V292, pF667, DOI 10.1152/ajprenal.00458.2005; Todaka H, 2004, J BIOL CHEM, V279, P35133, DOI 10.1074/jbc.M406260200; Trebak M., 2007, V179, P593; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wissenbach U, 2004, BIOL CELL, V96, P47, DOI 10.1016/j.biolcel.2003.12.003; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151	53	196	200	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2007	2	9							e827	10.1371/journal.pone.0000827	http://dx.doi.org/10.1371/journal.pone.0000827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HQ	17786199	Green Published, Green Submitted, gold			2022-12-27	WOS:000207455500011
J	North, BJ; Verdin, E				North, Brian J.; Verdin, Eric			Interphase Nucleo-Cytoplasmic Shuttling and Localization of SIRT2 during Mitosis	PLOS ONE			English	Article								The human NAD+-dependent protein deacetylase SIRT2 resides predominantly in the cytoplasm where it functions as a tubulin deacetylase. Here we report that SIRT2 maintains a largely cytoplasmic localization during interphase by active nuclear export in a Crm1-dependent manner. We identified a functional, leptomycin B-sensitive, nuclear export signal sequence within SIRT2. During the cell cycle, SIRT2 becomes enriched in the nucleus and is associated with mitotic structures, beginning with the centrosome during prophase, the mitotic spindle during metaphase, and the midbody during cytokinesis. Cells overexpressing wild-type or a catalytically inactive SIRT2 exhibit an increase in multinucleated cells. The findings suggest a novel mechanism of regulating SIRT2 function by nucleo-cytoplasmic shuttling, as well as a role for SIRT2 in the nucleus during interphase and throughout mitosis.	[North, Brian J.; Verdin, Eric] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes	Verdin, E (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA.	everdin@gladstone.ucsf.edu	Verdin, Eric/AAB-7999-2019	Verdin, Eric/0000-0003-3703-3183	The J. David Gladstone Institutes	The J. David Gladstone Institutes	We thank John C. W. Carroll, Jack Hull and Chris Goodfellow for graphics, Amanda Bradford for administrative assistance, and Stephen Ordway and Gary Howard for editorial assistance. This work was supported by The J. David Gladstone Institutes ( E. V.). Eric Verdin is a senior scholar of the Larry Ellison Medical Foundation.	Afshar G, 1999, GENE, V234, P161, DOI 10.1016/S0378-1119(99)00162-6; Bae NS, 2004, J BIOCHEM, V135, P695, DOI 10.1093/jb/mvh084; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Dundr M, 2000, J CELL BIOL, V150, P433, DOI 10.1083/jcb.150.3.433; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Garcia-Salcedo JA, 2003, EMBO J, V22, P5851, DOI 10.1093/emboj/cdg553; Grubisha O, 2005, FEBS J, V272, P4607, DOI 10.1111/j.1742-4658.2005.04862.x; Guarente L, 2000, GENE DEV, V14, P1021; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Hiratsuka M, 2003, BIOCHEM BIOPH RES CO, V309, P558, DOI 10.1016/j.bbrc.2003.08.029; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Michishita E, 2005, MOL BIOL CELL; Monneret C, 2005, EUR J MED CHEM, V40, P1, DOI 10.1016/j.ejmech.2004.10.001; Monzo P, 2005, MOL BIOL CELL, V16, P2891, DOI 10.1091/mbc.E04-09-0773; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; NISHI K, 1994, J BIOL CHEM, V269, P6320; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Perrod S, 2001, EMBO J, V20, P197, DOI 10.1093/emboj/20.1.197; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Shindo M, 1998, BIOCHEM BIOPH RES CO, V244, P285, DOI 10.1006/bbrc.1998.8250; Stenoien DL, 2003, CELL MOTIL CYTOSKEL, V55, P134, DOI 10.1002/cm.10120; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; Wilson JM, 2006, EMBO REP, V7, P1247, DOI 10.1038/sj.embor.7400829; Yamaga M, 1999, J BIOL CHEM, V274, P28537, DOI 10.1074/jbc.274.40.28537; Yoneda Y, 1999, CELL STRUCT FUNCT, V24, P425, DOI 10.1247/csf.24.425	42	206	216	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e784	10.1371/journal.pone.0000784	http://dx.doi.org/10.1371/journal.pone.0000784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726514	Green Published, gold			2022-12-27	WOS:000207455400001
J	Huang, JTJ; Leweke, FM; Tsang, TM; Koethe, D; Kranaster, L; Gerth, CW; Gross, S; Schreiber, D; Ruhrmann, S; Schultze-Lutter, F; Klosterkotter, J; Holmes, E; Bahn, S				Huang, Jeffrey T. -J.; Leweke, F. Markus; Tsang, Tsz M.; Koethe, Dagmar; Kranaster, Laura; Gerth, Christoph W.; Gross, Sonja; Schreiber, Daniela; Ruhrmann, Stephan; Schultze-Lutter, Frauke; Klosterkoetter, Joachim; Holmes, Elaine; Bahn, Sabine			CSF Metabolic and Proteomic Profiles in Patients Prodromal for Psychosis	PLOS ONE			English	Article								Background. The initial prodromal state of psychosis (IPS) is defined as an early disease stage prior to the onset of overt psychosis characterized by sub-threshold or more unspecific psychiatric symptoms. Little is known regarding the biochemical changes during this period. Methodology/Principal Findings. We investigated the metabolic/proteomic profiles of cerebrospinal fluid (CSF) of first-onset drug naive paranoid schizophrenia patients (n=54) and individuals presenting with initial prodromal symptoms (n=24), alongside healthy volunteers (n=70) using proton nuclear magnetic resonance (H-1-NMR) spectroscopy and surface enhanced laser desorption ionization (SELDI) mass spectrometry, respectively. Partial least square discriminant analysis (PLS-DA) showed that 36%/29% of IPS patients displayed proteomic/metabolic profiles characteristic of first-onset, drug naive schizophrenia, i.e., changes in levels of glucose and lactate as well as changes in a VGF-derived peptide (VGF23-62) and transthyretin protein concentrations. However, only 29% (n=7) of the investigated IPS patients (who to date have been followed up for up to three years) have so far received a diagnosis of schizophrenia. The presence of biochemical alterations in the IPS group did not correlate with the risk to develop schizophrenia. Conclusions/Significance. Our results imply that schizophrenia-related biochemical disease processes can be traced in CSF of prodromal patients. However, the biochemical disturbances identified in IPS patients, at least when measured at a single time point, may not be sufficient to predict clinical outcome.	[Huang, Jeffrey T. -J.; Bahn, Sabine] Univ Cambridge, Inst Biotechnol, Cambridge, England; [Leweke, F. Markus; Koethe, Dagmar; Kranaster, Laura; Gerth, Christoph W.; Gross, Sonja; Schreiber, Daniela; Ruhrmann, Stephan; Schultze-Lutter, Frauke; Klosterkoetter, Joachim] Univ Cologne, Dept Psychiat & Psychotherapy, Cologne, Germany; [Tsang, Tsz M.; Holmes, Elaine] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Biomol Med, Div SORA, London, England	University of Cambridge; University of Cologne; Imperial College London	Bahn, S (corresponding author), Univ Cambridge, Inst Biotechnol, Cambridge, England.	sb209@cam.ac.uk	Leweke, F. Markus/D-5435-2009; Schultze-Lutter, Frauke/AAU-1724-2021; Leweke, Markus/GVS-7897-2022; Ruhrmann, Stephan/AAG-9470-2020; Holmes, Elaine/A-2189-2015; Holmes, Elaine/ABE-6606-2020; Koethe, Dagmar/G-2462-2014	Leweke, F. Markus/0000-0002-8163-195X; Ruhrmann, Stephan/0000-0002-6022-2364; Holmes, Elaine/0000-0002-0556-8389; Koethe, Dagmar/0000-0002-8324-6756; Huang, Jeffrey/0000-0001-9982-2298	Stanley Medical Research Institute (SMRI); Koeln Fortune Program; Henry Smith Charity; BBSRC; NARSAD Essel Independent Investigator Fellowship	Stanley Medical Research Institute (SMRI); Koeln Fortune Program; Henry Smith Charity; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NARSAD Essel Independent Investigator Fellowship(NARSAD)	This research was supported by the Stanley Medical Research Institute (SMRI) and the Koeln Fortune Program. Further thanks to The Henry Smith Charity and the BBSRC for financial support. S. B. holds a NARSAD Essel Independent Investigator Fellowship.	FERNANDES J, 1982, LANCET, V1, P113; Hahm S, 1999, NEURON, V23, P537, DOI 10.1016/S0896-6273(00)80806-5; HAWKINS RA, 1986, AM J PHYSIOL, V250, pE169, DOI 10.1152/ajpendo.1986.250.2.E169; Holmes E, 2006, PLOS MED, V3, P1420, DOI 10.1371/journal.pmed.0030327; Huang JTJ, 2006, PLOS MED, V3, P2145, DOI 10.1371/journal.pmed.0030428; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Klosterkotter J, 2001, ARCH GEN PSYCHIAT, V58, P158, DOI 10.1001/archpsyc.58.2.158; Lencz T, 2006, BIOL PSYCHIAT, V59, P863, DOI 10.1016/j.biopsych.2005.09.005; Lencz T, 2003, SCHIZOPHRENIA BULL, V29, P717, DOI 10.1093/oxfordjournals.schbul.a007041; Levi A, 2004, CELL MOL NEUROBIOL, V24, P517, DOI 10.1023/B:CEMN.0000023627.79947.22; Marshall M, 2005, ARCH GEN PSYCHIAT, V62, P975, DOI 10.1001/archpsyc.62.9.975; McGlashan TH, 2006, AM J PSYCHIAT, V163, P790, DOI 10.1176/appi.ajp.163.5.790; McGorry PD, 2002, ARCH GEN PSYCHIAT, V59, P921, DOI 10.1001/archpsyc.59.10.921; Miller TJ, 1999, PSYCHIAT QUART, V70, P273, DOI 10.1023/A:1022034115078; Miller TJ, 2003, SCHIZOPHRENIA BULL, V29, P703, DOI 10.1093/oxfordjournals.schbul.a007040; Miller TJ, 2002, AM J PSYCHIAT, V159, P863, DOI 10.1176/appi.ajp.159.5.863; Morrison AP, 2004, BRIT J PSYCHIAT, V185, P291, DOI 10.1192/bjp.185.4.291; Phillips LJ, 2000, AUST NZ J PSYCHIAT, V34, pS164, DOI 10.1046/j.1440-1614.2000.00798.x; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Ruhrmann S, 2003, PHARMACOPSYCHIATRY, V36, pS162; Salton SRJ, 2000, FRONT NEUROENDOCRIN, V21, P199, DOI 10.1006/frne.2000.0199; Schreiber G, 2002, J ENDOCRINOL, V175, P61, DOI 10.1677/joe.0.1750061; SCHULTZELUTTER F, 2006, EUROPEAN PSYCHIAT, V21, pS27; Seidman LJ, 2003, SCHIZOPHRENIA BULL, V29, P803, DOI 10.1093/oxfordjournals.schbul.a007048; Strupp M, 2001, NEUROLOGY, V57, P2310, DOI 10.1212/WNL.57.12.2310; Wittchen H.-U., 1997, SKID STRUKTURIERTES; Yung AR, 2004, SCHIZOPHR RES, V67, P131, DOI 10.1016/S0920-9964(03)00192-0; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P353, DOI 10.1093/schbul/22.2.353; Yung AR, 2003, SCHIZOPHR RES, V60, P21, DOI 10.1016/S0920-9964(02)00167-6	29	86	87	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e756	10.1371/journal.pone.0000756	http://dx.doi.org/10.1371/journal.pone.0000756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712404	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455300004
J	Viera, A; Gomez, R; Parra, MT; Schmiesing, JA; Yokomori, K; Rufas, JS; Suja, JA				Viera, Alberto; Gomez, Rocio; Parra, Maria T.; Schmiesing, John A.; Yokomori, Kyoko; Rufas, Julio S.; Suja, Jose A.			Condensin I Reveals New Insights on Mouse Meiotic Chromosome Structure and Dynamics	PLOS ONE			English	Article							MITOTIC CHROMOSOME; XCAP-E; CHROMATID SEGREGATION; SYNAPTONEMAL COMPLEX; DOSAGE COMPENSATION; HISTONE H3; PROTEIN; CENTROMERE; PROPHASE; COHESIN	Chromosome shaping and individualization are necessary requisites to warrant the correct segregation of genomes in either mitotic or meiotic cell divisions. These processes are mainly prompted in vertebrates by three multiprotein complexes termed cohesin and condensin I and II. In the present study we have analyzed by immunostaining the appearance and subcellular distribution of condensin I in mouse mitotic and meiotic chromosomes. Our results demonstrate that in either mitotically or meiotically dividing cells, condensin I is loaded onto chromosomes by prometaphase. Condensin I is detectable as a fuzzy axial structure running inside chromatids of condensed chromosomes. The distribution of condensin I along the chromosome length is not uniform, since it preferentially accumulates close to the chromosome ends. Interestingly, these round accumulations found at the condensin I axes termini colocalized with telomere complexes. Additionally, we present the relative distribution of the condensin I and cohesin complexes in metaphase I bivalents. All these new data have allowed us to propose a comprehensive model for meiotic chromosome structure.	[Viera, Alberto; Gomez, Rocio; Parra, Maria T.; Rufas, Julio S.; Suja, Jose A.] Univ Autonoma Madrid, Dept Biol, Madrid, Spain; [Schmiesing, John A.; Yokomori, Kyoko] Univ Calif Irvine, Coll Med, Dept Biol Chem, Irvine, CA 92717 USA	Autonomous University of Madrid; University of California System; University of California Irvine	Viera, A (corresponding author), Univ Autonoma Madrid, Dept Biol, Edificio Biol, Madrid, Spain.	alberto.viera@uam.es	Suja, José A/L-4548-2014; Parra, María Teresa/AAA-1873-2019; gomez lencero, rocio/B-2171-2013; Rufas, Julio S/L-5174-2014; Viera, Alberto/J-2929-2013	Suja, José A/0000-0002-4266-795X; Parra, María Teresa/0000-0002-1158-6903; gomez lencero, rocio/0000-0003-4408-9812; Rufas, Julio S/0000-0002-7516-809X; Viera, Alberto/0000-0002-3602-4130	Ministerio de Educacion y Ciencia [BFU2006-06655/BCM, BFU20050-05668-C03-01/BCM]; Universidad Autonoma de Madrid [CCG06-UAM/SAL-0260]; Comunidad de Madrid; Fundacion Francisco Cobos	Ministerio de Educacion y Ciencia(Spanish Government); Universidad Autonoma de Madrid; Comunidad de Madrid(Comunidad de Madrid); Fundacion Francisco Cobos	This work was supported by grants BFU2006-06655/BCM and BFU20050-05668-C03-01/BCM from Ministerio de Educacion y Ciencia, and grant CCG06-UAM/SAL-0260 from Universidad Autonoma de Madrid and Comunidad de Madrid. Rocio Gomez is supported by a Fundacion Francisco Cobos and Ministerio de Educacion y Ciencia predoctoral fellowships.	Beenders B, 2003, CHROMOSOME RES, V11, P549, DOI 10.1023/A:1024999316867; Belmont AS, 2006, CURR OPIN CELL BIOL, V18, P632, DOI 10.1016/j.ceb.2006.09.007; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; Bhat MA, 1996, CELL, V87, P1103, DOI 10.1016/S0092-8674(00)81804-8; Cabello OA, 2001, MOL BIOL CELL, V12, P3527, DOI 10.1091/mbc.12.11.3527; Chan RC, 2004, J CELL BIOL, V167, P613, DOI 10.1083/jcb.200408061; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; EARNSHAW WC, 1989, GENOME, V31, P541, DOI 10.1139/g89-103; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; Fujimoto S, 2005, PLANTA, V222, P293, DOI 10.1007/s00425-005-1546-0; Geiman TM, 2004, NUCLEIC ACIDS RES, V32, P2716, DOI 10.1093/nar/gkh589; Gomez R, 2007, EMBO REP, V8, P173, DOI 10.1038/sj.embor.7400877; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Heale JT, 2006, MOL CELL, V21, P837, DOI 10.1016/j.molcel.2006.01.036; Hemann MT, 2000, NUCLEIC ACIDS RES, V28, P4474, DOI 10.1093/nar/28.22.4474; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Heng HHQ, 1996, P NATL ACAD SCI USA, V93, P2795, DOI 10.1073/pnas.93.7.2795; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Kalitsis P, 2006, P NATL ACAD SCI USA, V103, P8786, DOI 10.1073/pnas.0600250103; Kimura K, 2001, J BIOL CHEM, V276, P5417, DOI 10.1074/jbc.C000873200; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Kuznetsova I, 2006, CYTOGENET GENOME RES, V112, P248, DOI 10.1159/000089878; Kuznetsova IS, 2005, CHROMOSOME RES, V13, P9, DOI 10.1007/s10577-005-2346-x; LAEMMLI UK, 1977, COLD SPRING HARB SYM, V42, P351; Lieb JD, 1996, SCIENCE, V274, P1732, DOI 10.1126/science.274.5293.1732; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; MEYNE J, 1990, CHROMOSOMA, V99, P3, DOI 10.1007/BF01737283; MOENS PB, 1990, CHROMOSOMA, V100, P8, DOI 10.1007/BF00337598; MOENS PB, 1989, CHROMOSOMA, V98, P317, DOI 10.1007/BF00292383; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Neuwald AF, 2000, GENOME RES, V10, P1445, DOI 10.1101/gr.147400; OCHS RL, 1985, BIOL CELL, V54, P123, DOI 10.1111/j.1768-322X.1985.tb00387.x; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Page J, 2003, J CELL SCI, V116, P551, DOI 10.1242/jcs.00252; Parra MT, 2004, J CELL SCI, V117, P1221, DOI 10.1242/jcs.00947; Parra MT, 2003, J CELL SCI, V116, P961, DOI 10.1242/jcs.00330; Parra MT, 2002, CHROMOSOMA, V111, P53, DOI 10.1007/s00412-002-0185-5; Prieto I, 2002, EMBO REP, V3, P543, DOI 10.1093/embo-reports/kvf108; Prieto I, 2001, NAT CELL BIOL, V3, P761, DOI 10.1038/35087082; REIMER G, 1987, ARTHRITIS RHEUM, V30, P793, DOI 10.1002/art.1780300709; Revenkova E, 2006, CHROMOSOMA, V115, P235, DOI 10.1007/s00412-006-0060-x; Rodriguez EM, 2001, CHROMOSOMA, V110, P478, DOI 10.1007/s004120100162; RUFAS JS, 1987, GENOME, V29, P706, DOI 10.1139/g87-121; RUFAS JS, 1992, GENOME, V35, P1054, DOI 10.1139/g92-162; SAITOH N, 1994, J CELL BIOL, V127, P303, DOI 10.1083/jcb.127.2.303; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; Scherthan H, 2000, MOL BIOL CELL, V11, P4189, DOI 10.1091/mbc.11.12.4189; Schmiesing JA, 2000, MOL CELL BIOL, V20, P6996, DOI 10.1128/MCB.20.18.6996-7006.2000; Siddiqui NU, 2003, DEVELOPMENT, V130, P3283, DOI 10.1242/dev.00542; STARLING JA, 1990, NUCLEIC ACIDS RES, V18, P6881, DOI 10.1093/nar/18.23.6881; Steffensen S, 2001, CURR BIOL, V11, P295, DOI 10.1016/S0960-9822(01)00096-3; STRUNNIKOV AV, 1995, GENE DEV, V9, P587, DOI 10.1101/gad.9.5.587; SUJA JA, 1992, CHROMOSOMA, V101, P493, DOI 10.1007/BF00352472; Suja JA, 1999, J CELL SCI, V112, P2957; SUJA JA, 1991, GENOME, V34, P19, DOI 10.1139/g91-004; Suja Jose A., 2008, V2, P31, DOI 10.1007/7050_2006_023; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Sutani T, 1999, GENE DEV, V13, P2271, DOI 10.1101/gad.13.17.2271; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; Tres LL, 2005, MOL REPROD DEV, V72, P1, DOI 10.1002/mrd.20334; Uzbekov R, 2003, J CELL SCI, V116, P1667, DOI 10.1242/jcs.00311; Viera A, 2003, CHROMOSOME RES, V11, P797, DOI 10.1023/B:CHRO.0000005781.71466.da; Viera A, 2002, CYTOGENET GENOME RES, V98, P221, DOI 10.1159/000069851; Watrin E, 2003, J BIOL CHEM, V278, P25708, DOI 10.1074/jbc.M300192200; Yeong FM, 2003, CURR BIOL, V13, P2058, DOI 10.1016/j.cub.2003.10.032; Yu HG, 2005, CELL, V123, P397, DOI 10.1016/j.cell.2005.09.014; Yu HG, 2003, J CELL BIOL, V163, P937, DOI 10.1083/jcb.200308027; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	77	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2007	2	8							e783	10.1371/journal.pone.0000783	http://dx.doi.org/10.1371/journal.pone.0000783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HO	17712430	Green Published, gold, Green Accepted			2022-12-27	WOS:000207455300030
J	Nagai, H; Sheng, GJ				Nagai, Hiroki; Sheng, Guojun			Cis-Cotranscription of Two Beta Globin Genes during Chicken Primitive Hematopoiesis	PLOS ONE			English	Article								Chicken beta globin locus contains four genes, two of which, rho and epsilon, are expressed from the earliest stage of primitive hematopoiesis. Here we show that the transcription of these two genes in the nucleus engages in "on/off" phases. During each "on" phase, cotranscription of rho and epsilon in cis is favored. We propose that these two chicken beta globin genes are transcribed not by competing for a transcription initiation complex, but in a cooperative way.	[Nagai, Hiroki; Sheng, Guojun] RIKEN, Ctr Dev Biol, Lab Early Embryogenesis, Kobe, Hyogo, Japan	RIKEN	Sheng, GJ (corresponding author), RIKEN, Ctr Dev Biol, Lab Early Embryogenesis, Kobe, Hyogo, Japan.	sheng@cdb.riken.jp	Sheng, Guojun/G-4116-2014; Nagai, Hiroki/GXZ-7815-2022; Sheng, Guojun/G-8746-2013; Sheng, Guojun/I-4900-2015		RIKEN	RIKEN	This work is supported by RIKEN.	DOLAN M, 1981, CELL, V24, P669, DOI 10.1016/0092-8674(81)90093-3; EVANS T, 1990, ANNU REV CELL BIOL, V6, P95, DOI 10.1146/annurev.cellbio.6.1.95; Gribnau J, 1998, EMBO J, V17, P6020, DOI 10.1093/emboj/17.20.6020; Nakazawa F, 2006, BLOOD, V108, P3335, DOI 10.1182/blood-2006-05-021386; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; Trimborn T, 1999, GENE DEV, V13, P112, DOI 10.1101/gad.13.1.112; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0	7	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e703	10.1371/journal.pone.0000703	http://dx.doi.org/10.1371/journal.pone.0000703			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684550	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452400007
J	Weston, EM; Friday, AE; Lio, P				Weston, Eleanor M.; Friday, Adrian E.; Lio, Pietro			Biometric Evidence that Sexual Selection Has Shaped the Hominin Face	PLOS ONE			English	Article							MALE FACIAL ATTRACTIVENESS; DIMORPHISM; ALLOMETRY; ONTOGENY; PATTERNS; PROPORTIONS; PREFERENCES; SYMMETRY; GROWTH	We consider sex differences in human facial morphology in the context of developmental change. We show that at puberty, the height of the upper face, between the lip and the brow, develops differently in males and females, and that these differences are not explicable in terms of sex differences in body size. We find the same dimorphism in the faces of human ancestors. We propose that the relative shortening in men and lengthening in women of the anterior upper face at puberty is the mechanistic consequence of extreme maxillary rotation during ontogeny. A link between this developmental model and sexual dimorphism is made for the first time, and provides a new set of morphological criteria to sex human crania. This finding has important implications for the role of sexual selection in the evolution of anthropoid faces and for theories of human facial attractiveness.	[Weston, Eleanor M.] UCL, Dept Biol, London, England; [Weston, Eleanor M.; Friday, Adrian E.] Univ Museum Zool, Cambridge, England; [Lio, Pietro] Univ Cambridge, Comp Lab, Cambridge CB2 3QG, England	University of London; University College London; University of Cambridge; University of Cambridge	Weston, EM (corresponding author), Nat Hist Museum, Dept Palaeontol, Cromwell Rd, London SW7 5BD, England.	e.weston@nhm.ac.uk	P. Lió, Pietro Lio/AAV-3358-2021; van Lent, Laurence/G-5298-2010	P. Lió, Pietro Lio/0000-0002-0540-5053; van Lent, Laurence/0000-0002-9354-0932	European Commission; BBSRC [BB/D522689/1]; Biotechnology and Biological Sciences Research Council [BB/D522689/1, BB/D522689/2] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by European Commission Marie Curie Fellowship hosted by the Senckenberg Research Institute, Frankfurt, Germany and the Balfour Fund, Department of Zoology, University of Cambridge, UK. EW is a Recognized Researcher on a BBSRC grant reference number BB/D522689/1.	BHAT M, 1985, ANGLE ORTHOD, V55, P269; BJORK A, 1976, MONOGRAPH U MICHIGAN, V6, P61; Broadbent Sr BH, 1975, BOLTON STANDARDS DEN, P166; BROMAGE TG, 1989, J HUM EVOL, V18, P751, DOI 10.1016/0047-2484(89)90088-2; Bulygina E, 2006, AM J PHYS ANTHROPOL, V131, P432, DOI 10.1002/ajpa.20317; CUNNINGHAM MR, 1990, J PERS SOC PSYCHOL, V59, P61, DOI 10.1037/0022-3514.59.1.61; DeBruine LM, 2006, P ROY SOC B-BIOL SCI, V273, P1355, DOI 10.1098/rspb.2005.3445; DEVILLIERS H, 1968, SKULL S AFRICAN NEGR, P342; ENLOW D, 1996, ESSENTIALS FACIAL GR, P303; Ferrario VF, 1998, ANAT REC, V250, P480, DOI 10.1002/(SICI)1097-0185(199804)250:4<480::AID-AR12>3.0.CO;2-K; Hennessy RJ, 2002, AM J PHYS ANTHROPOL, V117, P37, DOI 10.1002/ajpa.10005; Hunt N, 1998, CLIN ORAL SCI, P120; Johnston VS, 2001, EVOL HUM BEHAV, V22, P251, DOI 10.1016/S1090-5138(01)00066-6; LIGTHELMBAKKER ASWMR, 1992, AM J ORTHOD DENTOFAC, V101, P509, DOI 10.1016/0889-5406(92)70124-S; Lockwood CA, 1999, AM J PHYS ANTHROPOL, V108, P97, DOI 10.1002/(SICI)1096-8644(199901)108:1<97::AID-AJPA6>3.0.CO;2-O; Martin R, 1988, ANTHR HDB VERGLEICHE, P742; McCollum MA, 1999, SCIENCE, V284, P301, DOI 10.1126/science.284.5412.301; McCollum MA, 1997, AM J PHYS ANTHROPOL, V102, P377, DOI 10.1002/(SICI)1096-8644(199703)102:3<377::AID-AJPA7>3.0.CO;2-S; McCollum MA, 1997, AM J PHYS ANTHROPOL, V103, P375, DOI 10.1002/(SICI)1096-8644(199707)103:3<375::AID-AJPA7>3.3.CO;2-J; O'Higgins P, 2002, J ZOOL, V257, P255, DOI 10.1017/S0952836902000857; OHIGGINS P, 1990, J ZOOL, V222, P399, DOI 10.1111/j.1469-7998.1990.tb04041.x; Penton-Voak IS, 2001, P ROY SOC B-BIOL SCI, V268, P1617, DOI 10.1098/rspb.2001.1703; Penton-Voak IS, 2001, ADV STUD BEHAV, V30, P219, DOI 10.1016/S0065-3454(01)80008-5; PROFFIT WR, 1983, J DENT RES, V62, P566, DOI 10.1177/00220345830620051201; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rightmire GP, 1998, AM J PHYS ANTHROPOL, V106, P61, DOI 10.1002/(SICI)1096-8644(199805)106:1<61::AID-AJPA5>3.3.CO;2-U; Rosas A, 2002, AM J PHYS ANTHROPOL, V117, P236, DOI 10.1002/ajpa.10023; Ruff C, 2002, ANNU REV ANTHROPOL, V31, P211, DOI 10.1146/annurev.anthro.31.040402.085407; Schaefer K, 2004, ANN ANAT, V186, P471, DOI 10.1016/S0940-9602(04)80086-4; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Shea B.T., 1985, P175; Shea BT, 1996, AM J PHYS ANTHROPOL, V100, P311; Sokal R. H., 1995, BIOMETRY PRINCIPLES; Swaddle JP, 2002, P ROY SOC B-BIOL SCI, V269, P2285, DOI 10.1098/rspb.2002.2165; SYMON D, 1995, CHIC SEX HIST SOC, P80; Thackeray JF, 2000, S AFR ARCHAEOL BULL, V55, P155, DOI 10.2307/3888964; Throckmorton GS, 2000, J ORAL MAXIL SURG, V58, P515, DOI 10.1016/S0278-2391(00)90014-4; URSI WJS, 1993, ANGLE ORTHOD, V63, P47; Vioarsdottir US, 2002, J ANAT, V201, P211; Weston EM, 2004, P ROY SOC B-BIOL SCI, V271, pS416, DOI 10.1098/rsbl.2004.0203; Weston EM, 2003, BIOL J LINN SOC, V80, P625, DOI 10.1111/j.1095-8312.2003.00263.x; WOOD BA, 1991, J ANAT, V174, P185; WOOD BA, 1991, KOOBI FORA RES PROJE, P492; Wood CG, 1996, NATO ADV SCI INST SE, V284, P407	45	160	166	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2007	2	8							e710	10.1371/journal.pone.0000710	http://dx.doi.org/10.1371/journal.pone.0000710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GL	17684556	Green Published, gold			2022-12-27	WOS:000207452400013
J	Coetzee, V; Barrett, L; Greeff, JM; Henzi, SP; Perrett, DI; Wadee, AA				Coetzee, Vinet; Barrett, Louise; Greeff, Jaco M.; Henzi, S. Peter; Perrett, David I.; Wadee, Ahmed A.			Common HLA Alleles Associated with Health, but Not with Facial Attractiveness	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MATING PREFERENCES; MATE CHOICE; NO EVIDENCE; GOOD GENES; HETEROZYGOSITY; SELECTION; EVOLUTION; MEN	Three adaptive hypotheses have been proposed to explain the link between the human leucocyte antigen (HLA) genes, health measures and facial attractiveness: inbreeding avoidance, heterozygote advantage and frequency-dependent selection. This paper reports findings that support a new hypothesis relating HLA to health. We suggest a new method to quantify the level of heterozygosity. HLA heterozygosity did not significantly predict health measures in women, but allele frequency did. Women with more common HLA alleles reported fewer cold and flu bouts per year, fewer illnesses in the previous year and rated themselves healthier than women with rare alleles. To our knowledge, this is the first study to show a positive correlation between HLA allele frequency and general health measures. We propose that certain common HLA alleles confer resistance to prevalent pathogens. Nevertheless, neither HLA heterozygosity nor allele frequency significantly predicted how healthy or attractive men rated the female volunteers. Three non-mutually exclusive explanations are put forward to explain this finding.	[Coetzee, Vinet; Greeff, Jaco M.] Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa; [Barrett, Louise; Henzi, S. Peter] Univ Lethbridge, Dept Psychol, Lethbridge, AB T1K 3M4, Canada; [Perrett, David I.] Univ St Andrews, Dept Psychol, St Andrews, Fife, Scotland; [Wadee, Ahmed A.] Univ Witwatersrand, Dept Immunol, Johannesburg, South Africa	University of Pretoria; University of Lethbridge; University of St Andrews; University of Witwatersrand	Coetzee, V (corresponding author), Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa.	vcoetzee@tuks.co.za	Coetzee, Vinet/F-2155-2011; Greeff, Jaco M/A-5582-2011	Coetzee, Vinet/0000-0003-1716-0804; Henzi, Peter/0000-0001-6175-1674; Perrett, David/0000-0002-6025-0939; Greeff, Jaco/0000-0003-2951-6791	National Research Foundation [2053809]	National Research Foundation	Funding: This material is based, in part, upon work supported by the National Research Foundation under Grant number 2053809 to JMG.	ALMARRI A, 1994, LANCET, V344, P1194, DOI 10.1016/S0140-6736(94)90510-X; Bittles AH, 2001, CLIN GENET, V60, P89, DOI 10.1034/j.1399-0004.2001.600201.x; COOK RD, 1982, RESIDUALS THEIR INFL; EGID K, 1989, ANIM BEHAV, V38, P548, DOI 10.1016/S0003-3472(89)80051-X; *EMBL EBI, IMGT HLA SEQ DAT; Freeman-Gallant CR, 2003, MOL ECOL, V12, P3077, DOI 10.1046/j.1365-294X.2003.01968.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; HARTL DL, 1987, PRIMER POPULATION GE; Hedrick PW, 1997, AM J HUM GENET, V61, P505, DOI 10.1086/515519; HEDRICK PW, 1987, BIOL J LINN SOC, V31, P311, DOI 10.1111/j.1095-8312.1987.tb01996.x; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Jeffery KJM, 2000, MICROBES INFECT, V2, P1335, DOI 10.1016/S1286-4579(00)01287-9; JIN K, 1995, BIOMETRICS, V51, P1064, DOI 10.2307/2533005; Johnstone RA, 1996, EVOLUTION, V50, P1382, DOI [10.2307/2410876, 10.1111/j.1558-5646.1996.tb03912.x]; KENRICK DT, 1989, SOCIOBIOLOGY SOCIAL, P5; Landry C, 2001, P ROY SOC B-BIOL SCI, V268, P1279, DOI 10.1098/rspb.2001.1659; Lopez-Vazquez A, 2005, HUM IMMUNOL, V66, P285, DOI 10.1016/j.humimm.2005.01.001; MARIEB EN, 1995, HUMAN ANATOMY PHYSL; MITTON JB, 1993, HEREDITY, V71, P59, DOI 10.1038/hdy.1993.107; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; Ober C, 1997, AM J HUM GENET, V61, P497, DOI 10.1086/515511; Paterson S, 1997, P ROY SOC B-BIOL SCI, V264, P1813, DOI 10.1098/rspb.1997.0250; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; POTTS WK, 1993, TRENDS GENET, V9, P408, DOI 10.1016/0168-9525(93)90103-O; Roberts SC, 2005, EVOL HUM BEHAV, V26, P213, DOI 10.1016/j.evolhumbehav.2004.09.002; ROSENBERG LT, 1983, IMMUNOGENETICS, V17, P89, DOI 10.1007/BF00364292; Ryan Michael J., 1997, P179; Statistics South Africa, MORT CAUS DEATH S AF; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornhill R, 2006, EVOL HUM BEHAV, V27, P131, DOI 10.1016/j.evolhumbehav.2005.06.001; Thornhill R, 2003, BEHAV ECOL, V14, P668, DOI 10.1093/beheco/arg043; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; *WHO, MORT PROF; YAMAZAKI K, 1976, J EXP MED, V144, P1324, DOI 10.1084/jem.144.5.1324; YAMAZAKI K, 1978, IMMUNOGENETICS, V6, P253, DOI 10.1007/BF01563915	36	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e640	10.1371/journal.pone.0000640	http://dx.doi.org/10.1371/journal.pone.0000640			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653267	Green Published, gold, Green Submitted			2022-12-27	WOS:000207452200009
J	Miller, MR; White, A; Wilson, K; Boots, M				Miller, Martin R.; White, Andrew; Wilson, Kenneth; Boots, Michael			The Population Dynamical Implications of Male-Biased Parasitism in Different Mating Systems	PLOS ONE			English	Article								Although there is growing evidence that males tend to suffer higher levels of parasitism than females, the implications of this for the population dynamics of the host population are not yet understood. Here we build on an established 'two-sex' model and investigate how increased susceptibility to infection in males affects the dynamics, under different mating systems. We investigate the effect of pathogenic disease at different case mortalities, under both monogamous and polygynous mating systems. If the case mortality is low, then male-biased parasitism appears similar to unbiased parasitism in terms of its effect on the population dynamics. At higher case mortalities, we identified significant differences between male-biased and unbiased parasitism. A host population may therefore be differentially affected by male-biased and unbiased parasitism. The dynamical outcome is likely to depend on a complex interaction between the host's mating system and demography, and the parasite virulence.	[Miller, Martin R.; Boots, Michael] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [White, Andrew] Heriot Watt Univ, Dept Math, Edinburgh, Midlothian, Scotland; [White, Andrew] Heriot Watt Univ, Maxwell Inst Math Sci, Edinburgh, Midlothian, Scotland; [Wilson, Kenneth] Univ Lancaster, Dept Biol Sci, Lancaster Environm Ctr, Lancaster, England	University of Sheffield; Heriot Watt University; Heriot Watt University; University of Edinburgh; Lancaster University	Miller, MR (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	m.r.miller@sheffield.ac.uk	Wilson, Kenneth/B-7452-2008	Wilson, Kenneth/0000-0001-5264-6522	Biotechnology and Biological Sciences Research Council; Natural Environment Research Council	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by a studentship from the Biotechnology and Biological Sciences Research Council and a Natural Environment Research Council Advanced Postdoctoral Fellowship.	Allee W., 1938, SOCIAL LIFE ANIMALS; Allee W.C, 1931, ANIMAL AGGREGATION S; Allen K.R., 1980, CONSERVATION MANAGEM; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BERRYMAN AA, 1989, TRENDS ECOL EVOL, V4, P26, DOI 10.1016/0169-5347(89)90014-1; CASWELL H, 1986, AM NAT, V128, P707, DOI 10.1086/284598; Caswell H, 2000, MATRIX POPULATION MO, V2nd; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Clutton-Brock T. H., 1988, REPROD SUCCESS; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; Ferrari N, 2004, ECOL LETT, V7, P88, DOI 10.1046/j.1461-0248.2003.00552.x; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; HASSELL MP, 1976, J ANIM ECOL, V45, P471, DOI 10.2307/3886; HOUDE AE, 1992, BEHAV ECOL, V3, P346, DOI 10.1093/beheco/3.4.346; KAVALIERS M, 1995, P ROY SOC B-BIOL SCI, V261, P31, DOI 10.1098/rspb.1995.0113; Koella JC, 1999, J THEOR BIOL, V198, P461, DOI 10.1006/jtbi.1999.0925; Labuda M, 1997, VIROLOGY, V235, P138, DOI 10.1006/viro.1997.8622; Lindstrom J, 1998, P ROY SOC B-BIOL SCI, V265, P483, DOI 10.1098/rspb.1998.0320; Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6; Lockhart AB, 1996, BIOL REV, V71, P415, DOI 10.1111/j.1469-185X.1996.tb01281.x; Mackinnon MJ, 1999, EVOLUTION, V53, P689, DOI [10.2307/2640710, 10.1111/j.1558-5646.1999.tb05364.x]; MASSOT M, 1992, ECOLOGY, V73, P1742, DOI 10.2307/1940026; MAY RM, 1985, AM NAT, V125, P573, DOI 10.1086/284363; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; MAY RM, 1976, AM NAT, V110, P573, DOI 10.1086/283092; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; MAY RM, 1983, PROC R SOC SER B-BIO, V219, P281, DOI 10.1098/rspb.1983.0075; McCarthy MA, 1997, ECOL MODEL, V103, P99, DOI 10.1016/S0304-3800(97)00104-X; McCurdy DG, 1998, OIKOS, V82, P303, DOI 10.2307/3546970; Milner-Gulland EJ, 2003, NATURE, V422, P135, DOI 10.1038/422135a; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; MORAN PAP, 1950, BIOMETRICS, V6, P250, DOI 10.2307/3001822; Muehlenbein MP, 2005, AM J HUM BIOL, V17, P527, DOI 10.1002/ajhb.20419; OHGUSHI T, 1995, RES POPUL ECOL, V37, P29, DOI 10.1007/BF02515758; Perkins SE, 2003, INT J PARASITOL, V33, P909, DOI 10.1016/S0020-7519(03)00128-0; Poulin R, 1996, AM NAT, V147, P287, DOI 10.1086/285851; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V247, P203, DOI 10.1098/rspb.1992.0030; Regoes RR, 2000, EVOLUTION, V54, P64, DOI 10.1111/j.0014-3820.2000.tb00008.x; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; Rolff J, 2002, P ROY SOC B-BIOL SCI, V269, P867, DOI 10.1098/rspb.2002.1959; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; Schalk G, 1997, OIKOS, V78, P67, DOI 10.2307/3545801; Scheuring I, 1999, J THEOR BIOL, V199, P407, DOI 10.1006/jtbi.1999.0966; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; SHERMAN PW, 1984, ECOLOGY, V65, P1617, DOI 10.2307/1939140; Skorping A, 2004, TRENDS ECOL EVOL, V19, P219, DOI 10.1016/j.tree.2004.02.006; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; White A, 1996, AM NAT, V148, P220, DOI 10.1086/285921; Wilson K, 2003, SCIENCE, V300, p55B, DOI 10.1126/science.1081430; Wilson K., 2002, P6; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	56	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2007	2	7							e624	10.1371/journal.pone.0000624	http://dx.doi.org/10.1371/journal.pone.0000624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GI	17637840	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000207452100014
J	Brodsky, LI; Wahed, AS; Li, J; Tavis, JE; Tsukahara, T; Taylor, MW				Brodsky, Leonid I.; Wahed, Abdus S.; Li, Jia; Tavis, John E.; Tsukahara, Takuma; Taylor, Milton W.			A Novel Unsupervised Method to Identify Genes Important in the Anti-viral Response: Application to Interferon/Ribavirin in Hepatitis C Patients	PLOS ONE			English	Article								Background. Treating hepatitis C with interferon/ribavirin results in a varied response in terms of decrease in viral titer and ultimate outcome. Marked responders have a sharp decline in viral titer within a few days of treatment initiation, whereas in other patients there is no effect on the virus (poor responders). Previous studies have shown that combination therapy modifies expression of hundreds of genes in vitro and in vivo. However, identifying which, if any, of these genes have a role in viral clearance remains challenging. Aims. The goal of this paper is to link viral levels with gene expression and thereby identify genes that may be responsible for early decrease in viral titer. Methods. Microarrays were performed on RNA isolated from PBMC of patients undergoing interferon/ribavirin therapy. Samples were collected at pre-treatment (day 0), and 1, 2, 7, 14 and 28 days after initiating treatment. A novel method was applied to identify genes that are linked to a decrease in viral titer during interferon/ribavirin treatment. The method uses the relationship between inter-patient gene expression based proximities and inter-patient viral titer based proximities to define the association between microarray gene expression measurements of each gene and viral-titer measurements. Results. We detected 36 unique genes whose expressions provide a clustering of patients that resembles viral titer based clustering of patients. These genes include IRF7, MX1, OASL and OAS2, viperin and many ISG's of unknown function. Conclusion. The genes identified by this method appear to play a major role in the reduction of hepatitis C virus during the early phase of treatment. The method has broad utility and can be used to analyze response to any group of factors influencing biological outcome such as antiviral drugs or anti-cancer agents where microarray data are available.	[Tsukahara, Takuma; Taylor, Milton W.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Brodsky, Leonid I.] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Wahed, Abdus S.; Li, Jia] Univ Pittsburgh, Grad Sch Publ Hlth, Epidemiol Data Ctr, Pittsburgh, PA USA; [Tavis, John E.] St Louis Univ, St Louis, MO 63103 USA	Indiana University System; Indiana University Bloomington; University of Haifa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Saint Louis University	Taylor, MW (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	taylor@indiana.edu	Taylor, Milton W./R-7549-2019	Wahed, Abdus/0000-0001-6911-7221	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Cancer Institute (NCI) [U01 DK60329, U01 DK60340, U01 DK60324, U01 DK60344, U01 DK60327, U01 DK60335, U01 DK60352, U01 DK60342, U01 DK60345, U01 DK60309, U01 DK60346, U01 DK60349, U01 DK60341]; National Center for Research Resources (NCRR) [M01 RR00645, M02 RR000079, M01 RR16500, M01 RR000042, M01 RR00046]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000645, M01RR000079, M01RR000046, M01RR000042, M01RR016500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK060345, U01DK060341, U01DK060342, U01DK060346, U01DK060349, U01DK060329, U01DK060344, U01DK060340, U01DK060309, U01DK060324, U01DK060352, U01DK060327, U01DK060335] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded as a cooperative agreement by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) with co-support from the Intramural Research Program of the National Cancer Institute (NCI) with further support under a Cooperative Research and Development Agreement (CRADA) with Roche Laboratories, Grant numbers: U01 DK60329, U01 DK60340, U01 DK60324, U01 DK60344, U01 DK60327, U01 DK60335, U01 DK60352, U01 DK60342, U01 DK60345, U01 DK60309, U01 DK60346, U01 DK60349, U01 DK60341. Other support: National Center for Research Resources (NCRR) General Clinical Research Centers Program grants: M01 RR00645 (New York Presbyterian), M02 RR000079 (University of California, San Francisco), M01 RR16500 (University of Maryland), M01 RR000042 (University of Michigan), M01 RR00046 (University of North Carolina).	Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; COX T, 2003, MULTIDIMENSIONAL SCA; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Desai SD, 2006, CANCER RES, V66, P921, DOI 10.1158/0008-5472.CAN-05-1123; Dong BH, 2004, J VIROL, V78, P8983, DOI 10.1128/JVI.78.17.8983-8993.2004; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Fried MW, 2000, AM J GASTROENTEROL, V95, P3225, DOI 10.1111/j.1572-0241.2000.03433.x; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gertz J, 2003, BIOINFORMATICS, V19, P2039, DOI 10.1093/bioinformatics/btg278; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hartnell A, 2001, BLOOD, V97, P288, DOI 10.1182/blood.V97.1.288; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; JAIL A, 1988, ALGORITHMS CLUSTERIN; Ji XH, 2003, HEPATOLOGY, V37, P610, DOI 10.1053/jhep.2003.50105; Johnson CL, 2006, TRENDS IMMUNOL, V27, P1, DOI 10.1016/j.it.2005.11.004; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Lim W, 2005, J IMMUNOL, V175, P5690, DOI 10.4049/jimmunol.175.9.5690; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; Oetke C, 2006, MOL CELL BIOL, V26, P1549, DOI 10.1128/MCB.26.4.1549-1557.2006; Okochi K, 2005, GENES CELLS, V10, P151, DOI 10.1111/j.1365-2443.2005.00826.x; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sanda C, 2006, J INTERF CYTOK RES, V26, P462, DOI 10.1089/jir.2006.26.462; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Snedecor G.W., 1989, AMES IOWA STATE U PR; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Tahara E, 2005, CANCER IMMUNOL IMMUN, V54, P729, DOI 10.1007/s00262-004-0645-2; Tan H, 2005, J INTERF CYTOK RES, V25, P632, DOI 10.1089/jir.2005.25.632; Taylor MW, 2007, J VIROL, V81, P3391, DOI 10.1128/JVI.02640-06; Taylor MW, 2004, J INTERF CYTOK RES, V24, P107, DOI 10.1089/107999004322813354; van den Berg TK, 2001, J IMMUNOL, V166, P3637, DOI 10.4049/jimmunol.166.6.3637; YANG HD, 1995, MOL CELL BIOL, V15, P6770; Zeuzem S, 2001, GASTROENTEROLOGY, V120, P1438, DOI 10.1053/gast.2001.24006	39	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2007	2	7							e584	10.1371/journal.pone.0000584	http://dx.doi.org/10.1371/journal.pone.0000584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GG	17589564	Green Published, Green Submitted, gold			2022-12-27	WOS:000207451900004
J	D'Avino, PP; Archambault, V; Przewloka, MR; Zhang, W; Lilley, KS; Laue, E; Glover, DM				D'Avino, Pier Paolo; Archambault, Vincent; Przewloka, Marcin R.; Zhang, Wei; Lilley, Kathryn S.; Laue, Ernest; Glover, David M.			Recruitment of Polo Kinase to the Spindle Midzone during Cytokinesis Requires the Feo/Klp3A Complex	PLOS ONE			English	Article								Background. Polo-like kinases control multiple events during cell division, including mitotic entry, centrosome organization, spindle formation, chromosome segregation and cytokinesis. Their roles during cytokinesis, however, are not well understood because the requirement of these kinases during early stages of mitosis complicates the study of their functions after anaphase onset. Methodology/Principal Findings. We used time-lapse microscopy to analyze the dynamics of Polo::GFP in Drosophila tissue culture cells during mitosis. After anaphase onset, Polo:: GFP concentrated at the spindle midzone, but also diffused along the entire length of the central spindle. Using RNA interference we demonstrate that the microtubule-associated proteins Feo and Klp3A are required for Polo recruitment to the spindle midzone, but not the kinesin Pavarotti as previously thought. Moreover, we show that Feo and Klp3A form a complex and that Polo co-localizes with both proteins during cytokinesis. Conclusion/Significance. Our results reveal that the Feo/Klp3A complex is necessary for Polo recruitment to the spindle midzone. A similar finding has also been recently reported in mammalian cells [ 1], suggesting that this basic mechanism has been conserved during evolution, albeit with some differences. Finally, since cleavage furrow formation and ingression are unaffected following feo RNAi, our data imply that Polo recruitment to the central spindle is not required for furrowing, but some other aspect of cytokinesis.	[D'Avino, Pier Paolo; Archambault, Vincent; Przewloka, Marcin R.; Glover, David M.] Univ Cambridge, Dept Genet, Canc Res UK Cell Cycle Genet Res Grp, Cambridge CB2 3EH, England; [Zhang, Wei; Lilley, Kathryn S.; Laue, Ernest] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge; University of Cambridge	D'Avino, PP (corresponding author), Univ Cambridge, Dept Genet, Canc Res UK Cell Cycle Genet Res Grp, Downing St, Cambridge CB2 3EH, England.	p.davino@gen.cam.ac.uk	Przewloka, Marcin R./AAA-5137-2020; Lilley, Kathryn/ABF-5787-2020; D'Avino, Pier Paolo/AAU-4577-2020	Przewloka, Marcin R./0000-0002-0329-9162; Lilley, Kathryn/0000-0003-0594-6543; Laue, Ernest/0000-0002-7476-4148; D'Avino, Pier Paolo/0000-0002-4773-6950; Glover, David/0000-0003-0956-0103	Cancer Research-UK; BBSRC; EMBO; HSFP; Biotechnology and Biological Sciences Research Council [BB/E011586/1] Funding Source: researchfish; Medical Research Council [G0501718] Funding Source: researchfish; BBSRC [BB/E011586/1] Funding Source: UKRI; MRC [G0501718] Funding Source: UKRI	Cancer Research-UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EMBO(European Molecular Biology Organization (EMBO)); HSFP; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Cancer Research-UK Programme Grant ( to DMG) and a BBSRC project grant ( to PPD, DMG, EL and KSL). VA held postdoctoral fellowships from EMBO and HSFP.	Adams RR, 1998, GENE DEV, V12, P1483, DOI 10.1101/gad.12.10.1483; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; Burgess DR, 2005, TRENDS CELL BIOL, V15, P156, DOI 10.1016/j.tcb.2005.01.006; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Carmena M, 1998, J CELL BIOL, V143, P659, DOI 10.1083/jcb.143.3.659; Chen F, 2007, CURR BIOL, V17, P293, DOI 10.1016/j.cub.2007.01.068; D'Avino PP, 2006, J CELL SCI, V119, P4402, DOI 10.1242/jcs.03210; D'Avino PP, 2005, J CELL SCI, V118, P1549, DOI 10.1242/jcs.02335; D'Avino PP, 2004, J CELL BIOL, V166, P61, DOI 10.1083/jcb.200402157; Glover DM, 2005, ONCOGENE, V24, P230, DOI 10.1038/sj.onc.1208279; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; LEE KS, 1995, MOL CELL BIOL, V15, P7143; Liu XQ, 2004, J CELL SCI, V117, P3233, DOI 10.1242/jcs.01173; Logarinho E, 1998, J CELL SCI, V111, P2897; Minestrini G, 2002, J CELL SCI, V115, P725; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Neef R, 2006, CURR BIOL, V16, P301, DOI 10.1016/j.cub.2005.12.030; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0; Pearson J, 2006, EXP CELL RES, V312, P770, DOI 10.1016/j.yexcr.2005.11.031; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Powers J, 1998, CURR BIOL, V8, P1133, DOI 10.1016/S0960-9822(98)70470-1; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; SUNKEL CE, 1988, J CELL SCI, V89, P25; Verbrugghe KJC, 2004, CURR BIOL, V14, P1755, DOI 10.1016/j.cub.2004.09.055; Verni F, 2004, CURR BIOL, V14, P1569, DOI 10.1016/j.cub.2004.08.054; WILLIAMS BC, 1995, J CELL BIOL, V129, P709, DOI 10.1083/jcb.129.3.709; Yoshida S, 2006, SCIENCE, V313, P108, DOI 10.1126/science.1126747; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102	36	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2007	2	6							e572	10.1371/journal.pone.0000572	http://dx.doi.org/10.1371/journal.pone.0000572			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GF	17593971	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000207451800016
J	Giusti, B; Gori, AM; Marcucci, R; Sestini, I; Saracini, C; Sticchi, E; Gensini, F; Fatini, C; Abbate, R; Gensini, GF				Giusti, Betti; Gori, Anna Maria; Marcucci, Rossella; Sestini, Ilaria; Saracini, Claudia; Sticchi, Elena; Gensini, Francesca; Fatini, Cinzia; Abbate, Rosanna; Gensini, Gian Franco			Role of C677T and A1298C MTHFR, A2756G MTR and-786 C/T eNOS Gene Polymorphisms in Atrial Fibrillation Susceptibility	PLOS ONE			English	Article								Background. Hyperhomocysteinemia has been suggested to play a role in the NonValvular Atrial Fibrillation (NVAF) pathogenesis. Polymorphisms in genes coding for homocysteine (Hcy) metabolism enzymes may be associated with hyperhomocysteinemia and NVAF. Methodologies. 456 NVAF patients and 912 matched controls were genotyped by an electronic microchip technology for C677T and A1298C MTHFR, A2756G MTR, and -786C/T eNOS gene polymorphisms. Hcy was determined by an immunoassay method. Principal Findings. The genotype distribution of the four polymorphisms as well as genotype combinations did not differ in patients and controls. Hcy was higher in patients than in controls (15.2, 95% CI 14.7-15.7 vs 11.3, 95% CI 11.0-11.6 mu mol/L; p<0.0001). In both populations, a genotype-phenotype association (p, 0.0001) between Hcy and C677T MTHFR polymorphism was observed; in controls a significant (p = 0.029) association between tHcy and -786C/T eNOS polymorphism was also observed. At the multivariate analysis the NVAF risk significantly increased in the upper quartiles of Hcy compared to the lowest: OR from 2.8 (1.68-4.54 95% CI) in Q2 to 12.9 (7.96-21.06 95% CI) in Q4. Conclusions. Our data demonstrated the four polymorphisms, although able, at least in part, to affect Hcy, were not associated with an increased risk of NVAF per se or in combination.	[Giusti, Betti; Gori, Anna Maria; Marcucci, Rossella; Sestini, Ilaria; Saracini, Claudia; Fatini, Cinzia; Abbate, Rosanna] Univ Florence, Dept Med & Surg Crit Care, DENOTHE, Florence, Italy; [Giusti, Betti; Gori, Anna Maria; Marcucci, Rossella; Sestini, Ilaria; Saracini, Claudia; Fatini, Cinzia; Abbate, Rosanna] Univ Florence, Ctr Res Transfer & High Educ, DENOTHE, Florence, Italy; [Gensini, Francesca] Univ Florence, Dept Clin Pathophysiol, Med Genet Sect, Florence, Italy; [Sticchi, Elena; Gensini, Gian Franco] IRCCS, Ctr S Maria Ulivi, Don Carlo Gnocchi ONLUS Fdn, Florence, Italy	University of Florence; University of Florence; University of Florence; IRCCS Fondazione Don Carlo Gnocchi Onlus	Giusti, B (corresponding author), Univ Florence, Dept Med & Surg Crit Care, DENOTHE, Florence, Italy.	betti.giusti@unifi.it	Giusti, Betti/K-6978-2016; Marcucci, Rossella/K-8471-2016; Sticchi, Elena/K-8237-2016; Gori, annamaria.gori@unifi.it/K-6077-2016	Giusti, Betti/0000-0002-8708-9444; Sticchi, Elena/0000-0002-0990-4618; GENSINI, FRANCESCA/0000-0001-6669-420X; Gori, annamaria.gori@unifi.it/0000-0001-6857-5861; Marcucci, Rossella/0000-0001-9549-7176	Italian Ministry of Health [FIRB 2003]; Ente Cassa di Risparmio Firenze	Italian Ministry of Health(Ministry of Health, Italy); Ente Cassa di Risparmio Firenze	This study was supported by a grant from the Italian Ministry of Health (FIRB 2003) and by the Ente Cassa di Risparmio Firenze. All authors disclose any potential conflict of interest.	Arndt M, 2002, CIRCULATION, V105, P720, DOI 10.1161/hc0602.103639; Ashfield-Watt PAL, 2002, AM J CLIN NUTR, V76, P180, DOI 10.1093/ajcn/76.1.180; Bescond A, 1999, BIOCHEM BIOPH RES CO, V263, P498, DOI 10.1006/bbrc.1999.1391; Chaussalet M, 2004, BIOCHEM BIOPH RES CO, V316, P170, DOI 10.1016/j.bbrc.2004.02.027; Chen J, 2002, PHARMACOGENETICS, V12, P339, DOI 10.1097/00008571-200206000-00011; Fatini C, 2005, CLIN CHEM, V51, P1159, DOI 10.1373/clinchem.2005.048850; Fowler Brian, 2005, Semin Vasc Med, V5, P77; Frusconi S, 2004, CLIN CHEM, V50, P775, DOI 10.1373/clinchem.2003.025197; Gellekink Henkjan, 2005, Semin Vasc Med, V5, P98, DOI 10.1055/s-2005-872396; Girelli D, 1998, BLOOD, V91, P4158, DOI 10.1182/blood.V91.11.4158.411k23_4158_4163; Giusti B, 2004, CELL MOL BIOL, V50, P945; Giusti B, 2003, EUR HEART J, V24, P2038, DOI 10.1016/j.ehj.2003.08.020; Hunt MJ, 2002, AM J PHYSIOL-CELL PH, V283, pC1073, DOI 10.1152/ajpcell.00152.2002; Jacques PF, 1996, CIRCULATION, V93, P7, DOI 10.1161/01.CIR.93.1.7; Kono S, 2005, CANCER SCI, V96, P535, DOI 10.1111/j.1349-7006.2005.00090.x; Marcucci R, 2004, AM HEART J, V148, P456, DOI 10.1016/j.ahj.2004.03.017; Nakano Y, 2004, J AM COLL CARDIOL, V43, P818, DOI 10.1016/j.jacc.2003.08.060; Ogino S, 2003, J HUM GENET, V48, P1, DOI 10.1007/s100380300000; Peters NS, 2002, LANCET, V359, P593, DOI 10.1016/S0140-6736(02)07748-6; Robien K, 2003, AM J EPIDEMIOL, V157, P571, DOI 10.1093/aje/kwg024; Rozen R, 1997, THROMB HAEMOSTASIS, V78, P523; Sharma P, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-1; Sharp L, 2004, AM J EPIDEMIOL, V159, P423, DOI 10.1093/aje/kwh066; Sood HS, 2003, AM J PHYSIOL-LUNG C, V284, pL333, DOI 10.1152/ajplung.00183.2002; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Weisberg IS, 2001, ATHEROSCLEROSIS, V156, P409, DOI 10.1016/S0021-9150(00)00671-7; Xu J, 2004, CIRCULATION, V109, P363, DOI 10.1161/01.CIR.0000109495.02213.52	28	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e495	10.1371/journal.pone.0000495	http://dx.doi.org/10.1371/journal.pone.0000495			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551576	Green Published, gold			2022-12-27	WOS:000207451500005
J	Hockings, KJ; Humle, T; Anderson, JR; Biro, D; Sousa, C; Ohashi, G; Matsuzawa, T				Hockings, Kimberley J.; Humle, Tatyana; Anderson, James R.; Biro, Dora; Sousa, Claudia; Ohashi, Gaku; Matsuzawa, Tetsuro			Chimpanzees Share Forbidden Fruit	PLOS ONE			English	Article							HUNTING BEHAVIOR; WILD CHIMPANZEES; SOCIAL-BEHAVIOR	The sharing of wild plant foods is infrequent in chimpanzees, but in chimpanzee communities that engage in hunting, meat is frequently used as a 'social tool' for nurturing alliances and social bonds. Here we report the only recorded example of regular sharing of plant foods by unrelated, non-provisioned wild chimpanzees, and the contexts in which these sharing behaviours occur. From direct observations, adult chimpanzees at Bossou (Republic of Guinea, West Africa) very rarely transferred wild plant foods. In contrast, they shared cultivated plant foods much more frequently (58 out of 59 food sharing events). Sharing primarily consists of adult males allowing reproductively cycling females to take food that they possess. We propose that hypotheses focussing on 'food-for-sex and -grooming' and 'showing-off' strategies plausibly account for observed sharing behaviours. A changing human-dominated landscape presents chimpanzees with fresh challenges, and our observations suggest that crop-raiding provides adult male chimpanzees at Bossou with highly desirable food commodities that may be traded for other currencies.	[Hockings, Kimberley J.; Anderson, James R.] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Humle, Tatyana] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Biro, Dora] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Sousa, Claudia] Univ Lisbon, Dept Anthropol, P-1699 Lisbon, Portugal; [Ohashi, Gaku; Matsuzawa, Tetsuro] Kyoto Univ, Primate Res Inst, Kyoto, Japan	University of Stirling; University of Wisconsin System; University of Wisconsin Madison; University of Oxford; Universidade de Lisboa; Kyoto University	Hockings, KJ (corresponding author), Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland.	k.j.hockings@stir.ac.uk	Anderson, James/H-8471-2019; Matsuzawa, Tetsuro/ABE-9654-2021	Matsuzawa, Tetsuro/0000-0002-8147-2725; Biro, Dora/0000-0002-3408-6274; Sousa, Claudia/0000-0003-1008-5952; Hockings, Kimberley/0000-0002-6187-644X	Stirling University studentship, MEXT [16002001]; JSPS-HOPE	Stirling University studentship, MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS-HOPE	Funding: This work was supported by a Stirling University studentship, MEXT grant # 16002001 and JSPS-HOPE.	Aureli F, 1997, AM J PRIMATOL, V41, P213, DOI 10.1002/(SICI)1098-2345(1997)41:3<213::AID-AJP4>3.0.CO;2-#; Bethell E., 2000, Primate Report, V56, P67; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Boesch C, 2000, CHIMPANZEES TAI FORE; De Waal F., 2000, CHIMPANZEE POLITICS; DEWAAL FBM, 1989, J HUM EVOL, V18, P433, DOI 10.1016/0047-2484(89)90074-2; Feistner A.T.C., 1989, P21; Gilby IC, 2006, ANIM BEHAV, V71, P953, DOI 10.1016/j.anbehav.2005.09.009; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hill, ADAPTIVE RESPONSES N, P139; Hockings KJ, 2006, CURR BIOL, V16, pR668, DOI 10.1016/j.cub.2006.08.019; Matsuzawa T, 2006, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P3, DOI 10.1007/4-431-30248-4_1; McGrew WC, 1996, FOOD STATUS QUEST IN, P39; Mitani JC, 1999, AM J PHYS ANTHROPOL, V109, P439, DOI 10.1002/(SICI)1096-8644(199908)109:4<439::AID-AJPA2>3.0.CO;2-3; Mitani JC, 2001, ANIM BEHAV, V61, P915, DOI 10.1006/anbe.2000.1681; Nakamura M., 2001, PAN AFR NEWS, V8, P28, DOI [10.5134/143398, DOI 10.5134/143398]; Nishida Toshisada, 1992, P159; Ohashi Gaku, 2007, Pan Africa News, V14, P14; Slocombe KE, 2005, AM J PRIMATOL, V65, P385, DOI 10.1002/ajp.20123; Stanford C.B., 1998, CHIMPANZEE RED COLOB; Stanford CB, 1998, CURR ANTHROPOL, V39, P399, DOI 10.1086/204757; Stanford CB, 2001, TREE OF ORIGIN, P95; Stevens JR, 2004, ANIM BEHAV, V67, P603, DOI 10.1016/j.anbehav.2003.04.012; SUGIYAMA Y, 1989, BEHAVIORAL STUDIES W, P43; TELEKI G, 1973, PREDATORY BEHAV WILD; TUTIN CEG, 1979, BEHAV ECOL SOCIOBIOL, V6, P29, DOI 10.1007/BF00293242; van Lawick-Goodall J., 1972, P25	28	84	86	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2007	2	9							e886	10.1371/journal.pone.0000886	http://dx.doi.org/10.1371/journal.pone.0000886			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HR	17849015	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455600032
J	Nielsen, M; Lundegaard, C; Blicher, T; Lamberth, K; Harndahl, M; Justesen, S; Roder, G; Peters, B; Sette, A; Lund, O; Buus, S				Nielsen, Morten; Lundegaard, Claus; Blicher, Thomas; Lamberth, Kasper; Harndahl, Mikkel; Justesen, Sune; Roder, Gustav; Peters, Bjoern; Sette, Alessandro; Lund, Ole; Buus, Soren			NetMHCpan, a Method for Quantitative Predictions of Peptide Binding to Any HLA-A and -B Locus Protein of Known Sequence	PLOS ONE			English	Article								Background. Binding of peptides to Major Histocompatibility Complex (MHC) molecules is the single most selective step in the recognition of pathogens by the cellular immune system. The human MHC class I system (HLA-I) is extremely polymorphic. The number of registered HLA-I molecules has now surpassed 1500. Characterizing the specificity of each separately would be a major undertaking. Principal Findings. Here, we have drawn on a large database of known peptide-HLA-I interactions to develop a bioinformatics method, which takes both peptide and HLA sequence information into account, and generates quantitative predictions of the affinity of any peptide-HLA-I interaction. Prospective experimental validation of peptides predicted to bind to previously untested HLA-I molecules, cross-validation, and retrospective prediction of known HIV immune epitopes and endogenous presented peptides, all successfully validate this method. We further demonstrate that the method can be applied to perform a clustering analysis of MHC specificities and suggest using this clustering to select particularly informative novel MHC molecules for future biochemical and functional analysis. Conclusions. Encompassing all HLA molecules, this high-throughput computational method lends itself to epitope searches that are not only genome- and pathogen-wide, but also HLA-wide. Thus, it offers a truly global analysis of immune responses supporting rational development of vaccines and immunotherapy. It also promises to provide new basic insights into HLA structure-function relationships. The method is available at http://www.cbs.dtu.dk/services/NetMHCpan.	[Nielsen, Morten; Lundegaard, Claus; Blicher, Thomas; Lund, Ole] Tech Univ Denmark, BioCtr DTU, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Lamberth, Kasper; Harndahl, Mikkel; Justesen, Sune; Roder, Gustav; Buus, Soren] Univ Copenhagen, Dept Expt Immunol, Inst Med Microbiol & Immunol, Copenhagen, Denmark; [Peters, Bjoern; Sette, Alessandro] La Jolla Inst Allergy & Immunol, San Diego, CA USA	Technical University of Denmark; University of Copenhagen; La Jolla Institute for Immunology	Nielsen, M (corresponding author), Tech Univ Denmark, BioCtr DTU, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	mniel@cbs.dtu.dk	Lundegaard, Claus/B-3938-2012; Buus, Soren/F-5446-2010; Nielsen, Morten/AAL-8700-2020; Sette, Alessandro/AFO-8916-2022; Lund, Ole/F-4437-2014; Nielsen, Morten/E-7754-2011	Nielsen, Morten/0000-0001-7885-4311; Lund, Ole/0000-0003-1108-0491; Nielsen, Morten/0000-0001-7885-4311; Buus, Soren/0000-0001-8363-1999	NIH [HHSN266200400025C, HHSN266200400083C, HHSN26620040006C]; European commission [LSHB-CT-2003-503231]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the NIH ( contracts HHSN266200400025C, HHSN266200400083C, and HHSN26620040006C) and sixth Framework program of the European commission ( grant LSHB-CT-2003-503231).	ADAMS HP, 1995, J IMMUNOL METHODS, V185, P181, DOI 10.1016/0022-1759(95)00111-M; Antes I, 2006, BIOINFORMATICS, V22, pE16, DOI 10.1093/bioinformatics/btl216; BALDI P, 2001, BIOINFORMATICS MACHI; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bordner AJ, 2006, PROTEINS, V63, P512, DOI 10.1002/prot.20831; Brusic V, 2002, IMMUNOL CELL BIOL, V80, P280, DOI 10.1046/j.1440-1711.2002.01088.x; BRUSIC V, 1994, COMPLEX SYSTEMS MECH, P253; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; BUUS S, 1987, SCIENCE, V235, P1353, DOI 10.1126/science.2435001; Donnes P, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-25; Doytchinova IA, 2004, J IMMUNOL, V172, P4314, DOI 10.4049/jimmunol.172.7.4314; Doytchinova IA, 2001, J MED CHEM, V44, P3572, DOI 10.1021/jm010021j; Fagerberg T, 2006, J MOL BIOL, V356, P521, DOI 10.1016/j.jmb.2005.11.059; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; Gulukota K, 1997, J MOL BIOL, V267, P1258, DOI 10.1006/jmbi.1997.0937; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HOBOHM U, 1992, PROTEIN SCI, V1, P409; JANOWITZ M, 2003, BIOCONSENSUS, V61, P163; KORBER BTM, 2001, HIV MOL IMMUNOLOGY 2; Lauemoller S L, 2000, Rev Immunogenet, V2, P477; Lefranc Marie-Paule, 2005, Immunome Res, V1, P3, DOI 10.1186/1745-7580-1-3; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; Mamitsuka H, 1998, PROTEINS, V33, P460, DOI 10.1002/(SICI)1097-0134(19981201)33:4<460::AID-PROT2>3.0.CO;2-M; MARGUSH T, 1981, B MATH BIOL, V43, P239, DOI 10.1007/BF02459446; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; PARKER KC, 1994, J IMMUNOL, V152, P163; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Press WH., 1992, NUMERICAL RECIPIES C, V2nd edn; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; RAMMENSEE HG, 1997, MHC LIGANDS PEPTIDE; Reche PA, 2002, HUM IMMUNOL, V63, P701, DOI 10.1016/S0198-8859(02)00432-9; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Segal MR, 2001, BIOMETRICS, V57, P632, DOI 10.1111/j.0006-341X.2001.00632.x; SETTE A, 1989, P NATL ACAD SCI USA, V86, P3296, DOI 10.1073/pnas.86.9.3296; Sette A, 2003, CURR OPIN IMMUNOL, V15, P461, DOI 10.1016/S0952-7915(03)00083-9; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; SETTE A, 1987, NATURE, V328, P395, DOI 10.1038/328395a0; Sette A, 2007, CURR OPIN IMMUNOL, V19, P106, DOI 10.1016/j.coi.2006.11.002; Sette Alessandro, 2005, Immunity, V22, P155, DOI 10.1016/j.immuni.2005.01.009; Sidney J, 2006, IMMUNOGENETICS, V58, P559, DOI 10.1007/s00251-006-0131-4; Srinivasan KN, 2004, BIOINFORMATICS, V20, P297, DOI 10.1093/bioinformatics/bth943; STEVEN GE, 2000, HLA FACTS BOOK; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Sylvester-Hvid C, 2002, TISSUE ANTIGENS, V59, P251, DOI 10.1034/j.1399-0039.2002.590402.x; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Zhu SF, 2006, BIOINFORMATICS, V22, P1648, DOI 10.1093/bioinformatics/btl141; [No title captured]	51	398	428	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2007	2	8							e796	10.1371/journal.pone.0000796	http://dx.doi.org/10.1371/journal.pone.0000796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HP	17726526	gold, Green Submitted, Green Published			2022-12-27	WOS:000207455400013
J	Jiang, SX; Fu, YG; Williams, J; Wood, J; Pandarinathan, L; Avraham, S; Makriyannis, A; Avraham, S; Avraham, HK				Jiang, Shuxian; Fu, Yigong; Williams, John; Wood, JodiAnne; Pandarinathan, Lakshmipathi; Avraham, Shiri; Makriyannis, Alexandros; Avraham, Shalom; Avraham, Hava Karsenty			Expression and Function of Cannabinoid Receptors CB1 and CB2 and Their Cognate Cannabinoid Ligands in Murine Embryonic Stem Cells	PLOS ONE			English	Article								Background. Characterization of intrinsic and extrinsic factors regulating the self-renewal/division and differentiation of stem cells is crucial in determining embryonic stem (ES) cell fate. ES cells differentiate into multiple hematopoietic lineages during embryoid body (EB) formation in vitro, which provides an experimental platform to define the molecular mechanisms controlling germ layer fate determination and tissue formation. Methods and Findings. The cannabinoid receptor type 1 (CB1) and cannabinoid receptor type 2 (CB2) are members of the G-protein coupled receptor (GPCR) family, that are activated by endogenous ligands, the endocannabinoids. CB1 receptor expression is abundant in brain while CB2 receptors are mostly expressed in hematopoietic cells. However, the expression and the precise roles of CB1 and CB2 and their cognate ligands in ES cells are not known. We observed significant induction of CB1 and CB2 cannabinoid receptors during the hematopoietic differentiation of murine ES (mES)-derived embryoid bodies. Furthermore, mES cells as well as ES-derived embryoid bodies at days 7 and 14, expressed endocannabinoids, the ligands for both CB1 and CB2. The CB1 and CB2 antagonists (AM251 and AM630, respectively) induced mES cell death, strongly suggesting that endocannabinoids are involved in the survival of mES cells. Treatment of mES cells with the exogenous cannabinoid ligand Delta(9)-THC resulted in the increased hematopoietic differentiation of mES cells, while addition of AM251 or AM630 blocked embryoid body formation derived from the mES cells. In addition, cannabinoid agonists induced the chemotaxis of ES-derived embryoid bodies, which was specifically inhibited by the CB1 and CB2 antagonists. Conclusions. This work has not been addressed previously and yields new information on the function of cannabinoid receptors, CB1 and CB2, as components of a novel pathway regulating murine ES cell differentiation. This study provides insights into cannabinoid system involvement in ES cell survival and hematopoietic differentiation.	[Jiang, Shuxian; Fu, Yigong; Avraham, Shiri; Avraham, Shalom; Avraham, Hava Karsenty] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Expt Med, Boston, MA 02215 USA; [Williams, John; Wood, JodiAnne; Pandarinathan, Lakshmipathi; Makriyannis, Alexandros] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Northeastern University	Avraham, HK (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Expt Med, Boston, MA 02215 USA.	havraham@bidmc.harvard.edu	Makriyannis, Alexandros/GRF-1518-2022	Makriyannis, Alexandros/0000-0003-3272-3687; Avraham, Hava/0000-0002-7545-3640	National Institutes of Health [CA 096805, K18 PAR-02-069];  [PO1-DA 09158];  [R38-DA 03801]; NATIONAL CANCER INSTITUTE [R01CA096805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009158, R01DA003801, R37DA003801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding: This work was supported by the National Institutes of Health (Grant CA 096805, H.A. a Career Enhancement Award K18 PAR-02-069, H.A.), PO1-DA 09158 (AM) and R38-DA 03801 (AM).	ABADJI V, 1994, J MED CHEM, V37, P1889, DOI 10.1021/jm00038a020; ABEL EL, 1980, MARIJUANA 1 12000 YE, P289; Adams GB, 2003, BLOOD, V101, P45, DOI 10.1182/blood-2002-02-0486; Alger BE, 2004, P NATL ACAD SCI USA, V101, P8512, DOI 10.1073/pnas.0402935101; Bautch VL, 1996, DEV DYNAM, V205, P1; BOUABOULA M, 1993, EUR J BIOCHEM, V214, P173, DOI 10.1111/j.1432-1033.1993.tb17910.x; Bouaboula M, 1999, MOL PHARMACOL, V55, P473; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Chin CN, 1999, J PHARMACOL EXP THER, V291, P837; Choi K, 1998, DEVELOPMENT, V125, P725; DAAKA Y, 1995, ADV EXP MED BIOL, V373, P91; Downing GJ, 2004, STEM CELLS, V22, P1168, DOI 10.1634/stemcells.2004-0101; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; GUDERMANN T, 1995, J MOL MED, V73, P51, DOI 10.1007/BF00270578; Guzman M, 2003, NAT REV CANCER, V3, P745, DOI 10.1038/nrc1188; Hart C, 2004, STEM CELLS, V22, P580, DOI 10.1634/stemcells.22-4-580; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Hillard CJ, 1999, J PHARMACOL EXP THER, V289, P1427; Howard AD, 2001, TRENDS PHARMACOL SCI, V22, P132, DOI 10.1016/S0165-6147(00)01636-9; Huffman JW, 1999, BIOORGAN MED CHEM, V7, P2905, DOI 10.1016/S0968-0896(99)00219-9; Jorda MA, 2002, BLOOD, V99, P2786; Juarez J, 2004, HISTOL HISTOPATHOL, V19, P299, DOI 10.14670/HH-19.299; Kimura T, 2004, BLOOD, V103, P4478, DOI 10.1182/blood-2003-03-0875; Kollet O, 2002, BLOOD, V100, P2778, DOI 10.1182/blood-2002-02-0564; Mahmud N, 2004, BIOL BLOOD MARROW TR, V10, P681, DOI 10.1016/j.bbmt.2004.07.002; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Matsuoka S, 2001, BLOOD, V98, P6, DOI 10.1182/blood.V98.1.6; Metcalf D, 2003, STEM CELLS, V21, P5, DOI 10.1634/stemcells.21-1-5; Molina-Holgado F, 2007, EUR J NEUROSCI, V25, P629, DOI 10.1111/j.1460-9568.2007.05322.x; Nilsson SK, 2004, CURR OPIN HEMATOL, V11, P102, DOI 10.1097/01.moh.0000133651.06863.9c; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Peled A, 2002, STEM CELLS, V20, P259, DOI 10.1634/stemcells.20-3-259; Pertwee RG, 1999, CURR MED CHEM, V6, P635; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Plett PA, 2002, EXP HEMATOL, V30, P1061, DOI 10.1016/S0301-472X(02)00880-9; Quesenberry PJ, 2005, EXP HEMATOL, V33, P9, DOI 10.1016/j.exphem.2004.10.012; Rao M, 2004, DEV BIOL, V275, P269, DOI 10.1016/j.ydbio.2004.08.013; SAVARESE TM, 1992, BIOCHEM J, V283, P1; Schatz AR, 1997, TOXICOL APPL PHARM, V142, P278, DOI 10.1006/taap.1996.8034; Shen W, 2001, EXP HEMATOL, V29, P1439, DOI 10.1016/S0301-472X(01)00741-X; THORSTEN G, 2003, PHARM RES, V47, P269; Viswanathan S, 2002, STEM CELLS, V20, P119, DOI 10.1634/stemcells.20-2-119; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424; Voermans C, 2001, J HEMATOTH STEM CELL, V10, P725, DOI 10.1089/152581601317210827; WILLIAMS J, 2007, ANAL CHEM IN PRESS; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Yanagida E, 2004, CELL CALCIUM, V36, P135, DOI 10.1016/j.ceca.2004.01.022	50	59	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e641	10.1371/journal.pone.0000641	http://dx.doi.org/10.1371/journal.pone.0000641			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653268	Green Published, gold, Green Submitted			2022-12-27	WOS:000207452200010
J	Meurens, F; Berri, M; Siggers, RH; Willing, BP; Salmon, H; Van Kessel, AG; Gerdts, V				Meurens, Francois; Berri, Mustapha; Siggers, Richard H.; Willing, Benjamin P.; Salmon, Henri; Van Kessel, Andrew G.; Gerdts, Volker			Commensal Bacteria and Expression of Two Major Intestinal Chemokines, TECK/CCL25 and MEC/CCL28, and Their Receptors	PLOS ONE			English	Article							REGULATORY T-CELLS; EPITHELIAL-CELLS; KAPPA-B; LYMPHOCYTE TRAFFICKING; CCR10 EXPRESSION; FUNCTIONAL-ROLE; CUTTING EDGE; CCL28; RECRUITMENT; TECK	Background. CCL25/TECK and CCL28/MEC are CC chemokines primarily expressed in thymic dendritic cells and mucosal epithelial cells. Their receptors, CCR9 and CCR10, are mainly expressed on T and B lymphocytes. In human, mouse, pig and sheep CCL25 and CCL28 play an important role in the segregation and the compartmentalization of the mucosal immune system. As evidenced by early comparisons of germ-free and conventional animals, the intestinal bacterial microflora has a marked effect on host intestinal immune functions. However, little is known about the impact of bacterial colonization on constitutive and induced chemokine expressions as well as on the generation of anti-inflammatory mechanisms. Methodology/Principal Findings. Therefore, we decided to focus by qPCR on the mRNA expression of two main gut chemokines, CCL25 and CCL28, their receptors CCR9 and CCR10, the Tregs marker Foxp3 and anti-inflammatory cytokines TGF-beta and IL-10 following colonization with different bacterial species within the small intestine. To accomplish this we used an original germ-free neonatal pig model and monoassociated pigs with a representative Gram-negative (Escherichia coli) or Gram-positive (Lactobacillus fermentum) commensal bacteria commonly isolated from the neonatal pig intestine. Our results show a consistent and marked effect of microbial colonization on the mRNA expression of intestinal chemokines, chemokine receptors, Foxp3 and TGF-beta. Moreover, as evidenced by in vitro experiments using two different cell lines, the pattern of regulation of CCL25 and CCL28 expression in the gut appears complex and suggests an additional role for in vivo factors. Conclusions/Significance. Taken together, the results highlight the key role of bacterial microflora in the development of a functional intestinal immune system in an elegant and relevant model for human immune system development.	[Meurens, Francois; Berri, Mustapha; Salmon, Henri] INRA, UR 1282, Nouzilly, France; [Siggers, Richard H.; Willing, Benjamin P.; Van Kessel, Andrew G.] Univ Saskatchewan, Dept Anim & Poultry Sci, Saskatoon, SK S7N 0W0, Canada; [Gerdts, Volker] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK S7N 0W0, Canada	INRAE; University of Saskatchewan; University of Saskatchewan	Meurens, F (corresponding author), INRA, UR 1282, Nouzilly, France.	meurens@tours.inra.fr	salmon, henri/B-2605-2010; Meurens, Francois JMA/J-3829-2019; Willing, Benjamin/AAA-9650-2019	Meurens, Francois JMA/0000-0002-0353-4871; Gerdts, Volker/0000-0001-8229-1611	Natural Science and Engineering Research Council of Canada (NSERC); Saskatchewan Health Research Foundation (SHRF); Saskatchewan Agriculture Development Fund Strategic Research Program	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Saskatchewan Health Research Foundation (SHRF); Saskatchewan Agriculture Development Fund Strategic Research Program	This research was supported by the Natural Science and Engineering Research Council of Canada (NSERC), the Saskatchewan Health Research Foundation (SHRF), and the Saskatchewan Agriculture Development Fund Strategic Research Program.	Banham AH, 2006, EUR J IMMUNOL, V36, P2832, DOI 10.1002/eji.200636459; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Bonini JA, 1997, DNA CELL BIOL, V16, P1023, DOI 10.1089/dna.1997.16.1023; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Choe H, 1998, J VIROL, V72, P6113, DOI 10.1128/JVI.72.7.6113-6118.1998; Corthesy B, 2007, J NUTR, V137, p781S, DOI 10.1093/jn/137.3.781S; Eksteen B, 2006, J IMMUNOL, V177, P593, DOI 10.4049/jimmunol.177.1.593; English K, 2006, IMMUNOL LETT, V103, P92, DOI 10.1016/j.imlet.2005.09.011; Ericsson A, 2004, EUR J IMMUNOL, V34, P2720, DOI 10.1002/eji.200425125; Feng NG, 2006, J IMMUNOL, V176, P5749, DOI 10.4049/jimmunol.176.10.5749; FURUSE M, 1994, COMP BIOCHEM PHYS A, V109, P547; Hieshima K, 2003, J IMMUNOL, V170, P1452, DOI 10.4049/jimmunol.170.3.1452; Hosoe N, 2004, AM J PHYSIOL-GASTR L, V286, pG458, DOI 10.1152/ajpgi.00167.2003; HU MCT, 1992, P NATL ACAD SCI USA, V89, P8254, DOI 10.1073/pnas.89.17.8254; Jaimes MC, 2004, J VIROL, V78, P10967, DOI 10.1128/JVI.78.20.10967-10976.2004; KAEFFER B, 1993, EUR J CELL BIOL, V62, P152; Kim CH, 1999, J LEUKOCYTE BIOL, V65, P6, DOI 10.1002/jlb.65.1.6; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Kunkel EJ, 2003, MICROCIRCULATION, V10, P313, DOI 10.1038/sj.mn.7800196; Kunkel EJ, 2003, J CLIN INVEST, V111, P1001, DOI 10.1172/JCI200317244; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Lammers KM, 2005, INFLAMM BOWEL DIS, V11, P447, DOI 10.1097/01.mpa.0000160302.40931.7b; Lazarus NH, 2003, J IMMUNOL, V170, P3799, DOI 10.4049/jimmunol.170.7.3799; Liu CL, 2005, BLOOD, V105, P31, DOI 10.1182/blood-2004-04-1369; Liu CL, 2006, BLOOD, V108, P2531, DOI 10.1182/blood-2006-05-024190; Meurens F, 2007, IMMUNOLOGY, V120, P544, DOI 10.1111/j.1365-2567.2006.02532.x; Meurens F, 2006, VET IMMUNOL IMMUNOP, V113, P313, DOI 10.1016/j.vetimm.2006.05.014; Norment AM, 2000, J IMMUNOL, V164, P639, DOI 10.4049/jimmunol.164.2.639; O'Gorman MT, 2005, CELL IMMUNOL, V238, P87, DOI 10.1016/j.cellimm.2006.02.003; O'Hara AM, 2006, IMMUNOLOGY, V118, P202, DOI 10.1111/j.1365-2567.2006.02358.x; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Pabst O, 2004, J EXP MED, V199, P411, DOI 10.1084/jem.20030996; Pan JL, 2000, J IMMUNOL, V165, P2943, DOI 10.4049/jimmunol.165.6.2943; Pescovitz MD, 1998, HANDBOOK OF INVERTEBRATE IMMUNOLOGY, P373; Petrof EO, 2004, GASTROENTEROLOGY, V127, P1474, DOI 10.1053/j.gastro.2004.09.001; Riedel CU, 2006, WORLD J GASTROENTERO, V12, P3729, DOI 10.3748/wjg.v12.i23.3729; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Seo SH, 1997, J VIROL, V71, P5173, DOI 10.1128/JVI.71.7.5173-5177.1997; Shirkey TW, 2006, EXP BIOL MED, V231, P1333, DOI 10.1177/153537020623100807; Stein JV, 2005, IMMUNOLOGY, V116, P1, DOI 10.1111/j.1365-2567.2005.02183.x; Strauch UG, 2005, GUT, V54, P1546, DOI 10.1136/gut.2004.059451; Tumbleson ME, 1996, ADVANCES IN SWINE IN BIOMEDICAL RESEARCH, VOLS 1 AND 2, P1; Vicari AP, 1997, IMMUNITY, V7, P291, DOI 10.1016/S1074-7613(00)80531-2; Waidmann M, 2002, GUT, V50, P170, DOI 10.1136/gut.50.2.170; Wang W, 2000, J BIOL CHEM, V275, P22313, DOI 10.1074/jbc.M001461200; WOSTMANN BS, 1996, GERMFREE GNOTOBIOTIC, P195; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Zaballos A, 1999, J IMMUNOL, V162, P5671; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241; Zhang LY, 2005, J NUTR, V135, P1752, DOI 10.1093/jn/135.7.1752	51	57	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2007	2	7							e677	10.1371/journal.pone.0000677	http://dx.doi.org/10.1371/journal.pone.0000677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GJ	17653288	gold, Green Published, Green Submitted			2022-12-27	WOS:000207452200030
J	Locasale, JW				Locasale, Jason W.			Computational Investigations into the Origins of Short-Term Biochemical Memory in T cell Activation	PLOS ONE			English	Article								Recent studies have reported that T cells can integrate signals between interrupted encounters with Antigen Presenting Cells (APCs) in such a way that the process of signal integration exhibits a form of memory. Here, we carry out a computational study using a simple mathematical model of T cell activation to investigate the ramifications of interrupted T cell-APC contacts on signal integration. We consider several mechanisms of how signal integration at these time scales may be achieved and conclude that feedback control of immediate early gene products (IEGs) appears to be a highly plausible mechanism that allows for effective signal integration and cytokine production from multiple exposures to APCs. Analysis of these computer simulations provides an experimental roadmap involving several testable predictions.	MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Locasale, JW (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	Locasale@MIT.edu	Locasale, Jason W/ABE-6505-2020	Locasale, Jason W/0000-0002-7766-3502	NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Work was undertaken through the sponsorship of Professor Arup Chakraborty who was able to support the work with funds provided through an NIH director's pioneer award	Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Arendt CW, 2002, CURR OPIN IMMUNOL, V14, P323, DOI 10.1016/S0952-7915(02)00346-1; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Faroudi M, 2003, J IMMUNOL, V171, P1128, DOI 10.4049/jimmunol.171.3.1128; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GOLDSMITH MA, 1988, SCIENCE, V240, P1029, DOI 10.1126/science.3259335; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Janeway C., 2004, IMMUNOBIOLOGY; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; MacKeigan JP, 2005, MOL CELL BIOL, V25, P4676, DOI 10.1128/MCB.25.11.4676-4682.2005; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Munitic I, 2005, J IMMUNOL, V174, P4010, DOI 10.4049/jimmunol.174.7.4010; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Reth M, 2004, NAT REV IMMUNOL, V4, P269, DOI 10.1038/nri1335; Rosette C, 2001, IMMUNITY, V15, P59, DOI 10.1016/S1074-7613(01)00173-X; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schade AE, 2004, J IMMUNOL, V172, P5828, DOI 10.4049/jimmunol.172.10.5828; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; van Kampen N.G., 2001, STOCHASTIC PROCESSES; Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5; Wylie DC, 2007, P NATL ACAD SCI USA, V104, P5533, DOI 10.1073/pnas.0611482104; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	27	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2007	2	7							e627	10.1371/journal.pone.0000627	http://dx.doi.org/10.1371/journal.pone.0000627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GI	17637843	Green Published, Green Submitted, gold			2022-12-27	WOS:000207452100017
J	Makombe, SD; Jahn, A; Tweya, H; Chuka, S; Yu, JKL; Hochgesang, M; Aberle-Grasse, J; Thambo, L; Schouten, EJ; Kamoto, K; Harries, AD				Makombe, Simon D.; Jahn, Andreas; Tweya, Hannock; Chuka, Stuart; Yu, Joseph Kwong-Leung; Hochgesang, Mindy; Aberle-Grasse, John; Thambo, Lameck; Schouten, Erik J.; Kamoto, Kelita; Harries, Anthony D.			A National Survey of Teachers on Antiretroviral Therapy in Malawi: Access, Retention in Therapy and Survival	PLOS ONE			English	Article								Background. HIV/AIDS is having a devastating effect on the education sector in sub-Saharan Africa. A national survey was conducted in all public sector and private sector facilities in Malawi providing antiretroviral therapy (ART) to determine the uptake of ART by teachers and their outcomes while on treatment. Methodology/Principal Findings. A retrospective cohort study was carried out based on patient follow-up records from ART Registers and treatment master cards in all 138 ART clinics in Malawi; observations were censored on September 30(th) 2006. By this date, Malawi's 102 public sector and 36 private sector ART clinics had registered a total of 72,328 patients for treatment. Of these, 2,643 (3.7%) were teachers. Adjusting for double-registration caused by clinic transfers, it is estimated that 2,380 individual teachers had ever accessed ART. There were 15% of teachers starting ART in WHO clinical stage 1 or 2 with a CD4-lymphocyte count of <= 250/mm(3) and 85% starting in stage 3 or 4. By 30(th) September 2006, 1,850 teachers were alive on ART (3.5% of all teachers in Malawi). The probability of being alive on ART at 6-months, 12-months, 18-months and 24-months after treatment initiation was 84%, 79%, 75% and 73% respectively. Retention in treatment was better for women (adjusted HR = 1.8) and in those starting ART in WHO Clinical Stage 1 and 2 (adjusted HR = 1.8). Conclusion/Significance. Rapid scale up of ART has allowed 2,380 HIV-positive teachers to access life-prolonging treatment. There is evidence that this intervention can help to mitigate some of the shortages of teaching personnel in resource-poor countries affected by a generalised HIV epidemic.	[Makombe, Simon D.; Schouten, Erik J.; Kamoto, Kelita; Harries, Anthony D.] Minist Hlth, Clin HIV Unit, Lilongwe, Malawi; [Jahn, Andreas; Tweya, Hannock; Thambo, Lameck] Lighthouse Trust, Lilongwe, Malawi; [Jahn, Andreas] Int Training & Educ Ctr HIV, Seattle, WA USA; [Chuka, Stuart] Malawi Business Coalit AIDS, Blantyre, Malawi; [Yu, Joseph Kwong-Leung] Mzuzu Cent Hosp, Mzuzu, Malawi; [Harries, Anthony D.] Family Hlth Int, Malawi Country Off, Lilongwe, Malawi; [Schouten, Erik J.] Management Sci Hlth, Lilongwe, Malawi; [Harries, Anthony D.] London Sch Hyg & Trop Med, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Makombe, SD (corresponding author), Minist Hlth, Clin HIV Unit, Lilongwe, Malawi.	adharries@malawi.net	Jahn, Andreas/ABB-7796-2020	Jahn, Andreas/0000-0003-4645-1600	World Health Organization	World Health Organization(World Health Organization)	Supervision visits were supported by the World Health Organization. Data collection for the study was supported by an anonymous donor.	[Anonymous], 2002, REP GLOB HIV AIDS EP; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Harries AD, 2002, T ROY SOC TROP MED H, V96, P34, DOI 10.1016/S0035-9203(02)90231-2; Kombe G, 2005, INT SOC SCI J, V57, P609, DOI 10.1111/j.1468-2451.2006.00578.x; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Libamba E, 2006, B WORLD HEALTH ORGAN, V84, P320; Libamba E, 2005, INT J TUBERC LUNG D, V9, P1062; Libamba E, 2007, B WORLD HEALTH ORGAN, V85, P156, DOI 10.2471/BLT.05.033688; Sachs J., 2005, PRACTICAL PLAN ACHIE; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; The Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration and ART Cohort Collaboration (ART-CC) groups, 2006, LANCET, V367, P817; *UNAIDS, 2000, AIDS AFR COUNTR COUN; *UNDP MAL I MAN, 2002, IMP HIV AIDS HUM RES; van Oosterhout JJG, 2005, JAIDS-J ACQ IMM DEF, V39, P626; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	17	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2007	2	7							e620	10.1371/journal.pone.0000620	http://dx.doi.org/10.1371/journal.pone.0000620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GI	17637836	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000207452100010
J	Delelis, O; Parissi, V; Leh, H; Mbemba, G; Petit, C; Sonigo, P; Deprez, E; Mouscadet, JF				Delelis, Olivier; Parissi, Vincent; Leh, Herve; Mbemba, Gladys; Petit, Caroline; Sonigo, Pierre; Deprez, Eric; Mouscadet, Jean-Francois			Efficient and Specific Internal Cleavage of a Retroviral Palindromic DNA Sequence by Tetrameric HIV-1 Integrase	PLOS ONE			English	Article								Background. HIV-1 integrase (IN) catalyses the retroviral integration process, removing two nucleotides from each long terminal repeat and inserting the processed viral DNA into the target DNA. It is widely assumed that the strand transfer step has no sequence specificity. However, recently, it has been reported by several groups that integration sites display a preference for palindromic sequences, suggesting that a symmetry in the target DNA may stabilise the tetrameric organisation of IN in the synaptic complex. Methodology/Principal Findings. We assessed the ability of several palindrome-containing sequences to organise tetrameric IN and investigated the ability of IN to catalyse DNA cleavage at internal positions. Only one palindromic sequence was successfully cleaved by IN. Interestingly, this symmetrical sequence corresponded to the 2-LTR junction of retroviral DNA circles-a palindrome similar but not identical to the consensus sequence found at integration sites. This reaction depended strictly on the cognate retroviral sequence of IN and required a full-length wild-type IN. Furthermore, the oligomeric state of IN responsible for this cleavage differed from that involved in the 39-processing reaction. Palindromic cleavage strictly required the tetrameric form, whereas 39-processing was efficiently catalysed by a dimer. Conclusions/Significance. Our findings suggest that the restriction-like cleavage of palindromic sequences may be a general physiological activity of retroviral INs and that IN tetramerisation is strongly favoured by DNA symmetry, either at the target site for the concerted integration or when the DNA contains the 2-LTR junction in the case of the palindromic internal cleavage.	[Delelis, Olivier; Leh, Herve; Mbemba, Gladys; Deprez, Eric; Mouscadet, Jean-Francois] Ecole Normale Super, CNRS, LBPA, UMR8113, Cachan, France; [Parissi, Vincent] Lab REGER, IFR Pathol Infect & Canc 66, Bordeaux, France; [Petit, Caroline; Sonigo, Pierre] Univ Paris 05, CNRS, Inst Cochin, Dept Malad Infect,INSERM,U567,UMR8104, F-75270 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Delelis, O (corresponding author), Ecole Normale Super, CNRS, LBPA, UMR8113, Cachan, France.	delelis@lbpa.ens-cachan.fr		Sonigo, Pierre/0000-0003-2686-1303	TrioH European [503480]; Centre National de la Recherche Scientifique; French National Agency	TrioH European; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French National Agency(French National Research Agency (ANR))	This work was supported by grants from the TrioH European project (FP6 grant 503480), the Centre National de la Recherche Scientifique, and the French National Agency for Research against AIDS (ANRS).	Agapkina J, 2006, J BIOL CHEM, V281, P11530, DOI 10.1074/jbc.M512271200; Craigie R, 2001, J BIOL CHEM, V276, P23213, DOI 10.1074/jbc.R100027200; Delelis O, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-31; Deprez E, 2004, MOL PHARMACOL, V65, P85, DOI 10.1124/mol.65.1.85; DUYK G, 1985, J VIROL, V56, P589, DOI 10.1128/JVI.56.2.589-599.1985; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Gerton JL, 1997, J BIOL CHEM, V272, P25809, DOI 10.1074/jbc.272.41.25809; Grandgenett DP, 2005, P NATL ACAD SCI USA, V102, P5903, DOI 10.1073/pnas.0502045102; GRANDGENETT DP, 1985, NUCLEIC ACIDS RES, V13, P6205, DOI 10.1093/nar/13.17.6205; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Katzman M, 1996, J VIROL, V70, P2598, DOI 10.1128/JVI.70.4.2598-2604.1996; Katzman M, 2000, VIRUS RES, V66, P87, DOI 10.1016/S0168-1702(99)00126-4; KATZMAN M, 1995, J VIROL, V69, P5687, DOI 10.1128/JVI.69.9.5687-5696.1995; Kilzer JM, 2003, VIROLOGY, V314, P460, DOI 10.1016/S0042-6822(03)00455-0; Laboulais C, 2001, BIOPHYS J, V81, P473, DOI 10.1016/S0006-3495(01)75715-3; LEAVITT AD, 1992, J VIROL, V66, P2359, DOI 10.1128/JVI.66.4.2359-2368.1992; Lee I, 2001, J MOL BIOL, V314, P433, DOI 10.1006/jmbi.2001.5177; Leh H, 2000, BIOCHEMISTRY-US, V39, P9285, DOI 10.1021/bi000398b; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Lewinski MK, 2005, ADV GENET, V55, P147, DOI 10.1016/S0065-2660(05)55005-3; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li M, 2005, J BIOL CHEM, V280, P29334, DOI 10.1074/jbc.M505367200; Miles LR, 2005, J VIROL, V79, P6859, DOI 10.1128/JVI.79.11.6859-6867.2005; Neugebauerova S, 2000, J BIOMOL STRUCT DYN, V18, P73, DOI 10.1080/07391102.2000.10506648; OLSEN JC, 1990, J VIROL, V64, P5475, DOI 10.1128/JVI.64.11.5475-5484.1990; Serhan F, 2004, J VIROL, V78, P6190, DOI 10.1128/JVI.78.12.6190-6199.2004; Sinha S, 2005, J VIROL, V79, P8208, DOI 10.1128/JVI.79.13.8208-8216.2005; Skinner LM, 2001, J BIOL CHEM, V276, P114, DOI 10.1074/jbc.M007032200; Smolov M, 2006, FEBS J, V273, P1137, DOI 10.1111/j.1742-4658.2006.05139.x; Svarovskaia ES, 2004, J VIROL, V78, P3210, DOI 10.1128/JVI.78.7.3210-3222.2004; VINK C, 1991, J VIROL, V65, P4636, DOI 10.1128/JVI.65.9.4636-4644.1991; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005	35	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2007	2	7							e608	10.1371/journal.pone.0000608	http://dx.doi.org/10.1371/journal.pone.0000608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GH	17622353	Green Submitted, Green Published, gold			2022-12-27	WOS:000207452000015
J	Shang, EH; Zhdanova, IV				Shang, Eva H.; Zhdanova, Irina V.			The Circadian System Is a Target and Modulator of Prenatal Cocaine Effects	PLOS ONE			English	Article							TRANSGENIC ZEBRAFISH; GENE-EXPRESSION; CLOCK; MELATONIN; NEURONS; CHILDREN	Background. Prenatal exposure to cocaine can be deleterious to embryonic brain development, but the results in humans remain controversial, the mechanisms involved are not well understood and effective therapies are yet to be designed. We hypothesize that some of the prenatal effects of cocaine might be related to dysregulation of physiological rhythms due to alterations in the integrating circadian clock function. Methodology and Principle Findings. Here we introduce a new high-throughput genetically well-characterized diurnal vertebrate model for studying the mechanisms of prenatal cocaine effects by demonstrating reduced viability and alterations in the pattern of neuronal development following repeated cocaine exposure in zebrafish embryos. This effect is associated with acute cocaine-induced changes in the expression of genes affecting growth (growth hormone, zGH) and neurotransmission (dopamine transporter, zDAT). Analysis of circadian gene expression, using quantitative real-time RT-PCR (QPCR), demonstrates that cocaine acutely and dose-dependently changes the expression of the circadian genes (zPer-3, zBmal-1) and genes encoding melatonin receptors (zMelR) that mediate the circadian message to the entire organism. Moreover, the effects of prenatal cocaine depend on the time of treatment, being more robust during the day, independent of whether the embryos are raised under the light-dark cycle or in constant light. The latter suggests involvement of the inherited circadian factors. The principal circadian hormone, melatonin, counteracts the effects of cocaine on neuronal development and gene expression, acting via specific melatonin receptors. Conclusions/Significance. These findings demonstrate that, in a diurnal vertebrate, prenatal cocaine can acutely dysregulate the expression of circadian genes and those affecting melatonin signaling, growth and neurotransmission, while repeated cocaine exposure can alter neuronal development. Daily variation in these effects of cocaine and their attenuation by melatonin suggest a potential prophylactic or therapeutic role for circadian factors in prenatal cocaine exposure.	[Shang, Eva H.; Zhdanova, Irina V.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA	Boston University	Zhdanova, IV (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA.	zhdanova@bu.edu		Zhdanova, Irina/0000-0002-8401-9571	National Institutes of Health [DA 1541801, MH 065528]; NIDA [DA-4-7733]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health grants, DA 1541801 and MH 065528, and NIDA contract DA-4-7733.	Andretic R, 1999, SCIENCE, V285, P1066, DOI 10.1126/science.285.5430.1066; Baas PW, 1997, CURR OPIN CELL BIOL, V9, P29, DOI 10.1016/S0955-0674(97)80148-2; Behnke M, 2006, J PEDIATR PSYCHOL, V31, P41, DOI 10.1093/jpepsy/jsj027; Cahill GM, 2002, CELL TISSUE RES, V309, P27, DOI 10.1007/s00441-002-0570-7; Danilova N, 2004, FASEB J, V18, P751, DOI 10.1096/fj.03-0544fje; Davis FC, 1997, J BIOL RHYTHM, V12, P498, DOI 10.1177/074873049701200603; Debruyne J, 2004, J NEUROGENET, V18, P403, DOI 10.1080/01677060490894540; Dekens MPS, 2003, CURR BIOL, V13, P2051, DOI 10.1016/j.cub.2003.10.022; Delaunay F, 2000, SCIENCE, V289, P297, DOI 10.1126/science.289.5477.297; DeLucia R, 1997, BRAZ J MED BIOL RES, V30, P637, DOI 10.1590/S0100-879X1997000500011; Dempsey DA, 1998, J ANAL TOXICOL, V22, P220, DOI 10.1093/jat/22.3.220; Friedman E, 1996, NEUROSCIENCE, V70, P739, DOI 10.1016/S0306-4522(96)83011-9; Gloster A, 1999, J COMP NEUROL, V405, P45, DOI 10.1002/(SICI)1096-9861(19990301)405:1<45::AID-CNE4>3.0.CO;2-M; GLOSTER A, 1994, J NEUROSCI, V14, P7319; Goldman D, 2001, TRANSGENIC RES, V10, P21, DOI 10.1023/A:1008998832552; Gulati-Leekha A, 2006, DEV BIOL, V296, P29, DOI 10.1016/j.ydbio.2006.03.024; Guo S, 1999, NEURON, V24, P555, DOI 10.1016/S0896-6273(00)81112-5; Holzschuh J, 2001, MECH DEVELOP, V101, P237, DOI 10.1016/S0925-4773(01)00287-8; Hurd MW, 2002, J BIOL RHYTHM, V17, P307, DOI 10.1177/074873002129002618; Hurt H, 2005, NEUROTOXICOL TERATOL, V27, P203, DOI 10.1016/j.ntt.2004.10.006; Kaneko M, 2005, PLOS BIOL, V3, P313, DOI 10.1371/journal.pbio.0030034; Kennaway DJ, 2004, FRONT BIOSCI, V9, P56, DOI 10.2741/1200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lin SN, 2001, J ANAL TOXICOL, V25, P497, DOI 10.1093/jat/25.7.497; Manev H, 2006, TRENDS PHARMACOL SCI, V27, P186, DOI 10.1016/j.tips.2006.02.003; McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102; Mendelson JH, 1999, NEUROPSYCHOPHARMACOL, V21, P294, DOI 10.1016/S0893-133X(99)00020-2; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Miller-Loncar C, 2005, NEUROTOXICOL TERATOL, V27, P213, DOI 10.1016/j.ntt.2004.10.007; NASSOGNE MC, 1995, P NATL ACAD SCI USA, V92, P11029, DOI 10.1073/pnas.92.24.11029; Niyomchai T, 2006, BRAIN RES BULL, V68, P310, DOI 10.1016/j.brainresbull.2005.09.001; REPPERT SM, 1995, NEURON, V15, P1003, DOI 10.1016/0896-6273(95)90090-X; *SAMHSA OFF APPL S, 2003, RES 2002 NAT SURV DR; Smale L, 2003, J BIOL RHYTHM, V18, P356, DOI 10.1177/0748730403256651; Thompson AM, 2005, NEUROPHARMACOLOGY, V49, P185, DOI 10.1016/j.neuropharm.2005.03.005; Vuilleumier R, 2006, ENDOCRINOLOGY, V147, P2273, DOI 10.1210/en.2005-1565; Zhdanova IV, 2005, SLEEP MED REV, V9, P51, DOI 10.1016/j.smrv.2004.04.003; Ziv L, 2005, J NEUROENDOCRINOL, V17, P314, DOI 10.1111/j.1365-2826.2005.01315.x	38	25	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2007	2	7							e587	10.1371/journal.pone.0000587	http://dx.doi.org/10.1371/journal.pone.0000587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GH	17622340	Green Published, gold, Green Submitted			2022-12-27	WOS:000207452000002
J	Carlson, J; Kadie, C; Mallal, S; Heckerman, D				Carlson, Jonathan; Kadie, Carl; Mallal, Simon; Heckerman, David			Leveraging Hierarchical Population Structure in Discrete Association Studies	PLOS ONE			English	Article								Population structure can confound the identification of correlations in biological data. Such confounding has been recognized in multiple biological disciplines, resulting in a disparate collection of proposed solutions. We examine several methods that correct for confounding on discrete data with hierarchical population structure and identify two distinct confounding processes, which we call coevolution and conditional influence. We describe these processes in terms of generative models and show that these generative models can be used to correct for the confounding effects. Finally, we apply the models to three applications: identification of escape mutations in HIV-1 in response to specific HLA-mediated immune pressure, prediction of coevolving residues in an HIV-1 peptide, and a search for genotypes that are associated with bacterial resistance traits in Arabidopsis thaliana. We show that coevolution is a better description of confounding in some applications and conditional influence is better in others. That is, we show that no single method is best for addressing all forms of confounding. Analysis tools based on these models are available on the internet as both web based applications and downloadable source code at http://atom.research.microsoft.com/bio/phylod.aspx.	[Carlson, Jonathan; Heckerman, David] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Carlson, Jonathan; Kadie, Carl] Microsoft Res, Machine Learning & Appl Stat Grp, Redmond, WA USA; [Mallal, Simon] Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA, Australia	University of Washington; University of Washington Seattle; Microsoft; Royal Perth Hospital; University of Western Australia	Heckerman, D (corresponding author), Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA.	heckerma@microsoft.com	Mallal, Simon Alexander/HDM-9561-2022	Mallal, Simon Alexander/0000-0002-7036-1309	Microsoft Research	Microsoft Research(Microsoft)	This work was funded by Microsoft Research. Microsoft Research had no role in any other aspect of this work.	Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Auranen M, 2003, MOL PSYCHIATR, V8, P879, DOI 10.1038/sj.mp.4001299; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BHATTACHARYA T, SCIENCE IN PRESS; Bruno WJ, 1996, MOL BIOL EVOL, V13, P1368, DOI 10.1093/oxfordjournals.molbev.a025583; Buck MJ, 2005, MOL BIOL EVOL, V22, P1627, DOI 10.1093/molbev/msi157; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; CONAWAY MR, 1990, BIOMETRICS, V46, P317, DOI 10.2307/2531437; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Evans DM, 2006, TRENDS GENET, V22, P350, DOI 10.1016/j.tig.2006.05.001; FELSENSTEIN, 1985, AM NATURALIST, V125; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Felsenstein J., 2004, INFERRING PHYLOGENIE; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Fossen T, 2005, J BIOL CHEM, V280, P42515, DOI 10.1074/jbc.M507375200; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Heckerman D, 1998, NATO ADV SCI I D-BEH, V89, P301; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; KENNEDY BW, 1992, J ANIM SCI, V70, P2000, DOI 10.2527/1992.7072000x; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Larson SM, 2000, J MOL BIOL, V303, P433, DOI 10.1006/jmbi.2000.4146; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; MADDISON DR, 1990, THESIS HARVARD U CAM; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Noivirt O, 2005, PROTEIN ENG DES SEL, V18, P247, DOI 10.1093/protein/gzi029; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pollock DD, 1997, PROTEIN ENG, V10, P647, DOI 10.1093/protein/10.6.647; Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601; Press W. H., 1992, ART SCI COMPUTING; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Ridley M., 1983, EXPLANATION ORGANIC; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Setakis E, 2006, GENOME RES, V16, P290, DOI 10.1101/gr.4346306; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; TAYLOR WR, 1994, PROTEIN ENG, V7, P341, DOI 10.1093/protein/7.3.341; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Voight BF, 2005, PLOS GENET, V1, P302, DOI 10.1371/journal.pgen.0010032; Wollenberg KR, 2000, P NATL ACAD SCI USA, V97, P3288, DOI 10.1073/pnas.070154797; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	55	30	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2007	2	7							e591	10.1371/journal.pone.0000591	http://dx.doi.org/10.1371/journal.pone.0000591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GG	17611623	gold, Green Published			2022-12-27	WOS:000207451900008
J	Ghosh, JG; Houck, SA; Clark, JI				Ghosh, Joy G.; Houck, Scott A.; Clark, John I.			Interactive Domains in the Molecular Chaperone Human alpha B Crystallin Modulate Microtubule Assembly and Disassembly	PLOS ONE			English	Article								Background. Small heat shock proteins regulate microtubule assembly during cell proliferation and in response to stress through interactions that are poorly understood. Methodology. Novel functions for five interactive sequences in the small heat shock protein and molecular chaperone, human alpha B crystallin, were investigated in the assembly/disassembly of microtubules and aggregation of tubulin using synthetic peptides and mutants of human alpha B crystallin. Principal Findings. The interactive sequence 113FISREFHR120 exposed on the surface of alpha B crystallin decreased microtubule assembly by similar to 45%. In contrast, the interactive sequences, (131)LTITSSLSSDGV(142) and 156ERTIPITRE164, corresponding to the beta 8 strand and the C-terminal extension respectively, which are involved in complex formation, increased microtubule assembly by similar to 34-45%. The alpha B crystallin peptides, 113FISREFHR120 and 156ERTIPITRE164, inhibited microtubule disassembly by similar to 26-36%, and the peptides 113FISREFHR120 and (131)LTITSSLSSDGV(142) decreased the thermal aggregation of tubulin by similar to 42-44%. The (131)LTITSSLSSDGV(142) and 156ERTIPITRE164 peptides were more effective than the widely used anti-cancer drug, Paclitaxel, in modulating tubulin <-> microtubule dynamics. Mutagenesis of these interactive sequences in wt human alpha B crystallin confirmed the effects of the alpha B crystallin peptides on microtubule assembly/disassembly and tubulin aggregation. The regulation of microtubule assembly by alpha B crystallin varied over a narrow range of concentrations. The assembly of microtubules was maximal at alpha B crystallin to tubulin molar ratios between 1:4 and 2:1, while molar ratios >2:1 inhibited microtubule assembly. Conclusions and Significance. Interactive sequences on the surface of human alpha B crystallin collectively modulate microtubule assembly through a dynamic subunit exchange mechanism that depends on the concentration and ratio of alpha B crystallin to tubulin. These are the first experimental results in support of the functional importance of the dynamic subunit model of small heat shock proteins.	[Ghosh, Joy G.; Houck, Scott A.; Clark, John I.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Clark, John I.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Clark, JI (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	clarkji@u.washington.edu			NEI NIH HHS [NEI EY04542, R01 EY004542] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY004542] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arai H, 1997, CELL STRUCT FUNCT, V22, P539, DOI 10.1247/csf.22.539; Atomi Y, 2001, Biol Sci Space, V15, P206; Attard G, 2006, PATHOL BIOL, V54, P72, DOI 10.1016/j.patbio.2005.03.003; BAI R, 1990, BIOCHEM PHARMACOL, V39, P1941, DOI 10.1016/0006-2952(90)90613-P; Bauer NG, 2006, J MOL NEUROSCI, V29, P153, DOI 10.1385/JMN:29:2:153; BENNARDINI F, 1992, CIRC RES, V71, P288, DOI 10.1161/01.RES.71.2.288; BERKOWITZ SA, 1981, J BIOL CHEM, V256, P1216; BONNE D, 1985, J BIOL CHEM, V260, P2819; Clavarezza M, 2006, ANN ONCOL, V17, pVII22, DOI 10.1093/annonc/mdl944; Day RM, 2003, CELL STRESS CHAPERON, V8, P183, DOI 10.1379/1466-1268(2003)008<0183:ASHCPF>2.0.CO;2; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; Djabali K, 1999, EXP CELL RES, V253, P649, DOI 10.1006/excr.1999.4679; Fujita Y, 2004, J CELL SCI, V117, P1719, DOI 10.1242/jcs.01021; Ghosh JG, 2005, PROTEIN SCI, V14, P684, DOI 10.1110/ps.041152805; Ghosh JG, 2005, BIOCHEMISTRY-US, V44, P14854, DOI 10.1021/bi0503910; GHOSH JG, 2007, BIOCHEMISTRY; Ghosh JG, 2006, BIOCHEMISTRY-US, V45, P13847, DOI 10.1021/bi061471m; Ghosh JG, 2006, CELL STRESS CHAPERON, V11, P187, DOI 10.1379/CSC-186.1; Ghosh JG, 2006, BIOCHEMISTRY-US, V45, P9878, DOI 10.1021/bi060970k; Gopalakrishnan S., 1993, Transactions of the Kansas Academy of Science, V96, P7, DOI 10.2307/3628308; Gruvberger-Saal SK, 2006, J CLIN INVEST, V116, P30, DOI 10.1172/JCI27462; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; Hardy J, 2003, J MOL NEUROSCI, V20, P203, DOI 10.1385/JMN:20:2:203; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hardy John, 2006, Current Alzheimer Research, V3, P71, DOI 10.2174/156720506775697098; Head MW, 2000, NEUROREPORT, V11, P361, DOI 10.1097/00001756-200002070-00028; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Jordan A, 1998, MED RES REV, V18, P259, DOI 10.1002/(SICI)1098-1128(199807)18:4<259::AID-MED3>3.3.CO;2-T; Kato K, 1996, J BIOL CHEM, V271, P26989, DOI 10.1074/jbc.271.43.26989; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; LAUDANSKI K, 2006, ARCH IMMUNOL THER EX; LAUNAY N, 2006, EXP CELL RES; Liang JJ, 2006, PROTEIN SCI, V15, P1619, DOI 10.1110/ps.062216006; Liang P, 1997, J CELL SCI, V110, P1431; LIESKA N, 1980, BIOCHIM BIOPHYS ACTA, V626, P136, DOI 10.1016/0005-2795(80)90205-6; Liu LY, 2006, ANAL BIOCHEM, V350, P186, DOI 10.1016/j.ab.2005.12.019; Maglara AA, 2003, J PHYSIOL-LONDON, V548, P837, DOI 10.1113/jphysiol.2002.034520; Mao JJ, 2001, NEUROPATH APPL NEURO, V27, P180, DOI 10.1046/j.1365-2990.2001.00310.x; Minami M, 2003, ACTA NEUROPATHOL, V105, P549, DOI 10.1007/s00401-003-0679-0; MITRA G, 2007, PROTEINS; Montero A, 2005, LANCET ONCOL, V6, P229, DOI 10.1016/S1470-2045(05)70094-2; Muchowski PJ, 1999, INVEST OPHTH VIS SCI, V40, P951; Muchowski PJ, 1999, J MOL BIOL, V289, P397, DOI 10.1006/jmbi.1999.2759; Pasta SY, 2004, MOL VIS, V10, P655; Prescott AR, 1996, OPHTHALMIC RES, V28, P58, DOI 10.1159/000267946; Quinlan Roy, 2002, Prog Mol Subcell Biol, V28, P219; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P155, DOI 10.1007/BF00296185; SAKURAI T, 2005, FASEB J; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; SHINOHARA H, 1993, J NEUROL SCI, V119, P203, DOI 10.1016/0022-510X(93)90135-L; Simmons TL, 2005, MOL CANCER THER, V4, P333; Studer S, 2000, J BIOL CHEM, V275, P37212, DOI 10.1074/jbc.M004701200; THOMPSON WC, 1981, CELL MOTIL CYTOSKEL, V1, P445, DOI 10.1002/cm.970010405; TOMOKANE N, 1991, AM J PATHOL, V138, P875; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; WANG J, 2007, NEUROBIOL AGING; Wang XJ, 2003, CIRC RES, V93, P998, DOI 10.1161/01.RES.0000102401.77712.ED; Wilhelmus MMM, 2006, NEUROPATH APPL NEURO, V32, P119, DOI 10.1111/j.1365-2990.2006.00689.x; Wisniewski T, 1998, NEUROCHEM RES, V23, P385, DOI 10.1023/A:1022465702518; Xi JH, 2006, FASEB J, V20, P846, DOI 10.1096/fj.05-5532com	61	58	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2007	2	6							e498	10.1371/journal.pone.0000498	http://dx.doi.org/10.1371/journal.pone.0000498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10GC	17551579	Green Submitted, gold, Green Published			2022-12-27	WOS:000207451500008
J	Melov, S; Tarnopolsky, MA; Beckman, K; Felkey, K; Hubbard, A				Melov, Simon; Tarnopolsky, Mark A.; Beckman, Kenneth; Felkey, Krysta; Hubbard, Alan			Resistance Exercise Reverses Aging in Human Skeletal Muscle	PLOS ONE			English	Article								Human aging is associated with skeletal muscle atrophy and functional impairment (sarcopenia). Multiple lines of evidence suggest that mitochondrial dysfunction is a major contributor to sarcopenia. We evaluated whether healthy aging was associated with a transcriptional profile reflecting mitochondrial impairment and whether resistance exercise could reverse this signature to that approximating a younger physiological age. Skeletal muscle biopsies from healthy older (N=25) and younger (N=26) adult men and women were compared using gene expression profiling, and a subset of these were related to measurements of muscle strength. 14 of the older adults had muscle samples taken before and after a six-month resistance exercise-training program. Before exercise training, older adults were 59% weaker than younger, but after six months of training in older adults, strength improved significantly (P<0.001) such that they were only 38% lower than young adults. As a consequence of age, we found 596 genes differentially expressed using a false discovery rate cut-off of 5%. Prior to the exercise training, the transcriptome profile showed a dramatic enrichment of genes associated with mitochondrial function with age. However, following exercise training the transcriptional signature of aging was markedly reversed back to that of younger levels for most genes that were affected by both age and exercise. We conclude that healthy older adults show evidence of mitochondrial impairment and muscle weakness, but that this can be partially reversed at the phenotypic level, and substantially reversed at the transcriptome level, following six months of resistance exercise training.	[Melov, Simon; Felkey, Krysta; Hubbard, Alan] Buck Inst Age Res, Novato, CA USA; [Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat & Med, Hamilton, ON, Canada; [Beckman, Kenneth] Childrens Hosp Oakland, Res Inst, Ctr Genet, Oakland, CA 94609 USA	Buck Institute for Research on Aging; McMaster University; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Melov, S (corresponding author), Buck Inst Age Res, Novato, CA USA.	smelov@buckinstitute.org; tarnopol@mcmaster.ca	Melov, Simon/AAC-9469-2020	Melov, Simon/0000-0001-8554-2834	National Institutes of Health [AG18679, AG024385]; Nathan Shock [P30AG025708]; Ellison Medical Foundation; Canadian Institute for Health Research (CIHR) [108073]; NATIONAL INSTITUTE ON AGING [R01AG024385, R01AG018679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nathan Shock; Ellison Medical Foundation(Lawrence Ellison Foundation); Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants AG18679 (SM), AG024385 (SM), a Nathan Shock Award to the Buck Institute (P30AG025708), an Ellison Medical Foundation Senior Scholar award (SM), and a grant to MT from the Canadian Institute for Health Research (CIHR # 108073).	Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, pE790, DOI 10.1152/ajpendo.1997.273.4.E790; Bronikowski AM, 2003, PHYSIOL GENOMICS, V12, P129, DOI 10.1152/physiolgenomics.00082.2002; Brose A, 2003, J GERONTOL A-BIOL, V58, P11; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Castillo EM, 2003, AM J PREV MED, V25, P226, DOI 10.1016/S0749-3797(03)00197-1; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Colman RJ, 2005, EXP GERONTOL, V40, P573, DOI 10.1016/j.exger.2005.05.001; DePinieux G, 1996, BRIT J CLIN PHARMACO, V42, P333, DOI 10.1046/j.1365-2125.1996.04178.x; Devries MC, 2006, AM J PHYSIOL-REG I, V291, pR1120, DOI 10.1152/ajpregu.00700.2005; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843; Ferrucci L, 1999, AM J EPIDEMIOL, V149, P645, DOI 10.1093/oxfordjournals.aje.a009865; FIATARONE MA, 1990, JAMA-J AM MED ASSOC, V263, P3029, DOI 10.1001/jama.263.22.3029; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; FRONTERA WR, 1988, J APPL PHYSIOL, V64, P1038, DOI 10.1152/jappl.1988.64.3.1038; Fuss JO, 2006, PLOS BIOL, V4, P899, DOI 10.1371/journal.pbio.0040203; Giresi PG, 2005, PHYSIOL GENOMICS, V21, P253, DOI 10.1152/physiolgenomics.00249.2004; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Hacker TA, 2006, AM J PHYSIOL-HEART C, V290, pH304, DOI 10.1152/ajpheart.00290.2005; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kujoth GC, 2006, CANCER RES, V66, P7386, DOI 10.1158/0008-5472.CAN-05-4670; LAUKKANEN P, 1995, AGE AGEING, V24, P468, DOI 10.1093/ageing/24.6.468; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102; Luukinen H, 1997, J AM GERIATR SOC, V45, P1302, DOI 10.1111/j.1532-5415.1997.tb02928.x; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974; MELOV S, 1995, NUCLEIC ACIDS RES, V23, P1419, DOI 10.1093/nar/23.8.1419; MELOV S, 2004, SCI AGING KNOWLEDGE, pRE7; Melton LJ, 2000, J AM GERIATR SOC, V48, P625; OHTA S, 1987, FEBS LETT, V226, P171, DOI 10.1016/0014-5793(87)80573-2; PAFFENBARGER RS, 1994, MED SCI SPORT EXER, V26, P857; Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024; Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; RANTANEN T, 1994, AGE AGEING, V23, P132, DOI 10.1093/ageing/23.2.132; Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364; Sanchis D, 1998, FEBS LETT, V436, P415, DOI 10.1016/S0014-5793(98)01178-8; Sanz A, 2006, ANTIOXID REDOX SIGN, V8, P582, DOI 10.1089/ars.2006.8.582; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Short KR, 2005, J APPL PHYSIOL, V99, P95, DOI 10.1152/japplphysiol.00129.2005; Tarnopolsky MA, 2001, MED SCI SPORT EXER, V33, P2044, DOI 10.1097/00005768-200112000-00011; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Yasuda N, 2005, J APPL PHYSIOL, V99, P1085, DOI 10.1152/japplphysiol.00247.2005; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	54	205	209	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2007	2	5							e465	10.1371/journal.pone.0000465	http://dx.doi.org/10.1371/journal.pone.0000465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DZ	17520024	Green Published, Green Submitted, gold			2022-12-27	WOS:000207446000013
J	Moodley, Y; Bruford, MW				Moodley, Yoshan; Bruford, Michael W.			Molecular Biogeography: Towards an Integrated Framework for Conserving Pan-African Biodiversity	PLOS ONE			English	Article								Background. Biogeographic models partition ecologically similar species assemblages into discrete ecoregions. However, the history, relationship and interactions between these regions and their assemblages have rarely been explored. Methodology/Principal Findings. Here we develop a taxon-based approach that explicitly utilises molecular information to compare ecoregion history and status, which we exemplify using a continentally distributed mammalian species: the African bushbuck (Tragelaphus scriptus). We reveal unprecedented levels of genetic diversity and structure in this species and show that ecoregion biogeographic history better explains the distribution of molecular variation than phenotypic similarity or geography. We extend these data to explore ecoregion connectivity, identify core habitats and infer ecological affinities from them. Conclusions/Significance. This analysis defines 28 key biogeographic regions for sub-Saharan Africa, and provides a valuable framework for the incorporation of genetic and biogeographic information into a more widely applicable model for the conservation of continental biodiversity.	[Moodley, Yoshan; Bruford, Michael W.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales	Cardiff University	Moodley, Y (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	moodley@mpiib-berlin.mpg.de	Bruford, Michael W/D-3750-2009; Bruford, Michael/Y-7463-2019	Bruford, Michael W/0000-0001-6357-6080; Bruford, Michael/0000-0001-6357-6080; Moodley, Yoshan/0000-0003-4216-2924	National Research Foundation of the Republic of South Africa; Cardiff University	National Research Foundation of the Republic of South Africa(National Research Foundation - South Africa); Cardiff University	This work was supported by a postdoctoral fellowship from the National Research Foundation of the Republic of South Africa and by Cardiff University. Neither had a role in the preparation of the manuscript nor in the design, conduct or analysis of the study.	ALLEN GLOVER M., 1939, BULL MUS COMP ZOOLOGY, V83, P1; Allen JA., 1871, B MUS COMP ZOOL HARV, V2, P161; Anderson M.J., 2003, DISTLM FORWARD FORTR; Anderson MJ, 2004, DISTLM V 5 FORTRAN C; ANSELL WFH, MAMMALS AFRICA IDENT, V15, P1; Arctander P, 1999, MOL BIOL EVOL, V16, P1724, DOI 10.1093/oxfordjournals.molbev.a026085; ARNASON U, 1993, MOL BIOL EVOL, V10, P960; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Behrensmeyer AK, 1997, SCIENCE, V278, P1589, DOI 10.1126/science.278.5343.1589; Best GA, 1962, ROWLAND WARDS RECORD, P198; Birungi J, 2000, MOL ECOL, V9, P1997, DOI 10.1046/j.1365-294X.2000.01107.x; Bobe R, 2001, PALEOBIOLOGY, V27, P1, DOI 10.1666/0094-8373(2001)027<0001:ROABTP>2.0.CO;2; Debruyne R, 2003, CR BIOL, V326, P687, DOI 10.1016/S1631-0691(03)00158-6; Doggart N, 2006, AFR J ECOL, V44, P134, DOI 10.1111/j.1365-2028.2006.00572.x; DORST J, 1970, FIELD GUIDE LARGER M, P252; EAST R, 1999, AFRICAN ANTELOPE DAT, P116; EXCOFFIER L, 1992, GENETICS, V131, P491; Flagstad O, 2001, P ROY SOC B-BIOL SCI, V268, P667, DOI 10.1098/rspb.2000.1416; GLEASON HA, 1964, NATURAL GEOGRAPHY PL, P420; GOOD R, 1964, GEOGRAPHY FLOWERING, P518; Grubb P., 1985, P11; Haltenorth T., 1963, Handbuch der Zoologie Berlin, V8, P1; HALTENORTH T, 1980, FIELD GUIDE MAMMALS, P57; HARRIS JM, 1988, LOS ANGELES COUNTY M, V399, P1; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Fernandez MH, 2006, J HUM EVOL, V50, P595, DOI 10.1016/j.jhevol.2005.11.004; Hewitt Godfrey M., 2004, Frontiers in Zoology, V1, P1, DOI 10.1186/1742-9994-1-4; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kalb JE, 1982, NATURE, V298, P98, DOI [10.1038/298098a0, DOI 10.1038/298098A0]; Kingdon J., 1997, KINGDON FIELD GUIDE, P476; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Leake MG, 2003, LOTHAGAM DAWN HUMANI, P678; Lorenzen ED, 2006, J HERED, V97, P119, DOI 10.1093/jhered/esj012; LYDEKKER R, 1914, CATALOGUE UNGULATE M, V3, P317; Muwanika VB, 2003, HEREDITY, V91, P361, DOI 10.1038/sj.hdy.6800341; Nersting LG, 2001, MOL ECOL, V10, P711, DOI 10.1046/j.1365-294x.2001.01205.x; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; PAABO S, 1988, NATURE, V334, P387, DOI 10.1038/334387b0; PARTRIDGE TC, 1995, PALEOCLIMATE EVOLUTI, P330; Pennington RT, 2004, PHILOS T R SOC B, V359, P515, DOI 10.1098/rstb.2003.1435; Pickford M., 1990, Human Evolution, V5, P1, DOI 10.1007/BF02436472; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Reed KE, 1997, J HUM EVOL, V32, P289, DOI 10.1006/jhev.1996.0106; Roelants K, 2004, MOL PHYLOGENET EVOL, V31, P730, DOI 10.1016/j.ympev.2003.09.011; Sambrook J, 1989, MOL CLONING LABORATO, V9, P16; Simonsen BT, 1998, MOL ECOL, V7, P225, DOI 10.1046/j.1365-294x.1998.00343.x; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Udvardy M.D.F, 1975, 18 IUCN; VRBA ES, 1985, S AFR J SCI, V81, P229; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	55	79	83	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2007	2	5							e454	10.1371/journal.pone.0000454	http://dx.doi.org/10.1371/journal.pone.0000454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DZ	17520013	Green Submitted, Green Published, gold			2022-12-27	WOS:000207446000002
J	Savir, Y; Tlusty, T				Savir, Yonatan; Tlusty, Tsvi			Conformational Proofreading: The Impact of Conformational Changes on the Specificity of Molecular Recognition	PLOS ONE			English	Article								To perform recognition, molecules must locate and specifically bind their targets within a noisy biochemical environment with many look-alikes. Molecular recognition processes, especially the induced-fit mechanism, are known to involve conformational changes. This raises a basic question: Does molecular recognition gain any advantage by such conformational changes? By introducing a simple statistical-mechanics approach, we study the effect of conformation and flexibility on the quality of recognition processes. Our model relates specificity to the conformation of the participant molecules and thus suggests a possible answer: Optimal specificity is achieved when the ligand is slightly off target; that is, a conformational mismatch between the ligand and its main target improves the selectivity of the process. This indicates that deformations upon binding serve as a conformational proofreading mechanism, which may be selected for via evolution.	[Savir, Yonatan; Tlusty, Tsvi] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Tlusty, T (corresponding author), Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel.	tsvi.tlusty@weizmann.ac.il	Tlusty, Tsvi/A-9880-2008	Tlusty, Tsvi/0000-0002-9662-3725	Minerva Foundation; Center for Complexity Science	Minerva Foundation; Center for Complexity Science	This work was supported by the Minerva Foundation and the Center for Complexity Science.	Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Bar-Ziv R, 2002, P NATL ACAD SCI USA, V99, P11589, DOI 10.1073/pnas.162369099; DRAPER DE, 1995, ANNU REV BIOCHEM, V64, P593, DOI 10.1146/annurev.bi.64.070195.003113; Fersht A., 1985, ENZYME STRUCTURE MEC; FERSHT AR, 1974, PROC R SOC SER B-BIO, V187, P397, DOI 10.1098/rspb.1974.0084; Frank DE, 1997, J MOL BIOL, V267, P1186, DOI 10.1006/jmbi.1997.0920; Gakamsky DM, 2004, P NATL ACAD SCI USA, V101, P9063, DOI 10.1073/pnas.0402840101; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Hammes GG, 2002, BIOCHEMISTRY-US, V41, P8221, DOI 10.1021/bi0260839; HERSCHLAG D, 1988, BIOORG CHEM, V16, P62, DOI 10.1016/0045-2068(88)90038-7; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; James LC, 2005, P NATL ACAD SCI USA, V102, P12730, DOI 10.1073/pnas.0500909102; Jimenez R, 2003, P NATL ACAD SCI USA, V100, P92, DOI 10.1073/pnas.262411399; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; KLEANTHOUS C, 2000, PROTEIN PRTOEIN RECO; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; PAULING LINUS, 1940, SCIENCE, V92, P77, DOI 10.1126/science.92.2378.77; Post CB, 1995, BIOCHEMISTRY-US, V34, P15881, DOI 10.1021/bi00049a001; Reiss H, 1997, PHYS REV LETT, V78, P4506, DOI 10.1103/PhysRevLett.78.4506; RINI JM, 1992, SCIENCE, V255, P959, DOI 10.1126/science.1546293; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Sagi D, 2006, NUCLEIC ACIDS RES, V34, P5021, DOI 10.1093/nar/gkl586; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; TANFORD C, 1979, P NATL ACAD SCI USA, V76, P4175, DOI 10.1073/pnas.76.9.4175; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Tlusty T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.258103; Tobi D, 2005, P NATL ACAD SCI USA, V102, P18908, DOI 10.1073/pnas.0507603102; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575; WOLFENDEN R, 1974, MOL CELL BIOCHEM, V3, P207, DOI 10.1007/BF01686645	38	91	92	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2007	2	5							e468	10.1371/journal.pone.0000468	http://dx.doi.org/10.1371/journal.pone.0000468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DZ	17520027	Green Submitted, Green Published, gold			2022-12-27	WOS:000207446000016
J	von Brunn, A; Teepe, C; Simpson, JC; Pepperkok, R; Friedel, CC; Zimmer, R; Roberts, R; Baric, R; Haas, J				von Brunn, Albrecht; Teepe, Carola; Simpson, Jeremy C.; Pepperkok, Rainer; Friedel, Caroline C.; Zimmer, Ralf; Roberts, Rhonda; Baric, Ralph; Haas, Juergen			Analysis of Intraviral Protein-Protein Interactions of the SARS Coronavirus ORFeome	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; HEPATITIS-VIRUS; SUBCELLULAR-LOCALIZATION; NUCLEOCAPSID PROTEIN; MEMBRANE-PROTEIN; INTERACTION MAP; 3A PROTEIN; GENOME; RNA; IDENTIFICATION	The severe acute respiratory syndrome coronavirus (SARS-CoV) genome is predicted to encode 14 functional open reading frames, leading to the expression of up to 30 structural and non-structural protein products. The functions of a large number of viral ORFs are poorly understood or unknown. In order to gain more insight into functions and modes of action and interaction of the different proteins, we cloned the viral ORFeome and performed a genome-wide analysis for intraviral protein interactions and for intracellular localization. 900 pairwise interactions were tested by yeast-two-hybrid matrix analysis, and more than 65 positive non-redundant interactions, including six self interactions, were identified. About 38% of interactions were subsequently confirmed by CoIP in mammalian cells. Nsp2, nsp8 and ORF9b showed a wide range of interactions with other viral proteins. Nsp8 interacts with replicase proteins nsp2, nsp5, nsp6, nsp7, nsp8, nsp9, nsp12, nsp13 and nsp14, indicating a crucial role as a major player within the replication complex machinery. It was shown by others that nsp8 is essential for viral replication in vitro, whereas nsp2 is not. We show that also accessory protein ORF9b does not play a pivotal role for viral replication, as it can be deleted from the virus displaying normal plaque sizes and growth characteristics in Vero cells. However, it can be expected to be important for the virus-host interplay and for pathogenicity, due to its large number of interactions, by enhancing the global stability of the SARS proteome network, or play some unrealized role in regulating protein-protein interactions. The interactions identified provide valuable material for future studies.	[von Brunn, Albrecht; Teepe, Carola; Haas, Juergen] Univ Munich, Genzentrum, Max Von Pettenkofer Inst, Lehrstuhl Virol, Munich, Germany; [Friedel, Caroline C.; Zimmer, Ralf] Univ Munich, Inst Informat, D-8000 Munich, Germany; [Simpson, Jeremy C.; Pepperkok, Rainer] European Mol Biol Lab, Heidelberg, Germany; [Roberts, Rhonda; Baric, Ralph] Univ N Carolina, Chapel Hill, NC USA	University of Munich; University of Munich; European Molecular Biology Laboratory (EMBL); University of North Carolina; University of North Carolina Chapel Hill	von Brunn, A (corresponding author), Univ Munich, Genzentrum, Max Von Pettenkofer Inst, Lehrstuhl Virol, Marchioninistr 15, Munich, Germany.	vonbrunn@lmb.uni-muenchen.de; haas@lmb.uni-muenchen.de	Zimmer, Ralf/L-9295-2019; Friedel, Caroline/AAG-5017-2019	Friedel, Caroline/0000-0003-3569-4877; Pepperkok, Rainer/0000-0002-9762-3583; Simpson, Jeremy/0000-0002-7956-7805	LMU Munchen; Bayerisches Staatsministerum fur Wissenschaft, Forschung und Kunst; National Institute of Health [AI059136, AI059443]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059136, P01AI059443] Funding Source: NIH RePORTER; Medical Research Council [G0501453] Funding Source: researchfish; MRC [G0501453] Funding Source: UKRI	LMU Munchen; Bayerisches Staatsministerum fur Wissenschaft, Forschung und Kunst; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the LMU Munchen (FoeFoLe Predoctoral Program to C.T.) and in part by a grant provided by the Bayerisches Staatsministerum fur Wissenschaft, Forschung und Kunst. The work was also supported in part by a grant from the National Institute of Health AI059136 and AI059443 to RSB.	Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Bartlam M, 2005, CURR OPIN STRUC BIOL, V15, P664, DOI 10.1016/j.sbi.2005.10.004; Bhardwaj K, 2006, J MOL BIOL, V361, P243, DOI 10.1016/j.jmb.2006.06.021; Bost AG, 2000, J VIROL, V74, P3379, DOI 10.1128/JVI.74.7.3379-3387.2000; Brockway SM, 2003, J VIROL, V77, P10515, DOI 10.1128/JVI.77.19.10515-10527.2003; Chan WS, 2005, MODERN PATHOL, V18, P1432, DOI 10.1038/modpathol.3800439; Choi IR, 2000, VIROLOGY, V267, P185, DOI 10.1006/viro.1999.0117; Chow SCS, 2006, J CLIN PATHOL, V59, P468, DOI 10.1136/jcp.2005.029868; Cuconati A, 1998, J VIROL, V72, P1297, DOI 10.1128/JVI.72.2.1297-1307.1998; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Fang XN, 2005, J BIOCHEM MOL BIOL, V38, P381; Flajolet M, 2000, GENE, V242, P369, DOI 10.1016/S0378-1119(99)00511-9; Gorbalenya AE, 2004, J VIROL, V78, P7863, DOI 10.1128/JVI.78.15.7863-7866.2004; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4847, DOI 10.1093/nar/17.12.4847; Graham RL, 2005, J VIROL, V79, P13399, DOI 10.1128/JVI.79.21.13399-13411.2005; Guo DY, 2001, J GEN VIROL, V82, P935, DOI 10.1099/0022-1317-82-4-935; Harcourt BH, 2004, J VIROL, V78, P13600, DOI 10.1128/JVI.78.24.13600-13612.2004; He RT, 2004, VIRUS RES, V105, P121, DOI 10.1016/j.virusres.2004.05.002; Huang C, 2006, J VIROL, V80, P210, DOI 10.1128/JVI.80.1.210-217.2006; Huang C, 2006, J VIROL, V80, P7287, DOI 10.1128/JVI.00414-06; Imbert I, 2006, EMBO J, V25, P4933, DOI 10.1038/sj.emboj.7601368; Ito N, 2005, J VIROL, V79, P3182, DOI 10.1128/JVI.79.5.3182-3186.2005; Ivanov KA, 2004, P NATL ACAD SCI USA, V101, P12694, DOI 10.1073/pnas.0403127101; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lehner B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r63; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Meier C, 2006, STRUCTURE, V14, P1157, DOI 10.1016/j.str.2006.05.012; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Prentice E, 2004, J VIROL, V78, P9977, DOI 10.1128/JVI.78.18.9977-9986.2004; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Seybert A, 2000, RNA, V6, P1056, DOI 10.1017/S1355838200000728; Shen S, 2005, BIOCHEM BIOPH RES CO, V330, P286, DOI 10.1016/j.bbrc.2005.02.153; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sutton G, 2004, STRUCTURE, V12, P341, DOI 10.1016/j.str.2004.01.016; Tan YJ, 2006, ANTIVIR RES, V72, P78, DOI 10.1016/j.antiviral.2006.05.010; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yount B, 2005, J VIROL, V79, P14909, DOI 10.1128/JVI.79.23.14909-14922.2005; Yuan XL, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-66; Yuan XL, 2005, VIRUS RES, V109, P191, DOI 10.1016/j.virusres.2005.01.001; Zhai YJ, 2005, NAT STRUCT MOL BIOL, V12, P980, DOI 10.1038/nsmb999; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853	48	167	171	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2007	2	5							e459	10.1371/journal.pone.0000459	http://dx.doi.org/10.1371/journal.pone.0000459			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DZ	17520018	gold, Green Published, Green Submitted			2022-12-27	WOS:000207446000007
J	Diaz-Uriarte, R; Rueda, OM				Diaz-Uriarte, Ramon; Rueda, Oscar M.			ADaCGH: A Parallelized Web-Based Application and R Package for the Analysis of aCGH Data	PLOS ONE			English	Article								Background. Copy number alterations (CNAs) in genomic DNA have been associated with complex human diseases, including cancer. One of the most common techniques to detect CNAs is array-based comparative genomic hybridization (aCGH). The availability of aCGH platforms and the need for identification of CNAs has resulted in a wealth of methodological studies. Methodology/Principal Findings. ADaCGH is an R package and a web-based application for the analysis of aCGH data. It implements eight methods for detection of CNAs, gains and losses of genomic DNA, including all of the best performing ones from two recent reviews (CBS, GLAD, CGHseg, HMM). For improved speed, we use parallel computing (via MPI). Additional information (GO terms, PubMed citations, KEGG and Reactome pathways) is available for individual genes, and for sets of genes with altered copy numbers. Conclusions/Significance. ADaCGH represents a qualitative increase in the standards of these types of applications: a) all of the best performing algorithms are included, not just one or two; b) we do not limit ourselves to providing a thin layer of CGI on top of existing BioConductor packages, but instead carefully use parallelization, examining different schemes, and are able to achieve significant decreases in user waiting time (factors up to 45x); c) we have added functionality not currently available in some methods, to adapt to recent recommendations (e. g., merging of segmentation results in wavelet-based and CGHseg algorithms); d) we incorporate redundancy, fault-tolerance and checkpointing, which are unique among web-based, parallelized applications; e) all of the code is available under open source licenses, allowing to build upon, copy, and adapt our code for other software projects.	[Diaz-Uriarte, Ramon; Rueda, Oscar M.] Spanish Natl Canc Ctr, Struct Biol & Biocomp Programme, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Diaz-Uriarte, R (corresponding author), Spanish Natl Canc Ctr, Struct Biol & Biocomp Programme, Madrid, Spain.	rdiaz02@gmail.com	Rueda, Oscar/ABF-5479-2020; Diaz-Uriarte, Ramon/M-5517-2013	Rueda, Oscar/0000-0003-0008-4884; Diaz-Uriarte, Ramon/0000-0002-6637-9039	Fundacion de Investigacion Medica Mutua Madrilena; Spanish Ministry of Education and Science (MEC) [TIC2003-09331-C02-02]	Fundacion de Investigacion Medica Mutua Madrilena; Spanish Ministry of Education and Science (MEC)(Spanish Government)	Funding provided by Fundacion de Investigacion Medica Mutua Madrilena and Project TIC2003-09331-C02-02 of the Spanish Ministry of Education and Science (MEC). The funders had no role in design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript. Funding used for salaries and equipment.	Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Alibes A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-9; ANDERSON B, 2006, BMC GENOMICS, V7; BAXTER SM, 2006, PLOS COMPUTATIONAL B, V2; CHARI R, 2006, CANC INFORM, V2; CHEN W, 2005, BMC BIOINFORMATICS, V6; CONDE L, 2007, NUCL ACIDS IN PRESS; Diaz-Uriarte R, 2005, DATA ANALYSIS AND VISUALIZATION IN GENOMICS AND PROTEOMICS, P193, DOI 10.1002/0470094419.ch12; Dongarra J., 2007, CT WATCH QUAT, V3, P1; Dudoit S, 2003, BIOTECHNIQUES, P45; Fogel Karl, 2005, PRODUCING OPEN SOURC; Forozan F, 2000, CANCER RES, V60, P4519; Foster I, 1995, DESIGNING BUILDING P; Fridlyand J, 2004, J MULTIVARIATE ANAL, V90, P132, DOI 10.1016/j.jmva.2004.02.008; Graham P., 2004, HACKERS PAINTERS; Heiskanen MA, 2000, CANCER RES, V60, P799; Holzmann K, 2004, CANCER RES, V64, P4428, DOI 10.1158/0008-5472.CAN-04-0431; Hsu L, 2005, BIOSTATISTICS, V6, P211, DOI 10.1093/biostatistics/kxi004; HUANG J, 2006, BMC BIOINFORMATICS, V7; Huang Jing, 2004, Human Genomics, V1, P287; Hughes C., 2003, PARALLEL DISTRIBUTED; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; KONTOGHIORGHES EJ, 2006, HDB PARALLEL COMPUTI; Lai WR, 2005, BIOINFORMATICS, V21, P3763, DOI 10.1093/bioinformatics/bti611; Lai YL, 2005, COMPUT BIOL CHEM, V29, P47, DOI 10.1016/j.compbiolchem.2004.12.004; Lingjaerde OC, 2005, BIOINFORMATICS, V21, P821, DOI 10.1093/bioinformatics/bti113; LIVA S, 2006, NUCL ACIDS RES, V34; Lockwood WW, 2006, EUR J HUM GENET, V14, P139, DOI 10.1038/sj.ejhg.5201531; Marioni JC, 2006, BIOINFORMATICS, V22, P1144, DOI 10.1093/bioinformatics/btl089; Menten B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-124; Misra A, 2005, CLIN CANCER RES, V11, P2907, DOI 10.1158/1078-0432.CCR-04-0708; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pacheco Peter., 1997, PARALLEL PROGRAMMING; Picard F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-27; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Price TS, 2005, NUCLEIC ACIDS RES, V33, P3455, DOI 10.1093/nar/gki643; RUEDA OM, 2007, FLEXIBLE AC IN PRESS; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sutter H, 2005, DR DOBBS J, V30, P16; Turek D., 2007, CTWATCH Q, V3, P31; Urban AE, 2006, P NATL ACAD SCI USA, V103, P4534, DOI 10.1073/pnas.0511340103; Van-Roy P., 2004, CONCEPTS TECHNIQUES; Waldo J, 1997, LECT NOTES COMPUT SC, V1222, P49; Willenbrock H, 2005, BIOINFORMATICS, V21, P4084, DOI 10.1093/bioinformatics/bti677; Ylstra B, 2006, NUCLEIC ACIDS RES, V34, P445, DOI 10.1093/nar/gkj456; Yu TW, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-145; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	49	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e737	10.1371/journal.pone.0000737	http://dx.doi.org/10.1371/journal.pone.0000737			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710137	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455200014
J	Freitas, R; Zhang, GJ; Cohn, MJ				Freitas, Renata; Zhang, GuangJun; Cohn, Martin J.			Biphasic Hoxd Gene Expression in Shark Paired Fins Reveals an Ancient Origin of the Distal Limb Domain	PLOS ONE			English	Article							APICAL ECTODERMAL RIDGE; CONTROL REGION DEFINES; PECTORAL FIN; HOMEOBOX GENES; POLARIZING ACTIVITY; DEVONIAN TETRAPOD; PATTERN-FORMATION; VERTEBRATE; EVOLUTION; ZEBRAFISH	The evolutionary transition of fins to limbs involved development of a new suite of distal skeletal structures, the digits. During tetrapod limb development, genes at the 59 end of the HoxD cluster are expressed in two spatiotemporally distinct phases. In the first phase, Hoxd9-13 are activated sequentially and form nested domains along the anteroposterior axis of the limb. This initial phase patterns the limb from its proximal limit to the middle of the forearm. Later in development, a second wave of transcription results in 59 HoxD gene expression along the distal end of the limb bud, which regulates formation of digits. Studies of zebrafish fins showed that the second phase of Hox expression does not occur, leading to the idea that the origin of digits was driven by addition of the distal Hox expression domain in the earliest tetrapods. Here we test this hypothesis by investigating Hoxd gene expression during paired fin development in the shark Scyliorhinus canicula, a member of the most basal lineage of jawed vertebrates. We report that at early stages, 5' Hoxd genes are expressed in anteroposteriorly nested patterns, consistent with the initial wave of Hoxd transcription in teleost and tetrapod paired appendages. Unexpectedly, a second phase of expression occurs at later stages of shark fin development, in which Hoxd12 and Hoxd13 are re-expressed along the distal margin of the fin buds. This second phase is similar to that observed in tetrapod limbs. The results indicate that a second, distal phase of Hoxd gene expression is not uniquely associated with tetrapod digit development, but is more likely a plesiomorphic condition present the common ancestor of chondrichthyans and osteichthyans. We propose that a temporal extension, rather than de novo activation, of Hoxd expression in the distal part of the fin may have led to the evolution of digits.	[Freitas, Renata; Zhang, GuangJun; Cohn, Martin J.] Univ Florida, Dept Zool, Gainesville, FL 32611 USA; [Cohn, Martin J.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Cohn, MJ (corresponding author), Univ Florida, Dept Zool, Canc Genet Res Complex, Gainesville, FL 32611 USA.	cohn@zoo.ufl.edu	Freitas, Renata/I-5917-2013; Zhang, GuangJun/K-2056-2012	Freitas, Renata/0000-0002-0123-7232; Zhang, GuangJun/0000-0002-0839-5161	FCT; University of Oporto; University of Florida; National Institutes of Health (NIH) [HD054554]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054554] Funding Source: NIH RePORTER	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); University of Oporto; University of Florida(University of Florida); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	RF received support from FCT, Praxis XXI through the GABBA program of the University of Oporto and from the University of Florida. GZ received support from graduate fellowship from the University of Florida. MJC received support from the University of Florida and from National Institutes of Health (NIH) grant HD054554.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; AHLBERG PE, 1994, NATURE, V368, P507, DOI 10.1038/368507a0; AKIMENKO MA, 1995, DEV BIOL, V170, P243, DOI 10.1006/dbio.1995.1211; AKIMENKO MA, 1995, DEVELOPMENT, V121, P347; AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; BALFOUR M, 1881, P ZOOL SOC LOND, V43, P656; BALLARD WW, 1993, J EXP ZOOL, V267, P318, DOI 10.1002/jez.1402670309; Blom H, 2007, GEODIVERSITAS, V29, P119; Chimal-Monroy J, 2003, DEV BIOL, V257, P292, DOI 10.1016/S0012-1606(03)00066-6; COATES M, 1993, NATURE, V364, P195, DOI 10.1038/364195b0; COATES MI, 1994, DEVELOPMENT, P169; Coates MI, 2003, THEOR BIOSCI, V122, P266; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; Coates MI, 2002, EVOL DEV, V4, P390, DOI 10.1046/j.1525-142X.2002.02026.x; Cohn MJ, 1997, NATURE, V387, P97, DOI 10.1038/387097a0; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; Dahn RD, 2007, NATURE, V445, P311, DOI 10.1038/nature05436; Davis MC, 2007, NATURE, V447, P473, DOI 10.1038/nature05838; Davis MC, 2004, J MORPHOL, V262, P608, DOI 10.1002/jmor.10264; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; DUBOULE D, 1995, CURR OPIN GENET DEV, V5, P525, DOI 10.1016/0959-437X(95)90058-O; Freitas R, 2004, DEV GENES EVOL, V214, P466, DOI 10.1007/s00427-004-0426-0; Freitas R, 2006, NATURE, V442, P1033, DOI 10.1038/nature04984; GONZALEZ F, 2007, DEV BIOL; Grandel H, 2003, THEOR BIOSCI, V122, P288, DOI 10.1007/s12064-003-0058-3; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; Grandel H, 2000, DEVELOPMENT, V127, P4169; Haraguchi R, 2000, DEVELOPMENT, V127, P2471; IZPISUABELMONTE JC, 1992, DEV BIOL, V152, P26, DOI 10.1016/0012-1606(92)90153-8; IZPISUABELMONTE JC, 1992, EMBO J, V11, P1451, DOI 10.1002/j.1460-2075.1992.tb05189.x; KESSEL M, 1993, NATURE, V364, P197, DOI 10.1038/364197a0; Kim CB, 2000, P NATL ACAD SCI USA, V97, P1655, DOI 10.1073/pnas.030539697; Kmita M, 2005, NATURE, V435, P1113, DOI 10.1038/nature03648; Kobayashi D, 2006, DEV GROWTH DIFFER, V48, P283, DOI 10.1111/j.1440-169x.2006.00870.x; Kondo T, 1997, NATURE, V390, P29, DOI 10.1038/36234; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Mabee PM, 2004, J MORPHOL, V261, P334, DOI 10.1002/jmor.10253; Mabee PM, 2000, AM ZOOL, V40, P789, DOI 10.1668/0003-1569(2000)040[0789:DDAPSE]2.0.CO;2; Metscher BD, 1999, DEV BIOL, V210, P1, DOI 10.1006/dbio.1999.9230; Miller RF, 2003, NATURE, V425, P501, DOI 10.1038/nature02001; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; Nelson CE, 1996, DEVELOPMENT, V122, P1449; NIETO MA, 1996, METHODS AVIAN EMBRYO; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; NISWANDER L, 1993, NATURE, V361, P68, DOI 10.1038/361068a0; NOHNO T, 1991, CELL, V64, P1197, DOI 10.1016/0092-8674(91)90274-3; Perriton CL, 2002, DEV BIOL, V247, P26, DOI 10.1006/dbio.2002.0668; Prohaska SJ, 2004, J MOL EVOL, V58, P212, DOI 10.1007/s00239-003-2545-z; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; SEARLS RL, 1971, DEV BIOL, V24, P198, DOI 10.1016/0012-1606(71)90095-9; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; Sordino P, 1996, TRENDS ECOL EVOL, V11, P114, DOI 10.1016/0169-5347(96)81089-5; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Spitz F, 2003, DEV BIOL, V259, P456; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Spitz F, 2001, GENE DEV, V15, P2209, DOI 10.1101/gad.205701; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; TABIN C, 1993, NATURE, V361, P692, DOI 10.1038/361692a0; Tanaka M, 2002, NATURE, V416, P527, DOI 10.1038/416527a; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; THOROGOOD P, 1991, NATO ADV SCI I A-LIF, V205, P347; THOROGOOD P, 1993, NATURE, V364, P196, DOI 10.1038/364196a0; THOROGOOD PV, 1975, J EMBRYOL EXP MORPH, V33, P581; Torok MA, 1998, DEV BIOL, V200, P225, DOI 10.1006/dbio.1998.8956; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; vanderHoeven F, 1996, MECH DEVELOP, V54, P9, DOI 10.1016/0925-4773(95)00455-6; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; VOGEL A, 1995, DEV BIOL, V171, P507, DOI 10.1006/dbio.1995.1300; WOOD A, 1982, ANAT REC, V204, P349, DOI 10.1002/ar.1092040408; Yonei-Tamura S, 1999, DEV BIOL, V211, P133, DOI 10.1006/dbio.1999.9290; Zakany J, 1997, P NATL ACAD SCI USA, V94, P13695, DOI 10.1073/pnas.94.25.13695; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262; ZAKANY J, 2007, DEV BIOL; Zhang XG, 2004, J EVOLUTION BIOL, V17, P1162, DOI 10.1111/j.1420-9101.2004.00741.x; Zhu M, 2002, NATURE, V420, P760, DOI 10.1038/420760a	78	104	107	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2007	2	8							e754	10.1371/journal.pone.0000754	http://dx.doi.org/10.1371/journal.pone.0000754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HN	17710153	Green Published, gold, Green Submitted			2022-12-27	WOS:000207455200030
